FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Foster, LJR
   Sanguanchaipaiwong, V
   Gabelish, CL
   Hook, J
   Stenzel, M
AF Foster, LJR
   Sanguanchaipaiwong, V
   Gabelish, CL
   Hook, J
   Stenzel, M
TI A natural-synthetic hybrid copolymer of polyhydroxyoctanoate-diethylene
   glycol: biosynthesis and properties
SO POLYMER
LA English
DT Article; Proceedings Paper
CT IUPAC World Polymer Congress
CY JUL 04-09, 2004
CL Paris, FRANCE
SP IUPAC
DE polyhydroxyalkanoate; diethylene glycol; microporous films
ID END GROUP-STRUCTURE; PSEUDOMONAS-OLEOVORANS; POLY(ETHYLENE GLYCOL);
   MOLECULAR-WEIGHT; POLYESTERS; POLYMERS
AB The bacterium Pseudomonas oleovorans was utilized to produce a novel natural-synthetic hybrid block copolymer. This hybrid biomaterial consists of the natural hydrophobic polymer polyhydroxyoctanoate (PHO) end-capped with hydrophilic synthetic diethylene glycol (DEG). The addition of the synthetic component, in the form of PEG106, to the bioprocessing stage significantly affected polymer yield and properties compared to its non-hybridized counterpart. Compared to PHO polymer, the PHO-DEG hybrid possessed a significantly higher C8 component and reduced molecular mass. In contrast, thermal and crystalline properties were similar in both polymer types. While the molecular weight ratio of the natural and synthetic blocks is approximately 1000: 1, the small hydrophilic component exerted a powerful influence during polymer processing. Under conditions of high humidity, solvent cast films of the PHO-DEG hybrid self-assembled into ordered microporous arrays. Thus, a novel natural-synthetic hybrid comprized of biocompatible components has been produced. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
   Univ New S Wales, Sch Chem Engn & Ind Chem, Ctr Adv Macromol Design, Sydney, NSW 2052, Australia.
   Univ New S Wales, Nucl Magnet Resonance Facil, Sydney, NSW 2052, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
EM j.foster@unsw.edu.au
RI Hook, James/D-6805-2011; Stenzel, Martina/B-8586-2008
OI Hook, James/0000-0002-1185-7320; Stenzel, Martina/0000-0002-6433-4419
CR ALBERTSSON PA, 1986, PARTITION CELL PARTI, pCH3
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Ashby RD, 2002, APPL MICROBIOL BIOT, V60, P154, DOI 10.1007/s00253-002-1110-9
   Ashby RD, 1997, TETRAHEDRON, V53, P15209, DOI 10.1016/S0040-4020(97)00958-7
   Ashby RD, 1999, BIOTECHNOL BIOENG, V62, P106, DOI 10.1002/(SICI)1097-0290(19990105)62:1<106::AID-BIT12>3.0.CO;2-X
   AZUMA Y, 1992, POLYMER, V33, P4763, DOI 10.1016/0032-3861(92)90690-X
   Brandl H, 1990, Adv Biochem Eng Biotechnol, V41, P77
   Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0
   Doi Y., 1990, MICROBIAL POLYESTERS
   Foster LJR, 1996, INT J BIOL MACROMOL, V19, P177, DOI 10.1016/0141-8130(96)01125-7
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   FOSTER LJR, 2000, POLYM RENEWABLE RESO, pCH6
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   HOWELLS ER, 1982, CHEM IND-LONDON, P508
   Inada Y, 1990, J BIOACT COMPAT POL, V5, P343, DOI 10.1177/088391159000500309
   Kai Z, 2003, BIOCH ENG J, V16, P115
   Kim O, 2000, J POLYM RES, V7, P91, DOI 10.1007/s10965-006-0108-x
   Labarre D, 2001, TRENDS BIOMATER ARTI, V15, P1
   Lee MY, 2000, POLYMER, V41, P1703, DOI 10.1016/S0032-3861(99)00347-X
   Lemogne M., 1925, ANN I PASTEUR PARIS, V39, P144
   Nishikawa T, 1999, MAT SCI ENG C-BIO S, V8-9, P495, DOI 10.1016/S0928-4931(99)00075-2
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Shi FY, 1996, MACROMOLECULES, V29, P10, DOI 10.1021/ma950707j
   Shi FY, 1996, MACROMOLECULES, V29, P7753, DOI 10.1021/ma960805k
   STEINBUCHEL A, 1996, BIOTECHNOLOGY, P405
   Stenzel-Rosenbaum MH, 2001, MACROMOLECULES, V34, P5433, DOI 10.1021/ma0021803
   YASIN M, 1993, PLAST RUB COMPOS PRO, V19, P15
NR 29
TC 24
Z9 25
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD AUG 8
PY 2005
VL 46
IS 17
BP 6587
EP 6594
DI 10.1016/j.polymer.2005.05.012
PG 8
WC Polymer Science
SC Polymer Science
GA 953TZ
UT WOS:000231104700034
DA 2018-10-19
ER

PT J
AU Mizutani, Y
   Hattori, M
   Okuyama, M
   Kasuga, T
   Nogami, M
AF Mizutani, Y
   Hattori, M
   Okuyama, M
   Kasuga, T
   Nogami, M
TI Preparation of porous poly(L-lactic acid) composite containing
   hydroxyapatite whiskers
SO CHEMISTRY LETTERS
LA English
DT Article
ID POLYMERS; PHOSPHATE; MEMBRANE; MATRICES; SCAFFOLD; INVITRO
AB A new type of porous biomaterial for bone repair was successfully prepared using poly(L-lactic acid) short fibers of approximate to 700 mu m and hydroxyapatite whiskers (W-HAs) of 60 mu m (in average length). When W-HAs of <= 70 wt% were introduced, the composites could have about 80% porosity including numerous, interconnecting pores of > 10 mu m in diameter. W-HAs play an important role in formation of the pores, which allow penetration of nutriments and ingrowth of bone cells.
C1 NGK Spark Plug Co Ltd, R&D Ctr, Komaki 4858510, Japan.
   Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Mizutani, Y (reprint author), NGK Spark Plug Co Ltd, R&D Ctr, 2808 Iwasaki, Komaki 4858510, Japan.
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Maeda H, 2004, MATER TRANS, V45, P989, DOI 10.2320/matertrans.45.989
   Maeda H, 2002, J MATER RES, V17, P727, DOI 10.1557/JMR.2002.0104
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mizutani Y, 2005, POLYMER, V46, P3789, DOI 10.1016/j.polymer.2005.03.037
   MIZUTANI Y, 2004, PHOSPHORUS RES B, V17, P180
   MIZUTANI Y, 2003, P 3 AS BIOC, V3, P1
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   TAMAI N, 2004, JOINT SURG, V23, P100
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
NR 19
TC 2
Z9 2
U1 1
U2 4
PU CHEMICAL SOC JAPAN
PI TOKYO
PA 1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN
SN 0366-7022
EI 1348-0715
J9 CHEM LETT
JI Chem. Lett.
PD AUG 5
PY 2005
VL 34
IS 8
BP 1110
EP 1111
DI 10.1246/cl.2005.1110
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 956LT
UT WOS:000231302000020
DA 2018-10-19
ER

PT J
AU Wollensak, G
   Iomdina, E
   Dittert, DD
   Salamatina, O
   Stoltenburg, G
AF Wollensak, G
   Iomdina, E
   Dittert, DD
   Salamatina, O
   Stoltenburg, G
TI Cross-linking of scleral collagen in the rabbit using riboflavin and UVA
SO ACTA OPHTHALMOLOGICA SCANDINAVICA
LA English
DT Article
DE progressive myopia; sclera; UVA; riboflavin; collagen cross-linking;
   Young's modulus
ID FORM-DEPRIVATION MYOPIA; PROGRESSIVE MYOPIA; DAMAGE
AB Purpose: Scleral biomechanical weakness and thinning is known to be one of the main factors in the pathogenesis of progressive myopia. We tried to strengthen rabbit sclera by cross-linking scleral collagen using ultraviolet A (UVA) and the photosensitizer riboflavin.
   Methods: Circumscribed 10 x 10 mm sectors of the posterior - equatorial sclera of six chinchilla rabbit eyes were treated in vivo using a UVA double diode with 4.2 mW/cm(2) UVA at 370 nm and applying 0.1% riboflavin-5-phosphate drops as photosensitizer for 30 min. 1 day postoperatively biomechanical stress-strain measurements of three treated scleral strips were performed using a microcomputer-controlled biomaterial testing device and compared to non-treated contralateral control sclera. In addition, three treated eyes were examined histologically by light microscopy, TUNEL staining and electron microscopy to evaluate side-effects.
   Results: Following the cross-linking treatment, the ultimate stress was 11.87 +/- 1.8 MPa versus 3.63 +/- 0.40 in the controls (increase of 227.9%, p = 0.014), Young's modulus 27.67 +/- 4.16 MPa versus 4.9 +/- 2.15 MPa in the controls (increase of 464.7%, p=0.021) and ultimate strain 92.2 +/- 7.43% versus 165.63 +/- 19.09% in the controls (decrease of 54.52%, p=0.012). Histologically, serious side-effects were found in the entire posterior globe with almost complete loss of the photoreceptors, the outer nuclear layer and the retinal pigment epithelium (RPE).
   Conclusions: Our new method of scleral collagen cross-linking proved very effective in increasing the scleral mechanical strength; the new treatment may represent an option for strengthening scleral tissue in progressive myopia. However, serious side-effects were observed in the outer retina. In future studies these side-effects could be avoided by reducing the irradiation dose below the cytotoxic level of the retina. Before its clinical application, the new method should be tested in a myopia animal model.
C1 Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
   Univ Clin Carl Gustav Carus, Inst Pathol, Dresden, Germany.
   Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow, Russia.
   Charite Berlin, Inst Neuropathol, Berlin, Germany.
RP Wollensak, G (reprint author), Wildentensteig 4, DE-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
   Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   Bell G R, 1993, J Am Optom Assoc, V64, P332
   BELL GR, 1978, J AM OPTOM ASSOC, V49, P1399
   Bullimore MA, 2002, INVEST OPHTH VIS SCI, V43, P2110
   CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Gorgels GMF, 1995, INVEST OPHTH VIS SCI, V36, P851
   Iomdina E.N., 1993, P 14 C BIOM PAR INT, P616
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Liu K.R., 1986, J FORMOS MED ASSOC, V85, P1032
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3
   Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005
   Saw SM, 2002, OPHTHALMOLOGY, V109, P415, DOI 10.1016/S0161-6420(01)00972-1
   Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P2043
   Weiss AH, 2003, BRIT J OPHTHALMOL, V87, P1025, DOI 10.1136/bjo.87.8.1025
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2004, CORNEA, V23, P43, DOI 10.1097/00003226-200401000-00008
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   ZUCLICH JA, 1989, HEALTH PHYS, V56, P671, DOI 10.1097/00004032-198905000-00012
NR 25
TC 62
Z9 72
U1 1
U2 7
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1395-3907
J9 ACTA OPHTHALMOL SCAN
JI Acta Ophthalmol. Scand.
PD AUG
PY 2005
VL 83
IS 4
BP 477
EP 482
DI 10.1111/j.1600-0420.2005.00447.x
PG 6
WC Ophthalmology
SC Ophthalmology
GA 953FY
UT WOS:000231063200014
PM 16029274
OA Bronze
DA 2018-10-19
ER

PT J
AU Jin, HJ
   Park, J
   Karageorgiou, V
   Kim, UJ
   Valluzzi, R
   Kaplan, DL
AF Jin, HJ
   Park, J
   Karageorgiou, V
   Kim, UJ
   Valluzzi, R
   Kaplan, DL
TI Water-stable silk films with reduced beta-sheet content
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BOMBYX-MORI SILK; MARROW STROMAL CELL; POLY(ETHYLENE OXIDE); FIBROIN
   MEMBRANE; SOLID-STATE; IN-VITRO; BIOMATERIALS; SPECTROSCOPY; FIBERS; NMR
AB Silk fibers have outstanding mechanical properties. These fibers are insoluble in organic solvents and water, are biocompatible, and exhibit slow biodegradation in vitro and in vivo due to the hydrophobic nature of the protein and the presence of a high content of beta-sheet structure. Regenerated silk fibroin can be processed into a variety of materials normally stabilized by the induction of beta-sheet formation through the use of solvents or by physical stretching. To extend the biomaterial utility of silk proteins, options to form water-stable silk-based materials with reduced beta-sheet formation would be desirable. To address this need for more rapidly degradable silk biomaterials, we report the preparation of water-stable films from regenerated silk fibroin solutions, with reduced beta-sheet content. The keys to this process are the preparation of concentrated (8 % by weight) aqueous solutions of fibroin and a subsequent water-based annealing procedure. These new materials degrade more rapidly due to the reduced P-sheet content, as determined in vitro via enzymatic hydrolysis, yet support human adult stem-cell expansion in vitro in a similar or improved fashion to the crystallized proteins in film form. These new silk-based materials extend the range of biomaterial properties that can be generated from this unique family of proteins.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
   Inha Univ, Dept Polymner Sci & Engn, Inchon 402751, South Korea.
RP Jin, HJ (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Karageorgiou, Vassilis/0000-0002-0892-510X
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   ASAKURA T, 1992, J POLYM SCI POL PHYS, V30, P693, DOI 10.1002/polb.1992.090300706
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Forlani G, 2000, INT BIODETER BIODEGR, V46, P271, DOI 10.1016/S0964-8305(00)00099-8
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Knight DP, 2002, PHILOS T R SOC B, V357, P155, DOI 10.1098/rstb.2001.1030
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   MAGOSHI J, 1979, J POLYM SCI POL PHYS, V17, P515, DOI 10.1002/pol.1979.180170315
   MERCER EH, 1954, TEXT RES J, V24, P135, DOI 10.1177/004051755402400208
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park A, 1996, J BIOMED MATER RES, V31, P117
   Pins GD, 1997, J APPL POLYM SCI, V63, P1429, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1429::AID-APP5>3.3.CO;2-O
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TSUKADA M, 1986, J POLYM SCI POL PHYS, V24, P457, DOI 10.1002/polb.1986.090240219
   Yang Y, 2003, J DENT RES, V82, P449, DOI 10.1177/154405910308200609
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
NR 33
TC 324
Z9 330
U1 3
U2 177
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG
PY 2005
VL 15
IS 8
BP 1241
EP 1247
DI 10.1002/adfm.200400405
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 956SG
UT WOS:000231319500002
DA 2018-10-19
ER

PT J
AU Marx, KA
   Zhou, T
   Montrone, A
   McIntosh, D
   Braunhut, SJ
AF Marx, KA
   Zhou, T
   Montrone, A
   McIntosh, D
   Braunhut, SJ
TI Quartz crystal microbalance biosensor study of endothelial cells and
   their extracellular matrix following cell removal: Evidence for
   transient cellular stress and viscoelastic changes during detachment and
   the elastic behavior of the pure matrix
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE quartz crystal microbalance; endothelial cells; MCF-7 cells;
   extracellular matrix; viscoelastic behavior; elastic behavior; actin;
   stress; fluorescence microscopy
ID LIVING CELLS; CANCER CELLS; DECYL ESTER; ADHESION; ATTACHMENT; GROWTH;
   SENSOR; RESONATORS; INTERFACE; SCAFFOLD
AB A quartz crystal microbalance (QCM) cell biosensor utilizing living endothelial cells (ECs) or human breast cancer cells (MCF-7) adhering to the gold QCM surface was used to study the relative contributions of the cells and their underlying extracellular matrix (ECM) to the measured QCM Delta f and Delta R shifts. The ECM represents a natural biomaterial that is synthesized by the cells to enable their attachment to surfaces. We followed the detachment of the ECs or MCF-7 cells from their ECM using a nonproteolytic method and were able to apportion the total frequency, Delta f, decrease of the biosensor into contributions from cell attachment and from the intact underlying ECM. We also demonstrated that the Delta f shift remaining after EC removal corresponds to ECM as determined by light microscopic visualization of the stained protein. During the process of cell detachment, we observed a novel transient increase in viscoelastic behavior expressed as a transient increase in the motional resistance, Delta R, parameter. Then we showed via a simulation experiment using ECs stained with fluorescent rhodamine-labeled phalloidin, an actin stain, that the transient viscoelastic increase correlated with cellular stress exhibited by the cells during removal with ethylene glycol bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid. Prior to cells lifting from their ECM, the attached ECs rearrange their actin microfilaments first into peripheral stress fibers and second into internal aggregates, to maintain cell-cell connectivity, retain their spread morphology, and attempt to adhere more tightly to their underlying ECM. The decrease in Delta R following its transient rise corresponds to cells finally losing their attachment focal points and lifting from the ECM. We also characterized the normalized f shifts, -Delta(Delta f)(ECM)/attached cell and -Delta(Delta f)(cells)/attached cell, as a function of varying the number of adherent cells. Finally, we demonstrate that the underlying native ECM biomaterial, from which all cells have been removed, does not exhibit any significant level of energy dissipation, in contrast to the cells when they are attached to the ECM. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Massachusetts, Ctr Intelligent Biomat, Lowell, MA 01854 USA.
   Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
   Univ Massachusetts, Dept Biol Sci, Lowell, MA 01854 USA.
RP Marx, KA (reprint author), Univ Massachusetts, Ctr Intelligent Biomat, Lowell, MA 01854 USA.
EM Kenneth_Marx@uml.edu
FU NIGMS NIH HHS [R21 GM 58583]
CR AYALON O, 1994, J CELL BIOL, V126, P247, DOI 10.1083/jcb.126.1.247
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Braunhut SJ, 2005, ASSAY DRUG DEV TECHN, V3, P77, DOI 10.1089/adt.2005.3.77
   Braunhut SJ, 2004, MATER RES SOC SYMP P, V1, P403
   Cavic BA, 1999, ANALYST, V124, P1405, DOI 10.1039/a903236c
   Christopher RA, 1997, J CELL SCI, V110, P569
   ENGERMAN RL, 1967, LAB INVEST, V17, P738
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   GRYTE DM, 1993, BIOTECHNOL PROGR, V9, P105, DOI 10.1021/bp00019a016
   Li J, 2005, BIOSENS BIOELECTRON, V20, P1333, DOI 10.1016/j.bios.2004.05.004
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Marx KA, 1999, BIOTECHNOL PROGR, V15, P522, DOI 10.1021/bp990038j
   Marx KA, 2003, BIOTECHNOL PROGR, V19, P987, DOI 10.1021/bp0201096
   Marx KA, 2002, MATER RES SOC SYMP P, V711, P125
   Marx KA, 2002, J ELECTROANAL CHEM, V521, P53, DOI 10.1016/S0022-0728(02)00644-7
   Marx KA, 2001, BIOSENS BIOELECTRON, V16, P773, DOI 10.1016/S0956-5663(01)00219-6
   Muratsugu M, 1997, ANAL CHIM ACTA, V342, P23, DOI 10.1016/S0003-2670(96)00576-4
   PAIGE K, 1991, IN VITRO CELL DEV B, V27, P151
   REDEPENNING J, 1993, ANAL CHEM, V65, P3378, DOI 10.1021/ac00071a008
   Rickert J, 1996, BIOSENS BIOELECTRON, V11, P591, DOI 10.1016/0956-5663(96)83294-5
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SU HB, 1994, ANAL CHEM, V66, P769, DOI 10.1021/ac00078a002
   Walles T, 2003, BIOMATERIALS, V24, P1233, DOI 10.1016/S0142-9612(02)00490-8
   Ward M, 1995, PHYSICAL ELECTROCHEM, P293
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180
   WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101
   ZAHIR N, 2002, CURR OPIN GENE DEV, V14, P71
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
   ZHOU T, 1999, DRUG DELIVERY IMPLAN, V550, P177
NR 31
TC 50
Z9 52
U1 0
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD AUG 1
PY 2005
VL 343
IS 1
BP 23
EP 34
DI 10.1016/j.ab.2005.05.013
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 950LM
UT WOS:000230858600002
PM 15979557
DA 2018-10-19
ER

PT J
AU Rydholm, AE
   Bowman, CN
   Anseth, KS
AF Rydholm, AE
   Bowman, CN
   Anseth, KS
TI Degradable thiol-acrylate photopolymers: polymerization and degradation
   behavior of an in situ forming biomaterial
SO BIOMATERIALS
LA English
DT Article
DE thiol-acrylate polymerization; in situ cross-linking;
   photopolymerization; hydrolytic degradation; poly(ethylene glycol)
ID B-PLA HYDROGEL; TISSUE ENGINEERING APPLICATIONS; GLYCOL) FUMARATE)
   HYDROGELS; STATISTICAL KINETIC-MODEL; POLY(ETHYLENE GLYCOL); BULK
   DEGRADATION; CROSS-LINKING; NETWORKS; ENE; DELIVERY
AB Degradable thiol-acrylate photopolymers are a new class of biomaterials capable of rapidly polymerizing under physiological conditions upon exposure to UV light, with or without added photoinitiators, and to depths exceeding 10 cm. These materials are formed in situ, and the versatility of their chemistry affords a high degree of control over the final material properties. For example, variations in monomer mole fractions directly affect the final network molecular structure, varying the time required to achieve complete mass loss from 25 to 100 days, the molecular weight distributions of the degradation products, and the swelling ratios and compressive moduli throughout degradation. Additionally, varying the mole fraction of multifunctional thiol monomer in the initial reaction mixture controls the concentration of reactive sites in the network available for post-polymerization modification of the polymer. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Colorado, Dept Chem & Biol Engn, Ctr Engn, Boulder, CO 80309 USA.
   Univ Colorado, Hlth Sci Ctr, Dept Restorat Dent, Denver, CO 80045 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Ctr Engn, Room ECCH 111,Campus Box 424, Boulder, CO 80309 USA.
EM kristi.anseth@colorado.edu
RI Bowman, Christopher/B-1490-2008
OI Bowman, Christopher/0000-0001-8458-7723
FU NIDCR NIH HHS [R01 DE12998]
CR Anseth KS, 2001, MACROMOL RAPID COMM, V22, P564, DOI 10.1002/1521-3927(20010501)22:8<564::AID-MARC564>3.0.CO;2-S
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P374, DOI 10.1021/bm010158r
   Berchtold KA, 2004, MACROMOLECULES, V37, P3165, DOI 10.1021/ma035862
   BERCHTOLD KA, 1999, RADT EUR 99 C P BERL, P767
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   CAO YL, 1999, TISSUE ENG METHODS P
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Cramer NB, 2003, MACROMOLECULES, V36, P7964, DOI 10.1021/ma034667s
   Cramer NB, 2002, MACROMOLECULES, V35, P5361, DOI 10.1021/ma0200672
   Cramer NB, 2001, J POLYM SCI POL CHEM, V39, P3311, DOI 10.1002/pola.1314
   CRAMER NB, 2004, IN PRESS J POLYM S A
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   HELLER J, 1985, J CONTROL RELEASE, V1, P233
   HOYLE CE, 1984, J POLYM SCI POL CHEM, V22, P1865, DOI 10.1002/pol.1984.170220808
   HOYLE CE, 2001, RADTECH JAP 2000 TEC, P211
   Jacobine A. F., 1993, RAD CURING POLYM SCI, V3, P219
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   KURISAWA M, 1995, MACROMOL RAPID COMM, V16, P663, DOI 10.1002/marc.1995.030160905
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Mason MN, 2001, MACROMOLECULES, V34, P4630, DOI 10.1021/ma010025y
   Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Metters AT, 2001, J PHYS CHEM B, V105, P8069, DOI 10.1021/jp004083h
   METTERS AT, 2000, THESIS BOULDER CO U
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Porter BD, 2000, J BIOMECH ENG-T ASME, V122, P286, DOI 10.1115/1.429659
   Posner T, 1905, BER DTSCH CHEM GES, V38, P646, DOI 10.1002/cber.190503801106
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Shung AK, 2003, TISSUE ENG, V9, P243, DOI 10.1089/107632703764664710
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Vernon B, 2003, J BIOMED MATER RES A, V64A, P447, DOI 10.1002/jbm.a.10369
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Woods J. G., 1992, RAD CURABLE ADHESIVE, P333
NR 48
TC 168
Z9 171
U1 7
U2 103
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4495
EP 4506
DI 10.1016/j.biomaterials.2004.11.046
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300001
PM 15722118
DA 2018-10-19
ER

PT J
AU Lan, MA
   Gersbach, CA
   Michael, KE
   Keselowsky, BG
   Garcia, AJ
AF Lan, MA
   Gersbach, CA
   Michael, KE
   Keselowsky, BG
   Garcia, AJ
TI Myoblast proliferation and differentiation on fibronectin-coated self
   assembled monolayers presenting different surface chemistries
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; integrin; self-assembled monolayers; fibronectin;
   differentiation; myoblast
ID FOCAL ADHESION KINASE; CELL-ADHESION; PROTEIN ADSORPTION; INTEGRIN
   BINDING; IN-VITRO; TYROSINE PHOSPHORYLATION; SKELETAL MYOBLASTS;
   ACTIVATION; MYOGENESIS; GROWTH
AB Biomaterial surface properties modulate protein adsorption and cell adhesion to elicit diverse cellular responses in biomedical and biotechnological applications. We used alkanethiol self-assembled monolayers presenting well-defined chemistries (OH, CH3, NH2, and COOH) to analyze the effects of surface chemistry on myoblast proliferation and differentiation. Surfaces were pre-coated with equivalent densities of fibronectin. C2C12 skeletal myoblasts exhibited surface-dependent differences in cell proliferation (COOH = NH2 > CH3 = OH). Myogenin and troponin T gene expression levels were up-regulated on CH3 and OH surfaces compared to other chemistries. Furthermore, immunostaining for sarcomeric myosin revealed surface chemistry-dependent differences in myogenic differentiation following the pattern OH > CH3 > NH2 = COOH. Immunostaining analyses of integrin subunits demonstrated surface chemistry-dependent differences in integrin binding to adsorbed fibronectin. OH and CH3 surfaces supported selective binding Of alpha(5)beta(1) integrin while the COOH and NH2, functionalities displayed binding of both alpha(5)beta(1), and alpha(v)beta(3). Myogenic differentiation correlated with differences in integrin binding; surface chemistries that supported selective binding Of alpha(5)beta(1) displayed enhanced differentiation. Finally, blocking beta(1), but not beta(3), integrins inhibited differentiation, implicating specific integrins in the differentiation process. These results demonstrate that Surface chemistry modulates myoblast proliferation and differentiation via differences in integrin binding to adsorbed fibronectin. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, GTEC Undergrad Res Scholars Program, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Emory Dept Biomed Engn, Georgia Tech, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Petit Inst Bioengn & Biosci, 315 Ferst Dr,Room 2314, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
FU NIGMS NIH HHS [T32 GM008433]; NIBIB NIH HHS [R01-EB003364]
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gersbach CA, 2004, BIOTECHNOL BIOENG, V88, P369, DOI 10.1002/bit.20251
   Goel HL, 2002, J CELL PHYSIOL, V193, P187, DOI 10.1002/jcp.10161
   Goel HL, 2002, DIFFERENTIATION, V70, P257, DOI 10.1046/j.1432-0436.2002.700604.x
   Goel HL, 2002, CELL PROLIFERAT, V35, P131, DOI 10.1046/j.1365-2184.2002.00232.x
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x
   Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Yao CC, 1996, J CELL SCI, V109, P3139
NR 35
TC 143
Z9 148
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4523
EP 4531
DI 10.1016/j.biomaterials.2004.11.028
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300004
PM 15722121
DA 2018-10-19
ER

PT J
AU Strehl, R
   Tallheden, T
   Sjogren-Jansson, E
   Minuth, WW
   Lindahl, A
AF Strehl, R
   Tallheden, T
   Sjogren-Jansson, E
   Minuth, WW
   Lindahl, A
TI Long-term maintenance of human articular cartilage in culture for
   biomaterial testing
SO BIOMATERIALS
LA English
DT Article
DE biocompatability; bioreactor; in vitro test; cell culture; human
   articular cartilage; tissue culture; perfusion; differentiation
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; INTERMITTENT
   HYDROSTATIC-PRESSURE; IN-VITRO; MATRIX METALLOPROTEINASES;
   EXTRACELLULAR-MATRIX; ARTIFICIAL TISSUES; KNEE; OSTEOARTHRITIS;
   PROTEOGLYCAN; DEFECTS
AB Cartilage is a tissue that derives its unique mechanical and biological properties from the combination of relatively few cells and a large amount of a complex extracellular matrix. Furthermore, cartilage tissue is comparatively slow to respond to changes or harmful influences. To date, the optimal generation and long-term maintenance of cultured human articular cartilage for in vitro testing of biomaterials, poses an experimental difficulty. Experiments using cultured isolated chondrocytes in combination with scaffolds often fail to yield results comparable to the in-vivo situation. Consequently, our aim was to develop a culture method that allows in vitro maintenance of human hyaline cartilage explants in an optimal quality over an extended period of time. Such a culture could, for example, be used to determine the long-term effect of a new scaffold on intact cartilage, as an in vitro model for repair processes and to investigate biomaterial integration.
   In this study we compared conventional static cultures with and without serum supplementation to a serum-free perfusion culture for the ability to maintain human articular cartilage explants in a morphologically intact and differentiated state over an extended period of time of up to 56 days. Results were evaluated and compared by morphological, histochemical and immunohistochemical methods.
   The experiments showed that short-term maintenance of cartilage in a differentiated state for up to 14 days is possible under all culture conditions tested. However, best long-term culture results for up to 56 days were obtained with perfusion culture under serum-free conditions. Such a perfusion culture system can be used to perform biocompatabilty tests in vitro by long-term coculture of biomaterial and intact human articular cartilage. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Sahlgrens Univ Hosp, Inst Lab Med, Dept Clin Chem & Transfus Med, RCEM1, SE-41345 Gothenburg, Sweden.
   Univ Regensburg, Dept Mol & Cellular Anat, D-93053 Regensburg, Germany.
RP Sjogren-Jansson, E (reprint author), Sahlgrens Univ Hosp, Inst Lab Med, Dept Clin Chem & Transfus Med, RCEM1, Bruna Straket 16, SE-41345 Gothenburg, Sweden.
EM raimund.strehl@cellartis.com; esj@medic.gu.se
RI Lindahl, Anders/H-9550-2014
OI Lindahl, Anders/0000-0003-2871-5166
CR Blevins FT, 1998, ORTHOPEDICS, V21, P761
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   BRITTBERG M, 1996, CLIN ORTHOP RELAT R, V326, P270
   BUCHWALTER JA, 1990, ARTICULAR CARTILAGE, P19
   Chambers MG, 2001, ARTHRITIS RHEUM, V44, P1455, DOI 10.1002/1529-0131(200106)44:6<1455::AID-ART241>3.0.CO;2-J
   DAVIDSON MK, 1987, ISRAEL J MED SCI, V23, P551
   DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334
   Dieppe P, 2000, KNEE, V7, P135, DOI 10.1016/S0968-0160(00)00043-0
   Domm C, 2000, ORTHOPADE, V29, P91
   Fuentes MA, 2002, ARCH ORAL BIOL, V47, P643, DOI 10.1016/S0003-9969(02)00052-3
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2002, Reumatismo, V54, P364
   Hangody L, 2001, FOOT ANKLE INT, V22, P552, DOI 10.1177/107110070102200704
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003
   Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310
   Hunter W, 1743, PHILOS T R SOC LOND, V470, P514, DOI DOI 10.1098/RSTL.1742.0079)
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   INSALL J, 1974, CLIN ORTHOP RELAT R, P61
   Ishiguro N, 2001, ARTHRITIS RHEUM, V44, P2503, DOI 10.1002/1529-0131(200111)44:11<2503::AID-ART430>3.0.CO;2-P
   Kaps C, 2002, MED BIOL ENG COMPUT, V40, P485, DOI 10.1007/BF02345083
   Marcacci M, 2002, KNEE SURG SPORT TR A, V10, P154, DOI 10.1007/s00167-001-0275-6
   Martensson O., 2002, Advances in Food Sciences, V24, P4
   Mattioli-Belmonte M, 2003, INT J ARTIF ORGANS, V26, P1077
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   MINUTH WW, 1992, EUR J CELL BIOL, V57, P132
   Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325
   Moskowitz Roland W, 2004, Am J Orthop (Belle Mead NJ), V33, P5
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   Strehl R, 2002, TISSUE ENG, V8, P37, DOI 10.1089/107632702753503036
   Suh JK, 1996, BIORHEOLOGY, V33, P289, DOI 10.1016/0006-355X(96)00023-6
   TALLHEDEN T, UNPUB CELL TRANSPLAN
   Torzilli PA, 1998, OSTEOARTHR CARTILAGE, V6, P260, DOI 10.1053/joca.1998.0119
   URBAN JPG, 1989, BIOCHIM BIOPHYS ACTA, V992, P59, DOI 10.1016/0304-4165(89)90050-0
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   Wang J, 2003, OSTEOARTHR CARTILAGE, V11, P801, DOI 10.1016/S1063-4584(03)00168-7
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
NR 42
TC 24
Z9 25
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4540
EP 4549
DI 10.1016/j.biomaterials.2004.11.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300006
PM 15722123
DA 2018-10-19
ER

PT J
AU Boura, C
   Muller, S
   Vautier, D
   Dumas, D
   Schaaf, P
   Voegel, JC
   Stoltz, JF
   Menu, P
AF Boura, C
   Muller, S
   Vautier, D
   Dumas, D
   Schaaf, P
   Voegel, JC
   Stoltz, JF
   Menu, P
TI Endothelial cell - interactions with polyelectrolyte multilayer films
SO BIOMATERIALS
LA English
DT Article
DE polyelectrolyte multilayers; endothelial cells; cell adhesion; beta 1
   integrins; focal adhesion kinase
ID FOCAL ADHESIONS; SHEAR-STRESS; CHONDROSARCOMA CELLS; PROTEIN
   INTERACTIONS; BYPASS GRAFTS; SURFACE; COATINGS; FLOW; CYTOSKELETAL;
   FIBRONECTIN
AB The seeding of endothelial cells (ECs) on biomaterial surfaces became a major challenge, allowing to improve the non-thrombogenic properties of these surfaces. Recently, the use of polyelectrolyte films has been suggested as a new versatile technique of surface modification aimed at tissue engineering. In this study, we evaluate the adhesion properties of ECs on two types of polyelectrolyte films ending either by poly(D-lysine) (PDL), or poly(allylamine hydrochloride) (PAH), and compared them to data obtained on PDL or PAH monolayers, glass and fibronectin (Fn)-coated glass. ECs seeded on polyelectrolyte films showed a good morphology, allowing ECs to resist physiological shear stress better compared to ECs seeded on glass or Fn. The expression of beta 1 integrins was slightly lower on polyelectrolyte films than on control surfaces. However, the phosphorylation of focal adhesion kinase, involved in the transduction of adhesion signal, was not modified on PAH ending films compared to control surfaces; whereas it became lower on PDL ending films. Finally, PAH ending films improve strongly ECs adhesion without disturbing the adhesion mechanism, necessary for the development of a new endothelium. These types of films or similar build-ups could thus be used in the future as a way to modify surfaces for vascular tissue engineering. (c) 2004 Elsevier Ltd. All rights reserved.
C1 CNRS, Lab Mecan & Ingn Cellulaire & Tissulaire, LEMTA, UMR 7563,Fac Sci, F-54505 Vandoeuvre Les Nancy, France.
   INSERM, U595, Fac Chirurg Dent, F-67085 Strasbourg, France.
   ULP, CNRS, Inst Charles Sadron, UPR 22, F-67083 Strasbourg, France.
RP Menu, P (reprint author), CNRS, Lab Mecan & Ingn Cellulaire & Tissulaire, LEMTA, UMR 7563,Fac Sci, F-54505 Vandoeuvre Les Nancy, France.
EM cedric.boura@medecinc.uhp-nancy.fr; menu@pharma.uhp-nancy.fr
RI Dumas, Dominique/A-5633-2012; Boura, Cedric/E-4070-2012; SCHAAF,
   Pierre/J-2751-2016
OI SCHAAF, Pierre/0000-0001-7423-5492
CR ALBELDA SM, 1993, LAB INVEST, V68, P4
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Barbee KA, 1995, BIOCHEM CELL BIOL, V73, P501, DOI 10.1139/o95-055
   Benkirane-Jessel N, 2004, ADV FUNCT MATER, V14, P174, DOI 10.1002/adfm.200304413
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Brown E, 1996, IMMUNOL LETT, V54, P189, DOI 10.1016/S0165-2478(96)02671-5
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X
   IVARSSON BL, 1989, J SURG RES, V47, P203, DOI 10.1016/0022-4804(89)90108-X
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mathur AB, 2003, J BIOMED MATER RES A, V64A, P155, DOI 10.1002/jbm.a.10403
   MCLEAN GW, 2000, J BIOL CHEM, V28, P2333
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Muller M, 2001, MACROMOL RAPID COMM, V22, P390, DOI 10.1002/1521-3927(20010301)22:6<390::AID-MARC390>3.0.CO;2-B
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Salacinski HJ, 2001, MED BIOL ENG COMPUT, V39, P609, DOI 10.1007/BF02345431
   Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7
   SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192
   SCHNEIDER A, 1992, J VASC SURG, V15, P649, DOI 10.1016/0741-5214(92)90010-6
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969
   Sirois E, 1998, BIOMATERIALS, V19, P1925, DOI 10.1016/S0142-9612(98)00094-5
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vautier D, 2003, CELL MOTIL CYTOSKEL, V56, P147, DOI 10.1002/cm.10140
   Vautier D, 2002, J BIOMAT SCI-POLYM E, V13, P713, DOI 10.1163/156856202320269175
   Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 41
TC 77
Z9 78
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4568
EP 4575
DI 10.1016/j.biomaterials.2004.11.036
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300009
PM 15722126
DA 2018-10-19
ER

PT J
AU Simpson, NE
   Khokhlova, N
   Oca-Cossio, JA
   McFarlane, SS
   Simpson, CP
   Constantinidis, I
AF Simpson, NE
   Khokhlova, N
   Oca-Cossio, JA
   McFarlane, SS
   Simpson, CP
   Constantinidis, I
TI Effects of growth regulation on conditionally-transformed
   alginate-entrapped insulin secreting cell lines in vitro
SO BIOMATERIALS
LA English
DT Article
DE alginate; insulinoma cells; bioartificial pancreas; tetracycline;
   doxycycline
ID BIOARTIFICIAL ENDOCRINE PANCREAS; ENCAPSULATED BETA-TC3 CELLS; ISLETS;
   MATRIX
AB The ability to control cell growth is an issue of critical importance for the use of transformed beta-cell lines within a bioartificial pancreas. Such control can be achieved either by entrapping the cells in a biomaterial that can inhibit cell proliferation or by genetically modifying the cells to regulate growth. Integrating tetracycline-off or -on operon systems into murine insulinoma cell lines (beta TC-tet and R7T1, respectively) allows cell growth regulation upon exposure to tetracycline (TC) or its derivative doxycycline (Dox), respectively. However, the effects of this regulatory approach on the long-term phenotypic metabolic and secretory stability of alginate-entrapped cells have yet to be thoroughly investigated. In this study, Cultures of beta TC-tet and RM cells entrapped in alginate beads were allowed to grow freely, or were growth-regulated, either at the onset, or after 20 days of growth. The data show that growth regulation of alginate-entrapped cells is achievable with chronic administration of the regulatory compound in a concentration-dependent manner. However, as these cultures age, the amount of insulin released does not always reflect the metabolic and histological characteristics of the Cultures. This change, coupled with a loss of glucose stimulated insulin secretion in the Dox treated R7T1 cell line, indicate a phenotypic shift of cells with an activated tet-operon. These observations have implications on the selection and long-term function of three-dimensional bioartificial pancreatic constructs that include conditionally transformed beta-cell lines. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Florida, Dept Med, Div Endocrinol, Lab Tissue Engn, Gainesville, FL 32610 USA.
   Georgia Tech, Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
RP Constantinidis, I (reprint author), Univ Florida, Dept Med, Div Endocrinol, Lab Tissue Engn, 1600 SW Archer Rd,POB 100226, Gainesville, FL 32610 USA.
EM consti@medicine.ufl.edu
FU NIDDK NIH HHS [DK47858, DK56980]
CR Benson JP, 1997, CELL TRANSPLANT, V6, P395, DOI 10.1016/S0963-6897(97)00044-4
   CHENG SY, 2004, UNPUB CELL TRANSPLAN
   Coger R, 1997, TISSUE ENG, V3, P375, DOI 10.1089/ten.1997.3.375
   Constantinidis I, 1999, BIOMATERIALS, V20, P2019, DOI 10.1016/S0142-9612(99)00104-0
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   EFRAT S, 1993, DIABETES, V42, P901, DOI 10.2337/diabetes.42.6.901
   Fleischer N, 1998, DIABETES, V47, P1419, DOI 10.2337/diabetes.47.9.1419
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645
   NEWGARD CB, 1994, DIABETES, V43, P341, DOI 10.2337/diabetes.43.3.341
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219
   Papas KK, 1997, BIOCHEM J, V326, P807, DOI 10.1042/bj3260807
   REACH G, 1993, DIABETIC MED, V10, P105, DOI 10.1111/j.1464-5491.1993.tb00025.x
   Simpson NE, 2004, BIOMATERIALS, V25, P2603, DOI 10.1016/j.biomaterials.2003.09.046
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   Stabler C, 2001, BIOMATERIALS, V22, P1301, DOI 10.1016/S0142-9612(00)00282-9
   SUN A, 1980, ARTIF ORGANS, V4, P275
   SUN AM, 1988, METHOD ENZYMOL, V137, P575
   TRIVEDI N, 2001, TRANSPLANTATION, V71, P211
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   WEBER CJ, 1999, CELL ENCAPSULATION T, P117
   Zimmer Y, 1999, FEBS LETT, V457, P65, DOI 10.1016/S0014-5793(99)01008-X
NR 23
TC 22
Z9 22
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4633
EP 4641
DI 10.1016/j.biomaterials.2004.11.054
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300016
PM 15722133
DA 2018-10-19
ER

PT J
AU Boomker, JM
   Luttikhuizen, DT
   Veninga, H
   de Leij, LFMH
   The, TH
   de Haan, A
   van Luyn, MJA
   Harmsen, MC
AF Boomker, JM
   Luttikhuizen, DT
   Veninga, H
   de Leij, LFMH
   The, TH
   de Haan, A
   van Luyn, MJA
   Harmsen, MC
TI The modulation of angiogenesis in the foreign body response by the
   poxviral protein M-T7
SO BIOMATERIALS
LA English
DT Article
DE gene therapy; glycosaminoglycan; immunomodulation; macrophage;
   chemotaxis
ID DERMAL SHEEP COLLAGEN; BIODEGRADABLE BIOMATERIAL; TISSUE REACTION;
   BINDING; RATS; GLYCOSAMINOGLYCANS; CHEMOKINES; GAMMA
AB The foreign body response is characterized by enhanced recruitment of inflammatory cells. As the directional movement of cells is controlled by chemokines, disruption of the chemokine network would be an attractive approach to improve biocompatibility of an implanted material. The sequestration of chemokines by cell surface-expressed glycosaminoglycans (GAGS) is vital for in vivo chemokine activity. The myxoma virus encodes a soluble protein, M-T7, that interacts with conserved GAG-binding domains of chemokines to block chemokine-mediated leukocyte recruitment. We hypothesized that M-T7 might also affect the function of other inflammation-associated proteins in addition to chemokines that bind to GAG. In our studies, we focussed on the modulation of the GAG-binding molecules macrophage chemoattractant protein-1 (MCP-1) and vascular endothelial growth factor-164 (VEGF(164)) in the inflammatory reaction against subcutaneously implanted degradable cross-linked dermal sheep collagen discs in AO rats. Genetic delivery of M-T7 delays the influx of macrophages into the collagen discs. In addition, angiogenesis around the implanted material was reduced. The discs revealed reduced levels of rat MCP-1 and rat VEGF(164). This was not due to down regulation of transcription of the genes that encode MCP-1 and VEGF(164). Our in vivo observations suggest that, in addition to chemokines such as MCP-1, M-T7 neutralizes VEGF(164). (C) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Groningen, Med Ctr, Med Biol Sect, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Med Ctr, Dept Clin Immunol, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Inst Drug Explorat, GUIDE, NL-9700 AV Groningen, Netherlands.
RP Boomker, JM (reprint author), Univ Groningen, Med Ctr, Med Biol Sect, Dept Pathol & Lab Med, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM j.m.boomker@med.rug.nl
OI Veninga, Henrike/0000-0001-8731-0615
CR Bedard ELR, 2003, TRANSPLANTATION, V76, P249, DOI 10.1097/01.TP.0000061604.57432.E3
   DAVIS HL, 1993, HUM GENE THER, V4, P733, DOI 10.1089/hum.1993.4.6-733
   DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d
   Lalani AS, 1997, J VIROL, V71, P4356
   Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934
   MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113
   Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
NR 18
TC 12
Z9 14
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 23
BP 4874
EP 4881
DI 10.1016/j.biomaterials.2004.11.059
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915PI
UT WOS:000228315900019
PM 15763267
DA 2018-10-19
ER

PT J
AU Anderson, DG
   Putnam, D
   Lavik, EB
   Mahmood, TA
   Langer, R
AF Anderson, DG
   Putnam, D
   Lavik, EB
   Mahmood, TA
   Langer, R
TI Biomaterial microarrays: rapid, microscale screening of polymer-cell
   interaction
SO BIOMATERIALS
LA English
DT Article
DE microarray; biomaterials; PLGA
ID STEM-CELLS; DIFFERENTIATION; CHONDROCYTES; DELIVERY; BIOLOGY; DESIGN;
   SHAPE
AB The identification of biomaterials that induce optimal gene expression patterns and allow for appropriate levels of cellular attachment is of central importance in tissue engineering and cell therapy. Herein, we describe the creation of cell-compatible, biomaterial microarrays, that allow rapid, microscale testing of biomaterial interactions with cells. As proof of principle, we simultaneously characterized over 3456 human mesenchymal stem cell (hMSC)-biomaterial composite interactions, and describe preliminary studies on the utility of these arrays with a neural stem cell line (NSC), and primary articular chondrocytes. (C) 2004 Elsevier Ltd. All rights reserved.
C1 MIT, Dept Chem Engn, Div Biol Engn, Cambridge, MA 02139 USA.
   Cornell Univ, Sch Chem & Biomol Engn, Dept Biomed Engn, Ithaca, NY USA.
   Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
RP Langer, R (reprint author), MIT, Dept Chem Engn, Div Biol Engn, 45 Carleton St,E25-342, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
OI Putnam, David/0000-0002-0794-4915
FU NHLBI NIH HHS [HL60435]
CR Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Brocchini S, 2001, ADV DRUG DELIVER REV, V53, P123, DOI 10.1016/S0169-409X(01)00224-1
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANZA RP, 2000, PRINCIPLES TISSUE EN
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029
NR 23
TC 194
Z9 198
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 23
BP 4892
EP 4897
DI 10.1016/j.biomaterials.2004.11.052
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915PI
UT WOS:000228315900021
PM 15763269
DA 2018-10-19
ER

PT J
AU Declerq, HA
   Verbeeck, RMH
   De Ridder, LIFJM
   Schacht, EH
   Cornelissen, MJ
AF Declerq, HA
   Verbeeck, RMH
   De Ridder, LIFJM
   Schacht, EH
   Cornelissen, MJ
TI Calcification as an indicator of osteoinductive capacity of biomaterials
   in osteoblastic cell cultures
SO BIOMATERIALS
LA English
DT Article
DE osteoblast differentiation; extracellular matrix; calcification; bone
   apatite; biomaterial
ID IN-VITRO MINERALIZATION; BIODEGRADABLE POLYMERS; BONE; DIFFERENTIATION;
   BIOMINERALIZATION; PROLIFERATION; ESTABLISHMENT; DEPOSITION; PERIOSTEUM;
   PHENOTYPE
AB Mineralized extracellular matrix formation is representative for the osteoinductive capacity of biomaterials and is often tested in vitro. Characteristics of in vitro mineralization of primary rat osteoblastic cells (bone marrow, calvaria, periosteum, fetal and adult long bone) and UMR-106 cells were compared by von Kossa staining, FTIR, X-ray diffractometry, TEM and related to parameters of early (ALP and collagen I formation) and late (osteocalcin secretion) osteoblast expression. All Cultures expressed high alkaline phosphatase activity and were able to form bone apatite. However, a nodular versus diffuse mineralization pattern was observed. Bone marrow, calvaria and periosteum (early passage) derived cells mineralized restrictively on the three-dimensional area of a nodule. The extracellular matrix consisted of collagen I fibers, among matrix vesicles loaded with needle-like crystals. Long bone, late passage periosteum derived and UMR-106 cells exhibited a diffuse mineralization pattern. Needle-like crystals were observed between the cells but collagen fibers and matrix Vesicles Could not be detected. Secretion of osteocalcin was detected in cultures derived from bone marrow and absent in UMR-106 and long bone derived cell cultures. The present study demonstrates that dystrophic calcification can not be distinguished from cell-mediated calcification with von Kossa, FTIR and X-ray diffractometry. Primary osteoblastic cells capable of forming nodules are recommended to evaluate the osteoinductive properties of biomaterials. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Ghent Univ, Dept Anat Embryol Histol & Med Phys, B-9000 Ghent, Belgium.
   Ghent Univ, Dept Dent Mat Sci, B-9000 Ghent, Belgium.
   Ghent Univ, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
RP Cornelissen, MJ (reprint author), Ghent Univ, Dept Anat Embryol Histol & Med Phys, Louis Pasteurlaan 2, B-9000 Ghent, Belgium.
EM Ria.Cornelissen@Ugent.be
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x
   Andre-Frei V, 2000, CALCIFIED TISSUE INT, V66, P204, DOI 10.1007/s002230010041
   Arnold U, 2002, BIOMATERIALS, V23, P2303, DOI 10.1016/S0142-9612(01)00364-7
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   AUBIN JE, 1998, HDB PRACTICAL ANIMAL, P88
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212
   Boskey AL, 2003, CALCIFIED TISSUE INT, V72, P533, DOI 10.1007/s00223-003-1002-8
   Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007
   Boskey AL, 1996, CALCIFIED TISSUE INT, V58, P177, DOI 10.1007/BF02526884
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Chak CW, 1995, CELL BIOL INT, V19, P979, DOI 10.1006/cbir.1995.1039
   DAVIES JE, 2002, METHODS TISSUE ENG, V26, P333
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   Driessens FCM, 1990, BIOMINERALS
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Goto T, 2003, BIOMATERIALS, V24, P3885, DOI 10.1016/S0142-9612(03)00258-8
   GRONOWICZ G, 1989, J BONE MINER RES, V4, P313
   Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101
   HALSTEAD LR, 1992, CALCIFIED TISSUE INT, V50, P93, DOI 10.1007/BF00297304
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826
   Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622
   KHOUJA HI, 1990, BONE, V11, P385, DOI 10.1016/8756-3282(90)90131-H
   KOSHIHARA Y, 1989, IN VITRO CELL DEV B, V25, P37
   Kuhn LT, 2000, J BONE MINER RES, V15, P1301, DOI 10.1359/jbmr.2000.15.7.1301
   Laczka-Osyczka A, 1998, J BIOMED MATER RES, V42, P433, DOI 10.1002/(SICI)1097-4636(19981205)42:3<433::AID-JBM13>3.0.CO;2-H
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Lynch MP, 1998, J CELL BIOCHEM, V68, P31
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.3.CO;2-Y
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   YOON KG, 1988, BIOCHEMISTRY-US, V15, P8521
NR 35
TC 98
Z9 101
U1 2
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 24
BP 4964
EP 4974
DI 10.1016/j.biomaterials.2005.01.025
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 919KQ
UT WOS:000228617300009
PM 15769532
DA 2018-10-19
ER

PT J
AU Marcon, P
   Marsich, E
   Vetere, A
   Mozetic, P
   Campa, C
   Donati, I
   Vittur, F
   Gamini, A
   Paoletti, S
AF Marcon, P
   Marsich, E
   Vetere, A
   Mozetic, P
   Campa, C
   Donati, I
   Vittur, F
   Gamini, A
   Paoletti, S
TI The role of Galectin-1 in the interaction between chondrocytes and a
   lactose-modified chitosan
SO BIOMATERIALS
LA English
DT Article
DE Galectin-1; glycopolymer; biomaterial; chondrocyte; cartilage
ID GALACTOSIDE-BINDING LECTIN; S-TYPE LECTIN; EXTRACELLULAR-MATRIX;
   ARTICULAR-CARTILAGE; CELL-ADHESION; GASTROINTESTINAL-TRACT;
   MOLECULAR-CLONING; EXPRESSION; SEQUENCE; LAMININ
AB Evidences for the involvement of the Galectin-1 in the interaction of pig chondrocytes with a lactose-modified chitosan, namely Chitlac, are reported. The Chitlac glycopolymer has been shown to promote pig chondrocyte aggregation and to induce extracellular matrix production. Highly pure Galectin-1 was obtained from pig spleen by affinity chromatography and its identity was determined by ion spray mass spectrometry analysis of tryptic peptide fragments obtained after in-gel digestion. The complete sequence of pig Galectin-1 CDS was obtained by screening a pig EST database using human Galectin-1 sequence as template. The Galectin-1 cDNA was cloned into a pGEX-4T-1 expression vector and the recombinant protein was purified, characterized and used to produce a rabbit anti-serum. Recombinant Galectin-1 interacts in a dose-dependent manner with Chitlac as determined with ELISA assay. Expression level of galeclin-1 gene, quantified by real-time PCR, was significantly higher in chondrocytes cultivated on Chitlac. In the same way, the presence of Chitlac stimulates secretion of Galectin-1 in culture medium that, by immunohistochemical analysis, revealed to be clustered on the surface of Chitlac-induced aggregates. These data indicate the role of Galectin-1 as a bridging agent between Chitlac and chondrocyte aggregates. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
   Bracco Imaging SpA CRM Trieste, I-34012 Trieste, Italy.
RP Vetere, A (reprint author), Univ Trieste, Dept Biochem Biophys & Macromol Chem, Via L Giorgieri 1, I-34127 Trieste, Italy.
EM vetere@bbcm.univ.trieste.it
RI Donati, Ivan/C-3725-2017
OI Paoletti, Sergio/0000-0001-5944-8182; Vetere,
   Amedeo/0000-0001-5608-0773; MARSICH, ELEONORA/0000-0002-0700-4464;
   Mozetic, Pamela/0000-0001-8641-0526
CR Ahmed H, 1996, J BIOCHEM, V120, P1007
   Andre S, 1999, J CANCER RES CLIN, V125, P461, DOI 10.1007/s004320050303
   BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7
   Brun P, 1999, J MATER SCI-MATER M, V10, P683, DOI 10.1023/A:1008960413362
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Colnot C, 1999, CELL MOL BIOL, V45, P1191
   COOPER DNW, 1999, GLYCOBIOLOGY, V9, P31
   COURAUD PO, 1989, J BIOL CHEM, V264, P1310
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   Dunphy JL, 2000, J BIOL CHEM, V275, P32106, DOI 10.1074/jbc.M003739200
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   GITT MA, 1992, J BIOL CHEM, V267, P10601
   GITT MA, 1995, J BIOL CHEM, V270, P5032, DOI 10.1074/jbc.270.10.5032
   Gitt MA, 1998, J BIOL CHEM, V273, P2954, DOI 10.1074/jbc.273.5.2954
   GRANDOLFO M, 1993, CALCIFIED TISSUE INT, V52, P42, DOI 10.1007/BF00675625
   GU MJ, 1994, J CELL SCI, V107, P175
   HIRABAYASHI J, 1988, J BIOCHEM-TOKYO, V104, P1
   Hughes RC, 2001, BIOCHIMIE, V83, P667
   Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253
   Jensen ON, 1999, METH MOL B, V112, P513
   JIA SH, 1988, J BIOL CHEM, V263, P6009
   Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1
   Kopitz J, 1998, J BIOL CHEM, V273, P11205, DOI 10.1074/jbc.273.18.11205
   Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200
   Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200
   LU JX, 1999, BIOMATERIALS, V20, P1133
   MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823
   Maeda N, 2003, J BIOL CHEM, V278, P18938, DOI 10.1074/jbc.M209673200
   Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.0.CO;2-N
   Mattioli-Belmonte M, 1999, MED BIOL ENG COMPUT, V37, P130, DOI 10.1007/BF02513279
   MERKLE RK, 1989, ARCH BIOCHEM BIOPHYS, V274, P404, DOI 10.1016/0003-9861(89)90453-0
   Moiseeva EP, 1999, J VASC RES, V36, P47, DOI 10.1159/000025625
   Nurminskaya M, 1996, DEV DYNAM, V206, P260, DOI 10.1002/(SICI)1097-0177(199607)206:3<260::AID-AJA4>3.0.CO;2-G
   Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708
   ODA Y, 1991, GENE, V99, P279
   OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Ramkumar R, 2000, J MOL RECOGNIT, V13, P299, DOI 10.1002/1099-1352(200009/10)13:5<299::AID-JMR504>3.0.CO;2-O
   RAZ A, 1991, CANCER RES, V51, P2173
   Rechreche H, 1997, EUR J BIOCHEM, V248, P225, DOI 10.1111/j.1432-1033.1997.00225.x
   Sambrook J, 2001, MOL CLONING LAB MANU
   Su ZZ, 1996, P NATL ACAD SCI USA, V93, P7252, DOI 10.1073/pnas.93.14.7252
   Symons A, 2000, GLYCOBIOLOGY, V10, P559, DOI 10.1093/glycob/10.6.559
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416
   VANDENBRULE FA, 1995, BIOCHEM BIOPH RES CO, V209, P760, DOI 10.1006/bbrc.1995.1564
   Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078
   Wasano K, 1997, J HISTOCHEM CYTOCHEM, V45, P275, DOI 10.1177/002215549704500212
   Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200
   ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q
NR 50
TC 32
Z9 33
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 24
BP 4975
EP 4984
DI 10.1016/j.biomaterials.2005.01.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 919KQ
UT WOS:000228617300010
PM 15769533
DA 2018-10-19
ER

PT J
AU Niu, XF
   Wang, YL
   Luo, YF
   Pan, J
   Shang, JF
   Guo, LX
AF Niu, XF
   Wang, YL
   Luo, YF
   Pan, J
   Shang, JF
   Guo, LX
TI Synthesis of the biomimetic polymer: Aliphatic diamine and RGDS modified
   poly(d,l-lactic acid)
SO CHINESE CHEMICAL LETTERS
LA English
DT Article
DE poly(d,l-lactic acid); maleic anhydride; butanediamine; arg-gly-asp-ser;
   modification
ID BIOMATERIAL
AB A novel poly(d, l-lactic acid) (PDLLA) based biomimetic polymer was synthesized by grafting maleic anhydride, butanediamine and arg-gly-asp-ser (RGDS) peptides onto the backbone of PDLLA, aiming to overcome the acidity and auto-accelerating degradation of PDLLA during degradation and to improve its biospecificity and biocompatibility. The synthetic copolymer was characterized by FTIR, C-13 NMR and amino acid analyzer (AAA).
C1 Chongqing Univ, Minist Educ, Ctr Bioengn, Key Lab Biomech & Tissue Engn, Chongqing 400044, Peoples R China.
RP Wang, YL (reprint author), Chongqing Univ, Minist Educ, Ctr Bioengn, Key Lab Biomech & Tissue Engn, Chongqing 400044, Peoples R China.
EM wyl@cqu.edu.cn
CR Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   Luo YF, 2004, CHINESE CHEM LETT, V15, P521
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Wang XM, 1997, T NONFERR METAL SOC, V7, P5
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yu Yen, 2000, SHENGWU YIYONG CAILI, P54
NR 8
TC 7
Z9 11
U1 0
U2 3
PU CHINESE CHEMICAL SOCIETY
PI BEIJING
PA C/O DEPT INT AFFAIRS, SECRETARY OF CHEM SOC, PO BOX 2709, BEIJING
   100080, PEOPLES R CHINA
SN 1001-8417
J9 CHINESE CHEM LETT
JI Chin. Chem. Lett.
PD AUG
PY 2005
VL 16
IS 8
BP 1035
EP 1038
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 952WM
UT WOS:000231036500013
DA 2018-10-19
ER

PT J
AU Poll, B
   Buttler, P
   Graber, HG
   Lampert, F
   Becker, C
AF Poll, B
   Buttler, P
   Graber, HG
   Lampert, F
   Becker, C
TI Engrafting periodontal fibroblasts with new 3-dimensional polylactide
   foams
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE polylactide scaffolds; periodontal fibroblasts; cell carrier matrix
ID GUIDED TISSUE REGENERATION; MONOCLONAL-ANTIBODIES; GINGIVAL FIBROBLASTS;
   IN-VITRO; CELLS; DEGRADATION; CULTURE
AB In clinical periodontics, "tissue engineering" techniques have been developed to guide the regenerative process following periodontal disease. We explored a new shaped biomaterial in order to promote cellular adhesion, proliferation and migration of periodontal cells. Granules of poly-D,L-lactide were foamed In specially designed moulds by a controlled gas-loading process. Explant cultures of periodontal tissue were seeded at different densities on the 3-dimensional scaffolds following analysis of cytotoxicity, cell proliferation and differentiation. The moulding procedure led to porous structures with predetermined tubes for cellular locomotion. Cells adhered to and populated the material's surface and inner cavities while retaining fibroblastic phenotype. An optimal ratio between cellular proliferation and mortality rate was achieved at a seeding density of > 10(6) cells/cm(3) scaffold. We designed modified polylactide scaffolds capable of acting as a stent and a cell carrier matrix. The foaming process is easy, cheap and suitable for commercial production.
C1 Rhein Westfal TH Aachen, Fac Med, Dept Urol, D-52074 Aachen, Germany.
   Rhein Westfal TH Aachen, Univ Hosp, Dept Urol, D-52074 Aachen, Germany.
   Rhein Westfal TH Aachen, Fac Med, Dept Operat Dent Periodontol & Prevent Dent, D-5100 Aachen, Germany.
   Rhein Westfal TH Aachen, Univ Hosp, Dept Operat Dent Periodontol & Prevent Dent, D-5100 Aachen, Germany.
RP Becker, C (reprint author), Rhein Westfal TH Aachen, Fac Med, Dept Urol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM cbecker@ukaachen.de
CR Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Becker C, 2002, EUR J ORAL SCI, V110, P137, DOI 10.1034/j.1600-0722.2002.11202.x
   BUCHHOLZ B, 1993, J MATER SCI-MATER M, V4, P381, DOI 10.1007/BF00122196
   FARJANEL J, 1984, BIOCHEM BIOPH RES CO, V123, P1002, DOI 10.1016/S0006-291X(84)80233-8
   Graber HG, 1999, J PERIODONTOL, V70, P388, DOI 10.1902/jop.1999.70.4.388
   Hillmann G, 2002, BIOMATERIALS, V23, P1461, DOI 10.1016/S0142-9612(01)00270-8
   Ignatius AA, 2001, J BIOMAT SCI-POLYM E, V12, P185, DOI 10.1163/156856201750180915
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Page Roy C, 2002, Compend Contin Educ Dent, V23, P11
   RATNER BD, 1996, BIOMATERIALS SCI INT, P64
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   Takata T, 2001, J PERIODONTAL RES, V36, P322, DOI 10.1034/j.1600-0765.2001.360508.x
   Unsal B, 1999, J Oral Sci, V41, P57
   Voges Jurgen, 2002, J Exp Ther Oncol, V2, P70, DOI 10.1046/j.1359-4117.2002.01012.x
   Ziccardi V B, 1996, N Y State Dent J, V62, P48
NR 16
TC 1
Z9 1
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 2005
VL 28
IS 8
BP 827
EP 833
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 972VG
UT WOS:000232480700009
PM 16211533
DA 2018-10-19
ER

PT J
AU Christenson, EM
   Dadsetan, M
   Anderson, JM
   Hiltner, A
AF Christenson, EM
   Dadsetan, M
   Anderson, JM
   Hiltner, A
TI Biostability and macrophage-mediated foreign body reaction of
   silicone-modified polyurethanes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 30th Annual Meeting of the Society-for-Biomaterials
CY APR 27-30, 2005
CL Memphis, TN
SP Soc Biomat
DE poly(ether urethane); poly(carbonate urethane); silicone; foreign body
   response; apoptosis
ID POLY(ETHERURETHANE UREA) ELASTOMERS; GIANT-CELL FORMATION; IN-VIVO;
   POLY(CARBONATE URETHANE); MONOCYTES MACROPHAGES; BIODEGRADATION;
   INTERLEUKIN-4; BIOCOMPATIBILITY; MECHANISMS; APOPTOSIS
AB In this study, the effect of soft segment chemistry on the phase morphology and in vivo response of commercial-grade poly(ether urethane) (PEU), silicone-modified PEU (PEU-S), poly(carbonate urethane) (PCU), and silicone-modified.PCU (PCU-S) elastomers were examined. Silicone-modified polyurethanes were developed to combine the biostability of silicone with the mechanical properties of PEUs. Results from the infrared spectroscopy confirmed the presence of silicone at the surface of the PEU-S and PCU-S films. Atomic force microscopy phase imaging indicated that the overall two-phase morphology of PEUs, necessary for its thermoplastic elastomeric properties, was not disrupted by the silicone modification. After material characterization, the in vivo foreign body response and biostability of the polyurethanes were studied using a subcutaneous cage implant protocol. The results from the cage implant study indicated that monocytes adhere, differentiate to macrophages which fuse to form foreign body giant cells on all of the polyurethanes. However, the silicone-modified surfaces promoted apoptosis of adherent macrophages at 4 days and high levels of macrophage fusion after 21 days. These results confirm that the surface of a biomaterial may influence the induction of apoptosis of adherent macrophages in vivo and are consistent with previous cell culture studies of these materials. This study validates the use of our standard cell culture protocol to predict in vivo behavior and further supports the hypothesis that interleukin-4 is the primary mediator of macrophage fusion and foreign body giant cell formation in vivo. The impact of these findings on the biostability of polyurethanes is the subject of current investigations. Attenuated total reflectance-Fourier transform infrared analysis of explanted specimens provided evidence of chain scission and crosslinking at the surface of all of the polyurethanes. The silicone modification did not fully inhibit the oxidative biodegradation of the polyether or polycarbonate soft segments; however, the rate of chain scission of PEU-S and PCU-S seemed to be slower than the control polyurethanes. To verify this finding and to quantify the rate of chain scission in order to predict long-term biostability, an in vitro environment that simulated the microenvironment at the adherent cell-material interface was used to accelerate the biodegradation of the polyurethanes. Polyurethane films were treated in vitro for up to 36 days in 20% hydrogen peroxide/0.1M cobalt chloride solution at 37 C. Characterization with attenuated total reflectance-Fourier transform infrared and scanning electron microscopy showed soft segment and hard segment degradation consistent with the chemical changes observed after long-term in vivo treatment. The biostability ranking of these four materials based on rate of chain scission and surface pitting was as follows: PEU < PEU-S : PCU < PCU-S. The silicone modification increased the biostability of the PEU and PCU elastomers while maintaining the thermoplastic elastomeric properties. (c) 2005 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Ctr Appl Polymer Res, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Hiltner, A (reprint author), Case Western Reserve Univ, Dept Macromol Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM pah6@cwru.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU NIBIB NIH HHS [EB-00272]
CR Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Dillon J., 1989, INFRARED SPECTROSCOP
   Fare S, 1999, J BIOMED MATER RES, V45, P62, DOI 10.1002/(SICI)1097-4636(199904)45:1<62::AID-JBM9>3.0.CO;2-F
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Gogolewski S., 1991, TRENDS POLYM SCI, V1, P47
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   KALMAN PG, 1991, J BIOMED MATER RES, V25, P199, DOI 10.1002/jbm.820250207
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Lambda N., 1998, POLYURETHANES BIOMED
   Lelah M. D., 1986, POLYURETHANES MED
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   Martin DJ, 2000, BIOMATERIALS, V21, P1021, DOI 10.1016/S0142-9612(99)00271-9
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Shive MS, 2002, J BIOMED MATER RES, V60, P148, DOI 10.1002/jbm.10035
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Szycher M, 1992, Med Device Technol, V3, P42
   Ward RS, 1996, ASAIO J, V42, P17
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   WIGGINS MJ, 2003, J BIOMED MATER RES A, V68, P668
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 31
TC 36
Z9 36
U1 0
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 141
EP 155
DI 10.1002/jbm.a.30317
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300001
PM 16201029
DA 2018-10-19
ER

PT J
AU Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
AF Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
TI Effects of nano HAP on biological and structural properties of glass
   bone cement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nanoscale hydroxyapatite; bone cement; cell proliferation
ID CALCIUM-PHOSPHATE CEMENT; ANTIBIOTIC DELIVERY SYSTEM; GIANT-CELL TUMOR;
   RELEASE
AB A novel type of glass-based nanoscale hydroxyapatite (HAP) bioactive bone cement (designed as GBN-HAPC) was synthesized by adding nanoscale hydroxyapatite crystalline (20-40 nm), into the self-setting glass-based bone cement (GBC). The inhibition rate of nanoscale HAP and micron HAP on osteosarcoma U2-OS cells was examined. The effects of nanoscale HAP on the crystal phase, microstructure and compressive strength of GBNHAPC were studied, respectively. It was concluded that nanoscale HAP could inhibit the cell proliferation, whereas micron HAP could not, and that nanoscale HAP could be dispersed in the cement evenly and the morphology did not change significantly after a longer immersion time. XRD and FTIR results show nanoscale HAP did not affect the setting reaction of the cement. Furthermore, GBNHAPC had a higher compressive strength (92.6 +/- 3.8 MPa) than GBC (80.1 +/- 3.0 MPa). It was believed that GBNHAPC might be a desirable biomaterial that could not only fill bone defects but also inhibit cancer cell growth. (c) 2005 Wiley Periodicals, Inc.
C1 Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
   Tongji Univ, Tongji Hosp, Shanghai 200065, Peoples R China.
RP Fu, Q (reprint author), Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
EM fuharry@hotmail.com
RI Fu, Qiang/B-1972-2013
CR Aoki H., 1993, REP I MED DENT ENG, V27, P39
   BINI SA, 1995, CLIN ORTHOP RELAT R, P245
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   CAMPANACCI M, 1987, J BONE JOINT SURG AM, V69A, P106, DOI 10.2106/00004623-198769010-00018
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Liu CS, 1997, J MATER SCI-MATER M, V8, P803, DOI 10.1023/A:1018529116330
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   OTSUKA M, 1994, J PHARM SCI, V83, P259, DOI 10.1002/jps.2600830230
   Otsuka M, 1997, BIOMATERIALS, V18, P1559, DOI 10.1016/S0142-9612(97)00097-5
   Shinzato S, 2001, J BIOMED MATER RES, V56, P571, DOI 10.1002/1097-4636(20010915)56:4<571::AID-JBM1129>3.0.CO;2-H
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
   Yang QZ, 2002, BIOMATERIALS, V23, P2751, DOI 10.1016/S0142-9612(02)00010-8
   ZHANG SC, 1996, J WUHAN UNIV TECHNOL, V18, P5
NR 15
TC 34
Z9 36
U1 0
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 156
EP 163
DI 10.1002/jbm.a.30322
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300002
PM 15962272
DA 2018-10-19
ER

PT J
AU Brodbeck, WG
   MacEwan, M
   Colton, E
   Meyerson, H
   Anderson, JM
AF Brodbeck, WG
   MacEwan, M
   Colton, E
   Meyerson, H
   Anderson, JM
TI Lymphocytes and the foreign body response: Lymphocyte enhancement of
   macrophage adhesion and fusion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE foreign body response; macrophages; lymphocytes; foreign body giant cell
ID IN-VIVO; MONOCYTES MACROPHAGES; SURFACE-CHEMISTRY; GIANT-CELLS; T-CELLS;
   INTERLEUKIN-4; EXPRESSION; DIFFERENTIATION; BIOMATERIALS; MIGRATION
AB The host foreign body response ensues immediately following implantation of medical devices and prostheses. We have previously identified the role of macrophages in adhering to biomaterial surfaces and guiding the foreign body response while fusing into foreign body giant cells (FBGCs) and concentrating degradative and phagocytic activities. Despite their early and transient presence around implanted biomaterials, few studies have focused on the role of lymphocytes in the foreign body response and biocompatibility. To address this, an in vitro human lymphocyte/macrophage coculture system has been developed. Using this system, it has been shown that when lymphocytes are present during the initial adhesion of monocytes, the rate of monocyte adhesion and fusion is significantly increased (1,500 cells/mm(2) and 60%, respectively) when compared to either no lymphocytes present (500 cells/mm(2) adhesion and 0% fusion). Although lymphocytes adhered to the tissue culture polystyrene surface, 90% of the lymphocytes were associated with adherent macrophages. However, these cell-cell direct interactions were not necessary to influence macrophage adhesion or fusion as separating the two cell types by a Transwell insert still resulted in significantly increased levels of macrophage adhesion (p < 0.05 when compared to macrophage only cultures). Conversely, the presence of macrophages in Transwell experiments increased lymphocyte proliferation rates at all time points tested. These studies begin to detail the interactions between lymphocytes and macrophages in the absence of known antigen that appropriately relates to the scenarios experienced upon implantation of biomedical devices and the initiation of the foreign body response. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
   Univ Hosp Cleveland, Dept Hematopathol & Flow Cytometry, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [EB-00282]
CR Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   BELLER DI, 1978, FED PROC, V37, P91
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   BODEKER BGD, 1980, EUR J IMMUNOL, V10, P702, DOI 10.1002/eji.1830100909
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375
   CEUSOT RJ, 2002, MOL IMMUNOL, V39, P997
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   HELLE M, 1988, EUR J IMMUNOL, V18, P957, DOI 10.1002/eji.1830180619
   HOUSSIAU FA, 1988, EUR J IMMUNOL, V18, P653, DOI 10.1002/eji.1830180427
   IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   Shankar Ravi, 1994, P67
   UYTTENHOVE C, 1988, J EXP MED, V167, P1417, DOI 10.1084/jem.167.4.1417
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 26
TC 51
Z9 52
U1 1
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 222
EP 229
DI 10.1002/jbm.a.30313
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300010
PM 15948198
DA 2018-10-19
ER

PT J
AU Whang, KM
   McDonald, J
   Khan, A
   Satsangi, N
AF Whang, KM
   McDonald, J
   Khan, A
   Satsangi, N
TI A novel osteotropic biomaterial OG-PLG: Synthesis and in vitro release
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE statin; controlled delivery; synthesis and characterization;
   poly[lactide-co-glycolide]; bone regeneration
ID BONE MORPHOGENETIC PROTEIN-2; COA REDUCTASE INHIBITORS; MASSIVE
   POLY(ALPHA-HYDROXY ACIDS); STRUCTURE PROPERTY RELATIONSHIPS;
   BIOABSORBABLE SCAFFOLDS; AQUEOUS-MEDIA; DEGRADATION; SIMVASTATIN;
   DELIVERY; POLYMER
AB Statins (e.g., simvastatin) have shown to induce expression of the bone morphogenic protein-2 gene in bone cells, but they are not used clinically because of a lack of a suitable delivery device. The overall objective is to develop optimized statin delivery devices for bone regeneration. The specific objective was to determine the effect of grafting statins to biodegradable poly[lactide-co-glycolide] (PLG) on release kinetics. Simvastatin was grafted to PLG (OG-PLG) and characterized using contact-angle measurements, attenuated total reflectance-Fourier transform infrared, and ultraviolet-visible spectroscopy to determine success of the synthesis. An ultraviolet-visible assay for measuring release of statins and degraded OG-PLG in media was also developed. In vitro release studies using films and scaffolds made with PLG, PLG blended with simvastatin (PLG + Sim), and OG-PLG (simvastatin grafted to PLG) blended into PLG at different concentrations showed that release rate of OG-PLG from films was significantly greater than that of PLG + Sim. However, release rate from scaffolds showed PLG + Sim to be significantly higher than that of OG-PLG. The diffusion-controlled release kinetics of simvastatin from PLG + Sim seems to be more heavily affected by device morphology, whereas the degradation-controlled release kinetics seem to be less affected. In short, release kinetics can be modulated by grafting statins to PLG. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Prosthodont, San Antonio, TX 78229 USA.
RP Whang, KM (reprint author), Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, 7703 Floyd Curl Dr,MSC 7890, San Antonio, TX 78229 USA.
EM whang@uthscsa.edu
FU NIDCR NIH HHS [DE14318, 1R03DE14653]
CR Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P3255, DOI 10.1001/jama.283.24.3255
   Ebara S, 2002, SPINE, V27, pS10, DOI 10.1097/01.BRS.0000020727.98493.20
   ENGEL CR, 1955, CAN J CHEM, V33, P1515, DOI 10.1139/v55-185
   Farnier M, 1998, AM J CARDIOL, V82, p3J, DOI 10.1016/S0002-9149(98)00423-8
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   HABERSTADT C, 1992, MATER RES SOC S P, V252, P3223
   HECKMAN JD, 1991, J BONE JOINT SURG AM, V73A, P750, DOI 10.2106/00004623-199173050-00015
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Issack Paul S, 2003, Am J Orthop (Belle Mead NJ), V32, P429
   LEWIS DH, 1990, DRUGS PHARM SCI BIOD, P1
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205
   MIYANO M, 1965, J AM CHEM SOC, V87, P3958, DOI 10.1021/ja01095a030
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Sandhu HS, 2003, SPINE, V28, pS64, DOI 10.1097/00007632-200308011-00012
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   Schrier J A, 2001, AAPS PharmSciTech, V2, pE18
   Schrier J A, 2001, AAPS PharmSciTech, V2, pE17
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   SERAJUDDIN ATM, 1991, J PHARM SCI, V80, P830, DOI 10.1002/jps.2600800905
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   Sykaras Nikitas, 2003, J Oral Sci, V45, P57
   THERIN M, 1992, BIOMATERIALS, V13, P594, DOI 10.1016/0142-9612(92)90027-L
   VYAS KP, 1990, DRUG METAB DISPOS, V18, P203
   Wang L, 2000, J PHARMACEUT BIOMED, V21, P1243, DOI 10.1016/S0731-7085(99)00231-9
   Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   WHANG K, 2000, AM SOC BON MIN RES 2, pS225
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
NR 42
TC 19
Z9 20
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 237
EP 246
DI 10.1002/jbm.a.30309
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300012
PM 15981201
DA 2018-10-19
ER

PT J
AU Whang, KM
   Grageda, E
   Khan, A
   McDonald, J
   Lawton, M
   Satsangi, N
AF Whang, KM
   Grageda, E
   Khan, A
   McDonald, J
   Lawton, M
   Satsangi, N
TI A novel osteotropic biomaterial OG-PLG: In vitro efficacy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE statin; simvastatin grafted to poly(lactide-co-glycolicle) (OG-PLG); rat
   bone marrow cells; bone regeneration
ID COA REDUCTASE INHIBITORS; MARROW STROMAL CELLS; OSTEOBLAST
   DIFFERENTIATION; BONE; SIMVASTATIN; EXPRESSION; PROTEIN; STATINS;
   FRACTURES; COMPACTIN
AB Previously, a novel osteotropic biomaterial, OG-PLG [simvastatin grafted to poly(lactide-co-glycolide), PLG], was synthesized and shown to have degradation-controlled release kinetics. The objective here was to determine the effect of grafting statins to PLG on bone regeneration in vitro. Rat bone marrow cells were stimulated in vitro with simvastatin dissolved in media, saponified simvastatin dissolved in media, simvastatin released through diffusion from emulsion freeze-dried scaffolds, and OG-PLG. Unstimulated cultures and cultures stimulated with dexamethasone were used as negative and positive controls, respectively. In vitro bone formation was assessed using the alkaline phosphatase (ALP) and von Kossa assays at different times up to 16 days. ALP analysis revealed that saponified simvastatin at 10(-7) M and OG-PLG significantly increased ALP expression at various time points. von Kossa assay showed that simvastatin, saponified simvastatin, and OG-PLG significantly enhanced mineralization, with the effect from OG-PLG being the most significant. In short, OG-PLG significantly enhanced in vitro bone cell mineralization beyond the effect of simvastatin or saponified simvastatin dissolved in media and simvastatin released via diffusion from scaffolds. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Prosthodont, San Antonio, TX 78229 USA.
RP Whang, KM (reprint author), Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, 7703 Floyd Curl Dr,MSC 7890, San Antonio, TX 78229 USA.
EM whang@uthscsa.edu
FU NIDCR NIH HHS [1 R03DE 14653, DE14318]
CR Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y
   Bi LX, 1999, CALCIFIED TISSUE INT, V64, P63, DOI 10.1007/s002239900580
   Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P3255, DOI 10.1001/jama.283.24.3255
   HABERSTADT C, 1992, MATER RES SOC S P, V252, P323
   HARRIS SE, 1994, J BONE MINER RES, V9, P389
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   KEYOMARSI K, 1991, CANCER RES, V51, P3602
   Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002.220682
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597
   Ohno T, 2003, TRANSPLANTATION, V76, P869, DOI 10.1097/01.TP.0000074992.49236.58
   Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987
   Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   TODD PA, 1990, DRUGS, V40, P583, DOI 10.2165/00003495-199040040-00007
   Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211
   Wang XD, 2003, ARCH BIOCHEM BIOPHYS, V415, P6, DOI 10.1016/S0003-9861(03)00213-3
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   WHANG K, 2005, IN PRESS J BIOMED MA
   Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0
NR 22
TC 14
Z9 14
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2005
VL 74A
IS 2
BP 247
EP 253
DI 10.1002/jbm.a.30370
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 945KB
UT WOS:000230500300013
PM 15962265
DA 2018-10-19
ER

PT J
AU Lee, VA
   Craig, RG
   Filisko, FE
   Zand, R
AF Lee, VA
   Craig, RG
   Filisko, FE
   Zand, R
TI Microcalorimetry of the adsorption of lysozyme onto polymeric substrates
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE lysozyme; protein adsorption; protein conformation; microcalorimetry;
   biocompatibility; interfacial energy
ID BOVINE PANCREAS RIBONUCLEASE; FOREIGN SURFACE INTERACTIONS; HUMAN-PLASMA
   ALBUMIN; PROTEIN ADSORPTION; 3-DIMENSIONAL STRUCTURE; POLYSTYRENE
   SURFACES; SERUM-ALBUMIN; THERMODYNAMICS; CALORIMETRY; MECHANISMS
AB The conformation of blood proteins adsorbed on biomaterial surfaces probably plays a significant role in the biocompatibility of bloodcontacting implants. This paper reports heats of adsorption of a globular protein, lysozyme, onto three uncharged polymeric substrates. Variations in heats among substrates reflect differences in the lysozyme/substrate interaction as well as the possibility of substrate-dependent conformations. In each case, a series of plateaus appeared in the adsorption isotherm with increasing concentration. In the cases of two substrates, polystyrene and poly(styrene-co-butyl methacrylate), endothermic discontinuities appeared at rises between plateaus. It is proposed that the step pattern in each isotherm reflects distinct conformational states of lysozyme on the substrate surfaces. Endothermic discontinuities may be latent heats associated with change to a more stable conformation after initial adsorption. The absence of discontinuities in the case of poly(styrene-co-allyl alcohol) suggests structural transitions occur to a smaller extent on this material and results in conformations different from those which occur when lysozyme is adsorbed by polystyrene or by poly(styrene-co-butyl methacrylate). (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA.
   Univ Michigan, Ann Arbor, MI 48109 USA.
RP Lee, VA (reprint author), Univ Texas, Hlth Sci Ctr, 7703 Floyd Curl Dr, San Antonio, TX 78285 USA.
EM leev@uthscsa.edu
CR BIRDI KS, 1973, J COLLOID INTERFACE, V43
   Cantor CR, 1980, BIOPHYSICAL CHEM
   CHATTORAJ DK, 1959, J AM CHEM SOC, V81, P5128, DOI 10.1021/ja01528a027
   CHIU TH, 1976, T AM SOC ART INT ORG, V22, P498
   COOPER A, 1976, P NATL ACAD SCI USA, V73, P2740, DOI 10.1073/pnas.73.8.2740
   FAIR BD, 1980, J COLLOID INTERF SCI, V77, P525, DOI 10.1016/0021-9797(80)90325-2
   FILISKO FE, 1986, BIOMATERIALS, V7, P348, DOI 10.1016/0142-9612(86)90005-0
   FLEER GJ, 1988, MAKROMOL CHEM-M SYMP, V17, P39, DOI 10.1002/masy.19880170106
   GIVOL D, 1965, P NATL ACAD SCI USA, V53, P676, DOI 10.1073/pnas.53.3.676
   HLADY V, 1979, J COLLOID INTERF SCI, V69, P460, DOI 10.1016/0021-9797(79)90135-8
   JOLLES P, 1960, ENZYMES
   KANG IK, 1988, BIOMATERIALS, V9, P138, DOI 10.1016/0142-9612(88)90112-3
   KOGOWSKI G, 1980, J PHYS CHEM-US, V84, P2262, DOI 10.1021/j100455a009
   KOUTSOUKOS PG, 1983, J COLLOID INTERF SCI, V95, P385, DOI 10.1016/0021-9797(83)90198-4
   KRESHECK GC, 1969, BIOCHEMISTRY-US, V8, P8, DOI 10.1021/bi00829a002
   Lee VA, 1996, J BIOMED MATER RES, V31, P51, DOI 10.1002/(SICI)1097-4636(199605)31:1<51::AID-JBM7>3.0.CO;2-P
   Levine S N, 1969, J Biomed Mater Res, V3, P83, DOI 10.1002/jbm.820030108
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Lu JR, 1998, J COLLOID INTERF SCI, V206, P212, DOI 10.1006/jcis.1998.5680
   LUNDSTROM I, 1987, POLYM SURFACES INTER
   Macritchie F, 1978, Adv Protein Chem, V32, P283, DOI 10.1016/S0065-3233(08)60577-X
   MARON SH, 1972, J MACROMOL SCI PHYS, VB  6, P57, DOI 10.1080/00222347208224789
   NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P295, DOI 10.1016/0021-9797(78)90307-7
   NYILAS E, 1974, T AM SOC ART INT ORG, VB 20, P480
   OLESEN H, 1968, ACTA CHEM SCAND, V22, P1386, DOI 10.3891/acta.chem.scand.22-1386
   PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551
   Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X
   SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015
   STEVENS O, 1967, P SOC EXP BIOL MED, V124, P187
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   YAN G, 1995, PROTEINS INTERFACES, V2
   1975, HDB BIOCH MOL BIOL, V2
NR 33
TC 12
Z9 12
U1 1
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD AUG 1
PY 2005
VL 288
IS 1
BP 6
EP 13
DI 10.1016/j.jcis.2005.02.057
PG 8
WC Chemistry, Physical
SC Chemistry
GA 936NB
UT WOS:000229861600002
PM 15927555
DA 2018-10-19
ER

PT J
AU Yang, JM
   Lin, HT
   Yang, SJ
AF Yang, JM
   Lin, HT
   Yang, SJ
TI Evaluation of poly(N-isopropylacrylamide) modified hydroxyl-terminated
   polybutadiene based polyurethane membrane
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE hydroxyl-terminated polybutadiene; polyurethane;
   poly(N-isopropylacrylamide); wettability; permeability
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; WATER-VAPOR TRANSMISSION; OXYGEN
   PERMEATION; SURFACE-PROPERTIES; BIOMATERIAL USAGE; WOUND DRESSINGS;
   CULTURED-CELLS; UV-RADIATION; TEMPERATURE
AB Hydroxyl-terminated polybutadiene (HTPB) based polyurethane was synthesized by reacting equal equivalent of 4,4-methylene dipheny) diisocyanate (MDI) and hydroxyl-terminated polybutadiene with 1,4-butane diol (BDO) as chain extender. The HTPB based polyurethane was modified by UV radiation with N-isopropylacrylamide monomer to get poly (N-isopropylacrylamide) modified polyurethane (PUNIPAAm). The cohesive properties were calculated by group contribution methods. The characterization of the PUNIPAAm membrane was studied by the Fourier transform infrared spectroscopy, Nikon Microphot-Fx, and Universal Testing Machine for the chemical composition, morphology, and stress-strain curve. Water content and contact angles of distilled water on the PUNIPAAm membrane were evaluated and the surface tension of PUNIPAAm was calculated. The diffusion coefficient of distilled water in the membrane was determined. The measurement of water vapor transmission rate on PUNIPAAm membranes was also evaluated. It was found that the values of surface tension, water vapor transmission rate, and diffusion coefficient of water on PUNIPAAm membranes were higher than those on pure polyurethane. The property changes reduced the permeability of oxygen through PUNIPAAm membrane. The preexponential terms (P-O) and activation energies (E-act) for oxygen through various PUNIPAAm membranes were obtained by the Arrhenius law. The preexponential term P-O for PUNIPAAm membranes is lower than that of pure PU; whereas there is no significant difference for the activation energy of oxygen through PUNIPAAm and pure PU. (c) 2005 Elsevier B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
CR CARDONA LR, 1996, BIOMATERIALS, V17, P1639
   CHEN CC, 2000, Patent No. 6022330
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   Lim YH, 1997, J APPL POLYM SCI, V64, P2647
   Lin FH, 2000, MATER CHEM PHYS, V64, P189, DOI 10.1016/S0254-0584(99)00262-X
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1995, J CONTROL RELEASE, V36, P125, DOI 10.1016/0168-3659(95)00054-C
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Takahashi H, 2003, BLOOD COAGUL FIBRIN, V14, P87, DOI 10.1097/01.mbc.0000046174.72384.29
   TAKEI YG, 1995, BIOMATERIALS, V16, P667, DOI 10.1016/0142-9612(95)99692-F
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   VANKREVELEN DW, 1976, PROPERTIES POLYM, pCH7
   Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yakushiji T, 1999, ANAL CHEM, V71, P1125, DOI 10.1021/ac980677t
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang JM, 1997, J APPL POLYM SCI, V65, P365, DOI 10.1002/(SICI)1097-4628(19970711)65:2<365::AID-APP17>3.0.CO;2-Z
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 2002, J MEMBRANE SCI, V208, P105, DOI 10.1016/S0376-7388(02)00180-1
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1995, ANGEW MAKROMOL CHEM, V231, P1, DOI 10.1002/apmc.1995.052310101
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   Yang JM, 2001, J MEMBRANE SCI, V187, P159, DOI 10.1016/S0376-7388(01)00340-4
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 37
TC 17
Z9 18
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD AUG 1
PY 2005
VL 258
IS 1-2
BP 97
EP 105
DI 10.1016/j.memsci.2005.02.033
PG 9
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 942QD
UT WOS:000230296000013
DA 2018-10-19
ER

PT J
AU El Fray, M
   Boccaccini, AR
AF El Fray, M
   Boccaccini, AR
TI Novel hybrid PET/DFA-TiO2 nanocomposites by in situ polycondensation
SO MATERIALS LETTERS
LA English
DT Article
DE polymers; nanomaterials; TiO2 nanoparticles
ID TISSUE ENGINEERING APPLICATIONS; COMPOSITE-MATERIALS; NANOPHASE
   CERAMICS; POLYESTER; TIO2; SOL; BIOCOMPATIBILITY; OSTEOBLAST;
   COPOLYMERS; ADHESION
AB Multiblock poly(aliphatic/aromatic-ester)s containing phthalic acid sequences (as in poly(ethylene terephthalate) (PET) or poly(butylene terephthalate) (PBT)) and a dimmer fatty acid (DFA) represent novel biocompatible materials offering the processability of thermoplastics combined with the good elasticity of rubber (thermoplastic elastomers, TPE). In the present investigation TiO2 nanoparticles were incorporated into PET/DFA copolymer with the aim of increasing mechanical properties and bioactivity, for use of the composites in tissue engineering and other biomedical applications. It was found that a relatively low concentration of TiO2 nanoparticles (0.13 vol.%) led to an impressive improvement of fracture strength (100%) and elongation at fracture (300%). As expected, the surface roughness increased with the addition of TiO2 nanoparticles. However upon immersion in simulated body fluid for up to 21 days, the composites did not exhibit formation of hydroxyapatite crystals on their surfaces, confirming the "bioinert" character of the composite constituents. This indicates that the possible bioactive behavior of the composites in in vitro or in vivo conditions may be related to the improved nanotopography imparted by TiO2 nanoparticle additions rather than due to chemistry related effects at the cell/biomaterial interface. (c) 2005 Elsevier B.V. All rights reserved.
C1 Szcsecin Univ Technol, Inst Polymer, PL-70322 Szczecin, Poland.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP El Fray, M (reprint author), Szcsecin Univ Technol, Inst Polymer, Pulaskiego 10, PL-70322 Szczecin, Poland.
EM mirfray@ps.pl
RI El Fray, Miroslawa/J-4128-2016; Boccaccini, Aldo/C-7905-2013
OI El Fray, Miroslawa/0000-0002-2474-3517
CR Areva S, 2004, J BIOMED MATER RES A, V70A, P169, DOI 10.1002/jbm.a.20120
   BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Chen XC, 2002, J MATER SCI LETT, V21, P1637, DOI 10.1023/A:1020871830587
   El Fray M, 2000, J MATER SCI-MATER M, V11, P757
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   El Fray M, 2003, NANOSTRUCTURED ELAST, P1
   ELFRAY M, 2003, SCI PAPERS I ORGANIC, V52, P481
   ETTLINGER M, TECHNICAL B PIGMENTS, V80, P5
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Holden G., 1996, THERMOPLASTIC ELASTO
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jokinen M, 1998, J BIOMED MATER RES, V42, P295, DOI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Moritz N, 2003, J BIOMED MATER RES A, V65A, P9, DOI 10.1002/jbm.a.10434
   Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Renke-Gluszko M, 2004, BIOMATERIALS, V25, P5191, DOI 10.1016/j.biomaterials.2003.12.021
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   SZYCHER M, 1990, POLYURETHANE ELASTOM
   Wang SX, 1999, J MATER SCI LETT, V18, P2009, DOI 10.1023/A:1006646219253
   Webster TJ, 2003, AM CERAM SOC BULL, V82, P23
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wise DL, 2000, BIOMATERIALS BIOENGI
   Zheng MP, 2000, J MATER SCI LETT, V19, P433, DOI 10.1023/A:1006703224379
NR 27
TC 37
Z9 37
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2005
VL 59
IS 18
BP 2300
EP 2304
DI 10.1016/j.matlet.2005.03.008
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 935XQ
UT WOS:000229817100014
DA 2018-10-19
ER

PT J
AU Lee, SH
   Takahashi, E
   Nomura, N
   Chiba, A
AF Lee, SH
   Takahashi, E
   Nomura, N
   Chiba, A
TI Effect of heat treatment on microstructure and mechanical properties of
   Ni- and C-free Co-Cr-Mo alloys for medical applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt chromium molybdenum alloy; microstructure; mechanical properties;
   heat treatment; biomaterial; nickel carbon free
ID IMPLANT ALLOY
AB The effect of pre-heat treatments, followed by a hot forging process, on the microstructure and strength of Co-Cr-Mo alloys was investigated. Four pre-heat treatments were conducted at 1170, 1200, 1230 and 1260 degrees C for three different time condition: 2, 6 and 15 h and then water cooled to room temperature. Tensile tests and XRD analyses were carried out on both as-east alloy and heat-treated alloys. The volume fraction of retained gamma phase increases with increasing the heat treatment temperature, suggesting that the gamma -> epsilon martensitic transformation is suppressed by a higher temperature heat treatment. Tensile strength slightly decreases with increasing the heat treatment temperature and the heat treatment time, whereas the ductility slightly increases. The a phase completely dissolves into matrix when the alloy is heat-treated at 1260 degrees C for longer than 6 h.
C1 Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welf Engn, Morioka, Iwate 0208551, Japan.
RP Lee, SH (reprint author), Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
RI NOMURA, Naoyuki/L-7149-2017; Chiba, Akihiko/D-1326-2011
CR Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   Huang P, 1999, MATER LETT, V39, P249, DOI 10.1016/S0167-577X(99)00022-1
   Montero-Ocampo C, 1999, METALL MATER TRANS A, V30, P611, DOI 10.1007/s11661-999-0052-6
   Pickering F. B., 1978, PHYS METALLURGY DESI, P10
   Sage M., 1950, REV METALL, V49, P139
   SHI LQ, 1994, J MATER SCI, V29, P1233, DOI 10.1007/BF00975070
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   TAYLOR RNJ, 1983, J MATER SCI, V18, P3265, DOI 10.1007/BF00544151
   ZHUANG LZ, 1989, J MATER SCI, V24, P381, DOI 10.1007/BF01107415
NR 9
TC 30
Z9 30
U1 0
U2 7
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2005
VL 46
IS 8
BP 1790
EP 1793
DI 10.2320/matertrans.46.1790
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 958VP
UT WOS:000231476600013
DA 2018-10-19
ER

PT J
AU Matsuura, H
   Inoue, T
   Ogasawara, K
   Sasaki, M
   Konno, H
   Kuzu, Y
   Nishimoto, H
   Ogawa, A
AF Matsuura, H
   Inoue, T
   Ogasawara, K
   Sasaki, M
   Konno, H
   Kuzu, Y
   Nishimoto, H
   Ogawa, A
TI Quantitative analysis of magnetic resonance imaging susceptibility
   artifacts caused by neurosurgical biomaterials: Comparison of 0.5, 1.5.
   and 3.0 Tesla magnetic fields
SO NEUROLOGIA MEDICO-CHIRURGICA
LA English
DT Article
DE ceramic; magnetic field strength; magnetic resonance imaging;
   neurosurgical implants
ID RECONSTRUCTION; QUANTIFICATION; COMPATIBILITY; VISUALIZATION; IMAGES
AB Magnetic resonance (MR) imaging is an important diagnostic tool for neurosurgical diseases but susceptibility artifacts caused by biomaterial instrumentation frequently causes difficulty in visualizing postoperative changes. The susceptibility artifacts caused by neurosurgical biomaterials were compared quantitatively by 0.5, 1.5, and 3.0 Tesla MR imaging. MR imaging of uniform size and shape of pieces ceramic (zirconia), pure titanium, titanium alloy, and cobalt-based alloy was performed at 0.5, 1.5, and 3.0 Tesla. A linear region of interest was defined across the center of the biomaterial in the transverse direction, and the susceptibility artifact diameter was calculated. Susceptibility artifacts developed around all biomaterials at all magnetic field strengths. The artifact diameters caused by pure titanium, titanium alloy, and cobalt-based alloy increased in the order of 0.5, 1.5, to 3.0 Tesla magnetic fields. The artifact diameter of ceramic was not influenced by magnetic field strength, and was the smallest of all biomaterials at all magnetic field strengths. The artifacts caused by biomaterials except ceramic increase with the magnetic field strength. Ceramic instrumentation will minimize artifacts in all magnetic fields.
C1 Iwate Med Univ, Sch Med, Dept Neurosurg, Morioka, Iwate 0208505, Japan.
   Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 0208505, Japan.
RP Inoue, T (reprint author), Iwate Med Univ, Sch Med, Dept Neurosurg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.
EM tainoue@iwate-med.ac.jp
CR BATZDORF U, 1991, SPINE, V16, P123, DOI 10.1097/00007632-199102000-00004
   BYDDER GM, 1982, AM J ROENTGENOL, V139, P215, DOI 10.2214/ajr.139.2.215
   CHRISTOFFERSSON JO, 1991, ACTA RADIOL, V32, P426, DOI 10.1177/028418519103200519
   CROOKS LE, 1982, RADIOLOGY, V144, P843, DOI 10.1148/radiology.144.4.7111736
   CROOKS LE, 1983, RADIOLOGY, V146, P123, DOI 10.1148/radiology.146.1.6849032
   FARAHANI K, 1990, COMPUT MED IMAG GRAP, V14, P409, DOI 10.1016/0895-6111(90)90040-I
   Frahm C, 1996, CARDIOVASC INTER RAD, V19, P335
   Grieve JP, 1999, NEURORADIOLOGY, V41, P680, DOI 10.1007/s002340050824
   KOBAYASHI S, 1981, SURG NEUROL, V15, P196, DOI 10.1016/0090-3019(81)90142-7
   KOYAMA T, 1986, SURG NEUROL, V25, P71, DOI 10.1016/0090-3019(86)90118-7
   Matsuura H, 2002, J NEUROSURG, V97, P1472, DOI 10.3171/jns.2002.97.6.1472
   Nitatori T, 1999, Radiat Med, V17, P329
   Port JD, 2000, J COMPUT ASSIST TOMO, V24, P958, DOI 10.1097/00004728-200011000-00024
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   Shellock FG, 1996, JMRI-J MAGN RESON IM, V6, P954, DOI 10.1002/jmri.1880060620
   TOMINAGA T, 1995, NEUROSURGERY, V36, P951, DOI 10.1227/00006123-199505000-00010
   YAMASHIMA T, 1988, ACTA NEUROCHIR, V90, P157, DOI 10.1007/BF01560572
NR 17
TC 31
Z9 34
U1 0
U2 3
PU JAPAN NEUROSURGICAL SOC
PI TOKYO
PA C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033,
   JAPAN
SN 0470-8105
J9 NEUROL MED-CHIR
JI Neurol. Med.-Chir.
PD AUG
PY 2005
VL 45
IS 8
BP 395
EP 398
DI 10.2176/nmc.45.395
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 957BG
UT WOS:000231343700003
PM 16127256
OA Bronze
DA 2018-10-19
ER

PT J
AU Krischek, B
   Morgenstern, E
   Mestres, P
   Klinkhardt, U
   Brannath, W
   Wieding, U
   Nemeh, A
   Heinrich, W
   Schenk, J
   Wenzel, T
   Wenzel, E
AF Krischek, B
   Morgenstern, E
   Mestres, P
   Klinkhardt, U
   Brannath, W
   Wieding, U
   Nemeh, A
   Heinrich, W
   Schenk, J
   Wenzel, T
   Wenzel, E
TI Adhesion, spreading, and aggregation of platelets in flowing blood and
   the reliability of the retention test Homburg
SO SEMINARS IN THROMBOSIS AND HEMOSTASIS
LA English
DT Article; Proceedings Paper
CT Symposium on Significance of Drug Monitoring and the Reliability of
   Platelet Function Tests
CY FEB, 2003
CL Innsbruck, AUSTRIA
SP Soc Thrombos & Haemostas Res
DE platelet function measurement; platelet adhesion; platelet aggregation;
   shear stress; platelet-biomaterial interaction
ID SUBENDOTHELIUM; DISEASE
AB Adhesion and aggregation are important parameters characterizing the function of intact platelets in flowing blood and in contact with a more or less thrombogenic surface. In the retention test Homburg (RTH), platelets are exposed to a standardized textured surface (Sysmex retention tubes) under defined conditions of flow. Platelet counts are performed before and after the Sysmex retention tube passage. The difference between these values indicates the percentage of retained platelets (retention index). Decreased retention in the RTH indicates a loss of function or defective platelet function; increase is associated with an increased activation of platelets, for example, in patients with vascular diseases. For further evaluation of the retention phenomenon the filters were fixed after cell passage and examined by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). SEM and TEM micrographs show activated platelets adhering and spreading on the filter surface, comparable with platelets on a disturbed endothelium.
   Also, we examined the influence of different G forces and centrifugation times on the retention behavior of the platelets in citrated platelet-rich plasma (PRP) and whole blood (WB). G forces influenced the retention index in PRP and WB significantly and in a different way. Finally, we used a platelet standard, as customary in the quality check, to determine the serial as well as the day-to-day precision.
C1 Univ Hosp Marburg, Dept Neurosurg, D-35033 Marburg, Germany.
   Univ Hosp Saarland, Inst Anat, Saarbrucken, Germany.
   Univ Hosp Frankfurt, Inst Clin Pharmacol, Frankfurt, Germany.
   Med Univ Vienna, Dept Med Stat, Vienna, Austria.
   Univ Hosp Saarland, Dept Clin Hemostaseol & Transfus Med, Saarbrucken, Germany.
   Univ Hosp Saarland, Working Party Hemostasis, Saarbrucken, Germany.
   Univ Marburg, Dept Neurosurg, Marburg, Germany.
RP Krischek, B (reprint author), Univ Hosp Marburg, Dept Neurosurg, Baldingerstr, D-35033 Marburg, Germany.
EM krischek@med.uni-marburg.de
CR Ahnadi CE, 2003, THROMB HAEMOSTASIS, V90, P940, DOI 10.1160/TH03-02-0097
   BAUMGARTNER HR, 1980, J LAB CLIN MED, V95, P208
   BAUMGARTNER HR, 1978, THROMB HAEMOSTASIS, V39, P782
   CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225
   Harrison P, 2000, BRIT J HAEMATOL, V111, P733
   Hayward CPM, 2003, THROMB HAEMOSTASIS, V90, P770
   HELLEM AJ, 1960, SCAND J CLIN LAB I S, V51, P1
   MESTRES P, 1999, EUR J CELL BIOL S50, V78, P32
   Michelson A D, 1999, Curr Opin Hematol, V6, P342, DOI 10.1097/00062752-199909000-00012
   Rand ML, 2003, TRANSFUS APHER SCI, V28, P307, DOI 10.1016/S1473-0502(03)00050-8
   SALZMAN E, 1963, J LAB CLIN MED, V62, P724
   SCHENK JF, 2001, J THROMB HAEMOST S, DOI UNSP P384
   SCHENK JF, 2002, ANN HEMATOL, V81, pA1
   TSCHOPP TB, 1979, HAEMOSTASIS, V8, P19
NR 14
TC 5
Z9 6
U1 0
U2 3
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0094-6176
J9 SEMIN THROMB HEMOST
JI Semin. Thromb. Hemost.
PD AUG
PY 2005
VL 31
IS 4
BP 449
EP 457
DI 10.1055/s-2005-916680
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 965YL
UT WOS:000231986700013
PM 16149023
DA 2018-10-19
ER

PT J
AU LeBlanc, KA
AF LeBlanc, KA
TI Incisional hernia repair: Laparoscopic techniques
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID VENTRAL HERNIA; EXPANDED POLYTETRAFLUOROETHYLENE; PATCH REPAIR;
   COMPLICATIONS; EXPERIENCE; RECURRENCE; LESSONS; PTFE; MESH
AB Repair of incisional hernias using the laparoscopic technique has continued to evolve since its inception in 1991. An analysis of the current literature has revealed that hernias as large as 1600 cm(2) have been successfully repaired with this method. The average size appears to be about 105 cm(2). Several choices of a biomaterial are available today, differing in the type of synthetic product or products that are used to manufacture them. Others incorporate an absorbable component. The goal of all of them is to prevent adhesion formation. The fixation devices that can be used are also varied. The results of laparoseopic incisional hernia repair are described. The conversion rate of these procedures is an impressive 2.4% with an enterotomy rate of 1.8%. These results affirm the low risk of this operation. The recurrence rate of 4.2% confirms the permanence of the repair. This procedure may become the standard of care in the near future.
C1 Minimally Invas Surg Inst, Baton Rouge, LA 70808 USA.
   Louisiana State Univ, Sch Med, Dept Surg, New Orleans, LA 70112 USA.
RP LeBlanc, KA (reprint author), Minimally Invas Surg Inst, 7777 Hennessy Blvd,Suite 612, Baton Rouge, LA 70808 USA.
EM DOCMBA2@aol.com
CR Aura T, 2002, J LAPAROENDOSC ADV A, V12, P263, DOI 10.1089/109264202760268041
   Bageacu S, 2002, SURG ENDOSC, V16, P345, DOI 10.1007/s00464-001-0018-2
   Ben-Haim M, 2002, SURG ENDOSC, V16, P785, DOI 10.1007/s00464-001-9126-2
   Berger D, 2002, SURG ENDOSC, V16, P1720, DOI 10.1007/s00464-002-9036-y
   Birgisson G, 2001, SURG ENDOSC-ULTRAS, V15, P1419, DOI 10.1007/s004640080077
   Bower CE, 2004, SURG ENDOSC, V18, P672, DOI 10.1007/s00464-003-8506-1
   Carbajo MA, 2003, SURG ENDOSC, V17, P118, DOI 10.1007/s00464-002-9079-0
   Cassar K, 2002, BRIT J SURG, V89, P534, DOI 10.1046/j.1365-2168.2002.02083.x
   Chelala E, 2003, Hernia, V7, P191
   Chowbey PK, 2000, J LAPAROENDOSC ADV A, V10, P79, DOI 10.1089/lap.2000.10.79
   Clark JL, 2001, J SURG RES, V99, P33, DOI 10.1006/jsre.2001.6093
   DeMaria EJ, 2000, SURG ENDOSC-ULTRAS, V14, P326, DOI 10.1007/s004640020013
   Eid GM, 2003, SURGERY, V134, P599, DOI 10.1016/S0039-6060(03)00273-6
   Franklin M E Jr, 2004, Hernia, V8, P23, DOI 10.1007/s10029-003-0163-8
   Franklin M E Jr, 2004, Hernia, V8, P186
   Frantzides CT, 2004, SURG ENDOSC, V18, P1488, DOI 10.1007/s00464-004-8105-9
   Gillian G Kevin, 2002, JSLS, V6, P315
   Heniford BT, 2003, ANN SURG, V238, P391, DOI 10.1097/01.sla.0000086662.49499.ab
   HESSELINK VJ, 1993, SURG GYNECOL OBSTET, V176, P228
   Kyzer S, 1999, SURG ENDOSC-ULTRAS, V13, P928, DOI 10.1007/s004649901137
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LeBlanc K A, 2001, Hernia, V5, P41, DOI 10.1007/BF01576164
   LeBlanc K A, 2003, Hernia, V7, P118, DOI 10.1007/s10029-003-0117-1
   LEBLANC KA, 1993, SURG LAPAROSC ENDOSC, V3, P39
   LeBlanc KA, 2002, SURG ENDOSC, V16, P1542, DOI 10.1007/s00464-001-8271-y
   LeBlanc Karl A, 2003, JSLS, V7, P383
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P393
   ROTH JS, 1999, HERNIA, V4, P209
   Sanchez L J, 2004, Hernia, V8, P138, DOI 10.1007/s10029-003-0195-0
   Toy FK, 1998, SURG ENDOSC-ULTRAS, V12, P955, DOI 10.1007/s004649900755
   VANDERLINDEN FTPM, 1988, NETH J SURG, V40, P127
NR 31
TC 51
Z9 57
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0364-2313
J9 WORLD J SURG
JI World J.Surg.
PD AUG
PY 2005
VL 29
IS 8
BP 1073
EP 1079
DI 10.1007/s00268-005-7971-1
PG 7
WC Surgery
SC Surgery
GA 949KD
UT WOS:000230783700025
PM 15983711
DA 2018-10-19
ER

PT J
AU Lee, HF
   Sheu, HS
   Jeng, US
   Huang, CF
   Chang, FC
AF Lee, HF
   Sheu, HS
   Jeng, US
   Huang, CF
   Chang, FC
TI Preparation and supramolecular self-assembly of a
   polypeptide-block-polypseudorotaxane
SO MACROMOLECULES
LA English
DT Article
ID ALPHA-CYCLODEXTRIN; POLY(ETHYLENE GLYCOL); INCLUSION COMPLEXES; DIBLOCK
   OLIGOMERS; COPOLYMERS; POLYMER; POLY(EPSILON-CAPROLACTONE); POLYVINYL;
   HYDROGELS; PEPTIDES
AB We have successfully prepared a new class of self-assembled biomaterial: a polypeptide-block-polypseudorotaxane diblock copolymer. This diblock copolymer is comprised of an a-helical polypeptide rod, based on gamma-benzyl-L-glutamate, and an originally coiled segment P(EO19-r-PO3); it forms inclusion complexes with a-cyclodextrins (alpha-CDs) to give crystalline polypseudorotaxanes. Formation of the polypseudorotaxane converts the conformation of P(EO19-r-PO3) from a flexible chain into a rodlike structure, which results in a novel block copolymer exhibiting a rod-rod conformation. Intrinsic interactions (e.g., the polypseudorotaxane's channel-type crystallization, the polypeptide's secondary structure, and microphase separation) within and between these rod-rod diblock copolymers contribute to their hierarchical self-assembly behavior, which we characterized using DSC, H-1 NMR spectroscopy, C-13 CP/MAS NMR spectroscopy, WAXS, and SAXS. The data obtained from the WAXS and SAXS studies clearly indicate the formation of juxtaposed bilayer-like nanostructure featuring hexagonally packed PBLG stacks and channel-type polypseudorotaxane moieties.
C1 Natl Chiao Tung Univ, Inst Appl Chem, Hsinchu 30050, Taiwan.
   Natl Synchrotron Radiat Res Ctr, Hsinchu Sci Pk, Taiwan.
RP Chang, FC (reprint author), Natl Chiao Tung Univ, Inst Appl Chem, Hsinchu 30050, Taiwan.
EM changfc@mail.nctu.edu.tw
RI Chang, Feng-Chih/G-5195-2010; Huang, Chih-Feng/C-2297-2012
OI Huang, Chih-Feng/0000-0002-8062-8708
CR BILLOT JP, 1976, MAKROMOL CHEM, V177, P1889
   BILLOT JP, 1977, MAKROMOL CHEM, V178, P641
   BLOCK H, 1983, POLYYBENZYL L GLUTAM
   Caillol S, 2003, MACROMOLECULES, V36, P1118, DOI 10.1021/ma021187c
   Chen JT, 1996, SCIENCE, V273, P343, DOI 10.1126/science.273.5273.343
   Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427
   DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1
   Deming TJ, 1997, ADV MATER, V9, P299, DOI 10.1002/adma.19970090404
   DEMING TJ, 2000, J POLYM SCI A, V38, P2011
   DOUY A, 1982, POLYMER, V23, P1039, DOI 10.1016/0032-3861(82)90405-0
   Gallot B, 1996, PROG POLYM SCI, V21, P1035, DOI 10.1016/S0079-6700(96)00010-X
   GEHRKE SH, 1993, ADV POLYM SCI, V110, P81
   GLATTER O, 1980, SMALL ANGLE XRAY SCA
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   HARADA A, 1993, MACROMOLECULES, V26, P5698, DOI 10.1021/ma00073a026
   HARADA A, 1990, MACROMOLECULES, V23, P2821, DOI 10.1021/ma00212a039
   Harada A, 1997, MACROMOLECULES, V30, P7115, DOI 10.1021/ma970680z
   HARADA A, 1993, NATURE, V364, P516, DOI 10.1038/364516a0
   HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0
   HARADA A, 1994, NATURE, V370, P126, DOI 10.1038/370126a0
   Huang L, 1998, POLYMER, V39, P4857, DOI 10.1016/S0032-3861(97)00568-5
   Hwang MJ, 2004, MACROMOLECULES, V37, P8820, DOI 10.1021/ma0487397
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kawaguchi Y, 2000, MACROMOLECULES, V33, P4472, DOI 10.1021/ma992103b
   Klok HA, 2001, ADV MATER, V13, P1217, DOI 10.1002/1521-4095(200108)13:16<1217::AID-ADMA1217>3.0.CO;2-D
   Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606
   Kong XX, 2004, MACROMOLECULES, V37, P8180, DOI 10.1021/ma048888p
   LAI YH, IN PRESS NUCL INST B
   Lecommandoux S, 2001, MACROMOLECULES, V34, P9100, DOI 10.1021/ma010940j
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee M, 2001, CHEM REV, V101, P3869, DOI 10.1021/cr0001131
   Li J, 2003, J AM CHEM SOC, V125, P1788, DOI 10.1021/ja026623p
   LI J, 2003, MACROMOLECULES, V37, P8820
   McMillan RA, 1999, MACROMOLECULES, V32, P3643, DOI 10.1021/ma981660f
   Muthukumar M, 1997, SCIENCE, V277, P1225, DOI 10.1126/science.277.5330.1225
   Papadopoulos P, 2004, BIOMACROMOLECULES, V5, P81, DOI 10.1021/bm034291q
   PERLY B, 1976, MAKROMOL CHEM, V177, P2569
   Rusa CC, 2001, MACROMOLECULES, V34, P1318, DOI 10.1021/ma001868c
   Schlaad H, 2002, POLYMER, V43, P5321, DOI 10.1016/S0032-3861(02)00360-9
   Shimomura T, 2000, POLYM ADVAN TECHNOL, V11, P837, DOI 10.1002/1099-1581(200008/12)11:8/12<837::AID-PAT61>3.0.CO;2-B
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   WATANABE J, 1984, POLYMER, V25, P1711, DOI 10.1016/0032-3861(84)90242-8
NR 42
TC 32
Z9 34
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 26
PY 2005
VL 38
IS 15
BP 6551
EP 6558
DI 10.1021/ma050254a
PG 8
WC Polymer Science
SC Polymer Science
GA 947EU
UT WOS:000230627000043
DA 2018-10-19
ER

PT J
AU Aoyagi, S
   Kudo, M
AF Aoyagi, S
   Kudo, M
TI Observation of fluorescence-labeled protein A on a biosensor surface by
   means of TOF-SIMS
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 10th International Meeting on Chemical Sensors
CY JUL 11-14, 2004
CL Tsukuba, JAPAN
DE TOF-SIMS; mutual information; protein; biosensor; quantum dot
ID ION MASS-SPECTROMETRY; IMMUNOSENSOR; FILMS
AB The ability to carry out evaluations of proteins on biomaterial surfaces such as the distribution of each protein and the orientation of immobilized proteins are required for the development of high performance materials. Since proteins all have the same basic chemical structure it is difficult to distinguish one from the others by means of spectroscopy, even though such techniques do provide useful chemical information. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) provides an avenue into the submicron-scale distribution of specific chemicals and enables investigation of chemical conditions on materials surfaces. Though TOF-SIMS also has problems with the characterization of the mass spectra of protein samples, the mass spectra can be interpreted using data analysis techniques such as are provided by information theory.
   In this study, the distribution of fluorescence-labeled protein A immobilized on glass plates was chemically visualized by means of TOF-SIMS and a spectra analysis technique making use of mutual information. With this analysis technique, TOF-SIMS spectra can be interpreted such that it allows one to select specific peaks for chemical imaging of proteins. In addition, fragment ions from protein A labeled with different fluorescence substances, FITC and quantum dots, are characterizable by means of the mutual information, and their chemical conditions are investigated. (c) 2004 Elsevier B.V. All rights reserved.
C1 Seikei Univ, Fac Engn, Dept Appl Phys, Musashino, Tokyo 1808633, Japan.
RP Aoyagi, S (reprint author), Seikei Univ, Fac Engn, Dept Appl Phys, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.
EM asatoka@nifty.com
CR Aoyagi S, 2005, BIOSENS BIOELECTRON, V20, P1680, DOI 10.1016/j.bios.2004.06.041
   Aoyagi S, 2004, APPL SURF SCI, V231, P470, DOI 10.1016/j.apsusc.2004.03.181
   Aoyagi S, 2004, APPL SURF SCI, V231, P432, DOI 10.1016/j.apsusc.2004.03.162
   Aoyagi S, 2004, J MEMBRANE SCI, V236, P91, DOI 10.1016/j.memsci.2004.02.010
   Aoyagi S, 2003, BIOSENS BIOELECTRON, V18, P791, DOI 10.1016/S0956-5663(03)00046-0
   AOYAGI S, 2003, J SURF SCI NANOTECHN, V1, P67
   Eckschlager K, 1990, J CHEMOMETR, V4, P195, DOI 10.1002/cem.1180040303
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Lin CI, 2004, J CHROMATOGR A, V1027, P259, DOI 10.1016/j.chroma.2003.10.037
   Lloyd KG, 2004, APPL SURF SCI, V231, P207, DOI 10.1016/j.apsusc.2004.03.016
   Medintz IL, 2003, NAT MATER, V2, P630, DOI 10.1038/nmat961
   SHANNON CE, 1947, MATH THEORY INFORMAT
   Wagner MS, 2004, APPL SURF SCI, V231, P366, DOI 10.1016/j.apsusc.2004.03.100
   Wagner MS, 2002, ANAL CHEM, V74, P1824, DOI 10.1021/ac0111311
NR 14
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JUL 22
PY 2005
VL 108
IS 1-2
BP 708
EP 712
DI 10.1016/j.snb.2004.12.012
PG 5
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 943CS
UT WOS:000230330300117
DA 2018-10-19
ER

PT J
AU Hussain, MA
   Agnihotri, A
   Siedlecki, CA
AF Hussain, MA
   Agnihotri, A
   Siedlecki, CA
TI AFM imaging of ligand binding to platelet integrin alpha(IIb)beta(3)
   receptors reconstituted into planar lipid bilayers
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; IIB-IIIA COMPLEX; OPTICAL TWEEZERS;
   CONFORMATIONAL REGULATION; ELECTRON-MICROSCOPY; FIBRINOGEN; RGD;
   THROMBASTHENIA; GLYCOPROTEINS; AGGREGATION
AB The platelet integrin alpha(IIb)beta(3) plays a key role in platelet adhesion, activation, and aggregation at the subendothelium and at protein-coated synthetic biomaterials. In this study, interactions between alpha(IIb)beta(3) and both protein and peptide ligands for the receptor were imaged under physiological conditions by high-resolution atomic force microscopy (AFM). To directly image the ligand-receptor interactions, alpha(IIb)beta(3) receptors were reconstituted into a supported lipid bilayer formed on a mica surface in the AFM fluid cell assembly and subsequently activated with Mn2+. Fibrinogen, the natural protein ligand for the integrin, as well as a nanogold-labeled peptide ligand (an RGD-containing heptamer) were infused into the AFM fluid cell, incubated with the reconstituted and activated receptors, and imaged under buffer. Height images illustrating topographical features showed the integrin reconstituted in the bilayer. Fibrinogen molecules binding to the receptors were easily observed in the height images, with fibrinogen showing its characteristic trinodular structure and occasionally bridging integrin receptors. Fibrinogen was observed to bind to integrins at the D-domain consistent with the location of the gamma-chain dodecapeptide, while fibrinogen bridging integrins bound to receptors on opposite sides of the protein consistent with a 2-fold axis of symmetry. Peptide ligands were not visible in height images; however, phase images that map the mechanical properties detected the nanogold labels and demonstrated the presence of peptide ligands bound to the receptors. The results demonstrate the ability of this high-resolution microscopy technique to directly visualize single ligand/receptor interactions in a dynamic and physiologically relevant environment, and establish a framework for future fundamental studies of single protein/receptor interactions during normal pathological processes as well as biomaterial surface-induced thrombosis.
C1 Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Biomed Engn Inst, Hershey, PA 17033 USA.
   Penn State Univ, Milton S Hershey Med Ctr, Dept Bioengn, Biomed Engn Inst, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Biomed Engn Inst, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
RI Hussain, Mohammad/K-3524-2012
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   ALBRECHT RM, 1989, AM J ANAT, V185, P149, DOI 10.1002/aja.1001850208
   ALBRECHT RM, 1992, METHOD ENZYMOL, V215, P456
   Arya M, 2002, LASER SURG MED, V30, P306, DOI 10.1002/lsm.10044
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9
   Boudreaux MK, 2001, VET PATHOL, V38, P249, DOI 10.1354/vp.38-3-249
   BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159
   Brouhard GJ, 2003, IEEE T BIO-MED ENG, V50, P121, DOI 10.1109/TBME.2002.805463
   CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1
   Dietrich Anja, 2002, J Biotechnol, V82, P211
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   EPPELL SJ, 1995, BIOPHYS J, V68, P671, DOI 10.1016/S0006-3495(95)80228-6
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   FARRELL DH, 1994, J BIOL CHEM, V269, P226
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   GINSBERG MH, 1995, THROMB HAEMOSTASIS, V74, P352
   HAINFELD JF, 1997, CELL VISION, V4, P408
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Hussain MA, 2004, MICRON, V35, P565, DOI 10.1016/j.micron.2004.02.010
   KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329
   Kokkoli E, 2004, LANGMUIR, V20, P2397, DOI 10.1021/la035597l
   Lee I, 2003, ULTRAMICROSCOPY, V97, P341, DOI 10.1016/S0304-3991(03)00059-7
   Lee I, 2001, SURF SCI, V491, P433, DOI 10.1016/S0039-6028(01)01309-7
   Lin H, 2000, BIOCHEMISTRY-US, V39, P3192, DOI 10.1021/bi991624o
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   MARGUERIE GA, 1980, J BIOL CHEM, V255, P154
   MULLER B, 1993, J BIOL CHEM, V268, P6800
   Nagao E, 1999, BIOPHYS J, V76, P3289, DOI 10.1016/S0006-3495(99)77481-3
   Pang GKH, 2000, ULTRAMICROSCOPY, V81, P35, DOI 10.1016/S0304-3991(99)00164-3
   PARISE LV, 1985, J BIOL CHEM, V260, P698
   Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174
   Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922
   Simmons SR, 1996, J LAB CLIN MED, V128, P39, DOI 10.1016/S0022-2143(96)90112-2
   STEINER B, 1989, J BIOL CHEM, V264, P13102
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Thompson NL, 1997, CURR OPIN BIOTECH, V8, P58, DOI 10.1016/S0958-1669(97)80158-9
   Tomiyama Y, 2000, INT J HEMATOL, V72, P448
   Tullu Milind S., 2001, Indian Journal of Pediatrics, V68, P563, DOI 10.1007/BF02723255
   WEISEL JW, 1992, J BIOL CHEM, V267, P16637
NR 41
TC 28
Z9 30
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 19
PY 2005
VL 21
IS 15
BP 6979
EP 6986
DI 10.1021/la046943h
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 945MU
UT WOS:000230507400045
PM 16008412
DA 2018-10-19
ER

PT J
AU Hao, L
   Lawrence, J
   Li, L
AF Hao, L
   Lawrence, J
   Li, L
TI The wettability modification of bio-grade stainless steel in contact
   with simulated physiological liquids by the means of laser irradiation
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society
CY MAY 24-28, 2004
CL Strasbourg, FRANCE
SP European Mat Res Soc
DE laser; wertability; 316LS stainless steel; surface energy
ID PARTIALLY-STABILIZED ZIRCONIA; CO2-LASER TREATMENT; SOLID-SURFACES;
   CELL-ADHESION; EXCIMER; MECHANISMS; METALS
AB Early surface events that occur rapidly upon implantation of a biomaterial into biological fluids determine the subsequent response. These involve wetting by physiological liquids followed by adsorption of proteins and cells to the biomaterials surface. A CO, laser and high power diode laser (HPDL) were used to modify the surface properties of the material and thus manipulate the wettability of the material and its interaction with physiological liquids. The contact angles, theta, of selected test liquids including simulated physiological liquids shows that the wettability of the stainless steel improved after CO2 and HPDL treatment. The determined adhesion work of stainless steel towards stimulated physiological fluid enhanced after laser treatment, implying better interaction with the biological liquids. It is demonstrated that the laser could be a novel and controllable technique for enhancing the biocompatibility of bio-grade stainless steel. (c) 2005 Elsevier B.V. All rights reserved.
C1 Loughborough Univ Technol, Wolfson Sch Mech Engn, Rapid Mfg Grp, Loughborough LE11 3TU, Leics, England.
   Univ Manchester, Inst Sci & Technol, Dept Mech Aerosp & Mfg Engn, Laser Proc Res Ctr, Manchester M60 1QD, Lancs, England.
RP Hao, L (reprint author), Loughborough Univ Technol, Wolfson Sch Mech Engn, Rapid Mfg Grp, Loughborough LE11 3TU, Leics, England.
EM l.hao@lboro.ac.uk
OI Hao, Liang/0000-0003-2071-7044; Lawrence, Jonathan/0000-0002-1649-9948
CR Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Annarelli CC, 1999, J COLLOID INTERF SCI, V213, P386, DOI 10.1006/jcis.1999.6153
   Critchlow GW, 1997, INT J ADHES ADHES, V17, P143, DOI 10.1016/S0143-7496(96)00037-1
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Hao L, 2004, J LASER APPL, V16, P252, DOI 10.2351/1.1809636
   Hao L, 2004, COLLOID SURFACE B, V34, P87, DOI 10.1016/j.colsurfb.2003.12.008
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   HEITZ J, 1992, APPL PHYS A-MATER, V55, P391, DOI 10.1007/BF00324090
   HENARI F, 1995, APPL OPTICS, V34, P581, DOI 10.1364/AO.34.000581
   KINLOCH AJ, 1987, ADHESION ADHESIVES S, P30
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lawrence J, 2002, J LASER APPL, V14, P107, DOI 10.2351/1.1471560
   Lawrence J, 2000, APPL SURF SCI, V154, P664, DOI 10.1016/S0169-4332(99)00416-X
   NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2
   Olfert M, 1996, J LASER APPL, V8, P79, DOI 10.2351/1.4745407
   RATNER BD, 1998, PROGR BIOMEDICAL ENG, V6, P219
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VOGLER EA, 1993, SURFACTANT SCI SERIE, V49, P184
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   李建国, 1993, Rare Metals, V12, P84
NR 24
TC 41
Z9 42
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUL 15
PY 2005
VL 247
IS 1-4
BP 453
EP 457
DI 10.1016/j.apsusc.2005.01.163
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 939UQ
UT WOS:000230098300071
DA 2018-10-19
ER

PT J
AU Andersson, M
   Andersson, J
   Sellborn, A
   Berglin, M
   Nilsson, B
   Elwing, H
AF Andersson, M
   Andersson, J
   Sellborn, A
   Berglin, M
   Nilsson, B
   Elwing, H
TI Quartz crystal microbalance-with dissipation monitoring (QCM-D) for real
   time measurements of blood coagulation density and immune complement
   activation on artificial surfaces
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE quartz crystal microbalance; blood coagulation; complement activation;
   enzyme immuno assay
ID PLASMON RESONANCE; WHOLE-BLOOD; POLYMER-FILMS; CROSS-LINKING; IN-VITRO;
   PROTEIN; ADSORPTION; CONTACT; ELLIPSOMETRY; BIOMATERIAL
AB A recently developed variant of quartz crystal microbalance (QCM) called QCM-with dissipation monitoring (QCM-D) allows simultaneous and simple measurements of changes in adsorbed mass as well as the viscoelastic property (D-factor) of deposited protein layers on the sensor surface. We have taken the QCM-D technology a step further and demonstrated its advantages in the study of protein assembly as a consequence of surface induced immune complement activation, or contact activated blood coagulation. In the present study we have continued our QCM-D investigations of surface assembly of fibrin clot formation and complement activation and incubated differently modified quartz sensor surfaces in blood plasma and sera. Polymer surfaces used were spin-coated polyethylene, poly(ethylene terephtalate), poly(methylmetacrylate) and poly(dimethylsiloxane). Also used were sputtered titanium and heparin grafted surfaces. In this investigation we found that we could describe the surface induced coagulation with four independent parameters: (1) Time of onset of coagulation, (2) fibrin deposition rate, (3) total frequency shift at stable plateau, and (4) fibrin clot density. The most important finding was that the blood plasma clot density can be assessed with the use of D determinations and that the clot density varied significantly with the chemical composition of the surface. However, the D-factor did not give any new analytical information about the possible complement activation mechanisms. Nevertheless, the QCM-D was found to be a reliable tool for the analysis of surface induced complement activation.
   We also compared the QCM-D technique with traditional enzyme immuno assay (EIA) measurements of soluble products from the surface activation of the complement and coagulation systems. We found that the results from EIA and QCM-D measurements corresponded well for the complement activation but not for the coagulation, probably due to the biological complexity of the coagulation system. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Gothenburg, Interface Biophys Lundberg Lab, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
   Univ Uppsala Hosp, Rudbeck Lab C5, Clin Immunol Sect, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden.
RP Andersson, M (reprint author), Univ Gothenburg, Interface Biophys Lundberg Lab, Dept Cell & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden.
EM marcus.andersson@gmm.gu.se
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR Andersson M, 2002, J BIOMAT SCI-POLYM E, V13, P907, DOI 10.1163/156856202320401951
   Bengtsson A, 1998, XENOTRANSPLANTATION, V5, P176, DOI 10.1111/j.1399-3089.1998.tb00025.x
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Bergseth G, 2000, THROMB RES, V99, P41, DOI 10.1016/S0049-3848(00)00226-7
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   Collen A, 2001, BLOOD, V97, P973, DOI 10.1182/blood.V97.4.973
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   DeHeer DH, 2001, J BIOMED MATER RES, V54, P12, DOI 10.1002/1097-4636(200101)54:1<12::AID-JBM2>3.0.CO;2-X
   ELWING H, 1986, EUR J BIOCHEM, V156, P359, DOI 10.1111/j.1432-1033.1986.tb09591.x
   Garbassi F., 1994, POLYM SURFACES PHYS
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   Hansson KM, 2002, BIOSENS BIOELECTRON, V17, P747, DOI 10.1016/S0956-5663(02)00048-9
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hong J, 2001, J LAB CLIN MED, V138, P139, DOI 10.1067/mlc.2001.116486
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   NILSSON B, 1988, J IMMUNOL METHODS, V107, P281, DOI 10.1016/0022-1759(88)90229-3
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   SAURBREY G, 1959, Z PHYS, V155, P206
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Vikinge TP, 2000, J BIOMED OPT, V5, P51, DOI 10.1117/1.429968
   Vikinge TP, 2000, BIOSENS BIOELECTRON, V15, P605, DOI 10.1016/S0956-5663(00)00125-1
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
NR 31
TC 66
Z9 70
U1 2
U2 51
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JUL 15
PY 2005
VL 21
IS 1
BP 79
EP 86
DI 10.1016/j.bios.2004.09.026
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 969XJ
UT WOS:000232268900009
PM 15967354
DA 2018-10-19
ER

PT J
AU Shchipunov, YA
   Karpenko, TY
   Krekoten, AV
   Postnova, IV
AF Shchipunov, YA
   Karpenko, TY
   Krekoten, AV
   Postnova, IV
TI Gelling of otherwise nongelable polysaccharides
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE sol-gel; chitosan; hyaluronate; cyclodextrin; mineralization; silica
   nanocomposite; organic-inorganic nanocomposite; hydrogel; biomaterial
ID POROUS SILICA MATERIALS; LINEAR VISCOELASTICITY; GEL POINT; HYDROGELS;
   PSEUDOPOLYROTAXANES; CYCLODEXTRIN; BIOLOGICALS; POLYMERS; DESIGN; CHITIN
AB It was shown first that solutions of nongelable polysaccharides, including such practically important ones as chitosan, hyaluronate, and cyclodextrin, can be gelled by generating silica in situ via sol-gel processing. This could be done owing to a novel silica precursor that is completely water-soluble and compatible with biopolymers. The gelation was caused by mineralization of carbohydrate macromolecules, which strengthened them and provided their cross-linking. (c) 2005 Elsevier Inc. All rights reserved.
C1 Russian Acad Sci, Inst Chem, Far E Dept, Vladivostok 690022, Russia.
RP Shchipunov, YA (reprint author), Russian Acad Sci, Inst Chem, Far E Dept, Vladivostok 690022, Russia.
EM yas@ich.dvo.ru
OI Postnova, Irina/0000-0002-5623-6763
CR Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Coradin T, 2003, J SOL-GEL SCI TECHN, V26, P1165, DOI 10.1023/A:1020787514512
   Coradin T, 2001, CHEM COMMUN, P2496, DOI 10.1039/b108324b
   Da Silva J. F., 2001, BIOL CHEM ELEMENTS I
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Goodwin J. W., 2000, RHEOLOGY CHEM INTRO
   Gruber JV, 1999, PRINCIPLES POLYM SCI, P325
   Han BH, 2003, MICROPOR MESOPOR MAT, V66, P127, DOI 10.1016/j.micromeso.2003.09.003
   Han BH, 2002, CHEM MATER, V14, P3477, DOI 10.1021/cm0113088
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Kaplan DL, 1998, BIOPOLYMERS RENEWABL, P1, DOI DOI 10.1007/978-3-662-03680-8_
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lu ZL, 2002, CHEM REV, V102, P3543, DOI 10.1021/cr010358t
   MEHROTRA RC, 1967, INDIAN J CHEM, V5, P444
   Meyer M, 2002, J PHYS CHEM B, V106, P1528, DOI 10.1021/jp013371q
   Pedroni V, 2000, COLLOID POLYM SCI, V278, P964, DOI 10.1007/s003960000348
   Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130
   Pierre A. C., 1998, INTRO SOL GEL PROCES
   Roberts G, 1992, CHITIN CHEM
   SANDFORD P. A., 1983, POLYSACCHARIDES, V2
   Sattler K, 1998, BER BUNSEN PHYS CHEM, V102, P1544, DOI 10.1002/bbpc.19981021106
   Shchipunov YA, 2003, J COLLOID INTERF SCI, V268, P68, DOI 10.1016/S0021-9797(03)00457-0
   Shchipunov YA, 2004, LANGMUIR, V20, P3882, DOI 10.1021/la0356912
   SHCHIPUNOV YA, IN PRESS J COLLOID I
   SHCHIPUNOV YA, 2005, IN PRESS HYDROBIOLOG
   Shumilina EV, 2002, COLLOID J+, V64, P372, DOI 10.1023/A:1015985229667
   SIMPSON TL, 1981, SILOCON SILICEOUS ST
   Syrbe A, 1998, INT DAIRY J, V8, P179, DOI 10.1016/S0958-6946(98)00041-7
   Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455
   VOLKANI BE, 1981, SILICON SILICEOUS ST, P157
   Wallington SA, 1997, J SOL-GEL SCI TECHN, V8, P1127, DOI 10.1023/A:1018396005125
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   YANAKI T, 2001, GELS HDB, V2, P30
   Zaremba CM, 1996, CURR OPIN SOLID ST M, V1, P425, DOI 10.1016/S1359-0286(96)80035-0
NR 40
TC 36
Z9 37
U1 2
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 15
PY 2005
VL 287
IS 2
BP 373
EP 378
DI 10.1016/j.jcis.2005.02.004
PG 6
WC Chemistry, Physical
SC Chemistry
GA 935AO
UT WOS:000229751300001
PM 15925600
DA 2018-10-19
ER

PT J
AU Makamba, H
   Hsieh, YY
   Sung, WC
   Chen, SH
AF Makamba, H
   Hsieh, YY
   Sung, WC
   Chen, SH
TI Stable permanently hydrophilic protein-resistant thin-film coatings on
   poly(dimethylsiloxane) substrates by electrostatic self-assembly and
   chemical cross-linking
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SURFACE MODIFICATION; POLYELECTROLYTE
   MULTILAYERS; MICROFLUIDIC DEVICES; POLY(ETHYLENE GLYCOL); ELECTROOSMOTIC
   FLOW; PLASMA TREATMENT; ELECTROPHORESIS; POLYMERS; POLYDIMETHYLSILOXANE
AB Poly(dimethylsiloxane) (PDMS) is a biomaterial that presents serious surface instability characterized by hydrophobicity recovery. Permanently hydrophilic PDMS surfaces were created using electrostatic self-assembly of polyethyleneimine and poly(acrylic acid) on top of a hydrolyzed poly(styrene-alt-maleic anhydride) base layer adsorbed on PDMS. Cross-linking of the polyelectrolyte multilayers (PEMS) by carbodiimide coupling and covalent attachment of poly(ethylene glycol) (PEG) chains to the PEMS produced stable, hydrophilic, protein-resistant coatings, which resisted hydrophobicity recovery in air. Attenuated total reflection Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy revealed that the thin films had excellent chemical stability and resisted hydrophobicity recovery in air over 77 days of measurement. The spectra also showed a dense coverage for PEG dialdehyde and excellent resistance to protein adsorption from undiluted rat serum. Atomic force microscopy revealed dense coverage with PEG dialdehyde and PEG diamine. Contact angle measurements showed that all films were hydrophilic and that the PEG dialdehyde-topped thin film had a virtually constant contact angle (similar to 20 degrees) over the five months of the study. Electrokinetic analysis of the coatings in microchannels always exposed to air also gave good protein separation and constant electroosmotic flow during the five months that the measurements were done. We expect that the stable, hydrophilic, protein-resistant thin-film coatings will be useful for many applications that require long-term surface stability.
C1 Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
RP Chen, SH (reprint author), Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
EM shchen@mail.ncku.edu.tw
RI Sung, Wang-Chou/G-3710-2011
CR ADAMSON AW, 1997, PHYS CHEM SURFACES, P357
   Bearinger JP, 2003, NAT MATER, V2, P259, DOI 10.1038/nmat851
   BERGSTROM K, 1993, COLLOID SURF A, V77, P159
   BRACH DW, 2001, BIOMATERIALS, V22, P1035
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DENICOLA RR, 1950, J UROLOGY, V63, P168, DOI 10.1016/S0022-5347(17)68748-2
   Dou YH, 2004, ELECTROPHORESIS, V25, P3024, DOI 10.1002/elps.200405986
   *DOW CORN CORP, 1998, IMPL INF BOOKL
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   Farhat TR, 2002, ELECTROCHEM SOLID ST, V5, pB13, DOI 10.1149/1.1452484
   Fritz JL, 1995, J ADHESION, V54, P33, DOI 10.1080/00218469508014379
   Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130
   Groll J, 2004, J AM CHEM SOC, V126, P4234, DOI 10.1021/ja0318028
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HERNWERTH S, 2003, J AM CHEM SOC, V125, P9359
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Holland NB, 1998, NATURE, V392, P799
   HU S, 2004, ANAL CHEM, V74, P1865
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   HUANG XH, 1988, ANAL CHEM, V60, P1837, DOI 10.1021/ac00168a040
   JACOBSON SC, 1994, ANAL CHEM, V66, P1107, DOI 10.1021/ac00079a028
   JESSEL N, 2003, J ADV MAT, V15, P692
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Lahann J, 2003, ANAL CHEM, V75, P2117, DOI 10.1021/ac020557s
   Lahey F., 1946, ANN SURG, V124, P1027
   Lai JY, 1996, J ADHES SCI TECHNOL, V10, P231, DOI 10.1163/156856196X00364
   LEGER L, 1992, REP PROG PHYS, V55, P431, DOI 10.1088/0034-4885/55/4/001
   Lin CC, 2002, ELECTROPHORESIS, V23, P3550, DOI 10.1002/1522-2683(200210)23:20<3550::AID-ELPS3550>3.0.CO;2-A
   Liu Y, 2000, ANAL CHEM, V72, P5939, DOI 10.1021/ac000932l
   Lobo RFM, 2003, NANOTECHNOLOGY, V14, P101, DOI 10.1088/0957-4484/14/1/322
   Lowman GM, 2002, THIN SOLID FILMS, V405, P135, DOI 10.1016/S0040-6090(01)01669-8
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   Mao HB, 2002, ANAL CHEM, V74, P379, DOI 10.1021/ac010822u
   MARGEL S, 1980, MACROMOLECULES, V13, P19, DOI 10.1021/ma60073a004
   MASUDA S, 1989, IEEE T IND APPL, V25, P762
   Metzke M, 2003, J AM CHEM SOC, V125, P7760, DOI 10.1021/ja0349507
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OWEN MJ, 1994, J ADHES SCI TECHNOL, V8, P1063, DOI 10.1163/156856194X00942
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Park MK, 2004, J AM CHEM SOC, V126, P13723, DOI 10.1021/ja0484707
   Piehler J, 1996, BIOSENS BIOELECTRON, V11, P579, DOI 10.1016/0956-5663(96)83293-3
   Qin D, 1996, ADV MATER, V8, P917, DOI 10.1002/adma.19960081110
   ROMAN GT, IN PRESS ANAL CHEM
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Slentz BE, 2002, J CHROMATOGR A, V948, P225, DOI 10.1016/S0021-9673(01)01319-X
   Stroock AD, 2003, LANGMUIR, V19, P2466, DOI 10.1021/la026379f
   Sung WC, 2003, ELECTROPHORESIS, V24, P3648, DOI 10.1002/elps.200305623
   THERRY B, 2003, BIOMACROMOLECULES, V4, P1564
   THIERRY B, 2004, J AM CHEM SOC, V126, P7494
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Wu A, 1999, J AM CHEM SOC, V121, P4883, DOI 10.1021/ja9833624
   Xiao DQ, 2002, LANGMUIR, V18, P9971, DOI 10.1021/la0205553
   Xiao DQ, 2004, ANAL CHEM, V76, P2055, DOI 10.1021/ac035254s
   Yang TL, 2003, J AM CHEM SOC, V125, P4779, DOI 10.1021/ja029469f
   Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o
NR 60
TC 86
Z9 90
U1 3
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD JUL 1
PY 2005
VL 77
IS 13
BP 3971
EP 3978
DI 10.1021/ac0502706
PG 8
WC Chemistry, Analytical
SC Chemistry
GA 942GL
UT WOS:000230270800030
PM 15987099
DA 2018-10-19
ER

PT J
AU Miller, L
   Guerra, AB
   Bidros, RS
   Trahan, C
   Baratta, R
   Metzinger, SE
AF Miller, L
   Guerra, AB
   Bidros, RS
   Trahan, C
   Baratta, R
   Metzinger, SE
TI A comparison of resistance to fracture among four commercially available
   forms of hydroxyapatite cement
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE hydroxyapatite cement; resistance fracture
ID CALCIUM-PHOSPHATE CEMENTS; CRANIAL BONE; BIOMECHANICAL ANALYSIS;
   CRANIOPLASTY; RECONSTRUCTION; COMPLICATIONS; TEMPERATURE; EXPERIENCE;
   FIXATION; GRAFTS
AB Hydroxyapatite cement is a relatively new biomaterial that has found widespread use in craniomaxillofacial surgery. Despite its common usage, complication rates as high as 32% have been reported. When failed implants are removed, implant fracture has been cited as a potential cause of failure. The purpose of this study was to evaluate resistance to fracture among 4 commercially available hydroxyapatite cement formulations. The materials tested included Norian Cramofacial Repair System (carbonated apatite cement) (AO North America, Devon, PA), Norian CRS Fast Set Putty (carbonated apatite cement) (AO North America), BoneSource (hydroxyapatite cement) (Stryker Leibinger, Portage, MI), and Mimix (hydroxyapatite cement) (Walter Lorenz Surgical, Inc, Jacksonville, FL). To ensure consistency, all materials were embedded in acrylic wells. Each material was placed into a well 2.54 cm in diameter and 0.953 cm in thickness. The materials were prepared per manufacturer specifications. All materials were incubated at 37.0 degrees C, in 6% CO2, 100% humidity for 36 hours. Using the Bionix NITS Test System, a 12-mm-diameter probe applied incremental force to the center of the disk at a rate of 0.1 mm per second. The transmitted force was measured using a Bionix NITS Axial-Torsional Load Transducer for each disk. The force which resulted in fracture was recorded for each material. Ten disks of each material were processed by this method, for a total of 40 disks. The significance of resistance to fracture for the 4 compounds was analyzed using 1-way analysis of variance with post hoc Scheffe method. Mean fracture force with related P values was plotted for direct comparison of group outcomes. Material type contributed significantly to variance in fracture force for the biomaterials studied. Norian CRS required the greatest mean fracture force (13 85 N, SD +/- 292 N), followed by Norian CRS Fast Set Putty (1143 N, SD +/- 193 N). Mimix required a mean fracture force of 740 N, SD +/- 79 N. BoneSource required a mean fracture force of 558 N, SD +/- 150 N. Mimix and BoneSource required significantly less force for fracture when compared with Norian CRS and Fast Set Putty (P < 0.01). Comparisons of fracture load resistance between 4 commonly used bone substitute materials have not been previously reported. Increasing biomaterial strength may reduce complications resulting from reinjury to cranioplasty sites. In this model, Norian CRS. and Norian, CRS Fast Set Putty demonstrated a significantly greater resistance to fracture when compared with BoneSource and Mimix.
C1 Aesthet Surg Associates, Metairie, LA 70006 USA.
   McCollough Inst Appearance & Hlth, Gulf Shores, AL USA.
   Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped Surg, New Orleans, LA USA.
RP Guerra, AB (reprint author), Aesthet Surg Associates, 3601 Houma Blvd,Suite 300, Metairie, LA 70006 USA.
EM drguerra@gmail.com
CR Baker SB, 2002, PLAST RECONSTR SURG, V109, P1789, DOI 10.1097/00006534-200205000-00003
   Barone CM, 2000, J CRANIOFAC SURG, V11, P495, DOI 10.1097/00001665-200011050-00010
   Brody HJ, 2001, DERMATOL SURG, V27, P792, DOI 10.1046/j.1524-4725.2001.01014.x
   Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   CHEN NT, 1994, PLAST RECONSTR SURG, V93, P714, DOI 10.1097/00006534-199404000-00009
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   COE JD, 1989, SPINE, V14, P1122, DOI 10.1097/00007632-198910000-00016
   Constantino PD, 1991, ARCH OTOLARYNGOL, V117, P379
   Eppley BL, 2004, J CRANIOFAC SURG, V15, P422, DOI 10.1097/00001665-200405000-00013
   Eppley BL, 2003, J CRANIOFAC SURG, V14, P209, DOI 10.1097/00001665-200303000-00014
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Fujishiro Y, 2001, J BIOMED MATER RES, V54, P525, DOI 10.1002/1097-4636(20010315)54:4<525::AID-JBM80>3.0.CO;2-#
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   KLINE RM, 1995, PLAST RECONSTR SURG, V95, P5, DOI 10.1097/00006534-199501000-00002
   LEWIS VL, 1990, ANN PLAS SURG, V24, P276, DOI 10.1097/00000637-199003000-00014
   MARTIN RI, 1995, J MATER SCI-MATER M, V6, P138, DOI 10.1007/BF00120289
   MATIC D, 2002, P 81 ANN M AM ASS PL
   Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012
   Mihara H, 2001, SPINE, V26, P1662, DOI 10.1097/00007632-200108010-00007
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Nahum A M, 1975, Clin Plast Surg, V2, P59
   ODOM GL, 1952, J NEUROSURG, V9, P606, DOI 10.3171/jns.1952.9.6.0606
   Ousterhout DK, 1996, CLIN PLAST SURG, V23, P183
   Pietrzak WS, 2003, J CRANIOFAC SURG, V14, P176, DOI 10.1097/00001665-200303000-00008
   RAY BS, 1947, J NEUROSURG, V4, P299, DOI 10.3171/jns.1947.4.4.0299
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   SARGENT LA, 1991, PLAST RECONSTR SURG, V89, P1176
   SCOTT M, 1962, SURG GYNECOL OBSTET, V115, P453
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   SPENCE WT, 1954, J NEUROSURG, V11, P219, DOI 10.3171/jns.1954.11.3.0219
   WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8
NR 35
TC 24
Z9 26
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD JUL
PY 2005
VL 55
IS 1
BP 87
EP 92
DI 10.1097/01.sap.0000162510.05196.c6
PG 6
WC Surgery
SC Surgery
GA 942ZT
UT WOS:000230322100030
PM 15985797
DA 2018-10-19
ER

PT J
AU Di Palma, F
   Guignandon, A
   Chamson, A
   Lafage-Proust, MH
   Laroche, N
   Peyroche, S
   Vico, L
   Rattner, A
AF Di Palma, F
   Guignandon, A
   Chamson, A
   Lafage-Proust, MH
   Laroche, N
   Peyroche, S
   Vico, L
   Rattner, A
TI Modulation of the responses of human osteoblast-like cells to
   physiologic mechanical strains by biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; biomaterial; roughness; mechanical strain; cell number;
   alkaline phosphatase; fibronectin; cadherin; titanium; MG-63
ID IN-VITRO; FIBRONECTIN FIBRILLOGENESIS; TITANIUM-ALLOY;
   ALKALINE-PHOSPHATASE; EXTRACELLULAR-MATRIX; N-CADHERIN; ROUGHNESS;
   ADHESION; MG-63; PROLIFERATION
AB In a previous study we demonstrated that MG-63 cells cultured on Ti-6Al-4V discs covered by alumina ceramic and submitted to intermittent mechanical strain (IMS) presented morphological alteration associated with enhanced differentiation. Here we examine how the mechanical response of osteoblasts can be modulated by the nature of the substrate. MG-63 cells were cultured on four materials: polystyrene and Ti-6Al-4V (average roughness = 0.48 mum) as smooth substrates; Ti-6Al-4V (average roughness = 5.76 pm) and Ti-6Al-4V covered with alumina (average roughness = 5.21 mum) as rough substrates. Mechanical strains were applied for 15 min, three times a day for 1-5 days with a 600 mustrains magnitude and a 0.25 Hz frequency. IMS stimulated alkaline phosphatase activity by 25-35% on all substrates and had no effect on cell growth on either substrate. Fibronectin (FN) was chosen as representative of cell-matrix interaction. FN production was increased by 60% after 1 day of stretching only on alumina-coated discs. FN organization examined on smooth substrates was affected by 5 days of IMS, showing a thickening of the fibres. The same modifications induced by IMS were previously observed on alumina-covered discs. Vinculin expression was not affected by IMS whatever the substrate. Cell-cell interactions were determined by N-cadherin immunoblotting. N-cadherin expression was increased by IMS specifically on rough substrates. Our results suggest that the nature of the surface did not influence the upregulation of alkaline phosphatase activity induced by IMS, but modulates specifically cell-substrate as well as cell-cell interactions in response to IMS. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ St Etienne, Fac Med, Lab Biol Tissu Osseux, INSERM,Equipe E366, F-42023 St Etienne 02, France.
RP Rattner, A (reprint author), Univ St Etienne, Fac Med, Lab Biol Tissu Osseux, INSERM,Equipe E366, 15 Rue Ambroise Pare, F-42023 St Etienne 02, France.
EM Aline.Rattner@univ-st-etienne.fr
RI Vico, Laurence/O-1927-2018
OI Vico, Laurence/0000-0002-2110-287X
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799
   Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998
   Bannister SR, 2002, J BIOMED MATER RES, V60, P167, DOI 10.1002/jbm.10037
   BOYAN BD, 1989, J BIOL CHEM, V264, P11879
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carvalho RS, 2002, J CELL BIOCHEM, V84, P497
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Di Palma F, 2004, BIOMATERIALS, V25, P2565, DOI 10.1016/j.biomaterials.2003.09-026
   Di Palma F, 2003, BIOMATERIALS, V24, P3139, DOI 10.1016/S0142-9612(03)00152-2
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Grizon F, 2002, J DENT, V30, P195, DOI 10.1016/S0300-5712(02)00018-0
   Guignandon A, 2003, CELL COMMUN ADHES, V10, P69, DOI 10.1080/15419060390260987
   Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2
   Labat B, 2000, BIOMATERIALS, V21, P1275, DOI 10.1016/S0142-9612(00)00013-2
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   Lin W, 2002, CONNECT TISSUE RES, V43, P22
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   Matsunaga T, 1999, CALCIFIED TISSUE INT, V65, P454, DOI 10.1007/s002239900732
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Moroni A, 1999, J ORTHOP TRAUMA, V13, P477, DOI 10.1097/00005131-199909000-00003
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ralphs JR, 2002, MATRIX BIOL, V21, P67, DOI 10.1016/S0945-053X(01)00179-2
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Sanders JE, 2001, J BIOMECH, V34, P1581, DOI 10.1016/S0021-9290(01)00145-2
   Santini MT, 2003, BIOELECTROMAGNETICS, V24, P327, DOI 10.1002/bem.10113
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   Winter LC, 2003, J BIOMED MATER RES A, V67A, P1269, DOI 10.1002/jbm.a.20028
   Yang RS, 2002, MOL PHARMACOL, V61, P1163, DOI 10.1124/mol.61.5.1163
   Zhuang JP, 2000, CIRC RES, V87, P316, DOI 10.1161/01.RES.87.4.316
NR 40
TC 18
Z9 19
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2005
VL 26
IS 20
BP 4249
EP 4257
DI 10.1016/j.biomaterials.2004.10.041
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902PM
UT WOS:000227369000006
PM 15683648
DA 2018-10-19
ER

PT J
AU Jansen, EJP
   Sladek, REJ
   Bahar, H
   Yaffe, A
   Gijbels, MJ
   Kuijer, R
   Bulstra, SK
   Guldemond, NA
   Binderman, I
   Koole, LH
AF Jansen, EJP
   Sladek, REJ
   Bahar, H
   Yaffe, A
   Gijbels, MJ
   Kuijer, R
   Bulstra, SK
   Guldemond, NA
   Binderman, I
   Koole, LH
TI Hydrophobicity as a design criterion for polymer scaffolds in bone
   tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; scaffolds; biocompatibility in vivo; demineralised
   bone matrix
ID CARTILAGE; DELIVERY; BIOMATERIALS; DEGRADATION; CULTURE; REPAIR; COILS;
   RATS
AB Porous polymeric scaffolds play a key role in most tissue-engineering strategies. A series of non-degrading porous scaffolds was prepared, based on bulk-copolymerisation of 1-vinyl-2-pyrrolidinone (NVP) and n-butyl methacrylate (BMA), followed by a particulate-leaching step to generate porosity. Biocompatibility of these scaffolds was evaluated in vitro and in vivo. Furthermore, the scaffold materials were studied using the so-called demineralised bone matrix (DBM) as an evaluation system in vivo. The DBM, which is essentially a part of a rat femoral bone after processing with mineral acid, provides a suitable environment for ectopic bone formation, provided that the cavity of the DBM is filled with bone marrow prior to subcutaneous implantation in the thoracic region of rats. Various scaffold materials, differing with respect to composition and, hence, hydrophilicity, were introduced into the centre of DBMs. The ends were closed with rat bone marrow, and ectopic bone formation was monitored after 4, 6, and 8 weeks, both through X-ray microradiography and histology. The 50:50 scaffold particles were found to readily accommodate formation of bone tissue within their pores, whereas this was much less the case for the more hydrophilic 70:30 counterpart scaffolds. New healthy bone tissue was encountered inside the pores of the 50:50 scaffold material, not only at the periphery of the constructs but also in the center. Active osteoblast cells were found at the bone-biomaterial interfaces. These data indicate that the hydrophobicity of the biomaterial is, most likely, an important design criterion for polymeric scaffolds which should promote the healing of bone defects. Furthermore, it is argued that stable, non-degrading porous biomaterials, like those used in this study, provide an important tool to expand our comprehension of the role of biomaterials in scaffold-based tissue engineering approaches. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   Univ Hosp Maastricht, Dept Orthopaed Surg, NL-6202 AZ Maastricht, Netherlands.
   Tel Aviv Univ, Dept Oral Biol, Maurice & Gabriela Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel.
   Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, Jerusalem, Israel.
   Univ Maastricht, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.
   Univ Maastricht, Dept Human Pathol, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
EM l.koole@bioch.unimaas.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Aldenhoff YBJ, 2004, BIOMATERIALS, V25, P3125, DOI 10.1016/j.biomaterials.2003.10.012
   Bahar H, 2003, J PERIODONTOL, V74, P366, DOI 10.1902/jop.2003.74.3.366
   Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bruining MJ, 2000, BIOMACROMOLECULES, V1, P418, DOI 10.1021/bm000009t
   Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271
   Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372
   Hanssen HHL, 1999, J BIOMED MATER RES, V48, P820, DOI 10.1002/(SICI)1097-4636(1999)48:6<820::AID-JBM9>3.0.CO;2-K
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Homicz MR, 2003, LARYNGOSCOPE, V113, P25, DOI 10.1097/00005537-200301000-00005
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   NIMNI ME, 1988, CLIN ORTHOP RELAT R, P255
   ODIAN W, 1991, PRINCIPLES POLYMERIZ
   Pijls RT, 2004, BIO-MED MATER ENG, V14, P383
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   WIEDEMANN AAM, 2003, BIOMATERIALS, V23, P3319
   Yaffe A, 1997, J PERIODONTOL, V68, P884, DOI 10.1902/jop.1997.68.9.884
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 22
TC 90
Z9 99
U1 3
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2005
VL 26
IS 21
BP 4423
EP 4431
DI 10.1016/j.biomaterials.2004.11.001
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 905OW
UT WOS:000227579500009
PM 15701371
DA 2018-10-19
ER

PT J
AU Devouge, S
   Salvagnini, C
   Marchand-Brynaert, J
AF Devouge, S
   Salvagnini, C
   Marchand-Brynaert, J
TI A practical molecular clip for immobilization of receptors and
   biomolecules on devices' surface: Synthesis, grafting protocol and
   analytical assay
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE surface chemistry; photografting; biochip; biomaterial
ID SELF-ASSEMBLED MONOLAYERS; BIOLOGICAL EVALUATION; RGD PEPTIDOMIMETICS;
   CELLULAR ADHESION; ENDOTHELIAL-CELLS; PLASMON RESONANCE; WET CHEMISTRY;
   MEMBRANES; ADSORPTION; PROTEIN
AB Deposition of O-succinimidyl 4-(p-azido-phenyl)butanoate (4) onto inorganic device (FTIR-ATR crystal) or polymer material (filtration membrane) followed by irradiation at 254 nm led to surface functionalisation with NHS esters. Further reaction with biomolecules allowed their covalent grafting. The reactivity of the photoactivated surfaces was assayed by two methods: (i) the coupling with 3,5-bis(trifluoromethyl)benzylamine (7) and subsequent XPS analysis; (ii) the coupling with 4,5-bis-tritiated lysine (10) and subsequent LSC measurement of the radioactivity. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Catholique Louvain, Unite Chim Organ & Med, B-1348 Louvain, Belgium.
RP Marchand-Brynaert, J (reprint author), Univ Catholique Louvain, Unite Chim Organ & Med, Batiment Lavoisier Pl L Pasteur 1, B-1348 Louvain, Belgium.
EM marchand@chim.ucl.ac.be
CR Bayley H, 1977, Methods Enzymol, V46, P69
   Biltresse S, 2000, J POLYM SCI POL CHEM, V38, P3510, DOI 10.1002/1099-0518(20001001)38:19<3510::AID-POLA70>3.0.CO;2-L
   Biltresse S, 2005, BIOMATERIALS, V26, P4576, DOI 10.1016/j.biomaterials.2004.11.042
   Biltresse S, 2002, J POLYM SCI POL CHEM, V40, P770, DOI 10.1002/pola.10156
   Biltresse S, 2004, BIOORGAN MED CHEM, V12, P5379, DOI 10.1016/j.bmc.2004.07.055
   Boxus T, 1996, POLYM ADVAN TECHNOL, V7, P589, DOI 10.1002/(SICI)1099-1581(199607)7:7<589::AID-PAT551>3.3.CO;2-2
   Brynda E, 1998, BIOSENS BIOELECTRON, V13, P165, DOI 10.1016/S0956-5663(97)00107-3
   CARNAZZI E, 1994, J MED CHEM, V37, P1841, DOI 10.1021/jm00038a013
   Chung TW, 2003, ARTIF ORGANS, V27, P155, DOI 10.1046/j.1525-1594.2003.07045.x
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   Duchet J, 1997, LANGMUIR, V13, P2271, DOI 10.1021/la960598h
   Duchet J, 2001, COMPOS INTERFACE, V8, P177, DOI 10.1163/15685540152594659
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kumar P, 2004, BIOORG MED CHEM LETT, V14, P1097, DOI 10.1016/jj.bmcl.2003.12.077
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Liley M, 1997, LANGMUIR, V13, P4190, DOI 10.1021/la970258b
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1
   Marchand-Brynaert J, 1998, RRD POLYM SCI, V2, P335
   MARCHANDBRYNAER. J, 1999, SURFACE CHEM ELECTRO, P91
   Marchant-Brynaert J., 2000, POLYM SURFACE MODIFI, V2, P281
   MAZAO R, 1984, J COLLOID INTERF SCI, V100, P465
   SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016
   SHIN H, 2003, BIOMATERIALS, V24, P4553
   Stefan IC, 2000, LANGMUIR, V16, P5945, DOI 10.1021/la0000466
   WEIGEL C, 1990, CHEM MOD S, V3, P39
   Zammatteo Nathalie, 2002, Biotechnol Annu Rev, V8, P85, DOI 10.1016/S1387-2656(02)08005-5
NR 29
TC 22
Z9 22
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD JUL 1
PY 2005
VL 15
IS 13
BP 3252
EP 3256
DI 10.1016/j.bmcl.2005.04.071
PG 5
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA 939HD
UT WOS:000230062300016
PM 15935661
DA 2018-10-19
ER

PT J
AU Moskovitz, Y
   Srebnik, S
AF Moskovitz, Y
   Srebnik, S
TI Mean-field model of immobilized enzymes embedded in a grafted polymer
   layer
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID PROTEIN ADSORPTION; HETEROPOLYMER ADSORPTION; CONFORMATIONAL-CHANGES;
   ALPHA-CHYMOTRYPSIN; SURFACES; BRUSHES; STABILITY; STABILIZATION;
   BIOMATERIALS; CONFINEMENT
AB Two-dimensional mean-field lattice theory is used to model immobilization and stabilization of an enzyme on a hydrophobic surface using grafted polymers. Although the enzyme affords biofunctionality, the grafted polymers stabilize the enzyme and impart biocompatibility. The protein is modeled as a compact hydrophobic-polar polymer, designed to have a specific bulk conformation reproducing the catalytic cleft of natural enzymes. Three scenarios are modeled that have medical or industrial importance: 1), It is shown that short hydrophilic grafted polymers, such as polyethylene glycol, which are often used to provide biocompatibility, can also serve to protect a surface-immobilized enzyme from adsorption and denaturation on a hydrophobic surface. 2), Screening of the enzyme from the surface and nonspecific interactions with biomaterial in bulk solution requires a grafted layer composed of short hydrophilic polymers and long triblock copolymers. 3), Hydrophilic polymers grafted on a hydrophobic surface in contact with an organic solvent form a dense hydrophilic nanoenvironment near the surface that effectively shields and stabilizes the enzyme against both surface and solvent.
C1 Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
RP Srebnik, S (reprint author), Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
EM simchas@tx.technion.ac.il
OI Srebnik, Simcha/0000-0001-9843-1869; Moskovitz,
   Yevgeny/0000-0001-9133-1961
CR AMBRUS CM, 1978, SCIENCE, V201, P837, DOI 10.1126/science.567372
   Biswas R, 2004, CHEM PHYS LETT, V387, P221, DOI 10.1016/j.cplett.2004.02.018
   Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7
   Celej MS, 2004, BIOCHEM J, V378, P1059, DOI 10.1042/BJ20031536
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Currie EPK, 1999, PURE APPL CHEM, V71, P1227, DOI 10.1351/pac199971071227
   DILL KA, 1995, PROTEIN SCI, V4, P561
   Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c
   Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201
   El-Sherif H, 2001, J MOL CATAL B-ENZYM, V14, P15, DOI 10.1016/S1381-1177(00)00237-X
   Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101
   Fang F, 2002, LANGMUIR, V18, P5497, DOI 10.1021/la020027r
   Fang F, 2001, BIOPHYS J, V80, P2568, DOI 10.1016/S0006-3495(01)76228-5
   Fernandez-Lafuente R, 1999, J MOL CATAL B-ENZYM, V7, P173, DOI 10.1016/S1381-1177(99)00040-5
   FERNANDEZLAFUENTE, 1999, ENZYME MICROB TECH, V24, P96
   FERNANDEZLAFUENTE, 1999, J MOL CATAL B-ENZYM, V7, P181
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hadicke E, 1999, PHYS CHEM CHEM PHYS, V1, P3891, DOI 10.1039/a903949j
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Henry M, 2003, LANGMUIR, V19, P6271, DOI 10.1021/la034081z
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOLM C, 2004, POLYELECTROLYTES DEF, V2, P67
   Huang YB, 2000, J CONTROL RELEASE, V65, P63, DOI 10.1016/S0168-3659(99)00233-3
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jonsson M, 2004, COLLOID SURFACE B, V37, P71, DOI 10.1016/j.colsurfb.2004.06.010
   Karlstrom G, 2001, COLLOID SURFACE B, V20, P245, DOI 10.1016/S0927-7765(00)00199-5
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   KIAEI D, 1992, RADIAT PHYS CHEM, V39, P463
   Kidoaki S, 2001, LANGMUIR, V17, P1080, DOI 10.1021/la000003p
   Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031911
   KLIBANOV AM, 1989, TRENDS BIOCHEM SCI, V14, P141, DOI 10.1016/0968-0004(89)90146-1
   LAVIN A, 1985, SCIENCE, V230, P543, DOI 10.1126/science.4048947
   LEININGER RI, 1966, SCIENCE, V152, P1625, DOI 10.1126/science.152.3729.1625
   Lensun L, 2002, LANGMUIR, V18, P9924, DOI 10.1021/la020473e
   Mateo C, 2000, ENZYME MICROB TECH, V26, P509, DOI 10.1016/S0141-0229(99)00188-X
   MCPHERSON TB, 1995, PROTEINS INTERFACES, V2, P395
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7
   Moskovitz Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.032902
   Pal SK, 2004, CHEM REV, V104, P2099, DOI 10.1021/cr020689l
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Ping G, 2003, J CHEM PHYS, V118, P8042, DOI 10.1063/1.1564053
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RUHE J, 2004, POLYELECTROLYTES DEF, P79
   Ryu G, 1992, ASAIO J, V38, pM644
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   SCHEUTJENS JMHM, 1979, J PHYS CHEM-US, V83, P1619, DOI 10.1021/j100475a012
   SCOPES RK, 1994, PROTEIN PURIFICATION, P95
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Srebnik S, 2001, J CHEM PHYS, V114, P9179, DOI 10.1063/1.1368400
   Srebnik S, 1998, J CHEM PHYS, V109, P6415, DOI 10.1063/1.477285
   Steels BM, 2000, J CHROMATOGR B, V743, P41, DOI 10.1016/S0378-4347(00)00206-1
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   TANG H, 1994, EUROPHYS LETT, V28, P19, DOI 10.1209/0295-5075/28/1/004
   TIBERG F, 1992, COLLOID POLYM SCI, V270, P1188, DOI 10.1007/BF01095059
   Trachtenberg M C, 1999, Life Support Biosph Sci, V6, P293
   Turkova J, 1999, J CHROMATOGR B, V722, P11, DOI 10.1016/S0378-4347(98)00434-4
   Ulbrich-Hofmann R, 1999, J MOL CATAL B-ENZYM, V7, P125, DOI 10.1016/S1381-1177(99)00026-0
   WANG CC, 1993, J BIOMAT SCI-POLYM E, V4, P357, DOI 10.1163/156856293X00041
   WATANABE S, 1988, METHOD ENZYMOL, V137, P545
   Wei Y, 2001, J NANOSCI NANOTECHNO, V1, P83, DOI 10.1166/jnn.2001.014
   WIJMANS CM, 1992, MACROMOLECULES, V25, P2657, DOI 10.1021/ma00036a016
   WIJMANS CM, 1994, J CHEM PHYS, V101, P8214, DOI 10.1063/1.468206
   Woodle MC, 1998, ADV DRUG DELIVER REV, V32, P139, DOI 10.1016/S0169-409X(97)00136-1
   YEUNG C, 1993, MACROMOLECULES, V26, P1914, DOI 10.1021/ma00060a018
   Zheng L, 1998, ANALYST, V123, P1735, DOI 10.1039/a800710a
   Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504
NR 68
TC 19
Z9 19
U1 0
U2 11
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUL
PY 2005
VL 89
IS 1
BP 22
EP 31
DI 10.1529/biophysj.104.053686
PG 10
WC Biophysics
SC Biophysics
GA 939ZX
UT WOS:000230114500007
PM 15805165
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Fukuhara, S
   Tomita, S
   Nakatani, T
   Fujisato, T
   Ohtsu, Y
   Ishida, M
   Yutani, C
   Kitamura, O
AF Fukuhara, S
   Tomita, S
   Nakatani, T
   Fujisato, T
   Ohtsu, Y
   Ishida, M
   Yutani, C
   Kitamura, O
TI Bone marrow cell-seeded biodegradable polymeric scaffold enhances
   angiogenesis and improves function of the infarcted heart
SO CIRCULATION JOURNAL
LA English
DT Article
DE angiogenesis; biomaterial; bone marrow cells; ischemic heart disease
ID FIBROBLAST-GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; CARDIAC GRAFT;
   TRANSPLANTATION; IMPLANTATION; MYOCARDIUM; MYOGENESIS; FAILURE; MODEL;
   RAT
AB Background The present study examined whether a bioengineered polyglycolic acid cloth (PGAC) impregnated with bone marrow cells (BMC) improved the function and angiogenesis of the infarcted heart.
   Methods and Results The coronary artery was ligated in Lewis rats and the infarcted area was covered with a PGAC in group 1 (n=8), with a PGAC containing basic-fibroblast growth factor (b-FGF) in group 2 (n=11) and a PGAC containing b-FGF and freshly isolated BMC in group 3 (n=10). In addition, BMC derived from transgenic mice expressing green fluorescent protein (GFP)-BMC were seeded into a PGAC, which was sutured over the infarcted area of C57BL/6 mice (n=5). In the rat study, developed and systolic pressures, dp/dt max and dp/dt min) were the highest in group 3, as were the capillary density in the PGAC and infarcted area. In the mouse study, there were few GFP-BMC in the PGAC, but none in the infarcted area.
   Conclusions A PGAC with BMC improved cardiac function by inducing angiogenesis without migration of BMC. Freshly isolated BMC work as angiogenic inducers and a PGAC is useful as a "drug delivery system".
C1 Natl Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka 5658565, Japan.
   Natl Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan.
   Natl Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan.
   Natl Cardiovasc Ctr, Dept Organ Transplantat, Suita, Osaka 5658565, Japan.
RP Tomita, S (reprint author), Natl Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
EM shinjitomita@hotmail.com
OI FUJISATO, Toshia/0000-0002-7206-093X
CR BEATTY PG, 1993, BLOOD, V81, P249
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   FUJISATO T, 2000, 6 WORLD BIOM C T, P1496
   FUKUHARA S, 2005, CELL TRANSPLANT, V13, P741
   Hamano K, 2000, CELL TRANSPLANT, V9, P439, DOI 10.1177/096368970000900315
   ISHIDA M, 2005, IN PRESS J HEART LUN
   Iwakura A, 2001, CIRCULATION, V104, P325
   KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682
   Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817
   Kobayashi T, 2000, J SURG RES, V89, P189, DOI 10.1006/jsre.2000.5828
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   MARTIN PJ, 1987, ADV IMMUNOL, V40, P379, DOI 10.1016/S0065-2776(08)60243-6
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Nishida S, 2003, CIRC J, V67, P334
   Noishiki Y, 1996, NAT MED, V2, P90, DOI 10.1038/nm0196-90
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Pouzet B, 2000, CIRCULATION, V102, P210
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Sata M, 2003, CIRC J, V67, P983, DOI 10.1253/circj.67.983
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Tomita S, 1999, CIRCULATION, V100, P247
   Whalen G F, 1989, Growth Factors, V1, P157, DOI 10.3109/08977198909029125
NR 28
TC 24
Z9 26
U1 0
U2 3
PU JAPANESE CIRCULATION SOCIETY
PI KYOTO
PA KINKI INVENTION CENTER, 14 YOSHIDA KAWAHARACHO, SAKYO-KU, KYOTO,
   606-8305, JAPAN
SN 1346-9843
J9 CIRC J
JI Circ. J.
PD JUL
PY 2005
VL 69
IS 7
BP 850
EP 857
DI 10.1253/circj.69.850
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 939WB
UT WOS:000230102200013
PM 15988112
OA Bronze
DA 2018-10-19
ER

PT J
AU Ito, A
   Otsuka, M
   Kawamura, H
   Ikeuchi, M
   Ohgushi, H
   Sogo, Y
   Ichinose, N
AF Ito, A
   Otsuka, M
   Kawamura, H
   Ikeuchi, M
   Ohgushi, H
   Sogo, Y
   Ichinose, N
TI Zinc-containing tricalcium phosphate and related materials for promoting
   bone formation
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE biomaterials and biological interface
ID OSTEOBLASTIC MC3T3-E1 CELLS; L-HISTIDINATO ZINC; CALCIUM-PHOSPHATE;
   PROTEIN-SYNTHESIS; RABBIT FEMORA; CERAMICS; RATS; BETA;
   CYTOCOMPATIBILITY; SOLUBILITY
AB Calcium phosphate is a suitable carrier of zinc, an essential element that has stimulatory effects on bone formation in vitro and in vivo as well as an inhibitory effect on osteoclastic bone resorption in vitro. The highest zinc content is attained in beta-tricalcium phosphate, where the zinc content reaches 6 wt%. Both rat and human bone marrow cells (BMCs) cultured on zinc-containing beta-tricalcium phosphate and hydroxyapatite composite ceramics differentiated more than BMCs cultured on zinc-free composite ceramics in the presence of beta-glycerophosphate and dexamethasone. The acceptable dose of zinc,was higher for human BMCs than for rat BMCs. The solubility of ZnTCP, which contains a nontoxic level of zinc, decreased to 52-92% that of pure TCP in the pH range of 5.0-7.4. However, the resorbed volume of ZnTCP was much lower than that expected from the in vitro solubility of ZnTCP, becoming as low as 26-20% that of TCP, which indicates that the reduction in the resorbability of ZnTCP would be attributable principally to its lowered cellular activation property relative to that associated with pure TCP. Probably due to the lowered cellular activation property associated with ZnTCP, bone loss at the bone-implant interface was significantly arrested in the long-term implantation of ZnTCP/HAP. The intramuscular injection of ZnTCP powder is effective in increasing bone mineral density in the vicinity of the injected site in osteopenic animals. All these findings suggest that zinc-containing calcium phosphate is a biomaterial that promotes bone formation. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.
   Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Kobe, Hyogo 6588558, Japan.
   Ryugasaki Saisekai Hosp, Dept Orthoped Surg, Ryugasaki, Ibaraki, Japan.
   Waseda Univ, Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.
RP Ito, A (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.
EM atsuo-ito@aist.go.jp
RI Sogo, Yu/L-8045-2018; Ito, Atsuo/M-6785-2018
OI Sogo, Yu/0000-0003-1228-4648; Ito, Atsuo/0000-0003-3318-040X
CR BETTGER WJ, 1993, J NUTR BIOCHEM, V4, P194, DOI 10.1016/0955-2863(93)90052-X
   Hamilton EI, 1973, SCIENCE TOTAL ENVIRO, V1, P341, DOI DOI 10.1016/0048-9697(73)90024-7
   HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737
   Ikeuchi M, 2003, J BIOMED MATER RES A, V67A, P1115, DOI 10.1002/jbm.a.10041
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, J BIOMED MATER RES, V60, P224, DOI 10.1002/jbm.10068
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Kawamura H, 2003, J BIOMED MATER RES A, V65A, P468, DOI 10.1002/jbm.a.10524
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Lowe NM, 2002, P NUTR SOC, V61, P181, DOI 10.1079/PNS2002154
   Lutz W, 2000, BIOCHEM BIOPH RES CO, V271, P1, DOI 10.1006/bbrc.2000.2570
   McCusker RH, 1998, J DAIRY SCI, V81, P1790, DOI 10.3168/jds.S0022-0302(98)75748-0
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040
   Sogo Y, 2004, MAT SCI ENG C-BIO S, V24, P709, DOI 10.1016/j.msec.2004.08.016
   Sogo Y, 2004, MATER SCI TECH-LOND, V20, P1079, DOI 10.1179/026708304225019704
   Sogo Y, 2002, J BIOMED MATER RES, V62, P457, DOI 10.1002/jbm.10200
   UNDERWOOD EJ, 1977, TRACE ELEMENTS HUMAN, P197
   World Health Organization, 1973, WHO TECH REP SER, V532, P9
   YAMAGUCHI M, 1990, RES EXP MED, V190, P295, DOI 10.1007/BF00000035
   YAMAGUCHI M, 1986, BIOCHEM PHARMACOL, V35, P773, DOI 10.1016/0006-2952(86)90245-5
   YAMAGUCHI M, 1994, MOL CELL BIOCHEM, V136, P163, DOI 10.1007/BF00926077
   YAMAGUCHI M, 1994, PEPTIDES, V15, P1367, DOI 10.1016/0196-9781(94)90110-4
NR 23
TC 88
Z9 92
U1 0
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 402
EP 406
DI 10.1016/j.cap.2004.10.006
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000002
DA 2018-10-19
ER

PT J
AU Zhai, Y
   Cui, FZ
   Wang, Y
AF Zhai, Y
   Cui, FZ
   Wang, Y
TI Formation of nano-hydroxyapatite on recombinant human-like collagen
   fibrils
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE recombinant human collagen; biomineralization; hydroxyapatite; tissue
   engineering; fibril
AB Mineralization of recombinant human-like collagen is an important biomaterial for bone tissue engineering. Features of the formation of nano-hydroxyapatite on recombinant human-like collagen surface were investigated by SEM, XRD, FTIR and TEM. Formation mechanism of the nano-crystals is also discussed. The nano-HA is about 6-25 nm in size and with their c-axis parallel to the fibrils orientation. (c) 2005 Elsevier B.V. All rights reserved.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
RP Cui, FZ (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
EM cuifz@mail.tsinghua.edu.cn
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Asher D M, 1999, Dev Biol Stand, V100, P103
   Cui FZ, 1996, J STRUCT BIOL, V117, P204, DOI 10.1006/jsbi.1996.0084
   Furuzono T, 2001, J MATER SCI LETT, V20, P111, DOI 10.1023/A:1006725931450
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hellman KB, 1996, DEV BIOL STAND, V88, P231
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   Miekka SI, 2003, VOX SANG, V84, P36, DOI 10.1046/j.1423-0410.2003.00256.x
   Patino MG, 2003, J PERIODONTAL RES, V38, P458, DOI 10.1034/j.1600-0765.2003.00017.x
   SCHRIEBER R, 1993, DEV BIOL STAND, V80, P195
   SIGEL H, 1982, CHEM REV, V82, P385, DOI 10.1021/cr00050a003
   SLAVICA L, 2001, THERMOCHIM ACTA, V374, P13
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   1371919A
NR 16
TC 58
Z9 66
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 429
EP 432
DI 10.1016/j.cap.2005.01.004
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000008
DA 2018-10-19
ER

PT J
AU Chung, HJ
   Go, DH
   Bae, JW
   Jung, IK
   Lee, JW
   Park, KD
AF Chung, HJ
   Go, DH
   Bae, JW
   Jung, IK
   Lee, JW
   Park, KD
TI Synthesis and characterization of Pluronic((R)) grafted chitosan
   copolymer as a novel injectable biomaterial
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE thermosensitivity; chitosan; Pluronic((R)); hydrogels; water soluble
ID RELEASE
AB Water-soluble thermosensitive chitosan copolymers were prepared by coupling Pluronic (R) onto chitosan using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS) as coupling agents. The physicochemical properties of the resulting copolymers were characterized and they formed thermally reversible hydrogels, which exhibit a lower critical solution temperature (LCST) at 34 degrees C in aqueous solutions. As a result, chitosan copolymers attest to the usefulness as an injectable material for cell and drug delivery because of their thermally reversible property. (c) 2005 Elsevier B.V. All rights reserved.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   Korea Inst Sci & Technol Informat, Dept Mat & Component Informat Anal, Seoul 130742, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
CR ALMGREN M, 1992, J COLLOID INTERF SCI, V151, P157, DOI 10.1016/0021-9797(92)90247-J
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   Cho KY, 2003, INT J PHARM, V260, P83, DOI 10.1016/S0378-5173(03)00259-X
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   LUNDSTED LG, 1976, BLOCK GRAFT COPOLYME, V2, P1
   Usami Y, 1997, CARBOHYD POLYM, V32, P115, DOI 10.1016/S0144-8617(96)00153-1
   YOSHIDA R, 1992, IND ENG CHEM RES, V31, P2339, DOI 10.1021/ie00010a013
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
NR 10
TC 71
Z9 75
U1 4
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 485
EP 488
DI 10.1016/j.cap.2005.01.015
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000020
DA 2018-10-19
ER

PT J
AU Zhang, SM
   Liu, J
   Zhou, W
   Cheng, L
   Guo, XD
AF Zhang, SM
   Liu, J
   Zhou, W
   Cheng, L
   Guo, XD
TI Interfacial fabrication and property of hydroxyapatite/polylactide
   resorbable bone fixation composites
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE biomaterial; interface; composite; hydroxyapatite; resorbability
AB Based on surface modification of hydroxyapatite with silane derivatives, interfacial fabrications of hydroxyapatite (HAP)/polylactide (PLA) resorbable bone fixation composites are realized. The results indicate that interfacial adhesion, swelling property, and ultimate mechanical properties of the HAP/PLA composites are significantly improved. As a result, the maximum bending strength enhances 27.8%. Scanning electron microscopy (SEM) observation suggests that the modified HA particles are homogeneously dispersed in the composites, their size ranges are about 2-15 mu m. The modified HA/PLA composites are of toughened rupture. This conclusion is consistent with bending property of the composites. Finally, a possible mechanism for the interfacial adhesion is also discussed. (c) 2005 Elsevier B.V. All rights reserved.
C1 Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
   Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430051, Peoples R China.
RP Zhang, SM (reprint author), Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Life Sci Bldg, Wuhan 430074, Peoples R China.
EM smzhang@mail.hust.edu.cn
RI guo, xiaodong/K-2600-2013
CR Deng XM, 2001, J MATER SCI LETT, V20, P281, DOI 10.1023/A:1006714010765
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   ZHANG SM, 2003, NEW ADV MAT SCI ENG, P230
NR 4
TC 35
Z9 39
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 516
EP 518
DI 10.1016/j.cap.2005.01.023
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000027
DA 2018-10-19
ER

PT J
AU Kim, YH
   Song, H
   Riu, DH
   Kim, SR
   Kim, HJ
   Moon, JH
AF Kim, YH
   Song, H
   Riu, DH
   Kim, SR
   Kim, HJ
   Moon, JH
TI Preparation of porous Si-incorporated hydroxyapatite
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE hydroxyapatite; silicon; incorporation; porous block; biomaterial
ID SILICON-SUBSTITUTED HYDROXYAPATITE
AB A porous silicon-incorporated hydroxyapatite has been prepared using natural coral as a calcium source to obtain a biomaterial having a good biocompatibility. Si-incorporated hydroxyapatite has been prepared by hydrothermal treatment in 2 M (NH4)(2)HPO4 and solvothermal treatment in silicon acetate saturated acetone solution at 180 degrees C of the natural coral repeatedly. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon dioxide or other calcium phosphate species. Compressive strength of the porous silicon-incorporated hydroxyapatite was 5.5 MPa and silicon content was ranged from 0.12% to 0.19% by weight. SEM and EDS investigation confirmed the presence of silicon in the framework of hydroxyapatite structure. (c) 2005 Published by Elsevier B.V.
C1 Korea Inst Ceram Engn & Technol, Seoul 153801, South Korea.
   Meta Biomed Co Ltd, Choongbuk 363880, South Korea.
   Yonsei Univ, Dept Ceram Engn, Seoul 120749, South Korea.
RP Kim, YH (reprint author), Korea Inst Ceram Engn & Technol, Seoul 153801, South Korea.
EM yhkokim@kicet.re.kr
CR Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Bertoni E, 1998, J INORG BIOCHEM, V72, P29, DOI 10.1016/S0162-0134(98)10058-2
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kim SR, 2002, KEY ENG MATER, V218-2, P85, DOI 10.4028/www.scientific.net/KEM.218-220.85
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   KOKUBO T., 1994, BIOCERAMICS, V7, P49
   POTER AE, 2003, BIOMATERIALS, V24, P4609
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Shi DL, 1998, MAT SCI ENG C-BIO S, V6, P175, DOI 10.1016/S0928-4931(98)00048-4
NR 12
TC 20
Z9 20
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 538
EP 541
DI 10.1016/j.cap.2005.01.031
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000033
DA 2018-10-19
ER

PT J
AU Tanzi, MC
AF Tanzi, MC
TI Bioactive technologies for hemocompatibility
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE bioactive; biomembrane mimicry; biomimetic; biopassive; glycomimesis;
   hemocompatibility materials; heparin immobilization; polyethylene oxide;
   surface immobilizing agents; surface modification
ID EXTRACORPOREAL-CIRCULATION CIRCUITS; TRILLIUM(TM) BIOPASSIVE SURFACE;
   BLOOD-COMPATIBLE MATERIALS; HEPARIN-COATED CIRCUITS; IN-VITRO;
   CARDIOPULMONARY BYPASS; ANTICOAGULANT ACTIVITY; RECOMBINANT HIRUDIN;
   PROTEIN ADSORPTION; POLYMER SURFACES
AB The contact of any biomaterial with blood gives rise to multiple pathophysiologic defensive mechanisms such as activation of the coagulation cascade, platelet adhesion and activation of the complement system and leukocytes. The reduction of these events is of crucial importance for the successful clinical performance of a cardiovascular device. This can be achieved by improving the hemocompatibility of the device materials or by pharmacologic inhibition of the key enzymes responsible for the activation of the cascade reactions, or a combination of both. Different strategies have been developed during the last 20 years, and this article attempts to review the most significant, by dividing them into three main categories: bioinert or biopassive, biomimetic and bioactive strategies. With regard to bioactive strategies, particular attention is given to heparin immobilization and recent related technologies. References from both scientific literature and commercial sites are provided. Future development and studies are suggested.
C1 Politecn Milan, Dept Bioengn, I-20123 Milan, Italy.
RP Tanzi, MC (reprint author), Politecn Milan, Dept Bioengn, Pzza L Da Vinci 32, I-20123 Milan, Italy.
EM tanzi@biomed.polimi.it
RI Tanzi, Maria Cristina/I-4620-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Aldenhoff YBJ, 1997, BIOMATERIALS, V18, P167, DOI 10.1016/S0142-9612(96)00095-6
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Amos R.A., 1995, ENCY HDB BIOMATERI A, V1, P895
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bentolila A, 2000, J MED CHEM, V43, P2591, DOI 10.1021/jm000089j
   Cazzaniga A, 2000, INT J ARTIF ORGANS, V23, P319
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   Chung YC, 2005, BIOMATERIALS, V26, P2313, DOI 10.1016/j.biomaterials.2004.06.043
   Cornelius RM, 2003, J BIOMED MATER RES A, V67A, P475, DOI 10.1002/jbm.a.10118
   Dal Park H, 2002, J BIOMED MATER RES, V60, P186
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   FEYRER R, 2003, CARDIOVASC ENG, V8, P1
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GRAINGER DW, 1990, J BIOMED MATER RES, V24, P403, DOI 10.1002/jbm.820240402
   Gu YJ, 1998, ANN THORAC SURG, V65, P1342, DOI 10.1016/S0003-4975(98)00223-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HOFMA SH, 2001, CURR INTERV CARDIOL, V3, P28
   Inui K, 1999, ARTIF ORGANS, V23, P1107, DOI 10.1111/j.1525-1594.1999.06335.x
   Ishihara K, 2000, J BIOMAT SCI-POLYM E, V11, P1183, DOI 10.1163/156856200744264
   Iwasaki Y, 2003, J BIOMED MATER RES A, V65A, P164, DOI 10.1002/jbm.a.10459
   Janvier G, 1996, ANN THORAC SURG, V62, P1926, DOI 10.1016/S0003-4975(96)00942-3
   Jee KS, 2004, BIOMACROMOLECULES, V5, P1877, DOI 10.1021/bm049795i
   Johnell M, 2005, BIOMATERIALS, V26, P1731, DOI 10.1016/j.biomaterials.2004.05.029
   Johnell M, 2002, J THORAC CARDIOV SUR, V124, P321, DOI 10.1067/mtc.2002.122551
   JOHNELL M, 2003, ACTA U UPSAL, V1299, P65
   Jun Z., 2003, COLLOID SURFACE B, V28, P1
   KAPPELMAYER J, 1993, CIRC RES, V72, P1075, DOI 10.1161/01.RES.72.5.1075
   KASHIWAGI T, 1993, BIOMATERIALS, V14, P1145, DOI 10.1016/0142-9612(93)90159-Y
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kim YH, 1997, MACROMOL SYMP, V118, P565, DOI 10.1002/masy.19971180174
   Kolusheva S, 2001, J AM CHEM SOC, V123, P417, DOI 10.1021/ja0034139
   KRISTENSEN EM, 2003, BIOMATERIALS, V23, P4153
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LENINGER RI, 1966, SCIENCE, V152, P1625
   Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   Lian FR, 2001, BIOCHEMISTRY-US, V40, P8508, DOI 10.1021/bi0101906
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Liu H, 2002, LANGMUIR, V18, P1332, DOI 10.1021/la011254g
   Liu JH, 1999, J APPL POLYM SCI, V74, P2947, DOI 10.1002/1097-4628(19991213)74:12<2947::AID-APP21>3.0.CO;2-1
   Lu JR, 2001, LANGMUIR, V17, P3382, DOI 10.1021/la0017429
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   MATSUDA T, 1990, T AM SOC ART INT ORG, V36, P161
   Matsusaki M, 2002, BIOCONJUGATE CHEM, V13, P23, DOI 10.1021/bc010008d
   McClung WG, 2001, BIOMATERIALS, V22, P1919, DOI 10.1016/S0142-9612(00)00378-1
   McClung WG, 2000, J BIOMED MATER RES, V49, P409, DOI 10.1002/(SICI)1097-4636(20000305)49:3<409::AID-JBM14>3.0.CO;2-0
   Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   Murphy EF, 1999, LANGMUIR, V15, P1313, DOI 10.1021/la9813580
   Olander B, 2003, BIOMACROMOLECULES, V4, P145, DOI 10.1021/bm025654+
   Oliveira GB, 2003, BIOMATERIALS, V24, P4777, DOI 10.1016/S0142-9612(03)00376-4
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   Ovrum E, 2003, J CARDIAC SURG, V18, P140, DOI 10.1046/j.1540-8191.2003.02007.x
   Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403
   Petrini P, 2000, J BIOMAT SCI-POLYM E, V11, P353, DOI 10.1163/156856200743751
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Phaneuf MD, 1998, ARTIF ORGANS, V22, P657, DOI 10.1046/j.1525-1594.1998.05091.x
   PHANEUF MD, 1997, BIOMATERIALS, V18, P1495
   Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4
   REGEN SL, 1983, MACROMOLECULES, V16, P335, DOI 10.1021/ma00236a034
   Ross EE, 2001, LANGMUIR, V17, P2305, DOI 10.1021/la010752
   SANDHU S, 2004, DEV BIOINTERACTING M, P1
   SEFTON MV, 2004, BIOMATERIALS SCI INT, P456
   Sharma CP, 2001, J BIOMATER APPL, V15, P359, DOI 10.1106/YY8L-M4DD-AGW1-QAGU
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Sinay P, 1999, NATURE, V398, P377, DOI 10.1038/18783
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   Spijker HT, 2003, BIOMATERIALS, V24, P4717, DOI 10.1016/S0142-9612(03)00380-6
   Sun XL, 2002, BIOMACROMOLECULES, V3, P1065, DOI 10.1021/bm025561s
   Svedhem S, 2003, LANGMUIR, V19, P6730, DOI 10.1021/la034172w
   Tang YW, 1996, J APPL POLYM SCI, V62, P1133, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1133::AID-APP1>3.0.CO;2-J
   Tanzi MC, 2004, NATO SCI SER II MATH, V180, P51
   TANZI MC, 1992, BIOMATERIALS, V13, P425, DOI 10.1016/0142-9612(92)90162-H
   Taton KS, 2002, COLLOID SURFACE B, V24, P123, DOI 10.1016/S0927-7765(01)00225-9
   Tayama E, 2000, ARTIF ORGANS, V24, P618, DOI 10.1046/j.1525-1594.2000.06615.x
   TEGOULIA VA, 2001, LANGMUIR, V17, P1533
   Tsai C C, 1994, ASAIO J, V40, pM619, DOI 10.1097/00002480-199407000-00073
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   Wang DA, 2003, J BIOMED MATER RES A, V65A, P498, DOI 10.1002/jbm.a.10533
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   WARD RS, 1995, MED PLASTICS BIOMATE
   WARD RS, 2004, T 7 WORLD BIOM C SYD, P433
   WARD RS, 1984, POLYURETHANES BIOMED, P180
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Wildevuur CRH, 1997, EUR J CARDIO-THORAC, V11, P616, DOI 10.1016/S1010-7940(96)01122-0
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wyers MC, 1999, CARDIOVASC PATHOL, V8, P153, DOI 10.1016/S1054-8807(99)00005-8
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   Yoneyama T, 2002, BIOMATERIALS, V23, P1455, DOI 10.1016/S0142-9612(01)00268-X
   Zehnder JL, 1999, NATURE, V400, P714, DOI 10.1038/23360
NR 104
TC 59
Z9 60
U1 4
U2 33
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD JUL
PY 2005
VL 2
IS 4
BP 473
EP 492
DI 10.1586/17434440.2.4.473
PG 20
WC Engineering, Biomedical
SC Engineering
GA 019KS
UT WOS:000235834600015
PM 16293086
DA 2018-10-19
ER

PT J
AU Tang, LP
   Hu, WJ
AF Tang, LP
   Hu, WJ
TI Molecular determinants of biocompatibility
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biocompatibility; biomaterials; fibrinogen; fibrosis; foreign body
   reactions; inflammation; macrophages; neutrophils; phagocytes
ID TUMOR-NECROSIS-FACTOR; ACUTE INFLAMMATORY RESPONSES; ADSORBED
   FIBRINOGEN; PROTEIN ADSORPTION; TISSUE REACTION; CONFORMATIONAL-CHANGES;
   ARTERIAL PROSTHESES; GAMMA-GLOBULIN; CELL-ADHESION; BIOMATERIALS
AB The biocompatibility of medical implants dictates the fate of almost all medical devices. It is well established that medical devices trigger a variety of adverse tissue responses, such as inflammation, fibrosis, infection and thrombosis. However, the mechanisms involved in biomaterial-mediated tissue responses remain largely unknown. The lack of such knowledge hinders the development of biomaterials with better biocompatibility and safety. The aim of this review is to summarize our current understanding of the processes governing foreign body reactions to tissue-contact devices. Obviously, this information is urgently needed for assisting the rational design of materials or medical devices to minimize undesirable tissue reactions upon implantation and, in addition, to promote the wound healing process.
C1 Univ Texas, Biomed Engn Program, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas, Biomed Engn Program, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu; wenjinghu@comcast.net
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   ALTMAN JJ, 1986, DIABETES, V35, P625, DOI 10.2337/diabetes.35.6.625
   ALTMAN JJ, 1986, T AM SOC ART INT ORG, V32, P145
   AMON M, 1994, INT OPHTHALMOL, V18, P9, DOI 10.1007/BF00919407
   AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ARCHER J, 1980, J SURG RES, V28, P77, DOI 10.1016/0022-4804(80)90086-4
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRANDSTEDT S, 1980, ACTA CHIR SCAND, V146, P483
   BRAQUET P, 1987, IMMUNOL TODAY, V8, P345, DOI 10.1016/0167-5699(87)90010-7
   Butler K, 1997, Biomed Sci Instrum, V34, P18
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Carro LP, 1999, ARTHROSCOPY, V15, P103, DOI 10.1053/ar.1999.v15.015010
   CHANDRAKASAN G, 1991, CELL MOL BIOL, V37, P751
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   CHUANG HYK, 1980, THROMB RES, V19, P1, DOI 10.1016/0049-3848(80)90398-9
   Clark HR, 1999, BIOTECHNOL PROGR, V15, P259, DOI 10.1021/bp990003j
   COLEMAN SE, 1986, J BIOMED MATER RES, V20, P301, DOI 10.1002/jbm.820200304
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   Fahey T J 3rd, 1990, Cytokine, V2, P92, DOI 10.1016/1043-4666(90)90002-B
   FAN ST, 1993, J IMMUNOL, V150, P2972
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   HANLON WA, 1991, J LEUKOCYTE BIOL, V50, P43
   HENRY CH, 1993, J ORAL MAXIL SURG, V51, P352, DOI 10.1016/S0278-2391(10)80343-X
   HENSON PM, 1975, J CLIN INVEST, V56, P1053, DOI 10.1172/JCI108152
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   Kryshtalskyj B, 1996, Ont Dent, V73, P40
   LEE RG, 1974, J BIOMED MATER RES, V8, P251, DOI 10.1002/jbm.820080507
   LEIBOVICH SJ, 1976, AM J PATHOL, V84, P501
   LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293
   MACRITCHIE F, 1972, J COLLOID INTERF SCI, V38, P484, DOI 10.1016/0021-9797(72)90264-0
   MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777
   MCRITCHIE DI, 1991, J LAB CLIN MED, V118, P48
   MORRISSEY BW, 1976, T AM SOC ART INT ORG, V22, P278
   MORRISSEY BW, 1978, J COLLOID INTERF SCI, V65, P423, DOI 10.1016/0021-9797(78)90093-0
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NUSBACHER J, 1978, BLOOD, V51, P359
   OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   POLLAK VE, 1982, AM J NEPHROL, V2, P195, DOI 10.1159/000166646
   PRESCOTT RJ, 1994, J CLIN PATHOL, V47, P375, DOI 10.1136/jcp.47.4.375
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   SCHAAF P, 1988, COLLOID SURFACE, V31, P89, DOI 10.1016/0166-6622(88)80184-7
   SCHIAVONE PA, 1993, KNEE SURG SPORT TR A, V1, P9
   Schroven I T, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P214, DOI 10.1007/BF01845590
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   STARK GB, 1990, ANN PLAS SURG, V24, P156, DOI 10.1097/00000637-199002000-00009
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG L, 2000, BIOMATERIAL ENG DEVI, V1, P3
   TANG L, 1999, TISSUE ENG PROSTHETI, P207
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   THORNHILL TS, 1990, BIOMATERIALS, V11, P69
   TRUMPY IG, 1993, J ORAL MAXIL SURG, V51, P624, DOI 10.1016/S0278-2391(10)80259-9
   TURNER RFB, 1991, BIOMATERIALS, V12, P361, DOI 10.1016/0142-9612(91)90003-S
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493
   VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   YATES SG, 1973, SURG GYNECOL OBSTET, V136, P12
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 80
TC 58
Z9 60
U1 2
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD JUL
PY 2005
VL 2
IS 4
BP 493
EP 500
DI 10.1586/17434440.2.4.493
PG 8
WC Engineering, Biomedical
SC Engineering
GA 019KS
UT WOS:000235834600016
PM 16293087
DA 2018-10-19
ER

PT J
AU Park, H
   Radisic, M
   Lim, JO
   Chang, BH
   Vunjak-Novakovic, G
AF Park, H
   Radisic, M
   Lim, JO
   Chang, BH
   Vunjak-Novakovic, G
TI A novel composite scaffold for cardiac tissue engineering
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE cardiac myoeyte; collagen; caprolactone; PLGA; biocompatibility;
   perfusion
ID INFARCTED MYOCARDIUM; HEART-VALVES; COLLAGEN; MUSCLE; CELLS; MODEL
AB One approach to the engineering of functional cardiac tissue for basic studies and potential clinical use involves bioreactor cultivation of dissociated cells on a biomaterial scaffold. Our objective was to develop a scaffold that is (1) highly porous with large interconnected pores (to facilitate mass transport), (2) hydrophilic (to enhance cell attachment), (3) structurally stable (to withstand the shearing forces during bioreactor cultivation), (4) degradable (to provide ultimate biocompatibility of the tissue graft), and (5) elastic (to enable transmission of contractile forces). The scaffold of choice was made as a composite of poly(DL-lactide-co-caprolaetone), poly(DL-lactide-co-glyeolide) (PLGA), and type I collagen, with open interconnected pores and the average void volume of 80 +/- 5%. Neonatal rat heart cells suspended in Matrigel were seeded into the scaffold at a physiologically high density (1.35 X 10(8) cells/cm(3)) and cultivated for 8 d in cartridges perfused with culture medium or in orbitally mixed dishes (25 rpm); collagen sponge (Ultrafoam (TM)) and PLGA sponge served as controls. Construct cellularity, presence of cardiac markers, and contractile properties were markedly improved in composite scaffolds as compared with both controls.
C1 MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Kyungpook Natl Univ, Inst Med Res, Taegu 700721, South Korea.
   Wake Forest Univ, Bowman Gray Sch Med, Inst Regenerat Med, Winston Salem, NC 27157 USA.
   Kyungpook Natl Univ, Dept Thorac & Cardiovasc Surg, Taegu 700721, South Korea.
RP Vunjak-Novakovic, G (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
EM gordana@mit.edu
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Radisic,
   Milica/0000-0003-1249-4135
CR Agrawal C M, 1995, Tissue Eng, V1, P241, DOI 10.1089/ten.1995.1.241
   Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Dohmen PM, 2002, ANN THORAC SURG, V74, P1438, DOI 10.1016/S0003-4975(02)03881-X
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   Hua FJ, 2002, J BIOMED MATER RES, V63, P161, DOI 10.1002/jbm.10121
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leor J, 2000, CIRCULATION, V102, P56
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Ozawa T, 2002, CIRCULATION, V106, P1176
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Radisic M, 2005, SCAFFOLDING TISSUE E, P491
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
NR 27
TC 78
Z9 80
U1 1
U2 17
PU SOC IN VITRO BIOLOGY
PI LARGO
PA 9315 LARGO DR WEST, STE 25, LARGO, MD 20774 USA
SN 1071-2690
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD JUL-AUG
PY 2005
VL 41
IS 7
BP 188
EP 196
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 975CZ
UT WOS:000232639900002
PM 16223333
DA 2018-10-19
ER

PT J
AU Mattioli-Belmonte, M
   Lucarini, G
   Virgili, L
   Biagini, G
   Detomaso, L
   Favia, P
   D'Agostino, R
   Gristina, R
   Gigante, A
   Bevilacqua, C
AF Mattioli-Belmonte, M
   Lucarini, G
   Virgili, L
   Biagini, G
   Detomaso, L
   Favia, P
   D'Agostino, R
   Gristina, R
   Gigante, A
   Bevilacqua, C
TI Mesenchymal stem cells on plasma-deposited acrylic acid coatings: An in
   vitro investigation to improve biomaterial performance in bone
   reconstruction
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE plasma-deposited coatings; acrylic acid; polymer surface modification;
   mesenchymal stem cells; cell behavior; bone scaffolds
ID BIOMEDICAL POLYMERS
AB In this in vitro investigation of a heterogeneous range of biofunctional and modulatory performances of mesenchymal stem cells (MSCs) grown on two plasma-deposited acrylic acid (pdAA) coatings, which differed in chemical characteristics, a view of their potential utility as hybrid scaffolds for bone tissue engineering was obtained. The in vitro behavior of MKS was compared to that of MG-63 cells, an osteoblast-like cell line that is commonly used to test biocompatibility of materials intended for bone-tissue interface. The coatings exerted a greater stimulus on MSCs and on MG-63 cells in comparison with control cultures. Both studied coatings exhibited satisfactory compatibility and modulatory effects on MSCs, thus they may be suitable for use in 2D or 3D scaffolds for bone tissue reconstruction.
C1 Univ Politecn delle Marche, Ist Morfol Umana Normale, I-60020 Ancona, Italy.
   Univ Bari, Dipartimento Chim, I-70126 Bari, Italy.
   Univ Bari, CNR, IMIP, I-70126 Bari, Italy.
   Univ Politecn Marche, Dipartimento Patol Mol & Terapie Innovat, I-60020 Ancona, Italy.
RP Mattioli-Belmonte, M (reprint author), Univ Politecn delle Marche, Ist Morfol Umana Normale, Via Tronto 10-A, I-60020 Ancona, Italy.
EM belmonte@med.univpm.it
RI Mattioli-Belmonte, Monica/J-5861-2012
OI GIGANTE, ANTONIO/0000-0003-0772-563X
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BeauvaisJouneau A, 1997, EXP CELL RES, V233, P1, DOI 10.1006/excr.1997.3554
   DAGOSTINO R, 1990, PLASMA MAT INTERACTI, V496
   DAGOSTINO R, 1997, NATO ASI SERIES E, V346
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   ETIENNEMANNEVIL.S, 2002, NATURE, V429, P629
   Favia P, 2003, SURF COAT TECH, V169, P707, DOI 10.1016/S0257-8972(03)00174-9
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   FAVIA P, 2002, VIDE, P1
   Fazzi R, 2002, LEUKEMIA RES, V26, P839, DOI 10.1016/S0145-2126(02)00008-5
   Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100
   Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107
   HERZOG EL, 2003, BLOOD, V102, P2483
   Hoffman A.S., 1996, BIOMATERIALS SCI INT, P124
   Huss R, 2002, BRIT J HAEMATOL, V118, P305, DOI 10.1046/j.1365-2141.2002.03587.x
   JAVAZON EH, 2004, EXPT HEMATOLOGY, V32, P4141
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   PALUMBO F, 1999, PLASMAS POLYM, V4, P133
   Pender SLF, 2000, AM J PATHOL, V157, P1955, DOI 10.1016/S0002-9440(10)64834-1
   RATNER BD, 1990, PLASMA DEPOSITION TR, P496
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   SHIMAZUI T, 2004, ONCOL REP, V118, P357
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Suh H, 2001, ARTIF ORGANS, V25, P459, DOI 10.1046/j.1525-1594.2001.025006459.x
   Torricelli P, 2003, BIOMED PHARMACOTHER, V57, P57, DOI 10.1016/S0753-3322(02)00329-3
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 27
TC 18
Z9 20
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2005
VL 20
IS 4
BP 343
EP 360
DI 10.1177/0883911505055159
PG 18
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 939RK
UT WOS:000230089900002
DA 2018-10-19
ER

PT J
AU Orsini, G
   Traini, T
   Scarano, A
   Degidi, M
   Perrotti, V
   Piccirilli, M
   Piattelli, A
AF Orsini, G
   Traini, T
   Scarano, A
   Degidi, M
   Perrotti, V
   Piccirilli, M
   Piattelli, A
TI Maxillary sinus augmentation with Bio-Oss((R)) particles: A light,
   scanning, and transmission electron microscopy study in man
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Bio-Oss((R)) particles; electron microscopy; humans
ID BONE-TITANIUM INTERFACE; ANORGANIC BOVINE BONE; PLATELET-RICH PLASMA;
   NONCOLLAGENOUS MATRIX PROTEINS; HUMAN OSTEOGENIC PROTEIN-1; HUMAN
   CORTICAL BONE; MINERAL BIO-OSS; DENTAL IMPLANTS; FLOOR ELEVATION;
   HISTOLOGICAL-EVALUATION
AB Biological interactions occurring at the bone-biomaterial interface are critical for long-term clinical success. Bio-Oss (R) is a deproteinized, sterilized bovine bone that has been extensively used in bone regeneration procedures. The aim of the present study was a comparative light, scanning, and electron microscopy evaluation of the interface between Bio-Oss (R) and bone in specimens retrieved after sinus augmentation procedures. Under light microscopy, most of the particles were surrounded by newly formed bone, while in a few cases, at the interface of some particles it was possible to observe marrow spaces and biological fluids. Under scanning electron microscopy, in most cases, the particle perimeter appeared lined by bone that was tightly adherent to the biomaterial surface. Transmission electron microscopy showed that the bone tissue around the biomaterial showed all the phases of the bone healing process. In some areas, randomly organized collagen fibers were present, while in other areas, newly formed compact bone was present. In the first bone lamella collagen fibers contacting the Bio-Oss (R) surface were oriented at 243.73 +/- 7.12 degrees (mean +/- SD), while in the rest of the lamella they were oriented at 288.05 +/- 4.86 degrees (mean +/- SD) with a statistically significant difference of 44.32 degrees (p < 0.001). In the same areas the intensity of gray value was 172.56 +/- 18.15 (mean +/- SD) near the biomaterial surface and 158.71 +/- 21.95 (mean +/- SD) in the other part of the lamella with an unstatistically significant difference of 13.79 (P = 0.071). At the bone-biomaterial interface there was also an electron-dense layer similar to cement lines. This layer had a variable morphology being, in some areas, a thin line, and in other areas, a thick irregular band. The analyses showed that Bio-Oss (R) particles do not interfere with the normal osseous healing process after sinus lift procedures and promote new bone formation. In conclusion, this study serves as a better understanding of the morphollogic characteristics of Bio-Oss (R) and its interaction with the surrounding tissues. (c) 2005 Wiley Periodicals, Inc.
C1 Univ G dAnnunzio, Dept Stomatol & Oral Sci, I-66100 Chieti, Italy.
   Univ G dAnnunzio, Sch Dent, I-66100 Chieti, Italy.
RP Piattelli, A (reprint author), Univ G dAnnunzio, Dept Stomatol & Oral Sci, Via Dei Vestini 31, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Orsini, Giovanna/B-5470-2016; Scarano, Antonio/F-6961-2017
OI Orsini, Giovanna/0000-0002-2641-0695; Scarano,
   Antonio/0000-0003-1374-6146; Traini, Tonino/0000-0002-0265-8709
CR Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Bosshardt DD, 2003, EUR J ORAL SCI, V111, P51, DOI 10.1034/j.1600-0722.2003.00015.x
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7
   CARTER DR, 1977, CLIN ORTHOP RELAT R, P265
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Davies JE, 1996, ANAT REC, V245, P426
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   De Lange G, 1993, J Oral Implantol, V19, P123
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DEMPSTER WT, J APPL PHYSL 1961, V16, P355
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   FAWNS HT, 1953, ANN RHEUM DIS, V12, P105, DOI 10.1136/ard.12.2.105
   FRASCA P, 1981, ACTA ANAT, V109, P115
   Furst G, 2003, CLIN ORAL IMPLAN RES, V14, P500, DOI 10.1034/j.1600-0501.2003.00859.x
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GOTTESMAN T, 1980, J BIOMECH, V13, P89, DOI 10.1016/0021-9290(80)90182-7
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P117, DOI 10.1034/j.1600-0501.1998.090207.x
   Haas R, 2002, INT J ORAL MAX IMPL, V17, P337
   Hofman S, 1999, BIOMATERIALS, V20, P1155, DOI 10.1016/S0142-9612(97)00082-3
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Kaufman Eliaz, 2003, J Esthet Restor Dent, V15, P272, DOI 10.1111/j.1708-8240.2003.tb00298.x
   Kawaguchi H, 2001, J PERIODONTAL RES, V36, P205, DOI 10.1034/j.1600-0765.2001.036004205.x
   KAWAGUCHI H, 1993, CELL MATER, V3, P337
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   LINDER L, 1985, ACTA ORTHOP SCAND, V56, P269, DOI 10.3109/17453678508993011
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P135, DOI 10.3109/17453678909149240
   LINDER L, CLIN ORTHOP 1992, V276, P147
   Maiorana C, 2003, INT J PERIODONT REST, V23, P227
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   Mayfield LJA, 2001, CLIN ORAL IMPLAN RES, V12, P508
   McAllister BS, 1998, INT J PERIODONT REST, V18, P227
   McKee MD, 1996, CONNECT TISSUE RES, V35, P197, DOI 10.3109/03008209609029192
   MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   McKee MD, 1996, ANAT RECORD, V245, P394, DOI 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K
   MCKEE MD, CELL MAT 1993, V3, P219
   MELLORS RC, 1964, LAB INVEST, V13, P183
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   Nanci A, 1999, J STRUCT BIOL, V126, P256, DOI 10.1006/jsbi.1999.4137
   Nanci A, 1998, BIOL MECH TOOTH ERUP, P487
   PARFITT AM, 1987, BONE, V8, pS1
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Proussaefs P, 2003, INT J PERIODONT REST, V23, P185
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Sennerby L, 1991, CLIN ORAL IMPLAN RES, V2, P103, DOI 10.1034/j.1600-0501.1991.020302.x
   SOKOLOFF L, AM J PATHOL 1973, V73, P261
   Steflik D E, 1992, Int J Oral Maxillofac Implants, V7, P497
   STEFLIK DE, 1993, J BIOMED MATER RES, V27, P791, DOI 10.1002/jbm.820270612
   STEFLIK DE, 1993, ORAL SURG ORAL MED O, V76, P467, DOI 10.1016/0030-4220(93)90014-U
   STEFLIK DE, 1989, J BIOMED MATER RES, V23, P895, DOI 10.1002/jbm.820230807
   STEFLIK DE, 1992, J ORAL IMPLANTOL, V18, P110
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P713
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 69
TC 60
Z9 63
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2005
VL 74B
IS 1
BP 448
EP 457
DI 10.1002/jbm.b.30196
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940PA
UT WOS:000230155200005
PM 15889429
DA 2018-10-19
ER

PT J
AU Schopper, C
   Ziya-Ghazvini, F
   Goriwoda, W
   Moser, D
   Wanschitz, F
   Spassova, E
   Lagogiannis, G
   Auterith, A
   Ewers, R
AF Schopper, C
   Ziya-Ghazvini, F
   Goriwoda, W
   Moser, D
   Wanschitz, F
   Spassova, E
   Lagogiannis, G
   Auterith, A
   Ewers, R
TI HA/TCP compounding of a porous CaP biomaterial improves bone formation
   and scaffold degradation - A long-term histological study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioresorbable; calcium phosphate(s); degradation; histology; bone
   remodeling
ID CALCIUM-PHOSPHATE CERAMICS; BETA-TRICALCIUM PHOSPHATE; DIFFERENT
   CHEMICAL-COMPOSITION; SOFT-TISSUES; HYDROXYAPATITE; IMPLANTS; DEFECTS;
   OSSEOINTEGRATION; RECONSTRUCTION; REGENERATION
AB In the present study, two biphasic calcium phosphate biomaterials (BCP) with HA/TCP ratios of 50150 and 30/70 were obtained from a pure HA biomaterial. The biomaterials which showed the same three-dimensional geometry were implanted into corticocancellous costal defects of sheep. In the specimens of all three biomaterials, abundant bone formation, mineral dissolution from the biomaterial scaffolds, and active cellular resorption of the scaffolds was present after 6 and 12 months. Backscattered electron microscopy showed bone invasion into the pores of the scaffolds and micromechanical interlocking at the bone/biomaterial interface without intervening soft tissue. The pattern of bone formation and scaffold resorption was different for cortical and cancellous bone. No time-based effect, however, was observed. Overall, the BCP biornaterials had formed significantly more bone than the HA biomaterial. Also, scaffold resorption, which was followed by a replacement with newly formed bone, was significantly higher in the BCP biornaterials. Although no significant differences were observed between both BCP biornaterials, the present study had confirmed the assumption that HA/TCP compounding was suitable to improve bone formation and scaffold resorption in the investigated biornaterials and at the same time maintain the osteoconductive properties of the scaffolds. (c) 2005 Wiley Periodicals. Inc.
C1 Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria.
   Ctr Telecommun & Navigat Surg, Inst Cranio Maxillo Facial & Oral Rehabil, Vienna, Austria.
   Med Univ Vienna, Dept Med Stat, Vienna, Austria.
RP Schopper, C (reprint author), Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria.
EM christian.schopper@meduniwien.ac.at
CR ASSAEL LA, 1991, J ORAL MAXIL SURG, V49, P1059, DOI 10.1016/0278-2391(91)90138-C
   Blokhuis TJ, 2000, J BIOMED MATER RES, V51, P369, DOI 10.1002/1097-4636(20000905)51:3<369::AID-JBM10>3.0.CO;2-J
   BOWERS GM, 1986, J PERIODONTOL, V57, P286, DOI 10.1902/jop.1986.57.5.286
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, P287
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1990, J BIOMED MATER RES, V24, P391
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269
   Donath K, 1988, TRENN DUENNSCHLIFF T
   Dorozhkin SV, 2002, ANGEW CHEM, V114, P3260
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   EWERS R, 1989, Patent No. 2532
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   Fujita R, 2003, J ORAL MAXIL SURG, V61, P1045, DOI 10.1016/S0278-2391(03)00317-3
   GAO TJ, 1995, BIOMATERIALS, V16, P1175, DOI 10.1016/0142-9612(95)93583-Y
   Gatti AM, 1998, BIOCERAMICS, V11, P399
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hoexter Daid L, 2002, J Oral Implantol, V28, P290, DOI 10.1563/1548-1336(2002)028<0290:BRGM>2.3.CO;2
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KLAWITTER JJ, 1979, THESIS CLEMSON U CLE
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Manjubala I, 2002, J BIOMED MATER RES, V63, P200, DOI 10.1002/jbm.10128
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Merry JC, 1998, J MATER SCI-MATER M, V9, P779, DOI 10.1023/A:1008975507498
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   Mundy G.R., 1999, BONE REMODELING ITS
   NERY EB, J PERIODONTOL 1992, V68, P729
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   PIATTELLI A, 1994, BIOCERAMICS, V7, P177
   RAWLINGS CE, 1993, NEUROSURGERY, V33, P935
   ROZEMA FR, 1991, THESIS U GRONINGEN G, P61
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   SAMMARCO VJ, FOOT ANKLE CLIN 2002, V7, P19
   SCHLIEPHAKE H, 1993, INT J ORAL MAX SURG, V22, P20, DOI 10.1016/S0901-5027(05)80350-9
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   SHEEN R, BR J PLAST SURG 1988, V41, P138
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Watzinger F, 2000, BRIT J ORAL MAX SURG, V38, P312, DOI 10.1054/bjom.1999.0228
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 51
TC 96
Z9 99
U1 3
U2 20
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2005
VL 74B
IS 1
BP 458
EP 467
DI 10.1002/jbm.b.30199
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940PA
UT WOS:000230155200006
PM 15912537
DA 2018-10-19
ER

PT J
AU Pan, J
   Wang, YL
   Qin, SH
   Zhang, BB
   Luo, YF
AF Pan, J
   Wang, YL
   Qin, SH
   Zhang, BB
   Luo, YF
TI Grafting reaction of poly(D,L)lactic acid with maleic anhydride and
   hexanediamine to introduce more reactive groups in its bulk
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE poly (D,L-lactic acid); grafting reaction; maleic anhydride;
   hexanediamine
ID POLYMER; POLYLACTIDE; COPOLYMERS; ADHESION
AB Bioactivity of biomaterials was a new requirement, especially in tissue engineering and drug delivery. As a traditional used biomaterial, polylactide (PLA) had no bioactivity, of course, and it still had few reactive groups to introduce some bioactive molecules in its bulk. Here, we want to introduce carboxyl groups and amino groups in the side chain of PLA to get more reactive groups for incorporating bioactive molecular later and to maintain the structure of main chain to keep its biodegradability, and to settle the acidity of PLA during hydrolysis at the same time. It was performed as follows: first, maleic anhydride was covalently grafted onto the side chain of PLA by a free radical reaction at 100 degrees C for 20 h with BPO as the initiator. Then, by amidation with a maleic anhydride group on PLA at room temperature, hexanediamine was incorporated. The resulting polymers have been characterized via GPC, C-13 NMR, DSC, and TGA. The graft ratio was tested by titration. The pH changes during hydrolysis in 0.1 M PBS with pH 7.4 of PLA, MPLA, and HPLA were investigated. All the results showed that this research has grafted maleic anhydride and then hexanediamine in the bulk of PLA. The molecular weight degradation during reaction was less than 20%. The graft ratios of were 2.68, 2.36, and 1.86%, respectively in 5, 10, and 20% raw MA in MPLA; and the anhydride groups grafted in MPLA can completely react with hexanediamine at room temperature. The pH value of HPLA remained neutral within 12 weeks' hydrolysis compared with the resulted acidity of PLA and NIPLA. (c) 2005 Wiley Periodicals, Inc.
C1 Chongqing Univ, Dept Bioengn, Chongqing 400044, Peoples R China.
RP Pan, J (reprint author), Chongqing Univ, Dept Bioengn, Chongqing 400044, Peoples R China.
EM panj@cqu.edu.cn
CR ARVANITOYANNIS I, 1995, POLYMER, V36, P2947, DOI 10.1016/0032-3861(95)94344-S
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Griffith G.L., 2000, ACTA MAT, V48, P263
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   GUTWALD R, 1994, J MATER SCI-MATER M, V5, P485, DOI 10.1007/BF00058988
   Heinen W, 1996, MACROMOLECULES, V29, P1151, DOI 10.1021/ma951015y
   LEE KY, 2001, CELL INTERACTIVE POL, V2, P51
   LEWIS CDH, 1990, BIODEGRADABLE POLYM
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   MCINTIRE LV, 2002, WTEC PANEL REPORT TI, P71
   Mooney D J, 1995, Tissue Eng, V1, P107, DOI 10.1089/ten.1995.1.107
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   OTSUKA H, 2000, P 22 ANN EMBS INT C
   RUSSELL KE, 1988, J POLYM SCI POL CHEM, V26, P2273, DOI 10.1002/pola.1988.080260821
   Sodergard A, 1998, RRD POLYM SCI, V2, P263
   Taguchi K, 1988, MACROMOLECULES, V21, P3338
   Trivedi BC, 1982, MALEIC ANHYDRIDE
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 23
TC 35
Z9 39
U1 2
U2 32
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2005
VL 74B
IS 1
BP 476
EP 480
DI 10.1002/jbm.b.30208
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940PA
UT WOS:000230155200008
PM 15889445
DA 2018-10-19
ER

PT J
AU Wang, DW
   Fermor, B
   Gimble, JM
   Awad, HA
   Guilak, F
AF Wang, DW
   Fermor, B
   Gimble, JM
   Awad, HA
   Guilak, F
TI Influence of oxygen on the proliferation and metabolism of adipose
   derived adult stem cells
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID MESENCHYMAL PROGENITOR CELLS; TISSUE-ENGINEERED CARTILAGE;
   ARTICULAR-CARTILAGE; STROMAL CELLS; IN-VITRO; GENE-EXPRESSION; LOWERED
   OXYGEN; DIFFERENTIATION; TENSION; BONE
AB Articular cartilage is an avascular connective tissue that exhibits little intrinsic capacity for repair. Articular cartilage exists in a reduced oxygen (similar to 5%) environment in vivo; therefore, oxygen tension may be an important factor that regulates the metabolism of chondrocyte progenitors. A number of recent studies have developed tissue engineering approaches for promoting cartilage repair using undifferentiated progenitor cells seeded on biomaterial scaffolds, but little is known about how oxygen might influence these engineered tissues. Human adipose-derived adult stem (hADAS) cells isolated from the stroma of subcutaneous fat were suspended in alginate beads and cultured in control or chondrogenic media in either low oxygen (5%) or atmospheric oxygen tension (20%)for up to 14 days. Under chondrogenic conditions, low oxygen tension significantly inhibited the proliferation of hADAS cells, but induced a two-fold increase in the rate of protein synthesis and a three-fold increase in total collagen synthesis. Low oxygen tension also increased glycosaminoglycan synthesis at certain timepoints. Immunohistochemical analysis showed significant production of cartilage-associated matrix molecules, including collagen type II and chondroitin-4-sulfate. These findings suggest oxygen tension may play an important role in regulating the proliferation and metabolism of hADAS cells as they undergo chondrogenesis, and the exogenous control of oxygen tension may provide a means of increasing the overall accumulation of matrix macromolecules in tissue-engineered cartilage.
C1 Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg,Orthopaed Res Labs, Durham, NC 27710 USA.
   Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg,Orthopaed Res Labs, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Awad, Hani/G-6976-2014
OI Awad, Hani/0000-0003-2197-2610; Guilak, Farshid/0000-0001-7380-0330
FU NIA NIH HHS [AG15768]; NIGMS NIH HHS [GM08679]; NIAMS NIH HHS [AR49294,
   AR50245, AR49790, AR48182]
CR Akizuki S, 1997, ARTHROSCOPY, V13, P9, DOI 10.1016/S0749-8063(97)90204-8
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   BERESFORD JN, 1984, BIOCHIM BIOPHYS ACTA, V801, P58, DOI 10.1016/0304-4165(84)90212-5
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Blevins FT, 1998, ORTHOPEDICS, V21, P761
   BRADLEY TR, 1978, J CELL PHYSIOL, V97, P517, DOI 10.1002/jcp.1040970327
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Fermor B, 1998, CELL BIOL INT, V22, P635, DOI 10.1006/cbir.1998.0302
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242
   Ghivizzani S C, 2000, Phys Med Rehabil Clin N Am, V11, P289
   Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X
   Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501
   Guilak F, 2004, BIORHEOLOGY, V41, P389
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   IWASAKI M, 1994, J BONE MINER RES, V9, P1195
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KOLLER MR, 1992, BLOOD, V80, P403
   Leddy HA, 2004, J BIOMED MATER RES B, V70B, P397, DOI 10.1002/jbm.b.30053
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081
   LEONARD CM, 1989, P NATL ACAD SCI USA, V86, P10113, DOI 10.1073/pnas.86.24.10113
   MAEDA H, 1986, EXP HEMATOL, V14, P930
   Martinez-Serrano Alberto, 2001, Current Gene Therapy, V1, P279, DOI 10.2174/1566523013348562
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Morrison SJ, 2000, J NEUROSCI, V20, P7370
   Muir H, 1970, J Bone Joint Surg Br, V52, P554
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Nehrer S, 2000, INVEST RADIOL, V35, P639, DOI 10.1097/00004424-200010000-00009
   NEVO Z, 1988, MECH AGEING DEV, V45, P157, DOI 10.1016/0047-6374(88)90105-4
   Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249
   Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H
   OTTE P, 1991, Z RHEUMATOL, V50, P304
   PETERKOFSKY B, 1982, IMMUNOCHEMISTRY EXTR, P19
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rempel D, 2001, J ORTHOPAED RES, V19, P143, DOI 10.1016/S0736-0266(00)00005-X
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027
   Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
   SHAPIRO IM, 1991, CARTILAGE MOL ASPECT, P97
   SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050
   SPENCER CA, 1990, BIOCHEM J, V265, P911, DOI 10.1042/bj2650911
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Strehl R, 2002, TISSUE ENG, V8, P37, DOI 10.1089/107632702753503036
   Studer L, 2000, J NEUROSCI, V20, P7377
   TAYLOR WG, 1974, EXP CELL RES, V86, P152, DOI 10.1016/0014-4827(74)90660-0
   Wickham M Quinn, 2003, Clin Orthop Relat Res, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 61
TC 153
Z9 172
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD JUL
PY 2005
VL 204
IS 1
BP 184
EP 191
DI 10.1002/jcp.20324
PG 8
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 931ZU
UT WOS:000229524800021
PM 15754341
DA 2018-10-19
ER

PT J
AU Smits, KM
   Schouten, JS
   Smits, LJ
   Stelma, FE
   Nelemans, P
   Prins, MH
AF Smits, KM
   Schouten, JS
   Smits, LJ
   Stelma, FE
   Nelemans, P
   Prins, MH
TI A review on the design and reporting of studies on drug-gene interaction
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Review
DE pharmacogenetics; methodology; study design and reporting; study
   quality; effect modification; drug-gene interactions
ID RANDOMIZED CONTROLLED-TRIALS; BETA(2)-ADRENERGIC RECEPTOR; BETA-AGONIST;
   POLYMORPHISMS; QUALITY; ALBUTEROL; ASSOCIATION; ASTHMATICS
AB Objective: Methodological standards for clinical pharmacogenetic studies should be developed to improve reporting of studies and facilitate their inclusion in systematic reviews. The essence of these studies lies within the concept of effect modification.
   Study Design and Setting: A narrative review discussing methodological issues in the design and reporting of pharmacogenetic studies.
   Results: Studying effect modification within a trial leads to the comparison of subgroups based on genotype. Differences in effect based on genotype should preferably be expressed in absolute terms (risk differences) to facilitate clinical decisions on treatment. Information on the distribution of potential effect modifiers or prognostic factors should be available to prevent a biased comparison of differences in effect between genotypes. The distribution of genotypes should also be presented and compared to Hardy-Weinberg equilibrium to check for selection bias. Additional points of interest include the possibility of selective nonavailability of biomaterial and the choice of a statistical model to study effect modification.
   Conclusion: Additional methodological issues should be taken into account when designing and reporting pharmacogenetic studies, to ensure high study quality. We present several important issues for future studies investigating drug-gene interactions that can serve as a basis for further discussion on methodology in pharmacogenetics. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Maastricht, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands.
RP Smits, KM (reprint author), Univ Maastricht, Dept Epidemiol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM kim.smits@epid.unimaas.nl
RI Smits, Luc/C-5331-2008; Schouten, Johannes S.A.G./M-9376-2016
OI Schouten, Johannes S.A.G./0000-0001-6495-7758
CR Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919
   COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452
   Fletcher R, 1996, CLIN EPIDEMIOLOGY ES
   Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219
   Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092
   Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042
   KOOPMAN JS, 1981, AM J EPIDEMIOL, V113, P716, DOI 10.1093/oxfordjournals.aje.a113153
   Kotani Y, 1999, J ASTHMA, V36, P583, DOI 10.3109/02770909909087295
   Lima JJ, 1999, CLIN PHARMACOL THER, V65, P519, DOI 10.1016/S0009-9236(99)70071-8
   MAITLANDVANDERZEE, 2000, EUR J PHARMACOL, V410, P121
   Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874
   Moher D, 1998, JAMA-J AM MED ASSOC, V279, P1489, DOI 10.1001/jama.279.18.1489
   MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W
   Rothman K.J, 1998, MODERN EPIDEMIOLOGY
   SACKETT DL, 2000, EVIDENCE BASED MED H
   Steimer W, 2002, CLIN CHIM ACTA, V315, P137, DOI 10.1016/S0009-8981(01)00713-6
   Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X
   Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762
   Taylor DR, 2000, J ASTHMA, V37, P691, DOI 10.3109/02770900009087308
   Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0
NR 20
TC 15
Z9 19
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-4356
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD JUL
PY 2005
VL 58
IS 7
BP 651
EP 654
DI 10.1016/j.jclinepi.2005.01.001
PG 4
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 938YB
UT WOS:000230038200002
PM 15939214
DA 2018-10-19
ER

PT J
AU Das, P
   Akkus, O
   Azad, AM
AF Das, P
   Akkus, O
   Azad, AM
TI Optimization of the mineral content in polymeric gels: The effect of
   calcium to phosphate molar ratio
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE biomimetics; mineralization; molar-ratio; Raman spectroscopy; SEM;
   hydroxyapatite
ID DIAPHYSEAL BONE DEFECTS; IN-VIVO; HYDROXYAPATITE; REGENERATION;
   BIOMATERIAL; TEMPERATURE; COMPOSITES; MEMBRANES; CRYSTAL; CARRIER
AB The influence of calcium to phosphate (Ca/P) molar ratio on the extent of mineralization in a model (poly)acrylamide gel was investigated under simulated physiological conditions. We hypothesized that the optimal growth of hydroxyapatite crystals will take place at the stoichiometric Ca/P molar ratio of 1.67. Phosphate ions were incorporated during the polymerization of the gel and mineralization was initiated by submersion of the gel in calcium acetate solution. Ca/P molar ratios were varied in the range of 0.5-5.0. The mineralized gel was characterized by Raman spectroscopy, scanning electron microscopy (SEM) and mineral weight fraction analysis via ashing. Raman spectra captured across the bulk of the gels indicated the presence of mineral at the core section. The phosphate symmetric stretching peak was observed in the range of 955-960cm(-1) which is characteristic of hydroxyapatite. SEM images showed that crystals formed at Ca/P = 2.0 were denser and larger in size than at other molar ratios. In agreement with SEM images, the dry weight fraction of mineral reached the maximum at the molar ratio of 2.0 and the extent of mineralization rapidly declined as the molar ratio diverged from 2.0. Also, the crystallinity of the mineral was optimum at the molar ratio of 2.0. Thus it appears that for effective mineralization, the molar ratio of the two ions needs to be in excess of the stoichiometric requirement, suggesting that ions are expended in processes other than the formation and growth of hydroxyapatite crystals. Therefore, the optimal level of mineralization in biontimetic-based growth of calcium phosphate crystals in sol-gel environment requires consideration of a range of molar ratios as opposed to using the molar ratios corresponding to that of the crystal species intended to grow. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Toledo, Dept Bioengn, Toledo, OH 43606 USA.
   Univ Toledo, Dept Chem Engn, Toledo, OH 43606 USA.
RP Akkus, O (reprint author), Univ Toledo, Dept Bioengn, 2801 W Bancroft St, Toledo, OH 43606 USA.
EM ozan.akkus@utoledo.edu
RI Akkus, Ozan/C-2320-2008
OI Akkus, Ozan/0000-0003-3523-3421
CR Anee TK, 2003, MATER CHEM PHYS, V80, P725, DOI 10.1016/S0254-0584(03)00116-0
   Ashok M, 2003, MATER LETT, V57, P2066, DOI 10.1016/S0167-577X(02)01140-0
   BRIGHT RW, 1984, OSTEOCHONDRAL ALLOGR, P241
   BRIGHT RW, 1984, OSTEOCHONDRAL ALLOGR, P223
   Campbell DG, 1999, AUST NZ J SURG, V69, P517, DOI 10.1046/j.1440-1622.1999.01615.x
   De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   GUGALA Z, 1999, J ORTHOP TRAUMA, V13, P18
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Iijima M, 1998, J CRYST GROWTH, V194, P125, DOI 10.1016/S0022-0248(98)00605-8
   IJIMA M, 1992, CALCIFIED TISSUE INT, V50, P357
   IMAI H, 2003, CHEM COMMUN, V15, P1952
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   JORGENSON SS, 1994, SPINE, V19, P2048, DOI 10.1097/00007632-199409150-00005
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Li JG, 1997, BIOMATERIALS, V18, P743, DOI 10.1016/S0142-9612(96)00206-2
   Marques PAAP, 2004, J MATER CHEM, V14, P1861, DOI 10.1039/b403495c
   Meinig RP, 1997, J ORTHOP TRAUMA, V11, P551, DOI 10.1097/00005131-199711000-00002
   Meinig RP, 1996, J ORTHOP TRAUMA, V10, P178, DOI 10.1097/00005131-199604000-00006
   Russell JL, 1999, ORTHOPEDICS, V22, P532
   Sotome S, 2004, MAT SCI ENG C-BIO S, V24, P341, DOI 10.1016/j.msec.2003.12.003
   Takagi S, 2001, J BIOMED MATER RES, V58, P36, DOI 10.1002/1097-4636(2001)58:1<36::AID-JBM50>3.3.CO;2-R
   Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118
   URIST MR, 1981, CLIN ORTHOP RELAT R, P97
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 28
TC 4
Z9 5
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD JUL 1
PY 2005
VL 280
IS 3-4
BP 587
EP 593
DI 10.1016/j.jcrysgro.2005.04.029
PG 7
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA 941SR
UT WOS:000230235000038
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Ajdukovic, Z
   Uskokovic, D
AF Ignjatovic, N
   Ajdukovic, Z
   Uskokovic, D
TI New biocomposite [biphasic calcium
   phosphate/poly-DL-lactide-co-glycolide/biostimulative agent] filler for
   reconstruction of bone tissue changed by osteoporosis
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COMPOSITE BIOMATERIALS; BIODEGRADABLE POLYMERS; HAP/PLLA COMPOSITE;
   HYDROXYAPATITE; BIOCERAMICS; CELLS
AB Biphasic calcium phosphate-poly-DL-lactide-co-glycolide composite biomaterial with and without biostimulative agents (protein-rich plasma or fibrin) was synthesised in the form suitable for reconstruction of bone defects. The composite used as filler was obtained by precipitation in solvent-non-solvent systems. The material, calcium phosphate granules covered by polymer, was characterised by wide-angle X-ray structural analysis, scanning electron microscopy, infrared spectroscopy and differential scanning calorimetry. Reparation of bone tissue damaged by osteoporosis was investigated in vivo on rats. The method applied enabled production of granules of calcium phosphate-poly-DL-lactide-co-glycolide composite biomaterial of average diameter 150-200 mu m. Histological analysis confirmed recuperation of the alveolar bone, which osteoporosis-induced defects were repaired using composite biomaterial. By addition of biostimulative agents, intensity of PP osteogenesis increases accompanied by the formation of regular, new bone structure. (C) 2005 Springer Science + Business Media, Inc.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia Monteneg.
   Univ Nis, Fac Stomatol, Nis, Serbia Monteneg.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia Monteneg.
EM uskok@itn.sanu.ac.yu
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   AJDUKOVIC Z, 2004, THESIS U NISH
   Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625
   BLACH N, 2002, BIOMATERIALS, V23, P1579
   BROWN P, 1998, BONE, V22, P45
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Chappard D, 1996, J BONE MINER RES, V11, P676
   Choi BH, 2004, INT J ORAL MAX SURG, V33, P56, DOI 10.1045/ijom.2003.0466
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FUJITA T, 1997, OSTEOPOROSIS INT, V7, P19
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HUMMEL D, 1984, ATLAS POLYM PLASTICS, P273
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   KLEMETTI E, 1993, J PROSTHET DENT, V70, P21, DOI 10.1016/0022-3913(93)90032-J
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Najman S, 2004, BIO-MED MATER ENG, V14, P61
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   RIGGS BL, 1991, WESTERN J MED, V154, P63
   Schliephake H, 2001, INT J ORAL MAX SURG, V30, P531, DOI 10.1054/ijom.2001.0164
   STAFFORD HJ, 1994, J ORTHOP RES, V12, P29, DOI 10.1002/jor.1100120105
   Thorn JJ, 2004, INT J ORAL MAX SURG, V33, P95, DOI 10.1054/ijom.2003.0461
   Trapani G, 2003, INT J PHARM, V268, P47, DOI 10.1016/j.ijpharm.2003.08.016
NR 30
TC 25
Z9 26
U1 3
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2005
VL 16
IS 7
BP 621
EP 626
DI 10.1007/s10856-005-2532-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 936LF
UT WOS:000229856800004
PM 15965593
DA 2018-10-19
ER

PT J
AU Xu, WH
   Xiao, ZY
   Zhang, TY
AF Xu, WH
   Xiao, ZY
   Zhang, TY
TI Mechanical properties of silicone elastomer on temperature in
   biomaterial application
SO MATERIALS LETTERS
LA English
DT Article
DE mechanical properties; silicone elastomer; biomaterial application
ID SURFACES; HARDNESS
AB The present work uses nanoindentation method to measure the hardness of silicone elastomer annealed at 80 degrees C, 120 degrees C, 200 degrees C, 300 degrees C, and 350 degrees C for 60 min, respectively. Based on the apparent surface analysis, a linear relationship is found between the hardness and the reciprocal of the penetration depth. It is found that hardness of the polymer sample obviously decreases after annealing at 80 degrees C, which is due to the removal of any potential surface residual stresses under the initial annealing process. If the annealing temperature is larger than 300 degrees C, the hardness increased a lot. Therefore, from the characterization of surface hardness, what kind of (delete) temperature ever reached in the device made of silicone elastomer in the biology field can be deduced. (c) 2005 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China.
   Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
RP Xu, WH (reprint author), Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China.
EM whxu@cashq.ac.cn
RI Zhang, Tong-Yi/A-8828-2016
OI xiao, zeyu/0000-0002-3457-5772
CR GORMAN SP, 2002, MED DEVICE TECHNOLOG
   Hamadani BH, 2004, APPL PHYS LETT, V84, P443, DOI 10.1063/1.1639945
   Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775
   Maeda N, 2002, SCIENCE, V297, P379, DOI 10.1126/science.1072378
   Milnes MR, 2002, ENVIRON HEALTH PERSP, V110, P393, DOI 10.1289/ehp.02110s3393
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Xu WH, 2001, APPL PHYS LETT, V79, P4112, DOI 10.1063/1.1426271
   Zhang TY, 2004, ACTA MATER, V52, P57, DOI 10.1016/j.actamat.2003.08.026
   Zhang TY, 2002, J MATER RES, V17, P1715, DOI 10.1557/JMR.2002.0254
   Zhang YP, 2004, J THERM BIOL, V29, P45, DOI 10.1016/j.jtherbio.2003.10.007
NR 10
TC 11
Z9 11
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL
PY 2005
VL 59
IS 17
BP 2153
EP 2155
DI 10.1016/j.matlet.2005.02.052
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 929XD
UT WOS:000229379000012
DA 2018-10-19
ER

PT J
AU Akahori, T
   Niinomi, M
   Koyanagi, Y
   Kasuga, T
   Toda, H
   Fukui, H
   Ogawa, M
AF Akahori, T
   Niinomi, M
   Koyanagi, Y
   Kasuga, T
   Toda, H
   Fukui, H
   Ogawa, M
TI Mechanical properties of biocompatible beta-type titanium alloy coated
   with calcium phosphate invert glass-ceramic layer
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-29 mass%niobium-13mass%tantalum-4.6mass%zirconium; bioactive
   glass; microstructure; tensile properties; Young's modulus; fatigue
   properties
ID BIOMEDICAL APPLICATIONS; HYDROXYAPATITE COATINGS; HEAT-TREATMENT;
   FATIGUE; TI-29NB-13TA-4.6ZR; MICROSTRUCTURE; BIOCERAMICS; BEHAVIOR;
   ALKALI
AB The presence of calcium phosphate invert glass-ceramic (designated as CPIG) layer on the surface of artificial implant products can improve the bonding between these products and bones.
   In this study, the morphology of the CPIG layer on the surface of a beta-type titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ), was investigated for biomaterial applications by a dip-coating treatment. Furthermore, the mechanical properties of TNTZ coated with the CPIG layer were also investigated.
   In the CPIG layer, a compositionally gradient zone with a thickness of approximately 2.0 mu m exists on the surface of the TNTZ. The titanium concentration in the zone increases with the decreasing distance from the CPIG surface toward the base materials. On the other hand, calcium and phosphorus concentrations in the zone increase with the distance from the TNTZ surface. The tensile bonding strength between TNTZ and the CPIG layer is 25 MPa and that between aged TNTZ and the CPIG layer is 18.6 MPa.
   For easily understanding the change in mechanical properties by a dip-coating treatment, the values of those on TNTZ and TNTZ coated with CPIG layer were shown as follows. The tensile strength increases remarkably by a dip-coating treatment as compared with that of assolutionized TNTZ while the elongation is a reverse trend. Young's modulus of TNTZ and aged TNTZ coated with the CPIG increases by 15 to 27 GPa after the dip-coating treatment as compared with that of as-solutionized TNTZ (approximately 60 GPa). The fatigue limit of TNTZ coated with the CPIG layer is nearly equal to that (approximately 300 MPa) of as-solutionized TNTZ. On the other hand, the fatigue limit of aged TNTZ coated with the CPIG layer is a 100 MPa higher than that of as-solutionized TNTZ.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   Daido Steel Co Ltd, R&D, Nagoya, Aichi 4578584, Japan.
RP Akahori, T (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2000, METALL MATER TRANS A, V31, P1949, DOI 10.1007/s11661-000-0222-z
   Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Ding SJ, 2003, SURF COAT TECH, V165, P248, DOI 10.1016/S0257-8972(02)00745-4
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HAYASHI K, 1999, J JPN SCI MECH ENG A, V65, P2080
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   KASAUGA T, 2001, BIOMATERIALS, V22, P577
   KASAUGA T, 2000, MAT JPN, V39, P250
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P99
   LANCEFIELD WR, 1993, INTRO BIOCERAMICS, P223
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   MINAKAWA K, 1989, TETSU TO HAGANE, V75, P1104, DOI 10.2355/tetsutohagane1955.75.7_1104
   Nelea V, 2003, SURF COAT TECH, V173, P315, DOI 10.1016/S0257-8972(03)00729-1
   Niinomi M, 2003, J JPN I MET, V67, P604, DOI 10.2320/jinstmet1952.67.10_604
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   Nonami T., 1998, MAT JPN, V37, P856
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 26
TC 10
Z9 10
U1 1
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1564
EP 1569
DI 10.2320/matertrans.46.1564
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500023
OA Bronze
DA 2018-10-19
ER

PT J
AU Maruyama, N
   Kawasaki, H
   Yamamoto, A
   Hiromoto, S
   Imai, H
   Hanawa, T
AF Maruyama, N
   Kawasaki, H
   Yamamoto, A
   Hiromoto, S
   Imai, H
   Hanawa, T
TI Friction-wear properties of nickel-free Co-Cr-Mo alloy in a simulated
   body fluid
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt-chromium-molybdenum alloy; friction-wear test; meta-on-metal
   friction; biomaterial
ID AUSTENITIC STEELS; HIGH-NITROGEN
AB Friction-wear properties of a Co-29 mass%Cr-6 mass%Mo alloy (ASTM F799-95) but reducing the amount of nickel were evaluated with friction-wear test using a pin-on-flat type reciprocating friction tester in air and phosphate buffered saline, PBS(-), as a quasi-biological environment under applied stress of 1.0, 3.5 and 5.0 MPa to understand the performance of this alloy for metal-on-metal type artificial hip joints. In addition, metal ions dissolved in PBS(-) after the test was quantified. As a result, wear loss in PBS(-) is much smaller than that in air and increases with the increase of applied stress in both air and PBS(-), while the coefficient of friction in steady state during the test is larger in PBS(-) than in air, according to lubrication behavior of wear debris and PBS(-). Wear damage in PBS(-) is smaller than that in air, however more small scale of irregularity is observed in PBS(-) than that in air. Nickel and molybdenum are preferentially dissolved during the test.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   Shibaura Inst Technol, Dept Mat Sci & Technol, Tokyo 1088548, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
RI HIROMOTO, Sachiko/H-2686-2011
CR Ahlroos T, 1997, WEAR, V211, P113, DOI 10.1016/S0043-1648(97)00074-4
   [Anonymous], 1999, IARC MON EV CARC RIS, V74, P65
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Huang P, 1999, MATER LETT, V39, P244, DOI 10.1016/S0167-577X(99)00021-X
   Ikeda D, 2002, SURF COAT TECH, V156, P301, DOI 10.1016/S0257-8972(02)00094-4
   KILNER T, 1982, J BIOMED MATER RES, V16, P63, DOI 10.1002/jbm.820160109
   KILNER T, 1986, J MATER SCI, V21, P1346
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Wang A, 1999, WEAR, V225, P708, DOI 10.1016/S0043-1648(98)00384-6
   WILLIAMS DF, 1998, ENCY MAT SCI TECHNOL, P41
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
   Zhou J, 2004, J TRIBOL-T ASME, V126, P386, DOI 10.1115/1.1611511
NR 13
TC 16
Z9 16
U1 0
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1588
EP 1592
DI 10.2320/matertrans.46.1588
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500026
OA Bronze
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Kano, K
   Suzuki, Y
   Asami, K
   Chiba, A
   Hanawa, T
AF Hiromoto, S
   Kano, K
   Suzuki, Y
   Asami, K
   Chiba, A
   Hanawa, T
TI Surface characterization and anodic polarization of
   nitrogen-ion-implanted nickel-free Co-Cr-Mo alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt-chromium-molybdenum alloy; nitrogen ion implantation; surface
   analysis; anodic polarization; biomaterial
ID PHYSIOLOGICAL SOLUTION; TITANIUM; XPS; ADSORPTION; TI-6AL-4V; CHROMIUM;
   OXIDES; IRON
AB Nitrogen ions were implanted in a nickel-free Co-Cr-Mo alloy in amounts of 10(19), 10(20), and 10(21) ions m(-2) with an acceleration energy of 150 keV and ion-beam current-density of 10(-15) MA m(-2) to improve the friction-wear properties. Changes in the composition of the surface layer of the alloy with ion implantation, autoclaving, and immersion in Hanks' solution as a simulated body fluid were characterized using X-ray photoelectron spectroscopy to evaluate the stability of the material and predict the safety and tissue compatibility of the material. The surface oxide layer on the mechanically polished Co-Cr-Mo alloy consisted of oxidic species of cobalt, chromium, and molybdenum, and its thickness was about 2.5 nm. The surface film contained a large amount of OH-, that is, the oxide was hydrated or oxyhydroxidized. After N2+ implantation, nitrogen atoms existed as cobalt nitride in the substrate just under the surface oxide and NH3 or NH4 in the surface oxide, and these amounts increased with the increase of the dose. Chromium was concentrated in the surface oxide but depleted in the substrate with ion implantation. Cobalt was preferentially oxidized by autoclaving and depleted in the substrate after autoclaving. Calcium phosphate was formed, and cobalt was preferentially dissolved during immersion in Hanks' solution. N2+-implanted Co-Cr-Mo alloy with an amount of 10(20) ions m(-2) showed the highest corrosion resistance.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan.
   RIKEN, Adv Dev & Supporting Ctr, Beam Applicat Team, Wako, Saitama 3510198, Japan.
   Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
RI HIROMOTO, Sachiko/H-2686-2011; Chiba, Akihiko/D-1326-2011
CR [Anonymous], 1999, IARC MONOGRAPHS EVAL, V74, P65
   ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K., 1985, P 6 EUR S CORR BEH A, P769
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   SORP S, 1977, SURF SCI, V68, P10
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Wagner C.D., 1979, HDB XRAY PHOTOELECTR, P80
   Wagner C.D., 1990, PRACTICAL SURFACE AN, V1, P595
   Wagner CD, 1979, HDB XRAY PHOTOELECTR, P74
NR 25
TC 3
Z9 3
U1 1
U2 8
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1627
EP 1632
DI 10.2320/matertrans.46.1627
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500032
OA Bronze
DA 2018-10-19
ER

PT J
AU Waar, K
   van der Mei, HC
   Harmsen, HJM
   de Vries, J
   Atema-Smit, J
   Degener, JE
   Busscher, HJ
AF Waar, K
   van der Mei, HC
   Harmsen, HJM
   de Vries, J
   Atema-Smit, J
   Degener, JE
   Busscher, HJ
TI Atomic force microscopy study on specificity and non-specificity of
   interaction forces between Enterococcus faecalis cells with and without
   aggregation substance
SO MICROBIOLOGY-SGM
LA English
DT Article
ID PLATE FLOW CHAMBER; SEX-PHEROMONE; STREPTOCOCCUS-FAECALIS; MICROBIAL
   ADHESION; INFECTIONS; DEPOSITION; VIRULENCE; BACTERIA; DEVICES
AB Enterococcus faecalis is one of the leading causes of hospital-acquired infections, and indwelling medical devices are especially prone to infection. E faecalis expressing aggregation substance (Agg) adheres to biomaterial surfaces by means of positive cooperativity, i.e. the ability of one adhering organism to stimulate adhesion of other organisms in its immediate vicinity. In this study, atomic force microscopy (AFM) was used to measure the specificity and non-specificity of interaction forces between E faecalis cells with and without Agg. Bacteria were attached to a substratum surface and a tip-less cantilever. Two E faecalis strains expressing different forms of Agg showed nearly twofold higher interaction forces between bacterial cells than a strain lacking Agg [adhesive force (F-adh), -1(.)3 nN]. The strong interaction forces between the strains with Agg were reduced after adsorption of antibodies against Agg from -2(.)6 and -2(.)3 nN to -1(.)2 and -1.3 nN, respectively. This suggests that the non-specific interaction force between the enterococci amounts to approximately 1(.)2 nN, while the specific force component is only twofold stronger. Comparison of the results of the AFM interaction forces with the positive cooperativity after adhesion to a biomaterial in a parallel-plate flow chamber showed that in the absence of strong interaction forces between the cells, positive cooperativity was also absent. In conclusion, this is believed to be the first time that the influence of specific antibodies on interaction forces between E faecalis cells has been demonstrated by AFM, thereby experimentally distinguishing between specific and non-specific force components.
C1 Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Busscher H J, 1992, FEMS Microbiol Rev, V8, P199
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   CLEWELL DB, 1985, J BACTERIOL, V162, P1212
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   De Boever EH, 2000, MOL MICROBIOL, V37, P1327, DOI 10.1046/j.1365-2958.2000.02072.x
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P602, DOI 10.1128/AAC.33.5.602
   Dufrene YF, 2000, BIOPHYS J, V78, P3286, DOI 10.1016/S0006-3495(00)76864-0
   Dufrene YF, 2003, CURR OPIN MICROBIOL, V6, P317, DOI 10.1016/S1369-5274(03)00058-4
   DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479
   IKE Y, 1983, P NATL ACAD SCI-BIOL, V80, P5369, DOI 10.1073/pnas.80.17.5369
   JACOB AE, 1974, J BACTERIOL, V117, P360
   JETT BD, 1994, CLIN MICROBIOL REV, V7, P462
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   MUSCHOLL A, 1993, EUR J BIOCHEM, V214, P333, DOI 10.1111/j.1432-1033.1993.tb17928.x
   Muscholl-Silberhorn A, 1999, MOL MICROBIOL, V34, P620, DOI 10.1046/j.1365-2958.1999.01631.x
   Poelstra KA, 2000, J BIOMED MATER RES, V51, P224, DOI 10.1002/(SICI)1097-4636(200008)51:2<224::AID-JBM11>3.0.CO;2-G
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795
   SJOLLEMA J, 1990, COLLOID SURFACE, V47, P337, DOI 10.1016/0166-6622(90)80082-F
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   van der Mei HC, 2000, BIOPHYS J, V78, P2668, DOI 10.1016/S0006-3495(00)76810-X
   VANOSS CJ, 1991, J DISPER SCI TECHNOL, V12, P201, DOI 10.1080/01932699108913120
   VANRAAMSDONK M, 1995, COLLOID SURFACE B, V4, P401, DOI 10.1016/0927-7765(95)01195-O
   Waar K, 2002, MICROBIOL-SGM, V148, P1863, DOI 10.1099/00221287-148-6-1863
   Waar K, 2002, J INFECT DIS, V185, P1121, DOI 10.1086/339682
   Yu JL, 1996, SCAND J GASTROENTERO, V31, P625, DOI 10.3109/00365529609009140
NR 29
TC 25
Z9 26
U1 1
U2 5
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD JUL
PY 2005
VL 151
BP 2459
EP 2464
DI 10.1099/mic.0.27877-0
PN 7
PG 6
WC Microbiology
SC Microbiology
GA 949OT
UT WOS:000230798700036
PM 16000736
OA Bronze
DA 2018-10-19
ER

PT J
AU Stiehl, JB
AF Stiehl, JB
TI Trabecular metal in hip reconstructive surgery
SO ORTHOPEDICS
LA English
DT Review
ID TANTALUM; BONE; IMPLANTS; INGROWTH
AB Biological ingrowth surfaces have become a standard prosthetic element in reconstructive hip surgery. A material's properties, three-dimensional architecture, and surface texture all play integral parts in its biological performance. Trabecular metal is an important new biomaterial that has been introduced to enhance the potential of biological ingrowth as well as provide a structural scaffold in cases of severe bone deficit. Initial clinical applications have focused on,bone restoration in tumor and salvage cases and in primary and revision reconstructive cases where the increased biological fixation would be of clinical benefit. The bone ingrowth potential and mechanical integrity of this material offer exciting options for orthopedic reconstructive surgeons.
C1 Columbia Hosp, Milwaukee, WI USA.
RP Stiehl, JB (reprint author), 575 W River Woods Pkwy, Milwaukee, WI 53212 USA.
CR Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1999, ANN M AM AC ORTH SUR
   CLAASSEN B, 1997, 23 ANN M SOC BIOM AP
   Friedman R J, 1994, Instr Course Lect, V43, P233
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   GUNSON A, 2001, ANN M AM SOC BIOM AP
   Heiner A. D., 1998, Journal of Musculoskeletal Research, V2, P267, DOI 10.1142/S0218957798000263
   LEWALLEN D, 2002, HARVARD HIP COURSE 2
   LEWIS RJ, 2003, ANN M AM AC ORTH SUR
   LITSKY AS, 1999, 25 ANN M SOC BIOM AP
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   POGGIE RA, 2001, 44 ANN M ORTH RES SO
   POGGIE RA, 2002, 44 ANN M ORTH RES SO
   POGGIE RA, 2002, 7 ANN INT BIOL S 200
   POGGIE RA, 1999, 45 ANN M ORTH RES SO
   Stiehl JB, 2000, J ARTHROPLASTY, V15, P849, DOI 10.1054/arth.2000.9320
   STIEHL JB, 1991, J ARTHROPLASTY S, V6, P85
   TOH KK, 2001, 44 ANN ORTH RES SOC
   TURNER TM, 1995, T SOC BIOMATERIALS, V21, P125
   UNGER AS, 2002, ANN M AM AC ORTH SUR
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   ZHANG Y, 1998, J MUSCULOSKELETAL RE, V3, P245
NR 26
TC 23
Z9 24
U1 1
U2 4
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0147-7447
J9 ORTHOPEDICS
JI Orthopedics
PD JUL
PY 2005
VL 28
IS 7
BP 662
EP 670
PG 9
WC Orthopedics
SC Orthopedics
GA 973SW
UT WOS:000232543900009
PM 16119281
DA 2018-10-19
ER

PT J
AU Li, XM
   Feng, QL
   Jiao, YF
   Cui, FH
AF Li, XM
   Feng, QL
   Jiao, YF
   Cui, FH
TI Collagen-based scaffolds reinforced by chitosan fibres for bone tissue
   engineering
SO POLYMER INTERNATIONAL
LA English
DT Article
DE chitosan fibre; compressive strength; porosity; scaffold; modifying
   factor
ID COLORIMETRIC ASSAY; BIOCOMPATIBILITY; CYTOTOXICITY; BIOMATERIAL; SYSTEMS
AB In this paper, porous bone scaffolds reinforced with chitosan fibres were prepared. The porosity and pore size of the reinforced scaffolds were both satisfactory. The reinforced scaffolds resembled natural bone in both components and crystal size. Only if the length of the fibres was no shorter than the critical length, could the fibres reinforce the material. We have proposed an empirical formula to calculate the critical length of the fibres for the porous materials and determined the modifying factor (F-1) for the porous bone scaffold investigated in this work. Along with the increase of the fibres' volume content, the compressive strength of the scaffold also increased. We have proposed a further empirical formula for calculating the compressive strength of the porous reinforced materials and determined the modifying factor (F-sigma) for the porous reinforced bone scaffold examined in these studies. Along with the degradation in vitro, the decrease in strength of the reinforced scaffold was less than that of the unreinforced scaffold. The growth rate of osteoblast cells on the reinforced scaffold was higher than that on the unreinforced scaffold. These results suggest that the reinforced scaffold may be a promising candidate matrix for repairing large bone defects. (c) 2005 Society of Chemical Industry.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
RP Feng, QL (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
OI Feng, Qingling/0000-0003-1288-300X
CR AGARWAL BD, 1980, ANAL PERFORMANCE FIB, P1012
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P117
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   HANCOX NJ, 1981, FIBRE COMPOSITE HYBR, P775
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   LIAO S, 2003, THESIS TSINGHUA U BE
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   SMITH MD, 1992, INT J ARTIF ORGANS, V15, P191
   TORUN KG, 2003, BIMATERIALS, V24, P1949
   VACANTI JP, 1997, PRINCIPLES TISSUE EN, P1
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Yan YN, 2003, MATER LETT, V57, P2623, DOI 10.1016/S0167-577X(02)01339-3
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 20
TC 40
Z9 44
U1 1
U2 20
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 2005
VL 54
IS 7
BP 1034
EP 1040
DI 10.1002/pi.1804
PG 7
WC Polymer Science
SC Polymer Science
GA 938BA
UT WOS:000229973700007
DA 2018-10-19
ER

PT J
AU Shih, IL
   Wu, PJ
   Shieh, CJ
AF Shih, IL
   Wu, PJ
   Shieh, CJ
TI Microbial production of a poly (gamma-glutamic acid) derivative by
   Bacillus subtilis
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE bioconjugate; Bacillus subtilis; poly (gamma-glutamic acid);
   biomaterial; gamma-PGA; glycerol
ID POLY(GAMMA-GLUTAMIC ACID); LICHENIFORMIS; BIOSYNTHESIS; MICROORGANISMS;
   POLYPEPTIDE
AB Bacillus subtilis Cl, a bacterium capable of producing a glycerol and gamma-PGA bioconjugate, was studied. C1 is a glutamate independent bacterium, which produces the gamma-PGA derivative in the absence of L-glutamate. A large amount of the bioconjugate, 21.4 g/l, was produced when the bacteria were cultured in medium T at 37 C, 150 rpm for 6 days. The number-average molecular weight (M) of the bioconjugate was over 1 x 107 as determined by gel permeation chromatography, amino acid analysis showed only glutamic acid peak and the H-1 NMR spectrum showed chemical shifts of both gamma-PGA and glycerol. The D-glutamate content was over 97% in every bioconjugate produced under the conditions used and the D-glutamate content was indifferent to the Mn2+ concentrations under study. During bioconjugate production, an intracellular glutamate racemase activity was detected, suggesting the enzyme is involved in the D-glutamate supply. The molecular weight of the bioconjugate varied with salt concentration in the medium; the molecular weight decreased by a factor of approximately 10 from 7.94 x 10(6) to 0.73 x 10(6) Da at 4-day cultivation time for cultures, which contained 0.05 and 5% NaCl, respectively. The viscosity of the bioconjugate produced by C1 is significantly higher than that of gamma-PGA itself. This bioconjugate is the first example of gamma-PGA derivative directly produced by microbes; thus, it is a unique biomaterial. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Da Yeh Univ, Dept Environm Engn, Changhua, Taiwan.
   Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan.
RP Shih, IL (reprint author), Da Yeh Univ, Dept Environm Engn, Changhua, Taiwan.
EM ils@mail.dyu.edu.tw
CR ABE K, 1997, BIOSCI BIOTECH BIOCH, V61, P1043
   Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764, DOI 10.1007/s00253-001-0848-9
   Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x
   Ashiuchi M, 1998, J BIOCHEM-TOKYO, V123, P1156
   BIRRER GA, 1994, INT J BIOL MACROMOL, V16, P265, DOI 10.1016/0141-8130(94)90032-9
   BORBELY M, 1994, POLYM BULL, V32, P127, DOI 10.1007/BF00306378
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   FUJII H, 1963, J AGR CHEM SOC JPN, V37, P407
   GOTO A, 1992, BIOSCI BIOTECH BIOCH, V56, P1031, DOI 10.1271/bbb.56.1031
   HANBY WE, 1946, BIOCHEM J, V40, P297, DOI 10.1042/bj0400297
   Inatsu Y, 2002, JARQ-JPN AGR RES Q, V36, P169, DOI 10.6090/jarq.36.169
   IVANOVICS G., 1937, Zeitschrift fur Immunitatsforschung, V90, P5
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   Kunioka M, 1997, APPL MICROBIOL BIOT, V47, P469, DOI 10.1007/s002530050958
   KUNIOKA M, 1993, KOBUNSHI RONBUNSHU, V50, P755, DOI 10.1295/koron.50.755
   LEONARD CG, 1958, J BACTERIOL, V76, P499
   Markland P, 1999, INT J PHARM, V178, P183, DOI 10.1016/S0378-5173(98)00373-1
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   SEKINE T, 2000, J BIOMED MATER RES, V35, P305
   Shih IL, 2003, BIOTECHNOL LETT, V25, P1709, DOI 10.1023/A:1026042302102
   Shih IL, 2002, ENZYME MICROB TECH, V31, P213, DOI 10.1016/S0141-0229(02)00103-5
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Shih IL, 2001, BIORESOURCE TECHNOL, V78, P267, DOI 10.1016/S0960-8524(01)00027-X
   WU PJ, 2004, THESIS DA YEH U TAIW
NR 26
TC 35
Z9 41
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
J9 PROCESS BIOCHEM
JI Process Biochem.
PD JUL
PY 2005
VL 40
IS 8
BP 2827
EP 2832
DI 10.1016/j.procbio.2004.12.009
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA 925IU
UT WOS:000229047600035
DA 2018-10-19
ER

PT J
AU Yao, L
   Swartz, DD
   Gugino, SF
   Russell, JA
   Andreadis, ST
AF Yao, L
   Swartz, DD
   Gugino, SF
   Russell, JA
   Andreadis, ST
TI Fibrin-based tissue-engineered blood vessels: Differential effects of
   biomaterial and culture parameters on mechanical strength and vascular
   reactivity
SO TISSUE ENGINEERING
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; REMODELING IN-VITRO; GROWTH-FACTOR-BETA; MEDIA
   EQUIVALENT; COLLAGEN; CONSTRUCTS; ARTERIES; MATRIX; REGENERATION;
   EXPRESSION
AB We have shown that fibrin- based small- diameter tissue- engineered blood vessels ( TEVs) exhibited considerable mechanical strength and could withstand implantation in the jugular veins of lambs, where they remained patent for 15 weeks. The microtopology of fibrin matrix is influenced by the concentration of fibrinogen and calcium, whereas fibrinolysis and matrix remodeling are affected by the presence of the fibrinolytic inhibitor aprotinin. Here we report the effects of these components on two key properties of TEVs, namely mechanical strength and vasoreactivity. We found that high concentrations of fibrinogen or calcium decreased significantly both strength and reactivity. Surprisingly, aprotinin increased mechanical strength but decreased vascular reactivity in a dose- dependent manner. Transforming growth factor beta(1) ( TGF- beta(1)) and insulin had a moderate effect on mechanical strength but significantly enhanced reactivity, through receptor- and non- receptor mediated pathways. In addition, the combination of TGF- beta(1), insulin, and aprotinin resulted in significant improvement of both properties. Our data suggest that the microtopology of fibrin matrix and the rates of fibrinolysis and extracellular matrix synthesis may affect the properties of TEVs significantly. They also indicate that biomaterial and culture parameters may have differential effects on mechanical properties versus vascular reactivity and, therefore, engineering blood vessels under conditions that maximize tissue strength may not always result in optimal function. Instead, strength and reactivity must be used in concert for more accurate evaluation of tissue- engineered vascular constructs.
C1 SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   SUNY Buffalo, Women & Childrens Hosp Buffalo, Buffalo, NY 14260 USA.
   SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM sandread@eng.buffalo.edu
CR Bader A, 2000, TRANSPLANTATION, V70, P7
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Geer DJ, 2004, TISSUE ENG, V10, P1006, DOI 10.1089/ten.2004.10.1006
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Gonzalez W, 2001, J CARDIOVASC PHARM, V37, P219, DOI 10.1097/00005344-200102000-00009
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Markewitz BA, 2001, CARDIOVASC RES, V49, P200, DOI 10.1016/S0008-6363(00)00221-2
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Nerem RM, 2000, YONSEI MED J, V41, P735, DOI 10.3349/ymj.2000.41.6.735
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Niklason LE, 1999, SCIENCE, V286, P1493, DOI 10.1126/science.286.5444.1493
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Sugo S, 2001, J CARDIOVASC PHARM, V37, P25, DOI 10.1097/00005344-200101000-00004
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Tranquillo RT, 2002, ANN NY ACAD SCI, V961, P251, DOI 10.1111/j.1749-6632.2002.tb03094.x
   Tuan TL, 1996, EXP CELL RES, V223, P127, DOI 10.1006/excr.1996.0065
   Wang MC, 1995, MAT SCI ENG C-BIOMIM, V3, P131, DOI 10.1016/0928-4931(95)00116-6
   Wozniak G, 2003, CARDIOVASC SURG, V11, P17, DOI 10.1016/S0967-2109(03)00067-X
NR 30
TC 58
Z9 61
U1 1
U2 21
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 991
EP 1003
DI 10.1089/ten.2005.11.991
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800002
PM 16144435
OA Green Published
DA 2018-10-19
ER

PT J
AU Walsh, JF
   Manwaring, ME
   Tresco, PA
AF Walsh, JF
   Manwaring, ME
   Tresco, PA
TI Directional neurite outgrowth is enhanced by engineered meningeal
   cell-coated substrates
SO TISSUE ENGINEERING
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD; OLFACTORY ENSHEATHING CELLS;
   ADULT-RAT; EXTRACELLULAR-MATRIX; AXONAL REGENERATION; CONTACT GUIDANCE;
   WHITE-MATTER; IN-VITRO; INHIBITORY MOLECULES
AB After injury to the CNS, the anatomical organization of the tissue is disrupted, posing a barrier to the regeneration of axons. Meningeal cells, a central participant in the CNS tissue response to injury, migrate into the core of the wound site in an unorganized fashion and deposit a disorganized extracellular matrix ( ECM) that produces a nonpermissive environment. Previous work in our laboratory has shown that the presentation of nanometer- scale topographic cues to these cells influences their morphological, cytoskeletal, and secreted ECM alignment. In the present study, we provided similar environmental cues to meningeal cells and examined the ability of the composite construct to influence dorsal root ganglion regeneration in vitro. When grown on control surfaces of meningeal cells lacking underlying topographic cues, there was no bias in neurite outgrowth. In contrast, when grown on monolayers of meningeal cells with underlying nanometer- scale topography, neurite outgrowth length was greater and was directed parallel to the underlying surface topography even though there exists an intervening meningeal cell layer. The observed outgrowth was significantly longer than on laminin- coated surfaces, which are considered to be the optimal substrata for promoting outgrowth of dorsal root ganglion neurons in culture. These results suggest that the nanometer- level surface finish of an implanted biomaterial may be used to organize the encapsulation tissue that accompanies the implantation of materials into the CNS. It furthermore suggests a simple approach for improving bridging materials for repair of nerve tracts or for affecting cellular organization at a device - tissue interface.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tussue Engn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tussue Engn, Salt Lake City, UT 84112 USA.
EM tresco@utah.ed
CR ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5
   Ahmed Z, 2003, TISSUE ENG, V9, P219, DOI 10.1089/107632703764664693
   Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   BROOK GA, 1994, EXP NEUROL, V126, P31, DOI 10.1006/exnr.1994.1040
   Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I
   Brook GA, 2001, GLIA, V33, P118, DOI 10.1002/1098-1136(200102)33:2<118::AID-GLIA1011>3.0.CO;2-Y
   CARBONELL AL, 1988, BRAIN RES, V439, P337, DOI 10.1016/0006-8993(88)91491-6
   Chauhan NB, 1999, INT J DEV NEUROSCI, V17, P255, DOI 10.1016/S0736-5748(99)00003-9
   Davies SJA, 1997, NATURE, V390, P680
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   Detrait E, 1998, J NEUROSCI METH, V84, P193, DOI 10.1016/S0165-0270(98)00114-9
   DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291
   EBENDAL T, 1977, CELL TISSUE RES, V175, P439
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Hermanns S, 2001, J NEUROSCI METH, V110, P141, DOI 10.1016/S0165-0270(01)00427-7
   KAO CC, 1977, EXP NEUROL, V54, P591, DOI 10.1016/0014-4886(77)90259-X
   KLIOT M, 1990, EXP NEUROL, V109, P57, DOI 10.1016/S0014-4886(05)80008-1
   KRIKORIAN JG, 1981, EXP NEUROL, V72, P698, DOI 10.1016/0014-4886(81)90018-2
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000
   Li Y, 2003, J NEUROSCI, V23, P7783
   LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1
   Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043
   Manwaring ME, 2001, BIOMATERIALS, V22, P3155, DOI 10.1016/S0142-9612(01)00068-0
   MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   Ness R, 1997, GLIA, V19, P47, DOI 10.1002/(SICI)1098-1136(199701)19:1<47::AID-GLIA5>3.0.CO;2-7
   Niclou SP, 2003, MOL CELL NEUROSCI, V24, P902, DOI 10.1016/S1044-7431(03)00243-4
   Pasterkamp RJ, 1998, PROG BRAIN RES, V117, P151
   Pettigrew DB, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-9
   Pettigrew DB, 1999, J NEUROSCI, V19, P8358
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Reier P J, 1988, Adv Neurol, V47, P87
   REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   RISLING M, 1983, BRAIN RES, V280, P15, DOI 10.1016/0006-8993(83)91169-1
   RUDGE JS, 1990, J NEUROSCI, V10, P3594
   Sajanti J, 1999, BBA-MOL BASIS DIS, V1454, P209, DOI 10.1016/S0925-4439(99)00016-2
   Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315
   SCHACHNER M, 1981, DEV BIOL, V83, P328, DOI 10.1016/0012-1606(81)90478-4
   SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0
   Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3
   Schreyer D J, 1987, Brain Res, V432, P291
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004
   SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867
   SILVER J, 1980, J COMP NEUROL, V189, P101, DOI 10.1002/cne.901890106
   Sims TJ, 1999, EXP BRAIN RES, V125, P495, DOI 10.1007/s002210050707
   Stepien E, 1999, CELL BIOL INT, V23, P105, DOI 10.1006/cbir.1998.0256
   SUNG JH, 1981, J NEUROPATH EXP NEUR, V40, P645, DOI 10.1097/00005072-198111000-00006
   VIDALSANZ M, 1987, J NEUROSCI, V7, P2894
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Yeung CK, 2001, NEUROSCI LETT, V301, P147, DOI 10.1016/S0304-3940(01)01628-7
   Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
NR 60
TC 27
Z9 28
U1 1
U2 8
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 1085
EP 1094
DI 10.1089/ten.2005.11.1085
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800011
PM 16144444
DA 2018-10-19
ER

PT J
AU Pangborn, CA
   Athanasiou, KA
AF Pangborn, CA
   Athanasiou, KA
TI Effects of growth factors on meniscal fibrochondrocytes
SO TISSUE ENGINEERING
LA English
DT Article
ID KNEE-JOINT MENISCUS; PRESSURE DISTRIBUTION; LOAD-BEARING;
   ULTRASTRUCTURE; CELLS
AB To tissue engineer the knee meniscus, our laboratory follows a paradigm that includes biomaterial scaffolding, mechanical stimulation, and growth factor addition. The aim of this study was to study extracellular matrix ( ECM) component uptake by meniscal fibrochondrocytes when stimulated with platelet- derived growth factor AB, transforming growth factor beta(1) ( TGF- beta(1)), insulin- like growth factor type 1, and basic fibroblast growth factor at various concentrations ( low, medium, and high levels for each). Growth factors were applied to monolayer cultures for 3 weeks in a soluble form as part of the culture medium. Radiolabeling with [H-3] proline and [S-35] sulfate was performed to indicate collagen and glycosaminoglycan production, respectively. TGF- beta(1) is the only growth factor that increased the uptake of both components. It showed the most consistent behavior and the highest response. There is no conclusive evidence whether the high concentration of TGF- beta(1) ( 100 ng/ mL) is better than the medium concentration ( 10 ng/ mL). Therefore the results of this study demonstrate that TGF- beta(1) at either 10 or 100 ng/ mL can be used to upregulate ECM production in monolayer cultures of meniscal fibrochondrocytes.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Athanasiou, KA (reprint author), Rice Univ, Dept Bioengn, MS-142,POB 1892, Houston, TX 77251 USA.
EM athanasiou@rice.edu
FU NIAMS NIH HHS [R01 AR47839-2]
CR AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409
   AHMED AM, 1992, KNEE MENISCUS BASIC, P59
   Anderson D R, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P44, DOI 10.1007/BF01552158
   Bhargava MM, 1999, AM J SPORT MED, V27, P636, DOI 10.1177/03635465990270051601
   Bullough P G, 1970, J Bone Joint Surg Br, V52, P564
   COLLIER S, 1995, OSTEOARTHR CARTILAGE, V3, P127, DOI 10.1016/S1063-4584(05)80045-7
   Detamore MS, 2004, ARCH ORAL BIOL, V49, P577, DOI 10.1016/j.archoralbio.2004.01.015
   FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887
   GHADIALLY FN, 1983, J ANAT, V136, P773
   GHOSH P, 1987, CLIN ORTHOP RELAT R, V224, P52
   HOSHINO A, 1987, J BONE JOINT SURG BR, V69, P807
   IMLER SM, 2003, 2003 SUMM BIOENG C J, P535
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, V149, P283
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   Nakano T, 1997, J ORTHOPAED RES, V15, P213, DOI 10.1002/jor.1100150209
   NEWMAN AP, 1989, AM J SPORT MED, V17, P164, DOI 10.1177/036354658901700205
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   Sweigart MA, 2001, TISSUE ENG, V7, P111, DOI 10.1089/107632701300062697
   Walker P S, 1975, Clin Orthop Relat Res, P184, DOI 10.1097/00003086-197506000-00027
   WHIPPLE RR, 1985, T 31 ANN M ORTH RES, P367
NR 21
TC 44
Z9 57
U1 2
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 1141
EP 1148
DI 10.1089/ten.2005.11.1141
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800017
PM 16144450
DA 2018-10-19
ER

PT J
AU Kumarasuriyar, A
   Jackson, RA
   Grondahl, L
   Trau, M
   Nurcombe, V
   Cool, SM
AF Kumarasuriyar, A
   Jackson, RA
   Grondahl, L
   Trau, M
   Nurcombe, V
   Cool, SM
TI Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate) supports in vitro
   osteogenesis
SO TISSUE ENGINEERING
LA English
DT Article
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; BIODEGRADABLE MEDICAL
   DEVICES; OSTEOBLAST-LIKE CELLS; MARROW STROMAL CELLS; BONE-MARROW;
   SURFACE-ROUGHNESS; HISTOLOGICAL-EVALUATION; GENE-EXPRESSION;
   DIFFERENTIATION; POLYMERS
AB Studies have demonstrated that polymeric biomaterials have the potential to support osteoblast growth and development for bone tissue repair. Poly( beta- hydroxybutyrate- co- beta- hydroxyvalerate) ( PHBV), a bioabsorbable, biocompatible polyhydroxy acid polymer, is an excellent candidate that, as yet, has not been extensively investigated for this purpose. As such, we examined the attachment characteristics, self- renewal capacity, and osteogenic potential of osteoblast- like cells ( MC3T3- E1 S14) when cultured on PHBV films compared with tissue culture polystyrene ( TCP). Cells were assayed over 2 weeks and examined for changes in morphology, attachment, number and proliferation status, alkaline phosphatase ( ALP) activity, calcium accumulation, nodule formation, and the expression of osteogenic genes. We found that these spindle- shaped MC3T3- E1 S14 cells made cell - cell and cell - substrate contact. Time- dependent cell attachment was shown to be accelerated on PHBV compared with collagen and laminin, but delayed compared with TCP and fibronectin. Cell number and the expression of ALP, osteopontin, and pro- collagen alpha 1( I) mRNA were comparable for cells grown on PHBV and TCP, with all these markers increasing over time. This demonstrates the ability of PHBV to support osteoblast cell function. However, a lag was observed for cells on PHBV in comparison with those on TCP for proliferation, ALP activity, and cbfa- 1 mRNA expression. In addition, we observed a reduction in total calcium accumulation, nodule formation, and osteocalcin mRNA expression. It is possible that this cellular response is a consequence of the contrasting surface properties of PHBV and TCP. The PHBV substrate used was rougher and more hydrophobic than TCP. Although further substrate analysis is required, we conclude that this polymer is a suitable candidate for the continued development as a biomaterial for bone tissue engineering.
C1 Inst Mol & Cell Biol, Stem Cell & Tissue Repair Lab, Singapore 138673, Singapore.
   Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.
   Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld, Australia.
   Univ Queensland, Ctr Nanotechnol & Biomat, St Lucia, Qld, Australia.
RP Cool, SM (reprint author), Inst Mol & Cell Biol, Stem Cell & Tissue Repair Lab, 61 Biopolis Dr Proteos, Singapore 138673, Singapore.
EM scool@imcb.a-star.edu.sg
RI Trau, Matt/E-3944-2015; ASTAR, IMCB/E-2320-2012
OI Trau, Matt/0000-0001-5516-1280; Grondahl, Lisbeth/0000-0001-6012-9808
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Boyan BD, 1995, CELL MATER, V5, P323
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   Di Toro R, 2004, EUR J PHARM SCI, V21, P161, DOI 10.1016/j.ejps.2003.10.001
   Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   GALGUT P, 1991, J CLIN PERIODONTOL, V18, P581, DOI 10.1111/j.1600-051X.1991.tb00093.x
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOGOLEWSKI S, 1992, Clinical Materials, V10, P13, DOI 10.1016/0267-6605(92)90079-9
   HAMMOND T, 1995, DEGRADABLE POLYM, P87
   Hankermeyer C R, 1999, Rev Environ Contam Toxicol, V159, P1
   Hatton P. V., 1994, Clinical Materials, V17, P71, DOI 10.1016/0267-6605(94)90014-0
   HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Howard D, 2002, BIOCHEM BIOPH RES CO, V299, P208, DOI 10.1016/S0006-291X(02)02561-5
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   IBARAKI K, 1992, J BONE MINER RES, V7, P743
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   Liao Su-san, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P36
   LIN TC, 1985, 11 ANN M SOC BIOM SA
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Lutton C, 2001, AUST J CHEM, V54, P621, DOI 10.1071/CH01118
   LUZIER WD, 1992, P NATL ACAD SCI USA, V89, P839, DOI 10.1073/pnas.89.3.839
   Malekzadeh R, 1998, J PERIODONTOL, V69, P1256, DOI 10.1902/jop.1998.69.11.1256
   Martin P, 1995, CELEST MECH DYN ASTR, V63, P29, DOI 10.1007/BF00691913
   Mas A, 1997, EUR POLYM J, V33, P331, DOI 10.1016/S0014-3057(96)00154-1
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   Pratap J, 2003, CANCER RES, V63, P5357
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Rouxhet L, 1998, MACROMOL SYMP, V130, P347, DOI 10.1002/masy.19981300130
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   SHIBATA Y, 1993, INT J BIOCHEM, V25, P239, DOI 10.1016/0020-711X(93)90012-4
   STEIN GS, 1990, FASEB J, V4, P3111
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
NR 53
TC 40
Z9 41
U1 1
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2005
VL 11
IS 7-8
BP 1281
EP 1295
DI 10.1089/ten.2005.11.1281
PG 15
WC Cell & Tissue Engineering
SC Cell Biology
GA 965OK
UT WOS:000231959800031
PM 16144464
DA 2018-10-19
ER

PT J
AU Busuttil, SJ
   Drumm, C
   Plow, EF
AF Busuttil, SJ
   Drumm, C
   Plow, EF
TI In vivo comparison of the inflammatory response induced by different
   vascular biomaterials
SO VASCULAR
LA English
DT Article; Proceedings Paper
CT 26th World Congress of the
   International-Society-of-Cardiovascular-Surgery
CY MAR 21-25, 2004
CL Maui, HI
SP Int Soc Cardiovasc Surg
DE biomaterials; inflammation; macrophages; neutrophils
ID COMPLEMENT ACTIVATION; BACTERIAL BIOFILMS; PROSTHESES; BIOCOMPATIBILITY;
   POLYETHYLENE; INVIVO
AB Biomaterial implants induce a local inflammatory response. A comparison of the inflammatory cell response was made between several biomaterials commonly used as vascular prostheses.
   Disks of polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), aluminum, titanium, copper, and stainless steel were surgically placed into the peritoneum of mice. Recruited macrophage and neutrophil populations were measured after recovery from the disk surface and peritoneal lavage.
   Following peritoneal biomaterial implants, there was no difference in total neutrophil or macrophage recruitment between mice implanted with PET, PTFE, aluminum, or titanium disks. However, there was significant attenuation of total neutrophil and macrophage recruitment to stainless steel compared with the other implants. Similarly, there was no significant difference in the percentage of leukocytes adherent to the PET, aluminum, or titanium disks. Macrophage adherence to the stainless steel disks was attenuated by 19.1%, and the number of neutrophils was attenuated by 69.1% when compared with PET implant mice. Mice implanted with copper disks universally expired.
   Leukocyte recruitment did not differ between PET, PTFE, aluminum, or titanium disks, suggesting that these materials stimulate similar inflammatory responses. Stainless steel disks recruited both fewer neutrophils and fewer macrophages and support lower adherence of these cells than the other biomaterials. Copper incited an overwhelming and fatal response.
C1 Case Western Reserve Univ, Dept Surg, Cleveland, OH 44106 USA.
   Cleveland Vet Affairs Med Ctr, Cleveland, OH USA.
   Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA.
RP Busuttil, SJ (reprint author), Case Western Reserve Univ, Dept Surg, Cleveland, OH 44106 USA.
EM sbusuttil@smail.umaryland.edu
FU NHLBI NIH HHS [HL 17964]
CR BANDYK DF, 1991, J VASC SURG, V13, P575
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   BERGAMINI TM, 1988, J VASC SURG, V7, P21, DOI 10.1067/mva.1988.avs0070021
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I
   RUTHERFORD RB, 2000, VASCULAR SURG
   SHAH PM, 1983, J TRAUMA, V23, P1030, DOI 10.1097/00005373-198312000-00002
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   Syrovets T, 1997, BLOOD, V89, P4574
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
NR 16
TC 12
Z9 12
U1 0
U2 5
PU B C DECKER INC
PI HAMILTON
PA 20 HUGHSON ST SOUTH, PO BOX 620, L C D 1, HAMILTON, ONTARIO L8N 3K7,
   CANADA
SN 1708-5381
J9 VASCULAR
JI Vascular
PD JUL-AUG
PY 2005
VL 13
IS 4
BP 230
EP 235
DI 10.1258/rsmvasc.13.4.230
PG 6
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 960ZX
UT WOS:000231632800006
PM 16229796
DA 2018-10-19
ER

PT J
AU Ng, LT
   Swami, S
AF Ng, LT
   Swami, S
TI IPNs based on chitosan with NVP and NVP/HEMA synthesised through
   photoinitiator-free photopolymerisation technique for biomedical
   applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE chitosan; IPN hydrogel; photopolymerisation; keratinocytes; biomaterial
ID COLORIMETRIC ASSAY; CONTROLLED-RELEASE; HYDROGELS; MALEIMIDE; DELIVERY
AB Biocompatible interpenetration polymeric network (IPN) hydrogels based on chitosan with N-vinylpyrrolidinone (NVP) as well as its copolymer with 2-hydroxymethyl methacrylate (HEMA) were synthesised using the photopolymerisation technique without the inclusion of any photoinitiator or crosslinking agent. These hydrogels were characterised using the Fourier-transform infrared spectroscopy (FTIR) technique. Equilibrium swelling of these hydrogels was performed in Milli-Q water and drug release studies were carried out using theophylline as the model drug. These tests showed that the IPN comprised of chitosan and NVP with a very small amount of N-hydroxymethyl maleimide (HMMI) included exhibited higher swelling abilities and fast drug release rates than the IPN which contained chitosan, NVP and HEMA. Kinetic studies of water diffusion into these hydrogels and drug release revealed that with the exception of the IPN with HEMA incorporated, the other hydrogels did not adhere to the Fickian diffusion model. These hydrogels were tested for their biocompatibility with human epidermal keratinocyte cells (HaCaT). A positive cell growth as evidenced by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) cell proliferation assay indicated that these hydrogels are non-toxic to human keratinocytes and can be potentially used as biomaterials for biomedical applications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Western Sydney, Coll Sci Technol & Environm, Sydney, NSW 1797, Australia.
RP Ng, LT (reprint author), Univ Western Sydney, Coll Sci Technol & Environm, Locked Bag 1797, Sydney, NSW 1797, Australia.
EM l.ng@uws.edu.au
CR GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   Hejazi R., 2002, POLYM BIOMATERIALS, P213
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ng LT, 2004, RADIAT PHYS CHEM, V69, P321, DOI 10.1016/S0969-806X(03)00476-6
   Ng LT, 2002, POLYM INT, V51, P1398, DOI 10.1002/pi.1062
   Ng LT, 2001, J APPL POLYM SCI, V79, P466
   Pessina A, 2001, CELL PROLIFERAT, V34, P243, DOI 10.1046/j.0960-7722.2001.00214.x
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Shu XZ, 2001, INT J PHARM, V212, P19, DOI 10.1016/S0378-5173(00)00582-2
   Singer T. O., 1994, J INT MARKETING, V2, P53
   TAWNEY PO, 1961, J ORG CHEM, V26, P15, DOI 10.1021/jo01060a004
NR 11
TC 31
Z9 32
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 20
PY 2005
VL 60
IS 4
BP 523
EP 528
DI 10.1016/j.carbpol.2005.03.009
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 939LW
UT WOS:000230075300013
DA 2018-10-19
ER

PT J
AU Laurence, S
   Bareille, R
   Baquey, C
   Fricain, JC
AF Laurence, S
   Bareille, R
   Baquey, C
   Fricain, JC
TI Development of a resorbable macroporous cellulosic material used as
   hemostatic in an osseous environment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cellulose; hemostatic; macroporous biomaterial; bone; biocompatibility
ID OXIDIZED CELLULOSE; COLORIMETRIC ASSAY; CYTO-TOXICITY; BIOCOMPATIBILITY;
   BIODEGRADATION; AGENTS; SPONGE; MODEL; RAT
AB The control of bleeding is a frequently encountered therapeutic problem, particularly during dental surgery. The most efficient substances used to resolve this problem are not risk-free because of their animal or human origins, so cellulosic materials are potentially of interest. The aim of this study was to develop a resorbable macroporous cellulosic material for use as a resorbable hemostatic agent in bone sites. The degradation and the cytocompatibility of the cellulosic material versus controls were evaluated and its behaviour in vivo was studied. An original process using calcium carbonate powder as inverse matrix was used to develop a macroporous material. In order to predegrade the cellulosic material for hemostatic use, oxidation was performed with periodate. A dialdehyde component unstable at physiological pH was thus obtained. The material was found to have cytotoxicity, biocompatibility, and resorption properties similar to control but its hemostatic power was higher. &COPY; 2005 Wiley Periodicals, Inc.
C1 Univ Bordeaux 2, INSERM U577, F-33076 Bordeaux, France.
RP Laurence, S (reprint author), Univ Bordeaux 2, INSERM U577, 146,Rue Leo Saignat, F-33076 Bordeaux, France.
EM seblaurel@wanadoo.fr
CR *AFNOR, 1999, EV BIOL DISP MED 13
   *AFNOR, 1999, EV BIOL DISP MED 14
   BALA K, 1982, BIOMATERIALS, V3, P97, DOI 10.1016/0142-9612(82)90041-2
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   BOYNE PJ, 1966, ORAL SURG ORAL MED O, V21, P805, DOI 10.1016/0030-4220(66)90104-6
   DEGENSHEIN GA, 1963, NEW YORK STATE J MED, V63, P2639
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   LEWIS KF, 1966, METHOD ENZYMOL, P269
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nevell TP, 1963, METHODS CARBOHYDRATE, V3, P164
   Nevell TP, 1985, CELLULOSE CHEM ITS A, P243
   Okamoto T, 1994, Braz Dent J, V5, P85
   PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6
   RACCUIA JS, 1992, AM J SURG, V163, P234, DOI 10.1016/0002-9610(92)90108-4
   SCHER KS, 1982, SURGERY, V91, P301
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   SINGH M, 1979, BIOMATER ARTIF CELL, V7, P495, DOI 10.3109/10731197909118964
   Sinha T. J., 1986, BIOMATERIALS, V7, P193
   SWIFT DM, 1986, J EXP ZOOL, V240, P65, DOI 10.1002/jez.1402400109
   Wagner WR, 1996, J SURG RES, V66, P100, DOI 10.1006/jsre.1996.0379
NR 23
TC 15
Z9 16
U1 2
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2005
VL 73A
IS 4
BP 422
EP 429
DI 10.1002/jbm.a.30280
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 933AG
UT WOS:000229595600005
PM 15880722
DA 2018-10-19
ER

PT J
AU Forch, R
   Zhang, ZH
   Knoll, W
AF Forch, R
   Zhang, ZH
   Knoll, W
TI Soft plasma treated surfaces: Tailoring of structure and properties for
   biomaterial applications
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Review
DE crosslinking; elasticity; plasma polymerisation; solvent effects;
   tailoring surface properties; three-dimensional interface
ID GUIDE MODE SPECTROSCOPY; ENHANCED FLUORESCENCE SPECTROSCOPY; SCANNING
   FORCE MICROSCOPY; VINYL ACETIC-ACID; ACRYLIC-ACID; MALEIC-ANHYDRIDE;
   POLYMER SURFACES; THIN-FILMS; MONOMOLECULAR FUNCTIONALIZATION; HUMAN
   KERATINOCYTES
AB This paper aims to discuss and review developments in plasma surface modification techniques which have been seen over the past few years, with particular emphasis on low energy or soft plasma assisted surface polymerisation processes. While early work focussed mainly on protective coatings and surface activation, the advancements in micro-technology in the 1980s followed by those in nanotechnology in the 1990s and 2000s have resulted in new challenges for surface processing and surface modification processes. The latest advancements in plasma polymer chemistry have shown tremendous potential for the synthesis of reasonably well defined molecular structures with a high retention of functional groups. Some of the latest achievements and newest insights into the behaviour of such deposits in a liquid environment will be discussed, with a particular focus on bio-nanotechnological applications. Utilising novel approaches in surface and interface analysis, it will be shown that plasma polymers can be tailored to have considerable elasticity with reversible swelling characteristics, offering a three-dimensional interface for biomolecular immobilisation procedures in a liquid environment.
C1 Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Forch, R (reprint author), Natl Univ Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM foerch@mpip-mainz.mpg.de
RI Foerch, Renate/B-8198-2011
CR Aizawa H, 2000, MAT SCI ENG C-BIO S, V12, P49, DOI 10.1016/S0928-4931(00)00157-0
   Akimoto T, 2003, BIOSENS BIOELECTRON, V18, P1447, DOI 10.1016/S0956-5663(03)00064-2
   Alexander MR, 1998, J MATER CHEM, V8, P937
   Alexander MR, 1999, POLYMER, V40, P5479, DOI 10.1016/S0032-3861(98)00784-8
   Alexander MR, 1998, SURF INTERFACE ANAL, V26, P961, DOI 10.1002/(SICI)1096-9918(199812)26:13<961::AID-SIA432>3.0.CO;2-7
   AMEEN AP, 1994, POLYMER, V35, P4382, DOI 10.1016/0032-3861(94)90096-5
   AMEEN AP, 1993, POLYMER, V34, P1795, DOI 10.1016/0032-3861(93)90418-A
   AUST EF, 1994, TRENDS POLYM SCI, V2, P313
   Barton D, 2003, CHEM COMMUN, P348, DOI 10.1039/b210781c
   Beck AJ, 1998, CHEM COMMUN, P1221, DOI 10.1039/a801778f
   BECK AJ, 1995, J CHEM SOC CHEM COMM, P1053, DOI 10.1039/c39950001053
   Beck AJ, 2003, TISSUE ENG, V9, P1123, DOI 10.1089/10763270360728035
   Beck AJ, 1996, POLYMER, V37, P5537, DOI 10.1016/S0032-3861(96)00479-X
   Berger R, 1997, MICROELECTRON ENG, V35, P373, DOI 10.1016/S0167-9317(96)00201-8
   Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BIEDERMANN H, 2004, PLASMA POLYM FILMS, V1
   Bumbu GG, 2004, MACROMOL CHEM PHYSIC, V205, P1713, DOI 10.1002/macp.200400195
   BURNSTEIN E, 1972, J VAC SCI TECHNOL, V11, P1004
   Calderon JG, 1998, MACROMOLECULES, V31, P3216, DOI 10.1021/ma970924f
   Calderon JG, 1997, ABSTR PAP AM CHEM S, V213, P534
   Candan S, 1998, J VAC SCI TECHNOL A, V16, P1702, DOI 10.1116/1.581288
   Chen XL, 1996, CHEM MATER, V8, P1067, DOI 10.1021/cm9504854
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cicala G, 2003, DIAM RELAT MATER, V12, P2020, DOI 10.1016/S0925-9635(03)00293-0
   Cicala G, 2002, MACROMOLECULES, V35, P8920, DOI 10.1021/ma025536e
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Dogue ILJ, 1995, NUCL INSTRUM METH B, V105, P164
   Evenson SA, 2000, CHEM MATER, V12, P3038, DOI 10.1021/cm000223o
   Favia P, 2003, SURF COAT TECH, V169, P609, DOI 10.1016/S0257-8972(03)00123-3
   Favia P, 2002, VIDE, V57, P40
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Feng XF, 2003, SURF COAT TECH, V171, P96, DOI 10.1016/S0257-8972(03)00246-9
   FOERCH R, 1992, J POLYM SCI POL CHEM, V30, P279, DOI 10.1002/pola.1992.080300212
   FOERCH R, 1991, KUNSTST-GER PLAST+, V81, P260
   FOERCH R, 1993, J ADHES SCI TECHNOL, V7, P1077, DOI 10.1163/156856193X00592
   FOERCH R, 1990, J POLYM SCI POL CHEM, V28, P193, DOI 10.1002/pola.1990.080280114
   France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d
   Friedrich J, 2003, J ADHES SCI TECHNOL, V17, P1591, DOI 10.1163/156856103322396695
   Friedrich J, 2003, COMPOS INTERFACE, V10, P139, DOI 10.1163/156855403765826865
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356
   Han LCM, 1998, J POLYM SCI POL CHEM, V36, P3121, DOI 10.1002/(SICI)1099-0518(199812)36:17<3121::AID-POLA14>3.0.CO;2-Q
   Han LCM, 1997, LANGMUIR, V13, P5941, DOI 10.1021/la9706779
   Han LCM, 2000, J VAC SCI TECHNOL B, V18, P799, DOI 10.1116/1.591279
   Han LM, 1998, CHEM MATER, V10, P1422, DOI 10.1021/cm970779k
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Hu JJ, 2003, ADV FUNCT MATER, V13, P692, DOI 10.1002/adfm.200304384
   IGARASHI S, UNPUB
   Jacobsen V, 2002, THIN SOLID FILMS, V409, P185, DOI 10.1016/S0040-6090(02)00128-1
   Jacobsen V, 2001, SURF COAT TECH, V142, P1105, DOI 10.1016/S0257-8972(01)01261-0
   Jenkins ATA, 2000, LANGMUIR, V16, P6381, DOI 10.1021/la991649o
   Kambhampati D, 2001, BIOSENS BIOELECTRON, V16, P1109, DOI 10.1016/S0956-5663(01)00239-1
   Kim J, 2003, ANAL BIOCHEM, V313, P41, DOI 10.1016/S0003-2697(02)00563-8
   Kitching KJ, 2003, ABSTR PAP AM CHEM S, V225, pU578
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   KNOLL W, 1997, HDB OPTICAL PROPERTI
   Kojima K, 2003, ANAL CHEM, V75, P1116, DOI 10.1021/ac0257391
   KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428
   Kuhn G, 2001, SURF COAT TECH, V142, P494, DOI 10.1016/S0257-8972(01)01056-8
   Lamendola R, 1998, EUR PHYS J-APPL PHYS, V4, P65, DOI 10.1051/epjap:1998244
   Leich MA, 1998, MACROMOLECULES, V31, P7618, DOI 10.1021/ma980332c
   LEICH MA, 1998, ABSTR PAP AM CHEM S, V215, P337
   Liebermann T, 2000, COLLOID SURFACE A, V171, P115, DOI 10.1016/S0927-7757(99)00550-6
   Liebermann T, 2000, COLLOID SURFACE A, V169, P337, DOI 10.1016/S0927-7757(00)00449-0
   Mackie NM, 1997, ABSTR PAP AM CHEM S, V213, P527
   Mackie NM, 1998, LANGMUIR, V14, P1227, DOI 10.1021/la970953j
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   MULLER M, 1999, SURF COAT TECH, V119, P802
   Muller R., 1991, INTEGRIERTE OPTIK
   Nakamura R, 1997, ANAL CHEM, V69, P4649, DOI 10.1021/ac970571i
   Neumann MS, 2000, AIDS EDUC PREV, V12, P1
   Neumann T, 2002, ADV FUNCT MATER, V12, P575, DOI 10.1002/1616-3028(20020916)12:9<575::AID-ADFM575>3.0.CO;2-4
   Neumann T, 2001, ISRAEL J CHEM, V41, P69, DOI 10.1560/F0Q3-WHXD-T7VH-JJ78
   OEHR C, 1999, SURF COAT TECH, V119, P25
   Pan YV, 2002, PLASMAS POLYM, V7, P171, DOI 10.1023/A:1016295419941
   PANCHALINGAM V, 1993, ABSTR PAP AM CHEM S, V205, P228
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RAETHER H, SURFACE PLASMONS
   Roy S, 2002, LANGMUIR, V18, P6319, DOI 10.1021/la025578w
   Ryan ME, 1996, CHEM MATER, V8, P37, DOI 10.1021/cm9503691
   Salz D, 2000, PHYS CHEM CHEM PHYS, V2, P3105, DOI 10.1039/b002327m
   SAVAGE CR, 1991, ABSTR PAP AM CHEM S, V201, P53
   SAVAGE CR, 1991, CHEM MATER, V3, P575, DOI 10.1021/cm00016a005
   Schiller S, 2002, CHEM MATER, V14, P235, DOI 10.1021/cm011139r
   Schlindwein WS, 2000, POLYM INT, V49, P953, DOI 10.1002/1097-0126(200009)49:9<953::AID-PI406>3.0.CO;2-L
   Schonherr H, 2000, CHEM COMMUN, P1303, DOI 10.1039/b003756g
   Schonherr H, 2000, CHEM MATER, V12, P3689, DOI 10.1021/cm0010351
   Sciarratta V, 2003, SURF COAT TECH, V174, P805, DOI 10.1016/S0257-8972(03)00564-4
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Swalen J. D., 1986, Journal of Molecular Electronics, V2, P155
   Tarducci C, 2002, CHEM MATER, V14, P2541, DOI 10.1021/cm010939z
   TAWA K, 2002, ABSTR PAP AM CHEM S, V223, P475
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Truica-Marasescu F, 2004, PLASMA PROCESS POLYM, V1, P153, DOI 10.1002/ppap.200400020
   van Os MT, 1999, CHEM MATER, V11, P3252, DOI 10.1021/cm991068k
   van Os MT, 1999, MATER RES SOC SYMP P, V544, P45
   Vohrer U, 2003, ANAL BIOANAL CHEM, V375, P929, DOI 10.1007/s00216-003-1750-3
   Walker AK, 1999, ANAL BIOCHEM, V271, P123, DOI 10.1006/abio.1999.4141
   Whittle JD, 2002, J MATER CHEM, V12, P2726, DOI 10.1039/b201471h
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Yang GH, 2002, J VAC SCI TECHNOL A, V20, P1955, DOI 10.1116/1.1513640
   Yasuda H, 2003, NUCL INSTRUM METH A, V515, P15, DOI 10.1016/j.nima.2003.08.125
   Yasuda H, 2000, J POLYM SCI POL CHEM, V38, P943, DOI 10.1002/(SICI)1099-0518(20000315)38:6<943::AID-POLA3>3.0.CO;2-3
   Yu F, 2003, ANAL CHEM, V75, P2610, DOI 10.1021/ac026161y
   Zhang J, 2003, THIN SOLID FILMS, V435, P108, DOI 10.1016/S0040-6090(03)00413-9
   Zhang J, 2003, ACTA PHYS SIN-CH ED, V52, P1707
   Zhang Y, 2002, POLYMER, V43, P7279, DOI 10.1016/S0032-3861(02)00711-5
   Zhang Z, 2003, SURF COAT TECH, V174, P588, DOI 10.1016/S0257-8972(03)00806-5
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
   ZHANG Z, 2004, THESIS U MAINZ MAINZ
   Zhang ZH, 2003, MACROMOLECULES, V36, P7689, DOI 10.1021/ma034673o
   Zou XP, 2002, SURF COAT TECH, V149, P119, DOI 10.1016/S0257-8972(01)01490-6
NR 117
TC 137
Z9 139
U1 1
U2 41
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JUN 14
PY 2005
VL 2
IS 5
BP 351
EP 372
DI 10.1002/ppap.200400083
PG 22
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 943WK
UT WOS:000230385400001
DA 2018-10-19
ER

PT J
AU Roach, P
   Farrar, D
   Perry, CC
AF Roach, P
   Farrar, D
   Perry, CC
TI Interpretation of protein adsorption: Surface-induced conformational
   changes
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID HUMAN-SERUM-ALBUMIN; QUARTZ-CRYSTAL MICROBALANCE; INDUCED
   STRUCTURAL-CHANGES; SCANNING FORCE MICROSCOPY; BIOMATERIAL SURFACES;
   BINDING; FIBRINOGEN; ADHESION; POLYURETHANES; SPECTROSCOPY
AB Protein adhesion plays a major role in determining the biocompatibility of materials. The first stage of implant integration is the adhesion of protein followed by cell attachment. Surface modification of implants (surface chemistry and topography) to induce and control protein and cell adhesion is currently of great interest. This communication presents data on protein adsorption (bovine serum albumin and fibrinogen) onto model hydrophobic (CH3) and hydrophilic (OH) surfaces, investigated using a quartz crystal microbalance (QCM) and grazing angle infrared spectroscopy. Our data suggest that albumin undergoes adsorption via a single step whereas fibrinogen adsorption is a more complex, multistage process. Albumin has a stronger affinity toward the CH3 compared to OH terminated surface. In contrast, fibrinogen adheres more rapidly to both surfaces, having a slightly higher affinity toward the hydrophobic surface. Conformational assessment of the adsorbed proteins by grazing angle infrared spectroscopy (GA-FTIR) shows that after an initial 1 h incubation few further time-dependent changes are observed. Both proteins exhibited a less organized secondary structure upon adsorption onto a hydrophobic surface than onto a hydrophilic surface, with the effect observed greatest for albumin. This study demonstrates the ability of simple tailor-made monochemical surfaces to influence binding rates and conformation of bound proteins through protein-surface interactions. Current interest in biocompatible materials has focused on surface modifications to induce rapid healing, both of implants and for wound care products. This effect may also be of significance at the next stage of implant integration, as cell adhesion occurs through the surface protein layer.
C1 Nottingham Trent Univ, Div Chem, Interdisciplinary Biomed Res Ctr, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England.
   Smith & Nephew Grp Res Ctr, York YO10 5DF, N Yorkshire, England.
RP Perry, CC (reprint author), Nottingham Trent Univ, Div Chem, Interdisciplinary Biomed Res Ctr, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England.
EM Carole.Perry@ntu.ac.uk
RI Zhou, Feng/E-9510-2011; Roach, Paul/G-2330-2012
OI Perry, Professor Carole/0000-0003-1517-468X
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BOS OJM, 1989, J BIOL CHEM, V264, P953
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Ferretti S, 2000, TRAC-TREND ANAL CHEM, V19, P530, DOI 10.1016/S0165-9936(00)00032-7
   FOSTER JF, 1977, ALBUMIN STRUCTURE FU, P53, DOI DOI 10.1016/B978-0-08-019603-9.50010-7
   Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kasemo B., 1999, ADV DENT RES, V13, P1
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kim HS, 1998, J AM CHEM SOC, V120, P4417, DOI 10.1021/ja9735315
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   REED RG, 1975, BIOCHEMISTRY-US, V14, P4578, DOI 10.1021/bi00692a004
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Shirtcliffe NJ, 2004, J MICROMECH MICROENG, V14, P1384, DOI 10.1088/0960-1317/14/10/013
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SJOHOLM I, 1973, J BIOL CHEM, V248, P8434
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TABORELLI M, 1995, J BIOMED MATER RES, V29, P707, DOI 10.1002/jbm.820290606
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Wu YQ, 2002, APPL SPECTROSC, V56, P1186, DOI 10.1366/000370202760295449
   Yang Z, 2000, P NATL ACAD SCI USA, V97, P3907, DOI 10.1073/pnas.080065697
NR 33
TC 793
Z9 805
U1 25
U2 543
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 8
PY 2005
VL 127
IS 22
BP 8168
EP 8173
DI 10.1021/ja042898o
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 933HM
UT WOS:000229619500055
PM 15926845
DA 2018-10-19
ER

PT J
AU Irwin, EF
   Ho, JE
   Kane, SR
   Healy, KE
AF Irwin, EF
   Ho, JE
   Kane, SR
   Healy, KE
TI Analysis of interpenetrating polymer networks via quartz crystal
   microbalance with dissipation monitoring
SO LANGMUIR
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; PROTEIN
   ADSORPTION; MULTILAYER FILMS; BIOMATERIAL SURFACES; PLATELET-ADHESION;
   OXIDE SURFACES; COUPLED WATER; IN-VITRO; POLYSTYRENE
AB A quartz crystal microbalance with dissipation monitoring (QCM-D) was used to assess the physical properties of interpenetrating polymer networks (IPNs) through swelling experiments in ambient humidity and in phosphate-buffered saline (PBS), pH 7.4. The IPNs, based on acrylamide (AAm) and poly(ethylene glycol) (pEG), swell from thin, rigid films when dry (16.7 +/- 5.2 nm on Si/SiO2) to expanded, viscoelastic films when hydrated (107 +/- 24.2 nm on Si/SiO2). The dry IPNs could be analyzed using the Sauerbrey relationship, but for the hydrated films it was necessary to interpret QCM-D data with a Kelvin-Voigt viscoelastic model. A complex modulus vertical bar G*vertical bar of 116 +/- 38.1 kPa for the swollen IPN surface on Si/SiO2 was defined by the model. The QCM-D was also employed to quantify the adsorption of human fibrinogen, a protein important in thrombus formation, onto the IPNs. Fibrinogen adsorption studies demonstrated the sensitivity of the QCM-D, as well as confirmed the nonfouling nature of the IPN surface, where less than 5 ng/cm(2) of fibrinogen was adsorbed.
C1 Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
RP Healy, KE (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM kehealy@socrates.berkeley.edu
FU NIAMS NIH HHS [AR43187-07]
CR BAKER JP, 1992, MACROMOLECULES, V25, P1955, DOI 10.1021/ma00033a019
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Bottom V. E., 1982, INTRO QUARTZ CRYSTAL
   Brant P, 1996, MACROMOLECULES, V29, P5628, DOI 10.1021/ma951349n
   Briggs D., 1998, SURFACE ANAL POLYM X
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DIMILLA PA, 1992, J COLLOID INTERF SCI, V153, P212, DOI 10.1016/0021-9797(92)90313-B
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   EXTRAND CW, 1994, POLYM ENG SCI, V34, P390, DOI 10.1002/pen.760340503
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337
   GARVEY MJ, 1974, J COLLOID INTERF SCI, V49, P57, DOI 10.1016/0021-9797(74)90298-7
   HARBERS GM, UNPUB LANGMUIR
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   HOOK F, 2004, BIOFUNCTIONAL SURFAC, P774
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Knobler CM, 1999, CURR OPIN COLLOID IN, V4, P46, DOI 10.1016/S1359-0294(99)00002-3
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Model MA, 2000, J BIOMED MATER RES, V50, P90, DOI 10.1002/(SICI)1097-4636(200004)50:1<90::AID-JBM13>3.0.CO;2-3
   Munro JC, 2004, MACROMOLECULES, V37, P925, DOI 10.1021/ma030297w
   Otzen DE, 2003, COLLOID SURFACE B, V29, P67, DOI 10.1016/S0927-7765(02)00186-8
   Park S, 2000, J BIOMED MATER RES, V53, P568, DOI 10.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-8
   Petty M. C., 1996, LANGMUIR BLODGETT FI
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Plunkett MA, 2003, LANGMUIR, V19, P6837, DOI 10.1021/la034281a
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970
   Reimhult E., 2002, PHYS REV E, V66
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Rodahl M, 1996, REV SCI INSTRUM, V67, P3238, DOI 10.1063/1.1147494
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Tsai WB, 1999, J BIOMAT SCI-POLYM E, V10, P163, DOI 10.1163/156856299X00117
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
NR 46
TC 61
Z9 61
U1 6
U2 66
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 7
PY 2005
VL 21
IS 12
BP 5529
EP 5536
DI 10.1021/la0470737
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 934OK
UT WOS:000229717900045
PM 15924485
DA 2018-10-19
ER

PT J
AU Jastrzebska, M
   Zalewska-Rejdak, J
   Wrzalik, R
   Kocot, A
   Barwinski, B
   Mroz, I
   Cwalina, B
AF Jastrzebska, M
   Zalewska-Rejdak, J
   Wrzalik, R
   Kocot, A
   Barwinski, B
   Mroz, I
   Cwalina, B
TI Dimethyl suberimidate cross-linked pericardium tissue: Raman
   spectroscopic and atomic force microscopy investigations
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 27th European Congress on Molecular Spectroscopy
CY SEP 05-10, 2004
CL AGH Univ Sci & Technol, Cracow, POLAND
SP AGH Univ Sci & Technol, Fac Mat Sci Ceram
HO AGH Univ Sci & Technol
DE cross-linking; collagen; Raman spectroscopy; atomic force microscopy
ID FT-RAMAN; ELECTRON-MICROSCOPY; RESONANCE RAMAN; TRIPLE HELICES; LASER
   RAMAN; COLLAGEN; PROTEINS; BINDING; SKIN; SCATTERING
AB Chemically stabilized pericardium tissue is widely used as a tissue-derived biomaterial for the preparation of bioprostheses such as heart valves or vascular grafts. The bifunctional imidoester dimethyl suberimidate (DMS) belongs to the wide class of the cross-linking reagents and is often used to cross-link a variety of proteins, including collagen matrices and collagen-based tissues. Raman spectroscopy in the wide frequency range 200-4000 cm(-1) and contact mode atomic force microscopy (AFM) have been employed to investigate the structural changes and chemical bonds in DMS cross-linked porcine pericardium tissue. It has been found, that in addition to the commonly accepted reaction with the F-amine groups of lysine or hydroxylysine residues, DMS may interact also with the carbonyl CO and amide NH groups of the peptide bond in collagen. Our paper presents for the first time spectral evidence for the peptide contribution to the formation of DMS-collagen cross-links. The results confirm also possible competition between the hydrolysis of the free imidoester group and cross-linking reaction. Products of the partial alkaline hydrolysis of DMS have been found in the spectra. The observed changes in the surface topography of the fibrils as well as in their spatial organization in the tissue support the formation of both intra- and interfibrillar cross-links in DMS-stabilized tissue. (c) 2005 Elsevier B.V. All rights reserved.
C1 Med Univ Silesia, Fac Pharm, Dept Biophys, PL-41200 Sosnowiec, Poland.
   Univ Silesia, Inst Phys, Dept Biophys & Mol Phys, PL-40007 Katowice, Poland.
   Univ Wroclaw, Inst Expt Phys, PL-50204 Wroclaw, Poland.
RP Jastrzebska, M (reprint author), Med Univ Silesia, Fac Pharm, Dept Biophys, Ostrogorska 30, PL-41200 Sosnowiec, Poland.
EM maja@slam.katowice.pl
CR Chalmers J.M., 2002, HDB VIBRATIONAL SPEC
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Charulatha V, 1997, J BIOMED MATER RES, V36, P478
   Chen DM, 2002, SPECTROCHIM ACTA A, V58, P2291, DOI 10.1016/S1386-1425(01)00725-9
   DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651
   Deng WG, 2001, FASEB J, V15, P2463, DOI 10.1096/fj.01-0259com
   Dick LA, 1999, BIOCHEMISTRY-US, V38, P6406, DOI 10.1021/bi981760d
   Du XZ, 2004, SPECTROCHIM ACTA A, V60, P401, DOI 10.1016/S1386-1425(03)00238-5
   Edwards HGM, 2002, VIB SPECTROSC, V28, P3, DOI 10.1016/S0924-2031(01)00141-2
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   GATHERCOLE LJ, 1993, J CHEM SOC FARADAY T, V89, P2589, DOI 10.1039/ft9938902589
   Gniadecka M, 1998, J INVEST DERMATOL, V110, P393, DOI 10.1046/j.1523-1747.1998.00146.x
   Jahn A, 2002, SPECTROCHIM ACTA A, V58, P2271, DOI 10.1016/S1386-1425(01)00697-7
   Jastrzebska M, 2003, J RAMAN SPECTROSC, V34, P424, DOI 10.1002/jrs.1016
   Jastrzebska M, 2003, J BIOMAT SCI-POLYM E, V14, P185, DOI 10.1163/156856203321142605
   JENA BP, 2002, ATOMIC FORCE MICROSC, V68
   Kato K, 2001, EUR PHYS J E, V6, P7, DOI 10.1007/s101890170022
   Leikin S, 1997, P NATL ACAD SCI USA, V94, P11312, DOI 10.1073/pnas.94.21.11312
   Lemor R, 2000, J RAMAN SPECTROSC, V31, P171, DOI 10.1002/(SICI)1097-4555(200003)31:3<171::AID-JRS470>3.0.CO;2-O
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   Liquier J, 1999, J RAMAN SPECTROSC, V30, P657
   Nagatomo S, 2002, BIOPHYS CHEM, V98, P217, DOI 10.1016/S0301-4622(02)00103-5
   NAIMARK WA, 1992, AM J PHYSIOL-HEART C, V262, pH1095
   Paez JMG, 2001, BIOMATERIALS, V22, P2759
   PRESCOTT B, 1984, BIOPOLYMERS, V23, P235, DOI 10.1002/bip.360230206
   Rajkumar BJM, 2002, SPECTROCHIM ACTA A, V58, P1923, DOI 10.1016/S1386-1425(01)00641-2
   Raspanti M, 2001, MATRIX BIOL, V20, P601, DOI 10.1016/S0945-053X(01)00174-3
   Rintoul L, 2000, BIOPOLYMERS, V57, P19, DOI 10.1002/(SICI)1097-0282(2000)57:1<19::AID-BIP4>3.0.CO;2-Z
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SEBAG J, 1994, INVEST OPHTH VIS SCI, V35, P2976
   Tait JK, 1995, SPECTROCHIM ACTA A, V51, P2101, DOI 10.1016/0584-8539(95)01456-5
   TWARDOWSKI J, 1994, RAMAN IR SPECTROSCOP
   Venturoni M, 2003, BIOCHEM BIOPH RES CO, V303, P508, DOI 10.1016/S0006-291X(03)00390-5
   Wang Y, 2002, J BIOMED MATER RES, V60, P300, DOI 10.1002/jbm.10108
   WILLIAMS AC, 1995, BBA-PROTEIN STRUCT M, V1246, P98, DOI 10.1016/0167-4838(94)00189-N
   Wu DY, 2004, SPECTROCHIM ACTA A, V60, P137, DOI 10.1016/S1386-1425(03)00190-2
   YUTHAVONG Y, 1975, BIOCHIM BIOPHYS ACTA, V382, P116, DOI 10.1016/0005-2736(75)90378-8
NR 38
TC 16
Z9 16
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD JUN 3
PY 2005
VL 744
SI SI
BP 789
EP 795
DI 10.1016/j.molstruc.2004.11.040
PG 7
WC Chemistry, Physical
SC Chemistry
GA 933UF
UT WOS:000229657700111
DA 2018-10-19
ER

PT J
AU Qiao, Q
   Wang, XC
   Sun, JM
   Zhao, R
   Liu, ZF
   Wang, Y
   Sun, BD
   Yan, YJ
   Qi, KM
AF Qiao, Q
   Wang, XC
   Sun, JM
   Zhao, R
   Liu, ZF
   Wang, Y
   Sun, BD
   Yan, YJ
   Qi, KM
TI Management for postoperative complications of breast augmentation by
   injected polyacrylamide hydrogel
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE biomaterial; breast augmentation; polyacrylamide hydrogel
ID IMPLANT
AB Polyacrylamide hydrogel, a new biomaterial, has been used for injected breast augmentation in China since 1997. A series of 30 patients with various complications after injected polyacrylamide hydrogel visited the author's department. Most of these patients had undergone injection of both breasts. The average age of the patients was 27.6 years, and the time of consultation for the complications was from 3 to 36 months postopertively. Nearly all the patients had breast lumps and other common complications including breast pain, disfigurement, and infection. Ultrasound examination showed diffuse, irregular, anechoic zones of mammary tissue. Pathologic results indicated inflammatory cell infiltration and fibrous capsular formation. An open suction technique and partial mastectomies via periareolar incisions were performed for the all patients. Most of their symptoms were relieved after removal of the polyacrylamide hydrogel. Only one patient had undergone immediate breast reconstruction with implants, whereas five patients had received breast implants secondarily via an axillary incision. The authors conclude that polyacrylamide hydrogel should be prohibited for injected breast augmentation before more scientific data are available about the long effect of the gel in breast tissue.
C1 Beijing Union Med Coll Hosp, Dept Plast & Cosmet Surg, Beijing 100730, Peoples R China.
RP Wang, XC (reprint author), Beijing Union Med Coll Hosp, Dept Plast & Cosmet Surg, Beijing 100730, Peoples R China.
EM wangxiancheng64@hotmail.com
CR AKIYAMA T, 1958, JAPAN J PLASTIC RECO, V1, P244
   Boo-Chai K, 1969, Br J Plast Surg, V22, P281, DOI 10.1016/S0007-1226(69)80120-7
   Chao MJ, 2000, J PRACT AESTH PLAST, V11, P16
   CHEN TH, 1995, BRIT J PLAST SURG, V48, P71, DOI 10.1016/0007-1226(95)90099-3
   Cheng NX, 2002, AESTHET PLAST SURG, V26, P375, DOI 10.1007/s00266-002-2052
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   CONWAY H, 1963, Plast Reconstr Surg, V32, P294, DOI 10.1097/00006534-196309000-00002
   DUNN KW, 1992, BRIT J PLAST SURG, V45, P315, DOI 10.1016/0007-1226(92)90060-B
   Filatov A V, 1998, Stomatologiia (Mosk), V77, P45
   GERSUNY R, 1911, UEBER SUBCUTANE PROT
   KING D J, 1989, Reviews on Environmental Health, V8, P3
   Kopf E., 1976, ROCKY MOUNTAIN M J, V75, P77
   Niechajev I, 2000, PLAST RECONSTR SURG, V105, P1173, DOI 10.1097/00006534-200003000-00055
   OHTAKE N, 1989, AESTHET PLAST SURG, V13, P67, DOI 10.1007/BF01571471
   ROBERT WC, 1977, BR J PLAST SURG, V60, P534
NR 15
TC 33
Z9 38
U1 2
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD JUN
PY 2005
VL 29
IS 3
BP 156
EP 161
DI 10.1007/s00266-004-0099-0
PG 6
WC Surgery
SC Surgery
GA 944WO
UT WOS:000230461800009
PM 15948018
DA 2018-10-19
ER

PT J
AU Goodman, PD
   Barlow, ET
   Crapo, PM
   Mohammad, SF
   Solen, KA
AF Goodman, PD
   Barlow, ET
   Crapo, PM
   Mohammad, SF
   Solen, KA
TI Computational model of device-induced thrombosis and thromboembolism
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE thrombosis; thrombogenecity; hemocompatibility
ID IIB-IIIA RECEPTOR; SHEAR-STRESS; HOLLOW-FIBER; CONCENTRATION PROFILES;
   PLATELET-AGGREGATION; ANTITHROMBIN-III; BLOOD-PLATELETS; FLOW-CYTOMETRY;
   ACTIVATION; ADHESION
AB A numerical model of thrombosis/thromboembolism (T/TE) is presented that predicts the progression of thrombus growth and thromboembolization in low-shear devices (hemodialyzers, oxygenators, etc.). Coupled convection-diffusion-reaction equations were solved to predict velocities, platelet agonist (ADP, thromboxane A2, and thrombin) concentrations, agonist-induced and shear-induced platelet activation, and platelet transport and adhesion to biomaterial surfaces and adherent platelets (hence, thrombus growth). Single-platelet and thrombus embolization were predicted from shear forces and surface adhesion strengths. Values for the platelet-biomaterial reaction constant and the platelet adhesion strength were measured in specific experiments, but all other parameter values were obtained from published sources. The model generated solutions for sequential time steps, while adjusting velocity patterns to accommodate growing surface thrombi.
   Heparinized human blood was perfused (0.75 ml/min) through 580 mu m-ID polyethylene flow cells with flow contractions (280 mu m-ID). Thrombus initiation, growth, and embolization were observed with videomicroscopy, while embolization was confirmed by light scattering, and platelet adhesion was determined by scanning electron microscopy.
   Numerical predictions and experimental observations were similar in indicating: 1) the same three thrombotic locations in the flow cell and the relative order of thrombus development in those locations, 2) equal thrombus growth rates on polyethylene and silicon rubber (in spite of differing overall T/TE), and 3) similar effects of flow rate (1.5 ml/min versus 0.75 ml/min) on platelet adhesion and thrombosis patterns.
C1 Brigham Young Univ, Dept Chem Engn, Provo, UT 84602 USA.
   Univ Utah, Dept Pathol, Salt Lake City, UT USA.
RP Solen, KA (reprint author), Brigham Young Univ, Dept Chem Engn, 350 CB,BYU Campus, Provo, UT 84602 USA.
EM ken_solen@byu.edu
CR AARTS PAMM, 1986, J BIOMECH, V19, P799, DOI 10.1016/0021-9290(86)90130-2
   ADAMS GA, 1983, AM J PHYSIOL, V244, pH109
   ADAMS GA, 1981, AM J PHYSIOL, V240, pH99
   Baldwin J T, 1990, ASAIO Trans, V36, pM274
   BASMADJIAN D, 1989, J BIOMED MATER RES, V23, P1315, DOI 10.1002/jbm.820231108
   BASMADJIAN D, 1990, ANN BIOMED ENG, V18, P685, DOI 10.1007/BF02368455
   BORN GVR, 1972, PLATELETS THROMBOSIS, P113
   DeSomer F, 1996, J CARDIOTHOR VASC AN, V10, P884, DOI 10.1016/S1053-0770(96)80050-4
   Eloot S, 2002, ARTIF ORGANS, V26, P590, DOI 10.1046/j.1525-1594.2002.07081.x
   FEUERSTEIN IA, 1991, J BIOMED MATER RES, V25, P185, DOI 10.1002/jbm.820250206
   FEUERSTEIN IA, 1975, T AM SOC ART INT ORG, V21, P427
   FOGELSON AL, 1992, SIAM J APPL MATH, V52, P1089, DOI 10.1137/0152064
   FOLIE BJ, 1989, BIOPHYS J, V56, P1121, DOI 10.1016/S0006-3495(89)82760-2
   FROJMOVIC M, 1991, BIOPHYS J, V59, P815, DOI 10.1016/S0006-3495(91)82294-9
   FROJMOVIC MM, 1994, BIOPHYS J, V67, P2060, DOI 10.1016/S0006-3495(94)80689-7
   FUNG YC, 1984, BIODYNAMICS CIRCULAT
   GIACOMINI A, 2001, LAB HEMATOL, V7, P180
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Goodman PD, 2000, ASAIO J, V46, P576, DOI 10.1097/00002480-200009000-00013
   GRABOWSKI EF, 1978, MICROVASC RES, V16, P183, DOI 10.1016/0026-2862(78)90054-7
   GRABOWSKI EF, 1972, IND ENG CHEM FUND, V11, P224, DOI 10.1021/i160042a013
   GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360
   GRIFFITH MJ, 1982, J BIOL CHEM, V257, P3899
   Gu YJ, 2000, ARTIF ORGANS, V24, P43, DOI 10.1046/j.1525-1594.2000.06351.x
   HELLUMS JD, 1994, ANN BIOMED ENG, V22, P445, DOI 10.1007/BF02367081
   HUBBELL JA, 1986, BIOPHYS J, V50, P937, DOI 10.1016/S0006-3495(86)83535-4
   JEN CJ, 1996, HEART CIRC PHYSL, V39, pH160
   JONES RL, 1979, CHEM BIOCH PHARM ACT, P210
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Kennedy SD, 1997, AM J CLIN PATHOL, V107, P99
   Langford EJ, 1996, ARTERIOSCL THROM VAS, V16, P51, DOI 10.1161/01.ATV.16.1.51
   Lemire PP, 2002, ARTIF ORGANS, V26, P971, DOI 10.1046/j.1525-1594.2002.07114.x
   Mandrusov E, 1998, AICHE J, V44, P233, DOI 10.1002/aic.690440202
   MCPHERSON LB, 1972, BLOOD, V44, P411
   MERRILL EW, 1967, J APPL PHYSIOL, V23, P178
   REYNOLDS LO, 1993, J BIOMAT SCI-POLYM E, V4, P451
   Ronco C, 2002, J AM SOC NEPHROL, V13, pS53
   ROSING J, 1985, BLOOD, V65, P319
   Solen K, 2003, J BIOMED OPT, V8, P70, DOI 10.1117/1.1527934
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P436, DOI 10.1114/1.200
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P449, DOI 10.1114/1.201
   STRONG AB, 1987, J BIOMED MATER RES, V21, P1039, DOI 10.1002/jbm.820210810
   STUBLEY GD, 1987, PHYSICOCHEM HYDRODYN, V8, P221
   TREICHLER J, 1993, ARTIF ORGANS, V17, P797
   TSCHOPP TB, 1976, THROMB HAEMOSTASIS, V35, P334
   TURRITO VT, 1975, T AM SOC ART INT ORG, V21, P593
   WEISS HJ, 1982, PLATELETS PATHOPHYSI
   Wootton DM, 2001, ANN BIOMED ENG, V29, P321, DOI 10.1114/1.1359449
   Wu YP, 1997, ARTERIOSCL THROM VAS, V17, P3202, DOI 10.1161/01.ATV.17.11.3202
NR 49
TC 47
Z9 49
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2005
VL 33
IS 6
BP 780
EP 797
DI 10.1007/s10439-005-2951-z
PG 18
WC Engineering, Biomedical
SC Engineering
GA 939LU
UT WOS:000230075100007
PM 16078618
DA 2018-10-19
ER

PT J
AU Garrigues, GE
   Cho, DR
   Rubash, HE
   Goldring, SR
   Herndon, JH
   Shanbhag, AS
AF Garrigues, GE
   Cho, DR
   Rubash, HE
   Goldring, SR
   Herndon, JH
   Shanbhag, AS
TI Gene expression clustering using self-organizing maps: analysis of the
   macrophage response to particulate biomaterials
SO BIOMATERIALS
LA English
DT Article
DE osteolysis; aseptic loosening; gene expression; self-organizing maps;
   macrophage; total joint replacement; microarrays; Ti-alloy; UHMWPE; wear
   debris
ID NECROSIS-FACTOR-ALPHA; TOTAL HIP-ARTHROPLASTY; WEAR DEBRIS; IN-VITRO;
   BONE-RESORPTION; TGF-BETA; OSTEOLYSIS; PARTICLES; MEMBRANE; REPLACEMENTS
AB The most common cause of total joint replacement failure is peri-implant bone loss causing pain and prosthesis loosening. This process, known as osteolysis or aseptic loosening, is characterized by macrophage phagocytosis of particulate implant wear debris. In an incompletely defined step, particulate biomaterial debris induces macrophages to release a variety of inflammatory mediators and signaling proteins that lead to bone loss. In an in vitro model of this process, we used microarray technology and data analysis techniques, including the use of self-organizing maps (SOMs), to understand the mRNA gene expression changes occurring in macrophages exposed to clinically relevant particles of ultra-high molecular weight polyethylene and TiAlV alloy. Earlier studies have been limited by technology that only allowed analysis of a few genes at a time, but the microarray techniques used in this paper generate the quantitative analysis of over a thousand genes simultaneously.
   Our microarray analysis utilized an SOM clustering to elucidate general patterns in the data, lists of top up- and down-regulated genes for each time point and genes with differential expression under different biomaterial exposures. The expression levels of the majority of genes (>95%) did not vary over time or with exposure to different biomaterials, but a few important genes, such as TNF-alpha, IL-1beta, IL-6, and MIP1alpha, proved to be highly regulated in response to biomaterial exposure. We also uncovered a novel set of genes, which not only validates and logically extends the current model of the pathogenesis of osteolysis and aseptic loosening, but also provides new targets for further research and therapeutics. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Harvard Univ, Sch Med, Biomat Lab, Massachusetts Gen Hosp, Boston, MA 02114 USA.
   Beth Israel Deaconess Med Ctr, Bone & Joint Inst, Boston, MA 02215 USA.
RP Shanbhag, AS (reprint author), Harvard Univ, Sch Med, Biomat Lab, Massachusetts Gen Hosp, GRJ 1115,55 Fruit St, Boston, MA 02114 USA.
EM shanbhag@helix.mgh.harvard.edu
FU NIAMS NIH HHS [AR47465 A03]
CR Absolom D R, 1986, Methods Enzymol, V132, P95
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478
   CAMPBELL P, 1994, J BIOMED MATER RES, V28, P523, DOI 10.1002/jbm.820280415
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, V244, P182
   GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685
   Haden ST, 2000, CALCIFIED TISSUE INT, V66, P414, DOI 10.1007/s002230010084
   Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   Held TK, 1999, INFECT IMMUN, V67, P206
   Herberts P, 2000, ACTA ORTHOP SCAND, V71, P111, DOI 10.1080/000164700317413067
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   Jacobs JJ, 1994, J AM ACAD ORTHOP SUR, V2, P212
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Jones DH, 2002, ANN RHEUM DIS, V61, P32
   KLAMPFER L, 1994, MOL CELL BIOL, V14, P6561, DOI 10.1128/MCB.14.10.6561
   Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409
   Makhluf HA, 2000, BIOCHEM BIOPH RES CO, V268, P669, DOI 10.1006/bbrc.2000.2182
   Maloney WJ, 1996, AAOS INSTR COURS LEC, V45, P171
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051
   Mattei MG, 1996, GENOMICS, V32, P168, DOI 10.1006/geno.1996.0098
   Morrissette Naomi, 1999, Trends in Cell Biology, V9, P199, DOI 10.1016/S0962-8924(99)01540-8
   Papadopoulos NG, 1997, CLIN RHEUMATOL, V16, P162, DOI 10.1007/BF02247845
   Peng CY, 1998, CELL GROWTH DIFFER, V9, P197
   ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584
   Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4
   SARMA V, 1992, J IMMUNOL, V148, P3302
   Schwarz EM, 2000, J ORTHOPAED RES, V18, P849, DOI 10.1002/jor.1100180602
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   Shanbhag AS, 1996, J ORTHOPAED RES, V14, P1000, DOI 10.1002/jor.1100140622
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   Shanbhag AS, 1998, J BIOMED MATER RES, V41, P497, DOI 10.1002/(SICI)1097-4636(19980905)41:3<497::AID-JBM21>3.3.CO;2-G
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P205
   Sinha RK, 1998, AAOS INSTR COURS LEC, V47, P307
   SOLBACH W, 1991, IMMUNOL TODAY, V12, P4, DOI 10.1016/0167-5699(91)90103-Z
   Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771
   Takai Y, 2001, PHYSIOL REV, V81, P153
   Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907
   Vermes C, 2001, J ARTHROPLASTY, V16, P95, DOI 10.1054/arth.2001.28719
   Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359
   Wright T., 1996, IMPLANT WEAR FUTURE
   Yang IH, 1999, J BIOMED MATER RES, V48, P220, DOI 10.1002/(SICI)1097-4636(1999)48:3<220::AID-JBM4>3.0.CO;2-P
   Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0
   Youssef P, 1999, J RHEUMATOL, V26, P2523
NR 59
TC 39
Z9 39
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2933
EP 2945
DI 10.1016/j.biomaterials.2004.06.034
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500015
PM 15603788
DA 2018-10-19
ER

PT J
AU Thian, ES
   Huang, J
   Best, SM
   Barber, ZH
   Bonfield, W
AF Thian, ES
   Huang, J
   Best, SM
   Barber, ZH
   Bonfield, W
TI Magnetron co-sputtered silicon-containing hydroxyapatite thin films - an
   in vitro study
SO BIOMATERIALS
LA English
DT Article
DE maimetron co-sputtering; silicon-substituted hydroxyapatite (Si-HA);
   thin films/coatings; human osteoblast-like (HOB) cells; heat treatment
ID OSTEOBLAST-LIKE CELLS; CA-P COATINGS; VIVO DISSOLUTION BEHAVIOR;
   CALCIUM-PHOSPHATE; TITANIUM IMPLANTS; CERAMIC COATINGS; BONE;
   DIFFERENTIATION; PROLIFERATION; BIOMATERIALS
AB The use of silicon-substituted hydroxyapatite (Si-HA) as a biomaterial has been reported recently. In vivo testing has shown that Si-HA promotes early bonding of the bone/implant interface. In order to extend its usage to major load-bearing applications such as artificial hip replacement implants, it has been proposed that the material could be used in the form of a coating on implant surfaces. This paper reports a preliminary study of the biocompatibility of magnetron co-sputtered silicon-containing hydroxyapatite (Si-HA) coatings on a metallic substrate. Magnetron co-sputtered Si-HA films of thickness 600 nm with a Si content of approximately 0.8 wt% were produced on titanium substrates. X-ray diffraction analysis showed that the as-deposited Si-HA films were either amorphous or made up of very small crystals. The crystallinity of Si-HA films was increased after post-deposition heat treatment at 700 degreesC for 3 h, and the principal peaks were attributable to HA. The formation of nano-scale silicon-calcium phosphate precipitates was noted on the heat-treated films. In vitro cell culture has demonstrated that human osteoblast-like cells attached and grew well on all films, with the highest cell growth and signs of mineralisation observed on the heat-treated Si-HA films. In addition, many focal contacts were produced on the films and the cells had well-defined actin cytoskeletal organisation. This work shows that as-deposited and heat-treated Si-HA films have excellent bioactivity and are good candidates when rapid bone apposition is required. Furthermore, heat-treated Si-HA films have improved biostability compared to as-deposited films under physiological conditions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge Ctr Med Mat, Cambridge CB2 3QZ, England.
   Univ Cambridge, Dept Mat Sci & Met, Dev Mat Grp, Cambridge CB2 3QZ, England.
RP Thian, ES (reprint author), Univ Cambridge, Dept Mat Sci & Met, Cambridge Ctr Med Mat, Pembroke St, Cambridge CB2 3QZ, England.
EM est23@cam.ac.uk
OI Thian, Eng San/0000-0001-6925-6811
CR Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Barrere F, 2003, J MATER SCI-MATER M, V14, P419, DOI 10.1023/A:1023210817683
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   DALTON JE, 1995, J BIOMED MATER RES, V29, P239, DOI 10.1002/jbm.820290215
   DEBRUIJN JD, 1994, BIOMATERIALS, V15, P543, DOI 10.1016/0142-9612(94)90021-3
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GIBSON IR, 1999, 12 INT S CER MED NAR, P191
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kitsugi T, 1996, J BIOMED MATER RES, V32, P149
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P961, DOI 10.1002/jbm.820280815
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MORONI A, 1994, J MATER SCI-MATER M, V5, P411, DOI 10.1007/BF00058975
   Moroni A, 1998, J BONE JOINT SURG AM, V80A, P547, DOI 10.2106/00004623-199804000-00011
   Ong JL, 2002, J BIOMED MATER RES, V59, P184, DOI 10.1002/jbm.1232
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Patel N, 2002, KEY ENG MATER, V218-2, P383, DOI 10.4028/www.scientific.net/KEM.218-220.383
   Porter AE, 2004, J MATER SCI, V39, P1895, DOI 10.1023/B:JMSC.0000016213.77001.71
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Thian ES, 2004, KEY ENG MAT, V254-2, P111, DOI 10.4028/www.scientific.net/KEM.254-256.111
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Wolke JGC, 2003, BIOMATERIALS, V24, P2623, DOI 10.1016/S0142-9612(03)00067-X
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Wolke JGC, 1998, J BIOMED MATER RES, V43, P270, DOI 10.1002/(SICI)1097-4636(199823)43:3<270::AID-JBM7>3.0.CO;2-K
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
NR 38
TC 100
Z9 104
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2947
EP 2956
DI 10.1016/j.biomaterials.2004.07.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500016
PM 15603789
DA 2018-10-19
ER

PT J
AU Bennewitz, NL
   Babensee, JE
AF Bennewitz, NL
   Babensee, JE
TI The effect of the physical form of poly(lactic-co-glycolic acid)
   carriers on the humoral immune response to co-delivered antigen
SO BIOMATERIALS
LA English
DT Article
DE poly (lactic-co-glycolic acid) microparticles and scaffolds; adjuvant;
   immune response; controlled release; tissue engineering
ID TOLL-LIKE RECEPTOR-4; DENDRITIC CELLS; POLY(L-LACTIC ACID); HOST
   RESPONSE; MODEL; MICROSPHERES; DEGRADATION; SCAFFOLDS; RELEASE; SIGNALS
AB A model shed antigen, ovalbumin (OVA), was incorporated into polymeric biomaterial carriers made of poly(lactic-co-glycolic acid) (PLGA) in the form of microparticles (MP) or scaffolds (SC). These polymeric biomaterial carrier vehicles with incorporated antigen were then injected or implanted into mice and the resulting time-dependent systemic humoral immune response towards the controlled released OVA was assessed by following the OVA-specific IgG concentration and isotypes using ELISA. To assess the differential level of enhancement of the immune response depending on the form of carrier vehicle (MP vs. SC), the total amount of polymer and OVA delivered was kept constant as well as the release rate of OVA for both carrier vehicles. The level of the humoral immune response was higher and sustained for OVA released from PLGA SC which were implanted with associated tissue damage, and lower and transient when the same amount of polymer and OVA were delivered from PLGA MP, which were minimally invasively delivered by injection. This immune response was primarily Th2 helper T cell-dependent, although for the strong adjuvant, CFA, and PLGA SC carriers there was both a Th2 and Th1 response contribution. These results implicate 'danger signals' associated with the implantation of the scaffolds due to tissue injury which primed the system for an enhanced immune response. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Georgia Tech, Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Georgia Tech, Emory Ctr Engn Living Tissues, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2000, TISSUE ENG, V6, P165, DOI 10.1089/107632700320784
   Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6
   GHOSH S, 1998, ANNU REV IMMUNOL, V16, P224
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Loudovaris T, 1996, TRANSPLANTATION, V61, P1678, DOI 10.1097/00007890-199606270-00003
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   Meese TM, 2002, J BIOMAT SCI-POLYM E, V13, P141, DOI 10.1163/156856202317414339
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Murillo M, 2002, J CONTROL RELEASE, V85, P237, DOI 10.1016/S0168-3659(02)00276-6
   Newman KD, 1998, J CONTROL RELEASE, V54, P49, DOI 10.1016/S0168-3659(97)00142-9
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   RUHE PQ, 2002, J BONE J SURG, V85, P75
   SAYEGH MH, 1994, TRANSPLANTATION, V57, P1295, DOI 10.1097/00007890-199405150-00001
   Scholl I, 2004, CLIN EXP ALLERGY, V34, P315, DOI 10.1111/j.1365-2222.2004.01884.x
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
NR 26
TC 60
Z9 60
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2991
EP 2999
DI 10.1016/j.biomaterials.2004.08.023
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500021
PM 15603794
DA 2018-10-19
ER

PT J
AU Park, GE
   Pattison, MA
   Park, K
   Webster, TJ
AF Park, GE
   Pattison, MA
   Park, K
   Webster, TJ
TI Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds
SO BIOMATERIALS
LA English
DT Article
DE PLGA; articular cartilage; chondrocyte; NaOH treatment; scaffold
ID MUSCLE-CELL FUNCTION; SURFACE-FEATURES; ACID) FOAMS; IN-VITRO;
   CARTILAGE; POLYMER; COMPOSITES; ADHESION
AB Compared to conventional poly(lactic-co-glycolic acid) (PLGA), previous studies have shown that NaOH-treated PLGA two-dimensional substrates enhanced functions of osteoblasts (bone-forming cells), vascular and bladder smooth muscle cells, and chondrocytes (cartilage-synthesizing cells). In this same spirit, the purpose of this in vitro study was to fabricate three-dimensional NaOH-treated PLGA scaffolds and determine their efficacy toward articular cartilage applications. To improve functions of chondrocytes including their adhesion, growth, differentiation, and extracellular matrix synthesis, PLGA scaffolds were modified via chemical etching techniques using 1 N NaOH for 10min. Results demonstrated that NaOH-treated PLGA three-dimensional scaffolds enhanced chondrocyte functions compared to non-treated scaffolds. Specifically, chondrocyte numbers, total intracellular protein content, and the amount of extracellular matrix components (such as glycosaminoglycans and collagens) were significantly greater on NaOH-treated than on non-treated PLGA scaffolds. Underlying material properties that may have enhanced chondrocyte functions include a more hydrophilic surface (due to hydrolytic degradation of PLGA by NaOH), increased surface area, altered porosity (both percent and diameter of individual pores), and a greater degree of nanometer roughness. For these reasons, this study adds a novel tissue-engineering scaffold to the cartilage biomaterial community: NaOH-treated PLGA. Clearly, such modifications to PLGA may ultimately enhance the efficacy of tissue-engineering scaffolds for articular cartilage repair. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Pharmaceut, W Lafayette, IN 47907 USA.
RP Webster, TJ (reprint author), Purdue Univ, Dept Biomed Engn, 1296 Potter Bldg, W Lafayette, IN 47907 USA.
EM twebster@ecn.purdue.edu
CR BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   MA PX, 1998, TISSUE ENG METHODS P, P47
   MATLAGA BF, 1983, J BIOMED MATER RES, V17, P185, DOI 10.1002/jbm.820170115
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Parsons JR, 1998, HDB BIOMATERIAL PROP, P40
   ROSEN JJ, 1980, POLYM SCI TECHNOL B, V12, P667
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   WALSH BJ, 1992, ANAL BIOCHEM, V203, P187, DOI 10.1016/0003-2697(92)90301-M
   WROBLE RR, 2000, PHYSICIAN SPORTSMED, V28, P11
NR 22
TC 158
Z9 170
U1 2
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3075
EP 3082
DI 10.1016/j.biomaterials.2004.08.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500029
PM 15603802
DA 2018-10-19
ER

PT J
AU Vacatello, M
   D'Auria, G
   Falcigno, L
   Dettin, M
   Gambaretto, R
   Di Bello, C
   Paolillo, L
AF Vacatello, M
   D'Auria, G
   Falcigno, L
   Dettin, M
   Gambaretto, R
   Di Bello, C
   Paolillo, L
TI Conformational analysis of heparin binding peptides
SO BIOMATERIALS
LA English
DT Article
ID MOLECULAR-DYNAMICS; FORCE-FIELD; NMR; SPECTROSCOPY; ADHESION; PROGRAM;
   BIOMATERIALS; MINIMIZATION; FIBRONECTIN; CELLS
AB A properly engineered biomaterial for dental/orthopaedic applications must induce specific responses from the osteoblasts at the implant site. A most desirable response is an efficient adhesion, as it represents the first phase in the cell/material interaction and the quality of this phase will influence the cell's capacity to organize into a new functional tissue. The four osteoblast-adhesive peptides discussed in this paper are mapped on the 339-364 sequence ((339)MAPRPSLAKKQRFRHRNRKGYRSQRG(364)) located in the primary heparin-binding site of human vitronectin (HVP). Adsorbed on a polystyrene scaffold, these peptides display different adhesive activities towards osteoblasts. In this paper we report on the structural analysis in solution of the peptides through NMR and computational techniques. We find that the peptides with the highest adhesive activities display a hydrophobic patch opposite to the charged surface candidate to interact with heparin. These findings suggest that the peptides might adsorb on the polystyrene support in a favourable orientation for their activity. Furthermore, molecular models obtained for the four peptides in solution were used in rigid docking simulations with a heparin model. Assuming that the peptide solution conformations are not very different from the polystyrene-adsorbed structures, the simulations reveal that peptide adhesive activity is also affected by the number of ionic interactions and spacing between charged residues. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy.
   CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy.
   Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
RP Vacatello, M (reprint author), Univ Naples Federico II, Dept Chem, Complesso Univ Monte S Angelo,Via Cintia, I-80126 Naples, Italy.
EM manuela@chemistry.unina.it
RI Falcigno, Lucia/A-6720-2012; D'Auria, Gabriella/E-2076-2011
OI D'Auria, Gabriella/0000-0002-1340-8545
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4
   Brooks III C. L., 1988, ADV CHEM PHYS, VLXXI, P33
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CASE DA, 1996, AMBER 6
   Chon JH, 2001, AM J PHYSIOL-CELL PH, V280, pC1394
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   DETTIN M, UNPUB BIOMATERIALS
   FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866
   GUNTERT P, 1997, DYANA J MOL BIOL, V273, P283
   JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KUMAR A, 1981, J AM CHEM SOC, V103, P3654, DOI 10.1021/ja00403a008
   LIFSON S, 1979, J AM CHEM SOC, V101, P5111, DOI 10.1021/ja00512a001
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D
   PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921
   VANGUNSTEREN WF, 1980, J COMPUT CHEM, V1, P266, DOI 10.1002/jcc.540010308
   WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   WUETHRICH K, 1983, J MOL BIOL, V169, P949
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 31
TC 10
Z9 10
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3207
EP 3214
DI 10.1016/j.biomaterials.2004.09.009
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500042
PM 15603815
DA 2018-10-19
ER

PT J
AU Zhang, J
   Senger, B
   Vautier, D
   Picart, C
   Schaaf, P
   Voegel, JC
   Lavalle, P
AF Zhang, J
   Senger, B
   Vautier, D
   Picart, C
   Schaaf, P
   Voegel, JC
   Lavalle, P
TI Natural polyelectrolyte films based on layer-by layer deposition of
   collagen and hyaluronic acid
SO BIOMATERIALS
LA English
DT Article
DE surface treatment; extracellular matrix (ECM); collagen; multilayered
   films; layer-by-layer assembly; biomimetic material
ID ATOMIC-FORCE MICROSCOPY; MULTILAYER FILMS; EXPONENTIAL-GROWTH; BIOACTIVE
   COATINGS; CELLULAR ADHESION; POLYMER-FILMS; CROSS-LINKING; IN-VITRO;
   ADSORPTION; SURFACES
AB The aim of the present work was to assemble extracellular matrix components into polyelectrolyte multilayers using the layer-by-layer deposition method. The films are constructed with type-I collagen and hyaluronic acid. The construction exhibits the general features observed during polyelectrolyte multilayer buildup: alternate positive and negative values of the zeta potential of the film during its construction and regular increase of the film thickness with the number, n, of deposition step. This increase is shown to be linear with n. As expected for a linearly growing film, the confocal microscopy shows that when the film is brought in contact with a collagen solution, collagen does not diffuse into the film but interacts only with its outer layer. However, the films are not constituted of homogeneously distributed polyanion/polycation complexes as it is usually observed, but they are formed of fibers as imaged by AFM. The typical width of these fibers increases with the number of deposition steps. Finally, it is found that chondrosarcoma cells spread well and synthesize extracellular matrix components only on the collagen ending films, whereas no cellular matrix was found for HA ending ones. Such architectures may be further functionalized by inclusion of active drugs, peptides, proteins..., and could be used as tunable biomaterial interfaces. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Strasbourg 1, Fac Chirurg Dentaire, Unit 595, INSERM, F-67085 Strasbourg, France.
   Ecole Europeenne Chim Polymers & Mat Strasbourg, F-67085 Strasbourg 2, France.
   Univ Strasbourg 1, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
RP Lavalle, P (reprint author), Univ Strasbourg 1, Fac Chirurg Dentaire, Unit 595, INSERM, 11 Rue Humann, F-67085 Strasbourg, France.
EM philippe.lavalle@odonto-ulp.u-strasbg.fr
RI Lavalle, Philippe/E-6328-2016; SCHAAF, Pierre/J-2751-2016
OI Lavalle, Philippe/0000-0001-8798-912X; SCHAAF,
   Pierre/0000-0001-7423-5492; PICART, Catherine/0000-0002-4854-6366;
   PICART, Catherine/0000-0003-0130-1000
CR Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Barbani N, 1999, J APPL POLYM SCI, V72, P971, DOI 10.1002/(SICI)1097-4628(19990516)72:7<971::AID-APP13>3.0.CO;2-N
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Caruso F, 1999, J AM CHEM SOC, V121, P6039, DOI 10.1021/ja990441m
   Caruso F, 1998, J PHYS CHEM B, V102, P2011, DOI 10.1021/jp980198y
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   Grant GGS, 2001, BIOMED MICRODEVICES, V3, P301, DOI 10.1023/A:1012456714628
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Ishida O, 1997, J BONE MINER RES, V12, P1657, DOI 10.1359/jbmr.1997.12.10.1657
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, IN PRESS ADV MAT
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Laurent TC, 1998, CHEM BIOL MED APPL H
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1994, PHYSICA B, V198, P89, DOI 10.1016/0921-4526(94)90134-1
   Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x
   McAloney RA, 2001, LANGMUIR, V17, P6655, DOI 10.1021/la010136q
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Schoeler B, 2003, MACROMOLECULES, V36, P5258, DOI 10.1021/ma034018g
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Sukhorukov GB, 1996, THIN SOLID FILMS, V284, P220, DOI 10.1016/S0040-6090(95)08309-X
   TAGIKAWA M, 1989, CANCER RES, V49, P3996
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   ZEMBALA M, 1994, COLLOID SURFACE B, V3, P119
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 50
TC 156
Z9 159
U1 1
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3353
EP 3361
DI 10.1016/j.biomaterials.2004.08.019
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500058
PM 15603831
DA 2018-10-19
ER

PT J
AU Horan, RL
   Antle, K
   Collette, AL
   Huang, YZ
   Huang, J
   Moreau, JE
   Volloch, V
   Kaplan, DL
   Altman, GH
AF Horan, RL
   Antle, K
   Collette, AL
   Huang, YZ
   Huang, J
   Moreau, JE
   Volloch, V
   Kaplan, DL
   Altman, GH
TI In vitro degradation of silk fibroin
SO BIOMATERIALS
LA English
DT Article
DE degradation; silk; scaffold; ligament; mechanical properties
ID LIGAMENT AUGMENTATION; BOMBYX-MORI; FIBERS
AB A significant need exists for long-term degradable biomaterials which can slowly and predictably transfer a load-bearing burden to developing biological tissue. In this study Bombyx mori silk fibroin yarns were incubated in 1 mg/ml Protease XIV at 37 degreesC to create an in vitro model system of proteolytic degradation. Samples were harvested at designated time points up to 12 weeks and (1) prepared for scanning electron microscopy (SEM), (2) lyophilized and weighed, (3) mechanical properties determined using a servohydraulic Instron 8511, (4) dissolved and run on a SDS-PAGE gel, and (5) characterized with Fourier transform infrared spectroscopy. Control samples were incubated in phosphate-buffered saline. Fibroin was shown to proteolytically degrade with predictable rates of change in fibroin diameter, failure strength, cycles to failure, and mass. SEM indicated increasing fragmentation of individual fibroin filaments from protease-digested samples with time of exposure to the enzyme; particulate debris was present within 7 days of incubation. Gel electrophoresis indicated a decreasing amount of the silk 25 kDa light chain and a shift in the molecular weight of the heavy chain with increasing incubation time in protease. Results support that silk is a mechanically robust biomaterial with predictable long-term degradation characteristics. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Altman, GH (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St,Room 153, Medford, MA 02155 USA.
EM gregory.altman@tufts.edu
FU NIAMS NIH HHS [R44 AR049139-03, R01 AR46563-01]
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bonnarens F, 1987, ANTERIOR CRUCIATE DE, V239-253
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   FRANK BC, 1997, J BONE JOINT SURG AM, V79, P1556
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Kumar K, 1999, ARTHROSCOPY, V15, P422, DOI 10.1016/S0749-8063(99)70061-7
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   MARKOLF KL, 1989, J BONE JOINT SURG AM, V71A, P887, DOI 10.2106/00004623-198971060-00013
   McCarthy Donal M., 1993, P343
   MUNETA T, 1994, J ORTHOPAED RES, V12, P138, DOI 10.1002/jor.1100120117
   Richert K. J., 2000, Dairy, Food and Environmental Sanitation, V20, P24
   TSUBOUCHI K, 2002, Patent No. 1241178
   Tsukada M, 1986, J SERIC SCI JPN, V55, P120
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   WEITZEL PP, 2002, ORTHOP CLIN N AM, P653
NR 22
TC 421
Z9 449
U1 15
U2 186
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3385
EP 3393
DI 10.1016/j.biomaterials.2004.09.020
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200002
PM 15621227
DA 2018-10-19
ER

PT J
AU Aizawa, M
   Porter, AE
   Best, SM
   Bonfield, W
AF Aizawa, M
   Porter, AE
   Best, SM
   Bonfield, W
TI Ultrastructural observation of single-crystal apatite fibres
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; microstructure; transmission electron microscopy;
   apatite fibre; single crystal
ID POROUS CERAMICS; HYDROXYAPATITE; BIOCERAMICS; PARTICLES
AB Hydroxyapatite (HAp) has been widely used as a biomaterial for substituting human hard tissues such as bone. By altering the morphology of HAp crystals, novel properties may be produced by controlling the orientation of the crystal planes. Apatite fibres were successfully synthesized by precipitation from aqueous solutions containing Ca(NO3)(2), (NH4)(2)HPO4, urea and HNO3. The products were composed of carbonate-containing apatite fibres with preferred orientation along the {h00} planes. Examination of individual fibres using transmission electron microscopy showed that the as-synthesized apatite fibres were highly strained single crystals with the c-axis orientation parallel to the long axis of the fibre. The crushed fibres consisted of domains that were preferentially oriented with the c-axis parallel to the long axis of the fibres. When the apatite fibres were heated to 800, 1000 and 1200 degreesC for 1 h, the domains were removed and grain boundaries, dislocations and voids were formed. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Meiji Univ, Dept Ind Chem, Sch Sci & Technol, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Aizawa, M (reprint author), Meiji Univ, Dept Ind Chem, Sch Sci & Technol, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.
EM mamorua@isc.meiji.ac.jp
CR Aizawa M, 2003, KEY ENG MAT, V240-2, P647, DOI 10.4028/www.scientific.net/KEM.240-242.647
   Aizawa M, 2000, J CERAM SOC JPN, V108, P249, DOI 10.2109/jcersj.108.1255_249
   Aizawa M, 1999, J MATER SCI, V34, P2865, DOI 10.1023/A:1004635418655
   Aizawa M, 1999, MATER RES BULL, V34, P1215, DOI 10.1016/S0025-5408(99)00118-X
   Aizawa M., 1998, INORG MATER, V5, P387
   AIZAWA M, 2001, KEY ENG MATER, V218, P465
   AIZAWA M, 1999, MAT INTEGRATION, V12, P75
   AIZAWA M, 1999, BIOCERAMICS, V12, P453
   AIZAWA M, 2003, T MAT RES SOC JPN, V28, P849
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOBBS JW, 1979, ANAL ELECT MICROSCOP, P437
   IOKU K, 1988, NIPPON KAGAKU KAISHI, P1565, DOI 10.1246/nikkashi.1988.1565
   *JOINT COMM POWD D, 90432 JOINT COMM POW
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   NAGATA F, 1995, J CERAM SOC JPN, V103, P70
NR 17
TC 84
Z9 87
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3427
EP 3433
DI 10.1016/j.biomaterials.2004.09.044
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200006
PM 15621231
DA 2018-10-19
ER

PT J
AU Unger, RE
   Peters, K
   Huang, Q
   Funk, A
   Paul, D
   Kirkpatrick, CJ
AF Unger, RE
   Peters, K
   Huang, Q
   Funk, A
   Paul, D
   Kirkpatrick, CJ
TI Vascularization and gene regulation of human endothelial cells growing
   on porous polyethersulfone (PES) hollow fiber membranes
SO BIOMATERIALS
LA English
DT Article
DE polyethersulfone; PES; vascularization; endothelial cell; cell
   compatibility; gene regulation
ID SILK FIBROIN NET; IN-VITRO; INVITRO ENDOTHELIALIZATION; BONE; GRAFTS;
   BIOMATERIALS; SUBSTRATE; CARTILAGE; SURFACES; CULTURE
AB Open-cell hollow fibers made of polyethersulfone (PES) manufactured in the absence of solvents with pore diameters smaller than 100mum were examined for vascularization by human endothelial cells. The goal of this study was to determine whether the 3-D porous character of the PES surface affected human endothelial cell morphology and functions. Freshly isolated human endothelial cells from the skin (HDMEC), from the lung (HPMEC) and from umbilical cords (HUVEC) and two human endothelial cell lines, HPMEC-ST1.6R and ISO-HAS.cl were added to PES fibers and cell adherence and growth was followed by confocal laser scanning microscopy. Prior coating of PES with gelatin or fibronectin was necessary for adhesion and spreading of cells over the uneven porous surface with time. Confluent cells exhibited typical strong PECAM-I expression at cell-cell borders. Little expression of the activation markers E-selectin, ICAM-1, and VCAM-1 was observed by RT-PCR of endothelial cells growing on PES. However, after stimulation for 4h by LPS, activation of these markers was observed and it was shown by immunofluorescent staining that induction occurred in most of the cells, thus confirming an intact functionality. Finally, cells growing as a monolayer on PES migrated to form microvessel-like structures when placed under conditions that stimulated angiogenesis. Thus, human endothelial cells grown on fibronectin-coated PES fibers retain important endothelial-cell specific morphological and functional properties and PES may serve as a useful biomaterial in tissue engineering and biotechnology applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Geesthacht, Germany.
RP Unger, RE (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM unger@pathologie.klinik.uni-mainz.de
RI Peters, Kirsten/S-3484-2016
CR ANDERSON JS, 1987, SURGERY, V101, P577
   BONOMINI D, 2003, CONTRIB NEPHROL, P117
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   David S, 2003, CONTRIB NEPHROL, V138, P43
   Doll B, 2001, CRIT REV EUKAR GENE, V11, P173
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081
   Huang Q, 1999, J MEMBRANE SCI, V161, P287, DOI 10.1016/S0376-7388(99)00122-2
   HUANG Q, 2001, MEMBRANE TECHNOL, V140, P6
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Hunter SK, 1999, ASAIO J, V45, P37, DOI 10.1097/00002480-199901000-00009
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   Locatelli F, 2003, Contrib Nephrol, P55
   Lonnemann G, 2001, ARTIF ORGANS, V25, P951, DOI 10.1046/j.1525-1594.2001.06832.x
   Moce-Llivina L, 2003, J VIROL METHODS, V109, P99, DOI 10.1016/S0166-0934(03)00046-6
   PAUL D, 2002, RECENT RES DEV, P179
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Ripamonti U., 2000, Current Pharmaceutical Biotechnology, V1, P47, DOI 10.2174/1389201003379031
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Stefoni Sergio, 2003, Contrib Nephrol, P68
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Zhao CS, 2001, ARTIF ORGANS, V25, P60
   ZILLA P, 1989, SURGERY, V105, P515
NR 32
TC 64
Z9 68
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3461
EP 3469
DI 10.1016/j.biomaterials.2004.09.047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200010
PM 15621235
DA 2018-10-19
ER

PT J
AU Witte, RP
   Kao, WYJ
AF Witte, RP
   Kao, WYJ
TI Keratinocyte-fibroblast paracrine interaction: the effects of substrate
   and culture condition
SO BIOMATERIALS
LA English
DT Article
DE hydrogels; PEG; cell adhesion; fibroblast co-culture; huKGF
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; GELATIN-BASED HYDROGELS;
   GROWTH-FACTOR; INTERPENETRATING NETWORKS; PHYSICOCHEMICAL ANALYSIS;
   POLYMER NETWORKS; IN-VITRO; REGENERATION; EXPRESSION; MIGRATION
AB Interactions between epidermal-dermal cells via soluble factors provide important signals in regulating the reepithelialization of wounded skin. For example, keratinocytes regulate the expression of keratinocyte growth factor (KGF) in fibroblasts through the release of interleukin-1 beta (IL-1beta). In this study, a previously developed polyethyleneglycol-based interpenetrating network (IPN) system was utilized as a platform for the delivery of keratinocyte-active factors. The effect of substrate chemistry, culture condition, and the delivery of exogenous keratinocyte-active factors on the keratinocyte behavior and the keratinocyte-fibroblast paracrine relationship was delineated. Adherent keratinocyte density on TCPS and glutaraldehyde-fixed gelatin hydrogels but not on IPN was significantly increased with culture time in the presence of growth supplements independent of the released KGF from the gelatin hydrogel and IPN. In the presence of fibroblasts, adherent keratinocyte density on gelatin hydrogels was higher than that without fibroblasts. This phenomenon was not observed on IPN and polycarbonate membrane. In summary, the delivered exogenous huKGF (i.e., released from a biomaterial matrix) operates in tandem with fibroblasts in regulating keratinocyte activation (i.e., IL-1beta release and adhesion) in a surface-dependent manner. Immunoassay analysis of cell culture keratinocyte-fibroblast paracrine relationship as characterized by IL-1beta and KGF could not be established in the presence of IPNs, 0.1% glutaraldehyde-fixed gelatin hydrogels, and polycarbonate membranes. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI USA.
RP Kao, WYJ (reprint author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NHLBI NIH HHS [HL-77825]; NIBIB NIH HHS [EB-00290]
CR Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Beer HD, 2000, J INVEST DERM SYMP P, V5, P34, DOI 10.1046/j.1087-0024.2000.00009.x
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Cho CS, 1999, INT J PHARM, V181, P235, DOI 10.1016/S0378-5173(99)00031-9
   Desai NP, 2000, J MICROENCAPSUL, V17, P677
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Freshny RI, 2000, CULTURE ANIMAL CELLS, P89
   Gillis P, 1999, J CELL SCI, V112, P2049
   Harris JM, 1997, ACS S SERIES, V680
   Hwang DC, 1996, J AGR FOOD CHEM, V44, P751, DOI 10.1021/jf9503826
   Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200
   Maas-Szabowski N, 1999, J CELL SCI, V112, P1843
   Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Michelson PH, 1999, AM J PHYSIOL-LUNG C, V277, pL737, DOI 10.1152/ajplung.1999.277.4.L737
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Putnins EE, 1999, CELL ADHES COMMUN, V7, P211, DOI 10.3109/15419069909010803
   Slonina D, 2001, RADIAT RES, V156, P761, DOI 10.1667/0033-7587(2001)156[0761:EOKGFO]2.0.CO;2
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0
   Zilinski JL, 2004, J BIOMED MATER RES A, V68A, P392, DOI 10.1002/jbm.a.20079
NR 25
TC 31
Z9 36
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3673
EP 3682
DI 10.1016/j.biomaterials.2004.09.054
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200033
PM 15621258
DA 2018-10-19
ER

PT J
AU Moore, T
   Adhikari, R
   Gunatillake, P
AF Moore, T
   Adhikari, R
   Gunatillake, P
TI Chemosynthesis of bioresorbable poly(gamma-butyrolactone) by
   ring-opening polymerisation: a review
SO BIOMATERIALS
LA English
DT Review
DE polyhydroxybutyric acid; polymerisation; scaffold; degradation
ID GAMMA-HYDROXYBUTYRIC ACID; UMBILICAL-CORD CELLS; BETA-BUTYROLACTONE;
   EPSILON-CAPROLACTONE; CYCLIC ESTERS; CAPILLARY-ELECTROPHORESIS;
   CATALYZED POLYMERIZATION; DIRECT COPOLYMERIZATION; DELTA-VALEROLACTONE;
   GHB LEVELS
AB Recent advances in the synthesis of poly(gamma-butyrolactone) have yielded homopolymers of up to 50,000Mw from the low-cost monomer gamma-butyrolactone. This monomer has for the better part of a century been thought impossible to polymerise. Poly(gamma-butyrolactone) displays properties that are ideal for tissue-engineering applications and the bacterially derived equivalent, poly(4-hydroxybutyrate) (P4HB), has been evaluated for such uses. The glass transition temperature (-48 to -51 degreesC), melting point (53-60degreesC), tensile strength (50 MPa), Young's modulus (70 MPa) and elongation at break (1000%) of P4HB make it a very useful biomaterial. Poly(gamma-butyrolactone) degrades to give gamma-hydroxybutyric acid which is a naturally occurring metabolite in the body and it has been shown to be bioresorbable.
   Investigation into the synthesis of poly(gamma-butyrolactone) has recently produced homo-oligomeric diols 400-1000Mw that are suitable for reacting with diisocyanates to form polyurethanes. Biodegradable polyurethanes made from diols of polyglycolide (PGA) and poly(epsilon-caprolactone) (PCL) have the disadvantage of high glass transition and slow degradation, respectively. Poly(gamma-butyrolactone) can be thought of as being the missing link in the biodegradable polyester family immediately between PGA and PCL and displaying intermediate properties. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Swinburne Univ Technol, Sch Sci & Engn, Hawthorn, Vic 3122, Australia.
   CSIRO, Clayton, Vic 3169, Australia.
   PolyNovo Biomat Pty Ltd, Clayton, Vic 3169, Australia.
RP Moore, T (reprint author), Swinburne Univ Technol, Sch Sci & Engn, John St, Hawthorn, Vic 3122, Australia.
EM tim.moore@csiro.au
RI Gunatillake, Pathiraja/A-1375-2008
OI Gunatillake, Pathiraja/0000-0002-7035-8214
CR ABATE R, 1994, MACROMOLECULES, V27, P332, DOI 10.1021/ma00080a004
   Adams TB, 1998, FOOD CHEM TOXICOL, V36, P249, DOI 10.1016/S0278-6915(97)00163-4
   Addolorato G, 2000, ALCOHOL, V20, P217, DOI 10.1016/S0741-8329(99)00084-1
   Addolorato G, 1999, LIFE SCI, V65, pPL191, DOI 10.1016/S0024-3205(99)00395-1
   Addolorato G, 1998, DRUG ALCOHOL DEPEN, V53, P7, DOI 10.1016/S0376-8716(98)00094-5
   Agarwal S, 2003, MACROMOLECULES, V36, P3545, DOI 10.1021/ma0258713
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   AUBIN M, 1981, POLYMER, V22, P1223, DOI 10.1016/0032-3861(81)90137-3
   Avella M, 1997, POLYMER, V38, P6135, DOI 10.1016/S0032-3861(97)00166-3
   BAILEY WJ, 1976, J POLYM SCI       PS, V56, P117
   Baldacci A, 2003, J CHROMATOGR A, V990, P99, DOI 10.1016/S0021-9673(02)01704-1
   Bortolotti F, 2004, J CHROMATOGR B, V800, P239, DOI 10.1016/j.jchromb.2003.09.062
   Bosman IJ, 2003, FORENSIC SCI INT, V133, P17, DOI 10.1016/S0379-0738(03)00044-6
   Burlakov VV, 2003, J MOL CATAL A-CHEM, V200, P63, DOI 10.1016/S1381-1169(03)00023-2
   Cai Q, 2002, POLYM ADVAN TECHNOL, V13, P105, DOI 10.1002/pat.161
   Carai MAM, 2001, EUR J PHARMACOL, V428, P315, DOI 10.1016/S0014-2999(01)01334-6
   Carothers W. H., 1932, J AM CHEM SOC, V54, P761, DOI [10.1021/ja01341a046, DOI 10.1021/JA01341A046]
   Cheeseman MA, 1999, FOOD CHEM TOXICOL, V37, P387, DOI 10.1016/S0278-6915(99)00024-1
   Craig K, 2000, J EMERG MED, V18, P65, DOI 10.1016/S0736-4679(99)00163-8
   Deng XM, 2000, EUR POLYM J, V36, P2739, DOI 10.1016/S0014-3057(00)00032-X
   Doi Y, 1996, POLYM DEGRAD STABIL, V51, P281, DOI 10.1016/0141-3910(95)00178-6
   Dong H, 1998, BIOTECHNOL LETT, V20, P905, DOI 10.1023/A:1005482232687
   Duda A, 1998, POLYM DEGRAD STABIL, V59, P215, DOI 10.1016/S0141-3910(97)00167-5
   Duda A, 1996, MACROMOL CHEM PHYSIC, V197, P1273, DOI 10.1002/macp.1996.021970408
   Elian AA, 2002, FORENSIC SCI INT, V128, P120, DOI 10.1016/S0379-0738(02)00183-4
   Elliott SP, 2003, FORENSIC SCI INT, V133, P9, DOI 10.1016/S0379-0738(03)00043-4
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Epple M, 1998, J BIOMED MATER RES, V43, P83
   Fattore L, 2000, ALCOHOL, V20, P247, DOI 10.1016/S0741-8329(99)00088-9
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   FUKUZAKI H, 1990, EUR POLYM J, V26, P457, DOI 10.1016/0014-3057(90)90052-6
   FUKUZAKI H, 1989, MAKROMOL CHEM, V190, P1553
   Gallimberti L, 2000, ALCOHOL, V20, P257, DOI 10.1016/S0741-8329(99)00089-0
   Galloway GP, 2000, ALCOHOL, V20, P263, DOI 10.1016/S0741-8329(99)00090-7
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Gessa GL, 2000, ALCOHOL, V20, P271, DOI 10.1016/S0741-8329(99)00091-9
   Gibson KM, 2003, BIOL PSYCHIAT, V54, P763, DOI 10.1016/S0006-3223(03)00113-6
   HALL HK, 1958, J AM CHEM SOC, V80, P6409, DOI 10.1021/ja01556a060
   HAMITOU A, 1977, J POLYM SCI POL CHEM, V15, P865, DOI 10.1002/pol.1977.170150409
   Hayakawa M, 1997, MACROMOL CHEM PHYS, V198, P1305, DOI 10.1002/macp.1997.021980502
   Higgins Thomas F. Jr., 1996, Journal of Emergency Medicine, V14, P435, DOI 10.1016/0736-4679(96)00080-7
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   HORI Y, 1995, POLYMER, V36, P4703, DOI 10.1016/0032-3861(95)96838-Y
   Hou QP, 2002, MACROMOL RAPID COMM, V23, P247
   Ingels M, 2000, J EMERG MED, V19, P47, DOI 10.1016/S0736-4679(00)00188-8
   INOUE S, 1961, MAKROMOLEKUL CHEM, V48, P229
   ITO K, 1970, MAKROMOLEKUL CHEM, V139, P153
   JEDLINSKI Z, 1991, MACROMOLECULES, V24, P349, DOI 10.1021/ma00002a002
   Kadner A, 2004, EUR J CARDIO-THORAC, V25, P635, DOI 10.1016/j.ejcts.2003.12.038
   Kadner A, 2002, ANN THORAC SURG, V74, pS1422
   Kadokawa J, 2002, GREEN CHEM, V4, P14, DOI 10.1039/b107609b
   Kageyama K, 1999, POLYM J, V31, P1005, DOI 10.1295/polymj.31.1005
   Kasuya K, 1996, INT J BIOL MACROMOL, V19, P35, DOI 10.1016/0141-8130(96)01097-5
   Kasuya K, 1999, INT J BIOL MACROMOL, V24, P329, DOI 10.1016/S0141-8130(99)00046-X
   KAUFMANN H, 1951, ANGEW CHEM, V63, P480
   Kiparisova EG, 1997, ZH FIZ KHIM+, V71, P974
   KORTE F, 1966, J POLYM SCI POL LETT, V4, P685, DOI 10.1002/pol.1966.110041004
   KRICHELDORF HR, 1985, MAKROMOL CHEM, V186, P955
   LeBeau MA, 2001, FORENSIC SCI INT, V119, P161, DOI 10.1016/S0379-0738(00)00426-6
   LEBEDEV B, 1984, MAKROMOL CHEM, V185, P1235
   Lee CW, 1998, EUR POLYM J, V34, P117, DOI 10.1016/S0014-3057(98)80001-3
   Lee CW, 1997, MACROMOL CHEM PHYSIC, V198, P1109, DOI 10.1002/macp.1997.021980414
   Lepoittevin B, 2002, POLYMER, V43, P4017, DOI 10.1016/S0032-3861(02)00229-X
   Mao JX, 2003, APPL CATAL A-GEN, V255, P337, DOI 10.1016/S0926-860X(03)00640-9
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MATHISEN T, 1991, J APPL POLYM SCI, V42, P2365, DOI 10.1002/app.1991.070420829
   Meredith JC, 2000, MACROMOL CHEM PHYSIC, V201, P733, DOI 10.1002/(SICI)1521-3935(20000301)201:6<733::AID-MACP733>3.3.CO;2-X
   Miglani JS, 2000, GEN HOSP PSYCHIAT, V22, P213, DOI 10.1016/S0163-8343(00)00071-2
   Miura H, 1999, KOBUNSHI RONBUNSHU, V56, P291, DOI 10.1295/koron.56.291
   Moncini M, 2000, ALCOHOL, V20, P285, DOI 10.1016/S0741-8329(99)00093-2
   Moriya Fumio, 2004, Leg Med (Tokyo), V6, P47, DOI 10.1016/j.legalmed.2003.09.004
   Na YH, 2002, MACROMOLECULES, V35, P727, DOI 10.1021/ma011530y
   NAKAMURA S, 1992, MACROMOLECULES, V25, P4237, DOI 10.1021/ma00043a001
   Nakayama A, 1998, POLYMER, V39, P1213, DOI 10.1016/S0032-3861(97)00401-1
   Nakayama A, 1996, J ENVIRON POLYM DEGR, V4, P205, DOI 10.1007/BF02067454
   Nicholson KL, 2001, DRUG ALCOHOL DEPEN, V63, P1, DOI 10.1016/S0376-8716(00)00191-5
   Nishiura M, 1999, MACROMOLECULES, V32, P8245, DOI 10.1021/ma990101l
   Nobes GAR, 1996, MACROMOLECULES, V29, P4829, DOI 10.1021/ma951774g
   Oishi A., 2000, Jpn. Pat., Patent No. [JP2000281767, 2000281767]
   Oishi A., 2003, Jpn. Pat., Patent No. [JP2003252968, 2003252968]
   PAJERSKI AD, 1993, MAKROMOL CHEM-M SYMP, V73, P7, DOI 10.1002/masy.19930730104
   Perry TE, 2003, ANN THORAC SURG, V75, P761, DOI 10.1016/S0003-4975(02)03776-1
   REEVE MS, 1994, MACROMOLECULES, V27, P825, DOI 10.1021/ma00081a030
   Rigamonti AE, 2000, ALCOHOL, V20, P293, DOI 10.1016/S0741-8329(99)00094-4
   ROTH RH, 1970, BIOCHEM PHARMACOL, V19, P1087, DOI 10.1016/0006-2952(70)90370-9
   ROTH RH, 1965, BIOCHEM PHARMACOL, V14, P177, DOI 10.1016/0006-2952(65)90073-0
   Saiyasombat W, 1998, POLYMER, V39, P5581, DOI 10.1016/S0032-3861(97)10370-6
   Sakurada K, 2002, TOXICOL LETT, V129, P207, DOI 10.1016/S0378-4274(02)00019-X
   Schneider I, 2001, GENET ENG NEWS, V21, P1
   SHELTON JR, 1971, J POLYM SCI A1, V9, P2789, DOI 10.1002/pol.1971.150091004
   TADA K, 1964, MAKROMOLEKUL CHEM, V77, P220
   Tang ZH, 2003, J POLYM SCI POL CHEM, V41, P1934, DOI 10.1002/pola.10740
   Tedeschi L, 2003, LIFE SCI, V72, P2481, DOI 10.1016/S0024-3205(03)00143-7
   TSUDA T, 1964, KOGYO KAGAKU ZASSHI, V67, P2150
   UYAMA H, 1993, CHEM LETT, P1149, DOI 10.1246/cl.1993.1149
   Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076
   Wong CGT, 2004, TRENDS PHARMACOL SCI, V25, P29, DOI 10.1016/j.tips.2003.11.001
   Yamashita M, 1996, MACROMOLECULES, V29, P1798, DOI 10.1021/ma951400n
   YAMASHITA Y, 1969, MACROMOLECULES, V2, P613, DOI 10.1021/ma60012a009
   YAMASHITA Y, 1966, J POLYM SCI A1, V4, P2121, DOI 10.1002/pol.1966.150040908
   YEVSTROPOV AA, 1980, VYSOKOMOL SOEDIN A+, V22, P2450
   Yoon JS, 1999, EUR POLYM J, V35, P781, DOI 10.1016/S0014-3057(98)00068-8
   ZHANG Y, 1990, MACROMOLECULES, V23, P3206, DOI 10.1021/ma00215a002
   ZHULIN VM, 1988, DOKL AKAD NAUK SSSR+, V298, P1411
NR 105
TC 59
Z9 61
U1 2
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 18
BP 3771
EP 3782
DI 10.1016/j.biomaterials.2004.10.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 899KR
UT WOS:000227143800001
PM 15626425
DA 2018-10-19
ER

PT J
AU Keskin, DS
   Tezcaner, A
   Korkusuz, P
   Korkusuz, F
   Hasirci, V
AF Keskin, DS
   Tezcaner, A
   Korkusuz, P
   Korkusuz, F
   Hasirci, V
TI Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery
   system for bone repair
SO BIOMATERIALS
LA English
DT Article
DE collagen; chondroitin sulfate; PLLA; SAIB; rhBMP-2; controlled drug
   delivery
ID RAT ECTOPIC MODEL; MORPHOGENETIC PROTEIN-2; CONTROLLED-RELEASE;
   BIOMATERIAL CARRIERS; INDUCED OSTEOGENESIS; DEFECTS; POLYMER;
   PHARMACOKINETICS; AUGMENTATION; SABER(TM)
AB Bone morphogenetic proteins (BMPs) are osteoinductive proteins used intensively in clinical investigations involving various bone-related treatments. Owing to their high potential in new bone formation they require local application at the treatment site. For this purpose various controlled delivery systems with BMPs as the excipients have been prepared in recent years. Focusing on this clinical need a disc-shaped BMP carrier was designed as a local delivery system using soluble collagen and chondroitin sulfate. In situ release studies carried out with a model protein (FITC-labeled Protein A) presented a very high rate of release; with most of the protein content being released within 24h. This rate could be decreased by providing a poly(L-lactide) (PLLA) and sucrose acetate isobutyrate-based (SAIB-based) coat around the release system, applied after BMP loading. In this way, it was possible to extend the release period from 24 h to about 12 days. In situ release of BMP from the same carriers, as quantitated using an ELISA kit, was even slower, with 50% of the protein being released in 15 days.
   In order to be able to secure the BMP delivery system at the bone defect site and to provide support a mesh knitted using Vicryl sutures and bonded with poly(L-lactide-co-glycolide) (PLGA) was tested in in vivo. Two time periods, I and 3 weeks, were used to evaluate the healing process. Osteoinduction by the BMP carrier system was assessed by histology-based bone scoring and X-ray examinations. PLLA-SAIB-coated collagen discs containing BMP presented good biocompatibility and optimum osteogenic stimulation. Structural changes in histological micrographs at week I indicated dose-dependent periosteal ossification. At the end of week 3 histological findings with both BMP (1 and 2 mug) doses were almost the same. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Middle E Tech Univ, Dept Sci Biol, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
   Middle E Tech Univ, Dept Engn Sci, TR-06531 Ankara, Turkey.
   Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey.
   Middle E Tech Univ, Med Ctr, TR-06531 Ankara, Turkey.
   Middle E Tech Univ, Dept Phys Educ & Sport, TR-06531 Ankara, Turkey.
RP Hasirci, V (reprint author), Middle E Tech Univ, Dept Sci Biol, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
EM vhasirci@metu.edu.tr
RI KORKUSUZ, PETEK/I-8321-2013; KORKUSUZ, FEZA/I-9501-2013; Xu,
   Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR AN YH, 1999, ANIMAL MODELS ORTHOP, P251
   Bennett BT, 1994, ESSENTIALS ANIMAL RE, P1
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Burns PJ, 1998, THERIOGENOLOGY, V49, P256, DOI 10.1016/S0093-691X(98)90609-4
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P257
   Knoll A, 1999, MICROVASC RES, V58, P1, DOI 10.1006/mvre.1999.2149
   Kokubo S, 2004, BIOMATERIALS, V25, P1795, DOI 10.1016/j.biomaterials.2003.08.030
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Laffargue P, 1999, BONE, V25, p55S, DOI 10.1016/S8756-3282(99)00134-9
   LU HH, 2003, BIOCHEM BIOPH RES CO, V13, P882
   Maeda H, 2004, INT J PHARM, V275, P109, DOI 10.1016/j.ijpharm.2004.01.040
   Nagao H, 2002, INT J ORAL MAX SURG, V31, P66, DOI 10.1054/ijom.2001.0133
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Okamoto T, 2004, J THORAC CARDIOV SUR, V127, P329, DOI 10.1016/j.jtcvs.2003.08.017
   Okumu FW, 2002, BIOMATERIALS, V23, P4353, DOI 10.1016/S0142-9612(02)00174-6
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Royals MA, 1999, J BIOMED MATER RES, V45, P231, DOI 10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Vehof JWM, 2002, J BIOMED MATER RES, V61, P440, DOI 10.1002/jbm.10216
NR 29
TC 49
Z9 52
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 18
BP 4023
EP 4034
DI 10.1016/j.biomaterials.2004.09.063
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 899KR
UT WOS:000227143800025
PM 15626448
DA 2018-10-19
ER

PT J
AU Macleod, TM
   Williams, G
   Sanders, R
   Green, CJ
AF Macleod, TM
   Williams, G
   Sanders, R
   Green, CJ
TI Histological evaluation of Permacol (TM) as a subcutaneous implant over
   a 20-week period in the rat model
SO BRITISH JOURNAL OF PLASTIC SURGERY
LA English
DT Article
DE biomaterials; subcutaneous implant; porcine; histological response;
   biocompatibitity
ID DERMAL COLLAGEN ALLOGRAFTS; SOFT-TISSUE AUGMENTATION; TEMPLATE; PIG
AB This study assessed the suitability of Permacol (TM) (a porcine derived, isocyanate cross linked collagen based biomaterial.) as an alternative to autologous tissue in soft tissue reconstruction. The Sprague-Dawley rat was used as a model for subcutaneous implantation over a 20 week period and comparison made with two other porcine biomaterials (small intestinal submucosa and glycerol treated-ethylene oxide sterilised porcine dermis). Implants were scored histometrically on the degree of acute inflammation, chronic inflammation, fibrosis and stromal response. The vascularity and percentage composition of collagen within Permacol (TM) were assessed by stereology and seescan image analysis, respectively. In general. terms, Permacol (TM) was well tolerated as a subcutaneous implant, with only a minor chronic inflammatory response remaining after a 20 week period of implantation. There was evidence of collagen degradation during this period and vascular ingrowth into Permacol (TM) was limited. Permacol (TM) has the potential for a broad range of applications in plastic surgery, but may benefit from modification to promote a more rapid degree of vascularisation. (c) 2005 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 Mt Vernon Hosp, Restorat Appearance & Funct Trust, Northwood HA6 2RN, Middx, England.
   Northwick Pk Hosp & Clin Res Ctr, Northwick Pk Inst Med Res, Harrow HA1 3UJ, Middx, England.
RP Macleod, TM (reprint author), City Hosp Nottingham, Dept Plast Surg, Hucknall Rd, Nottingham NG5 1PB, England.
EM tmhighlander@yahoo.co.uk
CR DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Eppley BL, 2001, PLAST RECONSTR SURG, V107, P757, DOI 10.1097/00006534-200103000-00016
   Ghosh MM, 1997, ANN PLAS SURG, V39, P390, DOI 10.1097/00000637-199710000-00010
   GRIFFITHS RW, 1982, BRIT J PLAST SURG, V35, P519, DOI 10.1016/0007-1226(82)90056-X
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P151
   Krauss MC, 1999, SEMIN CUTAN MED SURG, V18, P119, DOI 10.1016/S1085-5629(99)80036-4
   LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001
   LOEWE O, 1913, MUNCHEN MED WCHNSCHR, V24, P1320
   Matouskova E, 1997, BRIT J DERMATOL, V136, P901
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   OLIVER RF, 1975, NATURE, V258, P537, DOI 10.1038/258537a0
   OLIVER RF, 1976, CLIN ORTHOP RELAT R, P291
   OLIVER RF, 1972, BRIT J EXP PATHOL, V53, P540
   SHAKESPEARE PG, 1980, LANCET, V1, P795
   *TISS SCI LAB, 1998, IMPL BIOM
   Wang HJ, 1997, J TRAUMA, V42, P177, DOI 10.1097/00005373-199702000-00002
NR 16
TC 68
Z9 74
U1 0
U2 11
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0007-1226
J9 BRIT J PLAST SURG
JI Br. J. Plast. Surg.
PD JUN
PY 2005
VL 58
IS 4
BP 518
EP 532
DI 10.1016/j.bjps.2004.12.012
PG 15
WC Surgery
SC Surgery
GA 933YB
UT WOS:000229667700017
PM 15897038
DA 2018-10-19
ER

PT J
AU Duan, SF
   Zhu, W
   Yu, L
   Ding, JD
AF Duan, SF
   Zhu, W
   Yu, L
   Ding, JD
TI Negative cooperative effect of cytotoxicity of a di-component initiating
   system for a novel injectable tissue engineering hydrogel
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE tissue engineering; injectable biomaterial; hydrogel; initiator;
   cytotoxicity
ID HYALURONIC-ACID; IN-VITRO; SCAFFOLDS; CELLS; CYTOCOMPATIBILITY;
   CARTILAGE
AB Chemically cross-linked hydrogels constitute a novel injectable tissue engineering material. At present, one of the key problems is to find an appropriate initiator. This study evaluated the cytotoxicity in vitro of a water-soluble redox initiating system consisting of ammonium persulfate (APS) and N, N, N', N'-tetramethylethylenediamine (TEMED). Gelation time of PEG diacrylate macromer in phosphate buffer saline solution was first adjusted to guarantee that the examined initiator concentrations are sufficiently high to trigger polymerization of macromers. NIH/3T3 fibroblasts were employed to examine cytotoxicity via MTT measurements and optical microscopic observations. It has been found that the combined APS/TEMED system exhibits negative cooperative effect, for the underlying cytotoxicity is even lower than that of APS or TEMED at certain concentrations.
C1 Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
CR Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Cai Q, 2002, BIOMATERIALS, V23, P4483, DOI 10.1016/S0142-9612(02)00168-0
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   FENG XD, 1988, MAKROMOL CHEM, V189, P77
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu J, 1997, CRYOBIOLOGY, V35, P1, DOI 10.1006/cryo.1997.2018
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   Mao JS, 2003, CHINESE SCI BULL, V48, P1807, DOI 10.1360/03wb0243
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   [吴林波 Wu Linbo], 2003, [功能高分子学报, Journal of Functional Polymer], V16, P91
   Zhang XZ, 2000, CHEM J CHINESE U, V21, P1309
NR 15
TC 18
Z9 18
U1 0
U2 23
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD JUN
PY 2005
VL 50
IS 11
BP 1093
EP 1096
DI 10.1360/982004-459
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 962DY
UT WOS:000231712400007
DA 2018-10-19
ER

PT J
AU Simunek, A
   Cierny, M
   Kopecka, D
   Kohout, A
   Bukac, J
   Vahalova, D
AF Simunek, A
   Cierny, M
   Kopecka, D
   Kohout, A
   Bukac, J
   Vahalova, D
TI The sinus lift with phycogenic bone substitute - A histomorphometric
   study
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE Algipore; apatite; dental implants; histomorphometry; osseointegration;
   sinus lift
ID NARROW SIZE RANGE; MAXILLARY SINUS; AUTOGENOUS BONE; FLOOR ELEVATION;
   POROUS HYDROXYAPATITE; TRICALCIUM PHOSPHATE; IMPLANT PLACEMENT; DENTAL
   IMPLANTS; AUGMENTATION; COMBINATION
AB Objectives: The aim of this histomorphometric prospective study was to ascertain the efficacy of phycogenic bone substitute in an augmented sinus. The process of graft healing, bone remodeling, and biomaterial replacement was examined.
   Material and methods: The phycogenic material (fluorohydroxyapatite) made from calcium-encrusted sea algae was used for the sinus lifts. Twenty-four procedures were carried out (one-stage and two-stage equally) and 45 titanium stepped-screw implants were placed. The patients were followed for 12-23 months. In intervals of 6, 9, 12, or 15 months after the sinus lift, 24 graft specimens were taken with a trephine bur. These specimens were examined histomorphometrically.
   Results: The grafting material was gradually resorbed and replaced by newly formed bone. Between the sixth and 15th month after the sinus lift, the percentage of newly formed bone grew linearly (from 15.5&PLUSMN; 9.6% to 40.8&PLUSMN; 15.3%) and the percentage of bone substitute decreased linearly (from 34.5&PLUSMN; 8.6% to 13&PLUSMN; 9.6%). After 15 months, the density of trabeculae in grafted bone corresponded to cancellous bone of good quality; however, the bone substitute was not completely resorbed during this period. No significant difference between the quality of the newly formed bone in the cases of the one- and two-stage sinus lifts was found.
   Conclusion: Sinus lift carried out with phycogenic bone substitute was shown to be an effective method with limited invasiveness and a high survival rate of implants (97.8%).
C1 Charles Univ, Fac Med Hradec Kralove, Dept Stomatol, Hradec Kralove, Czech Republic.
   Fac Hosp, Fingerland Dept Pathol, Hradec Kralove, Czech Republic.
   Charles Univ, Fac Med Hradec Kralove, Dept Med Biophys, Hradec Kralove, Czech Republic.
RP Simunek, A (reprint author), Teaching Hosp, Dept Stomatol, Hradec Kralove 50005, Czech Republic.
EM simunek_antonin@email.cz
RI Kopecka, Dana/I-7589-2017; Simunek, Antonin/I-8232-2017
OI Kopecka, Dana/0000-0001-8375-2635; Simunek, Antonin/0000-0003-0219-3208
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   BIENIEK KW, 1990, DTSCH ZAHNARZTEBLATT, V1, P24
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   DRAPER NR, 1996, APPL REGRESSION ANAL, P26
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Fanuscu MI, 2003, INT J ORAL MAX IMPL, V18, P667
   FEIFEL H, 1995, DTSCH Z MUND KIEFER, V19, P1
   HAESSLER D, 1999, DENT IMPLANTOLOGIE, V3, P216
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Jakse N, 2003, CLIN ORAL IMPLAN RES, V14, P578, DOI 10.1034/j.1600-0501.2003.00928.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   JENSEN OT, 1999, SINUS BONE GRAFT
   KASPERK C, 1988, DEUT ZAHNAERZTL Z, V43, P116
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   Lorenzoni M, 2000, INT J PERIODONT REST, V20, P255
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   McCarthy C, 2003, INT J ORAL MAX IMPL, V18, P377
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P279, DOI 10.1034/j.1600-0501.2001.012003279.x
   Schepers E, 1998, INT J ORAL MAX IMPL, V13, P655
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   SCHUMANN B, 1997, DENT IMPLANTOLOGIE, V1, P68
   Szabo G, 2001, INT J ORAL MAX IMPL, V16, P681
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Trisi P, 1999, CLIN ORAL IMPLAN RES, V10, P1
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
NR 36
TC 15
Z9 15
U1 0
U2 3
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2005
VL 16
IS 3
BP 342
EP 348
DI 10.1111/j.1600-0501.2005.01097.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 924FR
UT WOS:000228964900011
PM 15877755
DA 2018-10-19
ER

PT J
AU Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
AF Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
TI The evaluation of processed cancellous bovine bone as a bone graft
   substitute
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterials; bovine hydroxyapatite; composite bone grafting;
   histomorphometry; ovine condylar defect; xenografting; xenoimplant
ID ANIMAL-DERIVED BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS;
   BIO-OSS(R); IMPLANTS; DEFECTS; AUGMENTATION; HUMANS
AB Objective: To determine the ability of a novel bovine cancellous bone xenoimplant to act as an osteoconductive graft in an ovine femoral defect model. An autograft harvested from the xenoimplant site was placed in a contralateral limb defect for comparison.
   Material and methods: The xenoimplant used had been rendered immunologically inert by a novel defatting and deproteinating process. Following surgical implantation of cores into condylar cancellous bone defects, fluorochrome labels were administered to 12 sheep at 2 1/2, 4 1/2 and 8 weeks. Incorporation of the xenoimplants and autografts into the host bone was compared radiographically and histomorphometrically at 10 weeks.
   Results: Radiographically, the degree of osteointegration was comparable. Histomorphometric data, consisting of labelled surface (LS) estimates, confirmed osteoconductive properties of both the xenoimplants and autografts. Remodelling activity was greatest in the xenoimplants at 2 1/2, weeks. At 4 1/2 weeks, there was more activity in the autograft, but by 8 weeks they were performing similarly. Xenoimplant-LS estimates were comparable or greater than those of the autograft at all times.
   Conclusions: Processed bovine cancellous bone xenoimplants were osteoconductive in this model and show promise for development as a biomaterial in human and veterinary orthopaedic surgery.
C1 Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Palmerston North, New Zealand.
   Univ Waikato, Dept Chem, Hamilton, New Zealand.
   Univ Otago, Wellington Sch Med, Wellington, New Zealand.
   Adelaide Vet Specialist & Referral Ctr, Vet Specialist Orthopaed Serv, Adelaide, SA, Australia.
RP Worth, A (reprint author), Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Private Bag 11-222, Palmerston North, New Zealand.
EM A.J.Worth@massey.ac.nz
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR Anderson JC, 2001, AM J ARCHAEOL, V105, P371, DOI 10.2307/507312
   Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Eriksen E, 1994, BONE HISTOMORPHOMETR, P33
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   KERWIN SC, 1991, COMP CONT EDUC PRACT, V13, P1558
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   OHASHI H, 1994, J MATER SCI-MATER M, V5, P225, DOI 10.1007/BF00121093
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Salama R, 1973, J Bone Joint Surg Br, V55, P402
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Wolff J., 1986, LAW BONE REMODELLING
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 18
TC 19
Z9 23
U1 0
U2 4
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2005
VL 16
IS 3
BP 379
EP 386
DI 10.1111/j.1600-0501.2005.01113.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 924FR
UT WOS:000228964900015
PM 15877759
DA 2018-10-19
ER

PT J
AU Altman, D
   Zetterstrom, J
   Lopez, A
   Anzen, B
   Falconer, C
   Hjern, F
   Mellgren, A
AF Altman, D
   Zetterstrom, J
   Lopez, A
   Anzen, B
   Falconer, C
   Hjern, F
   Mellgren, A
TI Functional and anatomic outcome after transvaginal rectocele repair
   using collagen mesh: A prospective study
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY JUN 21-26, 2003
CL NEW ORLEANS, LA
SP Amer Soc Colon & Rectal Surg
ID PELVIC ORGAN PROLAPSE; RECTAL INTUSSUSCEPTION; CYSTOCELE REPAIR; SEXUAL
   FUNCTION; DERMAL GRAFT; FASCIA LATA; DEFECOGRAPHY; EVACUATION;
   PERITONEOGRAPHY; INCONTINENCE
AB PURPOSE: This study was designed to evaluate rectocele repair using collagen mesh. METHODS: 32 female patients underwent surgical repair using collagen mesh. Outcome was assessed in 29 patients and preoperative assessment included standardized questionnaire, clinical examination, and defecography. At the six-month follow-up, patients answered a standardized questionnaire and underwent clinical examination. At the 12-month follow-up, patients answered a standardized questionnaire, underwent clinical examination, and defecography. RESULTS: Preoperatively, 26 patients had a Stage 11 and 3 patients had a Stage III rectocele. At the 6-month follow-up, five patients had rectocele ! Stage II (P < 0.001) and at the 12-month follow-up, seven patients had rectocele ! Stage 11 (P < 0.001) at clinical examination. At the preoperative defecography, all patients presented a rectocele. At the 12-month defecography, 14 patients had no rectocele (P < 0.001) and 15 had a rectocele. At the six-month follow-up, there was a significant decrease in rectal emptying difficulties, need of digital support of the posterior vaginal wall at defecation, and defecation frequency. At the 12-month follow-up, symptom improvement remained, but was less pronounced. CONCLUSIONS: Rectocele repair using collagen mesh improved anatomic support, but there is a substantial risk for recurrence with unsatisfactory anatomic and functional outcome one year after surgery. Rectocele repair using mesh was not associated with an increased risk of dyspareunia. Rectocele repair using biomaterial mesh reinforcement needs further evaluation before adopted into clinical practice.
C1 Danderyd Hosp, Karolinska Inst, Pelvic Floor Ctr, Div Obstet & Gynecol, Stockholm, Sweden.
   Danderyd Hosp, Karolinska Inst, Pelvic Floor Ctr, Div Surg, Stockholm, Sweden.
   Univ Minnesota, Div Colon & Rectal Surg, Minneapolis, MN USA.
RP Altman, D (reprint author), Danderyd Hosp, Dept Obstet & Gynecol, S-18288 Stockholm, Sweden.
EM damel.altman@ds.se
CR Altomare DF, 2002, DIS COLON RECTUM, V45, P1549, DOI 10.1097/01.DCR.0000034050.16880.12
   ARNOLD MW, 1990, DIS COLON RECTUM, V33, P684, DOI 10.1007/BF02150745
   Ayabaca SM, 2002, DIS COLON RECTUM, V45, P63, DOI 10.1007/s10350-004-6115-2
   Bremmer S, 1997, RADIOLOGY, V202, P373, DOI 10.1148/radiology.202.2.9015060
   Bremmer S, 1997, ACTA RADIOL, V38, P578
   Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0
   Cruikshank SH, 1999, AM J OBSTET GYNECOL, V180, P859, DOI 10.1016/S0002-9378(99)70656-3
   Cundiff GW, 1998, AM J OBSTET GYNECOL, V179, P1451, DOI 10.1016/S0002-9378(98)70009-2
   FitzGerald MP, 1999, AM J OBSTET GYNECOL, V181, P1339, DOI 10.1016/S0002-9378(99)70374-1
   Fitzgerald MP, 1999, BJU INT, V84, P785
   FRANCIS WJA, 1961, J OBSTET GYN BR COMM, V68, P1
   GOEI R, 1990, RADIOLOGY, V174, P124, DOI 10.1148/radiology.174.1.2294538
   Groutz A, 2001, UROLOGY, V58, P179, DOI 10.1016/S0090-4295(01)01177-3
   Ho YH, 1998, DIS COLON RECTUM, V41, P354, DOI 10.1007/BF02237491
   Iglesia C B, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P105, DOI 10.1007/BF02764826
   Kahn M A, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P37, DOI 10.1007/BF01900540
   Kahn MA, 1997, BRIT J OBSTET GYNAEC, V104, P82, DOI 10.1111/j.1471-0528.1997.tb10654.x
   KELVIN FM, 1992, RADIOLOGY, V184, P547, DOI 10.1148/radiology.184.2.1620863
   Kenton K, 1999, AM J OBSTET GYNECOL, V181, P1360, DOI 10.1016/S0002-9378(99)70406-0
   Kobashi KC, 2000, UROLOGY, V56, P9, DOI 10.1016/S0090-4295(00)00706-8
   Kohli N, 2001, Curr Womens Health Rep, V1, P53
   Kohli N, 2003, INT UROGYNECOL J PEL, V14, P146, DOI 10.1007/s00192-002-1013-4
   Lopez A, 2002, INT UROGYNECOL J PEL, V13, P22, DOI 10.1007/s001920200005
   Lopez A, 2001, INT UROGYNECOL J PEL, V12, P97, DOI 10.1007/PL00004032
   MELLGREN A, 1995, DIS COLON RECTUM, V38, P7, DOI 10.1007/BF02053850
   Miklos JR, 2002, INT UROGYNECOL J PEL, V13, P44, DOI 10.1007/s001920200009
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   Osterberg A, 1996, SCAND J GASTROENTERO, V31, P575, DOI 10.3109/00365529609009130
   PACKER MC, 1993, ANN R COLL SURG ENGL, V75, P193
   Patsner B, 2000, OBSTET GYNECOL, V95, P1029, DOI 10.1016/S0029-7844(99)00559-1
   RICHARDSON AC, 1993, CLIN OBSTET GYNECOL, V36, P976, DOI 10.1097/00003081-199312000-00022
   Rogers GR, 2001, INT UROGYNECOL J PEL, V12, P361, DOI 10.1007/s001920170012
   SHORVON PJ, 1989, GUT, V30, P1737, DOI 10.1136/gut.30.12.1737
   SIPROUDHIS L, 1993, DIS COLON RECTUM, V36, P1030, DOI 10.1007/BF02047295
   Sloots CEJ, 2003, INT J COLORECTAL DIS, V18, P342, DOI 10.1007/s00384-002-0469-5
   Stojkovic S G, 2003, Colorectal Dis, V5, P169, DOI 10.1046/j.1463-1318.2003.00427.x
   van Dam JH, 2000, INT J COLORECTAL DIS, V15, P54, DOI 10.1007/s003840050008
   Watson SJ, 1996, J AM COLL SURGEONS, V183, P257
NR 38
TC 32
Z9 37
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD JUN
PY 2005
VL 48
IS 6
BP 1233
EP 1241
DI 10.1007/s10350-005-0023-y
PG 9
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 930KY
UT WOS:000229415900019
PM 15868220
DA 2018-10-19
ER

PT J
AU Wunsch, L
   Ehlers, EM
   Russlies, M
AF Wunsch, L
   Ehlers, EM
   Russlies, M
TI Matrix testing for urothelial tissue engineering
SO EUROPEAN JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
DE urothelium; urothelial tissue engineering; mechanical matrix testing
ID ACELLULAR MATRIX; RECONSTRUCTION; REGENERATION
AB Introduction: Surgical reconstruction of the bladder is associated with many well-known complications. Tissue engineering is under discussion as a potential therapeutic strategy and many of the proposed benefits are of special interest for children. Biomaterials play a key role in tissue engineering. Many materials have been proposed for the experimental reconstruction of the bladder and urethra. They determine the biological and mechanical characteristics of the reconstructed tissues. Most publications focus on a single material. in order to identify the most suitable biomaterial it was the aim of this study to compare biological and mechanical features of different biomaterials seeded with urothelial cells in vitro. Materials and Methods: Commercially available biomaterials (Biogide((R)), Ethisorb((R)), Lyoplant((R)), SIS(R), Vicryl((R)), Xenoderm((R))) of biologic or synthetic origin were seeded with urothelial cells. Cell-matrix constructs were cultured and investigated by scanning electron microscopy for surface structure and cell morphology. They were also subjected to extension until failure and the force required was reported as f(max). Values obtained and curve shape were compared to specimens of bladder mucosa and submucosa. Results: Cell adhesion and morphology showed marked differences between materials. Cell shape varied from single spherical cells to confluent layers of flat urothelium. f(max) ranged from 0.02 N to 48.86 N for tested materials and 1.19 N for native bladder mucosa/submucosa. Discussion: The materials showed marked differences in biological and mechanical features in vitro. Cells cultured on biogenic matrices were more similar to native urothelium. Most of the tested materials showed different curve shapes and higher f(max) values than native bladder mucosa.
C1 Univ Lubeck, Dept Pediat Surg, D-23538 Lubeck, Germany.
   Univ Lubeck, Dept Anat, D-23538 Lubeck, Germany.
   Univ Lubeck, Dept Orthoped, D-23538 Lubeck, Germany.
RP Wunsch, L (reprint author), Univ Lubeck, Dept Pediat Surg, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
EM wuensch@medinf.mu-luebeck.de
CR ATALA A, 2002, CAMPBELLS UROLOGY, P2595
   Chen F, 2000, WORLD J UROL, V18, P67, DOI 10.1007/s003450050012
   Cross WR, 2003, BJU INT, V92, P165, DOI 10.1046/j.1464-410X.2003.04280.x
   Dahms SE, 1998, BRIT J UROL, V82, P411
   EWALT DH, 1992, J UROLOGY, V148, P544, DOI 10.1016/S0022-5347(17)36650-8
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Kim T., 2000, ADV STUD CONT MATH, V2, P9
   OBERPENNING FO, 1999, NAT BIOTECHNOL, V17, P2
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
NR 10
TC 14
Z9 16
U1 0
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0939-7248
J9 EUR J PEDIATR SURG
JI Eur. J. Pediatr. Surg.
PD JUN
PY 2005
VL 15
IS 3
BP 164
EP 169
DI 10.1055/s-2004-830356
PG 6
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 945XC
UT WOS:000230535100004
PM 15999308
DA 2018-10-19
ER

PT J
AU Tonello, C
   Vindigni, V
   Zavan, B
   Abatangelo, S
   Abatangelo, G
   Brun, P
   Cortivo, R
AF Tonello, C
   Vindigni, V
   Zavan, B
   Abatangelo, S
   Abatangelo, G
   Brun, P
   Cortivo, R
TI In vitro reconstruction of an endothelialized skin substitute provided
   with a microcapillary network using biopolymer scaffolds
SO FASEB JOURNAL
LA English
DT Article
DE endothelial cells; skin substitute; angiogenesis; hyaluronic acid;
   tissue engineering
ID CAPILLARY-LIKE NETWORK; HYALURONIC-ACID; HUMAN WOUNDS; CELLS; TISSUE;
   EQUIVALENT; KERATINOCYTES; REPLACEMENT; GRAFTS; DERMIS
AB SSuccessful in vitro reconstruction of skin requires the inclusion of several cell types that give rise in coculture to the specific elements present in native skin, and the appropriate scaffolding structure to house and support these cells. In addition to the two main structural components, epidermis and dermis, one critical apparatus of the skin is a capillary network that guarantees adequate perfusion of nutrients and oxygen. The aim of the present study was to develop an in vitro coculture system that assumed the human dermal-epidermal architecture and included a microcapillary network in a three-dimensional biomaterial that guaranteed ease of handling in a clinical setting. Endothelialized skin (ES) was prepared by coculturing three human cell types: keratinocytes, fibroblasts, and endothelial cells, obtained from human full-thickness skin samples, in scaffolds produced from modified hyaluronic acid. Results were evaluated by histological and immunohistochemical analyses at different time points. In vitro, engineered skin obtained with this composite culture developed into a well-differentiated upper layer of stratified keratinocytes lining a dermal-like structure, in which fibroblasts, extracellular matrix and a microvascular network were present. Furthermore, the biodegradable fabric produced from hyaluronic acid and used as the scaffolding support for this in vitro constructed skin graft greatly facilitated handling in the perioperative period.
C1 Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
RP Abatangelo, G (reprint author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Via G Colombo 3, I-35100 Padua, Italy.
EM g.abatangelo@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Black AF, 1998, FASEB J, V12, P1331
   BRIGGAMAN RA, 1968, J INVEST DERMATOL, V514, P54
   Brun P, 2000, Ostomy Wound Manage, V46, P44
   Caravaggi C, 2003, DIABETES CARE, V26, P2853, DOI 10.2337/diacare.26.10.2853
   CUONO CB, 1987, PLAST RECONSTR SURG, V80, P626, DOI 10.1097/00006534-198710000-00029
   EADY RA, 1994, J INVEST DERMATOL, V103, P13
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1
   Giuggioli D, 2003, RHEUMATOLOGY, V42, P694, DOI 10.1093/rheumatology/keg106
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   Griffiths M, 2004, TISSUE ENG, V10, P1180, DOI 10.1089/ten.2004.10.1180
   Grigolo B, 2003, Chir Organi Mov, V88, P351
   Guerret S, 2003, WOUND REPAIR REGEN, V11, P35, DOI 10.1046/j.1524-475X.2003.11107.x
   Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X
   HANSBROUGH JF, 1994, SURGERY, V115, P633
   Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Lam PK, 1999, J TRAUMA, V47, P918, DOI 10.1097/00005373-199911000-00017
   Lisignoli G, 2003, Chir Organi Mov, V88, P363
   Lobmann R, 2003, J DIABETES COMPLICAT, V17, P199, DOI 10.1016/S1056-8727(02)00218-0
   MURPHY JF, 2005, FASEB J ONLINE  0107
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205
   SCALA C, 1992, J HISTOCHEM CYTOCHEM, V40, P1799, DOI 10.1177/40.11.1431065
   Sehchner J. S., 2003, FASEB J, V17, P2250
   Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   TRAMPEZINSKI S, 2004, EXP DERMATOL, V13, P98
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Weber E, 2004, LYMPHOLOGY, V37, P15
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 36
TC 44
Z9 45
U1 1
U2 6
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JUN
PY 2005
VL 19
IS 8
BP 1546
EP +
DI 10.1096/fj.05-3804fje
PG 14
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 941IF
UT WOS:000230207800010
PM 15972294
DA 2018-10-19
ER

PT J
AU Kilian, O
   Alt, V
   Heiss, C
   Jonuleit, T
   Dingeldein, E
   Flesch, I
   Fidorra, U
   Wenisch, S
   Schnettler, R
AF Kilian, O
   Alt, V
   Heiss, C
   Jonuleit, T
   Dingeldein, E
   Flesch, I
   Fidorra, U
   Wenisch, S
   Schnettler, R
TI New blood vessel formation and expression of VEGF receptors after
   implantation of platelet growth factor-enriched biodegradable
   nanocrystalline hydroxyapatite
SO GROWTH FACTORS
LA English
DT Article
DE angiogenesis; platelet factors; VEGF; VEGF receptors; growth factor;
   biomaterial
ID VASCULAR-PERMEABILITY FACTOR; ENDOTHELIAL-CELLS; FLT-1; BONE;
   DIFFERENTIATION; ANGIOGENESIS; ACTIVATION; MECHANISMS; VASCULOTROPIN;
   LOCALIZATION
AB Vascular endothelial growth factor (VEGF) plays a key role for the interaction of osteoblasts and endothelial cells and, therefore, is an important factor for the osteointegration of bone substitutes. The aim of the current work was to study the effects of platelet growth factors (PLF) on new blood vessel formation and VEGF-receptors expression pattern in bone defects filled with nanocrystalline hydroxyapatite (HA) paste in miniature-pigs. Conventional histology, RT-PCR for VEGF and receptors mRNA, Western blot analysis, immunohistochemical staining and quantitative assessment of newly formed vessels was performed. HA enriched with platelet growth factor (HA/PLF+) led to an up-regulation of VEGF-R1 synthesis, a slightly enhanced number of newly formed vessels with higher sprouting activity compared with HA without PLF (HA/PLF-) filling defects. These observation are most likely attributable to a stimulating effect of TGF-beta from the platelet factor on VEGF expression in osteoblasts.
C1 Univ Giessen, Dept Trauma Surg, D-35392 Giessen, Germany.
   CellMed AG, Alzenau, Germany.
   Coripharm GmbH, Obernburg, Germany.
   Univ Tubingen, Dept Trauma Surg, Tubingen, Germany.
RP Kilian, O (reprint author), Univ Giessen, Dept Trauma Surg, Rudolf Buchheim St 7, D-35392 Giessen, Germany.
EM olaf.kilian@chiru.med.uni-giessen.de
CR ANTHONY FW, 1994, PLACENTA, V15, P567
   Augustin HG, 2001, CIRC RES, V89, P645, DOI 10.1161/res.89.8.645
   Boonyaprakob U, 2003, REPRODUCTION, V126, P393, DOI 10.1530/rep.0.1260393
   Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629
   CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Deindl E, 2003, PHYSIOL RES, V52, P147
   Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
   Fang JM, 1997, ANAT EMBRYOL, V196, P349, DOI 10.1007/s004290050104
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Fiallo P, 2002, AM J TROP MED HYG, V66, P180, DOI 10.4269/ajtmh.2002.66.180
   Gabler C, 1999, MOL REPROD DEV, V53, P376, DOI 10.1002/(SICI)1098-2795(199908)53:4<376::AID-MRD2>3.0.CO;2-Z
   Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313
   Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   KLEINHEINZ J, 2002, MUND KIEFER GESICHTS, V3, P175
   Koolwijk Pieter, 2001, Angiogenesis, V4, P53, DOI 10.1023/A:1016637700638
   LEI J, 1998, PLACENTA, V15, P557
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   MAYRWOHLFART U, 2002, BONE, V32, P472
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   Mitola S, 1997, BLOOD, V90, P1365
   Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013
   PLOUET J, 1990, J BIOL CHEM, V265, P22071
   Poulaki V, 2003, J CLIN ENDOCR METAB, V88, P5392, DOI 10.1210/jc.2003-030389
   Pufe T, 2002, CELL TISSUE RES, V309, P387, DOI 10.1007/s00441-002-0605-0
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   RUBANYI GM, 1994, PHARMACOL REV, V46, P325
   Saadeh PB, 2000, ENDOCRINOLOGY, V141, P2075, DOI 10.1210/en.141.6.2075
   Saadeh PB, 1999, AM J PHYSIOL, V277, P628
   Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785
   SHEN H, 1993, BLOOD, V81, P2767
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Tisher E, 1991, J BIOL CHEM, V266, P11947
   Tolnay E, 1998, VIRCHOWS ARCH, V432, P61, DOI 10.1007/s004280050135
   TOMBRANTINK J, 2004, BIOCHEM BIOPH RES CO, V16, P573
   Uchida S, 2003, BONE, V32, P491, DOI 10.1016/S8756-3282(03)00053-X
   VAILLETTE CJ, 2004, BONE, V34, P288
   VAISMAN N, 1990, J BIOL CHEM, V265, P19461
   Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493
   WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988
   Wang DG, 1999, CANCER RES, V59, P1464
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Welter H, 2003, EXP CLIN ENDOCR DIAB, V111, P33, DOI 10.1055/s-2003-37498
   Wilting J, 1996, DEV BIOL, V176, P76, DOI 10.1006/dbio.1996.9993
NR 51
TC 19
Z9 19
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0897-7194
J9 GROWTH FACTORS
JI Growth Factors
PD JUN
PY 2005
VL 23
IS 2
BP 125
EP 133
DI 10.1080/08977190500126306
PG 9
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 954CR
UT WOS:000231132200006
PM 16019434
DA 2018-10-19
ER

PT J
AU Kaplan, M
   Baysal, K
AF Kaplan, M
   Baysal, K
TI In vitro toxicity test of ethyl 2-cyanoacrylate, a tissue adhesive used
   in cardiovascular surgery, by fibroblast cell culture method
SO HEART SURGERY FORUM
LA English
DT Article
ID CYANOACRYLATE; CYTOTOXICITY; BONE
AB Background: The aim of this study was to evaluate the cytotoxicity of cyanoacrylate polymers ( ethyl 2-cyanoacrylate) by an elution test system. In such systems, the material is extracted with a cell culture medium, which is subsequently added onto cultured cells, resulting in an indirect contact between the biomaterial and cells.
   Methods: A cell line commonly utilized for cytotoxicity experiments; L929 mouse fibroblasts were used in this study. The effects of extract dilutions on cells were evaluated by two experiments: ( a) The cells were suspended and seeded in a medium containing the extract, followed by a short incubation to observe the effects on cell attachment; (b) cells were seeded in a normal medium. Following cell attachment, this was replaced with a medium containing the extract and long-term effects on cell proliferation were measured. The cytotoxicity was quantified using a cell viability assay, well established for use in the evaluation of cell - biomaterial interactions.
   Results: These results indicate that, in the test system utilized, a tenfold dilution of the extract results in an similar to 10% decrease in cells; this increases to between 30% and 45% in a 1: 1 dilution. When a large number of cells (3000/well) were used, proliferation of cells overcame the cytotoxic effect and consistent results could not be observed.
   Conclusions: In this study, the observed outcomes follow a similar trend on cell attachment and proliferation with acute effects ( 4 hours incubation) of the extracts on the cells, producing slightly higher toxicity. Our findings are parallel with the literature findings.
C1 Siyami Ersek Thorac & Cardiovasc Surg Training &, Dept Cardiovasc Surg, Istanbul, Turkey.
   Sci & Tech Res Council Turkey, Marmara Res Ctr, Res Inst Genet Engn & Biotechnol, Istanbul, Turkey.
RP Kaplan, M (reprint author), 67 Ada,Kardelen 4-4,D-11, TR-34758 Istanbul, Turkey.
EM mehmetkaplan@superonline.com
CR APPLEBAUM JS, 1993, ANN EMERG MED, V22, P1190, DOI 10.1016/S0196-0644(05)80988-6
   BRAUER GM, 1979, J BIOMED MATER RES, V13, P593, DOI 10.1002/jbm.820130406
   Cenni E, 1999, TOXICOL IN VITRO, V13, P801, DOI 10.1016/S0887-2333(99)00058-2
   CIAPETTI G, 1994, BIOMATERIALS, V15, P92, DOI 10.1016/0142-9612(94)90256-9
   DEBLANCO LP, 1994, ENDOD DENT TRAUMATOL, V10, P15
   Demirtas MA, 1998, ANN THORAC SURG, V66, P304
   Demirtas MM, 1999, ASIAN CARDIOVASC THO, V7, P195
   EASTMAN DP, 1998, J HEART VALVE DIS, V7, P888
   Evans CE, 1999, J HAND SURG-BRIT EUR, V24B, P658, DOI 10.1054/jhsb.1999.0279
   Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027
   Horsley WS, 1997, ANN THORAC SURG, V63, P1492, DOI 10.1016/S0003-4975(97)00115-X
   Kaplan M, 2004, EUR J DRUG METAB PH, V29, P77, DOI 10.1007/BF03190579
   Kaplan M, 2004, EUR J CARDIO-THORAC, V25, P167, DOI 10.1016/j.ejcts.2003.11.016
   LEAHEY AB, 1993, OPHTHALMOLOGY, V100, P173
   LEONARD F., 1967, J BIOMED MAT RES, V1, P3, DOI 10.1002/jbm.820010103
   Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Thumwanit V, 1999, AUST DENT J, V44, P248, DOI 10.1111/j.1834-7819.1999.tb00228.x
   WEBER SC, 1984, CLIN ORTHOP RELAT R, P249
   WERKER AM, 1997, ANN THORAC SURG, V63, P122
   YAVUZ SS, 2003, TURKISH THORAC CARDI, V11, P141
NR 21
TC 18
Z9 19
U1 0
U2 6
PU FORUM MULTIMEDIA PUBLISHING, LLC
PI CHARLOTTESVILLE
PA 375 GREENBRIER DR, CHARLOTTESVILLE, VA 22901 USA
SN 1098-3511
J9 HEART SURG FORUM
JI Heart Surg. Forum
PD JUN
PY 2005
VL 8
IS 3
BP E169
EP E172
DI 10.1532/HSF98.20041126
PG 4
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA 984WD
UT WOS:000233336400011
PM 15936999
DA 2018-10-19
ER

PT J
AU Crawford, A
   Frazer, A
   Fraser, S
   Dickinson, S
   Sims, T
   Hollander, AP
   Hatton, PV
AF Crawford, A
   Frazer, A
   Fraser, S
   Dickinson, S
   Sims, T
   Hollander, AP
   Hatton, PV
TI Deposition of collagen I, II and VI in tissue-engineered cartilage
   constructs: Effect of biomaterial morphology
SO INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
LA English
DT Meeting Abstract
CT Autumn Meeting of the British-Society-for-Matrix-Biology
CY SEP 13-14, 2004
CL Univ Bristol, Bristol, ENGLAND
SP Kendro, Fisher Sci, Thermo, SciQuip, Genzyme, Invitrogen, Leica, Geistlich, R&D Syst, Cellon SA, Verigen, Promega, SLS, Sigma Aldrich, Blackwell Med & Amaxa Biosyst
HO Univ Bristol
C1 Univ Sheffield, Sheffield, S Yorkshire, England.
   Univ Bristol, Bristol, Avon, England.
CR CRAWFORD A, 2004, BIOPOLYMER METHODS T
NR 1
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0959-9673
J9 INT J EXP PATHOL
JI Int. J. Exp. Pathol.
PD JUN
PY 2005
VL 86
IS 3
BP A44
EP A45
PG 2
WC Pathology
SC Pathology
GA 929UM
UT WOS:000229372100069
DA 2018-10-19
ER

PT J
AU Yun, AG
   Padgett, D
   Pellicci, P
   Dorr, LD
AF Yun, AG
   Padgett, D
   Pellicci, P
   Dorr, LD
TI Constrained acetabular liners - Mechanisms of failure
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE instability; constrained liner; acetabulum; impingement; failure
ID TOTAL HIP-ARTHROPLASTY; DISLOCATION; PROSTHESIS; COMPONENT; RECURRENT;
   SALVAGE
AB Although constrained acetabular liners have been successfully used for the treatment of recurrent hip instability, their usage has led to a growing number of associated complications. Twenty-seven patients (29 hips) who experienced failure of the constrained acetabular construct were retrospectively reviewed to define mechanisms of failure. Of these patients, 8 had a recurrent failure of another constrained liner. The 4 modes of failure were failure of fixation to the pelvis, liner dissociation, biomaterial failure, and femoral head dislocation. As constrained liners are highly subject to mechanical overload, the risk of failure can be minimized by reducing prosthetic impingement and avoiding technical errors. (c) 2005 Elsevier Inc. All rights reserved.
C1 Arthritis Inst, Inglewood, CA 90301 USA.
   Hosp Special Surg, New York, NY 10021 USA.
RP Yun, AG (reprint author), Arthritis Inst, 501 E Hardy St,3rd Floor, Inglewood, CA 90301 USA.
CR Anderson M J, 1994, J Arthroplasty, V9, P17, DOI 10.1016/0883-5403(94)90133-3
   Berry D J, 2001, Instr Course Lect, V50, P265
   BONNER KF, 2002, J BONE JOINT SURG AM, V9, P1587
   Callaghan JJ, 2001, CLIN ORTHOP RELAT R, P157
   Cobb TK, 1996, J BONE JOINT SURG AM, V78A, P80, DOI 10.2106/00004623-199601000-00011
   FRASER GA, 1981, J BONE JOINT SURG BR, V63, P552
   Goetz DD, 1998, J BONE JOINT SURG AM, V80A, P502, DOI 10.2106/00004623-199804000-00006
   Goetz DD, 1998, CLIN ORTHOP RELAT R, P171
   Kaper BP, 1998, J BONE JOINT SURG AM, V80A, P561, DOI 10.2106/00004623-199804000-00013
   Kaplan S J, 1987, J Arthroplasty, V2, P119, DOI 10.1016/S0883-5403(87)80018-9
   Lavigne MJF, 2001, J ARTHROPLASTY, V16, P13, DOI 10.1054/arth.2001.28362
   MELDRUM RD, 2001, J ARTHROPLASTY, V6, P748
   Shapiro G S, 2001, Instr Course Lect, V50, P281
NR 13
TC 29
Z9 31
U1 1
U2 3
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JUN
PY 2005
VL 20
IS 4
BP 536
EP 541
DI 10.1016/j.arth.2004.12.054
PG 6
WC Orthopedics
SC Orthopedics
GA 938YM
UT WOS:000230039300020
PM 16124973
DA 2018-10-19
ER

PT J
AU Hylton, DM
   Shalaby, SW
   Latour, RA
AF Hylton, DM
   Shalaby, SW
   Latour, RA
TI Direct correlation between adsorption-induced changes in protein
   structure and platelet adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE platelet adhesion; circular dichroism; protein adsorption; blood
   compatibility
ID CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE; CONFORMATIONAL
   STATES; ELLIPSOMETRY; SURFACES; PLASMA; FIBRINOGEN; SPECTRA; ENZYMES;
   LAYERS
AB It is widely recognized that adsorbed proteins on biomaterial surfaces tend to initiate thrombus formation, although the specific mechanisms involved are still not well understood. In attempts to decrease the conformational change of adsorbed proteins, surface treatments that reduce surface hydrophobicity have been considered, such as the sulfonation of low-density polyethylene and isotactic polypropylene. The objectives of this present research were to study how changes in surface chemistry influence the degree of conformational change of adsorbing proteins and to investigate the correlation between the change in adsorbed protein structure and platelet response. Adsorbed porcine serum albumin and porcine fibrinogen were used as the model proteins for determining the effects of sulfonation on protein conformational change. Circular dichroism spectroscopy studies showed that the proteins were less altered structurally on the sulfonated surfaces. Platelet adhesion studies were used to correlate the number of adhered platelets with the amount of conformational change in adsorbed proteins on the polymer surface. The results of these studies show a linear correlation between platelet adhesion and the degree of adsorption-induced protein conformational change. These findings suggest that the degree of protein conformational change after adsorption is a dominant mechanism governing platelet interactions with biomaterial surfaces. &COPY; 2005 Wiley Periodicals, Inc.
C1 Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
   Poly Med Inc, Anderson, SC 29625 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
EM LatourR@clemson.edu
CR ABBOTT WM, 1998, VASCULAR GRAFTS CHAR, P903
   Arwin H, 2000, THIN SOLID FILMS, V377, P48, DOI 10.1016/S0040-6090(00)01385-7
   Arwin H, 1998, THIN SOLID FILMS, V313, P764, DOI 10.1016/S0040-6090(97)00993-0
   BLONDELLE SE, 1995, BIOPHYS J, V68, P351, DOI 10.1016/S0006-3495(95)80194-3
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   ERNST CB, 2001, CURRENT THERAPY VASC, P944
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Kosa T, 1998, PHARMACEUT RES, V15, P449, DOI 10.1023/A:1011932516717
   Lodish H, 2000, MOL CELL BIOL, P1084
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V168, P247, DOI 10.1006/jcis.1994.1416
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303
   Malmsten M, 1997, J COLLOID INTERF SCI, V193, P88, DOI 10.1006/jcis.1997.5039
   MALMSTEN M, 1995, COLLOID SURFACE B, V3, P297
   MCMILLIN CR, 1974, J COLLOID INTERF SCI, V48, P345, DOI 10.1016/0021-9797(74)90170-2
   MINAR E, 1989, RADIOLOGY, V170, P767, DOI 10.1148/radiology.170.3.2521736
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PAOLETTI R, 1995, ARCH GERONTOL GERIAT, V20, P43, DOI 10.1016/0167-4943(94)00604-6
   SANDWICK RK, 1988, J COLLOID INTERF SCI, V121, P1, DOI 10.1016/0021-9797(88)90402-X
   SANDWICK RK, 1987, J COLLOID INTERF SCI, V115, P130, DOI 10.1016/0021-9797(87)90017-8
   Sonoda H, 2001, J BIOMED MATER RES, V55, P266, DOI 10.1002/1097-4636(20010605)55:3<266::AID-JBM1014>3.0.CO;2-C
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   Sreerama N, 1999, PROTEIN SCI, V8, P370
   Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420
   SREERAMA N, 1994, J MOL BIOL, V242, P497
   SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   WILLIAMS DF, 1971, BIOMED ENG, V6, P205
NR 28
TC 77
Z9 79
U1 1
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2005
VL 73A
IS 3
BP 349
EP 358
DI 10.1002/jbm.a.30295
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 925ZY
UT WOS:000229093600011
PM 15834930
DA 2018-10-19
ER

PT J
AU Patel, JD
   Iwasaki, Y
   Ishihara, K
   Anderson, JM
AF Patel, JD
   Iwasaki, Y
   Ishihara, K
   Anderson, JM
TI Phospholipid polymer surfaces reduce bacteria and leukocyte adhesion
   under dynamic flow conditions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE infection; shear stress; phospholipid polymers; Staphylococcus
   epidermidis; leukocytes
ID PROTEIN ADSORPTION; STAPHYLOCOCCUS-EPIDERMIDIS; SHEAR-STRESS;
   BIOMATERIAL INTERACTIONS; POLAR GROUP; BLOOD; HEMOCOMPATIBILITY;
   INFECTIONS; ACTIVATION; CHEMISTRY
AB Persistence of infection can occur when the host immune response is compromised because of the presence of a foreign implant. Surface modification of biomaterials with phospholipid polymers may enhance biocompatibility and reduce incidence of infection by impeding bacterial and leukocyte adhesion. A rotating disk model, which generates shear stress from 0 to 18 dynes/cm(2), was used to characterize adhesion of neutrophils, monocytes, and bacteria in phosphate-buffered saline (PBS) or 25%, human serum on polyethylene terephthalate surfaces coated with a phospholipid polymer, poly[&omega;-methacryloyloxyalkyl phosphorylcholine (MAPC)-co-n-butyl methacrylate (BMA)]. The material designated PMB30 contains a methylene chain length, (CH2)(n), of n = 2, whereas PMHB30 contains a chain length of n = 6. In PBS, bacterial adhesion was shear stress dependent with the lowest bacterial density observed on PMB30. However, the presence of serum proteins eliminated shear stress and surface chemistry effects in addition to bacterial adhesion reduced to &LT; 10% of adhesion in PBS. Trends for leukocyte adhesion in serum demonstrated shear dependence with PMB30 exhibiting the lowest cell density throughout the range of shear stresses. In conclusion, modification of the polyethylene terephthalate surfaces with phospholipid polymers resulted in reduced bacterial and leukocyte adhesion. Furthermore, shortening the methylene chain length of the MAPC copolymer most effectively reduced adhesion. &COPY; 2005 Wiley Periodicals, Inc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Iwasaki, Y (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Urugadai, Tokyo 1010062, Japan.
EM yasu.org@tmd.ac.jp
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P597, DOI 10.1128/AAC.33.5.597
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   Gong YK, 2005, J BIOMED MATER RES A, V72A, P1, DOI 10.1002/jba.a.30135
   GRAY ED, 1984, LANCET, V1, P365
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Higashi JM, 1999, HDB BIOMATERIALS EVA, P493
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwasaki Y, 1997, J COLLOID INTERF SCI, V192, P432, DOI 10.1006/jcis.1997.5047
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   Iwasaki Y, 2001, J BIOMED MATER RES, V57, P72, DOI 10.1002/1097-4636(200110)57:1<72::AID-JBM1143>3.0.CO;2-G
   Iwasaki Y, 1999, J BIOMAT SCI-POLYM E, V10, P513, DOI 10.1163/156856299X00450
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P151, DOI 10.1163/156856296X00228
   IWASAKI Y, 1994, J BIOMAT SCI-POLYM E, V6, P447, DOI 10.1163/156856294X00437
   KLEINSTREUER C, 1997, ENG FLUID DYNAMICS
   Levich V. G., 1962, PHYSICOCHEMICAL HYDR
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Sapatnekar S, 1997, J BIOMED MATER RES, V35, P409, DOI 10.1002/(SICI)1097-4636(19970615)35:4<409::AID-JBM1>3.0.CO;2-L
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Shive MS, 2002, J BIOMED MATER RES, V60, P148, DOI 10.1002/jbm.10035
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TANAKA S, 1994, MACROMOL RAPID COMM, V15, P319, DOI 10.1002/marc.1994.030150404
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   VONEIFF C, 2002, LANCET INFECT DIS, V3, P677
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 40
TC 39
Z9 43
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2005
VL 73A
IS 3
BP 359
EP 366
DI 10.1002/jbm.a.30302
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 925ZY
UT WOS:000229093600012
PM 15800952
DA 2018-10-19
ER

PT J
AU Zhang, HP
   Ruan, JM
   Zhou, ZC
   Li, YJ
AF Zhang, HP
   Ruan, JM
   Zhou, ZC
   Li, YJ
TI Preparation of monomer of degradable biomaterial poly (L-lactide)
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article
DE lactide; polylactide; purification; polymerization
ID POLYMERIZATION; POLYLACTONES; IMPLANTS
AB L-lactide was prepared from L-lactic acid with stannous octoate as the catalyst. The effects of reaction temperature and pressure on the ingredient of crude lactide were investigated. The results show that the mass fraction of meso-lactide increases with the increasing reaction temperature. Crude lactide containing 85.4% L-lactide is obtained when the reaction temperature is 200 degrees C. High purity of L-lactide with a yield of 40.6% is obtained by synthetic purifying method. The properties of L-lactide are characterized by optical purity, infrared spectrum and gas chromatogram/mass spectrum. The L-lactide samples purified by recrystallization and synthetic purifying methods are polymerized with the catalyst of stannous octoate, and the corresponding viscosity average relative molecular masses of poly(L-lactide) are 2.85 x 10(5) and 5.05 x 10(5), respectively. This indicates that the optical purity of L-lactide has great influence on the relative molecular mass of poly( L-lactide).
C1 Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
RP Zhang, HP (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
EM zhpxg@tom.com
CR BERGSMA JE, 1994, CELL MATER, V4, P31
   Chen LX, 2001, J WUHAN UNIV TECHNOL, V16, P10
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   ILLI OE, 1994, J MATER SCI-MATER M, V5, P417, DOI 10.1007/BF00058976
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   KRICHELDORF HR, 1985, POLYM BULL, V14, P497
   LEENSLAG JW, 1986, 5 INT C POL MED SURG, P101
   [娄玲 Lou Ling], 2003, [高分子材料科学与工程, Polymer Materials Science & Engineering], V19, P72
   Nicholson JW, 2002, J MATER SCI-MATER M, V13, P417, DOI 10.1023/A:1014305105445
   QUAN DP, 2000, APPL CHEM, V17, P268
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   SUONGHYU H, 1997, BIOMATERIALS, V18, P1503
   TAIZO F, 2000, J BIOMEDICAL MAT RES, V50, P410
   XIN J, 2002, J WUHAN UNIV TECHNOL, V24, P42
   YAMAGUCHI Y, PURIFYING METHOD LAC
   葛海雄, 2001, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V37, P251
NR 16
TC 6
Z9 9
U1 0
U2 10
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD JUN
PY 2005
VL 12
IS 3
BP 246
EP 250
DI 10.1007/s11771-005-0136-4
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 941NV
UT WOS:000230222400002
DA 2018-10-19
ER

PT J
AU Kim, CS
   Choi, SH
   Cho, KS
   Chai, JK
   Wikesjo, UME
   Kim, CK
AF Kim, CS
   Choi, SH
   Cho, KS
   Chai, JK
   Wikesjo, UME
   Kim, CK
TI Periodontal healing in one-wall intra-bony defects in dogs following
   implantation of autogenous bone or a coral-derived biomaterial
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE ankylosis; autogenous bone; bone grafting; calcium carbonate; dogs;
   histology; intra-bony defect; root resorption
ID CALCIUM-CARBONATE; HISTOLOGICAL-EVALUATION; CANCELLOUS BONE; BEAGLE
   DOGS; REPAIR; REGENERATION; GRAFTS; MARROW; RESORPTION; LESIONS
AB Aim: Autogenous bone grafts and bone biomaterials are being used as part of protocols aiming at reconstruction of periodontal defects. There is a limited biologic information on the effect of such materials on periodontal healing, in particular aberrant healing events that may prevent their general use. The objective of this study was, using histological techniques, to evaluate periodontal healing with focus on root resorption and ankylosis following implantation of autogenous bone and a coral-derived biomaterial into intra-bony defects in dogs.
   Methods: One-wall intra-bony periodontal defects were surgically created at the distal aspect of the second and the mesial aspect of the fourth mandibular premolars in either right or left jaw quadrants in four Beagle dogs. Each animal received particulated autogenous bone and the resorbable calcium carbonate biomaterial into discrete one-wall intra-bony defects. The mucoperiosteal flaps were positioned and sutured to their pre-surgery position. The animals were euthanized 8 weeks post-surgery when block sections of the defect sites were collected and prepared for qualitative histological analysis.
   Results: There were no significant differences in periodontal healing between sites receiving autograft bone and the coral-derived biomaterial. A well-organized periodontal ligament bridging new bone and cementum regeneration was observed extending coronal to a notch prepared to delineate the apical extent of the defect. Osteoid and bone with enclosed osteocytes were formed onto the surface of both autograft and coral particles. Although small resorption pits were evident in most teeth, importantly none of the biomaterials provoked marked root resorption. Ankylosis was not observed.
   Conclusion: Particulated autogenous bone and the coral-derived biomaterial may be implanted into periodontal defects without significant healing aberrations such as root resorption and ankylosis. The histopathological evaluation suggests that the autogenous bone graft has a limited osteogenic potential as demonstrated in this study model.
C1 Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept Periodontol,Res Inst Periodontal Regenerat, Seoul 120749, South Korea.
   Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA USA.
RP Kim, CS (reprint author), Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept Periodontol,Res Inst Periodontal Regenerat, 134 Shinchon Dong, Seoul 120749, South Korea.
EM ckkim@yumc.yonsei.ac.kr
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583; Kim, Chang-Sung/0000-0003-3902-1071
CR AXHAUSEN W, 1956, J BONE JOINT SURG AM, V38, P593, DOI 10.2106/00004623-195638030-00009
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   DRAGOO MR, 1973, J PERIODONTOL, V44, P614, DOI 10.1902/jop.1973.44.10.614
   ELLEGAARD B, 1975, J PERIODONTAL RES, V10, P88, DOI 10.1111/j.1600-0765.1975.tb00012.x
   FRANK R, 1974, J PERIODONTOL, V45, P626, DOI 10.1902/jop.1974.45.8.2.626
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HIATT WH, 1973, J PERIODONTOL, V44, P194, DOI 10.1902/jop.1973.44.4.194
   Kim CK, 1996, J PERIODONTOL, V67, P1301, DOI 10.1902/jop.1996.67.12.1301
   Kim CS, 2004, J PERIODONTOL, V75, P229, DOI 10.1902/jop.2004.75.2.229
   Kim HY, 2002, J PERIODONTOL, V73, P1457, DOI 10.1902/jop.2002.73.12.1457
   LEVIN MP, 1975, J BIOMED MATER RES, V9, P183, DOI 10.1002/jbm.820090207
   MARX RE, 1994, CLIN PLAST SURG, V21, P377
   Moon IS, 1996, J CLIN PERIODONTOL, V23, P945, DOI 10.1111/j.1600-051X.1996.tb00516.x
   OUHAYOUN JP, 1992, J MATER SCI-MATER M, V3, P222, DOI 10.1007/BF00713454
   Pallesen L, 2002, INT J ORAL MAX IMPL, V17, P498
   Park JS, 2003, J CLIN PERIODONTOL, V30, P443, DOI 10.1034/j.1600-051X.2003.10283.x
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   RENVERT S, 1985, J CLIN PERIODONTOL, V12, P441, DOI 10.1111/j.1600-051X.1985.tb01380.x
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   RIVAULT AF, 1971, J PERIODONTOL, V42, P787, DOI 10.1902/jop.1971.42.12.787
   SCHALLHORN RG, 1972, J PERIODONTOL, V43, P67, DOI 10.1902/jop.1972.43.2.67
   SCHROEDER HE, 1992, INT REV CYTOL, V142, P1, DOI 10.1016/S0074-7696(08)62074-4
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   WIKESJO UME, 2003, J PERIODONTOL, V74, P955
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 32
TC 41
Z9 43
U1 0
U2 2
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JUN
PY 2005
VL 32
IS 6
BP 583
EP 589
DI 10.1111/j.1600-051X.2005.00729.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 924KE
UT WOS:000228976900008
PM 15882215
DA 2018-10-19
ER

PT J
AU Gerard, C
   Catuogno, C
   Amargier-Huin, C
   Grossin, L
   Hubert, P
   Gillet, P
   Netter, P
   Dellacherie, E
   Payan, E
AF Gerard, C
   Catuogno, C
   Amargier-Huin, C
   Grossin, L
   Hubert, P
   Gillet, P
   Netter, P
   Dellacherie, E
   Payan, E
TI The effect of alginate, hyaluronate and hyaluronate derivatives
   biomaterials on synthesis of non-articular chondrocyte extracellular
   matrix
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID TISSUE-ENGINEERED CARTILAGE; IN-VITRO; SODIUM ALGINATE; COLLAGEN GELS;
   BEADS; ACID; PROLIFERATION; METABOLISM; EXPRESSION; PHENOTYPE
AB Cartilage engineering consists of re-constructing functional cartilage by seeding chondrocytes in suitable biomaterials in vitro. The characteristics of neocartilage differ upon the type of biomaterial chosen. This study aims at determining the appropriate scaffold material for articular cartilage reconstruction using non articular chondrocytes harvested from rat sternum. For this purpose, the use of polysaccharide hydrogels such as alginate (AA) and hyaluronic acid (HA) was investigated. Several ratios of AA/HA were used as well as three derivatives obtained by chemical modification of HA (HA-C18, HA-C12(2.3), HA-C12(2.5)-TEG(0.5)). Sternal chondrocytes were successfully cultured in 3D alginate and alginate/HA scaffolds. HA retention in alginate beads was found to be higher in beads seeded with cells than in beads without cells. HA-C18 improved HA retention in beads but inhibited the chondrocyte synthesis process. Cell proliferation and metabolism were enhanced in all biomaterials when beads were mechanically agitated. Preliminary results have shown that the chondrocyte neo-synthesised matrix had acquired articular characteristics after 21 days culture. (C) 2005 Springer Science + Business Media, Inc.
C1 Fac Med Vandoeuvre Nancy, UHP, CNRS, UMR 7561,Lab Pharmacol, F-54505 Vandoeuvre Les Nancy, France.
   Grp ENSIC, CNRS, UMR 7568, Lab Chim Phys Macromol, F-54000 Nancy, France.
RP Netter, P (reprint author), Fac Med Vandoeuvre Nancy, UHP, CNRS, UMR 7561,Lab Pharmacol, F-54505 Vandoeuvre Les Nancy, France.
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRODKIN KR, 2005, BIOMATERIALS, V25, P5929
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734
   Chowdhury TT, 2003, ARCH BIOCHEM BIOPHYS, V417, P105, DOI 10.1016/S0003-9861(03)00340-0
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   D'Souza AL, 2000, ARCH BIOCHEM BIOPHYS, V374, P59, DOI 10.1006/abbi.1999.1626
   Darling EM, 2004, J ORTHOP RES, V22, P1182, DOI 10.1016/j.orthres.2004.03.001
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Gigante A, 2003, J MATER SCI-MATER M, V14, P713, DOI 10.1023/A:1024915817061
   GIGANTHUSELSTEI.C, 2003, J MECH MED BIOL, V1, P59
   Goodstone NJ, 2004, TISSUE ENG, V10, P621, DOI 10.1089/107632704323061979
   GOSH P, 1994, CLIN EXP RHEUMATOL, V12, P75
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Homandberg GA, 1997, OSTEOARTHR CARTILAGE, V5, P309, DOI 10.1016/S1063-4584(97)80035-0
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Lee D A, 1993, Osteoarthritis Cartilage, V1, P137, DOI 10.1016/S1063-4584(05)80029-9
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Lindenhayn K, 1999, J BIOMED MATER RES, V44, P149, DOI 10.1002/(SICI)1097-4636(199902)44:2<149::AID-JBM4>3.0.CO;2-C
   Luyten FP, 2001, BEST PRACT RES CL RH, V15, P759, DOI 10.1053/berh.2001.0192
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Patti AM, 2001, TISSUE CELL, V33, P294, DOI 10.1054/tice.2001.0178
   Payan E, 1998, ANAL CHEM, V70, P4780, DOI 10.1021/ac9800558
   Pelletier S, 2000, CARBOHYD POLYM, V43, P343, DOI 10.1016/S0144-8617(00)00188-0
   PELLETIER S, 2000, J BIOMED MATER RES, V54, P102
   Shen Yan, 2004, Chin J Traumatol, V7, P42
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stove J, 2002, J ORTHOPAED RES, V20, P551, DOI 10.1016/S0736-0266(01)00141-3
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
NR 36
TC 33
Z9 36
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 541
EP 551
DI 10.1007/s10856-005-0530-3
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100009
PM 15928870
DA 2018-10-19
ER

PT J
AU Cellesi, F
   Tirelli, N
AF Cellesi, F
   Tirelli, N
TI A new process for cell microencapsulation and other biomaterial
   applications: Thermal gelation and chemical cross-linking in 'tandem'
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID COPOLYMER; ALGINATE; SYSTEM
AB The very rapid gelation of a cell- or biomolecule-containing solution is at the basis of most processes employed in microencapsulation. Adequately quick ('instantaneous') gelation kinetics are provided by a number of phenomena based on physical association.
   On the other hand, physical gels are inherently reversible structures, which can be solubilized or disrupted in response to often poorly controllable phenomena in the environment of application, such as dilution, changes in temperature, ion strength and composition, pH, or other physical or chemical parameters.
   Chemically cross-linked hydrogels would have therefore significant advantages in terms of stability and end-properties; however, the time required for chemical reactions to produce a chemically cross-linked material is in a more general case hardly compatible with microencapsulation processes.
   In a recent study of our laboratory we have proposed a new approach for providing both quick gelation kinetics and good stability, by simply combining the rapid kinetics of a physical hardening phenomenon with a slower chemical curing; the former process is thus responsible of the morphogenesis of the material, while the latter develops its end-properties. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Manchester, Sch Pharm, Manchester M13 9PL, Lancs, England.
   Univ Manchester, Mol Mat Ctr, Manchester M13 9PL, Lancs, England.
   ETH, Inst Biomed Engn, Zurich, Switzerland.
   ETH, Dept Mat, Zurich, Switzerland.
RP Tirelli, N (reprint author), Univ Manchester, Sch Pharm, Manchester M13 9PL, Lancs, England.
EM nicola.tirelli@man.ac.uk
RI Tirelli, Nicola/P-7210-2014; Tirelli, Nicola/P-3604-2018
OI Tirelli, Nicola/0000-0002-4879-3949; Tirelli,
   Nicola/0000-0002-4879-3949; CELLESI, FRANCESCO/0000-0001-6106-9317
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Brandenberger HR, 1999, BIOTECHNOL PROGR, V15, P366, DOI 10.1021/bp990033m
   BUGARSKI B, 1994, AICHE J, V40, P1026, DOI 10.1002/aic.690400613
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   CELLESI F, 2004, IN PRESS BIOTECHNOL
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Fundueanu G, 1999, BIOMATERIALS, V20, P1427, DOI 10.1016/S0142-9612(99)00050-2
   Hill RS, 1997, ANN NY ACAD SCI, V831, P332
   Lau BK, 2004, J POLYM SCI POL PHYS, V42, P2014, DOI 10.1002/polb.20105
   LEVEE MG, 1994, BIOTECHNOL BIOENG, V43, P734, DOI 10.1002/bit.260430807
   Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   MORTENSEN K, 1992, PHYS REV LETT, V68, P2340, DOI 10.1103/PhysRevLett.68.2340
   MORTENSEN K, 1993, MACROMOLECULES, V26, P4128, DOI 10.1021/ma00068a010
   Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004
   Prusse U, 1998, CHEM ENG TECHNOL, V21, P29, DOI 10.1002/(SICI)1521-4125(199801)21:1<29::AID-CEAT29>3.0.CO;2-Y
   ZIMMERMANN U, 2001, BIOTECHNOLOGY, P548
NR 21
TC 14
Z9 14
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 559
EP 565
DI 10.1007/s10856-005-0532-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100011
PM 15928872
DA 2018-10-19
ER

PT J
AU Turhani, D
   Cvikl, B
   Watzinger, E
   Weissenbock, M
   Yerit, K
   Thurnher, D
   Lauer, G
   Ewers, R
AF Turhani, D
   Cvikl, B
   Watzinger, E
   Weissenbock, M
   Yerit, K
   Thurnher, D
   Lauer, G
   Ewers, R
TI In vitro growth and differentiation of osteoblast-like cells on
   hydroxyapatite ceramic granule calcified from red algae
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; BONE; BEHAVIOR; DEFECTS; INVITRO; SINUS
AB Purpose: The purpose of this study was to analyze the interaction between osteoblast-like cells isolated from mandibular bone and hydroxyapatite ceramic bone substitute obtained from calcified red algae to assess the growth and differentiation of adherent cells on this biomaterial.
   Materials and Methods: The macroporous ceramic material C GRAFT/Algipore (The Clinician's Preference LLC, Golden, CO) is composed of 100% hydroxyapatite and possesses specific mechanical and physiochemical properties. Osteoblast-like cells were seeded on 200 mg of biomaterial and cultured for 6 and 21 days under osteogenic differentiation conditions. Specific alkaline phosphatase activity, DNA, and protein content of the proliferating cells were analyzed. The morphology of the cells in contact with the biomaterial was examined by scanning electron microscopy. The osteoblastic phenotype of the cells was confirmed by analysis of the expression of bone-specific genes (osteocalcin, osteopontin and collagen type I) by semi-quantitative reverse transcriptase polymerase chain reaction.
   Results: The DNA and protein content increased over the culture period. Scanning electron microscopy showed cells spreading on the surface of the biomaterials, covering the macropores, and colonizing the depth of the particles. The analysis of the expression patterns of bone-related genes confirmed the osteoblastic phenotype of the cultured cells.
   Conclusion: The results of this study showed that hydroxyapatite ceramic bone substitute obtained from calcified red algae support the proliferation and differentiation of human osteoblast-like cells on its surface in vitro and might be suitable for use as scaffolds in tissue engineering strategies in vivo. &COPY; 2005 American Association of Oral and Maxillofacial Surgeons.
C1 Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, A-1090 Vienna, Austria.
   Med Univ Vienna, Dept Otorhinolaryngol, A-1090 Vienna, Austria.
   Univ Dresden, Dept Oral & Maxillofacial Surg, Dresden, Germany.
RP Turhani, D (reprint author), Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM dritan.turhani@meduniwien.ac.at
OI Stein, Elisabeth/0000-0002-1240-506X
CR BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BAGAMBISA FB, 1994, CRANIOMAXILLOFAC SUR, V1, P12
   Baumann A, 1999, MUND KIEFER GESIC S1, V3, P70
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DODEN E, 1993, CALCIFIED TISSUE INT, V52, P30
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Ewers R, 1987, Zahnarztl Prax, V38, P318
   EWERS R, 1994, J CRANIO MAXILLOF S1, V22, P92
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   Herr G, 1993, Ann Chir Gynaecol Suppl, V207, P99
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KASPERK C, 1988, INT J ORAL MAX SURG, V17, P319
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   SCHOBER C, 1991, Z STOMATOL, V88, P259
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   SCHOPPER C, 2001, ORAL MAXILLOFAC SURG, V13, P3
   Terheyden H, 1997, Mund Kiefer Gesichtschir, V1, P272
   TERHEYDEN H, 1996, J CRANIOMAXILLOFA S1, V24, P114
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
   Young GM, 1997, J NEUROSCI METH, V77, P163, DOI 10.1016/S0165-0270(97)00123-4
NR 31
TC 37
Z9 40
U1 0
U2 6
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD JUN
PY 2005
VL 63
IS 6
BP 793
EP 799
DI 10.1016/j.jams.2005.02.015
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 932PR
UT WOS:000229566300013
PM 15944976
DA 2018-10-19
ER

PT J
AU Drachev, VP
   Thoreson, MD
   Nashine, V
   Khaliullin, EN
   Ben-Amotz, D
   Davisson, VJ
   Shalaev, VM
AF Drachev, VP
   Thoreson, MD
   Nashine, V
   Khaliullin, EN
   Ben-Amotz, D
   Davisson, VJ
   Shalaev, VM
TI Adaptive silver films for surface-enhanced Raman spectroscopy of
   biomolecules
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE protein sensing; metal nanostructures; surface-enhanced Raman
   scattering; insulin; protein binding reaction
ID RHODAMINE 6G MOLECULES; ISLAND FILMS; OPTICAL-PROPERTIES; SCATTERING
   SERS; LIGAND-BINDING; ELECTRODE; PYRIDINE; SPECTRA; NANOSTRUCTURES;
   NANOPARTICLES
AB The interaction of biological molecules with a typical substrate for surface-enhanced Raman scattering (SERS) often leads to their structural and functional changes. In this paper we describe SERS substrates, called adaptive silver films (ASFs), in which the biomaterial and the substrate act in concert to produce excellent Raman enhancement through local restructuring of the metal surface while at the same time preserving the properties (such as conformational state and binding activity) of the analyte. These adaptive substrates show great promise for SERS spectroscopy of many different types of biomolecules, and we provide several current examples of their use. Copyright (c) 2005 John Wiley & Sons, Ltd.
C1 Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.
RP Thoreson, MD (reprint author), Purdue Univ, Sch Elect & Comp Engn, 465 NW Ave, W Lafayette, IN 47907 USA.
EM mthoreso@purdue.edu
RI Drachev, Vladimir/J-5778-2013
CR ADRIAN FJ, 1982, J CHEM PHYS, V77, P5302, DOI 10.1063/1.443800
   ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071
   BAUER G, 2002, METHODS TOOLS BIOSCI, P253
   BERGMAN JG, 1981, OPT LETT, V6, P33, DOI 10.1364/OL.6.000033
   BROWN CR, 1985, CLIN CHEM, V31, P1500
   Brown KR, 1996, J AM CHEM SOC, V118, P1154, DOI 10.1021/ja952951w
   Butler JE, 2000, J IMMUNOASSAY, V21, P165, DOI 10.1080/01971520009349533
   Callender R, 1998, J RAMAN SPECTROSC, V29, P15, DOI 10.1002/(SICI)1097-4555(199801)29:1<15::AID-JRS211>3.0.CO;2-L
   Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z
   Cao YC, 2003, J AM CHEM SOC, V125, P14676, DOI 10.1021/ja0366235
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   CHEN CY, 1980, PHYS REV LETT, V45, P1287, DOI 10.1103/PhysRevLett.45.1287
   CHEN CY, 1979, SOLID STATE COMMUN, V32, P63, DOI 10.1016/0038-1098(79)90998-0
   DAVIES JP, 1986, ANAL CHEM, V58, P1290, DOI 10.1021/ac00298a005
   Drachev VP, 2003, PROC SPIE, V5221, P76, DOI 10.1117/12.510572
   Drachev VP, 2004, J PHYS CHEM B, V108, P18046, DOI 10.1021/jp047254h
   DRACHEV VP, 2001, OPTICAL PROPERTIES N, P113
   ECKERTOVA L, 1977, PHYS THIN FILMS
   Ferrari D, 2001, BIOPOLYMERS, V62, P249, DOI 10.1002/bip.1020
   FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1
   Gadenne P, 1997, PHYSICA A, V241, P161, DOI 10.1016/S0378-4371(97)00076-9
   Grubisha DS, 2003, ANAL CHEM, V75, P5936, DOI 10.1021/ac034356f
   GUTCHO S, 1977, CLIN CHEM, V23, P1609
   HAYES FJ, 1994, ANAL CHEM, V66, P1860, DOI 10.1021/ac00083a014
   Haynes CL, 2003, J PHYS CHEM B, V107, P7426, DOI 10.1021/jp027749b
   HOLLAND WR, 1984, PHYS REV LETT, V52, P1041, DOI 10.1103/PhysRevLett.52.1041
   HOLT RE, 1989, J AM CHEM SOC, V111, P2815, DOI 10.1021/ja00190a012
   JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6
   Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667
   LEITNER A, 1993, APPL OPTICS, V32, P102, DOI 10.1364/AO.32.000102
   LOMBARDI JR, 1986, J CHEM PHYS, V84, P4174, DOI 10.1063/1.450037
   MCCALL SL, 1980, PHYS LETT A, V77, P381, DOI 10.1016/0375-9601(80)90726-4
   Michaels AM, 1999, J AM CHEM SOC, V121, P9932, DOI 10.1021/ja992128q
   Michaels AM, 2000, J PHYS CHEM B, V104, P11965, DOI 10.1021/jp0025476
   MOSKOVITS M, 1978, J CHEM PHYS, V69, P4159, DOI 10.1063/1.437095
   MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783
   Musick MD, 1997, CHEM MATER, V9, P1499, DOI 10.1021/cm970087w
   Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102
   OTTO A, 1978, SURF SCI, V75, pL392, DOI 10.1016/0039-6028(78)90263-7
   PANDEY PKK, 1984, J CHEM PHYS, V80, P2959, DOI 10.1063/1.447045
   PERSSON BNJ, 1981, CHEM PHYS LETT, V82, P561, DOI 10.1016/0009-2614(81)85441-3
   POCKRAND I, 1980, SOLID STATE COMMUN, V35, P861, DOI 10.1016/0038-1098(80)91040-6
   Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171
   RITCHIE G, 1982, SURFACE ENHANCED RAM, P361
   Sarychev AK, 2000, PHYS REP, V335, P276
   Schatz G. S., 2002, HDB VIBRATIONAL SPEC, P759
   SCHLEGEL VL, 1991, ANAL CHEM, V63, P241, DOI 10.1021/ac00003a010
   Shafer-Peltier KE, 2003, J AM CHEM SOC, V125, P588, DOI 10.1021/ja028255v
   Shalaev V., 2000, NONLINEAR OPTICS RAN
   Sibbald MS, 1997, J ELECTROANAL CHEM, V438, P179, DOI 10.1016/S0022-0728(97)00035-1
   STOCKMAN MI, 1992, PHYS REV B, V46, P2821, DOI 10.1103/PhysRevB.46.2821
   Stuart HR, 1998, PHYS REV LETT, V80, P5663, DOI 10.1103/PhysRevLett.80.5663
   VANDUYNE RP, 1993, J CHEM PHYS, V99, P2101, DOI 10.1063/1.465276
   Vo-Dinh T, 1998, TRAC-TREND ANAL CHEM, V17, P557, DOI 10.1016/S0165-9936(98)00069-7
   Vo-Dinh T, 1999, J RAMAN SPECTROSC, V30, P785, DOI 10.1002/(SICI)1097-4555(199909)30:9<785::AID-JRS450>3.0.CO;2-6
   Vogel E, 1998, J RAMAN SPECTROSC, V29, P693, DOI 10.1002/(SICI)1097-4555(199808)29:8<693::AID-JRS283>3.0.CO;2-O
   VUORI J, 1991, CLIN CHEM, V37, P2087
   WEITZ DA, 1982, OPT LETT, V7, P168, DOI 10.1364/OL.7.000168
   XU YY, 1992, CLIN CHEM, V38, P2038
   YANG MS, 1993, ANAL CHEM, V65, P3713, DOI 10.1021/ac00072a027
   YANG WH, 1995, J CHEM PHYS, V103, P869, DOI 10.1063/1.469787
   YU NT, 1974, ARCH BIOCHEM BIOPHYS, V160, P614, DOI 10.1016/0003-9861(74)90438-X
   YU NT, 1972, J MOL BIOL, V70, P117, DOI 10.1016/0022-2836(72)90167-2
   YUNT, 1972, J AM CHEM SOC, V94, P3250
NR 64
TC 47
Z9 47
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
EI 1097-4555
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD JUN-JUL
PY 2005
VL 36
IS 6-7
BP 648
EP 656
DI 10.1002/jrs.1356
PG 11
WC Spectroscopy
SC Spectroscopy
GA 950AE
UT WOS:000230829200023
DA 2018-10-19
ER

PT J
AU Qing, XL
   Zheng, CL
   Cui, FZ
AF Qing, XL
   Zheng, CL
   Cui, FZ
TI In vitro endothelialization on CNx films deposited on PTFE
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article; Proceedings Paper
CT 11th China-Korea Symposium on Thin Film Materials
CY JUN 28-JUL 05, 2004
CL Chengdu, PEOPLES R CHINA
SP Nat Sci Fdn China, Inst Nucl Sci & Technol, Sichuan Univ, SW Inst Phys, Korea Sci & Engn Fdn, Hanyang Univ, Quantum Photon Sci Res Ctr, Inha Univ, Opt Technol Educ Ctr, Korean Vacuum Soc
DE carbon nitride films; endothelial cells; PTFE; biomaterial; IBAD
ID DIAMOND-LIKE CARBON; NITRIDE THIN-FILMS; IMMERSION ION-IMPLANTATION;
   SURFACE MODIFICATION; PLASMA TREATMENT; BIOCOMPATIBILITY; AMMONIA; RAMAN
AB Endothelial cells were successfully seeded onto carbon nitride (CNx) films deposited on polytetrafluoroethylene (PTFE) by using the ion beam-assisted deposition (IBAD) technique. X-ray photoelectron spectroscopy and, Raman characterization of the resulting films showed that MAD was efficient in fabricating CNx films with controllable nitrogen content and sp(2)/sp(3) fraction. The 48 hr cell culture indicated the endothelial cells grew best on CNx film with greatest nitrogen content. The CNx-coated PTFE may be a promising vascular prosthesis in vascular reconstruction.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Cui, FZ (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@tsinghua.edu.cn
CR Alonso F, 2002, DIAM RELAT MATER, V11, P1161, DOI 10.1016/S0925-9635(01)00582-9
   APOSTOLOS KT, 2000, BIOMATER SCI, V11, P1275
   Badey JP, 1996, POLYMER, V37, P1377, DOI 10.1016/0032-3861(96)81135-9
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   Bhattacharyya S, 1998, J APPL PHYS, V83, P3917, DOI 10.1063/1.367312
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Ferrari AC, 2003, DIAM RELAT MATER, V12, P905, DOI 10.1016/S0925-9635(02)00370-9
   He JL, 1998, NUCL INSTRUM METH B, V135, P512, DOI 10.1016/S0168-583X(97)00630-7
   Husein IF, 1996, MAT SCI ENG A-STRUCT, V209, P10, DOI 10.1016/0921-5093(95)10096-2
   Kim J, 2003, J KOREAN PHYS SOC, V42, pS956
   Kim JI, 2004, J KOREAN PHYS SOC, V44, P1071
   Kolitsch A, 2000, SURF COAT TECH, V128, P126, DOI 10.1016/S0257-8972(00)00590-9
   Li DJ, 2001, APPL SURF SCI, V180, P270, DOI 10.1016/S0169-4332(01)00356-7
   LIU AY, 1989, SCIENCE, V245, P841, DOI 10.1126/science.245.4920.841
   Lu A, 2001, BIOMATERIALS, V22, P1439, DOI 10.1016/S0142-9612(00)00302-1
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Riedo E, 2000, J APPL PHYS, V88, P4365, DOI 10.1063/1.1309041
   STEFAN L, 2002, BIOMATERIALS, V23, P767
NR 21
TC 1
Z9 1
U1 0
U2 0
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD JUN
PY 2005
VL 46
SU S
BP S24
EP S29
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 932YE
UT WOS:000229589900007
DA 2018-10-19
ER

PT J
AU Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
AF Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
TI Biomaterials functionalization using a novel peptide that selectively
   binds to a conducting polymer
SO NATURE MATERIALS
LA English
DT Article
ID DYNAMIC FORCE SPECTROSCOPY; ENERGY LANDSCAPES; POLYPYRROLE; SURFACE;
   ADHESION; FILMS; SPECIFICITY; MICROSCOPE; ATTACHMENT; TITANIUM
AB The goal in biomaterial surface modification is to retain a material's bulk properties while modifying only its surface to possess desired recognition and specificity. Here we develop a unique strategy for surface functionalization of an electrically conductive polymer, chlorine-doped polypyrrole (PPyCl), which has been widely researched for various electronic and biomedical applications. An M13 bacteriophage library was used to screen 109 different 12-mer peptide inserts against PPyCl. A binding phage (phi T59) was isolated, and its binding stability and specificity to PPyCl was assessed using fluorescence microscopy and titer count analysis. The relative binding strength and mechanism of the corresponding 12-mer peptide and its variants was studied using atomic force microscopy and fluorescamine assays. Further, the T59 peptide was joined to a cell adhesive sequence and used to promote cell attachment on PPyCl. This strategy can be extended to immobilize a variety of molecules to PPyCl for numerous applications. In addition, phage display can be applied to other polymers to develop bioactive materials without altering their bulk properties.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Bioengn, Cambridge, MA 02139 USA.
RP Sanghvi, AB (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E
   Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Barrett GC, 1998, AMINO ACIDS PEPTIDES
   Berglund J, 1998, ANAL COMMUN, V35, P3, DOI 10.1039/a708046h
   Blackburn S., 1978, AMINO ACID DETERMINA, P121
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cook AD, 1997, BIOMATERIALS, V18, P1417, DOI 10.1016/S0142-9612(97)00075-6
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/0368-1874(81)87387-X
   Evans E, 1998, FARADAY DISCUSS, V111, P1
   Flynn CE, 2003, J MATER CHEM, V13, P2414, DOI 10.1039/b307593a
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HRKACH J, 1999, J MAT SCI RES, V78, P92
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   Kontturi K, 1998, J ELECTROANAL CHEM, V453, P231, DOI 10.1016/S0022-0728(98)00246-0
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Labrou NE, 2003, J CHROMATOGR B, V790, P67, DOI 10.1016/S1570-0232(03)00098-9
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MORI T, 2004, CURR PHARM DESIGN, V19, P2335
   MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4
   Nakamura C, 2004, BIOPOLYMERS, V76, P48, DOI 10.1002/bip.10572
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8120, P1
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8100
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8110, P1
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Sutar D, 2002, THIN SOLID FILMS, V417, P40, DOI 10.1016/S0040-6090(02)00649-1
   Tamm J, 1997, ELECTROCHIM ACTA, V42, P2929, DOI 10.1016/S0013-4686(97)00114-X
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Undenfriend S, 1972, SCIENCE, V178, P871
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   Vidal JC, 1999, ANAL CHIM ACTA, V385, P213, DOI 10.1016/S0003-2670(98)00838-1
   Wang LX, 2001, REACT FUNCT POLYM, V47, P125, DOI 10.1016/S1381-5148(00)00079-1
   Whaley SR, 2000, NATURE, V405, P665
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
NR 49
TC 263
Z9 269
U1 7
U2 148
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD JUN
PY 2005
VL 4
IS 6
BP 496
EP 502
DI 10.1038/nmat1397
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 931RL
UT WOS:000229502700019
PM 15895095
DA 2018-10-19
ER

PT J
AU Conze, J
   Junge, K
   Klinge, U
   Weiss, C
   Polivoda, M
   Oettinger, AP
   Schumpelick, V
AF Conze, J
   Junge, K
   Klinge, U
   Weiss, C
   Polivoda, M
   Oettinger, AP
   Schumpelick, V
TI Intraabdominal adhesion formation of polypropylene mesh - Influence of
   coverage of omentum and polyglactin
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE adhesion; mesh; intraperitoneal onlay mesh technique; polypropylene;
   polyglactin; granuloma
ID ABDOMINAL-WALL DEFECTS; INCISIONAL HERNIA; ENTEROCUTANEOUS FISTULA;
   GREATER OMENTUM; REPAIR; INTRAPERITONEAL; IMPLANTATION; HERNIORRHAPHY;
   MODEL
AB Background: Adhesions after intraabdominal surgical procedures are related to high morbidity and mortality. Biomaterials, particularly those made of polypropylene, in the intraabdominal position have to be considered as pathophysiological cofactor in a multifactorial process of adhesion formation. To investigate the adhesive potential induced by the biomaterial, an animal model was performed. In addition, the influence of coverage by omentum or a polyglactin barrier was investigated.
   Methods: In, 18 Chinchilla rabbits the blomaterial was placed laparoscopically using the intraperitoneal onlay mesh technique. Using this model, a polypropylene-polyglactin mesh compound (PPMC) was used with three different implantation techniques: group 1, PPMC implantation without coverage (PPMC): group 2, PPMC implantation with additional omentum coverage (PPMC-O): and group 3, PPMC implantation with coverage of an absorbable polyglactin mesh (PPMC-V). The degree of adhesion formation was measured 90 days after implantation by computer-assisted planimetry. Morphometric examination followed the explantation analyzing the amount of foreign body response.
   Results: We found a significant reduction of adhesion formation for the PPMC and PPMC-O groups compared to the PPMC-V group, in which dense adhesions were found. Morphometric investigations of the perifilamental granulomas of the pure (PPMC) group revealed a typical foreign body reaction with a mild to moderate fibrosis around all mesh fibers. However, tissue specimens of the PPMC-O and PPMC-V groups indicated a similar inflammatory reaction but significantly increased connective tissue formation around the polymer fibers compared to the pure PPMC group.
   Conclusion: The intraabdominal placement of a pure PPMC shows a neoperitonealization and perifilamental collagenous ingrowth with almost no adhesions. Coverage with omentum (PPMC-O) or polyglactin mesh (PPMC-V) resulted in a significant increase in inflammation and perifilamentary connective tissue formation.
C1 Rhenish Westphalian Tech Univ, Dept Surg, D-52074 Aachen, Germany.
   Rhenish Westphalian Tech Univ, Inst Med Stat, D-52074 Aachen, Germany.
   Russian State Med Univ, Joint Inst Surg Res, Moscow 117437, Russia.
RP Conze, J (reprint author), Rhenish Westphalian Tech Univ, Dept Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
RI Oettinger, Alexander/G-8594-2014
OI Oettinger, Alexander/0000-0001-9894-0671
CR Baptista ML, 2000, SURGERY, V128, P86, DOI 10.1067/msy.2000.106810
   Barlehner E, 1996, ZBL CHIR, V121, P307
   BEELEN RHJ, 1991, NETH J SURG, V43, P145
   BELLOM JM, 1997, J BIOMATER APPL, V12, P112
   Bellon JM, 1998, BIOMATERIALS, V19, P669, DOI 10.1016/S0142-9612(97)00162-2
   Bendavid R, 1997, HERNIA, V1, P5
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   Bujan J, 1997, HISTOL HISTOPATHOL, V12, P683
   CARBAHO MA, 2003, SURG ENDOSC, V17, P18
   Chowbey PK, 2003, SURG LAPARO ENDO PER, V13, P101, DOI 10.1097/00129689-200304000-00008
   CHRISTOFORONI PM, 1996, AM SURGEON, V62, P935
   DURSTEINDECKER C, 1994, AM SURGEON, V60, P157
   ECKMANN B, 1985, LANGENBECK ARCH CHIR, V365, P91, DOI 10.1007/BF01261136
   Eller R, 1997, SURG ENDOSC-ULTRAS, V11, P24, DOI 10.1007/s004649900288
   Farmer L, 1998, AM SURGEON, V64, P144
   Franklin ME, 1998, SURG LAPAROSC ENDOSC, V8, P294, DOI 10.1097/00019509-199808000-00012
   Halverson AL, 1999, SURG ENDOSC-ULTRAS, V13, P14, DOI 10.1007/s004649900888
   JENKINS SD, 1983, SURGERY, V94, P392
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   MARCH CM, 1992, FERTIL STERIL, V57, P921
   MATLOUB HS, 1992, ANN PLAS SURG, V29, P508, DOI 10.1097/00000637-199212000-00005
   Mori N, 1998, PEDIATR SURG INT, V13, P487, DOI 10.1007/s003830050379
   Morris-Stiff GJ, 1998, J AM COLL SURGEONS, V186, P352, DOI 10.1016/S1072-7515(98)00002-7
   Schumpelick V, 2002, CHIRURG, V73, P888, DOI 10.1007/s00104-002-0535-0
   SEELIG MH, 1995, CHIRURG, V66, P739
   SIMMERMACHER RK, 1994, J AM SURG, V1758, P613
   Vrijland WW, 2000, BRIT J SURG, V87, P348, DOI 10.1046/j.1365-2168.2000.01364.x
NR 28
TC 30
Z9 33
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD JUN
PY 2005
VL 19
IS 6
BP 798
EP 803
DI 10.1007/s00464-004-2192-5
PG 6
WC Surgery
SC Surgery
GA 957OF
UT WOS:000231378500010
PM 15868269
DA 2018-10-19
ER

PT J
AU Saiano, F
   Ciofalo, M
   Cacciola, SO
   Ramirez, S
AF Saiano, F
   Ciofalo, M
   Cacciola, SO
   Ramirez, S
TI Metal ion adsorption by Phomopsis sp biomaterial in laboratory
   experiments and real wastewater treatments
SO WATER RESEARCH
LA English
DT Article
DE fungal biomaterial; chitin; chitosan; adsorption isotherm; heavy metal;
   wastewater
ID STREPTOMYCES-RIMOSUS BIOMASS; HEAVY-METALS; AQUEOUS-SOLUTION;
   ASPERGILLUS-NIGER; BIOSORPTION; REMOVAL; CHITIN; MODELS; NI2+
AB An insoluble material of polysaccharidic nature has been obtained by thermal alkali treatment of the filamentous fungus Phomopsis sp. FT-IR spectrum of the resulting material as well as its nitrogen content suggest that chitosan and glucans are the main components of the biomaterial. Information on Lewis base sites has also been obtained and used as a guideline in the evaluation of the complexing ability against a number of metal ions in aqueous media at pH in the range 4-6. Results indicate that after 24 h contact time, up to 870 mu mol/g of lead, 390 mu mol/g of copper, 230 mu mol/g of cadmium, 150 mu mol/g of zinc and 110 mu mol/g of nickel ions are adsorbed into the material. After approximately 10 min, about 70% of the overall adsorption process has already been completed. Adsorbed metal ions can be recovered by washing with dilute acid. Experiments have been extended to a real wastewater effluent confirming the potential of this biomaterial as a depolluting agent. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Palermo, Dipartimento ITAF, Sez Chim, I-90128 Palermo, Italy.
   Univ Palermo, Dipartimento SENFIMIZO, Sez Patol Vegetale & Microbiol Agraria, I-90128 Palermo, Italy.
RP Saiano, F (reprint author), Univ Palermo, Dipartimento ITAF, Sez Chim, Viale Sci,Edificio 4, I-90128 Palermo, Italy.
EM fsaiano@unipa.it
OI Cacciola, Santa Olga/0000-0001-7926-3601
CR ALONZO G, 2001, P 1 EUR BIOR C CHAN
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Bhanoori M, 2000, BBA-GEN SUBJECTS, V1523, P21, DOI 10.1016/S0304-4165(00)00090-8
   *CEM CORP, 1994, APPL MAN
   Coulibaly Lacina, 2003, African Journal of Biotechnology, V2, P620
   Galli E, 2003, LETT APPL MICROBIOL, V37, P133, DOI 10.1046/j.1472-765X.2003.01354.x
   Gavrilescu M, 2004, ENG LIFE SCI, V4, P219, DOI 10.1002/elsc.200420026
   Griffin DH, 1994, FUNGAL PHYSL
   Harvey D., 2000, MODERN ANAL CHEM
   Kapoor A, 1999, BIORESOURCE TECHNOL, V70, P95, DOI 10.1016/S0960-8524(98)00192-8
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kim CY, 1997, J APPL POLYM SCI, V63, P725, DOI 10.1002/(SICI)1097-4628(19970207)63:6<725::AID-APP5>3.0.CO;2-P
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   MATIS KA, 1994, BIOTECHNOL BIOENG, V44, P354, DOI 10.1002/bit.260440313
   Merce ALR, 2001, BIORESOURCE TECHNOL, V76, P29, DOI 10.1016/S0960-8524(00)00078-X
   Muzzarelli R. A. A., 1980, J APPL BIOCHEM, V2, P54
   Ozer A, 1999, PROCESS BIOCHEM, V34, P919, DOI 10.1016/S0032-9592(99)00011-4
   Pinghe Y., 1999, WATER RES, V33, P1960
   ROY D, 1993, J ENVIRON SCI HEAL A, VA28, P37, DOI 10.1080/10934529309375861
   Sag Y, 1998, PROCESS BIOCHEM, V33, P273, DOI 10.1016/S0032-9592(97)00060-5
   Say R, 2001, BIORESOURCE TECHNOL, V76, P67, DOI 10.1016/S0960-8524(00)00071-7
   Sebe G, 2004, SEP PURIF TECHNOL, V38, P121, DOI 10.1016/j.seppur.2003.10.009
   Sekhar KC, 1998, INT J MINER PROCESS, V53, P107, DOI 10.1016/S0301-7516(97)00061-6
   Selatnia A, 2004, MINER ENG, V17, P903, DOI 10.1016/j.mineng.2004.04.002
   Selatnia A, 2004, BIOCHEM ENG J, V19, P127, DOI 10.1016/j.bej.2003.12.007
   Vianna LNL, 2000, WORLD J MICROB BIOT, V16, P437, DOI 10.1023/A:1008953922144
   White C, 1997, FEMS MICROBIOL REV, V20, P503, DOI 10.1016/S0168-6445(97)00029-6
   Zhang L, 1998, WATER RES, V32, P1437, DOI 10.1016/S0043-1354(97)00348-5
NR 29
TC 38
Z9 44
U1 5
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0043-1354
J9 WATER RES
JI Water Res.
PD JUN
PY 2005
VL 39
IS 11
BP 2273
EP 2280
DI 10.1016/j.watres.2005.04.022
PG 8
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA 946RV
UT WOS:000230590800009
PM 15941575
DA 2018-10-19
ER

PT J
AU Sours, RE
   Zellelow, AZ
   Swift, JA
AF Sours, RE
   Zellelow, AZ
   Swift, JA
TI An in situ atomic force microscopy study of uric acid crystal growth
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID STONE FORMATION; URINARY-TRACT; UNITED-STATES; RENAL STONES;
   MONOHYDRATE; CRYSTALLIZATION; DISSOLUTION; KINETICS; FREQUENCY
AB Kidney stones are heterogeneous polycrystalline aggregates that can consist of several different building blocks. A significant number of human stones contain uric acid crystals as a crystalline component, though the molecular-level growth of this important biomaterial has not been previously well-characterized. In the present study, in situ atomic force microscopy (AFM) is used to investigate the real-time growth on the (100) surface of uric acid (UA) single crystals as a function of fundamental solution parameters. Layer-by-layer growth on UA (100) was found to be initiated at screw dislocation sites and to proceed via highly anisotropic rates which depend on the crystallographic direction. The smallest b-steps exhibited minimum heights corresponding to two molecular layers, while fast-moving c-steps more commonly showed monolayer heights. Growth kinetics measured under a range of flow rates, supersaturation levels, and pH values reveal linear trends in the growth kinetics, with faster growth attained in solutions with higher supersaturation and/or pH. The calculated kinetic parameters for UA growth derived from these experiments are in good agreement with the values reported for other crystal systems.
C1 Georgetown Univ, Dept Chem, Washington, DC 20057 USA.
RP Sours, RE (reprint author), Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA.
EM jas2@georgetown.edu
CR Astier JP, 2001, J CRYST GROWTH, V226, P294, DOI 10.1016/S0022-0248(01)01373-2
   Atsmon A, 1963, URIC ACID LITHIASIS
   BOISTELLE R, 1981, J CRYST GROWTH, V53, P1, DOI 10.1016/0022-0248(81)90050-6
   Cabrera N., 1958, GROWTH PERFECTION CR, P393
   Chernov A. A., 1995, SCI TECHNOLOGY CRYST, P67
   Chernov A.A., 1980, MODERN CRYSTALLOGRAP
   COE FL, 1983, KIDNEY INT, V24, P392, DOI 10.1038/ki.1983.172
   COTTET J, 1959, Pathol Biol, V7, P1975
   De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057
   Fink DA, 2003, CHEM MATER, V15, P2718, DOI 10.1021/cm021751y
   Frincu MC, 2004, LANGMUIR, V20, P6524, DOI 10.1021/la049091u
   FUSS M, 1978, EUR UROL, V4, P90
   GRENABO L, 1985, SCAND J UROL NEPHROL, V19, P285, DOI 10.3109/00365598509180271
   Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+
   Gvozdev NV, 2004, J CRYST GROWTH, V261, P539, DOI 10.1016/j.jcrysgro.2003.09.026
   HERRING LC, 1962, J UROLOGY, V88, P545, DOI 10.1016/S0022-5347(17)64842-0
   HESSE A, 1975, INVEST UROL, V12, P405
   HILLNER PE, 1992, ULTRAMICROSCOPY, V42, P1387, DOI 10.1016/0304-3991(92)90454-R
   JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173
   Konigsberger E, 2001, PURE APPL CHEM, V73, P785, DOI 10.1351/pac200173050785
   Land TA, 1997, SURF SCI, V384, P136, DOI 10.1016/S0039-6028(97)00187-8
   Luo TJM, 2000, J PHYS ORG CHEM, V13, P870, DOI 10.1002/1099-1395(200012)13:12<870::AID-POC324>3.0.CO;2-O
   MANDEL NS, 1989, J UROLOGY, V142, P1516, DOI 10.1016/S0022-5347(17)39145-0
   MANDEL NS, 1976, J AM CHEM SOC, V98, P2319, DOI 10.1021/ja00424a054
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   OSER BL, 1965, HAWKS PHYSL CHEM
   Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100
   RINGERTZ H, 1966, ACTA CRYSTALLOGR, V20, P397, DOI 10.1107/S0365110X66000914
   SCHOLZ D, 1979, UROL RES, V7, P161
   Sheng XX, 2003, J AM CHEM SOC, V125, P2854, DOI 10.1021/ja029575h
   Shirane Y, 1999, UROL RES, V27, P426, DOI 10.1007/s002400050131
   SIERAKOWSKI R, 1978, INVEST UROL, V15, P438
   Sours RE, 2002, J AM CHEM SOC, V124, P8630, DOI 10.1021/ja026083w
   SOURS RE, IN PRESS MOL CRYST L
   SUTOR DJ, 1974, BRIT J UROL, V46, P275, DOI 10.1111/j.1464-410X.1974.tb03828.x
   SWIFT JA, 1997, THESIS YALE U
   WARDLAW H S H, 1952, Med J Aust, V1, P180
NR 37
TC 26
Z9 26
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAY 26
PY 2005
VL 109
IS 20
BP 9989
EP 9995
DI 10.1021/jp0455733
PG 7
WC Chemistry, Physical
SC Chemistry
GA 928UG
UT WOS:000229296600018
PM 16852207
DA 2018-10-19
ER

PT J
AU Parrish, B
   Breitenkamp, RB
   Emrick, T
AF Parrish, B
   Breitenkamp, RB
   Emrick, T
TI PEG- and peptide-grafted aliphatic polyesters by click chemistry
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID RING-OPENING POLYMERIZATION; EPSILON-CAPROLACTONE; DELTA-VALEROLACTONE;
   DRUG-DELIVERY; COPOLYMERS; BIOMATERIALS; BLOCK; LIGATION; MICELLES;
   POLYMERS
AB Novel aliphatic polyesters with pendent acetylene groups were prepared by controlled ring-opening polymerization and subsequently used for grafting poly(ethylene glycol) and oligopeptide moieties by the Cu(I)-catalyzed addition of azides and alkynes, a type of "click" chemistry. These aliphatic polyesters possess an acetylene graft density that can be tailored by ring-opening copolymerization of alpha-propargyl-delta-valerolactone (1) with is an element of-caprolactone. Since the mild conditions associated with the click reaction are shown to be compatible with the polyester backbone, this method is a generally useful means for grafting numerous types of functionality onto aliphatic polyesters. The amphiphilic graft polyesters prepared in this study are shown to be biocompatible by in vitro cytotoxicity evaluation, suggesting their suitability for a range of biomaterial applications.
C1 Univ Massachusetts, Conte Ctr Polymer Res, Polymer Sci & Engn Dept, Amherst, MA 01003 USA.
RP Emrick, T (reprint author), Univ Massachusetts, Conte Ctr Polymer Res, Polymer Sci & Engn Dept, Amherst, MA 01003 USA.
EM tsemrick@mail.pse.umass.edu
FU NIGMS NIH HHS [T32 GM008515]
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Armarego W. L. F., 1996, PURIFICATION LAB CHE
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Carnahan MA, 2002, J AM CHEM SOC, V124, P5291, DOI 10.1021/ja025576y
   Chan W. C., 2000, FMOC SOLID PHASE PEP
   Cordova A, 1999, POLYMER, V40, P6709, DOI 10.1016/S0032-3861(99)00017-8
   De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m
   Duda A, 1998, POLYM DEGRAD STABIL, V59, P215, DOI 10.1016/S0141-3910(97)00167-5
   Gonzalez R, 2003, AM SURGEON, V69, P471
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Helms B, 2004, J AM CHEM SOC, V126, P15020, DOI 10.1021/ja044744e
   HERRMANN JL, 1973, CHEM COMMUN, P711
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee CC, 2004, J POLYM SCI POL CHEM, V42, P3563, DOI 10.1002/pola.20216
   Lee SC, 2003, J CONTROL RELEASE, V89, P437, DOI 10.1016/S0168-3659(03)00162-7
   Link AJ, 2004, J AM CHEM SOC, V126, P10598, DOI 10.1021/ja047629c
   Mecerreyes D, 2000, J POLYM SCI POL CHEM, V38, P870, DOI 10.1002/(SICI)1099-0518(20000301)38:5<870::AID-POLA11>3.0.CO;2-7
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mizutani M, 2002, BIOMACROMOLECULES, V3, P668, DOI 10.1021/bm0101670
   Moller M, 2000, J POLYM SCI POL CHEM, V38, P2067, DOI 10.1002/(SICI)1099-0518(20000601)38:11<2067::AID-POLA150>3.0.CO;2-1
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Nederberg F, 2004, MACROMOLECULES, V37, P954, DOI 10.1021/ma035433b
   Parrish B, 2004, MACROMOLECULES, V37, P5863, DOI 10.1021/ma048981d
   Parrish B, 2002, J POLYM SCI POL CHEM, V40, P1983, DOI 10.1002/pola.10277
   Rieger J, 2004, MACROMOLECULES, V37, P9738, DOI 10.1021/ma048768h
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   STOREY RF, 1991, MAKROMOL CHEM-M SYMP, V42-3, P185, DOI 10.1002/masy.19910420115
   Trollsas M, 2000, MACROMOLECULES, V33, P4619, DOI 10.1021/ma992161x
   Trollsas M, 1999, MACROMOLECULES, V32, P9062, DOI 10.1021/ma991039v
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Yu D, 1999, MACROMOLECULES, V32, P5186, DOI 10.1021/ma981734n
   Zalipsky S., 1997, POLYETHYLENE GLYCOL
NR 35
TC 473
Z9 485
U1 15
U2 266
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 25
PY 2005
VL 127
IS 20
BP 7404
EP 7410
DI 10.1021/ja050310n
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 928AX
UT WOS:000229244600044
PM 15898789
DA 2018-10-19
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
   Fukui, H
   Toda, H
AF Zhou, YL
   Niinomi, M
   Akahori, T
   Fukui, H
   Toda, H
TI Corrosion resistance and biocompatibility of Ti-Ta alloys for biomedical
   applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biocompatibility; cyto-toxicity; corrosion resistance; wear resistance;
   Ti-Ta alloy; metallic biomaterial
ID ANODIC POLARIZATION PROPERTIES; AQUEOUS CHLORIDE SOLUTIONS;
   TITANIUM-ALLOYS; PHYSIOLOGICAL SOLUTION; PITTING CORROSION; OXIDE-FILMS;
   ELECTROCHEMICAL-BEHAVIOR; METALLIC BIOMATERIALS; MECHANICAL-PROPERTIES;
   MEDICAL IMPLANTS
AB Corrosion resistance, wear resistance and biocompatibility of the studied Ti-Ta alloys with Ta contents of 10, 30 and 70 mass% together with the currently used metallic biomaterials pure titanium (Ti) and Ti-6Al-4V extra low interstitial (ELI) alloy were investigated for biomedical applications. Corrosion resistance was measured by an anodic polarization test using an automatic potentiostat in 5% HCl solution at 310 K. Wear resistance was evaluated using a pin-on-disk type friction wear test system with a load of 4.9 N at 310 K in a simulated body fluid (Ringer's solution), and biocompatibility was judged by evaluating the cyto-toxicity through MTT assay. The passive behaviors are observed for all the studied Ti-Ta alloys, and the TiO2 passive films strengthened by the more stable Ta2O5 passive films result in improved corrosion resistance of the studied Ti-Ta alloys with increasing Ta content. All the studied Ti-Ta alloys are non-cytotoxic like pure Ti. The crystal structure shows little influence on the corrosion resistance and cyto-toxicity of the studied Ti-Ta alloys. The experimental results conform the expected excellent corrosion resistance and biocompatibility of the studied Ti-Ta alloys, which are better than or similar to those of pure Ti or Ti-6Al-4V ELI alloy used as standard biomaterials, suggesting their promising potential for biomedical applications. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Pord Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Dept Pord Syst Engn, Toyohashi, Aichi 4418580, Japan.
EM ylzhou_2@yahoo.com
RI Niinomi, Mitsuo/B-5965-2011
CR *ASM INT HDB COMM, 1987, ASM HDB, V13
   Basame SB, 2000, J ELECTROCHEM SOC, V147, P1376, DOI 10.1149/1.1393364
   Boyer R., 1994, MAT PROPERTIES HDB
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   CASILLAS N, 1994, J ELECTROCHEM SOC, V141, P636, DOI 10.1149/1.2054783
   CASILLAS N, 1993, J ELECTROCHEM SOC, V140, pL142, DOI 10.1149/1.2220897
   Davis JR, 2000, CORROSION UNDERSTAND
   DESOUZA KA, 2003, MATER LETT, V4280, P1
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Gonzalez J, 1998, J MATER SCI, V33, P4173, DOI 10.1023/A:1004469622713
   Guleryuz H, 2004, BIOMATERIALS, V25, P3325, DOI 10.1016/j.biomaterials.2003.10.009
   HABZAKI H, 1997, T I MET FINISH, V75, P18
   Helsen J.A., 1998, METALS BIOMATERIALS
   HORNKJOL S, 1991, ELECTROCHIM ACTA, V36, P1443, DOI 10.1016/0013-4686(91)85332-2
   Imam M., 1996, ASTM STP, P3
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   KOLMAN DG, 1994, J ELECTROCHEM SOC, V141, P2633, DOI 10.1149/1.2059146
   Kolman DG, 1996, J ELECTROCHEM SOC, V143, P1847, DOI 10.1149/1.1836914
   LAQUE FL, 1963, CORROSION RESISTANCE
   LEACH JSL, 1988, CORROS SCI, V28, P43, DOI 10.1016/0010-938X(88)90005-4
   LEVY M, 1969, J ELECTROCHEM SOC, V116, P323, DOI 10.1149/1.2411838
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Mato S, 2003, SURF INTERFACE ANAL, V35, P477, DOI 10.1002/sia.1549
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okazaki Y, 1997, MATER T JIM, V38, P78, DOI 10.2320/matertrans1989.38.78
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Okazaki Y, 1997, MATER T JIM, V38, P344, DOI 10.2320/matertrans1989.38.344
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   PLENK H, 1990, CONCISE ENCY MED DEN, P355
   Poggie RA, 1996, MATER MANUF PROCESS, V11, P185, DOI 10.1080/10426919608947472
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   ROSSLER S, 2001, J MATER SCI-MATER M, V12, P871
   SEMLITSCH M, 1987, CLIN MATER, V2, P1, DOI DOI 10.1016/0267-6605(87)90015-1
   Shreir L., 1963, CORROSION, V1
   SINGH DDN, 1985, J ELECTROCHEM SOC, V132, P378, DOI 10.1149/1.2113843
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STEINEMANN SG, 1999, MAT MED ENG, V2, P199
   STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493
   STERN M, 1959, J ELECTROCHEM SOC, V106, P755, DOI 10.1149/1.2427492
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   TAYLOR DF, 1969, ENCY CHEM TECHNOLOGY, V19, P630
   Thair L, 2004, MATER CORROS, V55, P358, DOI 10.1002/maco.200303724
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   VERMILYEA DA, 1955, J ELECTROCHEM SOC, V102, P207, DOI 10.1149/1.2430031
   VERMILYEA DA, 1957, J ELECTROCHEM SOC, V104, P542, DOI 10.1149/1.2428649
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 62
TC 138
Z9 145
U1 1
U2 48
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 25
PY 2005
VL 398
IS 1-2
BP 28
EP 36
DI 10.1016/j.msea.2005.03.032
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 938KH
UT WOS:000229998100004
DA 2018-10-19
ER

PT J
AU Li, HY
   Chang, J
   Cao, AM
   Wang, JY
AF Li, HY
   Chang, J
   Cao, AM
   Wang, JY
TI In vitro evaluation of biodegradable poly(butylene succinate) as a novel
   biomaterial
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE alkaline phosphatase activity; biocompatibility; degradation;
   osteoblasts; poly(butylene succinate)
ID COMPOSITE SCAFFOLDS; BUILDING-BLOCKS; DEGRADATION; ACID); CELLS;
   POLYMERS; POLY(EPSILON-CAPROLACTONE); DIFFERENTIATION; ATTACHMENT;
   COPOLYMER
AB Poly(butylene succinate) (PBSU) can be easily synthesized by condensation polymerization of the starting materials of succinic acid and butan-1,4-diol. It has good degradability and possesses excellent processability. Due to these advantages, PBSU was first evaluated in the present study for its potential application as a novel biomaterial. The in vitro biocompatibility of the PBSU was evaluated by monitoring proliferation and differentiation of osteoblasts cultured on the PBSU film substrates for different periods. The results showed that the PBSU was biocompatible as the osteoblasts could proliferate and differentiate on the PBSU plates. In addition, the hydrolytic degradation behavior of the PBSU films in the phosphate-buffered saline (PBS) was also investigated and the results suggested that the PBSU degraded in the PBS solution with the same behavior as that of the degradable poly(alpha-hydroxyesters). In addition to the biocompatibility and hydrolytic degradation, some physical properties, including hydrophilicity, and mechanical and thermal properties of the PBSU substrates, were also determined and the results revealed that the PBSU was hydrophilic and ductile with excellent processability. The biocom-patibility of the PBSU, together with the advantages of hydrolytic degradability, hydrophilicity, and excellent processability, indicated that. PBSU has the potential to be used as a biomaterial for tissue repair.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Organ Chem, Polymer Mat Lab, Shanghai 200032, Peoples R China.
   E China Normal Univ, Sch Biol Sci, Shanghai 200062, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Ba CY, 2003, BIOMACROMOLECULES, V4, P1827, DOI 10.1021/bm034235p
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Bahari L, 1998, POLYM DEGRAD STABIL, V62, P551
   BESSEY OA, 1946, J BIOL CHEM, V164, P321
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Hashitani T, 2002, FUJITSU SCI TECH J, V38, P112
   IMAIZUMI M, 1967, Patent No. 5658627
   IMAIZUMI M, 1994, Patent No. 5314969
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   LU L, 1996, BIOMATERIALS, V7, P359
   Martin C, 1996, BIOMATERIALS, V17, P2373, DOI 10.1016/S0142-9612(96)00075-0
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MOTEKI Y, 1994, Patent No. 5360663
   Moursi AM, 1997, J CELL SCI, V110, P2187
   NAKAMURA A, 1994, Patent No. 5348700
   NICKLIN J, 1999, INSTANT NOTES MICROB
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shirahama H, 2001, J APPL POLYM SCI, V80, P340, DOI 10.1002/1097-4628(20010418)80:3<340::AID-APP1105>3.0.CO;2-F
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   TAKA T, 1994, Patent No. 5324794
   TAKAHASHI T, Patent No. 5525409
   TAKAHASHI T, 1994, Patent No. 5349028
   TAKAHASHI T, 1994, Patent No. 5310872
   TYAN YC, 2000, CHIN J MED BIOL ENG, V20, P25
   VanderMeer SAT, 1996, J MATER SCI-MATER M, V7, P359, DOI 10.1007/BF00154549
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT, P40
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Yang J, 2004, BIOMACROMOLECULES, V5, P209, DOI 10.1021/bm0343242
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   YASUDA Y, 1995, Patent No. 5391644
NR 45
TC 88
Z9 98
U1 0
U2 43
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 23
PY 2005
VL 5
IS 5
BP 433
EP 440
DI 10.1002/mabi.200400183
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 930NO
UT WOS:000229423100009
PM 15889389
DA 2018-10-19
ER

PT J
AU Nash, SMB
   Quayle, PA
   Schreiber, U
   Muller, JF
AF Nash, SMB
   Quayle, PA
   Schreiber, U
   Muller, JF
TI The selection of a model microalgal species as biomaterial for a novel
   aquatic phytotoxicity assay
SO AQUATIC TOXICOLOGY
LA English
DT Article
DE priority pollutants; unicellular algae; toxicity; chlorophyll
   fluorescence; bioassay
ID CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; SELENASTRUM-CAPRICORNUTUM;
   CHLORELLA-VULGARIS; QUANTUM YIELD; NITZSCHIA-CLOSTERIUM;
   COPPER-COMPLEXES; PAM-FLUOROMETRY; MARINE DIATOM; IN-VIVO
AB A phytotoxicity assay based on the ToxY-PAM dual-channel yield analyser has been developed and successfully incorporated into field assessments for the detection of phytotoxicants in water. As a means of further exploring the scope of the assay application and of selecting a model biomaterial to complement the instrument design, nine algal species were exposed to four chemical substances deemed of priority for water quality monitoring purposes (chlorpyrifos, copper, diuron and nonylphenol ethoxylate). Inter-species differences in sensitivity to the four toxicants varied by a factor of 1.9-100. Measurements of photosystem-II quantum yield using these nine single-celled microalgae as biomaterial corroborated previous studies which have shown that the ToxY-PAM dual-channel yield analyser is a highly sensitive method for the detection of PS-II impacting herbicides. Besides Phaeodactylum tricornutum, the previously applied biomaterial, three other species consistently performed well (Nitzschia closterium, Chlorella vulgaris and Dunaliella tertiolecta) and will be used in further test optimisation experiments. In addition to sensitivity, response time was evaluated and revealed a high degree of variation between species and toxicants. While most species displayed relatively weak and slow responses to copper, C. vulgaris demonstrated an IC10 of 51 &mu; g L-1, with maximum response measured within 25 minutes and inhibition being accompanied by a large decrease in fluorescence yield. The potential for this C vulgaris-based bioassay to be used for the detection of copper is discussed. There was no evidence that the standard ToxY-PAM protocol, using these unicellular algae species, could be used for the detection of chlorpyrifos or nonylphenol ethoxylate at environmentally relevant levels. &COPY; 2005 Elsevier B.V. All rights reserved.
C1 Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld 4108, Australia.
   Univ Wurzburg, Lehrstuhl Bot 1, Julius Sachs Inst Biowissensch, D-97082 Wurzburg, Germany.
RP Nash, SMB (reprint author), Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld 4108, Australia.
EM s.nash@uq.edu.au
RI Bengtson Nash, Susan/I-3942-2015; Mueller, Jochen/C-6241-2008
OI Bengtson Nash, Susan/0000-0001-5928-0850; Mueller,
   Jochen/0000-0002-0000-1973
CR ARELLANO JB, 1995, PHOTOSYNTH RES, V45, P127, DOI 10.1007/BF00032584
   BLANCK H, 1984, ECOTOX ENVIRON SAFE, V8, P339, DOI 10.1016/0147-6513(84)90003-4
   Butler G. L., 1977, Residue Reviews, V66, P19
   ElJay A, 1997, ARCH HYDROBIOL, V140, P273
   ElJay A, 1996, ARCH ENVIRON CON TOX, V31, P84, DOI 10.1007/BF00203911
   Eullaffroy P, 2003, WATER RES, V37, P1983, DOI 10.1016/S0043-1354(02)00621-8
   Ferraz DGD, 2004, CHEMOSPHERE, V56, P315, DOI 10.1016/j.chemosphere.2004.01.038
   FLORENCE TM, 1986, AQUAT TOXICOL, V8, P11, DOI 10.1016/0166-445X(86)90069-X
   FRANKLIN N, 1998, NEW TROPICAL ALGAL T
   Franklin NM, 2000, AQUAT TOXICOL, V48, P275, DOI 10.1016/S0166-445X(99)00042-9
   GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9
   GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131
   GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x
   GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029
   HALL JA, 1998, MFE80205 NIWA
   JEGERSCHOLD C, 1995, BIOCHEMISTRY-US, V34, P12747, DOI 10.1021/bi00039a034
   Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153
   Juneau P, 2002, ARCH ENVIRON CON TOX, V42, P155, DOI 10.1007/s00244-001-0027-0
   Juneau P, 2001, CHEMOSPHERE, V45, P589, DOI 10.1016/S0045-6535(01)00034-0
   KARUBE I, 1986, BIOSENSORS FUNDAMENT, P13
   KENAGA EE, 1980, AQUAT TOXICOL, P707
   Klem K, 2002, WEED RES, V42, P335, DOI 10.1046/j.1365-3180.2002.00293.x
   KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525
   Kupper H, 2002, J PHYCOL, V38, P429, DOI 10.1046/j.1529-8817.2002.t01-1-01148.x
   Lazar D, 1999, BBA-BIOENERGETICS, V1412, P1, DOI 10.1016/S0005-2728(99)00047-X
   MAGUE TH, 1980, LIMNOL OCEANOGR, V25, P262, DOI 10.4319/lo.1980.25.2.0262
   Merz D, 1996, FRESEN J ANAL CHEM, V354, P299
   Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558
   NASH SMB, IN PRESS MARINE POLL
   Nasha SMB, 2005, BIOSENS BIOELECTRON, V20, P1443, DOI 10.1016/j.bios.2004.09.019
   ORR P, 1990, EPS1RM12
   OVERNELL J, 1975, MAR BIOL, V29, P99
   Patsikka E, 1998, PLANT PHYSIOL, V117, P619, DOI 10.1104/pp.117.2.619
   Powner E. T., 1997, Sensor Review, V17, P107, DOI 10.1108/02602289710170276
   Pringsheim E. G., 1946, PURE CULTURES ALGAE
   RAWSON DM, 1989, BIOSENSORS, V4, P299, DOI 10.1016/0265-928X(89)80011-2
   Schreiber U, 2002, PHOTOSYNTH RES, V74, P317, DOI 10.1023/A:1021276003145
   SCHREIBER U, 1995, AUST J PLANT PHYSIOL, V22, P209, DOI 10.1071/PP9950209
   Schreiber U., 2004, CHLOROPHYLL FLUORESC
   SCHREIBER U, 2001, HDB OPERATION
   STAUBER JL, 1985, AQUAT TOXICOL, V6, P297, DOI 10.1016/0166-445X(85)90025-6
   STAUBER JL, 1987, MAR BIOL, V94, P511, DOI 10.1007/BF00431397
   Stein J. R., 1973, HDB PHYCOLOGICAL MET
   THOMPSON AS, 1988, CULTURE COLLECTION A
   Vedrine C, 2003, BIOSENS BIOELECTRON, V18, P457, DOI 10.1016/S0956-5663(02)00157-4
   Velasco-Garcia MN, 2003, BIOSYST ENG, V84, P1, DOI 10.1016/S1537-5110(02)00236-2
   Verschueren K, 2001, HDB ENV DATA ORGANIC
   Vulkan R, 2000, ENVIRON SCI TECHNOL, V34, P5115, DOI 10.1021/es/0000910
   WARE GW, 1999, REV ENV CONTAMINATIO
NR 49
TC 31
Z9 34
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-445X
J9 AQUAT TOXICOL
JI Aquat. Toxicol.
PD MAY 15
PY 2005
VL 72
IS 4
BP 315
EP 326
DI 10.1016/j.aquatox.2005.02.004
PG 12
WC Marine & Freshwater Biology; Toxicology
SC Marine & Freshwater Biology; Toxicology
GA 926BI
UT WOS:000229097300003
DA 2018-10-19
ER

PT J
AU Shchipunov, YA
   Kojima, A
   Imae, T
AF Shchipunov, YA
   Kojima, A
   Imae, T
TI Polysaccharides as a template for silicate generated by sol-gel
   processes
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE sol-gel; polysaccharide mineralization; hybrid silica nanocomposite;
   biomaterial
ID NANOCOMPOSITES; BIOLOGICALS; POLYMERS
AB The polysaccharides, as established previously (Yu.A. Shchipunov, J. Colloid Interface Sci. 268 (2003) W Yu.A. ShchipUnOV, T.YU. Karpenko, Langmuir 20 (2004) 3882), can manipulate the formation of hybrid silica nanocomposites by sol-gel processes. Here atomic force microscopy was applied to show whether carbohydrate macromolecules serve as a template for silicate. Mica was used as a substrate to adsorb polysaccharide. It was found that its surface is not neutral to the sol-gel processes, providing the silica precipitation. To hinder it, the mica was protected by a monomolecular film of arachidic acid with the help of a Langmuir-Blodgett technique. Hydrophobically modified cationic hydrohyethylcellulose was adsorbed from a diluted aqueous Solution. It was demonstrated that the carbohydrate macromolecules located on the hydrophobic Surface did promote silica precipitation, serving as a template. (c) 2004 Elsevier Inc. All rights reserved.
C1 Russian Acad Sci, Far E Dept, Inst Chem, Vladivostok 690022, Russia.
   Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.
   Nagoya Univ, Res Ctr Mat Sci, Nagoya, Aichi 4648602, Japan.
RP Shchipunov, YA (reprint author), Russian Acad Sci, Far E Dept, Inst Chem, Vladivostok 690022, Russia.
EM yas@ich.dvo.ru
CR Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   Da Silva J. F., 2001, BIOL CHEM ELEMENTS I
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   Dujardin E, 2002, ADV MATER, V14, P775, DOI 10.1002/1521-4095(20020605)14:11<775::AID-ADMA775>3.0.CO;2-0
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   MEHROTRA RC, 1967, INDIAN J CHEM, V5, P444
   Pierre A. C., 1998, INTRO SOL GEL PROCES
   SHCHIPANOV YA, 2001, RUSS J PHYS CHEM, V75, P1795
   Shchipunov YA, 2003, J COLLOID INTERF SCI, V268, P68, DOI 10.1016/S0021-9797(03)00457-0
   Shchipunov YA, 2004, LANGMUIR, V20, P3882, DOI 10.1021/la0356912
   Shchipunov YA, 2004, J BIOCHEM BIOPH METH, V58, P25, DOI 10.1016/S0165-022X(03)00108-8
   VOLKANI BE, 1981, SILICON SILICEOUS ST, P157
   Zaremba CM, 1996, CURR OPIN SOLID ST M, V1, P425, DOI 10.1016/S1359-0286(96)80035-0
NR 17
TC 28
Z9 29
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 15
PY 2005
VL 285
IS 2
BP 574
EP 580
DI 10.1016/j.jcis.2004.11.026
PG 7
WC Chemistry, Physical
SC Chemistry
GA 920ZB
UT WOS:000228732900018
PM 15837474
DA 2018-10-19
ER

PT J
AU Kajzer, W
   Kaczmarek, M
   Marciniak, J
AF Kajzer, W
   Kaczmarek, M
   Marciniak, J
TI Biomechanical analysis of stent-oesophagus system
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Advances in Materials and Processing
   Technologies/13th International Conference on Achievements in Mechanical
   and Materials Engineering
CY MAY 16-19, 2005
CL Gliwice Wisla, POLAND
DE biomaterials; oesophageal stent; finite element method
ID MALIGNANT GASTRIC OUTLET; EXPANDING METAL STENTS; ESOPHAGORESPIRATORY
   FISTULAS; PALLIATION; OBSTRUCTION; STENOSES
AB The paper presents the biomechanical analysis of a stent-oesophagus system. In particular, stresses and strains for the oesophageal stent (Z-type) reflecting its implantation technique were calculated. The obtained results are the basis for the optimization of the geometrical features of the stent and mechanical properties of the metallic biomaterial. (c) 2005 Elsevier B.V. All rights reserved.
C1 Silesian Tech Univ, Inst Engn Mat & Biomat, PL-44100 Gliwice, Poland.
RP Kajzer, W (reprint author), Silesian Tech Univ, Inst Engn Mat & Biomat, Ul Konarskiego 18A, PL-44100 Gliwice, Poland.
EM wojciech.kajzer@polsl.pl
OI Kajzer, Wojciech/0000-0001-9285-1272; Kaczmarek,
   Marcin/0000-0002-0049-1554
CR Adler DG, 2002, AM J GASTROENTEROL, V97, P72
   Binkert CA, 1996, RADIOLOGY, V199, P335, DOI 10.1148/radiology.199.2.8668774
   Feretis C, 1996, ENDOSCOPY, V28, P225, DOI 10.1055/s-2007-1005432
   Kim JH, 2001, ENDOSCOPY, V33, P838, DOI 10.1055/s-2001-17340
   Maetani I, 1996, GASTROINTEST ENDOSC, V44, P468, DOI 10.1016/S0016-5107(96)70102-5
   MARCINIAK J, 2002, BIOMATERIALS WYDAWNI
   MARCINIAK J, 2004, IZNYNIERIA BIOMATERI, V38, P84
   May A, 1998, AM J GASTROENTEROL, V93, P532
   Pinto Pabon I T, 2001, Cardiovasc Intervent Radiol, V24, P147, DOI 10.1007/s002700001742
   PRUSZYNSKI B, 1999, RADIOLOGY IMAGE DIAG
   RALAHON A, 1998, GASTROENTEROL CLIN B, V22, P19
   Saida Y, 1996, DIS COLON RECTUM, V39, P552, DOI 10.1007/BF02058710
   WALKE W, P 11 INT SCI C AMME, P595
   WEIGERT N, 1995, GASTROINTEST ENDOSC, V41, P490, DOI 10.1016/S0016-5107(05)80009-4
   *WILS COOK MED INC, DIAGN THER END ACC
   Yates MR, 1998, ENDOSCOPY, V30, P266, DOI 10.1055/s-2007-1001253
NR 16
TC 13
Z9 15
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAY 15
PY 2005
VL 162
SI SI
BP 196
EP 202
DI 10.1016/j.jmatprotec.2005.02.209
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 929VU
UT WOS:000229375500032
DA 2018-10-19
ER

PT J
AU Bengali, Z
   Pannier, AK
   Segura, T
   Anderson, BC
   Jang, JH
   Mustoe, TA
   Shea, LD
AF Bengali, Z
   Pannier, AK
   Segura, T
   Anderson, BC
   Jang, JH
   Mustoe, TA
   Shea, LD
TI Gene delivery through cell culture substrate adsorbed DNA complexes
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE gene delivery; reverse transfection; solid-phase delivery; lipofectamine
   2000; polyethylenimine; biomaterial; substrate-mediated
ID ANTIBODY-TETHERED ADENOVIRUS; IN-VITRO; TRANSFECTION; VECTOR;
   EXPRESSION; MICROARRAYS; VIVO; TRANSDUCTION; FIBRONECTIN; ENHANCEMENT
AB Efficient gene delivery is a fundamental goal of biotechnology and has numerous applications in both basic and applied science. Substrate-mediated delivery and reverse transfection enhance gene transfer by increasing the concentration of DNA in the cellular microenvironment through immobilizing a plasmid to a cell culture substrate prior to cell seeding. In this report, we examine gene delivery of plasmids that were complexed with cationic polymers (polyplexes) or lipids (lipoplexes) and subsequently immobilized to cell culture or biomaterial substrates by adsorption. Polyplexes and lipoplexes were adsorbed to either tissue culture polystyrene or serum-adsorbed tissue culture polystyrene, The quantity of DNA immobilized increased with time of exposure, and the deposition rate and final amount deposited depended upon the properties of the substrate and complex. For polyplexes, serum modification enhanced reporter gene expression up to 1 500-fold relative to unmodified substrates and yielded equivalent or greater expression compared to bolus delivery. For lipoplexes, serum modification significantly increased the number of transfected cells relative to unmodified substrates yet provided similar levels of expression. Immobilized complexes transfect primary cells with improved cellular viability relative to bolus delivery. Finally, this substrate-mediated delivery approach was extended to a widely used biomaterial, poly(lactide-co-glycolide). Immobilization of DNA complexes to tissue culture polystyrene substrates can be a useful tool for enhancing gene delivery for in vitro studies. Additionally, adapting this system to biornaterials may facilitate application to fields such as tissue engineering. (c) 2005 Wiley Periodicals, Inc.
C1 Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Interdept Biol Sci, Evanston, IL 60208 USA.
   Northwestern Univ, Div Plast & Reconstruct Surg, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Biol & Chem Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Jang, Jae-Hyung/G-8030-2012; Shea, Lonnie/B-7615-2009
FU NCI NIH HHS [P50 CA089018, P50-CA89018]; NIGMS NIH HHS [R01 GM066830,
   R01 GM41303, R01 GM066830-03, R01 GM041303]
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   Bailey SN, 2002, DRUG DISCOV TODAY, V7, pS113, DOI 10.1016/S1359-6446(02)02386-3
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Choosakoonkriang S, 2003, J PHARM SCI, V92, P1710, DOI 10.1002/jps.10437
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976
   Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Kofron MD, 2004, BIOMATERIALS, V25, P2637, DOI 10.1016/j.biomaterials.2003.09.042
   Lei P, 2002, J VIROL, V76, P8722, DOI 10.1128/JVI.76.17.8722-8728.2002
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Mogford JE, 2002, J CELL PHYSIOL, V190, P259, DOI 10.1002/JCP.10060
   Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Ogris M, 2001, AAPS PHARMSCI, V3, part. no.
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   SEGURA T, IN PRESS BIOMATERIAL
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   SON KK, 2000, BIOCHIM BIOPHYS ACTA, V1466, P1
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   STUART MAC, 1991, ADV COLLOID INTERFAC, V34, P477, DOI 10.1016/0001-8686(91)80056-P
   Tseng WC, 1997, J BIOL CHEM, V272, P25641, DOI 10.1074/jbc.272.41.25641
   Uchida E, 2002, BIOL PHARM BULL, V25, P891, DOI 10.1248/bpb.25.891
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Zelphati O, 1998, BBA-LIPID LIPID MET, V1390, P119, DOI 10.1016/S0005-2760(97)00169-0
   Zhang XH, 2001, J GENE MED, V3, P560, DOI 10.1002/jgm.224
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 39
TC 96
Z9 99
U1 0
U2 21
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY 5
PY 2005
VL 90
IS 3
BP 290
EP 302
DI 10.1002/bit.20393
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 920YW
UT WOS:000228732400003
PM 15800863
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Bruinink, A
   Kaiser, JP
   Meyer, DC
AF Bruinink, A
   Kaiser, JP
   Meyer, DC
TI Effect of biomaterial surface morphologies on bone marrow cell
   performance
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; DIFFERENTIATION; ROUGHNESS; TITANIUM;
   ADHESION; TISSUE; PROLIFERATION; ORIENTATION; EXPRESSION
C1 Empa Mat Sci & Technol, Lab Biocompatible Mat, CH-9014 St Gallen, Switzerland.
   Univ Zurich Uniklin, CH-8008 Zurich, Switzerland.
RP Bruinink, A (reprint author), Empa Mat Sci & Technol, Lab Biocompatible Mat, Lerchenfeldstr 5, CH-9014 St Gallen, Switzerland.
EM arie.bruinink@empa.ch; dmeyer@balgrist.unizh.ch
CR Acemoglu M, 2004, INT J PHARM, V277, P133, DOI 10.1016/j.ijpharm.2003.06.002
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 2003, J ORTHOPAED RES, V21, P638, DOI 10.1016/S0736-0266(02)00261-9
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   Bruinink A, 1992, BRAIN BITS PIECES, P23
   Brunette D.M., 1988, SURFACE CHARACTERIZA, P203
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jungbauer S, 2004, CHEMPHYSCHEM, V5, P85, DOI 10.1002/cphc.200300868
   Kaiser JP, 2004, J MATER SCI-MATER M, V15, P429, DOI 10.1023/B:JMSM.0000021115.55254.a8
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kotobuki N, 2004, CELL TRANSPLANT, V13, P377, DOI 10.3727/000000004783983756
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lossdorfer S, 2004, BIOMATERIALS, V25, P2547, DOI 10.1016/j.biomaterials.2003.09.094
   Madore C, 1997, J MICROMECH MICROENG, V7, P270, DOI 10.1088/0960-1317/7/4/002
   Marks SC, 1996, MICROSC RES TECHNIQ, V33, P121, DOI 10.1002/(SICI)1097-0029(19960201)33:2<121::AID-JEMT3>3.0.CO;2-W
   MAROM R, 2002, J CELL PHYSL, V202, P41
   Monkawa T, 2002, J AM SOC NEPHROL, V13, P1172, DOI 10.1097/01.ASN.0000013162.29833.45
   Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3
   Navarro JM, 1997, EUR J CLIN INVEST, V27, P620, DOI 10.1046/j.1365-2362.1997.1510698.x
   Qu J, 1996, Oral Dis, V2, P102
   Schneider GB, 2004, J BIOMED MATER RES A, V69A, P462, DOI 10.1002/jbm.a.30016
   Sells-Galvin R., 1994, J BONE MINER RES, V9, P1167
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Shi ZQ, 2004, GENE, V343, P117, DOI 10.1016/j.gene.2004.08.009
   Simmons CA, 2001, J ORTHOPAED RES, V19, P187, DOI 10.1016/S0736-0266(00)90006-8
   SUZUKI K, 1993, MATSUMOTO SHIGAKU, V19, P223
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
   Zohar R, 1997, BLOOD, V90, P3471
NR 40
TC 8
Z9 8
U1 1
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAY
PY 2005
VL 7
IS 5
BP 411
EP 418
DI 10.1002/adem.200500065
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 937KL
UT WOS:000229922900027
DA 2018-10-19
ER

PT J
AU Daniel, J
   Abe, K
   McFetridge, PS
AF Daniel, J
   Abe, K
   McFetridge, PS
TI Development of the human umbilical vein scaffold for cardiovascular
   tissue engineering applications
SO ASAIO JOURNAL
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; DIAMETER VASCULAR GRAFTS; ABOVE-KNEE
   REVASCULARIZATION; ACELLULAR MATRIX; CORD VEIN; IN-VITRO; BYPASS GRAFTS;
   BLOOD-VESSELS; CROSS-LINKING; COLLAGEN
AB Biologic function and the mechanical performance of vascular grafting materials are important predictors of graft patency. As such, "functional" materials that improve biologic integration and function have become increasingly sought after. An important alternative to synthetic materials is the use of biomaterials derived from ex vivo tissues that retain significant biologic and mechanical function. Unfortunately, inconsistent mechanical properties that result from tedious, time consuming, manual dissection methods have reduced the potential usefulness of many of these materials. We describe the preparation of the human umbilical vein (HUV) for use as an acellular, three-dimensional, vascular scaffold using a novel, automated dissection methodology. The goal of this investigation was to determine the effectiveness of the autodissection methodology to yield an ex vivo biomaterial with improved uniformity and reduced variance. Mechanical properties, including burst pressure, compliance, uniaxial tension testing, and suture holding capacity, were assessed to determine the suitability of the HUV scaffold for vascular tissue engineering applications. The automated methodology results in a tubular scaffold with significantly reduced sample to sample variation, requiring significantly less time to excise the vein from the umbilical cord than manual dissection methods. Short-term analysis of the interactions between primary human vascular smooth muscle cells and fibroblasts HUV scaffold have shown an excellent potential for cellular integration by native cellular remodeling processes. Our work has shown that the HUV scaffold is mechanically sound, uniform, and maintains its biphasic stress-strain relationship throughout tissue processing. By maintaining the mechanical properties of the native blood vessels, in concert with promising cellular interactions, the HUV scaffold may lead to improved grafts for vascular reconstructive surgeries.
C1 Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK USA.
   Univ Oklahoma, Ctr Bioengn, Norman, OK USA.
RP McFetridge, PS (reprint author), Univ Oklahoma, Sch Chem Biol & Mat Engn, 100 E Boyd St, Norman, OK USA.
RI Mcfetridge, Peter/A-2802-2010
CR ARNDT JO, 1968, PFLUG ARCH EUR J PHY, V301, P230, DOI 10.1007/BF00363770
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   BODNAR E, 1986, THORAC CARDIOV SURG, V34, P82, DOI 10.1055/s-2007-1020381
   Budd J S, 1991, Eur J Vasc Surg, V5, P397, DOI 10.1016/S0950-821X(05)80171-9
   Bujan J, 2000, EUR J VASC ENDOVASC, V20, P13, DOI 10.1053/ejvs.2000.1090
   Bychkov S M, 1969, Biokhimiia, V34, P204
   Campbell JH, 1999, CIRC RES, V85, P1173
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   COURTMAN DW, 1995, J BIOMED MATER RES, V29, P1507, DOI 10.1002/jbm.820291207
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   DARDIK H, 1988, J VASC SURG, V7, P336, DOI 10.1067/mva.1988.avs0070336
   DARDIK H, 1976, JAMA-J AM MED ASSOC, V236, P2859
   DARDIK H, 1976, SURGERY, V79, P618
   DARDIK H, 1979, AM J SURG, V138, P234, DOI 10.1016/0002-9610(79)90376-3
   Dardik H, 1995, Cardiovasc Surg, V3, P265, DOI 10.1016/0967-2109(95)93874-O
   Dardik H, 2001, J VASC SURG, V33, P658, DOI 10.1067/mva.2001.112315
   DARDIK I, 1973, J MED PRIMATOL, V2, P296
   DARDIK II, 1977, J CARDIOVASC SURG, V18, P555
   DARDIK II, 1975, SURG GYNECOL OBSTET, V140, P567
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Dohmen Pascal M, 2002, Asian Cardiovasc Thorac Ann, V10, P25
   Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258
   Gamba PG, 2002, PEDIATR SURG INT, V18, P327, DOI 10.1007/s00383-002-0849-5
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   HASSON JE, 1986, J VASC SURG, V4, P243, DOI 10.1067/mva.1986.avs0040243
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kadner A, 2004, EUR J CARDIO-THORAC, V25, P635, DOI 10.1016/j.ejcts.2003.12.038
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KLEIN J, 1983, BIOCHIM BIOPHYS ACTA, V755, P400, DOI 10.1016/0304-4165(83)90243-X
   Kwon TG, 2002, J UROLOGY, V168, P1754, DOI 10.1097/01.ju.0000030103.53181.7d
   L'Heureux N, 1998, FASEB J, V12, P47
   Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   McFetridge PS, 2004, J BIOMED MATER RES A, V70A, P224, DOI 10.1002/jbm.a.30060
   MCFETRIDGE PS, 2002, THESIS U BATH
   MECHANIC GL, 1992, CROSS LINKING COLLAG
   MEYER FA, 1983, BIOCHIM BIOPHYS ACTA, V755, P376, DOI 10.1016/0304-4165(83)90241-6
   MIYATA T, 1989, J VASC SURG, V10, P605, DOI 10.1067/mva.1989.14860
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Nerem RM, 2000, YONSEI MED J, V41, P735, DOI 10.3349/ymj.2000.41.6.735
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Oegema TR, 2000, CRYOBIOLOGY, V40, P370, DOI 10.1006/cryo.2000.2253
   OLIVER RF, 1985, IMPLANT TISSUE, P1
   Pegg DE, 1997, CRYOBIOLOGY, V34, P183, DOI 10.1006/cryo.1996.1997
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   REID LC, 1987, METHOD ISOLATION CON
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x
   Sawyer P, 1987, MODERN VASCULAR GRAF
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   SCHMIDT CE, 2000, BIOMATERIALS, V21, P2214
   SCHMIDT SP, 1999, TISSUE ENG VASCULAR, P61
   SEIFALIAN AM, 1999, TISSUE ENG VASCULAR, P621
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   TAMURA N, 1999, INT J ARTIF ORGANS, V22, P419
   Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004
   Teebken OE, 2004, EUR J VASC ENDOVASC, V27, P597, DOI 10.1016/j.ejvs.2004.01.027
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Vyavahare N, 1997, CIRCULATION, V95, P479
NR 70
TC 55
Z9 55
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD MAY-JUN
PY 2005
VL 51
IS 3
BP 252
EP 261
DI 10.1097/01.MAT.0000160872.41871.7E
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 926MH
UT WOS:000229126800013
PM 15968956
OA Bronze
DA 2018-10-19
ER

PT J
AU Watanabe, J
   Ishihara, K
AF Watanabe, J
   Ishihara, K
TI Cell engineering biointerface focusing on cytocompatibility using
   phospholipid polymer with an isomeric oligo(lactic acid) segment
SO BIOMACROMOLECULES
LA English
DT Article
ID PHOSPHORYLCHOLINE; WATER; STEREOCOMPLEX; COPOLYMERS; SUBSTRATE;
   ADHESION; ASSAY
AB Initial contact between a biological environment and a biomaterial ultimately decides the in vivo performance. Therefore, the fabrication of a delicate biointerface is important because it can be utilized as a platform for novel biomaterials. For the preparation of advanced biomedical devices such as biochips, nanoparticles, and cell engineering devices, the surface properties may be modified by the design of polymeric biomaterials. Anomalous phospholipid polymers with an isomeric oligo(lactic acid) segment were designed and evaluated as a biointerface. The phospholipid polymer containing 2-methacryloyloxyethyl phosphorylcholine was easily copolymerized with isomeric oligo(lactic acid) macromonomers, and the obtained polymer could easily form thin coating membranes as biointerfaces. The oligo(lactic acid) involves three kinds of isomers: DL-, D-, and L-forms. The favorable characteristic on the surface provides regulation of cell-material interactions on the biointerface. The oligo(lactic acid) segment could form hydrophobic domains, which were considered to be located on the interface, to enhance protein adsorption and cell adhesion. The most favorable characteristics on the biointerface were dual functions of cytocompatibility by the phospholipid polymer and cell adhesion property by the oligo(lactic acid) segment. In this study, we focused on the biological responses such as protein adsorption and cell adhesion by change in the oligo(lactic acid) component. The cell viability on the confluent stage was evaluated in terms of metabolic activity.
C1 Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@bmw.t.u-tokyo.ac.jp
CR Baskin A, 1980, J BIOMED MATER RES, V14, P393
   Biran I, 2002, ANAL CHEM, V74, P3046, DOI 10.1021/ac020009e
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Konno T, 2004, BIOMACROMOLECULES, V5, P342, DOI 10.1021/bm034356p
   MATSUDA T, 1994, J JAPANESE SOC BIOMA, V12, P187
   Miyamoto D, 2004, BIOMATERIALS, V25, P71, DOI 10.1016/S0142-9612(03)00474-5
   Miyazawa K, 2002, MACROMOLECULES, V35, P2440, DOI 10.1021/ma011898v
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Oki A, 2001, ELECTROPHORESIS, V22, P341, DOI 10.1002/1522-2683(200101)22:2<341::AID-ELPS341>3.0.CO;2-W
   Park J, 2004, ANAL CHEM, V76, P2649, DOI 10.1021/ac035321i
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Takei K, 2004, BIOMACROMOLECULES, V5, P858, DOI 10.1021/bm0344250
   Watanabe J, 2003, ARTIF ORGANS, V27, P242, DOI 10.1046/j.1525-1594.2003.07015.x
   Watanabe J, 2003, CHEM LETT, V32, P192, DOI 10.1246/cl.2003.192
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1109, DOI 10.1021/bm025586r
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   YONEYAMA T, 2002, BIOMATERIALS, V23, P1445
NR 22
TC 21
Z9 23
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1797
EP 1802
DI 10.1021/bm050138f
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900080
PM 15877407
DA 2018-10-19
ER

PT J
AU Andersson, J
   Ekdahl, KN
   Lambris, JD
   Nilsson, B
AF Andersson, J
   Ekdahl, KN
   Lambris, JD
   Nilsson, B
TI Binding of C3 fragments on top of adsorbed plasma proteins during
   complement activation on a model biomaterial surface
SO BIOMATERIALS
LA English
DT Article
DE complement; complement activation; biomaterials; proteins adsorption;
   C3b binding
ID ELLIPSOMETRIC IN-VITRO; SOLID-SURFACES; FACTOR-B; ADSORPTION; BLOOD;
   IMMUNOGLOBULINS; PURIFICATION; COMPSTATIN; GENERATION; CONVERTASE
AB In the present study we investigate whether complement activation in blood in contact with a model biomaterial surface (polystyrene) occurs directly on the material surface or on top of an adsorbed plasma protein layer. Quartz crystal microbalance-dissipation analysis (QCM-D) complemented with enzyme immunoassays and Western blotting were used. QCM-D showed that the surface was immediately covered with a plasma protein film of approximately 8 nm. Complement activation that started concomitantly with the adsorption of the protein film was triggered by a self-limiting classical pathway activation. After adsorption of the protein film, alternative pathway activation provided the bulk of the C3b deposition that added 25% more mass to the surface. The build up of alternative pathway convertase complexes using purified C3 and factors B and D on different protein films as monitored by QCM-D showed that only adsorbed albumin, IgG, but not fibrinogen, allowed Ob binding, convertase assembly and amplification. Western blotting of eluted proteins from the material surface demonstrated that the C3 fragments were covalently bound to other proteins. This is consistent with a model in which the activation is triggered by initiating convertases formed by means of the initially adsorbed proteins and the main O3b binding is mediated by the alternative pathway on top of the adsorbed protein film. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden.
   Univ Penn, Dept Pathol & Lab Med, Prot Chem Lab, Philadelphia, PA 19104 USA.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
EM Bo.Nilsson@klinimm.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730; Lambris, John/0000-0002-9370-5776
CR Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   CATANA E, 1991, J IMMUNOL METHODS, V138, P265, DOI 10.1016/0022-1759(91)90175-F
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   ELWING H, 1984, J IMMUNOL METHODS, V71, P185, DOI 10.1016/0022-1759(84)90064-4
   FISHELSON Z, 1982, J IMMUNOL, V129, P2603
   HAMMER CH, 1981, J BIOL CHEM, V256, P3995
   HED J, 1984, IMMUNOL LETT, V8, P295, DOI 10.1016/0165-2478(84)90013-0
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   LAMBRIS JD, 1984, J BIOL CHEM, V259, P2685
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1972, IMMUNOCHEMISTRY, V9, P709, DOI 10.1016/0019-2791(72)90015-8
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   ROSS GD, 1983, J EXP MED, V158, P334, DOI 10.1084/jem.158.2.334
   Sahu A, 1996, J IMMUNOL, V157, P884
   Sahu A, 2003, MOL IMMUNOL, V39, P557, DOI 10.1016/S0161-5890(02)00212-2
   Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3
   Tengvall P, 1998, BIOMATERIALS, V19, P935, DOI 10.1016/S0142-9612(98)00005-2
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   Tengvall P, 2001, J BIOMED MATER RES, V57, P285, DOI 10.1002/1097-4636(200111)57:2<285::AID-JBM1169>3.0.CO;2-C
   VENKATESH YP, 1988, MOL IMMUNOL, V25, P821, DOI 10.1016/0161-5890(88)90118-6
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
NR 31
TC 106
Z9 108
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 13
BP 1477
EP 1485
DI 10.1016/j.biomaterials.2004.05.011
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 889CX
UT WOS:000226422200004
PM 15522749
DA 2018-10-19
ER

PT J
AU Segura, T
   Chung, PH
   Shea, LD
AF Segura, T
   Chung, PH
   Shea, LD
TI DNA delivery from hyaluronic acid-collagen hydrogels via a
   substrate-mediated approach
SO BIOMATERIALS
LA English
DT Article
DE gene delivery; polyethyleneimine; neutravidin; biotin; reverse
   transfection; solid plase
ID DNA/TRANSFERRIN-PEI COMPLEXES; TARGETED GENE DELIVERY; IN-VIVO; CELLS;
   TRANSFECTION; SIZE; SURFACE; FIBRONECTIN; POLYPLEXES; EXPRESSION
AB Efficient and controlled gene delivery from biodegradable materials can be employed to stimulate cellular processes that lead to tissue regeneration. In this report, a substrate-mediated approach was developed to deliver DNA from hyaluronic acid-collagen hydrogels. The hydrogels were formed by crosslinking HA with poly(ethylene glycol) diglycidyl ether. Poly(ethylene imine)(PEI)/ DNA complexes were immobilized to the substrate using either biotin/neutravidin or non-specific adsorption. Complexes were formed in the presence or absence of salt to regulate complex size, and resulted in complexes with z-average diameters of 1221.7 +/- 152.3 and 139.4 +/- 1.3 nm, respectively. During 48-h incubation in PBS or hyaluronidase, DNA was released slowly from the hydrogel substrate (<30% of immobilized DNA), which was enhanced by incubation with conditioned media (approximate to50% of immobilized DNA). Transgene expression mediated by immobilized, large diameter complexes was 3 to 7-fold greater than for small diameter complexes. However, the percentage of cells expressing the transgene was greater for small diameter complexes (48.7%) than for large diameter complexes (22.3%). Spatially controlled gene transfer was achieved by topographically patterning the hydrogel to pattern cell adhesion. Biomaterial-based gene delivery can be applicable to numerous tissue engineering applications, or as a tool to examine tissue formation. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem Engn, 2145 Sheridad Rd,E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIGMS NIH HHS [R01GM066830, R01 GM066830-01A1, R01 GM066830]
CR Adami RC, 1999, J PHARM SCI, V88, P739, DOI 10.1021/js990042p
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Braddock M, 2001, ANN MED, V33, P313, DOI 10.3109/07853890109002083
   Choe MM, 2003, AM J PHYSIOL-LUNG C, V285, pL427, DOI 10.1152/ajplung.00005.2003
   Goula D, 1998, GENE THER, V5, P712, DOI 10.1038/sj.gt.3300635
   Hagstrom JE, 2000, CURR OPIN MOL THER, V2, P143
   Harbottle RP, 1998, HUM GENE THER, V9, P1037, DOI 10.1089/hum.1998.9.7-1037
   Honma K, 2001, BIOCHEM BIOPH RES CO, V289, P1075, DOI 10.1006/bbrc.2001.6133
   JULKUNEN I, 1984, BIOCHEM J, V219, P425, DOI 10.1042/bj2190425
   KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002
   Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418
   Kunath K, 2003, J CONTROL RELEASE, V88, P159, DOI 10.1016/S0168-3659(02)00458-3
   Kunath K, 2003, J GENE MED, V5, P588, DOI 10.1002/jgm.382
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Lucas P, 1999, J DRUG TARGET, V7, P143, DOI 10.3109/10611869909085498
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Ogris M, 1998, GENE THER, V5, P1425, DOI 10.1038/sj.gt.3300745
   Ogris M, 2001, AAPS PHARMSCI, V3, part. no.
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Oupicky D, 2000, BIOCONJUGATE CHEM, V11, P492, DOI 10.1021/bc990143e
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   PANNIER AK, IN PRESS MOL THER
   Plank C, 1999, HUM GENE THER, V10, P319, DOI 10.1089/10430349950019101
   PLANK C, 1992, BIOCONJUGATE CHEM, V3, P533, DOI 10.1021/bc00018a012
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Scholl SM, 2003, J BIOMED BIOTECHNOL, P35
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   SEGURA T, 2004, IN PRESS BIOMATERIAL
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Toncheva V, 1998, BBA-GEN SUBJECTS, V1380, P354, DOI 10.1016/S0304-4165(98)00004-X
   Trubetskoy VS, 1999, NUCLEIC ACIDS RES, V27, P3090, DOI 10.1093/nar/27.15.3090
   Trubetskoy VS, 1998, NUCLEIC ACIDS RES, V26, P4178, DOI 10.1093/nar/26.18.4178
   Trubetskoy VS, 1999, BIOCONJUGATE CHEM, V10, P624, DOI 10.1021/bc9801530
   Williams DA, 1999, ANN NY ACAD SCI, V872, P109, DOI 10.1111/j.1749-6632.1999.tb08457.x
   Wolf E, 1999, OPT PHOTONICS NEWS, V10, P6
   Xu B, 1998, GENE THER, V5, P1235, DOI 10.1038/sj.gt.3300719
NR 39
TC 105
Z9 109
U1 7
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 13
BP 1575
EP 1584
DI 10.1016/j.biomaterials.2004.05.007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 889CX
UT WOS:000226422200014
PM 15522759
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Johnell, M
   Larsson, R
   Siegbahn, A
AF Johnell, M
   Larsson, R
   Siegbahn, A
TI The influence of different heparin surface concentrations and
   antithrombin-binding capacity on inflammation and coagulation
SO BIOMATERIALS
LA English
DT Article
DE heparin; biomaterial; biocompatibility; cell activation
ID FLOW-CYTOMETRIC ASSAY; TISSUE FACTOR; EXTRACORPOREAL-CIRCULATION;
   CARDIOPULMONARY BYPASS; CELL-ADHESION; P-SELECTIN; IN-VITRO; ACTIVATION;
   BLOOD; EXPRESSION
AB The corline heparin surface (CHS) used in the extracorporeal circuit during coronary artery bypass grafting is shown to decrease the activation of inflammation and coagulation. Synchrotron radiation studies have shown that a single layer of the CHS may not completely cover the substrate surface. However, a double layer of CHS results in a uniform surface. We investigated the effect of surfaces with different surface concentrations of heparin on cell activation and coagulation compared to an uncoated surface.
   The CHS is prepared by a conditioning layer of polymeric amine onto which a macromolecular heparin conjugate is attached. We used PVC tubing, uncoated or modified with a single or double layer of the CHS, and circulated fresh whole blood from healthy volunteers in a loop model system at 37degreesC up to 4h. Blood was drawn from the loops at different times and activation of inflammation and coagulation was studied by real-time PCR, flow cytometry and ELISA. The activation of leukocytes and platelets and formation of leukocyte-platelet aggregates were reduced by use of the single-layered CHS compared to the uncoated surface. Use of double-layered CHS resulted in significantly reduced cell activation and thrombin generation. Development of the CHS obtained by the double layer of the coating has improved the biocompatibility of the surface. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Uppsala Univ, Akad Hosp, Lab Coagulat Res, Dept Med Sci, SE-75185 Uppsala, Sweden.
   Akad Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
RP Siegbahn, A (reprint author), Uppsala Univ, Akad Hosp, Lab Coagulat Res, Dept Med Sci, SE-75185 Uppsala, Sweden.
EM agneta.siegbahn@akademiska.se
CR Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Arefieva TL, 2001, J CELL PHYSIOL, V188, P403, DOI 10.1002/jcp.1127
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   Ben-Abraham R, 2003, PAEDIATR ANAESTH, V13, P655, DOI 10.1046/j.1460-9592.2003.01069.x
   CAZENAVE JP, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P49
   CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767
   FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Hunt BJ, 1998, ANN THORAC SURG, V65, P712, DOI 10.1016/S0003-4975(97)01345-3
   Johnell M, 2002, SCAND CARDIOVASC J, V36, P351, DOI 10.1080/140174302762659076
   Johnell M, 2002, J THORAC CARDIOV SUR, V124, P321, DOI 10.1067/mtc.2002.122551
   Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042
   KAPPELMAYER J, 1993, CIRC RES, V72, P1075, DOI 10.1161/01.RES.72.5.1075
   Kjalke M, 1998, THROMB HAEMOSTASIS, V80, P578
   Kristensen EME, 2003, BIOMATERIALS, V24, P4153, DOI 10.1016/S0142-9612(03)00297-7
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LARSSON R, 2004, IN PRESS ENCY BIOMAT
   Li NL, 1999, CYTOMETRY, V35, P154, DOI 10.1002/(SICI)1097-0320(19990201)35:2<154::AID-CYTO7>3.0.CO;2-Y
   Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322
   Malarstig A, 2003, THROMB RES, V112, P175, DOI 10.1016/j.thromres.2003.11.001
   Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66
   Neumann FJ, 1997, CIRCULATION, V95, P2387, DOI 10.1161/01.CIR.95.10.2387
   Petersen LC, 2001, SEMIN HEMATOL, V38, P39, DOI 10.1053/shem.2001.29510
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tenno T, 2000, LEUKEMIA, V14, P1105, DOI 10.1038/sj.leu.2401785
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
NR 27
TC 40
Z9 41
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1731
EP 1739
DI 10.1016/j.biomaterials.2004.05.029
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800014
PM 15576147
DA 2018-10-19
ER

PT J
AU De Jong, WH
   Bergsma, JE
   Robinson, JE
   Bos, RRM
AF De Jong, WH
   Bergsma, JE
   Robinson, JE
   Bos, RRM
TI Tissue response to partially in vitro predegraded poly-L-lactide
   implants
SO BIOMATERIALS
LA English
DT Article
DE PLA implant; histology; immunohistochemistry; predegradation;
   biocompatibility
ID FOREIGN-BODY REACTION; POLY(L-LACTIDE) BONE PLATES; DERMAL SHEEP
   COLLAGEN; INTERNAL-FIXATION; BIODEGRADABLE BIOMATERIAL;
   QUANTITATIVE-ANALYSIS; FRACTURE FIXATION; BLOCK-COPOLYMERS;
   DRUG-DELIVERY; IFN-GAMMA
AB The in vivo local reaction of as-polymerized poly-L-lactide composed of 96% L-lactide and 4% D-lactide (PLA96) was investigated by histology at 2, 13 and 26 weeks after subcutaneous implantation in rats. In order to simulate possible end stage reactions the PLA96 was also predegraded in vitro until approximately 50% weight loss. The local reaction of predegraded PLA (PLA96(168)) was compared to the local reaction of polyethylene (PE) and non-predegraded PLA (PLA96).
   For PE and PLA96 a mild local reaction was observed at all time points consisting of a minimal layer of macrophage like cells with incidentally multinucleated giant cells at the implant interface, surrounded by a mild connective tissue capsule. For PLA96 at weeks 13 and 26 some minimal alterations in terms of degradation and ingrowth of cells was noted. The in vitro incubation (90degreesC for 168 h) of PLA96(168) resulted for the thin 0.2 mm samples in complete degradation. Predegraded 0.5, 1.0 and 2.0 turn PLA96(168) samples were implanted and evaluated. The 1.0 and 2.0 mm samples could be evaluated for all time points investigated. but some 0.5 mm PLA96168 samples were already completely resorbed at week 2 after implantation. In general, responses found for the predegraded PLA96(168) at weeks 2, 13 and 26 were similar with a pronounced macrophage infiltrate containing birefringent material. encapsulation of polymer fragments, and the presence of a debris area consisting Of Polymer and cellular remnants. in lymph nodes foamy macrophages with birefringent material were only observed in lymph nodes draining sites with predegraded PLA96(168).
   Immunohistochemistry was performed for further characterization of the cellular infiltrate. At the implant interface of the nondegrading PE and PLA96, ED1 and OX6 (MHC class 11) positive cells were identified. In the capsule macrophage Eke cells expressed all three macrophage markers ED1, ED2, and ED3. CD4 and CD8 positive cells. indicating T helper and T supressor/cytotoxic cells, respectively. could be observed in low numbers, CD4 more than CD8. Both CD4 and CD8 were occasionally observed within the degrading PLA96(168) implant. Polymorphonuclear neutrophilic granulocytes were mainly observed at 2 weeks after implantation.
   We showed that predegradation Could be used as a means to study late tissue reactions to polymers. Complete degradation may be studied with relatively thin implants, but this may lead to rather optimistic interpretation of resorption periods. When materials are intended to be used for screws and/or plates for bone fixation, implants of at least 1.0-2.0 mm thickness should be used as these May show a more realistic representation of the resorption characteristics of the material under investigation. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Inst Publ Hlth & Environm, Lab Toxicol Pathol & Genet, NL-3720 BA Bilthoven, Netherlands.
   Univ Groningen Hosp, Dept Oral & Maxillofacial Surg, Groningen, Netherlands.
RP De Jong, WH (reprint author), Natl Inst Publ Hlth & Environm, Lab Toxicol Pathol & Genet, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM w.de.jong@rivm.nl
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Ashammakhi N, 2003, J CRANIOFAC SURG, V14, P247, DOI 10.1097/00001665-200303000-00021
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bergsma JE, 1995, J MATER SCI-MATER M, V6, P715, DOI 10.1007/BF00134307
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Bostman O, 2000, BIOMATERIALS, V21, P2553, DOI 10.1016/S0142-9612(00)00123-X
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Cordewener FW, 2000, BIOMATERIALS, V21, P2433, DOI 10.1016/S0142-9612(00)00111-3
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   DEVOR DE, 1993, TOXICOL PATHOL, V21, P261, DOI 10.1177/019262339302100301
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   *ISO, 1994, BIOL EV MED DEV 6
   Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 2000, J BIOMED MATER RES, V50, P259, DOI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   Kobayashi D, 1998, DRUG DEV IND PHARM, V24, P819, DOI 10.3109/03639049809088526
   LEENSLAG JW, 1987, MACROMOL CHEM, V45, P751
   Margevicius KJ, 1996, J BIOMED MATER RES, V31, P319, DOI 10.1002/(SICI)1097-4636(199607)31:3<319::AID-JBM5>3.0.CO;2-P
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   MATSUSUE Y, 1992, J BIOMED MATER RES, V26, P1553, DOI 10.1002/jbm.820261203
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Pietrzak WS, 2003, J CRANIOFAC SURG, V14, P176, DOI 10.1097/00001665-200303000-00008
   Pietrzak WS, 2000, TISSUE ENG, V6, P425, DOI 10.1089/107632700418128
   Prokop A, 2004, BIOMATERIALS, V25, P259, DOI 10.1016/S0142-9612(03)00496-4
   ROZEMA FR, 1994, J MATER SCI-MATER M, V5, P575, DOI 10.1007/BF00120333
   Saito N, 2001, J BONE JOINT SURG AM, V83A, pS92
   Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X
   Suuronen R, 2000, J Craniomaxillofac Trauma, V6, P19
   van den Berg TK, 2001, IMMUNOL REV, V184, P45, DOI 10.1034/j.1600-065x.2001.1840105.x
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   van Luyn MJA, 2001, BIOMATERIALS, V22, P1385, DOI 10.1016/S0142-9612(00)00295-7
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANDERELST M, 1995, BIOMATERIALS, V16, P103, DOI 10.1016/0142-9612(95)98270-O
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P1115, DOI 10.1002/jbm.820270817
   Walboomers XF, 2000, BIOMATERIALS, V21, P629, DOI 10.1016/S0142-9612(99)00230-6
NR 43
TC 50
Z9 50
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1781
EP 1791
DI 10.1016/j.biomaterials.2004.06.026
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800019
PM 15576152
DA 2018-10-19
ER

PT J
AU Kilian, O
   Fuhrmann, R
   Alt, V
   Noll, T
   Coskun, S
   Dingeldein, E
   Schnettler, R
   Franke, RP
AF Kilian, O
   Fuhrmann, R
   Alt, V
   Noll, T
   Coskun, S
   Dingeldein, E
   Schnettler, R
   Franke, RP
TI Plasma transglutaminase factor XIII induces microvessel ingrowth into
   biodegradable hydroxyapatite implants in rats
SO BIOMATERIALS
LA English
DT Article
DE plasma factor XIII; hydroxyapatite; confocal laser scanning microscopy;
   alpha smooth muscle actin antigen; CD34 antigen; angiogenesis
ID BONE-GRAFTS; CELL-ADHESION; ANGIOGENESIS; EXPRESSION; VASCULARIZATION;
   FIBRONECTIN; DEFECTS
AB Coagulation factor XIII is a member of the transglutaminase-family. Transgluaminases cross-link either fibrin monomers in blood coagulation or extracellular proteins in extracellular matrix formation. In early stages of bone healing migration and proliferation of endothelial cells lead to formation of new vessels. The aim of this study was to investigate the angiogenetic activity of plasma factor XIII in bone defects filled with nanoparticulate hydroxyapatite paste. A critical size defect was created in the tibial head of rats which was not filled in group I. In group 11 the defect was filled with hydroxyapatite group III with hydroxyapatite paste enriched with factor XIII. Ten days after surgery angiogenesis in the defects was assessed using immunohistochemistry and confocal laser scanning microscopy. Ac16 antibody was used to detect activation of factor XIII into factor XIIIA. In defects without biomaterial (group 1) vessel-rich connective tissue and diffuse distribution of capillaries was observed. In defects without pure hydroxyapatite (group 11) formation of capillaries was limited to the host bone-hydroxyapatite interface. In contrast. addition of plasma factor XIII to hydroxyapatite (group 111) stimulated formation of vessels within the biomaterial. The cur-rent study reveals that factor XIII can improve angiogenesis in hydroxyapatite. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Giessen, Dept Trauma Surg, D-35392 Giessen, Germany.
   Univ Ulm, Dept Biomat, D-89069 Ulm, Germany.
   Univ Giessen, Inst Physiol, Giessen, Germany.
   Osartis GmbH, Obernburg, Germany.
RP Kilian, O (reprint author), Univ Giessen, Dept Trauma Surg, Rudolf Buchheim Str 7, D-35392 Giessen, Germany.
EM olaf.kilian@chiru.med.uni-giessen.de
CR Adany Roza, 1996, Seminars in Thrombosis and Hemostasis, V22, P399, DOI 10.1055/s-2007-999038
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Barou O, 2002, BONE, V30, P604, DOI 10.1016/S8756-3282(02)00677-4
   BARRY ELR, 1988, J BIOL CHEM, V263, P10464
   BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P832, DOI 10.2106/00004623-199173060-00006
   Chakkalakal DA, 1999, BONE, V25, P321, DOI 10.1016/S8756-3282(99)00167-2
   CLAES L, 1985, ACTA ORTHOP SCAND, V56, P57
   Dardik R, 2003, ARTERIOSCL THROM VAS, V23, P1472, DOI 10.1161/01.ATV.0000081636.25235.C6
   El-Hakim IE, 1999, INT J ORAL MAX SURG, V28, P304, DOI 10.1016/S0901-5027(99)80164-7
   FINA L, 1990, BLOOD, V75, P2417
   FONSECA RJ, 1983, J ORAL MAXIL SURG, V41, P153, DOI 10.1016/0278-2391(83)90073-3
   GERNGROSS H, 1986, ARCH ORTHOP TRAUM SU, V106, P23, DOI 10.1007/BF00435648
   Glowacki J, 1998, CLIN ORTHOP S, V355, pS82
   Heath DJ, 2002, BIOMATERIALS, V23, P1519, DOI 10.1016/S0142-9612(01)00282-4
   KELLY PJ, 1990, CLIN ORTHOP RELAT R, P275
   KIENAPFEL H, 1995, Z ORTHOP GRENZGEB, V133, P394, DOI 10.1055/s-2008-1039944
   KIRKEBY OJ, 1992, SCAND J PLAST RECONS, V26, P141, DOI 10.3109/02844319209016004
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   MCDONAGH J, 1994, HEMOSTASIS THROMBOSI, P301
   MUZBEK I, 1993, THROMB HAEMOSTASIS, V69, P282
   MUZBEK L, 1995, THROMB HAEMOSTASIS, V73, P702
   Nurminskaya MV, 2002, J ORTHOPAED RES, V20, P575, DOI 10.1016/S0736-0266(01)00146-2
   Nurminskaya MV, 2002, DEV DYNAM, V223, P24, DOI 10.1002/dvdy.1230
   Ohtsubo S, 2003, HISTOL HISTOPATHOL, V18, P153, DOI 10.14670/HH-18.153
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Stromblad S, 1996, TRENDS CELL BIOL, V6, P462, DOI 10.1016/0962-8924(96)84942-7
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Ueki S, 1996, J CELL SCI, V109, P2727
   Wozniak Gernold, 1996, Seminars in Thrombosis and Hemostasis, V22, P445, DOI 10.1055/s-2007-999044
NR 31
TC 19
Z9 19
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1819
EP 1827
DI 10.1016/j.biomaterials.2004.06.015
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800023
PM 15576156
DA 2018-10-19
ER

PT J
AU Zinger, O
   Zhao, G
   Schwartz, Z
   Simpson, J
   Wieland, M
   Landolt, D
   Boyan, B
AF Zinger, O
   Zhao, G
   Schwartz, Z
   Simpson, J
   Wieland, M
   Landolt, D
   Boyan, B
TI Differential regulation of osteoblasts by substrate microstructural
   features
SO BIOMATERIALS
LA English
DT Article
DE titanium; microarchitecture; microstructure; roughness;
   photolithography; Osteoblasts; MG63 cells; PGE(2); surface;
   electrochemical micromachining
ID TITANIUM SURFACE-ROUGHNESS; SCREW-SHAPED IMPLANTS; GROWTH-FACTOR-BETA;
   CELLS IN-VITRO; BONE-BIOMATERIAL; ACID; OSTEOPONTIN; TOPOGRAPHY;
   EXPRESSION; COLLAGEN
AB Microtextured titanium implant surfaces enhance bone formation in vivo and osteoblast phenotypic expression in vitro, but the mechanisms are not understood. To determine the roles of specific microarchitectural features in modulating osteoblast behavior, we used Ti surfaces prepared by electrochemical micromachining as substrates for MG63 osteoblast-like cell culture. Cell response was compared to tissue culture plastic, a sand-blasted with large grit and acid-etched surface with defined mixed microtopography (SLA), polished Ti surfaces. and polished surfaces electrochemically machined through a photoresist pattern to produce cavities with 100, 30 and 10 mum diameters arranged so that the ratio of the microscopic-scale area of the cavities versus the microscopic-scale area of the flat region between the cavities was equal to I or 6. Microstructured disks were acid-etched. producing overall sub-micron-scale roughness (Ra = 0.7 mum). Cell number, differentiation (alkaline phosphatase: osteocalcin) and local factor levels (TGF-beta1; PGE(2)) varied with micro architecture. 100 mum cavities favored osteoblast attachment and growth. the sub-micron-scale etch 4 enhanced differentiation and TGF-beta1 production, whereas PGE(2) depended on cavity dimensions but not the sub-micron-scale roughness. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel.
   Univ Texas, Hlth Sci Ctr, San Antonio, TX USA.
   Inst Straumann AG, Waldenburg, Switzerland.
RP Boyan, B (reprint author), Georgia Inst Technol, Dept Biomed Engn, 315 Ferst Dr NW, Atlanta, GA 30332 USA.
EM Barbara.Boyan@bme.gatech.edu
RI Landolt, Dieter/G-9940-2011
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Bank I, 2003, CELL IMMUNOL, V223, P35, DOI 10.1016/S0008-8749(03)00147-3
   Bannister SR, 2002, J BIOMED MATER RES, V60, P167, DOI 10.1002/jbm.10037
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   BONEWALD LF, 1992, J BIOL CHEM, V267, P8943
   BONEWALD LF, 1990, J CELL PHYSIOL, V145, P200, DOI 10.1002/jcp.1041450203
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   BOYAN BD, 1989, J BIOL CHEM, V264, P11879
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 2001, J BIOMED MATER RES, V55, P350, DOI 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M
   BOYAN BD, 2003, J ORTHOP RES, V4, P638
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1991, BONE-BIOMATERIAL INTERFACE, P170
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6
   Cheroudi B, 1990, J BIOMED MATER RES, V24, P1203
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Davies John E, 2003, J Dent Educ, V67, P932
   DODDS RA, 1995, J BONE MINER RES, V10, P1666
   EVERTS V, 1992, J CELL PHYSIOL, V150, P221, DOI 10.1002/jcp.1041500202
   FRANCESCHI RT, 1985, J CELL PHYSIOL, V123, P401, DOI 10.1002/jcp.1041230316
   Hallgren C, 2001, J BIOMED MATER RES, V57, P485, DOI 10.1002/1097-4636(20011215)57:4<485::AID-JBM1194>3.0.CO;2-1
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Keller John C, 2003, Implant Dent, V12, P175
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   KORATKAR R, 1993, PROSTAG LEUKOTR ESS, V48, P175, DOI 10.1016/0952-3278(93)90107-8
   Landolt D, 2003, ELECTROCHIM ACTA, V48, P3185, DOI 10.1016/S0013-4686(03)00368-2
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MILLER SC, 1993, BONE, V14, P143, DOI 10.1016/8756-3282(93)90241-2
   OKIJI T, 1993, ARCH ORAL BIOL, V38, P31, DOI 10.1016/0003-9969(93)90151-B
   Ong J L, 1997, Implant Dent, V6, P19, DOI 10.1097/00008505-199700610-00004
   Ong J L, 1999, J Oral Implantol, V25, P95, DOI 10.1563/1548-1336(1999)025<0095:OPCRTC>2.3.CO;2
   Ong JL, 1998, J BIOMED MATER RES, V39, P176, DOI 10.1002/(SICI)1097-4636(199802)39:2<176::AID-JBM2>3.0.CO;2-M
   Perrin D, 2002, CLIN ORAL IMPLAN RES, V13, P465, DOI 10.1034/j.1600-0501.2002.130504.x
   ROESLER WJ, 1988, J BIOL CHEM, V263, P9063
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Schwartz Z, 2000, J PERIODONTOL, V71, P586, DOI 10.1902/jop.2000.71.4.586
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   SHEU TJ, 2002, J BONE MINER RES, V5, P915
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Sisk MA, 2001, CLIN ORAL IMPLAN RES, V12, P52, DOI 10.1034/j.1600-0501.2001.012001052.x
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
NR 51
TC 240
Z9 251
U1 4
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1837
EP 1847
DI 10.1016/j.biomaterials.2004.06.035
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800025
PM 15576158
DA 2018-10-19
ER

PT J
AU Wei, HJ
   Liang, HC
   Lee, MH
   Huan, YC
   Chang, Y
   Sung, HW
AF Wei, HJ
   Liang, HC
   Lee, MH
   Huan, YC
   Chang, Y
   Sung, HW
TI Construction of varying porous structures in acellular bovine pericardia
   as a tissue-engineering extracellular matrix
SO BIOMATERIALS
LA English
DT Article
DE acellular tissue; porosity; biochemical property; mechanical property;
   angiogenesis
ID CROSS-LINKING AGENT; FIXATIVE CONCENTRATION; MECHANICAL-PROPERTIES;
   IN-VITRO; COLLAGEN; GLYCOSAMINOGLYCANS; BIOMATERIAL; TEMPERATURE;
   ELASTIN; GENIPIN
AB In the study, a cell extraction process was used to remove the cellular components from bovine pericardia. Varying pore sizes and porosities of the acellular tissues were then created using acetic acid and collagenase and subsequently fixed with genipin. Biochemical analyses found that these acellular tissues with distinct porous structures consisted primarily of insoluble Collagen, elastin, and tightly bound glycosaminoglycans. The thermal stability. mechanical properties, and capability against enzymatic degradation of the bovine pericardial tissue remained unaltered after cell extraction. However, following further treatment with acetic acid and collagenase, the thermal stability and capability against enzymatic degradation of the acellular tissues declined. The porous structures of the implanted samples seem to determine whether successful microvessel-ingrowth takes place. The acetic-acid- and collagenase-treated tissues, due to their high pore size and porosity, showed a large number of microvessels infiltrating into the interstices of the implanted samples. In contrast, a low density of microvessels was observed infiltrating into the acellular tissue and penetration of microvessels into the cellular tissue was never encountered. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   Natl Yang Ming Univ, Taichung Vet Gen Hosp, Div Cardiovasc Surg, Taichung, Taiwan.
   Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan.
RP Sung, HW (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
EM hwsung@che.nthu.edu.tw
CR Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   Lee K., 2000, PRINCIPLES TISSUE EN, P409
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   MENGER MD, 1990, THORAC CARDIOV SURG, V38, P139, DOI 10.1055/s-2007-1014008
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NOISHIKI Y, 1986, J BIOMED MATER RES, V20, P337, DOI 10.1002/jbm.820200306
   Noishiki Y, 1986, ASAIO Trans, V32, P114
   Ramshaw JAM, 1999, J BIOMED MATER RES, V47, P309, DOI 10.1002/(SICI)1097-4636(19991205)47:3<309::AID-JBM4>3.0.CO;2-R
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   Sung HW, 2000, J BIOMED MATER RES, V52, P77, DOI 10.1002/1097-4636(200010)52:1<77::AID-JBM10>3.0.CO;2-6
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   Sung HW, 1999, J BIOMED MATER RES, V47, P116, DOI 10.1002/(SICI)1097-4636(199911)47:2<116::AID-JBM2>3.0.CO;2-J
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Wayne JS, 2001, J REHABIL RES DEV, V38, P191
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, P340
   Young B, 2000, WHEATERS FUNCTIONAL
NR 31
TC 34
Z9 37
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1905
EP 1913
DI 10.1016/j.biomaterials.2004.06.014
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800031
PM 15576164
DA 2018-10-19
ER

PT J
AU Jones, DS
   Djokic, J
   Gorman, SP
AF Jones, DS
   Djokic, J
   Gorman, SP
TI The resistance of polyvinylpyrrolidone-Iodine-poly(epsilon-caprolactone)
   blends to adherence of Escherichia coli
SO BIOMATERIALS
LA English
DT Article
DE poly(epsilon-caprolactone); povidone-iodine; microbial adherence; drug
   release
ID TUBE POLY(VINYL CHLORIDE); IN-VITRO; CANDIDA-ALBICANS; ENCRUSTATION;
   BIOFILM; PREVENTION; POLY(EPSILON-CAPROLACTONE); POLYURETHANE;
   BIOMATERIALS; INFECTIONS
AB In this study, the resistance of biodegradable biomaterials, composed of blends of poly(E-caprolactone) (PCL) and the Polymeric antimicrobial complex, polyvinylpyrrolidone-iodine (PVP-I) to the adherence of a clinical isolate of Escherichia coli is. described. Blends of PCL composed of a range of high (50 000 g mol(-1)) to low (5000 g mol(-1)) molecular weight ratios of polymer and either devoid of or containing PVP-I (1% w/w) were prepared by solvent evaporation. Following incubation (4h). there was no relationship between m. wt. ratio of PCL in films devoid of PVP-I and adherence of E. coli. Conversely, microbial adherence to PCL containing PVP-I decreased as the ratio of high:low m. wt. polymer was decreased and was approximately 1000 fold lower (ban that to comparator films devoid of PVP-I. Following periods of immersion of PVP-I containing PCL films under sink conditions in phosphate buffered saline, subsequent adherence of E coli was substantially reduced for 2 days (40:60m. ratio) and 6 days (100:0m. wt. ratio). Concurrent exposure of PCL and E coli to sub-minimum inhibitory concentrations (sub-MIC) of PVP-I significantly reduced microbial adherence to the biomaterial; however, the molecular weight ratio of PCL did not affect this outcome. Pretreatment of PCL with similar sub-MIC of PVP-I prior to inclusion within the microbial adherence assay significantly decreased the subsequent adherence of E. coli. Greatest reduction in adherence was observed following treatment of PCL wt. ratio) with 0.0156% w/w PVP-I. In conclusion,. this study has illustrated the utility of PVP-I as a suitable therapeutic agent for incorporation within PCL as a novel biomaterial. Due to the combined antimicrobial and biodegradable properties, these biomaterials offer a promising strategy for the reduction in medical device related infection. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Grp, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM d.jones@qab.ac.uk
CR Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014
   Bonner MC, 1997, INT J PHARM, V151, P201, DOI 10.1016/S0378-5173(97)04903-X
   BUSSCHER HJ, 1990, MICROBIAL CELL SURFA, P335
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   ELSHERIF A, 1995, BRIT J UROL, V76, P108, DOI 10.1111/j.1464-410X.1995.tb07842.x
   GORMAN SP, 1987, J CLIN PHARM THER, V12, P393, DOI 10.1111/j.1365-2710.1987.tb00552.x
   Gorman SP, 2001, BIOMATERIALS, V22, P2741, DOI 10.1016/S0142-9612(01)00017-5
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   GOTTARDI W, 1985, J HOSP INFECT, V6, P1, DOI 10.1016/S0195-6701(85)80040-2
   JANSEN B, 1990, ZBL BAKT-INT J MED M, V272, P401, DOI 10.1016/S0934-8840(11)80040-X
   Jones D. S., 2002, PHARM STAT
   Jones D.S., 1995, PHARM SCI, V1, P513
   Jones DS, 2000, PLAST RUBBER COMPOS, V29, P371, DOI 10.1179/146580100101541175
   Jones DS, 1995, PHARMACEUT RES, V12, P1896, DOI 10.1023/A:1016231620470
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 2002, PHARMACEUT RES, V19, P818, DOI 10.1023/A:1016104516034
   Jones DS, 2001, J MATER SCI-MATER M, V12, P399, DOI 10.1023/A:1011240818338
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001
   Medlicott NJ, 1996, INT J PHARM, V143, P25, DOI 10.1016/S0378-5173(96)04675-3
   MIYAKE Y, 1990, FEMS MICROBIOL LETT, V69, P211
   Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002
   STICKLER D, 1993, UROL RES, V21, P407, DOI 10.1007/BF00300077
   Tunney MM, 1997, INT J PHARMACEUT, V151, P121, DOI 10.1016/S0378-5173(97)04902-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1999, METHOD ENZYMOL, V310, P558
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   VANDENBROEK PJ, 1985, LANCET, V1, P563
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   ZISMAN A, 1995, J UROLOGY, V153, P718, DOI 10.1016/S0022-5347(01)67697-3
NR 33
TC 45
Z9 48
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 2013
EP 2020
DI 10.1016/j.biomaterials.2004.06.001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800042
PM 15576175
DA 2018-10-19
ER

PT J
AU Matsuda, A
   Kobayashi, H
   Itoh, S
   Kataoka, K
   Tanaka, J
AF Matsuda, A
   Kobayashi, H
   Itoh, S
   Kataoka, K
   Tanaka, J
TI Immobilization of laminin peptide in molecularly aligned chitosan by
   covalent bonding
SO BIOMATERIALS
LA English
DT Article
DE crab tendon; chitosan; 4-thiobutyrolactone; YIGSR; IKVAV; immobilization
ID SULFHYDRYL GROUPS; DELIVERY; SURFACES; RELEASE; SYSTEM; BEADS; FILMS;
   DRUG
AB We developed a new biomaterial effective for nerve regeneration consisting of molecularly aligned chitosan with laminin peptides bonded covalently. Molecularly aligned chitosan was prepared from crab (Macrocheira kaempferi) tendons by ethanol treatment and 4wt%-NaOH aqueous solutions to remove proteins and calcium phosphate, followed by deacetyl treatment using a 50wt%-NaOH aqueous solution at 100degreesC. Molecularly aligned tendon chitosan was chemically thiolated by reacting 4-thiobutyrolactone with the chitosan amino group. The introduction of thiol groups and their distribution to tendon chitosan and chitosan cast film were confirmed using ATR FT-IR, H-1-NMR, and EDS. The 1.24mumol/g of thiol groups introduced on the surface of tendon chitosan and the chitosan cast film was confirmed using ultraviolet (UV) spectra. Thiol groups of cysteine located at the end of synthetic laminin peptides were then reacted chemically with thiolated chitosan to form chitosan-S-S-laminin peptide. YIGSR estimated at 0.92 mumol/g and IKVAV estimated at 0.28 mumol/g on thiolated tendon chitosan were confirmed using UV spectra. YIGSR was estimated at 0.85 mumol/g and IKVAV was estimated at 0.34 mumol/g on the thiolated chitosan cast film. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Inst Mat Sci, Biomat Res Ctr, Tsukuba, Ibaraki 3050044, Japan.
   Japan Soc Promot Sci, Daito Ku, Tokyo 1100008, Japan.
   Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138510, Japan.
   Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
   Hokkaido Univ, Sapporo, Hokkaido 0010021, Japan.
RP Matsuda, A (reprint author), Natl Inst Mat Sci, Biomat Res Ctr, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM matsuda.atsushi@nims.go.jp; kobayashi.hisatoshi@nims.go.jp
RI kobayashi, hisatoshi/H-2720-2011; Kataoka, Kazunori/K-7108-2012
OI kobayashi, hisatoshi/0000-0001-9487-0725; Kataoka,
   Kazunori/0000-0002-8591-413X
CR BENESCH R, 1962, BIOCHIM BIOPHYS ACTA, V63, P166, DOI 10.1016/0006-3002(62)90349-9
   Bernkop-Schnurch A, 2000, J CONTROL RELEASE, V66, P39, DOI 10.1016/S0168-3659(99)00256-4
   BRUICE TC, 1964, J AM CHEM SOC, V86, P4886, DOI 10.1021/ja01076a032
   BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2
   CHEN SC, 2000, KLUW INT S ADV DATA, V21, P1
   Feeney R. E., 1982, Advances in Chemistry Series, V198, P3
   GIRAUDGUILLE MM, 1984, TISSUE CELL, V16, P75, DOI 10.1016/0040-8166(84)90020-X
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   Huang RH, 2003, CARBOHYD RES, V338, P483, DOI 10.1016/S0008-6215(02)00505-0
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Kofuji K, 2000, CHEM PHARM BULL, V48, P579
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   LOWRY TH, 1976, MECH THEORY ORGANIC, P177
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, POLYMER, V43, P757, DOI 10.1016/S0032-3861(01)00580-8
   Nishimura S, 1998, CARBOHYD RES, V306, P427, DOI 10.1016/S0008-6215(97)10081-7
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   STRYER L, 1988, BIOCHEMISTR
   TANFPASUTHADOL V, 2003, CARBOHYD RES, V338, P937
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Yamaguchi I, 2003, BIOMATERIALS, V24, P2031, DOI 10.1016/S0142-9612(02)00633-6
   Yamauchi K, 2001, BIOMATERIALS, V22, P855, DOI 10.1016/S0142-9612(00)00249-0
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
NR 28
TC 51
Z9 52
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2273
EP 2279
DI 10.1016/j.biomaterials.2004.07.032
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400009
PM 15585229
DA 2018-10-19
ER

PT J
AU Lieb, E
   Hacker, M
   Tessmar, J
   Kunz-Schughart, LA
   Fiedler, J
   Dahmen, C
   Hersel, U
   Kessler, H
   Schulz, MB
   Gopferich, A
AF Lieb, E
   Hacker, M
   Tessmar, J
   Kunz-Schughart, LA
   Fiedler, J
   Dahmen, C
   Hersel, U
   Kessler, H
   Schulz, MB
   Gopferich, A
TI Mediating specific cell adhesion to low-adhesive diblock copolymers by
   instant modification with cyclic RGD peptides
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; RGD peptide; integrin; osteoblast; surface modification;
   biomimetic material; poly(lactic acid); poly(ethylene oxide); diblock
   copolymer
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; POLYMER SCAFFOLDS; BONE-FORMATION;
   HYDROGELS; DIFFERENTIATION; BIOMATERIALS; SURFACES; PENTAPEPTIDES;
   MODULATION
AB One promising strategy to control the interactions between biomaterial surfaces and attaching cells involves the covalent grafting of adhesion peptides to polymers on which protein adsorption, which mediates unspecific cell adhesion, is essentially suppressed. This study demonstrates a surface modification concept for the covalent anchoring of RGD peptides to reactive diblock copolymers based on monoamine poly(ethylene glycol)-block-POIY(D,L-lactic acid) (H2N-PEG-PLA). Films of both the amine-reactive (ST-NHPEG(2)PLA(20)) and the thiol-reactive derivative (MP-NH-PEG(2)PLA(40)) were modified with cyclic alphavbeta3/alphavbeta5 integrin subtype specific RGD peptides simply by incubation of the films with buffered solutions of the peptides. Human osteoblasts known to express these integrins were used to determine cell-polymer interactions. The adhesion experiments revealed significantly increased cell numbers and cell spreading on the RGD-modified surfaces mediated by RGD-integrin-interactions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
   Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany.
   Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89081 Ulm, Germany.
   Tech Univ Munich, Dept Organ Chem Biochem, D-85747 Garching, Germany.
   Graz Univ, Inst Pharmaceut Sci Pharmaceut Technol, A-8010 Graz, Austria.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, Universitaetsstr 31, D-93040 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Zhou, Feng/E-9510-2011; Tessmar, Joerg/H-3606-2012; Hacker,
   Michael/D-3935-2011; Kessler, Horst/C-1178-2010
OI Tessmar, Joerg/0000-0001-7057-5369; Hacker, Michael/0000-0002-4776-2294;
   Schulz-Siegmund, Michaela/0000-0003-1340-1850
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D
   BESSELINK GAJ, 1993, APPL BIOCHEM BIOTECH, V43, P227, DOI 10.1007/BF02916455
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HERSEL UU, 2003, THESIS TU MUNICH
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mayr-Wohlfart U, 2001, J BONE JOINT SURG BR, V83B, P144, DOI 10.1302/0301-620X.83B1.10219
   MORIKE M, 1995, J MOL MED-JMM, V73, P571, DOI 10.1007/BF00195142
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Tessmar J, 2003, BIOMATERIALS, V24, P4475, DOI 10.1016/S0142-9612(03)00345-4
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
NR 34
TC 52
Z9 56
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2333
EP 2341
DI 10.1016/j.biomaterials.2004.07.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400016
PM 15585236
DA 2018-10-19
ER

PT J
AU Chen, H
   Zhang, Z
   Chen, Y
   Brook, MA
   Sheardown, H
AF Chen, H
   Zhang, Z
   Chen, Y
   Brook, MA
   Sheardown, H
TI Protein repellant silicone surfaces by covalent immobilization of
   poly(ethylene oxide)
SO BIOMATERIALS
LA English
DT Article
DE PEO; PDMS; hydrosilylation; protein adsorption
ID PLATELET-ADHESION; IN-VITRO; ADSORPTION; POLYDIMETHYLSILOXANE;
   POLYETHYLENE; RUBBER; POLY(DIMETHYLSILOXANE); BIOMATERIAL; HYDROGELS;
   VIVO
AB Polydimethylsiloxane elastomers were surface modified with passivating polyethylene oxide (PEO) polymers of different molecular weights, both monoftinctional and bifunctional. Following the introduction of Si-H groups on the surfaces by acid catalysed equilibration in the presence of polymethylhydrosiloxane, the PEO was linked by platinum-catalyzed hydrosilylation. ATR-FTIR, X-ray photoetectron spectroscopy (XPS) and water contact angle results confirmed that the PEO was successfully grafted to the silicone rubber. Atomic force microscopy and XPS suggested that surface coverage with PEO was very high on the modified surfaces but not complete. The protein-resistant properties of the PEO-modified surfaces were demonstrated by measuring he adsorption of fibrinogen from both buffer and plasma. Fibrinogen adsorption from buffer to the PEO-modified surfaces was reduced by more than 90% compared with controls. (C) 2004 Elsevier Ltd. All rights reserved.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Chem, Hamilton, ON L8S 4L7, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St, Hamilton, ON L8S 4L7, Canada.
EM mabrook@mcmaster.ca; sheardow@mcmaster.ca
RI chen, Hong/L-6932-2013
CR ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Bartzoka V, 2000, LANGMUIR, V16, P4589, DOI 10.1021/la991136h
   Bartzoka V, 1999, ADV MATER, V11, P257, DOI 10.1002/(SICI)1521-4095(199903)11:3<257::AID-ADMA257>3.0.CO;2-S
   Beamson G., 1992, HIGH RESOLUTION XPS
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Brook M, 1996, US patent, Patent No. 5571531
   Brook M. A, 2000, SILICON ORGANIC ORGA
   Brook MA, 2004, J MATER CHEM, V14, P1469, DOI 10.1039/b401278j
   Cha TW, 2002, ANAL BIOCHEM, V311, P27, DOI 10.1016/S0003-2697(02)00399-8
   Chang PCT, 1998, J BIOMED MATER RES, V39, P380
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   Chen KY, 1999, J BIOMAT SCI-POLYM E, V10, P1183, DOI 10.1163/156856299X00018
   Childs MA, 2001, BIOMACROMOLECULES, V2, P526, DOI 10.1021/bm0100054
   Clarson S. J., 1993, SILOXANE POLYM
   Compan V, 2004, BIOMATERIALS, V25, P359, DOI 10.1016/S0142-9612(03)00527-1
   Cornelius RM, 1997, J BIOMED MATER RES, V37, P314
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   Frederix F, 2004, J BIOCHEM BIOPH METH, V58, P67, DOI 10.1016/S0165-022X(03)00150-7
   Gettings R. L., 1998, SILICONES PHARM BIOM
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   HUANG J, 2002, Patent No. 081183
   Jon SY, 2003, LANGMUIR, V19, P9989, DOI 10.1021/la034839e
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Kossmehl G., 1980, US Patent, Patent No. [4,332,922, 4332922]
   Kunzler JF, 1996, TRENDS POLYM SCI, V4, P52
   LASSEN B, 1994, COLLOID POLYM SCI, V272, P1143, DOI 10.1007/BF00652384
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Merrett K, 2003, J BIOMED MATER RES A, V67A, P981, DOI 10.1002/jbm.a.10165
   Olander B, 2004, J APPL POLYM SCI, V91, P4098, DOI 10.1002/app.13659
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   SALAMONE JC, 1999, ABSTR PAP AM CHEM S, V217, P163
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Zelisko PM, 2002, LANGMUIR, V18, P8982, DOI 10.1021/la025867k
   Zhao J, 2003, LANGMUIR, V19, P1838, DOI 10.1021/la026228c
NR 39
TC 153
Z9 158
U1 6
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2391
EP 2399
DI 10.1016/j.biomaterials.2004.07.068
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400022
PM 15585242
DA 2018-10-19
ER

PT J
AU Kim, UJ
   Park, J
   Kim, HJ
   Wada, M
   Kaplan, DL
AF Kim, UJ
   Park, J
   Kim, HJ
   Wada, M
   Kaplan, DL
TI Three-dimensional aqueous-derived biomaterial scaffolds from silk
   fibroin
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; scaffold; salt leaching; biodegradation; biomaterial
ID BIODEGRADABLE POLYMER SCAFFOLDS; IN-VITRO; IMPEDANCE SPECTROSCOPY;
   IMAGE-ANALYSIS; SOLID-STATE; BONE; MORI; FABRICATION; HYDROGELS; FOAMS
AB A new all-aqueous process is described to form three-dimensional porous silk fibroin matrices with control of structural and morphological features. The result of this process are scaffolds with controllable porosity and pore sizes that fully degrade in the presence of proteases, unlike prior methods to generate silk-based biomaterials that required the use of organic solvent treatments to impart control of structure and stability in aqueous environments, with low rates of proteolytic hydrolysis. A mechanism is proposed for this novel process that imparts physical stability via hydrophobic interactions. Adjusting the concentration of silk fibroin in water, and the particle size of granular NaCl used in the process, leads to the control of morphological and functional properties of the scaffolds. The aqueous-derived scaffolds had highly homogeneous and interconnected pores with pore sizes ranging from 470 to 940 mum, depending on the mode of preparation. The scaffolds had porosities > 90% and compressive strength and modulus up to 320 +/- 10 and 3330 +/- 500 KPa, respectively, when formed from 10% aqueous solutions of fibroin. The scaffolds fully degraded upon exposure to protease during 21 days, unlike the scaffolds prepared from organic solvent processing. These new silk-based three-dimensional matrices provide useful properties as biomaterial matrices due to the all-aqueous mode of preparation, control of pore size, connectivity of pores, degradability and useful mechanical features. Importantly, this process offers an entirely new window of materials properties when compared with traditional silk fibroin-based materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Ctr Bioengn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem, Ctr Bioengn, Medford, MA 02155 USA.
   Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Bioengn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIBIB NIH HHS [EB003210]
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Asakura T., 1994, ENCY AGR SCI, P1
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Blacher S, 2001, COLLOID SURFACE A, V187, P375, DOI 10.1016/S0927-7757(01)00652-5
   Braun FN, 2003, INT J BIOL MACROMOL, V32, P59, DOI 10.1016/S0141-8130(03)00038-2
   Cai Q, 2003, BIOMATERIALS, V24, P3555, DOI 10.1016/S0142-9612(03)00199-6
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   CULLINANE DM, 2001, PRINCIPLES BONE BIOL, V1, P17
   Curtis RA, 2002, BIOPHYS CHEM, V98, P249, DOI 10.1016/S0301-4622(02)00071-6
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Grigsby JJ, 2001, BIOPHYS CHEM, V91, P231, DOI 10.1016/S0301-4622(01)00173-9
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kim E.S., 2001, FIBER POLYM, V2, P64, DOI DOI 10.1007/BF02875260
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Li GY, 2001, EUR J BIOCHEM, V268, P6600, DOI 10.1046/j.0014-2956.2001.02614.x
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Magoshi J., 1996, POLYM MAT ENCY, V1, P667
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   MITA K, 1994, J MOL EVOL, V38, P583
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   ROBINSON DR, 1965, J AM CHEM SOC, V87, P2470, DOI 10.1021/ja01089a029
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 51
TC 594
Z9 622
U1 13
U2 262
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2775
EP 2785
DI 10.1016/j.biomaterials.2004.07.044
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400062
PM 15585282
DA 2018-10-19
ER

PT J
AU Jager, M
   Sager, M
   Lensing-Hohn, S
   Krauspe, R
AF Jager, M
   Sager, M
   Lensing-Hohn, S
   Krauspe, R
TI The critical size bony defect in a small animal for bone healing studies
   (II): Implant evolution and surgical technique on a rat's femur
SO BIOMEDIZINISCHE TECHNIK
LA English
DT Article
DE bony defect; femur; implant; small animal
ID MESENCHYMAL STEM-CELLS; SEGMENTAL DEFECT; GENE-THERAPY; FRACTURE; MODEL;
   RHBMP-2; REPAIR
AB In the preclinical field of orthopaedic and trauma surgery critical size bony defects (CDS) were used to evaluate the biocompatibility and allow to investigate the osteoinductivity and -conductivity of bone substitutes. Concerning the anatomical size the laboratory rat indicates a lower limit in small animals which are appropriate for experiments on bone. The aim of this study was to define a CSD, to develop a suitable fixation system to stabilize bony fragments in CSD and to point out the specialities of the surgical technique. These informations should help for to design and practice studies concering bone healing on rat's femur. Based on previously acquired anatomical data of rat's femur, the technical challenges and anatomical specialities of different osteosynthesis techniques in rat's femur surgery are demonstrated. Our experiences with different fixation systems and techniques lead to the development of an external fixator, which guarantees for a stable bone fragment fixation, prevents severe soft tissue damage, allows of a roentgenologic evaluation of the defect zone and prevents from undesired direct biomaterial-implant interactions. Neither the proximal nor the distal femoral nailing technique is appropriate for a stable fixation in CSD of rat's femur. To evaluate the reliability of an own developed external fixator 42 nude rats with a 4.0 mm CSD were investigated clinically and roentgenologically over 10 weeks. The external fixator showed only a small implant failure rate. A solid fusion of the bone fragments was not observed within the 10 weeks follow-up period.
C1 Univ Hosp Duesseldorf, Dept Orthopaed, D-40225 Dusseldorf, Germany.
RP Jager, M (reprint author), Univ Dusseldorf, Dept Orthopaed, Orthopaed Res Lab, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM Jaeger@med.uni-duesseldorf.de
CR Baldik Y, 2002, CLIN ORTHOP RELAT R, P343, DOI 10.1097/01.blo.0000022182.66847.8b
   Bruder SP, 1998, CLIN ORTHOP RELAT R, V355, P247
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   Chen YJ, 2004, J ORTHOPAED RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Gebauer GP, 2002, J ORTHOPAED RES, V20, P587, DOI 10.1016/S0736-0266(01)00136-X
   Harrison LJ, 2003, J ORTHOP TRAUMA, V17, P11, DOI 10.1097/00005131-200301000-00003
   Jager M, 2005, BIOMED TECH, V50, P107, DOI 10.1515/BMT.2005.015
   Kokubu T, 2003, J ORTHOP RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Mark H, 2003, ACTA ORTHOP SCAND, V74, P476, DOI 10.1080/00016470310017820
   Moore DC, 2004, J BIOMED MATER RES A, V69A, P259, DOI 10.1002/jbm.a.20123
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Rose T, 2003, LANGENBECK ARCH SURG, V388, P347, DOI 10.1007/s00423-003-0401-7
   SCHALLER O, 1992, ILLUSTRATED VET ANAT
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Shen HC, 2004, J GENE MED, V6, P984, DOI 10.1002/jgm.588
   Tielinen L, 2001, ARCH ORTHOP TRAUM SU, V121, P191, DOI 10.1007/s004020000206
   Tsuchida H, 2003, J ORTHOPAED RES, V21, P44, DOI 10.1016/S0736-0266(02)00108-0
   Vogelin E, 2000, Mund Kiefer Gesichtschir, V4 Suppl 2, pS454, DOI 10.1007/PL00014572
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 21
TC 19
Z9 22
U1 0
U2 3
PU FACHVERLAG SCHIELE SCHON
PI BERLIN
PA MARKGRAFENSTRASSE 11, D-10969 BERLIN, GERMANY
SN 0013-5585
J9 BIOMED TECH
JI Biomed. Tech.
PD MAY
PY 2005
VL 50
IS 5
BP 137
EP 142
DI 10.1515/BMT.2005.020
PG 6
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA 010LA
UT WOS:000235195000003
PM 15966618
DA 2018-10-19
ER

PT J
AU Kurihara, H
   Morita, T
   Shinkai, M
   Nagamune, T
AF Kurihara, H
   Morita, T
   Shinkai, M
   Nagamune, T
TI Recombinant extracellular matrix-like proteins with repetitive elastin
   or collagen-like functional motifs
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE artificial extracellular matrix protein; biomaterial; cell adhesion;
   protein polymer; thermally responsive recombinant protein
ID DRUG-DELIVERY; POLYMERS; FIBRONECTIN; ELONGATION; EXPRESSION; SEQUENCES;
   DESIGN; PCR
AB Using overlap elongation PCR, we created repetitive DNA libraries encoding the elastin VPGVG and collagen-like GERGDRGDP sequences. From these libraries we isolated two repetitive DNA sequences, Col-5 encoding [(GERGDRGDP)(5)GER], and Ela-16 encoding [(VPGVG)(16)VPG]. Both proteins were expressed as thioredoxin fusion proteins. The resulting recombinant extracellular matrix-like proteins had the expected properties (cell adhesive ability and thermally responsive structural change) of the functional motif sequence unit used.
C1 Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Nagamune, T (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
EM nagamune@bio.t.u-tokyo.ac.jp
RI Nagamune, Teruyuki/R-7708-2017
OI Nagamune, Teruyuki/0000-0002-2435-0270
CR CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203
   Kurihara H, 2004, BIOTECHNOL PROGR, V20, P1855, DOI 10.1021/bp049925z
   Kurihara H, 2004, BIOCHEM BIOPH RES CO, V321, P988, DOI 10.1016/j.bbrc.2004.07.061
   MARCOTTE E, 1998, J MOL BIOL, V293, P151
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   SANDBERG LB, 1985, PATHOL BIOL, V33, P266
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
NR 15
TC 12
Z9 12
U1 1
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAY
PY 2005
VL 27
IS 9
BP 665
EP 670
DI 10.1007/s10529-005-4477-8
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 938WH
UT WOS:000230033600011
PM 15977075
DA 2018-10-19
ER

PT J
AU Penel, G
   Delfosse, C
   Descamps, M
   Leroy, G
AF Penel, G
   Delfosse, C
   Descamps, M
   Leroy, G
TI Composition of bone and apatitic biomaterials as revealed by intravital
   Raman microspectroscopy
SO BONE
LA English
DT Article
DE bone; intravital; Raman; biominerals; protein
ID IN-VIVO; HYDROGEN-PEROXIDE; HYDROXYAPATITE; SPECTROSCOPY; MICROSCOPY;
   BIOAPATITE; POWDERS; ENAMEL
AB Microcharacterization of biominerals allows a better understanding of the pathophysiological events that occur in calcified tissues and synthetic biomaterials. Different methods have been extensively used to conduct such investigations. A new model for the intravital study of the composition and structure of membranous bone by Raman microspectroscopy is described. Titanium bone chambers equipped with a fused-silica optical window were implanted transcutaneously in the calvaria of New Zealand rabbits. The implanted optical windows were well tolerated, and spectral acquisitions were performed without any additional invasive procedure. Bone and implanted apatitic biomaterials were analyzed at different times after surgery. All Raman bands were unambiguously identified in the bone and biomaterial spectra. The main PO4 and CO3 Raman bands in bone spectra were consistent with those found in the carbonated apatite spectrum. The major collagen bands were always observed around 1200-1300 (amide III) and 1600-1700 (amide I) &UDelta; cm(-1) and, 1400-1470 and 2800-3100 &UDelta; cm(-1) (bending and stretching modes of CH groups, respectively). The phenylalanine (Phe) band was identified in all spectra at 1003 &UDelta; cm(-1) and overlapped that of the weak HPO42- ion. The CH bands frequently overlapped the lipid bands. However a distinct protein and lipid bands were detected at 2950 and 2852 &UDelta; cm(-1), respectively. In bone areas close to blood vessels, the Raman signature of hemoglobin was detected with a characteristic band at 754 &UDelta; cm(-1). The changes observed in bone varied as a function of time and location. The composition and structure of all of the biomaterials studied-including those that were resorbable-seemed to remain stable over time and location. We report for the first time the complete intravital study of Raman spectra of bone and calcium phosphate biomaterials over a period of 8 months. This new approach does not require specimen preparation and allows simultaneous observation of mineral and organic bone constituents over time, which therefore should provide insightful information about their relationship. &COPY; 2005 Elsevier Inc. All rights reserved.
C1 Univ Lille 2, Fac Odontol, LBM Raman, Lille, France.
   Univ Valenciennes & Hainaut Cambresis, LMP, Maubeuge, Fr Polynesia.
RP Penel, G (reprint author), LBM Raman, Fac Chirurg Dent, Pl Verdun, F-59000 Lille, France.
EM gpenel@univ-lille2.fr
CR Albrektsson T, 1989, Int J Oral Maxillofac Implants, V4, P45
   Bohic S, 2000, BONE, V26, P341, DOI 10.1016/S8756-3282(99)00276-8
   BRANEMARK P I, 1968, Scandinavian Journal of Plastic and Reconstructive Surgery, V2, P71
   BRANEMARK PI, 1968, ADV MICROCIRCULAT, V1, P1
   BRANEMARK PI, 1968, BLUT, V5, P274
   Camacho NP, 1999, BONE, V25, P287, DOI 10.1016/S8756-3282(99)00165-9
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   FERRARO JR, 1994, INTRO RAMAN SPECTROS, V195, P250
   Freeman JJ, 2002, APPL SPECTROSC, V56, P770, DOI 10.1366/000370202760077513
   Freeman JJ, 2001, CALCIFIED TISSUE INT, V68, P156, DOI 10.1007/s002230001206
   Haston JL, 2003, J BIOL CHEM, V278, P41189, DOI 10.1074/jbc.M212854200
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Lakshmi RJ, 2003, APPL SPECTROSC, V57, P1100, DOI 10.1366/00037020360695964
   Leroy G, 2002, APPL SPECTROSC, V56, P1030, DOI 10.1366/000370202760249765
   Mendelsohn R, 2000, APPL SPECTROSC, V54, P1183, DOI 10.1366/0003702001950751
   Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068
   Omberg KM, 2002, APPL SPECTROSC, V56, P813, DOI 10.1366/000370202760171464
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Penel G, 1999, BONE, V25, p81S, DOI 10.1016/S8756-3282(99)00139-8
   Penel G, 1998, APPL SPECTROSC, V52, P312, DOI 10.1366/0003702981943428
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529
   Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189
   Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118
   Tarnowski CP, 2004, J BONE MINER RES, V19, P64, DOI 10.1359/JBMR.0301201
   TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Timlin JA, 2000, ANAL CHEM, V72, P2229, DOI 10.1021/ac9913560
   TSUDA H, 1994, J DENT RES, V73, P1703, DOI 10.1177/00220345940730110501
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
   Winet H, 1996, BONE, V19, pS39, DOI 10.1016/S8756-3282(96)00133-0
   WINET H, 1995, J ORTHOPAED RES, V13, P679, DOI 10.1002/jor.1100130507
   Wood BR, 2003, FEBS LETT, V554, P247, DOI 10.1016/S0014-5793(03)00975-X
   Zhang HQ, 2003, CERAM INT, V29, P413, DOI 10.1016/S0272-8842(02)00153-0
NR 37
TC 134
Z9 137
U1 1
U2 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAY
PY 2005
VL 36
IS 5
BP 893
EP 901
DI 10.1016/j.bone.2005.02.012
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 926QA
UT WOS:000229136500016
PM 15814305
DA 2018-10-19
ER

PT J
AU Chen, L
   Chen, XS
   Deng, MX
   Jing, XB
AF Chen, L
   Chen, XS
   Deng, MX
   Jing, XB
TI Synthesis and characterization of ABBA block copolymer of glycolide and
   epsilon-caprolactone
SO CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
LA English
DT Article
DE biomaterial; polyglycolide; poly (epsilon-caprolactone); ring-opening
   polymerization; block copolymer
ID BIODEGRADABLE POLYMERS; COLLOIDAL DISPERSIONS; DRUG-DELIVERY; L-LACTIDE;
   POLYMERIZATION; POLYLACTONES
AB A biodegradable ABBA block copolymer was synthesized via the ring-opening co-polymerization of E-caprolactone (CL, B) and glycolide (A) by means of step polymerization in the presence of ethylene glycol as an initiator and stannous octanoate as a catalyst at 110 degrees C for 48 h. The molecular length of the PCL prepolymer (BB) could be adjusted by controlling the molar ratio of the ethylene glycol initiator to c-caprolactone monomer. The structure and the composition of the block copolymer were determined by the weight ratio of the monomer glycolide (A) to PCL pre-polymer (BB). The block copolymers were characterized by H-1 NMR. GPC, DSC and X-ray. The results confirm the successful synthesis of an ABBA block copolymer.
C1 Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   NE Normal Univ, Fac Chem, Changchun 130022, Peoples R China.
RP Chen, XS (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
EM xschen@ciac.jl.cn
CR BARAKAT I, 1994, MACROMOL SYMP, V88, P227, DOI 10.1002/masy.19940880118
   Barakat I, 2001, J POLYM SCI POL CHEM, V39, P294, DOI 10.1002/1099-0518(20010115)39:2<294::AID-POLA50>3.0.CO;2-A
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Domb A.J., 1997, HDB BIODEGRADABLE PO, P3
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GRIJPMA DW, 1990, POLYMER, V31, P2201, DOI 10.1016/0032-3861(90)90096-H
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   KRICHELDORF HR, 1992, POLYMER, V33, P2817, DOI 10.1016/0032-3861(92)90459-A
   KRICHELDORF HR, 1984, MACROMOLECULES, V17, P2173, DOI 10.1021/ma00140a051
   KRICHELDORF HR, 1985, MAKROMOL CHEM S, V12, P25
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ling F, 2003, CHEM RES CHINESE U, V19, P516
   Ran XH, 2003, CHEM RES CHINESE U, V19, P107
   SAWHNEY AS, 1990, J BIOMED MATER RES, V24, P1397, DOI 10.1002/jbm.820241011
   VERT M, 1989, ANGEW MAKROMOL CHEM, V166, P155, DOI 10.1002/apmc.1989.051660111
   VERT M, 1986, MAKROMOL CHEM-M SYMP, V6, P109, DOI 10.1002/masy.19860060113
   VERT M, 1995, PURE APPL CHEM A, V32, P786
   Wang SG, 2004, CHEM RES CHINESE U, V20, P191
NR 20
TC 3
Z9 3
U1 0
U2 3
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 1005-9040
EI 2210-3171
J9 CHEM RES CHINESE U
JI Chem. Res. Chin. Univ.
PD MAY
PY 2005
VL 21
IS 3
BP 340
EP 344
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 933JN
UT WOS:000229624800020
DA 2018-10-19
ER

PT J
AU Arciola, CR
   Campoccia, D
   Gamberini, S
   Baldassarri, L
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Gamberini, S
   Baldassarri, L
   Montanaro, L
TI Prevalence of cna, fnbA and fnbB adhesin genes among Staphylococcus
   aureus isolates from orthopedic infections associated to different types
   of implant
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Article
DE collagen adhesion gene (cna); fibronectin-binding protein; bacterial
   adhesion; biomaterial-associated infections; Staphylococcus aureus
ID FIBRONECTIN-BINDING PROTEIN; COLLAGEN ADHESIN; PROSTHESIS INFECTIONS;
   VIRULENCE DETERMINANT; SEPTIC ARTHRITIS; OSTEOMYELITIS; EXPRESSION;
   STRAINS; IDENTIFICATION; PATHOGENESIS
AB Here are reported data on virulence determinants of Staphylococcus aureus from orthopedic surgical infections, emphasizing on the genes encoding fibronectin (fnbA, fnbB) and collagen (cna) adhesins. 191 S. aureus strains from orthopedic infections (53 from internal fixation devices, 29 external fixation devices, 15 knee arthroprostheses, 30 hip arthroprostheses, 45 surgical reconstruction and 19 non-associated to medical devices) were investigated for the presence of the genes of the collagen-binding protein Cna and of the two fibronectin-binding proteins, FnbA and FnbB. 87 (46%) strains were found to be cna+ without significant variations across the different surgical categories considered. Conversely, the fnbA and the fnbB genes were almost always present in all surgical categories. The finding that, among the investigated adhesins, fibronectin-adhesins are present in the majority of the implant associated S. aureus clinical isolates encourages the development of strategies to specifically block the interaction of bacteria with matrix fibronectin by antagonist ligands. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
C1 Rizzoli Orthoped Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   Ist Super Sanita, I-00161 Rome, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it; montanaro@alma.unibo.it
RI Baldassarri, Lucilla/B-1042-2013; Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
CR Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   CACARELLA C, 2002, INFECT IMMUN, V70, P3180
   Chakrabarti SK, 2000, J BACTERIOL, V182, P5893, DOI 10.1128/JB.182.20.5893-5897.2000
   CHEUNG AL, 1991, J SURG RES, V50, P150, DOI 10.1016/0022-4804(91)90239-I
   Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   GATERMANN S, 1994, INFECT IMMUN, V62, P4556
   Gillaspy AF, 1998, INFECT IMMUN, V66, P3170
   HOLDERBAUM D, 1987, J CLIN MICROBIOL, V25, P2258
   Jett BD, 2002, DNA CELL BIOL, V21, P397, DOI 10.1089/10445490260099683
   Jett BD, 2002, INFECT IMMUN, V70, P4697, DOI 10.1128/IAI.70.8.4697-4700.2002
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Montanaro L, 1998, MICROBIOLOGICA, V21, P359
   Montanaro L, 1999, MICROBIOLOGICA, V22, P331
   Nashev D, 2004, FEMS MICROBIOL LETT, V233, P45, DOI 10.1016/j.femsle.2004.01.032
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657
   Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002
   Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000
   Rice K, 2001, INFECT IMMUN, V69, P3791, DOI 10.1128/IAI.69.6.3791-3799.2001
   Ryding U, 1997, J INFECT DIS, V176, P1096, DOI 10.1086/516520
   Smeltzer MS, 2000, POULTRY SCI, V79, P1042, DOI 10.1093/ps/79.7.1042
   Thomas MG, 1999, J INFECT DIS, V179, P291, DOI 10.1086/314576
   Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611
NR 28
TC 60
Z9 62
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1097
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD MAY 1
PY 2005
VL 246
IS 1
BP 81
EP 86
DI 10.1016/j.femsle.2005.03.035
PG 6
WC Microbiology
SC Microbiology
GA 927WO
UT WOS:000229231400011
PM 15869965
OA Bronze
DA 2018-10-19
ER

PT J
AU Zakharov, NA
   Ezhova, ZA
   Koval', EM
   Kalinnikov, VT
   Chalykh, AE
AF Zakharov, NA
   Ezhova, ZA
   Koval', EM
   Kalinnikov, VT
   Chalykh, AE
TI Hydroxyapatite-carboxymethyl cellulose nanocomposite biomaterial
SO INORGANIC MATERIALS
LA English
DT Article
ID CORALLINE HYDROXYAPATITE; COMPOSITE; IMPLANTATION; CERAMICS; CHITOSAN
AB An organic-mineral composite of hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) nanoparticles and carboxymethyl cellulose (CMC) is synthesized via coprecipitation from a solution containing CaCl2, aqueous ammonia, (NH4)(2)HPO4, and CMC. The composition and microstructure of the composite and the lattice parameters and particle size of the hydroxyapatite are determined using x-ray diffraction, chemical analysis, IR spectroscopy, scanning and transmission electron microscopy techniques, electron diffraction, and x-ray microanalysis. The hydroxyapatite nanoparticles are shown to form agglomerates about 200 nm in size. The interaction between the nanoparticles and CMC macromolecules leads to the formation of a pore structure potentially attractive for biomedical applications.
C1 Russian Acad Sci, NS Kurnakov Gen & Inorgan Chem Inst, Moscow 119991, Russia.
   Russian Acad Sci, Inst Chem Phys, Moscow 119991, Russia.
RP Zakharov, NA (reprint author), Russian Acad Sci, NS Kurnakov Gen & Inorgan Chem Inst, Leninskii Pr 31, Moscow 119991, Russia.
EM zakharov@igic.ras.ru
RI Zakhorov, Nikolay/N-5164-2015; Chalykh, Anatoly/E-6236-2014; Koval,
   Elena/N-5148-2015
OI Chalykh, Anatoly/0000-0003-3272-2086; 
CR AOKI H, 1994, MED APPL HYDROXYAPAT, P13
   BIKLES N, 1971, CELLULOSE CELLULOSE
   Botha J, 2004, CALCIFIED TISSUE INT, V74, P162, DOI 10.1007/s00223-003-0124-3
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2003, BIOMATERIALS, V24, P3087, DOI 10.1016/S0142-9612(03)00150-9
   Doi Y, 1996, J BIOMED MATER RES, V31, P43, DOI 10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q
   Elliott J. C., 1994, STRUCTURE CHEM APATI, P111
   Felicio-Fernandes G, 2000, QUIM NOVA, V23, P441, DOI 10.1590/S0100-40422000000400002
   Gorelik S.S., 2002, RENTGENOGRAFICHESKII
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   *JOINT COMM POWD D, 9432 JOINT COMM POWD
   KASAVINA BS, 1979, ZHIZNKOSTNOI TKANI
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5
   Morales JG, 2001, CRYST RES TECHNOL, V36, P15
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Murugan R, 2003, MACROMOL RES, V11, P14, DOI 10.1007/BF03218272
   Murugan R, 2003, J BIOMAT SCI-POLYM E, V14, P457, DOI 10.1163/156856203766652066
   Murugan R, 2002, MATER LETT, V57, P429, DOI 10.1016/S0167-577X(02)00805-4
   Murugan R, 2002, TRENDS BIOMATER ARTI, V16, P43
   Murugan R., 2003, MATER LETT, V58, P230
   Murugan R, 2002, BIOCERAMICS, V240, P407
   Ogiso M, 1998, J BIOMED MATER RES, V43, P318, DOI 10.1002/(SICI)1097-4636(199823)43:3<318::AID-JBM13>3.0.CO;2-B
   Orlovskii VP, 1997, ZH NEORG KHIM+, V42, P1422
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   Purna S K, 2000, Burns, V26, P54
   Schwarzenbach G., 1970, KOMPLEKSONOMETRICHES
   Stoemenos J, 1999, APPL PHYS LETT, V74, P2602, DOI 10.1063/1.123910
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 35
TC 25
Z9 29
U1 3
U2 24
PU MAIK NAUKA/INTERPERIODICA
PI NEW YORK
PA C/O KLUWER ACADEMIC-PLENUM PUBLISHERS, 233 SPRING ST, NEW YORK, NY
   10013-1578 USA
SN 0020-1685
J9 INORG MATER+
JI Inorg. Mater.
PD MAY
PY 2005
VL 41
IS 5
BP 509
EP 515
DI 10.1007/s10789-005-0159-0
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 932KD
UT WOS:000229551700011
DA 2018-10-19
ER

PT J
AU Li, JP
   Li, SH
   Van Blitterswijk, CA
   de Groot, K
AF Li, JP
   Li, SH
   Van Blitterswijk, CA
   de Groot, K
TI A novel porous Ti6Al4V: Characterization and cell attachment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Ti6Al4V; porous; sintering; mechanical properties; cell attachment
ID POSTSINTERING HEAT-TREATMENTS; COATED TI-6AL-4V ALLOY;
   MECHANICAL-PROPERTIES; SURGICAL IMPLANTS; BONE INGROWTH; TITANIUM;
   FIXATION; METAL; PROSTHESIS; SURFACE
AB For the first time, a highly porous strong Ti6Al4V was produced by using a "polymeric sponge replication" method. A polymeric sponge, impregnated with a Ti6Al4V slurry prepared from Ti6A14V powders and binders, was subjected to drying and pyrolyzing to remove the polymeric sponge and binders. After sintering at a high temperature and under high vacuum, a porous Ti6A14V was produced. Optical microscopical observation, environmental scanning electron microscopy observation (with energy-dispersive micro X-ray analysis), mechanical tests, and metallurgical analyses were performed on the obtained porous Ti6A14V with regard to the porous structure (both macropores and micropores), mechanical properties, chemical composition, phase compositions, and cell attachment behavior. The porous Ti6A14V made by this method had a three-dimensional trabecular porous structure with interconnected pores mainly ranging from 400 to 700 mu m and a total porosity of about 90%. The compressive strength was 10.3 +/- 3.3 MPa and the elastic constant 0.8 +/- 0.3 GPa. MC3T3-E1 cells attached and spread well in the inner surface of pores. Being similar to cancellous, bone with regard to both interconnected porous structure and mechanical properties, the resulting porous Ti6A14V is expected to be a promising biomaterial for biomedical applications. (c) 2005 Wiley Periodicals, Inc. J Biomed Mater Res 73A: 223-233, 2005.
C1 Univ Twente, NL-3723 MB Bilthoven, Netherlands.
   Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China.
RP Li, JP (reprint author), Univ Twente, Prof Bronkhorstlaan 10-D, NL-3723 MB Bilthoven, Netherlands.
EM j.li@tnw.utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR Akiyama S, 1987, US Patent, Patent No. 4713277
   ASAOKA K, 1985, J BIOMED MATER RES, V19, P699, DOI 10.1002/jbm.820190609
   BOBYN JD, 1982, CLIN ORTHOP RELAT R, P301
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   CHEN PQ, 1983, CLIN ORTHOP RELAT R, P24
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   COOK SD, 1985, BIOMATER ARTIF CELL, V13, P37, DOI 10.3109/10731198509118841
   COOK SD, 1986, BIOMATER ARTIF CELL, V14, P167, DOI 10.3109/10731198609117541
   COOK SD, 1988, J BIOMED MATER RES, V22, P287, DOI 10.1002/jbm.820220404
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   ENGH CA, 1983, CLIN ORTHOP RELAT R, P52
   Galanete J., 1973, J BIOMED MATER RES, V4, P43, DOI DOI 10.1002/JBM.820070305
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Gergely V, 2003, COMPOS SCI TECHNOL, V63, P2301, DOI 10.1016/S0266-3538(03)00263-X
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   GU HQ, 1993, BIOMEDICAL MAT SCI
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Katz J L, 1988, Ann N Y Acad Sci, V523, P283, DOI 10.1111/j.1749-6632.1988.tb38522.x
   Kohn D.H., 1992, MAT SCI TECHNOLOGY C, P31
   KOHN DH, 1990, J BIOMED MATER RES, V24, P1483, DOI 10.1002/jbm.820241106
   KUO KN, 1983, CLIN ORTHOP RELAT R, P108
   Kwon SH, 2002, J AM CERAM SOC, V85, P3129
   LANDON GC, 1986, CLIN ORTHOP RELAT R, P49
   LIN JY, 2000, POWDER METALL TECHNO, V18, P12
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P438, DOI 10.1016/0022-3913(88)90039-X
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P662, DOI 10.1016/0022-3913(88)90378-2
   MANIATOPOULOS C, 1986, J BIOMED MATER RES, V20, P1309, DOI 10.1002/jbm.820200907
   MATIN B, 2000, ADV ENG MATER, V2, P196
   MU W, 1998, TITANIUM METALLURGY
   MURRAY GAW, 1981, J BONE JOINT SURG BR, V63, P138
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oliveira M.V., 2002, Mat. Res., V5, P269, DOI 10.1590/S1516-14392002000300009
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Pilliar R M, 1998, Oral Health, V88, P61
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   Pilliar RM, 1998, INT J POWDER METALL, V34, P33
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, P249
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   WEGMANN G, 2001, P EUR ADV MAT WEEK C
   WEINSTEIN AM, 1977, P 3 ANN M SOC BIOM N
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   Wilke A, 1999, ATLA-ALTERN LAB ANIM, V27, P137
   Wilson CE, 2004, J BIOMED MATER RES A, V68A, P123, DOI 10.1002/jbm.a.20015
   WU B, 1990, TECHNOLOGY POWDER ME, V8, P145
   Wu BD, 1988, RARE METAL MAT ENG, V4, P55
   Zhang C, 2000, J BIOMED MATER RES, V52, P354
NR 50
TC 92
Z9 94
U1 3
U2 29
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2005
VL 73A
IS 2
BP 223
EP 233
DI 10.1002/jbm.a.30278
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915FV
UT WOS:000228284400011
PM 15761810
DA 2018-10-19
ER

PT J
AU Haugen, H
   Gerhardt, LC
   Will, J
   Wintermantel, E
AF Haugen, H
   Gerhardt, LC
   Will, J
   Wintermantel, E
TI Biostability of polyether-urethane scaffolds: A comparison of two novel
   processing methods and the effect of higher gamma-irradiation dose
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE polyurethane(s); porosity; scaffolds; enzyme(s); biodegradation;
   degradation; sterilization; FTIR; in vitro; molecular weight; radiation
ID MONOCYTE-DERIVED MACROPHAGES; CHOLESTEROL ESTERASE; DIPHENYLMETHANE
   DIISOCYANATE; POLYCARBONATE-POLYURETHANES; BIODEGRADATION PRODUCTS;
   METHYLENE DIANILINE; DEGRADATION; ENZYME; POLY(URETHANE)S;
   IDENTIFICATION
AB This article deals with enzyme-induced biodegradation behavior of thermoplastic polyether-urethane (TPU). Porous scaffolds were processed by a new foaming method applied in hot pressing and injection molding. The scaffolds were subsequently &gamma; sterilized. The samples were incubated with cholesterol esterase (CE) for 28 days to simulate an enzymatic degradation order to assess polymer biostability. The main focus of degradation products was the most toxic one: methylene dianiline (MDA). LC/MS was used to separate the breakdown products and to identify possible MDA amounts. The results showed that (a) the hot-pressed sample released an MDA amount almost twice as large (0.26 ng &PLUSMN; 0.008) as that of the injection-molded samples (0.15 ng &PLUSMN; 0.003) after incubation with enzyme activity in the physiological range, and (b) a tenfold increase in CE activity revealed considerably higher MDA amounts (7540.0 ng &PLUSMN; 0.004). This enzyme concentration is physiologically unlikely, however, but may occur for extreme high inflammation behavior. Even for extremely high levels of CE enzyme, the scaffold will not discharge MDA above toxic levels. The injection-molded samples sterilized at 25 kGy seem to represent the most promising processing method. Therefore, the new injection-molding foaming process of polyether-urethane can be considered appropriate for use as a biomaterial. &COPY; 2005 Wiley Periodicals, Inc.
C1 Tech Univ Munich, Cent Inst Med Engn ZIMT, D-85748 Munich, Germany.
RP Haugen, H (reprint author), Tech Univ Munich, Cent Inst Med Engn ZIMT, Boltzmannstr 11, D-85748 Munich, Germany.
EM haugen@zimt.tum.de
RI Gerhardt, Lutz-Christian/F-4603-2010; Haugen, Havard Jostein/H-3551-2014
OI Haugen, Havard Jostein/0000-0002-6690-7233
CR *CALEPA, 1997, COMM DFP
   Haugen H, 2004, J MATER SCI-MATER M, V15, P343, DOI 10.1023/B:JMSM.0000021099.33619.ac
   HAUGEN H, IN PRESS BIOMATERIAL
   HAUGEN H, IN PRESS J BIOMED B
   HENSON PM, 1980, AM J PATHOL, V101, P494
   HIRATA N, 1995, RADIAT PHYS CHEM, V46, P377, DOI 10.1016/0969-806X(94)00134-6
   INABA T, 1993, J CLIN INVEST, V92, P750, DOI 10.1172/JCI116646
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LAMBA NMK, 1998, POLYURETHANES BIOMED, P181
   Lastbom L, 2003, SCAND J WORK ENV HEA, V29, P152, DOI 10.5271/sjweh.717
   LITTORIN M, 1994, SCAND J WORK ENV HEA, V20, P216, DOI 10.5271/sjweh.1405
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   SKARPING G, 1995, J CHROMATOGR B, V663, P209, DOI 10.1016/0378-4347(94)00425-5
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Tang YW, 2003, BIOMATERIALS, V24, P2003, DOI 10.1016/S0142-9612(02)00563-X
   Tang YW, 2003, BIOMATERIALS, V24, P2805, DOI 10.1016/S0142-9612(03)00081-4
   Wang GB, 1997, J BIOMED MATER RES, V36, P407, DOI 10.1002/(SICI)1097-4636(19970905)36:3<407::AID-JBM16>3.3.CO;2-U
   WEISBURGER EK, 1984, JNCI-J NATL CANCER I, V72, P1457
   WINTERMANTEL E, 2002, MEDIZINTECHNIK BIOKO, P89
   WINTERMANTEL F, 2002, MEDIZINTECHNIK BIOKO
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO XL, 1991, J AUSTR I STEEL CONS, V25, P2
NR 35
TC 7
Z9 7
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2005
VL 73B
IS 2
BP 229
EP 237
DI 10.1002/jbm.b.30237
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 923UR
UT WOS:000228935300004
PM 15756657
DA 2018-10-19
ER

PT J
AU Hayakawa, T
   Yoshinari, M
   Nemoto, K
AF Hayakawa, T
   Yoshinari, M
   Nemoto, K
TI Quartz-crystal microbalance-dissipation technique for the study of
   initial adsorption of fibronectin onto tresyl chloride-activated
   titanium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE titanium implants; tresyl chloride-activated titanium; quartz-crystal
   microbalance-dissipation (QCM-D) technique
ID PROTEIN-ADSORPTION; COMPLEMENT ACTIVATION; CELL-ADHESION;
   IMMOBILIZATION; BIOMATERIAL; ATTACHMENT; SURFACES; SUPPORTS; BILAYERS
AB The immobilization of cell-adhesive proteins onto titanium implants improves biological response at the implant-tissue interface. Previous studies demonstrated the easy and direct attachment of fibronectin onto titanium with the use of a 2,2,2-trifluoroethanesulfonyl chloride (tresyl chloride) activation technique. The present study investigated the initial adsorption behavior of fibronectin on tresyl chloride-activated titanium by the quartz-crystal microbalance-dissipation (QCM-D) technique. The crystal resonant frequency and the dissipation shift of the oscillator were simultaneously measured by the injection of fibronectin/phosphate-buffered saline solution (pH = 7.4). The tresyl chloride-activated titanium surface showed a faster and greater decrease in frequency than that of untreated titanium, indicating that a greater amount of fibronectin was adsorbed in the former case during a 120-min adsorption. The dissipation-frequency plots revealed that, during the initial stage of adsorption, the bond between fibronectin and tresyl chloride-activated titanium is stronger than that between fibronectin and untreated titanium. The QCM-D technique can provide new insights into the adsorption mechanism of fibronectin. (c) 2005 Wiley Periodicals, Inc.
C1 Nihon Univ, Sch Dent, Res Inst Oral Sci, Dept Dent Mat, Matsudo, Chiba 2718587, Japan.
   Tokyo Dent Coll, Dept Dent Mat Sci, Mihamaku, Chiba 2618502, Japan.
   Tokyo Dent Coll, Oral Hlth Sci Ctr, Mihamaku, Chiba 2618502, Japan.
RP Hayakawa, T (reprint author), Nihon Univ, Sch Dent, Res Inst Oral Sci, Dept Dent Mat, 2-870-1 Sakaechonishi, Matsudo, Chiba 2718587, Japan.
EM hayakawa@masact.nihon-u.ac.jp
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Andersson AS, 2003, J BIOMED MATER RES A, V64A, P622, DOI 10.1002/jbm.a.10442
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Boehm HP, 1971, FARADAY DISCUSS FARA, V52, P264
   BRANEMARK PI, 1977, J PLAST RECONSTR S S, V2
   DESSAU W, 1978, J CELL BIOL, V79, P342, DOI 10.1083/jcb.79.2.342
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   HASSELL JR, 1979, CELL, V17, P821, DOI 10.1016/0092-8674(79)90322-2
   Hayakawa T, 2003, BIOMED RES-TOKYO, V24, P223, DOI 10.2220/biomedres.24.223
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   Hayakawa T, 2003, J BIOMED MATER RES A, V67A, P684, DOI 10.1002/jbm.a.10143
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   ITO Y, 1987, BIOMATERIALS, V8, P464, DOI 10.1016/0142-9612(87)90083-4
   MALMSTROM HS, 1990, J PERIODONTOL, V61, P300, DOI 10.1902/jop.1990.61.5.300
   Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x
   NILSSON K, 1987, METHOD ENZYMOL, V135, P65
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   VINKINGE TP, 2000, BIOSENS BIOELECTRON, V15, P605
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   ZHENG J, 1995, J BIOMAT SCI-POLYM E, V7, P515
NR 26
TC 17
Z9 18
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2005
VL 73B
IS 2
BP 271
EP 276
DI 10.1002/jbm.b.30207
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 923UR
UT WOS:000228935300009
PM 15674829
DA 2018-10-19
ER

PT J
AU Roosjen, A
   de Vries, J
   van der Mei, HC
   Norde, W
   Busscher, HJ
AF Roosjen, A
   de Vries, J
   van der Mei, HC
   Norde, W
   Busscher, HJ
TI Stability and effectiveness against bacterial adhesion of poly(ethylene
   oxide) coatings in biological fluids
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE polyethylene oxide; bacterial adhesion; stability; contact angle; XPS
ID STREPTOCOCCUS-MUTANS ADHERENCE; PROTEIN ADSORPTION; POLYETHYLENE-GLYCOL;
   MICROBIAL ADHESION; FLOW CHAMBER; SURFACES; INHIBITION; BRUSHES; CHAINS;
   CONTAMINATION
AB Poly(ethylene oxide) (PEO) coatings have been shown to reduce the adhesion of different microbial strains and species and thus are promising as coatings to prevent biomaterial-centered infection of medical implants. Clinically, however, PEO coatings are not yet applied, as little is known about their stability and effectiveness in biological fluids. In this study, PEO coatings coupled to a glass substratum through silyl ether bonds were exposed for different time intervals to saliva, urine, or phosphate-buffered saline (PBS) as a reference at 37&DEG; C. After exposure, the effectiveness of the coatings against bacterial adhesion was assessed in a parallel plate flow chamber. The coatings appeared effective against Staphylococcus epidermidis adhesion for 24, 48, and 0.5 h in PBS, urine, and saliva, respectively. Using XPS and contact-angle measurements, the variations in effectiveness could be attributed to conditioning film formation. The overall short stability results from hydrolysis of the coupling of the PEO chains to the substratum. &COPY; 2005 Wiley Periodicals, Inc.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Wageningen Univ, Lab Phys Chem & Colloid Sci, NL-6703 HB Wageningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Dept Biomed Engn, Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.rug.nl
CR AMERONGEN AV, 1994, SPEEKSEL MONDGEZONDH, P7
   Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   Beamson G., 1992, HIGH RESOLUTION XPS
   BHATT MV, 1983, SYNTHESIS-STUTTGART, P249, DOI 10.1055/s-1983-30301
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Efremova NV, 2002, LANGMUIR, V18, P836, DOI 10.1021/la011303p
   ESCHER A, 1990, BIOFILMS, P445
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash MB, 2000, COLLOID SURFACE B, V19, P13, DOI 10.1016/S0927-7765(00)00131-4
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Han S, 1997, POLYMER, V38, P317, DOI 10.1016/S0032-3861(97)88175-X
   Harris J. M., 1992, POLYETHYLENE GLYCOL, P283
   HONG HG, 1994, LANGMUIR, V10, P153, DOI 10.1021/la00013a023
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JIN HL, 1995, PROG POLYM SCI, V20, P1043
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2
   KI DP, 1998, BIOMATERIALS, V19, P851
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   LEE J, 1989, J COLLOID INTERF SCI, V131, P252, DOI 10.1016/0021-9797(89)90166-5
   Lee JH, 2002, J BIOMED MATER RES, V60, P44, DOI 10.1002/jbm.10013
   Lee SW, 1998, BIOMATERIALS, V19, P1669, DOI 10.1016/S0142-9612(98)00044-1
   Maas JH, 2003, THIN SOLID FILMS, V426, P135, DOI 10.1016/S0040-6090(03)00033-6
   MARK HF, 1987, ENCY POLYM SCI ENG, V7, P472
   MOBLEY HLT, 1996, URINARY TRACT INFECT, P221
   NORDE W, IN PRESS LANGMUIR
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   OLSSON J, 1991, CARIES RES, V25, P51, DOI 10.1159/000261342
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   PARKKINEN J, 1988, INFECT IMMUN, V56, P2623
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   PINE SH, 1978, ORGANIC CHEM, P265
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   SEAH MP, 1994, SURF INTERFACE ANAL, V21, P336, DOI 10.1002/sia.740210603
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
NR 43
TC 76
Z9 77
U1 0
U2 24
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2005
VL 73B
IS 2
BP 347
EP 354
DI 10.1002/jbm.b.30227
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 923UR
UT WOS:000228935300018
PM 15736286
DA 2018-10-19
ER

PT J
AU Sakai, Y
   Ochi, M
   Uchio, Y
   Ryoke, K
   Yamamoto, S
AF Sakai, Y
   Ochi, M
   Uchio, Y
   Ryoke, K
   Yamamoto, S
TI Prevention and treatment of amputation neuroma by an atelocollagen tube
   in rat sciatic nerves
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE amputation neuroma; atelocollagen tube; rat; sciatic nerve; c-fos
ID SPINAL-CORD; PAINFUL NEUROMAS; EXPRESSION; PROTEIN; INJURY; STIMULATION;
   DEFECTS
AB To evaluate the potential of the atelocollagen tube as a cap for amputation neuromas, the histological and histochemical characteristics of the neuroma and spinal cord were compared with those following silicone capping. Four weeks after the transection of 18 rat sciatic nerves, the amputated neuroma was resected, and the nerve stump inserted into an atelocollagen or silicone tube. The histological changes in the nerve ends and c-fos expression in the dorsal horn of the fourth lumbar spinal cord were evaluated at 4 weeks postoperatively. The regenerated nerve structure in the atelocollagen or silicone tube was very thin. In contrast, a typical bulbous neuroma was observed in the control group (the nerve stump was left in place). The atelocollagen and silicone tube groups demonstrated fewer c-fos-expressed cells in the spinal cord than the controls. These results suggest that capping by an atelocollagen tube, like that by a silicone tube, might successfully prevent an amputated neuroma from forming, and suppress induced pain. The atelocollagen tube may be a promising biomaterial for the prevention or treatment of a painful amputation neuroma. &COPY; 2005 Wiley Periodicals, Inc.
C1 Shimane Univ, Sch Med, Dept Orthopaed, Izumo, Shimane, Japan.
   Hiroshima Univ, Sch Med, Dept Orthopaed, Hiroshima, Japan.
RP Sakai, Y (reprint author), Shimane Univ, Sch Med, Dept Orthopaed, Izumo, Shimane, Japan.
EM ws111213@med.shimane-u.ac.jp
CR BOEVE NR, 1977, J HAND SURG-AM, V2, P70
   CHI SI, 1993, BRAIN RES, V617, P220, DOI 10.1016/0006-8993(93)91089-B
   DELLON AL, 1986, PLAST RECONSTR SURG, V77, P427, DOI 10.1097/00006534-198603000-00016
   EVANS LH, 1968, J AM VET MED ASSOC, V153, P313
   FILAN SL, 1998, J HAND SURG-BRIT, V23, P220
   Furthmayr H, 1976, Int Rev Connect Tissue Res, V7, P61
   HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0
   Kajander KC, 1996, NEUROSCI LETT, V206, P9, DOI 10.1016/0304-3940(96)12447-2
   KUSAKA O, 1987, J JPN SOC SURG HAND, V4, P69
   LABORDE KJ, 1982, J HAND SURG-AM, V7, P190, DOI 10.1016/S0363-5023(82)80086-5
   Malizos K N, 1997, Am J Orthop (Belle Mead NJ), V26, P481
   MENETREY D, 1989, J COMP NEUROL, V285, P177, DOI 10.1002/cne.902850203
   NOVAK CB, 1995, J HAND SURG-AM, V20A, P221, DOI 10.1016/S0363-5023(05)80011-5
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   OHTANI H, 1990, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V10, P165
   PONTZ B, 1970, EUR J BIOCHEM, V16, P50, DOI 10.1111/j.1432-1033.1970.tb01051.x
   Saade NE, 1997, BRAIN RES, V769, P57
   Siddall PJ, 1999, BRAIN RES, V851, P281, DOI 10.1016/S0006-8993(99)02173-3
   Swanson A B, 1977, J Hand Surg Am, V2, P70
   Teixeira JOC, 1998, ARCH ORTHOP TRAUM SU, V117, P27, DOI 10.1007/BF00703435
   TSUTUI T, 1993, JPN J UROL, V84, P1465
   Tupper J W, 1976, J Hand Surg Am, V1, P144
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Yuksel F, 1997, BRIT J PLAST SURG, V50, P182, DOI 10.1016/S0007-1226(97)91367-9
   Zeltser R, 2000, PAIN, V89, P19, DOI 10.1016/S0304-3959(00)00342-0
NR 25
TC 14
Z9 14
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2005
VL 73B
IS 2
BP 355
EP 360
DI 10.1002/jbm.b.30219
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 923UR
UT WOS:000228935300019
PM 15793830
DA 2018-10-19
ER

PT J
AU Arul, V
   Gopinath, D
   Gomathi, K
   Jayakumar, R
AF Arul, V
   Gopinath, D
   Gomathi, K
   Jayakumar, R
TI Biotinylated GHK peptide incorporated collagenous matrix: A novel
   biomaterial for dermal wound healing in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE collagen; biotinylated GHK peptide; wound healing; antioxidant enzymes
ID STRUCTURAL IMPLICATIONS; TISSUE-REPAIR; HUMAN SKIN; COPPER; BINDING;
   PROTEIN; FIBROBLASTS; ACID; GENE; COMPLEXES
AB Matrikines are small peptide fragments of extracellular matrix proteins that display potent tissue repair activities. Difficulties in achieving sustained delivery of bioactive concentration of matrikines in the affected area limits their therapeutic use. The present study evaluates the effects biotinylated matrikine peptide (bio-glycyl-histidyl-lysine) incorporated collagen membrane for dermal wound healing processes in rats. Biotinylated peptide incorporated collagen matrix (PIC) showed better healing when compared to wounds treated with collagen matrix [CF (collagen film)] and without collagen [CR (control)]. Binding studies indicate that biotinylated GHK (Bio-GHK) binds effectively to the collagen matrix and red blood cell (RBC) membrane when compared with t-butyloxycarbonyl substituted GHK (Boc-GHK). Wound contraction, increased cell proliferation, and high expression of antioxidant enzymes in PIC treated group indicate enhanced wound healing activity when compared to CF and CR groups. Interestingly Bio-GHK incorporated collagen increases the copper concentration by ninefold at the wound site indicating the wound healing property of Bio-GHK can also be linked with both copper localization and matrikine activities. These results demonstrate the possibility of using Bio-GHK incorporated collagen film as a therapeutic agent in the wound healing process. &COPY; 2005 Wiley Periodicals, Inc.
C1 Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India.
RP Jayakumar, R (reprint author), Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India.
EM karkuvi@hotmail.com
RI hari, Rajeswary/I-3950-2017; KANNAYIRAM, GOMATHI/I-3910-2017
OI hari, Rajeswary/0000-0002-6247-0070; KANNAYIRAM,
   GOMATHI/0000-0002-6247-0070; Damodaran, Gopinath/0000-0002-1697-0357
CR ALBUQUERQUE ML, 2002, EXP BIOL MED, V277, P1006
   Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596
   Bergmeyer H.U., 1974, METHOD ENZYMAT AN, P438
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   BODANSKY A, 1984, PRACTICE PEPTIDE SYN, V21
   BRYCE GF, 1965, J BIOL CHEM, V240, P3837
   Buffoni F, 1995, ARCH INT PHARMACOD T, V330, P345
   Chandler LA, 2000, MOL THER, V2, P153, DOI 10.1006/mthe.2000.0102
   Chandler LA, 2000, WOUND REPAIR REGEN, V8, P473, DOI 10.1046/j.1524-475x.2000.00473.x
   Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200
   COLLINS T, 1995, FASEB J, V9, P899
   Deyl ZAM, 1976, METHODOLOGY CONNECTI, P1
   Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8
   Grilli M, 1996, J BIOL CHEM, V271, P15002, DOI 10.1074/jbc.271.25.15002
   Grodzinski J.J., 1999, REACT FUNCT POLYM, V39, P99, DOI DOI 10.1016/S1381-5148(98)00054-6
   Jones PW, 2000, J INORG BIOCHEM, V81, P1, DOI 10.1016/S0162-0134(00)00119-7
   Kayashima T, 2002, BBA-GEN SUBJECTS, V1573, P1, DOI 10.1016/S0304-4165(02)00338-0
   KOBUCHI H, 1999, AM J PHYSIOL-CELL PH, V277, P403
   Kurup RK, 2003, PATHOL ONCOL RES, V9, P107, DOI 10.1007/BF03033754
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANEESHA EA, 2003, COLLOID POLYM SCI, V281, P766
   MAQUART FX, 1993, J CLIN INVEST, V92, P2368, DOI 10.1172/JCI116842
   MAQUART FX, 1990, ANN NY ACAD SCI, V580, P573, DOI 10.1111/j.1749-6632.1990.tb17997.x
   MAST BA, 1993, MATRIX, V13, P441, DOI 10.1016/S0934-8832(11)80110-1
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   ODEDRA R, 1991, PHARMACOL THERAPEUT, V49, P111, DOI 10.1016/0163-7258(91)90025-H
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7
   PICKART I, 1980, J CELL PHYSL, V102, P123
   RABENSTEIN DL, 1995, FEBS LETT, V376, P216, DOI 10.1016/0014-5793(95)01286-5
   Sidhu GS, 1999, J INVEST DERMATOL, V113, P773, DOI 10.1046/j.1523-1747.1999.00761.x
   STECK TL, 1970, SCIENCE, V168, P255, DOI 10.1126/science.168.3928.255
   Streaker ED, 2002, BIOCHEMISTRY-US, V41, P14263, DOI 10.1021/bi0203839
   Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042
   Zheng YJ, 2001, ORG LETT, V3, P3277, DOI 10.1021/ol010138
NR 42
TC 31
Z9 31
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2005
VL 73B
IS 2
BP 383
EP 391
DI 10.1002/jbm.b.30246
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 923UR
UT WOS:000228935300023
PM 15803494
DA 2018-10-19
ER

PT J
AU Cardaropoli, G
   Araujo, M
   Hayacibara, R
   Sukekava, F
   Lindhe, J
AF Cardaropoli, G
   Araujo, M
   Hayacibara, R
   Sukekava, F
   Lindhe, J
TI Healing of extraction sockets and surgically produced - augmented and
   non-augmented - defects in the alveolar ridge. An experimental study in
   the dog
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE biomaterial; bone defect; bone formation; extraction socket; grafting;
   wound healing
ID TOOTH EXTRACTION; PERIODONTAL-LIGAMENT; TISSUE REGENERATION;
   BONE-FORMATION; ORAL IMPLANTS; BIO-OSS(R); CLINICIANS; BIOLOGY; HUMANS
AB Objectives: The current experiments had three aims (i) to determine whether the absence of the periodontal ligament (PDL) may alter features of the healing of an extraction socket, (ii) to examine if there were differences in the proportion of different tissues in resolved extraction sockets and surgically produced defects after 3 months of healing, (iii) to study the influence of different biomaterials on the healing of surgically produced bone defects.
   Material and Methods: Extraction sites: In five dogs, the 4th mandibular pre-molars were hemi-sected and the distal roots were removed. The extraction socket of one of the pre-molars was instrumented to eliminate all remnants of the PDL tissue. The socket of the contra-lateral pre-molar was left without instrumentation. The dogs were sacrificed after 3 months of healing.
   Defect sites: In five dogs, the pre-molars and 1st molars on both sides of the mandible were first removed and 3 months of healing allowed. After this interval three standardized cylindrical defects were prepared in each side of the mandible. The defects were 3.5 mm in diameter and 8 mm deep.
   In each quadrant one defect was grafted with Bio-Oss(R) Collagen, one with Collagen Sponge and one defect was left non-grafted. The dogs were sacrificed 3 months after the grafting procedure.
   Results: Extraction sites: The two categories of extraction sockets did not differ with respect to gross morphological features. The tissue of the extraction sites, apical of a newly formed bone bridge, was dominated by bone marrow. Few trabeculae of lamellar bone were also present.
   Defect sites: The non-augmented defect was sealed by a hard-tissue bridge. In the central and apical portions of the defect bone marrow made up about 61%, and mineralized bone 39% of the tissues. The invagination of the surface of this crestal bone was 0.8 +/- 0.3 mm.
   The defect augmented with Collagen Sponge was covered by a hard-tissue bridge 38% of the tissue within the defect was made up of bone marrow while the remaining 62% was occupied by mineralized bone. The invagination of the hard-tissue bridge was on the average 0.6 +/- 0.1 mm.
   In defects augmented with Bio-Oss(R) Collagen the biomaterial occupied a substantial portion of the tissue volume. Eighty-five percent of the periphery of the Bio-Oss(R) particles were found to be in direct contact with newly formed mineralized bone. Woven bone and bone marrow made up 47% and 26% of the newly formed tissue. The invagination of the most coronal part of the bone defect was 0.1 +/- 0.1 mm.
   Conclusion: Sockets that following tooth removal had their PDL tissue removed exhibited similar features of healing after 3 months as sockets which had the PDL retained. The tissues present in an extraction site appeared to be more mature than those present in a surgically produced defect of similar dimension. The Bio-Oss(R) Collagen augmented defect exhibited less wound shrinkage than the non-augmented defect.
C1 Univ Gothenburg, Sahlgrenska Acad, Dept Periodontol, Fac Odontol, S-40530 Gothenburg, Sweden.
   Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
RP Cardaropoli, G (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Periodontol, Fac Odontol, Box 450, S-40530 Gothenburg, Sweden.
EM Giuseppe.Cardaropoli@odontologi.gu.se
RI Sukekava, Flavia/F-9134-2018
OI Sukekava, Flavia/0000-0003-1331-5821
CR AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   AMSEL S, 1969, ANAT RECORD, V164, P101, DOI 10.1002/ar.1091640107
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 1999, J CLIN PERIODONTOL, V26, P643, DOI 10.1034/j.1600-051X.1999.261003.x
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Becker W, 2003, PERIODONTOL 2000, V33, P26, DOI 10.1046/j.0906-6713.2003.03303.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Carmagnola D, 2002, J CLIN PERIODONTOL, V29, P377, DOI 10.1034/j.1600-051X.2002.290501.x
   DAHLIN C, 1990, SCAND J PLAST RECONS, V24, P13, DOI 10.3109/02844319009004514
   EVIAN CI, 1982, J PERIODONTOL, V53, P81, DOI 10.1902/jop.1982.53.2.81
   Frost H M, 1989, Clin Orthop Relat Res, P283
   Frost H M, 1983, Henry Ford Hosp Med J, V31, P3
   FROST HM, 1989, CLIN ORTHOP RELAT R, P294
   Hollinger J, 1996, ORAL SURG ORAL MED O, V82, P594, DOI 10.1016/S1079-2104(96)80431-8
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   KUBOKI Y, 1988, J DENT RES, V67, P944, DOI 10.1177/00220345880670061101
   Lekic PC, 2001, ANAT REC, V262, P193
   LIN WL, 1994, ANAT REC, V240, P492, DOI 10.1002/ar.1092400407
   LUNDGREN D, 1995, CLIN ORAL IMPLAN RES, V6, P54, DOI 10.1034/j.1600-0501.1995.060107.x
   MCCULLOCH CAG, 1983, J PERIODONTAL RES, V18, P339, DOI 10.1111/j.1600-0765.1983.tb00369.x
   Mital M, 1966, Surg Forum, V17, P451
   SCHENK RK, 1994, GUIDED BONE REGENERA, P49
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Stavropoulos A, 2001, Clin Implant Dent Relat Res, V3, P156, DOI 10.1111/j.1708-8208.2001.tb00136.x
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Zitzmann NU, 1998, ORAL SURG ORAL MED O, V85, P8, DOI 10.1016/S1079-2104(98)90391-2
NR 29
TC 141
Z9 147
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD MAY
PY 2005
VL 32
IS 5
BP 435
EP 440
DI 10.1111/j.1600-051X.2005.00692.x
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 916BS
UT WOS:000228361000001
PM 15842256
DA 2018-10-19
ER

PT J
AU Garcia, AJ
   Reyes, CD
AF Garcia, AJ
   Reyes, CD
TI Bio-adhesive surfaces to promote osteoblast differentiation and bone
   formation
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Review
DE integrin; fibronectin; RGD; type I collagen; GFOGER; cell adhesion;
   biomaterial
ID ACTIVATED PROTEIN-KINASE; AMINO-ACID-SEQUENCE; IN-VITRO;
   EXTRACELLULAR-MATRIX; CELL-ADHESION; SYNTHETIC PEPTIDE; IMPLANT
   MATERIALS; FIBRONECTIN CONFORMATION; INTEGRIN ALPHA(5)BETA(1);
   CHEMICAL-MODIFICATION
AB Binding of integrin adhesion receptors to extracellular matrix components, such as fibronectin and type I collagen, activates signaling pathways directing osteoblast survival, cell-cycle progression, gene expression, and matrix mineralization. Biomimetic strategies exploit these adhesive interactions to engineer bio-inspired surfaces that promote osteoblast adhesion and differentiation, bone formation, and osseointegration. These emerging initiatives focus on directing integrin binding through presentation of bio-adhesive motifs derived from extracellular matrices. These biomolecular approaches provide promising strategies for the development of biologically active implants and grafting substrates for enhanced bone repair.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, George W Woodruff Sch Mech Engn, 315 Ferst Dr,2314 Petit Biotechnol Bldg, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Behravesh E, 2003, J BIOMED MATER RES A, V66A, P698, DOI 10.1002/jbm.a.10003
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   FISHER JE, 1993, ENDOCRINOLOGY, V132, P1411, DOI 10.1210/en.132.3.1411
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Globus RK, 1998, J CELL SCI, V111, P1385
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   GRONOWICZ GA, 1994, J BONE MINER RES, V9, P193, DOI 10.1002/jbmr.5650090208
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Huang Y, 2003, DRUG DEV IND PHARM, V29, P79, DOI 10.1081/DDC-120016686
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   SHIN H, 2004, BIOMATERIALS, V25, P985
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WEISS RE, 1981, EXP CELL RES, V133, P247, DOI 10.1016/0014-4827(81)90316-5
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 87
TC 190
Z9 204
U1 1
U2 70
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAY
PY 2005
VL 84
IS 5
BP 407
EP 413
DI 10.1177/154405910508400502
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 918DY
UT WOS:000228520900002
PM 15840774
DA 2018-10-19
ER

PT J
AU Hao, L
   Lawrence, J
AF Hao, L
   Lawrence, J
TI Improved adsorption of human plasma fibronectin on magnesia partially
   stabilized zirconia (MgO-PSZ) bloceramic resulting from CO2 laser
   irradiation
SO JOURNAL OF LASER APPLICATIONS
LA English
DT Article
DE CO2 laser; magnesia partially stabilized zirconia (MgO-PSZ); human
   plasma fibronectin; wettability characteristics; ellipsometry
ID WETTABILITY CHARACTERISTICS; PROTEIN ADSORPTION; CELL-ADHESION; SURFACE;
   TITANIUM; BLOOD; ELLIPSOMETRY; RESISTANCE; CERAMICS; EXCIMER
AB The adsorption of proteins onto a biomaterial surface from the surrounding fluid phase is rapid, with the surface properties of the biomaterial determining the type, amount, and conformation of the adsorbed proteins. Magnesia partially stabilized zirconia (MgO-PSZ), a bioinert ceramic used at the high-load bearing sites, does not naturally form a direct bond with bone. It is believed that a favorable adsorption of the fibronectin could promote cell adhesion and subsequently the bonding between the bone and MgO-PSZ implant. Thus, the aim of this study is to investigate adsorption of human plasma fibronectin on the untreated MgO-PSZ and CO2 laser modified MgO-PSZ using an ellipsometry. It found that CO2 laser treatment brought about a higher amount of the adsorbed fibronectin layer on the modified MgO-PSZ compared with the untreated sample. The adsorption of human plasma fibronectin was influenced by the surface properties, especially positively related to the wettability characteristic. The result implies that the fibronectin adsorption on the MgO-PSZ surfaces was probably due to the polar and chemical interactions, since the considerable change in gamma(p)(sv), instead of minor difference in gamma(d)(sv) of the MgO-PSZ was the main mechanism governing the wettability characteristics after CO2 laser irradiation. The work provides important information regarding protein-bioceramic interactions and feasible of the technique for mediating the protein adsorption and the bonding between tissue implant. (c) 2005 Laser Institute of America.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Mfg Engn Div, Singapore 639798, Singapore.
RP Hao, L (reprint author), Loughborough Univ Technol, Wolfson Sch Mech & Mfg Engn, Mfg Res Grp, Loughborough LE11 3TU, Leics, England.
EM l.hao@lboro.ac.uk
CR ADAM NK, 1958, J CHEM SOC, V18, P2206
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   Arwin H, 1998, THIN SOLID FILMS, V313, P764, DOI 10.1016/S0040-6090(97)00993-0
   Christensen A, 1998, PHYS REV B, V58, P8050, DOI 10.1103/PhysRevB.58.8050
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Feng B, 2002, MATER CHARACT, V49, P129, DOI 10.1016/S1044-5803(02)00341-8
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Galli C, 2002, COLLOID SURFACE B, V26, P255, DOI 10.1016/S0927-7765(02)00015-2
   GOOD RJ, 1960, J PHYS CHEM-US, V64, P561, DOI 10.1021/j100834a012
   GRAIN CF, 1967, J AM CERAM SOC, V50, P288, DOI 10.1111/j.1151-2916.1967.tb15111.x
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Hao L, 2004, J BIOMATER APPL, V19, P81, DOI 10.1177/0885328204043546
   Hao L, 2004, OPT LASER ENG, V42, P355, DOI 10.1016/j.optlaseng.2003.10.002
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   HORBETT TA, 1996, CELL CULTURING SURFA, P351
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KINLOCH AJ, 1987, ADHESION ADHESIVES S, P30
   Lawrence J, 1999, SURF COAT TECH, V115, P273, DOI 10.1016/S0257-8972(99)00251-0
   Lawrence J, 1999, APPL SURF SCI, V138, P388, DOI 10.1016/S0169-4332(98)00431-0
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P1075, DOI 10.1088/0022-3727/32/10/301
   Liu QG, 1999, SOLID STATE IONICS, V121, P61, DOI 10.1016/S0167-2738(98)00529-3
   MALMSTEN M, 1995, COLLOID SURFACE B, V3, P371
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   OLSSON J, 1995, COLLOID SURFACE B, V5, P161, DOI 10.1016/0927-7765(95)01212-2
   Pei YT, 1996, SURF COAT TECH, V81, P131, DOI 10.1016/0257-8972(95)02483-2
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Song Q, 1998, J ADHES SCI TECHNOL, V12, P957
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
NR 34
TC 0
Z9 0
U1 2
U2 2
PU LASER INST AMER
PI ORLANDO
PA 13501 INGENUITY DR, SUITE 128, ORLANDO, FL 32826 USA
SN 1042-346X
J9 J LASER APPL
JI J. Laser Appl.
PD MAY
PY 2005
VL 17
IS 2
BP 127
EP 133
DI 10.2351/1.1848531
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 926YA
UT WOS:000229158400008
DA 2018-10-19
ER

PT J
AU Majima, T
   Funakosi, T
   Iwasaki, N
   Yamane, ST
   Harada, K
   Nonaka, S
   Minami, A
   Nishimura, SI
AF Majima, T
   Funakosi, T
   Iwasaki, N
   Yamane, ST
   Harada, K
   Nonaka, S
   Minami, A
   Nishimura, SI
TI Alginate and chitosan polyion complex hybrid fibers for scaffolds in
   ligament and tendon tissue engineering
SO JOURNAL OF ORTHOPAEDIC SCIENCE
LA English
DT Article
ID ANTERIOR CRUCIATE; DERIVATIVES; SURFACE; CHITIN; CELLS
AB Selecting the material for a scaffold is critically important for the success of tissue engineering. To simplify complicated biosynthetic matrices and achieve a novel class of potential materials, a model of polyion complex fibers was prepared from alginate and chitosan. In the current in vitro study, we thought that alginate-based chitosan hybrid biomaterials could provide excellent supports for fibroblast adhesion. In the current study, alginate polymer fiber (alginate group) and alginate-based chitosan hybrid polymer fibers (alginate with 0.05% chitosan, alginate-chitosan 0.05% group; alginate with 0.1% chitosan, alginate-chitosan 0.1% group) were originally prepared. We investigated the adhesion behavior of rabbit tendon fibroblast onto alginate polymer fibers versus the adhesion of the fibroblast onto alginate-based chitosan hybrid polymer fibers. Furthermore, mechanical properties and synthesis of the extracellular matrix were investigated. Mechanically, the novel fiber has considerable tensile strength of more than 200MPa. We demonstrated that the alginate-based chitosan hybrid polymer fibers showed much improved adhesion capacity with fibroblast compared with alginate polymer fiber. Additionally, morphologic studies revealed the dense fiber of the type I collagen produced by the fibroblast in the hybrid polymer fibers. We concluded that an alginate-based chitosan hybrid polymer fiber has considerable potential as a desirable biomaterial scaffold for tendon and ligament tissue engineering.
C1 Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Sapporo, Hokkaido, Japan.
   Inst Biol Chem, Sapporo, Hokkaido, Japan.
   Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Lab Biomacromol Chem, Sapporo, Hokkaido, Japan.
RP Majima, T (reprint author), Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.
RI Iwasaki, Norimasa/D-6448-2012; Nishimura, Shinichiro/F-5277-2011;
   Majima, Tokifumi/E-2412-2012
CR Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Degim Z, 2002, AMINO ACIDS, V22, P187, DOI 10.1007/s007260200007
   DUNN MG, 1995, J BIOMED MATER RES, V29, P1363, DOI 10.1002/jbm.820291107
   FRANK C, 1985, CLIN ORTHOP RELAT R, V196, P15
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   Huang JQ, 2002, J ORAL MAXIL SURG, V60, P1449, DOI 10.1053/joms.2002.36108
   Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0
   Ibarra Clemente, 1996, Surgical Forum, V47, P612
   Iozzo RV, 1996, FASEB J, V10, P598
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Koski JA, 2000, ORTHOP CLIN N AM, V31, P437, DOI 10.1016/S0030-5898(05)70162-0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LO IKY, 2000, CURR OPINION ORTHOPA, V11, P421
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   NAGINENI CN, 1992, J ORTHOPAED RES, V10, P465, DOI 10.1002/jor.1100100402
   NISHIMURA S, 1985, INT J BIOL MACROMOL, V7, P100, DOI 10.1016/0141-8130(85)90038-8
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   Sakai S, 2000, J MICROENCAPSUL, V17, P691
   Tamura H, 2002, MAT SCI ENG C-BIO S, V20, P143, DOI 10.1016/S0928-4931(02)00024-3
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
   WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
NR 27
TC 99
Z9 103
U1 5
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0949-2658
EI 1436-2023
J9 J ORTHOP SCI
JI J. Orthop. Sci.
PD MAY
PY 2005
VL 10
IS 3
BP 302
EP 307
DI 10.1007/s00776-005-0891-y
PG 6
WC Orthopedics
SC Orthopedics
GA 933GI
UT WOS:000229616500012
PM 15928894
DA 2018-10-19
ER

PT J
AU Seabra, AB
   Da Rocha, LL
   Eberlin, MN
   De Oliveira, MG
AF Seabra, AB
   Da Rocha, LL
   Eberlin, MN
   De Oliveira, MG
TI Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for
   topical S-nitrosoglutathione and nitric oxide release
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE nitric oxide detection; S-nitrosoglutathione; poly(vinyl alcohol);
   poly(vinyl pyrrolidone); nitric oxide delivery; mass spectrometry;
   UV/Vis spectroscopy; polymeric drug delivery systems; targeted drug
   delivery; polymeric biomaterials
ID VOLATILE ORGANIC-COMPOUNDS; NITROSO-N-ACETYLCYSTEINE; MASS-SPECTROMETRY;
   EXPRESSION; SYNTHASE; ALCOHOL); NITRATE; PLASMA; DONORS
AB Nitric oxide (NO) is responsible for biological actions in mammals, ranging from the control of arterial pressure to immunological responses. In this study, S-nitrosoglutathione (GSNO), a spontaneous NO donor, was incorporated in solid films of blended poly(vinyl alcohol) (PVA) and poly(vinyl pyrrolidone) (PVP) comprising a biomaterial with potential for the local delivery of NO. In dry conditions, the extinction of the absorption bands of GSNO was correlated with the increase of the absorption band of its dimmer, GS-SG, implying NO release through the homolytic cleavage of the S-N bond. Mass spectrometry was used to confirm and to monitor the release of free NO from solid PVA/PVP-GSNO films to the gas phase. Kinetic measurement based on the Griess reaction was used to show that solid PVA/PVP-GSNO films are also capable of releasing both NO and GSNO to aqueous solution trough diffusion. Storage experiments have shown that GSNO is highly stabilized in the dry PVA/PVP matrix. The results indicate that GSNO-containing PVA/PVP films may be used for delivering free NO and/or GSNO topically and controllably. (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association.
C1 Univ Estadual Campinas, Inst Quim, UNICAMP, Lab Thomson Espectrometria Massas, BR-13083970 Campinas, SP, Brazil.
RP De Oliveira, MG (reprint author), Univ Estadual Campinas, Inst Quim, UNICAMP, Lab Thomson Espectrometria Massas, CP 6154, BR-13083970 Campinas, SP, Brazil.
EM mgo@iqm.unicamp.br
RI Seabra, Amedea/G-4247-2012; de Oliveira, Marcelo/B-4709-2013; Eberlin,
   Marcos/B-8106-2012
OI de Oliveira, Marcelo/0000-0002-9371-9975; Seabra,
   Amedea/0000-0003-0591-0380
CR Adhuna A, 2000, IMMUNOL LETT, V71, P171, DOI 10.1016/S0165-2478(00)00158-9
   Al-Sa'doni H, 2000, CLIN SCI, V98, P507, DOI 10.1042/CS19990267
   Alberici RM, 1998, J AM SOC MASS SPECTR, V9, P1321, DOI 10.1016/S1044-0305(98)00112-3
   ALBERICI RM, APPL CATAL B, V30, P389
   Albert J, 2001, THROMB RES, V102, P161, DOI 10.1016/S0049-3848(01)00227-4
   ARCHER S, 1993, FASEB J, V7, P349
   Aslan M, 2002, IMMUNOL RES, V26, P107, DOI 10.1385/IR:26:1-3:107
   Avice JC, 1999, RAPID COMMUN MASS SP, V13, P1197
   Bateman RM, 2002, CLIN CHEM, V48, P570
   de Oliveira MG, 2002, J PHYS CHEM A, V106, P8963, DOI 10.1021/jp025756u
   DEOLIVEIRA MG, 1995, J CHEM SOC DA, V12, P2013
   Gaston B, 1999, BBA-BIOENERGETICS, V1411, P323, DOI 10.1016/S0005-2728(99)00023-7
   Gendron FP, 2003, J NEUROCHEM, V87, P344, DOI 10.1046/j.1471-4159.2003.01995.x
   GUILLORY W A, 1965, J Chem Phys, V42, P2457, DOI 10.1063/1.1696316
   HUTCHINS JB, 1987, EXP EYE RES, V45, P1, DOI 10.1016/S0014-4835(87)80075-1
   LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0
   Mendes MA, 1996, ANAL CHEM, V68, P3502, DOI 10.1021/ac9604346
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5
   Ohwada T, 2003, J SYN ORG CHEM JPN, V61, P45, DOI 10.5059/yukigoseikyokaishi.61.45
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Park JKJ, 1997, ANAL BIOCHEM, V249, P61, DOI 10.1006/abio.1997.2159
   Raspollini MR, 2004, GYNECOL ONCOL, V92, P806, DOI 10.1016/j.ygyno.2003.12.023
   Ricardo KFS, 2002, NITRIC OXIDE-BIOL CH, V7, P57, DOI 10.1016/S1089-8603(02)00009-5
   Rogero SO, 2003, ARTIF ORGANS, V27, P424, DOI 10.1046/j.1525-1594.2003.07249.x
   Seabra AB, 2004, BRIT J DERMATOL, V151, P977, DOI 10.1111/j.1365-2133.2004.06213.x
   Seabra AB, 2004, BIOMATERIALS, V25, P3773, DOI 10.1016/j.biomaterials.2003.10.035
   Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4
   Shishido SM, 2000, PHOTOCHEM PHOTOBIOL, V71, P273, DOI 10.1562/0031-8655(2000)071<0273:PGMRTR>2.0.CO;2
   Smith DJ, 1998, J CONTROL RELEASE, V51, P153, DOI 10.1016/S0168-3659(97)00161-2
   Sun J, 2003, SENSORS-BASEL, V3, P276, DOI 10.3390/s30800276
   Weinberger B, 1999, PHARMACOL THERAPEUT, V84, P401, DOI 10.1016/S0163-7258(99)00044-3
   Witte MB, 2002, BRIT J SURG, V89, P1594, DOI 10.1046/j.1365-2168.2002.02263.x
NR 33
TC 17
Z9 19
U1 1
U2 14
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0022-3549
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD MAY
PY 2005
VL 94
IS 5
BP 994
EP 1003
DI 10.1002/jps.20314
PG 10
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 921VA
UT WOS:000228792200008
PM 15793801
DA 2018-10-19
ER

PT J
AU Mostow, EN
   Haraway, GD
   Dalsing, M
   Hodde, JP
   King, D
AF Mostow, EN
   Haraway, GD
   Dalsing, M
   Hodde, JP
   King, D
CA OASIS Venus Ulcer Study Grp
TI Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in
   the treatment of chronic leg ulcers: A randomized clinical trial
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; VENOUS STASIS ULCERS; COMPRESSION;
   ULCERATION; DEVICE; PROTEOGLYCANS; SURGERY
AB Background: Venous leg ulcers are a major cause of morbidity, economic loss, and decreased quality of life in affected patients. Recently, biomaterials derived from natural tissue sources have been used to stimulate wound closure. One such biomaterial obtained from porcine small-intestine submucosa (SIS) has shown promise as an effective treatment to manage full-thickness wounds. Our objective was to compare the effectiveness of SIS wound matrix with compression vs compression alone in healing chronic leg ulcers within 12 weeks.
   Metbods. This was a prospective, randomized, controlled multicenter trial. Patients were 120 patients with at least I chronic leg ulcer. Patients were randomly assigned to receive either weekly topical treatment of SIS plus compression therapy (n = 62) or compression therapy alone (n = 58). Ulcer size was determined at enrollment and weekly throughout the treatment. Healing was assessed weekly for up to 12 weeks. Recurrence after 6 months was recorded. The primary outcome measure was the proportion of ulcers healed in each group at 12 weeks.
   Results. After 12 weeks of treatment, 55% of the wounds in the SIS group were healed, as compared with 34% in the standard-care group (P = .0196). None of the healed patients treated with SIS wound matrix and seen for the 6-month follow-up experienced ulcer recurrence.
   Conclusions. The SIS wound matrix, as an adjunct therapy, significantly improves healing of chronic leg ulcers over compression therapy alone.
C1 NE Ohio Univ, Coll Med, Akron Gen Med Ctr, Akron, OH USA.
   NE Ohio Univ, Coll Med, Dept Dermatol, Akron, OH USA.
   Case Western Reserve Univ, Coll Med, Cleveland, OH 44106 USA.
   Oklahoma State Univ, Ctr Hlth Sci, Stillwater, OK 74078 USA.
   Tulsa Wound Care Clin, Tulsa, OK USA.
   Indiana Univ, Ctr Med, Indianapolis, IN 46204 USA.
   Cook Biotech Inc, W Lafayette, IN USA.
   STATKING Consulting Inc, Fairfield, OH USA.
RP Mostow, EN (reprint author), 157 W Cedar St,Ste 101, Akron, OH 44307 USA.
EM emostow@neoucom.edu
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Angle N, 1997, BRIT MED J, V314, P1019, DOI 10.1136/bmj.314.7086.1019
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Barwell JR, 2000, EUR J VASC ENDOVASC, V20, P363, DOI 10.1053/ejvs.2000.1196
   Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8
   Bello M, 1999, BRIT J SURG, V86, P755, DOI 10.1046/j.1365-2168.1999.01155.x
   Berliner E, 2003, J VASC SURG, V37, P539, DOI 10.1067/mva.2003.103
   Brem Harold, 2004, Am J Surg, V188, P1, DOI 10.1016/S0002-9610(03)00284-8
   Brown-Etris M, 2002, WOUNDS, V14, P150
   Demling RH, 2004, WOUNDS, V16, P18
   FALANGA V, 1993, J DERMATOL SURG ONC, V19, P764, DOI 10.1111/j.1524-4725.1993.tb00422.x
   Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x
   Ghauri ASK, 2000, BRIT J SURG, V87, P1048, DOI 10.1046/j.1365-2168.2000.01491.x
   Hodde J, 2002, BIOTECHNOL BIOENG, V79, P211, DOI 10.1002/bit.10281
   HODDE J, 2004, P 12 INT C IMM 4 ANN, P429
   Hodde J P, 2005, J Wound Care, V14, P23
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, WOUNDS, V13, P195
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MONK BE, 1982, CLIN EXP DERMATOL, V7, P397, DOI 10.1111/j.1365-2230.1982.tb02447.x
   Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495
   O'Brien JF, 2003, BRIT J SURG, V90, P794, DOI 10.1002/bjs.4167
   Olin JW, 1999, VASC MED, V4, P1
   Phillips TJ, 2000, J AM ACAD DERMATOL, V43, P627, DOI 10.1067/mjd.2000.107496
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Robson MC, 2001, WOUND REPAIR REGEN, V9, P347, DOI 10.1046/j.1524-475x.2001.00347.x
   Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183
NR 31
TC 196
Z9 206
U1 1
U2 17
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD MAY
PY 2005
VL 41
IS 5
BP 837
EP 843
DI 10.1016/j.jvs.2005.01.042
PG 7
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 925ZM
UT WOS:000229092300018
PM 15886669
OA Bronze
DA 2018-10-19
ER

PT J
AU Sakaguchi, N
   Niinomi, M
   Akahori, T
   Takeda, J
   Toda, H
AF Sakaguchi, N
   Niinomi, M
   Akahori, T
   Takeda, J
   Toda, H
TI Effect of Ta content on mechanical properties of Ti-30Nb-XTa-5Zr
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE titanium alloy; Ta content; deformation mechanism; elastic modulus;
   microstructure; biomaterial; powder metallurgy
ID TITANIUM-ALLOY; TI-29NB-13TA-4.6ZR; FATIGUE
AB In this study, we investigated the effect of Ta content on the mechanical properties of Ti-30Nb-XTa-5Zr fabricated by a powder metallurgy method, for biomedical applications.
   The Ta content ranged from 0% to 20 mass%. The microstructures of Ti-30Nb-XTa-5Zr that contain less than 5 mass% Ta comprise beta phase and an omega phase. The tensile properties of Ti-30Nb-XTa-5Zr change with a change in their deformation mechanisms. The deformation mechanisms of Ti-30Nb-XTa-5Zr, which contains less than 10 mass% Ta, is the stress-induced martensite (SIM) transformation, while that of Ti-30Nb-XTa-5Zr, which contains over 20 mass% Ta, is the slip mechanism. The minimum elastic modulus is obtained in Ti-30Nb-10Ta-5Zr, which comprises a single phase. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Educ, Toyohashi, Aichi 4418580, Japan.
   Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Educ, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM Niinomi@sp-Mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2001, PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS AND PROCESSING, VOLS I AND II, P209
   FEDOTOV SG, 1970, P 2 INT C TAIT BOST, P871
   HANADA S, 1985, METALL TRANS A, V16, P789, DOI 10.1007/BF02814829
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   SAKAGUCHI N, P ATEM 03 JAP SOC ME
NR 12
TC 34
Z9 37
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 370
EP 376
DI 10.1016/j.msec.2005.04.003
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000018
DA 2018-10-19
ER

PT J
AU Fassina, L
   Visai, L
   Asti, L
   Benazzo, F
   Speziale, P
   Tanzi, MC
   Magenes, G
AF Fassina, L
   Visai, L
   Asti, L
   Benazzo, F
   Speziale, P
   Tanzi, MC
   Magenes, G
TI Calcified matrix production by SAOS-2 cells inside a polyurethane porous
   scaffold, using a perfusion bioreactor
SO TISSUE ENGINEERING
LA English
DT Article
ID ENHANCED OSTEOBLAST ADHESION; MARROW STROMAL OSTEOBLASTS; IN-VITRO; BONE
   SIALOPROTEIN; FLOW PERFUSION; FLUID-FLOW; 3-DIMENSIONAL CULTURE;
   EXTRACELLULAR-MATRIX; GENE-EXPRESSION; SERUM-PROTEINS
AB The repair and regeneration of damaged or resected bone are problematic. Bone autografts show optimal skeletal incorporation, but often bring about complications. Hence, there is increasing interest in designing new biomaterials that could potentially be used in the form of scaffolds as bone substitutes. In this study we used a hydrophobic cross-linked polyurethane in a typical tissue-engineering approach, that is, the seeding and in vitro culturing of cells within a porous scaffold. The polyurethane porous scaffold had an average pore diameter of 624 mu m. Using a perfusion bioreactor, we investigated the effect of shear stress on SAOS-2 human osteoblast proliferation and calcified matrix production. The physical, morphological, and compressive properties of the polyurethane foam were characterized. At a scaffold perfusion rate of 3 mL/min, in comparison with static conditions without perfusion, we observed 33% higher cell proliferation; higher secretion of osteopontin, osteocalcin, decorin, and type I collagen (9.16- fold, 71.9-fold, 30.6-fold, and 18.12-fold, respectively); and 10-fold increased calcium deposition. The design of the bioreactor and the design of the polyurethane foam aimed at obtaining cell colonization and calcified matrix deposition. This cultured biomaterial could be used, in clinical applications, as an osteoinductive implant for bone repair.
C1 Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
   Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   Univ Pavia, IRCCS San Matteo, Dipartimento SMEC, I-27100 Pavia, Italy.
   Politecn Milan, Dipartimento Bioengn, I-20133 Milan, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Fassina, Lorenzo/K-9283-2015; Tanzi, Maria Cristina/I-4620-2013;
   Magenes, Giovanni/C-4202-2012
OI Fassina, Lorenzo/0000-0002-5587-4632; Tanzi, Maria
   Cristina/0000-0002-4913-6633; Magenes, Giovanni/0000-0002-7558-1490
CR Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171
   Anderson H., 1999, J MUSCULOSKELET RES, V3, P39
   Anderson HC, 2002, J BONE MINER METAB, V20, P73, DOI 10.1007/s007740200010
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P129
   ANDERSON HC, 1992, BONE MINER, V16, P46
   Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   Bellahcene A, 2000, CIRC RES, V86, P885, DOI 10.1161/01.RES.86.8.885
   Bernstein EF, 1996, J AM ACAD DERMATOL, V34, P209, DOI 10.1016/S0190-9622(96)80114-9
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   Botchwey EA, 2003, BIORHEOLOGY, V40, P299
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Burger EH, 1999, FASEB J, V13, P101
   BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x
   Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333
   Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989
   Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Emmans GC, 1997, J THEOR BIOL, V186, P189, DOI 10.1006/jtbi.1996.0357
   Fare S., 2002, ADV MAT BIOMEDICAL A, P17
   FARE S, 2002, IEEE EMBS SPECIAL TO
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   GARNERO P, 1994, J BONE MINER RES, V9, P255
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   GOMPERTZ B, PHILOS T R, V513, P1825
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hernigou P, 2000, ACTA ORTHOP SCAND, V71, P508, DOI 10.1080/000164700317381225
   Hocking AM, 1998, MATRIX BIOL, V17, P1
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   KASUGAI S, 1992, J CELL PHYSIOL, V152, P467, DOI 10.1002/jcp.1041520305
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   KLEINNULEND J, 1995, FASEB J, V9, P441
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laitinen M., 1997, J MUSCULOSKELET RES, V1, P21
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Luan YJ, 2000, COMP BIOCHEM PHYS A, V126, P213, DOI 10.1016/S1095-6433(00)00200-2
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Martin-Green M, 2000, PRINCIPLES TISSUE EN, P33
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   SALTZMAN LM, 2000, PRINCIPLES TISSUE EN, P221
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649
   Smalt R., 1997, AM J PHYSIOL, V273, P751
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   SUGANUMA J, 1988, J APPL BIOMATER RES, V22, P1071
   Tanzi M C, 2003, J Appl Biomater Biomech, V1, P58
   Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   YAMAGATA T, 1968, J BIOL CHEM, V243, P1523
   YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   YOSHIDA K, 1989, ANAL BIOCHEM, V177, P327, DOI 10.1016/0003-2697(89)90061-4
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Yuasa T, 2001, J BIOMED MATER RES, V54, P344
NR 82
TC 46
Z9 48
U1 2
U2 8
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAY
PY 2005
VL 11
IS 5-6
BP 685
EP 700
DI 10.1089/ten.2005.11.685
PG 16
WC Cell & Tissue Engineering
SC Cell Biology
GA 942ZE
UT WOS:000230320600004
PM 15998210
DA 2018-10-19
ER

PT J
AU Semler, EJ
   Dasgupta, A
   Moghe, PV
AF Semler, EJ
   Dasgupta, A
   Moghe, PV
TI Cytomimetic engineering of hepatocyte morphogenesis and function by
   substrate-based presentation of acellular E-cadherin
SO TISSUE ENGINEERING
LA English
DT Article
ID CELL-ADHESION MOLECULES; DENSITY-DEPENDENT REGULATION; ATOMIC-FORCE
   MICROSCOPY; MATURE RAT HEPATOCYTES; GROWTH-FACTOR RECEPTOR; N-CADHERIN;
   PRIMARY CULTURE; EXTRACELLULAR-MATRIX; BETA-CATENIN; MUSCLE
   DIFFERENTIATION
AB Although cadherin-mediated intercellular contacts can be integral to the maintenance of functionally competent hepatocytes in vitro, the ability to engineer hepatocellular differentiated function via acellular E-cadherin has yet to be thoroughly explored. To investigate the potential of substrate-presented, a cellular E-cadherin to modulate hepatocellular self-assembly and functional fate, rat hepatocytes were cultured at sparse densities on surfaces designed to display recombinant E-cadherin/Fc chimeras. On these substrates, hepatocytes were observed to recognize microdisplayed E-cadherin/Fc and responded by modulating the spatial distribution of the intracellular cadherin-complexing protein beta-catenin. Substrate-presented E-cadherin/Fc was also found to markedly alter patterns of hepatocyte morphogenesis, as cellular spreading and two-dimensional reorganization were significantly inhibited under these conditions, leading to multicellular aggregates that were considerably more three-dimensional in nature. Increasing cadherin exposure was also associated with elevated levels of albumin and urea secretion, two markers of hepatocyte differentiation, over control cultures. This suggested that cell-substrate cadherin engagement established more functionally competent hepatocellular phenotypes, coinciding with the notion that E-cadherin is a differentiation-inducing ligand for these cells. The morphogenetic and function-promoting effects of substrate-bound E-cadherin/Fc were further enhanced under conditions in which protein A was utilized as an anchoring molecule to present cadherin molecules, suggesting that ligand mobility may play an important role in the effective establishment of cell-to-substrate cadherin interactions. Interestingly, the percent increase in function detected for conditions of high cadherin exposure versus control cultures was found to be substantially higher at extremely low cell densities. This observation indicated that hepatocytes respond to substrate-presented E-cadherin even in the absence of native intercellular interactions and associated juxtacrine signaling. The incorporation of acellular E-cadherin on biomaterial substrates may thus potentially present a means to prevent hepatocellular dedifferentiation by maintaining liver-specific function in otherwise severely functionally repressive culture conditions.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
   Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, C230 Engn,98 Brett Rd, Piscataway, NJ 08854 USA.
EM Moghe@rci.rutgers.edu
FU NIBIB NIH HHS [EB 001046-01A1-1P41]
CR Arkadopoulos N, 1998, INT J ARTIF ORGANS, V21, P781
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   Ben-Ze'Ev A, 1999, ANN NY ACAD SCI, V886, P37, DOI 10.1111/j.1749-6632.1999.tb09398.x
   BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887
   BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253
   Brieva TA, 2004, TISSUE ENG, V10, P553, DOI 10.1089/107632704323061915
   Brieva TA, 2004, BIOTECHNOL BIOENG, V85, P283, DOI 10.1002/bit.10855
   Brieva TA, 2001, BIOTECHNOL BIOENG, V76, P295, DOI 10.1002/bit.10041
   BUCHER NLR, 1990, SEMIN LIVER DIS, V10, P11, DOI 10.1055/s-2008-1040453
   Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5
   Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   El-Bahrawy MA, 1998, MICROSC RES TECHNIQ, V43, P224, DOI 10.1002/(SICI)1097-0029(19981101)43:3<224::AID-JEMT4>3.0.CO;2-Q
   ELIASSON M, 1988, J BIOL CHEM, V263, P4323
   Fagman H, 2003, ENDOCRINOLOGY, V144, P3618, DOI 10.1210/en.2003-0393
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Goichberg P, 2001, J CELL SCI, V114, P1309
   Goichberg P, 1998, MOL BIOL CELL, V9, P3119, DOI 10.1091/mbc.9.11.3119
   GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hamada T, 1997, J HEPATOL, V26, P353, DOI 10.1016/S0168-8278(97)80052-9
   Hamamoto R, 1998, J BIOCHEM, V124, P972, DOI 10.1093/oxfordjournals.jbchem.a022215
   Hamilton GA, 2001, CELL TISSUE RES, V306, P85
   Hansen LK, 1998, TISSUE ENG, V4, P65, DOI 10.1089/ten.1998.4.65
   Harington KJ, 2000, ANN SURG ONCOL, V7, P783, DOI 10.1007/s10434-000-0783-5
   He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509
   Hines MD, 1999, J CELL SCI, V112, P4569
   Hou DX, 2001, CELL BIOL INT, V25, P239, DOI 10.1006/cbir.2000.0596
   Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4
   Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415
   Kemler R, 1992, Semin Cell Biol, V3, P149
   Kim TH, 1998, EXP CELL RES, V244, P93, DOI 10.1006/excr.1998.4209
   Knudsen KA, 1998, J CELL BIOCHEM, P168, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<168::AID-JCB21>3.0.CO;2-V
   Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624
   Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9
   Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200
   Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4
   Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104
   Lambert M, 2000, J CELL SCI, V113, P2207
   Leckband D, 2000, CURR OPIN CELL BIOL, V12, P587, DOI 10.1016/S0955-0674(00)00136-8
   Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827
   Levenberg S, 1998, J CELL SCI, V111, P347
   LINDBLAD WJ, 1991, HEPATOLOGY, V13, P282, DOI 10.1002/hep.1840130213
   MAREEL M, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P63
   Marrs JA, 1996, INT REV CYTOL, V165, P159, DOI 10.1016/S0074-7696(08)62222-6
   MIZUNO K, 1993, J BIOCHEM-TOKYO, V114, P96, DOI 10.1093/oxfordjournals.jbchem.a124147
   Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1
   Moghe PV, 1997, BIOTECHNOL BIOENG, V56, P706, DOI 10.1002/(SICI)1097-0290(19971220)56:6<706::AID-BIT14>3.0.CO;2-5
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   Nachtigal P, 2001, Acta Medica (Hradec Kralove), V44, P83
   NAKAMURA T, 1983, P NATL ACAD SCI-BIOL, V80, P7229, DOI 10.1073/pnas.80.23.7229
   NAKAMURA T, 1984, J BIOL CHEM, V259, P8056
   Nieset JE, 1997, J CELL SCI, V110, P1013
   Nitou M, 2002, EXP CELL RES, V279, P330, DOI 10.1006/excr.2002.5616
   Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449
   Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698
   Orsulic S, 1999, J CELL SCI, V112, P1237
   Owens DW, 2000, BIOCHEM BIOPH RES CO, V269, P369, DOI 10.1006/bbrc.2000.2292
   PARSONSWINGERTER PA, 1993, BIOTECHNOL PROGR, V9, P600, DOI 10.1021/bp00024a006
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
   Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207
   RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858
   Ranucci CS, 2000, BIOMATERIALS, V21, P783, DOI 10.1016/S0142-9612(99)00238-0
   Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323
   Rubinek T, 2003, J CLIN ENDOCR METAB, V88, P3724, DOI 10.1210/jc.2003-030090
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Sawamoto K, 1997, IN VITRO CELL DEV-AN, V33, P569
   Schnadelbach O, 2000, MOL CELL NEUROSCI, V15, P288, DOI 10.1006/mcne.1999.0819
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Semler EJ, 2001, BIOTECHNOL BIOENG, V75, P510, DOI 10.1002/bit.10113
   Sharma RI, 2004, J BIOMED MATER RES A, V69A, P114, DOI 10.1002/jbm.a.20125
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7
   STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206
   Sundback CA, 2000, GASTROENTEROLOGY, V118, P438
   Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542
   TAKEHARA T, 1992, J BIOCHEM-TOKYO, V112, P330, DOI 10.1093/oxfordjournals.jbchem.a123900
   TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.bi.59.070190.001321
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x
   Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6
   Utton MA, 2001, J NEUROCHEM, V76, P1421, DOI 10.1046/j.1471-4159.2001.00140.x
   Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516
   Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.0.CO;2-P
   Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x
   YARMUSH ML, 1992, ANN NY ACAD SCI, V665, P238, DOI 10.1111/j.1749-6632.1992.tb42588.x
   Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7
NR 90
TC 16
Z9 16
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD MAY
PY 2005
VL 11
IS 5-6
BP 734
EP 750
DI 10.1089/ten.2005.11.734
PG 17
WC Cell & Tissue Engineering
SC Cell Biology
GA 942ZE
UT WOS:000230320600009
PM 15998215
DA 2018-10-19
ER

PT J
AU Phillips, JM
   Kao, WJ
AF Phillips, JM
   Kao, WJ
TI Macrophage adhesion on gelatin-based interpenetrating networks grafted
   with PEGylated RGD
SO TISSUE ENGINEERING
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; POLYMER NETWORKS; FBGC FORMATION;
   FIBRONECTIN; HYDROGELS; ALGINATE; BEHAVIOR; RELEASE
AB Human blood-derived macrophage adhesion on interpenetrating networks (IPNs) composed of PEGylated RGD-modified gelatin and poly(ethylene glycol) diacrylate was studied. The interaction between biomaterial immobilized with biofunctional peptides such as RGD and macrophages is central in the design of tissue-engineering scaffolds. PEGylated RGD-modified gelatin was synthesized via several steps involving PEG derivations and characterized by high-performance liquid chromatography, mass spectroscopy, gel permeation chromatography, and the trinitrobenzenesulfonic acid method. IPNs containing modified or unmodified gelatin were cultured with human macrophages and monitored at 2, 24, 96, and 168 h. At each time point, IPNs containing gelatin modified with PEGylated RGD showed a comparable adherent macrophage density as tissue culture polystyrene and a significantly higher cell density than other IPN formulations containing unmodified gelatin or gelatin modified with PEGylated triglycine. Although surface- immobilized RGD can serve to mediate the adhesion of different cell types on the biomaterial surface, the interaction of RGD with immune/inflammatory cells such as macrophages should also be considered when assessing the potential host response of tissue- engineering scaffolds.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Dept Biomed Engn, Coll Engn, Madison, WI USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NIBIB NIH HHS [EB-00290]; NHLBI NIH HHS [HL-77825]
CR Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Cho CS, 1999, INT J PHARM, V181, P235, DOI 10.1016/S0378-5173(99)00031-9
   Desai NP, 2000, J MICROENCAPSUL, V17, P677
   Einerson N. J., 2002, BIOMATERIALS, V24, P509
   ELISSEEF J, 2000, J BIOMED MATER RES, V2, P164
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hurwitz E, 2000, CANCER IMMUNOL IMMUN, V49, P226, DOI 10.1007/s002620000112
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   KAO WJ, 1999, BIOMATERIALS, V23, P2213
   Kao WUJ, 2002, J BIOMED MATER RES, V62, P478, DOI 10.1002/jbm.10317
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Kao WYJ, 2002, J CONTROL RELEASE, V78, P219, DOI 10.1016/S0168-3659(01)00503-X
   KOSTER J, 2002, INTEGRIN SUBUNITS CO
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   MARSHALL JF, 1995, J CELL SCI, V108, P1227
   MARTINEK K, 1977, BIOCHIM BIOPHYS ACTA, V485, P1, DOI 10.1016/0005-2744(77)90188-7
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MULLER U, 1995, MOL BIOL CELL, V6, P433
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   PINKSE GG, 2004, LIVER INT, V3, P218
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   WITTE RP, 2004, J BIOMED MATER RES A, V71, P50
   Zilinski JL, 2004, J BIOMED MATER RES A, V68A, P392, DOI 10.1002/jbm.a.20079
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 29
TC 27
Z9 27
U1 4
U2 10
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAY
PY 2005
VL 11
IS 5-6
BP 964
EP 973
DI 10.1089/ten.2005.11.964
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 942ZE
UT WOS:000230320600029
PM 15998235
DA 2018-10-19
ER

PT J
AU Marin, F
   Luquet, G
AF Marin, F
   Luquet, G
TI Molluscan biomineralization: The proteinaceous shell constituents of
   Pinna nobilis L.
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Learning from Nature
   How to Design New Implantable Biomaterials
CY OCT 13-24, 2003
CL Alvor, PORTUGAL
DE mollusc shell; calcitic prisms; nacre; shell matrix; biochemistry;
   molecular genetics; biomimetics
ID ORGANIC MATRIX; POLYACRYLAMIDE GELS; ACIDIC PROTEINS; SOLUBLE MATRIX;
   NACRE; MACROMOLECULES; GROWTH; INVERTEBRATES; ORIENTATION; SENSITIVITY
AB The shell of molluscs is a remarkable example of a natural composite biomaterial, synthesized at ambient temperature. Consequently, many consider it as a model for trying to develop at little cost new biomimetic materials of superior mechanical properties. The peculiar resistance of shells to fracture lies in an organic matrix, which is closely associated with the mineral phase. This matrix regulates the crystal growth, by allowing nucleation of the crystals only where appropriate, by favoring crystal elongation in privileged directions, and by inhibiting their growth. This matrix is a mixture of glycoproteins and polysaccharides, the primary structure and function of which are poorly known. Pinna nobilis, the Mediterranean fan mussel, is one of the few molluscs for which molecular data on shell proteins are available. In the present paper, we review what is known, at molecular level, on the macromolecular constituents of the shell of R nobilis by describing three proteins, the characterization of which is still going on: the first one, mucoperlin, is specific of the nacreous layer The two others were obtained from the calcitic prismatic layer and one of them was localized by immunogold and further tested to check its ability to modify the shapes of CaCO3 crystals. The data shown here, together with data obtained from the pearl oyster or the abalone, put into question some common ideas about molluscan mineralization. &COPY; 2005 Elsevier B.V All rights reserved.
C1 Univ Bourgogne, CNRS, UMR 5561 Biogeosci, F-21000 Dijon, France.
RP Marin, F (reprint author), Univ Bourgogne, CNRS, UMR 5561 Biogeosci, 6,Blvd Gabriel, F-21000 Dijon, France.
EM frederic.marin@u-bourgogne.fr
CR ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005
   Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Carter J. G, 1990, SKELETAL BIOMINERALI
   CASEIRO J, 1995, CR ACAD SCI II A, V321, P9
   Checa A, 2000, TISSUE CELL, V32, P405, DOI 10.1054/tice.2000.0129
   Crenshaw M.A., 1972, Biomineralization Res Rep, V6, P6
   Cuif J. P., 1985, SCI REP PORT CROS NA, V11, P95
   CUIF J-P, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P679
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Falini G, 2003, CALCIFIED TISSUE INT, V72, P548, DOI 10.1007/s00223-002-1055-0
   Feng QL, 2000, MAT SCI ENG C-BIO S, V11, P19, DOI 10.1016/S0928-4931(00)00138-7
   Goldberg HA, 1997, ANAL BIOCHEM, V251, P227, DOI 10.1006/abio.1997.2252
   Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548
   HALLORAN BA, 1995, COMP BIOCHEM PHYS B, V111, P221, DOI 10.1016/0305-0491(94)00245-P
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5
   Lowenstam HA, 1989, BIOMINERALIZATION
   Marin F, 2003, PROTEIN EXPRES PURIF, V30, P246, DOI 10.1016/S1046-55928(03)00105-0
   Marin F, 2001, PROTEIN EXPRES PURIF, V23, P175, DOI 10.1006/prep.2001.1487
   Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200
   MARIN FI, UNPUB
   Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6
   MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   SALEUDDIN ASM, 1983, MOLLUSCA, V4, P199
   Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6
   Schmidt W. J., 1924, ZOOL JAHRB ABT ANT O, V45, P1
   SIKES CS, 1988, CHEMTECH, V18, P620
   Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443
   TISDELL CA, 2000, SPC PEARL OYSTER INF, V14, P21
   WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036
   WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023
   Weiss IM, 2001, BIOCHEM BIOPH RES CO, V285, P244, DOI 10.1006/bbrc.2001.5170
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397
   Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x
NR 39
TC 33
Z9 35
U1 3
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 28
PY 2005
VL 25
IS 2
BP 105
EP 111
DI 10.1016/j.msec.2005.01.003
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 932EA
UT WOS:000229535800003
DA 2018-10-19
ER

PT J
AU Basu, S
   Gerchman, Y
   Collins, CH
   Arnold, FH
   Weiss, R
AF Basu, S
   Gerchman, Y
   Collins, CH
   Arnold, FH
   Weiss, R
TI A synthetic multicellular system for programmed pattern formation
SO NATURE
LA English
DT Article
ID GENE-EXPRESSION; VIBRIO-FISCHERI; BACTERIA; LUXR; NETWORKS; LACTONES;
   GROWTH
AB Pattern formation is a hallmark of coordinated cell behaviour in both single and multicellular organisms(1-3). It typically involves cell-cell communication and intracellular signal processing. Here we show a synthetic multicellular system in which genetically engineered 'receiver' cells are programmed to formring-like patterns of differentiation based on chemical gradients of an acyl-homoserine lactone (AHL) signal that is synthesized by 'sender' cells. In receiver cells, 'band-detect' gene networks respond to user-defined ranges of AHL concentrations. By fusing different fluorescent proteins as outputs of network variants, an initially undifferentiated 'lawn' of receivers is engineered to form a bullseye pattern around a sender colony. Other patterns, such as ellipses and clovers, are achieved by placing senders in different configurations. Experimental and theoretical analyses reveal which kinetic parameters most significantly affect ring development over time. Construction and study of such synthetic multicellular systems can improve our quantitative understanding of naturally occurring developmental processes and may foster applications in tissue engineering, biomaterial fabrication and biosensing.
C1 Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.
   Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.
   CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP Weiss, R (reprint author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.
EM rweiss@princeton.edu
RI Gerchman, Yoram/F-5226-2015
OI Gerchman, Yoram/0000-0002-8637-9589; Collins,
   Cynthia/0000-0003-1647-860X
CR Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240
   Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9
   Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101
   BENJACOB E, 1995, PHYS REV LETT, V75, P2899, DOI 10.1103/PhysRevLett.75.2899
   Choi S. H., 1992, Molecular Marine Biology and Biotechnology, V1, P408
   Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x
   Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x
   FUQUA WC, 1994, J BACTERIOL, V176, P269
   Golden JW, 1998, CURR OPIN MICROBIOL, V1, P623, DOI 10.1016/S1369-5274(98)80106-9
   Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334
   Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678
   Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824
   PTASHNE M, 1986, GENETIC SWITCH PHAGE
   SCHERRER R, 1986, CAN J MICROBIOL, V32, P607, DOI 10.1139/m86-113
   WEISS R, 2002, NSC 1 1 WORKSH NON S
   WEISS R, 2000, DNA6 6 INT M DNA BAS, P1
   WEISS R, 2001, THESIS MIT
   Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002
NR 18
TC 582
Z9 604
U1 11
U2 156
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD APR 28
PY 2005
VL 434
IS 7037
BP 1130
EP 1134
DI 10.1038/nature03461
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 920MD
UT WOS:000228693300043
PM 15858574
DA 2018-10-19
ER

PT J
AU Keselowsky, BG
   Collard, DM
   Garcia, AJ
AF Keselowsky, BG
   Collard, DM
   Garcia, AJ
TI Integrin binding specificity regulates biomaterial surface chemistry
   effects on cell differentiation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE cell adhesion; signaling; osteoblast; mineralization
ID FIBRONECTIN CONFORMATION; OSTEOBLASTIC DIFFERENTIATION; TRANSCRIPTION
   FACTOR; IN-VITRO; ADHESION; ACTIVATION; ALPHA-5-BETA-1; MINERALIZATION;
   PROLIFERATION; POLYSTYRENE
AB Biomaterial surface chemistry has profound consequences on cellular and host responses, but the underlying molecular mechanisms remain poorly understood. Using self-assembled monolayers as model biomaterial surfaces presenting well defined chemistries, we demonstrate that surface chemistry modulates osteoblastic differentiation and matrix mineralization independently from alterations in cell proliferation. Surfaces were precoated with equal densities of fibronectin (FIN), and surface chemistry modulated FN structure to alter integrin adhesion receptor binding. OH- and NH2-terminated surfaces up-regulated osteoblast-specific gene expression, alkaline phosphatase enzymatic activity, and matrix mineralization compared with surfaces presenting COOH and CH3 groups. These surface chemistry-dependent differences in cell differentiation were controlled by binding of specific integrins to adsorbed FN. Function-perturbing antibodies against the central cell binding domain of FN completely inhibited matrix mineralization. Furthermore, blocking antibodies against beta(1), integrin inhibited matrix mineralization on the OH and NH2 surfaces, whereas function-perturbing antibodies specific for beta(3) integrin increased mineralization on the COOH substrate. These results establish surf ace-dependent differences in integrin binding as a mechanism regulating differential cellular responses to biomaterial surfaces. This mechanism could be exploited to engineer materials that control integrin binding specificity to elicit desired cellular activities to enhance the integration of biomaterials and improve the performance of biotechnological culture supports.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Aubin J. E., 2002, PRINCIPLES BONE BIOL, V1, P59
   BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   BRODBECK WG, 2003, P NATL ACAD SCI USA, V99, P10287
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Moursi AM, 1997, J CELL SCI, V110, P2187
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
NR 30
TC 422
Z9 428
U1 2
U2 90
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 26
PY 2005
VL 102
IS 17
BP 5953
EP 5957
DI 10.1073/pnas.0407356102
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 921BI
UT WOS:000228738800013
PM 15827122
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Zergioti, I
   Karaiskou, A
   Papazoglou, DG
   Fotakis, C
   Kapsetaki, M
   Kafetzopoulos, D
AF Zergioti, I
   Karaiskou, A
   Papazoglou, DG
   Fotakis, C
   Kapsetaki, M
   Kafetzopoulos, D
TI Femtosecond laser microprinting of biomaterials
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID DNA MICROARRAY; PATTERNS
AB This Letter demonstrates a laser rapid prototyping method that can be used for fabricating high-density resolution patterns of biomaterials. Ultraviolet femtosecond laser pulses have been used for directly printing a wide range of biomaterials in complicated patterns and structures. The ultrashort laser pulses reduce the thermal effects, thus allowing the effective deposition of sensitive biomaterials at high spatial resolution for microfabricating patterns. We present the microprinting of different biomaterial patterns, such as DNA (deoxyribonucleic acid) and proteins, with spatial resolution down to 50 &mu; m and we demonstrate that they maintain their properties and biological functions and, thus, can be practically used as biosensors. &COPY; 2005 American Institute of Physics.
C1 Natl Tech Univ Athens, Dept Phys, Athens 15780, Greece.
   Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion 71110, Greece.
   Univ Crete, Dept Phys, Iraklion, Greece.
   Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Greece.
RP Zergioti, I (reprint author), Natl Tech Univ Athens, Dept Phys, Iroon Polytech 9, Athens 15780, Greece.
EM zegioti@central.ntua.gr
RI Papazoglou, Dimitris/D-9146-2013; Fotakis, Costas/G-8751-2011
OI Papazoglou, Dimitris/0000-0003-4537-5108; 
CR Chrisey DB, 2000, SCIENCE, V289, P879, DOI 10.1126/science.289.5481.879
   Fodor SPA, 1997, SCIENCE, V277, P393, DOI 10.1126/science.277.5324.393
   HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204
   Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730
   Karaiskou A, 2003, APPL SURF SCI, V208, P245, DOI 10.1016/S0169-4332(02)01396-X
   Ringeisen BR, 2002, BIOMATERIALS, V23, P161, DOI 10.1016/S0142-9612(01)00091-6
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schena M, 1999, DNA MICROARRAYS PRAC
   Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639
   Wanke MC, 1997, SCIENCE, V275, P1284, DOI 10.1126/science.275.5304.1284
NR 10
TC 72
Z9 72
U1 3
U2 13
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD APR 18
PY 2005
VL 86
IS 16
AR 163902
DI 10.1063/1.1906325
PG 3
WC Physics, Applied
SC Physics
GA 925GD
UT WOS:000229040300075
DA 2018-10-19
ER

PT J
AU Vinu, A
   Miyahara, M
   Ariga, K
AF Vinu, A
   Miyahara, M
   Ariga, K
TI Biomaterial immobilization in nanoporous carbon molecular sieves:
   Influence of solution pH, pore volume, and pore diameter
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID LANGMUIR-BLODGETT FILMS; MESOPOROUS SILICA; ALUMINUM INCORPORATION;
   MECHANICAL STABILITY; GLUCOSE-OXIDASE; CYTOCHROME-C; ADSORPTION; SBA-15;
   MCM-41; TEMPLATE
AB The adsorption of lysozyme (Lz) onto nanoporous carbon molecular sieves with various pore diameters has been studied at different solution pH values. All the adsorption isotherms have successfully been correlated by the Langmuir equation. The amount of adsorbed Lz depends on the solution pH as well as on the specific pore volume and pore diameter of the adsorbents. The maximum adsorption was observed near the isoelectric point of the Lz (pI approximate to 11), suggesting that suppression of electric repulsion between the enzymes plays an important role in the adsorption process. Moreover, the amount adsorbed depends on the pore size and pore volume of the nanoporous carbon adsorbents, indicating that the Lz molecules are adsorbed inside the mesopores. CMK-3-150 shows a larger amount of Lz adsorption as compared to CMK-3. The increased Lz adsorption capacity of CMK-3-150 may be due to the larger pore volume and pore diameter as compared to that of CMK-3. The unaltered structural order of the nanoporous adsorbents after the adsorption has been confirmed by the physicochemical characterization techniques such as XRD and N-2 adsorption. In addition, FT-IR spectroscopic studies confirm that the Lz used in this study is stable even after the adsorption on the nanoporous carbon. These results indicate that nanoporous carbon has superior water stability and thus is a more appropriate adsorbent for biomaterials than nanoporous silica.
C1 Int Ctr Young Scientists, Tsukuba, Ibaraki 3050044, Japan.
   Natl Inst Mat Sci, Supermol Grp, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan.
RP Vinu, A (reprint author), Int Ctr Young Scientists, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM vinu.ajayan@nims.go.jp
RI ARIGA, Katsuhiko/H-2695-2011; Vinu, Ajayan/H-9814-2012
OI Vinu, Ajayan/0000-0002-7508-251X
CR Adams S, 2002, LANGMUIR, V18, P4854, DOI 10.1021/la0112413
   Ariga K, 2004, CHEM REC, V3, P297, DOI 10.1002/tcr.10071
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785
   Hammond W, 1999, MICROPOR MESOPOR MAT, V27, P19, DOI 10.1016/S1387-1811(98)00222-4
   Han SJ, 2003, MICROPOR MESOPOR MAT, V58, P131, DOI 10.1016/S1387-1811(02)00611-X
   Hartmann M, 2002, LANGMUIR, V18, P8010, DOI 10.1021/la025782j
   Hartmann M, 2002, CHEM COMMUN, P1238, DOI 10.1039/b202662g
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046
   Joseph T, 2003, J MOL CATAL A-CHEM, V206, P13, DOI 10.1016/S1381-1169(03)00452-7
   Jun S, 2000, J AM CHEM SOC, V122, P10712, DOI 10.1021/ja002261e
   Karthik M, 2004, APPL CATAL A-GEN, V268, P139, DOI 10.1016/j.apcata.2004.03.028
   Karthik M, 2004, MICROPOR MESOPOR MAT, V70, P15, DOI 10.1016/j.micromeso.2004.02.012
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lee J, 2004, J MATER CHEM, V14, P478, DOI 10.1039/b311541k
   Lee J, 1999, CHEM COMMUN, P2177, DOI 10.1039/a906872d
   Lu K., 1997, CARBON, V35, P427
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   Lvov Y., 1999, PROTEIN ARCHITECTURE
   Malmsten M, 2003, BIOPOLYMERS INTERFAC
   Marler B, 1996, MICROPOROUS MATER, V6, P375, DOI 10.1016/0927-6513(96)00016-8
   Okabe A, 2002, ANGEW CHEM INT EDIT, V41, P3414, DOI 10.1002/1521-3773(20020916)41:18<3414::AID-ANIE3414>3.0.CO;2-T
   OKAHATA Y, 1988, LANGMUIR, V4, P1373, DOI 10.1021/la00084a030
   OKAHATA Y, 1989, THIN SOLID FILMS, V180, P65, DOI 10.1016/0040-6090(89)90055-2
   Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9
   Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H
   Rusling J F, 2003, BIOMOLECULAR FILMS D
   Ryoo R, 2001, ADV MATER, V13, P677, DOI 10.1002/1521-4095(200105)13:9<677::AID-ADMA677>3.3.CO;2-3
   Ryoo R, 1999, J PHYS CHEM B, V103, P7743, DOI 10.1021/jp991673a
   Sayari A, 2001, CHEM MATER, V13, P3151, DOI [10.1021/cm011039l, 10.1021/cm0110391]
   Vinu A, 2004, J PHYS CHEM B, V108, P11496, DOI 10.1021/jp048411f
   Vinu A, 2004, CHEM MATER, V16, P3056, DOI 10.1021/cm049718u
   Vinu A, 2004, J PHYS CHEM B, V108, P7323, DOI 10.1021/jp037303a
   Vinu A, 2004, CHEM LETT, V33, P588, DOI 10.1246/cl.2004.588
   Vinu A, 2004, APPL CATAL A-GEN, V265, P1, DOI 10.1016/j.apcata.2003.12.044
   Vinu A, 2003, CHEM MATER, V15, P1385, DOI 10.1021/cm0213523
   Vinu A, 2003, J PHYS CHEM B, V107, P8297, DOI 10.1021/jp035246f
   VINU A, IN PRESS CATAL TODAY
   WILSON KP, 1992, J BIOL CHEM, V267, P10842
   YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988
   Zhang QM, 2004, J AM CHEM SOC, V126, P988, DOI 10.1021/ja0395l5r
NR 42
TC 199
Z9 201
U1 1
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD APR 7
PY 2005
VL 109
IS 13
BP 6436
EP 6441
DI 10.1021/jp050454o
PG 6
WC Chemistry, Physical
SC Chemistry
GA 912WS
UT WOS:000228111200057
PM 16851717
DA 2018-10-19
ER

PT J
AU Ma, HW
   Hyun, J
   Zhang, ZP
   Beebe, TP
   Chilkoti, A
AF Ma, HW
   Hyun, J
   Zhang, ZP
   Beebe, TP
   Chilkoti, A
TI Fabrication of biofunctionalized quasi-three-dimensional microstructures
   of a nonfouling comb polymer using soft lithography
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; TOPOGRAPHICAL CONTROL; CELL BEHAVIOR;
   BIOMATERIAL SURFACES; PROTEIN ADSORPTION; CONTACT GUIDANCE; RGD
   PEPTIDES; NETWORKS; ADHESION; GROWTH
AB This paper describes a simple set of patterning methods that are applicable to diverse substrates and allow the routine and rapid fabrication of protein patterns embedded within a background that consists of quasi-three-dimensional microstructures of a cell-resistant polymer. The ensemble of methods reported here utilizes three components to create topographically nonfouling polymeric structures that present cell-adhesive protein patterns in the regions between the microstructures: the first component is an amphiphilic comb polymer that is comprised of a methyl methacrylate backbone and pendant oligo(ethylene glycol) moieties along the side chain, physically deposited films of which are protein- and cell-resistant. ne second component of the fabrication methodology involves the use of different variants of soft lithography, such as microcontact printing to create nonfouling topographical features of the comb polymer that demarcate cell-adhesive regions of the third component: a cell-adhesive extracellular protein or peptide. The ensemble of methods reported in this paper was used to fabricate quasi-three-dimensional patterns that present topographical and biochemical cues on a variety of substrates, and was shown to successfully maintain cellular patterns for up to two months in serum-containing medium. We believe that this, and other such methods under development that allow independent and systematic control of chemistry, topography and substrate compliance will provide versatile "test-beds" for fundamental studies in cell biology as well as allow the discovery of rational design principles for the development of biomaterials and tissue-engineering scaffolds.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   Seoul Natl Univ, Sch Biol Resources & Mat Engn, Seoul 151742, South Korea.
   Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
RP Ma, HW (reprint author), Duke Univ, Dept Biomed Engn, Box 90281, Durham, NC 27708 USA.
EM chilkoti@duke.edu
CR ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   BAIN CD, 1989, ANGEW CHEM INT EDIT, V28, P506, DOI 10.1002/anie.198905061
   Barbucci R, 2003, MAT SCI ENG C-BIO S, V23, P329, DOI 10.1016/S0928-4931(02)00283-7
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   CARTER SB, 1967, EXP CELL RES, V48, P189, DOI 10.1016/0014-4827(67)90298-4
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1978, NATURE, V274, P52, DOI 10.1038/274052a0
   DRUMHELLER PD, 1994, BIOTECHNOL BIOENG, V43, P772, DOI 10.1002/bit.260430812
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Ghosh P, 1999, ANGEW CHEM INT EDIT, V38, P1592, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1592::AID-ANIE1592>3.0.CO;2-I
   HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Horbett TA, 1995, ACS SYM SER, V602, P1
   Hyun J, 2001, LANGMUIR, V17, P6358, DOI 10.1021/la010695x
   Hyun JH, 2003, ADV MATER, V15, P576, DOI 10.1002/adma.200304496
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Ivanchenko MI, 1995, ACS SYM SER, V602, P463
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MERRILL EW, 1992, POLYM MED BIOMEDICAL, P39
   MEYLE J, 1994, J MATER SCI-MATER M, V5, P463, DOI 10.1007/BF00058984
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Nitschke M, 2000, J BIOMED MATER RES, V50, P340, DOI 10.1002/(SICI)1097-4636(20000605)50:3<340::AID-JBM7>3.0.CO;2-S
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m
   Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Renault JP, 2003, J PHYS CHEM B, V107, P703, DOI 10.1021/jp0263424
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   SUN YH, 1986, J BIOACT COMPAT POL, V1, P316
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Xia N, 2002, LANGMUIR, V18, P3255, DOI 10.1021/la011423x
   Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Zhang Z. L., UNPUB
NR 60
TC 32
Z9 33
U1 1
U2 12
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD APR
PY 2005
VL 15
IS 4
BP 529
EP 540
DI 10.1002/adfm.200400088
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 916VG
UT WOS:000228413900001
DA 2018-10-19
ER

PT J
AU Kamm, B
   Kamm, M
   Kiener, A
   Meyer, HP
AF Kamm, B
   Kamm, M
   Kiener, A
   Meyer, HP
TI Polycarnitine - a new biomaterial
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
ID L-CARNITINE; EFFICIENT SYNTHESIS; ESCHERICHIA-COLI; METABOLISM
AB The natural product L-carnitine is - due to its biotechnological accessibility and specific properties - on the way to becoming an attractive biobased bulk product. L-Carnitine is a natural betaine with vitamin properties. Carnitine is an essential part of the fatty acid metabolism of human beings and animals. Carnitine was first isolated in 1905 from meat extract and important recent developments include the biosyntheses of L-carnitine from L-lysine or gamma-butyrobetaine. Our synthesis routes are designed to maintain the primary structure and specific properties of carnitine, such as hydrophilicity and "stiffening" effects for polymeric structures and applications. L-Carnitine is converted via lactonization or olefinization into polymerizable basic molecules. The properties and the applications of carnitine polymers are described.
C1 Biorefinery De GmbH, D-14471 Potsdam, Germany.
   Lonza AG Biotechnol, CH-3930 Visp, Switzerland.
RP Kamm, B (reprint author), Res Ctr Teltow Seehof, Res Inst Bioact Polymer Syst EV, Kantstr 55, D-14513 Teltow, Germany.
EM kamm@biopos.de
CR BAHL JJ, 1987, ANNU REV PHARMACOL, V27, P257, DOI 10.1146/annurev.pa.27.040187.001353
   BANDRUP J, 1999, POLYM HDB FREE RADIC
   Bartolomucci G, 2000, AGRO FOOD IND HI TEC, V11, P12
   BELLAMY FD, 1990, TETRAHEDRON LETT, V31, P7323, DOI 10.1016/S0040-4039(00)88555-X
   Bernabei I, 1996, CHEM-EUR J, V2, P826, DOI 10.1002/chem.19960020715
   BERNABEI I, 1994, ANGEW CHEM INT EDIT, V33, P2077
   BERNABEI I, 1994, ANGEW CHEM, V106, P2202
   Brass JM, 1997, J BIOTECHNOL, V59, P63, DOI 10.1016/S0168-1656(97)00165-X
   Brescia F, 2002, CLIN DRUG INVEST, V22, P23, DOI 10.2165/00044011-200222001-00004
   BROQUIST HP, 1980, CARNITINE BIOSYNTHES, P7
   BUDAVARI S, 1989, MERCK INDEX, P281
   Castellar MR, 1998, J APPL MICROBIOL, V85, P883, DOI 10.1046/j.1365-2672.1998.00601.x
   DAUTZENBERG H, 1994, POLYELECTROLYTES
   ELLSNER T, 2000, Patent No. 0024919
   Elssner T, 2000, BIOCHEMISTRY-US, V39, P10761, DOI 10.1021/bi000776c
   FRAENKEL G, 1957, VITAM HORM, V15, P73, DOI 10.1016/S0083-6729(08)60508-7
   FRIEDMAN S, 1960, BIOCHEM PREP, V7, P26
   FRITZ IB, 1963, J BIOL CHEM, V238, P2509
   Hanschmann H, 1997, BIOTECHNOL LETT, V19, P679, DOI 10.1023/A:1018399001074
   JUNG H, 1991, P EUR C BIOTECHNOL, V5, P251
   JUNG H, 1993, ADV BIOCH ENG BIOTEC, V50, P22
   KAMM B, 2001, Patent No. 0194429
   KAMM B, 2004, UNPUB CARNITINE ALLY
   KAMM B, 2004, THESIS U POTSDAM
   KAMM B, 2001, Patent No. 0194441
   KAMM B, 2000, Patent No. 10027393
   KAMM B, 2000, Patent No. 10027391
   KASAI N, 1992, TETRAHEDRON LETT, V33, P1211, DOI 10.1016/S0040-4039(00)91898-7
   Kleber HP, 1997, FEMS MICROBIOL LETT, V147, P1
   KONRAD E, 1995, Patent No. 13539859
   KULLA H, 1993, Patent No. 5187093
   KULLA H, 1986, Patent No. 195944
   KULLA H, 1985, Patent No. 0195944
   KULLA HG, 1991, CHIMIA, V45, P81
   LINNEWEH W, 1928, Z PHYSL CHEM, V175, P91
   LONZA, 1987, Patent No. 4708936
   LONZA AG, 1999, BIOTECHNOL FORUM, V1, P14
   Marzi M, 2000, J ORG CHEM, V65, P6766, DOI 10.1021/jo000503n
   MURRAY WJ, 1980, J THEOR BIOL, V82, P559, DOI 10.1016/0022-5193(80)90178-2
   ULRICH F, 2001, ACTA CHIR AUSTRIACA, V33, P15
   YOKOZEKI K, 1988, AGR BIOL CHEM TOKYO, V52, P2415, DOI 10.1080/00021369.1988.10869060
   ZHOU BN, 1983, J AM CHEM SOC, V105, P5925, DOI 10.1021/ja00356a041
   ZIMMERMANN TP, 1997, CHIRALITY IND, V2, P287
NR 43
TC 9
Z9 10
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD APR
PY 2005
VL 67
IS 1
BP 1
EP 7
DI 10.1007/s00253-004-1801-5
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 913XA
UT WOS:000228187700001
PM 15614565
DA 2018-10-19
ER

PT J
AU Li, YW
   Schutte, RJ
   Abu-Shakra, A
   Reichert, WM
AF Li, YW
   Schutte, RJ
   Abu-Shakra, A
   Reichert, WM
TI Protein array method for assessing in vitro biomaterial-induced cytokine
   expression
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; cytokine; monocyte; titanium; macrophage
ID MACROPHAGE RESPONSE; PARTICLES; VIVO; BIOCOMPATIBILITY; ENDOTOXIN;
   DEBRIS
AB This study demonstrates the feasibility of a cytokine-based in vitro test for biomaterials. The combination of monocyte culture and protein array technology tested in this study permitted the detection of subtle changes in cytokine expression following an exposure to titanium (Ti) particles. However, a broader range of materials and sample configurations must be examined before these promising results can be translated into a reliable and predictive in vitro biomaterials testing protocol. Modified glass slides were robotically printed with eight identical arrays consisting of capture antibodies against four mouse cytokines [IL-6, TNF-alpha, MIP-2, TGF-beta1] and two positive and two negative detection controls. RAW 264.7 mouse monocytes seeded into six-well plates at 10(5) cells/ well were treated with either sterilized Ti particles (test biomaterial), or lipopolysaccharide (LPS; positive control), or untreated (negative control). Aliquots (80 mul) of culture medium collected at 1, 6, 24, 48, and 72 h were applied to the protein arrays for simultaneous sandwich fluoroimmunoassay, followed by imaging the fluorescent intensities on a conventional microarray scanner. LPS induced the release of all four cytokines between 1 and 6h treatment periods, whereas Ti induction of cytokines showed a gradual and subtle increase in cytokine expression for >24h. Among the four cytokines assayed, TNF-alpha and MIP-2 were most prominently expressed, while IL-6 was slightly elevated and TGF-beta1 was undetected above background. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   N Carolina Cent Univ, Dept Biol, Durham, NC 27707 USA.
RP Reichert, WM (reprint author), Duke Univ, Dept Biomed Engn, 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.
EM reichert@duke.edu
FU NHLBI NIH HHS [HL/DK54932]
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brooks RA, 2002, J BONE JOINT SURG BR, V84B, P295, DOI 10.1302/0301-620X.84B2.12061
   Cho DR, 2002, J ORTHOPAED RES, V20, P704, DOI 10.1016/S0736-0266(01)00179-6
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   Heil TL, 2002, J ORAL REHABIL, V29, P401, DOI 10.1046/j.1365-2842.2002.00893.x
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   *INT ORG STAND, 1993, TEST CYT VITR METH 5
   Jones LC, 2001, J BONE JOINT SURG BR, V83B, P448, DOI 10.1302/0301-620X.83B3.10734
   Knight PR, 2004, SHOCK, V21, P26, DOI 10.1097/01.shk.0000101668.49265.19
   Li YW, 2003, ANAL CHEM, V75, P5274, DOI 10.1021/ac034563f
   Li YW, 2003, LANGMUIR, V19, P1557, DOI 10.1021/la026322t
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   Mitchell W, 2003, BIOMATERIALS, V24, P737, DOI 10.1016/S0142-9612(02)00405-2
   SALVATI EA, 1993, CLIN ORTHOP RELAT R, P160
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   Trindade MCD, 2001, BIOMATERIALS, V22, P253, DOI 10.1016/S0142-9612(00)00181-2
NR 19
TC 28
Z9 28
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2005
VL 26
IS 10
BP 1081
EP 1085
DI 10.1016/j.biomaterials.2004.04.018
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871QE
UT WOS:000225147500001
PM 15451627
DA 2018-10-19
ER

PT J
AU Kroese-Deutman, HC
   Ruhe, PQ
   Spauwen, PHM
   Jansen, JA
AF Kroese-Deutman, HC
   Ruhe, PQ
   Spauwen, PHM
   Jansen, JA
TI Bone inductive properties of rhBMP-2 loaded porous calcium phosphate
   cement implants inserted at an ectopic site in rabbits
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate cement; bone morphogenetic protein (BMP); growth
   factors; ectopic bone formation; osteoinduction; bone tissue engineering
ID GROWTH-FACTOR-BETA; MORPHOGENETIC PROTEIN-2; BIOMATERIAL CARRIERS;
   BOVINE BONE; OSTEOINDUCTION; MODEL; REGENERATION; PHARMACOKINETICS;
   HYDROXYAPATITE; EXPRESSION
AB Recombinant human bone morphogenetic protein-2 (rhBMP-2) is known for its osteoinductive potential in bone tissue engineering. Calcium phosphate (Ca-P) cements are injectable, osteoconductive ceramic materials in which a macroporous structure can be induced during the setting reaction. In this study, the osteoinductive capability of rhBMP-2 loaded porous Ca-P cement was evaluated.
   Porous Ca-P cement discs were made and loaded with rhBMP-2 in vitro and implanted subcutaneously in the back of New Zealand white rabbits. The implantation period was either 2 or 10 weeks. Histological analysis of retrieved specimens revealed evident bone formation in the rhBMP-2 loaded Ca-P cement discs (pore fill: 18+/-6%) after 10 weeks of implantation. Bone formation occurred only in rhBMP-2 loaded porous Ca-P cement discs. Degradation of the Ca-P cement could not be confirmed after 10 weeks of implantation. The scaffold maintained its shape and stability during this time period.
   We conclude that porous Ca-P cement is a suitable carrier material for ectopic bone engineering. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Dept Biomat, POB 9101,THK 117, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014
CR BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309
   BROWN WE, 1985, Patent No. 4518430
   Comuzzi L, 2002, CLIN ORAL IMPLAN RES, V13, P304, DOI 10.1034/j.1600-0501.2002.130311.x
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Hartman EHM, 2002, J INVEST SURG, V15, P185, DOI 10.1080/08941930290085967
   HOLLINGER JO, 1989, J BIOMED MATER RES, V23, P17, DOI 10.1002/jbm.820230103
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LEE DD, 1999, CLIN ORTHOP RELAT R, V367, P396
   LUCAS PA, 1989, J BIOMED MATER RES-A, V23, P23, DOI 10.1002/jbm.820231306
   Murata M, 1998, INT J ORAL MAX SURG, V27, P391, DOI 10.1016/S0901-5027(98)80071-4
   Omura S, 1998, INT J ORAL MAX SURG, V27, P129, DOI 10.1016/S0901-5027(98)80312-3
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   REDDI AH, 1995, CLIN ORTHOP RELAT R, P115
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   REDDI AH, 1993, J BONE MINER RES, V8, pS499
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   SCHWARTZ Z, 1993, J BIOMED MATER RES, V27, P1029, DOI 10.1002/jbm.820270808
   Si XH, 1998, INT J ORAL MAX SURG, V27, P310, DOI 10.1016/S0901-5027(05)80622-8
   Tatakis DN, 2002, J PERIODONTAL RES, V37, P93, DOI 10.1034/j.1600-0765.2002.00021.x
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yoshida K, 1998, J CRANIO MAXILL SURG, V26, P112, DOI 10.1016/S1010-5182(98)80050-4
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 40
TC 75
Z9 83
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2005
VL 26
IS 10
BP 1131
EP 1138
DI 10.1016/j.biomaterials.2004.04.021
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871QE
UT WOS:000225147500006
PM 15451632
DA 2018-10-19
ER

PT J
AU De Munck, J
   Braem, M
   Wevers, M
   Yoshida, Y
   Inoue, S
   Suzuki, K
   Lambrechts, P
   Van Meerbeek, B
AF De Munck, J
   Braem, M
   Wevers, M
   Yoshida, Y
   Inoue, S
   Suzuki, K
   Lambrechts, P
   Van Meerbeek, B
TI Micro-rotary fatigue of tooth-biomaterial interfaces
SO BIOMATERIALS
LA English
DT Article
DE adhesion; fatigue; fracture mechanism; dental adhesive; enamel; dentin
ID BOND STRENGTH; COMPOSITE RESTORATIONS; HUMAN DENTIN; ENAMEL; ADHESIVES;
   CEMENTS; RESISTANCE; FLEXURE; LIMITS; ETCH
AB The bonding effectiveness of restorative materials to tooth tissue is typically measured statically. Clinically tooth/composite bonds are however subjected to cyclic sub-critical loads. Therefore, in vitro fatigue testing of dental adhesives should predict better the in vivo performance of adhesives. The objective of this study was to determine the fatigue resistance of two representative adhesives, a self-etch and an etch&rinse adhesive, bonded to enamel and dentin. Therefore, tooth/composite interfaces were cyclically loaded using a miniaturized version of a rotating beam fatigue testing device. Subsequently, the load at which 50% of the specimens fail after 105 cycles, was determined as the median micro-rotary fatigue resistance (muRFR). For both adhesives, the muRFR was about 30-40% lower than the corresponding micro-tensile bond strength (muTBS) to both enamel and dentin. Analysis of the fracture surfaces by Feg-SEM revealed typical fatigue fracture patterns. It is concluded that resin/tooth interfaces are vulnerable to progressive damage by sub-critical loads, with the 3-step etch&rinse adhesive being more resistant to fatigue than the 2-step self-etch adhesive. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Catholic Univ Louvain, Sch Dent, Dept Conservat Dent, Leuven BIOMAT Res Ct, B-3000 Louvain, Belgium.
   Univ Antwerp, RUCA, Dept TEWO, Lab Dent Mat, B-2020 Antwerp, Belgium.
   Catholic Univ Louvain, MTM, B-3001 Heverlee, Belgium.
   Okayama Univ, Grad Sch Med & Dent, Dept Biomat, Okayama 7008525, Japan.
   Okayama Univ, Biomed Engn Res Ctr, Okayama 7008525, Japan.
   Hokkaido Univ, Dent Hosp, Div Gen Dent, Kita Ku, Sapporo, Hokkaido 0608586, Japan.
RP Van Meerbeek, B (reprint author), Catholic Univ Louvain, Sch Dent, Dept Conservat Dent, Leuven BIOMAT Res Ct, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
EM bart.vanmeerbeek@med.kuleuven.ac.be
RI YOSHIDA, Yasuhiro/B-2472-2011; Wevers, Martine/S-4700-2016; Inoue,
   Satoshi/A-5522-2012
OI Wevers, Martine/0000-0002-8797-5454; BRAEM, Marc/0000-0002-8260-4240
CR Ausiello P, 2002, DENT MATER, V18, P295, DOI 10.1016/S0109-5641(01)00042-2
   Baran G, 2001, CRIT REV ORAL BIOL M, V12, P350, DOI 10.1177/10454411010120040501
   Baran GR, 1999, J ORAL REHABIL, V26, P775, DOI 10.1046/j.1365-2842.1999.00451.x
   Boghosian A, 1996, Compend Contin Educ Dent, V17, P750
   BRAEM M, 1994, J DENT, V22, P97, DOI 10.1016/0300-5712(94)90010-8
   BRAEM MJA, 1994, J BIOMED MATER RES, V28, P1397, DOI 10.1002/jbm.820281203
   De Munck J, 2002, EUR J ORAL SCI, V110, P322, DOI 10.1034/j.1600-0722.2002.21281.x
   De Munck J, 2003, J DENT RES, V82, P136, DOI 10.1177/154405910308200212
   DEMUNCK J, 2004, IN PRESS OPER DENT
   Dewji HR, 1998, EUR J ORAL SCI, V106, P594, DOI 10.1046/j.0909-8836.1998.eos106110.x
   DRAUGHN RA, 1979, J DENT RES, V58, P1093, DOI 10.1177/00220345790580031101
   Drummond JL, 1996, J BIOMED MATER RES, V32, P533, DOI 10.1002/(SICI)1097-4636(199612)32:4<533::AID-JBM6>3.3.CO;2-5
   Dunne NJ, 2003, BIOMATERIALS, V24, P239, DOI 10.1016/S0142-9612(02)00296-X
   Frankenberger R, 1999, Clin Oral Investig, V3, P11, DOI 10.1007/s007840050072
   GIVAN DA, 1995, J PROSTHET DENT, V73, P377
   Hannig M, 2002, EUR J ORAL SCI, V110, P464, DOI 10.1034/j.1600-0722.2002.21326.x
   HAWBOLT EB, 1983, J DENT RES, V62, P1226, DOI 10.1177/00220345830620121101
   HTANG A, 1995, DENT MATER, V11, P7, DOI 10.1016/0109-5641(95)80002-6
   Inoue S, 2001, J Adhes Dent, V3, P237
   JAMESON MW, 1993, J BIOMECH, V26, P1055, DOI 10.1016/S0021-9290(05)80005-3
   Mitchell CA, 1998, J ORAL REHABIL, V25, P472
   Pashley D H, 1999, J Adhes Dent, V1, P299
   PERDIGAO J, 1995, J BIOMED MATER RES, V29, P1111, DOI 10.1002/jbm.820290911
   Phrukkanon S, 1998, DENT MATER, V14, P212, DOI 10.1016/S0109-5641(98)00034-7
   REMMERSWAAL JAM, 1990, THESIS TECHNICAL U D
   Roulin-Moloney A. C., 1989, FRACTOGRAPHY FAILURE, P233
   RUSE ND, 1995, J BIOMED MATER RES, V29, P411, DOI 10.1002/jbm.820290316
   SAKAGUCHI RL, 1992, DENT MATER, V8, P131, DOI 10.1016/0109-5641(92)90068-N
   Scherrer SS, 2003, J PROSTHET DENT, V89, P579, DOI 10.1016/S0022-3913(03)00174-4
   SHIRAI K, 2004, IN PRESS DENT MAT
   STARK HL, 1986, ENG FRACT MECH, V25, P395, DOI 10.1016/0013-7944(86)90253-5
   Van Meerbeek B, 2003, OPER DENT, V28, P215
   Van Meerbeek B, 1999, J Adhes Dent, V1, P7
   Van Meerbeek B, 2004, OPER DENT, V29, P376
   Van Meerbeek B, 1998, J DENT RES, V77, P50, DOI 10.1177/00220345980770010501
   VANMEERBEEK B, 1993, J DENT RES, V72, P1434, DOI 10.1177/00220345930720101401
   VANMEERBEEK B, 2004, IN PRESS DENT MAT
   VANNOORT R, 1989, J DENT, V17, P61, DOI 10.1016/0300-5712(89)90131-0
   WISKOTT HWA, 1994, DENT MATER, V10, P215
   Yamamoto M, 1995, Dent Mater J, V14, P175
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
NR 41
TC 66
Z9 66
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2005
VL 26
IS 10
BP 1145
EP 1153
DI 10.1016/j.biomaterials.2004.04.013
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871QE
UT WOS:000225147500008
PM 15451634
DA 2018-10-19
ER

PT J
AU Williams, CG
   Malik, AN
   Kim, TK
   Manson, PN
   Elisseeff, JH
AF Williams, CG
   Malik, AN
   Kim, TK
   Manson, PN
   Elisseeff, JH
TI Variable cytocompatibility of six cell lines with photoinitiators used
   for polymerizing hydrogels and cell encapsulation
SO BIOMATERIALS
LA English
DT Article
DE photopolymerization; cytotoxicity; hydrogel; cell encapsulation; cell
   proliferation; free radical
ID DEGRADABLE PEG HYDROGELS; IN-VITRO; PORCINE ISLETS; CARTILAGE;
   PHOTOPOLYMERIZATION; PHOTOENCAPSULATION; CYTOTOXICITY; CHONDROCYTES;
   PEROXIDATION; ANTIOXIDANT
AB The development of biocompatible photopolymerizing polymers for biomedical and tissue engineering applications has the potential to reduce the invasiveness and cost of biomaterial implants designed to repair or augment tissues. However, more information is needed about the cellular toxicity of the compounds and initiators used in these systems. The current study evaluates the cellular toxicity of three ultraviolet sensitive photoinitiators on six different cell populations that are used for engineering numerous tissues. The photoinitiator 2-hydroxy-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959) caused minimal toxicity (cell death) over a broad range of mammalian cell types and species. It was also demonstrated that different cell types have variable responses to identical concentrations of the same photoinitiator. While inherent differences in the cell lines may contribute to the variable cytotoxicity, a correlation between cellular proliferation rate (population doubling time) and increased cytotoxicity of the photoinitiator was observed. Cell lines that divided more quickly were more sensitive to photoinitiator-induced cell death. In summary, the photoinitiator Irgacure 2959 is well tolerated by many cell types over a range of mammalian species. Cell photoencapsulation strategies may be optimized to improve cell survival by manipulating proliferation rate. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   Johns Hopkins Univ Hosp, Div Plast & Reconstruct Surg, Dept Surg, Baltimore, MD 21287 USA.
   Seoul Natl Univ, Dept Orthoped Surg, Bundang Hosp, Seoul, South Korea.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
EM jhe@bme.jhu.edu
RI Kim, Tae Kyun/J-5446-2012
CR Atsumi T, 1998, ARCH ORAL BIOL, V43, P73, DOI 10.1016/S0003-9969(97)00073-3
   BONORDEN WR, 1994, NUTR TOXICOLOGY
   Bryant S J, 1999, Biomed Sci Instrum, V35, P309
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   DUMANIAN GA, 1995, PLAST RECONSTR SURG, V95, P901, DOI 10.1097/00006534-199595050-00021
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4
   FRESHNEY RI, 2000, CULTURE ANIMAL CELLS, P335
   Fujisawa S, 2002, TOXICOLOGY, V177, P39, DOI 10.1016/S0300-483X(02)00194-4
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   Hill RS, 1997, ANN NY ACAD SCI, V831, P332
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MOAN J, 1989, CIBA F SYMP, V146, P95
   Naji L, 2004, LIFE SCI, V74, P2227, DOI 10.1016/j.lfs.2003.08.046
   Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   Scranton A.B., 1996, PHOTOPOLYMERIZATION
   Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P531, DOI 10.1097/00006534-199902000-00025
   Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259
   TERAKADO M, 1984, J DENT RES, V63, P901, DOI 10.1177/00220345840630061801
NR 32
TC 398
Z9 403
U1 14
U2 107
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2005
VL 26
IS 11
BP 1211
EP 1218
DI 10.1016/j.biomaterials.2004.04.024
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 876TX
UT WOS:000225521700002
PM 15475050
DA 2018-10-19
ER

PT J
AU Hong, J
   Azens, A
   Ekdahl, KN
   Granqvist, CG
   Nilsson, B
AF Hong, J
   Azens, A
   Ekdahl, KN
   Granqvist, CG
   Nilsson, B
TI Material-specific thrombin generation following contact between metal
   surfaces and whole blood
SO BIOMATERIALS
LA English
DT Article
DE metals; hemocompatibility; thrombogenicity; platelet activation;
   coagulation; complement
ID IN-VITRO MODEL; PROTEIN ADSORPTION; ACTIVATION; COMPLEMENT; TITANIUM;
   PLASMA; BIOMATERIAL; IMPLANTS; STENT; OSSEOINTEGRATION
AB Little is known about the blood compatibility of metals used in various medical devices. We have previously shown that titanium and derivatives thereof are among the most thrombogenic materials which may explain its outstanding osteointegrating properties. The aim of the present study was to characterize the thrombogenic and complement-activating properties of various metals used today in medical applications.
   Polyester chips were coated with 50- to 100-nm thick layers of aluminium, iridium, indium, nickel, tantalum, tin, titanium, or zirconium using magnetron sputtering. The metal-coated chips were then incubated in direct contact with whole blood in an in vitro chamber model, and the blood was then analyzed for platelet counts, thrombin-antithrombin (AT), fXIIa-AT, fXIa-AT and fXIIa-CIINH complexes and the complement parameters C3a and sC5b-9.
   Titanium, tantalum and indium were found to exhibit pronounced thrombogenic properties, whereas aluminium, nickel and, in particular, iridium were essentially non-thrombogenic. Tin and zirconium were intermediate activators. All metals activated complement to a similar degree, with the exception of aluminium, which had more pronounced activating properties.
   This study clearly indicates that metals indeed have varying thrombogenic and complement activating properties. These studies have implications for the selection of metals intended for medical applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab, SE-75185 Uppsala, Sweden.
   Uppsala Univ, Angstrom Lab, Dept Engn Sci, SE-75121 Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Hosp, Dept Oncol Radiol & Clin Immunol, Clin Immunol Sect, Rudbeck Lab, SE-75185 Uppsala, Sweden.
EM jaan.hong@klinimm.uu.se; Bo.Nilsson@klinimm.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
CR Allain J, 1999, J BONE JOINT SURG BR, V81B, P835, DOI 10.1302/0301-620X.81B5.9454
   Ananyeva NM, 2002, BLOOD, V99, P4475, DOI 10.1182/blood-2001-11-0140
   Bhargava B, 2000, CATHETER CARDIO INTE, V51, P364, DOI 10.1002/1522-726X(200011)51:3<364::AID-CCD28>3.0.CO;2-D
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Chapman B., 1980, GLOW DISCHARGE PROCE
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   CUOMO JJ, 1989, HDB BEAM PROCESS TEC
   Dunn IF, 2000, J NEURO-ONCOL, V50, P121, DOI 10.1023/A:1006436624862
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Frost A, 1999, ACTA ORTHOP SCAND, V70, P497, DOI 10.3109/17453679909000988
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Gutensohn K, 1997, THROMB RES, V86, P49, DOI 10.1016/S0049-3848(97)00044-3
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hong J, 2001, J LAB CLIN MED, V138, P139, DOI 10.1067/mlc.2001.116486
   Jensen RL, 1998, SURG NEUROL, V49, P189, DOI 10.1016/S0090-3019(97)00218-8
   Kim SG, 2002, J ORAL MAXIL SURG, V60, P1018, DOI 10.1053/joms.2002.34413
   KONUMA M., 1992, FILM DEPOSITION PLAS
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Marzouk SAM, 1998, ANAL CHEM, V70, P5054, DOI 10.1021/ac980608e
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x
   Monties JR, 1997, ARTIF ORGANS, V21, P730, DOI 10.1111/j.1525-1594.1997.tb03731.x
   Nilsson B, 1998, BLOOD, V92, P1661
   Park SW, 1997, AM J CARDIOL, V79, P901, DOI 10.1016/S0002-9149(97)00017-9
   Phillips SJ, 2001, ASAIO J, V47, P429, DOI 10.1097/00002480-200109000-00002
   PIXLEY RA, 1985, J BIOL CHEM, V260, P1723
   Rompen EH, 1999, CLIN ORAL IMPLAN RES, V10, P85, DOI 10.1034/j.1600-0501.1999.100202.x
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Sun BC, 1999, ANN THORAC SURG, V68, P688, DOI 10.1016/S0003-4975(99)00539-1
   Takami Y, 1998, ARTIF ORGANS, V22, P753, DOI 10.1046/j.1525-1594.1998.6184R.x
   Tengvall P, 1998, BIOMATERIALS, V19, P935, DOI 10.1016/S0142-9612(98)00005-2
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wasa K., 1992, HDB SPUTTER DEPOSITI
NR 35
TC 48
Z9 48
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2005
VL 26
IS 12
BP 1397
EP 1403
DI 10.1016/j.biomaterials.2004.05.036
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 880AG
UT WOS:000225760100008
PM 15482827
DA 2018-10-19
ER

PT J
AU Teramoto, H
   Nakajima, K
   Takabayashi, C
AF Teramoto, H
   Nakajima, K
   Takabayashi, C
TI Preparation of elastic silk sericin hydrogel
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE hydrogel; silk; sericin; Sericin-hope; sponge
ID BOMBYX-MORI; PROTEIN; POLYPEPTIDES; FIBROIN
AB This paper reports a preparation method for silk sericin hydrogel using the Sericin-hope silkworm, whose cocoons consist almost exclusively of sericin. Sericin solution, prepared from Sericin-hope cocoons, contains intact sericin and forms elastic hydrogels with the addition of ethanol. The sericin hydrogel can be prepared without crosslinking by chemicals or irradiation and might be usable as a naturally occurring biomaterial.
C1 Natl Inst Agrobiol Sci, New Silk Mat Lab, Okayama, Nagano 3940021, Japan.
RP Teramoto, H (reprint author), Natl Inst Agrobiol Sci, New Silk Mat Lab, 1-4-8 Gohda, Okayama, Nagano 3940021, Japan.
EM teramoto@nias.affrc.go.jp
OI Teramoto, Hidetoshi/0000-0002-2075-0218
CR Fedic Robert, 2002, Journal of Insect Biotechnology and Sericology, V71, P1
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   TAKEI F, 1984, J CELL BIOL, V99, P2005, DOI 10.1083/jcb.99.6.2005
   Tekeuchi A., 2003, J BIOMED MATER RES A, V65, P283
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2004, BIOMACROMOLECULES, V5, P1392, DOI 10.1021/bm034537r
   Voegeli R., 1993, COSMET TOILETRIES, V108, P101
   YAMAMOTO T, 2001, Patent No. 2001245550
   Zhu Liang Jun, 1995, Journal of Sericultural Science of Japan, V64, P415
NR 14
TC 44
Z9 48
U1 4
U2 61
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD APR
PY 2005
VL 69
IS 4
BP 845
EP 847
DI 10.1271/bbb.69.845
PG 3
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 923ND
UT WOS:000228915700026
PM 15849429
OA Bronze
DA 2018-10-19
ER

PT J
AU Danino, AM
   Malka, G
   Revol, M
   Servant, JM
AF Danino, AM
   Malka, G
   Revol, M
   Servant, JM
TI A scanning electron microscopical study of the two sides of
   polypropylene mesh (Marlex((R))) and PTFE (Gore Tex((R))) mesh 2 years
   after complete abdominal wall reconstruction. A study of 15 cases
SO BRITISH JOURNAL OF PLASTIC SURGERY
LA English
DT Article; Proceedings Paper
CT 45th Annual Meeting of the
   French-Society-of-Plastic-and-Reconstructive-Surgery
CY OCT, 2001
CL Paris, FRANCE
SP French Soc Plast & Reconstruct Surg
DE abdominal wall; polypropylene; polytetrafluoroethylene
ID REPAIR; DEFECTS; PROSTHESIS; MIGRATION; HERNIA
AB The use of biomaterials for the repair of abdominal wall defect is becoming common and safe. It has been 20 years since the senior author developed a method to reconstruct the very large transfixing abdominal wait defect with a combination of two biomaterials (Gore Tex (R) PTFE as a neo peritoneum and polypropylene superficial to this in order to give rigidity to the abdominal wall) and a superficial flap. An observation at the electron microscopy level of the two sides of the implants' surfaces was performed. At the time of a late abdominal watt surgical revision on 15 patients, the prosthesis fragments have been analyzed at the electron microscopy level. The aim of our study was to analyze the late evolution of the different sides of these prostheses. Our results showed, for the first time in vivo, that there is an impressive stability of the deep side of PTFE ultra structure after implantation, a significant difference of the two sides of PTFE at the ultrastructural level and the creation of an intermediate tissue between the two meshes. In contrast, the polypropylene invariably gave rise to adhesions and colonisation by the surrounding tissues. Findings confirmed that the structure and porosity of a biomaterial play a key rote in the appearance of adhesions and their consistency. (c) 2004 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 Dijon Univ Hosp, Gen Hosp, Dept Plast & Reconstruct Surg, F-21000 Dijon, France.
   St Louis Univ Hosp, Dept Plast & Reconstruct Surg, Paris, France.
   St Louis Univ Hosp, Dept Electron Microscopy, Paris, France.
RP Danino, AM (reprint author), Dijon Univ Hosp, Gen Hosp, Dept Plast & Reconstruct Surg, 3 Rue Faubourg Raine, F-21000 Dijon, France.
EM alain.danino@chu-dijon.fr
RI danino, alain/E-4103-2012
CR AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 2000, J MATER SCI-MATER M, V11, P25, DOI 10.1023/A:1008981517743
   Bellon JM, 1997, J BIOMED MATER RES, V38, P197
   Bellon JM, 1999, EUR J SURG, V165, P145
   BUJAN J, 2001, EUR SURG RES, V33, P180
   CHEW DK, 2000, SURGERY, V125, P1095
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   Majeski J, 1998, SOUTH MED J, V91, P496, DOI 10.1097/00007611-199805000-00020
   Schoenfeld A, 2000, MICRON, V31, P35, DOI 10.1016/S0968-4328(99)00066-9
   Sukkar SM, 2001, AM J SURG, V181, P115, DOI 10.1016/S0002-9610(00)00566-3
   Wantz, 1999, J AM COLL SURGEONS, V188, P429
NR 13
TC 8
Z9 11
U1 0
U2 1
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0007-1226
J9 BRIT J PLAST SURG
JI Br. J. Plast. Surg.
PD APR
PY 2005
VL 58
IS 3
BP 384
EP 388
DI 10.1016/j.bjps.2004.06.004
PG 5
WC Surgery
SC Surgery
GA 915PY
UT WOS:000228317500016
PM 15780235
DA 2018-10-19
ER

PT J
AU Miraux, S
   Raffard, GR
   Pothuaud, L
   De Taillac, L
   Amedee, J
   Canioni, P
   Thiaudiere, E
   Franconi, JM
AF Miraux, S
   Raffard, GR
   Pothuaud, L
   De Taillac, L
   Amedee, J
   Canioni, P
   Thiaudiere, E
   Franconi, JM
TI NMR Microscopy with a high-resolution liquid-state spectroscopy probe
SO CONCEPTS IN MAGNETIC RESONANCE PART B-MAGNETIC RESONANCE ENGINEERING
LA English
DT Article
DE NMR microscopy; high-resolution spectroscopy probe; FLASH; biomaterial;
   mouse femoris
ID MAGNETIC-RESONANCE MICROSCOPY; MRI
AB NMR microscopy is usually achieved at ultra-high-static magnetic field (>= 9.4 Tesla) with the use of home-built coils adapted to the size of the sample. in that way, well-resolved images can be obtained with voxel size smaller than 50 mu m. The purpose of this article is to show that high-resolution imaging can be realized at lower field strength (4.7 Tesla) using 5- and 10-mm probes initially dedicated to vertical magnets. These coils are easily adaptable to horizontal imaging systems. Excellent quality and filling factors permitted isotropic resolutions (> 50 mu m) on a biomaterial and on mouse femoris. This study also demonstrates that spoiled-gradient echo sequence (FLASH) with low reception bandwidth or with the use of gadolinium are particularly effective for 3D MR microscopy. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Bordeaux 2, Magnet Resonance Ctr, F-33076 Bordeaux, France.
   INSERM, U577, Bordeaux, France.
RP Franconi, JM (reprint author), Univ Bordeaux 2, Magnet Resonance Ctr, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM franconi@rmsb.u-bordeaux2.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013
CR Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5
   Callaghan P.T., 1991, PRINCIPLES NUCL MAGN
   Darrasse L, 2003, BIOCHIMIE, V85, P915, DOI 10.1016/j.biochi.2003.09.016
   Gardner JR, 2001, MAGNET RESON MED, V45, P1122, DOI 10.1002/mrm.1148
   HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6
   Hogers B, 2001, J MAGN RESON IMAGING, V14, P83, DOI 10.1002/jmri.1155
   Lee SC, 2001, J MAGN RESON, V150, P207, DOI 10.1006/jmre.2001.2319
   Mapelli M, 1997, MAGN RESON IMAGING, V15, P693, DOI 10.1016/S0730-725X(97)00006-4
   Olt S, 2000, J MAGN RESON, V144, P297, DOI 10.1006/jmre.2000.2076
   Pothuaud L, 2000, J MICROSC-OXFORD, V199, P149, DOI 10.1046/j.1365-2818.2000.00725.x
   POTHUAUD L, UNPUB IEEE T IMAGE P
   Wecker S, 2002, MAGN RESON IMAGING, V20, P105, DOI 10.1016/S0730-725X(01)00445-3
NR 12
TC 2
Z9 2
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-5031
J9 CONCEPT MAGN RESON B
JI Concepts Magn. Reson. Part B
PD APR
PY 2005
VL 25B
IS 1
BP 12
EP 17
DI 10.1002/cmr.b.20030
PG 6
WC Chemistry, Physical; Instruments & Instrumentation; Physics, Atomic,
   Molecular & Chemical; Spectroscopy
SC Chemistry; Instruments & Instrumentation; Physics; Spectroscopy
GA 921BL
UT WOS:000228739100002
DA 2018-10-19
ER

PT J
AU Ginalska, G
   Osinska, M
   Uryniak, A
   Urbanik-Sypniewska, T
   Belcarz, A
   Rzeski, W
   Wolski, A
AF Ginalska, G
   Osinska, M
   Uryniak, A
   Urbanik-Sypniewska, T
   Belcarz, A
   Rzeski, W
   Wolski, A
TI Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene
   terephthalate vascular prostheses
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE gelatin-sealed vascular prostheses; covalent immobilisation; in vitro
   bacterial adherence; endothelial cell proliferation
ID IN-SITU REPLACEMENT; DACRON GRAFT; INFECTION; RIFAMPIN; PREVENTION;
   TRICLOSAN; COLLAGEN; ELUTION
AB Objectives. To create an antibiotic-modified vascular prosthesis with a prolonged bactericidal activity, susceptible to endothelialisation.
   Methods. We used a covalent method of gentamicin sulphate immobilisation to polyethylene terephthalate prosthesis scaled with gelatin. Antibacterial activity was assayed in Luria-Bertani medium against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa strains. Prosthesis endothelialisation was performed using bovine aorta endothelial cells (BAEC).
   Results. Gentamicin was bound to vascular prostheses in the amount of 12 g per kg of prosthesis. Ninety-seven percent Of antibiotic bound in covalent way and remained on the biomaterial for at least 30 days during shaking in PBS solution. Gentamicin-modified prostheses exerted bactericidal or bacteriostatic effect on growth of clinical and reference bacterial strains, prevented biofilm formation and were highly susceptible to endothelialisation. BAEC viability exceeded 90%, which indicated that Getamicin-vascular prostheses were not toxic for these cells.
   Conclusions. Covalent gentamicin immobilisation resulted in effective antibacterial protection of vascular prostheses against clinical and reference strains of S. aureus, E. coli and P. aeruginosa and allowed for a strong adherence of endothelial cells to antibiotic-modified prostheses.
C1 Marie Curie Sklodowska Univ, Dept Biochem, PL-20031 Lublin, Poland.
   Municipal Hosp, Div Gen & Vasc Surg, Rzeszow, Poland.
   Marie Curie Sklodowska Univ, Inst Microbiol, Dept Gen Microbiol, Lublin, Poland.
   Marie Curie Sklodowska Univ, Inst Microbiol & Biotechnol, Dept Virol & Immunol, Lublin, Poland.
   Publ Clin Hosp 4, Div Vasc Surg, Lublin, Poland.
RP Ginalska, G (reprint author), Marie Curie Sklodowska Univ, Dept Biochem, 3 Maria Curie Sklodowska Sq, PL-20031 Lublin, Poland.
EM ginal@hermes.umcs.lublin.pl
RI Rzeski, Wojciech/S-5419-2018
OI Rzeski, Wojciech/0000-0002-4511-1498; Osinska-Jaroszuk,
   Monika/0000-0002-3465-0461; Belcarz, Anna/0000-0001-9899-5314; Ginalska,
   Grazyna/0000-0002-9961-4226
CR [Anonymous], 1999, BRIT PHARMACOPOEIA, V1, P695
   AVRAMOVIC JR, 1991, AUST NZ J SURG, V61, P436, DOI 10.1111/j.1445-2197.1991.tb00258.x
   Belt H. V. D., 2001, BIOMATERIALS, V22, P1607
   Earnshaw JJ, 2000, EUR J VASC ENDOVASC, V20, P409, DOI 10.1053/ejvs.2000.1197
   GAHTAN V, 1995, J SURG RES, V58, P105, DOI 10.1006/jsre.1995.1017
   Galdbart JO, 1996, J SURG RES, V66, P174, DOI 10.1006/jsre.1996.0391
   Ginalska G, 2004, J BIOMATER APPL, V18, P279, DOI 10.1177/0885328204041443
   GINALSKA G, IN PRESS INT J PHARM
   GINALSKA G, 2003, Patent No. 358934
   GOEAUBRISSONNIERE O, 1994, J VASC SURG, V19, P739, DOI 10.1016/S0741-5214(94)70050-8
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Hernandez-Richter T, 2003, EUR J VASC ENDOVASC, V26, P550, DOI 10.1016/S1078-5884(03)00344-7
   Hernandez-Richter T, 2000, EUR J VASC ENDOVASC, V20, P413, DOI 10.1053/ejvs.2000.1199
   LACHAPELLE K, 1994, J VASC SURG, V19, P675, DOI 10.1016/S0741-5214(94)70041-9
   Lovering AM, 1999, EUR J VASC ENDOVASC, V17, P347, DOI 10.1053/ejvs.1998.0785
   Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x
   Prager M, 2001, SURGERY, V130, P408, DOI 10.1067/msy.2001.115904
   Seelig MH, 2000, EUR J SURG, V166, P340
   Strachan C J, 1991, Eur J Vasc Surg, V5, P627, DOI 10.1016/S0950-821X(05)80896-5
   Vicaretti M, 1998, CARDIOVASC SURG, V6, P268, DOI 10.1016/S0967-2109(98)00003-9
   Vicaretti M, 2000, INT ANGIOL, V19, P158
   Zdzisinska B, 2000, VET IMMUNOL IMMUNOP, V74, P237, DOI 10.1016/S0165-2427(00)00175-6
   1998, BRIT PHARMACOPOEIA, V1, P302
NR 24
TC 21
Z9 22
U1 2
U2 16
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD APR
PY 2005
VL 29
IS 4
BP 419
EP 424
DI 10.1016/j.ejvs.2004.12.030
PG 6
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 911MI
UT WOS:000228006500015
PM 15749043
OA Bronze
DA 2018-10-19
ER

PT J
AU Jastrzebska, M
   Barwinski, B
   Mroz, I
   Turek, A
   Zalewska-Rejdak, J
   Cwalina, B
AF Jastrzebska, M
   Barwinski, B
   Mroz, I
   Turek, A
   Zalewska-Rejdak, J
   Cwalina, B
TI Atomic force microscopy investigation of chemically stabilized
   pericardium tissue
SO EUROPEAN PHYSICAL JOURNAL E
LA English
DT Article
ID CROSS-LINKING TREATMENTS; SHRINKAGE TEMPERATURE; BOVINE PERICARDIUM;
   COLLAGEN FIBRILS; BIOPROSTHESES; BIOMATERIALS
AB Native and chemically stabilized porcine pericardium tissue was imaged by the contact mode atomic force microscopy (AFM), in air. Chemically stabilized pericardium is used as a tissue-derived biomaterial in various fields of the reconstructive and replacement surgery. Collagen type I is the main component of the fibrous layer of the pericardium tissue. In this study, the surface topography of collagen fibrils in their native state in tissue and after chemical stabilization with different cross-linking reagents: glutaraldehyde (GA), dimethyl suberimidate (DMS) and tannic acid (TA) was investigated. It has been found that chemical stabilization causes considerable changes in the surface topography of collagen fibrils as well as in the spatial organization of the fibrils within the tissue. The observed changes in the D-spacing pattern of the collagen fibril correspond to the formation of intrafibrilar cross-links, whereas formation of interfibrilar cross-links is mainly responsible for the observed tangled spatial arrangement of fibrils and crimp structure of the tissue surface. The crimp structure was distinctly seen for the GA cross-linked tissue. Surface heterogeneity of the cross-linking process was observed for the DMS-stabilized tissue. SDS-PAGE electrophoresis was performed in order to evaluate the stabilization effect of the tissues treated with the cross-linking reagents. It has been found that stabilization with DMS, GA or TA enhances significantly the tissue resistance to SDS/NaCl extraction. The relation between the tissue stability and changes in the topography of the tissue surface was interpreted in terms of different nature of cross-links formed by DMS, GA and TA with collagen.
C1 Med Univ Silesia, Fac Pharm, Dept Biophys, PL-41200 Sosnowiec, Poland.
   Univ Wroclaw, Inst Expt Phys, PL-50204 Wroclaw, Poland.
RP Jastrzebska, M (reprint author), Med Univ Silesia, Fac Pharm, Dept Biophys, Ostrogorska 30, PL-41200 Sosnowiec, Poland.
EM maja@slam.katowice.pl
CR Bart S., 2002, BIOORG MED CHEM LETT, V12, P1567
   Calero P, 2002, BIOMATERIALS, V23, P3473, DOI 10.1016/S0142-9612(02)00054-6
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Charulatha V, 1997, J BIOMED MATER RES, V36, P478
   Haslam E, 1998, PRACTICAL POLYPHENOL
   Heijmen FH, 1997, BIOMATERIALS, V18, P749, DOI 10.1016/S0142-9612(96)00202-5
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Jastrzebska M, 2004, EUR PHYS J E, V14, P137, DOI 10.1140/epje/i2003-10143-2
   Jastrzebska M, 2003, J RAMAN SPECTROSC, V34, P424, DOI 10.1002/jrs.1016
   Jastrzebska M, 2003, J BIOMAT SCI-POLYM E, V14, P185, DOI 10.1163/156856203321142605
   Jastrzebska M, 2001, IEEE T DIELECT EL IN, V8, P527, DOI 10.1109/94.933378
   JASTRZEBSKA M, 2005, IN PRESS J MOL STRUC
   JAYAKRISHNAN A, 1996, BIOMATERIALS, V17, P571
   Jena B. P., 2002, METHODS CELL BIOL, V68
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Kato K, 2001, EUR PHYS J E, V6, P7, DOI 10.1007/s101890170022
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   NIMNI ME, 1998, COLLAGEN BIOCH, V1
   Paige MF, 2001, MICRON, V32, P355, DOI 10.1016/S0968-4328(00)00038-X
   Raspanti M, 1997, J STRUCT BIOL, V119, P118, DOI 10.1006/jsbi.1997.3865
   Raspanti M, 2001, MATRIX BIOL, V20, P601, DOI 10.1016/S0945-053X(01)00174-3
   RUIJGROK JM, 1994, J MATER SCI-MATER M, V5, P80, DOI 10.1007/BF00121695
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Venturoni M, 2003, BIOCHEM BIOPH RES CO, V303, P508, DOI 10.1016/S0006-291X(03)00390-5
   Westermeier R., 2001, ELECTROPHORESIS PRAC
   Yamamoto S, 2002, JPN J OPHTHALMOL, V46, P496, DOI 10.1016/S0021-5155(02)00558-0
NR 31
TC 14
Z9 14
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1292-8941
J9 EUR PHYS J E
JI Eur. Phys. J. E
PD APR
PY 2005
VL 16
IS 4
BP 381
EP 388
DI 10.1140/epje/i2004-10093-1
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 966NH
UT WOS:000232026200005
PM 15750684
DA 2018-10-19
ER

PT J
AU Keszei, S
   Matko, S
   Bertalan, G
   Anna, P
   Marosi, G
   Toth, A
AF Keszei, S
   Matko, S
   Bertalan, G
   Anna, P
   Marosi, G
   Toth, A
TI Progress in interface modifications: from compatibilization to adaptive
   and smart interphases
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE composite; basalt fibre; fire retardancy; thermal; pH responsive
   biomaterials; compatible; adaptive; smart interphase
ID FIBER-REINFORCED POLYPROPYLENE; GRAFTED MOLECULAR BRUSHES; POLYOLEFIN
   SYSTEMS; COMPOSITES; POLYMER; BASALT; ADHESION; NANOCOMPOSITES;
   RETARDANCY; SURFACES
AB Common consideration and classification of surface and interface phenomena in wide areas of material science are discussed through three examples: basalt fiber reinforced composite; flame retarded polypropylene and polyorganosiloxane nanocomposite. Interface-related characteristics of polymer composites and biomaterials are discussed using uniform principles. A new classification of the interphases is introduced including the compatible, adaptive and smart interfacial layers. In case of basalt fiber reinforced polypropylene reactive interface modification is performed in a new and economic way using reactive surfactants. These additives accomplish the compatibilization of the phases during reactive compounding/processing. The fire retardancy of polypropylene system containing ammonium polyphosphate and clay nanoparticles is enhanced by adaptive polysiloxane interphase. Clay additive provides thermal and pH responsive character to silicone based biomaterial thus it can be applied for forming smart interphases. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Budapest Univ Technol & Econ, Dept Organ Chem Technol, H-1111 Budapest, Hungary.
   Hungarian Acad Sci, Res Lab Mat & Environm Chem, Chem Res Ctr, H-1525 Budapest, Hungary.
RP Marosi, G (reprint author), Budapest Univ Technol & Econ, Dept Organ Chem Technol, Muegyetem Rkp 3, H-1111 Budapest, Hungary.
EM gmarosi@mail.bme.hu
RI Marosi, Gyorgy/B-9597-2013
CR Anderson James M., 1996, P165
   Anna P, 2001, POLYM DEGRAD STABIL, V73, P463, DOI 10.1016/S0141-3910(01)00130-6
   BANHEGYI G, 1992, COLLOID POLYM SCI, V270, P113, DOI 10.1007/BF00652177
   BATIASHVILI MS, Patent No. 16666480
   Bertalan G, 2001, SOLID STATE IONICS, V141, P211, DOI 10.1016/S0167-2738(01)00795-0
   BERTALAN G, 2000, Patent No. 218016
   Botev M, 1999, J APPL POLYM SCI, V74, P523, DOI 10.1002/(SICI)1097-4628(19991017)74:3<523::AID-APP7>3.0.CO;2-R
   Brown HR, 2001, MACROMOLECULES, V34, P3720, DOI 10.1021/ma991821v
   BUZAGH A, 1952, KOLLOID Z Z POLYM, V125, P14, DOI 10.1007/BF01519607
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Gutowski WS, 2003, J ADHESION, V79, P445, DOI 10.1080/00218460390214226
   Gutowski WV, 2002, COMPOS INTERFACE, V9, P89, DOI 10.1163/156855402753642926
   HUSZAR A, 1975, Patent No. 167063
   HUSZAR A, 1978, Patent No. 4116897
   Kardos J. L., 1985, MOL CHARACTERISATION
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   Luzinov I, 2004, PROG POLYM SCI, V29, P635, DOI 10.1016/j.progpolymsci.2004.03.001
   Maatoug MA, 2000, MACROMOL MATER ENG, V282, P30, DOI 10.1002/1439-2054(20001001)282:1<30::AID-MAME30>3.0.CO;2-9
   Marosi G, 2003, POLYM DEGRAD STABIL, V82, P379, DOI 10.1016/S0141-3910(03)00223-4
   Marosi G, 2002, POLYM ADVAN TECHNOL, V13, P1103, DOI 10.1002/pat.284
   Marosi G, 2001, MACROMOL SYMP, V176, P189, DOI 10.1002/1521-3900(200112)176:1<189::AID-MASY189>3.0.CO;2-Z
   MAROSI G, 1998, FIRE RETARDANCY POLY, P325
   Marosi G., 1986, POLYM COMPOSITE, P457
   MAROSI G, 2003, TIRRENIA, V15, P16
   Marosi Gy., 1993, J POLYM ENG, V12, P34
   Marosi Gy., 2001, ACS SYM SER, V797, P161
   Matko S, 2003, MACROMOL SYMP, V202, P255, DOI 10.1002/masy.200351222
   MATONIS VA, 1969, POLYM ENG SCI, V9, P90, DOI 10.1002/pen.760090204
   Park JM, 1999, COMPOS SCI TECHNOL, V59, P355, DOI 10.1016/S0266-3538(98)00085-2
   PARK JM, 1994, J ADHES SCI TECHNOL, V8, P1473, DOI 10.1163/156856194X00753
   Pukanszky B, 1999, ADV POLYM SCI, V139, P109
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   RATZSCH M, 1990, ADV COLLOID INTERFAC, V31, P225, DOI 10.1016/0001-8686(90)80007-M
   Ravadits I, 2001, POLYM DEGRAD STABIL, V74, P419, DOI 10.1016/S0141-3910(01)00179-3
   ROHRMANN J, Patent No. 634451
   RUSZNAK I, 1985, PLASTE KAUTSCH, V32, P254
   Szabo JS, 2003, POLYM TEST, V22, P711, DOI 10.1016/S0142-9418(03)00005-9
   VANOSS CJ, 1993, POLYM SURFACES INTER
   Varghese S, 2003, POLYMER, V44, P4921, DOI 10.1016/S0032-3861(03)00480-4
   WU J, 1971, J POLYM SCI C, V34, P19
   1986, Patent No. 2453491
NR 41
TC 32
Z9 37
U1 5
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD APR
PY 2005
VL 41
IS 4
BP 697
EP 705
DI 10.1016/j.eurpolymj.2004.10.039
PG 9
WC Polymer Science
SC Polymer Science
GA 908IQ
UT WOS:000227781100006
DA 2018-10-19
ER

PT J
AU Spoerl, E
   Boehm, AG
   Pillunat, LE
AF Spoerl, E
   Boehm, AG
   Pillunat, LE
TI The influence of various substances on the biomechanical behavior of
   lamina cribrosa and peripapillary sclera
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; GLYCATION END-PRODUCTS;
   NORMAL-TENSION GLAUCOMA; INTRAOCULAR-PRESSURE; MATRIX
   METALLOPROTEINASES; MECHANICAL COMPLIANCE; DIABETES-MELLITUS; COLLAGEN;
   DAMAGE
AB PURPOSE. Changes in the biomechanical properties of the lamina cribrosa (LC) and of the peripapillary sclera (ppSc) may play a role in the pathogenesis of glaucoma. The purpose of this study was to assess the influence of glyceraldehyde, methylglyoxal, and collagenase A on the mechanical properties of the LC and ppSc.
   METHODS. Two strips of 1-mm width were cut from each of 80 porcine eyes and 24 pairs of enucleated human eyes. One strip contained the LC and the other the adjacent superior ppSc. One half of the strips was divided into groups and treated with 0.5 M glyceraldehyde, 0.5 M methylglyoxal, and 0.1% collagenase A. The other strips served as the control. The stress strain relation was measured in the stress range of 0.02 to 6.0 MPa by a biomaterial tester.
   RESULTS. Stress values at 20% strain of the human LC changed from 1.97 +/- 1.48 to 3.40 +/- 1.60 MPa after incubation with glyceraldehyde ( P = 0.029), from 2.42 +/- 2.22 to 5.46 +/- 1.91 MPa ( P = 0.014) after incubation with methylglyoxal, and from 2.43 +/- 1.3 to 1.35 +/- 0.19 MPa after incubation with collagenase A. The stress values of human ppSc without glyceraldehyde were 3.40 +/- 2.59 and 7.45 +/- 4.46 MPa after incubation with glyceraldehyde ( P = 0.047), 4.80 +/- 3.05 MPa without methylglyoxal and 16.10 +/- 5.53 MPa ( P = 0.001) after incubation with methylglyoxal, 4.14 +/- 2.56 MPa without collagenase A, and 1.97 +/- 0.55 MPa after incubation with collagenase A. At a 20% strain, Young's moduli of the untreated LC were in the range of E = 11.8 to 15.6 MPa and E = 28.5 to 36.0 MPa of the untreated ppSc.
   CONCLUSIONS. Glyceraldehyde and methylglyoxal increase the stiffness of the LC and of the ppSc in human and in porcine eyes. These substances induce changes in the extracellular matrix according to the Maillard reaction as it occurs during the ageing process or in case of high blood glucose levels. Collagenase reduces the stiffness of the tissues.
C1 Univ Dresden, Dept Ophthalmol, D-01307 Dresden, Germany.
RP Spoerl, E (reprint author), Univ Dresden, Dept Ophthalmol, Fetscherstr 74, D-01307 Dresden, Germany.
EM eberhard.spoerl@uniklinikum-dresden.de
CR Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D
   ALBON J, 1995, BRIT J OPHTHALMOL, V79, P368, DOI 10.1136/bjo.79.4.368
   Albon J, 2000, BRIT J OPHTHALMOL, V84, P311, DOI 10.1136/bjo.84.3.311
   Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318
   Amano S, 2001, BRIT J OPHTHALMOL, V85, P52, DOI 10.1136/bjo.85.1.52
   Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1280
   Bonovas S, 2004, DIABETIC MED, V21, P609, DOI 10.1111/j.1464-5491.2004.01173.x
   Burgoyne CF, 1995, OPHTHALMOLOGY, V102, P1800, DOI 10.1016/S0161-6420(95)30791-9
   CAHANE M, 1992, OPHTHALMIC RES, V24, P280, DOI 10.1159/000267179
   Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3
   Downs JC, 2003, J BIOMECH ENG-T ASME, V125, P124, DOI 10.1115/1.1536930
   Edwards ME, 2001, CURR EYE RES, V23, P215, DOI 10.1076/ceyr.23.3.215.5460
   FRIBERG TR, 1988, EXP EYE RES, V47, P429, DOI 10.1016/0014-4835(88)90053-X
   Golubnitschaja O, 2004, J GLAUCOMA, V13, P66, DOI 10.1097/00061198-200402000-00013
   Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714
   Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8
   Ivanisevic M, 2002, COLLEGIUM ANTROPOL, V26, P41
   Kirwan RP, 2004, J GLAUCOMA, V13, P327, DOI 10.1097/00061198-200408000-00011
   KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173
   LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031
   Mabuchi F, 2004, INVEST OPHTH VIS SCI, V45, P1841, DOI 10.1167/iovs.03-1008
   Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4
   MORRISON JC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1220, DOI 10.1001/archopht.1989.01070020286040
   Nishimura K, 2003, INT ANGIOL, V22, P229
   Odetti P, 1996, DIABETOLOGIA, V39, P1440, DOI 10.1007/s001250050596
   Pena JDO, 1998, EXP EYE RES, V67, P517, DOI 10.1006/exer.1998.0539
   Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303
   QUIGLEY HA, 1982, OPHTHALMOLOGY, V89, P219
   QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137
   QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6
   QUIGLEY HA, 1977, AM J OPHTHALMOL, V84, P358, DOI 10.1016/0002-9394(77)90680-8
   Rath EZ, 1996, GRAEF ARCH CLIN EXP, V234, P434, DOI 10.1007/BF02539409
   Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133
   Spoerl E, 1999, J REFRACT SURG, V15, P711
   SZCZUDLOWSKI K, 1979, MED HYPOTHESES, V5, P481, DOI 10.1016/0306-9877(79)90114-2
   Tezel G, 2001, GLIA, V34, P178, DOI 10.1002/glia.1052
   TIELSCH JM, 1995, OPHTHALMOLOGY, V102, P48
   Traverso N, 1997, AGING-CLIN EXP RES, V9, P432
   Varela HJ, 1997, J GLAUCOMA, V6, P303
   Yoshikawa K, 1999, JPN J OPHTHALMOL, V43, P225, DOI 10.1016/S0021-5155(99)00004-0
   ZEIMER RC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1232, DOI 10.1001/archopht.1989.01070020298042
   ZEIMER RC, 1984, CURR EYE RES, V3, P699, DOI 10.3109/02713688409065591
NR 44
TC 50
Z9 54
U1 0
U2 11
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2005
VL 46
IS 4
BP 1286
EP 1290
DI 10.1167/iovs.040978
PG 5
WC Ophthalmology
SC Ophthalmology
GA 910DB
UT WOS:000227908900026
PM 15790892
DA 2018-10-19
ER

PT J
AU Baldwin, L
   Flanagan, BF
   Hunt, JA
AF Baldwin, L
   Flanagan, BF
   Hunt, JA
TI Flow cytometric measurement of phagocytosis reveals a role for C3b in
   metal particle uptake by phagocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE phagocytosis; aseptic loosening; complement; macrophage
ID ORTHOPEDIC BIOMATERIAL PARTICLES; COMPLEMENT ACTIVATION; TNF-ALPHA;
   IN-VITRO; MACROPHAGES; POLYETHYLENE; PROTEIN; ADHESION; SURFACE; SIZE
AB A methodology for the quick and efficient study of phagocytosis has been developed. It uses the flow cytometer to exploit the change in size and granularity that occurs in cells upon the ingestion of particulate material. The numbers of cells that have phagocytosed particles can be calculated from the distinct shift in regions that occurs. The method also allows the factors governing phagocytosis to be studied in detail through the use of blocking agents or antibodies. Blood-derived monocytes were studied to investigate the role of complement in metal particle phagocytosis to further understand aseptic loosening. Factor C3b was found to be fundamental to the opsonization and phagocytosis of metal particles by monocytes. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Liverpool, UKCTE, Liverpool L69 3GA, Merseyside, England.
   Univ Liverpool, Dept Immunol, Liverpool L69 3GA, Merseyside, England.
RP Baldwin, L (reprint author), Univ Liverpool, UKCTE, Liverpool L69 3GA, Merseyside, England.
EM lisab@liv.ac.uk
RI Hunt, John/G-6366-2012
OI Hunt, John/0000-0002-5168-4778
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   AOGSTONI A, 1989, J BIOMATER APPL, V4, P102
   ASGHAR SS, 2000, FRONT BIOSCI, V5, P63
   Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   Huang Y, 2002, J IMMUNOL, V169, P2627, DOI 10.4049/jimmunol.169.5.2627
   Inomoto M, 2000, J Orthop Sci, V5, P369, DOI 10.1007/s007760070045
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Karp CL, 2001, MICROBES INFECT, V3, P109, DOI 10.1016/S1286-4579(00)01358-7
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#
   Ma N, 2002, J BIOMAT SCI-POLYM E, V13, P257
   Mahiout A, 1997, J MATER SCI-MATER M, V8, P287, DOI 10.1023/A:1018560211844
   MATTHEWS BJ, 2000, J BIOMED MATER RES, V52, P296
   Miyanishi K, 2003, J BONE MINER RES, V18, P1573, DOI 10.1359/jbmr.2003.18.9.1573
   Noordin S, 2004, BIOMATERIALS, V25, P5347, DOI 10.1016/j.biomaterials.2003.11.057
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SMITH RA, 2001, BIOCHEM SOC T, V30, P1037
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   VIDEM V, 1992, ANN THORAC SURG, V54, P725, DOI 10.1016/0003-4975(92)91018-5
   Watkins NJ, 1997, IMMUNOPHARMACOLOGY, V38, P111, DOI 10.1016/S0162-3109(97)00068-4
NR 26
TC 7
Z9 9
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2005
VL 73A
IS 1
BP 80
EP 85
DI 10.1002/jbm.a.30252
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 906ZR
UT WOS:000227684500010
PM 15714502
DA 2018-10-19
ER

PT J
AU Raghavan, D
   Kropp, BP
   Lin, HK
   Zhang, YY
   Cowan, R
   Madihally, SV
AF Raghavan, D
   Kropp, BP
   Lin, HK
   Zhang, YY
   Cowan, R
   Madihally, SV
TI Physical characteristics of small intestinal submucosa scaffolds are
   location-dependent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE small intestinal submucosa (SIS); location-dependent alterations
ID SMOOTH-MUSCLE-CELLS; MECHANICAL-PROPERTIES; BLADDER REGENERATION; VENOUS
   VALVE; DOG-MODEL; BIOMATERIAL; SUBSTRATE; COLLAGEN; GRAFTS; GROWTH
AB Using biodegradable scaffolds as an alternative to engineer new tissues has become an attractive candidate in various transplantation protocols. In particular, small intestinal submucosa (SIS), a dense connective matrix harvested from the small intestine, has gained attention due to a number of favorable properties. However, use of SIS is constrained by obtaining reliable, reproducible products in large-scale preparations that affect the regenerative process. To better understand the heterogeneous nature of SIS, this study focused on evaluating the location-dependent alterations in the physical characteristics of the matrices harvested from distal and proximal ends and processed inhouse (referred as hand-made). Additionally, results were compared with a commercially available machine-made Cook (R) SIS. Tensile properties during monotonic loading and cyclical loading were compared in wet conditions. Further-more, permeability of these membranes to urea was analyzed using a custom-built chamber, and the microarchitecture was analyzed via scanning electron microscopy. These results showed that distal samples were more elastic and less permeable to urea relative to other samples. However, permeability in each sample was direction-dependent, that is, mucosal to serosal direction was less permeable compared to sorasal to mucosal direction in all the samples. Cook (R) SIS was more susceptible to cyclical loading and had a shorter range of load carrying capacity. In summary, results show that physical characteristics of SIS are location-dependent. (c) 2005 Wiley Periodicals, Inc.
C1 Oklahoma State Univ, Sch Mech Engn, Stillwater, OK 74078 USA.
   Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73104 USA.
   Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
RP Madihally, SV (reprint author), Oklahoma State Univ, Sch Mech Engn, Stillwater, OK 74078 USA.
EM svm@okstate.edu
RI Madihally, Sundararajan/D-9285-2012
OI Madihally, Sundararajan/0000-0001-7498-5760
FU PHS HHS [OK-056968]
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Brountzos E, 2003, J VASC INTERV RADIOL, V14, P349, DOI 10.1097/01.RVI.0000058410.01661.62
   Cheng EY, 2000, WORLD J UROL, V18, P26, DOI 10.1007/PL00007071
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   Colvert JR, 2002, J UROLOGY, V168, P1872, DOI 10.1097/01.ju.0000027285.05828.e6
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Kropp BP, 2002, J UROLOGY, V168, P1742, DOI 10.1097/01.ju.0000028154.79247.ca
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Pavcnik D, 2002, J VASC SURG, V35, P598, DOI 10.1067/mva.2002.118825
   Persidis A, 1999, NAT BIOTECHNOL, V17, P508, DOI 10.1038/8700
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Robinson PS, 2004, J BIOMECH ENG-T ASME, V126, P252, DOI 10.1115/1.1695570
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Truslcey G. A., 2004, TRANSPORT PHENOMENA, P317
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang YC, 2004, FASEB J, V8, P8
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 40
TC 50
Z9 53
U1 0
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2005
VL 73A
IS 1
BP 90
EP 96
DI 10.1002/jbm.a.30268
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 906ZR
UT WOS:000227684500012
PM 15693016
DA 2018-10-19
ER

PT J
AU Abramson, SD
   Alexe, G
   Hammer, PL
   Kohn, J
AF Abramson, SD
   Alexe, G
   Hammer, PL
   Kohn, J
TI A computational approach to predicting cell growth on polymeric
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE computational modeling; cell growth; degradable polymers; rat lung
   fibroblasts; normal foreskin fibroblasts; cell culture; combinatorial
   design; tyrosine-derived polyarylates
ID LOGICAL ANALYSIS; SURFACES; DESIGN; VALIDATION
AB A predictive model that can correlate the chemical composition of a biomaterial with the biological response of cells that are in contact with that biomaterial would represent a major advance and would facilitate the rational design of new biomaterials. As a first step toward this goal, we report here on the use of Logical Analysis of Data (LAD) to model the effect of selected polymer properties on the growth of two different cell types, rat lung fibroblasts (RLF, a transformed cell line), and normal foreskin fibroblasts (NFF, nontransformed human cells), on 112 surfaces obtained from a combinatorially designed library of polymers. LAD is a knowledge extraction methodology, based on using combinatorics, optimization, and Boolean logic. LAD was trained on a subset of 62 polymers and was then used to predict cell growth on 50 previously untested polymers. Experimental validation indicated that LAD correctly predicted the high and low cell growth polymers and found optimal ranges for polymer chemical composition, surface chemistry, and bulk properties. Particularly noteworthy is that LAD correctly identified high-performing polymer surfaces, which surpassed commercial tissue culture polystyrene as growth substratum for normal foreskin fibroblasts. Our results establish the feasibility of using computational modeling of cell growth on flat polymeric surfaces to identify promising "lead" polymers for applications that require either high or low cell growth. (c) 2005 Wiley Periodicals, Inc.
C1 Rutgers State Univ, Dept Chem & Biol Chem, New Brunswick, NJ 08903 USA.
   Rutgers State Univ, New Jersey Ctr Biomat, New Brunswick, NJ 08903 USA.
   Rutgers State Univ, Ctr Operat Res, New Brunswick, NJ 08903 USA.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem & Biol Chem, New Brunswick, NJ 08903 USA.
EM joachim@rutchem.rutgers.edu
FU NIBIB NIH HHS [R01 EB00286, P41 EB001046]
CR Amis EJ, 2002, MRS BULL, V27, P295, DOI 10.1557/mrs2002.96
   ANDERSON DG, 2004, NAT BIOTECHNOL
   Boros E, 1997, MATH PROGRAM, V79, P163, DOI 10.1007/BF02614316
   Boros E, 2000, IEEE T KNOWL DATA EN, V12, P292, DOI 10.1109/69.842268
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   Crama Y., 1988, Annals of Operations Research, V16, P299, DOI 10.1007/BF02283750
   FIORDELISO J, 1995, POLYM BIOMATERIALS S, P695
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   HAMMER P, 1986, P INT C MULT ATTR DE
   Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i
   Hutmacher DW, 2002, DRUGS TODAY, V38, P113, DOI 10.1358/dot.2002.38.2.820107
   Janvier G, 1996, ANN THORAC SURG, V62, P1926, DOI 10.1016/S0003-4975(96)00942-3
   Kholodovych V, 2004, POLYMER, V45, P7367, DOI 10.1016/j.polymer.2004.09.002
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kohnen W., 2000, HDB BACTERIAL ADHESI, P581
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lynn DM, 2001, J AM CHEM SOC, V123, P8155, DOI 10.1021/ja016288p
   MAGNANI A, 2002, PROTEIN ADSORPTION C, P669
   PACHENCE JM, 2000, PRINCIPLES TISSUE EN, P263
   Park A, 1996, J BIOMED MATER RES, V31, P117
   Reynolds CH, 1999, J COMB CHEM, V1, P297, DOI 10.1021/cc9900044
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   SMITH JR, 2005, IN PRESS QSAR COMB S
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   WOLD S, 1983, ACTA PHARMACOL TOX, V52, P158
NR 29
TC 31
Z9 31
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2005
VL 73A
IS 1
BP 116
EP 124
DI 10.1002/jbm.a.30266
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 906ZR
UT WOS:000227684500015
PM 15714501
DA 2018-10-19
ER

PT J
AU Zheng, MH
   Chen, J
   Kirilak, Y
   Willers, C
   Xu, J
   Wood, D
AF Zheng, MH
   Chen, J
   Kirilak, Y
   Willers, C
   Xu, J
   Wood, D
TI Porcine small intestine submucosa (SIS) is not an acellular collagenous
   matrix and contains porcine DNA: Possible implications in human
   implantation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE SIS membrane; rotator cuff; porcine cells; DAP12 gene; bioengineering
ID DOG
AB Porcine small intestinal submucosa (SIS) has been recommended as a cell-free, biocompatible biomaterial for the repair of rotator cuff tendon tear. However, we have observed noninfectious edema and severe pain in patients who have undergone SIS implantation for tendon repair. The aim of this study was to conduct an independent assessment of the safety and efficacy of Restore (TM) SIS membrane. The Restore (TM) orthobiologic implant was examined by histology and the nested PCR technique using porcine immunoreceptor DAP12 gene to examine if SIS membrane contained porcine cells or DNA, respectively. The material was also implanted into mice and rabbits for the evaluation of biological reaction and inflammatory response. Restore (TM) SIS was found to contain multiple layers of porcine cells. Chloroacetate esterase staining showed that some of these cells were mast cells. Nested PCR of the DAP12 gene demonstrated that Restore (TM) SIS contained porcine DNA material. Subcutaneous implantation of Restore (TM) SIS membrane in mice, and in rabbits for rotator cuff tendon repair, showed that the membrane caused an inflammatory reaction characterized by massive lymphocyte infiltration. In conclusion, Restore (TM) SIS is not an acellular collagenous matrix, and contains porcine DNA. Our results contradict the current view that Restore (TM) SIS is a cell-free biomaterial, and that no inflammatory response is elicited by its implantation. We suggest that further studies should be conducted to evaluate the clinical safety and efficacy of SIS implant biomaterials. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Western Australia, Sch Pathol & Surg, Unit Orthopaed, QEII Med Ctr, Nedlands, WA 6009, Australia.
RP Zheng, MH (reprint author), Univ Western Australia, Sch Pathol & Surg, Unit Orthopaed, QEII Med Ctr, 2nd Floor M Block,, Nedlands, WA 6009, Australia.
EM zheng@cyllene.uwa.edu.au
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Gu Yan, 2002, Zhonghua Yi Xue Za Zhi, V82, P1279
   JOHN BD, 1990, THEORY PRACTICE HIST, P407
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Movin T, 1997, ACTA ORTHOP SCAND, V68, P170, DOI 10.3109/17453679709004002
   Shalabi A, 2002, ACTA RADIOL, V43, P198, DOI 10.1080/028418502127347781
   Soergel TM, 2003, J UROLOGY, V170, P1577, DOI 10.1097/01.ju.0000083802.87337.af
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   TIMPL R, 1984, EXTRACELLULAR MATRIX, P118
   Wallace DG, 1988, COLLAGEN BIOTECHNOLO, P118
   WANG LT, 1996, J CLIN MOL PATHOL, V49, P176
   Woo S. L., 1988, INJURY REPAIR MUSCUL, P133
   Yim D, 2000, IMMUNOGENETICS, V51, P436, DOI 10.1007/s002510050642
NR 18
TC 215
Z9 223
U1 0
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2005
VL 73B
IS 1
BP 61
EP 67
DI 10.1002/jbm.b.30170
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 912KE
UT WOS:000228076000009
PM 15736287
DA 2018-10-19
ER

PT J
AU Assis, SL
   Rogero, SO
   Antunes, RA
   Padilha, AF
   Costa, I
AF Assis, SL
   Rogero, SO
   Antunes, RA
   Padilha, AF
   Costa, I
TI A comparative study of the in vitro corrosion behavior and cytotoxicity
   of a superferritic stainless steel, a Ti-13Nb-13Zr alloy, and an
   austenitic stainless steel in Hank's solution
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE superferritic stainless steel; titanium alloy; austenitic stainless
   steel; biomaterial; corrosion; cytotoxicity
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; BIOMATERIAL APPLICATIONS;
   TI-6AL-7NB ALLOY; TITANIUM; RESISTANCE; COMPATIBILITY; IMPLANTS; OXIDE;
   FILM
AB In this study, the in vitro corrosion resistance of a superferritic stainless steel in naturally aerated Hank's solution at 37 degrees C has been determined to evaluate the steel for use as a biomaterial. The potentiodynamic polarization method and electrochemical impedance spectroscopy (EIS) were used to determine the corrosion resistance. The polarization results showed very low current densities at the corrosion potential and electrochemical behavior typical of passive metals. At potentials above 0.75 V (SCE), and up to that of the oxygen evolution reaction, the superferritic steel exhibited transpassive behavior followed by secondary passivation. The superferritic stainless steel exhibited high pitting resistance in Hank's solution. This steel did not reveal pits even after polarization to 3000 mV (SCE). The EIS results indicated high impedance values at low frequencies, supporting the results obtained from the polarization measurements. The results obtained for the superferritic steel have been compared with those of the Ti-13Nb-13Zr alloy and an austenitic stainless steel, as Ti alloys are well known for their high corrosion resistance and biocompatibility, and the austenitic stainless steel is widely used as an implant material. The cytotoxicity tests indicated that the superferritic steel, the austenitic steel, and the Ti-13Nb-13Zr alloy were not toxic. Based on corrosion resistance and cytotoxicity results, the superferritic stainless steel can be considered as a potential biomaterial. (c) 2005 Wiley Periodicals, Inc.
C1 IPEN, CNEN SP, Ctr Ciencia & Tecnol Mat, BR-05508900 Sao Paulo, Brazil.
   EPUSP, Dept Met & Mat Engn, BR-05508900 Sao Paulo, Brazil.
RP Costa, I (reprint author), IPEN, CNEN SP, Ctr Ciencia & Tecnol Mat, Av Prof Lineu Prestes 2242, BR-05508900 Sao Paulo, Brazil.
EM icosta@ipen.br
RI Antunes, Renato/K-4738-2015; Costa, Isolda/E-8506-2012; Padilha, Angelo
   Fernando/D-9595-2016
OI Antunes, Renato/0000-0003-1540-6495; Costa, Isolda/0000-0002-4987-3334;
   Padilha, Angelo Fernando/0000-0002-5494-9137
CR ALEXANDER A, 1996, BIOMATERIALS SCI, P41
   *ASTM, 1983, ASTM STP, V810
   CONSIDINE DM, 1976, VANNOSTRANDS SCI ENC, P2210
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DORAN A, 1998, BIOMATERIALS, V9, P1001
   ELBASIOUNY MS, 1982, CORROSION, V38, P237, DOI 10.5006/1.3577344
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   HEFNY MM, 1982, BRIT CORROS J, V17, P38, DOI 10.1179/000705982798274633
   International Standardization Organization, 1992, 109935 ISO
   Kannan S, 2003, MATER LETT, V57, P2382, DOI 10.1016/S0167-577X(02)01239-9
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Lavos-Valereto C, 2002, J BIOMED MATER RES, V63, P664, DOI 10.1002/jbm.10351
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   MANSFELD F, 1988, J ELECTROCHEM SOC, V135, P828, DOI 10.1149/1.2095786
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Rogero Sizue Ota, 2003, Mat. Res., V6, P317, DOI 10.1590/S1516-14392003000300003
   Rogero SO, 2000, TOXICOL IN VITRO, V14, P497, DOI 10.1016/S0887-2333(00)00047-3
   SCHNEIDER SG, 2001, PREPARATION CHARACTE
   SIVAKUMAR M, 1993, J MATER SCI, V28, P6081, DOI 10.1007/BF00365025
   *USP, 1995, USP, V23, P1697
   Venugopalan R, 2000, BIOMATERIALS, V21, P1669, DOI 10.1016/S0142-9612(00)00049-1
   Woods TO, 2003, AM SOC TEST MATER, V1438, P82, DOI 10.1520/STP11156S
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
NR 28
TC 28
Z9 35
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2005
VL 73B
IS 1
BP 109
EP 116
DI 10.1002/jbm.b.30205
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 912KE
UT WOS:000228076000015
PM 15660438
DA 2018-10-19
ER

PT J
AU Hao, L
   Lawrence, J
   Phua, YF
   Chian, KS
   Lim, GC
   Zheng, HY
AF Hao, L
   Lawrence, J
   Phua, YF
   Chian, KS
   Lim, GC
   Zheng, HY
TI Enhanced human osteoblast cell adhesion and proliferation on 316 LS
   stainless steel by means of CO2 laser surface treatment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE CO2 laser; osteoblast cell adhesion and proliferation; 316 LS stainless
   steel; wettability characteristics; surface roughness
ID POWER DIODE-LASER; PARTIALLY-STABILIZED ZIRCONIA; ETHYLENE-PROPYLENE
   RUBBER; WETTABILITY CHARACTERISTICS; SOLID-SURFACES; TITANIUM; IMPLANTS;
   BONE; BIOMATERIAL; MECHANISMS
AB An effective and novel technique for improving the biocompatibility of a biograde 316 LS stainless steel through the application of CO2 laser treatment to modify the surface properties of the material is described herein. Different surface properties, such as surface roughness, surface oxygen content, and surface energy for CO2 laser-treated 316 LS stainless steel, untreated, and mechanically roughened samples were analyzed, and their effects on the wettability characteristics of the material were studied. It was found that modification of the wettability characteristics of the 316 LS stainless steel following CO2 laser treatment was achieved. This improvement was identified as being mainly due to the change in the polar component of the surface energy. One-day cell adhesion tests showed that cells not only adhered and spread better, but also grew faster on the CO2 laser-treated sample than on either the untreated or mechanically roughened sample. Further, compared with the untreated sample, MTT cell proliferation analysis revealed that the mechanically roughed surface resulted in a slight enhancement, and CO2 laser treatment brought about a significant increase in cell proliferation. An increase in the wettability of the 316 LS stainless steel was observed to positively correlate with the cell proliferation. (c) 2004 Wiley Periodicals. Inc.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Mfg Engn Div, Singapore 639798, Singapore.
   Singapore Inst Mfg Technol, Singapore 638075, Singapore.
RP Hao, L (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Mfg Engn Div, 50 Nanyang Ave, Singapore 639798, Singapore.
EM haoliang@pmail.ntu.edu.sg
RI Chian, Kerm Sin/B-4771-2008
OI Lawrence, Jonathan/0000-0002-1649-9948; Hao, Liang/0000-0003-2071-7044
CR ADAM NK, 1958, J CHEM SOC, V18, P2206
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Dadsetan M, 2001, J BIOMED MATER RES, V57, P183, DOI 10.1002/1097-4636(200111)57:2<183::AID-JBM1157>3.0.CO;2-M
   DANN JR, 1970, J COLLOID INTERF SCI, V32, P302, DOI 10.1016/0021-9797(70)90054-8
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   GOLDBERG VM, 1995, CLIN ORTHOP RELAT R, P122
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   HAO L, IN PRESS J BIOMATER
   HAO L, IN PRESS J LASER APP
   Jaycock MJ, 1981, CHEM INTERFACES, P234
   Kawahara D, 1996, Int J Oral Maxillofac Implants, V11, P435
   KINLOCH AJ, 1987, ADHESION ADHESIVES S, P30
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lawrence J, 2002, P ROY SOC A-MATH PHY, V458, P2445, DOI 10.1098/rspa.2002.0984
   Lawrence J, 2002, J LASER APPL, V14, P107, DOI 10.2351/1.1471560
   Lawrence J, 1999, OPT LASER ENG, V32, P353, DOI 10.1016/S0143-8166(00)00007-5
   Lawrence J, 1999, SURF COAT TECH, V115, P273, DOI 10.1016/S0257-8972(99)00251-0
   MICHAELS C M, 1991, Journal of Oral Implantology, V17, P132
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   MIRZADEH H, 1995, RADIAT PHYS CHEM, V46, P859, DOI 10.1016/0969-806X(95)00278-6
   NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
NR 35
TC 41
Z9 42
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2005
VL 73B
IS 1
BP 148
EP 156
DI 10.1002/jbm.b.30194
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 912KE
UT WOS:000228076000020
PM 15627247
DA 2018-10-19
ER

PT J
AU Lucas-Girot, A
   Verdier, MC
   Tribut, O
   Sangleboeuf, JC
   Allain, H
   Oudadesse, H
AF Lucas-Girot, A
   Verdier, MC
   Tribut, O
   Sangleboeuf, JC
   Allain, H
   Oudadesse, H
TI Gentamicin-loaded calcium carbonate materials: Comparison of two
   drug-loading modes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE calcium carbonate; gentamicin; porous; mechanical properties; drug
   release
ID ANTIBIOTIC RELEASE SYSTEMS; POLYMETHYLMETHACRYLATE BEADS;
   BONE-INFECTIONS; DELIVERY; OSTEOMYELITIS; ARTHROPLASTY; IMPLANTS; HIP
AB Synthetic aragonite-based porous materials were drug loaded with gentamicin sulphate, an antibiotic active on Staphylococcus aureus responsible for osteomyelitis. Drug loading was accomplished by two different ways: by integration of gentamicin in material during processing or by soaking material into gentamicin solutions. We first investigated the influence of drug loading on compressive strength of materials. Results indicate that soaked materials presented the same compressive strength than unloaded materials with the same porosity. By contrast, the integration of gentamicin during processing increased significantly the compressive strength of materials. The materials drug content before elution was a least 10 times higher when gentamicin was integrated during processing comparatively to soaked materials. The study of in vitro gentamicin release showed that for materials with gentamicin integrated during material processing, high concentrations of gentamicin were released up to 8 or 12 days, against 4 days for soaked materials. The transport coefficients calculation, for the first step of release, indicated that the rate of release was higher for materials with integrated gentamicin because of the higher gentamicin content. The porosity rate influenced the rate of release for materials positively with gentamicin integrated during processing contrary to soaked materials for which a higher porosity rate allowed a deeper penetration of gentamicin during drug loading and then a slightly slower release. Results indicate that aragonite-based material with gentamicin integrated during material processing may be used either as resorbable device for release of high concentrations of gentamicin or as biomaterial for combined therapy: bone substitution and prevention or treatment of osteomyelitis. (c) 2005 Wiley Periodicals. Inc.
C1 Univ Rennes 1, UMR 6511, Inst Chim Rennes, Chim Solide & Inorgan Mol Lab, F-35042 Rennes, France.
   Univ Rennes 1, Lab Phamacol Expt & Clin, F-35043 Rennes, France.
   Univ Rennes 1, LARMAUR, F-35042 Rennes, France.
RP Lucas-Girot, A (reprint author), Univ Rennes 1, UMR 6511, Inst Chim Rennes, Chim Solide & Inorgan Mol Lab, CS 74205,Campus Beaulieu,Bat 10B, F-35042 Rennes, France.
EM anita.lucas@univ-rennes1.fr
RI Sangleboeuf, Jean-Christophe/N-7588-2014
CR Aimin C, 1999, Clin Orthop Relat Res, P239, DOI 10.1097/00003086-199909000-00031
   Benoit MA, 1997, INT ORTHOP, V21, P403
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   CALHOUN J, 1988, J BONE JOINT SURG AM, V70A, P1246, DOI 10.2106/00004623-198870080-00019
   FIDDIAN NJ, 1984, J BONE JOINT SURG BR, V66, P493
   Gursel I, 2001, BIOMATERIALS, V22, P73, DOI 10.1016/S0142-9612(00)00170-8
   HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005
   Itokazu M, 1998, Bull Hosp Jt Dis, V57, P125
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Kawanabe K, 1998, J BONE JOINT SURG BR, V80B, P527, DOI 10.1302/0301-620X.80B3.8576
   Korkusuz F, 2001, J BIOMED MATER RES, V55, P217, DOI 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y
   KORZYBSKI T, 1978, GENTAMICIN ANTIBIOTI, P712
   Lambotte J C, 1998, Chirurgie, V123, P572, DOI 10.1016/S0001-4001(99)80006-3
   Lasserre A, 1998, CRIT REV THER DRUG, V15, P1
   Lucas A, 1999, J SOLID STATE CHEM, V146, P73, DOI 10.1006/jssc.1999.8310
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   LUCAS A, 1997, Patent No. 2743496
   LUCASGIROT A, 2001, BIOMATERIALS, V23, P503
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Padilla S, 2002, J CONTROL RELEASE, V83, P343, DOI 10.1016/S0168-3659(02)00168-2
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   ROZENKRANTZ BE, 1980, ANAL POFILES DRUG SU, V9, P295
   Sasaki S, 1999, J Orthop Sci, V4, P361, DOI 10.1007/s007760050117
   SCHNEIDER SJ, 1991, ENG MAT HDB, V4, P120
   THOMA K, 1991, PHARMAZIE, V46, P266
   Thomazeau H, 1997, Chirurgie, V121, P663
   Trecant M, 1997, BIOMATERIALS, V18, P141, DOI 10.1016/S0142-9612(96)00108-1
NR 28
TC 21
Z9 22
U1 1
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2005
VL 73B
IS 1
BP 164
EP 170
DI 10.1002/jbm.b.30210
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 912KE
UT WOS:000228076000022
PM 15678498
DA 2018-10-19
ER

PT J
AU Romero-Gonzalez, J
   Peralta-Videa, JR
   Rodriguez, E
   Ramirez, SL
   Gardea-Torresdey, JL
AF Romero-Gonzalez, J
   Peralta-Videa, JR
   Rodriguez, E
   Ramirez, SL
   Gardea-Torresdey, JL
TI Determination of thermodynamic parameters of Cr(VI) adsorption from
   aqueous solution onto Agave lechuguilla biomass
SO JOURNAL OF CHEMICAL THERMODYNAMICS
LA English
DT Article
DE chromium (VI); thermodynamic parameters; adsorption; Agave lechuguilla
ID SURFACTANT-MODIFIED MONTMORILLONITE; HEAVY-METALS; CHROMIUM; RECOVERY;
   REMOVAL; BINDING; SPECIATION; REDUCTION; MECHANISM; TRIVALENT
AB The temperature dependence of the Cr(VI) bioadsorption and its possible reduction to Cr(III) by Agave lechuguilla biomass were studied. The experimental data obtained in batch experiments at different temperatures were fitted to the Langmuir and Freundlich isotherms to obtain the characteristic parameters of each model. The adsorption equilibrium data fitted well with the Freundlich model. The average model parameters calculated from Freundlich's isotherms (adsorption capacity K-F = 4 (.) 10(-2) mol (.) g(-1) and an average adsorption intensity value n = 13.07) showed that A. lechuguilla can be considered as an effective biomaterial for Cr(VI) removal from aqueous solution. Thermodynamic parameters (Delta G(o), Delta H-o, and Delta S-o) for Cr(VI) adsorption determined in the temperature range from (283 to 313) K suggest that a portion of Cr(VI) may be bound to functional groups on the surface of the adsorbent and then reduced to Cr(III). Additionally, the parameters of the Dubinin-Radushkevick equation indicated that the sorption of chromium species onto lechuguilla biomass mainly proceeds through binding surface functional groups. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Texas, Dept Chem, El Paso, TX 79968 USA.
RP Gardea-Torresdey, JL (reprint author), Univ Texas, Dept Chem, El Paso, TX 79968 USA.
EM jgardea@utep.edu
CR Aksu Z, 2002, WATER RES, V36, P3063, DOI 10.1016/S0043-1354(01)00530-9
   AKSU Z, 2002, PROCESS BIOCHEM, P1
   BLUNDEN G, 1980, STEROIDS, V35, P503, DOI 10.1016/S0039-128X(80)80004-3
   Daneshvar N, 2002, J HAZARD MATER, V94, P49, DOI 10.1016/S0304-3894(02)00054-7
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gaballah I, 1998, J GEOCHEM EXPLOR, V62, P241, DOI 10.1016/S0375-6742(97)00068-X
   Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0
   Gardea-Torresdey JL, 2002, MICROCHEM J, V71, P157, DOI 10.1016/S0026-265X(02)00007-3
   GENTRY HS, 1982, AGAVES CONTINENTAL N, P60
   GREENE B, 1988, Biorecovery, V1, P27
   GUO Y, 2002, MATER CHEM PHYS, V78, P132
   Helfferich F.G., 1962, ION EXCHANGE
   Hong KJ, 2000, CHEMOSPHERE, V41, P345, DOI 10.1016/S0045-6535(99)00489-0
   Hong KJ, 2002, CHEMOSPHERE, V49, P379, DOI 10.1016/S0045-6535(02)00321-1
   Jordao CP, 1997, SCI TOTAL ENVIRON, V207, P1, DOI 10.1016/S0048-9697(97)00232-5
   Juang RS, 2002, J COLLOID INTERF SCI, V254, P234, DOI 10.1006/jcis.2002.8629
   Kocaoba S, 2002, TALANTA, V57, P23, DOI 10.1016/S0039-9140(01)00677-4
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Kratochvil D, 1998, ENVIRON SCI TECHNOL, V32, P2693, DOI 10.1021/es971073u
   Krishna BS, 2000, J COLLOID INTERF SCI, V229, P230, DOI 10.1006/jcis.2000.7015
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Parsons JG, 2002, MICROCHEM J, V71, P211, DOI 10.1016/S0026-265X(02)00013-9
   Pellerin C., 2000, ENV HLTH PERSPECT, V108, P402
   Reddy KR, 1997, J HAZARD MATER, V55, P135, DOI 10.1016/S0304-3894(97)00020-4
   ROMEROGONZALEZ J, IN PRESS BIOINORG CH
   *USEPA, 1992, NAT PRIM DRINK WAT R, P93
   WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204
   *WHO, 1996, GUID DRINK WAT QUAL, P206
NR 28
TC 107
Z9 112
U1 2
U2 20
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0021-9614
J9 J CHEM THERMODYN
JI J. Chem. Thermodyn.
PD APR
PY 2005
VL 37
IS 4
BP 343
EP 347
DI 10.1016/j.jct.2004.09.013
PG 5
WC Thermodynamics; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 913KO
UT WOS:000228150700005
DA 2018-10-19
ER

PT J
AU Al Rmalli, SW
   Harrington, CF
   Ayub, M
   Haris, PI
AF Al Rmalli, SW
   Harrington, CF
   Ayub, M
   Haris, PI
TI A biomaterial based approach for arsenic removal from water
SO JOURNAL OF ENVIRONMENTAL MONITORING
LA English
DT Article
ID CONTAMINATED DRINKING-WATER; HYACINTH ROOTS; PLANTS; PHYTOREMEDIATION;
   ACCUMULATION; BANGLADESH; CADMIUM; GROUNDWATER; ADSORPTION; CRASSIPES
AB We demonstrate that the non-living, dried roots of the water hyacinth plant [Eichhornia crassipes (Mart.) Solms] can rapidly remove arsenic from water. Atomic absorption spectrometry was used to demonstrate that more than 93% of arsenite (As(III)) and 95% of arsenate (As(v)) were removed from a solution containing 200 mu g As 1(-1) within 60 minutes of exposure to a powder produced from dried roots. No difference in removal efficiency was observed between the two oxidation states of As studied. The amount of arsenic remaining in solution was found to be less than 10 mu g 1(-1) which is the WHO guideline limit value for As in drinking water. The presence of arsenic in drinking water in a number of countries in the developing world has been found to be much higher than the WHO level, affecting the health of millions of people. In this paper, we show that a biomaterial produced from dried water hyacinth roots, a plant that is found in abundant supply in many parts of the world, can provide a simple, effective and yet cheap method for removing arsenic from contaminated water.
C1 De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England.
RP Haris, PI (reprint author), De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England.
EM pharis@dmu.ac.uk
RI Harrington, Chris/M-3453-2018
OI Harrington, Chris/0000-0003-4101-556X
CR Al Rmalli SW, 2005, SCI TOTAL ENVIRON, V337, P23, DOI 10.1016/j.scitotenv.2004.06.008
   BROWN SL, 1994, J ENVIRON QUAL, V23, P1151, DOI 10.2134/jeq1994.00472425002300060004x
   Cebrian M. E., 1994, V27, P93
   CHIGBO FE, 1982, ENVIRON POLLUT A, V27, P31, DOI 10.1016/0143-1471(82)90060-5
   CLIFFORD D, 1986, ENVIRON SCI TECHNOL, V20, P1072, DOI 10.1021/es00153a001
   DUSHENKOV V, 1995, ENVIRON SCI TECHNOL, V29, P1239, DOI 10.1021/es00005a015
   Elizalde-Gonzalez MP, 2001, J ENVIRON MONITOR, V3, P22, DOI 10.1039/b006636m
   ELSON CM, 1980, WATER RES, V14, P1307, DOI 10.1016/0043-1354(80)90190-6
   FICKLIN WH, 1983, TALANTA, V30, P371, DOI 10.1016/0039-9140(83)80084-8
   GOSWAMI D, 2000, INT J WATER, V1, P61, DOI DOI 10.1504/IJW.2000.002053
   HAO YY, 1993, J ENVIRON SCI HEAL A, V28, P2333, DOI 10.1080/10934529309376013
   Katsoyiannis IA, 2004, WATER RES, V38, P17, DOI 10.1016/j.watres.2003.09.011
   Kelley C, 1999, ENVIRON SCI TECHNOL, V33, P1439, DOI 10.1021/es9807789
   Khan AH, 2000, J ENVIRON SCI HEAL A, V35, P1021, DOI 10.1080/10934520009377018
   LOW KS, 1994, J ENVIRON SCI HEAL A, V29, P171, DOI 10.1080/10934529409376028
   Mazen AMA, 1998, BIOL PLANTARUM, V40, P411
   Misbahuddin M, 2002, ARCH ENVIRON HEALTH, V57, P516, DOI 10.1080/00039890209602082
   Nikolaidis N.P., 1998, INT C ARS POLL GROUN
   Raven KP, 1998, ENVIRON SCI TECHNOL, V32, P344, DOI 10.1021/es970421p
   Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643
   Salt DE, 1997, ENVIRON SCI TECHNOL, V31, P1636, DOI 10.1021/es960802n
   SALT DE, 1995, BIO-TECHNOL, V13, P468, DOI 10.1038/nbt0595-468
   SALTABAS O, 1994, TOXICOL ENVIRON CHEM, V41, P131, DOI 10.1080/02772249409357968
   Sinha S, 2002, ENVIRON MONIT ASSESS, V80, P17, DOI 10.1023/A:1020357427074
   Soltan ME, 2003, ADV ENVIRON RES, V7, P321, DOI 10.1016/S1093-0191(02)00002-3
   Tanabe K, 2001, APPL ORGANOMET CHEM, V15, P241, DOI 10.1002/aoc.134
   US Environmental Protection Agency, 2000, 815R00026 EPA
   Wang YP, 1999, PEDIATR HEMAT ONCOL, V16, P1, DOI 10.1080/088800199277533
   World Health Organization - WHO, 2001, ENV HLTH CRIT, V224
   Zhu YL, 1999, J ENVIRON QUAL, V28, P339, DOI 10.2134/jeq1999.00472425002800010042x
NR 30
TC 50
Z9 53
U1 0
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1464-0325
J9 J ENVIRON MONITOR
JI J. Environ. Monit.
PD APR
PY 2005
VL 7
IS 4
BP 279
EP 282
DI 10.1039/b500932d
PG 4
WC Chemistry, Analytical; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA 918XK
UT WOS:000228582700027
PM 15798792
DA 2018-10-19
ER

PT J
AU Mansur, HS
   Orefice, RL
   Vasconcelos, WL
   Lobato, ZP
   Machado, LJC
AF Mansur, HS
   Orefice, RL
   Vasconcelos, WL
   Lobato, ZP
   Machado, LJC
TI Biomaterial with chemically engineered surface for protein
   immobilization
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; IMMUNOSORBENT-ASSAY ELISA; SERRULATUS
   SCORPION-VENOM; PORCINE INSULIN; ENCAPSULATION; ADSORPTION; ANTIBODIES;
   NETWORKS; SILICATE; BEHAVIOR
AB The last 3 decades have been a revolution in the area of sol-gel-derived materials. They can be used to encapsulate biomolecules such as enzymes, antibodies, hormones, and proteins retaining their functional state. Proteins can be immobilized in many ways but it is crucial that they retain their native conformational structure and, therefore, bioactivity. Porous silica gel matrixes with modified surfaces offer unlimited possibilities to control the protein-solid interaction behavior. The bioimmobilization process on sol-gel biomaterials with chemically engineered surface has driven applications on solid-phase materials, affinity chromatography, biosensors and many others. In the present work, we have aimed to produce surface-modified silica glass materials obtained via sol-gel route to be used as solid support on drug delivery systems and as solid-phase in immunodiagnostic. The functionalization process was carried out by reacting alkoxysilanes with 5 different silane surface modifying chemical groups: tetraethoxysilane (TEOS), 3-mercaptopropyltrimethoxysilane ( MPTMS) and 3-aminopropyltriethoxysilane (APTES), 3-glycidoxypropyltrimethoxysilane ( GPTMS) and 3-isocyanatopropyltriethoxysilane (ICPES). The bioactivity assays were based on two main tests: ( a) An in vivo bioresponse of rats with sol-gel disk implants with insulin protein incorporated. In vivo tests with adult male rats were used to verify the immobilized insulin bioactivity after implantation of different biomaterial with functionalized surfaces. All surface modified materials have presented hypoglycemic peak response associated with the insulin bioactivity. (b) The produced solid-phase sol-gel disks with protein substrates were tested through Enzyme Linked ImmunoSorbent Assay ( ELISA). The immunoassay results have showed that glasses with chemically functionalized surfaces regulated the extent of bioimmobilization of protein. The amine, thiol and hydroxyl terminated porous gels have showed significant interaction with the antibody-antigen, during the coupling process. We believe that it is due to balance of forces associated with Van der Waals interaction, hydrophilic and hydrophobic forces and steric hindrance acting at the surface. Therefore, such novel biomaterial could be advantageously used in drug delivery systems and in immunoassays of diagnostic kits. (C) 2005 Springer Science + Business Media, Inc.
C1 UFMG, Dept Met & Mat Engn, Belo Horizonte, MG, Brazil.
   UFMG, Dept Vet Med, Belo Horizonte, MG, Brazil.
   UFMG, Sch Med, Dept Internal Med, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), UFMG, Dept Met & Mat Engn, Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Lobato, Zelia/0000-0002-9399-3691;
   Mansur, Herman/0000-0002-3032-495X
CR BELTZ BS, 1989, IMMUNOCYTOCHEMICAL T, P26
   CHAVEZOLORTEGUI C, 1994, TOXICON, V32, P1649, DOI 10.1016/0041-0101(94)90323-9
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   de Avila RAM, 2004, TOXICON, V44, P233, DOI 10.1016/j.toxicon.2004.04.015
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X
   Flora KK, 2001, CHEM MATER, V13, P4170, DOI [10.1021/cm010155l, 10.1021/cm0101551]
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Jin W, 2002, ANAL CHIM ACTA, V461, P1, DOI 10.1016/S0003-2670(02)00229-5
   Kusnezow W, 2003, J MOL RECOGNIT, V16, P165, DOI 10.1002/jmr.625
   Livage J, 1997, CURR OPIN SOLID ST M, V2, P132, DOI 10.1016/S1359-0286(97)80057-5
   LIVAGE J, 1994, SPIE, V2288, P493
   Mansur H, 2002, SPECTROSC-INT J, V16, P351, DOI 10.1155/2002/183053
   Mansur HS, 2001, ADSORPTION, V7, P105, DOI 10.1023/A:1011687706161
   Mansur HS, 2000, BIOMACROMOLECULES, V1, P789, DOI 10.1021/bm0056198
   PALOMAKI P, 1991, J IMMUNOL METHODS, V145, P55, DOI 10.1016/0022-1759(91)90310-C
   RAO PN, 1992, STEROIDS, V57, P154, DOI 10.1016/0039-128X(92)90001-P
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SUZUKI K, 1992, J VIROL METHODS, V38, P113, DOI 10.1016/0166-0934(92)90174-C
   YAMAGUCHI N, 1992, CAN J PHYSIOL PHARM, V70, P167, DOI 10.1139/y92-024
   ZUSMAN R, 1992, ANAL BIOCHEM, V201, P103, DOI 10.1016/0003-2697(92)90180-F
NR 23
TC 63
Z9 64
U1 3
U2 80
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2005
VL 16
IS 4
BP 333
EP 340
DI 10.1007/s10856-005-0632-y
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 914CA
UT WOS:000228201000008
PM 15803278
DA 2018-10-19
ER

PT J
AU Li, XK
   Chang, J
AF Li, XK
   Chang, J
TI Preparation and characterization of bioactive collagen/wollastonite
   composite scaffolds
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID APATITE FORMATION; FABRICATION; MATRICES
AB A novel biodegradable collagen/wollastonite composite was prepared as three-dimensional scaffolds by freeze-drying method. Scanning electron microscope (SEM) micrographs of scaffolds showed a continuous structure of interconnected pores, and pore size was about 100 mu m. The tensile strength of the scaffolds was improved by incorporation of wollastonite and the in vitro bioactivity of the scaffolds was evaluated by examining the hydroxyapatite ( HA) deposition on their surface in simulated body fluid (SBF). After soaking in SBF for 7 days, collagen reconstituted to fibers and HA nodules formed on collagen fibers. The result suggests that the incorporation of wollastonite could improve the mechanical strength and the in vitro bioactivity of the composite. The scaffolds could be a potential biomaterial for bone tissue engineering. (C) 2005 Springer Science + Business Media, Inc.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
CR CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   De Aza PN, 2000, BIOMATERIALS, V21, P1735, DOI 10.1016/S0142-9612(00)00058-2
   DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DeAza PN, 1996, J MICROSC-OXFORD, V182, P24, DOI 10.1111/j.1365-2818.1996.tb04794.x
   GROSS J, 1952, P SOC EXP BIOL MED, V80, P462
   HUANGLEE LLH, 1993, BIOMED ENG-APP BAS C, V5, P664
   JACKSON DS, 1955, NATURE, V176, P69, DOI 10.1038/176069a0
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LI HY, IN PRESS BIOMATERIAL
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Siriphannon P, 1999, J MATER RES, V14, P529, DOI 10.1557/JMR.1999.0076
   TRELSTAD RL, 1976, P NATL ACAD SCI USA, V73, P4027, DOI 10.1073/pnas.73.11.4027
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   YONG J, 2003, WEAR, V255, P734
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   ZHAO L, IN PRESS J MAT SCI M
NR 20
TC 28
Z9 29
U1 1
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2005
VL 16
IS 4
BP 361
EP 365
DI 10.1007/s10856-005-0636-7
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 914CA
UT WOS:000228201000012
PM 15803282
DA 2018-10-19
ER

PT J
AU Wang, F
   Li, MS
   Lu, YP
   Qi, YX
AF Wang, F
   Li, MS
   Lu, YP
   Qi, YX
TI A simple sol-gel technique for preparing hydroxyapatite nanopowders
SO MATERIALS LETTERS
LA English
DT Article
DE biomaterial; HA; nanopowders; sol-gel
ID HYDROTHERMAL SYNTHESIS; CALCIUM-PHOSPHATE; POWDERS; COATINGS
AB HA powder was prepared using a sol-gel method with phosphoric pentoxide (P2O5) and calcium nitrate tetrahydrate (Ca(NO3)(2) (.) 4H(2)O). The effect of sintering temperatures on crystalline degree and composition of the HA phase, and also the effect of aging times on crystal size of the HA powder were studied using XRD and TEM. It was found that at sintering temperatures ranging from 600 to 900 degreesC, the dominant phase in the powders was HA with small amounts of calcium oxide and beta-tricalcium phosphate (beta-TCP) at 800 and 900 degreesC, and only HA phase was observed at 600 and 700 degreesC. 10-15 nm HA powders were obtained using this technique. This technique has an advantage over other sot-gel methods in more simple and shorter time because of no requiring pH value control and long hydrolysis time. (C) 2004 Elsevier B.V. All rights reserved.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Shanghai Univ Sci & Technol, Sch Chem & Environm Engn, Jinan 250031, Peoples R China.
RP Li, MS (reprint author), Shandong Univ, Sch Mat Sci & Engn, 73 Jingshi Rd, Jinan 250061, Peoples R China.
EM wf890916@163.com
CR Anee TK, 2003, MATER CHEM PHYS, V80, P725, DOI 10.1016/S0254-0584(03)00116-0
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   BRNKER CK, 1990, SOL GEL SCI
   Chai CS, 1998, BIOMATERIALS, V19, P2291, DOI 10.1016/S0142-9612(98)90138-7
   Huang LY, 2000, J MATER SCI-MATER M, V11, P667, DOI 10.1023/A:1008934522363
   JCPDS, 1994, JCPDS CARD NO 9 432
   Kim W, 2000, J MATER SCI, V35, P5401, DOI 10.1023/A:1004859231795
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Lim GK, 1999, J MATER CHEM, V9, P1635, DOI 10.1039/a809644i
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Lopez-Macipe A., 1998, J MATER SYNTH PROC, V6, P121
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Weng WJ, 1998, BIOMATERIALS, V19, P125, DOI 10.1016/S0142-9612(97)00177-4
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
NR 15
TC 62
Z9 67
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD APR
PY 2005
VL 59
IS 8-9
BP 916
EP 919
DI 10.1016/j.matlet.2004.08.041
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 899SB
UT WOS:000227164000013
DA 2018-10-19
ER

PT J
AU Coreno, AJ
   Coreno, AO
   Cruz, RJJ
   Rodriguez, CC
AF Coreno, AJ
   Coreno, AO
   Cruz, RJJ
   Rodriguez, CC
TI Mechanochemical synthesis of nanocrystalline carbonate-substituted
   hydroxyapatite
SO OPTICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st Topical Meeting on Nanostructured Materials and Nanotechnology (CIO
   2004)
CY SEP 22-24, 2004
CL Leon, MEXICO
DE hydroxyapatite; mechanosynthesis; biomaterial
ID MIXTURES; POWDERS
AB Carbonate-substituted hydroxyapatite has been produced by solid-state reactions using a mechanochemical synthesis method. Ammonium phosphate monobasic and calcium carbonate were used as raw materials. Mixtures of the initial powders were prepared using a Ca/P molar ratio similar to that of non-substituted hydroxyapatite, Ca-10(PO4)(6)(OH)(2). Dry milling of the powders was performed by using a ball to powder weight ratio equals 20:1. The obtained product was characterized by means of infrared spectroscopy, transmission electron microscopy and X-ray diffraction. Under the employed synthesis conditions hydroxyapatite is obtained after 2 h of milling. The crystallinity and the amount of the hydroxyapatite increase as milling time does. After milling for 6 h, nanosized apatite which has a possible composition Ca9+y(CO3)(PO4)(5)(OH)(1+2y) is obtained. (c) 2004 Elsevier B.V. All rights reserved.
C1 UA Estado Hidalgo, Ctr Invest Mat Met, Pachuca, Hgo, Mexico.
   Inst Met, Fac Ingn, San Luis Potosi, Mexico.
RP Coreno, AJ (reprint author), UA Estado Hidalgo, Ctr Invest Mat Met, Carretera Pachuca,Tulacingo Km 4-5, Pachuca, Hgo, Mexico.
EM jcoreno@uaeh.reduaeh.mx
RI Coreno Alonso, Oscar/A-3413-2016
CR BERTOLUZZA A, 1995, J MATER SCI-MATER M, V6, P76, DOI 10.1007/BF00120411
   BROWN PW, 1994, HYDROXYAPATITE RELAT, P34
   DEPTULA A, 1992, J NON-CRYST SOLIDS, V147, P537, DOI 10.1016/S0022-3093(05)80672-6
   Gross KA, 1998, J MATER SCI-MATER M, V9, P839, DOI 10.1023/A:1008948228880
   GUTMAN E, 1997, MECHANOCHEMISTRY MAT
   Hench LL, 1996, BIOMATERIALS SCI INT, P73
   Hwang K, 1999, SURF COAT TECH, V115, P172, DOI 10.1016/S0257-8972(99)00174-7
   Kim W, 2000, J CHEM ENG JPN, V33, P768, DOI 10.1252/jcej.33.768
   Kim W, 2000, J MATER SCI, V35, P5401, DOI 10.1023/A:1004859231795
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P19
   McCormick PG, 1998, JOM-J MIN MET MAT S, V50, P61, DOI 10.1007/s11837-998-0290-x
   Rhee SH, 2002, BIOMATERIALS, V23, P1147, DOI 10.1016/S0142-9612(01)00229-0
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Silva CC, 2003, SOLID STATE SCI, V5, P553, DOI 10.1016/S1293-2558(03)00035-9
   SONI PR, 2001, MECH ALLOYING FUNDAM, P14
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   TORIMAYA M, 1996, J EUR CERAM SOC, V16, P426
   YEONG B, 2000, J AM CERAM SOC, V84, P465
   Yeong KCB, 2001, BIOMATERIALS, V22, P2705, DOI 10.1016/S0142-9612(00)00257-X
NR 19
TC 25
Z9 26
U1 2
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-3467
J9 OPT MATER
JI Opt. Mater.
PD APR
PY 2005
VL 27
IS 7
BP 1281
EP 1285
DI 10.1016/j.optmat.2004.11.025
PG 5
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 921UR
UT WOS:000228791300018
DA 2018-10-19
ER

PT J
AU Rice, MA
   Dodson, BT
   Arthur, JA
   Anseth, KS
AF Rice, MA
   Dodson, BT
   Arthur, JA
   Anseth, KS
TI Cell-based therapies and tissue engineering
SO OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; POLY(L-LACTIC ACID) FOAMS; MESENCHYMAL
   STEM-CELLS; HUMAN SEPTAL CARTILAGE; CROSS-LINKING DENSITY;
   HYALURONIC-ACID; IN-VITRO; BIOMECHANICAL PROPERTIES;
   CHEMICAL-MODIFICATION; MECHANICAL-PROPERTIES
AB Tissue engineering involves the restoration of tissue structure or function through the use of living cells [1]. The specific applications may include direct injection of cells, combination of cells with a biomaterial scaffold in vitro or in situ, or implantation of a biomaterial scaffold alone that can induce surrounding cells into tissue restoration. The basic concept of tissue engineering is summarized in Fig. 1. This general process consists of cell isolation and expansion followed by a reimplantation procedure that may include cells and a scaffold material or, more likely, a combination of the two.
   From an otolaryngologic perspective, most head and neck applications would probably involve chondrocytes (cartilage cells) and osteoblasts (boneproducing cells) along with some type of scaffold material because of the importance of initial shape and support. At first glance, tissue engineering seems to be a simple concept, but a number of major challenges must be addressed before it will become a widely approved and accepted method for tissue replacement. A basic summary and classification of some of the major challenges are presented in Table 1. Some of these challenges are cellular; they range from identifying an appropriate cell source to devising ways to expand the cells and make sure that they function appropriately once they are being depended on to produce new tissue. Many engineering challenges also exist. For example, the properties of the scaffold material can have a major impact on the viability of cells and the quality of tissue created. In addition, engineered neotissues must overcome clinical challenges, including adhesion and integration into defect sites that may be poorly vascularized.
C1 Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   Univ Colorado, Ctr Hlth Sci, Dept Otolaryngol Head & Neck Surg, Boulder, CO 80262 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, ECCH 111,Campus Box 424, Boulder, CO 80309 USA.
EM Kristi.Anseth@colorado.edu
CR Allemann M, 2001, J BIOMED MATER RES, V55, P13
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Bhadra D, 2002, PHARMAZIE, V57, P5
   BRENT B, 1992, PLAST RECONSTR SURG, V90, P355, DOI 10.1097/00006534-199209000-00001
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burdick JA, 2003, BIOMATERIALS, V24, P1613, DOI 10.1016/S0142-9612(02)00538-0
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Chang Jin Soon, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P336, DOI 10.1097/01.moo.0000134830.38177.ad
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Davisson T, 2002, J ORTHOPAED RES, V20, P842, DOI 10.1016/S0736-0266(01)00160-7
   de Jong AL, 2000, ARCH OTOLARYNGOL, V126, P49, DOI 10.1001/archotol.126.1.49
   Dennis JE, 1996, J CELL PHYSIOL, V167, P523, DOI 10.1002/(SICI)1097-4652(199606)167:3<523::AID-JCP16>3.3.CO;2-E
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   Grad S, 2003, J BIOMED MATER RES A, V66A, P571, DOI 10.1002/jbm.a.10007
   HEDBERG EL, IN PRESS J BIOMED MA
   Hertegard S, 2003, OTOLARYNG HEAD NECK, V128, P401, DOI 10.1067/mhn.2003.96
   Homicz MR, 2003, LARYNGOSCOPE, V113, P25, DOI 10.1097/00005537-200301000-00005
   Hunter CJ, 2004, OSTEOARTHR CARTILAGE, V12, P117, DOI 10.1016/j.joca.2003.08.009
   Kamil SH, 2004, LARYNGOSCOPE, V114, P867, DOI 10.1097/00005537-200405000-00015
   Kaufman MR, 2003, CLIN PLAST SURG, V30, P539, DOI 10.1016/S0094-1298(03)00071-3
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kojima K, 2003, ANN THORAC SURG, V76, P1884, DOI 10.1016/S0003-4975(03)01193-7
   Kojima K, 2003, FASEB J, V17, P823, DOI 10.1096/fj.02-0462com
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Majumdar M. P., 1995, Blood, V86, p494A
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miyata S, 2004, MAT SCI ENG C-BIO S, V24, P425, DOI 10.1016/j.msec.2003.11.007
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nussenbaum Brian, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P311, DOI 10.1097/01.moo.0000132242.81060.4a
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Parikh S N, 2002, J Postgrad Med, V48, P142
   PEPPAS NA, 1986, HYDROGELS MED PHARM, V2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Rice MA, 2004, J BIOMED MATER RES A, V70A, P560, DOI 10.1002/jbm.a.30106
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Rotter N, 2002, BIOMATERIALS, V23, P3087, DOI 10.1016/S0142-9612(02)00031-5
   Roy R, 2004, J BIOMED MATER RES A, V68A, P597, DOI 10.1002/jbm.a.10068
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Taguchi T, 2002, J BIOMED MATER RES, V61, P330, DOI 10.1002/jbm.10147
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Walton RL, 2002, PLAST RECONSTR SURG, V110, P234, DOI 10.1097/00006534-200207000-00041
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
NR 75
TC 20
Z9 32
U1 0
U2 9
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0030-6665
EI 1557-8259
J9 OTOLARYNG CLIN N AM
JI Otolaryngol. Clin. N. Am.
PD APR
PY 2005
VL 38
IS 2
BP 199
EP +
DI 10.1016/j.otc.2004.10.010
PG 17
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 925BM
UT WOS:000229026500003
PM 15823589
DA 2018-10-19
ER

PT J
AU Potier, E
   Petite, H
AF Potier, E
   Petite, H
TI Therapeutic application of mesenchymal stem cells in orthopaedics
SO PATHOLOGIE BIOLOGIE
LA English
DT Article
DE tissue engineering; stem cells; biomaterial; bone reconstruction
ID MARROW STROMAL CELLS; TISSUE-ENGINEERED BONE; HUMAN ADIPOSE-TISSUE;
   IN-VITRO; OSTEOGENESIS IMPERFECTA; PRECURSOR CELLS; DIFFERENTIATION;
   CULTURE; DEFECTS; MOUSE
AB Stem cell therapy of skeletal tissues involves the transplantation of stem cells to the tissues that have been damaged by injury or disease. Although these cells can be derived from embryos, the preferred source of skeletal stem cells is the bone marrow as it contains adult stem cells that can be easily driven towards a bone phenotype. More recently, cells with similar potentialities have also been derived from adipose tissue, muscle, or blood. A biomaterial (ceramics or polymers) is often required as a scaffold to promote cell adhesion, proliferation and differentiation as well as encourage vascular invasion and ultimately new bone formation. The first clinical studies are encouraging and suggests that stem cell therapy could be a prime method for bone reconstruction. (c) 2004 Elsevier SAS. Tons droits reserves.
C1 Fac Med Lariboisiere, CNRS, UMR 7052, Lab Rech Orthoped, F-75010 Paris, France.
RP Potier, E (reprint author), Fac Med Lariboisiere, CNRS, UMR 7052, Lab Rech Orthoped, 10 Ave Verdun, F-75010 Paris, France.
EM estherpot@hotmail.com
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060; Potier, Esther/0000-0001-7919-2110
CR Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642
   AMIT M, 2000, CLONALLY DERIVED HUM, V227, P271
   Anderson GB, 1996, ANIM REPROD SCI, V45, P231, DOI 10.1016/S0378-4320(96)01581-3
   Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BAB I, 1988, BONE MINER, V4, P373
   Bishop NJ, 1999, NAT MED, V5, P466, DOI 10.1038/8528
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323
   Caplan AI, 1998, ADV DRUG DELIV REV, V33, P3
   Coulombel L, 2003, M S-MED SCI, V19, P683, DOI 10.1051/medsci/20031967683
   Deasy BM, 2002, CURR OPIN MOL THER, V4, P382
   DEASY BM, 2001, MUSCLE DERIVED STEM, V27, P924
   Duguy N, 2000, Ann Chir Plast Esthet, V45, P364
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   FERRARI G, 1998, MUSCLE REGENERATION, V279, P1528
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   GOSHIMA J, 1991, OSTEOGENIC POTENTIAL, P298
   Hannouche D, 2001, J BONE JOINT SURG BR, V83B, P157, DOI 10.1302/0301-620X.83B2.12106
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jensen GS, 2002, MED HYPOTHESES, V59, P422, DOI 10.1016/S0306-9877(02)00147-0
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Krause DS, 2002, GENE THER, V9, P754, DOI 10.1038/sj.gt.3301760
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133
   Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2
   LEE JY, 2000, CLONAL ISOLATION MUS, V150, P1085
   Levy MM, 2001, BONE, V29, P317, DOI 10.1016/S8756-3282(01)00585-3
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Marini JC, 1999, NAT MED, V5, P466, DOI 10.1038/8326
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OREFFO RO, 1999, FUTURE POTENTIALS US, V25, pS5
   PEREIRA RF, 1998, MARROW STROMAL CELLS, V95, P1142
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Petite H, 2002, BIOTECHNOL GENET ENG, V19, P83
   Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987
   PITTENGER MF, 1999, MULTILINEAGE POTENTI, V284, P143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   TOMA C, 2002, HUMAN MESENCHYMAL ST, V105, P93
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Vogel G, 2001, SCIENCE, V292, P1820, DOI 10.1126/science.292.5523.1820
   Wada MR, 2002, DEVELOPMENT, V129, P2987
   Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024
   Williams JT, 1999, AM SURGEON, V65, P22
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.3.CO;2-3
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 66
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0369-8114
J9 PATHOL BIOL
JI Pathol. Biol.
PD APR
PY 2005
VL 53
IS 3
BP 142
EP 148
DI 10.1016/j.patbio.2004.03.003
PG 7
WC Pathology
SC Pathology
GA 913HN
UT WOS:000228142300003
PM 15781372
DA 2018-10-19
ER

PT J
AU Barralet, JE
   Tremayne, M
   Lilley, KJ
   Gbureck, U
AF Barralet, JE
   Tremayne, M
   Lilley, KJ
   Gbureck, U
TI Modification of calcium phosphate cement with alpha-hydroxy acids and
   their salts
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; BONE CEMENTS; CITRATE IONS; STRENGTH;
   POLYMETHYLMETHACRYLATE; RECONSTRUCTION; BIOMATERIAL; ADDITIVES;
   MOLECULES; TISSUE
AB Calcium phosphate cements (CPCs) are usually modified by organic/inorganic additives to improve their mechanical performance and to adjust their theological and setting properties to clinical requirements. In this work we used several nontoxic and biocompatible alpha-hydroxylated organic acids (glycolic, lactic, malic, tartaric, and citric acids) and their calcium and sodium salts for the modification of CPC. The unmodified cement used in this study consisted of an equimolar powder mixture of tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA) mixed with water at a powder mass/liquid volume ratio of 3.3 g/mL,. It had a compressive strength of 38 MPa and an initial setting time of 8 min. The free acids as cement liquids had mainly a detrimental effect on the strength of the cement and led to a decreased setting time around 2-4 min, while the calcium salts did not significantly alter the cement properties. However, the sodium salts of the oligocarboxylic acids (malic, tartaric, and citric acids) resulted in a liquefying effect combined with a strong reinforcement of the mechanical strength, such that compressive strength increased to 78-99 MPa. The liquefying effect and prolonged setting time of these compounds was thought to derive from a strong increase in the surface charge of both reactants and the reaction product hydroxyapatite as determined by potential, which increased from about -15 and -18 mV in pure water for TTCP and DCPA, respectively, to values around -40 to -50 mV. In contrast, the calcium salts did not alter potentials due to the formation of neutral and stable complexes in aqueous solution.
C1 McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England.
   Univ Birmingham, Sch Dent, Biomat Unit, Birmingham B4 6NN, W Midlands, England.
   Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
RP Barralet, JE (reprint author), McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
EM jake.barralet@mcgill.ca
RI barralet, jake/A-5820-2008; Gbureck, Uwe/G-1430-2012
OI barralet, jake/0000-0003-3543-6042; 
CR Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Barralet JE, 2003, ADV MATER, V15, P2091, DOI 10.1002/adma.200305469
   Bohner M, 2000, J MATER SCI-MATER M, V11, P155, DOI 10.1023/A:1008927624493
   Bohner M, 1996, J AM CERAM SOC, V79, P1427, DOI 10.1111/j.1151-2916.1996.tb08746.x
   BRECEVIC L, 1979, CALCIFIED TISSUE INT, V28, P131, DOI 10.1007/BF02441231
   Breusch SJ, 2003, ORTHOPADE, V32, P41, DOI 10.1007/s00132-002-0411-0
   BROWN WE, 1985, Patent No. 4518430
   *CAMBR CORP, 1997, CS MOPAC PRO
   CHOW LC, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P127
   dos Santos LA, 2003, ARTIF ORGANS, V27, P412, DOI 10.1046/j.1525-1594.2003.07248.x
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Fujishiro Y, 2001, J BIOMED MATER RES, V54, P525, DOI 10.1002/1097-4636(20010315)54:4<525::AID-JBM80>3.0.CO;2-#
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   Gbureck U, 2004, BIOMATERIALS, V25, P2187, DOI 10.1016/j.biomaterials.2003.08.066
   Gbureck U, 2002, BIOMOL ENG, V19, P51, DOI 10.1016/S1389-0344(02)00010-2
   GINEBRA MP, 1995, J MATER SCI-MATER M, V6, P612, DOI 10.1007/BF00121286
   GLUSKER JP, 1980, ACCOUNTS CHEM RES, V13, P345, DOI 10.1021/ar50154a002
   Hench L L, 1973, Med Instrum, V7, P136
   Ishikawa K, 1999, J BIOMED MATER RES, V44, P322, DOI 10.1002/(SICI)1097-4636(19990305)44:3<322::AID-JBM11>3.0.CO;2-S
   KINGERY WD, 1950, J AM CERAM SOC, V33, P242, DOI 10.1111/j.1151-2916.1950.tb14172.x
   Kopylov P, 2002, J HAND SURG-BRIT EUR, V27B, P538, DOI 10.1054/jhsb.2002.0799
   KURTZ HA, 1990, J COMPUT CHEM, V11, P82, DOI 10.1002/jcc.540110110
   LEE DD, 2000, Patent No. 6132463
   LEESON MC, 1993, CLIN ORTHOP RELAT R, V295, P239
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leroux L, 1999, BONE, V25, p31S, DOI 10.1016/S8756-3282(99)00130-1
   Liou SC, 2002, BIOMATERIALS, V23, P4541, DOI 10.1016/S0142-9612(02)00198-9
   Popova A, 2000, J AM CERAM SOC, V83, P2556
   REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5
   ROSEN HM, 1991, ANGLE ORTHOD, V61, P185
   Sarda S, 2003, J BIOMED MATER RES A, V65A, P215, DOI 10.1002/jbm.a.10458
   Sarda S, 2002, J BIOMED MATER RES, V61, P653, DOI 10.1002/jbm.10264
   Sarda S, 2001, J MATER SCI-MATER M, V12, P905, DOI 10.1023/A:1012832325957
   Sarkar MR, 2001, J BIOMED MATER RES, V58, P329, DOI 10.1002/1097-4636(2001)58:3<329::AID-JBM1025>3.3.CO;2-0
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Suvorova EI, 1998, J CRYST GROWTH, V186, P262, DOI 10.1016/S0022-0248(97)00445-4
   TAKAGI S, 1995, J DENT RES, V74, P559
   TENHUISEN KS, 1994, J MATER SCI-MATER M, V5, P291, DOI 10.1007/BF00122399
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
NR 42
TC 52
Z9 56
U1 2
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD MAR 22
PY 2005
VL 17
IS 6
BP 1313
EP 1319
DI 10.1021/cm048803z
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 908FF
UT WOS:000227772100012
DA 2018-10-19
ER

PT J
AU Lim, JY
   Hansen, JC
   Siedlecki, CA
   Runt, J
   Donahue, HJ
AF Lim, JY
   Hansen, JC
   Siedlecki, CA
   Runt, J
   Donahue, HJ
TI Human foetal osteoblastic cell response to polymer-demixed
   nanotopographic interfaces
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE cell-substratum interface; nanotopography; osteoblast; focal adhesion;
   nanobioscience
ID SUBSTRATUM SURFACE CHARACTERISTICS; CONTACT GUIDANCE; IN-VITRO;
   TOPOGRAPHIC COMPENSATION; NANO-TOPOGRAPHY; THIN-FILMS; FIBROBLASTS;
   ADHESION; BEHAVIOR; BLENDS
AB Nanoscale cell-substratum interactions are of significant interest in various biomedical applications. We investigated human foetal osteoblastic cell response to randomly distributed nanoisland topography with varying heights (11, 38 and 85 nm) produced by a polystyrene (PS)/polybromostyrene polymer-demixing technique. Cells displayed island-conforming lamellipodia spreading, and filopodia projections appeared to play a role in sensing the nanotopography. Cells cultured on 11 nm high islands displayed significantly enhanced cell spreading and larger cell dimensions than cells oil larger nanoislands or flat PS control, on which cells often displayed a stellate shape. Development of signal transmitting structures such as focal adhesive vinculin protein and cytoskeletal actin stress fibres was more pronounced. as was their colocalization, in cells cultured oil smaller nanoisland surfaces. Cell adhesion and proliferation were greater with decreasing island height. Alkaline phosphatase (AP) activity, all early stage marker of bone cell differentiation. also exhibited nanotopography dependence, i.e. higher AP activity on 11 nm islands compared with that on larger islands or flat PS. Therefore, randomly distributed island topography with varying nanoscale heights not only affect adhesion-related cell behaviour but also bone cell phenotype. Our results suggest that modulation of nanoscale topography may be exploited to control cell function at cell biomaterial interfaces.
C1 Penn State Univ, Milton S Hershey Med Ctr, Coll Med,Ctr Biomed Devices & Funct Tissue Engn, Div Musculoskeletal Sci,Dept Orthopaed & Rehabil, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Surg, Biomed Engn Inst, Hershey, PA 17033 USA.
   Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA.
RP Donahue, HJ (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med,Ctr Biomed Devices & Funct Tissue Engn, Div Musculoskeletal Sci,Dept Orthopaed & Rehabil, 500 Univ Dr, Hershey, PA 17033 USA.
EM hdonahue@psu.edu
RI He, Yong/F-8752-2012
CR Affrossman S, 2000, COLLOID POLYM SCI, V278, P888, DOI 10.1007/s003960000359
   Affrossman S, 1998, MACROMOLECULES, V31, P6280, DOI 10.1021/ma971676q
   Affrossman S, 1996, MACROMOLECULES, V29, P5010, DOI 10.1021/ma9516910
   Al-Omari WM, 2001, J ORAL REHABIL, V28, P645, DOI 10.1046/j.1365-2842.2001.00722.x
   Alberts B, 1994, MOL BIOL CELL
   Bico J, 2001, EUROPHYS LETT, V55, P214, DOI 10.1209/epl/i2001-00402-x
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Donahue HJ, 2000, AM J PHYSIOL-CELL PH, V278, pC315
   Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3
   Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GUCKENBIEHL B, 1994, PHYSICA B, V198, P127, DOI 10.1016/0921-4526(94)90141-4
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Lacouture ME, 2002, J BONE MINER RES, V17, P481, DOI 10.1359/jbmr.2002.17.3.481
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lim JY, 2005, TISSUE ENG, V11, P19, DOI 10.1089/ten.2005.11.19
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   MEYLE J, 1994, J MATER SCI-MATER M, V5, P463, DOI 10.1007/BF00058984
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Oakley C, 1997, EXP CELL RES, V234, P413, DOI 10.1006/excr.1997.3625
   Oakley C, 1995, BIOCHEM CELL BIOL, V73, P473, DOI 10.1139/o95-053
   OAKLEY C, 1995, CELL MOTIL CYTOSKEL, V31, P45, DOI 10.1002/cm.970310106
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   RUPP F, 2004, BIOMATERIALS, V25, P1129
   SHIRATO I, 1991, CELL TISSUE RES, V266, P1, DOI 10.1007/BF00678705
   Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   WOJCIAKSTOTHARD B, 1996, EXP CELL RES, V223, P126
   Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156
NR 51
TC 124
Z9 127
U1 0
U2 25
PU ROYAL SOCIETY
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J ROY SOC INTERFACE
JI J. R. Soc. Interface
PD MAR 22
PY 2005
VL 2
IS 2
BP 97
EP 108
DI 10.1098/rsif.2004.0019
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998TE
UT WOS:000234341600011
PM 16849169
OA Green Published
DA 2018-10-19
ER

PT J
AU Parker, T
   Upton, Z
   Vellinga, D
   Wei, M
   Leavesley, D
AF Parker, T
   Upton, Z
   Vellinga, D
   Wei, M
   Leavesley, D
TI Potential pitfalls of radiolabel adsorption to ceramic biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE adsorption; biomaterial; ceramic; osteoblast; proliferation
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; TOTAL HIP REPLACEMENTS; CELL-LINE
   SAOS-2; IN-VITRO; OSTEOBLAST ADHESION; TRITIATED-THYMIDINE; INITIAL
   ATTACHMENT; TITANIUM IMPLANTS; DENTAL IMPLANTS; COATED IMPLANTS
AB The use of radiolabeled precursor molecules for the metabolic analysis of cell functions is commonplace. Tritiated thymidine, in particular, has been used to quantitate cellular proliferation in numerous cells, including osteoblasts, when cultured on various biomaterials. Our aim was to assess cellular protein synthesis and proliferation, on a range of fluoride ion-substituted hydroxyapatites. Initially, we used a classical metabolic analysis strategy with radiolabeled tracer molecules. Our results suggested that these materials supported enhanced protein synthesis and proliferation of SaOS-2 human osteoblast-like cells. However, control samples also revealed enhanced adsorption of the radiolabeled tracer. We have shown that this arises because partially fluoride ion-substituted hydroxyapatite exhibits enhanced adsorptive characteristics of radiolabeled leucine and thymidine over tissue culture plastic, hydroxyapatite, and fluoroapatite. Moreover, manual cell count data obtained through SEM analysis showed no significant difference in cell proliferation between any of the materials, further indicating that our initial results were artifacts. These results highlight the use and reporting of appropriate cell-free controls are critical in bioassays examining functional responses of cells to biomaterials, and if absent, may confound accurate data interpretation. Our findings have general implications for investigations of cell function on other novel ceramic biomaterials. (C) 2005 Wiley Periodicals, Inc.
C1 Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Bioregenerat Domain, Brisbane, Qld 4001, Australia.
   Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia.
   Queensland Univ Technol, Sch Mech Mfg & Med Engn, Brisbane, Qld 4001, Australia.
RP Vellinga, D (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Bioregenerat Domain, GPO Box 2434, Brisbane, Qld 4001, Australia.
EM a0.parker@student.qut.edu.au
RI Upton, Zee/I-9777-2012; Leavesley, David/C-9532-2009
OI Leavesley, David/0000-0002-1033-5459; Parker, Tony/0000-0002-5118-524X
CR ALLIOTLICHT B, 1994, ARCH ORAL BIOL, V39, P481, DOI 10.1016/0003-9969(94)90144-9
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bess E, 1999, Implant Dent, V8, P126, DOI 10.1097/00008505-199902000-00004
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRISENO BM, 1990, J ENDODONT, V16, P383, DOI 10.1016/S0099-2399(06)81910-2
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   Darimont GL, 2002, BIOMATERIALS, V23, P2569, DOI 10.1016/S0142-9612(01)00392-1
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Espehaug B, 1997, J BONE JOINT SURG BR, V79B, P590, DOI 10.1302/0301-620X.79B4.7420
   FRANCIS GL, 1986, BIOCHEM J, V233, P207, DOI 10.1042/bj2330207
   Gineste L, 1999, J BIOMED MATER RES, V48, P224, DOI 10.1002/(SICI)1097-4636(1999)48:3<224::AID-JBM5>3.3.CO;2-1
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   ITOKAZU M, 1994, CLIN MATER, V17, P173, DOI 10.1016/0267-6605(94)90033-7
   KAWASAKI T, 1990, J CHROMATOGR, V515, P91, DOI 10.1016/S0021-9673(01)89306-7
   KAWASAKI T, 1990, J CHROMATOGR, V515, P125, DOI 10.1016/S0021-9673(01)89307-9
   KO TC, 1993, SURGERY, V114, P147
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Layman DL, 1998, J BIOMED MATER RES, V40, P282, DOI 10.1002/(SICI)1097-4636(199805)40:2<282::AID-JBM13>3.0.CO;2-O
   Lind M, 2001, BIOMATERIALS, V22, P189, DOI 10.1016/S0142-9612(00)00165-4
   MacDonald DE, 2001, J BIOMED MATER RES, V54, P480
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   MAURER HR, 1981, CELL TISSUE KINET, V14, P111, DOI 10.1111/j.1365-2184.1981.tb00516.x
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   MINN H, 1995, J NUCL MED, V36, P252
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Morscher EW, 1998, J BONE JOINT SURG BR, V80B, P267, DOI 10.1302/0301-620X.80B2.8316
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nerini-Molteni S, 2001, TUMOR BIOL, V22, P92, DOI 10.1159/000050602
   Netz DJA, 2001, INT J PHARM, V213, P117, DOI 10.1016/S0378-5173(00)00659-1
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   ODESSEY R, 1986, PROBLEMS POTENTIAL B
   Ohta K, 2001, J BIOMED MATER RES, V55, P409, DOI 10.1002/1097-4636(20010605)55:3<409::AID-JBM1030>3.0.CO;2-Z
   Okazaki M, 1999, BIOMATERIALS, V20, P1303, DOI 10.1016/S0142-9612(99)00030-7
   Okazaki M, 1998, BIOMATERIALS, V19, P611, DOI 10.1016/S0142-9612(97)00151-8
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Oonishi H, 1997, J BONE JOINT SURG BR, V79B, P87, DOI 10.1302/0301-620X.79B1.1290
   PETERSON WJ, 1987, J IMMUNOL METHODS, V96, P171, DOI 10.1016/0022-1759(87)90311-5
   Peterson WJ, 2002, CELL PROLIFERAT, V35, P9, DOI 10.1046/j.1365-2184.2002.00219.x
   Queiroz AC, 2001, BIOMATERIALS, V22, P1393, DOI 10.1016/S0142-9612(00)00296-9
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   RODAN SB, 1987, CANCER RES, V47, P4961
   Sanchez E, 2001, EUR J PHARM BIOPHARM, V52, P151, DOI 10.1016/S0939-6411(01)00169-2
   SCHACHTSCHABEL DO, 1976, EUR SURG RES, V8, P71, DOI 10.1159/000127849
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   VANBLITTERSWIJK CA, 1991, BIOMATERIALS, V12, P187, DOI 10.1016/0142-9612(91)90198-J
   Verne E, 2002, BIOMATERIALS, V23, P3395, DOI 10.1016/S0142-9612(02)00040-6
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WEI M, 2002, BIOCERAMICS, P671
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 54
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2005
VL 72A
IS 4
BP 363
EP 372
DI 10.1002/jbm.a.30247
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 903ZD
UT WOS:000227463400003
PM 15669059
DA 2018-10-19
ER

PT J
AU Santoro, MM
   Toscano, AM
   Kozlova, N
AF Santoro, MM
   Toscano, AM
   Kozlova, N
TI Biomaterial and adhesive properties of nano-patterned surfaces.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 229th National Meeting of the American-Chemical-Society
CY MAR 13-17, 2005
CL San Diego, CA
SP Amer Chem Soc
C1 Univ Massachusetts, Dept Polymer Sci, Amherst, MA 01003 USA.
   Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
EM santore@mail.pse.umass.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 13
PY 2005
VL 229
MA 186-POLY
BP U933
EP U934
PN 2
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 008UQ
UT WOS:000235066604186
DA 2018-10-19
ER

PT J
AU Usha, R
   Ramasami, T
AF Usha, R
   Ramasami, T
TI Structure and conformation of intramolecularly cross-linked collagen
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE formaldehyde; glutaraldehyde; collagen; circular dichroism
ID FORMALDEHYDE; CHAIN
AB This work reports the effects of cross-linking agent like formaldehyde (HCHO) and glutaraldehyde (GA) on monomeric collagen and its conformational stability using circular dichroism. The nature of the bonds formed and the stability of the cross-links introduced vary with the aldehyde. The amount of HCHO required is four times greater than GA to induce similar changes in the molar ellipticity. This is due to the structural changes of collagen-aldehyde reaction. The change in the molar ellipticity and Rpn ratio for HCHO and GA treated collagen suggest possible aggregation of collagen molecule. The relative viscosity of native and aldehyde treated collagen was measured and correlated to the changes seen in the CD spectra. The small amount of aldehydes are needed to induce changes in the conformational stability of collagen. This can be applied to the biomaterial and biomedical application. (C) 2004 Elsevier B.V. All rights reserved.
C1 Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Usha, R (reprint author), Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
EM usharamamoorthy54@yahoo.co.in
RI Thangarasu, Kandasamy/B-8503-2009
CR BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   Cater C. W., 1963, J SOC LEATHER TRADES, V47, P259
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6060
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   Covington AD, 1997, CHEM SOC REV, V26, P111, DOI 10.1039/cs9972600111
   Gayatri R, 2000, BBA-GEN SUBJECTS, V1524, P228, DOI 10.1016/S0304-4165(00)00164-1
   Gayatri R, 2001, BIOCHEM BIOPH RES CO, V283, P229, DOI 10.1006/bbrc.2001.4713
   HARRIS ED, 1972, BIOCHIM BIOPHYS ACTA, V278, P133, DOI 10.1016/0005-2795(72)90114-6
   NIMNI ME, 1988, COLLAGEN, V111, P1
   PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4129, DOI 10.1021/bi00823a015
   TIFFANY ML, 1969, BIOPOLYMERS, V8, P347, DOI 10.1002/bip.1969.360080306
   TIFFANY ML, 1966, BIOPOLYMERS, V15, P513
   Usha R, 2004, J POLYM SCI POL PHYS, V42, P3859, DOI 10.1002/polb.20191
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   Watanabe K, 1997, POLYMER, V38, P5155, DOI 10.1016/S0032-3861(97)00046-3
   Watanabe K, 1996, POLYMER, V37, P1285, DOI 10.1016/0032-3861(96)80856-1
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 19
TC 49
Z9 57
U1 2
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 10
PY 2005
VL 41
IS 1
BP 21
EP 24
DI 10.1016/j.colsurfb.2004.11.001
PG 4
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 901FN
UT WOS:000227268500004
PM 15698752
DA 2018-10-19
ER

PT J
AU Sen Gupta, A
   Lopina, ST
AF Sen Gupta, A
   Lopina, ST
TI Properties of L-tyrosine based polyphosphates pertinent to potential
   biomaterial applications
SO POLYMER
LA English
DT Article
DE L-tyrosine; polyphosphates; degradation
ID GENE DELIVERY; POLYMERS
AB Since their introduction by Kohn and Langer et al. in 1984, L-tyrosine based 'pseudo' poly(amino acids) have undergone extensive research in the area of polymeric biomaterials. Starting from L-tyrosine based diphenolic monomers, polyiminocarbonates, polycarbonates and polyarylates have been developed by Kohn and co-workers and are being investigated for potential orthopedic biomaterial applications. Mao et al. have reported development Of L-tyrosine based polyphosphates and polyphosphonates in a patent, however, detailed structural and physico-chemical characterization studies on such polymers have not been reported yet. For the purpose of the current paper, using a novel solid phase process for synthesis Of L-tyrosine based diphenolic monomers and adapting the polymerization process described by Mao et al., L-tyrosine based polyphosphates were developed and investigated for their pertinent bioengineering properties. The properties investigated consist of chemical solubility, hydrophilicity and hydrolytic degradation. The results of this investigation are crucial to validate further investigation of biomaterial applications of these polymers. (c) 2005 Published by Elsevier Ltd.
C1 Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
EM lopina@uakron.edu
CR BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   ERTEL SI, 1992, POLYM MAT SCI ENG, V66, P224
   Huang SW, 2004, BIOMACROMOLECULES, V5, P306, DOI 10.1021/bm034241l
   James K, 1996, TRENDS POLYM SCI, V4, P394
   KOHN J, 1990, DRUGS PHARM SCI, V45, P195
   KOHN J, 1990, POLYM PREPR, V31, P178
   KOHN J, 1988, PEPT CHEM BIOL P AM, V10, P658
   KOHN J, 1984, POLYM MAT SCI ENG, V51, P119
   MAO H, 1999, Patent No. 591225
   PENCZEK S, 1993, MACROMOLECULES, V26, P2228, DOI 10.1021/ma00061a014
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   Renier ML, 1997, J BIOMED MATER RES, V34, P95, DOI 10.1002/(SICI)1097-4636(199701)34:1<95::AID-JBM13>3.0.CO;2-O
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   RICHARDS M, 1991, J POLYM SCI POL CHEM, V29, P1157, DOI 10.1002/pola.1991.080290809
   Sen Gupta A, 2004, J POLYM SCI POL CHEM, V42, P4906, DOI 10.1002/pola.20320
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   SUGANUMA J, 1992, MATER RES SOC SYMP P, V252, P339
   Wan ACA, 2004, J BIOMED MATER RES B, V70B, P91, DOI 10.1002/jbm.b.30022
   Wang J, 2001, J AM CHEM SOC, V123, P9480, DOI 10.1021/ja016062m
   Wen J, 2004, J PHARM SCI-US, V93, P2142, DOI 10.1002/jps.20121
   Zhao Z, 2003, ADV DRUG DELIVER REV, V55, P483, DOI 10.1016/S0169-409X(03)00040-1
NR 21
TC 25
Z9 28
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD MAR 10
PY 2005
VL 46
IS 7
BP 2133
EP 2140
DI 10.1016/j.polymer.2005.01.023
PG 8
WC Polymer Science
SC Polymer Science
GA 906PP
UT WOS:000227654500014
DA 2018-10-19
ER

PT J
AU Leach, JB
   Wolinsky, JB
   Stone, PJ
   Wong, JY
AF Leach, JB
   Wolinsky, JB
   Stone, PJ
   Wong, JY
TI Crosslinked alpha-elastin biomaterials: towards a processable elastin
   mimetic scaffold
SO ACTA BIOMATERIALIA
LA English
DT Article
DE elastin; biomaterial; vascular tissue engineering; degradable;
   crosslinking
ID EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE;
   PHYSICAL-PROPERTIES; FIBERS; TROPOELASTIN; POLYPEPTIDES; TISSUES;
   CULTURE; MICROFIBRILS
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.
RP Wong, JY (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM jywong@bu.edu
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
FU NHLBI NIH HHS [1 R01 HL 72900-01A1]; NIBIB NIH HHS [5R21 EB 00988]
CR Bellingham CM, 2004, CURR OPIN SOLID ST M, V8, P135, DOI 10.1016/j.cossms.2004.01.007
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4
   COX BA, 1973, BIOCHIM BIOPHYS ACTA, V317, P209, DOI 10.1016/0005-2795(73)90215-8
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   Fung YC, 1993, BIOMECHANICS MECH PR
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Ito S, 1997, Cardiovasc Surg, V5, P176, DOI 10.1016/S0967-2109(97)00004-5
   Ito S, 1998, ASAIO J, V44, pM501, DOI 10.1097/00002480-199809000-00036
   JACOT JG, UNPUB DETERMINATION
   JOHNSON DJ, 1995, CIRC RES, V77, P1107, DOI 10.1161/01.RES.77.6.1107
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004
   L'Heureux N, 1998, FASEB J, V12, P47
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091
   Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   NOISHIKI Y, 2004, ENCY BIOMATERIALS BI, P1264
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P21, DOI 10.1042/bj0610021
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5
   Silver FH, 2001, CRIT REV BIOMED ENG, V29, P279, DOI 10.1615/CritRevBiomedEng.v29.i3.10
   Sperling L.H., 2001, INTRO PHYS POLYM SCI
   STONE PJ, 1991, AM REV RESPIR DIS, V144, P284, DOI 10.1164/ajrccm/144.2.284
   Stone PJ, 1997, AM J RESP CELL MOL, V17, P289, DOI 10.1165/ajrcmb.17.3.2597
   STONE PJ, 1987, IN VITRO CELL DEV B, V23, P663
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Tranquillo RT, 2002, ANN NY ACAD SCI, V961, P251, DOI 10.1111/j.1749-6632.2002.tb03094.x
   Urry DW, 2002, J MUSCLE RES CELL M, V23, P543, DOI 10.1023/A:1023422925910
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   VOLPIN D, 1976, BIOCHIM BIOPHYS ACTA, V439, P253, DOI 10.1016/0005-2795(76)90181-1
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   YAMAMOTO K, 1995, EXP CELL RES, V218, P339, DOI 10.1006/excr.1995.1164
   Zhao XB, 2002, J MATER SCI-MATER M, V13, P11, DOI 10.1023/A:1013618115163
NR 44
TC 71
Z9 73
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2005
VL 1
IS 2
BP 155
EP 164
DI 10.1016/j.actbio.2004.12.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008FA
UT WOS:000235024400002
PM 16701792
DA 2018-10-19
ER

PT J
AU Han, SI
   Kang, SW
   Kim, BS
   Im, SS
AF Han, SI
   Kang, SW
   Kim, BS
   Im, SS
TI A novel polymeric ionomer as a potential biomaterial: Crystallization
   behavior, degradation, and in-vitro cellular interactions
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID POLY(BUTYLENE SUCCINATE); POLY(TETRAMETHYLENE SUCCINATE); RHEOLOGICAL
   PROPERTIES; WETTABILITY GRADIENT; PHYSICAL-PROPERTIES; MORPHOLOGY;
   CRYSTALS; SURFACES; ADHESION; GROWTH
AB To evaluate the potential of polyester-based ionomers as biomaterials, we have characterized them in terms of crystallization behavior, degradation, and in-vitro cellular interactions. The polymers used are poly(butylene succinate)-based ionomers (PBSis) with 1 to 5 mol-% dimethyl 5-sodium sulfoisophthalate. Even a few incorporated ionic groups significantly decreases the folding surface energy, indicating that folding into crystalline lamellae is more difficult for chains restricted by ionic aggregates. Transmission electron microscopy (TEM) does not reveal any distinct aggregation of ionic clusters following hydrolytic degradation, which suggests that the physical crosslinkage due to ionic interactions is vulnerable to hydrolysis. The in-vitro cellular interactions of polyester-based ionomers is assessed by the culture of human dermal fibroblasts with PBSi extracts or in direct contact with the PBSi films. Cells on PBSi films and in their extracts exhibit appropriate specific growth rates and normal metabolic function regardless of the incorporated ionic content compared with poly[(D,L-lactic acid)-co-(glycolic acid)] (75:25, PLGA), which is well known to be biocompatible. The cells growing on PBSi films spread to a sufficient extent, displaying relatively active filopodial growth, as compared to that of parent PBS. These results suggest that the conspicuous topology and hydrophilic nature of the ionomer surface affect cellular interactions, and that this ionomer therefore has potential applications as a biomaterial.
C1 Hanyang Univ, Dept Fiber & Polymer Engn, Seongdong Ku, Seoul 133791, South Korea.
   Hanyang Univ, Dept Chem Engn, Seongdong Ku, Seoul 133791, South Korea.
RP Han, SI (reprint author), Hanyang Univ, Dept Fiber & Polymer Engn, Seongdong Ku, Seoul 133791, South Korea.
EM imss007@hanyang.ac.kr
RI Kim, Byung-Soo/O-2352-2013
CR CIAPETTI G, 1994, BIOMATERIALS, V15, P63, DOI 10.1016/0142-9612(94)90199-6
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Han SI, 2004, MACROMOL RAPID COMM, V25, P753, DOI 10.1002/marc.200300272
   Han SI, 2003, BIOMATERIALS, V24, P3453, DOI 10.1016/S0142-9612(03)00223-0
   Han SI, 2003, POLYMER, V44, P7165, DOI 10.1016/S0032-3861(03)00673-6
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   HOFFMAN JD, 1976, TREATIES SOLID STATE, V3
   IHN KJ, 1995, MACROMOLECULES, V28, P2460, DOI 10.1021/ma00111a045
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Kai Z, 2003, BIOCH ENG J, V16, P115
   Kim JS, 2002, MACROMOLECULES, V35, P155, DOI 10.1021/ma010480u
   LAURITZEN JI, 1973, J APPL PHYS, V44, P4340, DOI 10.1063/1.1661962
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   MA X, 1995, MACROMOLECULES, V28, P3953, DOI 10.1021/ma00115a031
   MAGILL JH, 1964, J APPL PHYS, V35, P3249, DOI 10.1063/1.1713206
   MANDELKERN L, 1954, J APPL PHYS, V25, P830, DOI 10.1063/1.1721753
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   Miyata T, 1998, POLYMER, V39, P1399, DOI 10.1016/S0032-3861(97)00418-7
   Nishida M, 1996, MACROMOLECULES, V29, P1507, DOI 10.1021/ma9513630
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Park JW, 2002, POLYM INT, V51, P239, DOI 10.1002/pi.848
   PHILLIPS PJ, 1989, J POLYM SCI POL PHYS, V27, P155, DOI 10.1002/polb.1989.090270110
   SHERMAN JW, 1996, POLYM PREPR AM CHEM, V37, P952
   Storey RF, 1998, POLYM PREPR AM CHEM, V39, P602
   Szymczyk A, 1999, POLYM ADVAN TECHNOL, V10, P579, DOI 10.1002/(SICI)1099-1581(199910)10:10<579::AID-PAT911>3.3.CO;2-9
   TAKAGI H, 1995, J CLIN INVEST, V96, P2120, DOI 10.1172/JCI118265
   TAKAHASHI T, 1995, RHEOL ACTA, V34, P163, DOI 10.1007/BF00398436
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   VASANTHAKUMARI R, 1983, POLYMER, V24, P175, DOI 10.1016/0032-3861(83)90129-5
   Yoo ES, 1999, J POLYM SCI POL PHYS, V37, P1357, DOI 10.1002/(SICI)1099-0488(19990701)37:13<1357::AID-POLB2>3.0.CO;2-Q
   Yoo YT, 1998, POLYM J, V30, P538, DOI 10.1295/polymj.30.538
   Yoo YT, 2003, POLYM DEGRAD STABIL, V79, P257, DOI 10.1016/S0141-3910(02)00289-6
   Yoshikawa K, 1996, MACROMOLECULES, V29, P1235, DOI 10.1021/ma950691x
NR 34
TC 32
Z9 32
U1 2
U2 25
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR
PY 2005
VL 15
IS 3
BP 367
EP 374
DI 10.1002/adfm.200400079
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 907WZ
UT WOS:000227750100002
DA 2018-10-19
ER

PT J
AU Fortun, K
   Fortun, M
AF Fortun, K
   Fortun, M
TI Scientific imaginaries and ethical plateaus in contemporary US
   toxicology
SO AMERICAN ANTHROPOLOGIST
LA English
DT Article
ID SCIENCE; TOXICOGENOMICS; KNOWLEDGE
AB This article contributes to a growing literature in the anthropology of science, focusing on contemporary U.S. toxicology and the development of "toxicogenomics." Toxicogenomics research aims to understand impacts of environmental stressors at the genetic level and to create a "systems toxicology" that combines different kinds of biological data for holistic understanding. Toxicologists are challenged to deal with greater and greater complexity while fulfilling their historic mission of producing results relevant to regulatory, legal, and clinical decision making. Although there is now a robust body of anthropological work on the sciences-in practice, as sites of cultural production, and as cultural and political-economic forces in a variety of domains-a relatively underdeveloped theme is subject formation within the sciences. This article directs ethnographic attention toward understanding how scientific imaginaries take shape and interpolate technical, biomaterial, political-economic, social, cultural, and ethical elements. We map such efforts in contemporary toxicogenomics as an instance of "civic science."
C1 Rensselaer Polytech Inst, Dept Sci & Technol Studies, Troy, NY 12180 USA.
RP Fortun, K (reprint author), Rensselaer Polytech Inst, Dept Sci & Technol Studies, Troy, NY 12180 USA.
CR Bateson Gregory, 1972, STEPS ECOLOGY MIND
   BIAGIOLO M, 1993, GALILEO COURTIER PRA
   BLANCHETTE JF, 2002, THESIS DEP SCI TECHN
   Carson R., 1962, SILENT SPRING
   Cohen L, 1999, DAEDALUS, V128, P135
   Cornell D, 1992, PHILOS LIMIT
   DASVEENA, 2002, LIVING WORKING NEW M
   Deleuze Gilles, 1983, NIETZSCHE PHILOS
   Deleuze Gilles, 1987, 1000 PLATEAUS CAPITA
   Derrida Jacques, 1974, GRAMMATOLOGY
   Doull J, 2001, Annu Rev Pharmacol Toxicol, V41, P1, DOI 10.1146/annurev.pharmtox.41.1.1
   Dumit J., 2003, PICTURING PERSONHOOD
   *EPA, 2003, 240R03001 EPA
   Fischer Michael M. J., 2003, EMERGENT FORMS LIFE
   Fischer MMJ, 2004, AM ANTHROPOL, V106, P389, DOI 10.1525/aa.2004.106.2.389
   Fischer MMJ, 1999, ANNU REV ANTHROPOL, V28, P455, DOI 10.1146/annurev.anthro.28.1.455
   Fortun K, 2004, OSIRIS, V19, P283, DOI 10.1086/649407
   FORTUN K, 2003, REV ANTHR, V32, P171, DOI DOI 10.1080/00988150390197695
   Fortun K., 2001, ADVOCACY BHOPAL ENV
   FORTUN M, IN PRESS PROMISING G
   FORTUN M, 2004, 1 INT CESAGEN CTR ET
   Foucault M, 1972, ARCHAEOLOGY KNOWLEDG
   Foucault M., 1986, CARE SELF, V3
   Foucault M, 1984, FOUCAULT READER, P340
   Foucault Michel, 1980, HIST SEXUALITY, V1
   FRANKLIN S, 1995, ANNU REV ANTHROPOL, V24, P163, DOI 10.1146/annurev.an.24.100195.001115
   Fujimura J. H., 2003, GENETIC NATURE CULTU, P176
   Fujimura JH, 1997, CRAFTING SCI SOCIOHI
   Galison P., 1997, IMAGE LOGIC MAT CULT
   Gallo MA., 2001, CASARETT DOULLS TOXI, P3
   GIESON G, 1995, PRIVATE SCI L PASTEU
   GINSBURG F, 1991, ANNU REV ANTHROPOL, V20, P311
   Haas E., 1990, KNOWLEDGE POWER 3 MO
   Haas P. M., 1990, SAVING MEDITERRANEAN
   Hayden Cori, 2003, WHEN NATURE GOES PUB
   Heath D, 1998, SCI TECHNOL HUM VAL, V23, P71, DOI 10.1177/016224399802300104
   HELMREICH S, 1998, SILICON SECOND NATUR
   Iannaccone PM, 2001, ENVIRON HEALTH PERSP, V109, pA8, DOI 10.1289/ehp.109-a8
   JACOB F, 1988, STATUE WITHIN
   Jacob F., 1982, POSSIBLE ACTUAL
   KAHN J, 2002, COLLIDING CATEGORIES
   Knorr-Cetina Karen, 1995, HDB SCI TECHNOLOGY S, P140
   Krimsky S., 2000, HORMONAL CHAOS SCI S
   Krupp F, 1999, COMMUNICATION
   LAOUR B, 1988, PASTEURIZATION FRANC
   LAOUR B, 1987, SCI ACTION FOLLOW SC
   Latour Bruno, 1979, LAB LIFE
   LEPKOWSKI W, 1984, CHEM ENG NEWS, V60, P19
   LOCK M, 1993, ANNU REV ANTHROPOL, V22, P133, DOI 10.1146/annurev.an.22.100193.001025
   London E, 2000, ENVIRON HEALTH PERSP, V108, P401, DOI 10.1289/ehp.00108s3401
   LONG J, 1985, CHEM ENG NEWS, V63, P16
   MARCUS G, 1998, CORPORATE FUTURES
   MARCUS G, ZEROING
   MARCUS G, 1999, PARANOIA WITHIN REAS
   MARCUS G, 1986, ANTHR CULTURAL CRITQ
   MARCUS GE, 1996, CONNECTED
   Marcus George E., 1995, TECHNOSCIENTIFIC IMA
   Markowitz G, 2002, DECEIT DENIAL DEADLY
   MARTIN E, 1993, FLEXIBLE BODIES TRAC
   Masco J, 2002, PUBLIC CULTURE, V14, P441, DOI 10.1215/08992363-14-3-441
   Rabinow P., 1996, MAKING PCR STORY BIO
   RAJAN KS, 2002, THESIS MIT
   Rapp R, 1999, TESTING WOMEN TESTIN
   Rheinberger H. J., 1998, INSCRIBING SCI SCI T, P285
   RHEINBERGER HJ, 1997, HISTORY EPISTEMIC TH
   Shapin S., 1985, LEVIATHAN AIR PUMP H
   Sharp RR, 2004, NAT REV GENET, V5, P311, DOI 10.1038/nrg1320
   SHIELDS A, 2005, AM PSYCHOL, V60
   SINCLAIR U, 1965, JUNGLE
   Smith LL, 2001, TRENDS PHARMACOL SCI, V22, P281, DOI 10.1016/S0165-6147(00)01714-4
   TAUSSIG KS, IN PRESS SCI CULTURE
   Tennant RW, 2002, ENVIRON HEALTH PERSP, V110, pA8, DOI 10.1289/ehp.110-a8
   THORTON J, 2000, PANDORAS POISON ORGA
   Traweek S., 1989, BEAMTIMES LIFETIMES
   Traweek Sharon, 2000, DOING SCI CULTURE, P21
   U. S. EPA, 1998, CHEM HAZ DAT AV STUD
   *US GEN ACC OFF, 2000, GAO01257 US GEN ACC
   *US NIH, 2003, CANCER ENV YOU NEED
   Varmus HE, 2000, J LAW MED ETHICS, V28, P46
   Wargo J., 1996, OUR CHILDRENS TOXIC
   Waters Michael, 2003, Environmental Health Perspectives, V111, P15
   WEBER M, 1958, SCI VOCATION
NR 82
TC 60
Z9 60
U1 1
U2 11
PU AMER ANTHROPOLOGICAL ASSOC
PI ARLINGTON
PA 4350 NORTH FAIRFAX DRIVE SUITE 640, ARLINGTON, VA 22203 USA
SN 0002-7294
J9 AM ANTHROPOL
JI Am. Anthropol.
PD MAR
PY 2005
VL 107
IS 1
BP 43
EP 54
DI 10.1525/aa.2005.107.1.043
PG 12
WC Anthropology
SC Anthropology
GA 910IC
UT WOS:000227923400005
DA 2018-10-19
ER

PT J
AU Barker, TH
   Framson, P
   Puolakkainen, PA
   Reed, M
   Funk, SE
   Sage, EH
AF Barker, TH
   Framson, P
   Puolakkainen, PA
   Reed, M
   Funk, SE
   Sage, EH
TI Matricellular homologs in the foreign body response - Hevin suppresses
   inflammation, but Hevin and SPARC together diminish angiogenesis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID EXTRACELLULAR-MATRIX; SECRETED PROTEIN; GIANT-CELLS; NULL MICE; SC1;
   EXPRESSION; CALCIUM; BINDING; GLYCOPROTEIN; INHIBITOR
AB Implanted foreign materials, used to restore or assist tissue function, elicit an initial acute inflammatory response followed by chronic fibrosis that leads to the entrapment of the biomaterial in a thick, poorly vascularized collagenous capsule. Matricellular proteins, secreted macromolecules that interact with extracellular matrix proteins but do not in themselves serve structural roles, have been identified as important mediators of the foreign body response that includes inflammation, angiogenesis, and collagen synthesis and assembly. In this report we delineate functions of hevin and SPARC, two homologs of the SPARC family of matricellular proteins, in the foreign body response. Despite their sequence similarity, hevin and SPARC mediate different aspects of this fibrotic response. Using mice with targeted gene deletions, we show that hevin is central to the progression of biomaterial-induced inflammation whereas SPARC regulates the formation of the collagenous capsule. Although vascular density within the capsule is unaltered in the absence of either protein, SPARC-hevin double-null capsules show substantially increased numbers of vessels, indicating compensatory functions for these two proteins in the inhibition of angiogenesis. These results provide important information for further development of implant technology.
C1 Benaroya Res Inst, Hope Heart Program, Seattle, WA 98101 USA.
   Univ Washington, Dept Med, Seattle, WA 98195 USA.
   Univ Helsinki, Cent Hosp, Dept Surg, FIN-00014 Helsinki, Finland.
RP Sage, EH (reprint author), Benaroya Res Inst, Hope Heart Program, Virginia Mason,1201 9th Ave, Seattle, WA 98101 USA.
EM hsage@benaroyaresearch.org
FU PHS HHS [R01 40711]
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Bonnet F, 1996, J BIOL CHEM, V271, P4373
   Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7
   BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503
   Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x
   Bradshaw AD, 2001, WOUND REPAIR REGEN, V9, P522, DOI 10.1046/j.1524-475x.2001.00522.x
   Brekken RA, 2004, J HISTOCHEM CYTOCHEM, V52, P735, DOI 10.1369/jhc.3A6245.2004
   Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091
   Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008
   Girard JP, 1996, J BIOL CHEM, V271, P4511
   GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7
   Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200
   Hohenester E, 1996, NAT STRUCT BIOL, V3, P67, DOI 10.1038/nsb0196-67
   JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557
   McKinnon PJ, 2000, MOL CELL BIOL, V20, P656, DOI 10.1128/MCB.20.2.656-660.2000
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   Mothe AJ, 2001, BRAIN RES, V892, P27, DOI 10.1016/S0006-8993(00)03141-3
   Mothe AJ, 2001, HEARING RES, V155, P161, DOI 10.1016/S0378-5955(01)00246-5
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Oritani K, 1997, BLOOD, V90, P3404
   Puolakkainen P, 2003, AM J PATHOL, V162, P627, DOI 10.1016/S0002-9440(10)63856-4
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   SAGE EH, 1991, J BIOL CHEM, V266, P14831
   SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341
   Soderling JA, 1997, J HISTOCHEM CYTOCHEM, V45, P823, DOI 10.1177/002215549704500607
   St Croix B, 2000, SCIENCE, V289, P1197
   Sullivan MM, 2004, INT J BIOCHEM CELL B, V36, P991, DOI 10.1016/j.biocel.2004.01.017
   Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Zho Q, 1991, J BIOMED MATER RES, V25, P177
NR 36
TC 40
Z9 41
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD MAR
PY 2005
VL 166
IS 3
BP 923
EP 933
DI 10.1016/S0002-9440(10)62312-7
PG 11
WC Pathology
SC Pathology
GA 901ND
UT WOS:000227288300028
PM 15743803
DA 2018-10-19
ER

PT J
AU Orive, G
   Carcaboso, AM
   Hernandez, RM
   Gascon, AR
   Pedraz, JL
AF Orive, G
   Carcaboso, AM
   Hernandez, RM
   Gascon, AR
   Pedraz, JL
TI Biocompatibility evaluation of different alginates and alginate-based
   microcapsules
SO BIOMACROMOLECULES
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; MANNURONIC ACID; PLL CAPSULES; SPECTROSCOPY;
   ASSAY
AB Biocompatibility of biomaterials and biomaterial-based medical devices is a critical issue for the long-term function on multiple therapeutic systems. In the past few years, there has been an increasing interest in producing more biocompatible biomaterials and in developing novel assays to analyze the quality of the products. In this study, a battery of in vitro techniques to assess the biocompatibility of alginates with different compositions and purities and alginate-based microcapsules is presented. Study of the protein and polyphenol content of the alginates revealed clear differences between the nonpurified and the purified alginates. A similar behavior was observed when the mitogenic activity and the tumor necrosis factor-alpha secretion induced by the alginates were assessed. Interestingly, when the latter two techniques were adapted to evaluate the different alginate microcapsules, a correlation with the results obtained for the alginate samples was observed. These results reinforce the idea of using the full battery of assays here reported to screen alginates and alginate-based microcapsules before implantation.
C1 Univ Basque Country, Fac Pharm, Lab Pharm & Pharmaceut Technol, Vitoria, Spain.
RP Pedraz, JL (reprint author), Univ Basque Country, Fac Pharm, Lab Pharm & Pharmaceut Technol, Vitoria, Spain.
EM knppemuj@vc.ehu.es
RI Hernandez, Rosa Maria/S-6332-2017
OI PEDRAZ MUNOZ, JOSE LUIS/0000-0002-3938-2267; Carcaboso,
   Angel/0000-0002-8485-426X; Hernandez, Rosa Maria/0000-0002-3947-409X
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922
   de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345
   DEVOS P, 1999, BIOMATERIALS, V18, P2273
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   Kulseng B, 1996, SCAND J IMMUNOL, V43, P335, DOI 10.1046/j.1365-3083.1996.d01-43.x
   Leinfelder U, 2003, BIOMATERIALS, V24, P4161, DOI 10.1016/S0142-9612(03)00299-0
   Orive G, 2003, TRENDS PHARMACOL SCI, V24, P207, DOI 10.1016/S0165-6147(03)0073-7
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   SKJAK-BRAEK G, 1989, Biotechnology and Bioengineering, V33, P90, DOI 10.1002/bit.260330112
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   TRACEY KJ, 1994, ANNU REV MED, V45, P491
   ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L
   Vacanti JP, 1999, LANCET, V354, pSI32
   van Hoogmoed CG, 2003, J BIOMED MATER RES A, V67A, P172, DOI 10.1002/jbm.a.10086
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   Zimmermann H, 2003, BIOMATERIALS, V24, P2083, DOI 10.1016/S0142-9612(02)00639-7
   ZIMMERMANN U, 1992, ELECTROPHORESIS, V13, P269, DOI 10.1002/elps.1150130156
NR 23
TC 66
Z9 66
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2005
VL 6
IS 2
BP 927
EP 931
DI 10.1021/bm049380x
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 907AT
UT WOS:000227687800054
PM 15762661
DA 2018-10-19
ER

PT J
AU Sanders, JE
   Lamont, SE
   Karchin, A
   Golledge, SL
   Ratner, BD
AF Sanders, JE
   Lamont, SE
   Karchin, A
   Golledge, SL
   Ratner, BD
TI Fibro-porous meshes made from polyurethane micro-fibers: effects of
   surface charge on tissue response
SO BIOMATERIALS
LA English
DT Article
DE polyurethane; fibrous tissue; blood flow; vessel ingrowth
ID CELL-ADHESION; ELECTROSTATIC INTERACTION; VASCULAR PROSTHESIS;
   THERMODYNAMIC MODEL; ENDOTHELIAL-CELLS; GROWTH; WETTABILITY; DEPOSITION;
   POLYMERS; DIAMETER
AB The purpose of this research was to evaluate the influence of surface charge on fibrous encapsulation, cell nuclei density, and vessel ingrowth into small-fiber, fibro-porous, biomaterial meshes. Meshes electrospun from polyurethane with mean fiber diameters of 5.8 mum and mean fiber spacing of 64.9 mum were plasma coated with films of different relative surface charge: Hexafluoropropylene (HF) (neutral), N,N-dimethylaminoethyl methacrylate (NN) (positive charge), and methacrylic acid (MA) (negative charge). Samples were implanted in rat subcutaneous dorsum for 5 weeks then fibrous capsule presence around the implants, cell nuclei density, and vessel number were assessed. Results showed that within the resolution of the histological analysis methods used, no implant experienced fibrous encapsulation. There was no significant difference between cell nuclei density and coating for the four groups: uncoated. HF-coated. NN-coated. and MA-coated. HF-coated and NN-coated samples had lower vessel numbers than uncoated samples (p = 0.055 and 0.032, respectively). MA-coated samples had vessel numbers not significantly different from uncoated polyurethane (slightly negatively charged) samples (p = 0.879). The results suggest that negatively charged surfaces may facilitate vessel ingrowth into fibro-porous mesh biomaterials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn, Bagley 461, Seattle, WA 98195 USA.
EM jsanders@u.washington.edu
FU NCRR NIH HHS [RR-01296]; NICHD NIH HHS [R01 HD038554, R01 HD038554-01,
   HD-38554]
CR ANDERSSON M, 1994, J BIOL CHEM, V269, P926
   Annis D, 1978, Trans Am Soc Artif Intern Organs, V24, P209
   Bet MR, 2003, BIOMATERIALS, V24, P131, DOI 10.1016/S0142-9612(02)00270-3
   Bowlin GL, 1997, CELL TRANSPLANT, V6, P631, DOI 10.1016/S0963-6897(97)00095-X
   CRISCUOLO GR, 1988, J NEUROSURG, V69, P254, DOI 10.3171/jns.1988.69.2.0254
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   DICOSMO F, 1989, COLLOID SURFACE, V42, P255
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   Hohman MM, 2001, PHYS FLUIDS, V13, P2221, DOI 10.1063/1.1384013
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   KLEINSOYER C, 1989, BIOMATERIALS, V10, P85, DOI 10.1016/0142-9612(89)90036-7
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   PARK JE, 1993, MOL BIOL CELL, V4, P1317
   Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Sanders JE, 2003, J BIOMED MATER RES A, V65A, P462, DOI 10.1002/jbm.a.10525
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   SANDERS JE, 2004, UNPUB J BIOMED MAT R
   SEYFERT S, 1995, BIOMATERIALS, V16, P201, DOI 10.1016/0142-9612(95)92118-P
   STEWART MG, 1989, COLLOID SURFACE, V42, P215
   SUGIMOTO Y, 1981, EXP CELL RES, V135, P39, DOI 10.1016/0014-4827(81)90297-4
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Wilson G J, 1993, ASAIO J, V39, pM526
NR 27
TC 43
Z9 44
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2005
VL 26
IS 7
BP 813
EP 818
DI 10.1016/j.biomaterials.2004.03.030
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 860DK
UT WOS:000224319300015
PM 15350787
DA 2018-10-19
ER

PT J
AU Tan, WJ
   Teo, GP
   Liao, K
   Leong, KW
   Mao, HQ
   Chan, V
AF Tan, WJ
   Teo, GP
   Liao, K
   Leong, KW
   Mao, HQ
   Chan, V
TI Adhesion contact dynamics of primary hepatocytes on poly(ethylene
   terephthalate) surface
SO BIOMATERIALS
LA English
DT Article
DE polyacrylic acid; biophysics; adhesion; kinetics
ID ATOMIC-FORCE MICROSCOPY; LIVER-TRANSPLANTATION; COLLAGEN; DENSITY;
   MUSCLE; CELLS; IMMOBILIZATION; MECHANICS; CULTURE; FILM
AB The design of bioartificial liver assist device requires an effective attachment of primary hepatocytes on polymeric biomaterials. A better understanding of this cell-surface interaction would aid the optimal choice of biomaterials. In this study, the adhesion contact dynamics of primary hepatocytes on poly(ethylene terephthalate) (PET) surface with grafted poly(acrylic acid) (PAA) and coated collagen is probed with confocal reflectance interference contrast microscopy (C-RICM) in conjunction with phase contrast microscopy. An increase of acrylic acid density from 0 to 12 nmole/cm(2) raises both the root-mean-square surface roughness and amount of adsorbed collagen of PET surface. C-RICM demonstrates that hepatocytes form tight adhesion contacts upon seeding on both plain PET and PAA-grafted PET (both with collagen coating) despite the insignificant two-dimensional cell spreading. At two hours after cell seeding, the normalized contact area and adhesion energy of hepatocytes on 12 nmole/cm(2) PAA-grafted-PET (with collagen coating) is 27% and 114% higher, respectively, than that on collagen coated plain PET. Interestingly, the growth kinetics of adhesion patch for hepatocyte on PAA-grafted PET with collagen coating is best fitted by Rproportional to(t0.5) and is significantly different from that on collagen coated plain PET, which is best fitted by Rproportional to(t0.25). Overall, this study demonstrates the modulation of biophysical response of adherent hepatocytes through the control of the biomaterial surface properties. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Nanyang Technol Univ, Div Chem & Biomol Engn, Mol Bioengn Lab, Nanosci & Nanotechnol Ctr, Singapore 639798, Singapore.
   Johns Hopkins Singapore Biomed Ctr, Singapore 117597, Singapore.
   Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
   Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
RP Chan, V (reprint author), Nanyang Technol Univ, Div Chem & Biomol Engn, Mol Bioengn Lab, Nanosci & Nanotechnol Ctr, Singapore 639798, Singapore.
EM mvchan@ntu.edu.sg
RI Chan, Vincent/G-6197-2010; Liao, Kin/A-7915-2014; Leong,
   Kam/A-7270-2009; Mao, Hai-Quan/A-3350-2010
OI Chan, Vincent/0000-0003-2149-4479; Liao, Kin/0000-0001-6352-2349; Leong,
   Kam/0000-0002-8133-4955; Mao, Hai-Quan/0000-0002-4262-9988
FU NCI NIH HHS [5P01CA79862-020003]
CR Barbani N, 1999, J APPL POLYM SCI, V72, P971, DOI 10.1002/(SICI)1097-4628(19990516)72:7<971::AID-APP13>3.0.CO;2-N
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   Chan V, 2002, LANGMUIR, V18, P3134, DOI 10.1021/la015684i
   de Gennes PG, 2003, LANGMUIR, V19, P7112, DOI 10.1021/la034421g
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3
   Gutsche AT, 1996, BIOMATERIALS, V17, P387, DOI 10.1016/0142-9612(96)85577-3
   Honore C, 2003, TRANSPLANT INT, V16, P692, DOI 10.1007/s00147-003-0605-3
   Ichai P, 2003, HEPATOLOGY, V38, P443, DOI 10.1053/jhep.2003.50327
   LOU HF, 2003, BIOMATERIALS, V24, P4893
   Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X
   Okabe Y, 1999, IEEE T ULTRASON FERR, V46, P1269, DOI 10.1109/58.796131
   Pierres A, 2003, BIOPHYS J, V84, P2058, DOI 10.1016/S0006-3495(03)75013-9
   Planchamp C, 2003, J PHARM PHARMACOL, V55, P1181, DOI 10.1211/0022357021963
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Torok E, 2001, CELLS TISSUES ORGANS, V169, P34, DOI 10.1159/000047858
   Uyama S, 2001, TRANSPLANTATION, V71, P1226, DOI 10.1097/00007890-200105150-00008
   Wan KT, 2001, MED BIOL ENG COMPUT, V39, P605, DOI 10.1007/BF02345154
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wu FJ, 1996, BIOTECHNOL BIOENG, V50, P404, DOI 10.1002/(SICI)1097-0290(19960520)50:4<404::AID-BIT7>3.0.CO;2-P
   Yin C, 2003, J BIOMED MATER RES A, V67A, P1093, DOI 10.1002/jbm.a.10033
   Yin C, 2003, BIOMATERIALS, V24, P837, DOI 10.1016/S0142-9612(02)00416-7
   Ying L, 2003, BIOMACROMOLECULES, V4, P157, DOI 10.1021/bm025676w
   Ying PQ, 2003, COLLOID SURFACE B, V32, P1, DOI 10.1016/S0927-7765(02)00133-9
   Zhang JY, 1996, SURF INTERFACE ANAL, V24, P718
NR 27
TC 19
Z9 20
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2005
VL 26
IS 8
BP 891
EP 898
DI 10.1016/j.biomaterials.2004.03.041
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 861UK
UT WOS:000224443900007
PM 15353200
DA 2018-10-19
ER

PT J
AU Ramamurthi, A
   Vesely, I
AF Ramamurthi, A
   Vesely, I
TI Evaluation of the matrix-synthesis potential of crosslinked hyaluronan
   gels for tissue engineering of aortic heart valves
SO BIOMATERIALS
LA English
DT Article
DE hylan; extracellular matrix; cell culture; hydrogel
ID SMOOTH-MUSCLE CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; ELASTIN; HYLAN;
   GLYCOSAMINOGLYCANS; COMPLICATIONS; BIOMATERIAL; COLLAGEN; CULTURES
AB Our goal is to fabricate continuous sheets of elastin atop non-biodegradable hydrogels (hylans) containing crosslinked hyaluronan, a glycosaminoglycan. Such elastin-hyaluronan composites may be useful to tissue engineer replacements for the glycosaminoglycan- and elastin-rich layers of the native aortic valve cusp. Neonatal rat aortic smooth muscle cells were cultured atop hylan gels with micro-textured surfaces, and on plastic, and the components of the extracellular matrix (collagen, elastin) were periodically analyzed.
   The hylan substrates induced the cells to proliferate more rapidly and over longer time periods (similar to4 weeks) relative to those cultured on plastic (2-3 weeks). Consequently, at all assay times, the amounts of elastin was derived from the hylan-based cell cultures was 25% or more than that derived from cells cultured on plastic. However, when elastin content was normalized to the cell DNA content, no significant differences were found in the two substrates beyond the first two weeks of culture. Conversely, at culture times greater than 2 weeks, cells cultured atop hylan gels produced amounts of collagen/nanogram of DNA that were similar to56% less than that synthesized by cells cultured on plastic. Cells grown on hylan deposited an unusual matrix layer, rich in elastin, at the hylan-cell interface. This elastin was found to be organized into fenestrated sheets and loose elastin fibers, structures that were also isolated from the elastin matrix of the ventricularis layer of porcine aortic valve cusps. We have thus demonstrated that hylan gels are useful as substrates to induce elastin synthesis in culture to obtain structures that resemble the elastin matrix of the native aortic valve. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA.
   Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Vesely, I (reprint author), Childrens Hosp Los Angeles, Saban Res Inst, MS 137, Los Angeles, CA 90027 USA.
EM ivesely@chla.usc.edu
FU PHS HHS [R01 070980]
CR Balazs E A, 1986, US patent, Patent No. [4582865, 4,582,865]
   BARONE LM, 1985, BIOCHIM BIOPHYS ACTA, V840, P245, DOI 10.1016/0304-4165(85)90125-4
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Croce MA, 2001, TISSUE CELL, V33, P326, DOI 10.1054/tice.2001.0180
   FORNIERI C, 1987, J CELL BIOL, V105, P1463, DOI 10.1083/jcb.105.3.1463
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Hinek A, 1996, EXP CELL RES, V225, P122, DOI 10.1006/excr.1996.0163
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   LARSEN NE, 1992, J ORTHOPAED RES, V10, P23, DOI 10.1002/jor.1100100104
   Larsen NE, 1995, MATER RES SOC SYMP P, V394, P149, DOI 10.1557/PROC-394-149
   MURATA K, 1981, J MOL CELL CARDIOL, V13, P281, DOI 10.1016/0022-2828(81)90316-3
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   OAKES BW, 1982, EUR J CELL BIOL, V27, P34
   PARKS WC, 1989, ELASTIN ELASTASES, V1, P213
   Pedagogos E, 2001, NEPHRON, V88, P347, DOI 10.1159/000046019
   PELLETIER JP, 1993, J RHEUMATOL, V20, P19
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   Ramamurthi A, 2003, J BIOMED MATER RES A, V66A, P317, DOI 10.1002/jbm.a.10588
   Scott MJ, 1996, J HEART VALVE DIS, V5, P464
   Shi YL, 2002, BIOMED SCI INSTRUM, V38, P35
   SILVER MD, 1987, HUM PATHOL, V18, P577, DOI 10.1016/S0046-8177(87)80357-X
   Simionescu DT, 2003, J HEART VALVE DIS, V12, P217
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Vesely I, 1998, J BIOMECH, V31, P115
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
NR 31
TC 75
Z9 82
U1 2
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2005
VL 26
IS 9
BP 999
EP 1010
DI 10.1016/j.biomaterials.2004.04.016
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 867ZS
UT WOS:000224882200006
PM 15369688
DA 2018-10-19
ER

PT J
AU Sommer, AP
   Rozlosnik, N
AF Sommer, AP
   Rozlosnik, N
TI Formation of crystalline ring patterns on extremely hydrophobic
   supersmooth substrates: Extension of ring formation paradigms
SO CRYSTAL GROWTH & DESIGN
LA English
DT Article
ID MODEL SIMULATION; DROPS; NANOSPHERES
AB The mechanism by which nanoparticles suspended in liquids self-organize on substrates to ring patterns has attracted much attention, because of a large body of possible practicable applications. Recent work demonstrated that, for example, gravity affects ring geometry, showing that the mechanism of ring formation is indeed not fully understood. Current models suppose that the pinning of the contact line between drops and substrates is a prerequisite for ring formation and that the process is induced either by surface irregularities of the substrate itself, or by self-pinning, triggered by the attachment of suspended material to the substrate. The latter mode was illustrated for drops of aqueous suspensions, evaporating on atomically flat hydrophilic substrates, e.g., freshly cleaved mica. Conversely, the crucial role of pinning on ring formation was derived from the observation that no rings were formed on smooth Teflon. Here WE! provide the first experimental evidence of the formation of rings on supersmooth hydrophobic surfaces lacking the known conditions required for particle immobilization. Results are suitable to extend existing models and are expected to be instrumental in the predictable design of cell-integrative crystalline ring patterns on biomaterial surfaces and the production of symmetrical ring patterns in proteomics, where the rings are particularly useful to study interaction scenarios between competing proteins.
C1 Univ Ulm, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
   Riso Natl Lab, Danish Polymer Ctr, DK-4000 Roskilde, Denmark.
RP Sommer, AP (reprint author), Univ Ulm, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
EM samoan@gmx.net
RI Rozlosnik, Noemi/A-3090-2012
CR Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756
   Deegan RD, 2000, PHYS REV E, V61, P475, DOI 10.1103/PhysRevE.61.475
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Rozlosnik N, 2003, LANGMUIR, V19, P1182, DOI 10.1021/la025906s
   Shmuylovich L, 2002, LANGMUIR, V18, P3441, DOI 10.1021/la011484v
   Sommer AP, 2004, J PHYS CHEM B, V108, P8, DOI 10.1021/jp0363747
   Sommer AP, 2005, CRYST GROWTH DES, V5, P21, DOI 10.1021/cg049812n
   Sommer AP, 2004, J PROTEOME RES, V3, P1086, DOI 10.1021/pr049935v
   Sommer AP, 2004, J PHYS CHEM B, V108, P8096, DOI 10.1021/jp0487049
   Sommer AP, 2003, NANO LETT, V3, P573, DOI 10.1021/nl0258269
   Sommer AP, 2002, J PROTEOME RES, V1, P111, DOI 10.1021/pr025501t
NR 11
TC 58
Z9 59
U1 1
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1528-7483
J9 CRYST GROWTH DES
JI Cryst. Growth Des.
PD MAR-APR
PY 2005
VL 5
IS 2
BP 551
EP 557
DI 10.1021/cg0496989
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 903GW
UT WOS:000227414900026
DA 2018-10-19
ER

PT J
AU Sommer, AP
AF Sommer, AP
TI Controlling arrangement of 60 nm nanospheres in evaporating sessile
   drops with low level laser light
SO CRYSTAL GROWTH & DESIGN
LA English
DT Article
ID FIELD OPTICAL ANALYSIS; WATER; SURFACES; FILMS
AB The interplay between liquid flow and surface interaction can arrange colloidal particles in drops evaporating on substrates into crystalline rings. Recently, it was reported that magnetic fields can affect the crystallinity in rings formed by suspensions containing paramagnetic particles. Here, it is demonstrated that laser light, applied at intensities as low as 1000 W m(-2), has a manifest impact on the attachment and self-organization of 60 nm particles on wet substrates. Results indicate that the physical state of water layers attached to substrates can be modulated by low level laser light even in an aqueous milieu, and imply the subaquatic persistence of an ordered interlayer formed by molecules with less degrees of freedom, as compared to those in the bulk liquid. Low level laser light has already been shown to change the height of nanoscopic water layers on substrates in air. Nanoscopic water layers are not only important in determining the arrangement of nanoparticles into two-dimensional crystals, they also control the lifetime of scanning near-field optical microscopy sensors, adhesion processes on biochips, nonspecific interactions at biomaterial/cell interfaces, charge transfer between ice crystals and graupel pellets in thunderclouds, and presumably the attachment of nanobacteria and proteins to tissues in blood. Modalities by which laser light and nanoscopic water layers cooperatively control the attachment of nanoparticles to substrates are illustrated in representative scenarios. Results could be converted into various practical applications, especially in nanotechnology and biomedicine, and unlock a novel and promising field of research.
C1 Univ Ulm, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
RP Sommer, AP (reprint author), Univ Ulm, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
EM samoan@gmx.net
CR Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Doppenschmidt A, 2000, LANGMUIR, V16, P6709, DOI 10.1021/la990799w
   Freund J, 1999, MICROSC RES TECHNIQ, V44, P327, DOI 10.1002/(SICI)1097-0029(19990301)44:5<327::AID-JEMT3>3.0.CO;2-E
   Helseth LE, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.042601
   KUHN H, 1970, J CHEM PHYS, V53, P101, DOI 10.1063/1.1673749
   Nelson J, 2003, ATMOS CHEM PHYS, V3, P1237, DOI 10.5194/acp-3-1237-2003
   Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514
   Shmuylovich L, 2002, LANGMUIR, V18, P3441, DOI 10.1021/la011484v
   Sommer AP, 2004, J PHYS CHEM B, V108, P8, DOI 10.1021/jp0363747
   Sommer AP, 2004, J PROTEOME RES, V3, P670, DOI 10.1021/pr049978b
   Sommer AP, 2004, J PHYS CHEM B, V108, P8096, DOI 10.1021/jp0487049
   Sommer AP, 2003, NANO LETT, V3, P573, DOI 10.1021/nl0258269
   Sommer AP, 2003, NANO LETT, V3, P321, DOI 10.1021/nl025940r
   Sommer AP, 2003, NANO LETT, V3, P19, DOI 10.1021/nl025839m
   Sommer AP, 2002, J PROTEOME RES, V1, P475, DOI 10.1021/pr0255396
   Sommer AP, 2002, J PROTEOME RES, V1, P111, DOI 10.1021/pr025501t
   Sommer AP, 2002, MICRON, V33, P227, DOI 10.1016/S0968-4328(01)00021-X
   Sommer AP, 2001, ATMOS RES, V58, P129, DOI 10.1016/S0169-8095(01)00086-2
   Sommer AP, 2001, J CLIN LASER MED SUR, V19, P29, DOI 10.1089/104454701750066910
   SOMMER AP, IN PRESS J PROTEOME
   SOMMER AP, 2002, P 2 INT C NEAR FIELD, P78
NR 22
TC 5
Z9 5
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1528-7483
J9 CRYST GROWTH DES
JI Cryst. Growth Des.
PD MAR-APR
PY 2005
VL 5
IS 2
BP 559
EP 563
DI 10.1021/cg049805z
PG 5
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 903GW
UT WOS:000227414900027
DA 2018-10-19
ER

PT J
AU Tjandra, JJ
   Lim, JF
   Hiscock, R
AF Tjandra, JJ
   Lim, JF
   Hiscock, R
TI Benefits of injectable silicone biomaterial for fecal incontinence due
   to internal sphincter dysfunction is sustained at 12 months - a
   randomized trial
SO DISEASES OF THE COLON & RECTUM
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY APR 30-MAY 05, 2005
CL Philadelphia, PA
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD MAR
PY 2005
VL 48
IS 3
BP 633
EP 633
PG 1
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 913ID
UT WOS:000228144000096
DA 2018-10-19
ER

PT J
AU Parsons, C
   Jones, DS
   Gorman, SP
AF Parsons, C
   Jones, DS
   Gorman, SP
TI The intraocular lens: challenges in the prevention and therapy of
   infectious endophthalmitis and posterior capsular opacification
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE cataract; infectious endophthalmitis; intraocular lens; polymers;
   posterior capsular opacification; prophylaxis; therapy
ID SCANNING-ELECTRON-MICROSCOPY; CATARACT-SURGERY;
   STAPHYLOCOCCUS-EPIDERMIDIS; IN-VITRO; BACTERIAL ENDOPHTHALMITIS;
   PHOTODYNAMIC THERAPY; CLINICAL-OUTCOMES; EPITHELIAL-CELLS; RABBIT EYES;
   ICA LOCUS
AB Cataract Is the leading cause of visual Impairment worldwide. In the UK, some 30% of the population over 65 years of age have visually Impairing cataract. Importantly, 88% of those with treatable visual impairment from cataract are not In contact with any ocular healthcare service, representing a major potential healthcare need (1). In the USA, It has been estimated that 17.2% of the population (approximately 20.5 million) over 40 years of age have cataract in either eye and by 2020, this number is expected to rise to 30.1 million. Currently, cataract Is responsible for 60% of Medicare costs associated with vision (2). Furthermore, as the populations of Industrialized countries such as the UK and the USA continue to age, the costs associated with treatment of cataract can only be expected to increase. Consequently, the development of the intraocular lens to replace the cataractous lens and the advances in Intraocular lens design and implantation represent a major development in cataract treatment. However, despite such advances, cataract surgery is not without complications, such as postoperative infectious endophthalmitis, a rare but potentially devastating condition, and posterior capsular opacification, a less serious but much more common problem. This review will examine the epidemiology of cataracts, the polymeric construction of Intraocular lenses implanted during cataract surgery and the complications of postoperative infectious endophthalmitis and posterior capsular opacification with regard to therapeutic interventions and prophylactic strategies. Advances in biomaterial design and function will be discussed as novel approaches to prevent such postoperative complications.
C1 Queens Univ Belfast, Med Devices Grp, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
RP Gorman, SP (reprint author), Queens Univ Belfast, Med Devices Grp, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM c.parsons@qub.ac.uk; d.jones@qub.ac.uk; s.gorman@qub.ac.uk
CR Aslam TM, 2003, SURV OPHTHALMOL, V48, P594, DOI 10.1016/j.survophthal.2003.08.002
   BANKES K, 1999, CLIN OPHTHALMOLOGY T, P73
   BEHARCOHEN FF, 1995, INVEST OPHTH VIS SCI, V36, P2434
   BEHARCOHEN FF, 1995, INVEST OPHTH VIS SCI, V36, P2425
   Benz MS, 2004, AM J OPHTHALMOL, V137, P38, DOI 10.1016/S0002-9394(03)00896-1
   Bohigian GM, 1999, OPHTHALMIC SURG LAS, V30, P295
   Callegan MC, 2002, CLIN MICROBIOL REV, V15, P111, DOI 10.1128/CMR.15.1.111-124.2002
   Chisari G, 2004, INT J CLIN PHARM TH, V42, P35
   Ciulla TA, 2002, OPHTHALMOLOGY, V109, P13, DOI 10.1016/S0161-6420(01)00899-5
   Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487
   Desai P, 1999, BRIT J OPHTHALMOL, V83, P1336, DOI 10.1136/bjo.83.12.1336
   Duncan G, 1997, NAT MED, V3, P1026, DOI 10.1038/nm0997-1026
   ELDER MJ, 1995, EYE, V9, P102, DOI 10.1038/eye.1995.16
   GANONG WF, 2001, REV MED PHYSL, P144
   Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1
   Garcia-Saenz MC, 2001, J CATARACT REFR SURG, V27, P1969, DOI 10.1016/S0886-3350(01)00997-X
   Gorman SP, 2001, BIOMATERIALS, V22, P2741, DOI 10.1016/S0142-9612(01)00017-5
   Gorman SP, 1991, MECH ACTION CHEM BIO, P271
   Han DP, 1996, AM J OPHTHALMOL, V122, P1
   Hariprasad SM, 2003, ARCH OPHTHALMOL-CHIC, V121, P345, DOI 10.1001/archopht.121.3.345
   Hollick EJ, 2000, AM J OPHTHALMOL, V129, P577, DOI 10.1016/S0002-9394(99)00447-X
   Inan UU, 2001, GRAEF ARCH CLIN EXP, V239, P693, DOI 10.1007/s004170100329
   Ishida I, 2001, GRAEF ARCH CLIN EXP, V239, P770, DOI 10.1007/s004170100336
   Jett BD, 1997, ZBL BAKT-INT J MED M, V285, P341
   Johnson MW, 1997, OPHTHALMOLOGY, V104, P261, DOI 10.1016/S0161-6420(97)30326-1
   Kim JT, 2002, EXP EYE RES, V74, P585, DOI 10.1006/exer.2001.1150
   KNORZ MC, 1993, J CATARACT REFR SURG, V19, P766, DOI 10.1016/S0886-3350(13)80347-1
   Kodjikian L, 2002, INVEST OPHTH VIS SCI, V43, P3717
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4382, DOI 10.1167/iovs-03-0185
   Koh HJ, 2002, OPHTHALMIC RES, V34, P107, DOI 10.1159/000063652
   Kohnen T, 1996, J CATARACT REFR SURG, V22, P1255, DOI 10.1016/S0886-3350(96)80079-4
   Kowalski RP, 2004, AM J OPHTHALMOL, V138, P33, DOI 10.1016/j.ajo.2004.02.051
   Kresloff MS, 1998, SURV OPHTHALMOL, V43, P193, DOI 10.1016/S0039-6257(98)00036-8
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Maloof A, 2003, J CATARACT REFR SURG, V29, P1566, DOI 10.1016/S0886-3350(03)00058-0
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   MEACOCK WR, 2002, INVEST OPHTH VIS SCI, V43, P429
   Montan PG, 2002, J CATARACT REFR SURG, V28, P977, DOI 10.1016/S0886-3350(01)01269-X
   MORK P, 1987, ACTA OPHTHALMOL, V65, P572
   NEWELL FW, 1996, OPHTHALMOLOGY PRINCI, P365
   Ng EWM, 1998, AM J OPHTHALMOL, V126, P278, DOI 10.1016/S0002-9394(98)00157-3
   Olson RJ, 2003, AM J OPHTHALMOL, V136, P146, DOI 10.1016/S0002-9394(03)00226-5
   Olson RJ, 2004, SURV OPHTHALMOL, V49, P55
   Pandey SK, 2002, J CATARACT REFR SURG, V28, P139, DOI 10.1016/S0886-3350(01)01069-0
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   Pinna A, 2000, OPHTHALMOLOGY, V107, P2162, DOI 10.1016/S0161-6420(00)00408-5
   POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P239, DOI 10.1001/archopht.1994.01090140115033
   Prosdocimo G, 2003, J CATARACT REFR SURG, V29, P1551, DOI 10.1016/S0886-3350(02)02051-5
   Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5
   Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004
   Scaramuzza A, 2001, J CATARACT REFR SURG, V27, P1047, DOI 10.1016/S0886-3350(00)00829-4
   Schauersberger J, 2003, J CATARACT REFR SURG, V29, P361, DOI 10.1016/S0886-3350(02)01741-8
   Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3
   SCHEIN OD, 1994, OPHTHALMOLOGY, V101, P1142
   Schmitz S, 1999, OPHTHALMOLOGY, V106, P1869, DOI 10.1016/S0161-6420(99)90395-0
   Seward H, 2004, EYE, V18, P555, DOI 10.1038/sj.eye.6700648
   Seward HC, 1997, BRIT J OPHTHALMOL, V81, P340, DOI 10.1136/bjo.81.5.340
   SPEAKER MG, 1991, OPHTHALMOLOGY, V98, P1769
   SunaricMegevand G, 1997, BRIT J OPHTHALMOL, V81, P1006, DOI 10.1136/bjo.81.11.1006
   Takahashi H, 2004, J CATARACT REFR SURG, V30, P1773, DOI 10.1016/j.jcrs.2004.02.023
   Tassignon MJBR, 2002, J CATARACT REFR SURG, V28, P1182, DOI 10.1016/S0886-3350(02)01375-5
   van Tenten Y, 2002, OPHTHALMIC RES, V34, P113, DOI 10.1159/000063653
   Van Tenten Y, 2001, EXP EYE RES, V72, P41, DOI 10.1006/exer.2000.0924
   Werner L, 2004, J CATARACT REFR SURG, V30, P1114, DOI 10.1016/j.jcrs.2003.09.044
   Werner L, 2003, PHACOEMULSIFICATION, P435
   Werner Liliana, 2004, Ophthalmol Clin North Am, V17, P233, DOI 10.1016/j.ohc.2004.02.002
   Wisniewski SR, 2000, OPHTHALMOLOGY, V107, P1274, DOI 10.1016/S0161-6420(00)00165-2
   Woodcock M, 2004, BRIT MED J, V328, P92, DOI 10.1136/bmj.328.7431.92
NR 69
TC 16
Z9 16
U1 0
U2 7
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD MAR
PY 2005
VL 2
IS 2
BP 161
EP 173
DI 10.1586/17434440.2.2.161
PG 13
WC Engineering, Biomedical
SC Engineering
GA 019KQ
UT WOS:000235834400012
PM 16293053
DA 2018-10-19
ER

PT J
AU Delanoy, G
   Li, Q
   Yu, J
AF Delanoy, G
   Li, Q
   Yu, J
TI Activity and stability of laccase in conjugation with chitosan
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE chitosan; pH-sensitive biomaterials; protein conjugation; laccase assay;
   enzyme immobilization
ID CHITIN
AB Laccase is one of a few enzymes that can directly reduce oxygen into water under ambient conditions, while oxidizing a variety of aromatic compounds. Its conjugation with chitosan gene I rates a pH-sensitive functional biomaterial that changes its solubility in response to pH variation. The molecular conjugation between lac I case and chitosan of different molecular mass was investigated with a carbodiimide reaction to understand the mechanism of the enzyme's activity loss during conjugation. With 81-93% laccase being conjugated, a moderate activity loss (16-28% less than the initial activity) was observed in conjugation solution. A second severe activity loss (63-78% less than the conjugated activity) occurred during a cycle of phase change consisting of precipitation, centrifugation and re-dissolution of the enzyme-chitosan conjugates. The chitosan molecular size has little effect on the first moderate activity loss in the conjugation reaction, but visible effect on the substantial activity loss associated with phase change. Small chitosan molecules gave high residual activity. The conjugated laccase exhibited a high stability in the following repeated phase changes and had the same temperature and pH profile as those of free laccase. Compared to free laccase, the conjugated laccase had a similar affinity (K.), but reduced turnover (kc,) that was adversely affected with increase of molecular mass of chitosan. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Hawaii Manoa, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA.
   Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.
RP Yu, J (reprint author), Univ Hawaii Manoa, Hawaii Nat Energy Inst, 1680 EW Rd, Honolulu, HI 96822 USA.
EM jianyu@hawaii.edu
RI Yu, Jian/C-9224-2016
OI Yu, Jian/0000-0001-8446-5494
CR Antorini M, 2002, BBA-PROTEIN STRUCT M, V1594, P109, DOI 10.1016/S0167-4838(01)00289-8
   Bernkop-Schnurch A, 1999, PHARMAZIE, V54, P369
   Berth G, 1998, CARBOHYD POLYM, V36, P205, DOI 10.1016/S0144-8617(98)00029-0
   CANTARELLI C, 1989, FOOD BIOTECHNOL, V3, P203, DOI 10.1080/08905438909549709
   Chang KLB, 1997, CARBOHYD RES, V303, P327, DOI 10.1016/S0008-6215(97)00179-1
   Chen TH, 2001, BIOMACROMOLECULES, V2, P456, DOI 10.1021/bm000125w
   GARDIOL AE, 1991, ENZYME MICROB TECHNO, V13, P473
   Gianfreda L, 1999, BIOREMEDIAT J, V3, P1, DOI DOI 10.1080/10889869991219163
   Guzman J, 2003, INT J BIOL MACROMOL, V33, P57, DOI 10.1016/S0141-8130(03)00067-9
   Hermanson G. T., 1992, IMMOBILIZED AFFINITY
   Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X
   Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5
   LLLUM L, 1994, PHARM RES, V11, P1186
   MAYER AM, 2002, PHYTOCHEMISTRY, V60, P51
   Rege PR, 1999, CARBOHYD RES, V321, P235, DOI 10.1016/S0008-6215(99)00172-X
   Ruiz AI, 2000, BIOTECHNOL LETT, V22, P229, DOI 10.1023/A:1005698301681
   Siso MIG, 1997, PROCESS BIOCHEM, V32, P211
   Song Y, 2002, FOOD RES INT, V35, P459, DOI 10.1016/S0963-9969(01)00144-2
   THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19
   Vazquez-Duhalt R, 2001, BIOCONJUGATE CHEM, V12, P301, DOI 10.1021/bc000095u
   Wong YX, 1999, WATER RES, V33, P3512, DOI 10.1016/S0043-1354(99)00066-4
NR 21
TC 33
Z9 38
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR
PY 2005
VL 35
IS 1-2
BP 89
EP 95
DI 10.1016/j.ijbiomac.2005.01.003
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 912RJ
UT WOS:000228096800013
PM 15769520
DA 2018-10-19
ER

PT J
AU Rose, SL
   Babensee, JE
AF Rose, SL
   Babensee, JE
TI Procoagulant phenotype of endothelial cells after coculture with
   biomaterial-treated blood cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; human umbilical vein endothelial cells (HUVECs);
   leukocytes; platelets; procoagulant
ID ACTIVATED POLYMORPHONUCLEAR LEUKOCYTES; TUMOR-NECROSIS-FACTOR; ADHESION
   MOLECULES; IN-VITRO; PLASMINOGEN-ACTIVATOR; VASCULAR GRAFTS; TISSUE
   FACTOR; EXPRESSION; MICROPARTICLES; COAGULATION
AB Understanding endothelial cell (EC)/blood/biomaterial interactions is crucial for the advancement of cardiovascular devices that often fail because of the lack of nonthrombogenic biomaterials. To begin to assess these interactions, a static EC/blood cell/biomaterial model was used. Isolated blood cells were pretreated with model biomaterial beads with different surface chemistries: polystyrene (PS), and PS beads grafted with 3-kDa polyethylene glycol (PEG) with either a hydroxyl (PS-PEG-OH) or amine (PS-PEG-NH2) terminal group at 5.4 or 54 X 10(4) beads/mL. Biomaterial-treated monocytes, neutrophils, or platelets were applied to human umbilical vein ECs (HUVECs) for 5 or 24 h of static coculture, and the resultant procoagulant HUVEC phenotype was characterized using several methods. Flow cytometry was used to assess surface expression of tissue factor (TF), adenosine triphosphate diphosphohydrolase, phosphatidylserine, and thrombomodulin, a functional TF assay was used to assess TF activity, and a plasma recalcification assay examined clotting times on HUVECs. Static coculture of HUVEC with biomaterial-treated neutrophils induced a procoagulant phenotype as exemplified by upregulation of TF expression and total functional activity, and downregulation of adenosine triphosphate diphosphohydrolase and thrombomodulin expression. The plasma recalcification assay demonstrated that HUVECs cocultured with biomaterial-treated monocytes significantly shortened clotting times, with some effect of similarly treated neutrophils. (C) 2005 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia-babensee@bme.gatech.edu
CR Bos GW, 1999, THROMB HAEMOSTASIS, V82, P1757
   Chung JH, 1996, CIRCULATION, V93, P2014, DOI 10.1161/01.CIR.93.11.2014
   COLE EH, 1985, TRANSPLANTATION, V40, P363, DOI 10.1097/00007890-198510000-00005
   Ding ZM, 1999, J IMMUNOL, V163, P5029
   ESMON CT, 1982, J BIOL CHEM, V257, P7944
   Forlow SB, 2000, BLOOD, V95, P1317
   Fujimi S, 2003, J TRAUMA, V54, P114, DOI 10.1097/01.TA.0000046317.49507.F2
   Fujimi S, 2002, J TRAUMA, V52, P443, DOI 10.1097/00005373-200203000-00005
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P176, DOI 10.1002/(SICI)1097-4636(199711)37:2<176::AID-JBM5>3.3.CO;2-Z
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   HERRING M, 1978, SURGERY, V84, P498
   Hess C, 1999, J IMMUNOL, V163, P4564
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217
   Imbert E, 2001, J BIOMED MATER RES, V56, P376, DOI 10.1002/1097-4636(20010905)56:3<376::AID-JBM1106>3.0.CO;2-R
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lester EA, 2003, J BIOMED MATER RES A, V64A, P397, DOI 10.1002/jbm.a.10378
   LORENZET R, 1998, BLOOD COAGUL FIBRI S, V9, P49
   MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1
   Macnair R, 1998, P I MECH ENG H, V212, P465, DOI 10.1243/0954411981534222
   McMillan R, 2001, J BIOMED MATER RES, V54, P272, DOI 10.1002/1097-4636(200102)54:2<272::AID-JBM15>3.0.CO;2-3
   Mesri C, 1998, J IMMUNOL, V161, P4382
   NAWROTH PP, 1986, J EXP MED, V163, P740, DOI 10.1084/jem.163.3.740
   Pu FR, 2002, BIOMATERIALS, V23, P4705, DOI 10.1016/S0142-9612(02)00219-3
   RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111
   Remy M, 1999, BIOMATERIALS, V20, P241, DOI 10.1016/S0142-9612(98)00167-7
   Remy-Zolghadri M, 2004, J VASC SURG, V39, P613, DOI 10.1016/j.jvs.2003.08.007
   Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153
   RUJINI S, 2003, J TRAUMA, V54, P114
   SATTA N, 1994, J IMMUNOL, V153, P3245
   SCARPATI EM, 1989, J BIOL CHEM, V264, P20705
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   Sipehia R, 2001, J CARDIOVASC SURG, V42, P537
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   van der Zijpp YJT, 2003, J BIOMED MATER RES A, V65A, P51, DOI 10.1002/jbm.a.10327
   Wettero J, 2003, BIOMATERIALS, V24, P1559, DOI 10.1016/S0142-9612(02)00543-4
NR 38
TC 12
Z9 12
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2005
VL 72A
IS 3
BP 269
EP 278
DI 10.1002/jbm.a.30222
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 900OC
UT WOS:000227223200004
PM 15657946
DA 2018-10-19
ER

PT J
AU Nilsson, A
   Liljensten, E
   Bergstrom, C
   Sollerman, C
AF Nilsson, A
   Liljensten, E
   Bergstrom, C
   Sollerman, C
TI Results from a degradable TMC joint Spacer (Artelon) compared with
   tendon arthroplasty
SO JOURNAL OF HAND SURGERY-AMERICAN VOLUME
LA English
DT Article
DE CMC-I; degradable biomaterial; implant; OA; TMC
ID THUMB CARPOMETACARPAL OSTEOARTHRITIS; LONG-TERM EVALUATION;
   INTERPOSITION ARTHROPLASTY; TRAPEZIOMETACARPAL JOINT; LIGAMENT
   RECONSTRUCTION; IMPLANT ARTHROPLASTY; SURGICAL-MANAGEMENT; FOLLOW-UP;
   GORE-TEX; ARTHRODESIS
AB Purpose: A new spacer for the trapeziometacarpal joint (TMC) based on a biological and tissue-preserving concept for the treatment of TMC osteoarthritis (OA) has been evaluated. The purpose was to combine a spacing effect with stabilization of the TMC joint.
   Methods: Artelon (Artimplant AB, Sweden) TMC Spacer is synthesized of a degradable polyurethaneurea (Artelon), which has been shown to be biocompatible over time and currently is used in ligament augmentation procedures. Fibers of the polymer were woven into a T-shaped device in which the vertical portion separates the bone edges of the TMC joint and the horizontal portion stabilizes the joint. Fifteen patients with disabling pain and isolated TMC OA were included in the study. Ten patients received the spacer device and the remaining 5 (control group) were treated with a trapezium resection arthroplasty with abductor pollicis longus (APL) stabilization. The median ages of the 2 groups were 60 and 59 years, respectively. Pain, strength, stability, and range of motion were measured before and after surgery. Radiographic examination was performed in all patients before and after surgery. At follow-up evaluation 3 years after surgery an unbiased observer evaluated all patients. Biopsy specimens were obtained from 1 patient 6 months after surgery.
   Results: All patients were stable clinically without signs of synovitis. In both groups all patients were pain free. The median values for both key pinch and tripod pinch increased compared with before surgery in the spacer group but not in the APL group. The biopsy examinations showed incorporation of the device in the surface of the adjacent bone and the surrounding connective tissue. No signs of foreign-body reaction were seen.
   Conclusions: This study showed significantly better pinch strength after Artelon TMC Spacer implantation into the TMC joint compared with APL arthroplasty. Copyright (c) 2005 by the American Society for Surgery of the Hand.
C1 Sahlgrenska Univ Hosp, Dept Hand Surg, Sahlgrenska, Sweden.
   Artimplant AB, Gothenburg, Sweden.
RP Nilsson, A (reprint author), Univ Gothenburg, Sahlgrenska Hosp, Dept Hand Surg, S-41319 Gothenburg, Sweden.
CR AMADIO P C, 1990, Annales de Chirurgie de la Main et du Membre Superieur, V9, P358, DOI 10.1016/S0753-9053(05)80509-5
   Belcher HJCR, 2001, J HAND SURG-BRIT EUR, V26, P159, DOI 10.1054/jhsb.2001.0554
   Bezwada HP, 2002, J HAND SURG-AM, V27A, P409, DOI 10.1053/jhsu.2002.31733
   BURTON RI, 1986, J HAND SURG-AM, V11A, P324, DOI 10.1016/S0363-5023(86)80137-X
   COONEY WP, 1987, CLIN ORTHOP RELAT R, P35
   CREIGHTON JJ, 1991, J HAND SURG-AM, V16A, P510, DOI 10.1016/0363-5023(91)90024-6
   Dell P C, 1978, J Hand Surg Am, V3, P243
   Downing ND, 2001, J HAND SURG-AM, V26A, P862, DOI 10.1053/jhsu.2001.27761
   EATON RG, 1987, HAND CLIN, V3, P455
   Forseth MJ, 2003, J HAND SURG-AM, V28A, P342, DOI 10.1053/jhsu.2003.50042
   FROIMSON AI, 1987, HAND CLIN, V3, P489
   GERVIS WH, 1949, J BONE JOINT SURG BR, V31, P537
   Gibbons CER, 1999, INT ORTHOP, V23, P216, DOI 10.1007/s002640050354
   Gisselfalt K, 2002, BIOMACROMOLECULES, V3, P951, DOI 10.1021/bm025535u
   Greenberg JA, 1997, J HAND SURG-AM, V22, P658, DOI 10.1016/S0363-5023(97)80125-6
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Hartigan BJ, 2001, J BONE JOINT SURG AM, V83A, P1470, DOI 10.2106/00004623-200110000-00002
   Ishida O, 2000, SCAND J PLAST RECONS, V34, P245
   IYER KM, 1981, HAND, V13, P246, DOI 10.1016/S0072-968X(81)80004-6
   IYER KM, 1981, HAND, V13, P251, DOI 10.1016/S0072-968X(81)80005-8
   KARLSSON MK, 1992, SCAND J PLAST RECONS, V26, P101, DOI 10.3109/02844319209035191
   Kuschner S H, 1996, Am J Orthop (Belle Mead NJ), V25, P91
   Liljensten E, 2002, J MATER SCI-MATER M, V13, P351, DOI 10.1023/A:1014380332762
   Muermans S, 1998, J HAND SURG-BRIT EUR, V23B, P64, DOI 10.1016/S0266-7681(98)80222-2
   Mureau MAM, 2001, J HAND SURG-AM, V26A, P869, DOI 10.1053/jhsu.2001.26659
   PELLEGRINI VD, 1986, J HAND SURG-AM, V11A, P309, DOI 10.1016/S0363-5023(86)80136-8
   Perez-Ubeda MJ, 2003, J HAND SURG-AM, V28A, P917, DOI 10.1016/S0363-5023(03)00378-2
   SIGFUSSON R, 1991, SCAND J PLAST RECONS, V25, P73, DOI 10.3109/02844319109034926
   SOLLERMAN C, 1995, SCAND J PLAST RECONS, V29, P167, DOI 10.3109/02844319509034334
   SOLLERMAN C, 1993, SCAND J PLAST RECONS, V27, P217, DOI 10.3109/02844319309078114
   SWANSON AB, 1981, J HAND SURG-AM, V6, P125, DOI 10.1016/S0363-5023(81)80165-7
   THOMSEN P, 2001, BONE ENG, P117
   TOMAINO MM, 1995, J BONE JOINT SURG AM, V77, P345
   WEILBY A, 1988, J HAND SURG-BRIT EUR, V13B, P421, DOI 10.1016/0266-7681(88)90171-4
   Wolock B S, 1989, J Arthroplasty, V4, P65, DOI 10.1016/S0883-5403(89)80055-5
NR 35
TC 62
Z9 63
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0363-5023
J9 J HAND SURG-AM
JI J. Hand Surg.-Am. Vol.
PD MAR
PY 2005
VL 30A
IS 2
BP 380
EP 389
DI 10.1016/j.jhsa.2004.12.001
PG 10
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 908XY
UT WOS:000227824700022
PM 15781363
DA 2018-10-19
ER

PT J
AU Goncalves, AC
   Griffiths, LG
   Anthony, RV
   Orton, EC
AF Goncalves, AC
   Griffiths, LG
   Anthony, RV
   Orton, EC
TI Decellularization of bovine pericardium for tissue-engineering by
   targeted removal of xenoantigens
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article; Proceedings Paper
CT 76th Annual Scientific Session of the American-Heart-Association
CY NOV 07-12, 2003
CL ORLANDO, FL
SP Amer Heart Assoc
ID TRILEAFLET HEART-VALVES; IN-VITRO; XENOTRANSPLANTATION; CYTOTOXICITY;
   BIOMATERIAL; EXTRACTION; LEAFLETS; CONDUITS
AB Background and aim of study: Assessment of decellularization of xenogeneic biological scaffolds for tissue engineering has relied primarily on histological cellularity, though this may not ensure the removal of known xenogeneic antigens such as galactose-alpha 1,3-galactose (alpha-gal) and MHC I.
   Methods: Bovine pericardium (BP) underwent standard (Std) decellularization consisting of hypotonic lysis and treatment with DNAse/RNAse. In addition to Std decellularization, tissues were treated for 24 h with either 0.5% Triton X-100, 0.5% sodium deoxycholate (SD), 0.1% sodium dodecyl sulfate (SDS), alpha-galactosidase (5 U/ml) or phospholipase (PL) A(2) (150 U/ml). Tissues underwent a 96-h washout under gentle agitation at 27 degrees C, and then evaluated by light microscopy for % cellularity, and by immunohistochemistry and Western blot for alpha-gal, bovine MHC I and smooth muscle alpha-actin.
   Results: Standard treatment of BP resulted in only partial removal histological cellularity and persistence of alpha-gal, MHC I and alpha-actin. Adding SD treatment resulted in apparent acellularity, but persistence of xenogeneic antigens. Only the addition of SDS resulted in complete histological acellularity and removal of xenogeneic antigens. Treatment with a-galactosidase selectively removed alpha-gal from BP.
   Conclusion: Histological cellularity is not an adequate end-point for assuring removal of antigenicity from xenogeneic biological scaffolds. However, known xenogeneic antigens can be targeted for removal by novel decellularization treatments such as alpha-galactosidase.
C1 Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
   Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.
RP Orton, EC (reprint author), Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
EM corton@colostate.edu
CR AUGUSTIN C, 1995, CELL BIOL TOXICOL, V11, P167, DOI 10.1007/BF00756519
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Cebotari S, 2002, CIRCULATION S1, V106, pI63
   COURTMAN DW, 1995, J BIOMED MATER RES, V29, P1507, DOI 10.1002/jbm.820291207
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Dohmen PM, 2002, ANN THORAC SURG, V74, P1438, DOI 10.1016/S0003-4975(02)03881-X
   Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P87
   Elkins RC, 2002, ANN THORAC SURG, V74, P1434, DOI 10.1016/S0003-4975(02)04351-5
   GALILI U, 1988, J BIOL CHEM, V263, P17755
   GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519
   Goldstein S, 2000, ANN THORAC SURG, V70, P1962, DOI 10.1016/S0003-4975(00)01812-9
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2002, CIRCULATION S1, V106
   Igaz Peter, 2001, Yale Journal of Biology and Medicine, V74, P329
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   Mayer JE, 2001, J THORAC CARDIOV SUR, V122, P8, DOI 10.1067/mtc.2001.115926
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   O'Brien JG, 1999, J ELDER ABUSE NEGL, V11, P1, DOI 10.1300/J084v11n02_01
   Platt JL, 2001, J CARDIAC SURG, V16, P439, DOI 10.1111/j.1540-8191.2001.tb00548.x
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Shinoka T, 1997, CIRCULATION, V96, P102
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Sodian R, 2000, CIRCULATION, V102, P22
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   THALL A, 1990, BIOCHEMISTRY-US, V29, P3959, DOI 10.1021/bi00468a024
NR 30
TC 41
Z9 44
U1 1
U2 9
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD MAR
PY 2005
VL 14
IS 2
BP 212
EP 217
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 905OX
UT WOS:000227579700012
PM 15792182
DA 2018-10-19
ER

PT J
AU Silva, LP
   Kuckelhaus, S
   Guedes, MHA
   Lacava, ZGM
   Tedesco, AC
   Morais, PC
   Azevedo, RB
AF Silva, LP
   Kuckelhaus, S
   Guedes, MHA
   Lacava, ZGM
   Tedesco, AC
   Morais, PC
   Azevedo, RB
TI Kinetic of magnetic nanoparticles uptake evaluated by morphometry of
   mice peritoneal cells
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Magnetic Fluids
CY AUG 02-06, 2004
CL Guaruja, BRAZIL
SP FINEP, FAPESP, CNPq, CAPES, ICTP
DE magnetic fluid; biomaterial; morphometry; macrophages; phagocytosis
ID LIGHT-MICROSCOPY; FLUID; MACROPHAGES; RESONANCE; PHAGOCYTES
AB The development of magnetic fluids (MFs) has led to a wide range of new biomedical applications. Nevertheless, few studies have examined the kinetics of the magnetic nanoparticles (MNPs) internalization by phagocytes. In this study, we present morphometry as a method to quantify the cell surface covered by MNPs. The maximum cell surface covered by MNPs aggregates was 32.5% (8.5 min), 18.3% (24.1 min), and 18.0% (20.2 min) in DMSA, citric acid and dextran-coated MNPs, respectively. We concluded that the phagocytosis process of MNPs is strongly dependent upon the coating species. (c) 2004 Published by Elsevier B.V.
C1 Univ Brasilia, Dept Genet & Morfol, Inst Ciencias Biol, BR-70910900 Brasilia, DF, Brazil.
   Univ Sao Paulo, FFCLRP USP, BR-14040901 Ribeirao Preto, SP, Brazil.
   Univ Brasilia, Inst Fis Nucl Fis Aplicada, BR-70919970 Brasilia, DF, Brazil.
RP Silva, LP (reprint author), Univ Brasilia, Dept Genet & Morfol, Inst Ciencias Biol, BR-70910900 Brasilia, DF, Brazil.
EM paulinoluciano@unb.br; razevedo@unb.br
RI Silva, Luciano/G-4915-2012; Azevedo, Ricardo/D-6273-2012; Tedesco,
   Antonio/B-7584-2012
OI Silva, Luciano/0000-0001-9075-7725; Tedesco, Antonio/0000-0003-4198-9321
CR Barratt G, 2003, CELL MOL LIFE SCI, V60, P21, DOI 10.1007/s000180300002
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   Chaves SB, 2002, IEEE T MAGN, V38, P3231, DOI 10.1109/TMAG.2002.802495
   Dubowitz DJ, 2001, NEUROREPORT, V12, P2335, DOI 10.1097/00001756-200108080-00011
   Faraasen S, 2003, PHARMACEUT RES, V20, P237, DOI 10.1023/A:1022366921298
   Freitas MLL, 2002, J MAGN MAGN MATER, V252, P396, DOI 10.1016/S0304-8853(02)00655-8
   Jordan A, 1996, INT J HYPERTHER, V12, P705, DOI 10.3109/02656739609027678
   Lacava LM, 2001, BIOPHYS J, V80, P2483, DOI 10.1016/S0006-3495(01)76217-0
   Lacava LM, 2003, J APPL PHYS, V93, P7563, DOI 10.1063/1.1540178
   Lacava ZGM, 1999, J MAGN MAGN MATER, V194, P90, DOI 10.1016/S0304-8853(98)00583-6
   Lacava ZGM, 1999, J MAGN MAGN MATER, V201, P431, DOI 10.1016/S0304-8853(99)00002-5
   LACAVA ZGM, IN PRESS SPECTROSCOP
   LOHMANNMATTHES ML, 1990, ATEMWEG LUNGENKRANK, V16, P323
   Newsholme F, 1999, J NUTR BIOCHEM, V10, P316
   Twigg HL, 2004, SEM RESP CRIT CARE M, V25, P21, DOI 10.1055/s-2004-822302
NR 15
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAR
PY 2005
VL 289
BP 463
EP 465
DI 10.1016/j.jmmm.2004.11.130
PG 3
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 912YU
UT WOS:000228117100131
DA 2018-10-19
ER

PT J
AU Bayston, R
   Bhundia, C
   Ashraf, W
AF Bayston, R
   Bhundia, C
   Ashraf, W
TI Hydromer-coated catheters to prevent shunt infection?
SO JOURNAL OF NEUROSURGERY
LA English
DT Article
DE shunt infection; bacterial adhesion; Hydromer; prevention; pediatric
   neurosurgery
ID CEREBROSPINAL-FLUID SHUNTS; STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL
   ADHESION; HYDROCEPHALUS SHUNTS; BIOMATERIAL; COLONIZATION; INVITRO;
   SURFACE
AB Object. The authors sought to determine whether Hydromer-coated catheters (HCCs) reduce bacterial adhesion compared with plain silicone, with and without plasma conditioning; to determine whether soaking the catheter in antibiotic solution reduces catheter colonization; and to ascertain their likely efficacy in prevention of shunt infection.
   Methods. Segments of HCCs were soaked in antibiotic solutions and then tested for antimicrobial activity on serial zone plates. All antibiotic agents lost activity within 2 days, except rifampin (9 days). Bacterial adhesion (Staphylococcus epidermidis) to the external Surface was measured with and without plasma protein conditioning. Chemiluminescence showed that HCCs significantly reduced adhesion, especially with protein conditioning. Bacterial challenge of the luminal Surface of the HCCs under flow conditions showed no difference from plain silicone; this was also the case after soaking in high concentrations of antibiotic agents and was confirmed by scanning electron microscopy. Examination of the inner and outer surfaces of HCCs by laser confocal microscopy disclosed that the outer surface, but not the lumen, was Hydromer coated.
   Conclusions. The findings of this study indicate that HCCs do not impact the major risk factors for infection; therefore, it may be inferred that HCCs cannot be expected to reduce shunt infection significantly.
C1 Univ Nottingham Hosp, Biomat Related Infect Grp, QMN, Nottingham NG7 2UH, England.
RP Bayston, R (reprint author), Univ Nottingham Hosp, Biomat Related Infect Grp, QMN, C Floor,W Block, Nottingham NG7 2UH, England.
EM roger.bayston@nottingham.ac.uk
CR BAYSTON R, 1989, J NEUROL NEUROSUR PS, V52, P605, DOI 10.1136/jnnp.52.5.605
   BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25
   Bayston R, 2004, J ANTIMICROB CHEMOTH, V53, P778, DOI 10.1093/jac/dkh183
   Boelens JJ, 2000, J ANTIMICROB CHEMOTH, V45, P221, DOI 10.1093/jac/45.2.221
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   BRIDGETT MJ, 1993, BIOMATERIALS, V14, P184, DOI 10.1016/0142-9612(93)90021-S
   BROWN EM, 1994, LANCET, V344, P1547
   Brydon HL, 1996, J NEUROL NEUROSUR PS, V60, P671, DOI 10.1136/jnnp.60.6.671
   Das JR, 1998, J APPL MICROBIOL, V84, P852
   DRAKE JM, 1993, NEUROSURG QUART, V3, P283
   Giammona G, 1997, J PHARM PHARMACOL, V49, P1051, DOI 10.1111/j.2042-7158.1997.tb06040.x
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   GUEVARA JA, 1987, J NEUROSURG, V67, P438, DOI 10.3171/jns.1987.67.3.0438
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   KEY CB, 1995, PEDIATR EMERG CARE, V11, P265, DOI 10.1097/00006565-199510000-00001
   Kulkarni AV, 2001, J NEUROSURG, V94, P195, DOI 10.3171/jns.2001.94.2.0195
   NOMURA S, 2001, CURRENT T HY TOKYO, V11, P38
   OBRIEN M, 1979, CHILD BRAIN, V5, P304
   POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029
   Proctor RA, 1998, DRUG RESIST UPDATE, V1, P227, DOI 10.1016/S1368-7646(98)80003-4
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   SHAPIRO S, 1988, NEUROSURGERY, V22, P868, DOI 10.1227/00006123-198805000-00009
   TAKAHASHI Y, 2001, CURRENT T HY TOKYO, V11, P42
   Wilcox M, 1998, J HOSP INFECT, V38, P322, DOI 10.1016/S0195-6701(98)90084-6
NR 25
TC 13
Z9 13
U1 1
U2 2
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI CHARLOTTESVILLE
PA UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA
SN 0022-3085
J9 J NEUROSURG
JI J. Neurosurg.
PD MAR
PY 2005
VL 102
IS 2
SU S
BP 207
EP 212
DI 10.3171/jns.2005.102.2.0207
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 912GR
UT WOS:000228066100011
PM 16156231
DA 2018-10-19
ER

PT J
AU de Oliveira, AG
   Giacomelli, FC
   Giacomelli, C
   Spinelli, A
AF de Oliveira, AG
   Giacomelli, FC
   Giacomelli, C
   Spinelli, A
TI Microstructure and surface composition effects on the transpassivation
   of NiTi wires for implant purposes
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE NiTi alloy; electrochemical behavior; artificial saliva; microstructure
   and surface composition of NiTi alloy
ID SHAPE-MEMORY ALLOY; TITANIUM ORTHODONTIC WIRES; ACETIC ACID-SOLUTION;
   CORROSION-RESISTANCE; DIFFERENT TEMPERATURES; AQUEOUS-SOLUTIONS;
   DIFFERENT PH; ION RELEASE; SOL-GEL; BEHAVIOR
AB The microstructure and surface composition effects on the transpassivation behavior of untreated and heat treated at 500 &DEG; C NiTi wires used for implant purposes were investigated by electrochemical techniques ( open circuit potential and potentiodynamic polarization curves), X- ray diffraction ( XRD) and scanning electron microscopy ( SEM). The potential at which the passive film breaks down ( E (b)) ( transpassivation) was found to be strictly dependent on both the chemical composition of oxide covering layer and the microstructure of the biomaterial. It could be concluded that the disordered microstructure of untreated NiTi is highly resistant to transpassivation ( E b &SIM; 1.00 V/ SCE), but the presence of a native oxygen rich oxide film onto it makes the dissolution easier ( E (b) &SIM; 0.00 V/ SCE). Upon thermally treating, the microstructure becomes ordered and less resistant to dissolution ( E (b) &SIM; 0.12 V/ SCE), but in this case the presence of an oxygen rich native film influenced E b in a lower extent ( E (b) &SIM; 0.03 V/ SCE).
C1 Univ Fed Santa Catarina, Dept Quim, BR-88040900 Florianopolis, SC, Brazil.
RP de Oliveira, AG (reprint author), Univ Fed Santa Catarina, Dept Quim, BR-88040900 Florianopolis, SC, Brazil.
EM spin@qmc.ufsc.br
RI Spinelli, Almir/G-5771-2012; Giacomelli, Fernando/E-5791-2012; Oliveira,
   Anderson/J-8838-2017; GIACOMELLI, CRISTIANO/H-7393-2014
OI Spinelli, Almir/0000-0001-5993-8851; Giacomelli,
   Fernando/0000-0002-6872-9354; GIACOMELLI, CRISTIANO/0000-0002-3283-7396;
   Oliveira, Anderson/0000-0003-1752-0726
CR AlKharafi FM, 1997, ELECTROCHIM ACTA, V42, P579, DOI 10.1016/S0013-4686(96)00202-2
   Badawy WA, 1998, ELECTROCHIM ACTA, V44, P693, DOI 10.1016/S0013-4686(98)00180-7
   Black J., 1992, BIOL PERFORMANCE MAT
   DUERIG T, 1999, MAT SCI ENG A-STRUCT, V275, P149
   El Medawar L, 2002, BIOMOL ENG, V19, P153, DOI 10.1016/S1389-0344(02)00041-2
   Es-Souni M, 2002, BIOMATERIALS, V23, P2887, DOI 10.1016/S0142-9612(01)00416-1
   ESPINOS JP, 1993, SURF SCI, V295, P402, DOI 10.1016/0039-6028(93)90287-T
   Fernandes FMB, 2002, SENSOR ACTUAT A-PHYS, V99, P55, DOI 10.1016/S0924-4247(01)00898-6
   Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   Hsu HC, 1998, DENT MATER, V14, P339, DOI 10.1016/S0109-5641(99)00002-0
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Huang X, 2001, SCRIPTA MATER, V45, P153, DOI 10.1016/S1359-6462(01)01005-3
   Iijima M, 2002, BIOMATERIALS, V23, P1769, DOI 10.1016/S0142-9612(01)00303-9
   Iijima M, 2002, DENT MATER, V18, P88, DOI 10.1016/S0109-5641(01)00025-2
   Liu JX, 2002, J INORG MATER, V17, P797
   Liu JX, 2001, J INORG MATER, V16, P75
   Man HC, 2001, SCRIPTA MATER, V45, P1447, DOI 10.1016/S1359-6462(01)01182-4
   MATHIEU JB, 1978, J ELECTROCHEM SOC, V125, P1044, DOI 10.1149/1.2131618
   MATHIEU JB, 1978, J ELECTROCHEM SOC, V125, P1039, DOI 10.1149/1.2131617
   Messer RLW, 2000, DENT MATER, V16, P207, DOI 10.1016/S0109-5641(00)00010-5
   O'Brien B, 2002, BIOMATERIALS, V23, P1739, DOI 10.1016/S0142-9612(01)00299-X
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Rondelli G, 2002, BIOMATERIALS, V23, P639, DOI 10.1016/S0142-9612(01)00142-9
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   VETTER KJ, 1971, ELECTROCHIM ACTA, V16, P1923, DOI 10.1016/0013-4686(71)85147-2
NR 27
TC 4
Z9 4
U1 0
U2 3
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD MAR-APR
PY 2005
VL 16
IS 2
BP 131
EP 138
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 925HL
UT WOS:000229044100002
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Oliver, JM
   King, JR
   McKinlay, KJ
   Brown, PD
   Grant, DM
   Scotchford, CA
   Wood, JV
AF Oliver, JM
   King, JR
   McKinlay, KJ
   Brown, PD
   Grant, DM
   Scotchford, CA
   Wood, JV
TI Thin-film theories for two-phase reactive flow models of active cell
   motion
SO MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA
LA English
DT Article
DE active cell motion; cell-crawling cycle; two-phase reactive flow model;
   poroviscous free surface flows; actin network dynamics; thin-film
   lubrication theory; osteoblast
ID MIGRATION; DYNAMICS; MOTILITY; LOCOMOTION; KINETICS; SURFACE;
   PROTRUSION; DETACHMENT; CYTOPLASM; NETWORKS
AB The aim of this paper is to develop a broadly-applicable and self-consistent thin-film biphasic modelling framework for the full crawling cycle of a single animal cell. A hierarchy of thin-film two-phase 'reactive flow' models is derived; between them these cover a wide range of biologically relevant parameter regimes. The mathematical properties and biological implications of the resulting systems of high-order nonlinear degenerate parabolic-elliptic evolution equations are investigated. Linear-stability arguments suggest the formation of highly localized regions of high or low network density associated with small irregular oscillations or 'ruffling' of the plasma membrane. Local analyses at the contact line identify the classes of admissible contact-line conditions, through which we study for the first time the effect on the cell-scale motion of the 'mesoscopic' contact-line physics, which consists of the chemical and mechanical mechanisms for protrusive and retractive force generation near the outer cell periphery. One of the formulations is used to develop a minimal model for cell body translocation over a thin pseudopod, which predicts that myosin-driven contraction is not essential for rapid translocation. An analytic prediction for the translocation speed is given in terms of the network viscosity and slip coefficient (a parameter measuring the adhesion strength), of the membrane tension and of the thicknesses of the pseudopod and actin cortex; this is in good agreement with the translocation speed of osteoblasts on biomaterial substrates commonly used for orthopaedic implants. Limitations of the modelling approach and directions for future work are outlined.
C1 Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England.
   Univ Nottingham, Sch Mech Mat Mfg Engn & Management, Nottingham NG7 2RD, England.
   Rutherford Appleton Labs, Council Cent Labs Res Councils, Didcot OX11 0QX, Oxon, England.
   Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.
RP Oliver, JM (reprint author), Univ Nottingham, Sch Math Sci, Univ Pk, Nottingham NG7 2RD, England.
EM james.oliver@nottingham.ac.uk
OI Scotchford, Colin/0000-0003-1937-6692; Grant, David/0000-0002-6786-7720;
   Brown, Paul/0000-0002-1911-5225
CR ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017
   Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9
   Alberts B., 1998, ESSENTIAL CELL BIOL
   Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6
   Alt W., 2003, GEOMETRIC ANAL NONLI, P431
   Bottino D, 2002, J CELL SCI, V115, P367
   Bottino DC, 1998, EUR BIOPHYS J BIOPHY, V27, P532, DOI 10.1007/s002490050163
   Bray D., 2001, CELL MOVEMENTS MOL M
   Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062
   Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161
   Cowin SC, 2000, J BIOMECH ENG-T ASME, V122, P553, DOI 10.1115/1.1324665
   Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   deGennes PG, 1979, SCALING CONCEPTS POL
   DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0
   DEMBO M, 1989, COMMENTS THEORETICAL, V1, P159
   DICKENSON R, 2002, BIOPHYS J, V82, P606
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   DREW D, 1983, ANNU REV FLUID MECH, V50, P205
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   EVANS E, 1993, BIOPHYS J, V64, P1306, DOI 10.1016/S0006-3495(93)81497-8
   Frisch T, 2002, J BIOMECH, V35, P1137, DOI 10.1016/S0021-9290(02)00075-1
   GREENSPAN HP, 1978, J FLUID MECH, V84, P125, DOI 10.1017/S0022112078000075
   Happel J, 1991, LOW REYNOLDS NUMBER
   Hardouin P, 2000, JOINT BONE SPINE, V67, P419
   HE A, 1997, EXP CELL RES, V233, P252
   HOCKING LM, 1992, J FLUID MECH, V239, P671, DOI 10.1017/S0022112092004579
   HODGES S, 2002, J FLUID MECH, V460, P387
   KELLEY CT, 1995, ITERATIVE METHODS LI
   KING J, 2004, IN PRESS EUR J APPL
   King J. R., 2001, IUTAM S FREE SURF FL, P7, DOI 10.1007/978-94-010-0796-2_2
   King JR, 2001, EUR J APPL MATH, V12, P321
   KOMORI T, 1977, TEXT RES J, V47, P309
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lemons J. E., 1996, MED APPL TITANIUM IT
   Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3
   McKinlay KJ, 2004, J BIOMED MATER RES A, V69A, P359, DOI 10.1002/jbm.a.30011
   Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7
   Mogilner A, 1996, EUR BIOPHYS J BIOPHY, V25, P47, DOI 10.1007/s002490050016
   Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050
   Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6
   Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1
   MOGILNER A, 2001, PATTERN FORMATION MO, P269
   MYERS T, 1998, SIAM REV, V40, P4441
   Oron A, 1997, REV MOD PHYS, V69, P931, DOI 10.1103/RevModPhys.69.931
   PALECEK S, 1998, ANN BIOMED ENG, V27, P219
   PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SPIROS A, 1998, THESIS U BRIT COLUMB
   TOKITA M, 1991, J CHEM PHYS, V95, P4613, DOI 10.1063/1.461729
   TOLL S, 1993, J RHEOL, V37, P123, DOI 10.1122/1.550460
   Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6
   WARD MD, 1994, BIOPHYS J, V67, P2522, DOI 10.1016/S0006-3495(94)80742-8
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783
   Witelski TP, 2003, APPL NUMER MATH, V45, P331, DOI 10.1016/S0168-9274(02)00194-0
   Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026
NR 59
TC 20
Z9 20
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1477-8599
J9 MATH MED BIOL
JI Math. Med. Biol.
PD MAR
PY 2005
VL 22
IS 1
BP 53
EP 98
DI 10.1093/imammb/dqh022
PG 46
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 899FH
UT WOS:000227129800004
PM 15716300
DA 2018-10-19
ER

PT J
AU Yasuda, H
   Kuroda, S
   Nanba, R
   Ishikawa, T
   Shinya, N
   Terasaka, S
   Iwasaki, Y
   Nagashima, K
AF Yasuda, H
   Kuroda, S
   Nanba, R
   Ishikawa, T
   Shinya, N
   Terasaka, S
   Iwasaki, Y
   Nagashima, K
TI A novel coating biomaterial for intracranial aneurysms: Effects and
   safety in extra- and intracranial carotid artery
SO NEUROPATHOLOGY
LA English
DT Article
DE biomaterial; cerebral aneurysm; coating; fibrin glue; polyglycolic acid
   felt
ID CEREBROSPINAL-FLUID LEAKAGE; RUPTURED ANEURYSMS; FIBRIN SEALANT;
   HISTOLOGICAL-CHANGES; COMPLICATION; GLUE; REINFORCEMENT; GRANULOMA
AB Methyl-2-cyanoacrylate, a widely used material for coating cerebral aneurysm, was recently withdrawn. The aim of the present study was to develop an alternative coating material for cerebral aneurysm, which is safe, effective and stable within the brain. In the first experiment, an aneurysm model of the common carotid artery was produced in a rabbit by the local application of elastase. The aneurysm produced was covered by no material (Group A), a cellulose cotton sheet and conventional methyl-2-cyanoacrylate (Group B), a newly produced polyglycolic acid felt and fibrin glue (Group C), or a cellulose cotton sheet and fibrin glue (Group D). Histological examination showed that the materials resulted in the formation of tight connective tissue around the artery, and that the material was completely replaced by the connective tissue after 12 weeks. This change was found exclusively in Group C, but not in Group A or the other materials, although a temporary thickening of the intima was also observed at the site of the elastase application in Group C. In Group D, a long-term, marked thickening of the intima was observed. In the second experiment, using an intracranial internal carotid artery from a beagle, the applied polyglycolic acid felt and fibrin glue to the intracranial artery induced the formation of connective tissue around the artery that was completely absorbed 16 weeks after surgery. There were no signs of intimal thickening or of adverse reactions in nervous tissue. The present results suggest that polyglycolic acid felt and fibrin glue is a possible candidate for a safe, effective biomaterial to wrap or coat cerebral aneurysm.
C1 Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   Chemoserotherapeut Res Inst, Kumamoto, Japan.
   Hokkaido Univ, Grad Sch Med, Lab Mol & Cellular Pathol, Sapporo, Hokkaido, Japan.
RP Kuroda, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, N 15 W 7, Sapporo, Hokkaido 0608638, Japan.
EM skuroda@med.hokudai.ac.jp
RI Terasaka, Shunsuke/A-5814-2012
CR ARAKI C, 1963, NEUROCHIRURGIA STUTT, V25, P123
   CHAMBI I, 1990, J NEUROSURG, V72, P163, DOI 10.3171/jns.1990.72.2.0163
   COSSU M, 1993, NEUROSURGERY, V32, P344, DOI 10.1227/00006123-199303000-00002
   de Vries J, 2002, SURG NEUROL, V57, P415, DOI 10.1016/S0090-3019(02)00736-X
   DEVRIES J, 2002, SURG NEUROL, V57, P422
   EBINA K, 1993, ACTA NEUROCHIR, V125, P161, DOI 10.1007/BF01401845
   FUJIWARA S, 1990, ACTA NEUROCHIR, V103, P27, DOI 10.1007/BF01420188
   HAISA T, 1990, J NEUROSURG, V72, P292, DOI 10.3171/jns.1990.72.2.0292
   Herrera O, 1999, NEUROL MED-CHIR, V39, P134, DOI 10.2176/nmc.39.134
   Herrera O, 1999, NEUROL MED CHIR TOKY, V39, P139
   Juan GM, 1999, NEUROL MED-CHIR, V39, P908, DOI 10.2176/nmc.39.908
   JUAN GM, 1999, NEUROL MED CHIR TOKY, V39, P912
   Kawamura S, 1998, NEUROL MED-CHIR, V38, P12, DOI 10.2176/nmc.38.12
   KAWAMURA S, 1998, NEUROL MED CHIR TOKY, V38, P18
   KURITA H, 1995, NEUROSURGERY, V36, P1225, DOI 10.1227/00006123-199506000-00029
   Menovsky T, 2002, NEUROSURGERY, V51, P1453, DOI 10.1227/01.NEU.0000036414.94363.20
   Menovsky T., 2002, NEUROSURGERY, V51, P1455
   MINAKAWA T, 1987, NEUROSURGERY, V21, P660, DOI 10.1227/00006123-198711000-00010
   Miskolczi L, 1998, NEUROSURGERY, V43, P595, DOI 10.1097/00006123-199809000-00110
   Miskolczi L, 1998, NEUROSURGERY, V43, P600
   Mizuno H, 1995, Nihon Kyobu Geka Gakkai Zasshi, V43, P1559
   Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251
   SADASIVAN B, 1990, SURG NEUROL, V34, P3, DOI 10.1016/0090-3019(90)90165-L
   Sawamura Y, 1999, NEUROSURGERY, V44, P332, DOI 10.1097/00006123-199902000-00048
   SMITH TW, 1985, J NEUROSURG, V62, P108, DOI 10.3171/jns.1985.62.1.0108
   Tateishi J, 2001, BIOLOGICALS, V29, P17, DOI 10.1006/biol.2001.0269
   TAYLOR JC, 1977, J NEUROSURG, V47, P828, DOI 10.3171/jns.1977.47.6.0828
   Terasaka Shunsuke, 1994, Neurological Surgery, V22, P1015
   Uzan M, 1996, NEUROSURG REV, V19, P89, DOI 10.1007/BF00418076
   VANCALENBERGH F, 1995, ACTA NEUROCHIR, V136, P62, DOI 10.1007/BF01411436
NR 30
TC 13
Z9 13
U1 0
U2 3
PU BLACKWELL PUBLISHING ASIA
PI CARLTON
PA 54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA
SN 0919-6544
J9 NEUROPATHOLOGY
JI Neuropathology
PD MAR
PY 2005
VL 25
IS 1
BP 66
EP 76
DI 10.1111/j.1440-1789.2004.00590.x
PG 11
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 899VW
UT WOS:000227174900008
PM 15822820
DA 2018-10-19
ER

PT J
AU Roche, E
   Santana, A
   Vicente-Salar, N
   Reig, JA
AF Roche, E
   Santana, A
   Vicente-Salar, N
   Reig, JA
TI From stem cells to insulin-producing cells: towards a bioartificial
   endocrine pancreas
SO PANMINERVA MEDICA
LA English
DT Review
DE stem cells; diabetes mellitus; cell therapy
ID IN-VITRO DIFFERENTIATION; BETA-CELLS; BONE-MARROW; DIABETES-MELLITUS;
   SECRETING CELLS; ISLETS; GLUCOSE; EXPRESSION; MICE; THERAPY
AB The total absence or low production of insulin by beta-cells avoids a proper control of glycemia forcing diabetic people to daily insulin injection for survival. Islet transplantation represents a hallmark in the cure of diabetes and has been successfully applied to more than 400 patients, resulting in insulin independency for periods longer than 4 years. However, transplantation trials for diabetes have to face the scarcity of islets from cadaveric donors. Therefore, the finding of renewable sources of cells could circumvent this problem. In this respect, embryonic or adult stem cells are representing an interesting alternative. Stem cells display robust proliferation and the plasticity to differentiate to other cell types, including insulin-containing cells. The current therapeutical use in the future of bioengineered insulin-secreting cells derived from stem cells needs at present to fulfill several criteria. These criteria concern to the type of stem cell to be used as starting biomaterial (embryonic or adult), the in vitro differentiation protocol applied, the functional phenotype reached for the final cell product and the transplantation associated problems (likely immune rejection and tumor formation). This review will try to focus on these different aspects in order to emphasize in the key points to consider for designing unified strategies for diabetes cell therapy.
C1 Univ Miguel Hernandez, Inst Bioingn, Alicante 03550, Spain.
RP Roche, E (reprint author), Univ Miguel Hernandez, Inst Bioingn, Alicante 03550, Spain.
EM eroche@umh.es
RI Roche, Enrique/V-5738-2017
OI Roche, Enrique/0000-0001-5128-1672
CR Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691
   Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a
   Benoist C, 1997, CELL, V89, P1, DOI 10.1016/S0092-8674(00)80174-9
   Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100
   Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190
   Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197
   Charollais A, 2000, J CLIN INVEST, V106, P235, DOI 10.1172/JCI9398
   Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9
   Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   DEFRONZO RA, 2004, INT TXB DIABETES MEL
   DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527
   Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520
   Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718
   Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3
   HALBAN PA, 1994, BIOCHEM J, V299, P1
   Hernandez-Sanchez C, 2003, EMBO J, V22, P5582, DOI 10.1093/emboj/cdg515
   Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841
   Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999
   Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502
   ING QL, 2003, NAT BIOTECHNOL, V21, P183
   Jamal AM, 2003, CELL DEATH DIFFER, V10, P987, DOI 10.1038/sj.cdd.4401266
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843
   Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867
   Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344
   Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x
   Lechner A, 2004, DIABETES, V53, P616, DOI 10.2337/diabetes.53.3.616
   Leon-Quinto T, 2004, DIABETOLOGIA, V47, P1442, DOI 10.1007/s00125-004-1458-8
   Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9
   Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866
   Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a
   Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394
   Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y
   Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030
   Moritoh Y, 2003, DIABETES, V52, P1163, DOI 10.2337/diabetes.52.5.1163
   Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137
   OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723
   Piper K, 2002, DIABETOLOGIA, V45, P1045, DOI 10.1007/s00125-002-0864-z
   Poitout V, 1996, ANNU REV MED, V47, P69
   Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   PRENTKI M, 2000, CAN J DIABETES CARE, V25, P36
   Rajagopal J, 2003, SCIENCE, V299, P363
   Ramiya VK, 2000, NAT MED, V6, P278
   Roche E, 2003, MED BIOL ENG COMPUT, V41, P384, DOI 10.1007/BF02348079
   Roche E, 2003, CYTOTECHNOLOGY, V41, P145, DOI 10.1023/A:1024878807264
   Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091
   ROCHE E, 2003, ARS PHARM, V44, P313
   Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1
   Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2
   Schuit FC, 2001, DIABETES, V50, P1, DOI 10.2337/diabetes.50.1.1
   Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   SMITH KM, 1999, PORPHYRIN HDB, V1, P13
   Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157
   Soria B, 2001, DIABETOLOGIA, V44, P407, DOI 10.1007/s001250051636
   Tanaka SS, 2000, GENE DEV, V14, P841
   Treutelaar MK, 2003, DIABETES, V52, P2503, DOI 10.2337/diabetes.52.10.2503
   Vicario-Abejon C, 2003, J NEUROSCI, V23, P895
   Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9
   Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699
   Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100
   Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457
   Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521
NR 72
TC 7
Z9 8
U1 0
U2 2
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0031-0808
J9 PANMINERVA MED
JI Panminerva Medica
PD MAR
PY 2005
VL 47
IS 1
BP 39
EP 51
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA 946ID
UT WOS:000230564700005
PM 15985976
DA 2018-10-19
ER

PT J
AU Valimaki, VV
   Yrjans, JJ
   Vuorio, EI
   Aro, HT
AF Valimaki, VV
   Yrjans, JJ
   Vuorio, EI
   Aro, HT
TI Molecular biological evaluation of bioactive glass microspheres and
   adjunct bone morphogenetic protein 2 gene transfer in the enhancement of
   new bone formation
SO TISSUE ENGINEERING
LA English
DT Article
ID MESSENGER-RNA; IN-VITRO; MOUSE DEVELOPMENT; HUMAN OSTEOBLASTS; IONIC
   PRODUCTS; BMP-2 GENE; EXPRESSION; CELLS; DISSOLUTION; MICROROUGH
AB Bioactive glass is a promising osteoconductive silica-based biomaterial for guidance of new bone growth. On the basis of several in vitro studies, the material appears able to promote osteoblast functions. In our in vivo study, the osteopromotive effect of bioactive glass microspheres seemed to surpass the osteoinductive action of direct adenovirus-mediated human bone morphogenetic protein 2 (BMP-2) gene transfer in a noncritical size bone defect model. The current study was initiated to elucidate the molecular mechanism behind bioactive glass action with or without adjunct BMP-2 gene transfer. A standardized bone defect of the rat tibia was filled with bioactive glass microspheres and injected with adenovirus carrying the human BMP-2 gene (RAdBMP-2). Control defects were left empty or filled with bioactive glass microspheres with injection of adenovirus carrying the lacZ reporter gene or saline. Quantitative polymerase chain reaction confirmed the expression of the transferred human BMP-2 gene at the defect area at 4 days, but not in intact reference tissues. Bone matrix components (collagens I, II, and III, osteocalcin, osteonectin, and osteopontin) and resorption markers (cathepsin K and MMP-9), determined by Northern analysis, showed a completely different pattern of gene expression in defects filled with bioactive glass compared with control defects left to heal without filling. Bioactive glass induced a long-lasting production of bone matrix with concurrent upregulation of osteoclastic markers, a sign of high bone turnover. Combining RAdBMP-2 gene transfer with bioactive glass decelerated the high turnover, but did not influence the balance of synthesis and resorption. This molecular analysis confirmed not only the highly osteopromotive effect of bioactive glass microspheres, but also the accelerated rate of new bone resorption on its surface. At least in noncritical size defects this impact of bioactive glass seems to saturate new bone formation on its surface and thereby overshadow the effect of BMP-2 gene transfer.
C1 Univ Turku, Dept Orthoped Surg & Traumatol, Orthoped Res Unit, FIN-20520 Turku, Finland.
   Univ Turku, Dept Med Biochem & Mol Biol, FIN-20520 Turku, Finland.
RP Aro, HT (reprint author), Univ Turku, Dept Orthoped Surg & Traumatol, Orthoped Res Unit, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.
EM hannu.aro@utu.fi
OI Aro, Hannu/0000-0003-3118-9144
CR Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Itala A, 2003, J BIOMED MATER RES B, V65B, P163, DOI 10.1002/jbm.b.10529
   Itala A, 2002, J BIOMED MATER RES, V62, P404, DOI 10.1002/jbm.10273
   Kaufmann EABE, 2000, TISSUE ENG, V6, P19, DOI 10.1089/107632700320856
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   MAJALAHTIPALVIAINE, 2000, ENDOCRINOLOGY, V141, P731
   METSARANTA M, 1991, BIOCHIM BIOPHYS ACTA, V1089, P241, DOI 10.1016/0167-4781(91)90014-D
   PITKANEN V, 1995, J AEROSOL SCI, V26, P831
   Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6
   Rantakokko J, 1999, J BONE MINER RES, V14, P1934, DOI 10.1359/jbmr.1999.14.11.1934
   REPONEN P, 1994, ANN NY ACAD SCI, V732, P472, DOI 10.1111/j.1749-6632.1994.tb24789.x
   Uusitalo H, 2001, J BONE MINER RES, V16, P1837, DOI 10.1359/jbmr.2001.16.10.1837
   Uusitalo H, 2001, MATRIX BIOL, V20, P123, DOI 10.1016/S0945-053X(01)00126-3
   VALIMAKI VV, 2003, 49 ANN M ORTH RES SO
   Virolainen P, 1997, J BIOMED MATER RES, V35, P9, DOI 10.1002/(SICI)1097-4636(199704)35:1<9::AID-JBM2>3.3.CO;2-H
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   YOUNG MF, 1990, CONNECT TISSUE RES, V24, P17, DOI 10.3109/03008209009152419
NR 26
TC 29
Z9 30
U1 0
U2 4
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAR
PY 2005
VL 11
IS 3-4
BP 387
EP 394
DI 10.1089/ten.2005.11.387
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 924SA
UT WOS:000228999400006
PM 15869418
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Structural and biochemical characterization of renal capsule matrix
   (RCM) biomaterial
SO WOUND REPAIR AND REGENERATION
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAR-APR
PY 2005
VL 13
IS 2
BP A20
EP A20
PG 1
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 913EA
UT WOS:000228133200083
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Skin cell attachment to an implanted percutaneous biomaterial: A mouse
   model
SO WOUND REPAIR AND REGENERATION
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAR-APR
PY 2005
VL 13
IS 2
BP A6
EP A6
PG 1
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 913EA
UT WOS:000228133200027
DA 2018-10-19
ER

PT J
AU Lewandowska-Szurniel, M
   Sikorski, K
   Szummer, A
   Komender, J
   Kowalski, M
   Daniels, AU
AF Lewandowska-Szurniel, M
   Sikorski, K
   Szummer, A
   Komender, J
   Kowalski, M
   Daniels, AU
TI Experimental model for observation of micromotion in cell culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE micromotion; osteoblast; hydroxyapatite; titanium; alumina; in vitro
ID FLUID SHEAR-STRESS; PERIODONTAL-LIGAMENT CELLS; AORTIC
   ENDOTHELIAL-CELLS; OSTEOBLAST-LIKE CELLS; BONE-RESORPTION; IN-VITRO;
   MECHANICAL STIMULATION; HYDROSTATIC-PRESSURE; POTASSIUM CHANNEL;
   GROWTH-FACTOR
AB It is known that the micromotion between implant and bone inhibits direct bone growth either on or into implant surfaces in vivo. Nevertheless, biocompatibility tests in vitro of biomaterials for bone/implant interfaces are mainly performed under static conditions. This work describes a dynamic, in vitro experimental simulation of the effect of mutual, small-scale implant surface-tissue displacement on adhered cells. Disks of simulated tissue (PVP hydrogel) were subjected to cyclic micromotion ranging from 0 at the center to 1000 mum at the periphery at similar to 13 Hz, relative to biomaterial surfaces or tissue culture polystyrene controls populated with human osteoblasts in standard tissue culture plate wells. The effect of the interfacial micromotion on the number of cells remaining attached was quantitated by XTT assay. The activity level of the remaining cells was determined by an alkaline phosphatase assay, and cell stress was evaluated by nitrogen assay. Significantly more cells (ANOVA) became detached from similarly prepared surfaces of titanium, hydroxyapatite, and alumina compared to the polystyrene control, and detachment from alumina was greater than for the other two materials. The activity of the remaining attached cells was lower as compared to the static (no micromotion) control but not significantly different among the biomaterials. All nitrogen assays were negative, suggesting minimal cell stress occurred. The method is proposed as a useful and discriminating in vitro tool for biocompatibility studies focused on cell adhesion to biomaterials under conditions related to those which exist at the implant/bone interface in vivo, and it allows subsequent studies of the still-viable cells by other methods. (C) 2004 Wiley Periodicals, Inc.
C1 Med Univ Warsaw, Dept Biophys & Human Physiol, PL-02004 Warsaw, Poland.
   Med Univ Warsaw, Ctr Biostruct Res, Dept Transplantol, PL-02004 Warsaw, Poland.
   Med Univ Warsaw, Ctr Biostruct Res, Cent Tissue Bank, PL-02004 Warsaw, Poland.
   Warsaw Univ Technol, Fac Mat Sci & Engn, PL-00661 Warsaw, Poland.
   Med Univ Warsaw, Dept Orthopaed, PL-02004 Warsaw, Poland.
   Univ Basel, Lab Orthoped Biomech, CH-4003 Basel, Switzerland.
RP Lewandowska-Szurniel, M (reprint author), Med Univ Warsaw, Dept Biophys & Human Physiol, Chalubinskiego 5, PL-02004 Warsaw, Poland.
EM mszumiel@ib.amwaw.edu.pl
OI Lewandowska-Szumiel, Malgorzata/0000-0002-7140-0541
CR Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   ASPENBERG P, 1992, ACTA ORTHOP SCAND, V63, P141, DOI 10.3109/17453679209154809
   Banes AJ, 1985, J CELL SCI, V75, P35
   BREAULT LG, 1995, J PERIODONTOL, V66, P545, DOI 10.1902/jop.1995.66.7.545
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F
   FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0
   Gallagher James A., 1996, P233
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X
   HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879
   HUNG CT, 1995, CLIN ORTHOP RELAT R, P256
   Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010
   Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2
   KLEIN CL, 1994, COLLOID SURFACE B, V3, P229
   KLEINNULEND J, 1995, J CELL PHYSIOL, V163, P115, DOI 10.1002/jcp.1041630113
   KOLPAKOV V, 1995, CIRC RES, V77, P823, DOI 10.1161/01.RES.77.4.823
   Kudelska-Mazur D, 2001, ENG BIOMATER, V15/16, P51
   LEWANDOWSKASZUMIEL, 1999, ATLA-ALTERN LAB ANIM, V27, P271
   LEWIN R, 1986, SCIENCE, V232, P1192, DOI 10.1126/science.3704643
   LOWIK CWGM, 1994, J CLIN INVEST, V93, P1465, DOI 10.1172/JCI117124
   MacPherson H, 1999, BONE, V24, P179, DOI 10.1016/S8756-3282(98)00173-2
   MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796
   NEWELL DG, 1996, CELL TISSUE CULTURE, pB4
   O'Connor L, 2000, CURR OPIN CELL BIOL, V12, P257, DOI 10.1016/S0955-0674(99)00084-8
   OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787
   OHNO M, 1993, CIRCULATION, V88, P193, DOI 10.1161/01.CIR.88.1.193
   OOKAWA K, 1992, J BIOMECH, V25, P1321, DOI 10.1016/0021-9290(92)90287-B
   PARKKINEN JJ, 1995, J ORTHOPAED RES, V13, P495, DOI 10.1002/jor.1100130404
   Pitsillides AA, 1995, FASEB J, V9, P1614
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   ROSIAK JM, 1991, ACS SYM SER, V475, P271
   Sadler GP, 1996, WORLD J SURG, V20, P822, DOI 10.1007/s002689900125
   Sato M, 1996, J BIOMECH, V29, P461, DOI 10.1016/0021-9290(95)00069-0
   SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514
   Schinagl RM, 1999, J ORTHOPAED RES, V17, P121, DOI 10.1002/jor.1100170118
   SHIMIZU N, 1995, J DENT RES, V74, P1382, DOI 10.1177/00220345950740071001
   SHYU KG, 1995, BIOCHEM BIOPH RES CO, V211, P241, DOI 10.1006/bbrc.1995.1802
   SIKORSKI K, Patent No. 339046
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SOBALLE K, 1992, ACTA ORTHOP SCAND, V63, P128, DOI 10.3109/17453679209154808
   STANFORD CM, 1995, J ORTHOPAED RES, V13, P664, DOI 10.1002/jor.1100130505
   THOUMINE O, 1995, LAB INVEST, V73, P565
   Tomczok J, 1996, BIOMATERIALS, V17, P1359, DOI 10.1016/0142-9612(96)87275-9
   Van Der Vis HM, 1999, ACTA HISTOCHEM, V101, P203, DOI 10.1016/S0065-1281(99)80019-1
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
   YOUSEFIAN J, 1995, AM J ORTHOD DENTOFAC, V108, P402, DOI 10.1016/S0889-5406(95)70038-2
NR 47
TC 4
Z9 4
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2005
VL 72B
IS 2
BP 379
EP 387
DI 10.1002/jbm.b.30172
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892GS
UT WOS:000226638700024
PM 15654711
DA 2018-10-19
ER

PT J
AU Roveri, N
   Morpurgo, M
   Palazzo, B
   Parma, B
   Vivi, L
AF Roveri, N
   Morpurgo, M
   Palazzo, B
   Parma, B
   Vivi, L
TI Silica xerogels as a delivery system for the controlled release of
   different molecular weight heparins
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE silica xerogel; heparins; bioactive material; controlled release
   material; biomaterial
ID CONTROLLED DRUG-DELIVERY; ANTITHROMBIN-III; CARRIER; BIOMATERIALS;
   BINDING; ASSAY
AB In this work, we investigated a sol-gel derived silica matrix as a delivery system for the prolonged release of different molecular weight heparins, which allows the glycosaminoglicons to retain their whole biological activity. Several xerogels were obtained by embedding different molecular weight heparins into matrices prepared by using different amount of NH4OH as a catalyst during gel formation. Gel synthesis parameters, drug release properties, and xerogels surface area were evaluated. Unfractionated, low and oligo-molecular weight heparins were embedded into xerogels and the effect of the molecular weight on the release kinetics and the retained biological activity has been investigated. The results show that the surface area of the matrix is a determinant parameter affecting drug release kinetics. This structural feature can be modified by varying the catalyst tetraethoxysilane molar ratio used during the matrix synthesis. In most cases release kinetics fitted the Higuchi diffusive model and a lower diffusion rate was observed from silica matrices characterized by a smaller surface area. In the case of matrices with lower surface area, loaded with unfractionated heparin, zero order kinetics was observed. In this paper, we have defined a heparin release silica xerogel system and we have pointed out how modulation of its synthesis parameters allows adjusting the release of heparin according to therapeutic needs.
C1 Univ Bologna, Alma Mater Studiorum, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy.
   OPOCRIN SpA, I-41040 Corlo Formigine, MO, Italy.
RP Roveri, N (reprint author), Univ Bologna, Alma Mater Studiorum, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy.
EM norberto.roveri@unibo.it
RI morpurgo, margherita/I-7911-2012
OI morpurgo, margherita/0000-0002-8767-1995
CR Ahola MS, 2001, BIOMATERIALS, V22, P2163, DOI 10.1016/S0142-9612(00)00407-5
   AVNIR D, 1992, ACS SYM SER, V499, P384
   BAKER R, 1987, CONTROLLED RELEASE B
   Barton TJ, 1999, CHEM MATER, V11, P2633, DOI 10.1021/cm9805929
   Bottcher H, 1998, J SOL-GEL SCI TECHN, V13, P277, DOI 10.1023/A:1008603622543
   BREDDIN KK, 1988, J THROMB HAEMOST RES, V18, P1
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   GRASSHOFF K, 1983, METHODS SEAWATER ANA, P174
   GREGG SJ, 1997, ADSORPTION SURFACE A
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HEYMAN PW, 1985, J BIOMED MATER RES, V19, P419, DOI 10.1002/jbm.820190407
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Kortesuo P, 2000, BIOMATERIALS, V21, P193, DOI 10.1016/S0142-9612(99)00148-9
   LANE DA, 1989, HEPARIN CHEM BIOL PR, P115
   LEGEROS JP, 1998, BIOCERAMICS
   MORPURGO M, 2004, EUR C DRUG DEL PHARM, P170
   MORPURGO M, UNPUB J MAT CHEM
   MORPURGO M, 2002, 4 WORLD M PHARM BIOP
   Santos EM, 1999, BIOMATERIALS, V20, P1695, DOI 10.1016/S0142-9612(99)00066-6
   SCHMITT E, 1983, BIOMATERIALS, V4, P309, DOI 10.1016/0142-9612(83)90034-0
   SMITH PK, 1980, ANAL BIOCHEM, V109, P466, DOI 10.1016/0003-2697(80)90679-X
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   TEIEN AN, 1977, THROMB RES, V10, P399, DOI 10.1016/0049-3848(77)90150-5
   THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2
   UNGER K, 1983, DRUG DEV IND PHARM, V9, P69, DOI 10.3109/03639048309048546
   VANDELDEN CJ, 1995, J BIOMED MATER RES, V29, P1317, DOI 10.1002/jbm.820291103
NR 29
TC 28
Z9 28
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD FEB
PY 2005
VL 381
IS 3
BP 601
EP 606
DI 10.1007/s00216-004-2765-0
PG 6
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 907EE
UT WOS:000227697400010
PM 15289979
DA 2018-10-19
ER

PT J
AU De Giglio, E
   Cometa, S
   Sabbatini, L
   Zambonin, PG
   Spoto, G
AF De Giglio, E
   Cometa, S
   Sabbatini, L
   Zambonin, PG
   Spoto, G
TI Electrosynthesis and analytical characterization of PMMA coatings on
   titanium substrates as barriers against ion release
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE PMMA; electrosynthesis; XPS; titanium; ion release; biomaterial
ID RAY PHOTOELECTRON-SPECTROSCOPY; METHYL-METHACRYLATE; METAL-ELECTRODES;
   STAINLESS-STEEL; BONE TISSUE; ELECTROPOLYMERIZATION; SURFACE;
   POLYMERIZATION; ALUMINUM; MECHANISM
AB The performance of polyacrylic coatings as barrier films against corrosion of titanium-based orthopaedic implants was investigated. In particular, poly(methyl methacrylate) (PMMA) was electrosynthesized on titanium substrates by electro-reductive processes from aqueous monomer solutions. The obtained PMMA coatings were characterized by Fourier transform infrared spectroscopy (FTIR) and X-ray photoelectron spectroscopy (XPS). The effect of an annealing treatment on the morphology of coatings with respect to uniformity and porosity of films was assessed by scanning electron microscopy (SEM). An inductively coupled plasma-mass spectrometry (ICP-MS) technique was used for ion concentration measurements in ion release tests performed on TiAlV sheets modified with PMMA coatings (annealed and unannealed). Results indicated that the annealing process produces coatings with considerable anticorrosion performances.
C1 Univ Bari, Dept Chem, I-70126 Bari, Italy.
   Univ Catania, Dept Chem, I-95125 Catania, Italy.
RP De Giglio, E (reprint author), Univ Bari, Dept Chem, Via E Orabona 4, I-70126 Bari, Italy.
EM e.degiglio@chimica.uniba.it
OI De Giglio, Elvira/0000-0001-9387-6201; Sabbatini,
   Luigia/0000-0002-5099-2242
CR Agarwal R, 1999, J APPL POLYM SCI, V71, P1665, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1665::AID-APP14>3.0.CO;2-S
   Browne M, 2000, BIOMATERIALS, V21, P385, DOI 10.1016/S0142-9612(99)00200-8
   BUCHWALTER LP, 1990, J VAC SCI TECHNOL A, V8, P781, DOI 10.1116/1.576917
   CHOLOD MS, 1987, POLYM MAT ENCY
   Cram SL, 2003, J ADHES SCI TECHNOL, V17, P1403, DOI 10.1163/156856103769172814
   Cram SL, 2003, J APPL POLYM SCI, V87, P765, DOI 10.1002/app.11436
   Cram SL, 2002, ELECTROCHIM ACTA, V47, P1935, DOI 10.1016/S0013-4686(02)00097-X
   De Giglio E, 2001, J BIOMAT SCI-POLYM E, V12, P63, DOI 10.1163/156856201744452
   Desimoni E., 1986, Computer Enhanced Spectroscopy, V3, P107
   Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5
   GARG BK, 1978, J APPL POLYM SCI, V22, P65, DOI 10.1002/app.1978.070220107
   HOOK TJ, 1986, ANAL CHEM, V58, P1285, DOI 10.1021/ac00298a004
   KUMAZAWA R, 2002, BIOMATERIALS, V23, P37
   LEE CS, 1995, J APPL POLYM SCI, V57, P931, DOI 10.1002/app.1995.070570805
   Lucksanasombool P, 2002, J MATER SCI-MATER M, V13, P203, DOI 10.1023/A:1013890331714
   MACCALLUM JR, 1982, EUR POLYM J, V18, P717, DOI 10.1016/0014-3057(82)90102-1
   MALITESTA C, 1989, J CHEM SOC FARAD T 1, V85, P1685, DOI 10.1039/f19898501685
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   PALMISANO F, 1995, J ELECT SPECTROSC RE, V76, P629
   Rie KT, 1995, SURF COAT TECH, V74-75, P973, DOI 10.1016/0257-8972(95)08316-2
   Roberts NB, 1998, J INORG BIOCHEM, V69, P171, DOI 10.1016/S0162-0134(97)10015-0
   SALVATI L, 1986, P SPE 44 ANN TECHN C
   TENG FS, 1977, J ELECTROCHEM SOC, V124, P995, DOI 10.1149/1.2133515
   TENG FS, 1979, J APPL POLYM SCI, V23, P101, DOI 10.1002/app.1979.070230109
   TRAPP GA, 1978, BIOL PSYCHIAT, V13, P709
   VanKooten TG, 1997, J MATER SCI-MATER M, V8, P835
   WISBEY A, 1991, BIOMATERIALS, V12, P470, DOI 10.1016/0142-9612(91)90144-Y
NR 27
TC 13
Z9 13
U1 2
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD FEB
PY 2005
VL 381
IS 3
BP 626
EP 633
DI 10.1007/s00216-004-2801-0
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 907EE
UT WOS:000227697400013
PM 15657712
DA 2018-10-19
ER

PT J
AU Diener, A
   Nebe, B
   Luthen, F
   Becker, P
   Beck, U
   Neumann, HG
   Rychly, J
AF Diener, A
   Nebe, B
   Luthen, F
   Becker, P
   Beck, U
   Neumann, HG
   Rychly, J
TI Control of focal adhesion dynamics by material surface characteristics
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; titanium; surface topography; vinculin; focal adhesion;
   mobility
ID CELL-MATRIX ADHESIONS; FIBROBLASTS; FIBRONECTIN; TOPOGRAPHY; INTEGRINS;
   RGD; BIOMATERIALS; MORPHOLOGY; MIGRATION; CROSSTALK
AB The mechanisms of cell adhesion to the extracellular matrix (ECM) which are of fundamental importance for function, survival, and growth of cells involve the formation of focal adhesions to facilitate integrin signaling. Recently, it became evident that focal adhesions are not stable but move to enable cell migration and ECM formation. We examined the number, size, and dynamic behavior of focal adhesions in living MG-63 osteoblastic cells, which were cultured on titanium surfaces with different roughnesses and on stainless steel (SS). As a marker for focal adhesions we used GFP-tagged vinculin, a cytoskeletal protein. Focal adhesions were smaller on titanium and on SS than on collagen-coated glass coverslips. The corundum-blasted rough surface of titanium induced the smallest adhesions. On all the surfaces that we have tested, we observed a mobility of focal adhesions. On collagen-coated coverslips focal adhesions moved with a speed of 60 nm/min. The speed was reduced on titanium and still more restricted on SS. The topography did not affect the mobility of focal adhesions. We conclude that on the material surfaces that we have studied a reduced mobility of focal adhesions may strengthen the linkages between cell and ECM but impair the ability to dynamically organize and remodel the EM The results may have a great impact in the functional evaluation of tailored biomaterial surfaces for the application in tissue engineering. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Rostock, Dept Internal Med, D-18053 Rostock, Germany.
   DOT GmbH, D-18059 Rostock, Germany.
   Univ Rostock, Dept Elect Elect & Informat Technol, D-18053 Rostock, Germany.
RP Rychly, J (reprint author), Univ Rostock, Dept Internal Med, Ernst Heydemann Str 6, D-18053 Rostock, Germany.
EM joachim.rychly@med.uni-rostock.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
CR Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   MULLER C, 2003, J BONE MINER RES S2, V18, pS47
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877
   PAVALKO FM, 2003, J CELL BIOCHEM, V858, P104
   Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Rychly J, 1998, CELL BIOL INT, V22, P7, DOI 10.1006/cbir.1997.0210
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172
   Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291
   Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823
   Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje
   von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Zajaczkowski MB, 2003, TISSUE ENG, V9, P525, DOI 10.1089/107632703322066705
   Zamir E, 2000, NAT CELL BIOL, V2, P191
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 42
TC 133
Z9 138
U1 1
U2 69
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 4
BP 383
EP 392
DI 10.1016/j.biomaterials.2004.02.038
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RG
UT WOS:000224135400004
PM 15275812
DA 2018-10-19
ER

PT J
AU Keselowsky, BG
   Garcia, AJ
AF Keselowsky, BG
   Garcia, AJ
TI Quantitative methods for analysis of integrin binding and focal adhesion
   formation on biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; integrin; focal adhesion; vinculin; talin
ID CELL-ADHESION; FIBRONECTIN; ACTIVATION; POLYSTYRENE
AB Integrin binding and focal adhesion assembly are critical to cellular responses to biomaterial surfaces in biomedical and biotechnological applications. While immunostaining techniques to study focal adhesion assembly are well established, a crucial need remains for quantitative methods for analyzing adhesive structures. We present simple yet robust approaches to quantify integrin binding and focal adhesion assembly on biomaterial surfaces. Integrin binding to fibronectin and a RGD-containing synthetic peptide was quantified by sequentially cross-linking integrin ligand complexes via a water-soluble homo-bifunctional cross-linker, extracting bulk cellular components in detergent, and detecting bound integrins by ELISA. Focal adhesion components (vinculin, talin, alpha-actinin) localized to adhesion plaques were isolated from bulk cytoskeletal and cytoplasmic components by mechanical rupture at a plane close to the basal cell surface and quantified by Western blotting. These approaches represent simple and efficient methodologies to analyze structure-function relationships in cell-material interactions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Andersson H, 2001, J APPL ELECTROCHEM, V31, P1, DOI 10.1023/A:1004105622558
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BRANDS R, 1988, EXP CELL RES, V176, P309, DOI 10.1016/0014-4827(88)90333-3
   BRODBECK WG, 2003, P NATL ACAD SCI USA, V99, P10287
   Clark RA, 1990, J INVEST DERMATOL, V94, p128S
   ENOMOTOIWAMOTO M, 1993, CELL ADHES COMMUN, V1, P191, DOI 10.3109/15419069309097253
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   HAIMOVICH B, 1991, CELL REGUL, V2, P271
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   KESCLOWSKY BG, 2003, J BIOMED MATER RES, V66, P247
   KESELOWSKY BG, IN PRESS BIOMATERIAL
   PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
NR 26
TC 60
Z9 62
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 4
BP 413
EP 418
DI 10.1016/j.biomaterials.2004.02.050
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RG
UT WOS:000224135400007
PM 15275815
DA 2018-10-19
ER

PT J
AU Svensson, A
   Nicklasson, E
   Harrah, T
   Panilaitis, B
   Kaplan, DL
   Brittberg, M
   Gatenholm, P
AF Svensson, A
   Nicklasson, E
   Harrah, T
   Panilaitis, B
   Kaplan, DL
   Brittberg, M
   Gatenholm, P
TI Bacterial cellulose as a potential scaffold for tissue engineering of
   cartilage
SO BIOMATERIALS
LA English
DT Article
DE cellulose; cartilage tissue engineering; chondrocytes; scaffold
ID ARTICULAR-CARTILAGE; IN-VITRO; CHONDROCYTES; HYDROGELS; MATRIX;
   BIOMATERIALS; COLLAGEN; CULTURE; REPAIR
AB Tissue constructs for cartilage with native mechanical properties have not been described to date. To address this need the bacterial cellulose (BC) secreted by Gluconacetobacter xylinus ( = Acetobacter xylinum) was explored as a novel scaffold material due to its unusual material properties and degradability. Native and chemically modified BC materials were evaluated using bovine chondrocytes. The results indicate that unmodified BC supports chondrocyte proliferation at levels of approximately 50% of the collagen type II substrate while providing significant advantages in terms of mechanical properties. Compared to tissue culture plastic and calcium alginate, unmodified BC showed significantly higher levels of chondrocyte growth. Chemical sulfation and phosphorylation of the BC, performed to mimic the glucosaminoglycans of native cartilage, did not enhance chondrocyte growth while the porosity of the material did affect chondrocyte viability. The BC did not induce significant activation of proinflammatory cytokine production during in vitro macrophage screening. Hence, unmodified BC was further explored using human chondrocytes. TEM analysis and RNA expression of the collagen II from human chondrocytes indicated that unmodified BC supports proliferation of chondrocytes. In addition, ingrowth of chondrocytes into the scaffold was verified by TEM. The results suggest the potential for this biomaterial as a scaffold for tissue engineering of cartilage. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Chalmers Univ Technol, Dept Mat & Surface Chem Biopolymer Technol, SE-41296 Gothenburg, Sweden.
   Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.
   Univ Gothenburg, Kungsbacka Hosp, Cartilage Res Unit, Dept Orthopaed, SE-43480 Kungsbacka, Sweden.
RP Gatenholm, P (reprint author), Chalmers Univ Technol, Dept Mat & Surface Chem Biopolymer Technol, SE-41296 Gothenburg, Sweden.
EM pg@pol.chalmers.se
RI Sano, Michael/E-1715-2011; Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   FREEMAN MAR, 1973, ADULT ARTICULAR CART
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Gugala Z, 2000, J BIOMED MATER RES, V49, P183, DOI 10.1002/(SICI)1097-4636(200002)49:2<183::AID-JBM5>3.0.CO;2-D
   Hardingham T., 2002, ARTHRITIS RES S3, V3z, P63
   Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Jurvelin JS, 1997, J BIOMECH, V30, P235, DOI 10.1016/S0021-9290(96)00133-9
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6
   Lee JW, 2001, APPL ENVIRON MICROB, V67, P3970, DOI 10.1128/AEM.67.9.3970-3975.2001
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Ma PX, 1999, J BIOMED MATER RES, V44, P217
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Naritomi T, 1998, J FERMENT BIOENG, V85, P89, DOI 10.1016/S0922-338X(97)80360-1
   POOLE AR, 2001, CLIN ORTHOP S, V391, P26
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   ROSS P, 1991, MICROBIOL REV, V55, P35
   SCHREIBER RE, 1999, BIOARTIFICIAL ORGANS, V2, P398
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tahara N, 1997, BIOSCI BIOTECH BIOCH, V61, P1862, DOI 10.1271/bbb.61.1862
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Wilkins RJ, 2000, J MEMBRANE BIOL, V177, P95, DOI 10.1007/s002320001103
NR 35
TC 530
Z9 558
U1 25
U2 230
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 4
BP 419
EP 431
DI 10.1016/j.biomaterials.2004.02.049
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RG
UT WOS:000224135400008
PM 15275816
DA 2018-10-19
ER

PT J
AU Lu, SH
   Sacks, MS
   Chung, SY
   Gloeckner, DC
   Pruchnic, R
   Huard, J
   de Groat, WC
   Chancellor, MB
AF Lu, SH
   Sacks, MS
   Chung, SY
   Gloeckner, DC
   Pruchnic, R
   Huard, J
   de Groat, WC
   Chancellor, MB
TI Biaxial mechanical properties of muscle-derived cell seeded small
   intestinal submucosa for bladder wall reconstitution
SO BIOMATERIALS
LA English
DT Article
DE bladder tissue engineering; stein cell; scaffold; mechanical properties;
   soft tissue biomechanics
ID MYOBLAST TRANSFER THERAPY; VASCULAR GRAFT; AUGMENTATION CYSTOPLASTY;
   COLLAGEN-FIBERS; URINARY-TRACT; DOG-MODEL; REPAIR; TRANSPLANTATION;
   CONTRACTILITY; SUBSTITUTION
AB Bladder wall replacement remains a challenging problem for urological surgery due to leakage, infection, stone formation, and extensive time needed for tissue regeneration. To explore the feasibility of producing a more functional biomaterial for bladder reconstitution, we incorporated muscle-derived cells (MDC) into small intestinal submucosa (SIS) scaffolds. MDC were harvested from mice hindleg muscle, transfected with a plasmid encoding for beta-galactosidase, and placed into single-layer SIS cell culture inserts. Twenty-five MDC and/or SIS specimens were incubated at 37 degreesC for either 10 or 20 days. After harvesting, mechanical properties were characterized using biaxial testing, and the areal strain under 1 MPa peak stress used to quantify tissue compliance. Histological results indicated that MDC migrated throughout the SIS after 20 days. The mean (+/-SE) areal strain of the 0 day control group was 0.182 +/- 0.027 (n = 5). After 10 days incubation, the mean (+/-SE) areal strain in MDC/SIS was 0.247 +/- 0.014 (n = 5) compared to 10 day control SIS 0.200 +/- 0.024 (n = 6). After 20 days incubation, the mean areal strain of MDC/SIS was 0.255 +/- 0.019 (n = 5) compared to control SIS 0.170 +/- 0.025 (n = 5). Both 10 and 20 days seeded groups were significantly different (P = 0.027) than that of incubated SIS alone, but were not different from each other. These results suggest that MDC growth was supported by SIS and that initial remodeling of the SIS ECM had occurred within the first 10 days of incubation, but may have slowed once the MDC had grown to confluence within the SIS. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Pittsburgh, Mcgowan Inst Regenerat Med, Engineered Tissue Mech Lab, Pittsburgh, PA 15219 USA.
   Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15219 USA.
   Vet Gen Hosp, Dept Surg, Div Urol, Taipei 11217, Taiwan.
   Natl Yang Ming Univ, Sch Med, Taipei 11211, Taiwan.
   Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15219 USA.
   Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15219 USA.
   Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15219 USA.
RP Sacks, MS (reprint author), Univ Pittsburgh, Mcgowan Inst Regenerat Med, Engineered Tissue Mech Lab, 100 Technol Dr,Room 250, Pittsburgh, PA 15219 USA.
EM msacks@pitt.edu
FU NIDDK NIH HHS [R01 DK55387]; NIAMS NIH HHS [R01-AR049398-01]
CR Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Chancellor MB, 2000, NEUROUROL URODYNAM, V19, P279, DOI 10.1002/(SICI)1520-6777(2000)19:3<279::AID-NAU9>3.0.CO;2-M
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   GLEESON MJ, 1992, J UROLOGY, V148, P1377, DOI 10.1016/S0022-5347(17)36916-1
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   Gloeckner DC, 2002, J UROLOGY, V167, P2247, DOI 10.1016/S0022-5347(05)65137-3
   HERBERT ST, 1993, ANN BIOMED ENG, V21, P727, DOI 10.1007/BF02368651
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   ORBERG J, 1983, CONNECT TISSUE RES, V11, P285, DOI 10.3109/03008208309004861
   ORBERG JW, 1982, CONNECT TISSUE RES, V9, P187, DOI 10.3109/03008208209160260
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Qu Z, 2000, GENE THER, V7, P428, DOI 10.1038/sj.gt.3301103
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Yokoyama T, 2001, UROLOGY, V57, P826, DOI 10.1016/S0090-4295(00)01083-9
   Yuasa K, 1998, FEBS LETT, V425, P329, DOI 10.1016/S0014-5793(98)00251-8
NR 31
TC 41
Z9 54
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 4
BP 443
EP 449
DI 10.1016/j.biomaterials.2004.05.006
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RG
UT WOS:000224135400010
PM 15275818
DA 2018-10-19
ER

PT J
AU Lenhert, S
   Meier, MB
   Meyer, U
   Chi, LF
   Wiesmann, HP
AF Lenhert, S
   Meier, MB
   Meyer, U
   Chi, LF
   Wiesmann, HP
TI Osteoblast alignment, elongation and migration on grooved polystyrene
   surfaces patterned by Langmuir-Blodgett lithography
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; bone tissue engineering; interface; Langmuir-Blodgett
   lithography; nanoimprinting; nanotopography
ID CELL; PROLIFERATION; ADHESION
AB Topographically patterned surfaces are known to influence cellular behavior in a controllable manner. However, the relatively large surface areas (several cm 2) required for many biomaterial applications are beyond the practical limits of traditional lithography. Langmuir-Blodgett lithography, a recently developed method, was used to fabricate regularly spaced grooves of different depths (50 and 150 nm) with a periodicity of 500 nm over several square centimeter on silicon surfaces. These topographies were transferred into polystyrene surfaces by means of nanoimprinting. Primary osteoblasts were cultured on the patterned polymer surfaces. They were observed to align, elongate and migrate parallel to the grooves. The combination of Langmuir-Blodgett lithography with nanoimprinting enables the fabrication of large, nanostructured surface areas on a wide spectrum of different biomaterials. Osteoblasts show a significant anisotropic behavior to these surfaces, which can enhance cell settlement oil the surface or be used to direct tissue generation on the biomaterial interface. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Klinikum Munster, Klin & Poliklin Mund & Kiefer Gesichtschirurg, D-48149 Munster, Germany.
   Univ Munster, Inst Phys, D-48149 Munster, Germany.
RP Lenhert, S (reprint author), Univ Klinikum Munster, Klin & Poliklin Mund & Kiefer Gesichtschirurg, Waldeyerstr 30, D-48149 Munster, Germany.
EM lenhert@uni-muenster.de
RI lenhert, steven/B-7689-2009; Chi, Lifeng/A-1419-2015
CR ABBOTT NL, 1992, SCIENCE, V257, P1380, DOI 10.1126/science.257.5075.1380
   ANDRIAENSEN Y, 2000, LANGMUIR, V16, P8194
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   BROCHARDWYART F, 1995, SOFT MATTER PHYS, P1
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   FISCHER EG, 1990, J IMMUNOL METHODS, V128, P235, DOI 10.1016/0022-1759(90)90215-H
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gleiche M, 2000, NATURE, V403, P173, DOI 10.1038/35003149
   Hallgren C, 2003, BIOMATERIALS, V24, P701, DOI 10.1016/S0142-9612(02)00266-1
   Hartig M, 2000, EUR BIOPHYS J BIOPHY, V29, P499, DOI 10.1007/s002490000100
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Itala A, 2001, J BIOMED MATER RES, V56, P282, DOI 10.1002/1097-4636(200108)56:2<282::AID-JBM1096>3.0.CO;2-5
   JONES SJ, 1977, CELL TISSUE RES, V184, P179
   LENHERT S, IN PRESS ADV MAT
   TENNANT DM, 1998, NANOTECHNOLOGY, P161
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wilkinson CDW, 1998, J VAC SCI TECHNOL B, V16, P3132, DOI 10.1116/1.590451
NR 21
TC 127
Z9 130
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 5
BP 563
EP 570
DI 10.1016/j.biomaterials.2004.02.068
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RJ
UT WOS:000224135700011
PM 15276364
DA 2018-10-19
ER

PT J
AU Yamane, S
   Iwasaki, N
   Majima, T
   Funakoshi, T
   Masuko, T
   Harada, K
   Minami, A
   Monde, K
   Nishimura, S
AF Yamane, S
   Iwasaki, N
   Majima, T
   Funakoshi, T
   Masuko, T
   Harada, K
   Minami, A
   Monde, K
   Nishimura, S
TI Feasibility of chitosan-based hyaluronic acid hybrid biomaterial for a
   novel scaffold in cartilage tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE chitin/chitosan; chondrocyte; hyaluronic acid/hyaluronan; cell culture;
   cell adhesion
ID BOVINE ARTICULAR CHONDROCYTES; IN-VITRO; CHONDROITIN SULFATE;
   MESSENGER-RNA; COLLAGEN GELS; DERIVATIVES; CHITIN; PROLIFERATION;
   EXPRESSION; ADHESION
AB In this study, we hypothesized that hyaluronic acid could provide superior biological effects on the chondrocytes in a three-dimensional culture system. To test this hypothesis, we investigated the in vitro behavior of rabbit chondrocytes oil a novel chitosan-based hyaluronic acid hybrid polymer fiber. The goal of the current study was to show the Superiority of this novel fiber as a scaffold biomaterial for cartilage tissue engineering. Chitosan polymer fibers (chitosan group) and chitosan-based hyaluronic acid hybrid polymer fibers (HA 0.04% and HA 0.07% groups, chitosan coated with hyaluronic acid 0.04% and 0.07%, respectively) were originally developed by the wetspinning method. Articular chondrocytes were isolated from Japanese white rabbits and cultured in the sheets consisting of each polymer fiber. The effects of each polymer fiber oil cell adhesivity, proliferation, morphological changes. and synthesis of the extracellular matrix were analyzed by quantitative a cell attachment test, DNA quantification, light and scanning electron microscopy, semi-quantitative RT-PCR, and immunohistochemical analysis. Cell adhesivity, proliferation and the synthesis of agrecan were significantly higher in the hybrid fiber (HA 0.04% and 0.07%) groups than in the chitosan group. On the cultured hybrid polymer materials, scanning electron microscopic observation showed that chondrocytes proliferated while maintaining their morphological phenotype and with a rich extracellular matrix synthesis around the cells. Immunohistochemical staining with an anti-type II collagen antibody demonstrated rich production of the type II collagen in the pericellular matrix from the chondrocytes. The chitosan-based hyaluronic acid hybrid polymer fibers show great potential as a desirable biomaterial for cartilaginous tissue scaffolds. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido 0608648, Japan.
   Hokkaido Univ, Frontier Res Ctr Postgenomic Sci & Technol, Sapporo, Hokkaido 0608648, Japan.
   Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Lab Biomacromol Chem, Sapporo, Hokkaido 0608648, Japan.
   Inst Biol Chem, Sapporo, Hokkaido, Japan.
RP Yamane, S (reprint author), Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, 14jyo Nishi Schyome, Sapporo, Hokkaido 0608648, Japan.
EM s-yamane@med.hokudai.ac.jp
RI Majima, Tokifumi/E-2412-2012; Nishimura, Shinichiro/F-5277-2011; Monde,
   Kenji/F-5286-2011; Iwasaki, Norimasa/D-6448-2012
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   Brittberg M, 2001, CLIN ORTHOP RELAT R, pS337
   CAPLAN AI, 1997, CLIN ORTHOP RELAT R, V342, P254
   CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Hart DA, 1998, BBA-GENE STRUCT EXPR, V1397, P331, DOI 10.1016/S0167-4781(98)00018-9
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HIRANO S, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P283
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   KATO Y, 1995, J RHEUMATOL, V22, P158
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KIMURA T, 1984, CLIN ORTHOP RELAT R, V186, P231
   LARSEN NE, 1992, J ORTHOPAED RES, V10, P23, DOI 10.1002/jor.1100100104
   LAURENT TC, 1992, FASEB J, V6, P2397
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Majima T, 2000, J ORTHOPAED RES, V18, P524, DOI 10.1002/jor.1100180403
   Marchuk L, 1998, BBA-GEN SUBJECTS, V1379, P171, DOI 10.1016/S0304-4165(97)00094-9
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MURDOCH AD, 2003, 49 ANN M ORTH RES SO
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   NISHIMURA S, 1985, INT J BIOL MACROMOL, V7, P100, DOI 10.1016/0141-8130(85)90038-8
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Sciore P, 1998, J ORTHOPAED RES, V16, P429, DOI 10.1002/jor.1100160406
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   SHIMAZU A, 2003, ARTHRITIS RHEUM, V36, P2479
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tamura H, 2002, MAT SCI ENG C-BIO S, V20, P143, DOI 10.1016/S0928-4931(02)00024-3
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   UNDERHILL C, 1992, J CELL SCI, V103, P293
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 45
TC 187
Z9 218
U1 7
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 6
BP 611
EP 619
DI 10.1016/j.biomaterials.2004.03.013
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RK
UT WOS:000224135800004
PM 15282139
DA 2018-10-19
ER

PT J
AU Makinen, TJ
   Veiranto, M
   Knuuti, J
   Jalava, J
   Tormala, P
   Aro, HT
AF Makinen, TJ
   Veiranto, M
   Knuuti, J
   Jalava, J
   Tormala, P
   Aro, HT
TI Efficacy of bioabsorbable antibiotic containing bone screw in the
   prevention of biomaterial-related infection due to Staphylococcus aureus
SO BONE
LA English
DT Article
DE osteomyelitis; implant-related infection; Staphylococcus aureus;
   bioabsorbable; ciprofloxacin
ID POSITRON-EMISSION-TOMOGRAPHY; IMPLANTS; OSTEOMYELITIS; PROPHYLAXIS;
   POLYMERS; DELIVERY; RATS; PET
AB Impregnation of antimicrobial agents within biodegradable orthopedic implants provides a possibility for local antimicrobial prophylaxis of biomaterial-related infections. The objective of this study was to evaluate the efficacy of a bioabsorbable ciprofloxacin containing bone screw (Ab-PLGA) in the prevention of biomaterial-related infection due to Staphylococcus aureus in a rabbit model. Animals in Group I (n = 8) received a Ab-PLGA screw contaminated with S. aureus, while animals in Group II (n = 8) received a stainless steel (SS) screw contaminated with S. aureus. In two negative control groups, the animals received a Ab-PLGA screw (Group III, n = 4) or a SS screw (Group IV, n = 4) without bacterial contamination. F-18-FDG-PET imaging, performed at 6 weeks, was applied as a novel quantitative in vivo imaging modality of implant-related infection. Infection was verified by swab cultures, direct cultures of the retrieved implant, and quantitative cultures of pulverized bone. The concentrations of ciprofloxacin in serum and local bone tissue were determined by a high performance liquid chromatographic (HPLC) method with fluorescence (FLD) detection. In the group of contaminated Ab-PLGA screws, all cultures were negative. In the group of contaminated SS screws, all cultures of retrieved implants and six cultures out of eight of pulverized bone were positive for inoculated S. aureus. In negative control groups, all cultures were negative except one contaminant (S. cohnii) found in a SS screw culture. Verified infection of contaminated SS screws was collaborated by the increased F-18-FDG-PET uptake (P = 0.004 compared with the group of contaminated Ab-PLGA screws). The mean bone tissue concentration of ciprofloxacin varied from 2.54 to 0.83 mu g/g bone as a function of distance from the implantation site. The serum concentration of ciprofloxacin remained undetectable and below the resolution of the analytic method (< 5.0 ng/ml). This study confirmed the in vivo efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to S. aureus. (c) 2004 Elsevier Inc. All rights reserved.
C1 Univ Turku, Orthopaed Res Unit, Dept Orthopaed Surg & Traumatol, FIN-20520 Turku, Finland.
   Tampere Univ Technol, Inst Biomat, Tampere, Finland.
   Turku Univ, Cent Hosp, Turku PET Ctr, FIN-20520 Turku, Finland.
   Natl Publ Hlth Inst, Dept Human Microbial Ecol & Inflammat, Turku, Finland.
RP Aro, HT (reprint author), Univ Turku, Orthopaed Res Unit, Dept Orthopaed Surg & Traumatol, FIN-20520 Turku, Finland.
EM hannu.aro@utu.fi
OI Knuuti, Juhani/0000-0003-3156-9593; Aro, Hannu/0000-0003-3118-9144
CR Ambrose CG, 2003, CLIN ORTHOP RELAT R, P279, DOI 10.1097/01.blo.0000093920.26658.ae
   BLACKBURN WD, 1991, ARTHRITIS RHEUM, V34, P110, DOI 10.1002/art.1780340118
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   COURTBROWN CM, 1990, SCAND J INFECT DIS S, V70, P74
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   De Winter F, 2001, J BONE JOINT SURG AM, V83A, P651, DOI 10.2106/00004623-200105000-00002
   DEGRADO TR, 1994, J NUCL MED, V35, P1398
   Dellamonica P, 1993, Drugs, V45 Suppl 3, P102
   Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059
   GARVIN KL, 1994, J BONE JOINT SURG AM, V76A, P1500, DOI 10.2106/00004623-199410000-00009
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   HAMACHER K, 1986, J NUCL MED, V27, P235
   Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916
   Holtom Paul D, 2003, Instr Course Lect, V52, P745
   JANSEN B, 1993, J ANTIMICROB CHEMOTH, V32, P69, DOI 10.1093/jac/32.suppl_A.69
   Kanellakopoulou K, 1999, ANTIMICROB AGENTS CH, V43, P714, DOI 10.1128/AAC.43.3.714
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Koort JK, 2004, J NUCL MED, V45, P1406
   Kraft CN, 2001, ARCH ORTHOP TRAUM SU, V121, P338, DOI 10.1007/s004020000235
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   SUGARMAN B, 1986, AM J MED, V28, P78
   Sugawara Y, 1999, EUR J NUCL MED, V26, P333, DOI 10.1007/s002590050395
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   van Griethuysen A, 2001, J CLIN MICROBIOL, V39, P86, DOI 10.1128/JCM.39.1.86-89.2001
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Wilde A H, 1993, Curr Opin Rheumatol, V5, P317
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
NR 29
TC 36
Z9 38
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD FEB
PY 2005
VL 36
IS 2
BP 292
EP 299
DI 10.1016/j.bone.2004.11.009
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 908PR
UT WOS:000227800200012
PM 15780955
DA 2018-10-19
ER

PT J
AU Knabe, C
   Stiller, M
   Berger, G
   Reif, D
   Gildenhaar, R
   Howlett, CR
   Zreiqat, H
AF Knabe, C
   Stiller, M
   Berger, G
   Reif, D
   Gildenhaar, R
   Howlett, CR
   Zreiqat, H
TI The effect of bioactive glass ceramics on the expression of bone-related
   genes and proteins in vitro
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone-substitutes; cell-biomaterial interactions; glass ceramics; human
   bone-derived cells; in situ hybridization
ID BETA-TRICALCIUM PHOSPHATE; OSTEOBLASTIC PHENOTYPE; EXTRACELLULAR-MATRIX;
   AUTOGENOUS BONE; MESSENGER-RNAS; CELLS; DIFFERENTIATION; PROLIFERATION;
   AUGMENTATION; REGENERATION
AB Using biodegradable bone substitutes in alveolar ridge augmentation avoids second-site surgery for autograft harvesting. Considerable efforts have been undertaken to develop rapidly resorbable bone substitute materials with a higher degree of biodegradability than tricalcium phosphate (TCP). This study examines the effect of novel biodegradable glass ceramics on the expression of bone-related genes and proteins by human bone-derived cells (HBDC) and compares this behavior with that of TCP. Test materials used were alpha-TCP, a surface-treated glass ceramic GB9N with crystalline phase Ca2KNa(PO4)(2) and a small amount of amorphous silica phosphate; AP40 - a glass ceramic based on crystalline phases of apatite and wollastonite; and a glass ceramic Mg5 composed of 20.6% CaO, 58.5% P2O5, 14.4% Na2O, 4.1% MgO and 2.4% CaF2 (wt%). HBDC were grown on the substrata for 3, 5, 7, 14 and 21 days, counted and probed for various bone-related mRNAs and proteins (type I collagen (Col I), osteocalcin (OC), osteopontin (OP), osteonectin (ON), alkaline phosphatase (ALP) and bone sialoprotein (BSP)). The substrata supported continuous cellular growth for 21 days. By day 21, GB9N had the highest number of HBDC. GB9N induced significantly enhanced expression of Col I, ALP, OP, OC and ON mRNA at 3 days; of OP, OC and ON mRNA and protein at 7 and 14 days; and of ALP, OP and OC mRNA and Col I, ALP, BSP, ON and OP protein at 21 days. Since all novel glass ceramics supported cellular proliferation together with expression of bone-related genes and proteins at least as much as TCP, these ceramics can be regarded as potential bone substitutes. GB9N had the most effect on osteoblastic differentiation, thus suggesting that this material may possess a higher potency to enhance osteogenesis than TCP.
C1 Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, D-14197 Berlin, Germany.
   UNSW, Sch Med Sci, Fac Med, Dept Pathol,Bone Biomat Unit, Sydney, NSW, Australia.
   Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Maxillofacial & Plast Facial Surg, Div Oral Surg, D-14197 Berlin, Germany.
   Fed Inst Mat Res & Testing, Lab Biomat, Berlin, Germany.
   Biovis Inc, Ilmenau, Germany.
RP Knabe, C (reprint author), Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
EM Christine.Knabe@medizin.fu-berlin.de
OI Reif, David/0000-0001-7815-6767
CR Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Aubin JE, 2000, BONE ENG, P19
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P43
   BERGER G, 1995, BIOMATERIALS, V16, P1241, DOI 10.1016/0142-9612(95)98131-W
   BERGER G, 1995, BIOCERAMICS, V8, P453
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BUSER D, 1994, GUIDED BONE REGENERA, P89
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   Davies JE, 1996, ANAT REC, V245, P426
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   GROSS UM, 1991, BONE-BIOMATERIAL INTERFACE, P308
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Ignatius AA, 2001, J BIOMED MATER RES, V55, P285, DOI 10.1002/1097-4636(20010605)55:3<285::AID-JBM1016>3.3.CO;2-T
   KAHARI VM, 1987, MED SCI RES-BIOCHEM, V15, P417
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   Merten HA, 2001, J CRANIOFAC SURG, V12, P59, DOI 10.1097/00001665-200101000-00010
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Ohsawa K, 2000, J BIOMED MATER RES, V52, P460, DOI 10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.3.CO;2-L
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   REIF D, 1998, UNFALLCHIRURG BIODEG, P270
   RODAN GA, 1984, BONE MINERAL RES ANN, V2, P244
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   SCHNEIDER M, 1994, CRYST RES TECHNOL, V29, P671, DOI 10.1002/crat.2170290516
   SODEK J, 1991, BONE-BIOMATERIAL INTERFACE, P97
   SODEK J, 2000, BONE ENG, P31
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   von Arx T, 2002, INT J ORAL MAX SURG, V31, P190, DOI 10.1054/ijom.2001.0205
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
   Zreiqat H., 1996, Cells and Materials, V6, P45
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 42
TC 37
Z9 41
U1 0
U2 6
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2005
VL 16
IS 1
BP 119
EP 127
DI 10.1111/j.1600-0501.2004.01066.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 888AE
UT WOS:000226345800015
PM 15642039
DA 2018-10-19
ER

PT J
AU Tatard, VM
   Menei, P
   Benoit, JP
   Montero-Menei, CN
AF Tatard, VM
   Menei, P
   Benoit, JP
   Montero-Menei, CN
TI Combining polymeric devices and stem cells for the treatment of
   neurological disorders: A promising therapeutic approach
SO CURRENT DRUG TARGETS
LA English
DT Review
DE neuronal disorders; cell therapy; tissue engineering; drug delivery;
   neurotrophic factors; microparticles; scaffolds; stem cells
ID MARROW STROMAL CELLS; NERVE GROWTH-FACTOR;
   AMYOTROPHIC-LATERAL-SCLEROSIS; BLOOD-BRAIN-BARRIER; ADRENAL CHROMAFFIN
   CELLS; POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES; PROGRESSIVE
   PARKINSONS-DISEASE; FETAL VENTRAL MESENCEPHALON; EMBRYONIC DOPAMINE
   NEURONS; PIGMENT EPITHELIAL-CELLS
AB Cell therapy will probably become a major therapeutic strategy for neuronal disorders in the coming years. Nevertheless, due to poor survival of grafted cells and limited differentiation and integration in the host tissue, certain ameliorations must be envisaged. To address these difficulties, several strategies have been developed and among them, two methods seem particularly promising : in situ controlled drug delivery and implantation of cells adhered on biomaterial-based scaffolds. Indeed, the ability of drugs, Such as growth factors, to regulate neuronal survival and/or plasticity infers the use of these molecules to treat neurodegeneration associated with human diseases. Moreover, the synthesis of cell scaffolds which mimic the extra-cellular matrix can help guide morphogenesis and tissue repair. Furthermore, cells can be cultivated on these matrices that may eventually make graft therapy a more practical approach for the treatment of neurological diseases. Nevertheless, for those two encouraging approaches multiple parameters have to be considered. such as the drug targeting strategy, but also the physical and morphological characteristics of the scaffold and the type of cells to be conveyed. This review thus focuses on those two promising strategies and also on their possible association to improve stein cell therapy of neurodegenerative disorders. Indeed, tissue replacement by grafting cells within or adhered onto drug delivering biomaterial-based devices, has recently been reported and seems to be very promising.
C1 INSERM, U646, Lab Ingn Vectorisat Particulaire, Angers, France.
   CHU Angers, Dept Neurochirurg, Angers, France.
RP Montero-Menei, CN (reprint author), INSERM, U646, Lab Ingn Vectorisat Particulaire, Angers, France.
EM claudia.montero-menei@angers.inserm.fr
RI Benoit, Jean-Pierre/K-4387-2015; MENEI, Philippe/L-6860-2015;
   Montero-Menei, claudia/K-5373-2015
CR Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   Aebischer P, 1996, HUM GENE THER, V7, P851, DOI 10.1089/hum.1996.7.7-851
   Amino S, 2002, J BIOCHEM, V131, P887, DOI 10.1093/oxfordjournals.jbchem.a003179
   Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912
   Amoureux MC, 2000, J NEUROSCI, V20, P3631
   Arnhold S, 2000, J NEUROSURG, V93, P1026, DOI 10.3171/jns.2000.93.6.1026
   Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691
   Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763
   Aubert-Pouessel A, 2004, J CONTROL RELEASE, V95, P463, DOI 10.1016/j.jconrel.2003.12.012
   Aubert-Pouessel A, 2002, PHARMACEUT RES, V19, P1046, DOI 10.1023/A:1016482809810
   Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908
   Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544
   Bachoud-Levi AC, 2000, HUM GENE THER, V11, P1723, DOI 10.1089/10430340050111377
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Bakay RAE, 2004, FRONT BIOSCI, V9, P592
   Balasubramanian SV, 2000, PHARMACEUT RES, V17, P344, DOI 10.1023/A:1007561308498
   Barker RA, 2000, CELL TRANSPLANT, V9, P235, DOI 10.1177/096368970000900209
   BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   Bensadoun JC, 2000, EXP NEUROL, V164, P15, DOI 10.1006/exnr.2000.7409
   Berezin V, 2004, J MOL NEUROSCI, V22, P33, DOI 10.1385/JMN:22:1-2:33
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Bjorklund A, 1997, NEUROBIOL DIS, V4, P186, DOI 10.1006/nbdi.1997.0151
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   Blanchet PJ, 2003, PROG NEURO-PSYCHOPH, V27, P607, DOI 10.1016/S0278-5846(03)00048-4
   Borlongan CV, 1998, EXP NEUROL, V151, P203, DOI 10.1006/exnr.1998.6790
   Borlongan CV, 2001, NEUROBIOL DIS, V8, P636, DOI 10.1006/nbdi.2001.0410
   Boury F, 1997, BIOMATERIALS, V18, P125, DOI 10.1016/S0142-9612(96)00102-0
   Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014
   Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   Brundin P, 2000, BRAIN, V123, P1380, DOI 10.1093/brain/123.7.1380
   Bunge MB, 2003, J REHABIL RES DEV, V40, P55, DOI 10.1682/JRRD.2003.08.0055
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   Buzanska L, 2002, J CELL SCI, V115, P2131
   Calhoun JD, 2003, BIOCHEM BIOPH RES CO, V306, P191, DOI 10.1016/S0006-291X(03)00937-9
   CAMARATA PJ, 1992, NEUROSURGERY, V30, P313, DOI 10.1227/00006123-199203000-00001
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431
   Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193
   Carrascosa C, 2004, BIOMATERIALS, V25, P707, DOI 10.1016/S0142-9612(03)00562-3
   Carrascosa C, 2003, J BIOMATER APPL, V18, P95, DOI 10.1177/088532803038026
   Carvey PM, 2001, EXP NEUROL, V171, P98, DOI 10.1006/exnr.2001.7735
   CERVOSNAVARRO J, 1988, HISTOL HISTOPATHOL, V3, P203
   Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6
   Cherksey BD, 1996, NEUROSCIENCE, V75, P657, DOI 10.1016/0306-4522(96)00262-X
   Chiba S, 2003, CELL TRANSPLANT, V12, P457, DOI 10.3727/000000003108747019
   Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253
   D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Date I, 1997, EXP NEUROL, V147, P10, DOI 10.1006/exnr.1997.6579
   Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935
   DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0
   Doudet DJ, 2004, EXP NEUROL, V189, P361, DOI 10.1016/j.expneurol.2004.06.009
   Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/scd.2004.13.325
   DRUCKERCOLIN R, 1988, PROG BRAIN RES, V78, P567
   Duconseille E, 2001, RESTOR NEUROL NEUROS, V18, P39
   Elcin YM, 2003, TISSUE ENG, V9, P1047, DOI 10.1089/107632703322495682
   Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114
   Emerich DF, 1996, J NEUROSCI, V16, P5168
   Emerich DF, 1998, CELL TRANSPLANT, V7, P213, DOI 10.1016/S0963-6897(97)00163-2
   Faisant N, 2002, INT J PHARM, V242, P281, DOI 10.1016/S0378-5173(02)00188-6
   Faisant N, 2003, EUR J PHARM BIOPHARM, V56, P271, DOI 10.1016/S0939-6411(03)00104-8
   Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Fournier E, 2003, CANCER, V97, P2822, DOI 10.1002/cncr.11388
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   FRAICHARD A, 1995, J CELL SCI, V108, P3181
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002
   FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202
   Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999
   FRIDEN PM, 1994, NEUROSURGERY, V35, P294, DOI 10.1227/00006123-199408000-00016
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   GOETZ CG, 1989, NEW ENGL J MED, V320, P337, DOI 10.1056/NEJM198902093200601
   Gratsch TE, 2002, DEV BIOL, V245, P83, DOI 10.1006/dbio.2002.0629
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hagell P, 1999, BRAIN, V122, P1121, DOI 10.1093/brain/122.6.1121
   Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863
   Harrison J, 2004, BIOMATERIALS, V25, P4963, DOI 10.1016/j.biomaterials.2004.01.054
   HEFTI F, 1994, NEUROBIOL AGING, V15, pS193
   HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109
   HELLER J, 1980, BIOMATERIALS, V1, P51, DOI 10.1016/0142-9612(80)90060-5
   Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307
   HERRMANN JB, 1970, ARCH SURG-CHICAGO, V100, P486
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   HURTIG H, 1989, ANN NEUROL, V25, P607, DOI 10.1002/ana.410250613
   Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482
   ISACSON O, 1995, NAT MED, V1, P1189, DOI 10.1038/nm1195-1189
   Iza M, 1998, J CONTROL RELEASE, V52, P41, DOI 10.1016/S0168-3659(97)00191-0
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   JALIL R, 1990, J MICROENCAPSUL, V7, P297, DOI 10.3109/02652049009021842
   Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X
   Johansen P, 2000, EUR J PHARM BIOPHARM, V50, P129, DOI 10.1016/S0939-6411(00)00079-5
   Jollivet C, 2004, NEUROSCI LETT, V362, P79, DOI 10.1016/j.neulet.2004.02.068
   Jollivet C, 2004, NEUROSCI LETT, V356, P207, DOI 10.1016/j.neulet.2003.11.051
   Jollivet C, 2004, BIOMATERIALS, V25, P933, DOI 10.1016/S0142-9612(03)00601-X
   Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137
   Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0
   KHAN T, 1990, NEUROSCI LETT, V118, P172, DOI 10.1016/0304-3940(90)90619-K
   Kim HT, 2004, YONSEI MED J, V45, P32
   Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q
   Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767
   KORDOWER JH, 1994, P NATL ACAD SCI USA, V91, P9077, DOI 10.1073/pnas.91.19.9077
   Kordower JH, 1997, J COMP NEUROL, V387, P96, DOI 10.1002/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I
   KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702
   Kordower JH, 1996, J COMP NEUROL, V370, P203
   Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303
   Krewson CE, 1996, J BIOMAT SCI-POLYM E, V8, P103
   Krewson CE, 1996, BRAIN RES, V727, P169
   Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536
   Lee SJ, 2002, J BIOMAT SCI-POLYM E, V13, P197, DOI 10.1163/156856202317414375
   LETOURNEAU PC, 1994, J NEUROSCI, V14, P915
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li RH, 2000, J NEUROSCI RES, V59, P342, DOI 10.1002/(SICI)1097-4547(20000201)59:3<342::AID-JNR7>3.0.CO;2-Z
   Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9
   Lie DC, 2002, J NEUROSCI, V22, P6639
   Lindgren M, 2000, BIOCONJUGATE CHEM, V11, P619, DOI 10.1021/bc990156s
   LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529
   LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208
   Lu W, 1995, PDA J Pharm Sci Technol, V49, P13
   Lu X, 1997, J COMP NEUROL, V388, P484
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Mahoney MJ, 1996, J PHARM SCI, V85, P1276, DOI 10.1021/js9601602
   MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5
   McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176
   McKay RD, 2004, PHILOS T ROY SOC B, V359, P851, DOI 10.1098/rstb.2004.1472
   MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q
   Menei P, 2003, ACT NEUR S, V88, P51
   Menei P, 2004, CANCER, V100, P405, DOI 10.1002/cncr.11922
   Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253
   Mezey E, 2000, EUR J PHARMACOL, V405, P297, DOI 10.1016/S0014-2999(00)00561-6
   Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418
   Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4
   Newman KD, 2004, BIOMATERIALS, V25, P5763, DOI 10.1016/j.biomaterials.2004.01.027
   Nishimura F, 2003, STEM CELLS, V21, P171, DOI 10.1634/stemcells.21-2-171
   Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69
   NYILAS E, 1983, T AM SOC ART INT ORG, V29, P307
   Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197
   Oiwa Y, 2002, BRAIN RES, V947, P271, DOI 10.1016/S0006-8993(02)02934-7
   Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2
   Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720
   Olanow CW, 2003, ANN NEUROL, V53, pS1, DOI 10.1002/ana.10566
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Park S, 2003, NEUROSCI LETT, V353, P91, DOI 10.1016/j.neulet.2003.08.082
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   Pean JM, 1998, J CONTROL RELEASE, V56, P175, DOI 10.1016/S0168-3659(98)00086-8
   Pean JM, 1999, PHARMACEUT RES, V16, P1294, DOI 10.1023/A:1014818118224
   Penn RD, 1997, NEUROSURGERY, V40, P94, DOI 10.1097/00006123-199701000-00021
   PESCHANSKI M, 1994, BRAIN, V117, P487, DOI 10.1093/brain/117.3.487
   PETERSON DI, 1989, NEUROLOGY, V39, P235, DOI 10.1212/WNL.39.2.235
   Pinzon A, 2001, J NEUROSCI RES, V64, P533, DOI 10.1002/jnr.1105
   Rathjen J, 2002, DEVELOPMENT, V129, P2649
   Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0
   Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430
   Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11
   SABATE O, 1995, NAT GENET, V9, P256, DOI 10.1038/ng0395-256
   Salehi A, 2004, J NEURAL TRANSM, V111, P323, DOI 10.1007/s00702-003-0091-x
   Sanberg PR, 1996, NAT BIOTECHNOL, V14, P1692, DOI 10.1038/nbt1296-1692
   Sanberg PR, 1997, NAT MED, V3, P1129, DOI 10.1038/nm1097-1129
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Saporta S, 1997, CELL TRANSPLANT, V6, P579, DOI 10.1016/S0963-6897(97)00115-2
   Sautter J, 1998, EXP NEUROL, V149, P230, DOI 10.1006/exnr.1997.6718
   Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785
   Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7
   Schulze D, 2000, IMECHE CONF TRANS, V2000, P97
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   SEIGER A, 1993, BEHAV BRAIN RES, V57, P255, DOI 10.1016/0166-4328(93)90141-C
   Shaw D, 2003, J CRANIOFAC SURG, V14, P308, DOI 10.1097/00001665-200305000-00008
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith SB, 1998, EXP EYE RES, V66, P403, DOI 10.1006/exer.1997.0443
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   Storch A, 2000, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706
   STORCH A, 2004, CELL TISSUE RES
   STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8
   Studer L, 2000, J NEUROSCI, V20, P7377
   Subramanian T, 2002, CELL TRANSPLANT, V11, P207
   Subramanian T, 2001, SEMIN NEUROL, V21, P103, DOI 10.1055/s-2001-13125
   Takano N, 2002, PIGM CELL RES, V15, P192, DOI 10.1034/j.1600-0749.2002.01079.x
   Tatard VM, 2004, CELL TRANSPLANT, V13, P573, DOI 10.3727/000000004783983675
   TATARD VM, 2004, IN PRESS BIOMATERIAL
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0
   Tornqvist N, 2000, EXP NEUROL, V164, P130, DOI 10.1006/exnr.2000.7411
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tseng JL, 1998, NEUROREPORT, V9, P1817, DOI 10.1097/00001756-199806010-00027
   Uchida T, 1996, CHEM PHARM BULL, V44, P235
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   Veziers J, 2001, J NEUROSURG, V95, P489, DOI 10.3171/jns.2001.95.3.0489
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   Wang LJ, 2002, J NEUROSCI, V22, P6920
   Wang N, 1997, J BIOMAT SCI-POLYM E, V9, P75
   Watts RL, 2003, J NEURAL TRANSM-SUPP, P215
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.3.CO;2-3
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
   WU XS, 1995, ENCY HDB BIOMATERIAL, V1151
   Yan J, 2001, J NEUROCHEM, V76, P307, DOI 10.1046/j.1471-4159.2001.00073.x
   Yang F, 2000, CHROMOSOME RES, V8, P93, DOI 10.1023/A:1009251917072
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011
   Zawada WM, 1998, BRAIN RES, V786, P96, DOI 10.1016/S0006-8993(97)01408-X
   Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100
   Zhou JW, 1997, DEV BRAIN RES, V100, P43, DOI 10.1016/S0165-3806(97)00019-9
NR 224
TC 28
Z9 29
U1 1
U2 15
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-4501
EI 1873-5592
J9 CURR DRUG TARGETS
JI Curr. Drug Targets
PD FEB
PY 2005
VL 6
IS 1
BP 81
EP 96
DI 10.2174/1389450053344885
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 903JO
UT WOS:000227422200009
PM 15720216
DA 2018-10-19
ER

PT J
AU Kulbatski, I
   Mothe, AJ
   Nomura, H
   Tator, CH
AF Kulbatski, I
   Mothe, AJ
   Nomura, H
   Tator, CH
TI Endogenous and exogenous CNS derived stem/progenitor cell approaches for
   neurotrauma
SO CURRENT DRUG TARGETS
LA English
DT Review
DE neural stem/progenitors; traumatic brain injury; spinal cord injury;
   transplantation; neurotrophins; endogenous; regeneration
ID NEURAL STEM-CELLS; RAT SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM;
   FIBROBLAST-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; ADULT-MOUSE BRAIN;
   NEUROEPITHELIAL PRECURSOR CELLS; NEUROTROPHIC FACTOR PROTECTS; OLFACTORY
   ENSHEATHING CELLS; MAGNETIC-RESONANCE TRACKING
AB Neural stem/progenitor cells capable of generating new neurons and glia, reside in specific areas of the adult mammalian central nervous system (CNS), including the ependymal region of the spinal cord and the subventricular zone (SVZ), hippocampus, and dentate gyros of the brain. Much is known about the neurogenic regions in the CNS, and their response to various stimuli including injury, neurotrophins (NFs), morphogens, and environmental factors like learning, stress, and aging. This work has shaped our current views about the CNS's potential to recover lost tissue and function post-traumatically and the therapies to support the intrinsic regenerative capacity of the brain or spinal cord. Recently, intensive research has explored the potential or harvesting, culturing, and transplanting neural stem/progenitors as a therapeutic intervention for spinal cord injury (SCI) and traumatic brain injury (TBI). Another strategy has focused on maximizing the potential of this endogenous population of cells by Stimulating their recruitment, proliferation, migration, and differentiation in vivo following traumatic lesions to the CNS. The promise of such experimental treatments has prompted tissue and biomaterial engineers to implant synthetic three-dimensional biodegradable scaffolds seeded with neural stem/progenitors into CNS lesions. Although there is no definitive answer about the ideal cell type for transplantation, strong evidence supports the use of region specific neural stem/progenitors. The technical and logistic considerations for transplanting neural stem/progenitors are extensive and crucial to optimizing and maintaining cell survival both before and after transplantation, as well as for tracking the fate of transplanted cells. These issues have been systematically addressed in many animal models, that has improved our understanding and approach to clinical therapeutic paradigms.
C1 Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.
   Univ Toronto, Fac Med, Toronto, ON, Canada.
RP Tator, CH (reprint author), Toronto Western Hosp, 399 Bathurst St McLaughlin Pavilion 12-423, Toronto, ON M5T 2S8, Canada.
EM charles.tator@uhn.on.ca
CR Aberg MAI, 2000, J NEUROSCI, V20, P2896
   ADRIAN EK, 1962, J NEUROPATH EXP NEUR, V21, P597, DOI 10.1097/00005072-196210000-00007
   Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539
   Allamargot C, 2001, BRAIN RES, V918, P28, DOI 10.1016/S0006-8993(01)02761-5
   ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303
   Arsenijevic Y, 1998, J NEUROSCI, V18, P2118
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P330, DOI 10.3171/spi.2004.1.3.0330
   BARONVANEVERCOOREN A, 1993, J NEUROSCI RES, V35, P428
   BARONVANEVERCOOREN A, 1991, NEUROSCI LETT, V131, P241, DOI 10.1016/0304-3940(91)90623-2
   BEATTIE MS, 1990, J NEUROBIOL, V21, P1108, DOI 10.1002/neu.480210714
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3
   BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86
   Benraiss A, 2001, J NEUROSCI, V21, P6718
   Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477
   BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001
   Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9
   Brezun JM, 2000, HIPPOCAMPUS, V10, P37, DOI 10.1002/(SICI)1098-1063(2000)10:1<37::AID-HIPO4>3.0.CO;2-C
   BRUNI JE, 1987, ACTA ANAT, V128, P265
   Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.3.CO;2-T
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Butt AM, 2000, J NEUROSCI RES, V59, P477, DOI 10.1002/(SICI)1097-4547(20000215)59:4<477::AID-JNR2>3.0.CO;2-J
   Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9
   Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197
   CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0
   Canning DR, 1996, INT J DEV NEUROSCI, V14, P153, DOI 10.1016/0736-5748(96)00004-4
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   CAO QL, 2002, NEURAL STEM CELLS ME, V198, P307
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005
   CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3
   Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035
   Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4
   Christie SD, 2004, CAN J NEUROL SCI, V31, P87, DOI 10.1017/S0317167100002882
   Ciaroni S, 1999, J COMP NEUROL, V411, P495
   Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001
   Craig CG, 1996, J NEUROSCI, V16, P2649
   DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S
   DAS GD, 1983, J NEUROL SCI, V62, P191, DOI 10.1016/0022-510X(83)90199-5
   DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103
   Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192
   Dempsey RJ, 2003, J NEUROCHEM, V87, P586, DOI 10.1046/j.1471-4159.2003.02022.x
   Dervan AG, 2003, J COMP NEUROL, V458, P293, DOI 10.1002/cnr.10594
   DIENER PS, 1994, NEUROREPORT, V5, P1913, DOI 10.1097/00001756-199410000-00018
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71
   EGAR M, 1972, EXP NEUROL, V37, P422, DOI 10.1016/0014-4886(72)90085-4
   Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597
   Enomoto M, 2003, EUR J NEUROSCI, V17, P1223, DOI 10.1046/j.1460-9568.2003.02555.x
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Falci S, 1997, J NEUROTRAUM, V14, P875, DOI 10.1089/neu.1997.14.875
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   FERNANDEZ E, 1993, NEUROSURGERY, V33, P889
   FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144
   FRIEDMAN B, 1995, J NEUROSCI, V15, P1044
   FRIM DM, 1993, NEUROREPORT, V4, P367, DOI 10.1097/00001756-199304000-00006
   FRIM DM, 1994, P NATL ACAD SCI USA, V91, P5104, DOI 10.1073/pnas.91.11.5104
   FRISA PS, 1994, J NEUROSCI RES, V39, P47, DOI 10.1002/jnr.490390107
   FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453
   Frisen J, 1998, CELL MOL LIFE SCI, V54, P935, DOI 10.1007/s000180050224
   Fujiwara Y, 2004, NEUROSCI LETT, V366, P287, DOI 10.1016/j.neulet.2004.05.080
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9
   Gates M A, 2000, Prog Brain Res, V127, P115
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015
   GILMORE SA, 1980, BRAIN RES, V201, P185, DOI 10.1016/0006-8993(80)90783-0
   Goh ELK, 2003, J HEMATOTH STEM CELL, V12, P671, DOI 10.1089/15258160360732696
   GOLDBERG WJ, 1988, J NEUROSCI RES, V19, P34, DOI 10.1002/jnr.490190106
   Gotz M, 2003, NEUROSCIENTIST, V9, P379, DOI 10.1177/1073858403257138
   Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365
   Gould E, 1997, J NEUROSCI, V17, P2492
   Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168
   Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263
   Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374
   Grill R, 1997, J NEUROSCI, V17, P5560
   Gritti A, 1996, J NEUROSCI, V16, P1091
   Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2
   Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8
   Hammang JP, 1997, EXP NEUROL, V147, P84, DOI 10.1006/exnr.1997.6592
   HARVEY AR, 2000, LABELING IDENTIFYING, P319
   Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B
   HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4
   HEFTI F, 1997, NEUROPROTECTION CNS, P243
   Hildebrandt K, 1999, J NEURAL TRANSM, V106, P549, DOI 10.1007/s007020050178
   Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202
   HOCKFIELD S, 1985, J NEUROSCI, V5, P3310
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4
   Horan P K, 1990, Methods Cell Biol, V33, P469
   Horner PJ, 2000, J NEUROSCI, V20, P2218
   HOULE JD, 1988, J COMP NEUROL, V269, P535, DOI 10.1002/cne.902690406
   HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0
   Ijichi A, 1996, GENE THER, V3, P389
   Ito H, 2003, J NEUROSCI RES, V71, P648, DOI 10.1002/jnr.10532
   Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041
   Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Kehl LJ, 1997, SCIENCE, V276, P586, DOI 10.1126/science.276.5312.586
   Kemp P, 1999, SIGHT SOUND, V9, P3
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0
   Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013
   Kim DH, 1996, NEUROREPORT, V7, P2221, DOI 10.1097/00001756-199609020-00033
   KITCHENS DL, 1994, J NEUROBIOL, V25, P797, DOI 10.1002/neu.480250705
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178
   Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687
   Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974
   Kondziolka D, 2002, J CLIN NEUROSCI, V9, P225, DOI 10.1054/jocn.2001.1043
   Kondziolka Douglas, 2003, Phys Med Rehabil Clin N Am, V14, pS153, DOI 10.1016/S1047-9651(02)00057-8
   Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768
   KOSHINAGA M, 1993, EXP NEUROL, V120, P32, DOI 10.1006/exnr.1993.1038
   Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8
   KRAUSRUPPERT R, 1975, J NEUROL SCI, V26, P555, DOI 10.1016/0022-510X(75)90056-8
   Kuhn HG, 1997, J NEUROSCI, V17, P5820
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899
   Lachmann T, 2002, NEUROPS COG, V20, P3
   Lacza Z, 2003, BRAIN RES PROTOC, V11, P145, DOI 10.1016/S1385-299X(03)00039-4
   Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983
   Lavik Erin, 2002, Methods Mol Biol, V198, P89
   Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99
   Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li WW, 1998, J NEUROSCI, V18, P8853
   Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8
   Liker MA, 2003, BRAIN RES, V971, P168, DOI 10.1016/S0006-8993(03)02337-0
   LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1
   LIPTON SA, 1988, P NATL ACAD SCI USA, V85, P2388, DOI 10.1073/pnas.85.7.2388
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014
   Lu K, 2002, SPINE, V27, P887, DOI 10.1097/00007632-200204150-00021
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Lundberg C, 1997, EXP NEUROL, V145, P342, DOI 10.1006/exnr.1997.6503
   Maas AIR, 2004, ACT NEUR S, V89, P113
   Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753
   Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0
   Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6
   Malberg JE, 2000, J NEUROSCI, V20, P9104
   Markakis EA, 1999, J COMP NEUROL, V406, P449
   Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x
   Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000
   MARTENS J, 1998, SOC NEUR ABSTR, V24, P1528
   MATTHEWS MA, 1979, ACTA NEUROPATHOL, V45, P27, DOI 10.1007/BF00691801
   Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653
   McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x
   McDonald JW, 2004, J NEUROTRAUM, V21, P383, DOI 10.1089/089771504323004539
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Meltzer H, 1998, J NEUROSURG, V88, P93, DOI 10.3171/jns.1998.88.1.0093
   MICHEL ME, 1979, J NEUROCYTOL, V8, P529, DOI 10.1007/BF01208508
   Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964
   Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5
   MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853
   Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7
   Montgomery CT, 1996, EXP NEUROL, V137, P277, DOI 10.1006/exnr.1996.0026
   MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537
   Morrison SJ, 2001, CURR OPIN CELL BIOL, V13, P666, DOI 10.1016/S0955-0674(00)00269-6
   MORSHEAD CM, 1992, J NEUROSCI, V12, P249
   MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9
   Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x
   Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219
   Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008
   Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8
   Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268
   NORDLANDER RH, 1978, J COMP NEUROL, V180, P349, DOI 10.1002/cne.901800211
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   O'Kane CJ, 2003, SEMIN CELL DEV BIOL, V14, P3, DOI 10.1016/S1084-9521(02)00162-3
   Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341
   OHARA CM, 1994, TISSUE CELL, V26, P599, DOI 10.1016/0040-8166(94)90012-4
   Onifer SM, 1997, CELL TRANSPLANT, V6, P327, DOI 10.1016/S0963-6897(97)00037-7
   ONIFER SM, 1993, CELL TRANSPLANT, V2, P131, DOI 10.1177/096368979300200207
   OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743
   Oudega M, 1996, EXP NEUROL, V140, P218, DOI 10.1006/exnr.1996.0131
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5
   PARAMORE CG, 1992, J NEUROSCI METH, V44, P7, DOI 10.1016/0165-0270(92)90108-P
   Parent JM, 1997, J NEUROSCI, V17, P3727
   Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002
   Park KI, 1999, J NEUROTRAUM, V16, P675, DOI 10.1089/neu.1999.16.675
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Parmar M, 2003, MOL CELL NEUROSCI, V23, P531, DOI 10.1016/S1044-7431(03)00097-6
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   PECHAN PA, 1995, NEUROREPORT, V6, P669, DOI 10.1097/00001756-199503000-00021
   Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040
   Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199
   Plant GW, 2000, CELL TRANSPLANT, V9, P759, DOI 10.1177/096368970000900603
   Quinn SM, 1999, J NEUROSCI RES, V57, P590, DOI 10.1002/(SICI)1097-4547(19990901)57:5<590::AID-JNR2>3.0.CO;2-X
   Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399
   Rajan P, 1998, J NEUROSCI, V18, P3620
   RAKIC P, 1968, AM J ANAT, V122, P317, DOI 10.1002/aja.1001220210
   RAMONCUETO A, 1998, NEUROSCIENCE, V18, P3803
   REIER PJ, 1992, EXP NEUROL, V115, P177, DOI 10.1016/0014-4886(92)90245-L
   REIER PJ, 1992, J NEUROTRAUM, V9, pS223
   REIER PJ, 1988, PROG BRAIN RES, V78, P173
   RENDE M, 1993, J COMP NEUROL, V338, P560, DOI 10.1002/cne.903380406
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   REYNOLDS ME, 1991, BRAIN RES, V559, P149, DOI 10.1016/0006-8993(91)90298-A
   Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3
   Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1227/01.NEU.0000027826.68845.CF
   Rietze R, 2000, J COMP NEUROL, V424, P397
   ROSENBERG WS, 1992, MOL BRAIN RES, V16, P311, DOI 10.1016/0169-328X(92)90240-C
   Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007
   Savitz SI, 2002, ANN NEUROL, V52, P266, DOI 10.1002/ana.60000
   Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Scott BW, 2000, EXP NEUROL, V165, P231, DOI 10.1006/exnr.2000.7458
   Senior K, 2002, LANCET NEUROL, V1, P269, DOI 10.1016/S1474-4422(02)00145-X
   Setoguchi T, 2004, EXP NEUROL, V189, P33, DOI 10.1016/j.expneurol.2003.12.007
   SHIGENO T, 1991, J NEUROSCI, V11, P2914
   Shihabuddin LS, 2000, J NEUROSCI, V20, P8727
   Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697
   Shimazaki T, 2001, J NEUROSCI, V21, P7642
   Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SIMPSON SB, 1968, J COMP NEUROL, V134, P193, DOI 10.1002/cne.901340207
   SIMPSON SB, 1994, PROG BRAIN RES, V103, P229
   SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5
   SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x
   STANFIELD BB, 1988, EXP BRAIN RES, V72, P399
   Stemple DL, 1997, NEURON, V18, P1, DOI 10.1016/S0896-6273(01)80018-0
   STOKES BT, 1992, EXP NEUROL, V116, P1, DOI 10.1016/0014-4886(92)90171-L
   STOPPINNI L, J NEUROSCI METHODS, V27, P121
   Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0
   Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0
   Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x
   Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634
   Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039
   Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185
   Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007
   TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x
   Tator CH, 1995, CONT MANAGEMENT SPIN, V3, P9
   Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   TOHYAMA T, 1992, LAB INVEST, V66, P303
   TOOYAMA I, 1991, NEUROSCIENCE, V40, P769, DOI 10.1016/0306-4522(91)90011-C
   Torii MA, 1999, DEVELOPMENT, V126, P443
   Tropepe V, 1997, J NEUROSCI, V17, P7850
   Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192
   Tzeng SF, 2001, J NEUROSCI RES, V66, P1161
   UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459
   van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439
   van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427
   van Praag H, 1999, NAT NEUROSCI, V2, P266
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   VAQUERO J, 1981, ACTA NEUROCHIR, V59, P209, DOI 10.1007/BF01406350
   Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x
   Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9
   Wagner C L, 1999, J Perinatol, V19, P14, DOI 10.1038/sj.jp.7200080
   WALICKE PA, 1988, J NEUROSCI, V8, P2618
   WALLACE MC, 1987, SURG NEUROL, V27, P209, DOI 10.1016/0090-3019(87)90031-0
   Weinstein DE, 1996, BRAIN RES, V743, P11, DOI 10.1016/S0006-8993(96)00979-1
   Weiss ML, 2003, EXP NEUROL, V182, P288, DOI 10.1016/S0014-4886(03)00128-6
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7
   Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621
   WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207
   Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974
   Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397
   Wirth ED, 2001, J NEUROTRAUM, V18, P911, DOI 10.1089/089771501750451839
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
   Wu SF, 2002, J NEUROSCI RES, V69, P940, DOI 10.1002/jnr.10346
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056
   Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798
   Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001
   Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029
   Yang P, 2002, J NEUROSCI RES, V69, P466, DOI 10.1002/jnr.10320
   Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998
   Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869
   Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8
   Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650
   ZHOU CF, 1985, NEUROSCIENCE, V16, P819, DOI 10.1016/0306-4522(85)90096-X
   Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3
   Zigova T, 1996, DEV BIOL, V173, P459, DOI 10.1006/dbio.1996.0040
   Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684
NR 286
TC 56
Z9 71
U1 0
U2 12
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-4501
EI 1873-5592
J9 CURR DRUG TARGETS
JI Curr. Drug Targets
PD FEB
PY 2005
VL 6
IS 1
BP 111
EP 126
DI 10.2174/1389450053345037
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 903JO
UT WOS:000227422200011
PM 15720218
DA 2018-10-19
ER

PT J
AU Pastor, MT
   Esteras-Chopo, A
   de la Paz, ML
AF Pastor, MT
   Esteras-Chopo, A
   de la Paz, ML
TI Design of model systems for amyloid formation: lessons for prediction
   and inhibition
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID BETA-SHEET PROTEINS; FIBRIL FORMATION; AGGREGATION RATES; SEQUENCE
   DETERMINANTS; PEPTIDE; MUTATIONS; BETA(2)-MICROGLOBULIN; POLYPEPTIDE;
   PROPENSITY; CONSTRUCTION
AB The determination of the physico-chemical principles underlying amyloid deposition is fundamental to the identification of therapeutic strategies to prevent or cure amyloid-related disorders. Given the complexity of the molecular events involved in protein self-association, researchers have designed simplified systems that facilitate the discovery of factors that predispose polypeptides to amyloid formation and aggregation. These systems have provided valuable knowledge about the determinants underlying the structural transitions to the polymeric P-sheet state present in amyloid fibers and in more disordered aggregates. The integration of this knowledge is crucial to the identification of the regions responsible for the amyloidogenic and aggregating behavior of a given protein. The reliable discovery of amyloid-promoting fragments in proteins should have a great impact on the development of anti-amyloid agents. Also, methods that identify aggregation-prone motifs have a broad range of biotechnological applications, such as the improvement of the solubility of recombinant proteins for pharmaceutical and industrial purposes, and peptide-based biomaterial engineering.
C1 European Mol Biol Lab, D-69117 Heidelberg, Germany.
RP de la Paz, ML (reprint author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.
EM delapaz@embl.de
CR Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200
   Brown CL, 2002, J AM CHEM SOC, V124, P6846, DOI 10.1021/ja0261271
   Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493
   Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299
   Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   Ciani B, 2002, J BIOL CHEM, V277, P10150, DOI 10.1074/jbc.M107663200
   de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100
   de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199
   Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a
   Doig AJ, 2002, BIOCHEM SOC T, V30, P537, DOI 10.1042/bst0300537
   Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043
   Fernandez A, 2003, P NATL ACAD SCI USA, V100, P6446, DOI 10.1073/pnas.0731893100
   FERNANDEZESCAMILLA, 2004, NAT BIOTECHNOL, V22, P1302
   Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4
   Jones S, 2003, J MOL BIOL, V325, P249, DOI 10.1016/S0022-2836(02)01227-5
   Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Matsuura T, 2002, PROTEIN SCI, V11, P2631, DOI 10.1110/ps.0215102
   Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2
   McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791
   Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200
   Permanne B, 2002, FASEB J, V16, P860, DOI 10.1096/fj.01-0841fje
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099
   Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Takahashi Y, 2000, STRUCT FOLD DES, V8, P915, DOI 10.1016/S0969-2126(00)00183-0
   Takahashi Y, 2004, BIOORGAN MED CHEM, V12, P693, DOI 10.1016/j.bmc.2003.11.022
   Takahashi Y, 2002, CHEMBIOCHEM, V3, P637, DOI 10.1002/1439-7633(20020703)3:7<637::AID-CBIC637>3.0.CO;2-9
   Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504
   Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0
   Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200
   TURNELL WG, 1992, J MOL BIOL, V227, P1205, DOI 10.1016/0022-2836(92)90532-O
   Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002
   Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101
   von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129
   Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6
   Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098
   Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604
   Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078
NR 52
TC 40
Z9 40
U1 0
U2 6
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD FEB
PY 2005
VL 15
IS 1
BP 57
EP 63
DI 10.1016/j.sbi.2005.01.004
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 905UU
UT WOS:000227596800009
PM 15718134
DA 2018-10-19
ER

PT J
AU Hurteaux, R
   Edwards-Levy, F
   Laurent-Maquin, D
   Levy, MC
AF Hurteaux, R
   Edwards-Levy, F
   Laurent-Maquin, D
   Levy, MC
TI Coating alginate microspheres with a serum albumin-alginate membrane:
   application to the encapsulation of a peptide
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE biomaterial; microcapsule; microsphere; propylene glycol alginate;
   sustained release; transacylation
ID MECHANICAL-PROPERTIES; COATED BEADS; HYDROGELS; RELEASE; GROWTH; PH
AB Calcium alginate gel microspheres coated with a human serum albumin (HSA)-alginate membrane were prepared adapting a transacylation method previously applied to large beads. The procedure involved emulsification of an aqueous solution of sodium alginate and propylene glycol alginate (PGA) in an oily phase, followed by addition of CaCl2. The resulting gel microspheres were transferred in an aqueous solution of HSA. The addition of 0.5 M NaOH started the reaction between PGA and HSA, producing amide bonds and forming a membrane around the particles. An optimization study was conducted, notably exploring the addition of HSA to the internal phase. The microcapsules were studied with respect to morphology (optical and scanning electron microscopy) and size (laser granulometry), in comparison with uncoated gel microspheres. Biocompatibility was checked in osteoblast cultures. Lysine-arginine-phenylalanine-lysine (KRFK) was encapsulated and the release kinetics was studied in vitro. The method provided stable microspheres (size around 60 mum), with a membrane surviving a treatment with citrate and resisting lyophilization. The microcapsules were shown biocompatible. The release of KRFK was slower (release time > 8 days) than that of uncoated microspheres. These microcapsules might be useful as peptide containers to be combined with prosthetic materials for improving osteointegration. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Reims, CNRS, FRE2715, IFR Biomol 53,Equipe Pharmacotech,Fac Pharm, F-51096 Reims, France.
   Univ Reims, INSERM, ERM Interfaces Biomat Tissus Hotes 0203, IFR Biomol 53,Fac Odontol, F-51096 Reims, France.
RP Edwards-Levy, F (reprint author), Univ Reims, CNRS, FRE2715, IFR Biomol 53,Equipe Pharmacotech,Fac Pharm, 51 Rue Cognacq Jay, F-51096 Reims, France.
EM florence.edwards@univ-reims.fr
OI Edwards-Levy, Florence/0000-0002-5271-5281
CR BENITA S, 1984, LAB PHARM, V32, P694
   Carin M, 2003, BIOTECHNOL BIOENG, V82, P207, DOI 10.1002/bit.10559
   Edwards-Levy F, 1999, BIOMATERIALS, V20, P2069, DOI 10.1016/S0142-9612(99)00111-8
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Joly A, 1997, TRANSPLANTATION, V63, P795, DOI 10.1097/00007890-199703270-00002
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LEVY MC, 1991, J PHARM SCI, V80, P578, DOI 10.1002/jps.2600800617
   Levy MC, 1996, J MICROENCAPSUL, V13, P169, DOI 10.3109/02652049609052905
   MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7
   MATSUYAMA K, 1987, J PHARM PHARMACOL, V39, P190, DOI 10.1111/j.2042-7158.1987.tb06247.x
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shinya E, 1999, BIOMED PHARMACOTHER, V53, P471, DOI 10.1016/S0753-3322(00)88106-8
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Tabata Yasuhiko, 2000, Pharmaceutical Science and Technology Today, V3, P80, DOI 10.1016/S1461-5347(00)00242-X
   TOMIDA H, 1993, CHEM PHARM BULL, V41, P1475
   Vuola J, 2002, J BIOMED MATER RES, V59, P152, DOI 10.1002/jbm.1228
NR 20
TC 39
Z9 41
U1 2
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD FEB
PY 2005
VL 24
IS 2-3
BP 187
EP 197
DI 10.1016/j.ejps.2004.10.010
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 895UQ
UT WOS:000226889600005
PM 15661490
DA 2018-10-19
ER

PT J
AU Chang, EJ
   Kim, HH
   Huh, JE
   Kim, IA
   Ko, JS
   Chung, CP
   Kim, HM
AF Chang, EJ
   Kim, HH
   Huh, JE
   Kim, IA
   Ko, JS
   Chung, CP
   Kim, HM
TI Low proliferation and high apoptosis of osteoblastic cells on
   hydrophobic surface are associated with defective Ras signaling
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE hydrophobicity; osteoblast; Ras; proliferation; apoptosis; biomaterial
ID GROWTH-FACTOR; CYCLIN D1; KINASE-ACTIVITY; PROGRESSION; ACTIVATION;
   EXPRESSION; PROTEIN; SURVIVAL; PHASE; REQUIREMENT
AB The hydrophobic (HPB) nature of most polymeric biomaterials has been a major obstacle in using those materials in vivo due to low compatibility with cells. However, there is little knowledge of the molecular detail to explain how surface hydrophobicity affects cell responses. In this study, we compared the proliferation and apoptosis of human osteoblastic MG63 cells adhered to hydrophilic (HPL) and hydrophobic surfaces. On the hydrophobic surface, less formation of focal contacts and actin stress fibers, a delay in cell cycle progression, and an increase in apoptosis were observed. By using fibroblast growth factor 1 (FGF1) as a model growth factor, we also investigated intracellular signaling pathways on hydrophilic and hydrophobic surfaces. The activation of Ras, Akt, and ERK by FGF1 was impaired in MG63 cells on the hydrophobic surface. The overexpression of constitutively active form of Ras and Akt rescued those cells from apoptosis and recovered cell cycle progression. Furthermore, their overexpression also restored the actin cytoskeletal organization on the hydrophobic surface. Finally, the proliferative, antiapoptotic, and cytoskeletal effects of constitutively active Ras in MG63 cells on the hydrophobic surface were blocked by wortmannin and PD98059 that inhibit Akt and ERK activation, respectively. Therefore, our results suggest that the activation of Ras and its downstream molecules Akt and ERK to an appropriate level is one of crucial elements in the determination of osteoblast cell responses. The Ras pathway may represent a cell biological target that should be considered for successful surface modification of biomaterials to induce adequate cell responses in the bone tissue. (C) 2004 Elsevier Inc. All rights reserved.
C1 Seoul Natl Univ, Coll Dent, Lab Study Mol Biointerfaces, Dept CMF Cell & Dev Biol, Seoul 110749, South Korea.
   Seoul Natl Univ, DRI, Seoul 110749, South Korea.
   Seoul Natl Univ, Intellectual Biointerface Engn Ctr, Seoul 110749, South Korea.
   Seoul Natl Univ, Coll Dent, Dept Periodontol, Seoul 110749, South Korea.
RP Kim, HM (reprint author), Seoul Natl Univ, Coll Dent, Lab Study Mol Biointerfaces, Dept CMF Cell & Dev Biol, Seoul 110749, South Korea.
EM hyunmkim@plaza.snu.ac.kr
CR Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   Bohmer RM, 1996, MOL BIOL CELL, V7, P101
   Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091
   Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x
   Dangi S, 2003, CELL SIGNAL, V15, P667, DOI 10.1016/S0898-6568(03)00002-0
   DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033
   Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X
   Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001
   Lawlor MA, 2001, J CELL SCI, V114, P2903
   Lin TH, 1997, J BIOL CHEM, V272, P8849
   Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4
   Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864
   Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611
   Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197
   Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600
   Sieg DJ, 2000, NAT CELL BIOL, V2, P249
   Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9
   Vermeer AWP, 2001, BBA-GEN SUBJECTS, V1526, P61, DOI 10.1016/S0304-4165(01)00101-5
   Xue LZ, 2000, J BIOL CHEM, V275, P8817, DOI 10.1074/jbc.275.12.8817
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 23
TC 45
Z9 47
U1 0
U2 4
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495, UNITED STATES
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD FEB 1
PY 2005
VL 303
IS 1
BP 197
EP 206
DI 10.1016/j.yexcr.2004.09.024
PG 10
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 884UH
UT WOS:000226111600018
PM 15572039
DA 2018-10-19
ER

PT J
AU Kanaya, N
   Kobayashi, N
   Tahara, Y
   Suzuki, S
   Sato, S
AF Kanaya, N
   Kobayashi, N
   Tahara, Y
   Suzuki, S
   Sato, S
TI Distributed control system using a remote distributed object model for
   1.8-GeV synchrotron radiation beamlines at TSRF
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE accelerator control system; distributed control; electron storage ring;
   light source; synchrotron radiation
ID FAST-CLOSING VALVE; BEAM LINES; DESIGN
AB A distributed control system has been developed to control synchrotron radiation beamlines for the 1.8-GeV storage ring at Tohoku Synchrotron Radiation Facility (TSRF), Tohoku University, which has 50 beamlines for soft X-ray optics/microscopy, lithography, and biomaterial research. The system is composed of outlying nodes and remote operator consoles connected to a network. Each beamline is controlled by its own outlying node independently of adjacent beamlines in accordance with physics experimental requirements. The control system protects ultra-high vacuum components of the beamline and the storage ring by closing valves/shutters upon detecting a vacuum failure. The system was implemented using a distributed object model, Java remote method invocation (RMI). The control system provides information on the operation of the beamlines to remote clients such as operator consoles over the network in order to operate the TSRF. The design and implementation of the distributed control system as well as the control scheme for the synchrotron radiation beamlines at TSRF are described in this paper.
C1 Ibaraki Univ, Dept Elect & Elect Engn, Fac Engn, Ibaraki 3168511, Japan.
   Tohoku Univ, Dept Phys, Grad Sch Sci, Sendai, Miyagi 9808578, Japan.
RP Kanaya, N (reprint author), Ibaraki Univ, Dept Elect & Elect Engn, Fac Engn, Ibaraki 3168511, Japan.
EM kanaya@ee.ibaraki.ac.jp
CR GARNAIRE A, 1992, P INT C ACC LARG EXP, P375
   *GNU, 1999, GEN PUBL LIC
   KANAYA N, 1986, IEEE T NUCL SCI, V33, P1071, DOI 10.1109/TNS.1986.4334535
   KANAYA N, 1989, IEEE T NUCL SCI, V36, P1391, DOI 10.1109/23.35361
   KANAYA N, 1984, IEEE T NUCL SCI, V31, P957, DOI 10.1109/TNS.1984.4333412
   KANAYA N, 1990, IEEE T NUCL SCI, V37, P2, DOI 10.1109/23.52602
   KANAYA N, 2002, P EUR PART ACC C PAR, P2016
   KANAYA N, 1999, NUCL INSTRUM METH A, V425, P499
   KLOTZ WD, 1992, P INT C ACC LARG EXP, P121
   KOBAYASHI T, 2004, MEMORANDUM MAN MACHI
   SATO S, 1989, REV SCI INSTRUM, V60, P1965, DOI 10.1063/1.1140901
   SATO S, 1997, TURNS005
   SATO S, 1998, 13 WORKSH SYNCHR RAD
   SATO S, 1983, NUCL INSTRUM METH A, V288, P31
   Suzuki S, 2001, NUCL INSTRUM METH A, V467, P72, DOI 10.1016/S0168-9002(01)00255-8
   SUZUKI S, 1998, COMMITTEE ELECT BEAM
   2004, LINUX KERNEL ARCH
NR 17
TC 2
Z9 2
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD FEB
PY 2005
VL 52
IS 1
BP 478
EP 483
DI 10.1109/TNS.2004.842729
PN 3
PG 6
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 913QW
UT WOS:000228169000010
DA 2018-10-19
ER

PT J
AU Tas, AC
   Aldinger, F
AF Tas, AC
   Aldinger, F
TI Formation of apatitic calcium phosphates in a Na-K-phosphate solution of
   pH 7.4
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID X-RAY-DIFFRACTION; SINTERING BEHAVIOR; BONE-FORMATION; HYDROXYAPATITE;
   CARBONATE; TCP; BIOMATERIAL; TEMPERATURE; CONVERSION; ARAGONITE
AB Poorly crystalline, apatitic calcium phosphate powders have been synthesized by slowly adding a Na- and K-containing reference phosphate solution with a pH value of 7.4 to an aqueous calcium nitrate solution at 37 degreesC. Nano-particulated apatitic powders obtained were shown to contain small amounts of Na and K, which render them more similar in chemical composition to that of the bone mineral. Precipitated and dried powders were found to exhibit self-hardening cement properties when kneaded in a mortar with a sodium citrate- and sodium phosphate-containing starter solution. The same phosphate solution used in powder synthesis was found to tie able to partially convert natural, white and translucent marble pieces of calcite (CaCO3) into calcium-deficient hydroxyapatite upon aging the samples in that solution for 3 days at 60degreesC. Sample characterization was performed by using scanning electron microscopy, X-ray diffraction, Fourier-transform infrared spectroscopy, inductively-coupled plasma atomic emission spectroscopy, and simultaneous thermogravimetry and differential thermal analysis. (C) 2005 Springer Science + Business Media, Inc.
C1 Max Planck Inst Met Res, Pulvermet Lab, D-70569 Stuttgart, Germany.
RP Tas, AC (reprint author), Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA.
EM c_tas@hotmail.com
RI Tas, A. Cuneyt/B-1966-2008
CR ASADA M, 1988, J MATER SCI, V23, P3202, DOI 10.1007/BF00551295
   BROWN WE, 1985, Patent No. 4518430
   Cheng ZH, 1998, LANGMUIR, V14, P6681, DOI 10.1021/la980339n
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   EBRAHIMPOUR A, 1993, J COLLOID INTERF SCI, V159, P158, DOI 10.1006/jcis.1993.1307
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gadaleta SJ, 1996, CALCIFIED TISSUE INT, V58, P9, DOI 10.1007/s002239900004
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HAYEK E, 1963, INORG SYN, V7, P63, DOI 10.1002/9780470132388.ch17
   HENCH LL, 1993, INTRO BIOCERAMICS, P142
   ICDD PDF: International Centre for Diffraction Data, POWD DIFFR FIL
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   Jinawath S, 2002, MAT SCI ENG C-BIO S, V22, P35, DOI 10.1016/S0928-4931(02)00110-8
   Kapolos J, 1999, LANGMUIR, V15, P6557, DOI 10.1021/la981285k
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   KOSHINO T, 1995, BIOMATERIALS, V16, P125, DOI 10.1016/0142-9612(95)98274-I
   LAZIC S, 1995, J CRYST GROWTH, V147, P147, DOI 10.1016/0022-0248(94)00587-7
   LEE DD, 2000, Patent No. 6027742
   LIDE DR, 1991, HDB CHEM PHYSICS, P8
   Manjubala I, 2001, MATER CHEM PHYS, V71, P272, DOI 10.1016/S0254-0584(01)00293-0
   MANN S, 2001, BIOMINERALIZATION PR, P11
   MCLEAN FC, 1968, BONE, P56
   Nyquist R. A., 1997, HDB INFRARED RAMAN S
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   Peters F, 2001, J CHEM SOC DALTON, P3585, DOI 10.1039/b106986c
   ROY DM, 1975, Patent No. 3929971
   SALINGAR Y, 1994, SOIL SCI SOC AM J, V58, P1628, DOI 10.2136/sssaj1994.03615995005800060007x
   Socrates G., 1994, INFRARED CHARACTERIS
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Tas AC, 2001, POWDER DIFFR, V16, P102, DOI 10.1154/1.1330273
   TERMINE JD, 1970, ARCH BIOCHEM BIOPHYS, V140, P307, DOI 10.1016/0003-9861(70)90071-8
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g
NR 41
TC 25
Z9 25
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2005
VL 16
IS 2
BP 167
EP 174
DI 10.1007/s10856-005-5919-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KW
UT WOS:000227282400011
PM 15744606
DA 2018-10-19
ER

PT J
AU Qiao, Y
   Pan, E
   Chakravarthula, SS
   Han, F
   Liang, J
   Gudlavalleti, S
AF Qiao, Y
   Pan, E
   Chakravarthula, SS
   Han, F
   Liang, J
   Gudlavalleti, S
TI Measurement of mechanical properties of rectal wall
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ORGAN; MODULUS; FILMS
AB In this paper, a pig's rectum was studied as a model biomaterial and its mechanical behaviors under tensile, compressive, and shear stresses were measured accurately using a multipurpose microtesting system. Based on the stress-strain relations of samples of different orientations, the tangential moduli were calculated through a reverse method combined with self-correlation analysis. The experimental data exhibited pronounced nonlinear and anisotropic characteristics. It was found that the effective compliance in tension along the longitudinal direction was larger than that along the circumferential direction, but smaller than that along the out-of-plane direction. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Akron, Dept Civil Engn, Akron, OH 44325 USA.
   William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
   GE Global Res Ctr, EPT Lifting Technol, Niskayuna, NY 12309 USA.
RP Qiao, Y (reprint author), Univ Akron, Dept Civil Engn, Akron, OH 44325 USA.
EM yqiao@uakron.edu
RI Pan, Ernian/F-4504-2011
OI Pan, Ernian/0000-0001-6640-7805
FU NCI NIH HHS [R01CA091020]
CR Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   BARON JC, 1992, UROL RES, V20, P247, DOI 10.1007/BF00299727
   Beckwith T. G., 1993, MECH MEASUREMENTS, P45
   Belytschko T., 2003, NONLINEAR FINITE ELE
   Bounaim A, 2003, LECT NOTES COMPUT SC, V2668, P705
   Brock KK, 2003, MED PHYS, V30, P290, DOI 10.1118/1.1539039
   DALL FH, 1993, GUT, V34, P1581, DOI 10.1136/gut.34.11.1581
   Duck F., 1990, PHYS PROPERTIES TISS
   Espinosa HD, 2003, J MECH PHYS SOLIDS, V51, P47, DOI 10.1016/S0022-5096(02)00062-5
   Felt-Bersma RJF, 2000, DIS COLON RECTUM, V43, P1732, DOI 10.1007/BF02236859
   Fu M, 1997, J PEDIATR SURG, V32, P7, DOI 10.1016/S0022-3468(97)90080-4
   Fung YC, 1993, BIOMECHANICS MECH PR
   Gilja OH, 2002, ULTRASOUND MED BIOL, V28, P1457, DOI 10.1016/S0301-5629(02)00614-2
   Greek S, 1999, J MICROMECH MICROENG, V9, P245, DOI 10.1088/0960-1317/9/3/305
   Gregersen H, 1999, NEUROGASTROENT MOTIL, V11, P109
   GUDLAVALLETI S, 2001, P 2001 ASME IMECE NE
   Jensen BD, 2001, J MICROELECTROMECH S, V10, P336, DOI 10.1109/84.946779
   KROGH K, 2001, DIS COLON RECTUM, V44, P196
   Li D, 2003, IEEE T MICROW THEORY, V51, P1179, DOI 10.1109/TMTT.2003.809624
   Liang J, 2003, MED PHYS, V30, P2116, DOI 10.1118/1.1587631
   NAGASHIMA M, 1995, EUR J PEDIATR SURG, V5, P167, DOI 10.1055/s-2008-1066196
   Rao GN, 1997, INT J COLORECTAL DIS, V12, P33, DOI 10.1007/s003840050075
   READ DT, 1998, MECH MATER, V6, P11
   SCHAFER R, 1995, GASTROENTEROLOGY, V108, pA684, DOI 10.1016/0016-5085(95)27050-7
   SHARPE WN, 1997, J MICROMECH MICROENG, V3, P317
   Sreenivasa G, 2003, INT J RADIAT ONCOL, V55, P407, DOI 10.1016/S0360-3016(02)04144-5
   Thompson P. M., 2002, Computing and Visualization in Science, V5, P13, DOI 10.1007/s00791-002-0084-6
   Yan D, 1999, INT J RADIAT ONCOL, V44, P665, DOI 10.1016/S0360-3016(99)00007-3
NR 28
TC 13
Z9 13
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2005
VL 16
IS 2
BP 183
EP 188
DI 10.1007/s10856-005-5988-5
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KW
UT WOS:000227282400013
PM 15744608
DA 2018-10-19
ER

PT J
AU Johnston, EE
   Bryers, JD
   Ratner, BD
AF Johnston, EE
   Bryers, JD
   Ratner, BD
TI Plasma deposition and surface characterization of oligoglyme, dioxane,
   and crown ether nonfouling films
SO LANGMUIR
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) CHAINS; PROTEIN ADSORPTION; POLYETHYLENE OXIDE;
   POLYSTYRENE SURFACES; BIOMATERIAL SURFACES; DIMETHYL-ETHER; ADHESION;
   POLYMERS; FORCES; COLONIZATION
AB Plasma-deposited PEG-like films are emerging as promising materials for preventing protein and bacterial attachment to surfaces. To date, there has not been a detailed surface analysis to examine the chemistry and molecular structure of these films as a function of both precursor size and structure. In this paper, we describe radio-frequency plasma deposition of a series of short-chain oligoglymes, dioxane, and crown ethers onto glass cover slips to create poly(ethylene glycol)-like coatings. The resultant films were characterized by X-ray photoelectron spectroscopy (XPS), time-of-flight secondary ion mass spectrometry (TOF-SIMS), dynamic contact angle goniometry, and radiolabeled fibrinogen adsorption. Detailed analysis of the high-mass (120-300 m/z) TOF-SIMS oligoglyme film spectra revealed six classes of significant fragments. Two new models are proposed to describe how these fragments could be formed by distinct film-building processes: incorporation of intact and fragmented precursor molecules. The models also provide for the incorporation of hydrocarbon - a species that is not present in the precursors but is evidenced in XPS C-1s spectra of these films. Two additional models describe the effects of incorporating intact and fragmented cyclic precursors.
C1 Univ Washington, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, Box 351720 Bagley Hall 484, Seattle, WA 98195 USA.
CR ANDRADE JD, 1988, BIOMATERIALS, V9, P76, DOI 10.1016/0142-9612(88)90074-9
   ARAKAWA T, 1985, BIOCHEMISTRY-US, V24, P6756, DOI 10.1021/bi00345a005
   BEAMSON G, 1992, HIGH RESOLUTOIN XPS
   BENNINGHOVEN A, 1997, J SURF ANAL, V3, P248
   BERG JC, 1993, WETTABILITY, V49, P531
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BRAATZ JA, 1992, J BIOMAT SCI-POLYM E, V3, P451, DOI 10.1163/156856292X00439
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V1
   BRYERS JD, 2000, BIOFILMS, V2
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Denes AR, 2001, J APPL POLYM SCI, V81, P3425, DOI 10.1002/app.1799
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Dunkirk S G, 1991, J Biomater Appl, V6, P131, DOI 10.1177/088532829100600203
   Efremova NV, 2000, BIOCHEMISTRY-US, V39, P3441, DOI 10.1021/bi992095r
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   HERCULES DM, 1993, J MOL STRUCT, V292, P49, DOI 10.1016/0022-2860(93)80089-E
   HUMPHRIES M, 1987, FEMS MICROBIOL ECOL, V45, P297, DOI 10.1111/j.1574-6968.1987.tb02380.x
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JOHNSTON EE, 1997, POLYM MAT SCI ENG, V77, P577
   JOHNSTON EE, 1998, MAT RES SOC ABSTR FA, P464
   JOHNSTON EE, 1997, THESIS U WASHINGTON
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KLEIN J, 1986, MAKROMOL CHEM-M SYMP, V1, P125, DOI 10.1002/masy.19860010111
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEGGETT GJ, 1995, SURF INTERFACE ANAL, V23, P22, DOI 10.1002/sia.740230104
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1996, PLASMAS POLYM, V1, P127
   LOPEZ GP, 1991, THESIS U WASHINGTON
   Marsh LH, 2002, J BIOMED MATER RES, V61, P641, DOI 10.1002/jbm.10174
   McLafferty F.W., 1993, INTERPRETATION MASS
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P458
   NEWMAN JC, 1991, STATIC SIMS HDB POLY
   NIEHUIS E, 1992, TIME FLIGHT SIMS 2 I, P269
   Price ME, 2001, BBA-BIOMEMBRANES, V1512, P191, DOI 10.1016/S0005-2736(01)00330-3
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Shard AG, 1996, SURF INTERFACE ANAL, V24, P787, DOI 10.1002/(SICI)1096-9918(199611)24:12<787::AID-SIA181>3.3.CO;2-5
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   SHEU MS, 1992, THESIS U WASHINGTON
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vickerman J. C., 1989, SECONDARY ION MASS S
   WU YJ, 2001, PLASMAS POLYM, V6, P123
NR 51
TC 92
Z9 94
U1 2
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 1
PY 2005
VL 21
IS 3
BP 870
EP 881
DI 10.1021/la036274s
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 891XL
UT WOS:000226614200013
PM 15667162
DA 2018-10-19
ER

PT J
AU Unsworth, LD
   Sheardown, H
   Brash, JL
AF Unsworth, LD
   Sheardown, H
   Brash, JL
TI Protein resistance of surfaces prepared by sorption of end-thiolated
   poly(ethylene glycol) to gold: Effect of surface chain density
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL);
   PLATELET-ADHESION; ADSORPTION; OXIDE); FIBRINOGEN; LAYERS;
   CHEMISORPTION; FIBRONECTIN; ATTACHMENT
AB Nonspecific protein adsorption generally occurs at the biomaterial-tissue interface and usually has adverse consequences. Thus, surfaces that are protein-resistant are eagerly sought with the expectation that these materials will exhibit improved biocompatibility. Surfaces modified with end-tethered poly(ethylene oxide) (PEO) have been shown to be protein-resistant to some degree. Although the mechanisms are unclear, it has been suggested that chain length, chain density, and chain conformation are important factors. To investigate the effects of PEO chain density, we selected a model system based on the chemisorption of chain-end thiolated PEO to a gold substrate. Chain density was varied by varying PEO solubility (proximity to cloud point) and incubation time in the chemisorption solution. The adsorption of fibrinogen and lysozyme to these surfaces was investigated. It was found that for 750 and 2000 MW PEO layers, resistance to fibrinogen increased with chain density and was maximal at a density of similar to0.5 chains/nm(2) (80% decrease in adsorption compared to unmodified gold). As PEO chain density increased beyond 0.5/nm(2) adsorption increased. For PEO of 5000 MW the optimal chain density was 0.27/nm(2) and gave only a 60% reduction in fibrinogen adsorption. It is suggested that, at high chain density, the chemisorbed PEO is dehydrated giving a surface that is no longer protein resistant. The PEO-modified surfaces were found also to be resistant to lysozyme adsorption with reductions similar to, if somewhat less than, those for fibrinogen. The fibrinogen to lysozyme molar ratios were within the expected range for close-packed layers of these proteins in their native conformation and were relatively insensitive to PEO chain density and MW. This may suggest that such adsorption as did occur, even at chain densities giving minimum adsorption, may have been on patches of unmodified gold.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM brashjl@mcmaster.ca
RI Unsworth, Larry/A-7231-2011
OI Unsworth, Larry/0000-0003-3162-3545
CR ADAMS GA, 1981, T AM SOC ART INT ORG, V27, P219
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Anne A, 2002, MACROMOLECULES, V35, P5578, DOI 10.1021/ma020071d
   ARAI T, 1990, COLLOID SURFACE, V51, P1, DOI 10.1016/0166-6622(90)80127-P
   BARBOSA RV, 1995, MACROMOLECULAR REP A, V32, P663
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BRASH JL, 1995, PROTEINS INTERFACES, V2, P18
   Du YJ, 2003, J APPL POLYM SCI, V90, P594, DOI 10.1002/app.12545
   Du YJ, 2000, COLLOID SURFACE B, V17, P59, DOI 10.1016/S0927-7765(99)00053-3
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   HERDE H, 1977, PLASMA PROTEIN FRACT
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Norde W., 1995, PROTEINS INTERFACES, P26
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TIBERG F, 1992, COLLOID POLYM SCI, V270, P1188, DOI 10.1007/BF01095059
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Unsworth LD, 2005, J COLLOID INTERF SCI, V281, P112, DOI 10.1016/j.jcis.2004.08.022
   Vanderah DJ, 2004, J AM CHEM SOC, V126, P13639, DOI 10.1021/ja047744n
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   YAN G, 1995, PROTEINS INTERFACES, V2, P256
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 36
TC 233
Z9 236
U1 6
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 1
PY 2005
VL 21
IS 3
BP 1036
EP 1041
DI 10.1021/la047672d
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 891XL
UT WOS:000226614200037
PM 15667186
DA 2018-10-19
ER

PT J
AU Agashe, M
   Raut, V
   Stuart, SJ
   Latour, RA
AF Agashe, M
   Raut, V
   Stuart, SJ
   Latour, RA
TI Molecular simulation to characterize the adsorption behavior of a
   fibrinogen gamma-chain fragment
SO LANGMUIR
LA English
DT Article
ID ACUTE INFLAMMATORY RESPONSES; SELF-ASSEMBLED MONOLAYERS; FOREIGN-BODY
   REACTIONS; FORCE-FIELD; POLY(ETHYLENE OXIDE); THEORETICAL-ANALYSIS;
   PROTEIN ADSORPTION; CRYSTAL-STRUCTURE; DYNAMICS; SURFACES
AB Implants invoke inflammatory responses from the body even if they are chemically inert and nontoxic. It has been shown that a crucial precedent event in the inflammatory process is the spontaneous adsorption of fibrinogen (Fg) on implant surfaces, which is typically followed by the presence of phagocytic cells. Interactions between the phagocyte integrin Mac-1 and two short sequences within the fibrinogen gamma chain, gamma190-202 and gamma377-395, may partially explain phagocyte accumulation at implant surfaces. These two sequences are believed to form an integrin binding site that is inaccessible when Fg is in its soluble-state structure but then becomes available for Mac-1 binding following adsorption, presumably due to adsorption-induced conformational changes. The objective of this research was to theoretically investigate this possibility by using molecular dynamics simulations of the gamma-chain fragment of Fg over self-assembled monolayer (SAM) surfaces presenting different types of surface chemistry. The GROMACS software package was used to carry out the molecular simulations in an explicit solvation environment over a 5 ns period of time. The adsorption of the gamma-chain of fibrinogen was simulated on five types of SAM surfaces. The simulations showed that this protein fragment exhibits distinctly different adsorption behavior on the different surface chemistries. Although the trajectory files showed that significant conformational changes did not occur in this protein fragment over the time frame of the simulations, it was predicted that the protein does undergo substantial rotational and translational motions over the surface prior to stabilizing in various preferred orientations. This suggests that the kinetics of surface-induced conformational changes in a protein's structure might be much slower than the kinetics of orientational changes, thus enabling the principles of adsorption thermodynamics to be used to guide adsorbing proteins into defined orientations on surfaces before large conformational changes can occur. This finding may be very important for biomaterial surface design as it suggests that surface chemistry can potentially be used to directly control the orientation of adsorbing proteins in a manner that either presents or hides specific bioactive sites contained within a protein's structure, thereby providing a mechanism to control cellular responses to the adsorbed protein layer.
C1 Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
   Clemson Univ, Dept Chem, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
EM LatourR@clemson.edu
RI Stuart, Steven/H-1111-2012
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BASALYGA DM, 2002, J BIOMED MATER RES A, V64, P120
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Berendsen HJC, 1981, INTERMOLECULAR FORCE, V11, P331
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   CREAGER SE, 1994, LANGMUIR, V10, P3675, DOI 10.1021/la00022a048
   CRISTINA M, 2003, J BIOMED MATER RES A, V67, P158
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0
   Goldstein H, 2002, CLASSICAL MECH, P150
   HAUTMAN J, 1991, J CHEM SOC FARADAY T, V87, P2031, DOI 10.1039/ft9918702031
   HELENE CF, 1998, BLOOD, V92, P2195
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kandt C, 2004, BIOPHYS J, V86, P705, DOI 10.1016/S0006-3495(04)74149-1
   Kazuhiro N., 2001, J BIOSCI BIOENG, V91, P233
   Kreuzer HJ, 2003, J AM CHEM SOC, V125, P8384, DOI 10.1021/ja0350839
   Latour RA, 2002, BIOMATERIALS, V23, P4633, DOI 10.1016/S0142-9612(02)00213-2
   Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052
   Leach A.R., 1996, MOL MODELLING PRINCI, P131
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   MACKERELL AD, 1998, ENCY COMPUTATIONAL C, V3, P2191
   MACKERELL AD, 1998, ENCY COMPUTATIONAL C, V1, P271
   MAIOROV VN, 1995, PROTEINS, V22, P273, DOI 10.1002/prot.340220308
   MAR W, 1994, LANGMUIR, V10, P188, DOI 10.1021/la00013a028
   Pitt WG, 1997, J COLLOID INTERF SCI, V185, P258, DOI 10.1006/jcis.1996.4607
   Raffaini G, 2003, LANGMUIR, V19, P3403, DOI 10.1021/la026853h
   Rigby D, 1997, POLYM INT, V44, P311, DOI 10.1002/(SICI)1097-0126(199711)44:3<311::AID-PI880>3.3.CO;2-8
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Smith GD, 2002, J COMPUT CHEM, V23, P1480, DOI 10.1002/jcc.10166
   SMITH GD, 1993, J PHYS CHEM-US, V97, P12752, DOI 10.1021/j100151a021
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   VANDERSPOEL D, 2002, GROMACS USER MANUAL
   Wang RLC, 2000, PHYS CHEM CHEM PHYS, V2, P1721, DOI 10.1039/a909598e
   WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051
   WEST JB, 1985, BEST TAYLORS PHYSL B, P441
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   Yang Z, 2000, P NATL ACAD SCI USA, V97, P3907, DOI 10.1073/pnas.080065697
   Yee VC, 1997, STRUCTURE, V5, P125, DOI 10.1016/S0969-2126(97)00171-8
NR 44
TC 109
Z9 116
U1 3
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 1
PY 2005
VL 21
IS 3
BP 1103
EP 1117
DI 10.1021/la0478364
PG 15
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 891XL
UT WOS:000226614200048
PM 15667197
DA 2018-10-19
ER

PT J
AU Leor, J
   Amsalem, Y
   Cohen, S
AF Leor, J
   Amsalem, Y
   Cohen, S
TI Cells, scaffolds, and molecules for myocardial tissue engineering
SO PHARMACOLOGY & THERAPEUTICS
LA English
DT Review
DE biomaterial; cell; heart; scaffold; tissue engineering; transplantation
ID EMBRYONIC STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; VENTRICULAR OUTFLOW
   TRACT; POROUS ALGINATE SCAFFOLDS; GROWTH-FACTOR-I; INFARCTED HEART;
   CARDIAC-MUSCLE; SMOOTH-MUSCLE; THERAPEUTIC ANGIOGENESIS; SKELETAL
   MYOBLASTS
AB Unlike heart valves or blood vessels. heart muscle has no replacement alternatives. The most challenging goal in the field of cardiovascular tissue engineering is the creation/ regeneration of an engineered heart muscle. Recent advances in methods of stem cell isolation, culture in bioreactors. and the synthesis of bioactive materials promise to create engineered cardiac tissue ex vivo. At the same time. new approaches arc conceived that explore ways to induce tissue regeneration after injury. The purpose of our review is to describe the principles status, and challenges of myocardial tissue engineering with emphasize on the concept of in situ cardiac tissue engineering and regeneration. (C) 2004 Elsevier Inc. All rights reserved.
C1 Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
   Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
RP Leor, J (reprint author), Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
EM leorj@post.tau.ac.il
RI COHEN, SMADAR/F-1901-2012; Leor, Jonathan/O-2930-2017
CR Akhyari P, 2002, CIRCULATION, V106, P1137
   Akins RE, 1999, TISSUE ENG, V5, P103, DOI 10.1089/ten.1999.5.103
   Anversa P, 2004, CIRCULATION, V109, P2832, DOI 10.1161/01.CIR.0000132469.85026.46
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Bursac N, 2003, TISSUE ENG, V9, P1243, DOI 10.1089/10763270360728152
   Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cohen S, 2004, SCI AM, V291, P44, DOI 10.1038/scientificamerican1104-44
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Copeland JG, 2004, NEW ENGL J MED, V351, P859, DOI 10.1056/NEJMoa040186
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Dimmeler S, 2003, J AM COLL CARDIOL, V42, P2081, DOI 10.1016/j.jacc.2003.09.016
   Dohmen Pascal M, 2002, Asian Cardiovasc Thorac Ann, V10, P25
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Etzion S, 2001, Am J Cardiovasc Drugs, V1, P233, DOI 10.2165/00129784-200101040-00002
   Griffith LG, 1998, BIOMATERIALS, V19, P979, DOI 10.1016/S0142-9612(97)00185-3
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   JESSUP M, 2003, NEW ENGL J MED, V345, P2007
   Kadner A, 2004, EUR J CARDIO-THORAC, V25, P635, DOI 10.1016/j.ejcts.2003.12.038
   Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kim MR, 2002, BIOTECHNOL PROGR, V18, P495, DOI 10.1021/bp020287z
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Koo LY, 2002, J CELL SCI, V115, P1423
   Krupnick A. S., 2001, Journal of Heart and Lung Transplantation, V20, P197, DOI 10.1016/S1053-2498(00)00417-4
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lanza R, 2004, CIRC RES, V94, P820, DOI 10.1161/01.RES.0000120863.53562.DF
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Lee MS, 2004, ANN INTERN MED, V140, P729, DOI 10.7326/0003-4819-140-9-200405040-00013
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Leor J, 2004, CIRCULATION, V110, P279
   Leor J, 1996, CIRCULATION, V94, P332
   LEOR J, 2000, CIRCULATION, V102, P156
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   LI RK, 2004, YONSEI MED J S, V45, pS72
   Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05
   Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68
   Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101
   NARMONEVA DA, 2004, CIRCULATION, DOI PII 01.CIR.0000140667.0000137070.0000140607
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Oz MC, 2003, J THORAC CARDIOV SUR, V126, P983, DOI 10.1016/S0022-5223(036)00049-7
   Ozawa T, 2004, CELL TRANSPLANT, V13, P169, DOI 10.3727/000000004773301852
   Ozawa T., 2002, CIRCULATION S1, V106, P1176
   PAPADAKI M, 2001, AM J PHYSIOL-HEART C, V280, P168
   Park HJ, 1999, J UROLOGY, V162, P1106, DOI 10.1016/S0022-5347(01)68084-4
   Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Scheubel RJ, 2003, J AM COLL CARDIOL, V42, P2073, DOI 10.1016/j.jacc.2003.07.025
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   SHIMIZU T, 2002, CIRC RES, V90, P40
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8
   Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3
   Takano H, 2003, CURR PHARM DESIGN, V9, P1121, DOI 10.2174/1381612033455008
   Thompson C, 1999, SOC LIGHT TREATMENT, V11, P11
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   VACANTI JP, 1999, LANCET S1, V354, pS132
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X
   Winn N, 2002, COLD SPRING HARB SYM, V67, P507, DOI 10.1101/sqb.2002.67.507
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   YOON YS, 2004, CIRCULATION, DOI PII 01.CIR.0000134696.0000108436.0000134665
   Zandonella C, 2003, NATURE, V421, P884, DOI 10.1038/421884a
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   ZIMMERMANN WH, 2002, CIRCULATION, V106, P151
   Zou YZ, 2003, CIRCULATION, V108, P748, DOI 10.1161/01.CIR.0000081773.76337.44
NR 110
TC 205
Z9 221
U1 5
U2 57
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0163-7258
J9 PHARMACOL THERAPEUT
JI Pharmacol. Ther.
PD FEB
PY 2005
VL 105
IS 2
BP 151
EP 163
DI 10.1016/j.pharmthera.2004.10.003
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 896JR
UT WOS:000226930900005
PM 15670624
DA 2018-10-19
ER

PT J
AU Bajpai, AK
AF Bajpai, AK
TI Blood protein adsorption onto a polymeric biomaterial of polyethylene
   glycol and poly[(2-hydroxyethyl methacrylate)-co-acrylonitrile] and
   evaluation of in vitro blood compatibility
SO POLYMER INTERNATIONAL
LA English
DT Article
DE adsorption; BSA; kinetics; hydrogel; blood compatibility
ID BOVINE SERUM-ALBUMIN; POLY(ETHYLENE OXIDE); ULTRAFILTRATION MEMBRANES;
   MICROFILTRATION MEMBRANES; FUNCTIONALIZED POLYMERS; SURFACE
   MODIFICATION; TRIBLOCK COPOLYMERS; NETWORKS IPNS; PARTICLES; INTERFACE
AB A semi-interpenetrating polymer network (semi-IPN) of polyethylene glycol (PEG) and crosslinked poly[(2-hydroxyethyl methacrylate)-co-acrylonitrile] was prepared and adsorption of bovine serum albumin (BSA) on the IPN surfaces was investigated. The dynamic nature of the adsorption process was studied, and the effects of various experimental factors such as pH and ionic strength on the adsorption isotherms of BSA were investigated. Various kinetic parameters, such as the adsorption coefficient, rate constant for adsorption and penetration rate constants, were calculated. For assessment of in vitro blood compatibility of the IPN surfaces, water sorption, blood clot formation tests and percent hemolysis measurements were performed. (C) 2004 Society of Chemical Industry.
C1 Govt Autonomous Sci Coll, Bose Mem Res Lab, Dept Chem, Jabalpur 482001, MP, India.
RP Bajpai, AK (reprint author), Govt Autonomous Sci Coll, Bose Mem Res Lab, Dept Chem, Jabalpur 482001, MP, India.
EM akbmrl@yahoo.co.in
CR AKHTAR S, 1995, J MEMBRANE SCI, V107, P209, DOI 10.1016/0376-7388(95)00118-9
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ANDRADE J D, 1992, Clinical Materials, V11, P19, DOI 10.1016/0267-6605(92)90026-P
   Andrade J D, 1973, Med Instrum, V7, P110
   ANDRADE JD, 1996, ADV CHEM SERIES, V248
   Andreopoulos AG, 1998, J BIOMATER APPL, V12, P291, DOI 10.1177/088532829801200402
   BAJPAI AK, 1994, J APPL POLYM SCI, V51, P651, DOI 10.1002/app.1994.070510409
   Bajpai AK, 2001, J MACROMOL SCI PURE, V38, P1123, DOI 10.1081/MA-100107133
   Bangs LB, 1996, PURE APPL CHEM, V68, P1873, DOI 10.1351/pac199668101873
   Baszkin A, 2001, J COLLOID INTERF SCI, V244, P18, DOI 10.1006/jcis.2001.7907
   BRASH JL, 1995, ACS S SERIES, V662
   BRINK LES, 1993, J MEMBRANE SCI, V76, P281, DOI 10.1016/0376-7388(93)85225-L
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DING ZY, 1991, J POLYM SCI POL PHYS, V29, P1035, DOI 10.1002/polb.1991.090290815
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   GILGES M, 1994, ANAL CHEM, V66, P2038, DOI 10.1021/ac00085a019
   Goldstein A., 1974, PRINCIPLES DRUG ACTI
   GRAHAM NB, 1982, POLYMER, V23, P1345, DOI 10.1016/0032-3861(82)90276-2
   GRAINGER D, 1987, ADV BIOMEDICAL POLYM
   GRAINGER DW, 1989, J COLLOID INTERF SCI, V132, P161, DOI 10.1016/0021-9797(89)90226-9
   HANSON M, 1992, J CHROMATOGR, V599, P65, DOI 10.1016/0021-9673(92)85459-7
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HOFFMAN A S, 1992, Clinical Materials, V11, P13, DOI 10.1016/0267-6605(92)90025-O
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   ISHIHARA K, 1993, BLOOD COMPATIBLE POL
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Kataoka K, 1998, J BIOMAT SCI-POLYM E, V9, P111, DOI 10.1163/156856298X00460
   KIM KJ, 1988, DESALINATION, V70, P229, DOI 10.1016/0011-9164(88)85057-4
   KONDO A, 1991, BIOTECHNOL BIOENG, V37, P537, DOI 10.1002/bit.260370607
   KOUTSOUKOS PG, 1983, J COLLOID INTERF SCI, V95, P385, DOI 10.1016/0021-9797(83)90198-4
   LEE J, 1989, J COLLOID INTERF SCI, V131, P252, DOI 10.1016/0021-9797(89)90166-5
   LIGOURE C, 1990, J PHYS-PARIS, V51, P1313, DOI 10.1051/jphys:0199000510120131300
   LYN YS, 1995, COLLOID SURFACE B, V4, P65
   MALMSTEN M, 1992, MACROMOLECULES, V25, P2474, DOI 10.1021/ma00035a028
   MISSIRLIS Y, 1991, MODERN ASPECTS PROTE
   NAGAOKA S, 1984, POLYM BIOMATERIALS, P361
   NG CL, 1994, J CHROMATOGR A, V659, P427, DOI 10.1016/0021-9673(94)85085-2
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RAMARAJ B, 1994, POLYMER, V35, P2167, DOI 10.1016/0032-3861(94)90245-3
   Revilla J, 1996, J COLLOID INTERF SCI, V180, P405, DOI 10.1006/jcis.1996.0319
   Sarkar D, 1996, INDIAN J BIOCHEM BIO, V33, P39
   Sathian J, 2003, J BIOMED MATER RES A, V65A, P435, DOI 10.1002/jbm.a.10489
   SCHROEN CGPH, 1993, J MEMBRANE SCI, V80, P265, DOI 10.1016/0376-7388(93)85151-L
   SINGH DK, 1994, J APPL POLYM SCI, V53, P1115, DOI 10.1002/app.1994.070530814
   Siqueira DF, 1996, LANGMUIR, V12, P972, DOI 10.1021/la950519m
   STENGAARD FF, 1988, DESALINATION, V70, P207, DOI 10.1016/0011-9164(88)85055-0
   TAN JS, 1990, J COLLOID INTERF SCI, V136, P415, DOI 10.1016/0021-9797(90)90389-6
   Yoon JY, 1998, COLLOID SURFACE B, V10, P365, DOI 10.1016/S0927-7765(97)00068-4
NR 50
TC 20
Z9 20
U1 1
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD FEB
PY 2005
VL 54
IS 2
BP 304
EP 315
DI 10.1002/pi.1673
PG 12
WC Polymer Science
SC Polymer Science
GA 893PO
UT WOS:000226731900010
DA 2018-10-19
ER

PT J
AU Zhou, HJ
   Zhang, Y
AF Zhou, HJ
   Zhang, Y
TI Hierarchical chain model of spider capture silk elasticity
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID TITIN IMMUNOGLOBULIN DOMAINS; STACKING INTERACTIONS; STRANDED-DNA; GENE;
   WEBS
AB Spider capture silk is a biomaterial with both high strength and high elasticity, but the structural design principle underlying these remarkable properties is still unknown. It was revealed recently by atomic force microscopy that an exponential force-extension relationship holds both for capture silk mesostructures and for intact capture silk fibers [N. Becker et al., Nat. Mater. 2, 278 (2003)]. In this Letter a simple hierarchical chain model was proposed to understand and reproduce this striking observation. In the hierarchical chain model, a polymer is composed of many structural motifs which organize into structural modules and supramodules in a hierarchical manner. Each module in this hierarchy has its own characteristic force. The repetitive patterns in the amino-acid sequence of the major flagelliform protein of spider capture silk is in support of this model.
C1 Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.
   SUNY Buffalo, Ctr Excellence Bioinformat, Buffalo, NY 14203 USA.
RP Zhou, HJ (reprint author), Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.
RI YZ, YZ/B-3243-2011; Zhou, Hai-Jun/A-9804-2009
OI Zhou, Hai-Jun/0000-0003-4228-4438
CR Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   BONTHRONE KM, 1992, P ROY SOC B-BIOL SCI, V248, P141, DOI 10.1098/rspb.1992.0054
   Branden C., 1999, INTRO PROTEIN STRUCT
   Dessinges MN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248102
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Kaplan D., 1994, ACS S SERIES
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3
   Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008
   Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764
   SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819
   VANHOLDE KE, 1989, CHROMATIN
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Zhang Y, 2001, BIOPHYS J, V81, P1133, DOI 10.1016/S0006-3495(01)75770-0
   Zhou HJ, 1999, PHYS REV LETT, V82, P4560
NR 21
TC 35
Z9 35
U1 1
U2 11
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
EI 1079-7114
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD JAN 21
PY 2005
VL 94
IS 2
AR 028104
DI 10.1103/PhysRevLett.94.028104
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 889YN
UT WOS:000226478900086
PM 15698235
DA 2018-10-19
ER

PT J
AU Herrero-Vanrell, R
   Rincon, AC
   Alonso, M
   Reboto, V
   Molina-Martinez, IT
   Rodriguez-Cabello, JC
AF Herrero-Vanrell, R
   Rincon, AC
   Alonso, M
   Reboto, V
   Molina-Martinez, IT
   Rodriguez-Cabello, JC
TI Self-assembled particles of an elastin-like polymer as vehicles for
   controlled drug release
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE elastin-like polymer; self assembly; smart behaviour; controlled drug
   release
ID THERMALLY RESPONSIVE POLYMERS; POLYPEPTIDE; DELIVERY; TEMPERATURE;
   TRANSITION
AB Elastin-like polymers (ELPs) are a new kind of protein-based polymers showing interesting properties in the biomaterial field. This work explored the use of self-assembled poly(VPAVG) micro- and nanoparticles as vehicles for the controlled release of the model drug dexamethasone phosphate (DMP). Poly(VPAVG) has shown to form stable particles with a size below 3 mum as a water or PBS polymer solution was warmed above its transition temperature (similar to30 degreesC). Due to the peculiar composition of the monomer, the formation and redissolution of the self-assembled microparticles shows an interesting hysteresis behaviour by which the particles are formed at this temperature but do not redissolve until a strong undercooling of similar to12-15 degreesC is achieved. Therefore, the particles, once formed, are stable either at room or body temperature. These self-assembled particles are able to encapsulate significant amounts of the model drug when self-assembling was carried out in a co-solution polymer DMP. The release profiles showed a sustained DMP release for about 30 days. Being the potential of this new polymeric carrier high, further research is being conducted to functionalise the poly(VPAVG) base as a way to induce a stronger polymer-drug binding and, accordingly, a more sustained release. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Complutense, Sch Pharm, Dept Pharm & Pharmaceut Technol, Madrid 28040, Spain.
   Univ Valladolid, EUP, Dpto Quim Analit, Valladolid 47014, Spain.
RP Rodriguez-Cabello, JC (reprint author), Univ Valladolid, ETSII, Dpto Fis Mat Condensada, Pseo Cauce S-N, Valladolid 47014, Spain.
EM cabello@eis.uva.es
RI ALONSO, MATILDE/G-6719-2017; Molina Martinez, Irene Teresa/G-4970-2017;
   Rodriguez-Cabello, Jose Carlos/G-6555-2017; Herrero-Vanrell,
   Rocio/G-6849-2017
OI ALONSO, MATILDE/0000-0002-6853-8427; Molina Martinez, Irene
   Teresa/0000-0002-9157-571X; Rodriguez-Cabello, Jose
   Carlos/0000-0002-3438-858X; Herrero-Vanrell, Rocio/0000-0001-9764-7975
CR Alonso M, 2001, MACROMOLECULES, V34, P8072, DOI 10.1021/ma010455o
   Alonso M, 2000, MACROMOLECULES, V33, P9480, DOI 10.1021/ma001348h
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Lee J, 2001, J BIOMAT SCI-POLYM E, V12, P229, DOI 10.1163/156856201750180942
   Lee TAT, 2000, ADV MATER, V12, P1105, DOI 10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1
   Manno M, 2001, BIOPOLYMERS, V59, P51, DOI 10.1002/1097-0282(200107)59:1<51::AID-BIP1005>3.0.CO;2-8
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Meyer DE, 2001, CANCER RES, V61, P1548
   Reguera J, 2003, MACROMOLECULES, V36, P8470, DOI 10.1021/ma034572q
   Rodriguez-Cabello JC, 2002, ADV MATER, V14, P1151, DOI 10.1002/1521-4095(20020816)14:16<1151::AID-ADMA1151>3.0.CO;2-Y
   RODRIGUEZCABELL.JC, 2004, CHEM PHYS LETT, V8, P127
   SANDBERG LB, 1985, PATHOL BIOL, V33, P266
   SCHMIDT P, 2004, IN PRESS BIOMACROMOL
   Stayton PS, 2000, J CONTROL RELEASE, V65, P203, DOI 10.1016/S0168-3659(99)00236-9
   Urry D. W., 2005, WHAT SUSTAINS LIFE C
   URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1985, BIOPOLYMERS, V24, P2345, DOI 10.1002/bip.360241212
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   URRY DW, IN PRESS PROTEIN BAS
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
NR 24
TC 145
Z9 153
U1 1
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 20
PY 2005
VL 102
IS 1
BP 113
EP 122
DI 10.1016/j.jconrel.2004.10.001
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 892CR
UT WOS:000226627800010
PM 15653138
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Sanmartin, AC
   Herrero, EJ
   Millan, I
   Cordon, A
   Rocha, A
   Maestro, MA
   Burgos, R
   Tellez, G
   Castillo-Olivares, JL
AF Paez, JMG
   Sanmartin, AC
   Herrero, EJ
   Millan, I
   Cordon, A
   Rocha, A
   Maestro, MA
   Burgos, R
   Tellez, G
   Castillo-Olivares, JL
TI Mechanical resistance of a new biomaterial, ostrich pericardium, and a
   new method of joining tissues combining suturing and a biological
   adhesive
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE mechanical properties; pericardium; suture; prosthesis; biological
   adhesives
ID CARDIAC BIOPROSTHESES; BOVINE PERICARDIUM; VALVES; GLUTARALDEHYDE;
   REOPERATION; DURABILITY; ELASTICITY; BEHAVIOR
AB We studied the mechanical behavior in response to tensile stress of samples of ostrich pericardium bonded with a cyanoacrylate glue or sewn with a rectangular, overlapping suture that was subsequently sealed with the same bioadhesive. Seventy-two trials were performed in three series of 24 samples each: series AG, glued with an overlap of 1 cm(2); series ASG, sewn with a rectangular, overlapping suture and sealed; and series AC, control samples that were left intact. The mean stress at rupture in series AG (glued) was 0.1 MPa, much lower than the working stress of a human valve leaflet, which is approximately 0.25 MPa. In the control series, this stress was 26.28 MPa. At rupture in series ASG (sutured/glued), the suture material was being subjected to a stress of 64.91 MPa, thus confirming the existence of an interaction between the suture and the shear stress exerted by the suture on the samples of pericardium. In series ASG, the mean value for the resistance to rupture when measured in machine kg was 8.83 kg, lower than but similar to that recorded in the control series AC (10.26 kg). The percentages of reversible deformation, or elongation, once the samples were torn were similar in series AC (19.15%) and ASG (21.93%). This phenomenon can only be explained by the damage to the collagen fibers in the area around the rupture, while other more distant regions work at a lower load within the elastic limit. We conclude that cyanocrylate adhesives alone are not suitable as bonding materials in cardiac bioprostheses. The results with the rectangular, overlapping suture, when subsequently sealed with an adhesive, can be considered good because, although this approach does not impede shear stress, it does maintain an excellent degree of resistance to rupture of the samples thus joined. We stress the need to take into account the concentration of the load in the design of bioprostheses. (C) 2004 Wiley Penodicals, Inc.
C1 Clin Puerta Hierro, Serv Cirugia Expt, Madrid 28035, Spain.
   Escuele Tecn Super Ingn Ind, Dept Mecan Estructural & Resistencia Mat, Madrid, Spain.
   Clin Puerta Hierro, Serv Bioestadist, Madrid 28035, Spain.
   Clin Puerta Hierro, Serv Cirurgia Cardiovasc, Madrid 28035, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Serv Cirugia Expt, C-San Martin Porres 4, Madrid 28035, Spain.
EM josempaez@telefonica.net
CR BERNAL JM, 1995, ANN THORAC SURG, V60, pS248, DOI 10.1016/0003-4975(95)00218-A
   Bingley JA, 2000, ANN THORAC SURG, V69, P1764, DOI 10.1016/S0003-4975(00)01250-9
   Burr Lawrence H., 1995, Annals of Thoracic Surgery, V60, P264
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   EDWARDS TJ, 1995, ANN THORAC SURG, V60, pS211, DOI 10.1016/0003-4975(95)00220-F
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GLOWER DD, 1995, J THORAC CARDIOV SUR, V109, P877, DOI 10.1016/S0022-5223(95)70311-X
   GOSALBEZ J, 1996, SCAND J THORAC C S44, V30, P74
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   Greene D, 1999, Arch Facial Plast Surg, V1, P292, DOI 10.1001/archfaci.1.4.292
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   Munro AI, 1995, ANN THORAC SURG, V59, pS470
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 2002, J BIOMED MATER RES, V62, P73, DOI 10.1002/jbm.10266
   Paez JMG, 1996, J BIOMED MATER RES, V30, P47
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   QUINTANARGUERRERO, 2001, BIOMATERIALS, V22, P957
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   San Martin AC, 1998, J MATER SCI-MATER M, V9, P77
   TIMOSHENKO S, 1970, RESISTENCIA MAT, P1
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 27
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN 15
PY 2005
VL 72B
IS 1
BP 9
EP 16
DI 10.1002/jbm.b.30139
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883KU
UT WOS:000226011300002
DA 2018-10-19
ER

PT J
AU Jun, HW
   West, JL
AF Jun, HW
   West, JL
TI Modification of polyurethaneurea with PEG and YIGSR peptide to enhance
   endothelialization without platelet adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE vascular graft; endothelialization; polyurethaneurea; YIGSR; PEG
ID ELASTOMERS; BIOCOMPATIBILITY; SURFACES; GRAFTS; DOMAIN
AB Improved endothelialization without platelet adhesion is essential to enhance the long-term patency of synthetic vascular grafts and other blood-contacting devices. We have developed a dually modified polyurethaneurea by incorporating endothelial cell adhesive YIGSR peptide sequences as chain extenders and nonthrombogenic PEG as a soft segment (PUUYIGSR-PEG) in the polymer backbone. PUUYIGSR-PEG was successfully synthesized and characterized by proton NMR, FTIR, GPC, DSC, ESCA, and contact angle measurement. Despite having similar molecular weight, the peptide/PEG-modified polyurethaneurea (PUUYIGSR-PEG) showed superior mechanical properties compared to the control PEG-modified polyurethaneurea (PUUPPD-PEG). Virtually no platelet adhesion was observed on PUUYIGSR-PEG, while endothelial cell adhesion, spreading, and migration were significantly greater on PUUYIGSR-PEG compared to PUUPPD-PEG. Thus, this bioactive polymer may be an appropriate biomaterial for small diameter vascular grafts. (C) 2004 Wiley Periodicals, Inc.
C1 Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
RP West, JL (reprint author), Rice Univ, Dept Bioengn, 6100 Main St,MS 142, Houston, TX 77005 USA.
EM jwest@rice.edu
RI West, Jennifer/A-4582-2008
OI West, Jennifer/0000-0001-8550-2875
CR ANDRIEUX A, 1991, J BIOL CHEM, V266, P14202
   BLACKWELL J, 1983, J POLYM SCI POL PHYS, V21, P2169, DOI 10.1002/pol.1983.180211024
   BLACKWELL J, 1979, POLYMER, V20, P13, DOI 10.1016/0032-3861(79)90035-1
   CLOWES AW, 1993, CARDIOVASC PATHOL, V2, P179
   DEE KC, 1994, MATER RES SOC SYMP P, V331, P115
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   DEIBLE CR, 1998, J BIOMED MATER RES, V41, P252
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HUBBELL JA, 1992, POLYM MAT SCI ENG, V66, P30
   Jun HW, 2004, J BIOMAT SCI-POLYM E, V15, P73, DOI 10.1163/156856204322752246
   KIM SW, 1996, BIOMATERIALS SCI INT, P297
   KOBAYASHI H, 1992, J NEUROSURG, V77, P397, DOI 10.3171/jns.1992.77.3.0397
   Lee HJ, 1999, J BIOMED MATER RES, V47, P564
   LEE HK, 1993, J APPL POLYM SCI, V50, P1269, DOI 10.1002/app.1993.070500718
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MAZUR C, 1994, J LAB CLIN MED, V124, P589
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park JH, 2002, J BIOMAT SCI-POLYM E, V13, P527, DOI 10.1163/15685620260178382
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   Sung C. S. P., 1980, MACROMOLECULES, V13, P111
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
NR 24
TC 63
Z9 67
U1 4
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN 15
PY 2005
VL 72B
IS 1
BP 131
EP 139
DI 10.1002/jbm.b.30135
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883KU
UT WOS:000226011300017
PM 15389489
OA Bronze
DA 2018-10-19
ER

PT J
AU Loher, S
   Stark, WJ
   Maciejewski, M
   Baiker, A
   Pratsinis, SE
   Reichardt, D
   Maspero, F
   Krumeich, F
   Gunther, D
AF Loher, S
   Stark, WJ
   Maciejewski, M
   Baiker, A
   Pratsinis, SE
   Reichardt, D
   Maspero, F
   Krumeich, F
   Gunther, D
TI Fluoro-apatite and calcium phosphate nanoparticles by flame synthesis
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID TRICALCIUM PHOSPHATE; SPRAY-PYROLYSIS; BONE-FORMATION; HYDROXYAPATITE;
   CERAMICS; COATINGS; IMPLANTS; SPECTRA; MACROPOROSITY; BIOMATERIALS
AB Calcium phosphate nanoparticles with calcium/phosphorus molar ratios ranging from 1.43 to 1.67 have been synthesized by simultaneous combustion of calcium carboxylate and tributyl-phosphate based precursors in a flame spray reactor. Fluoro-apatite and zinc or magnesium doped calcium phosphates were obtained by adding trifluoroacetic acid or corresponding carboxylates into the fuel. Nanoparticle morphology and the structure of sintered ceramics were studied using transmission and scanning electron microscopy. Thermal evolution of calcium phosphate phases was investigated by powder X-ray diffraction, Fourier transform infrared spectroscopy, and thermal analysis. A molar ratio of Ca/P < 1.5 in the precursor promoted the formation of dicalcium pyrophosphate (Ca2P2O7). Phase pure beta-tricalcium phosphate was obtained with a precursor Ca/P ratio of 1.52 after subsequent calcination at 900 degreesC. The regular, open structure with interconnecting micropores and the facile substitution of both anions and cations suggests possible application as a biomaterial.
C1 ETH Honggerberg, Dept Chem & Appl Biosci, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland.
   ETH Zentrum, Dept Mech & Proc Engn, Particle Technol Lab, CH-8092 Zurich, Switzerland.
   ETH Honggerberg, Inorgan Chem Lab, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   Degradable Solut AG, CH-8952 Schlieren, Switzerland.
RP Stark, WJ (reprint author), ETH Honggerberg, Dept Chem & Appl Biosci, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland.
EM wendelin.stark@chem.ethz.ch
RI Stark, Wendelin/A-8680-2008; Baiker, Alfons/S-6912-2017
OI Baiker, Alfons/0000-0003-1408-464X; Krumeich, Frank/0000-0001-5625-1536
CR Arias JL, 2003, BIOMATERIALS, V24, P3403, DOI 10.1016/S0142-9612(03)00202-3
   Barinov SM, 2003, INORG MATER+, V39, P877, DOI 10.1023/A:1025041817017
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   de Groot K, 1983, BIOCERAMICS CALCIUM
   Dong ZL, 2003, BIOMATERIALS, V24, P97, DOI 10.1016/S0142-9612(02)00267-3
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   EMERSON WH, 1962, ARCH ORAL BIOL, V7, P671, DOI 10.1016/0003-9969(62)90116-4
   FARLEY JR, 1983, SCIENCE, V222, P330
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   FREUND F, 1977, J CHEM SOC DALTON, P1136, DOI 10.1039/dt9770001136
   Fulmer MT, 2002, BIOMATERIALS, V23, P751, DOI 10.1016/S0142-9612(01)00180-6
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gineste L, 1999, J BIOMED MATER RES, V48, P224, DOI 10.1002/(SICI)1097-4636(1999)48:3<224::AID-JBM5>3.3.CO;2-1
   Gunther D, 1997, J ANAL ATOM SPECTROM, V12, P939, DOI 10.1039/a701423f
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HEZEL A, 1967, SPECTROCHIM ACTA A-M, VA 23, P1583, DOI 10.1016/0584-8539(67)80381-7
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Kim S, 2004, CHEM MATER, V16, P2336, DOI 10.1021/cm0497531
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.3.CO;2-A
   LeGeros R.Z., 1991, CALCIUM PHOSPHATES O, V15
   LEGEROS RZ, 1995, ENCY HDB BIOMATERI A
   Madler L, 2002, J AEROSOL SCI, V33, P369, DOI 10.1016/S0021-8502(01)00159-8
   Marchal J, 2004, CHEM MATER, V16, P822, DOI 10.1021/cm021783l
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P717, DOI 10.1002/jbm.820270604
   MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   Overgaard S, 1999, J BONE JOINT SURG BR, V81B, P725, DOI 10.1302/0301-620X.81B4.9282
   Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2
   Sarkar MR, 2001, J BIOMED MATER RES, V58, P329, DOI 10.1002/1097-4636(2001)58:3<329::AID-JBM1025>3.3.CO;2-0
   Somrani S, 2003, J MATER CHEM, V13, P888, DOI 10.1039/b210900j
   Stark W. J., 2004, Patent No. [WO 2004/005184, 2004005184]
   Stark WJ, 2002, IND ENG CHEM RES, V41, P4921, DOI 10.1021/ie020200e
   Stark WJ, 2002, POWDER TECHNOL, V126, P103, DOI 10.1016/S0032-5910(02)00077-3
   Strobel R, 2003, J CATAL, V213, P296, DOI 10.1016/S0021-9517(02)00082-9
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Wei M, 2003, J MATER SCI-MATER M, V14, P311, DOI 10.1023/A:1022975730730
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Yang XH, 1998, J MATER CHEM, V8, P2233, DOI 10.1039/a802067a
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
NR 46
TC 132
Z9 134
U1 1
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JAN 11
PY 2005
VL 17
IS 1
BP 36
EP 42
DI 10.1021/cm048776c
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 886KS
UT WOS:000226226700008
DA 2018-10-19
ER

PT J
AU Ginalska, G
   Kowalczuk, D
   Osinska, M
AF Ginalska, G
   Kowalczuk, D
   Osinska, M
TI A chemical method of gentamicin bonding to gelatine-sealed prosthetic
   vascular grafts
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE biomaterial; poly(ethylene terephthalate); covalent immobilization;
   antibacterial capabilities; SEM
ID INFECTION; IMPLANTATION; RELEASE; BEADS
AB Our aim was to develop a new method of chemical binding of gentamicin to vascular prostheses made of poly(ethylene terephthalate) (PET) fibres and covered with pig gelatine. We estimated (with the HPLC method) the immobilization yield, which equalled 76 or 8% depending on the concentration of the antibiotic used and the amount of gentamicin bound to the prosthesis (1.08-20.6 mg/g of prosthesis). The antibiotic was coupled in two modes: stable covalent binding or weak adhesion. The results confirmed that only a small quantity of the antibiotic (1.03-3.09%) was bound by adsorption. The modification of the prosthesis surface with immobilized gentamicin was visualized with a scanning microscope (SEM). Bacteriostatic properties of bound gentamicin were verified against different concentrations (cfu) of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus strains. We have found lack of growth of these pathogen strains in Luria-Bertani (LB) medium containing pieces of gentamicin-coupled prosthesis during at least 28 days of the experiment. Contrary to that, a control medium containing pieces of prosthesis only soaked with gentamicin allowed a constant growth of bacteria. (C) 2004 Elsevier B.V. All rights reserved.
C1 Marie Curie Sklodowska Univ, Dept Biochem, PL-20031 Lublin, Poland.
   Med Univ, Dept Med Chem, PL-20093 Lublin, Poland.
RP Ginalska, G (reprint author), Marie Curie Sklodowska Univ, Dept Biochem, PL-20031 Lublin, Poland.
EM ginal@hermes.umcs.lublin.pl
OI Ginalska, Grazyna/0000-0002-9961-4226; Osinska-Jaroszuk,
   Monika/0000-0002-3465-0461; Kowalczuk, Dorota/0000-0001-7458-5054
CR [Anonymous], 1998, BRIT PHARMACOPOEIA
   [Anonymous], 1999, BRIT PHARMACOPOEIA, V1, P695
   ASHTON TR, 1990, P SOC BIOMATER, V13, P235
   AVRAMOVIC JR, 1991, AUST NZ J SURG, V61, P436, DOI 10.1111/j.1445-2197.1991.tb00258.x
   Belt H. V. D., 2001, BIOMATERIALS, V22, P1607
   BOWMAN WC, 1980, TXB PHARM
   GAHTAN V, 1995, J SURG RES, V58, P105, DOI 10.1006/jsre.1995.1017
   GELABERT HA, 1992, ANTIBIOTIC IMPREGNAT, P88
   Ginalska G, 2004, J BIOMATER APPL, V18, P279, DOI 10.1177/0885328204041443
   GINALSKA G, 2004, POLSKI PRZEGLAD CHIR, V76, P1061
   GINALSKA G, 2004, J BIOCYBERN BIOMED E, V24, P17
   GINALSKA G, 2003, Patent No. 358934
   GOEAUBRISSONNIERE, 1999, BIOMATERIALS, V20, P229
   GRINGAUZ A, 1997, INTRO MED CHEM DRUGS, P247
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Huebner J, 1999, ANNU REV MED, V50, P223
   KINNEY EV, 1991, J SURG RES, V50, P430, DOI 10.1016/0022-4804(91)90020-M
   LAPPI DA, 1976, BIOCHEM BIOPH RES CO, V69, P878, DOI 10.1016/0006-291X(76)90455-1
   Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   PUZOVA H, 1994, FEMS IMMUNOL MED MIC, V9, P223, DOI 10.1111/j.1574-695X.1994.tb00497.x
   Strachan C J, 1991, Eur J Vasc Surg, V5, P627, DOI 10.1016/S0950-821X(05)80896-5
   Vicaretti M, 1998, CARDIOVASC SURG, V6, P268, DOI 10.1016/S0967-2109(98)00003-9
   Virto MR, 2003, BIOMATERIALS, V24, P79, DOI 10.1016/S0142-9612(02)00254-5
NR 25
TC 24
Z9 25
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD JAN 6
PY 2005
VL 288
IS 1
BP 131
EP 140
DI 10.1016/j.ijpharm.2004.09.021
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 889YV
UT WOS:000226479700015
PM 15607265
DA 2018-10-19
ER

PT J
AU Mao, C
   Zhao, WB
   Zhu, CH
   Zhu, AP
   Shen, J
   Lin, SC
AF Mao, C
   Zhao, WB
   Zhu, CH
   Zhu, AP
   Shen, J
   Lin, SC
TI In vitro studies of platelet adhesion on UV radiation-treated nylon
   surface
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE surface modification; radiation grafting; O-butyrylchitosan; nylon;
   blood compatibility; platelet adhesion
ID BLOOD COMPATIBILITY; CHITOSAN; IMMOBILIZATION; DERIVATIVES
AB The aim of the study was to prepare a novel blood,compatible of nylon film by a-rafting O-butyrylchitosan (OBCS). The immobilization was accomplished by irradiating with ultraviolet light, OBCS being coated on the film surface to photolyze azide groups, thus crosslinking OBCS and nylon together. Surface properties of nylon were investigated by attenuated total reflection Fourier transform infrared spectroscopy, electron spectroscopy for chemical analysis and water contact angle measurements. The blood compatibility of the OBCS-grafted nylon films was evaluated by platelet rich plasma contacting experiments and the results were observed by scanning electron microscopy. The blood compatibility of OBCS grafted nylon films seems better than that of blank nylon films. The modifications could be carried out to tailor nylon biomaterial to meet the specific needs of different biomedical applications. These results suggest that the blood compatible of nylon/OBCS films make them suitable biomaterials for some applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   Nanjing Univ, Lab Mesoscop Mat Surface, Dept Chem, Inst Analyt Sci, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Hankou Rd 22, Nanjing 210093, Peoples R China.
EM njusic2002@yahoo.com.cn
CR Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   GRANT S, 1988, POLYM COMMUN, V29, P342
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HAYASHI A, 1992, MACROMOLECULES, V25, P5094, DOI 10.1021/ma00045a041
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   JIE C, 1999, RADIAT PHYS CHEM, V55, P87
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kyrolainen M, 1997, ANAL CHIM ACTA, V353, P281, DOI 10.1016/S0003-2670(97)87787-2
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   NHO YC, 2000, RADIAT PHYS CHEM, V64, P67
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   PAEZ GJM, 2001, BIOMATERIALS, V22, P2731
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   Risbud M, 2001, BIOMATERIALS, V22, P1591, DOI 10.1016/S0142-9612(00)00325-2
   Shinde UA, 1999, FITOTERAPIA, V70, P333, DOI 10.1016/S0367-326X(99)00031-3
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   Yang MR, 1997, MATER CHEM PHYS, V48, P71, DOI 10.1016/S0254-0584(97)80081-8
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
NR 21
TC 25
Z9 29
U1 2
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 3
PY 2005
VL 59
IS 1
BP 19
EP 25
DI 10.1016/j.carbpol.2004.08.016
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 889JQ
UT WOS:000226439700003
DA 2018-10-19
ER

PT J
AU Richman, GP
   Tirrell, DA
   Asthagiri, AR
AF Richman, GP
   Tirrell, DA
   Asthagiri, AR
TI Quantitatively distinct requirements for signaling-competent cell
   spreading on engineered versus natural adhesion ligands
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 8th European Symposium on Controlled Drug Delivery
CY APR 07-09, 2004
CL Noordwijk, NETHERLANDS
DE biomaterial; extracellular matrix; focal adhesion kinase; integrin; PGD
ID EXTRACELLULAR-MATRIX PROTEINS; FIBRONECTIN RECEPTOR; SYNERGY SITE;
   BETA-SUBUNIT; INTEGRIN; DOMAINS; ALPHA; RGD; BIOMATERIALS; ACTIVATION
AB To design synthetic microenvironments that elicit desired cell behaviors, we must better understand the molecular mechanisms by which cells interact with candidate biomaterials. Using cell lines with distinct alpha(5)beta(1) integrin expression profiles, we demonstrate that this integrin mediates cell spreading on substrata coated with genetically engineered artificial extracellular matrix (aECM) proteins containing the RGD sequence (RGD-containing aECM protein [(a)RGD]) but lacking the PHSRN synergy site. Furthermore, (a)RGD-mediated adhesion stimulates an intracellular focal adhesion kinase (FAK) signal that is indicative of integrin tethering. Although both (a)RGD and the natural ECM protein fibronectin (FN) support alpha(5)beta(1) integrin-mediated cell spreading, quantitative single-cell analysis revealed that (a)RGD-mediated spreading requires ten-fold greater threshold amount of integrin expression than FN-mediated spreading. Our analysis demonstrates that (a)RGD-based substrata mediate both biophysical (cell spreading) and biochemical (FAK signaling) events via the alpha(5)beta(1) integrin, albeit with efficacy quantitatively distinct from that of natural ECM proteins that possess the full spectrum of adhesion and synergy domains. (c) 2004 Elsevier B.V. All rights reserved.
C1 CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP Asthagiri, AR (reprint author), CALTECH, Div Chem & Chem Engn, Mail Code 210-41, Pasadena, CA 91125 USA.
EM anand@cheme.caltech.edu
FU NHLBI NIH HHS [5 R01 HL59987-03]
CR AOTA S, 1994, J BIOL CHEM, V269, P24756
   Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413
   DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7
   Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157
   Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046
   Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098
   YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223
NR 20
TC 19
Z9 19
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 3
PY 2005
VL 101
IS 1-3
SI SI
BP 3
EP 12
DI 10.1016/j.jconrel.2004.07.034
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 884LP
UT WOS:000226086800002
PM 15588889
DA 2018-10-19
ER

PT S
AU Yuan, H
   Chen, N
   Lu, XY
   Zheng, BH
   Cui, W
   Song, XL
AF Yuan Hua
   Chen Ning
   Lu Xiaoying
   Zheng Buzhong
   Cui Wei
   Song Xiaoling
GP IEEE
TI Natural hydroxyapatite/chitosan composite for bone substitute materials
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
ID RECOMBINANT HUMAN BONE; CHITOSAN; BIOMATERIAL; PROTEIN-2
AB We developed the natural hydroxyapatite/chitosan composite that could be molded into any desired shape. The powder component consists of natural hydroxyapatite, which is epurated from bone of pigs. The liquid component consists of malic acid and chitosan. To study the possibility of the composite on repairing bone defects, 15 white rabbits were each operated on left tibias to create two square bone defects. One of the defects was reconstructed with the composite; the other was not repaired as a blank control. 3 of the animals were killed at the end of 2 weeks, 4 weeks, 8 weeks, 12 weeks and 16 weeks respectively to be evaluated with anatomy and histology. No apparent reject reaction was found, except for a mild inflammatory infiltrate found at postoperative 2 weeks. Fibrous tissue became thinner at postoperative 2-8weeks and bony connection was partly shown at postoperative 12 weeks. The new bone was the same as the recipient bone at postoperative 16 weeks. The hydroxyapatite/chitosan composite has good biocompatibility and osteoconduction. It is a potential repairing material for clinical application.
C1 Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210029, Peoples R China.
RP Chen, N (reprint author), Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210029, Peoples R China.
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   FRANK CD, 2003, J ORTHOP RES, V21, P521
   Hidalgo DA, 1995, PLAST RECONSTR SURG, V96, P597
   KATTHAGEN BD, 1984, ARCH ORTHOP TRAUM SU, V103, P291, DOI 10.1007/BF00432417
   KAWAKAMI T, 1992, BIOMATERIALS, V13, P759, DOI 10.1016/0142-9612(92)90014-F
   Koempel JA, 1998, J BIOMED MATER RES, V41, P359, DOI 10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B
   Konishi S, 2002, J SPINAL DISORD TECH, V15, P237, DOI 10.1097/01.BSD.000018290.84059.64
   LU XY, 2001, CHINA POWDER SCI TEC, V7, P16
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Pogrel MA, 1997, J ORAL MAXIL SURG, V55, P1200, DOI 10.1016/S0278-2391(97)90165-8
   Shikinami Y, 1996, BIOCERAMICS, V9, P391
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   ZHENG BZ, 2004, THESIS BIOMEDICAL EN
NR 14
TC 2
Z9 3
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 4888
EP 4891
DI 10.1109/IEMBS.2005.1615568
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998404110
PM 17281338
DA 2018-10-19
ER

PT S
AU Huang, Y
   Lu, XY
   Zhong, YP
AF Huang Yan
   Lu Xiao-ying
   Zhong Yin-ping
GP IEEE
TI Quantitative evaluation and secondary structure analysis of proteins
   adsorbed on biomaterial surfaces using FTIR
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
DE biomaterial; protein adsorption; PU (H50-50); PS; FTIR
ID ADSORPTION
AB The quantity and secondary structure of adsorbed albumin (Alb) and immunoglobulin G (IgG) on two kinds of biomaterial surfaces-polyurethane (PU (H50-50)) and polystyrene (PS) were studied using Fourier transform infrared spectroscopy (FTIR). The original spectra tested by FTIR were processed using second-derivation and self-deconvolution techniques to obtain the content of different secondary structures of adsorbed proteins, which could be used to evaluate the denatured degree of proteins. Results showed that the quantity of Alb adsorbed on PU (H50-50) surface is larger than PS. The hydrophobic features of material played a role in conformational change of adsorbed protein, and indicated that the denatured degree caused by hydrophobic PS was greater than hydrophilic PU (H50-50). The blood compatibility of PU (H50-50) was likely to be better than PS.
C1 Southeast Univ, State Key Lab Bioelect Biomed & Engn Dept, Nanjing 210096, Peoples R China.
RP Lu, XY (reprint author), Southeast Univ, State Key Lab Bioelect Biomed & Engn Dept, Nanjing 210096, Peoples R China.
CR Bummer PM, 1996, INT J PHARM, V132, P143, DOI 10.1016/0378-5173(95)04344-6
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   FINK DJ, 1987, ANAL BIOCHEM, V165, P147, DOI 10.1016/0003-2697(87)90213-2
   FORBES CD, 1994, HAEMOSTASIS THROMBOS, P1301
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V220, P13, DOI 10.1006/jcis.1999.6479
   GU HQ, 1993, BIOMEDICAL MAT, P142
   HUANG Y, 2002, THESIS BIOMEDICAL EN, P28
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   KAUPPINEN JK, 1981, ANAL CHEM, V53, P1454, DOI 10.1021/ac00232a034
   Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X
   WANG DC, 1999, ACTA BIOPHYSIC SINIC, V15, P166
   WU JG, 1994, CURRENT TECHNIQUE FO, P193
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 13
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 4892
EP 4895
DI 10.1109/IEMBS.2005.1615569
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998404111
PM 17281339
DA 2018-10-19
ER

PT B
AU Wang, ZG
   Lu, XY
   Li, WY
   Wang, HL
   Zhang, ZY
   Wang, YF
   Wei, C
AF Wang, ZG
   Lu, XY
   Li, WY
   Wang, HL
   Zhang, ZY
   Wang, YF
   Wei, C
BE He, JP
   Gao, SK
   Lin, JR
TI Study of microelectronics for detecting and stimulating of central
   neural signals
SO 2005 First International Conference on Neural Interface and Control
   Proceedings
LA English
DT Proceedings Paper
CT 1st International Conference on Neural Interface and Control (CNIC)
CY MAY 26-28, 2005
CL Wuhan, PEOPLES R CHINA
SP Huazhong Univ Sci & Technol, Arizona State Univ, Tsinghua Univ
DE central neural ftinction regeneration; body-embedded circuits;
   biocompatibility of biomaterial
AB Test circuits for the signal detection and the function electrical stimulation (FES) of neurons have been designed, implemented at first by using discrete devices and characterized off-body. The detecting circuit consisting of three-stage operational amplifiers has a controllable gain up to 10(5), a -3 dB; bandwidth of 30 kHz, and an equivalent input noise of about 9 nV/root Hz. The FES circuit consisting of two-stage operational amplifiers has a bandwidth of more than 10 kHz and a variable gain from 20 dB to 60 dB can provide a current of more than 1 mA to a load of 10 k Omega. They are intended to connect with both cuff-type and staff-type microelectrodes. Integrated circuits (IC) for the neural signal process have been designed with features of low voltage and low power. A more biocompatible composite has been synthesized to modify the silicon and related material.
C1 Southeast Univ, Inst RF&OE ICs, Nanjing 210096, Peoples R China.
RP Wang, ZG (reprint author), Southeast Univ, Inst RF&OE ICs, Nanjing 210096, Peoples R China.
RI 邱, 爽/A-2155-2015; Wang, Yufeng/A-3207-2015
CR LOTTE NS, 2002, IEEE T BIOMED ENG, V49
   NIELSEN JH, 2001, ICECS 2001, V3, P1183
   WANG ZG, 2004, 3 SIN JOINT S OPT MI
NR 3
TC 10
Z9 10
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8902-6
PY 2005
BP 192
EP 195
PG 4
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Neurosciences
SC Computer Science; Engineering; Neurosciences & Neurology
GA BCT96
UT WOS:000231205500048
DA 2018-10-19
ER

PT S
AU Nair, K
   Sun, W
AF Nair, K
   Sun, W
GP IEEE
TI Preliminary study of viscoelastic bulk properties for cell-substrate
   interaction in scaffold guided tissue engineering
SO 2005 IEEE 31ST ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 31st Annual Northeast Bioengineering Conference
CY APR 02-03, 2005
CL Stevens Inst Technol, Hoboken, NJ
SP IEEE, EMB
HO Stevens Inst Technol
AB In the field of tissue Engineering the development of biomaterial surfaces that allow cell attachment for viability and growth is highly challenging. These materials are used in the development of scaffolds to provide a supporting framework and also to provide a controlled spatial distribution of cells which could guide tissue formation. Our group focuses in designing scaffolds that can engineer tissue growth by tuning the geometry, mechanical properties or chemical properties of the material. For effective and complete designing quantitative analysis of interactions of the cell and scaffold is highly significant. This would be of great value for controlling cell behavior and the processes involved in incorporating the cells into the scaffolds for directing cellular responses and tissue formation. This paper discusses the material considerations and design parameters required for conducting this study.
C1 Drexel Univ, Lab Comp Aided Tissue Engn, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Nair, K (reprint author), Drexel Univ, Lab Comp Aided Tissue Engn, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
CR CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   DIETMAR WH, 2000, BIOMATERIALS, V21, P2543
   JOYCE Y, 2004, SURF SCI, V570, P119
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Pettit EJ, 1998, PHYSIOL REV, V78, P949
   VOZZI G, 2004, MAT RES SOC S P, V1
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 0-7803-9105-5
J9 NORTHEAST BIOENGIN C
PY 2005
BP 184
EP 186
PG 3
WC Engineering, Biomedical
SC Engineering
GA BCO98
UT WOS:000230459300087
DA 2018-10-19
ER

PT S
AU Kwon, J
   Park, S
   Kim, B
   Park, JO
AF Kwon, J
   Park, S
   Kim, B
   Park, JO
GP IEEE
TI Bio-material property measurement system for locomotive mechanism in
   gastro-intestinal tract
SO 2005 IEEE International Conference on Robotics and Automation (ICRA),
   Vols 1-4
SE IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION
LA English
DT Proceedings Paper
CT IEEE International Conference on Robotics and Automation (ICRA)
CY APR 18-22, 2005
CL Barcelona, SPAIN
SP IEEE
DE locomotion; earthworm-like robot; bio-material property;
   gastro-intestinal tract
AB Recently, diseases in gastro-intestinal tract have drastically increased. As a result, endoscopic technologies are being developed to diagnose and treat these diseases. Biomaterial property is essential information to develop endoscopic devices especially capsule type endoscope. Because the capsule endoscope is moved by the peristaltic motion, it has some limitations to get the image of the digestive organ. Therefore, locomotive mechanism for capsule is necessary. In order to develop the locomotive mechanism, the information of biomaterial property is required. Especially, the friction force between capsule endoscope and the tissues of the gastro-intestinal tract is very important information. In this paper, we propose the bio-material property measuring system which can supply the information for the design of the locomotive mechanism. By using the proposed measuring system, we evaluate the effects of design parameters such as velocity, diameter size and shape of capsule endoscope that influence the friction force to the capsule endoscope to get the dominant parameters. As a result, we can offer the useful information to design the locomotive mechanism of the capsule endoscope.
C1 Korea Inst Sci & Technol, Microsyst Res Ctr, Seoul 130650, South Korea.
RP Kwon, J (reprint author), Korea Inst Sci & Technol, Microsyst Res Ctr, POB 131, Seoul 130650, South Korea.
CR Fung YC, 1993, BIOMECHANICS MECH PR
   LEE Y, 2004, IEEE C ROBOTICS AUTO
   Pratt G., 2000, IEEE ROBOTICS AUTOMA
   ROSEN J, 1999, IEEE T BIOMED ENG, V46
   RYU J, 2002, P INT S MICR HUM SCI, P85
   SUZUMORI K, 1999, IEEE ASME T MECH, V4
   TANIMOTO M, 1998, 11 ANN INT WORKSH MI, P504
NR 7
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1050-4729
BN 0-7803-8914-X
J9 IEEE INT CONF ROBOT
PY 2005
BP 1303
EP 1308
PG 6
WC Robotics
SC Robotics
GA BDU48
UT WOS:000235460101017
DA 2018-10-19
ER

PT B
AU Qu, CY
   Qin, QH
   Kang, YL
AF Qu, Chuan-Yong
   Qin, Qing-Hua
   Kang, Yi-Lan
BE Ren, WX
   Ong, KCG
   Tan, JSY
TI Theoretical prediction of surface bone remodeling under axial and
   transverse loads
SO 9th International Conference on Inspection Appraisal Repairs &
   Maintenance of Structures
LA English
DT Proceedings Paper
CT 9th International Conference on Inspection, Appraisal, Repairs and
   Maintenance of Structures
CY OCT 20-21, 2005
CL Fuzhou, PEOPLES R CHINA
SP Cent S Univ, Fuzhou Univ
DE surface bone remodeling; biomaterial; biomechanics;
   magnetoelectroelastic
ID ADAPTIVE ELASTICITY; DRY BONE; PIEZOELECTRICITY
AB Theoretical prediction of surface bone remodeling in the diaphysis of the long bone under various transverse loads are made within the framework of adaptive elastic theory. These loads include external lateral pressure, electric, magnetic and thermal loads. An explicit solution is obtained for analyzing problems of surface bone remodeling. Numerical results are presented to verify the proposed formulation and to show the effects of mechanical, thermal and magnetoelectric loads on bone remodeling process. The theory can also be applied to the problem of predicting surface remodeling in the bone subjected to coupled axial force, external lateral pressure, electric, magnetic and thermal loads as a result of a force-fitted medullary pin.
C1 Tianjin Univ, Tianjin 300072, Peoples R China.
RP Qu, CY (reprint author), Tianjin Univ, Tianjin 300072, Peoples R China.
RI Qin, Qinghua/A-4845-2008
CR Aschero G, 1999, J BIOMECH, V32, P573, DOI 10.1016/S0021-9290(99)00021-4
   Aschero G, 1996, J BIOMECH, V29, P1169, DOI 10.1016/0021-9290(96)00011-5
   Charnay A., 1972, J BIOMECH, V5, P173
   COWIN SC, 1981, J BIOMECH, V14, P471, DOI 10.1016/0021-9290(81)90097-X
   COWIN SC, 1979, J BIOMECH, V12, P269, DOI 10.1016/0021-9290(79)90069-1
   DEMIRAY H, 1983, INT J ENG SCI, V21, P1117, DOI 10.1016/0020-7225(83)90051-4
   Gao CF, 2004, INT J ENG SCI, V42, P1347, DOI 10.1016/j.ijengsci.2004.03.005
   GJELSVIK A, 1973, J BIOMECH, V6, P69, DOI 10.1016/0021-9290(73)90039-0
   GUZELSU N, 1978, J BIOMECH, V11, P257, DOI 10.1016/0021-9290(78)90052-0
   HART RT, 1984, J BIOMECH ENG-T ASME, V106, P342, DOI 10.1115/1.3138503
   HEGEDUS DH, 1976, J ELASTICITY, V6, P337, DOI 10.1007/BF00040896
   JOHNSON MW, 1980, J BIOMECH, V13, P565, DOI 10.1016/0021-9290(80)90057-3
   Kryszewski M, 2004, ACTA PHYS POL A, V105, P389, DOI 10.12693/APhysPolA.105.389
   Qin QH, 2004, INT J SOLIDS STRUCT, V41, P2447, DOI 10.1016/j.ijsolstr.2003.12.026
   QIN QH, 2005, IN PRESS BIOMATERIAL
   Silva CC, 2001, MAT SCI ENG B-SOLID, V86, P210, DOI 10.1016/S0921-5107(01)00674-2
   Tsili MC, 2000, J BIOMECH, V33, P235, DOI 10.1016/S0021-9290(99)00145-1
   Zhang Y, 2002, KEY ENG MAT, V224-2, P121, DOI 10.4028/www.scientific.net/KEM.224-226.121
NR 18
TC 1
Z9 1
U1 0
U2 2
PU CI-PREMIER PTE LTD
PI SINGAPORE
PA 150 ORCHARD ROAD #07-14, ORCHARD PLAZA, SINGAPORE, 238841, SINGAPORE
BN 981-05-3548-1
PY 2005
BP 373
EP 380
PG 8
WC Construction & Building Technology; Engineering, Civil; Mechanics
SC Construction & Building Technology; Engineering; Mechanics
GA BFC72
UT WOS:000241008400041
DA 2018-10-19
ER

PT S
AU Kuure-Kinsey, M
   Weber, D
   Bungay, HR
   Plawsky, JL
   Bequette, BW
AF Kuure-Kinsey, M
   Weber, D
   Bungay, HR
   Plawsky, JL
   Bequette, BW
GP IEEE
TI Modeling and predictive control of a rotating disk bioreactor
SO ACC: Proceedings of the 2005 American Control Conference, Vols 1-7
SE PROCEEDINGS OF THE AMERICAN CONTROL CONFERENCE
LA English
DT Proceedings Paper
CT American Control Conference 2005 (ACC)
CY JUN 08-10, 2005
CL Portland, OR
SP Amer Automat Control Council, IFAC, AIAA, AIChE, AIST, ASCE, ASME, IEEE, ISA, SCS
ID BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM
AB A rotating disk bioreactor (RDB) produces cohesive cellulose gels rapidly because of the high surface area, high volumetric efficiency, and low power consumption. A novel feature of the RDB that we have developed is that solids added to the medium enter the gel and are held at selected locations. Different solid materials such as silica gel, glass spheres, metallic powders, carbon, and common plant cellulose can be incorporated into the gel and gradients, stripes or bands of solids can be formed, resulting in a new type of biomaterial with applications in foods, medicine, bioprocessing, and manufacture of novel forms of paper. Incorporation of solid particles into the gelatinous matrix of bacterial cellulose involves complicated fluid/particle hydrodynamics. Experimental results are shown for a semibatch RDB, while simulation studies apply model predictive control (MPC) to a continuous RDB. Two MPC approaches are developed and analyzed for setpoint tracking and disturbance rejection.
C1 Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA.
RP Kuure-Kinsey, M (reprint author), Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA.
CR BROWN RM, 1992, ACS C P SER
   Chao YP, 2000, BIOTECHNOL BIOENG, V68, P345
   Cutler C. R., 1980, P JOINT AUT CONTR C
   EMBUSCADO ME, 1994, FOOD HYDROCOLLOID, V8, P407, DOI 10.1016/S0268-005X(09)80084-2
   LAPUZ M M, 1967, Philippine Journal of Science, V96, P91
   MASAOKA S, 1993, J FERMENT BIOENG, V75, P18, DOI 10.1016/0922-338X(93)90171-4
   Morari M, 1999, COMPUT CHEM ENG, V23, P667, DOI 10.1016/S0098-1354(98)00301-9
   MORMINIO R, 2003, APP MICROBIOL BIOTEC, V628, P503
   MORMINO R, 2002, THESIS RENSSELAER PO
   Muske KR, 2002, J PROCESS CONTR, V12, P617, DOI 10.1016/S0959-1524(01)00051-8
   MUSKE KR, 1993, AICHE J, V39, P262, DOI 10.1002/aic.690390208
   OKIYAMA A, 1993, FOOD HYDROCOLLOID, V6, P493, DOI 10.1016/S0268-005X(09)80073-8
   Serafica G, 2002, APPL MICROBIOL BIOT, V58, P756, DOI 10.1007/s00253-002-0978-8
   TAKAI M, 1994, BACTERIAL CELLULOSE, pCH13
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   YAMANAKA S, 1994, APPL BACTERIAL CELLU, pCH11
NR 16
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0743-1619
BN 0-7803-9098-9
J9 P AMER CONTR CONF
PY 2005
BP 3259
EP 3264
DI 10.1109/ACC.2005.1470474
PG 6
WC Automation & Control Systems; Computer Science, Artificial Intelligence
SC Automation & Control Systems; Computer Science
GA BCY93
UT WOS:000231947704047
DA 2018-10-19
ER

PT J
AU Ehteshami, G
   Brune, DC
   Lopez, JC
   Massia, SP
AF Ehteshami, G
   Brune, DC
   Lopez, JC
   Massia, SP
TI A bioconjugate of Lys and Arg mimics biological activity of the
   Arg-Gly-Asp peptide sequence
SO ACTA BIOMATERIALIA
LA English
DT Article
DE cell adhesion; RGD peptide mimetic; biomaterial coatings; integrin
   antagonist
ID RGD-PEPTIDES; IN-VIVO; BONE-FORMATION; CELL-ADHESION; INTEGRINS;
   IMPLANTS; MATRIX; VITRO
C1 Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
   Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.
RP Massia, SP (reprint author), Arizona State Univ, Harrington Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
EM smassia@asu.edu
FU NHLBI NIH HHS [K02HL067837, R01HL060450]
CR CRAIG WS, 1995, BIOPOLYMERS, V37, P157, DOI 10.1002/bip.360370209
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F
   Engleman VW, 1996, ANNU REP MED CHEM, V31, P191, DOI 10.1016/S0065-7743(08)60459-5
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Halberstadt C, 2002, TISSUE ENG, V8, P309, DOI 10.1089/107632702753725067
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Lobb RR, 2002, METHOD CELL BIOL, V69, P17, DOI 10.1016/S0091-679X(02)69005-3
   LOESBACK A, 2001, J BIOMED MATER RES, V57, P575
   Massia S.P., 1999, TISSUE ENG PROSTHETI, P583
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Massia SP, 2004, J BIOMED MATER RES A, V68A, P177, DOI 10.1002/jbm.a.20009
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mertz Patricia M., 1996, Journal of Burn Care and Rehabilitation, V17, P199, DOI 10.1097/00004630-199605000-00004
   POLAREK JW, 1994, WOUNDS, V6, P46
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   WOERLY S, 1994, J NEURAL TRANSP PLAS, V5, P245
NR 18
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2005
VL 1
IS 1
BP 85
EP 91
DI 10.1016/j.actbio.2004.09.005
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008EW
UT WOS:000235024000008
PM 16701782
DA 2018-10-19
ER

PT J
AU Maxwell, DJ
   Hicks, BC
   Parsons, S
   Sakiyama-Elbert, SE
AF Maxwell, DJ
   Hicks, BC
   Parsons, S
   Sakiyama-Elbert, SE
TI Development of rationally designed affinity-based drug delivery systems
SO ACTA BIOMATERIALIA
LA English
DT Article
DE combinatorial; controlled release; nerve regeneration
ID FIBROBLAST-GROWTH-FACTOR; HEPARINIZED COLLAGEN MATRICES;
   ANTITHROMBIN-III; CONTROLLED-RELEASE; FIBRIN GELS; FUSION PROTEINS;
   CROSS-LINKING; BINDING; PEPTIDES
AB Many drug delivery systems have been developed to provide sustained release of proteins in vivo. However, the ability to predict and control the rate of release from delivery systems is still a challenge. Toward this goal, we screened a random drug-binding peptide library (12 amino acids) to identify peptides of varying (i.e. low, moderate, and high) affinity for a model polysaccharide drug (heparin). Peptide domains of varying affinity for heparin identified from the library were synthesized using standard solid phase chemistry. A mathematical model of drug release from a biomaterial scaffold containing drug-binding peptide domains identified from the library was developed. This model describes the binding kinetics of drugs to the peptides, the diffusion of free drug, and the kinetics of enzymatic matrix degradation. The effect of the ratio of binding sites to drug, the effect of varying the binding kinetics and the rate of enzymatic matrix degradation oil the rate of drug release was examined. The in vitro release of the model drug from scaffold containing the peptide drug-binding domains was measured. The ability of this system to deliver and modulate the biological activity of protein drugs was also assessed using nerve growth factor (NGF) in a chick dorsal root ganglia (DRG) neurite extension model. These studies demonstrate that our rational approach to drug delivery system design can be used to control drug release from tissue-engineered scaffolds and may be useful for promoting tissue regeneration in vivo. (c) 2004 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
RP Sakiyama-Elbert, SE (reprint author), Washington Univ, Dept Biomed Engn, Campus Box 1097,1 Brookings Dr, St Louis, MO 63130 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
CR Andrades JA, 1999, EXP CELL RES, V250, P485, DOI 10.1006/excr.1999.4528
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Herbert CB, 1996, J COMP NEUROL, V365, P380, DOI 10.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-0
   HURLETJENSEN A, 1983, THROMB RES, V29, P609, DOI 10.1016/0049-3848(83)90215-3
   ICHINOSE A, 1983, FEBS LETT, V153, P369, DOI 10.1016/0014-5793(83)80645-0
   Kridel SJ, 1996, J BIOL CHEM, V271, P20935, DOI 10.1074/jbc.271.34.20935
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   OLSON ST, 1981, J BIOL CHEM, V256, P1073
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1
   ROGHANI M, 1992, J BIOL CHEM, V267, P22156
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schroeder-Tefft JA, 1997, J CONTROL RELEASE, V49, P291, DOI 10.1016/S0168-3659(97)10055-4
   Tuan TL, 1996, CONNECT TISSUE RES, V34, P1, DOI 10.3109/03008209609028888
   TYLERCROSS R, 1994, PROTEIN SCI, V3, P620
   TylerCross R, 1996, ARCH BIOCHEM BIOPHYS, V334, P206, DOI 10.1006/abbi.1996.0448
   VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
NR 25
TC 44
Z9 44
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2005
VL 1
IS 1
BP 101
EP 113
DI 10.1016/j.actbio.2004.09.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008EW
UT WOS:000235024000010
PM 16701784
DA 2018-10-19
ER

PT J
AU Ranade, SV
   Richard, RE
   Helmus, MN
AF Ranade, SV
   Richard, RE
   Helmus, MN
TI Styrenic block copolymers for biomaterial and drug delivery applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE biomaterials; block copolymers; structure-property relationships;
   microphase separation; drug delivery; stems; kraton; SBS; SEBS; SIBS
ID PACLITAXEL-ELUTING STENT; ATOMIC-FORCE MICROSCOPY; SLOW-RELEASE;
   SURFACE-MORPHOLOGY; PART II; LESIONS; TRIAL; RESTENOSIS; CARDIOLOGY;
   BUTADIENE
C1 Boston Sci Corp, Corp Res & Adv Technol Dev, Natick, MA 01760 USA.
RP Ranade, SV (reprint author), Boston Sci Corp, Corp Res & Adv Technol Dev, 1 Boston Sci Pl, Natick, MA 01760 USA.
EM ranades@bsci.com
OI Ranade, Shrirang/0000-0002-9457-2477
CR Aggarwal RK, 1996, CIRCULATION, V94, P3311, DOI 10.1161/01.CIR.94.12.3311
   ANNIS BK, 1992, MAKROMOL CHEM, V193, P2589
   Antony P, 2003, POLYM ENG SCI, V43, P243, DOI 10.1002/pen.10021
   Babapulle MN, 2002, CIRCULATION, V106, P2859, DOI 10.1161/01.CIR.0000038984.30279.89
   BANTJES A, 1978, BRIT POLYM J, V10, P267, DOI 10.1002/pi.4980100410
   BERG E, 1995, Patent No. 5464650
   BERLOWITZTARRANT L, 1998, Patent No. 5840387
   Bhatia V, 2004, POSTGRAD MED J, V80, P13, DOI 10.1136/pgmj.2003.009431
   BISHOP ET, 1969, ARTIFICIAL HEART PRO, P133
   Cadieux P., 2002, J COLL SURF B, V28, P95
   Chieffo A, 2004, HERZ, V29, P147, DOI 10.1007/s00059-004-2555-7
   Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6
   DING N, 1996, Patent No. 96002721
   Folkes M. J., 1973, Physics of glassy polymers, P548
   Forster S., 2002, ANGEW CHEM INT EDIT, V41, P688
   GOOSEN MFA, 1979, J BIOMED MATER RES, V13, P347, DOI 10.1002/jbm.820130302
   Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1
   GRUBE E, 2002, CIRCULATION CLIN INV, V106, P76
   HELMUS MN, 1982, ADV CHEM SER, V199, P81
   JEONG MH, 1995, 68 SCI SESS, V92, P1
   KASZAS G, 1989, J MACROMOL SCI CHEM, VA26, P1099, DOI 10.1080/00222338908052037
   Kennedy J.P., 1990, U.S. Patent, Patent No. [4,946,899, 4946899]
   Kennedy J. P., 1992, DESIGNED POLYM CARBO
   Kim G, 1998, MACROMOLECULES, V31, P2670, DOI 10.1021/ma9714070
   Kumar N, 2001, ADV DRUG DELIVER REV, V53, P23, DOI 10.1016/S0169-409X(01)00219-8
   Kwon Y, 2002, POLYM PREPR, V43, P266
   LEWIS PR, 1971, POLYMER, V12, P258, DOI 10.1016/0032-3861(71)90050-4
   MAEDA M, 1986, J BIOMED MATER RES, P25
   MAJETI NV, 2002, ADV POLYM SCI, V160, P45
   NAKASHIMA T, 1977, J BIOMED MATER RES, V11, P787, DOI 10.1002/jbm.820110512
   OKANO T, 1979, POLYM PREPRINTS, V20, P571
   PICHA GJ, 1978, J BIOENG, V2, P301
   PINCHUK L, 2001, T WORLD BIOM C, P1452
   Pinchuk L, 1998, US Patent, Patent No. [5,741,331, 5741331, no 5,741331]
   PINCHUK L, 2003, Patent No. 20030171496
   Pinchuk N.S., 2003, US Patent, Patent No. [6,545,097, 6545097]
   Puskas J.E., 2004, U.S. Patent, Patent No. [6,747,098, 6747098]
   Puskas JE, 2004, J POLYM SCI POL CHEM, V42, P3091, DOI 10.1002/pola.20114
   Puskas JE, 2002, MACROMOL SYMP, V183, P191, DOI 10.1002/1521-3900(200207)183:1<191::AID-MASY191>3.0.CO;2-N
   PUSKAS JE, 2004, POLYM PREPRINTS, P45
   PUSKAS JE, 2000, PROG POLYM SCI, V25, P404
   PUSKAS JE, 2003, J POLYM ADV TECH, V14, P1
   RICHARD R, 2004, 31 ANN M CONTR REL S
   SALTZMAN WM, 2001, DRUG DELIVERY ENG PR, P235
   SCHOEPHOESTER R, 2002, P 6 ANN HILT HEAD WO
   SCHWARZ M, 2004, 31 ANN M CONTR REL S
   Silber Sigmund, 2003, J Interv Cardiol, V16, P485, DOI 10.1046/j.1540-8183.2003.01065.x
   Snyder R. W., 2003, STANDARD HDB BIOMEDI
   Sousa JE, 2003, CIRCULATION, V107, P2383, DOI 10.1161/01.CIR.0000069331.67148.2F
   Sousa JE, 2003, CIRCULATION, V107, P2274, DOI 10.1161/01.CIR.0000069330.41022.90
   SOUSA JE, 2002, PRACTICAL INTERVENTI, P279
   STECKEL M, 2004, BIOMATERIALS REGENER
   Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
   Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A
   TINGEY KG, 1988, SURFACE CHARACTERIZA, P255
   Vachon D., 2001, Patent, Patent No. [US 6,306,419 B1, 6306419]
   VACHON D, 2002, POLYM PREPRINTS, V43, P644
   VROMAN L, 1980, BLOOD, V55, P156
   Wise DL, 2000, HDB PHARM CONTROLLED
NR 60
TC 79
Z9 81
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2005
VL 1
IS 1
BP 137
EP 144
DI 10.1016/j.actbio.2004.09.004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008EW
UT WOS:000235024000013
PM 16701787
DA 2018-10-19
ER

PT S
AU Duce, C
   Micheli, A
   Solaro, R
   Starita, A
   Tine, MR
AF Duce, C.
   Micheli, A.
   Solaro, R.
   Starita, A.
   Tine, M. R.
BE Simos, T
   Maroulis, G
TI Recursive neural networks for quantitative structure-property
   relationship analysis of polymers.
SO ADVANCES IN COMPUTATIONAL METHODS IN SCIENCES AND ENGINEERING 2005, VOLS
   4 A & 4 B
SE LECTURE SERIES ON COMPUTER AND COMPUTATIONAL SCIENCES
LA English
DT Proceedings Paper
CT International Conference on Computational Methods in Sciences and
   Engineering (ICCMSE 2005)
CY OCT 21-26, 2005
CL Corinth, GREECE
SP Amer Chem Soc, Amer Phys Soc
DE recursive neural networks; QSPR/QSAR; polymer; glass transition
   temperature; biomaterial; artificial intelligence; molecular structure.
ID GLASS-TRANSITION TEMPERATURES; PREDICTION; MONOMER
AB We report an overview of the results obtained in the prediction of the glass transition temperature of a set of acyclic acrylic and methactylic polymers by Recursive Neural Networks (RecNN). The RecNN approach allows us a completely novel approach to QSPR/QSAR analysis by a direct adaptive processing of molecular graphs, both in case of small molecules or polymers.
C1 Univ Pisa, Dept Chem & Ind Chem, I-56126 Pisa, Italy.
RP Duce, C (reprint author), Univ Pisa, Dept Chem & Ind Chem, Via Risorgimento 35, I-56126 Pisa, Italy.
EM celia@dcci.unipi.it
CR Bicerano J., 2002, PREDICTION POLYM PRO
   Camelio P, 1997, J POLYM SCI POL CHEM, V35, P2579
   DUCE C, 2005, THESIS U PISA
   JOYCE SJ, 1995, J CHEM SOC FARADAY T, V91, P2491, DOI 10.1039/ft9959102491
   Karasz F. E., 1968, MACROMOLECULES, V1, P537
   Katritzky AR, 1998, J CHEM INF COMP SCI, V38, P300, DOI 10.1021/ci9700687
   Katritzky AR, 1996, J CHEM INF COMP SCI, V36, P879, DOI 10.1021/ci950156w
   KOEHLER MG, 1989, POLYMER, V30, P116, DOI 10.1016/0032-3861(89)90392-3
   Mattioni BE, 2002, J CHEM INF COMP SCI, V42, P232, DOI [10.1021/ci010062o, 10.1021/6010062o]
   Micheli A, 2001, J CHEM INF COMP SCI, V41, P202, DOI 10.1021/ci0000399
   MICHELI A, 2003, THESIS U PISA
   Sumpter BG, 1996, J THERM ANAL CALORIM, V46, P833, DOI 10.1007/BF01983605
   Van Krevelen D. W., 1976, PROPERTIES POLYM
NR 13
TC 3
Z9 3
U1 0
U2 4
PU VSP BV-C/O BRILL ACAD PUBL
PI LEIDEN
PA PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 1573-4196
BN 90-6764-443-9
J9 LECT SER COMPUTER CO
PY 2005
VL 4A-4B
BP 1546
EP 1549
PG 4
WC Engineering, Multidisciplinary; Mathematics, Applied; Physics,
   Multidisciplinary; Physics, Mathematical
SC Engineering; Mathematics; Physics
GA BEL90
UT WOS:000238054400389
DA 2018-10-19
ER

PT S
AU Fong, SW
   Klaseboer, E
   Turangan, CK
   Hung, KC
   Khoo, BC
AF Fong, S. W.
   Klaseboer, E.
   Turangan, C. K.
   Hung, K. C.
   Khoo, B. C.
BE Simos, T
   Maroulis, G
TI Bubble dynamics near biomaterials in an ultrasound field - A numerical
   analysis using boundary element method
SO ADVANCES IN COMPUTATIONAL METHODS IN SCIENCES AND ENGINEERING 2005, VOLS
   4 A & 4 B
SE LECTURE SERIES ON COMPUTER AND COMPUTATIONAL SCIENCES
LA English
DT Proceedings Paper
CT International Conference on Computational Methods in Sciences and
   Engineering (ICCMSE 2005)
CY OCT 21-26, 2005
CL Corinth, GREECE
SP Amer Chem Soc, Amer Phys Soc
DE ultrasonic cavitation; numerical simulation; biomaterials; bubble
   collapse; jet impact; jet velocity
ID OSCILLATING BUBBLE
AB Ultrasonic cavitation phenomena play a key role in numerous medical procedures such as ultrasound-assisted lipoplasty, phacoemulsification, lithotripsy, brain tumor surgery, muscle and bone therapies, and intraocular or transdermal drug delivery. This study investigates numerically the interaction of a bubble near a biomaterial involved in the treatments mentioned (fat, skin, cornea, brain, muscle, cartilage, or bone) when subjected to an ultrasound field. A range of frequencies is used to study the bubble behavior in terms of its growth and collapse shapes, and the maximum jet velocity obtained. Simulation results show complex dynamic behaviors of the bubble. For instance, in some cases a jet is formed directed away from the biomaterial, and in others, towards it. In certain cases, the bubble eventually breaks into two, with or without the formation of opposite penetrating jets. Very high maximum jet velocities (700-900 ms(-1)) are observed in some cases.
C1 Inst High Performance Comp, Singapore, Singapore.
   Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore.
   Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
RP Khoo, BC (reprint author), Inst High Performance Comp, Singapore, Singapore.
EM fongsw@ihpc.a-star.edu.sg; mpekbc@nus.edu.sg
CR Klaseboer E, 2004, J APPL PHYS, V96, P5808, DOI 10.1063/1.1803925
   Klaseboer E, 2004, COMPUT MECH, V33, P129, DOI 10.1007/s00466-003-0508-2
   SATO K, 1994, J ACOUST SOC AM, V95, P2416, DOI 10.1121/1.409851
NR 3
TC 0
Z9 0
U1 2
U2 6
PU VSP BV-C/O BRILL ACAD PUBL
PI LEIDEN
PA PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 1573-4196
BN 90-6764-443-9
J9 LECT SER COMPUTER CO
PY 2005
VL 4A-4B
BP 1800
EP 1803
PG 4
WC Engineering, Multidisciplinary; Mathematics, Applied; Physics,
   Multidisciplinary; Physics, Mathematical
SC Engineering; Mathematics; Physics
GA BEL90
UT WOS:000238054400448
DA 2018-10-19
ER

PT B
AU Shrivastava, S
   Sammakia, B
AF Shrivastava, Saurabh
   Sammakia, Bahgat
GP ASME
TI Transient mixed-convection with applications to cooling of biomaterials
SO Advances in Electronic Packaging 2005, Pts A-C
LA English
DT Proceedings Paper
CT ASME/Pacific Rim Technical Conference on Integration and Packaging of
   MEMS, NEMS, and Electronic Systems
CY JUL 17-22, 2005
CL San Francisco, CA
SP ASME, Elect & Photon Packaging Div
DE transient mixed convection in a cavity; thermal management of
   biomaterials
ID ISOLATED HEAT-SOURCE
AB 2-Dimensional transient mixed-convection in a horizontal rectangular enclosed cavity heated from a lower solid block is numerically studied. The enclosure simulates the thermal reservoir for the storage and shipment of biomaterials. The lower solid block containing the thermal biomass that has adiabatic sides and bottom wall, is coupled along the top wall with a hollow cavity of aspect ratio (H/L=0.5), whose side and top walls are assumed to be surrounded by a phase change material and has been assigned constant temperature of 273K. Initially, the temperature of the biomaterials is raised to 283K; the upper cavity is filled with quiescent air and uniform temperature at time zero. Laminar airflow is assumed with a fan in middle of the cavity. The basic characteristics and flow structures during the transition of natural-convection-dominated flow to forced-convection-dominated flow are determined. The problem is solved for the range of mixed-convection regime and the fluid flow structure and heat transfer is found to be dependent on mixed-convection as determined by the buoyancy parameter Gr/Re-2. As anticipated, the forced-convection-dominated flow is found to be more effective in cooling of the thermal biomass than the natural-convection dominated flow. This study shows that using the assisted forced convection results in an increase in the cooling performance of the biomaterial container in the natural-convection-dominated type mixed-convection flow. Examining the area averaged Surface Nusselt number along the coupled wall with time and the rate of heat transfer from the thermal biomass during the Quasi-steady stage validates the above hypothesis.
C1 SUNY Binghamton, Dept Mech Engn, Binghamton, NY 13902 USA.
RP Shrivastava, S (reprint author), SUNY Binghamton, Dept Mech Engn, PO 6000, Binghamton, NY 13902 USA.
CR Bejan Adrian, CONVECTION HEAT TRAN
   GEBHART B, 1988, J HEAT TRANS-T ASME, V110, P1166, DOI 10.1115/1.3250618
   GEBHART B, 1987, BUOYANCY INDUCED FLO
   HELLUMS JD, 1961, CHEM ENG PROGR S SER, V57, P75
   KANG BH, 1990, J HEAT TRANS-T ASME, V112, P653, DOI 10.1115/1.2910437
   Ozsunar A, 2001, INT COMMUN HEAT MASS, V28, P985, DOI 10.1016/S0735-1933(01)00302-5
   PAPANICOLAOU E, 1990, NUMER HEAT TR A-APPL, V18, P427, DOI 10.1080/10407789008944802
   SAMMAKIA B, 1985, INT J HEAT MASS TRAN, V28, P1837, DOI 10.1016/0017-9310(85)90206-6
   SAMMAKIA B, 1982, INT J HEAT MASS TRAN, V25, P835, DOI 10.1016/0017-9310(82)90096-5
   Sammakia B., 1981, Numerical Heat Transfer, V4, P331, DOI 10.1080/01495728108961796
   SHAW HJ, 1993, NUMER HEAT TR A-APPL, V23, P445, DOI 10.1080/10407789308913682
   SHRIVASTAVA S, 2004, 9 INT C THERM THERM
NR 12
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4200-2
PY 2005
BP 337
EP 344
DI 10.1115/IPACK2005-73235
PG 8
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BFI20
UT WOS:000241978200043
DA 2018-10-19
ER

PT B
AU Nakayama, M
   Suzuki, H
AF Nakayama, Mitsuyuki
   Suzuki, Hideto
GP ASME
TI A basic study of characteristics between stress and deflection on
   strength test of bio-ceramics
SO Advances in Electronic Packaging 2005, Pts A-C
LA English
DT Proceedings Paper
CT ASME/Pacific Rim Technical Conference on Integration and Packaging of
   MEMS, NEMS, and Electronic Systems
CY JUL 17-22, 2005
CL San Francisco, CA
SP ASME, Elect & Photon Packaging Div
AB Comparing the mechanical characteristics of bio-ceramics with the elaborate bone, there are two important conditions required for it. First, the strength must be three times larger than that of the elaborate bone. Second, Young's modulus must be two or three times larger than that. However, the biomaterial which satisfies these conditions hasn't developed. So, it is the main purpose of this research to clarify the relation between stress and deflection on strength test of bio-ceramics, and to get the fundamental data for improvement.
   In this paper, it is discussed how such quantity as deflection, stress and stress increasing rate are related. As the result, the following characteristics were found. First, deflection and the breaking stress increase as an average grain diameter of bio-ceramics becomes small. Second, the behavior of the stress increasing rate to deflection can be classified into two types. These are the fluctuation type and the stable type. Third, the experimental equations are obtained against the maximum deflection. One is for the breaking stress, and the other is for the maximum stress increasing rate.
   From the discussion, it was found that the characteristics of stress and deflection depended on such material properties of bio-ceramics as Young's modulus, an average grain diameter, and micro-structure of the biomaterials.
C1 Oyama Natl Coll Technol, Dept Elect Engn, Oyama 3230806, Japan.
RP Nakayama, M (reprint author), Oyama Natl Coll Technol, Dept Elect Engn, 771,Nakakuki, Oyama 3230806, Japan.
CR SOGA N, 1992, AGUNE, P78
   SUZUKI H, IPACK2003
   2002, KYOCERA KYOCERA CERA, P7
   1992, ADV CERAMICS MAT, P246
NR 4
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4200-2
PY 2005
BP 1715
EP 1718
DI 10.1115/IPACK2005-73147
PG 4
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BFI20
UT WOS:000241978202014
DA 2018-10-19
ER

PT S
AU L'Etang, A
   Huang, Z
AF L'Etang, A.
   Huang, Z.
BE DulieuBarton, JM
   Quinn, S
TI FE simulation of laser ultrasonic surface waves in a biomaterial model
SO Advances in Experimental Mechanics IV
SE APPLIED MECHANICS AND MATERIALS
LA English
DT Proceedings Paper
CT 4th International Conference on Advances in Experimental Mechanics
CY SEP 06-08, 2005
CL Univ Southhampton, Southampton, ENGLAND
SP British Soc Strain Measurement, AIRBUS, AWE, Instron Ple, Inst Mech Engineers, Inst Phys, Engn Integr Soc, Soc Explt Mech, Canadian Soc Mech Engineers, Japanese Soc Explt Mech, Assoc Francaise Mecan
HO Univ Southhampton
DE laser ultrasonics; FEM; surface waves; material characterization
ID FINITE-ELEMENT-METHOD
AB This paper describes a study of laser generated ultrasonic waves in an 2-layer elastic, isotropic biomaterial model, in order to establish a modelling technique to simulate the thermoelastic response of high-power short pulse laser beams in human skin. The theory proposed in this paper takes into consideration the fundamental understanding of the laser/material interface. A finite element model using the commercial finite element code ANSYS is used to study the effects of laser pulse duration and energy flux contribution to the surface waves. The simulation comprises a set of boundary conditions that approximate a heat flux point source located on top of the surface of the material. Because of the time scale of interest, the elastic effects do not feed back into the thermal problems, so that a sequential coupled-field analysis was performed where the thermal and elastodynamic fields are uncoupled and treated separately. The initial finite element analysis involves a transient thermal analysis using a heat flux with Gaussian spatial variation to simulate the laser pulse heating. The results from the thermal analysis were read and applied to the structural analysis where the out-of-plane displacements histories are analyzed in the skin model with varying thicknesses.
C1 Univ Dundee, Div Mech Engn & Mechatron, Dundee DD1 4HN, Scotland.
RP L'Etang, A (reprint author), Univ Dundee, Div Mech Engn & Mechatron, Dundee DD1 4HN, Scotland.
CR DIKE JJ, 1998, REV PROGR QUANT NDE, V18, P1
   HUTCHINS DA, 1988, PHYS ACOUSTICS, V18, P21
   Jiang SC, 2002, BURNS, V28, P713, DOI 10.1016/S0305-4179(02)00104-3
   LEE JH, 1995, COMPUT STRUCT, V54, P499, DOI 10.1016/0045-7949(94)00348-7
   Moser F, 1999, NDT&E INT, V32, P225, DOI 10.1016/S0963-8695(98)00045-0
   NIEDERHAUSER JJ, 2004, THESIS SWISS FEDERAL
   Schneider D, 1996, THIN SOLID FILMS, V290, P305, DOI 10.1016/S0040-6090(96)09029-3
   Scruby CB, 1990, LASER ULTRASONICS TE
   TANNER C, 2002, SPIE MED IMAGING IMA, V4683, P1807
   Xu BQ, 2004, J APPL PHYS, V95, P2116, DOI 10.1063/1.1637712
   Xu BQ, 2004, J APPL PHYS, V95, P2109, DOI 10.1063/1.1639142
   Zhou M, 2003, J APPL PHYS, V94, P2968, DOI 10.1063/1.1597759
NR 12
TC 5
Z9 5
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 0-87849-987-3
J9 APPL MECH MATER
PY 2005
VL 3-4
BP 85
EP 90
DI 10.4028/www.scientific.net/AMM.3-4.85
PG 6
WC Mechanics
SC Mechanics
GA BEN45
UT WOS:000238287200013
DA 2018-10-19
ER

PT S
AU Ling, SJ
   Sen, LM
   Peng, LY
AF Ling, SJ
   Sen, LM
   Peng, LY
BE Kim, YJ
   Bae, HD
   Kim, YJ
TI The bond strength and fracture behaviors of hydroxyapatite coatings on
   carbon/carbon composites
SO ADVANCES IN FRACTURE AND STRENGTH, PTS 1- 4
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT Asian Pacific Conference on Fracture and Strength
CY OCT 06-08, 2004
CL Jeju Isl, SOUTH KOREA
DE plasma spraying; carbon/carbon composites; hydroxyapatite coating; a
   shear strength
AB The effect of the density of carbon/carbon composites (C/C composites) and pre-sandblasted treatment technology on the bond strength between hydroxyapatite (HA) coatings and CIC composites had been studied. The microstructure and fracture surfaces had been examined by scanning electron microscopy (SEM). The shear strength of the HA coatings-C/C substrates was detected on a RGD-5 electric tension machine. Observations of fracture surfaces showed that carbon fiber bundles could bond well with HA coatings under the power of 40 kW. Results indicated that a HA coating onto C/C composite substrates was a new promising biomaterial for replacing loaded human bones.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250100, Peoples R China.
   Beijing Inst Petrochem Technol, Beijing, Peoples R China.
   Shandong Univ, Sch Mat Sci & Engn, Jinan 250100, Peoples R China.
RP Ling, SJ (reprint author), Shandong Univ, Sch Mat Sci & Engn, Jinan 250100, Peoples R China.
EM suijl@263.net; msli@sdu.edu.cn; bio@sdu.edu.cn
CR Leea I. S., 2001, SURF COAT TECH, V131, P181
   MAISTRELLI GL, 1992, J BONE JOINT SURG BR, V74, P452
   Sui JL, 2004, SURF COAT TECH, V176, P188, DOI 10.1016/S0257-8972(03)00646-7
   Zhang CG, 2001, BIOMATERIALS, V22, P1357, DOI 10.1016/S0142-9612(00)00289-1
NR 4
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-978-4
J9 KEY ENG MAT
PY 2005
VL 297-300
BP 233
EP 236
DI 10.4028/www.scientific.net/KEM.297-300.233
PN 1-4
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Mechanics; Materials Science, Characterization & Testing; Materials
   Science, Composites
SC Materials Science; Mechanics
GA BDE59
UT WOS:000233131200038
DA 2018-10-19
ER

PT S
AU Zhou, GD
   Liu, W
   Cui, L
   Cao, YL
AF Zhou, GD
   Liu, W
   Cui, L
   Cao, YL
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI In vivo chondrogenesis of BMSCs at non-chondrogenesis site by
   co-transplantation of BMSCs and chondrocytes with pluronic as
   biomaterial
SO ASBM6: ADVANCED BIOMATERIALS VI
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE bone marrow stromal cells; chondrocytes; chondrogenesis; in vivo;
   pluronic
ID DIFFERENTIATION; CELLS
AB Bone Marrow Stromal Cells (BMSCs) have chondrogenesis potential if chondrogenic environments or factors are provided. This study tests the hypothesis that chondrocytes can promote BMSC chondrogenesis at non-chondrogensis site. Porcine BMSCs and auricular chondrocytes were mixed at different ratios and 2.5x10(7) mixed cells were resuspended in 0.5 ml 30% Pluronic, and then the mixture was injected into nude mice subcutaneously as experimental groups. Chondrocytes or BMSCs at the same cell number were mixed with 0.5 ml Pluronic and injected respectively as controls. 2.5 x 10(7) chondrocytes were mixed and injected as low concentration chondrocyte control. 8 weeks later, all specimens in experimental groups and chondrocyte group formed mature cartilage with abundant collagen 11 expression. Mature lacuna structures and metachromatic matrices were also observed in these specimens with the same level of GAG contents. Average wet weight of specimens in experimental groups was over 70% of that in chondrocyte group. In contrast, specimens in BMSC group showed mainly fibrous tissue. Only a small amount of cartilage was formed in specimens of low concentration chondrocyte group and the average wet weight was below 30% of that in chondrocyte group. These results demonstrate that chondrocytes can provide chondrogenic microenvironment and thus promote in vivo chondrogenesis of BMSCs at non-chondrogenesis sites. It also indicates that Pluronic is an ideal injectable biomaterial for cartilage tissue engineering.
C1 Shanghai Med Univ 2, Shanghai Tissue Engn Ctr, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China.
RP Zhou, GD (reprint author), Shanghai Med Univ 2, Shanghai Tissue Engn Ctr, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China.
EM guangdongzhou@126.com; liuwei_2000@yahoo.com; yilincao@yahoo.com
CR BHAUMICK B, 1993, REGUL PEPTIDES, V48, P113, DOI 10.1016/0167-0115(93)90340-E
   GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139
   Maeda S, 2002, CALCIFIED TISSUE INT, V70, P54, DOI 10.1007/s002230010032
   ZHOU GD, 2002, TISSUE ENG, V6, P1133
NR 4
TC 8
Z9 10
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MATER
PY 2005
VL 288-289
BP 3
EP 6
DI 10.4028/www.scientific.net/KEM.288-289.3
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600001
DA 2018-10-19
ER

PT S
AU Zhao, CS
   Yang, KG
   Wen, X
   Li, F
   Zheng, XB
   Nishi, N
AF Zhao, CS
   Yang, KG
   Wen, X
   Li, F
   Zheng, XB
   Nishi, N
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Preparation of DNA hybrid polyethersulfone microspheres for endocrine
   disruptor removal
SO ASBM6: ADVANCED BIOMATERIALS VI
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE DNA; polyethersulfone; microspheres; hybrid; endocrine disruptors
ID FUNCTIONAL UTILIZATION
AB In this paper, DNA hybrid polyethersulfone (PES) microspheres, including DNA-loaded porous particles and DNA-encapsulated hollow particles, are fabricated using a liquid-liquid phase separation method based on precipitation technique; the microspheres are then used for the removal of poisonous organic chemicals and endocrine disruptors. With the increase of the DNA amount incorporated into the spheres, the removal ratios increased both for the poisonous organic chemicals and endocrine disruptors. The particles without DNA also remove and accumulate poisonous organic chemicals due to the high porosity of the spheres. The results suggested that DNA hybrid PES particles could be prepared by a liquid-liquid phase separation method, and have potential to serve as a useful functional biomaterial for medical, engineering, and environmental application.
C1 Sichuan Univ, Coll Polymer Sci & Engn, Dept Biomed Polymer & Artificial Organs, Chengdu 610065, Peoples R China.
   Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Sapporo, Hokkaido 0600810, Japan.
RP Zhao, CS (reprint author), Sichuan Univ, Coll Polymer Sci & Engn, Dept Biomed Polymer & Artificial Organs, Chengdu 610065, Peoples R China.
EM zhaochsh70@163.com; yangkerry@163.com; nishin@ees.hokudai.ac.jp
RI Yang, Kaiguang/C-7259-2009
OI Yang, Kaiguang/0000-0001-9544-2714
CR Kawaguchi H, 2000, PROG POLYM SCI, V25, P1171, DOI 10.1016/S0079-6700(00)00024-1
   Zhao C, 2004, J MICROENCAPSUL, V21, P283, DOI 10.1080/02652040310001637884
   Zhao CS, 2004, J COLLOID INTERF SCI, V275, P470, DOI 10.1016/j.jcis.2004.02.079
NR 3
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MATER
PY 2005
VL 288-289
BP 113
EP 116
DI 10.4028/www.scientific.net/KEM.288-289.113
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600028
DA 2018-10-19
ER

PT S
AU Lu, B
   Lu, XF
   Zhang, Z
   Zhang, J
   Bu, H
   Cheng, JQ
   Li, YP
AF Lu, B
   Lu, XF
   Zhang, Z
   Zhang, J
   Bu, H
   Cheng, JQ
   Li, YP
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI The long term study of HA/TCP biphasic ceramics' osteoinduction
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE HA/TCP; biphasic ceramic; osteoinduction
ID CALCIUM-PHOSPHATE CERAMICS; BONE
AB Massive bone defects are a great challenge to reconstructive surgery. The preferred treatment is an autologous bone graft. But the supply of suitable bone is limited and its collection is painful, with a risk of infection, hemorrhage, cosmetic disability, nerve damage, and a loss of function. So researchers never stop the study of bone graft substitutes. Because of good biocompatibility and intension, Ca-P biomaterial has become a hot spot recently[1]. Since Ca-P biomaterials are similar to inorganic natural bone component and structure[2,3], it is interesting to do a comparative study on bone inductivity of the two kinds of materials.
C1 Sichuan Univ, W China Hosp, Lab Transplant Engn & Immunol, Chengdu, Peoples R China.
RP Lu, B (reprint author), Sichuan Univ, W China Hosp, Lab Transplant Engn & Immunol, Chengdu, Peoples R China.
EM yzmy@mail.sc.cninfo.net
CR Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   Daculsi G, 1989, BIOCERAMICS, V2, P3
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Hashizume H, 1998, J Orthop Sci, V3, P42, DOI 10.1007/s007760050020
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   MESTSEGER DS, 1982, J AM DENT ASSOC, V105, P1035
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   ZHOU P, 1996, J SICHUAN U NATURAL, V33, P155
NR 11
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 237
EP 240
DI 10.4028/www.scientific.net/KEM.288-289.237
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600058
DA 2018-10-19
ER

PT S
AU An, YH
   Farino, M
   Kang, QK
   Demcheva, M
   Vournakis, J
AF An, YH
   Farino, M
   Kang, QK
   Demcheva, M
   Vournakis, J
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Glucosamine coating for inhibiting bacterial adhesion to titanium
   surfaces
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE bacterial adhesion; titanium; Staphylococcus aureus; glucosamine
ID MOLECULAR-WEIGHT CHITOSANS
AB It is known that glucosamine/chitosan derivatives have the ability of inhibiting bacterial adhesion to tooth and biomaterial surfaces. The hypotheses of this article included 1) the inhibition effects of different (chemically) glucosamine products are different and 2) more water-soluble glucosamine preparation(s) may have a superior inhibition effect. The basic testing systems are in vitro static adhesion models and the amount of the adhesion is evaluated by direct counting using epifluorecense microscopy. The test material is a smooth surfaced commercially pure titanium (cp-Ti). The bacterium tested is Staphylococcus aureus. The results showed that compared to the control samples (without glucosamine or chitosan coating) the sulfated p-GlcNAc and Sigma glucosamine HCl significantly inhibited S. aureus adhesion to titanium surfaces (94% and 78% respectively)
C1 Med Univ S Carolina, Orthopaed Res Lab, Charleston, SC 29425 USA.
   Marine Polymer Technol Inc, Boston, MA USA.
RP An, YH (reprint author), Med Univ S Carolina, Orthopaed Res Lab, Charleston, SC 29425 USA.
EM any@musc.edu; farino@musc.edu; kangqk@musc.edu; marina_d@webmpt.com;
   johnv@webmpt.com
CR An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   An YH, 2000, HDB BACTERIAL ADHESI
   SANO H, 1991, Bulletin of Tokyo Dental College, V32, P9
   Sano H, 2001, Bull Tokyo Dent Coll, V42, P243, DOI 10.2209/tdcpublication.42.243
   Sano Hiroshi, 2002, Bull Tokyo Dent Coll, V43, P75, DOI 10.2209/tdcpublication.43.75
   Tarsi R, 1997, J DENT RES, V76, P665, DOI 10.1177/00220345970760020701
   Tarsi R, 1998, ORAL MICROBIOL IMMUN, V13, P217, DOI 10.1111/j.1399-302X.1998.tb00699.x
NR 8
TC 2
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 343
EP 346
DI 10.4028/www.scientific.net/KEM.288-289.343
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600084
DA 2018-10-19
ER

PT S
AU Yang, GH
   Yang, J
   Wang, JM
   Cui, L
   Liu, W
   Cao, YL
AF Yang, GH
   Yang, J
   Wang, JM
   Cui, L
   Liu, W
   Cao, YL
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Biological behaviors of keratinocytes cultured on chitosan-gelatin
   membrane
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE keratinocyte; chitosan; gelatin; biological behavior; culture
AB Chitin/Chitosan membrane has been used as wound dressing materials to facilitate clinical wound healing for many years. However, there are fewer articles studying the cell-biomaterial interaction in vitro or in vivo. In this study, the biological characteristics of human keratinocytes cultured on chitosan membrane that was mixed with gelatin in different ratio were investigated in vitro. Chitosan-gelatin membrane (CGM) in different ratio were prepared with N, N-(3-dimethylaminopropyl)-N'-ethyl carbodiimide (EDC). CGMs were divided into four groups: pure chitosan membrane, 7:3 (chitosan: gelatin), 5:5 and 3:7 groups. Human keratinocytes were isolated from foreskin by Dispase/Trypsin-EDTA digestion. Keratinocytes of passage3 were then seeded on the surface of CGM. Cloning forming efficiency (CFE) and migration distance of cultured keratinocytes on CGM were measured. The CFE of keratinocytes cultured on the surface of pure chitosan membrane was 9.8 +/- 2.08%; cultured on 7:3 CGM was 14.33 +/- 1.53%, 5:5 CGM was 19.17 +/- 1.26%, 3:7 CGM was 18.33 +/- 2.08%. The migration distance of cultured keratinocytes on pure chitosan membrane was 61.47 +/- 2.70 mu m, 7:3 CGM was 66.22 +/- 9.39 mu m, 5:5 CGM was 120.31 +/- 15.82 mu m, 3:7 CGM was 225.38 +/- 10.48 mu m. This sutdy demonstrated that increasing contents of gelatin in CGM could promote keratinocyte proliferation and migration. The results also suggested the membrane prepared from chitosan and gelatin can be utilized as a good keratinocyte delivery system.
C1 Shanghai 9th Peoples Hosp, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China.
   Second Med Univ, Shanghai Tissue Engn Res & Dev Ctr, Shanghai, Peoples R China.
RP Yang, GH (reprint author), Shanghai 9th Peoples Hosp, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China.
EM ghyang_md@yahoo.com.cn
CR Graeme I., 2001, BIOMATERIALS, V22, P2959
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SHARON MS, 2004, BIOMATERIALS, V25, P1249
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
NR 6
TC 4
Z9 5
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 401
EP 404
DI 10.4028/www.scientific.net/KEM.288-289.401
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600098
DA 2018-10-19
ER

PT S
AU Fan, YJ
   Chen, GP
   Tanaka, J
   Tateishi, T
AF Fan, YJ
   Chen, GP
   Tanaka, J
   Tateishi, T
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Biodegradable polyamides containing amino acid residues: A
   chemoenzymatic synthesis
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE polyamide; amino acid; enzyme; protease; polymerization
ID RING-OPENING POLYMERIZATION; EPSILON-CAPROLACTONE; ORGANIC MEDIA; WATER;
   COPOLYMERIZATION; POLYESTERS
AB Polyamides containing amino acid residues were synthesized through a chemoenzymatic route. At first, monomers containing amino acid esters at both ends were prepared from amino acid esters and bifunctional acid chlorides through a Scotten-Baumann reaction under organic condition. Diamine was used as bifunctional nucleophilic reagent to aminolysis the amino acid ester bonds of these monomers under protease catalysts, leading to the polycondensation to form the desired polyamides containing amino acid residues. Spectra characterizations confirmed the structure of obtained polyamides. The factors that influence the polymerization, including the type of enzymes, the amount of enzymes, and the water contents in the solvent, were also discussed. It is expected that the obtained polyamides have the potential for biomaterial applications.
C1 Ctr Biomat, Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan.
RP Fan, YJ (reprint author), Ctr Biomat, Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM FAN.Yujiang@nims.go.jp; Guoping.CHEN@nims.go.jp;
   TANAKA.Junzo@nims.go.jp; TATEISHI.Tetsuya@nims.go.jp;
   TANAKA.Junzo@nims.go.jp
CR Bisht KS, 1998, J AM CHEM SOC, V120, P1363, DOI 10.1021/ja972391w
   CHEN CS, 1987, J AM CHEM SOC, V109, P2812, DOI 10.1021/ja00243a040
   Fan YJ, 2001, J POLYM SCI POL CHEM, V39, P1318, DOI 10.1002/pola.1109
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Kikuchi H, 2000, MACROMOLECULES, V33, P8971, DOI 10.1021/ma0010534
   KNANI D, 1993, J POLYM SCI POL CHEM, V31, P1221, DOI 10.1002/pola.1993.080310518
   Kobayashi S, 2001, PROG POLYM SCI, V26, P1525, DOI 10.1016/S0079-6700(01)00026-0
   Kumar A, 2000, MACROMOLECULES, V33, P6303, DOI 10.1021/ma000344+
   Suarez N, 1998, BIOMATERIALS, V19, P2347, DOI 10.1016/S0142-9612(98)00151-3
   Wu XY, 1996, BIOTECHNOL TECH, V10, P793, DOI 10.1007/BF00222568
   ZAKS A, 1988, J BIOL CHEM, V263, P8017
NR 11
TC 1
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 469
EP 472
DI 10.4028/www.scientific.net/KEM.288-289.469
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600115
DA 2018-10-19
ER

PT S
AU Xu, YX
   Wang, WJ
   Zhang, Y
   Song, XH
   Li, L
   Wang, JJ
   Cui, FZ
   Feng, QL
AF Xu, YX
   Wang, WJ
   Zhang, Y
   Song, XH
   Li, L
   Wang, JJ
   Cui, FZ
   Feng, QL
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI A novel method for evaluating compatibility of hepatocytes with some
   kinds of biomaterials
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE biomaterial; biocompatibility; hepatocyte; automatic biochemical
   analyzer
ID LIVER
AB To evaluate the biocompatibility of biomedical materials for hepatic tissue engineering, another new method was introduced to observe hepatocytes functions. In this experiment, hepatocytes were seeded onto four kinds of membranes of PLLA, PLGA (90:10), PLGA (75:25), and Chitosan cross-linked with collagen. The culture mediums were collected at 21 day after seeding, and then albumin (Alb), Urea (UN), glucose (Glu), total protein (TP), and triglyceride (TG) in the supernatant were detected by automatic biochemical analyzer. Results showed that hepatocytes on film of Chitosan cross-linked with collagen exhibited the highest level of TP and TG. These results were highly corresponding with the results of morphological observation. This data indicated that analyzing TP and TG in culture medium by automatic biochemical analyzer might be applied to evaluate hepatocytes biocompatibility on materials as a convenient and feasible method.
C1 Chinese Peoples Liberat Army Gen Hosp, Inst Gen Surg, Beijing 1000853, Peoples R China.
   Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Xu, YX (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Gen Surg, Beijing 1000853, Peoples R China.
EM xu_yingxin@hotmail.com; wwj01@mails.tsinghua.edu.cn
CR [Anonymous], 1992, 10993 ISO
   Catapano G, 1996, INT J ARTIF ORGANS, V19, P61
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   Elcin YM, 1998, ARTIF ORGANS, V22, P837
   FRIEND JR, 1999, TISSUE ENG METHODS P, P245
   Kang S, 2000, BBA-MOL CELL BIOL L, V1529, P223, DOI 10.1016/S1388-1981(00)00151-7
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   STRAIN AJ, SCIENCE, V295, P5557
NR 8
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 511
EP 514
DI 10.4028/www.scientific.net/KEM.288-289.511
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600125
DA 2018-10-19
ER

PT S
AU Zhao, AS
   Yang, P
   Leng, YX
   Sun, H
   Wang, J
   Wan, GJ
   Huang, N
AF Zhao, AS
   Yang, P
   Leng, YX
   Sun, H
   Wang, J
   Wan, GJ
   Huang, N
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Research on platelet adsorption behavior using enzyme immunoassays and
   LDH testing
SO ASBM6: ADVANCED BIOMATERIALS VI
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE LDH; EIA; platelet adhesion; platelet activation
AB Platelet adhesion and activation restrict the clinical applicability of blood-contacting biomaterial because platelet-biomaterial interaction can result in the formation of a haemostatic plug or thrombus. In this study we used LDH (lactate dehydrogenase) tests to evaluate the adsorption behavior of platelets on material surfaces. Enzyme immunoassay (EIA) was applied to evaluate platelet activation using a special monoclonal antibody directly binding to the P-selectin on the activated platelet membrane. The results show compared with the conventional detecting tools of platelet adhesion / activation such as optical microscopy. LDH (lactate dehydrogenase) testing and EIA (enzyme immunoassay) are surface-sensitive methods for the investigation of various aspects of platelet adsorption and activation on different biomaterials.
C1 SW Jiaotong Univ, Lab Surface Engn Artif Organs Sichuan, Chengdu 610031, Peoples R China.
   SW Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Chengdu 610031, Peoples R China.
RP Zhao, AS (reprint author), SW Jiaotong Univ, Lab Surface Engn Artif Organs Sichuan, Chengdu 610031, Peoples R China.
EM nhuang@263.net
RI Wan, GJ/A-3648-2009; Wan, Guojiang/A-6651-2013; Leng,
   Yongxiang/G-5488-2010
OI Wan, Guojiang/0000-0002-1636-5405; Leng, Y.X./0000-0001-6823-1233
CR CHEN JY, 2002, J CHINESE BIOMEDICAL, V5, P411
   MUSTARD JF, 1987, ANN NY ACAD SCI, V516, P12, DOI 10.1111/j.1749-6632.1987.tb33026.x
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579
   SAKARIASSEN KS, 1988, THROMB HAEMOSTASIS, V60, P392
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
NR 6
TC 4
Z9 5
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MATER
PY 2005
VL 288-289
BP 515
EP 518
DI 10.4028/www.scientific.net/KEM.288-289.515
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600126
DA 2018-10-19
ER

PT J
AU Kim, HJ
   Kim, HS
   Matsumoto, A
   Chin, IJ
   Jin, HJ
   Kaplan, DL
AF Kim, HJ
   Kim, HS
   Matsumoto, A
   Chin, IJ
   Jin, HJ
   Kaplan, DL
TI Processing windows for forming silk fibroin biomaterials into a 3D
   porous matrix
SO AUSTRALIAN JOURNAL OF CHEMISTRY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; BOMBYX-MORI SILK; IN-VITRO; POLY(ETHYLENE
   OXIDE); SPIDER SILK; SCAFFOLDS; FILMS; RESPONSES; HYDROGELS; INSECTS
AB In the present study we clarify phase diagrams related to silk fibroin processing into three-dimensional porous structures useful for biomaterials and for scaffolds in tissue engineering. All-aqueous and organic solvent (hexafluoroisopropanol) modes of processing are compared relative to solution concentration of silk protein polymer and size of porogen (NaCl particles). The results clarify the range of conditions under which these biomaterial matrices can be formed, with a broader range of pore sizes and smoother surface morphology generated from the organic solvent process. These structures are directly applicable to fundamental studies of protein-based biomaterial assembly as well as cell interactions and tissue formation with these systems.
C1 Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Matsumoto, Akira/B-6935-2011
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hou QP, 2003, J BIOMED MATER RES B, V67B, P732, DOI 10.1002/jbm.b.10066
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN D, 1994, ACS S SERIES, V544
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   MCGRATH K, 1998, PROTEIN BASED MAT
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MEINEL L, 2005, IN PRESS BONE
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   RATNER BD, 2005, BIOMATERIALS SCI
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   WANG Y, 2005, IN PRESS BIOMATERIAL
NR 41
TC 42
Z9 44
U1 3
U2 15
PU C S I R O PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 0004-9425
J9 AUST J CHEM
JI Aust. J. Chem.
PY 2005
VL 58
IS 10
BP 716
EP 720
DI 10.1071/CH05170
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 981MW
UT WOS:000233093700005
DA 2018-10-19
ER

PT J
AU Itoh, S
   Kikuchi, M
   Koyama, Y
   Matumoto, HN
   Takakuda, K
   Shinomiya, K
   Tanaka, J
AF Itoh, S
   Kikuchi, M
   Koyama, Y
   Matumoto, HN
   Takakuda, K
   Shinomiya, K
   Tanaka, J
TI Development of a novel biomaterial, hydroxyapatite/collagen (HAp/Col)
   composite for medical use
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE hydroxyapatite/type I collagen (HAp/Col) composite; bone remodeling
   unit; artificial vertebra system; anterior fusion of the cervical spine;
   recombinant human bone morphogenetic protein-2 (rhBMP-2); poly-L-lactide
   (PLLA) plate
ID BIOCOMPATIBILITY
AB A hydroxyapatite/type I collagen (HAp/Col) composite, aligning hydroxyapatite nano-crystals along collagen molecules, has been synthesized. The biocompatibility, osteoconductivity and efficacy as an rhBMP-2 carrier of this novel biomaterial implanted in the weight-bearing site have been examined. The HAp/Col implants adsorbing 0 or 400 mug/ml of rhBMP-2 were implanted into bone defects of tibiae in 3 beagle dogs and fixed according to the Ilizarov method. As a control, bone defects of 20 mm remaining in 2 beagle dogs and the dogs were allowed to walk using a Ilizarov external skeletal fixator. The radiological and histological findings suggest that the implants induce bone remodeling units and are a superior carrier of rhBMP-2 due to the stimulation of early callus and new bone formation. As a next step, anterior fusion was carried out on 6 beagle dogs with the implants adsorbing 400 mug/ml of rhBMP-2, and 9 dogs with the implants without rhBMP-2. In 3 dogs of the rhBMP-treated group, as well as 6 dogs of the non-rhBMP-treated group, the implant was fixed with a poly-L-lactide plate. Histological and radiographical analysis suggest that enhancement of callus formation and bone bridging by rhBMP-treatment is effective to prevent collapse of the implant.
C1 Tokyo Med & Dent Univ, Dept Orthopaed Surg, Div Mol Tissue Engn, Bunkyo Ku, Tokyo 1138519, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Tokyo Med & Dent Univ, Dept Biomech Engn, Bunkyo Ku, Tokyo 1138519, Japan.
RP Itoh, S (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Div Mol Tissue Engn, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM itoso.gene@cmn.tmd.ac.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
CR AOKI H, 1994, MED APPL HYDROXYAPAT, P1
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2000, MATER RES SOC SYMP P, V599, P51
   KIKUCHI M, 1999, BIOCERAMICS, V12, P393
   SHINOMIYA K, 2001, TISSUE ENG THERAP US, V5, P165
   Takagi K, 2000, INT OFFSHORE POLAR E, P72
NR 9
TC 30
Z9 36
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 1-2
BP 29
EP 41
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HY
UT WOS:000226003400004
PM 15623928
DA 2018-10-19
ER

PT J
AU Minuth, WW
   Schumacher, K
   Strehl, R
AF Minuth, WW
   Schumacher, K
   Strehl, R
TI Renal epithelia in long term gradient culture for biomaterial testing
   and tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE stem cells; kidney; epithelia; biomaterial testing; tissue engineering;
   gradient perfusion culture
ID NEONATAL RABBIT KIDNEY; COLLECTING DUCT; IN-VITRO; INTERCALATED CELLS;
   DIFFERENTIATION; REPLACEMENT; PRINCIPAL; CONTAINER; COLLAGEN; SYSTEM
AB In the organism epithelia perform perfect barrier functions. Strong rheological and mechanical influences constitute the normal environment of this tissue throughout life. Most epithelia are exposed to different fluids at the luminal and basal sides. To obtain realistic information about tissue development in modern biomaterial testing and tissue engineering it is necessary to mimik the natural environment of epithelia. Cultured cells are brought in contact with an artificial extracellular matrix to determine whether proper development into a functional epithelium occurs. As under natural conditions the cultures have to withstand mechanical and fluid stress over a prolonged period of time in close contact to a selected biomaterial. However, development of tissue-specific features such as polarization, tightness and transport under in vitro conditions will only occur, if the biomaterial and the culture conditions support tissue development. Leakage, edge damage and pressure differences during culture have to be avoided so that the natural functions of the growing epithelium can develop. Our aim is to generate functional epithelia derived from renal explants containing stem cells, which are microsurgically isolated and placed into specific O-ring carriers for optimal handling. The cells develop in combination with a collagenous matrix from an embryonic into a functional collecting duct (rCD) epithelium. To achieve optimal culture conditions the tissue is placed in a gradient culture container. A typical environment can be simulated by superfusing different culture media at the luminal and basal sides. Within days epithelia growing inside the gradient container build up a physiological barrier, which is maintained during the whole culture period. The described method allows to investigate the influence of new biomaterials over prolonged periods of time.
C1 Univ Regensburg, Dept Mol & Cellular Anat, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Mol & Cellular Anat, Univ Str 31, D-93053 Regensburg, Germany.
EM will.minuth@vkl.uni-regensburg.de
CR Bader A, 1999, EXP CELL RES, V246, P221, DOI 10.1006/excr.1998.4295
   Coppelli A, 1996, ACTA DIABETOL, V33, P166, DOI 10.1007/BF00569429
   EMMONS C, 1994, J CLIN INVEST, V93, P417, DOI 10.1172/JCI116976
   Fey-Lamprecht F, 1998, J MATER SCI-MATER M, V9, P711, DOI 10.1023/A:1008994601138
   Goto Y, 1999, AM J RESP CELL MOL, V20, P312, DOI 10.1165/ajrcmb.20.2.3062
   GROSS P, 1988, PFLUG ARCH EUR J PHY, V412, P434, DOI 10.1007/BF01907564
   Gustafson CJ, 1999, BURNS, V25, P331, DOI 10.1016/S0305-4179(99)00004-2
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   ISCOVE NN, 1978, J EXP MED, V147, P923, DOI 10.1084/jem.147.3.923
   KIM J, 1994, AM J PHYSIOL, V266, pF977
   Ludwikowski B, 1999, BJU INT, V84, P507
   Miki H, 1999, ASAIO J, V45, P502, DOI 10.1097/00002480-199909000-00025
   MINUTH WW, 1987, DIFFERENTIATION, V36, P12, DOI 10.1111/j.1432-0436.1987.tb00177.x
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   MINUTH WW, 1993, KIDNEY INT, V44, P337
   Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Ohshima N, 1997, J CHIN INST CHEM ENG, V28, P441
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.3.CO;2-L
   Schumacher K, 2002, CELL PHYSIOL BIOCHEM, V12, P63, DOI 10.1159/000063782
   Schumacher K, 2001, AM J NEPHROL, V21, P165, DOI 10.1159/000046242
   Schumacher K, 2002, BIOMATERIALS, V23, P805, DOI 10.1016/S0142-9612(01)00186-7
   Stockmann M, 1999, PFLUG ARCH EUR J PHY, V438, P107, DOI 10.1007/s004240050886
   Strehl R, 1999, CELL TISSUE RES, V298, P539, DOI 10.1007/s004410050076
   Strehl R, 1997, KIDNEY INT, V52, P1469, DOI 10.1038/ki.1997.477
   Surowiec SM, 2000, J SURG RES, V88, P34, DOI 10.1006/jsre.1999.5759
   Takimoto Y, 1998, J THORAC CARDIOV SUR, V116, P98, DOI 10.1016/S0022-5223(98)70247-8
   TAUC M, 1992, BIOL CELL, V76, P55, DOI 10.1016/0248-4900(92)90195-7
   Van Dorp AGM, 1999, WOUND REPAIR REGEN, V7, P214
   Waybill PN, 1999, J VASC INTERV RADIOL, V10, P1051, DOI 10.1016/S1051-0443(99)70191-0
NR 31
TC 13
Z9 14
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 1-2
BP 51
EP 63
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HY
UT WOS:000226003400006
PM 15623930
DA 2018-10-19
ER

PT J
AU Yarlagadda, PKDV
   Chandrasekharan, M
   Shyan, JYM
AF Yarlagadda, PKDV
   Chandrasekharan, M
   Shyan, JYM
TI Recent advances and current developments in tissue scaffolding
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Review
DE tissue scaffolding; titanium; bioactive materials; bone reconstruction
ID BIODEGRADABLE POLYMER SCAFFOLDS; SOLID FREEFORM FABRICATION; BMP-INDUCED
   OSTEOGENESIS; FREE-FORM FABRICATION; MECHANICAL-PROPERTIES; IN-VITRO;
   EXTRACELLULAR-MATRIX; BONE-GRAFT; POROUS HYDROXYAPATITE; BIOACTIVE GLASS
AB A bio-scaffold can be broadly termed as a structure used to substitute an organ either permanently or temporarily to restore functionality. The material that can be used varies with the application intended. Tissue engineering is one such application demanding certain requirements to be met before it is applied. One of the applications in tissue engineering is the tissue scaffold, which provides either a permanent or temporary support to the damaged tissues/organ until the functionalities are restored. A biomaterial can exhibit specific interactions with cells that will lead to stereotyped responses. The use of a particular material and morphology depends on various factors such as osteoinduction, osteoconduction, angiogenesis, growth rates of cells and degradation rate of the material in case of temporary scaffolds, etc. The current work reviews the state of art in tissue scaffolds and focuses on permanent scaffold materials and applications with a brief overview of temporary scaffold materials and their disadvantages.
C1 Queensland Univ Technol, Sch Mech Mfg & Med Engn, Brisbane, Qld 4001, Australia.
   Singapore Inst Mfg Technol, Singapore 638075, Singapore.
RP Yarlagadda, PKDV (reprint author), Queensland Univ Technol, Sch Mech Mfg & Med Engn, GPO Box 2434, Brisbane, Qld 4001, Australia.
EM y.prasad@qut.edu.au
OI Yarlagadda, Prasad KDV/0000-0002-7026-4795
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ALTMAN GH, 2002, BIOMATERIALS, V24, P401
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   ATALA A, 1993, J UROLOGY, V149, P1099, DOI 10.1016/S0022-5347(17)36307-3
   ATNER BD, 2000, BIOMATERIALS SCI
   BABENSEE JE, 1998, ADV DRUG DELIVERY RE, V33
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BALL MD, 1998, J BONE JOINT SURG BR, V80, P258
   BAZEED MA, 1983, UROLOGY, V21, P53, DOI 10.1016/0090-4295(83)90123-1
   Bhat AL, 1999, EUR SPINE J, V8, P304, DOI 10.1007/s005860050178
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Bigi A, 2002, J BIOMED MATER RES, V59, P709, DOI 10.1002/jbm.10045
   BLACK J, 1986, PATHOLOGY BONE, P5
   BLOKHUIS TJM, 2000, J TRAUM INJ INF CRIT, V48, P17
   Brandt MT, 2002, J ORAL MAXIL SURG, V60, P337, DOI 10.1053/joms.2002.30603
   Brannen CL, 2000, NEUROREPORT, V11, P1123, DOI 10.1097/00001756-200004070-00042
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   BRUDER SP, 1998, 44 ANN M ORTH RES SO, P147
   BUTLER D, 2000, BIOMECH ENG, P122
   CHAPMAN MW, 1997, J BONE JOINT SURG AM, V79, P485
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   CHOWDHURY SM, 1996, J SURG RES, V61, P81
   CIMA LG, 1991, ASME, V113, P143
   COOMBES AGA, 1992, BIOMATERIALS, V13, P217, DOI 10.1016/0142-9612(92)90187-S
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Curodeau A, 2000, J BIOMED MATER RES, V53, P525, DOI 10.1002/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO;2-1
   DAHMS SE, 1998, BR J UROL, V82, P41
   DAVIES JE, 1991, BONE BIOMATERIAL INT
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Donzelli PS, 1999, J BIOMECH, V32, P1037, DOI 10.1016/S0021-9290(99)00106-2
   DRAPER JW, 1956, SURGERY, V39, P434
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   Durucan C, 2000, J BIOMED MATER RES, V51, P717, DOI 10.1002/1097-4636(20000915)51:4<717::AID-JBM21>3.0.CO;2-Q
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   ELGHANNAM A, 1999, J ORTHOP RES, V17, P40
   Fetner A E, 1994, Compendium, V15, P935
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Furthmayr H, 1976, Int Rev Connect Tissue Res, V7, P61
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GOLDSTEIN MB, 1967, J UROLOGY, V97, P664, DOI 10.1016/S0022-5347(17)63095-7
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Graham N B, 1998, Med Device Technol, V9, P22
   Graham N B, 1998, Med Device Technol, V9, P18
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   HAM W, 1969, HISTOLOGY
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   Hench L. L., 1982, BIOCOMPATABILITY ORT, V2
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HENDREN WH, 1986, J PEDIATR SURG, V21, P189, DOI 10.1016/S0022-3468(86)80828-4
   HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1
   HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236
   Hoffman A.S., 1996, BIOMATERIALS SCI INT, P124
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   Hong SB, 2001, J DENT RES, V80, P860, DOI 10.1177/00220345010800030301
   Hui PW, 1996, J BIOMECH, V29, P123, DOI 10.1016/0021-9290(95)00010-0
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HUTSCHENREITER G, 1978, INVEST UROL, V15, P375
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   KOBAYASHI H, 1991, CURR EYE RES, V10, P899, DOI 10.3109/02713689109020325
   KOMI PV, 1990, J BIOMECH, V23, P23, DOI 10.1016/0021-9290(90)90038-5
   KREKLAU B, 1999, BIOMATERIALS, V20, P1744
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KWAN MK, 1989, J BIOMECH, V22, P921, DOI 10.1016/0021-9290(89)90076-6
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Levy RA, 1997, AM J NEURORADIOL, V18, P1522
   LI ST, 1995, BIOMEDICAL ENG HDB, P627
   Li Y, 2001, BIOMATERIALS, V22, P609, DOI 10.1016/S0142-9612(00)00224-6
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   LINA ASP, 2001, BIOMATERIALS, V24, P481
   Lu SX, 1998, AICHE J, V44, P1689, DOI 10.1002/aic.690440720
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Malaviya P, 1998, J BIOMECH, V31, P1043, DOI 10.1016/S0021-9290(98)00123-7
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   Mikos A. G., 1996, U.S. patent, Patent No. [5,514,378, 5514378]
   Minamide A, 1999, SPINE, V24, P1863, DOI 10.1097/00007632-199909150-00002
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Neuhoff H, 1917, SURG GYNECOL OBSTET, V14, P383
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   NIWA T, 1994, J PHARM SCI, V83, P727, DOI 10.1002/jps.2600830527
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Panchbhavi VK, 2003, FOOT ANKLE SURG, V9, P51
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Perka C, 2000, CLIN ORTHOP RELAT R, P245
   Porter NL, 2001, J BIOMED MATER RES, V56, P504, DOI 10.1002/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J
   Price N, 1997, J BIOMED MATER RES, V37, P394, DOI 10.1002/(SICI)1097-4636(19971205)37:3<394::AID-JBM10>3.0.CO;2-C
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   RAMOSHEBI LN, 2002, EXPERT REV MOL MED, P1
   Rhee SH, 2001, J AM CERAM SOC, V84, P459
   RIMELL JT, 2000, J BIOMED MATER RES, V5553, P414
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   ROY DJ, 2001, 47 ANN M ORTH RES SO
   Russell RJ, 1999, ANAL CHEM, V71, P3126, DOI 10.1021/ac990060r
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   SAM AE, 1995, OSTEOARTHR CARTILAGE, V3, P47
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   SCHUGENS C, 1995, J BIOMED MATER RES, V29, P1349, DOI 10.1002/jbm.820291106
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shishkovsky IV, 2001, TECH PHYS LETT+, V27, P211, DOI 10.1134/1.1359830
   Shors C, 1993, INTRO BIOCERAMICS, P181
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P67
   SIMON SR, 1994, ORTHOPEDIC BASIC SCI
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   STOODLEY MA, 1996, J CLIN NEUROSCI, V3, P49
   Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   TENCER AF, 1987, J ORTHOPAED RES, V5, P275, DOI 10.1002/jor.1100050214
   Thalgott John S, 2002, Spine J, V2, P63, DOI 10.1016/S1529-9430(01)00155-3
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   VAIL NK, 1999, MAT DES, V29, P23
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WAITE PD, 2001, J ORAL MAXILLOFAC SU, V59, P1034
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   WILSON J, 1994, BIOCERAMICS, V7
   Wu BM, 1996, J CONTROL RELEASE, V40, P77, DOI 10.1016/0168-3659(95)00173-5
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   YAN Y, 2003, IN PRESS MAT LETT
   YLIMEN P, 1991, ARCH ORTHOP TRAUMA S, V110, P250
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   ZHANG R, 1994, J BIOMED MATER RES, V44, P46
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   2000, P WTEC WORKSH TISS E, P175
NR 161
TC 96
Z9 107
U1 0
U2 21
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 3
BP 159
EP 177
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 935AC
UT WOS:000229750100004
PM 15911997
DA 2018-10-19
ER

PT J
AU Hedia, HS
AF Hedia, HS
TI Effect of cancellous bone on the functionally graded dental implant
   concept
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE dental implant; functionally graded material (FGM); finite element;
   optimization; von mises stress; biocompatibility
ID NONHOMOGENEOUS MATERIALS; CRACK PROBLEM; STRESS; BIOMATERIALS; MODULUS;
   FIELDS
AB In a previous work by the author [H.S. Hedia and M. Nemat-Alla, Design optimization of functionally graded dental implant, submitted to be published in the J. Bio-Medical Materials and Engineering], a functionally graded material dental implant was designed without cansellous bone in the model. In this investigation the effect of presence cancellous bone as a thin layer around the dental implant was investigated.
   It is well known that the main inorganic component of natural bone is hydroxyapatite (HAP) and that the main organic component is collagen (Col). Hydroxyapatite HAP implants are not bioabsorbable, and because induction of bone into and around the artificially made HAP is not always satisfactory, loosening or breakage of HAP implants may occur after implantation in the clinical application. The development of a new material which is bioabsorbable and which has osteoconductive activity is needed. Therefore, the aim of the current investigation is to design an implant, in the presence of cancellous bone as a thin layer around it, from functionally graded material. In this study, a novel biomaterial, collagen/hydroxyapatite (Col/HAP) as a functionally graded material (FGM), was developed using the finite element and optimization techniques which are available in the ANSYS package. These materials have a self-organized character similar to that of natural bone. The investigations have shown that the maximum stress in the cortical bone and cancellous bone for the Col/HAP functionally graded implant has been reduced by about 40% and 19% respectively compared to currently used titanium dental implants.
C1 Mansoura Univ, Fac Engn, Prod Engn & MC Design Dept, Mansoura, Egypt.
RP Hedia, HS (reprint author), Mansoura Univ, Fac Engn, Prod Engn & MC Design Dept, Mansoura, Egypt.
EM hedia@mans.edu.eg
RI Hedia, Hassan/I-8289-2012
CR *ANSYS, 1992, ANSYS US MAN VERS 5
   Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BOUGHTON P, 2000, CERAMIC POLYM FUNCTI
   Brear K, 1988, Eng Med, V17, P163
   Choi HJ, 1996, J APPL MECH-T ASME, V63, P479, DOI 10.1115/1.2788893
   CLIF SE, 1993, STRESS STRAIN DIST H, P133
   Clift S E, 1992, Proc Inst Mech Eng H, V206, P233, DOI 10.1243/PIME_PROC_1992_206_295_02
   Erdogan F, 1997, J APPL MECH-T ASME, V64, P449, DOI 10.1115/1.2788914
   ERDOGAN F, 1991, J APPL MECH-T ASME, V58, P410, DOI 10.1115/1.2897201
   FUCHIYAMA T, 1993, CERAMIC T FUNCTIONAL, V34, P425
   FUJIMOTO T, 2001, P 4 INT C THERM STRE, P121
   HAYES WC, 1986, FRONTIERS BIOMECHANI, P196
   Hedia HS, 2002, BIO-MED MATER ENG, V12, P111
   HUISKES R, 1984, CALCIF TISS INT S, V3361, P110
   HUISKES R, 1986, FRONTIERS BIOMECHANI, P245
   ITOH S, 2000, 46 ANN M ORTH RES SO
   Jallot E, 1998, MED ENG PHYS, V20, P697, DOI 10.1016/S1350-4533(98)00073-3
   JIN ZH, 1994, J APPL MECH-T ASME, V61, P738, DOI 10.1115/1.2901529
   KATTI K, 2002, ASCE 15 ASCE ENG MEC
   KERNER EH, 1956, P PHYS SOC LOND B, V69, P808, DOI 10.1088/0370-1301/69/8/305
   Kingery WD, 1976, INTRO CERAMICS
   Miyao R, 2001, J DENT MAT, V20, P344
   NEMATALLA M, 2002, 3 ASS U INT C MECH E
   NODA N, 1993, J THERM STRESSES, V16, P181, DOI 10.1080/01495739308946224
   NODA N, 1995, JSME INT J A-MECH M, V38, P364, DOI 10.1299/jsmea1993.38.3_364
   Reis RL, 2001, MATER RES INNOV, V4, P263, DOI 10.1007/s100190000103
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suresh S., 1998, FUNDAMENTALS FUNCTIO
   Wang BL, 2000, J APPL MECH-T ASME, V67, P87, DOI 10.1115/1.321153
   ZIENKIEWICZ OC, 1977, FINITE ELEMENT METHO
NR 30
TC 9
Z9 10
U1 0
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 3
BP 199
EP 209
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 935AC
UT WOS:000229750100007
PM 15912000
DA 2018-10-19
ER

PT S
AU Garcia, C
   Paucar, C
   Gaviria, J
   Duran, A
AF Garcia, C
   Paucar, C
   Gaviria, J
   Duran, A
BE Li, P
   Zhang, K
   Colwell, CW
TI Effect of some physical-chemical variables in the synthesis of
   hydroxyapatite by the precipitation route
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE biomedical applications; chemical properties; hydroxyapatite;
   precipitation route; synthesis
ID PHOSPHATE
AB The synthetic hydroxyapatite is a very useful material for numerous applications in medicine as a biomaterial. One of the most economic manufacturing process is the precipitation route. In the present work, synthetic hydroxyapatite was prepared using the precipitation route, starting with aqueous solutions of calcium nitrate (Ca(NO3).4H(2)O) and ammonium phosphate (H-2(PO4)NH4). The effects of physical-chemical variables such as pH, temperature, time of agitation, ageing time and heat treatment of the mixture were evaluated. The characterization of the samples obtained in different conditions made possible to conclude about the optimal values of the studied variables for the synthesis of this material in laboratory conditions.
C1 Univ Nacl Colombia Medellin, Fac Ciencias, Escuelas Fis & Quim, Medellin 3840, Colombia.
   CSIC, Inst Ceram & Vidrio, E-28049 Madrid, Spain.
RP Garcia, C (reprint author), Univ Nacl Colombia Medellin, Fac Ciencias, Escuelas Fis & Quim, Medellin 3840, Colombia.
EM cpgarcia@unalmed.edu.co; cgpaucar@unalmed.edu.co;
   jgarango@unalmed.edu.co; aduran@icv.csic.es
RI Garcia, Claudia/P-7860-2017; Paucar, Carlos/P-4755-2017
OI Garcia, Claudia/0000-0002-8241-9969; Paucar, Carlos/0000-0003-1457-0445
CR Elliott J. C., 1994, STRUCTURE CHEM APATI, P111
   Hsieh MF, 2001, J AM CERAM SOC, V84, P2123
   Lin FH, 1998, BIOMATERIALS, V19, P1101, DOI 10.1016/S0142-9612(98)00040-4
   Lin FH, 2000, MAT SCI ENG C-BIO S, V13, P97, DOI 10.1016/S0928-4931(00)00182-X
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   SANTOS C, 1994, THESIS U SANTIAGO SA
   SECKLER MM, 1999, MAT RES, V2, P59
   Velayudhan S, 2000, MATER LETT, V46, P142, DOI 10.1016/S0167-577X(00)00157-9
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
NR 11
TC 9
Z9 9
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 47
EP 50
DI 10.4028/www.scientific.net/KEM.284-286.47
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500012
OA Green Published
DA 2018-10-19
ER

PT S
AU Wu, C
   Murakami, Y
   Sassa, K
   Iwai, K
   Asai, S
AF Wu, C
   Murakami, Y
   Sassa, K
   Iwai, K
   Asai, S
BE Li, P
   Zhang, K
   Colwell, CW
TI Control of crystal orientation of hydroxyapatite by imposing a high
   magnetic field
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioceramics; high magnetic field; hydroxyapatite; orientation
ID SUBSTRATE
AB The controlled development of texture microstructure in ceramics is one effective way to improve their properties, such as electrical, mechanical properties and biocompatibility. A bioceramics with oriented crystal structure has attracted great interest. In bone reparations, Hydroxyapatite (HAp)-based biomaterials were frequently used. And HAp is the main mineral constituent of the hard tissue of human bodies, which occurs with a hexagonal crystal. A HAp crystal turns out to have different surface properties in a- (or b-) plane and c-plane. In this regard, to get highly oriented HAp is very important before using HAp as a biomaterial. And the crystal orientated HAp is useful not only as biomaterials but also as protein absorbents. In this research, two different kinds of HAp-based biomaterial with oriented structure (HAp bioceramics and HAp-coated titanium composite) were studied.
C1 Nagoya Univ, Dept Mat Proc Engn, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.
RP Wu, C (reprint author), Nagoya Univ, Dept Mat Proc Engn, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.
EM h042101d@mbox.nagoya-u.ac.jp; j45580a@nucc.cc.nagoya-u.ac.jp;
   d42859a@nucc.cc.nagoya-u.ac.jp; c42538a@nucc.cc.nagoya-u.ac.jp
RI Murakami, Yuichiro/L-9403-2018
OI Murakami, Yuichiro/0000-0001-7579-5299
CR ANDERSON MP, 1984, ACTA METALL MATER, V32, P783, DOI 10.1016/0001-6160(84)90151-2
   Inoue K, 2003, KEY ENG MATER, V240-2, P513, DOI 10.4028/www.scientific.net/KEM.240-242.513
   Inoue K, 2003, MATER TRANS, V44, P1133, DOI 10.2320/matertrans.44.1133
   Jiang GW, 1998, J BIOMED MATER RES, V43, P77, DOI 10.1002/(SICI)1097-4636(199821)43:1<77::AID-JBM9>3.0.CO;2-J
   KAWASAKI T, 1978, J CHROMATOGR, V151, P95, DOI 10.1016/S0021-9673(00)85374-1
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kuroda K, 2002, J BIOMED MATER RES, V61, P354, DOI 10.1002/jbm.10197
   Morikawa H, 1998, MATER T JIM, V39, P814, DOI 10.2320/matertrans1989.39.814
   TAHASHI M, 2003, JIM, V44, P285
   TEDEY SA, 2000, J BIOMEDICAL MAT RES, V50, P353
NR 10
TC 1
Z9 1
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 75
EP 78
DI 10.4028/www.scientific.net/KEM.284-286.75
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500019
DA 2018-10-19
ER

PT S
AU Hench, LL
   Notingher, I
AF Hench, LL
   Notingher, I
BE Li, P
   Zhang, K
   Colwell, CW
TI A bio-photonics system for rapid in vitro testing of cells and ceramics
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE LDA; living cells; PCA; phenotype; Raman spectroscopy
ID LIVING CELLS
AB We present a new bio-photonic method based on Raman spectroscopy able to characterize living cells in in-vitro cultures. The main advantages of this technology are: no labels or other contrast enhancers are required; provides real-time analysis; cells can be maintained in physiological conditions during the measurements; no cell-damage is induced during the measurements; it is rich in information about the biochemical composition of the cell. The results show that this spectroscopic method can be used to study the most important cellular functions involved in cell-biomaterial interactions, such as cell death, differentiation, de-differentiation and mineralization. The method offers the potential for studying cell-bioceramics interaction and reduce the need of animal testing until the final steps of proving efficacy prior to clinical trials.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
RP Hench, LL (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Exhibit Rd, London SW7 2AZ, England.
EM l.hench@imperial.ac.uk; i.notingher@imperial.ac.uk
CR Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HENCH LL, 1996, CLIN PERFORMANCE SKE
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378
   Notingher I, 2002, SPECTROSC-INT J, V16, P43, DOI 10.1155/2002/408381
   NOTINGHER I, 2003, KEY ENG MATER, V254, P769, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.254-256.769
   NOTINGHER I, 2004, IN PRESS J CELL BIOC
   Shafer-Peltier KE, 2002, J CELL BIOCHEM, P125, DOI 10.1002/jcb.10418
   Wolthuis R, 1999, FLUORESCENT LUMINESC, P433
NR 10
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 531
EP 536
DI 10.4028/www.scientific.net/KEM.284-286.531
PG 6
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500130
DA 2018-10-19
ER

PT S
AU Damien, E
   Causa, F
   Ambrosio, L
   Revell, PA
AF Damien, E
   Causa, F
   Ambrosio, L
   Revell, PA
BE Li, P
   Zhang, K
   Colwell, CW
TI In vivo characterisation of a novel hydrophilic composite for total
   intervertebral disc substitution
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bone; composite material; hydrogel; hydroxyapatite; in vivo;
   intervertebral disc; pHEMA; spinal implant
ID BIOMATERIAL; BONE
AB Intervertebral disc (IVD) damage due to degeneration, trauma or inflammation is the main cause for lower back pain leading to morbidity and loss of function of the spinal column. Until recently the state of the art treatment for degenerative disc disease (DDD) was arthrodesis. Developments in vertebral arthroplasty enable degenerated disc to be replaced with prosthetic IVD devices while maintaining motion at the affected part. The ability of the intervertebral device to support the in vivo loading environment is critical for the clinical success of such devices. However, such properties are depended on the location and structure of IVD, as the mechanical properties of IVD change locally [1].
   The objective of this study was to evaluate the in vivo tissue compatibility of a novel composite, made with poly 2-hydroxyethyl methacrylate (pHEMA), poly epsilon-caprolactone (PCL) and poly ethylene terephthalate (PET) in an animal model. In vivo qualitative and quantitative results at 6 weeks post intraosseous implantation in rabbit femur revealed that this hydrogel, in contact with bone tissue, showed no tissue damage at the implant-bone interface. This novel composite disc prosthetic material is biocompatible as bone growth was observed into the implant and there was no evidence of toxicity to bone or inflammatory responses at the peri-implant tissue.
C1 UCL, Eastman Dent Inst, London WC1X 8LD, England.
   CNR, Inst Composite & Biomed Mat, I-80125 Naples, Italy.
RP Damien, E (reprint author), UCL, Eastman Dent Inst, London WC1X 8LD, England.
EM edamien@eastman.ucl.ac.uk
OI Causa, Filippo/0000-0002-5436-3857; AMBROSIO, LUIGI/0000-0002-8367-2405
CR Bruining MJ, 2000, BIOMATERIALS, V21, P595, DOI 10.1016/S0142-9612(99)00223-9
   Causa F, 2002, J MATER SCI-MATER M, V13, P1277, DOI 10.1023/A:1021143516436
   Damien E, 2003, J BIOMED MATER RES A, V66A, P241, DOI 10.1002/jbm.a.10564
   Hutcheon GA, 2001, BIOMATERIALS, V22, P667, DOI 10.1016/S0142-9612(00)00229-5
   Lou X, 2004, BIOMATERIALS, V25, P5071, DOI 10.1016/j.biomaterials.2004.01.058
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   NATHAN P, 1976, T AM SOC ART INT ORG, V22, P30
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   RODRIGUES S, 2003, P 18 EUR C BIOM, P127
   ROSEN JJ, 1980, POLYM SCI TECHNOL B, V12, P667
NR 10
TC 0
Z9 0
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 795
EP 798
DI 10.4028/www.scientific.net/KEM.284-286.795
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500194
DA 2018-10-19
ER

PT B
AU Thomas, P
   Summer, B
AF Thomas, P.
   Summer, B.
BE Dantonio, JA
   Dietrich, M
TI Allergic reactions to metal implants: Influence of wear debris
SO BIOCERAMICS AND ALTERNATIVE BEARINGS IN JOINT ARTHROPLASTY
SE Ceramics in Orthopaedics
LA English
DT Proceedings Paper
CT 10th International BIOLOX Symposium
CY JUN 10-11, 2005
CL Washington, DC
ID ORTHOPEDIC BIOMATERIAL PARTICLES; T-CELL CLONALITY; IN-VITRO;
   PERIPROSTHETIC OSTEOLYSIS; CONTACT SENSITIVITY; CYTOKINE EXPRESSION;
   HIP-ARTHROPLASTY; STAINLESS-STEEL; TITANIUM-ALLOY; NICKEL
C1 [Thomas, P.] Univ Munich, Klin & Poliklin Dermatol & Allergol, D-80337 Munich, Germany.
RP Thomas, P (reprint author), Univ Munich, Klin & Poliklin Dermatol & Allergol, Frauenlobstr 9-11, D-80337 Munich, Germany.
CR AHANBHAG AS, 1994, J BONE JOINT SURG, V76, P60
   AKATSU T, 1991, J BONE MINER RES, V6, P183
   BLOCK J, 1999, BIOL PERFORMANCE MAT, P215
   Budinger L, 2000, ALLERGY, V55, P108, DOI 10.1034/j.1398-9995.2000.00107.x
   CARLSSON A, 1989, ACTA DERM-VENEREOL, V69, P62
   CARLSSON AS, 1980, ACTA ORTHOP SCAND, V51, P57, DOI 10.3109/17453678008990769
   Cavani A, 2003, J IMMUNOL, V171, P5760, DOI 10.4049/jimmunol.171.11.5760
   CRAMERS M, 1977, ACTA ORTHOP SCAND, V48, P245, DOI 10.3109/17453677708988763
   Duchna HW, 1998, ZBL CHIR, V123, P1271
   FISCHER-BRANDIES E., 1992, DTSCH ZAHNARZTL Z, V47, P526
   Gawkrodger DJ, 2003, BRIT J DERMATOL, V148, P1089, DOI 10.1046/j.1365-2133.2003.05404.x
   GIANT TT, 1993, J BONE MINER RES, V8, P1071
   GOEBELER M, 1993, J INVEST DERMATOL, V100, P759, DOI 10.1111/1523-1747.ep12476328
   GOH CL, 1986, CONTACT DERMATITIS, V14, P237, DOI 10.1111/j.1600-0536.1986.tb01232.x
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hayashi K, 1999, CONTACT DERMATITIS, V41, P115
   HILDEBRAND HF, 1988, BIOCOMPATIBILITY CO, P201
   JANEWAY CA, 1999, IMMUNOBIOLOGY IMMUNE, P461
   KACHLER W, 2004, BIOMATERIALIEN, V5, P108
   KLASCHKA F, 1990, SEMIN DERMATOL, V9, P210
   KUBBA R, 1981, ARCH DERMATOL, V117, P554, DOI 10.1001/archderm.117.9.554
   Levenson T, 1996, ANN ALLERG ASTHMA IM, V77, P119, DOI 10.1016/S1081-1206(10)63497-7
   Magina Sofia, 2003, Am J Contact Dermat, V14, P63
   MAYOR MB, 1980, AM J SURG, V139, P477, DOI 10.1016/0002-9610(80)90323-2
   Merritt K, 1996, CLIN ORTHOP RELAT R, pS233
   MEYRICK TRH, 1987, BMJ-BRIT MED J, V294, P106
   MITCHISON NA, 1992, ANNU REV IMMUNOL, V10, P1
   Miyanishi K, 2003, J BONE MINER RES, V18, P1573, DOI 10.1359/jbmr.2003.18.9.1573
   MOLLER H, 1990, CONTACT DERMATITIS, V23, P217, DOI 10.1111/j.1600-0536.1990.tb05001.x
   MOZZANICA N, 1990, BRIT J DERMATOL, V122, P309, DOI 10.1111/j.1365-2133.1990.tb08278.x
   Novak N, 2004, ALLERGY, V59, P5, DOI 10.1046/j.1398-9995.2003.00337.x
   Pathak YV, 1996, J BIOMATER APPL, V11, P62, DOI 10.1177/088532829601100103
   RAKOSKI J, 1986, ALLERGOLOGIE, V9, P160
   Rodgers K, 1997, FUND APPL TOXICOL, V36, P1, DOI 10.1006/faat.1996.2279
   Scott P, 1997, Semin Immunol, V9, P285, DOI 10.1006/smim.1997.0084
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   SINIGAGLIA F, 1994, J INVEST DERMATOL, V102, P398, DOI 10.1111/1523-1747.ep12372149
   Summer B, 2001, ALLERGY, V56, P767, DOI 10.1034/j.1398-9995.2001.056008767.x
   SUMMER B, 2004, ARCH DERMATOL RES, V294, P462
   SUMMER B, 2004, ALLERGY FRONTIERS FU, P93
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   Thomas P, 2001, INT ARCH ALLERGY IMM, V124, P292, DOI 10.1159/000053736
   Thomas P, 1999, J ALLERGY CLIN IMMUN, V103, pS85
   Thomas P, 2000, ALLERGY, V55, P969, DOI 10.1034/j.1398-9995.2000.00619.x
   THOMAS P, 1996, KAPITEL, V3, P96
   Thomas P., 2000, BIOCERAMICS HIP JOIN, P117
   THOMAS P, 2004, ALLERGO J, V13, P51
   Thomssen H, 2001, J RHEUMATOL, V28, P1121
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   VEIEN NK, 1994, CONTACT DERMATITIS, V31, P137, DOI 10.1111/j.1600-0536.1994.tb01951.x
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   WATERMAN AH, 1985, CONTACT DERMATITIS, V13, P294, DOI 10.1111/j.1600-0536.1985.tb02581.x
   Werfel T, 1997, J IMMUNOL, V158, P2500
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Willert HG, 1996, CLIN ORTHOP RELAT R, P4
   Willert HG, 1996, CLIN ORTHOP RELAT R, P51
   WILLERT HG, 2000, OSTEOLOGIE, V9, P165
   WILLMANN G, 2000, MED ORTH TECH, V120, P10
   Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001
   YAO JL, 1995, J BONE MINER RES, V10, P1417
   Zemtsov A, 1997, CONTACT DERMATITIS, V36, P266, DOI 10.1111/j.1600-0536.1997.tb00216.x
NR 61
TC 0
Z9 0
U1 0
U2 3
PU STEINKOPFF DARMSTADT
PI BERLIN 33
PA C/O SPRINGER VERLAG, HEIDELBERGER PLATZ 3, 1000 BERLIN 33, GERMANY
BN 978-3-7985-1540-6; 978-3-7985-1518-5
J9 CER ORTHO
PY 2005
BP 25
EP 32
DI 10.1007/3-7985-1540-9_4
PG 8
WC Biotechnology & Applied Microbiology; Orthopedics
SC Biotechnology & Applied Microbiology; Orthopedics
GA BLY28
UT WOS:000271420600004
DA 2018-10-19
ER

PT S
AU Mansur, HS
   Mansur, AAP
   Pereira, MM
AF Mansur, HS
   Mansur, AAP
   Pereira, MM
BE Li, P
   Zhang, K
   Colwell, CW
TI XRD, SEM/EDX and FTIR characterization of Brazilian natural coral
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioceramics; biomaterial; characterization; coral; scaffolds
AB In the present work, natural coral from Brazilian reefs were studied according to their crystallography by X-ray diffraction and microstructure by Scanning Electron Microscopy (SEM/EDX). FTIR spectroscopy was also used to evaluate the chemical functionalities and major components present in the material. The SEM morphology results have shown a tri-dimensional coral structure with porous ranging from 50 to 200 mu m. Aragonite was identified as the major crystalline phase through XRD analysis and FTIR spectroscopy. Strontium calcium carbonate, (Sr,Ca)CO3, was also identified by XRD analysis. After sintering at 900 degrees/1h, the conversion from aragonite to CaO and calcite was observed. These results have endorsed the high potential application of natural coral materials as 3D scaffolds for biomedical application, because of calcium carbonate compounds can be converted to RA by hydrothermal and biomimetic coating processes.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
EM ahmansur@demet.ufmg.br; aapiscitelli@uol.com.br; mpereira@demet.ufmg.br
OI Mansur, Herman/0000-0002-3032-495X; Mansur,
   Alexandra/0000-0003-1526-2508
CR Farmer V. C., 1974, INFRARED SPECTRA MIN
   FERNANDES GF, 2000, QUIM NOVA, V23, P441
   FERRARI K. R., 2000, CERAMICA IND, V5, P53
   VUOLA J, 2001, NATURAL CORAL HYDROX
   White WB, 1997, ENVIRON GEOL, V30, P46, DOI 10.1007/s002540050131
   Xu Y, 2001, MATER CHARACT, V47, P83, DOI 10.1016/S1044-5803(01)00154-1
NR 6
TC 2
Z9 2
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 43
EP 46
DI 10.4028/www.scientific.net/KEM.284-286.43
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500011
DA 2018-10-19
ER

PT S
AU Mukaida, M
   Neo, M
   Mizuta, Y
   Ikeda, Y
   Nakamura, T
AF Mukaida, M
   Neo, M
   Mizuta, Y
   Ikeda, Y
   Nakamura, T
BE Li, P
   Zhang, K
   Colwell, CW
TI Analysis of the resorption of calcium phosphate cement by using
   high-resolution X-ray 3-D CT
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE 3D reconstruction; biomaterial; calcium phosphate cement; quantitative
   analyses; X-ray CT
ID IN-VIVO; MONOXIDE
AB High resolution X-ray CT is a powerful means for analyzing comprehensive ceramic biomaterials in a living body. The benefit of this method is that morphological and volume changes of implant materials can be evaluated without retrieve of the implant in an animal body, resulting in no killing of the animals and long term evaluation even more than one year.
   In this study, in situ techniques for observation of calcium phosphate cement is developed. Calcium phosphate cement (CPC) was implanted into a femur and under skin of a rat. The volume and morphology change of the CPC were repeatedly measured using the same rat for more than 12 months.
   The 3-dimentional (3-D) structures of the CPC were imaged and reconstructed from hundreds of 2-D cross sectional CT images, which were obtained at one time by a 360 degree rotation of the sample. The structure of the CPC was visualized with 3-D, and the volume were numerically analyzed by using a 3-D structure analyzing computer software, which enabled two-value processing and estimation of the quantities of the CPC. Moreover some of the CPC samples were retrieved and were observed by SEM.
   In the results, the surface of the calcium phosphate cement changed from smooth to jagged with increasing implanted period. The CPC volume implanted into bone was gradually decreased with increasing implanted period. The volume loss was 8 % after 12 months. The CPC volume under skin after 1 month increased by 7 %. After that the volume gradually decreased in next 3 months. Absorption process of CPC in a rat will be discussed.
C1 Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Japan Fine Ceram Ctr, Atsuta Ku, Nagoya, Aichi 4568587, Japan.
RP Mukaida, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.
EM mmasashi@kuhp.kyoto-u.ac.jp; neo@kuhp.kyoto-u.ac.jp; mizuta@jfcc.or.jp;
   ikeda@jfcc.or.jp; ntaka@kuhp.kyoto-u.ac.jp
CR IKEDA Y, UNPUB P 26 COC BEACH
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
NR 4
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 149
EP 152
DI 10.4028/www.scientific.net/KEM.284-286.149
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500037
DA 2018-10-19
ER

PT S
AU Song, H
   Kim, SR
   Jung, SJ
   Lee, JK
   Kim, HJ
   Kim, YH
AF Song, H
   Kim, SR
   Jung, SJ
   Lee, JK
   Kim, HJ
   Kim, YH
BE Li, P
   Zhang, K
   Colwell, CW
TI Dissolution studies of silicon containing self setting bone cement
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE dissolution rate; self-setting bone cement; silicon-containing
   HA-Whisker
ID CALCIUM-PHOSPHATE CEMENT; SUBSTITUTED HYDROXYAPATITE
AB Silicon containing self setting bone cement has been prepared by adding silicon containing hydroxyapatite whisker to obtain a biomaterial having an improved resorption properties. Silicon containing calcium phosphate bone cement was composed of alpha-TCP: TeCP: DCPD: Si-HA whisker with a NH4H2PO4 as a setting liquid. From the XRD analysis, it was confirmed that calcium deficient hydroxyapatite phase appeared when it immersed in PBS solution. The dissolution rate of silicon containing calcium phosphate cement was measured in PBS solution and showed high dissolution rate. Based on in-vivo test, silicon containing self setting bone cement can be considered a useful material for bone bonding materials.
C1 Korea Inst Ceram Engn & Technol, Seoul, South Korea.
   Meta Biomed Co Ltd, Choongbuk 363880, South Korea.
RP Song, H (reprint author), Korea Inst Ceram Engn & Technol, Seoul, South Korea.
EM yhkokim@kicet.re.kr
CR ADRIANJATOVO H, 1996, J MATER SCI-MATER M, V7, P34
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   ISHIKAWA K, 1995, BIOMATERIALS, V16, P527, DOI 10.1016/0142-9612(95)91125-I
   Kim SR, 2002, KEY ENG MATER, V218-2, P85, DOI 10.4028/www.scientific.net/KEM.218-220.85
   OTSUKA M, 1993, CHEM PHARM BULL, V41, P2055
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Tas AC, 2001, J AM CERAM SOC, V84, P295
NR 7
TC 1
Z9 1
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 169
EP 172
DI 10.4028/www.scientific.net/KEM.284-286.169
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500042
DA 2018-10-19
ER

PT S
AU Bernstein, A
   Brandt, J
   Gildenhaar, R
   Berger, G
   Hein, W
AF Bernstein, A
   Brandt, J
   Gildenhaar, R
   Berger, G
   Hein, W
BE Li, P
   Zhang, K
   Colwell, CW
TI The bone reaction to ceramic coated pins - Animal study
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE biocompatibility; biomaterial; bone; ceramics; coating; surface reaction
C1 Univ Halle Wittenberg, Dept Orthopaed, D-06097 Halle Saale, Germany.
   Fed Inst Mat Res & Testing, D-12200 Berlin, Germany.
RP Bernstein, A (reprint author), Univ Halle Wittenberg, Dept Orthopaed, Magdeburger Str 22, D-06097 Halle Saale, Germany.
EM anke.bersnstein@medizin.uni-halle.de; georg.berger@bam.de
CR DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Gildenhaar R, 2004, KEY ENG MAT, V254-2, P407, DOI 10.4028/www.scientific.net/KEM.254-256.407
   GILDENHAAR R, 14 S VERL WILE VCH
NR 3
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 179
EP 182
DI 10.4028/www.scientific.net/KEM.284-286.179
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500044
DA 2018-10-19
ER

PT S
AU Kasuga, T
   Maeda, H
   Jell, G
   Notingher, I
   Hench, LL
AF Kasuga, T
   Maeda, H
   Jell, G
   Notingher, I
   Hench, LL
BE Li, P
   Zhang, K
   Colwell, CW
TI Preparation of vaterite/poly(lactic acid) composites with excellent
   apatite-forming ability
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE apatite formation; biomineralization; calcium carbonate; composite;
   poly(lactic acid)
AB A new type of ceramic-polymer biomaterial having excellent apatite-forming ability in simulated body fluid (SBF) was prepared by hot-pressing a mixture consisting of poly(-L-lactic acid) (PLA) and calcium carbonate (vaterite). The composite containing 30% vaterite showed no brittle fracture behavior and comparably high bending strength of similar to 50 MPa. Apatite layer of several micrometers in thickness formed on its surface after soaking in SBF at 37 degrees C only for 1 day. Osteoclast culture tests showed that the composite coated with apatite has excellent bioresorbability. After incubation of human osteoblasts, mineralized bone nodule formation was seen on the surface.
C1 Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp; l.hench@imperial.ac.uk
RI Jell, Gavin/C-4893-2009; Jell, Gavin/B-7855-2010
CR Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Maeda H, 2004, MATER TRANS, V45, P989, DOI 10.2320/matertrans.45.989
   Maeda H, 2002, J MATER RES, V17, P727, DOI 10.1557/JMR.2002.0104
   MAEDA H, 2004, J CERAM SOC JPN, V112, pS803
   Notingher I, 2004, KEY ENG MAT, V254-2, P769, DOI 10.4028/www.scientific.net/KEM.254-256.769
   Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378
   SHIBUTANI T, 1993, J BONE MINER RES, V8, P331
NR 9
TC 3
Z9 3
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 449
EP 452
DI 10.4028/www.scientific.net/KEM.284-286.449
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500110
DA 2018-10-19
ER

PT S
AU Valerio, P
   Mendes, CCP
   Pereira, MM
   Goes, AM
   Leite, MF
AF Valerio, P
   Mendes, CCP
   Pereira, MM
   Goes, AM
   Leite, MF
BE Li, P
   Zhang, K
   Colwell, CW
TI Glutamate release by osteoblasts in the presence of ionic products from
   bioactive glass 60S
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioactive glass; glutamate; osteoblast
ID CALCIUM
AB Osteoblasts constitutively release glutamate and this release appears to be regulated by calcium entry. In this work we investigated if the bioactive glass with 60% of silicon (BG60S) could alter glutamate release by osteoblasts. We demonstrated that osteoblasts incubated with medium containing ionic products from the dissolution of BG60S showed lower release of glutamate when compared to control, Since intracellular calcium (Ca-i(2+)) increase is required for glutamate release we investigated the subcellular distribution of the calcium channel inositol triphosphate receptors (InsP3Rs) in the presence of BG60S compared to control. We found that the type-III InsP3R was not expressed in osteoblast, while the type-II InsP3R was expressed mainly in the cytosol. We also found that the expression of type-II InsP3R decreased in BG60S treated osteoblasts compared to control. On the other hand, we found that the type-I InsP3R was expressed mainly in the nucleus and its expression increased in the presence of the biomaterial.
C1 Univ Fed Minas Gerais, Dept Biochem & Physiol, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Engn Met, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
RP Valerio, P (reprint author), Univ Fed Minas Gerais, Dept Biochem & Physiol, Belo Horizonte, MG, Brazil.
EM patricia.valerio@terra.com.br; m.pereira@demet.ufmg.br;
   goes@icb.ufmg.br; leitemd@dedalus.lcc.ufmg.br
CR BANGHU PS, 2001, BONE, V29, P16
   Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8
   Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980
   Habel B, 1998, EUR BIOPHYS J BIOPHY, V27, P411, DOI 10.1007/s002490050149
   HINOI E, 2004, J PHARM SCI, V94, P920
   Kirischuk S, 1999, NEUROSCIENCE, V92, P1051, DOI 10.1016/S0306-4522(99)00067-6
   Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100
   TOSHIIDE A, 2002, MOL CELL NEUROSCI, V20, P56
   Turner CH, 2002, CALCIFIED TISSUE INT, V70, P435, DOI 10.1007/s00223-001-1024-z
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Yang YX, 2004, J NEUROCHEM, V88, P1361, DOI 10.1046/j.1471-4159.2003.02279.x
NR 11
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 537
EP 540
DI 10.4028/www.scientific.net/KEM.284-286.537
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500131
DA 2018-10-19
ER

PT S
AU Oliveira, AL
   Santos, MI
   Pedro, AA
   Reis, RL
AF Oliveira, AL
   Santos, MI
   Pedro, AA
   Reis, RL
BE Li, P
   Zhang, K
   Colwell, CW
TI Bisphosphonates incorporated on a Ca-P biomimetic coating produced by a
   sodium silicate based methodology stimulate osteoblastic activity
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE biodegradable polymers; biomimetic coating; bisphosphonate; calcium
   phosphate; drug therapy; sodium silicate; starch
AB In the present study sodium clodronate, a well known therapeutic agent from the family of bisphosphonates (BP) was incorporated in an apatite coating, previously formed on the surface of a starch based biomaterial by a sodium silicate methodology, as a strategy to develop a site-specific drug delivery system for bone tissue regeneration. The effects on the resulting apatite coatings were evaluated in terms of morphology, chemistry and structure. As a preliminary approach, this first study aimed at evaluating also the effects of this BP on the viability, growth and function of a human osteoblast cell line, since there is still little information available on the interaction between BPs and this type of cells.
C1 Univ Minho, Bs Res Grp Biomat Biodegradables Biomimet, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4780058 Guimaraes, Portugal.
RP Oliveira, AL (reprint author), Univ Minho, Bs Res Grp Biomat Biodegradables Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM analeite@dep.uminho.pt; marina@dep.uminho.pt;
   cadrianopedro@dep.uminho.pt; rgreis@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Oliveira, Ana/J-3404-2013; Reis, Rui
   L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Oliveira, Ana/0000-0001-8012-4203; Reis,
   Rui L./0000-0002-4295-6129
CR ELVIRA C, 2002, BIOMATERIALS, P1955
   FLEISCH H, 2001, EXPERT OPINION THERA, P1371
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
NR 4
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 615
EP 618
DI 10.4028/www.scientific.net/KEM.284-286.615
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500150
DA 2018-10-19
ER

PT S
AU Zhang, K
   Washburn, NR
   Antonucci, JM
   Simon, CG
AF Zhang, K
   Washburn, NR
   Antonucci, JM
   Simon, CG
BE Li, P
   Zhang, K
   Colwell, CW
TI In vitro culture of osteoblasts with three dimensionally ordered
   macroporous sol-gel bioactive glass (3DOM-BG) particles
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE apatite; bioactive glass; biocompatibility; cytotoxicity; in vitro;
   osteoblast; sol-gel
ID MINERALIZATION; HYDROXYAPATITE; SURFACE; SILICA
AB Three dimensionally ordered macroporous sol-gel bioactive glasses (3DOM-BGs) are a type of biomaterial that is both bioactive and resorbable. In this study, 80% SiO2 - 20 % CaO (molar fraction) 3DOM-BG particles were prepared using a colloidal crystal templating method via a sol-gel process. The as-prepared 3DOM-BG particles can quickly convert to a calcium-deficient, bone-like apatite after soaking in a simulated body fluid (SBF). MC3T3-E1 osteoblastic cells were cultured in the presence of 3DOM-BG particles. Preliminary results from cell studies showed that 3DOM-BG particles are not cytotoxic and are compatible with MC3T3-E1 osteoblast-like cells in vitro.
C1 NIST, Biomat Grp, Gaithersburg, MD 20899 USA.
RP Zhang, K (reprint author), NIST, Biomat Grp, Gaithersburg, MD 20899 USA.
EM kai.zhang@nist.gov; bnewell.washburn@nist.gov;
   cjoseph.antonucci@nist.gov; carl.simon@nist.gov; kai.zhang@nist.gov
CR Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   Stein A, 2001, CURR OPIN SOLID ST M, V5, P553, DOI 10.1016/S1359-0286(01)00022-5
   Wheeler DL, 2000, J ORTHOPAED RES, V18, P140, DOI 10.1002/jor.1100180120
   Yan HW, 2001, CHEM MATER, V13, P1374, DOI 10.1021/cm000895e
   Zhang K, 2003, J BIOMED MATER RES A, V66A, P860, DOI 10.1002/jbm.a.10093
   ZHANG K, IN PRESS J AM CERAM
NR 13
TC 0
Z9 0
U1 2
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 655
EP 658
DI 10.4028/www.scientific.net/KEM.284-286.655
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500160
DA 2018-10-19
ER

PT S
AU Wang, M
   Au, CL
   Lai, PK
   Bonfield, W
AF Wang, M
   Au, CL
   Lai, PK
   Bonfield, W
BE Li, P
   Zhang, K
   Colwell, CW
TI Tensile and compressive behaviours and properties of a bone analogue
   biomaterial
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE composite; compressive properties; hydroxyapatite; mechanical behaviour;
   polyethylene; tensile properties
ID HYDROXYAPATITE REINFORCED POLYETHYLENE
AB For the purpose of mimicking the structure and matching mechanical properties of human cortical bone, a natural composite material, hydroxyapatite (HA) reinforced high density polyethylene (HDPE) has been developed as a bioactive, analogue material for bone replacement. This synthetic composite material is now in clinical use. To understand the deformation behaviour and determine mechanical properties of HA/HDPE composite under different loading modes and loading conditions, tensile and compression tests were performed in the current investigation. It was observed that under tension, HA/HDPE composite exhibited two types of deformation behaviour: ductile and brittle. Under compression, the composite deformed in a ductile manner and did not fracture at high compressive strains. It was found that an increase in HA content resulted in increases in Young's modulus, compressive modulus, tensile strength and compressive yield strength of the composite. A higher strain rate led to higher modulus and strength values and lower tensile fracture strains of the composite.
C1 Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.
   Hong Kong Polytech Univ, Rehabil Engn Ctr, Hong Kong, Hong Kong, Peoples R China.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge, England.
RP Wang, M (reprint author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.
EM memwang@hku.hk
RI Wang, Min/C-1584-2009
CR Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   Wang M, 2004, KEY ENG MAT, V254-2, P611, DOI 10.4028/www.scientific.net/KEM.254-256.611
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M, 1998, J MATER SCI-MATER M, V9, P621, DOI 10.1023/A:1008975323486
NR 4
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 693
EP 696
DI 10.4028/www.scientific.net/KEM.284-286.693
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500169
DA 2018-10-19
ER

PT S
AU Rousseau, M
   Bourrat, X
   Stempfle, P
   Brendle, M
   Lopez, E
AF Rousseau, M
   Bourrat, X
   Stempfle, P
   Brendle, M
   Lopez, E
BE Li, P
   Zhang, K
   Colwell, CW
TI Multi-scale structure of the Pinctada mother of pearl: Demonstration of
   a continuous and oriented organic framework in a natural ceramic
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE biomaterial; crystal growth; nacre; organic matrix; structure
ID SHELL
AB Sheet nacre is a promising natural bioceramic, which consists on the internal lustrous "mother of pearl" layer of many molluscan shells, e.g. Pinctada, our model. The aim of this work is to study the structure of the flat polygonal tablets of nacre, in order to understand the multi-scale organization of this composite material and the role of the organic template during the growth of the biocrystal.
   We studied the organic matrix, in situ with techniques such as darkfield transmission electronic microscopy (TEM) on small cross-sections of nacre of Pinctada maxima, or intermittent-contact atomic force microscopy coupled with phase imaging on samples of nacre of Pinctada margaritifera polished parallel to the surface of the tablets. In this study, we demonstrate the continuity of the organic framework and the crystallographic orientation in the biocrystal at 2 relevant levels nano- and micro-scale.
C1 CNRS, UMR 5178, MNHN, F-75231 Paris, France.
   Univ Bordeaux 1, LCTS, F-33600 Pessac, France.
   ICSI, F-68057 Mulhouse, France.
   Equipe Interfaces Mat Fonctionnels, Ecole Natl Ingn Tarbes, Lab Genie Prod, F-65016 Tarbes, France.
RP Rousseau, M (reprint author), CNRS, UMR 5178, MNHN, 7 Rue Cuvier, F-75231 Paris, France.
EM rousseam@gmx.net; bourrat@lcts.u-bordeaux.fr; philippe.stempfle@enit.fr;
   lopez@mnhn.fr
CR BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   MUTVEI H, 1969, STOCKHOLM CONTR GEOL, V20, P1
   ROUSSEAU M, IN PRESS J STRUCT BI
   Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i
   Wada K., 1961, B NATN PEARL RES LAB, V7, P703
   WISE S JR, 1970, Eclogae Geologicae Helvetiae, V63, P775
NR 7
TC 7
Z9 7
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 705
EP 708
DI 10.4028/www.scientific.net/KEM.284-286.705
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500172
DA 2018-10-19
ER

PT S
AU Mansur, HS
   Mansur, AAP
   Bicallho, SMCM
AF Mansur, HS
   Mansur, AAP
   Bicallho, SMCM
BE Li, P
   Zhang, K
   Colwell, CW
TI Lignin-hydroxyapatite/tricalcium phosphate biocomposites: SEM/EDX and
   FTIR characterization
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioceramics; biomaterial; characterization; lignin; scaffolds
AB In the present work, a novel biocomposite has been developed based on lignin (Lig) and HA/beta-TCP bioceramic materials. The Lig/HA and Lig/beta-TCP systems were investigated by Scanning Electron Microscopy coupled to EDX microprobe (SEM/EDX). Lignin is a lignosulfonate natural polymer with complex random coupling and the exact chemical structure is yet unknown. FTIR spectroscopy is an important tool for lignin characterization based on several major vibration bands associated with generally found chemical groups. Consequently, FTIR spectroscopy was used to evaluate the chemical functionalities and major components present in the material. SEM photomicrographs of biocomposites Lig/HA and Lig/beta-TCP have shown uniform dispersion of the natural polymer binder in the bioceramic matrix. Also, chemical composition obtained by EDX spectra have indicated lignin evenly distributed in the HA and beta-TCP compounds. Novel biocomposites based on lignin/RA and lignin/beta-TCP were developed with porosity ranging from 50 to 100 mu m. These results have confirmed the high potential application of lignin as a non-toxic natural polymer binder to be used as 3D scaffold template for biomedical applications.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br; aapiscitelli@uol.com.br; jhs@jhs.med.br
OI Mansur, Alexandra/0000-0003-1526-2508; Mansur,
   Herman/0000-0002-3032-495X
CR HUTMACHER DW, 2000, BIOMATERIALS, V21, P25
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   Nada AAMA, 1998, POLYM DEGRAD STABIL, V60, P247, DOI 10.1016/S0141-3910(97)00072-4
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
NR 4
TC 10
Z9 11
U1 3
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 745
EP 748
DI 10.4028/www.scientific.net/KEM.284-286.745
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500182
DA 2018-10-19
ER

PT S
AU Lee, HW
   Im, SU
   Song, SE
   Kim, CS
   Choi, SY
   Lee, YK
   Kim, KN
   Kim, CK
   Choi, SH
AF Lee, HW
   Im, SU
   Song, SE
   Kim, CS
   Choi, SY
   Lee, YK
   Kim, KN
   Kim, CK
   Choi, SH
BE Li, P
   Zhang, K
   Colwell, CW
TI The effect of calcium aluminate bone cement incorporating LiF-maleic
   acid on the bone regeneration of 1-wall intrabony defects in beagle dogs
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE beagle dog; bone; calcium aluminate bone cement; LiF-maleic acid
AB This study evaluated periodontal repair and biomaterial reaction following implantation of a newly fabricated calcium aluminate bony cement incorporating LiF-maleic acid on the regeneration of 1-wall intrabony defects in the beagle dogs. The surgical control group received a flap operation only, while the experimental group was treated with calcium aluminate bony cement incorporating LiF-maleic acid. The subjects were sacrificed 12 weeks after surgery and a comparative histologic analysis was done. In the experimental group, the grafted calcium aluminate cement was not absorbed and fibrous connective tissue was epithelized around the particles of the grafted bony cement. Because of certain favorable properties, such as its easy manipulation and its ability to maintain the morphology of the defect site by acting as a scaffold, the newly developed cement is suitable for us as a graft material, and could be used very effectively in alveolar augmentation. However, further study needs to be conducted before it can be used as a bone graft material for periodontal tissue regeneration.
C1 Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
   Yonsei Univ, Coll Dent, Dept Periodontol,Res Inst Periodontal Regenerat, Brain Korea Project Med Sci 21, Seoul 120749, South Korea.
   Yonsei Univ, Coll Dent, Dept Res, Inst Dent Biomat & Bioengn, Seoul 120749, South Korea.
   Yonsei Univ, Sch New Mat Sci & Engn, Seoul 120749, South Korea.
RP Lee, HW (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
OI Choi, Seong-Ho/0000-0001-6704-6124
CR Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   Fujimura K, 2003, CLIN ORAL IMPLAN RES, V14, P659, DOI 10.1034/j.1600-0501.2003.00975.x
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   KOKUBO T, 1991, J CERAM SOC JPN, V99, P391
   MELLONIG JT, 1984, INT J PERIODONT REST, V4, P41
   OH SH, 2003, J BIOMED MATER RES, P104
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x
NR 7
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 847
EP 850
DI 10.4028/www.scientific.net/KEM.284-286.847
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500207
DA 2018-10-19
ER

PT S
AU Min, DH
   Kim, MJ
   Yun, JH
   Kim, CS
   Lee, YK
   Choi, SH
   Kim, KN
   Kim, CK
AF Min, DH
   Kim, MJ
   Yun, JH
   Kim, CS
   Lee, YK
   Choi, SH
   Kim, KN
   Kim, CK
BE Li, P
   Zhang, K
   Colwell, CW
TI Effect of calcium phosphate glass scaffold with chitosan membrane on the
   healing of alveolar bone in 1 wall intrabony defect in the beagle dogs
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE beagle dog; bone; calcium phosphate glass; chitosan non-woven membrane
AB This study evaluated periodontal repair and biomaterial reaction following implantation of a newly fabricated calcium phosphate block bone with chitosan membrane on the regeneration of 1-wall intrabony defects in the beagle dogs. The surgical control group received a flap operation only, while the experimental group I was treated with a chitosan nonwoven membrane only and the experimental group 11 was treated with a chitosan nonwoven membrane and a calcium phosphate block bone. The subjects were sacrificed 12 weeks after surgery and a comparative histometric analysis was done. No root resorption or ankylosis were observed in the experimental group. Mann-Whitney U test showed that the experimental group 11 produced statistically significant higher gain in connective tissue adhesion, new cementum regeneration and new bone formation. Based on histological results, the calcium phosphate block bone successfully functioned as a osteoconductive scaffold for invading cells of host.
C1 Yonsei Univ, Dept Periodont, Seoul 120752, South Korea.
   Yonsei Univ, Coll Dent, Res Dept, Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
   Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
RP Min, DH (reprint author), Yonsei Univ, Dept Periodont, Seoul 120752, South Korea.
EM leeyk@yumc.yonsei.ac.kr; shchoi726@yumc.yonsei.ac.kr
OI Yun, Jeong-Ho/0000-0003-3929-4467
CR Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   EDMUNDO B, 1992, J PERIODONTOL, V63, P729
   Lee YK, 2003, KEY ENG MAT, V240-2, P391, DOI 10.4028/www.scientific.net/KEM.240-242.391
   LYNCH KL, 1992, BIOCERAMICS, V3, P295
   Park JS, 2003, J CLIN PERIODONTOL, V30, P443, DOI 10.1034/j.1600-051X.2003.10283.x
   Ray R D, 1972, Otolaryngol Clin North Am, V5, P389
NR 7
TC 4
Z9 4
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 851
EP 854
DI 10.4028/www.scientific.net/KEM.284-286.851
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500208
DA 2018-10-19
ER

PT S
AU Yamaguchi, S
   Yao, T
AF Yamaguchi, S
   Yao, T
BE Li, P
   Zhang, K
   Colwell, CW
TI Development of bioactive alumina-wollastonite composite by
   electrophoretic deposition
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE apatite; bioactivity; composite; electrophoretic deposition EPD;
   interlocking effect
AB Alumina is excellent biomaterial and used in hip prostheses, dental implants and so on. Wollastonite particles were deposited in pores of porous alumina by electrophoretic deposition and an alumina-wollastonite composite was produced. Apatite was formed both inside the pores and on the surface of the composite of the alumina-wollastonite composite by soaking in a simulated body fluid. It was indicated that the deposited wollastonite particles induced the apatite formation. Novel composite material with both excellent mechanical properties and high bioactivity was developed.
C1 Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.
RP Yamaguchi, S (reprint author), Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.
EM yao@energy.kyoto-u.ac.jp
CR Bonfield W., 1984, NATURAL LIVING BIOMA, P43
   Evans FG, 1961, BIOMECHANICAL STUDIE, P49
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1990, J BIOMED MATER RES, V24, pP721
   YAO T, 2001, Patent No. 200170183
   YAO T, 2003, BIOCERAMICS, V240, P67
NR 6
TC 4
Z9 4
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 863
EP 866
DI 10.4028/www.scientific.net/KEM.284-286.863
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500211
DA 2018-10-19
ER

PT S
AU Henkel, KO
   Bienengraber, V
   Lenz, S
   Gerber, T
AF Henkel, KO
   Bienengraber, V
   Lenz, S
   Gerber, T
BE Li, P
   Zhang, K
   Colwell, CW
TI Comparison of a new kind of calcium phosphate formula versus
   conventional calcium phosphate matrices in treating bone defects - A
   long-term investigation in pigs
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bone substitute materials; bone-formation; calcium phosphates;
   histological investigation
ID HYDROXYAPATITE
AB In clinical practice arises an increasing need for bone substitute materials. The main inorganic part of bone is the hydroxyapatite (HA). A new hydroxyapatite formula was created by a sol-gel-process at low temperature level [4]. The aim of this investigation was to test the biodegradation and the induction of bone formation by this new material and to compare these versus conventional fabricated HA and beta-TCP. 30 one-year-old Goettingen minipigs were divided into five groups. Critical size defect (> 5 CM) in the mandible was treated differently in all 5 groups:-group I- filling with pure UA, which was fabricated by sol-gel-technique, group II- control, only gelatinous material was given, group III- conventional B-TCP [Cerasorb((R))], in group IV-conventional HA [Endobone (R)] and in group V [Targobone (R)], a non denatureted bovine collagen matrix was used. Macroscopical and microscopical investigations of the former defects were made eight months postoperatively. The bone formation was superior in the sol-gel-HA-group (group I) in comparison with the control groups (group II) and the conventional fabricated ceramics groups (III and IV). In the sol-gel-HA group, the biodegradation of this new biomaterial was considered to very good with a resorption rate of more than 98%; eight months postoperatively. In this group complete bone formation was seen in former defects. In the control group, only an incomplete bone formation with 48.4% of the defect area was noted. This difference was significant (p < 0.001). A less bone formation was also observed in group III and IV with 57.6% and 56.9%. The bovine non-denaturated collagen matrix (group V) leads to only 20% of new formed bone. The new calcium phosphate formula made by a sol-gel method seems to be superior and suitable for filling bone defects.
C1 Univ Rostock, Klin & Polklin Mund Kiefer & Gesichtschirurg, DE-18057 Rostock, Germany.
   Univ Rostock, Fachbereich Phys, DE-18051 Rostock, Germany.
RP Henkel, KO (reprint author), Univ Rostock, Klin & Polklin Mund Kiefer & Gesichtschirurg, Stempelstr 13, DE-18057 Rostock, Germany.
EM kai-olaf.henkel@med.uni-rostock.de;
   volker.bienengraeber@med-uni-rostock.de; solveg.lenz@med.uni-rostock.de;
   gerber@physik1.uni-rostock.de
CR Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Shi DL, 2002, J BIOMED MATER RES, V63, P71, DOI 10.1002/jbm.10087
   Traykova T, 2004, KEY ENG MAT, V254-2, P679, DOI 10.4028/www.scientific.net/KEM.254-256.679
NR 4
TC 7
Z9 7
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 885
EP 888
DI 10.4028/www.scientific.net/KEM.284-286.885
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500216
DA 2018-10-19
ER

PT S
AU Piconi, C
   Maccauro, G
   Muratori, F
AF Piconi, C
   Maccauro, G
   Muratori, F
BE Li, P
   Zhang, K
   Colwell, CW
TI Alumina matrix composites in arthroplasty
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE alumina; ceramic; composite; zirconia
ID ZIRCONIA-TOUGHENED ALUMINA; CERAMIC BALL HEADS; ZRO2 FRACTION; WEAR;
   PROSTHESES; JOINTS
AB It is well known that the introduction of zirconia into the alumina matrix has a positive effect on bending strength of the material, and especially on toughness which is the main limit of alumina ceramics. While the many attempts made in the past to develop alumina matrix composites suitable for biomedical applications containing zirconia as a toughening phase (Zirconia Toughened Alumina - ZTA) did not leave the developmental stage, recently ball heads and inlays for THR bearings made out a three phase alumina matrix composite were introduced into the market. In the alumina matrix of this material both zirconia and exagonal aluminate platelets are distributed, and then it belongs to the class of Zirconia and Platelets Toughened Alumina - ZPTA. Besides ball heads and inlays, also several other innovative orthopedic devices made out this new ceramic biomaterial are in different development stage. This paper reviews the present status of alumina matrix composites in orthopedic application, with special attention to ZPTA.
C1 Catholic Univ Rome, Rome, Italy.
   Catholic Univ Rome, Dip Orthoped & Traumatol, I-00167 Rome, Italy.
RP Piconi, C (reprint author), Catholic Univ Rome, Polo Didatt Format,Lgo O Respighi 1, Rome, Italy.
EM corpico@libero.it; giuliomac@tiscali.it; fmuratori@inwind.it
OI MACCAURO, Giulio/0000-0002-7359-268X
CR Affatato S, 1999, BIOMATERIALS, V20, P971, DOI 10.1016/S0142-9612(98)00253-1
   Affatato S, 1999, BIOMATERIALS, V20, P1925, DOI 10.1016/S0142-9612(99)00093-9
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   BURGER W, Patent No. 5830816
   Burger W., 1997, KERAM Z, V49, P1067
   CIAPETTI G, 2000, P 9 SIMCER CENTR CER, P39
   CLAUSSEN N, 1984, SCI TECHNOLOGY ZIRCO, V2, P325
   Deville S, 2003, J EUR CERAM SOC, V23, P2975, DOI 10.1016/S0955-2219(03)00313-3
   GARINO J, 2002, BIOCERAMICS JOINT AR, P131
   Heimke G, 2002, BIOMATERIALS, V23, P1539, DOI 10.1016/S0142-9612(01)00262-9
   Insley GM, 2004, KEY ENG MAT, V254-2, P675, DOI 10.4028/www.scientific.net/KEM.254-256.675
   Kaddick C, 2002, BIOCERAMICS JOINT AR, P16
   KADDICK C, 2000, BIOCERAMICS HIP JOIN, P146
   Lazennec JY, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P51
   Maccauro G, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P47
   MANDRINO A, 1992, J MATER SCI-MATER M, V3, P457, DOI 10.1007/BF00701243
   Merkert P, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P129
   Merkert P., 2003, BIOCERAMICS JOINT AR, P123
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Rack R, 2000, BIOCERAMICS HIP JOIN, P141
   Rack R., 2001, BIOCERAMICS JOINT AR, P103
   Rieu J., 1993, Clinical Materials, V12, P211, DOI 10.1016/0267-6605(93)90075-I
   SALOMONI A, 1994, J MATER SCI-MATER M, V5, P651, DOI 10.1007/BF00120349
   Stewart TD, 2003, J BIOMED MATER RES B, V66B, P567, DOI 10.1002/jbm.b.10035
   WILLMANN G, 2001, KEY ENG MATER, V192, P545
   ZABRA L, 2004, BIOCERAMICS JOINT AR, P163
NR 28
TC 11
Z9 11
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 979
EP 982
DI 10.4028/www.scientific.net/KEM.284-286.979
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500239
DA 2018-10-19
ER

PT S
AU Weiss, P
   Clergeau, LP
   Enckel, B
   Amouriq, Y
   Giumelli, B
   Jean, A
   Daculsi, G
AF Weiss, P
   Clergeau, LP
   Enckel, B
   Amouriq, Y
   Giumelli, B
   Jean, A
   Daculsi, G
BE Li, P
   Zhang, K
   Colwell, CW
TI A new injectable bone substitute concept (MBCP Gel (TM)): First clinical
   results in human maxillo-facial surgery
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE calcium phosphate; clinical trial; injectable bone substitute
ID IN-VITRO; DOGS
AB For the first time, an injectable bone substitute (IBS) made of a suspension of Calcium phosphate ceramic was used in a clinical trial in human after extraction of non conservable tooth (36 or 46). 11 patients did agree for implantation of their sockets with the biomaterial. It was an explorative study and the results showed no pain due to the biomaterial implantation, no infection, no inflammation and perfect biocompatibility. The safety and the bioactivity of this concept of biomaterial were confirmed in human implantation after several animals' pre-clinical studies.
C1 Fac Chirurgie Dentaire, INSERM, Lab Rech Mat Interet Biol, F-44042 Nantes, France.
   CHU Nantes, Ctr Soins & Rech Dentaire, F-44042 Nantes, France.
RP Weiss, P (reprint author), Fac Chirurgie Dentaire, INSERM, Lab Rech Mat Interet Biol, 1 Pl Alexis Ricordeau,BP 84215, F-44042 Nantes, France.
EM pweiss@sante.univ-nantes.fr
RI Weiss, Pierre/P-1372-2014; LABOUX, OLIVIER/A-8270-2015; Daculsi,
   Guy/P-1320-2014
OI Weiss, Pierre/0000-0002-6159-8590; Daculsi, Guy/0000-0003-1030-3446
CR DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DELECRIN J, 1994, CELL MATER, V4, P51
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   KAEMMERLEN P, 1989, NEW ENGL J MED, V321, P121
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   WEISS P, 1999, BONE, V25, P67
NR 11
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 1053
EP 1056
DI 10.4028/www.scientific.net/KEM.284-286.1053
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500257
DA 2018-10-19
ER

PT B
AU Straus, J
AF Straus, J
BE Thiele, F
   Ashcroft, RE
TI Patents on biomaterial - A new colonialism or a means for technology
   transfer and benefit-sharing?
SO BIOETHICS IN A SMALL WORLD
SE WISSENSCHAFTSETHIK UND TECHNIKFOLGENBEURTEILUNG
LA English
DT Proceedings Paper
CT Conference on Bioethics in a Small World
CY APR 10-12, 2003
CL Bad Neuenahr Ahrweiler, GERMANY
ID BIODIVERSITY; PROPERTY
CR ALPER J, 1994, SCIENCE, V264, P1399, DOI 10.1126/science.8197450
   BASLAR, 1998, CONCEPT COMMON HERIT, P9
   BEIER, 1996, GATT TRIPS AGREEMENT, P160
   BLANENEY, 1997, BIOPROSPECTING PROTE
   *BOARD AGR NAT RES, 1993, MAN GLOB GEN RES AGR, P117
   BOYD, 2003, J WORLD INTELLECTUAL, P229
   BOYD, 2003, J WORLD INTELLECTUAL, P230
   BURK DL, 1993, SCIENCE, V260, P1900, DOI 10.1126/science.8316830
   CHAMBERS, 2003, J WORLD INTELLECTUAL, P311
   CHAMBERS, 2003, J WORLD INTELLECTUAL, P315
   CHAMBERS, 2003, J WORLD INTELLECTUAL, P314
   *CIPR, 2002, INT INT PROP RIGHTS
   Cohen J, 1997, SCIENCE, V276, P1329, DOI 10.1126/science.276.5317.1329
   *COL U SCH INT PUB, 1999, 4 COL U SCH INT PUBL, P12
   *COM, 1997, 446 COM
   CORREA, 1998, J WORLD INTELLECTUAL, V1, P79
   CORREA, 1998, J WORLD INTELLECTUAL, V1, P75
   CORREA, 1994, EIPR, P327
   CORREA, 1998, J WORLD INTELLECTUAL, V1, P76
   CORREA, 1994, EIPR, P329
   CORREA, 1994, EIPR, P328
   CORREA, 1998, J WORLD INTELLECTUAL, V1, P82
   CRESPI, 1996, OECD SURVEY CURRENT, P15
   CULLET, 2001, J WORLD INTELLECTUAL, P217
   CULLET, 2001, J WORLD INTELLECTUAL
   DOLDER, 2003, PATENTE GRUNDLAGE BI, P349
   EISNER T, 1994, P AM PHILOS SOC, V138, P385
   FLAM F, 1994, SCIENCE, V266, P1324, DOI 10.1126/science.7973722
   GABRIEL, 2003, PROTECTION LIFE SCI, P91
   GIRSBERGER, 2002, KEINE PATENTE WEIZEN, V7, P541
   GOSAIN, 2002, PATENT WORLD, P14
   HACKETT, 1992, ABA J, P43
   HAEUSSLER, 1994, USE BIODIVERSITY SUS, P71
   HATHAWAY, 1992, ABA J, P42
   Hendrickx F., 1993, ENVIRON POLICY LAW, V23, P250
   JENKINS, 1995, NW J INT LAW BUSINES, V15, P636
   JENKINS, 1995, NW J INT LAW BUSINES, V15, P645
   JENKS, 1995, NW J INT LAW BUSINES, V15, P650
   KADID, 1993, YALE LAW J, V103, P243
   KADIDAL, 1996, IDEA, V37, P371
   KADIDAL, 1993, YALE LAW J, V103, P237
   KADIDAL S, 1993, YALE LAW J, V103, P223, DOI 10.2307/797080
   KOTHARI, ACESS BENEFIT SHARIN, P201
   LERCH, 1996, VERFUGUNGSRECHTE BIO, P91
   MEYERS, 1999, BSLR, V4, P131
   MOONEY, 1983, LAW SEED ANOTHER DEV, P1
   MUGABE, 1996, TECHNOLOGY TRANSFER, P16
   MUGABE, 1997, ACCESS GENETIC RESOU, P71
   ODEK, 1994, J INTELL PROP L, V2, P150
   Odek J.O., 1994, J INTELLECTUAL PROPE, V2, P141
   PENNISI, 1998, SCIENCE, V279, P1445
   Pennisi E, 1998, SCIENCE, V279, P1624, DOI 10.1126/science.279.5357.1624
   PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347
   Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068
   PLUCKNETT, 1987, GENE BANKS WORLD FOO
   *PTO, 1992, BIOT GROUP EXPL OBJ, V44, P120
   RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099
   REAKAKUDLA, 1997, UNDERSTANDING PROTEC
   REHM, 1995, LEGAL EC ETHICAL DIM, P281
   ROBERTS L, 1992, SCIENCE, V256, P1142, DOI 10.1126/science.256.5060.1142
   ROBERTSON, 1995, TREATY BIOL DIVERSIT
   ROHRBAUGH, 1997, AIPLA QJ, V25, P373
   ROHRBAUGH, 1997, AIPLA QJ, V25, P371
   ROMPCZYK, 1998, REICHTUM SUDENS GEGE, P18
   ROSENTHAL, 1997, OEDC P INV BIOL DIV, P253
   SEDJO, 1992, J LAW EC, V35, P201
   SEDJO, 1992, J LAW EC, V35, P208
   SEDJO, 1992, J LAW EC, V35, P202
   SEDJO, 1992, J LAW EC, V35, P211
   SEDJO RA, 1992, J LAW ECON, V35, P199, DOI 10.1086/467250
   SHERMAN, 2003, REGULATING ACCESS US
   SHIVA, 1998, BIOPIRACY PLUNDER NA
   SIMPSON, 1999, HDB INCENTIVE MEASUR
   SIMPSON, 1999, PRICE BIODIVERSITY, P65
   STOIANOFF, 1998, ACCESS AUSTR BIOL RE
   STONE, 1992, SCIENCE, V256, P1624
   STRAUS, 1993, IIC, V24, P605
   STRAUS, 1997, RECHTLICHE ETHISCHE, P56
   STRAUS, 1993, IIC, V24, P607
   STRAUS, 1988, INTELLECTUAL PROPERT, V21, P21
   STRAUS J, 1993, IIC-INT REV IND PROP, V24, P602
   TANKSLEY, 1997, SCIENCE, V277, P163
   Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063
   TINKER, 1994, BUFFALO J INT LAW, V1, P16
   TINKER, 1994, BUFFALO J INT LAW, V1, P18
   TINKER, 1994, BUFFALO J INT LAW, V1, P1
   TINKER, 1994, BUFFALO J INT LAW, V1, P13
   van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106
   *WIPO, 2003, PCTRWG413 WIPO
   *WIPO, PCTRWG413 WIPO, P10
   *WIPO UNEP, 2000, ROL INT PORP RIGHTS, P33
   WOLFGANG, 1995, SCIENCE, V269, P1506
   WORNER, 2000, GEN PIRATEN PATENTEN
   ZISWILER, 1993, BIOL VERSCHWINDENS U, V6, P575
   1995, UNEPCBDCOP213
   1998, O J EC C, V110, P29
   UNEPCBDWGABS1NF4
   2002, WIPOGRTKF12411
   2002, WIPOGRTKFIC411
   1998, OJ EC L, V213
   UNEPCBDCOP320
   1996, UNEPCBDCOP320
NR 102
TC 2
Z9 2
U1 1
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 3-540-23595-7
J9 WISSENSCH TECHNIKFOL
PY 2005
VL 24
BP 45
EP 72
PG 28
WC Biotechnology & Applied Microbiology; Ethics; Medical Ethics; Social
   Issues
SC Biotechnology & Applied Microbiology; Social Sciences - Other Topics;
   Medical Ethics; Social Issues
GA BCE08
UT WOS:000228809300006
DA 2018-10-19
ER

PT J
AU Metters, A
   Hubbell, J
AF Metters, A
   Hubbell, J
TI Network formation and degradation behavior of hydrogels formed by
   Michael-type addition reactions
SO BIOMACROMOLECULES
LA English
DT Article
ID FREE-RADICAL POLYMERIZATION; POLY(ETHYLENE GLYCOL) HYDROGELS;
   STATISTICAL KINETIC-MODEL; DRUG-DELIVERY; CROSS-LINKING; PRIMARY
   CYCLIZATION; CONTROLLED-RELEASE; BULK-DEGRADATION; MULTIFUNCTIONAL
   MONOMERS; EXTRACELLULAR MATRICES
AB Hydrolytically labile poly(ethylene glycol)-based hydrogels are fabricated via a Michael-type addition reaction between unsaturated acrylate moieties and nucleophilic thiols. Although these gels offer the advantage of selective, in situ polymerization and potential as biocompatible matrixes for cell and protein encapsulation, a thorough understanding of the complex structure-property relationships that control the macroscopic behaviors of these cross-linked networks before and during hydrolytic degradation does not exist. Therefore, in this work, a novel theoretical model is presented to describe the formation and hydrolytic degradation of the step-polymerized gels. The model accounts for variations in hydrolysis kinetics as well as structural effects such as precursor functionality and the presence of primary cycles or other structural nonidealities that lower the cross-linking efficiency of the networks. Comparison of model predictions and experimental data validate this methodology for optimizing biomaterial design and reveal that structural nonidealities play a key role in determining the degradation behavior of real cross-linked systems. Decreasing precursor concentration and functionality during network formation generate high concentrations of network nonidealities that ultimately lead to higher initial swelling ratios and faster apparent rates of degradation.
C1 Univ Zurich, CH-8044 Zurich, Switzerland.
   Swiss Fed Inst Technol, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
RP Metters, A (reprint author), Univ Zurich, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   AWHNEY AS, 1993, MACROMOLECULES, V26, P581
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dusek K, 1997, TRENDS POLYM SCI, V5, P268
   Dusek K, 2000, PROG POLYM SCI, V25, P1215, DOI 10.1016/S0079-6700(00)00028-9
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   Elliott JE, 2004, POLYMER, V45, P1503, DOI 10.1016/j.polymer.2003.12.040
   Elliott JE, 2003, POLYMER, V44, P327, DOI 10.1016/S0032-3861(02)00734-6
   Elliott JE, 2002, MACROMOLECULES, V35, P7125, DOI 10.1021/ma012001x
   Elliott JE, 2002, POLYM REACT ENG, V10, P1, DOI 10.1081/PRE-120002902
   Elliott JE, 2001, CHEM ENG SCI, V56, P3173, DOI 10.1016/S0009-2509(00)00547-9
   Elliott JE, 2001, MACROMOLECULES, V34, P4642, DOI 10.1021/ma010153m
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   GOBIN AS, 2002, FASEB J, P16
   Heggli M, 2003, BIOCONJUGATE CHEM, V14, P967, DOI 10.1021/bc0340621
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   Karp JM, 2003, MRS BULL, V28, P301, DOI 10.1557/mrs2003.85
   Kim B, 2003, INT J PHARM, V266, P29, DOI 10.1016/S0378-5173(03)00378-8
   Koh WG, 2002, LANGMUIR, V18, P2459, DOI 10.1021/la0115740
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lu SX, 2000, MACROMOLECULES, V33, P2509, DOI 10.1021/ma9915024
   LUSTIG SR, 1988, J APPL POLYM SCI, V36, P735, DOI 10.1002/app.1988.070360401
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Martens P, 2001, J PHYS CHEM B, V105, P5131, DOI 10.1021/jp004102n
   Mason MN, 2001, MACROMOLECULES, V34, P4630, DOI 10.1021/ma010025y
   MERRILL EW, 1993, BIOMATERIALS, V14, P1117, DOI 10.1016/0142-9612(93)90154-T
   Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t
   Metters AT, 2001, J PHYS CHEM B, V105, P8069, DOI 10.1021/jp004083h
   MIKOS AG, 1988, BIOMATERIALS, V9, P419
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   ODIAN G, 1991, PRINCIPLES POLYM
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Schoenmakers RG, 2004, J CONTROL RELEASE, V95, P291, DOI 10.1016/j.jconrel.2003.12.009
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   van Nostrum CF, 2003, ACS SYM SER, V846, P129, DOI 10.1021/bk-2003-0846.ch010
   Zhao X, 1998, J PHARM SCI, V87, P1450, DOI 10.1021/js980065o
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   ZISCH AH, 2003, FASEB J, P17
NR 54
TC 206
Z9 209
U1 5
U2 65
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2005
VL 6
IS 1
BP 290
EP 301
DI 10.1021/bm049607o
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 887ZP
UT WOS:000226344300038
PM 15638532
DA 2018-10-19
ER

PT J
AU Burdick, JA
   Chung, C
   Jia, XQ
   Randolph, MA
   Langer, R
AF Burdick, JA
   Chung, C
   Jia, XQ
   Randolph, MA
   Langer, R
TI Controlled degradation and mechanical behavior of photopolymerized
   hyaluronic acid networks
SO BIOMACROMOLECULES
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; TISSUE-ENGINEERED CARTILAGE; PEG HYDROGELS;
   IN-VITRO; CHONDROCYTES; PHOTOENCAPSULATION; SCAFFOLD
AB Hyaluronic acid is a natural polysaccharide found abundantly throughout the body with many desirable properties for application as a biomaterial, including scaffolding for tissue engineering. In this work, hyaluronic acid with molecular weights ranging from 50 to 1100 kDa was modified with methacrylic anhydride and photopolymerized into networks with a wide range of physical properties. With macromer concentrations from 2 to 20 wt %, networks exhibited volumetric swelling ratios ranging from similar to42 to 8, compressive moduli ranging from similar to2 to over 100 kPa, and degradation times ranging from less than I day up to almost 38 days in the presence of 100 U/mL of hyaluronidase. When 3T3-fibroblasts were photoencapsulated in the hydrogels, cells remained viable with low macromer concentrations but decreased sequentially as the macromer concentration increased. Finally, auricular swine chondrocytes produced neocartilage when photoencapsulated in the hyaluronic acid networks. This work presents a next step toward the development of advanced in vivo curable biomaterials.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Plast Surg, Boston, MA 02115 USA.
RP Langer, R (reprint author), 77 Massachusetts Ave,E25-342, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
FU NIDCR NIH HHS [K22 DE-015761-01, 5R01 DE-13023-05, K22 DE015761, K22
   DE015761-01, R01 DE013023]
CR BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   FLORY PJ, 1953, PRINCIPLES POLYMER C
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   TAYLOR K B, 1969, Histochemical Journal, V1, P199, DOI 10.1007/BF01081408
   Ting V, 1998, ANN PLAS SURG, V40, P413, DOI 10.1097/00000637-199804000-00016
NR 28
TC 397
Z9 402
U1 20
U2 191
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2005
VL 6
IS 1
BP 386
EP 391
DI 10.1021/bm049508a
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 887ZP
UT WOS:000226344300049
PM 15638543
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Liao, JD
   Lin, SP
   Wu, YT
AF Liao, JD
   Lin, SP
   Wu, YT
TI Dual properties of the deacetylated sites in chitosan for molecular
   immobilization and biofunctional effects
SO BIOMACROMOLECULES
LA English
DT Article
ID COUPLING MICROWAVE PLASMA; RADICAL-DOMINANT PLASMA; PHOTOCROSSLINKABLE
   CHITOSAN; COPOLYMER MEMBRANE; IN-VITRO; HEPARIN; BIOMATERIAL; SUBSTRATE;
   FILMS
AB Polypropylene nonwoven fabric was surface-activated by high-density oxygen microwave plasma, followed by graft copolymerization with acrylic acid (AAc) and then coupling with chitosan molecules. The pAAc-grafted surface containing C=O in carboxylic acid exhibited a hydrophilic character capable of promoting water absorbency. A larger portion of minimum 85% deacetylated sites in chitosan molecules was then coupled with the grafted pAAc (around 149 mug.cm(-2)) by forming amide bonds at their interface. The covalently bonded chitosan was weighted around 44 mug.cm(-2). The smaller portion of the deacetylated sites demonstrated a distinctive structure as polycations, i.e., NH3+, on the immobilized chitosan. The respective structures following sequential reactions were identified using Fourier transform infrared-attenuated total reflection and X-ray photoelectron spectroscopy with peaks deconvolution. The NH3+ sites on the immobilized chitosan exhibited biofunctional in anticoagulation and in antibacterial property. Blood cells agglutination or agglomeration upon the chitosan-immobilized surface, in particular for red blood cells and platelets, resulted from hydrophilic effect derived from the grafted pAAc and the chitosan itself, and ionic attractions between polyeations and blood cells. In addition, the agglutinated cells retained their original morphologies. It is therefore very promising to apply this durable chitosan-immobilized surface for making an antibacterial support, at the same time, for retaining blood cell affinity.
C1 Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
RP Liao, JD (reprint author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, 1 Univ Rd, Tainan 701, Taiwan.
EM jdliao@mail.ncku.edu.tw
CR [Anonymous], 1993, METH DIL ANT SUSC TE
   Beamson G., 1992, HIGH RESOLUTION XPS
   Chandy TSP, 1990, ARTIF CELLS ARTIF OR, V18, P1, DOI DOI 10.3109/10731199009117286
   Chen AM, 1999, CLIN ORTHOP RELAT R, P239
   Chen-Yang YW, 2000, MACROMOLECULES, V33, P5638, DOI 10.1021/ma990065q
   GRILL A., 1994, COLD PLASMA MAT FABR
   HOFFMAN AS, 1990, J APPL POLYM SCI APP, V46, P341
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   *JAP IND, JISL190I JAP IND, P98
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kim CH, 1997, POLYM BULL, V38, P387, DOI 10.1007/s002890050064
   Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
   Kofuji K, 2000, CHEM PHARM BULL, V48, P579
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Leuba S, 1986, CHITIN NATURE TECHNO, P215
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Liao JD, 2002, J PHYS CHEM B, V106, P77, DOI [10.1021/jp011119c, 10.1021/jp01119c]
   LIN CM, 1998, Patent No. 325210
   Moulder J. F., 1995, HDB XRAY PHOTOELECTR
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   OKONIEWSKI M, 1988, J APPL POLYM SCI, V35, P1241, DOI 10.1002/app.1988.070350510
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   PAPINEAU AM, 1991, FOOD BIOTECHNOL, V5, P45, DOI 10.1080/08905439109549790
   Purna S K, 2000, Burns, V26, P54
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Ratner BD, 1996, BIOMATERIALS SCI INT, P105
   RIGBY AJ, 1996, TECH TEXTILES IN SEP, P22
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   Tyan YC, 2003, J BIOMED MATER RES A, V67A, P1033, DOI 10.1002/jbm.a.10024
   Tyan YC, 2003, J MATER SCI-MATER M, V14, P775, DOI 10.1023/A:1025036421604
   Tyan YC, 2002, J BIOMATER APPL, V17, P153, DOI 10.1106/088532802030478
   Tyan YC, 2002, BIOMATERIALS, V23, P65, DOI 10.1016/S0142-9612(01)00080-1
   Wang MC, 2003, LANGMUIR, V19, P9774, DOI 10.1021/la030207g
   Wang MC, 2002, J PHYS CHEM B, V106, P6220, DOI 10.1021/jp014166d
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
NR 37
TC 50
Z9 52
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2005
VL 6
IS 1
BP 392
EP 399
DI 10.1021/bm0494951
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 887ZP
UT WOS:000226344300050
PM 15638544
DA 2018-10-19
ER

PT J
AU Zhang, ZP
   Yoo, R
   Wells, M
   Beebe, TP
   Biran, R
   Tresco, P
AF Zhang, ZP
   Yoo, R
   Wells, M
   Beebe, TP
   Biran, R
   Tresco, P
TI Neurite outgrowth on well-characterized surfaces: preparation and
   characterization of chemically and spatially controlled fibronectin and
   RGD substrates with good bioactivity
SO BIOMATERIALS
LA English
DT Article
DE surface modification; protein attachment; fibronectin; RGD; peptide
   attachment; heterobifunctional crosslinker; pluronics (TM); microcontact
   printing; neurite outgrowth; XPS; TOF-SIMS; contact angle; AFM; neuron
   pathfinding
ID ATOMIC-FORCE MICROSCOPY; NEURONAL CELL ATTACHMENT; EXTRACELLULAR-MATRIX;
   INTEGRIN EXPRESSION; NERVOUS-SYSTEM; IN-VITRO; LAMININ; GUIDANCE;
   ASTROCYTES; MIGRATION
AB Study of axonal growth and ligand-receptor interactions requires specificity and careful characterization of the biomaterial substrates to which the neurons bind. It would be impossible to predict the effects of important variables such as composition, surface density, spatial distribution, and conformation of the ligands on axonal growth of a neuron without highly specific surface characterization. Here, we compare two methods of surface modification (hereafter referred to as "Heterobifunctional Crosslinker" and "Pluronics(TM)" methods) used for immobilization of fibronectin (FN) and FN-derived, RGD-containing peptides to the substrates. We also characterized their performance in neurite outgrowth experiments. Various surface analytical techniques such as contact angle measurement, XPS, and time-of-flight secondary ion mass spectrometry (TOF-SIMS) were used for the analysis of the substrates at each step of the two different chemistries involved. FN-patterned surfaces were created by micro-contact printing methods and confirmed by imaging TOF-SIMS, and AFM techniques. After immobilization of FN and/or FN-derived RGD-containing peptide, including the formation of micron-scale patterns of FN, the modified surfaces were plated with neurons from postnatal rat dorsal root ganglia (DRG) and incubated in serum-free medium. Both the peptide- and/or protein-modified substrates supported significantly greater neurite outgrowth than controls, and outgrowth on both substrate chemistries was inhibited by the addition of soluble RGD peptide. Patterned FN surfaces were successful in spatially controlling the neuron attachment and outgrowth. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Delaware, Dept Chem & Biochem, Brown Lab 175, Newark, DE 19716 USA.
   Univ Utah, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
   Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Beebe, TP (reprint author), Univ Delaware, Dept Chem & Biochem, Brown Lab 175, Newark, DE 19716 USA.
EM beebe@udel.edu
OI Yoo, Raphael/0000-0003-3314-648X
FU NINDS NIH HHS [R01-NS43928]; NIBIB NIH HHS [R01-EB00463]
CR BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514
   BRODKEY JA, 1993, EXP NEUROL, V123, P251, DOI 10.1006/exnr.1993.1158
   CLEMENCE JF, 1995, BIOCONJUGATE CHEM, V6, P411, DOI 10.1021/bc00034a011
   Condic ML, 1999, J NEUROSCI, V19, P10036
   Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878
   DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291
   FALLON JR, 1985, J CELL BIOL, V100, P198, DOI 10.1083/jcb.100.1.198
   FRASER MB, 1991, J CRANIOFAC GENET DE, V11, P214
   Grabham PW, 1997, J NEUROSCI, V17, P5455
   HAN T, 1995, ANAL CHIM ACTA, V307, P365, DOI 10.1016/0003-2670(94)00671-8
   HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519
   HYUN J, 2003, ADV MATER, V7, P1
   Inglis W, 2001, LANGMUIR, V17, P7402, DOI 10.1021/la010511e
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   LIESI P, 1990, EXPERIENTIA, V46, P900, DOI 10.1007/BF01939382
   LIESI P, 1986, EXP CELL RES, V163, P175, DOI 10.1016/0014-4827(86)90570-7
   Lo YS, 1999, LANGMUIR, V15, P1373, DOI 10.1021/la981003g
   Lo YS, 2002, J PHYS CHEM B, V106, P9847, DOI 10.1021/jp020863+
   Lo YS, 2001, LANGMUIR, V17, P3741, DOI 10.1021/la001569g
   Lo YS, 1999, LANGMUIR, V15, P6522, DOI 10.1021/la990371x
   LUCKENBILLEDDS L, 1995, CELL TISSUE RES, V279, P371
   LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6
   MA H, UNPBU ADV FUNCT MAT
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   RABKECLEMMER CE, 1994, LANGMUIR, V10, P1796, DOI 10.1021/la00018a030
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   SELAK I, 1985, DEV NEUROSCI-BASEL, V7, P278, DOI 10.1159/000112296
   SILVER J, 1980, J COMP NEUROL, V189, P101, DOI 10.1002/cne.901890106
   SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3
   SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3
   UHM JH, 1999, FRONT BIOSCI, V15, P1093
   YOO R, UNPUB LANGMUIR
   ZHANG Z, UNPUB LANGMUIR
NR 42
TC 76
Z9 80
U1 0
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 1
BP 47
EP 61
DI 10.1016/j.biomaterials.2004.02.004
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855BP
UT WOS:000223948200005
PM 15193880
DA 2018-10-19
ER

PT J
AU Daamen, WF
   Nillesen, STM
   Hafmans, T
   Veerkamp, JH
   van Luyn, MJA
   van Kuppevelt, TH
AF Daamen, WF
   Nillesen, STM
   Hafmans, T
   Veerkamp, JH
   van Luyn, MJA
   van Kuppevelt, TH
TI Tissue response of defined collagen-elastin scaffolds in young and adult
   rats with special attention to calcification
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; tissue engineering; calcification; tissue response;
   biocompatibility
ID EXTRACELLULAR-MATRIX; HEART-VALVES; CHONDROITIN-SULFATE; BIOPROSTHESES;
   MINERALIZATION; BIOMATERIALS; PRETREATMENT; INHIBITION; FIBERS
AB Collagen-elastin scaffolds may be valuable biomaterials for tissue engineering because they combine tensile strength with elasticity. In this study, the tissue response to and the calcification of these scaffolds were evaluated. In particular, the hypothesis was tested that calcification, a common phenomenon in biomaterials, may be due to microfibrils within the elastic fibre, and that these microfibrils might generate a tissue response. Four scaffolds were subcutaneously implanted, viz. collagen, collagen + pure elastin, collagen + microfibril-containing, and collagen + pulverised elastic ligament (the source for elastin). Explants were evaluated at day 3, 7 and 21.
   In young Sprague Dawley rats, collagen + ligament calcified substantially, whereas collagen + elastin (with and without microfibrils) calcified less, and collagen did not. Calcification started at elastic fibres. In both Sprague Dawley and Wistar adult rats, however, none of the scaffolds calcified. Mononuclear cell infiltration was prominent in young and adult Sprague Dawley rats. In adult Wistar rats, this infiltration was associated with the presence of microfibrils.
   Degradation of scaffolds and new matrix formation were related with cellular influx and degree of vascularisation.
   In conclusion, absence of microfibrils from the elastic fibre does not prevent calcification in young Sprague Dawley rats, but does reduce the tissue response in adult Wistar rats. Cellular response and calcification differs with age and strain and therefore the choice of animal model is of key importance in biomaterial evaluation. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem 194, NL-6500 HB Nijmegen, Netherlands.
   Univ Groningen, Dept Pathol & Lab Med, Fac Med Sci, NL-9713 GZ Groningen, Netherlands.
RP van Kuppevelt, TH (reprint author), Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem 194, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM a.vankuppevelt@ncmls.kun.nl
RI Kuppevelt, A.H.M.S.M./L-4463-2015; Daamen, Willeke/D-5854-2015
OI Daamen, Willeke/0000-0003-3155-3030
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Andre-Frei V, 2000, CALCIFIED TISSUE INT, V66, P204, DOI 10.1007/s002230010041
   Bailey MT, 2003, J BIOMED MATER RES A, V66A, P93, DOI 10.1002/jbm.a.10543
   Bancroft JD, 1990, THEORY PRACTICE HIST
   Chanda J, 1999, BIOMATERIALS, V20, P1753, DOI 10.1016/S0142-9612(98)00078-7
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   FARTASCH M, 1990, DERMATOLOGICA, V181, P187, DOI 10.1159/000247921
   Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   NIMNI ME, 1988, CALCIFIED TISSUE INT, V42, P313, DOI 10.1007/BF02556366
   PAULE WJ, 1992, J BIOMED MATER RES, V26, P1169, DOI 10.1002/jbm.820260907
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Rabaud M, 1992, J Biomater Appl, V7, P20, DOI 10.1177/088532829200700102
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Schinke T, 1999, NAT GENET, V21, P150, DOI 10.1038/5928
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Simionescu DT, 2003, J HEART VALVE DIS, V12, P217
   Singla A, 2003, J BIOMED MATER RES A, V64A, P706, DOI 10.1002/jbm.a.10375
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   van Wachem PB, 2000, J BIOMED MATER RES, V53, P18, DOI 10.1002/(SICI)1097-4636(2000)53:1<18::AID-JBM3>3.3.CO;2-A
   VANLUYN MJA, 1995, J MATER SCI-MATER M, V6, P288, DOI 10.1007/BF00120273
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Vyavahare N, 1999, AM J PATHOL, V155, P973, DOI 10.1016/S0002-9440(10)65197-8
NR 32
TC 47
Z9 52
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 1
BP 81
EP 92
DI 10.1016/j.biomaterials.2004.02.011
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855BP
UT WOS:000223948200008
PM 15193883
DA 2018-10-19
ER

PT J
AU Siebers, MC
   ter Brugge, PJ
   Walboomers, XF
   Jansen, JA
AF Siebers, MC
   ter Brugge, PJ
   Walboomers, XF
   Jansen, JA
TI Integrins as linker proteins between osteoblasts and bone replacing
   materials. A critical review
SO BIOMATERIALS
LA English
DT Review
DE integrins; osteoblasts; bone replacing materials
ID CELL-ADHESION MOLECULES; CALCIUM-PHOSPHATE; IMPLANT MATERIALS; IN-VITRO;
   FIBRONECTIN CONFORMATION; GENE-EXPRESSION; MARROW-CELLS; INTRACELLULAR
   CALCIUM; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION
AB The adhesion of osteoblasts to substrates is mediated through proteins that have adsorbed to the substrate, providing integrins on the cell membrane with ligands to connect to. The integrins regulate cell behavior through bi-directional signaling pathways. This critical review has the purpose to consider the research that has been performed with osteoblasts, integrins, and bone replacing materials. Until now, most research has been done to investigate the integrin expression of osteoblasts in culture during cellular adhesion. However, it remains difficult to draw general conclusions from this research. Nevertheless, it can be concluded that the used substrates and protein or peptide coatings can influence the integrin expression and cellular behavior. Additional research has to be done to fully understand all the parameters involved in integrin expression, the adhesion of cells to substrates, and the subsequent cellular behavior. For this purpose, model substrates are under development. The signaling pathway is receiving more and more attention, but for biomaterial purposes, too little consideration is paid to the translation of the in vitro results to the in vivo situation, and to practical applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Erasmus MC Rotterdam, Dept Immunol, NL-3000 DR Rotterdam, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014; Walboomers, X.Frank/B-3692-2013
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Aubin J E, 1998, J Cell Biochem Suppl, V30-31, P73
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003
   Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6
   Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6
   Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X
   Danen EHJ, 2003, J PATHOL, V200, P471, DOI 10.1002/path.1416
   De Ruijter JE, 2001, TISSUE ENG, V7, P279, DOI 10.1089/10763270152044143
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Di Silvio L, 2002, BIOMATERIALS, V23, P101, DOI 10.1016/S0142-9612(01)00084-9
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   DUCHEYNE P, 1988, Journal of Oral Implantology, V14, P325
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Huang Hui, 2003, J Oral Implantol, V29, P73, DOI 10.1563/1548-1336(2003)029<0073:EOFORI>2.3.CO;2
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   Hulshoff JEG, 1997, CLIN ORAL IMPLAN RES, V8, P393, DOI 10.1034/j.1600-0501.1997.080506.x
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Koo LY, 2002, J CELL SCI, V115, P1423
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Lacefield W R, 1999, Adv Dent Res, V13, P21
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MANN BK, 1999, BIOMATERIALS, V20, P2257
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Nesti LJ, 2002, ANN NY ACAD SCI, V961, P178, DOI 10.1111/j.1749-6632.2002.tb03078.x
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   OToole TE, 1997, MATRIX BIOL, V16, P165, DOI 10.1016/S0945-053X(97)90004-4
   Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rodriguez-Fernandez JL, 1999, BIOESSAYS, V21, P1069, DOI 10.1002/(SICI)1521-1878(199912)22:1<1069::AID-BIES13>3.0.CO;2-C
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   SCHWARTZ MA, 1994, J BIOL CHEM, V269, P11133
   Scotchford CA, 2003, BIOMATERIALS, V24, P1147, DOI 10.1016/S0142-9612(02)00488-X
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Simon KO, 1997, J BIOL CHEM, V272, P29380, DOI 10.1074/jbc.272.46.29380
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Takada Y, 1997, MATRIX BIOL, V16, P143, DOI 10.1016/S0945-053X(97)90002-0
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3
   ter Brugge PJ, 2002, TISSUE ENG, V8, P615, DOI 10.1089/107632702760240535
   ter Brugge PJ, 2002, BIOMATERIALS, V23, P3269, DOI 10.1016/S0142-9612(02)00085-6
   ter Brugge PJ, 2002, J BIOMED MATER RES, V61, P399, DOI 10.1002/jbm.10172
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   VROMAN L, 1971, FED PROC, V30, P1494
   Wataha JC, 1996, J ORAL REHABIL, V23, P79, DOI 10.1111/j.1365-2842.1996.tb01214.x
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   WLODARSKI KH, 1990, CLIN ORTHOP RELAT R, P276
   Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001
   Yamada KM, 1997, MATRIX BIOL, V16, P137, DOI 10.1016/S0945-053X(97)90001-9
   Yang C, 2001, ORAL SURG ORAL MED O, V92, P606, DOI 10.1067/moe.2001.118477
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 97
TC 205
Z9 222
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 2
BP 137
EP 146
DI 10.1016/j.biomaterials.2004.02.021
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855YR
UT WOS:000224011300003
PM 15207460
DA 2018-10-19
ER

PT J
AU Meinel, L
   Hofmann, S
   Karageorgiou, V
   Kirker-Head, C
   McCool, J
   Gronowicz, G
   Zichner, L
   Langer, R
   Vunjak-Novakovic, G
   Kaplan, DL
AF Meinel, L
   Hofmann, S
   Karageorgiou, V
   Kirker-Head, C
   McCool, J
   Gronowicz, G
   Zichner, L
   Langer, R
   Vunjak-Novakovic, G
   Kaplan, DL
TI The inflammatory responses to silk films in vitro and in vivo
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; collagen; polylactic acid; inflammation; in vitro; in
   vivo
ID DELAYED-HYPERSENSITIVITY REACTIONS; MEDIATED IMMUNOLOGICAL REACTIONS;
   STRUCTURAL BASIS; STEM-CELLS; COLLAGEN; BIOMATERIALS; SUTURES;
   BIOCOMPATIBILITY; OSTEOGENESIS; COMPOSITE
AB Silks have a long history of biomedical use as sutures. Silk can be purified, chemically modified to attach RGD sequences and processed into highly porous scaffolds for tissue engineering. We report biocompatibility studies of silk films (with or without covalently bound RGD) that were seeded with bone-marrow derived mesenchymal stem cells (MSC) and (a) cultured in vitro with human MSC or (b) seeded with autologous rat MSC and implanted in vivo. Controls for in vitro studies included tissue culture plastic (TCP; negative control), TCP with lipopolysaccharide (LPS) in the cell culture medium (positive control), and collagen films,controls for in vivo studies included collagen, PLA and TCP. After 9 h of culture, the expression of the pro-inflammatory Interleukin I beta (IL-1beta) and inflammatory cyclooxygenase 2 (COX-2) in human MSC were comparable for silk, collagen and TCP. After 30 and 96 h, gene expression of IL-1beta and COX-2 in MSC returned to the baseline (pre-seeding) levels. These data were corroborated by measuring IL-1beta and prostaglandin E2 levels in culture medium. The rate of cell proliferation was higher on silk films than either on collagen or TCP. In vivo, films made of silk, collagen or PLA were seeded with rat MSCs, implanted intramuscularly in rats and harvested after 6 weeks. Histological and immunohistochemical evaluation of silk explants revealed the presence of circumferentially oriented fibroblasts, few blood vessels, macrophages at the implant-host interface, and the absence of giant cells. Inflammatory tissue reaction was more conspicuous around collagen films and even more around PLA films when compared to silk. These data suggest that (a) purified degradable silk is biocompatible and (b) the in vitro cell culture model (hMSC seeded and cultured on biomaterial films) gave inflammatory responses that were comparable to those observed in vivo. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Univ Hosp Orthopaed Surg Friedrichsheim, D-60528 Frankfurt, Germany.
   Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8057 Zurich, Switzerland.
   Tufts Univ, Sch Vet Med, Orthopaed Res Lab, North Grafton, MA 01536 USA.
   Univ Connecticut, Ctr Hlth, Dept Orthopaed, Farmington, CT 06030 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Hofmann, Sandra/F-2832-2010; Meinel, Lorenz/D-9997-2015
OI Hofmann, Sandra/0000-0002-2568-8388; Meinel, Lorenz/0000-0002-7549-7627;
   Gronowicz, Gloria/0000-0001-7158-3598; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574; Karageorgiou, Vassilis/0000-0002-0892-510X
FU NIBIB NIH HHS [R01 EB003210-01]; NIAMS NIH HHS [R01 AR46563-01]
CR ADELMANN BC, 1972, IMMUNOLOGY, V23, P739
   ADELMANN BC, 1972, IMMUNOLOGY, V23, P723
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   Gibbons D. F., 1992, DEGRADATION PHENOMEN, P97
   HALSTED W, 1892, ANN SURG, V16, P505
   LANGE F, 2007, MUNCHEN MED WOCHEN, V17, P834
   Lange F, 1903, VERH DTSCH ORTHOP GE, V2, P10
   Ludloff K., 1927, ZENTRALBL CHIR, V54, P3162
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NATHAN RM, 1988, J ORTHOPAED RES, V6, P324, DOI 10.1002/jor.1100060304
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Rossitch E Jr, 1987, N C Med J, V48, P669
   ROZEMA FR, 1992, DEGRADATION PHENOMEN, P123
   SALTHOUSE TN, 1980, OTOLARYNG HEAD NECK, V88, P658, DOI 10.1177/019459988008800606
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   SALTHOUSE TN, 1983, BIOMATERIALS RECONST, P40
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P155, DOI 10.1016/0142-9612(90)90148-J
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Woodward S C, 1968, Ann N Y Acad Sci, V146, P225, DOI 10.1111/j.1749-6632.1968.tb20285.x
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
NR 34
TC 466
Z9 492
U1 11
U2 195
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 2
BP 147
EP 155
DI 10.1016/j.biomaterials.2004.02.047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855YR
UT WOS:000224011300004
PM 15207461
DA 2018-10-19
ER

PT J
AU Silikas, N
   Al-Kheralf, A
   Watts, DC
AF Silikas, N
   Al-Kheralf, A
   Watts, DC
TI Influence of P/L ratio and peroxide/amine concentrations on
   shrinkage-strain kinetics during setting of PMMA/MMA biomaterial
   formulations
SO BIOMATERIALS
LA English
DT Article
DE polymerisation; shrinkage; bone cement; polymethyl methacrylate; degree
   of conversion; initiator; powder/liquid ratio
ID ACRYLIC BONE-CEMENT; POLYMERIZATION SHRINKAGE; MONOMER
AB This study investigated the effects on polymerisation shrinkage-strain for two unmodified powder and liquid formulations of polymethyl methacrylate (PMMA), methyl methacrylate (MMA) dough-type systems, by varying the powder/liquid (P/L) ratio. Furthermore, the shrinkage-strain effects for the 1.0:1.0 P/L ratio of adding additional amounts of amine and benzoyl peroxide (BPO) were studied. The rationale was the continuing importance of bone cements and the renewed interest in acrylic biomaterials, based on MMA and PMMA co-polymers, as used in new fibre-reinforced systems, where low P/L ratios may be important. Shrinkage-strain is directly related to extent of monomer conversion and has intrinsic importance related to interfacial disruption. Shrinkage-strain kinetics were determined using the "bonded disk" method. The first series of experiments studied two unmodified self-curing materials (MEA and PAL), where specimens with different P/L ratios by volume (3.0, 2.5, 2.0, 1.5 and 1.0 to 1.0) were mixed for 60 s. In these formulations, final shrinkage-strain values correlated positively with P/L ratios, rather than negatively, as would be expected from fully polymerised material. This highlights a problem of under-polymerisation through deviation from an optimum or recommended P/L ratio: When an additional 1.0% BPO was added in the powder, final shrinkage-strain values correlated negatively rather than positively, with P/L ratio for both products, except at ratio 1.0: 1.0. Specimens mixed at 1.0: 1.0 P/L ratio, with increasing amounts of BPO and amine resulted in higher final shrinkage-strain values, indicative of more complete polymerisation. Shrinkage-strain and optimum polymerisation are related, but clinically rather antagonist properties with respect to effective biomaterial utilisation and performance. In both design and surgical application of these polymethacrylate formulations, possible adverse effects of changing P/L ratio, producing either excessive shrinkage-strain or under-polymerisation, must be understood and where possible controlled. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Manchester, Sch Dent, Biomat Sci Unit, Manchester M15 6FH, Lancs, England.
RP Watts, DC (reprint author), Univ Manchester, Sch Dent, Biomat Sci Unit, HIgher Cambridge St, Manchester M15 6FH, Lancs, England.
EM david.watts@man.ac.uk
RI Silikas, Nick/B-2990-2009
OI Silikas, Nick/0000-0003-4576-4584; Watts, David/0000-0002-9105-2775
CR Belkoff SM, 2002, J BIOMED MATER RES, V63, P396, DOI 10.1002/jbm.10258
   BOWEN RL, 1973, J APPL POLYM SCI, V17, P2213, DOI 10.1002/app.1973.070170720
   BRANDRUP J, 1975, POLYM HDB
   DENT E, 1958, J AM DENT ASSOC, V56, P375
   Gilbert JL, 2000, J BIOMED MATER RES, V52, P210, DOI 10.1002/1097-4636(200010)52:1<210::AID-JBM27>3.0.CO;2-R
   GROSS A, 1976, QUINTESSENCE DENT TE, V1, P11
   JEROLIMOV V, 1989, DENT MATER, V5, P18, DOI 10.1016/0109-5641(89)90086-9
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   LOSHAEK S, 1953, J AM CHEM SOC, V75, P3544, DOI 10.1021/ja01110a068
   Oldfield FF, 1999, J BIOMED MATER RES, V44, P436, DOI 10.1002/(SICI)1097-4636(19990315)44:4<436::AID-JBM10>3.0.CO;2-L
   Pascual B, 1999, J BIOMED MATER RES, V48, P447, DOI 10.1002/(SICI)1097-4636(1999)48:4<447::AID-JBM8>3.0.CO;2-I
   Pascual B, 1999, BIOMATERIALS, V20, P465, DOI 10.1016/S0142-9612(98)00192-6
   PATEL MP, 1987, BIOMATERIALS, V8, P53, DOI 10.1016/0142-9612(87)90030-5
   Vallittu P K, 1996, Eur J Prosthodont Restor Dent, V4, P83
   VASQUEZ B, 1997, J MATER SCI-MATER M, V8, P455
   Watts DC, 2000, DENT MATER, V16, P447, DOI 10.1016/S0109-5641(00)00043-9
   Watts DC, 1999, DENT MATER, V15, P39, DOI 10.1016/S0109-5641(99)00012-3
   WATTS DC, 1991, DENT MATER, V7, P281, DOI 10.1016/S0109-5641(05)80030-2
NR 18
TC 46
Z9 46
U1 4
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 2
BP 197
EP 204
DI 10.1016/j.biomaterials.2004.02.028
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855YR
UT WOS:000224011300009
PM 15207466
DA 2018-10-19
ER

PT J
AU Liu, L
   Sheardown, H
AF Liu, L
   Sheardown, H
TI Glucose permeable poly (dimethyl siloxane) poly (N-isopropyl acrylamide)
   interpenetrating networks as ophthalmic biomaterials
SO BIOMATERIALS
LA English
DT Article
DE poly (dimethyl siloxane); poly (N-isopropylacrylamide); interpenetrating
   network; glucose permeation; artificial cornea
ID CORNEAL EPITHELIAL-CELLS; SILICONE-RUBBER MEMBRANE; SURFACE
   MODIFICATION; POLY(VINYL ALCOHOL); ARTIFICIAL CORNEA; POLYACRYLAMIDE
   HYDROGEL; POLYMERIC NETWORKS; IN-VITRO; POLY(N-ISOPROPYLACRYLAMIDE);
   PDMS
AB Poly (dimethyl siloxane) (PDMS) has been widely used as a biomaterial in ophthalmic and other applications due to its good compatibility, high mechanical strength, excellent oxygen permeability and transparency. However, for use as an artificial cornea, contact lens and in other applications, modifications with hydrophilic functional groups or polymers are necessary to improve wettability for tear protein and mucin interactions and to improve glucose permeability for cellular health. Poly (N-isopropyl acrylamide) (PNIPAAM) is a biocompatible and hydrophilic polymer that has been extensively studied on controlled drug release applications due to its lower critical solution temperature (LCST) phenomenon. In the current work, a composite interpenetrating network (IPN) of PDMS and PNIPAAM was formed to generate polymers with oxygen and glucose permeability as well as improved wettability compared to PDMS homopolymers and greater mechanical strength than PNIPAAM homopolymers. Transparent vinyl and hydroxyl terminated PDMS/PNIPAAM IPNs (PDMS-V and PDMS-OH IPNs, respectively) were successfully synthesized. Transmission electron microscopy images verified the structure of the IPNs. Surface analysis suggested that PNIPAAM was present on the surface as well as in the bulk material. PDMS-OH IPNs generated from a PDMS-OH matrix cured in the presence of solvent had the highest glucose permeability at 10(-7) cm(2)/s, comparable to that of the native cornea. The LCST phenomenon remained in these materials, although changes were not as abrupt as with pure PNIPAAM. These results suggest that these materials may be further developed as ophthalmic biomaterials or for controlled drug-release applications. (C) 2004 Published by Elsevier Ltd.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM sheardow@mcmaster.ca
CR Abbasi F, 2003, J POLYM SCI POL PHYS, V41, P2145, DOI 10.1002/polb.10559
   Abbasi F, 2002, J APPL POLYM SCI, V86, P3480, DOI 10.1002/app.10774
   Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Abbasi F, 2002, J APPL POLYM SCI, V85, P1825, DOI 10.1002/app.10609
   Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   Chirila TV, 1998, PROG POLYM SCI, V23, P447, DOI 10.1016/S0079-6700(97)00036-1
   Hron P, 1999, ANGEW MAKROMOL CHEM, V268, P29
   Hron P, 1997, BIOMATERIALS, V18, P1069, DOI 10.1016/S0142-9612(97)00039-2
   Hsiue GH, 1996, ARTIF ORGANS, V20, P1196
   HSUIE GH, 2002, BIOMATERIALS, V23, P457
   Khorasani MT, 1999, RADIAT PHYS CHEM, V55, P685, DOI 10.1016/S0969-806X(99)00212-1
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P61, DOI 10.1016/S1381-5148(02)00215-8
   Kim SJ, 2001, KEY ENG MATER, V198-1, P301, DOI 10.4028/www.scientific.net/KEM.198-199.301
   Lai YC, 1997, J BIOMED MATER RES, V35, P349, DOI 10.1002/(SICI)1097-4636(19970605)35:3<349::AID-JBM9>3.0.CO;2-H
   Lai YC, 1996, J APPL POLYM SCI, V61, P2051, DOI 10.1002/(SICI)1097-4628(19960919)61:12<2051::AID-APP1>3.0.CO;2-9
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Lopez-Alemany A, 2002, J BIOMED MATER RES, V63, P319, DOI 10.1002/jbm.10186
   MCCAREY BE, 1990, CURR EYE RES, V9, P1025, DOI 10.3109/02713689008997577
   Merrett K, 2003, J BIOMED MATER RES A, V67A, P981, DOI 10.1002/jbm.a.10165
   Merrett K, 2001, J BIOMAT SCI-POLYM E, V12, P647, DOI 10.1163/156856201316883467
   Muniz EC, 2001, J MATER SCI-MATER M, V12, P879, DOI 10.1023/A:1012863705484
   Shin MS, 2002, J APPL POLYM SCI, V85, P957, DOI 10.1002/app.10409
   SPERLING LH, 1997, IPNS WORLD
   SPERLING LH, 1997, POLYM MULTICOMPOTIEN
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Stile RA, 2002, BIOMACROMOLECULES, V3, P591, DOI 10.1021/bm0101466
   Turner JS, 2000, MACROMOLECULES, V33, P3714, DOI 10.1021/ma991873k
   Turner JS, 2003, MACROMOLECULES, V36, P1962, DOI 10.1021/ma012253y
   Willis SL, 2001, BIOMATERIALS, V22, P3261, DOI 10.1016/S0142-9612(01)00164-8
   Zhang J, 2002, J BIOMAT SCI-POLYM E, V13, P511, DOI 10.1163/15685620260178373
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
   Zhang XZ, 2002, LANGMUIR, V18, P2538, DOI 10.1021/la011410j
NR 33
TC 101
Z9 107
U1 6
U2 101
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 3
BP 233
EP 244
DI 10.1016/j.biomaterials.2004.02.025
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855ZW
UT WOS:000224014400001
PM 15262466
DA 2018-10-19
ER

PT J
AU Vandiver, J
   Dean, D
   Patel, N
   Bonfield, W
   Ortiz, C
AF Vandiver, J
   Dean, D
   Patel, N
   Bonfield, W
   Ortiz, C
TI Nanoscale variation in surface charge of synthetic hydroxyapatite
   detected by chemically and spatially specific high-resolution force
   spectroscopy
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; surface analysis; bioactivity; atomic force microscopy;
   bone repair; biocompatibility
ID ELECTRICALLY POLARIZED HYDROXYAPATITE/; SIMULATED BODY-FLUID; BONE
   CELL-FUNCTION; APATITE FORMATION; SUBSTITUTED HYDROXYAPATITE;
   ELECTRON-MICROSCOPY; IN-VIVO; ADHESION; MONOLAYERS; ADSORPTION
AB The normal intersurface forces between nanosized probe tips functionalized with COO-- and NH3+-terminated alkanethiol self-assembling monolayers and dense polyerystalline phase pure synthetic hydroxyapatite (HA) were measured via a powerful nanomechanical technique called chemically specific high-resolution force spectroscopy. The data taken on approach of the probe tip to the HA surface was compared to the nonlinear Poisson-Boltzmann-based electrostatic double layer theory to predict the surface charge per unit area of the HA, sigma(HA) (C/m(2)), as a function of ionic strength, position within a variety of grains, and across grain boundaries. The average sigma(HA) was found to be similar to-0.02C/m(2) and to vary from -0.0037 to -0.072C/m(2) with nanoscale position in relation to grain boundaries and crystal planes up to -0.19C/m(2)/mum. Positional measurement of nanoscale surface properties holds great promise in elucidating the molecular origins of physicochemical processes occurring at the biomaterial interface. (C) 2004 Elsevier Ltd. All rights reserved.
C1 MIT, Dept Mat Sci, Cambridge, MA 02139 USA.
   MIT, Dept Engn, Cambridge, MA 02139 USA.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Ortiz, C (reprint author), MIT, Dept Mat Sci, 77 Massachusetts Ave,RM13-4022, Cambridge, MA 02139 USA.
EM cortiz@mit.edu
RI Dean, Delphine/F-3391-2010
OI Dean, Delphine/0000-0002-8631-2640
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899
   Brown PW, 1999, J PHYS CHEM B, V103, P1671, DOI 10.1021/jp982554i
   CLEVELAND J, COMMUNICATION
   DEAN D, 2002, LANGMUIR, V19, P5526
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1
   Devereux OF, 1963, INTERACTION PLANE PA
   Dubok VA, 2000, POWDER METALL MET C+, V39, P381, DOI 10.1023/A:1026617607548
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   GIBSON IR, 1999, BIOCERAMICS SINGAPOR, P191
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HERTZ H, 1896, HERTZ MISCELLANEOUS
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   ISRAEVLACHVILI J, 1991, INTERMOLECULAR SURFA
   Jacobasch HJ, 1998, COLLOID POLYM SCI, V276, P434, DOI 10.1007/s003960050263
   JAMES M, 1992, LANGMUIR, V8, P420, DOI 10.1021/la00038a017
   KANDORI K, 1992, COLLOID SURFACE, V68, P283, DOI 10.1016/0166-6622(92)80214-M
   Kandori K, 2000, PHYS CHEM CHEM PHYS, V2, P2015, DOI 10.1039/a909396f
   Kissa E., 1999, DISPERSIONS CHARACTE
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Lee WT, 2000, J PHYS-CONDENS MAT, V12, P9829, DOI 10.1088/0953-8984/12/48/302
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Pedersen HG, 1999, J AM CERAM SOC, V82, P1137
   Raemdonck W.V., 1984, METAL CERAMIC BIOMAT
   SANFELD A, 1968, THERMODYNAMICS CHARG
   Sato K, 2000, J BIOMED MATER RES, V50, P16, DOI 10.1002/(SICI)1097-4636(200004)50:1<16::AID-JBM3>3.0.CO;2-G
   Schreiber F, 2000, PROG SURF SCI, V65, P151, DOI 10.1016/S0079-6816(00)00024-1
   Seog J, 2002, MACROMOLECULES, V35, P5601, DOI 10.1021/ma0121621
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Werner C, 2001, COLLOID SURFACE A, V192, P205, DOI 10.1016/S0927-7757(01)00725-7
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Zhu PX, 2001, J COLLOID INTERF SCI, V243, P31, DOI 10.1006/jcis.2001.7888
NR 42
TC 64
Z9 67
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 3
BP 271
EP 283
DI 10.1016/j.biomaterials.2004.02.053
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855ZW
UT WOS:000224014400004
PM 15262469
DA 2018-10-19
ER

PT J
AU Tachibana, A
   Kaneko, S
   Tanabe, T
   Yamauchi, K
AF Tachibana, A
   Kaneko, S
   Tanabe, T
   Yamauchi, K
TI Rapid fabrication of keratin-hydroxyapatite hybrid sponges toward
   osteoblast cultivation and differentiation
SO BIOMATERIALS
LA English
DT Article
DE wool keratin sponge; hydroxyapatite hybrid; osteoblast scaffolds;
   osteoblast differentiation
ID BONE-LIKE APATITE; BIOMATERIAL; LYSOZYME; COLLAGEN; PROTEIN; GROWTH;
   ASSAY; CELLS
AB Wool keratin sponges were reported to be useful scaffolds for long-term and high-density cell cultivation (J. Biotechnol. 93 (2002) 165). The hybrid of the keratin sponges with calcium phosphate materials gave the additional function. Two rapid fabrication methods for calcium phosphate hybrid biomaterials were described. Firstly, the CaP-precipitated sponges were obtained by only the immersion of the carboxyl-sponges, chemically introduced with high amount of carboxyl groups on the sponges, in calcium and phosphate ions containing buffers such as PBS(+) for only 1-3 days. Neither sponge, introduced with amino or amido groups or non-treated, gave significant calcium phosphate precipitation. The carboxyl-sponges were mimics of matrix gamma-carboxyglutamic acid protein, which is responsible for osteoblast calcification. Secondly, the hydroxyapatite particle suspension was added onto carboxyl-sponges to fabricate trapped sponge. The trapped hydroxyapatite particles might interact with keratin protein of the sponge walls. Preliminary experiments measuring the expression of alkaline phosphatase, early osteoblast differentiation marker, suggested that both hybrid sponges, CaP-precipitated and trapped sponges, alter the differentiation pattern of preosteoblasts, MC3T3-E1. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Osaka City Univ, Grad Sch Engn, Dept Appl & Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Yamauchi, K (reprint author), Osaka City Univ, Grad Sch Engn, Dept Appl & Bioappl Chem, Sumiyoshi Ku, Sugimoto 3-3-138, Osaka 5588585, Japan.
EM tatibana@bioa.eng.osaka-cu.ac.jp; Yamauchi@bioa.eng.osaka-cu.ac.jp
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Gopalakrishnan R, 2001, ENDOCRINOLOGY, V142, P4379, DOI 10.1210/en.142.10.4379
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   John A, 2001, J BIOMAT SCI-POLYM E, V12, P689, DOI 10.1163/156856201316883485
   Kurimoto A, 2003, J BIOSCI BIOENG, V96, P307, DOI 10.1263/jbb.96.307
   Kurimoto A, 2001, J BIOTECHNOL, V86, P1, DOI 10.1016/S0168-1656(00)00400-4
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   TANABE T, 2001, RRD PRO ENG 2, V1, P247
   Yamauchi K, 1997, COLLOID SURFACE B, V9, P117, DOI 10.1016/S0927-7765(96)01322-7
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
NR 17
TC 112
Z9 116
U1 4
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2005
VL 26
IS 3
BP 297
EP 302
DI 10.1016/j.biomaterials.2004.02.032
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 855ZW
UT WOS:000224014400006
PM 15262471
DA 2018-10-19
ER

PT J
AU Ronco, C
   Levin, NW
AF Ronco, C
   Levin, NW
TI Mechanisms of solute transport in extracorporeal therapies
SO CARDIOVASCULAR DISORDERS IN HEMODIALYSIS
SE CONTRIBUTIONS TO NEPHROLOGY
LA English
DT Article
ID IN-VIVO EVALUATION; REFERENCE METHODOLOGY; POLYSULFONE MEMBRANE; FLOW
   DISTRIBUTION; HEMODIALYSIS; ULTRAFILTRATION; FLUID; VITRO
AB Diffusion and convection are the main mechanisms involved in the membrane separation processes occurring in extracorporeal hemodialysis.
   Operational parameters should be optimized in hollow fiber hemodialyzers to achieve the maximal efficiency.
   The nature of blood which is a non Newtonian fluid. requires specific attention in the design of dialyzers to ensure that the blood compartment operates properly. Similar attention must be placed in the design of the dialysate compartment to ensure a homogeneous distribution of the fluid and to prevent blood to dialysate flow mismatch.
   Finally, the membrane represents the third component of the hemodialyzer. Membrane performance depends on the used biomaterial, its biocompatibility, the thickness, the hydrophilic-hydrophobic mixture, the hydraulic permeability and the number and diameter of the pores.
   In this setting, diffusion and convection tend to reciprocally interfere, producing a final result that depends on the prevalence of one or the other mechanism for every specific solute.
C1 St Bortolo Hosp, Dept Nephrol, IT-36100 Vicenza, Italy.
   Beth Israel Med Ctr, Renal Res Inst, New York, NY 10003 USA.
RP Ronco, C (reprint author), St Bortolo Hosp, Dept Nephrol, IT-36100 Vicenza, Italy.
EM cronco@goldnet.it
CR ALWALL N, 1947, ACTA MED SCAND, V128, P317
   BABB AL, 1972, T AM SOC ART INT ORG, V18, P98
   BABB AL, 1975, KIDNEY INT, V7, P23
   BERGSTROM J, 1978, CLIN NEPHROL, V9, P156
   HENDERSO.LW, 1967, T AM SOC ART INT ORG, V13, P216
   HENDERSON LW, 1975, J LAB CLIN MED, V85, P372
   HENDERSON LW, 1989, TXB DIALYSIS, P300
   KOLFF WJ, 1965, ANN INTERN MED, V62, P608, DOI 10.7326/0003-4819-62-3-608
   MAHER JF, 1960, T AM SOC ART INT ORG, V6, P123
   Ronco C, 2000, INT J ARTIF ORGANS, V23, P601
   Ronco C, 2001, NEPHRON, V89, P243, DOI 10.1159/000046080
   Ronco C, 1999, INT J ARTIF ORGANS, V22, P616
   Ronco C, 1999, INT J ARTIF ORGANS, V22, P604
NR 13
TC 9
Z9 9
U1 0
U2 0
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 0302-5144
J9 CONTRIB NEPHROL
JI Contrib.Nephrol.
PY 2005
VL 149
BP 10
EP 17
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA BCT39
UT WOS:000231115900002
PM 15876823
DA 2018-10-19
ER

PT J
AU Kurisawa, M
   Chung, JE
   Yang, YY
   Gao, SJ
   Uyama, H
AF Kurisawa, M
   Chung, JE
   Yang, YY
   Gao, SJ
   Uyama, H
TI Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine
   conjugates for drug delivery and tissue engineering
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID POLY(AMINO ACID)S; POLYMERIZATION; POLYMERS; GELATION
AB The sequential injection of hyaluronic acid-tyramine conjugates and enzymes forms biodegradable hydrogels in vivo by enzyme-induced oxidative coupling, offering high potential as a promising biomaterial for drug delivery and tissue engineering.
C1 Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
   Osaka Univ, Grad Sch Engn, Dept Chem Mat, Suita, Osaka 5650871, Japan.
RP Kurisawa, M (reprint author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,Nanos 04-01, Singapore 138669, Singapore.
EM mkurisawa@ibn.a-star.edu.sg
RI KURISAWA, MOTOICHI/C-1325-2014; Yang, Yi Yan/C-1338-2014
OI KURISAWA, MOTOICHI/0000-0003-2413-6933; Yang, Yi Yan/0000-0002-1871-5448
CR Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Fukuoka T, 2004, BIOMACROMOLECULES, V5, P977, DOI 10.1021/bm034490
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kimura M, 2004, J BIOMAT SCI-POLYM E, V15, P631, DOI 10.1163/156856204323046898
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LAURENT TC, 1992, FASEB J, V6, P2397
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   SCOTT JE, 1995, J ANAT, V187, P259
   Tachibana Y, 2003, CHEM COMMUN, P106, DOI 10.1039/b210181e
   YUI N, 1992, J CONTROL RELEASE, V22, P105
NR 15
TC 259
Z9 261
U1 6
U2 105
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2005
IS 34
BP 4312
EP 4314
DI 10.1039/b506989k
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 957JK
UT WOS:000231365900018
PM 16113732
DA 2018-10-19
ER

PT J
AU Yang, ZM
   Xu, KM
   Wang, L
   Gu, HW
   Wei, H
   Zhang, MJ
   Xu, B
AF Yang, ZM
   Xu, KM
   Wang, L
   Gu, HW
   Wei, H
   Zhang, MJ
   Xu, B
TI Self-assembly of small molecules affords multifunctional supramolecular
   hydrogels for topically treating simulated uranium wounds
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID ANTIINFLAMMATORY AGENTS; ORGANOGEL FORMATION; WATER; NANOFIBERS;
   GELATION; BIOMATERIALS; DERIVATIVES; GELATORS; CELLS; ACIDS
AB Two types of therapeutic agents, which have discrete yet complementary functions, self-assemble into nanofibers in water to formulate a new supramolecular hydrogel as a self-delivery biomaterial to reduce the toxicity of uranyl oxide at the wound sites.
C1 Hong Kong Univ Sci & Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R China.
   Hong Kong Univ Sci & Technol, Bioengn Program, Hong Kong, Hong Kong, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
RP Xu, B (reprint author), Hong Kong Univ Sci & Technol, Dept Chem, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.
EM chbingxu@ust.hk
RI XU, Bing/A-7828-2008; Gu, Hongwei/B-9567-2014; Yang, Zhimou/F-1798-2010
OI XU, Bing/0000-0002-4639-387X; Gu, Hongwei/0000-0001-9962-4662; Zhang,
   Mingjie/0000-0001-9404-0190
CR Abdallah DJ, 2000, ADV MATER, V12, P1237
   BURCH RM, 1991, P NATL ACAD SCI USA, V88, P355, DOI 10.1073/pnas.88.2.355
   Chen XJ, 2003, CELL TRANSPLANT, V12, P160
   de Loos M, 1997, J AM CHEM SOC, V119, P12675, DOI 10.1021/ja972899z
   Estroff LA, 2000, ANGEW CHEM INT EDIT, V39, P3447, DOI 10.1002/1521-3773(20001002)39:19<3447::AID-ANIE3447>3.0.CO;2-X
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Hafkamp RJH, 1997, CHEM COMMUN, P545, DOI 10.1039/a608266a
   Hardman J. G., 1995, PHARM BASIS THERAPEU
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Heeres A, 2003, J AM CHEM SOC, V125, P14252, DOI 10.1021/ja036954h
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Jung JH, 2001, J AM CHEM SOC, V123, P8785, DOI 10.1021/ja010508h
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Kobayashi H, 2002, ORG LETT, V4, P1423, DOI 10.1021/ol025519+
   Kolbel M, 2001, ADV MATER, V13, P1115, DOI 10.1002/1521-4095(200107)13:14<1115::AID-ADMA1115>3.0.CO;2-Y
   Langer R, 1998, NATURE, V392, P5
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Menger FM, 2000, J AM CHEM SOC, V122, P11679, DOI 10.1021/ja0016811
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Rathore R, 2003, J AM CHEM SOC, V125, P8712, DOI 10.1021/ja035518s
   SCHWEITZER D, 1978, CHEM PHYS, V29, P181, DOI 10.1016/0301-0104(78)85070-8
   Shirakawa M, 2003, J AM CHEM SOC, V125, P9902, DOI 10.1021/ja035933k
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SREENIVASACHARY N, 2005, NATL ACAD SCI US, V102, P5938
   Sreerama N, 2000, CIRCULAR DICHROISM P
   Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282
   Vega D, 2002, ACTA CRYSTALLOGR C, V58, pM77, DOI 10.1107/S0108270101019655
   Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f
   Yang ZM, 2004, CHEM COMMUN, P2424, DOI 10.1039/b408897b
   Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340
   Yang ZM, 2004, CHEM COMMUN, P208, DOI 10.1039/b310574a
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang Y, 2004, J AM CHEM SOC, V126, P15028, DOI 10.1021/ja044401g
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
NR 34
TC 133
Z9 133
U1 3
U2 67
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
J9 CHEM COMMUN
JI Chem. Commun.
PY 2005
IS 35
BP 4414
EP 4416
DI 10.1039/b507314f
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 959YP
UT WOS:000231555800007
PM 16136235
DA 2018-10-19
ER

PT J
AU Zhou, J
   Qiu, YZ
   Zang, XP
   Pan, CW
   Chen, Q
   Shen, J
   Lin, SC
AF Zhou, J
   Qiu, YZ
   Zang, XP
   Pan, CW
   Chen, Q
   Shen, J
   Lin, SC
TI Molecular engineering studies on nonthrombogenic biomaterials - A novel
   class of nonthrombogenic biomaterials with zwitterionic structure of
   carboxybetaines
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE nonthrombogenic biomaterials; zwitterionic biomaterial; carboxybetaine
   structure; surface graft-copolymerization
ID BLOOD COMPATIBILITY; IMPROVE HEMOCOMPATIBILITY; SURFACE MODIFICATION;
   SEGMENTED POLYURETHANE; PLATELET-ADHESION; MONOMER; PHOSPHORYLCHOLINE;
   SULFOBETAINE; POLYMERS; BEARING
AB N,N-dimethyl-N-methacryloyloxyethyl-N-carboxyethyl ammonium (DMMCA) was graft-copolymerized onto the surface of segmented poly(ether urethane) (SPEU) and PE film. The carboxybetaine structure on SPEU and PE film surfaces was confirmed by ATR-FTIR, XPS and water contact angle measurements. Through the experiments with platelet adhesion and protein adhesion assay in vitro, the two materials studied, including poly-DMMCA gel, all show excellent nonthrombogenicity. This confirms once again that the zwitterionic molecular structure on the surfaces of materials is essential for improving their nonthrombogenicity and biocompatibility.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
EM Sicong_Lin@yahoo.com
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   BROWN AB, 1972, Patent No. 3671305
   Chen L, 2003, CHINESE J POLYM SCI, V21, P45
   CHIEN JCW, 1968, J POLYM SCI A1, V6, P381, DOI 10.1002/pol.1968.150060208
   HUANG ZX, 1983, KEXUE TONGBAO, V28, P632
   IKADA Y, 1992, RADIAT PHYS CHEM, V39, P509
   Ishihara K, 1998, J BIOMATER APPL, V13, P111, DOI 10.1177/088532829801300203
   Kokatnur V. R., 1941, J AM CHEM SOC, V63, P1432
   Lin S.C., 1997, POLYM B, V1, P1
   Lin SC, 1998, POLYM B, V1, P1
   MIZUGUCHI R, 1980, Patent No. 4215028
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
   Wang L, 2003, CHEM J CHINESE U, V24, P1034
   Xu JM, 2003, COLLOID SURFACE B, V30, P215, DOI 10.1016/S0927-7765(03)00084-5
   YANG FL, 1982, GAOFENZI TONGXUN, P302
   Yang ZM, 2003, J BIOMAT SCI-POLYM E, V14, P707, DOI 10.1163/156856203322274950
   Yuan J, 2003, J BIOMATER APPL, V18, P123, DOI 10.1177/088532803038100
   Yuan J, 2003, CHINESE J POLYM SCI, V21, P419
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan J, 2003, COLLOID SURFACE B, V30, P147, DOI 10.1016/S0927-7765(03)00082-1
   Yuan YL, 2003, COLLOID SURFACE B, V29, P247, DOI 10.1016/S0927-7765(02)00210-2
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   Zhang J, 2003, COLLOID SURFACE B, V30, P249, DOI 10.1016/S0927-7765(03)00069-9
   Zhang J, 2003, BIOMATERIALS, V24, P4223, DOI 10.1016/S0142-9612(03)00365-X
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhang J, 2003, EUR POLYM J, V39, P847, DOI 10.1016/S0014-3057(02)00286-0
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
NR 28
TC 1
Z9 1
U1 2
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0256-7679
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD JAN
PY 2005
VL 23
IS 1
BP 93
EP 102
DI 10.1142/S0256767905000163
PG 10
WC Polymer Science
SC Polymer Science
GA 904KN
UT WOS:000227496800014
DA 2018-10-19
ER

PT J
AU Rickert, D
   Lendlein, A
   Kelch, S
   Moses, MA
   Franke, RP
AF Rickert, D
   Lendlein, A
   Kelch, S
   Moses, MA
   Franke, RP
TI Expression of MMPs and TIMPs in primary epithelial cell cultures of the
   upper aerodigestive tract seeded on the surface of a novel polymeric
   biomaterial
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE primary cell cultures; pharynx; metalloproteinases; multi-block
   copoolymer; head and neck surgery
ID MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; DIFFERENTIAL EXPRESSION;
   WOUND REPAIR; FIBROBLASTS; CARTILAGE; ADHESION
AB Introduction: Using standard cell biological and biochemical experimental approaches we were able to test the ability of a particular polymer construct to support the adhesion, proliferation, and the cellular acitivity of pharyngeal cells. The delicate balance between Matrix Metalloproteinases (MMPs) and their endogenous inhibitors (Tissue Inhibitor of MMPs, TIMPs) have a decisive function in the remodeling of the extracellular matrix during cellular ingrowth. Novel polymeric biomaterials may be useful to develop new therapeutic options in head and neck surgery. Methods: Primary cell cultures of the pharynx of Sprague-Dawley rats were seeded on the surface of a thermoplastic multi-block copolymer and on a polystyrene surface as control. Conditioned media of the primary cells was analyzed for MMPs and TIMPs. The MMP and TIMP expression was analysed by zymography and a radiometric enzyme assay. Results: No statistically significant differences in the levels of MMP-1, MMP-2, MMP-9 and TIMPs were detected between cells grown on the novel polymer surface versus control. Conclusion: An appropriate understanding of the molecular machinery that regulates gene expression and cellular growth in tissue engineered contructs is the requirement for an optimal adaptation of biodegradable biomaterials to develop new therapeutic options in otolaryngology and head and neck surgery.
C1 Univ Ulm, Dept Otolaryngol & Head & Neck Surg, D-89075 Ulm, Germany.
   Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
   GKSS Forschungszentrum GmbH, Inst Chem, D-14513 Teltow, Germany.
   Harvard Univ, Sch Med, Childrens Hosp, Dept Surg, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.
RP Rickert, D (reprint author), Univ Ulm, Dept Otorhinolaryngol Head & Neck Surg, Prittwitzstr 43, D-89075 Ulm, Germany.
EM Dorothee.Rickert@medizin.uni-ulm.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR BRAUNHUT SJ, 1994, J BIOL CHEM, V269, P13472
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3
   Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA
   Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183, DOI 10.1111/j.1749-6632.2002.tb03079.x
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043
   Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.3.CO;2-0
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Peled ZM, 2002, PLAST RECONSTR SURG, V110, P801, DOI 10.1097/01.PRS.0000019915.20203.EC
   Platt JL, 1998, NATURE, V392, P11
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   Ravanti L, 2000, INT J MOL MED, V6, P391
   Sigurdson L, 2002, J BIOMED MATER RES, V59, P357, DOI 10.1002/jbm.1252
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024
   Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x
   Stoltz JF, 2001, CLIN HEMORHEOL MICRO, V24, P263
   Sun HB, 2002, FRONT BIOSCI-LANDMRK, V7, pA169
   Sutinen M, 1998, BRIT J CANCER, V77, P2239, DOI 10.1038/bjc.1998.372
   Vaalamo M, 1999, HUM PATHOL, V30, P795, DOI 10.1016/S0046-8177(99)90140-5
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 27
TC 16
Z9 17
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2005
VL 32
IS 2
BP 117
EP 128
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 912UH
UT WOS:000228104900005
PM 15764820
DA 2018-10-19
ER

PT J
AU Brandt, O
AF Brandt, O
TI Interaction of blood-cells/-components and tissue cells with body
   foreign surfaces in a cone plate rheometer under hydrodynamic shear load
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE rheometer; shear stress; hemocompatibility; histocompatibility;
   clotting; thrombus formation; biomaterial surfaces; platelets; rheometer
   system; GP-VI antibody
ID CORONARY STENTS
C1 Gesell Engn & Interdisziplinaren Technol Transfer, D-89081 Ulm, Germany.
RP Brandt, O (reprint author), Gesell Engn & Interdisziplinaren Technol Transfer, D-89081 Ulm, Germany.
CR FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0
   Franke RP, 2001, CLIN HEMORHEOL MICRO, V24, P101
   JUNG F, 1992, CLIN HEMORHEOL, V12, P747
   Jung F, 2003, CLIN HEMORHEOL MICRO, V28, P189
   Jung F, 2001, BIOMED TECH, V46, P200, DOI 10.1515/bmte.2001.46.7-8.200
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   SEYFERT UT, 1997, CLIN LAB, V43, P571
NR 7
TC 3
Z9 3
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2005
VL 32
IS 2
BP 145
EP 149
PG 5
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 912UH
UT WOS:000228104900007
PM 15764822
DA 2018-10-19
ER

PT J
AU Konttinen, YT
   Zhao, DS
   Beklen, A
   Ma, GF
   Takagi, M
   Kivela-Rajamaki, M
   Ashammakhi, N
   Santavirta, S
AF Konttinen, YT
   Zhao, DS
   Beklen, A
   Ma, GF
   Takagi, M
   Kivela-Rajamaki, M
   Ashammakhi, N
   Santavirta, S
TI The microenvironment around total hip replacement prostheses
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID AGGRESSIVE GRANULOMATOUS LESIONS; HUMAN SYNOVIAL FIBROBLASTS; TOTAL
   JOINT ARTHROPLASTY; INTERFACE TISSUE; GENE-EXPRESSION; ACETABULAR
   COMPONENTS; ORTHOPEDIC IMPLANTS; INTEGRIN RECEPTORS; BONE-RESORPTION;
   FOLLOW-UP
AB The metal stem of the totally replaced hip carries load and resists fatigue, but it is electrochemically corroded. Metallic atoms act as haptens, induce type 1 T-helper cells/Th1-type immune responses and enhance periprosthetic osteolysis. Stiff metal implants, which do not have the same elasticity as the surrounding bone, cause stress shielding. Cyclic loading and lack of ligamentous support lead to mechanical and ischemia reperfusion injury and particle formation from bone, polymethylmethacrylate, and porous implant surfaces, which accelerate third-body polyethylene wear. Surgical injury and micromotion induce the formation of a fibrous capsule interface. Type-B lining cells produce lubricin and surface-active phospholipids to promote solid-to-solid lubrication but may loosen the implant from bone. The pumping action of the cyclically loaded joint and synovial fluid pressure waves dissect the implant-host interface and transports polyethylene particles and pro-inflammatory mediators to the interface. Hyaluronan induces formation of a synovial lining like layer. Because of its localization close to bone, foreign body inflammation at the interface stimulates osteoclastogenesis and peri-implant bone loss. Metal-on-metal and ceramic-on-ceramic pairs might minimize third body wear, but can lead to high-impact load of the acetabulum. Diamond coating of a metal-on-polyethylene couple might solve both of these problems. The basic biomaterial solutions allow good mechanical performance and relatively long life in-service, but surface modifications (porous coating, hydroxyapatite, diamond, bioglass, and others) may facilitate performance of the implant and improve the biomaterial and body interfaces.
C1 Univ Helsinki, Cent Hosp, Dept Med Invartes Med, Helsinki, Finland.
   ORTON Orthopaed Hosp, Invalid Fdn, Helsinki, Finland.
   COXA Joint Replacement Hosp, Tampere, Finland.
   Yamagata Sch Med, Dept Orthopaed Surg, Yamagata, Japan.
   Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
   Univ Helsinki, Cent Hosp, Dept Orthopaed & Traumatol, Helsinki, Finland.
RP Konttinen, YT (reprint author), Biomedicum, Dept Med Invartes Med, POB 700, FIN-00029 Helsinki, Finland.
EM yrjo.konttinen@helsinki.fi
CR ANTHONY PP, 1990, J BONE JOINT SURG BR, V72, P971
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Arora A, 2003, J BIOMED MATER RES A, V64A, P693, DOI 10.1002/jbm.a.10200
   ASPENBERG P, 1998, CLIN ORTHOP RELAT R, V352, P75
   ATHANASOU NA, 1995, ANN RHEUM DIS, V54, P392, DOI 10.1136/ard.54.5.392
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Catelas I, 2003, BIOMATERIALS, V24, P383, DOI 10.1016/S0142-9612(02)00351-4
   Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6
   COHEN B, 1995, J BONE JOINT SURG BR, V77, P815
   COOK SD, 1988, CLIN ORTHOP RELAT R, V234, P90
   Darimont GL, 2002, BIOMATERIALS, V23, P2569, DOI 10.1016/S0142-9612(01)00392-1
   Disegi JA, 2000, INJURY, V31, pS2
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   ENGH CA, 1993, CLIN ORTHOP RELAT R, V292, P177
   Eschbach L, 2000, INJURY, V31, pS22
   Gasser B, 2000, INJURY, V31, pS48
   GAY S, 1993, ANN RHEUM DIS, V52, pS39, DOI 10.1136/ard.52.Suppl_1.S39
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Goodman SB, 1998, J BONE JOINT SURG BR, V80B, P531, DOI 10.1302/0301-620X.80B3.8158
   Hornez JC, 2002, BIOMOL ENG, V19, P103, DOI 10.1016/S1389-0344(02)00017-5
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010
   Iwanaga T, 2000, ARCH HISTOL CYTOL, V63, P17, DOI 10.1679/aohc.63.17
   Jagger DC, 1999, J ORAL REHABIL, V26, P185, DOI 10.1046/j.1365-2842.1999.00375.x
   Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1
   Jay GD, 2000, J RHEUMATOL, V27, P594
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Kadoya Y, 1998, ACTA ORTHOP SCAND, V69, P1
   KARRHOLM J, 1994, J BONE JOINT SURG BR, V76B, P912
   Konttinen Y, 2001, J PATHOL, V194, P384, DOI 10.1002/1096-9896(200107)194:3<384::AID-PATH896>3.0.CO;2-8
   Konttinen YT, 2001, J BONE MINER RES, V16, P1780, DOI 10.1359/jbmr.2001.16.10.1780
   KONTTINEN YT, 1997, CURR ORTHOPAED, V11, P40
   Kroger H, 1996, J BONE MINER RES, V11, P1526
   Krzypow DJ, 2000, BIOMATERIALS, V21, P2081, DOI 10.1016/S0142-9612(00)00138-1
   Lappalainen R., 1998, CLIN ORTHOP RELAT R, V352, P118
   LEBLANC AD, 1990, J BONE MINER RES, V5, P843
   Li T.H., 2000, TROPICAL MYCOLOGY 20, P1
   Li TF, 2002, RHEUMATOLOGY, V41, P319, DOI 10.1093/rheumatology/41.3.319
   Li TF, 1999, ACTA ORTHOP SCAND, V70, P446, DOI 10.3109/17453679909000979
   Li TF, 2000, J RHEUMATOL, V27, P727
   Li TF, 2000, CLIN EXP RHEUMATOL, V18, P221
   Li TF, 2000, RHEUMATOL INT, V19, P177, DOI 10.1007/s002960000044
   Lu Z, 1997, J BIOMED MATER RES, V34, P221
   Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0
   Mandelin J, 2003, J BONE JOINT SURG BR, V85B, P1196, DOI 10.1302/0301-620X.85B8.13311
   Manley MT, 1998, J BONE JOINT SURG AM, V80A, P1175, DOI 10.2106/00004623-199808000-00011
   Marti A, 2000, INJURY, V31, pS18
   McCormack BAO, 1999, J BIOMECH, V32, P467, DOI 10.1016/S0021-9290(99)00018-4
   Merklein F, 1998, BIOMED TECH, V43, P354, DOI 10.1515/bmte.1998.43.12.354
   Molfetta L, 2000, J ORTHOP TRAUMATOL, V1, P17
   Morawietz L, 2003, VIRCHOWS ARCH, V443, P57, DOI 10.1007/s00428-003-0818-y
   Morscher E W, 2002, Acta Orthop Belg, V68, P1
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   PANAYI GS, 1992, ARTHRITIS RHEUM, V35, P729, DOI 10.1002/art.1780350702
   Parker J.R., 1992, British Arachnological Society Newsletter, P1
   Pohler OEM, 2000, INJURY, V31, pS7
   Ramaniraka NA, 2000, J BONE JOINT SURG BR, V82B, P297, DOI 10.1302/0301-620X.82B2 .9613
   RATNER DR, 1996, BIOMATERIALS SCI INT, P1
   SAARI H, 1993, J RHEUMATOL, V20, P87
   Sabo D, 1998, CALCIFIED TISSUE INT, V62, P177, DOI 10.1007/s002239900413
   Sabokbar A, 1997, J BONE JOINT SURG BR, V79B, P129, DOI 10.1302/0301-620X.79B1.6966
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P980
   Santavirta S, 2003, ACTA ORTHOP SCAND, V74, P380
   Santavirta S, 1998, CURR ORTHOPAED, V12, P51, DOI 10.1016/S0268-0890(98)90008-1
   Santavirta S, 1999, J LONG-TERM EFF MED, V9, P67
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   Schmidt R, 2002, INT ORTHOP, V26, P299, DOI 10.1007/s00264-002-0377-x
   Schwarz IM, 1998, BRIT J RHEUMATOL, V37, P21
   Silver F. H., 1994, BIOMATERIALS MED DEV, P1
   Sumner Dale R., 1992, Chirurgia degli Organi di Movimento, V77, P413
   TALLROTH K, 1989, J BONE JOINT SURG BR, V71, P571
   Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260
   VACANTI CA, 1999, CLIN ORTHOP S, V367, P375
   Walczak J, 1998, BIOMATERIALS, V19, P229, DOI 10.1016/S0142-9612(97)00208-1
   Weyand CM, 1998, LAB INVEST, V78, P677
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   WILLMANN G, 2000, HIP INT, V10, P193
NR 77
TC 88
Z9 92
U1 1
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD JAN
PY 2005
IS 430
BP 28
EP 38
DI 10.1097/01.blo.0000150451.50452.da
PG 11
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 885GQ
UT WOS:000226145500004
PM 15662301
DA 2018-10-19
ER

PT S
AU Kimura, Y
AF Kimura, Y
BE DeHosson, JTM
   Brebbia, CA
   Nishida, SI
TI Improvement of corrosion resistance and bio compatibility of Ni-Ti shape
   memory alloy by various surface modifications
SO Computer Methods and Experimental Measurements for Surface Effects and
   Contact Mechanics VII
SE WIT TRANSACTIONS ON ENGINEERING SCIENCES
LA English
DT Proceedings Paper
CT 7th International Conference on Computer Methods and Experimental
   Measurements for Surface Effects and Contact Mechanics
CY SEP, 2005
CL Bologna, ITALY
SP Wessex Inst Technol, Univ Groningen, WIT Transact Engn Sci
DE nickel-titanium shape memory alloy; cytocompatibility;
   bio-compatibility; biomaterial
AB Nickel-titanium shape memory alloy (Ni-Ti alloy) has unique mechanical properties such as shape memory effect and super elasticity along with good wear and corrosion resistances. For this reason Ni-Ti alloy is expected to be used as implant material in the biomedical field. However, the biocompatibility of the Ni-Ti alloy is not fully examined. The purpose of this research is to evaluate in vitro cytocompatibility and to try to improve corrosion resistance for Ni-Ti alloy by various surface modifications. Ni-Ti alloy showed good cytocompatibility compared with that of a Ti-6Al-4V alloy, judging from the small amount of hIL-1 beta and LDH generations. Biocompatibility of the Ni-Ti alloy is superior compared with pure nickel. Also, it was made clear that the biocompatibility of the Ni-Ti alloy showed almost the same level as that of stainless steel, which gave a lot of actual results as a biomaterial until now. Therefore, it was understood that there is no problem in the biocompatibility of the Ni-Ti alloy for application as a biomaterial. Moreover, corrosion resistance of in air oxidized Ni-Ti alloy was recognized to be greatly improved.
C1 Kogakuin Univ, Dept Mat Sci & Technol, Tokyo 160, Japan.
RP Kimura, Y (reprint author), Kogakuin Univ, Dept Mat Sci & Technol, Tokyo 160, Japan.
CR Eliades T, 2000, EUR J ORTHODONT, V22, P317, DOI 10.1093/ejo/22.3.317
   Gil FJ, 1998, P I MECH ENG H, V212, P473, DOI 10.1243/0954411981534231
   KAKIUCHI T, 1996, KNOWLEDGE IMMUNOLOGY, P41
   MIYAZAKI S, 1993, MECH PROPERTIES SHAP, pCH1
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   TANAKA K, 1999, J SOC MATER SCI JPN, V48, P1341
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   TORRISI L, 1998, BIOMED MAT ENG, V9, P39
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
NR 9
TC 0
Z9 0
U1 0
U2 1
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
SN 1746-4471
BN 1-84564-022-5
J9 WIT TRANS ENG SCI
PY 2005
VL 49
BP 3
EP 11
PG 9
WC Engineering, Mechanical; Mechanics; Materials Science, Characterization
   & Testing
SC Engineering; Mechanics; Materials Science
GA BDU51
UT WOS:000235463100001
DA 2018-10-19
ER

PT S
AU Ignjatovic, N
   Ninkov, P
   Ajdukovic, Z
   Konstantinovic, V
   Uskokovic, D
AF Ignjatovic, N
   Ninkov, P
   Ajdukovic, Z
   Konstantinovic, V
   Uskokovic, D
BE Uskokovic, DP
   Milonjic, SK
   Rakovic, DI
TI Biphasic calcium phosphate/poly-(DL-lactide-co-glycolide) biocomposite
   as filler and blocks for reparation of bone tissue
SO CURRENT RESEARCH IN ADVANCED MATERIALS AND PROCESSES
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 6th Conference of the Yugoslav-Materials-Research-Society
CY SEP 13-17, 2004
CL Herceg Novi, SERBIA MONTENEG
SP Republic Serbia, Minist Sci & Environm Protect, Yugoslav Mat Res Soc
DE bone repair; calcium phosphate; composite; cytotoxicity; in vitro; in
   vivo
ID LACTIDE COMPOSITE BIOMATERIALS; HYDROXYAPATITE; POLYMERS
AB Composite biomaterials, like calciumphosphate/bioresorbable polymer, offer excellent potential for reconstruction and reparation of bone tissue defects induced by different sources. In this paper synthesis of calciumphosphate/poly-DL-lactide-co-glycolide (BCP/DLPLG) composite biomaterial formed as filler and blocks was studied. BCP/DLPLG composite biomaterial was produced in the form of spherical granules of BCP covered by a DLPLG layer, average diameter of 150-250 mu m. By cold and hot pressing of granules at up to 10000 kg/cm(2), blocks with fine distribution of phases and porosity up to 3% were obtained. Characterization was performed by wide-angle X-ray structural analysis (WAXS), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), infrared spectroscopy (IR), and mechanical properties by defining the compressive strength. In vitro citotoxicity research was carried out on cellular cultures of fibroblasts of human (MRC5) and mouse (L929). In vivo research was performed in two steps. Reparatory ability of BCP/DLPLG in mice was examined in the first step, and then bone tissue reconstruction possibilities on 10 patients in the next step. In vitro tests showed very good fibroblast adhesion and non-citotoxicity of the composite. A material is considered non-cytotoxic if the cell survival is above 50%, and in our case it was 90%. In vivo research on mice indicated high level of reparatory ability of this composite with formation of new bone and vascular tissue six weeks after reparation. Application of this composite for healing infrabone defects of patients showed a high level of osseous regeneration.
C1 SASA, Inst Tech Sci, Belgrade, Serbia Monteneg.
   Univ Novi Sad, Clin Stomatol, Fac Med, Novi Sad 21000, Serbia Monteneg.
   Univ Nish, Fac Med, Clin Stomatol, Nish 18000, Yugoslavia.
   Fac Stomatol, Clin Maxillofacial Surg, Belgrade, Serbia Monteneg.
RP Ignjatovic, N (reprint author), SASA, Inst Tech Sci, Belgrade, Serbia Monteneg.
EM nenad@usa.com; dujoni@ptt.yu; zoricaa@eunet.yu; vskvita@eunet.yu;
   uskok@itn.sanu.ac.yu
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Bogdanovic G, 1994, ARCH ONCOL, V2, P181
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HUMMEL D, 1984, ATLAS POLYM PLASTICS, P273
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   Trapani G, 2003, INT J PHARM, V268, P47, DOI 10.1016/j.ijpharm.2003.08.016
   Wallin Richard F., 1998, 109935 ISO
NR 15
TC 15
Z9 15
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-971-7
J9 MATER SCI FORUM
PY 2005
VL 494
BP 519
EP 524
DI 10.4028/www.scientific.net/MSF.494.519
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Characterization &
   Testing
SC Materials Science
GA BCR96
UT WOS:000230985800085
DA 2018-10-19
ER

PT S
AU Radic, M
   Ignjatovic, N
   Nedic, Z
   Mitric, M
   Milicevic, D
   Uskokovic, D
AF Radic, M
   Ignjatovic, N
   Nedic, Z
   Mitric, M
   Milicevic, D
   Uskokovic, D
BE Uskokovic, DP
   Milonjic, SK
   Rakovic, DI
TI Synthesis and characterization of biphasic calcium
   phosphate/poly-(DL-lactide-co-glycolide) biocomposite
SO CURRENT RESEARCH IN ADVANCED MATERIALS AND PROCESSES
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 6th Conference of the Yugoslav-Materials-Research-Society
CY SEP 13-17, 2004
CL Herceg Novi, SERBIA MONTENEG
SP Republic Serbia, Minist Sci & Environm Protect, Yugoslav Mat Res Soc
DE biphasic calcium phosphate; composite BCP/DLPLG; differential scanning
   calorimetry; infrared spectroscopy; poly-(DL-lactide-co-glycolide);
   scanning electron microscopy; X-ray diffraction
ID COMPOSITES; BIOMATERIALS; DEGRADATION; POLYMERS
AB In this paper we report the results on synthesis of a composite biomaterial based on biphasic calcium phosphate (BCP) and poly-(DL-lactide-co-glycolide) (DLPLG). Besides, we have investigated the influence of new synthesis method on the structure and characteristics of the composite. The synthesis of biphasic calcium phosphate from Ca(NO3)(2) x 4H(2)O and (NH4)(3) PO4 in alkali environment was performed by means of precipitation technique. Composite material BCP/DLPLG was first prepared from commercial granules using chemical methods. Powdered polymer DLPLG was then homogenized at appropriate ratio with addition of biphasic calcium phosphate into the suspension. All samples were characterized by DSC, IR, X-Ray and SEM techniques.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia Monteneg.
   Fac Phys Chem, Belgrade, Serbia Monteneg.
   Vinca Inst Nucl Sci, Lab Theoret & Condensed Matter Phys, Belgrade, Serbia Monteneg.
   Vinca Inst Nucl Sci, Lab Radiochem & Phys, Belgrade, Serbia Monteneg.
RP Radic, M (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia Monteneg.
EM magdalena@itn.sanu.ac.yu; advamat@itn.sanu.ac.yu; zoran@ffh.bg.ac.yu;
   mmitric@vin.bg.ac.yu; dejanmilicevic@vin.bg.ac.yu; uskok@itn.sanu.ac.yu
RI Stevanovic, Magdalena/A-6120-2011; Ignjatovic, Nenad/C-4489-2008;
   Mitric, Miodrag/D-5056-2011; Uskokovic, Dragan/B-4129-2008
OI Stevanovic, Magdalena/0000-0002-3989-0237; Ignjatovic,
   Nenad/0000-0002-5749-094X; Uskokovic, Dragan/0000-0002-0421-4968;
   Milicevic, Dejan/0000-0001-7746-0708; Mitric,
   Miodrag/0000-0002-1709-9890
CR Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   IGNJATOVIC N, 2001, THESIS U BELGRADE
   IGNJATOVIC N, 2004, MATER SCI FORUM, V453, P543
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   *JCPDS, 340010 JCPDS HAP INT
   *JCPDS, 90432 JCPDS BETATCP
   Kiremitci-Gumusderelioglu M, 1999, TURK J CHEM, V23, P153
   MARRA KG, 2000, Patent No. 6165486
   Murakami H, 1999, INT J PHARM, V187, P143, DOI 10.1016/S0378-5173(99)00187-8
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   TAKASHI U, 2001, KEY ENG MATER, V192, P519
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   WATANABEL T, 1999, BIOCERAMICS, V15, P24
   Zhang R, 2001, 47 ANN M ORTH RES SO
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 23
TC 7
Z9 7
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-971-7
J9 MATER SCI FORUM
PY 2005
VL 494
BP 537
EP 542
DI 10.4028/www.scientific.net/MSF.494.537
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Characterization &
   Testing
SC Materials Science
GA BCR96
UT WOS:000230985800088
DA 2018-10-19
ER

PT J
AU Tognetto, D
   Sanguinetti, G
   Ravalico, G
AF Tognetto, D
   Sanguinetti, G
   Ravalico, G
TI Tissue reaction to hydrophilic intraocular lenses
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Article
DE biocompatibility; cataract; hydrophilic acrylic; intraocular lens;
   phacoemulsification
ID EPITHELIAL-CELL PROLIFERATION; COLLAGEN TYPE-IV; ANTERIOR CAPSULE
   OPACIFICATION; HUMAN AUTOPSY EYES; POLY(METHYL METHACRYLATE); IN-VITRO;
   SURFACE-PROPERTIES; CATARACT-SURGERY; AQUEOUS FLARE; BIOCOMPATIBILITY
AB The implant of intraocular lenses (IOLs) following cataract surgery induces a foreign body reaction to the IOL and a lens epithelial cell reaction. The host response to the IOL Is mainly influenced by biomaterial properties. With the increasing use of phacoemulsification and small Incision cataract surgery, there Is growing interest in the use of foldable IOLs made of different materials. Hydrophilic acrylic IOLs Include a wide group of foldable biomaterials different in terms of water content. These lenses have been reported to show a good biocompatibility after implantation. Nevertheless, tissue reaction to the Implant of hydrophilic lenses is variable and not directly related to the hydrophilicity of their surface. A different adsorption of proteins on the IOL optic surface might be responsible for the different cellular reaction and lens epithelial cell response. Other properties besides hydrophilicity should be taken Into account to classify IOL biomaterials.
C1 Univ Trieste, Ist Clin Oculist, Osped Maggiore, I-34129 Trieste, Italy.
RP Tognetto, D (reprint author), Univ Trieste, Ist Clin Oculist, Osped Maggiore, Piazza Osped 1, I-34129 Trieste, Italy.
OI Tognetto, Daniele/0000-0001-7197-7765
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1
   ALLARAKHIA L, 1987, J CATARACT REFR SURG, V13, P607, DOI 10.1016/S0886-3350(87)80149-9
   AMON M, 1991, J CATARACT REFR SURG, V17, P774, DOI 10.1016/S0886-3350(13)80410-5
   Amon M, 1996, J CATARACT REFR SURG, V22, P825, DOI 10.1016/S0886-3350(96)80169-6
   Amon M, 2001, J CATARACT REFR SURG, V27, P178, DOI 10.1016/S0886-3350(01)00742-8
   AYAKI M, 1993, AM J OPHTHALMOL, V115, P668, DOI 10.1016/S0002-9394(14)71468-0
   Caporossi A, 1998, J CATARACT REFR SURG, V24, P1343, DOI 10.1016/S0886-3350(98)80226-5
   Cunanan CM, 1998, J CATARACT REFR SURG, V24, P341, DOI 10.1016/S0886-3350(98)80322-2
   CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   DAVISON JA, 1992, J CATARACT REFR SURG, V18, P421, DOI 10.1016/S0886-3350(13)80086-7
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FERGUSON VMG, 1991, BRIT J OPHTHALMOL, V75, P106, DOI 10.1136/bjo.75.2.106
   Hollick EJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P872
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   IBARAKI N, 1995, AM J OPHTHALMOL, V119, P706, DOI 10.1016/S0002-9394(14)72774-6
   ISHIBASHI T, 1993, ARCH OPHTHALMOL-CHIC, V111, P1685, DOI 10.1001/archopht.1993.01090120109030
   Johnston RL, 1999, J CATARACT REFR SURG, V25, P1109, DOI 10.1016/S0886-3350(99)00137-6
   KAPPELHOF JP, 1986, AM J OPHTHALMOL, V102, P750, DOI 10.1016/0002-9394(86)90403-4
   Kohnen T, 1996, J CATARACT REFR SURG, V22, P1342, DOI 10.1016/S0886-3350(96)80095-2
   Kurosaka D, 1996, BRIT J OPHTHALMOL, V80, P906, DOI 10.1136/bjo.80.10.906
   Leaming DV, 1996, J CATARACT REFR SURG, V22, P931, DOI 10.1016/S0886-3350(96)80194-5
   Lenis K, 1998, ACTA OPHTHALMOL SCAN, V76, P184, DOI 10.1034/j.1600-0420.1998.760212.x
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1792, DOI 10.1016/S0886-3350(00)00748-3
   Linnola RJ, 1999, J CATARACT REFR SURG, V25, P1486, DOI 10.1016/S0886-3350(99)00238-2
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1807, DOI 10.1016/S0886-3350(00)00747-1
   Mamalis N, 2002, J CATARACT REFR SURG, V28, P1, DOI 10.1016/S0886-3350(01)01283-4
   Miyake K, 1996, J CATARACT REFR SURG, V22, P764, DOI 10.1016/S0886-3350(96)80159-3
   Mullner-Eidenbock A, 2001, J CATARACT REFR SURG, V27, P734, DOI 10.1016/S0886-3350(01)00846-X
   Nagamoto T, 1996, J CATARACT REFR SURG, V22, P847, DOI 10.1016/S0886-3350(96)80173-8
   NAGAMOTO T, 1995, J CATARACT REFR SURG, V21, P208, DOI 10.1016/S0886-3350(13)80512-3
   Nishi O, 1996, BRIT J OPHTHALMOL, V80, P63, DOI 10.1136/bjo.80.1.63
   NISHI O, 1992, BRIT J OPHTHALMOL, V76, P338, DOI 10.1136/bjo.76.6.338
   Nishi O, 1996, J CATARACT REFR SURG, V22, P852, DOI 10.1016/S0886-3350(96)80174-X
   OLIVERO DK, 1993, INVEST OPHTH VIS SCI, V34, P2825
   Oshika T, 1996, JPN J OPHTHALMOL, V40, P419
   Pande MV, 1996, J CATARACT REFR SURG, V22, P770, DOI 10.1016/S0886-3350(96)80160-X
   Pande MV, 1996, BRIT J OPHTHALMOL, V80, P469, DOI 10.1136/bjo.80.5.469
   Ravalico G, 1997, OPHTHALMOLOGY, V104, P1084, DOI 10.1016/S0161-6420(97)30181-X
   Schauersberger J, 2001, J CATARACT REFR SURG, V27, P850, DOI 10.1016/S0886-3350(00)00861-0
   Seward HC, 1997, BRIT J OPHTHALMOL, V81, P340, DOI 10.1136/bjo.81.5.340
   SHAH SP, 1995, ADV CEM BASED MATER, V2, P1, DOI 10.1016/1065-7355(95)90032-2
   Tognetto D, 2002, J CATARACT REFR SURG, V28, P644, DOI 10.1016/S0886-3350(01)01158-0
   UMEZAWA S, 1993, J CATARACT REFR SURG, V19, P371, DOI 10.1016/S0886-3350(13)80308-2
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Wenzel M, 1993, SPECULAR MICROSCOPY
   Willie D., 1999, WILLIAMS DICT BIOMAT, P1
   WOLTER JR, 1982, GRAEF ARCH CLIN EXP, V219, P103, DOI 10.1007/BF02152294
   WOLTER JR, 1985, OPHTHALMOLOGY, V92, P135
   WOLTER JR, 1993, J CATARACT REFR SURG, V19, P789
NR 49
TC 5
Z9 5
U1 1
U2 13
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD JAN
PY 2005
VL 2
IS 1
BP 57
EP 60
DI 10.1586/17434440.2.1-57
PG 4
WC Engineering, Biomedical
SC Engineering
GA 018XI
UT WOS:000235797700015
PM 16293029
DA 2018-10-19
ER

PT S
AU Ebenstein, DM
   Park, J
   Kaplan, DL
   Wahl, KJ
AF Ebenstein, DM
   Park, J
   Kaplan, DL
   Wahl, KJ
BE Wahl, KJ
   Huber, N
   Mann, AB
   Bahr, DF
   Cheng, YT
TI Nanomechanical and microstructural properties of Bombyx mori silk films
SO Fundamentals of Nanoindentation and Nanotribology III
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Fundamentals of Nanoindentation and Nanotribology III held
   at the 2004 MRS Fall Meeting
CY NOV 29-DEC 03, 2004
CL Boston, MA
SP MRS
ID SPIDER SILK; FIBROIN; BIOMATERIAL; BEHAVIOR
AB Instrumented indentation and micro-Raman spectroscopy were used to investigate the mechanical and structural properties of Bombyx mori silk films. Twelve different films were prepared from B. mori silk fibroin protein using a variety of post-deposition processing treatments (e.g. soaking in methanol, soaking in water, stretching, and/or enzymatic etching). The results show that different treatments lead to changes in both the conformation of the silk fibroin protein and the mechanical properties of the films.
C1 USN, Res Lab, Div Chem, Washington, DC 20375 USA.
RP Ebenstein, DM (reprint author), USN, Res Lab, Div Chem, Washington, DC 20375 USA.
OI Wahl, Kathryn/0000-0001-8163-6964
CR Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Monti P, 2001, J RAMAN SPECTROSC, V32, P103, DOI 10.1002/jrs.675
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PARK J, 2004, THESIS TUFTS U
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Tsukada M, 1998, J POLYM SCI POL PHYS, V36, P2717, DOI 10.1002/(SICI)1099-0488(19981115)36:15<2717::AID-POLB5>3.3.CO;2-F
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
NR 11
TC 1
Z9 1
U1 0
U2 6
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-789-X
J9 MATER RES SOC SYMP P
PY 2005
VL 841
BP 57
EP 62
PG 6
WC Materials Science, Multidisciplinary; Mechanics; Materials Science,
   Characterization & Testing
SC Materials Science; Mechanics
GA BCI82
UT WOS:000229609400008
DA 2018-10-19
ER

PT J
AU Gronnow, MJ
   Luque, R
   Macquarrie, DJ
   Clark, JH
AF Gronnow, MJ
   Luque, R
   Macquarrie, DJ
   Clark, JH
TI A novel highly active biomaterial supported palladium catalyst
SO GREEN CHEMISTRY
LA English
DT Article
ID SUZUKI REACTION; CHITOSAN; ARYLATION; OLEFIN
AB We have developed an expanded starch supported palladium catalyst which is highly active in Suzuki, Heck and Sonogashira reactions.
C1 Univ York, Dept Chem, Clean Technol Ctr, York YO10 5DD, N Yorkshire, England.
   Univ Cordoba, Dept Quim Organ, Cordoba 14014, Spain.
RP Gronnow, MJ (reprint author), Univ York, Dept Chem, Clean Technol Ctr, York YO10 5DD, N Yorkshire, England.
EM q62alsor@uco.es; jhc1@york.ac.uk
RI Luque, Rafael/F-9853-2010
OI Luque, Rafael/0000-0003-4190-1916
CR Adlim M, 2004, J MOL CATAL A-CHEM, V212, P141, DOI 10.1016/j.molcata.2003.08.012
   BANDINI M, UNPUB
   BUDARIN V, IN PRESS CHEM COMMUN
   Buisson P, 2002, AUST J CHEM, V55, P73, DOI 10.1071/CH02004
   Clark J. H., 2004, PCT Patent Application, Patent No. [PCT/GB2004/003276, 2004003276]
   Clark JH, 2000, GREEN CHEM, V2, P53, DOI 10.1039/a908685d
   Corma A, 2002, APPL CATAL A-GEN, V236, P179, DOI 10.1016/S0926-860X(02)00285-5
   Doi S, 2002, CHEM COMMUN, P2632, DOI 10.1039/b207780a
   dos Santos DS, 2004, LANGMUIR, V20, P10273, DOI 10.1021/la048328j
   Hardy JJE, 2004, GREEN CHEM, V6, P53, DOI 10.1039/b312145n
   HECK RF, 1971, J AM CHEM SOC, V93, P6896, DOI 10.1021/ja00754a034
   Huang HZ, 2004, CARBOHYD RES, V339, P2627, DOI 10.1016/j.carres.2004.08.005
   Huang HZ, 2004, BIOMACROMOLECULES, V5, P2340, DOI 10.1021/bm0497116
   KUMAR KR, 1986, J CHEM SOC CHEM COMM, P130, DOI 10.1039/c39860000130
   Leadbeater NE, 2003, J ORG CHEM, V68, P5660, DOI 10.1021/jo034230i
   MACQUARRIE DJ, 2004, IN PRESS ACS S SERIE
   MIYAURA N, 1981, SYNTHETIC COMMUN, V11, P513, DOI 10.1080/00397918108063618
   MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581
   Mubofu EB, 2001, GREEN CHEM, V3, P23, DOI 10.1039/b009190l
   MUBOFU EB, 2001, THESIS U YORK
   PATTERSON I, 2001, ANGEW CHEM INT EDIT, V40, P603
   Paul S, 2003, GREEN CHEM, V5, P635, DOI 10.1039/b306097g
   Quignard F, 2000, LANGMUIR, V16, P9106, DOI 10.1021/la000937d
   Sonogashira K, 2002, J ORGANOMET CHEM, V653, P46, DOI 10.1016/S0022-328X(02)01158-0
   VINCENT T, 2004, ENVIRON MANAGE, V71, P15
NR 25
TC 97
Z9 99
U1 2
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
J9 GREEN CHEM
JI Green Chem.
PY 2005
VL 7
IS 7
BP 552
EP 557
DI 10.1039/b501130b
PG 6
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 938ND
UT WOS:000230009200011
DA 2018-10-19
ER

PT J
AU Minamisawa, M
   Minamisawa, H
   Yoshida, S
   Takai, N
AF Minamisawa, M
   Minamisawa, H
   Yoshida, S
   Takai, N
TI Characterization of adsorption gels prepared from plant biomaterials
SO GREEN CHEMISTRY
LA English
DT Article
ID METAL-IONS; AQUEOUS-SOLUTIONS; CHELATING RESIN; ARSENITE ANIONS;
   SEPARATION; ARSENATE; CHITOSAN; SORPTION; REMOVAL; COMPLEX
AB The adsorption of Pb(II), Cu(II), Cd(II), and Zn(II) by new biomaterial gels synthesized in cross-linked reactions from agricultural wastes such as lemon, yuzu (Citrus junos), and coffee was investigated. Experimental data of adsorption equilibrium from the heavy metal solutions correlate well with Freundlich isotherm equations. The adsorption mechanism involved acid ion-exchange reactions between the heavy metal and the carboxylic acid of pectic acid in the lemon and yuzu gels, improving the amounts of Pb(II), Cu(II), Cd(II), and Zn(II) adsorbed onto the lemon and yuzu gels by approximately 5- and 6-fold, respectively. The maximum adsorption capacities of the yuzu and lemon gels for Pb(II) and Cu(II) were high. Among the biomaterial gels investigated, the lemon gel possessed the highest complexation ability with these heavy metals. In addition, the adsorption of nitrate ion (NO3-) was especially strong by the Pb(II)-adsorbed lemon gel, as shown by IR absorption spectrophotometry. These results indicate that lemon and yuzu gels can function, as new "green chemistry'' adsorbents, which can be generated from recycled wastes, involve zero emissions, and provide effective recovery of precious resources.
C1 Tokyo Coll Medicopharmaco Technol, Edogawa Ku, Tokyo 1348530, Japan.
   Nihon Univ, Coll Ind Technol, Dept Basic Sci, Chiba 2758576, Japan.
   Nihon Univ, Coll Ind Technol, Ctr High Technol, Chiba 2758576, Japan.
   Tokyo Denki Univ, Coll Sci & Engn, Dept Biotechnol, Hatoyama, Saitama 3500394, Japan.
RP Minamisawa, M (reprint author), Tokyo Coll Medicopharmaco Technol, Edogawa Ku, 6-5-12 Higashikasai, Tokyo 1348530, Japan.
EM minami@cit.nihon-u.ac
CR CHANDA M, 1988, REACT POLYM, V8, P85, DOI 10.1016/0167-6989(88)90348-0
   Dong Y, 2000, ENVIRON POLLUT, V110, P515, DOI 10.1016/S0269-7491(99)00312-7
   EGAWA H, 1985, SEPAR SCI TECHNOL, V20, P653, DOI 10.1080/01496398508060697
   EISCHEN RP, 1958, J CHEM PHYS, V24, P482
   FONER AH, 2004, ISR ENV B, V15, P1992
   HANADA F, 2004, CHEM IND, V57, P828
   Haron MJ, 1999, CHEMOSPHERE, V39, P2459, DOI 10.1016/S0045-6535(99)00155-1
   INOUE K, 1993, B CHEM SOC JPN, V66, P2915, DOI 10.1246/bcsj.66.2915
   Inoue K, 1999, ANAL CHIM ACTA, V388, P209, DOI 10.1016/S0003-2670(99)00090-2
   KAISE T, 1999, J JPN SOC WATER ENV, V22, P337
   KIMIRA M, 1983, KOUGAITO TAISAKU, V19, P341
   Ma Q.Y., 1999, WATER AIR SOIL POLL, V110, P1
   MA QY, 1995, ENVIRON SCI TECHNOL, V29, P1118, DOI 10.1021/es00004a034
   MATUNAGA H, 1996, REACT FUNCT POLYM, V29, P167
   Minamisawa M, 2004, J AGR FOOD CHEM, V52, P5606, DOI 10.1021/jf0496402
   MINAMISAWA M, 2004, CHEM AUST        MAY, P17
   PANDAY KK, 1985, WATER RES, V19, P869, DOI 10.1016/0043-1354(85)90145-9
   PATTERSON JW, 1975, HEAVY METALS AQUATIC, P261
   RICHTER ED, 1986, SCI TOTAL ENVIRON, V48, P109, DOI 10.1016/0048-9697(86)90157-9
   RICHTER ED, 1992, ISRAEL J MED SCI, V28, P454
   Sata T, 1996, J POLYM SCI POL CHEM, V34, P1475
   SHERMAN DM, 2001, ENV GEOCHEMISTRY
   TEZUKA M, 1999, J JPN SOC WATER ENV, V22, P329
   Tezuka S, 2004, GREEN CHEM, V6, P104, DOI 10.1039/b314938m
   *US DEP HHS, 1991, CDC WEEKL MORB REP
   Yano M, 1997, ANAL SCI, V13, P359, DOI 10.2116/analsci.13.Supplement_359
   Yano M., 2001, KANKYOKAGAKUKAISHI, V14, P345
   YOSHIDA I, 1978, SEPAR SCI TECHNOL, V13, P173, DOI 10.1080/01496397808057099
NR 28
TC 21
Z9 21
U1 0
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
J9 GREEN CHEM
JI Green Chem.
PY 2005
VL 7
IS 8
BP 595
EP 601
DI 10.1039/b501946j
PG 7
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 955SB
UT WOS:000231246800006
DA 2018-10-19
ER

PT S
AU Salzer, R
   Steiner, G
   Tunc, S
AF Salzer, R
   Steiner, G
   Tunc, S
BE Kundu, T
TI In-vivo investigation of protein adsorption on implant surfaces
SO Health Monitoring and Smart Nondestructive Evaluation of Structural and
   Biological Systems IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Health Monitoring and Smart Nondestructive Evaluation of
   Structural and Biological Systems IV
CY MAR 07-09, 2005
CL San Diego, CA
SP SPIE
DE infrared; Raman; spectroscopic imaging; biomolecules; biomimetic
   material
ID ATOMIC-FORCE MICROSCOPY; DEPENDENT CONFORMATIONS; FIBRINOGEN
AB A decisive problem in biomedical or biomaterial research of the post-genomic era is the determination of protein structure and function. Common techniques that can give full structural information do not permit in-vivo measurements. Vibrational Proteomics - an innovative combination of biochemical techniques and infrared or Raman spectroscopy - can provide information which will hell) substantially to fill this gap. Infrared and Raman spectroscopy are well established as methods for qualitative and quantitative analysis of protein secondary structure, in solution and even when adsorbed to implant surfaces. Their singular advantage over other techniques is that spectra can be obtained for proteins in a wide range of environments, in solutions and on surfaces including polymers, metals and bioceramics. Here we report on structural changes in fibrinogen from the dissolved to the adsorbed state on implant material of different hydrophobicity. FTIR imaging permits the identification of coagulation spots on the implant.
C1 Dresden Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
RP Salzer, R (reprint author), Dresden Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
RI Tunc, Sibel/C-1651-2016
CR Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Jones DB, 2004, PROTEOMICS, V4, P1007, DOI 10.1002/pmic.200300662
   JORGENSEN L, 2003, INT J PHARM, V18, P7
   JUN HW, 2005, BIOMACROMOLECULES
   Kawamoto N, 1998, J BIOMAT SCI-POLYM E, V9, P543, DOI 10.1163/156856298X00037
   Kopecky V, 2003, BIOCHEM BIOPH RES CO, V300, P41, DOI 10.1016/S0006-291X(02)02765-1
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   MATHEWS CK, 1999, BIOCHEMISTRY-US, P161
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Salzer R, 2003, P SOC PHOTO-OPT INS, V5047, P362, DOI 10.1117/12.484153
   SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TUNC S, UNPUB COLLOIDS SUR B
NR 18
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5749-3
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5768
BP 19
EP 26
DI 10.1117/12.598386
PG 8
WC Engineering, Civil; Instruments & Instrumentation; Materials Science,
   Characterization & Testing; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BCO19
UT WOS:000230386200003
DA 2018-10-19
ER

PT B
AU Thomas, WE
AF Thomas, Wendy E.
GP ASME
TI Using a laminar flow system to explain shear-enhanced bacterial adhesion
SO ICMM 2005, Proceedings of the 3rd International Conference on
   Microchannels and Minichannels, Pt A
LA English
DT Proceedings Paper
CT 3rd International Conference on Microchannels and Minichannels
CY JUN 13-15, 2005
CL Univ Toronto, Toronto, CANADA
SP ASME
HO Univ Toronto
DE flow chamber; adhesion; bacteria; cell; shear stress
ID PLATELET-ADHESION; CELL-ADHESION; SELECTIN; KINETICS; BONDS; FORCE;
   DISSOCIATION; BINDING
AB Microfluidic parallel plate flow chambers provide a method for evaluating the role of molecular mechanics in the dynamic adhesion of cells or bacteria. We use optical microscopy for real-time monitoring of adherent cells in laminar flow conditions to study a counter-intuitive observation. Escherichia coli, our most common intestinal bacteria, require shear stress to bind to surfaces coated with mannose, a carbohydrate expressed on many host cells. In fact, even cells that are already bound will detach if the flow is turned down. Because these flow chambers involve bacteria binding to surfaces similar to biomaterial or tissue surfaces in our body, these experiments shed light on bacterial adhesion in vivo. However, flow chamber experiments can be carefully controlled so that they can also be used to determine the mechanism behind this unusual behavior. We show that the effect of shear stress on transport of bacteria to the surface cannot explain these results. Rather, increased shear stress causes bacteria to roll instead of detach and to switch to a stationary mode of adhesion.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Thomas, WE (reprint author), Univ Washington, Dept Bioengn, Box 351721, Seattle, WA 98195 USA.
CR Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169
   Andrews RK, 1997, INT J BIOCHEM CELL B, V29, P91, DOI 10.1016/S1357-2725(96)00122-7
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Chang KC, 1999, BIOPHYS J, V76, P1280, DOI 10.1016/S0006-3495(99)77291-7
   DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8
   Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101
   Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0
   Forero M, 2004, NANO LETT, V4, P1593, DOI 10.1021/nl049329z
   Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8
   KAPLANSKI G, 1993, BIOPHYS J, V64, P1922, DOI 10.1016/S0006-3495(93)81563-7
   Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605
   McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8
   Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200
   Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
NR 19
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4185-5
PY 2005
BP 751
EP 759
PG 9
WC Engineering, Mechanical
SC Engineering
GA BFM11
UT WOS:000243025300092
DA 2018-10-19
ER

PT J
AU Grimnes, S
   Martinsen, OG
AF Grimnes, S
   Martinsen, OG
TI Cole electrical impedance model - A critique and an alternative
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE bioimpedance theory; biomaterial; cell suspension model; Cole model;
   constant phase element (CPE); dielectric; electrical network theory;
   electrical relaxation theory; tissue model
ID STRIATED MUSCLE; SKIN
AB The Cole single-dispersion impedance model is based upon a constant phase element (CPE), a conductance parameter as a dependent parameter and a characteristic time constant as an independent parameter. Usually however, the time constant of tissue or cell suspensions is conductance dependent, and so the Cole model is incompatible with general relaxation theory and not a model of first choice. An alternative model with conductance as a free parameter influencing the characteristic time constant of the biomaterial has been analyzed. With this free-conductance model it is possible to separately follow CPE and conductive processes, and the nominal time constant no longer corresponds to the apex of the circular arc in the complex plane.
C1 Univ Oslo, Dept Phys, N-0316 Oslo, Norway.
   Dept Clin & Biomed Engn, N-0027 Oslo, Norway.
RP Martinsen, OG (reprint author), Univ Oslo, Dept Phys, POB 1048, N-0316 Oslo, Norway.
EM ogm@fys.uio.no
RI Martinsen, Orjan/M-4459-2014
OI Martinsen, Orjan/0000-0003-1632-4352
CR Cole K. S., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P110
   Cole K. S., 1972, MEMBRANES IONS IMPUL
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   Cole KS, 1928, J GEN PHYSIOL, V12, P29, DOI 10.1085/jgp.12.1.29
   Debye P., 1929, POLAR MOL
   EPELBOIN I, 1970, J ELECTROCHEM SOC, V117, P1052, DOI 10.1149/1.2407718
   FALK G, 1964, PROC R SOC SER B-BIO, V160, P69, DOI 10.1098/rspb.1964.0030
   FATT P, 1964, PROC R SOC SER B-BIO, V159, P606, DOI 10.1098/rspb.1964.0023
   Fricke H., 1932, Philosophical Magazine, V14, P310
   GOUGEROT L, 1948, J RADIOL ELECTROL, V29, P479
   Grimnes S, 2000, BIOIMPEDANCE BIOELEC
   Kuo F F-K, 1966, NETWORK ANAL SYNTHES
   MACDONALD JR, 1987, IMPENDANCE SPECTROSC
   MCADAMS ET, 1994, IEEE T BIO-MED ENG, V41, P498, DOI 10.1109/10.293225
   Rigaud B, 1996, CRIT REV BIOMED ENG, V24, P257, DOI 10.1615/CritRevBiomedEng.v24.i4-6.20
   SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147
   YAMAMOTO T, 1981, MED BIOL ENG COMPUT, V19, P302, DOI 10.1007/BF02442549
   YAMAMOTO T, 1977, MED BIOL ENG COMPUT, V15, P219, DOI 10.1007/BF02441041
   YAMAMOTO T, 1978, MED BIOL ENG COMPUT, V16, P592
NR 19
TC 40
Z9 42
U1 1
U2 13
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD JAN
PY 2005
VL 52
IS 1
BP 132
EP 135
DI 10.1109/TBME.2004.836499
PG 4
WC Engineering, Biomedical
SC Engineering
GA 881DN
UT WOS:000225843700017
PM 15651574
DA 2018-10-19
ER

PT J
AU Desai, SD
   Patel, JV
   Patel, MR
   Sinha, VK
AF Desai, SD
   Patel, JV
   Patel, MR
   Sinha, VK
TI PET waste based polyurethane adhesive for rubber joints
SO INDIAN JOURNAL OF CHEMICAL TECHNOLOGY
LA English
DT Article
DE PET based polyols; polyurethane adhesive; rubber joints; depolymerized
   oligomers
ID POLYESTER POLYOLS; POLY(ETHYLENE-TEREPHTHALATE) WASTES; GLYCOL;
   KINETICS; RESINS; WOOD
AB Biomaterial based polyhydric compounds were synthesized and utilized for the depolymerization of PET. Three different oligomers were synthesized by using 5, 15 and 25% PET. Depolymerized oligomers were esterified with dehydrated castor oil (DCO) fatty acids to give polyester polyols. Polyurethane adhesives were synthesized using these polyols for joining rubber-rubber assembly. Bond strength was measured by 180degrees peel test. Mode of failure was studied by scanning electron microscopy (SEM) analysis. Depolymerised PET oligomers, polyols and polyurethane were characterized by FTIR spectroscopy. Also, polyurethane adhesives were evaluated for their performance and chemical resistance.
C1 NV Patel Coll Pure & Appl Sci, Vallabh Vidyanagar 388120, Gujarat, India.
EM mmrpatel@yahoo.com
CR AbdelAzim AAA, 1997, POLYM J, V29, P21, DOI 10.1295/polymj.29.21
   BALIGA S, 1989, J POLYM SCI POL CHEM, V27, P2071, DOI 10.1002/pola.1989.080270625
   COCKS LV, 1976, LAB HDB OIL FAT ANAL
   DESAI DH, 1973, THESIS SARDAR PATEL
   Desai SD, 2003, J POLYM RES-TAIWAN, V10, P141, DOI 10.1023/A:1026099732272
   Desai SD, 2003, INT J ADHES ADHES, V23, P393, DOI 10.1016/S0143-7496(03)00070-8
   DESAI SD, 2003, INT J POLYM MATER, V52, P1
   DONNELLY MJ, 1993, POLYM INT, V32, P197, DOI 10.1002/pi.4990320214
   Farahat MS, 2000, MACROMOL MATER ENG, V283, P1
   Guclu G, 1998, J APPL POLYM SCI, V69, P2311
   HALACHEVA N, 1995, POLYMER, V36, P867, DOI 10.1016/0032-3861(95)93119-7
   HOFER R, 2000, EUR COATING, V3, P34
   John N., 1998, J APPL POLYM SCI, V168, P1185
   KIZLICAN N, 2000, J APPL POLYM SCI, V76, P648
   KUJAWAPENCZEK B, 1976, POLYM WARSAW, V21, P311
   LEE SC, 1994, J APPL POLYM SCI, V52, P869, DOI 10.1002/app.1994.070520705
   Mansour SH, 2002, POLYM TEST, V21, P497, DOI 10.1016/S0142-9418(01)00115-5
   MARTINMARTINEZ JM, 1998, 1 INT C ADH SCI TECH
   MILGROM I, 1992, PRODUCTS PROCESSES, P59
   MULLER E, 1963, HOUBEN WEYL, V14, P2
   OTEY FH, 1965, IND ENG CHEM PROD RD, V4, P228, DOI 10.1021/i360016a003
   Paszun D, 1997, IND ENG CHEM RES, V36, P1373, DOI 10.1021/ie960563c
   PATEL JV, 2000, J POLYM MATER, V18, P103
   Sniezko A., 1981, POLIMERY, V26, P358
   VAIDYA UR, 1988, J APPL POLYM SCI, V35, P775, DOI 10.1002/app.1988.070350317
   VAIDYA UR, 1989, J APPL POLYM SCI, V38, P1179, DOI 10.1002/app.1989.070380615
   Vick CB, 1998, FOREST PROD J, V48, P71
NR 27
TC 6
Z9 7
U1 1
U2 4
PU NATL INST SCIENCE COMMUNICATION
PI NEW DELHI
PA DR K S KRISHNAN MARG, NEW DELHI 110 012, INDIA
SN 0971-457X
J9 INDIAN J CHEM TECHN
JI Indian J. Chem. Technol.
PD JAN
PY 2005
VL 12
IS 1
BP 82
EP 87
PG 6
WC Chemistry, Applied; Engineering, Chemical
SC Chemistry; Engineering
GA 896OA
UT WOS:000226942200014
DA 2018-10-19
ER

PT J
AU Wilk, R
   Stewing, F
   Rutz, F
   Kleine-Ostmann, T
   Koch, M
AF Wilk, Rafal
   Stewing, Felix
   Rutz, Frank
   Kleine-Ostmann, Thomas
   Koch, Martin
TI Label-free detection of biomaterials using terahertz technology
SO INTERNATIONAL JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
DE THz spectroscopy; biomolecules; DNA analysis; marker-free gene tests;
   THz filters
ID TIME-DOMAIN SPECTROSCOPY; VIBRATIONAL-MODES; SYSTEM; DNA
AB We present terahertz (THz) absorption spectra of various biomolecules (tripeptide gly-gly-gly and oligo-nucleotides poly[A] and poly[C]). While the tripeptide shows unique resonances in the THz range due to intramolecular vibrations, the different oligo-nucleotides can be distinguished due to different absorption properties. In space-resolved THz free-space measurements, we were able to repeatedly distinguish between dried drops of poly[A] and poly[C]. In addition, we present the design for a new class of filters for on-chip analysis of biomaterials. As compared to filters described earlier in the literature, the new structures have an increased sensitivity and require much less biomaterial.
C1 Tech Univ Carolo Wilhelmina Braunschweig, Inst Hochfrequenztech, D-38106 Braunschweig, Germany.
RP Wilk, R (reprint author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Hochfrequenztech, Schleinitzstr 22, D-38106 Braunschweig, Germany.
EM Rafal.Wilk@tu-bs.de; f.stewing@tu-bs.de; f.rutz@tu-bs.de;
   t.kleine-ostmann@tu-bs.de; Martin.Koch@tu-bs.de
CR Brucherseifer M, 2000, APPL PHYS LETT, V77, P4049, DOI 10.1063/1.1332415
   FISCHER B, COMMUNICATION
   Fischer BM, 2002, PHYS MED BIOL, V47, P3807, DOI 10.1088/0031-9155/47/21/319
   Johnston MB, 2003, CHEM PHYS LETT, V377, P256, DOI 10.1016/S0009-2614(03)01136-9
   Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549
   Nagel M, 2002, APPL PHYS LETT, V80, P154, DOI 10.1063/1.1428619
   Nahata A, 1996, APPL PHYS LETT, V69, P2321, DOI 10.1063/1.117511
   Uhd Jepsen P., 1996, J OPT SOC AM B, V13, P2424
   VANEXTER M, 1990, IEEE T MICROW THEORY, V38, P1684, DOI 10.1109/22.60016
   Walther M, 2003, CHEM PHYS, V288, P261, DOI 10.1016/S0301-0104(03)00031-4
   Walther M, 2002, BIOPOLYMERS, V67, P310, DOI 10.1002/bip.10106
   Wu Q, 1996, APPL PHYS LETT, V68, P2924, DOI 10.1063/1.116356
NR 12
TC 1
Z9 1
U1 2
U2 9
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA
PA WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 896, CH-1215
   GENEVA, SWITZERLAND
SN 1475-7435
J9 INT J NANOTECHNOL
JI Int. J. Nanotechnol.
PY 2005
VL 2
IS 3
BP 303
EP 311
DI 10.1504/IJNT.2005.008067
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 074FI
UT WOS:000239797700010
DA 2018-10-19
ER

PT J
AU Wright, AM
   McKee, M
   Renaud, A
   Ranganathan, P
AF Wright, AM
   McKee, M
   Renaud, A
   Ranganathan, P
TI Cytometric viability of human corneal epithelial cells grown on tissue
   culture plastic and a biomaterial
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Meeting of the Association-for-Research-in-Vision-and-Ophthalmology
   (ARVO 2005)
CY MAY 01-05, 2005
CL Ft Lauderdale, FL
SP Assoc Res Vision Ophthalmol
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PY 2005
VL 46
SU S
MA 871
PG 1
WC Ophthalmology
SC Ophthalmology
GA 911CZ
UT WOS:000227980400861
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Sanmartin, AC
   Herrero, EJ
   Millan, I
   Cordon, A
   Rocha, A
   Maestro, MA
   Tellez, G
   Castillo-Olivares, JL
AF Paez, JMG
   Sanmartin, AC
   Herrero, EJ
   Millan, I
   Cordon, A
   Rocha, A
   Maestro, MA
   Tellez, G
   Castillo-Olivares, JL
TI Resistance and stability of a new method for bonding biological
   materials using sutures and biological adhesives
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE bioadbesives; sutures; mechanical resistance; pericardium; bioprostheses
ID TISSUE SELECTION SITES; BOVINE PERICARDIUM; BIOPROSTHETIC VALVES; FIBER
   ARCHITECTURE; HEART-VALVES; GLUTARALDEHYDE; CALCIFICATION; REOPERATION;
   ELASTICITY; THREADS
AB The valve leaflets of cardiac bioprostheses are secured and shaped by sutures which, given their high degree of resistance and poor elasticity, have been implicated in the generation of stresses within the leaflets contributing to the failure of the bioprostheses. Bioadhesives are bonding materials that have begun to be utilized in surgery, although there is a lack of experience in their use with inert tissues or bioprostheses.
   Tensile testing is performed until rupture in samples of calf pericardium, a biomaterial employed in the manufacture of bioprosthetic heart valve leaflets.
   One hundred and thirty-two trials are carried out in three types of samples: intact or control tissue (n = 12); samples transected and glued in an overlapping manner with a cyanoacrylate (n = 60); and samples transected, sewn with a commercially available suture material and reinforced at the suture holes with the same cyanoacrylate (n = 60). Seven days after their preparation, 12 samples from each group, including the controls, are subjected to tensile testing until rupture and the findings are compared.
   In the stability study, groups of 12 each of the remaining 48 glued and 48 sutured and glued samples underwent tensile testing until rupture on days 30, 60, 90, and 120, after their preparation.
   The results show that bonding with the adhesive provided a resistance ranging between 1.04 and 1.87 kg, probably insufficient for use in valve leaflets, but also afforded a high degree of elasticity. After 120 days, both the glued and the sutured and glued series show excellent elastic behavior, with no rigidity or hardening of the pericardium. These samples present reversible elongation, or strain, when they surpass their elastic limit at rupture. This finding may be due to a load concentration that is damaging to the pericardium, to the behavior of the tissue as an amorphous material, or perhaps to both circumstances.
   These results need to be confirmed in future studies as they may be of value in the design and manufacture of cardiac bioprostheses.
C1 Clin Puerta Hierro, Serv Cirugia Expt, Madrid 28035, Spain.
   Clin Puerta Hierro, Serv Bioestadist, Madrid 28035, Spain.
   Clin Puerta Hierro, Serv Cirugia Cardiovasc, Madrid 28035, Spain.
   Escuela Tecn Super Ingn Ind, Dept Mecan Estructural & Resistencia Mat, Madrid 28006, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Serv Cirugia Expt, San Martin de Porres 4, Madrid 28035, Spain.
EM JMGPAEZ@telefonica.net
CR Bingley JA, 2000, ANN THORAC SURG, V69, P1764, DOI 10.1016/S0003-4975(00)01250-9
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   CIAPETTI G, 1994, BIOMATERIALS, V15, P63, DOI 10.1016/0142-9612(94)90199-6
   Duncan AC, 1997, J THORAC CARDIOV SUR, V113, P302, DOI 10.1016/S0022-5223(97)70327-1
   EDWARDS TJ, 1995, ANN THORAC SURG, V60, pS211, DOI 10.1016/0003-4975(95)00220-F
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GONSALBEZ J, 1996, SCAND J THORAC CAR S, V44
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   GRANDE AH, 1987, NUEVOS MAT VIDRIOS M, P13
   Greene D, 1999, Arch Facial Plast Surg, V1, P292, DOI 10.1001/archfaci.1.4.292
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 1996, J BIOMED MATER RES, V30, P47
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   QUINTANARGUERRERO, 2001, BIOMATERIALS, V22, P957
   SABANATHAN S, 1993, EUR J CARDIO-THORAC, V7, P657, DOI 10.1016/1010-7940(93)90264-C
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   San Martin AC, 1998, J MATER SCI-MATER M, V9, P77
   TIMOSHENKO S, 1970, RESISTENCIA MAT, P1
   TIMOSHENKO S, 1970, RESISTENCIA MAT 2, P316
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   YINCHAO T, 1990, J BIOMED MATER RES, V24, P1355
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 34
TC 4
Z9 4
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2005
VL 19
IS 3
BP 215
EP 236
DI 10.1177/0885328205046633
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 886QD
UT WOS:000226242500003
PM 15613381
DA 2018-10-19
ER

PT J
AU Li, JS
   Mak, AFT
AF Li, JS
   Mak, AFT
TI Hydraulic permeability of polyglycolic acid scaffolds as a function of
   biomaterial degradation
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE polyglycolic acid; scaffold; degradation; permeability
ID IN-VITRO DEGRADATION
AB Using a simple experimental setup, the hydraulic permeability of fibrous nonwoven polyglycohc acid (PGA) scaffolds is studied after different degradation durations in PBS. The hydraulic permeability of the scaffolds increased with the degradation time. After being incubated for about 4 weeks, the permeability of the scaffold begins to drop. It is noted that the PGA scaffold apparently begins to contract and cannot maintain its original shape after 4 weeks of degradation. These results underpin the understanding of the biotransport processes in the scaffolds during tissue engineering experiments.
C1 Hong Kong Polytech Univ, Jockey Club Rehabil Engn Ctr, Kowloon, Hong Kong, Peoples R China.
RP Mak, AFT (reprint author), Hong Kong Polytech Univ, Jockey Club Rehabil Engn Ctr, Kowloon, Hong Kong, Peoples R China.
EM rcafmak@polyu.edu.hk
RI Li, Jiashen/J-6946-2012; Li, Jiashen/E-8571-2015
OI Li, Jiashen/0000-0001-7333-5280; 
CR Agrawal C. M., 2000, STP ASTM
   Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Athanasiou KA, 1998, TISSUE ENG, V4, P53, DOI 10.1089/ten.1998.4.53
   Chaignaud BE, 1997, SYNTHETIC BIODEGRADA
   Gugala Z, 2000, J BIOMED MATER RES, V49, P183, DOI 10.1002/(SICI)1097-4636(200002)49:2<183::AID-JBM5>3.0.CO;2-D
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Shum AWT, 2003, POLYM DEGRAD STABIL, V81, P141, DOI 10.1016/S0141-3910(03)00083-1
   Vacanti JP, 2000, PRINCIPLES TISSUE EN
NR 13
TC 21
Z9 22
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2005
VL 19
IS 3
BP 253
EP 266
DI 10.1177/0885328205047219
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 886QD
UT WOS:000226242500005
PM 15613383
DA 2018-10-19
ER

PT J
AU Hwang, JJ
   Jelacic, S
   Samuel, NT
   Maier, RV
   Campbell, CT
   Castner, DG
   Hoffman, AS
   Stayton, PS
AF Hwang, JJ
   Jelacic, S
   Samuel, NT
   Maier, RV
   Campbell, CT
   Castner, DG
   Hoffman, AS
   Stayton, PS
TI Monocyte activation on polyelectrolyte multilayers
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyelectrolyte; hyaluronic acid; poly-L-lysine; monocyte; biomaterial;
   time of flight second ion mass spectroscopy; surface plasmon resonance
ID ADSORBED PROTEIN FILMS; SURFACES; ADSORPTION; SYSTEMS; MICROCAPSULES;
   CYTOTOXICITY; CYTOKINES; COMPONENT; ADHESION; BUILDUP
AB The adherence and activation of primary human monocytes was investigated on a polyelectrolyte multilayer film containing hyaluronic acid (HA) and poly-L-lysine (PLL). The sequential layer-by-layer deposition of the multilayer film was characterized by surface plasmon resonance. Eight alternating bilayers displayed an effective thickness of 16.15 nm with a total polymer coverage of 2.10 mu g/cm(2). For cell studies, HA-PLL multilayers were constructed on tissue culture polystyrene (TCPS) substrates and characterized by time of flight second ion mass spectrometry (ToF-SIMS) analysis. Principal component analysis of the ToF-SIMS spectra resolved no significant difference in surface chemistry between PLL-terminated and HA-terminated multilayer surfaces. Monocyte adhesion on PLL- and HA-terminated surfaces was measured by the lactate dehydrogenase assay and showed a significant decrease in cell adhesion after 24 h incubation. Cell viability measured by Live/Dead fluorescent staining showed significant cell death in the adherent cell population over these 24 h. Tumor necrosis factor-alpha (TNF-alpha) production, a measure of monocyte activation, was quantified by ELISA and. normalized to the number of adherent monocytes. The activation of monocytes on PLL-terminated and HA-terminated surfaces was nearly identical, and both surfaces had TNF-alpha levels that were 8-fold higher than TCPS. These results demonstrate that sufficient PILL had diffused into the surface layer to direct monocyte adherence and to induce cytokine activation and cell death on the HA-terminated multilayer films. The diffusion of the second multilayer component to the coating surface should, thus, be taken into account in the design of polyelectrolyte-based biomaterial coating strategies.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98104 USA.
   Univ Washington, Dept Chem, Seattle, WA 98104 USA.
RP Stayton, PS (reprint author), Univ Washington, Dept Bioengn, Box 351721, Seattle, WA 98195 USA.
EM stayton@u.washington.edu
FU NHLBI NIH HHS [R24-HL64387]; NIBIB NIH HHS [EB 002027]
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+
   BARER R, 1954, Q J MICROSC SCI, V95, P339
   Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h
   CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   FREY BL, 1995, ANAL CHEM, V67, P4452, DOI 10.1021/ac00120a003
   Gomez-Alejandre S, 2000, INT J BIOL MACROMOL, V27, P287, DOI 10.1016/S0141-8130(00)00130-6
   Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   LESLIE TE, 1985, BIOPOLYMERS, V24, P695, DOI 10.1002/bip.360240409
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   MATSUDA T, 1993, ASAIO J, V39, P327
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Morra M, 2003, J COLLOID INTERF SCI, V259, P236, DOI 10.1016/S0021-9797(02)00204-7
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Prokop A, 1998, ADV POLYM SCI, V136, P1
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Rosengart MR, 2002, SHOCK, V17, P109, DOI 10.1097/00024382-200202000-00005
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.0.CO;2-Y
   Vautier D, 2002, J BIOMAT SCI-POLYM E, V13, P713, DOI 10.1163/156856202320269175
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 34
TC 20
Z9 20
U1 1
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 2
BP 237
EP 251
DI 10.1163/1568562053115480
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 907QW
UT WOS:000227734000008
PM 15794488
DA 2018-10-19
ER

PT J
AU Labow, RS
   Sa, D
   Matheson, LA
   Santerre, JP
AF Labow, RS
   Sa, D
   Matheson, LA
   Santerre, JP
TI Polycarbonate-urethane hard segment type influences esterase substrate
   specificity for human-macrophage-mediated biodegradation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyurethanes; macrophages; esterase; inhibitors; biodegradation
ID ENZYME-INDUCED BIODEGRADATION; MONOCYTE-DERIVED MACROPHAGES; CHOLESTEROL
   ESTERASE; POLYURETHANES; DEPENDENCE; POLY(URETHANE)S; INFLAMMATION;
   HYDROLYSIS; MORPHOLOGY; CHEMISTRY
AB Previous studies have shown that esterase activity can degrade a variety of polyurethanes (PUs), including polycarbonate-based PUs (PCNUs). When Cultured on PCNUs, differing in their chemistries, monocyte-derived macrophages (MDM) synthesized and secreted different amounts of both cholesterol esterase (CE) and monocyte-specific esterase (MSE). MDM were seeded on PCNUs synthesized with hexane diisocyanate (HDI) or 4,4'-methylene-bis-phenyl diisocyanate (NIDI), PCN and [C-14]butanediol (BD) in the ratio 3: 2: 1 (referred to as HDI321 or MDI321). The effect of phenylmethylsulfonyl fluoride (PMSF, a serine esterase and proteinase inhibitor), sodium fluoride (NaF, a MSE inhibitor) and sodium taurocholate (NaT, a CE stimulator) was assessed on degradation (measured by radiolabel release (RR)) and esterase activity in MDM lysate. The results were compared to the effect that these reagents had on commercially available CE and carboxyl esterase (CXE), which has a specificity similar to MSE. NaF inhibited CXE- and MDM-mediated RR to the same extent as for both PCNUs. However, the MDM-mediated RR from MDI321 was 1.8-times higher than HDI321 in the presence of NaT (P = 0.005). This study suggests that the difference in diisocyanate chemistry may dictate the relative contribution of each esterase to a specific material's degradation. This may be related to both the substrate specificity of each esterase, as well as by the relative amount of each esterase that the specific biomaterial substrates induce the cells to synthesize and secrete.
C1 Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   Univ Ottawa, Dept Surg, Ottawa, ON, Canada.
   Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   Univ Toronto, Fac Dent, Toronto, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM rlabow@ottawaheart.ca
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1996, BIOMATERIALS, V17, P2381, DOI 10.1016/S0142-9612(96)00088-9
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   MCBANE JE, 2005, IN PRESS J BIOMED MA
   QUINN DM, 1985, BIOCHIM BIOPHYS ACTA, V834, P267, DOI 10.1016/0005-2760(85)90165-1
   SABOORI AM, 1990, J BIOL CHEM, V265, P19792
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Tang YW, 2003, BIOMATERIALS, V24, P2003, DOI 10.1016/S0142-9612(02)00563-X
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   VAHOUNY GV, 1964, ARCH BIOCHEM BIOPHYS, V107, P7, DOI 10.1016/0003-9861(64)90262-0
   Wang GB, 1997, J BIOMED MATER RES, V36, P407, DOI 10.1002/(SICI)1097-4636(19970905)36:3<407::AID-JBM16>3.3.CO;2-U
NR 23
TC 25
Z9 26
U1 1
U2 8
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 9
BP 1167
EP 1177
DI 10.1163/1568562054798563
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 971MS
UT WOS:000232389000008
PM 16231606
DA 2018-10-19
ER

PT J
AU Cao, WL
   Wang, AJ
   Jing, DH
   Gong, YD
   Zhao, NM
   Zhang, XF
AF Cao, WL
   Wang, AJ
   Jing, DH
   Gong, YD
   Zhao, NM
   Zhang, XF
TI Novel biodegradable films and scaffolds of chitosan blended with
   poly(3-hydroxybutyrate)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE chitosan; poly(3-hydroxybutyrate); emulsion blending; mechanical
   properties; porous blended scaffold
ID TISSUE; BIOCOMPATIBILITY; COMPOSITES; COLLAGEN; MATRIX; CHITIN; ACID)
AB In order to develop a novel biomaterial, films of chitosan blended with poly(3-hydroxybutyrate) (PHB) were prepared by an emulsion blending technique and their properties were characterized. Scanning electron microscopy (SEM) showed that PHB microspheres were formed and were entrapped in chitosan matrices, which made the film surface rough. With increasing PHB content, the roughness of the film surface increased, while the swelling capability of the films decreased. In a wet state, the blended films exhibited a lower elastic modulus, a higher elongation-at-break and a higher tensile strength compared with chitosan films. Cell-culture experiments revealed that the blended films had better cytocompatibility than chitosan films. To explore the potential application of the blended material in tissue engineering, the porous blended scaffolds were fabricated and their pore morphology was observed by SEM. The results revealed that not only pore structure but also pore wall morphology of the blended scaffolds could be controlled by selecting the parameters of the fabrication process. These advantageous properties indicate that the blended chitosan/PHB material is promising for tissue engineering applications.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RP Zhang, XF (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
EM zxf-dbs@mail.tsinghua.edu.cn
RI Wang, Aijun/C-7559-2013; Jing, Duohui/B-5039-2015
OI Wang, Aijun/0000-0002-2985-3627; Jing, Duohui/0000-0002-1491-8002
CR Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Cheng GX, 2003, J MATER SCI-MATER M, V14, P1073, DOI 10.1023/B:JMSM.0000004004.37103.f4
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Francis SJ, 2000, BIOMATERIALS, V21, P2589, DOI DOI 10.1016/S0142-9612(00)00126-5
   HOPE PS, 1993, POLYM BLENDS ALLOYS, P181
   Ikejima T, 1999, MACROMOL CHEM PHYSIC, V200, P413, DOI 10.1002/(SICI)1521-3935(19990201)200:2<413::AID-MACP413>3.0.CO;2-Q
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Madison KW, 2003, J OPT SOC AM B, V20, P113, DOI 10.1364/JOSAB.20.000113
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NORMA G, 2000, POLYM TEST, V19, P485
   Nugraha E, 2004, J POLYM ENVIRON, V12, P1
   Olabarrieta I, 2001, POLYMER, V42, P4401, DOI 10.1016/S0032-3861(00)00680-7
   Perugini P, 2003, INT J PHARM, V252, P1, DOI 10.1016/S0378-5173(02)00602-6
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   Roh IJ, 2002, J BIOMAT SCI-POLYM E, V13, P769, DOI 10.1163/156856202760197401
   SALDANHA V, 2000, BIOMATERIALS, V2, P2427
   Schulz PC, 1998, COLLOID POLYM SCI, V276, P1159, DOI 10.1007/s003960050359
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Willemse RC, 1999, POLYMER, V40, P6645, DOI 10.1016/S0032-3861(98)00874-X
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   YOSHIAKI K, 2000, PHARM DES TECHNOL, V5, P77
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 29
TC 26
Z9 30
U1 0
U2 14
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 11
BP 1379
EP 1394
DI 10.1163/156856205774472308
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 992XB
UT WOS:000233916200004
PM 16370239
DA 2018-10-19
ER

PT J
AU Tsao, AK
   Roberson, JR
   Christie, MJ
   Heck, DA
   Robertson, DD
   Poggie, RA
AF Tsao, AK
   Roberson, JR
   Christie, MJ
   Heck, DA
   Robertson, DD
   Poggie, RA
TI Biomechanical and clinical evaluations of a porous tantalum implant for
   the treatment of early-stage osteonecrosis
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article; Proceedings Paper
CT 72nd Annual Meeting of the American-Academy-of-Orthopaedic-Surgeons
CY FEB 23-27, 2005
CL Washington, DC
SP Amer Acad Orthopaed Surg
ID AVASCULAR NECROSIS; CORE DECOMPRESSION; FEMORAL-HEAD; BIOMATERIAL
C1 Univ Mississippi, Dept Orthopaed Surg, Med Ctr, Jackson, MS 39216 USA.
RP Tsao, AK (reprint author), Univ Mississippi, Dept Orthopaed Surg, Med Ctr, 2500 N State St, Jackson, MS 39216 USA.
EM atsao@orthopedics.umsmed.edu
CR AARON RK, 1997, OSTEONECROSIS ETIOLO, P301
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BOBYN JD, 1999, SCI EXH ANN M AM AC
   BROWN TD, 1999, SCI EXH ANN M AM AC
   BUCKLEY PD, 1991, J BONE JOINT SURG AM, V73A, P1357, DOI 10.2106/00004623-199173090-00011
   Heiner A. D., 1998, Journal of Musculoskeletal Research, V2, P267, DOI 10.1142/S0218957798000263
   Heiner AD, 2001, T ORTHOP RES SOC, V26, P480
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Pedersen DR, 1997, T ORTHOP RES SOC, V22, P598
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   Steinberg ME, 1997, OSTEONECROSIS ETIOLO, P277
   Tang CL, 1998, MICROSURG, V18, P383, DOI 10.1002/(SICI)1098-2752(1998)18:6<383::AID-MICR8>3.0.CO;2-5
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 15
TC 67
Z9 92
U1 0
U2 2
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PY 2005
VL 87A
SU 2
BP 22
EP 27
DI 10.2106/JBJS.E.00490
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 992JI
UT WOS:000233879800004
PM 16326720
OA Bronze
DA 2018-10-19
ER

PT J
AU Koo, KT
   Polimeni, G
   Qahash, M
   Kim, CK
   Wikesjo, UME
AF Koo, KT
   Polimeni, G
   Qahash, M
   Kim, CK
   Wikesjo, UME
TI Periodontal repair in dogs: guided tissue regeneration enhances bone
   formation in sites implanted with a coral-derived calcium carbonate
   biomaterial
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE bone regeneration; coral biomaterial; dogs; guided tissue regeneration;
   tissue engineering
ID TITANIUM-REINFORCED MEMBRANES; CEMENTUM REGENERATION; GRAFT SUBSTITUTE;
   DEFECTS; HYDROXYAPATITE; COMPOSITE; THERAPY
AB Background: Previous studies suggest that a bioresorbable calcium carbonate coral implant (CI) supports space provision and bone formation for guided tissue regeneration (GTR). However, it could not be discerned whether observed effects were because of GTR or whether the CI possessed osteoconductive properties enhancing bone formation. The objective of this study was to evaluate bone formation associated with the CI biomaterial in the presence and absence of provisions for GTR.
   Methods: Routine, critical size, 6 mm, supra-alveolar periodontal defects were created in 12 young adult Beagle dogs. Five animals received the CI alone (Biocoral(R) 1000). Seven animals received the CI/GTR combination using an expanded polytetrafluoroethylene barrier (GORE-TEX(R) Regenerative Material). The animals were euthanized at 4 weeks postsurgery and tissue blocks of the experimental sites were collected and processed for histometric analysis.
   Results: Clinical healing was uneventful. The histopathologic and histometric analysis revealed significantly increased bone formation (height and area) in sites receiving the CI/GTR combination compared with CI alone (2.3+/-0.6 versus 1.2+/-0.9 mm; and 3.1+/-0.8 versus 1.2+/-1.1 mm(2); p<0.05). The CI biomaterial appeared to be mostly unassociated with new bone formation; the CI particles were observed sequestered in newly formed bone, fibrovascular marrow, and in the supra-alveolar connective tissue. Cementum formation was limited and observed in few sites for both treatment protocols.
   Conclusion: While GTR promoted new bone formation, the CI contributed limited, if any, osteoconductive effects.
C1 Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19140 USA.
   Yonsei Univ, Coll Dent, Dept Periodontol, Res Inst Periodontal Regenerat, Seoul 120749, South Korea.
RP Koo, KT (reprint author), Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, 3223 N Broad St, Philadelphia, PA 19140 USA.
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Boden SD, 1997, J SPINAL DISORD, V10, P1
   Boyne PJ, 2001, INT J PERIODONT REST, V21, P333
   CORTELLINI P, 1995, J PERIODONTOL, V66, P797, DOI 10.1902/jop.1995.66.9.797
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   Koo KT, 2004, J CLIN PERIODONTOL, V31, P439, DOI 10.1111/j.1600-051X.2004.00508.x
   Kujala S, 2002, Scand J Surg, V91, P186
   Mellonig JT, 1996, CLIN ORTHOP RELAT R, P116
   Moon IS, 1996, J CLIN PERIODONTOL, V23, P945, DOI 10.1111/j.1600-051X.1996.tb00516.x
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   Polimeni G, 2004, J CLIN PERIODONTOL, V31, P725, DOI 10.1111/j.1600-051X.2004.00542.x
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   Tatakis DN, 2000, J CLIN PERIODONTOL, V27, P698, DOI 10.1034/j.1600-051x.2000.027009698.x
   TINTI C, 1994, J PERIODONTOL, V65, P1088, DOI 10.1902/jop.1994.65.11.1088
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Tuominen T, 2000, INT ORTHOP, V24, P289, DOI 10.1007/s002640000164
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Wikesjo UME, 1998, J CLIN PERIODONTOL, V25, P475, DOI 10.1111/j.1600-051X.1998.tb02476.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x
   WIKESJO UME, 2003, J PERIODONTOL, V74, P955
NR 27
TC 17
Z9 22
U1 0
U2 9
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JAN
PY 2005
VL 32
IS 1
BP 104
EP 110
DI 10.1111/j.1600-051X.2004.00632.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 888AS
UT WOS:000226347200018
PM 15642067
DA 2018-10-19
ER

PT J
AU Suba, C
   Velich, N
   Turi, C
   Szabo, G
AF Suba, C
   Velich, N
   Turi, C
   Szabo, G
TI Surface analysis methods of biomaterials used in oral surgery:
   Literature review
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE titanium; surface analysis; anodic oxidation
ID TITANIUM IMPLANTS; OXIDE-GROWTH; IN-VITRO; BEHAVIOR; ALLOYS; PLATES;
   LASER; MORPHOLOGY; ROUGHNESS
AB Titanium is the most frequently used biomaterial in oral surgery because of its positive physical and chemical properties. Clinical studies proved that the properties of titanium can be improved by surface modification techniques. To study the surface of biomaterials, the positive effects of the coatings, the response of the organism (corrosion resistance, physical and chemical stability, the thickness of various coatings, biocompatibility), one must choose and use the adequate analytical method for one's goal. In this article, the authors present the most frequently used analytical methods for the study of the surface morphology and composition of biomaterials. Also, they outline the advantages and disadvantages of specific analytical methods and the field where they are used.
C1 Semmelweis Univ, Dept Oral & Maxillofacial Surg, H-1085 Budapest, Hungary.
RP Szabo, G (reprint author), Semmelweis Univ, Dept Oral & Maxillofacial Surg, Maria U 52, H-1085 Budapest, Hungary.
EM subacs@softhome.net
CR Acero J, 1999, J CRANIO MAXILL SURG, V27, P117, DOI 10.1016/S1010-5182(99)80025-0
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Albrektsson T, 2000, APPL OSSEOINTEGRATIO, V1, P21
   BRANEMARK P-I, 1977, Scandinavian Journal of Plastic and Reconstructive Surgery Supplementum, V16, P7
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Gaggl A, 2000, BIOMATERIALS, V21, P1067, DOI 10.1016/S0142-9612(00)00002-8
   Gottlow J, 2000, APPL OSSEOINTEGRATIO, V1, P25
   Gottlow J, 2000, APPL OSSEOINTEGRATIO, V1, P28
   Hall J, 2000, APPL OSSEOINTEGRATIO, V1, P5
   HALLIE E, 2000, IMPLANTS, V15, P355
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Joob-Fancsaly A, 2002, SMART MATER STRUCT, V11, P819, DOI 10.1088/0964-1726/11/5/330
   Karacs A, 2003, MAT SCI ENG C-BIO S, V23, P431, DOI 10.1016/S0928-4931(02)00316-8
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   LARSSON C, 2000, APPL OSSEOINTEGR RES, V1, P9
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   Lim YJ, 2001, INT J ORAL MAX IMPL, V16, P333
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Lopez MF, 2002, SURF INTERFACE ANAL, V33, P570, DOI 10.1002/sia.1422
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   MCQUEEN D, 1982, ADV BIOMATER, V4, P179
   MOBERG LE, 1989, INT J ORAL MAX SURG, V18, P311, DOI 10.1016/S0901-5027(89)80102-X
   MOSSER A, 1992, BIOMATERIALS HARD TI, P143
   Placko HE, 2000, INT J ORAL MAX IMPL, V15, P355
   Quirynen M, 1994, Int J Oral Maxillofac Implants, V9, P71
   Sawase T, 2000, CLIN ORAL IMPLAN RES, V11, P44, DOI 10.1034/j.1600-0501.2000.011001044.x
   Sawase T, 1999, Clin Implant Dent Relat Res, V1, P92, DOI 10.1111/j.1708-8208.1999.tb00097.x
   Sennerby L, 2000, APPL OSSEOINTEGR RES, V1, P31
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Szabo G, 1999, J LONG-TERM EFF MED, V9, P247
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Velich N, 2002, J CRANIOFAC SURG, V13, P636, DOI 10.1097/01.SCS.0000026450.58930.8B
   Vincent Crisl B., 1999, HDB MONOCHROMATIC XP
   WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1
   Wieland M, 2001, INT J ORAL MAX IMPL, V16, P163
NR 36
TC 3
Z9 3
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2005
VL 16
IS 1
BP 31
EP 36
DI 10.1097/00001665-200501000-00008
PG 6
WC Surgery
SC Surgery
GA 886GR
UT WOS:000226215400008
PM 15699642
DA 2018-10-19
ER

PT J
AU Moreira-Gonzalez, A
   Lobocki, C
   Barakat, K
   Andrus, L
   Bradford, M
   Gilsdorf, M
   Jackson, IT
AF Moreira-Gonzalez, A
   Lobocki, C
   Barakat, K
   Andrus, L
   Bradford, M
   Gilsdorf, M
   Jackson, IT
TI Evaluation of 45S5 bioactive glass combined as a bone substitute in the
   reconstruction of critical size calvarial defects in rabbits
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE biomaterials; Bioglass (R); critical size defect; periosteal cells;
   tissue engineering
ID CULTURED PERIOSTEAL CELLS; IN-VITRO; BIOGLASS; VIVO; DIFFERENTIATION;
   HYDROXYAPATITE; PROLIFERATION
AB Biomaterial research and tissue engineering have guided new developments in bone replacement. In this study, the osteoconductive and osteoinductive properties of 45S5 Bioglass(R) (Novabone-C/M(R), Porex Surg., Newnan, GA), granules as a bone replacement material for large calvarial defects were evaluated. Rabbit periosteal cells were expanded in culture and used in vivo. Alkaline-phosphatase assay, collagen type I, and calcium expression were applied to confirm osteoblast phenotype. In the in vivo phase, a 15-mm diameter critical size calvarial defect was created in rabbits (n = 14). The defect was reconstructed according to four treatment groups: autogenous bone (n = 2), Bioglass alone (n = 2), Bioglass + bone (n = 5), Bioglass + periosteal cells (n = 5). The animals were killed 12 weeks after surgery, and the samples were analyzed. Periosteal cells grew successfully in vitro. Because of their fast proliferation and potential to differentiate into osteoblasts, they were an excellent source of cells for bone tissue engineering. The best ossification was seen when autogenous bone was used (79.4% ossified), whereas only 8.2% of the defect in the Bioglass group showed ossification. Addition of bone or cells to the Bioglass increased the area of ossification to 42.7% and 30.2%, respectively. Defects replaced with Bioglass showed varying degrees of inflammatory reaction because of the intense cell-mediated biodegradation process. Based on these findings, the use of Bioglass granules to repair large craniofacial defects cannot be advised.
C1 Inst Craniofacial & Reconstruct Surg, Southfield, MI 48075 USA.
   Providence Hosp, Dept Res, Southfield, MI 48037 USA.
RP Jackson, IT (reprint author), Inst Craniofacial & Reconstruct Surg, 16001 W Nine Mile Rd,3rd Floor Fisher Ctr, Southfield, MI 48075 USA.
EM ianjackson@juno.com
CR Al Ruhaimi KA, 2001, INT J ORAL MAX IMPL, V16, P105
   BERGMAN SA, 1995, BIOCERAMICS, V8, P17
   Breitbart AS, 1999, ANN PLAS SURG, V42, P488, DOI 10.1097/00000637-199905000-00005
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Dodde R, 2000, J CRANIOFAC SURG, V11, P346, DOI 10.1097/00001665-200011040-00013
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Fukuta K, 1992, J Craniofac Surg, V3, P25, DOI 10.1097/00001665-199207000-00010
   GUERRIERO C, 1995, ITAL J ANAT EMBRYO S, V1, P83
   Hankey DP, 2001, ACTA ORTHOP SCAND, V72, P395, DOI 10.1080/000164701753542069
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Isogai N, 2000, PLAST RECONSTR SURG, V105, P953, DOI 10.1097/00006534-200003000-00019
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kinnunen I, 2000, J CRANIO MAXILL SURG, V28, P229, DOI 10.1054/jcms.2000.0140
   Lovelace TB, 1998, J PERIODONTOL, V69, P1027, DOI 10.1902/jop.1998.69.9.1027
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   MERWIN GE, 1986, ARCH OTOLARYNGOL, V112, P280
   NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Peltola MJ, 2001, J BIOMED MATER RES, V58, P261, DOI 10.1002/1097-4636(2001)58:3<261::AID-JBM1015>3.3.CO;2-Z
   RIZZI SC, 2001, J BIOMED MATER RES, V15, P55
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
   Shapoff C A, 1997, Compend Contin Educ Dent, V18, P352
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   STANLEY HR, 1987, J PROSTHET DENT, V58, P607, DOI 10.1016/0022-3913(87)90393-3
   Suominen E, 1996, SCAND J PLAST RECONS, V30, P281, DOI 10.3109/02844319609056406
   Takushima A, 1998, J SURG RES, V78, P68, DOI 10.1006/jsre.1998.5378
   Voegele TJ, 2000, ANTICANCER RES, V20, P3575
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 32
TC 24
Z9 28
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2005
VL 16
IS 1
BP 63
EP 70
DI 10.1097/00001665-200501000-00013
PG 8
WC Surgery
SC Surgery
GA 886GR
UT WOS:000226215400013
PM 15699647
DA 2018-10-19
ER

PT J
AU Fujisawa, S
   Ishihara, M
   Kadoma, Y
AF Fujisawa, S
   Ishihara, M
   Kadoma, Y
TI H-1 and C-13 NMR chemical shifts of methacrylate molecules associated
   with DMPC and/or DPPC liposomes
SO JOURNAL OF LIPOSOME RESEARCH
LA English
DT Article
DE dimethacrylates; DPPC liposomes; interaction; NMR chemical shifts; DSC;
   PM3
ID DIPALMITOYLPHOSPHATIDYLCHOLINE DPPC; PHOSPHOLIPID LIPOSOMES;
   CYTOTOXICITY; MONOMERS; CONTACT; MODEL
AB In the light of recent developments, changes in H-1 and C-13 NMR chemical shifts of methacrylate molecule associated with DMPC (L-alpha dimyristoylphosphatidylcholine) or DPPC (L-alpha-dipalmitoylphosphatidylcholine) liposomes as a model for mimic native lipid bilayers were studied at 30, 37. and 52 degrees C. The chemical shifts of 3Ha, 3C and 4C resonances in methacrylates (see Fig. 2) were greatly shifted higherfield, suggesting the methacrylate molecule-lipid bilayer interaction. Comparison of the findings with methyl methacrylate (MMA), ethylene dimethacrylate (EDMA), and triethyleneglycol dimethacrylate (TEGDMA) revealed that the interaction of dimethacrylates (EDMA, TEGDMA) was greater than monomethacrylate, MMA. Their interaction with DMPC liposomes was also judged by a differential scanning calorimetry (DSC), indicating that the interaction was charcterized by decreasing the enthalpy, entropy, and transition cooerativity. The evidence of the upfield NMR-shifts for methacrylate molecules was also judged by the descriptors such as the reactivity (HOMO-LUMO energy) and the electrostatic function (partial charges) between methacrylate molecules and DPPC calculated by, a PM 3 semiempirical MO method. The upfield NMR shifts were considerably well interpreted from the descriptors. NMR screening technique in methacrylates to phospholipid targets would be highly valuable in biomaterial developments.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
CR Abou-Donia MB, 2000, J TOXICOL ENV HEAL A, V59, P97, DOI 10.1080/009841000157005
   BERGERON RJ, 1977, J AM CHEM SOC, V99, P5146, DOI 10.1021/ja00457a040
   Cristian L, 2003, P NATL ACAD SCI USA, V100, P14772, DOI 10.1073/pnas.2536751100
   FUJISAWA S, 1981, Journal of Biomedical Materials Research, V15, P787, DOI 10.1002/jbm.820150603
   FUJISAWA S, 1988, J DENT RES, V67, P1438, DOI 10.1177/00220345880670111501
   Fujisawa S, 1998, J THERM ANAL CALORIM, V51, P151, DOI 10.1007/BF02719018
   Fujisawa S, 2000, ORAL DIS, V6, P215
   Fujisawa S, 2004, J LIPOSOME RES, V14, P39, DOI 10.1081/LPR-120039662
   FUJISAWA S, 1982, J DENT RES, V61, P1206, DOI 10.1177/00220345820610102101
   Fujisawa S, 2001, ARTIF CELL BLOOD SUB, V29, P245, DOI 10.1081/BIO-100103048
   FUJISAWA S, 1984, J BIOMED MATER RES, V18, P1105, DOI 10.1002/jbm.820180912
   Henry JC, 2002, CLIN ORTHOP RELAT R, P231
   Iguchi I, 1996, J BIOMED MATER RES, V32, P349
   LAWRENCE WH, 1972, J DENT RES, V51, P526, DOI 10.1177/00220345720510024701
   McLaren E A, 1999, Pract Periodontics Aesthet Dent, V11, P423
   Merkhan IK, 2004, J BIOMED MATER RES A, V69A, P577, DOI 10.1002/jbm.a.30033
   ORITA Y, 1992, THESIS TOKYO I TECHN
   Rahman A., 1986, NUCL MAGNETIC RESONA
   Rustemeyer T, 1998, TOXICOL APPL PHARM, V148, P83, DOI 10.1006/taap.1997.8304
   Samuni AM, 1998, J THERM ANAL CALORIM, V51, P37, DOI 10.1007/BF02719009
   Stockman BJ, 2002, PROG NUCL MAG RES SP, V41, P187, DOI 10.1016/S0079-6565(02)00049-3
   WOOD DJ, 1977, J AM CHEM SOC, V99, P1735, DOI 10.1021/ja00448a009
NR 22
TC 1
Z9 1
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0898-2104
J9 J LIPOSOME RES
JI J. Liposome Res.
PY 2005
VL 15
IS 3-4
BP 167
EP 174
DI 10.1080/08982100500364172
PG 8
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 997UB
UT WOS:000234273200003
PM 16393908
DA 2018-10-19
ER

PT J
AU Hurteaux, R
   Benhayoune, H
   Edwards-Levy, F
   Bouthors, S
   Balossier, G
   Laurent-Maquin, D
AF Hurteaux, R
   Benhayoune, H
   Edwards-Levy, F
   Bouthors, S
   Balossier, G
   Laurent-Maquin, D
TI Preparation and characterization of an electrodeposited calcium
   phosphate coating associated with a calcium alginate matrix
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HYDROXYAPATITE COATINGS; MECHANICAL-PROPERTIES; COATED BEADS; STABILITY
AB A new way of optimizing osteoconduction of biomaterials is to bring to them biological properties. In this work, we associated a novel release system with an electrodeposited calcium phosphate (CaP) coated titanium alloy Ti6AI4V. The characterization of this material was performed by means of light microscopy, scanning electron microscopy (SEM), scanning transmission electron microscopy (STEM) and X-ray energy dispersive spectroscopy (EDXS). The electrodeposited CaP coating was a tricalcium phosphate, and the release system was composed of microcapsules entrapped in an alginate film. We observed that the alginate matrix had a close contact with the coating. An intermediate layer containing calcium and phosphorus appeared at the interface between the alginate matrix and the CaP coating. These results allowed us to conclude that the association of two techniques, i.e. electrodeposition followed by deposition of a calcium alginate matrix, led to the elaboration of a new biomaterial. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Reims, INSERM, ERM 203, IFR 53, F-51095 Reims, France.
   Univ Reims, CNRS UMR 6013, Lab Pharmacotech, IFR 53, F-51095 Reims, France.
RP Hurteaux, R (reprint author), Univ Reims, INSERM, ERM 203, IFR 53, 1 Rue Marechal Juin, F-51095 Reims, France.
EM reynald.hurteaux@univ-reims.fr
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771; Edwards-Levy,
   Florence/0000-0002-5271-5281
CR Benhayoune H, 2002, J MATER SCI-MATER M, V13, P1057, DOI 10.1023/A:1020348807133
   Carin M, 2003, BIOTECHNOL BIOENG, V82, P207, DOI 10.1002/bit.10559
   Edwards-Levy F, 1999, BIOMATERIALS, V20, P2069, DOI 10.1016/S0142-9612(99)00111-8
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Han Y, 1999, J MATER SCI-MATER M, V10, P243, DOI 10.1023/A:1008914330004
   Han Y, 2001, J BIOMED MATER RES, V54, P96, DOI 10.1002/1097-4636(200101)54:1<96::AID-JBM11>3.3.CO;2-L
   JIANQI H, 2002, ORAL MAXILLOFAC SURG, V60, P1449
   Joly A, 1997, TRANSPLANTATION, V63, P795, DOI 10.1097/00007890-199703270-00002
   Levy MC, 1996, J MICROENCAPSUL, V13, P169, DOI 10.3109/02652049609052905
   SHIKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415
   Shinya E, 1999, BIOMED PHARMACOTHER, V53, P471, DOI 10.1016/S0753-3322(00)88106-8
   WANG BC, 1995, J BIOMED MATER RES, V29, P1483, DOI 10.1002/jbm.820291204
   YANG CY, 1995, J MATER SCI-MATER M, V6, P249, DOI 10.1007/BF00120267
NR 13
TC 5
Z9 5
U1 2
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2005
VL 16
IS 1
BP 9
EP 13
DI 10.1007/s10856-005-6440-6
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KV
UT WOS:000227282300002
PM 15754138
DA 2018-10-19
ER

PT J
AU Wiedmann-Al-Ahmad, M
   Gutwald, R
   Gellrich, NC
   Hubner, U
   Schmelzeisen, R
AF Wiedmann-Al-Ahmad, M
   Gutwald, R
   Gellrich, NC
   Hubner, U
   Schmelzeisen, R
TI Search for ideal biomaterials to cultivate human osteoblast-like cells
   for reconstructive surgery
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-FORMATION; ALKALINE-PHOSPHATASE; IMPLANTS; COMPLICATIONS; DEFECTS
AB In this study we cultured human osteoblast-like cells on 16 different biomaterials to find an optimal biomaterial for subsequent use in reconstructive surgery. The tested biomaterials can be divided into five groups: collagen-based membranes of bovine, equine or calf origin, tricalcium phosphate based membranes (alpha and beta), hyaluronic acid based, anorganic bovine bone and anorganic silicone-based membranes. Cell proliferation and cell colonization (Environmental Scanning Electron Microscope, ESEM) analysis were performed.
   The results of the study demonstrated that four of the examined biomaterial/cell constructs showed a very good proliferation rate and cell density: No. 3 (Tissue Vlies(R)), No. 7 (Sepra film), No. 16 (Biobrane(R)) and No. 17 (Biomend(TM)). No favourable group of biomaterials was noticeable. Moreover, the results indicate that these four biomaterials as a part of bone constructs are the best tools for engineering new bone tissue. In contrast, biomaterials No. 19a (Bio-Oss(R)) and 19b (Bio-Oss(R) Collagen) showed the lowest proliferation rates. The result of No. 19b was improved by treatment in the perfusion chamber for 48 h as well as by additional use of vacuum. The present study is an important base for further analysis of biomaterials and consequentely for the development of tissue engineering. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Freiburg, Klin & Poliklin Mund Kiefer & Gesichtschirurg, D-79106 Freiburg, Germany.
RP Wiedmann-Al-Ahmad, M (reprint author), Univ Freiburg, Klin & Poliklin Mund Kiefer & Gesichtschirurg, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM wiedmannalahmad@t-online.de
OI Schmelzeisen, Rainer/0000-0002-9686-6989
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Alpar B, 2000, Clin Oral Investig, V4, P219, DOI 10.1007/s007840000079
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   Behrens P, 2000, ORTHOPADE, V29, P129
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Cancian DCJ, 1999, INT J ORAL MAX IMPL, V14, P859
   CARMICHAEL J, 1987, CANCER RES, V47, P943
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   DUTTING A, 1988, Z ORTHOP GRENZGEB, V126, P44, DOI 10.1055/s-2008-1044866
   GRUSHKINLERNER L, 1995, CELL LINE, V5, P1
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   HYLDSTRUP L, 1988, SCAND J CLIN LAB INV, V48, P611, DOI 10.3109/00365518809085780
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Mailhot JM, 1998, CLIN ORAL IMPLAN RES, V9, P43, DOI 10.1034/j.1600-0501.1998.090106.x
   NEFFUSI JR, 1985, DIFFERENTIATION, V25, P711
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Pinholt EM, 1991, SCAND J DENT RES, V99, P1
   Saad B, 2000, ARTIF ORGANS, V24, P939, DOI 10.1046/j.1525-1594.2000.06664.x
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   WERGEDAL JE, 1984, P SOC EXP BIOL MED, V176, P60
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 24
TC 28
Z9 31
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2005
VL 16
IS 1
BP 57
EP 66
DI 10.1007/s10856-005-6447-z
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KV
UT WOS:000227282300009
PM 15754145
DA 2018-10-19
ER

PT J
AU Ng, AMH
   Bin Saim, A
   Tan, KK
   Tan, GH
   Mokhtar, SA
   Rose, IM
   Othman, F
   Idrus, RBH
AF Ng, AMH
   Bin Saim, A
   Tan, KK
   Tan, GH
   Mokhtar, SA
   Rose, IM
   Othman, F
   Idrus, RBH
TI Comparison of bioengineered human bone construct from four sources of
   osteogenic cells
SO JOURNAL OF ORTHOPAEDIC SCIENCE
LA English
DT Article
DE bone tissue engineering; periosteum; bone marrow; cancellous bone;
   cortical bone
ID STEM-CELLS
AB Osteoprogenitor cells have been reported to be present in periosteum, cancellous, and cortical bone. and bone marrow but no attempt to identify the best cell source for bone tissue engineering has yet been reported. In this study. we aimed to investigate the growth and differentiation pattern of cells derived from these four sources in terms of cell doubling time and expression of osteoblast-specific markers in both monolayer cells and three-dimensional cell constructs in vitro. In parallel, human plasma derived-fibrin was evaluated for use as biomaterial when forming three-dimensional bone constructs. Our findings showed osteoprogenitor cells derived from periosteum to be most proliferative followed by cortical bone, cancellous bone, and then bone marrow aspirate. Bone-forming activity was observed in constructs formed with cells derived from periosteum, whereas calcium deposition was seen throughout the constructs formed with cells derived from cancellous and cortical bones. Although no mineralization activity was seen in constructs formed with osteoprogenitor cells derived from bone marrow, well-organized lacunae as would appear in the early phase of bone reconstruction were noted. Scanning electron microscopy evaluation showed cell proliferation throughout the fibrin matrix, suggesting the possible application of human fibrin as the bioengineered tissue scaffold at non-load-bearing sites.
C1 Hosp Univ Kebangsaan Malaysia, Tissue Engn Lab, Kuala Lumpur, Malaysia.
   Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Kuala Lumpur, Malaysia.
   Hosp Univ Kebangsaan Malaysia, Dept Orthopaed & Traumatol, Kuala Lumpur, Malaysia.
   Hosp Univ Kebangsaan Malaysia, Dept Pathol, Kuala Lumpur, Malaysia.
   Univ Putra Malaysia, Fac Med & Hlth Sci, Selangor, Malaysia.
   Univ Kebangsaan Malaysia, Dept Physiol, Kuala Lumpur 50300, Malaysia.
RP Idrus, RBH (reprint author), Hosp Univ Kebangsaan Malaysia, Tissue Engn Lab, Kuala Lumpur, Malaysia.
CR AMINUDDIN BS, 2000, LARYNGOSCOPE, V110, P1894
   AMINUDDIN BS, 2003, KPJ MED J, V1, P3
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   BIANFI A, 2000, EXP HEMATOL, V28, P707
   Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Muschler GF, 2002, CLIN ORTHOP RELAT R, P66, DOI 10.1097/00003086-200202000-00008
   Perka C, 2001, TISSUE ENG, V7, P359, DOI 10.1089/10763270152044215
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   RUSZYMAH BHI, 2002, P 5 INT M TESI DEC 8
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
NR 13
TC 31
Z9 42
U1 1
U2 1
PU SPRINGER TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 0949-2658
J9 J ORTHOP SCI
JI J. Orthop. Sci.
PY 2005
VL 10
IS 2
BP 192
EP 199
DI 10.1007/s00776-004-0884-2
PG 8
WC Orthopedics
SC Orthopedics
GA 916XP
UT WOS:000228420400012
PM 15815868
DA 2018-10-19
ER

PT B
AU Lu, L
   Dembzynski, RS
   Mondrinos, MJ
   Wootton, D
   Lelkes, PI
   Zhou, J
AF Lu, Lin
   Dembzynski, Robert S.
   Mondrinos, Mark J.
   Wootton, David
   Lelkes, Peter I.
   Zhou, Jack
GP ASME
TI Manufacturing system development for fabrication of bone scaffold
SO Manufacturing Engineering and Materials Handling, 2005 Pts A and B
SE Manufacturing Engineering Division of the American Society of Mechanical
   Engineers
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 05-11, 2005
CL Orlando, FL
SP ASME, Proc Ind Div, ASME, Rail Transportat Div, ASME, Noise Control & Acoust Div, ASME, Triol Div, ASME, Pressure Vessels & Piping Div, ASME, Bioengn Div, ASME, Mat Div, ASME, Appl Mech Div, ASME, Fluids Engn Div, ASME, Micro Elect Mech Syst Div, ASME, Heat Transfer Div, ASME, Nucl Engn Div, ASME, Power Div, ASME, Solar Energy Div, ASME, Safety Engn & Risk Anal Div, ASME, Technol & Soc Div, ASME, Adv Energy Syst Div, ASME, Aerosp Div, ASME, Comp & Informat Engn Div
ID PHOSPHATE COMPOSITE SCAFFOLD; RESORBABLE POLYMERS; TISSUE; CHEMISTRY;
   ACID)
AB Musculoskeletal conditions are a major health concern in United States because of a large aging population and increased occurrence of sport-related injuries. The need for bone substitutes is especially important. Traditional treatments of bone-defect have many of limitations. Bone tissue engineering may offer a less painful alternative to traditional bone grafts with lower risk of infection. This research integrates biomimetic modeling, solid freeform fabrication (SFF), systems and control, and tissue engineering in one intelligent system for structured, highly porous biomaterials, which will be applied to bone scaffolds. Currently a new SFF-based fabrication system has been developed, which uses a pressurized extrusion to print highly biocompatible and water soluble sucrose bone scaffold porogens. To date, this system can build simple bone structures. In parallel we are utilizing a commercial rapid prototyping (RP) machine to fabricate thermoplastic porogens of various designs to determine the feasibility of injecting a highly viscous scaffold material into porogens. Materials which have been successfully used to make scaffolds by injection include calcium phosphate cement (CPC), molten poly-caprolactone (PCL), 90/10 and 80/20 (v/v %) composite of PCL and calcium phosphate (CaPO4,). Results presented for the injection method include characterization of attainable feature resolution of the RP machine, as well as preliminary cell-biomaterial interaction data demonstrating biocompatibility of CPC scaffolds. The preliminary results using a commercial rapid prototyping machine have demonstrated that the indirect porogen technique can improve 2-4 folds the resolution of SFF system in fabricating bone scaffolds. The resultant scaffolds demonstrate that the defined porous structures will be suitable for tissue engineering applications.
C1 Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Lu, L (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
CR Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   CHEN CS, 1995, BIOMATERIALS, V16, P777, DOI 10.1016/0142-9612(95)99640-8
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   COOMBES AGA, 1992, BIOMATERIALS, V13, P297, DOI 10.1016/0142-9612(92)90053-Q
   COOMBES AGA, 1992, BIOMATERIALS, V13, P217, DOI 10.1016/0142-9612(92)90187-S
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gadzag A., 1995, J AM ACAD ORTHOP SUR, V3, P1
   HAINES AH, 1981, ADV CARBOHYD CHEM BI, V39, P13
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   KELLY EB, NEW FRONTIERS BONE G
   KHAN R, 1984, PURE APPL CHEM, V56, P833, DOI 10.1351/pac198456070833
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   LANGE AE, 1994, SAMPE J, V30
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nikolaychik VV, 1996, J BIOMAT SCI-POLYM E, V7, P881, DOI 10.1163/156856296X00057
   Nikolaychik VV, 1996, ASAIO J, V42, pM487, DOI 10.1097/00002480-199609000-00035
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   PORTER NL, FABRICATION POROUS C
   RUBIO E, 1991, J AM CHEM SOC, V113, P695, DOI 10.1021/ja00002a060
   RUHE PQ, 2003, J BONE JOINT SURG, P75
   Singhal A R, 1996, Tissue Eng, V2, P197, DOI 10.1089/ten.1996.2.197
   Sodian R., 2000, ASAIO J, V46, P238
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
NR 32
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4223-1
J9 MANUF ENG DIV ASME
PY 2005
VL 16
BP 127
EP 136
PN 1-2
PG 10
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BFI47
UT WOS:000242016100017
DA 2018-10-19
ER

PT B
AU Stone, JJS
   Wang, FW
   O'Driscoll, SW
   An, KN
AF Stone, James J-S
   Wang, Francis W.
   O'Driscoll, Shawn W.
   an, Kai-N An
GP ASME
TI Computer-aided design, manufacturing and modeling of polymer scaffolds
   for tissue engineering
SO MANUFACTURING ENGINEERING AND MATERIALS HANDLING, 2005 PTS A AND B
SE Manufacturing Engineering Division of the American Society of Mechanical
   Engineers
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 05-11, 2005
CL Orlando, FL
SP ASME, Proc Ind Div, ASME, Rail Transportat Div, ASME, Noise Control & Acoust Div, ASME, Triol Div, ASME, Pressure Vessels & Piping Div, ASME, Bioengn Div, ASME, Mat Div, ASME, Appl Mech Div, ASME, Fluids Engn Div, ASME, Micro Elect Mech Syst Div, ASME, Heat Transfer Div, ASME, Nucl Engn Div, ASME, Power Div, ASME, Solar Energy Div, ASME, Safety Engn & Risk Anal Div, ASME, Technol & Soc Div, ASME, Adv Energy Syst Div, ASME, Aerosp Div, ASME, Comp & Informat Engn Div
ID RAPID PROTOTYPING TECHNIQUES; IN-VITRO; ORTHOPEDIC IMPLANTS; DEPOSITION;
   FABRICATION; COMPOSITE; CARTILAGE; VIVO
AB A custom computer-controlled rapid prototyping system was designed and developed in this research. This system for bio-manufacturing of polymer scaffolds included 3D motion control components, a nozzle, a pressure controller, and a temperature-control led reservoir containing a biomaterial. Heating elements built into the reservoir melted the biomaterial. The pressure line attached to the reservoir provided a controllable force that extruded the polymer biomaterial through the nozzle and deposited the polymer biomaterial onto a platform to fabricate scaffolds. A low pressure (830 KPa) system was designed and fabricated to accommodate different temperatures, motion speeds, and viscosities of polymer biomaterials. The reservoir with the nozzle was mounted to servo motor-controlled linear x-y motion devices along with a third servo motor-controlled device that controlled the z-position of the platform. Poly(epsilon-caprolactone) [PCL] was used to fabricate scaffolds with designed structure that were used in cell and tissue regeneration studies. 3D computer-aided design (CAD) with Pro-Engineer and computational finite element analysis (FEA) programs with MSC_Patran and MSC_Marc were used to model scaffold designs with appropriate architecture and material selection. The CAD models were used in FEA to develop new methods for determining mechanical properties of tissue scaffolds of desired structure and geometry. FEA models were validated by mechanical testing and other published results. Technology developed in this research has potential for the advancement of bio-manufacturing, and design optimization of scaffolds for tissue engineering.
C1 N Dakota State Univ, Dept Engn Mech, Fargo, ND 58105 USA.
RP Stone, JJS (reprint author), N Dakota State Univ, Dept Engn Mech, Fargo, ND 58105 USA.
OI O'Driscoll, Shawn/0000-0002-8225-3372
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Anseth KS, 1996, MACROMOL CHEM PHYSIC, V197, P833, DOI 10.1002/macp.1996.021970306
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Bronzino J D, 2000, BIOMEDICAL ENG HDB
   Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3
   DENIZ A, 2000, J MICROMECH MICROENG, V10, P80
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Patrick C. W., 1998, FRONTIERS TISSUE ENG
   Quinn T P, 2004, Biomed Sci Instrum, V40, P249
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 27
TC 0
Z9 0
U1 1
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4223-1
J9 MANUF ENG DIV ASME
PY 2005
VL 16
BP 169
EP 174
PG 6
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BFI47
UT WOS:000242016100022
DA 2018-10-19
ER

PT J
AU Nash, SMB
   McMahon, K
   Eaglesham, G
   Muller, JF
AF Nash, SMB
   McMahon, K
   Eaglesham, G
   Muller, JF
TI Application of a novel phytotoxicity assay for the detection of
   herbicides in Hervey Bay and the Great Sandy Straits
SO MARINE POLLUTION BULLETIN
LA English
DT Article; Proceedings Paper
CT Conference for Reef Research
CY MAR, 2004
CL Townsville, AUSTRALIA
DE herbicides; phytotoxicity; bioassay; aquatic; toxicity equivalents;
   diuron
ID CHLOROPHYLL FLUORESCENCE; QUANTUM YIELD; WATER; ATRAZINE; SENSITIVITY;
   AUSTRALIA; RECOVERY; MOVEMENT; TOXICITY; SEAGRASS
AB A novel phytotoxicity assay was incorporated into an environmental assessment of Hervey Bay and the Great Sandy Straits, to investigate the role of run-off associated herbicides in the deteriorated health of intertidal seagrass meadows. Dose response curves of common herbicides were performed and their toxicity equivalents elucidated to assist in analysis. The results of the assay were reproducible and corresponded strongly with results of chemical analyses. The incorporation of the assay into the assessment of surface waters added an important aspect to the study by allowing investigation of the toxicity of cumulative herbicide concentrations and yielding biologically relevant data. The highest herbicide concentration detected during the study was equivalent to 0.23 mu g 1(-1) diuron; a concentration known to inhibit photosynthetic efficiency of the assay biomaterial by approximately 3%. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld 4108, Australia.
   Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia.
   Queensland Hlth Sci Serv, Brisbane, Qld 4108, Australia.
RP Nash, SMB (reprint author), Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld 4108, Australia.
EM s.nash@uq.edu.au
RI Bengtson Nash, Susan/I-3942-2015; Mueller, Jochen/C-6241-2008
OI Bengtson Nash, Susan/0000-0001-5928-0850; McMahon,
   Kathryn/0000-0003-4355-6247; Mueller, Jochen/0000-0002-0000-1973
CR Altenburger R, 2000, ENVIRON TOXICOL CHEM, V19, P2341, DOI 10.1897/1551-5028(2000)019<2341:POTTOM>2.3.CO;2
   Carter AD, 2000, WEED RES, V40, P113, DOI 10.1046/j.1365-3180.2000.00157.x
   EGGEN RIL, 2004, ENV SCI TECHNOL 0201, P58
   ElJay A, 1996, ARCH ENVIRON CON TOX, V31, P84, DOI 10.1007/BF00203911
   Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4
   GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9
   GLOTFELTY DE, 1984, J ENVIRON QUAL, V13, P115, DOI 10.2134/jeq1984.00472425001300010021x
   HAMILTON D, 1996, PESTICIDES FERTILISE
   HAYNES D, 2000, REEF RES AUSTR, P3
   Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153
   Koblizek M, 1998, BIOTECHNOL BIOENG, V60, P664, DOI 10.1002/(SICI)1097-0290(19981220)60:6<664::AID-BIT3>3.0.CO;2-B
   Kreuger J, 1998, SCI TOTAL ENVIRON, V216, P227, DOI 10.1016/S0048-9697(98)00155-7
   LARSON SJ, 1995, CHEMOSPHERE, V31, P3305, DOI 10.1016/0045-6535(95)00176-9
   Longstaff BJ, 1999, J EXP MAR BIOL ECOL, V234, P1, DOI 10.1016/S0022-0981(98)00137-3
   MARTY JL, 1995, TRAC-TREND ANAL CHEM, V14, P329, DOI 10.1016/0165-9936(95)97060-E
   MCMAHON K, 2004, IN PRESS MARINE POLL
   NASH SMB, 2004, IN PRESS BIOSENSORS
   PEZZULLO J, 2004, INTERACTIVE STAT PAG
   PREEN AR, 1995, AQUAT BOT, V52, P3, DOI 10.1016/0304-3770(95)00491-H
   *RAMS CONV SECR, 2004, RAMS SIT DAT SERV
   Schreiber U, 2002, PHOTOSYNTH RES, V74, P317, DOI 10.1023/A:1021276003145
   SCHREIBER U, 1995, AUST J PLANT PHYSIOL, V22, P209, DOI 10.1071/PP9950209
   SCHREIBER U, 2001, DUAL CHANNES PHOTOSY
   Soukupova J, 1999, PHOTOSYNTHETICA, V37, P209, DOI 10.1023/A:1007051804296
   THOMPSON DG, 1993, ENVIRON TOXICOL CHEM, V12, P1695, DOI 10.1897/1552-8618(1993)12[1695:IOHAMM]2.0.CO;2
   VandenBrink PJ, 1997, ECOTOX ENVIRON SAFE, V38, P13, DOI 10.1006/eesa.1997.1555
   WAUCHOPE RD, 1978, J ENVIRON QUAL, V7, P459, DOI 10.2134/jeq1978.00472425000700040001x
NR 27
TC 14
Z9 15
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-326X
EI 1879-3363
J9 MAR POLLUT BULL
JI Mar. Pollut. Bull.
PY 2005
VL 51
IS 1-4
BP 351
EP 360
DI 10.1016/j.marpolbul.2004.10.017
PG 10
WC Environmental Sciences; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA 911DM
UT WOS:000227981800033
DA 2018-10-19
ER

PT J
AU Mattioli-Belmonte, M
   Gabbanelli, F
   Marcaccio, M
   Giantomassi, F
   Tarsi, R
   Natali, D
   Callegari, A
   Paolucci, F
   Biagini, G
AF Mattioli-Belmonte, M
   Gabbanelli, F
   Marcaccio, M
   Giantomassi, F
   Tarsi, R
   Natali, D
   Callegari, A
   Paolucci, F
   Biagini, G
TI Bio-characterisation of tosylate-doped polypyrrole films for biomedical
   applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE tosylate-doped polypyrrole; over-oxidation; biomaterial
ID CONDUCTING POLYMER; MECHANICAL-PROPERTIES; GLUCOSE-OXIDASE; ADHESION;
   OVEROXIDATION; BIOMATERIALS; MORPHOLOGY
AB Electroactive polymers such as polypyrrole (PPy) are receiving particular interest because they can combine inherent biological properties that can specifically trigger desired cellular responses for many biological applications. The aim of the present work was to evaluate more efficient solutions, achieved by different oxidisations of tosylate-doped PPy films in different chemico-physical conditions. in view of their long-term biomedical applications. The conductivity and the release of the tosylate ion were assessed. Morpho-functional studies were also performed. A gradual increase in impedance of the oxidised tosylate-doped PPy films soaked in MEM and a reduced conductivity after over-oxidation was found. Scanning electron microscopy (SEM) analysis showed the presence of a hierarchical organisation of the PPy films and a partially different morphology between oxidised and over-oxidised films. Cell behaviour was also randomly affected in relation to the oxidative state of the studied Ppy films. On the basis of the results, growth of these tosylate-doped Ppy films directly in the sol-gel matrix or on the surface of metal alloys could be hypothesised in order to improve bioactive material of potential use in modern regenerative medicine. However, in view of their in vivo application, over-oxidation must be considered as it may represent the degraded material that is likely to form under a biological oxidising environment. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Politecn Marche, Ist Morfol Umana Normale, Fac Med & Chirurg, I-60020 Ancona, Italy.
   Univ Bologna, Dipartimento Chim Ciamician, Bologna, Italy.
   Univ Politecn Marche, Ist Microbiol & Sci Biomed, Ancona, Italy.
RP Mattioli-Belmonte, M (reprint author), Univ Politecn Marche, Ist Morfol Umana Normale, Fac Med & Chirurg, Via Tronto 10-A, I-60020 Ancona, Italy.
EM belmonte@univpm.it
RI Mattioli-Belmonte, Monica/J-5861-2012; Paolucci, Francesco/A-8708-2008
OI Paolucci, Francesco/0000-0003-4614-8740
CR Aoki T, 1996, BIOMATERIALS, V17, P1971, DOI 10.1016/0142-9612(96)00015-4
   BECK F, 1987, BER BUNSEN PHYS CHEM, V91, P967, DOI 10.1002/bbpc.19870910927
   Cen L, 2003, BIOSENS BIOELECTRON, V18, P363, DOI 10.1016/S0956-5663(02)00149-5
   CHEN Y, 2000, ANALYST, V225, P2249
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DIAZ AF, 1983, IBM J RES DEV, V27, P342, DOI 10.1147/rd.274.0342
   DIAZ AF, 1986, HDB CONDUCTING POLYM, V1, P81
   DUFFITT GL, 1992, J CHEM SOC FARADAY T, V88, P1417, DOI 10.1039/ft9928801417
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   HEINZE J, 2001, ORGANIC ELECTROCHEMI, P1309
   KANATZIDIS MG, 1990, CHEM ENG NEWS, V68, P36, DOI 10.1021/cen-v068n049.p036
   KO JM, 1994, SYNTHETIC MET, V64, P9, DOI 10.1016/0379-6779(94)90267-4
   Lombello CB, 2002, J MATER SCI-MATER M, V13, P867, DOI 10.1023/A:1016552413295
   Long LH, 2001, BIOCHEM BIOPH RES CO, V286, P991, DOI 10.1006/bbrc.2001.5514
   LYONS MEG, 1993, ANALYST, V118, P361, DOI 10.1039/an9931800361
   MATTJOLIBELMONT.M, 2002, 65 NANOMED, V65
   NOFTLE RE, 1987, J ELECTROANAL CHEM, V227, P229, DOI 10.1016/0022-0728(87)80078-5
   PANDE R, 1993, MATER RES SOC SYMP P, V292, P135
   PICKUP PG, 1999, MOD ASPECT ELECTROC, P33
   PREZYNA LA, 1991, MACROMOLECULES, V24, P5283, DOI 10.1021/ma00019a010
   Rodriguez I, 2000, J ELECTROANAL CHEM, V491, P117, DOI 10.1016/S0022-0728(00)00194-7
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Van der Pauw L.J., 1958, Philips Research Reports, V13, P1
   WARREN LF, 1989, J ELECTROCHEM SOC, V136, P2286, DOI 10.1149/1.2097303
   Warriner K, 1997, MAT SCI ENG C-BIOMIM, V5, P81, DOI 10.1016/S0928-4931(97)00026-X
   WYNNE KJ, 1985, MACROMOLECULES, V18, P2361, DOI 10.1021/ma00154a005
   YANG R, 1990, J PHYS CHEM-US, V94, P6117, DOI 10.1021/j100378a087
NR 31
TC 16
Z9 18
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2005
VL 25
IS 1
BP 43
EP 49
DI 10.1016/j.msec.2004.04.002
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 888KH
UT WOS:000226372300007
DA 2018-10-19
ER

PT J
AU Sindut, R
   Cholewa-Kowalska, K
   Najman, J
   Laczka, M
   Karpov, M
   Osyczka, AM
   Leboy, P
AF Sindut, R
   Cholewa-Kowalska, K
   Najman, J
   Laczka, M
   Karpov, M
   Osyczka, AM
   Leboy, P
TI Bioactive glass coatings
SO MATERIALS SCIENCE-POLAND
LA English
DT Article
DE biomaterials; bioactivity; sol-gel method
ID CELL-DIFFERENTIATION; CERAMICS
AB Four kinds of gel-derived materials of the CaO-P2O5-SiO2 (S2, II, I, A2) system were obtained in the form of thin coatings on microscope slides. The obtained materials differed from each other in the ratio of the basic components (CaO and SiO2). The coatings were characterised with regard to the state of the surface as well as to the phase composition of the materials. In order to determine any bioactive properties of the gel-derived coatings in vitro, tests in simulated body fluid (SBF) were made and biochemical examinations using cultured human marrow stromal cells (hMSC) were conducted. It was found that surface crystallisation of hydroxyapatite (HAp) indicating the bioactivity of the material occurred in SBF only in the case of A2 coatings, which are characterised by the highest ratio of CaO: SiO2. Tests with hMSC showed that the A2 biomaterial promotes both the osteogenesis and remodelling of bone (osteoclastogenesis).
C1 AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Glass Technol & Amorphous Coating, PL-30059 Krakow, Poland.
   Cracow Univ Technol, Fac Chem Engn & Technol, PL-31155 Krakow, Poland.
   Univ Penn, Philadelphia, PA 19104 USA.
RP Laczka, M (reprint author), AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Glass Technol & Amorphous Coating, PL-30059 Krakow, Poland.
EM mlaczka@poczta.fm
CR DISLICH H, 1985, J NON-CRYST SOLIDS, V73, P599, DOI 10.1016/0022-3093(85)90379-5
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P78
   Laczka M, 2000, J BIOMED MATER RES, V52, P601, DOI 10.1002/1097-4636(20001215)52:4<601::AID-JBM4>3.3.CO;2-9
   Laczka-Osyczka A, 1998, J BIOMED MATER RES, V42, P433, DOI 10.1002/(SICI)1097-4636(19981205)42:3<433::AID-JBM13>3.0.CO;2-H
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Santos EM, 1998, J BIOMED MATER RES, V41, P87, DOI 10.1002/(SICI)1097-4636(199807)41:1<87::AID-JBM11>3.0.CO;2-E
NR 10
TC 2
Z9 2
U1 0
U2 5
PU OFICYNA WYDAWNICZA POLITECHNIKI WROCLAWSKIEJ
PI WROCLAW
PA WYBRZEZE WYSPIANSKIEGO 27, 50-370 WROCLAW, POLAND
SN 0137-1339
J9 MATER SCI-POLAND
JI Mater. Sci.
PY 2005
VL 23
IS 1
BP 123
EP 136
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 923FU
UT WOS:000228896000013
DA 2018-10-19
ER

PT S
AU Ebenstein, DM
   Park, J
   Kaplan, DL
   Wahl, KJ
AF Ebenstein, DM
   Park, J
   Kaplan, DL
   Wahl, KJ
BE Viney, C
   Katti, K
   Ulm, FJ
   Hellmich, C
TI Nanomechanical and microstructural properties of Bombyx mori silk films
SO Mechanical Properties of Bioinspired and Biological Materials
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Mechanical Properties of Bioinspired and Biological
   Materials held at the 2004 MRS Fall Meeting
CY NOV 29-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc, Hysitron Co
ID SPIDER SILK; FIBROIN; BIOMATERIAL; BEHAVIOR
AB Instrumented indentation and micro-Raman spectroscopy were used to investigate the mechanical and structural properties of Bombyx mori silk films. Twelve different films were prepared from B. mori silk fibroin protein using a variety of post-deposition processing treatments (e.g. soaking in methanol, soaking in water, stretching, and/or enzymatic etching). The results show that different treatments lead to changes in both the conformation of the silk fibroin protein and the mechanical properties of the films.
C1 USN, Res Lab, Div Chem, Washington, DC 20375 USA.
RP Ebenstein, DM (reprint author), USN, Res Lab, Div Chem, Washington, DC 20375 USA.
OI Wahl, Kathryn/0000-0001-8163-6964
CR Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Monti P, 2001, J RAMAN SPECTROSC, V32, P103, DOI 10.1002/jrs.675
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PARK J, 2004, THESIS TUFTS U
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Tsukada M, 1998, J POLYM SCI POL PHYS, V36, P2717, DOI 10.1002/(SICI)1099-0488(19981115)36:15<2717::AID-POLB5>3.3.CO;2-F
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
NR 11
TC 2
Z9 2
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-792-X
J9 MATER RES SOC SYMP P
PY 2005
VL 844
BP 107
EP 112
PG 6
WC Materials Science, Biomaterials; Materials Science, Characterization &
   Testing
SC Materials Science
GA BCF71
UT WOS:000229087800015
DA 2018-10-19
ER

PT B
AU Narayan, RJ
   Bell, BF
AF Narayan, R. J.
   Bell, B. F., Jr.
BE Helmus, M
   Medlin, D
TI Pulsed laser deposition of diamondlike carbon-hydroxyapatite composites
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
ID THIN-FILMS; COATINGS; TITANIUM
AB Hydroxyapatite (HA) mimics the behavior of natural bone, and provides a strong, long-lasting adhesive interface between a bone replacement implant and the surrounding tissue. HA is not commonly used in practice for large weight-bearing implants because studies suggest that delamination of the hydroxyapatite film may lead to implant wear and loosening. Furthermore, the hydroxyapatite coating also acts only as a temporary barrier to ion release from the bulk biomaterial. We developed a diamondlike carbon (DLC)/HA bilayer. The underlying titanium substrate is first coated with DLC using pulsed laser deposition (PLD). The DLC surface is then coated with HA to form the final bilayer material. The films were characterized using SEM, TEM, XRD, Raman spectroscopy, and mechanical testing. These composite hydroxyapatite/diamondlike carbon bilayers are promising for use in several different orthopaedic and dental implant designs.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Narayan, RJ (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RI Narayan, Roger/J-2789-2013
OI Narayan, Roger/0000-0002-4876-9869
CR ALLEN MJ, 1995, T ORTHOP RES SOC, V20, P489
   BRULEY J, 1995, J MICROSC-OXFORD, V180, P22, DOI 10.1111/j.1365-2818.1995.tb03653.x
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   DONNET C, 1994, SURF COAT TECH, V68, P626, DOI 10.1016/0257-8972(94)90228-3
   HAYASHI K, 1993, J BIOMED MATER RES, V27, P557, DOI 10.1002/jbm.820270502
   Hegde Muralidhar L., 2003, Journal of Molecular Neuroscience, V22, P19
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   OLEARY A, 1995, KEY ENG MAT, V99-1, P301, DOI 10.4028/www.scientific.net/KEM.99-100.301
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Rodriguez-Mercado JJ, 2003, TOXICOL LETT, V144, P359, DOI 10.1016/S0378-4274(03)00255-8
   Sharma AK, 2000, MAT SCI ENG B-SOLID, V77, P139, DOI 10.1016/S0921-5107(00)00434-7
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Voevodin AA, 2002, J VAC SCI TECHNOL A, V20, P1434, DOI 10.1116/1.1487875
   Wei Q, 1998, MAT SCI ENG B-SOLID, V53, P262, DOI 10.1016/S0921-5107(98)00150-0
   Wei Q, 1999, J VAC SCI TECHNOL A, V17, P3406, DOI 10.1116/1.582074
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 71
EP 74
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900011
DA 2018-10-19
ER

PT B
AU Trausch, I
   Istephanous, N
   Rack, H
   Qazi, JI
AF Trausch, I.
   Istephanous, N.
   Rack, H.
   Qazi, J. I.
BE Helmus, M
   Medlin, D
TI Effect of grain size on the electrochemical properties of oxide films on
   titanium and its alloys for orthopedic and spinal applications
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB The clinical demands on new load bearing orthopedic and spinal implants could benefit from recent development in process engineering, such as equal channel angular extrusion, for the fabrication of ultra-fine grained raw materials. These demands include strength and fatigue performance. In concert with the optimized mechanical properties pre-requisite of implant materials, biocompatibility and biostability are critical requirements for long-term efficacy of metals utilized in therapeutic or chronic implantable medical devices. These attributes are primarily dictated and influenced by the properties of the surface oxide film, typically 2 to 10 nm in thickness. This film is a critical interfacial feature that governs the interaction between the metallic biomaterial and the biological environment.
   Electrochemical techniques. were utilized to study the polarization behaviors of oxide films on ultra-fine grained and commercial titanium metals namely CpTi and Ti-6A1-4V. These techniques permit the rapid evaluation of the corrosion resistance of a metal in a test electrolyte by accelerating one or more naturally occurring reactions. Several quantitative parameters can be extracted from the electrochemical experiments, such as corrosion rates, pitting potentials, and passivation tendencies.
   This paper discusses the effect of grain size and anodization on the corrosion resistance of ultra-fine grained and commercially available CpTi and Ti-6Al-4V metals targeted for orthopedic and spinal application.
C1 Medtronic Inc, Minneapolis, MN 55432 USA.
RP Trausch, I (reprint author), Medtronic Inc, 710 Medtron Pkwy NE, Minneapolis, MN 55432 USA.
CR ISTEPHANOUS N, 2003, INT C PROC MAN ADV M, V426, P3157
   LONG M, 2000, MAT SCI, V45, P102
   LONG M, 1988, TITANIUM ALLOYS TOTA, V19, P1621
   VALIEV RZ, 2003, P MAT PROCESSES MED
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
NR 5
TC 0
Z9 0
U1 0
U2 6
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 380
EP 385
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900066
DA 2018-10-19
ER

PT B
AU Zardiackas, L
   Roach, M
   Disegi, J
AF Zardiackas, L.
   Roach, M.
   Disegi, J.
BE Helmus, M
   Medlin, D
TI Galvanic corrosion of cobalt-base and titanium-base implant material
   couples
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB A wide array of cobalt-base and titanium-base implant materials is used for orthopaedic applications. It is generally acknowledged by most biomaterial specialists that mixing of metals in the body is not a desirable situation because of possible galvanic corrosion reactions. However, complex orthopedic devices may be designed to utilize the favorable properties of various components which may include coupling cobalt and titanium biomaterials. The generation of anodic polarization (AP) corrosion curves in a physiological solution is a convenient method for estimating whether galvanic corrosion will be expected. The AP screening method is helpful but is not considered the final determinant regarding whether galvanic corrosion problems will be encountered. The present study determined the galvanic corrosion susceptibility of coupled cobalt and titanium implant bar specimens and implant components. All testing was performed according to ASTM G 71 in Ringer's solution at 37 degrees C. Sample attachment methods and special sealing techniques were evaluated to avoid crevice and pitting corrosion reactions between the specimen and holder. For bar specimen testing, cobalt-base alloys were coupled with Ti-6Al-7Nb in one series of tests. Bar specimen testing was also performed with unalloyed Ti vs. Ti-6Al-Nb and unalloyed Ti vs. Ti-6Al-4V ELI for information purposes. Finally, galvanic corrosion testing was performed on mixed couples of cobalt-based and Ti-6Al-7Nb implant components. Post-testing evaluation of the implant components included ICP analysis of the testing solutions to identify soluble concentrations of appropriate metal ions in the spent Ringer's solution.
C1 Univ Mississippi, Med Ctr, Jackson, MS 39216 USA.
RP Zardiackas, L (reprint author), Univ Mississippi, Med Ctr, Jackson, MS 39216 USA.
OI Roach, Michael/0000-0002-8250-4610
CR *ASTM INT, 2003, 71 ASTM G
   BARBOSA M, 1991, CORROSION MECH METAL, P250
   DISEGI J, 1993, NIOBIUM IMPLANT MAT, P8
   Kruger J., 1979, ASTM SPEC TECH PUBL, P107
   MEARS D, 1975, USE DISIMILAR METALS, V148, P133
NR 5
TC 0
Z9 0
U1 1
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 398
EP 402
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900069
DA 2018-10-19
ER

PT S
AU Giordani, EJ
   Jorge, AM
   Balancin, O
AF Giordani, EJ
   Jorge, AM
   Balancin, O
BE RodriguezIbabe, JM
   Gutierrez, I
   Lopez, B
   IzaMendia, I
TI Evidence of strain-induced precipitation on a Nb- and N-bearing
   austenitic stainless steel biomaterial
SO MICROALLOYING FOR NEW STEEL PROCESSES AND APPLICATIONS
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Conference on Microalloying for New Steel Processes and
   Applications
CY SEP 07-09, 2005
CL Donostia San Sebastian, SPAIN
SP Arcelor, Cometal S A, Diputac Foral Guipuzcoa, Univ Invest, Dpto Educ, Dpto Ind, Comerc Turismo, Excmo Ayuntamiento Donostia San Sebastian, Kutxa, Minist Educ & Cienc, Minist Ind, Niobium Products Co GmbH, European Commiss Res Directorate Gen, Vanitec, Strateg Minerals Corp
DE static recrystallization; hot torsion test; ISO 5832-9; metallic
   biomaterial; austenitic stainless steel
ID FLOW-STRESS; RECRYSTALLIZATION
AB The kinetics of static recrystallization of a niobium- and nitrogen-bearing austenitic stainless steel, 22Cr-10Ni-3.5Mn-2.5Mo-0.4Nb-0.35N, was studied. The recrystallization kinetics were studied through the metallographic analysis of specimens submitted to hot torsion tests. The samples were strained to epsilon = 0.3 with a strain rate of 1 s(-1) at temperatures ranging from 1000 degrees C to 1200 degrees C and delay times ranging from 0.1 s to 900 s. The recrystallized fractions as a function of temperature and delay time after the deformation were measured and these indicated that the material only recrystallizes completely at T >= 1100 degrees C. At T <= 1050 degrees C, the recrystallized fractions that were measured did not exceed 16 %, even for delay times as long as 900 s. Multipass torsion tests under continuous cooling conditions were carried out and strain-induced precipitation of the Z-phase was seen. The inhibition of the static recrystallization took place for T < 1110 degrees C. Based on this evidence, the grain refinement brought about by recrystallization controlled processing and conventional controlled processing were assessed.
C1 Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Giordani, EJ (reprint author), Univ Fed Sao Carlos, Dept Mat Engn, Via Washington Luiz,Km 235, BR-13565905 Sao Carlos, SP, Brazil.
EM enricogiordani@uol.com.br; moreira@power.ufscar.br;
   balancin@power.ufscar.br
RI Jorge Junior, Alberto/B-2566-2012
OI Jorge Junior, Alberto/0000-0002-8121-9834
CR BAI DQ, 1993, METALL TRANS A, V24, P2151, DOI 10.1007/BF02648589
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Hughes A. N., 1978, Engineering in Medicine, V7, P135
   *INT ORG STAND, 1992, 58329 INT ORG STAND
   JACK DH, 1972, J IRON STEEL I, V210, P790
   Jorge AM, 2003, J MATER PROCESS TECH, V142, P415, DOI 10.1016/S0924-0136(03)00620-4
   Mataya MC, 1996, METALL MATER TRANS A, V27, P1251, DOI 10.1007/BF02649862
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   PUSSEGODA LN, 1991, ISIJ INT, V31, P278, DOI 10.2355/isijinternational.31.278
NR 9
TC 7
Z9 7
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-981-4
J9 MATER SCI FORUM
PY 2005
VL 500-501
BP 179
EP 186
DI 10.4028/www.scientific.net/MSF.500-501.179
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BDK23
UT WOS:000233985500018
DA 2018-10-19
ER

PT S
AU Patz, TM
   Doraiswamy, A
   Narayan, R
   Menegazzo, N
   Kranz, C
   Mizaikoff, B
   Modi, R
   Chrisey, DB
AF Patz, TM
   Doraiswamy, A
   Narayan, R
   Menegazzo, N
   Kranz, C
   Mizaikoff, B
   Modi, R
   Chrisey, DB
BE Laurencin, CT
   Botchwey, EA
TI Matrix assisted pulsed laser evaporation of poly (D,L) lactic acid films
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
ID DEPOSITION
AB We have deposited poly (D, L lactic: acid) (PDLLA) thin films using matrix assisted pulsed laser evaporation (MAPLE). FTIR spectroscopy revealed that the PDLLA had similar absorption bands to the dropcast material. X-ray photoelectron spectroscopy has shown that peaks corresponding to C-H, C-O and C=O represented 38.4, 30.1 and 31.4% of the Cls spectrum, respectively. XPS Ols analysis revealed that the O=C and O-C components make up 52 and 48 % of the Ols content. Atomic force microscopy revealed that MAPLE deposition provides smooth, continuous thin biomaterial films. These matrix assisted pulsed laser evaporation-deposited biomaterial thin films may serve to improve the irnplant/tissue interface.
C1 Georgia Inst Technol, Bioengn Program, Atlanta, GA 30332 USA.
RP Patz, TM (reprint author), Georgia Inst Technol, Bioengn Program, Atlanta, GA 30332 USA.
RI Mizaikoff, Boris/G-9959-2013
OI Mizaikoff, Boris/0000-0002-5583-7962
CR Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Beamson G., 1992, HIGH RESOLUTION XPS
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Ellenbogen KA, 1999, PACE, V22, P39, DOI 10.1111/j.1540-8159.1999.tb00298.x
   Inagaki N, 2003, J APPL POLYM SCI, V89, P96, DOI 10.1002/app.12160
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   LEUCHTNER RE, 1992, SURF COAT TECH, V51, P476, DOI 10.1016/0257-8972(92)90285-I
   Mayumi A, 2003, J FAC AGR KYUSHU U, V48, P97
   REUBEN BG, 1995, J CHEM TECHNOL BIOT, V63, P85, DOI 10.1002/jctb.280630112
   Shichiri M, 1998, ARTIF ORGANS, V22, P32, DOI 10.1046/j.1525-1594.1998.06043.x
   Slavkin HC, 1996, J AM DENT ASSOC, V127, P1254, DOI 10.14219/jada.archive.1996.0421
NR 11
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 249
EP 254
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900036
DA 2018-10-19
ER

PT S
AU Ballard, JD
   Dell'Acqua-Bellavitis, LM
   Bizios, R
   Siegel, RW
AF Ballard, JD
   Dell'Acqua-Bellavitis, LM
   Bizios, R
   Siegel, RW
BE Laurencin, CT
   Botchwey, EA
TI Nanoparticle-decorated surfaces for the study of cell-protein-substrate
   interactions
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
ID ENHANCED OSTEOBLAST ADHESION
AB The present study was motivated by the need for accurately-controlled and well-characterized novel biomaterial formulations for the study of cell-protein-material interactions. For this purpose, the current research has focused on the design, fabrication and characterization of model native oxide-coated silicon surfaces decorated with silica nanoparticles of select sizes, and has examined the adhesion of osteoblasts and fibroblasts on these nanoparticle-decorated surfaces. The results demonstrate the capability to deposit nanoparticles of select diameters and substrate surface coverage onto native silicon oxide-coated silicon, the firm attachment of these nanoparticles to the underlying native silicon oxide, and that nanoparticle size and coverage modulate adhesion of osteoblasts and fibroblasts to these substrates. The material formulations tested provide a well-controlled and well-characterized set of model substrates needed to study the effects of nanoscale features on the functions of cells that are critical to the clinical fate of implantable biomaterials.
C1 Rensselaer Polytech Inst, Troy, NY 12181 USA.
RP Ballard, JD (reprint author), Rensselaer Polytech Inst, Troy, NY 12181 USA.
CR MCMANUS AJ, 2004, J BIOMED MAT RES
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
NR 4
TC 3
Z9 3
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 339
EP 344
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900051
DA 2018-10-19
ER

PT S
AU Wieghaus, KA
   Capitosti, SM
   Brown, ML
   Botchwey, EA
AF Wieghaus, KA
   Capitosti, SM
   Brown, ML
   Botchwey, EA
BE Laurencin, CT
   Botchwey, EA
TI Novel angiogenic compounds for targeted drug delivery
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
ID GROWTH-FACTORS; THALIDOMIDE; BLOOD
AB Induction of angiogenesis is necessary for the success of engineered implantable tissues in order to meet oxygen and nutrient requirements of cells during tissue repair. Insufficient vascularization in bone graft reconstruction may impede healing and initiate hypoxic cell death at the interior of the implant. As a result, endogenous growth factors have been studied to enhance angiogenesis during wound repair. However, these peptide-based molecules are highly sensitive to processing that occurs during scaffold biomaterial fabrication and treatment for tissue engineering purposes. We report here the development of new small molecule regulators of angiogenesis that may circumvent the impediments associated with protein-based growth factor delivery. In this study, we report the design and evaluation of SC-3-143 as a regulator of endothelial function. We show that the compound significantly increases the formation of microvascular networks in vitro, and selectively enhances endothelial survivability by reducing endothelial cell death under serum deprived culture conditions.
C1 Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
RP Wieghaus, KA (reprint author), Univ Virginia, Dept Biomed Engn, Box 800759,415 Lane Rd,MR-5 Bldg, Charlottesville, VA 22908 USA.
CR Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Chen JZ, 2004, J CARDIOVASC PHARM, V43, P347, DOI 10.1097/00005344-200403000-00004
   CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
   DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Rajkumar SV, 2001, LEUKEMIA, V15, P1274, DOI 10.1038/sj.leu.2402183
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   WIEGHAUS KA, UNPUB
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
NR 10
TC 1
Z9 1
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 357
EP 361
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900054
DA 2018-10-19
ER

PT S
AU Yoo, HJ
   Kim, HD
AF Yoo, HJ
   Kim, HD
BE Chung, KH
   Shin, YH
   Park, SN
   Cho, HS
   Yoo, SA
   Min, BJ
   Lim, HS
   Yoo, KH
TI Preparation and properties of crosslinked polyurethane containing
   hydrophilic PEO component for biomaterials
SO ON THE CONVERGENCE OF BIO-INFORMATION-, ENVIRONMENTAL-, ENERGY-, SPACE-
   AND NANO-TECHNOLOGIES, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st International Womens Conference on BIEN-Technology
CY NOV 13-16, 2003
CL Paichai Univ, Daejeon, SOUTH KOREA
SP Assoc Korean Woman Sci & Engineers
HO Paichai Univ
DE polyurethane; polyethylene oxide (PEO); biomaterials
ID PLATELET-ADHESION; PROTEIN ADSORPTION; GRADIENT SURFACES; COPOLYMERS;
   OXIDE
AB A series of multiblock polyurethanes containing various poly(ethylene oxide) (PEO) contents (0-80 wt%) were prepared from hexamethylene diisocyanate (HDI)/PEO/poly(tetramethylene oxide) (PTMO)/polybutadiene diol (PBD)/1,4-butanediol (BD) and used as modifying additives (30 wt%) to improve the properties of biomedical grade Pellethene(R). A hydrophilic PEO component was introduced by the addition of PEO-containing polyurethanes and dicumyl peroxide (DCP) as the crosslinking agents in a Pellethene(R) matrix. As the PEO content (PEO block length) increased, the hydrogen-bonding fraction of the crosslinked polyurethane also increased, indicating an increase in the phase separation with an increase in the PEO content in the crosslinked polyurethane. Using electron spectroscopy for a chemical analysis, the ratio of ether carbon to alkyl carbon in the crosslinked polyurethane film increased remarkably with an increase, in the PEO content. Meanwhile, the water contact angle of the crosslinked polyurethane film surfaces decreased with increasing PEO content. The water absorption and mechanical properties of the crosslinked polyurethane films increased with increasing and the platelet adhesion on the crosslinked polyurethane film surfaces decreased significantly. Accordingly, these results suggest that the crosslinked polyurethane containing a hydrophilic PEO component may be more effective for a biomaterial application that is in direct contact with blood.
C1 Pusan Natl Univ, Coll Engn, Dept Text Engn, Pusan 609735, South Korea.
RP Kim, HD (reprint author), Pusan Natl Univ, Coll Engn, Dept Text Engn, Pusan 609735, South Korea.
EM kimhd@pusan.ac.kr
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andrade J. D., 1987, ASAIO J, V33, P75
   BAILEY FE, 1976, POLYETHLENE OXIDE, P209
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   Flemming RG, 1999, J BIOMAT SCI-POLYM E, V10, P679, DOI 10.1163/156856299X00874
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   HORBETT TA, 1993, J COLLOID INTERF SCI, V27, P1559
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   JANSEN B, 1985, J BIOMED MATER RES, V19, P1085, DOI 10.1002/jbm.820190918
   Jeong BJ, 1996, J COLLOID INTERF SCI, V178, P757, DOI 10.1006/jcis.1996.0174
   KJELLANDER R, 1981, J CHEM SOC FARAD T 1, V77, P2053, DOI 10.1039/f19817702053
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   LOGEARTAVRAMOGLOU, 1999, J BIOMED MATER RES, V48, P578
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   Uyama Y, 1998, ADV POLYM SCI, V137, P3
NR 22
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2005
VL 277-279
BP 82
EP 89
DI 10.4028/www.scientific.net/KEM.277-279.82
PG 8
WC Engineering, Multidisciplinary; Materials Science, Ceramics; Materials
   Science, Composites
SC Engineering; Materials Science
GA BBQ59
UT WOS:000227164500016
DA 2018-10-19
ER

PT J
AU Barbour, W
   Saika, S
   Miyamoto, T
   Ohnishi, Y
AF Barbour, W
   Saika, S
   Miyamoto, T
   Ohnishi, Y
TI Biological compatibility of polymethyl methacrylate, hydrophilic acrylic
   and hydrophobic acrylic intraocular lenses
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE biocompatibility; intraocular lenses; lens epithelial cells;
   macrophages/monocytes; rabbits
ID MOUSE PERITONEAL SPACE; BODY GIANT-CELLS; EPITHELIAL-CELLS; RABBIT EYE;
   CELLULAR INVASION; IN-VITRO; SURFACE; IMPLANTATION; SILICONE;
   BIOCOMPATIBILITY
AB Purpose: Extensive clinical investigations of the biocompatibility of different intraocular lenses (IOLs) have been made in an effort to optimize the outcome of modern cataract surgery. The aim of this study was to add animal eye experimental implantation data regarding cellular reaction on the anterior surface of IOLs. Methods: Thirteen adult albino rabbits had phacoemulsification/aspiration of the crystalline lens followed by implantation of a posterior chamber IOL in each eye. Three types of IOLs were studied: Hydroview(R) (Bausch & Lomb; n=7), Acrysof(R) (Alcon, USA; n=7), and polymethyl methacrylate (PMMA; HOYA, Japan; n=7). The animals were killed by intravenous pentobarbital 1, 4, or 8 weeks later. The IOLs were explanted and stained with hematoxylin and eosin, and observed under a light microscope. The shape of mouse ascites-induced macrophages on the anterior surface of the three different IOL types ( Hydroview, PMMA, and Acrysof) was studied after 24 h of oven culture. Results: Hydrophilic acrylic IOLs showed the highest affinity for lens epithelial cell (LEC) outgrowth, and the lowest and slowest maturation rate reaction of macrophages. PMMA IOLs showed the lowest affinity for LEC outgrowth, and the highest reaction of macrophages. Hydrophobic acrylic IOLs showed intermediate results both regarding LECs and macrophages. Conclusions: Results suggest that IOL biomaterial properties are the key factor that influences the quantity of monocytes/macrophages as well as the process of their maturation/senescence. LEC outgrowth is influenced both by the biomaterial of IOLs and by the monocyte/macrophage reaction. Copyright (C) 2005 S. Karger AG, Basel.
C1 Wakayama Med Univ, Dept Ophthalmol, Wakayama 6410012, Japan.
RP Barbour, W (reprint author), Wakayama Med Univ, Dept Ophthalmol, 811-1 Kimiidera, Wakayama 6410012, Japan.
EM w.barbour@doctor.com
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1
   Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6
   AMON M, 1991, J CATARACT REFR SURG, V17, P774, DOI 10.1016/S0886-3350(13)80410-5
   AMON M, 1994, EYE, V8, P649, DOI 10.1038/eye.1994.161
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   Daynes T, 2002, J CATARACT REFR SURG, V28, P1124, DOI 10.1016/S0886-3350(02)01460-8
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   Hesse Y, 2003, GRAEF ARCH CLIN EXP, V241, P823, DOI 10.1007/s00417-003-0718-5
   Hollick EJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P872
   KANAGAWA R, 1989, JPN J OPHTHALMOL, V33, P337
   Kubota H, 1999, Tanpakushitsu Kakusan Koso, V44, P2013
   MIYAKE K, 1984, AM J OPHTHALMOL, V98, P451, DOI 10.1016/0002-9394(84)90130-2
   OHARA K, 1985, AM J OPHTHALMOL, V99, P304, DOI 10.1016/0002-9394(85)90360-5
   Ohmi S, 1999, J CATARACT REFR SURG, V25, P1147, DOI 10.1016/S0886-3350(99)00140-6
   OLIVERO DK, 1993, INVEST OPHTH VIS SCI, V34, P2825
   Ravalico G, 1997, OPHTHALMOLOGY, V104, P1084, DOI 10.1016/S0161-6420(97)30181-X
   Schauersberger J, 2001, J CATARACT REFR SURG, V27, P850, DOI 10.1016/S0886-3350(00)00861-0
   SHAH SM, 1995, J CATARACT REFR SURG, V21, P466, DOI 10.1016/S0886-3350(13)80542-1
   SHAH SM, 1994, BRIT J OPHTHALMOL, V78, P91, DOI 10.1136/bjo.78.2.91
   SIEVERS H, 1984, AM J OPHTHALMOL, V97, P743, DOI 10.1016/0002-9394(84)90507-5
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   Turner A, 2001, CLIN EXP OPHTHALMOL, V29, P426, DOI 10.1046/j.1442-9071.2001.d01-34.x
   UENOYAMA K, 1989, J CATARACT REFR SURG, V15, P559, DOI 10.1016/S0886-3350(89)80116-6
   UENOYAMA K, 1988, J CATARACT REFR SURG, V14, P197, DOI 10.1016/S0886-3350(88)80096-8
   UENOYAMA K, 1988, J CATARACT REFR SURG, V14, P192, DOI 10.1016/S0886-3350(88)80095-6
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   VERSURA P, 1992, J CATARACT REFR SURG, V18, P58, DOI 10.1016/S0886-3350(13)80384-7
   Vogt A., 1930, LEHRBUCH ATLAS SPALT
   WENZEL M, 1988, GRAEF ARCH CLIN EXP, V226, P449, DOI 10.1007/BF02170007
   WOLTER JR, 1982, GRAEF ARCH CLIN EXP, V219, P103, DOI 10.1007/BF02152294
   WOLTER JR, 1985, OPHTHALMOLOGY, V92, P135
   WOLTER JR, 1982, OPHTHALMIC SURG LAS, V13, P939
   WOLTER JR, 1993, J CATARACT REFR SURG, V19, P789
   Yalon M, 1984, J Am Intraocul Implant Soc, V10, P315
   Yamanaka A, 1989, EUR J IMPLANT REF SU, V1, P15
NR 35
TC 8
Z9 9
U1 1
U2 8
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
J9 OPHTHAL RES
JI Ophthalmic Res.
PY 2005
VL 37
IS 5
BP 255
EP 261
DI 10.1159/000087100
PG 7
WC Ophthalmology
SC Ophthalmology
GA 964WI
UT WOS:000231911300004
PM 16037680
DA 2018-10-19
ER

PT J
AU Szarska, S
   Wojcik, A
AF Szarska, S
   Wojcik, A
TI Photostimulated defect formation in gel-derived biomaterial
SO OPTICA APPLICATA
LA English
DT Article; Proceedings Paper
CT 7th Seminar Porous Glasses - Special Glasses PGL
CY SEP 10-14, 2005
CL Szklarska, POLAND
DE bio-gel; biomaterials; exoelectron emission
ID FRACTOLUMINESCENCE SPECTRA; BIOACTIVE GLASSES; SILICA GLASS; RADIATION;
   CENTERS
AB Intensive research in the field of biomaterials proved that introducing bone implants to a human body causes a modification of an electric field connected with the bone surface. It is possible that this may be, to a great extend, the cause of an adverse reaction of the body to the implant. The surface of implant materials may be highly variable depending on the preparation procedure and external agents. The aim of the investigation was to confirm the porosity of the biomaterials (gel glasses, corundum and cement), using a scanning and optical microscope, and thermoluminescence. The charge transfer was measured by a photo-stimulated exoemission method. The measurement results prove a high sensitivity of our experimental method to the effects of the surface glass modifications. Moreover, the results of our measurements allow preliminary identification of the transport mechanism in the material under consideration.
C1 Wroclaw Univ Technol, Inst Phys, PL-50370 Wroclaw, Poland.
   Univ Zielona Gora, Inst Phys, PL-65516 Zielona Gora, Poland.
RP Szarska, S (reprint author), Wroclaw Univ Technol, Inst Phys, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
CR Borsowska A, 2003, OPT APPL, V33, P107
   Botter-Jensen L, 2003, RADIAT MEAS, V37, P535, DOI 10.1016/S1350-4487(03)00020-9
   Dekhtyar Y, 1997, INT J ADHES ADHES, V17, P75, DOI 10.1016/S0143-7496(96)00017-6
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Jones J.R., 2005, BIOMATERIALS ARTIFIC
   Jones JR, 2001, J BIOMED MATER RES, V58, P720, DOI 10.1002/jbm.10053
   KAWAGUCHI Y, 1995, PHYS REV B, V52, P9224, DOI 10.1103/PhysRevB.52.9224
   Kawaguchi Y, 1996, PHYS REV B, V54, P9721, DOI 10.1103/PhysRevB.54.9721
   LACZKA M, 1996, SZKLO CERAMIKA, V1, P14
   LANGFORD SC, 1989, J VAC SCI TECHNOL A, V7, P1829, DOI 10.1116/1.576010
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   Padlyak B, 2000, OPT APPL, V30, P709
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Pilliar RM, 2003, BIO-IMPLANT INTERFACE: IMPROVING BIOMATERIALS AND TISSUE REACTIONS, P43
   ROSIEK G, 1984, SZKLO CERAMIKA, V25, P41
   Shi D, 2004, BIOMATERIALS TISSUE
   Surdo AI, 2004, RADIAT MEAS, V38, P667, DOI 10.1016/j.radmeas.2004.12.001
   Szarska St., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V670, P109
   Tale I, 2004, RADIAT MEAS, V38, P639, DOI 10.1016/j.radmeas.2004.04.002
   WALA D, 2001, CEMENT WAPNO, P60
NR 20
TC 0
Z9 0
U1 0
U2 0
PU TECHNICAL UNIV WROCLAW
PI WROCLAW
PA WYBRZEZE WYSPIANSKIEGO 27, EXPORT-IMPORT DIVISION, 50-370 WROCLAW,
   POLAND
SN 0078-5466
J9 OPT APPL
JI Opt. Appl.
PY 2005
VL 35
IS 4
BP 799
EP 807
PG 9
WC Optics
SC Optics
GA 045VO
UT WOS:000237771000016
DA 2018-10-19
ER

PT S
AU Chan, BP
AF Chan, BP
BE Jacques, SL
   Roach, WP
TI A photochemical crosslinking technology for tissue engineering -
   Enhancement of the physico-chemical properties of collagen-based
   scaffolds
SO Optical Interactions with Tissue and Cells XVI
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Interactions with Tissue and Cells XVI
CY JAN 24-26, 2005
CL San Jose, CA
SP SPIE
DE photochemical crosslinking; collagen; physicochemical properties
ID PHYSICAL-PROPERTIES; MATRICES; STABILIZATION; MEMBRANES
AB Collagen gel is a natural biomaterial commonly used in tissue engineering because of its close resemblance to nature, negligible immunogenecity and excellent biocompatibility. However, unprocessed collagen gel is mechanically weak, highly water binding and vulnerable to chemical and enzymatic attacks that limits its use in tissue engineering in particular tissues for weight-bearing purposes.
   The current project aimed to strengthen and stabilize collagen scaffolds using a photochemical crosslinking technique. Photochemical crosslinking is rapid, efficient, non-thermal and does not involve toxic chemicals, comparing with other crosslinking methods such as glutaraldehyde and gamma irradiation.
   Collagen scaffolds were fabricated using rat-tail tendon collagen. An argon laser was used to process the collagen gel after equilibrating with a photosensitizing reagent. Scanning electronic microscope was used to characterize the surface and cross-sectional morphology of the membranes. Physico-chemical properties of the collagen scaffolds such as water-binding capacity, mechanical properties and thermostability were studied.
   Photochemical crosslinking significantly reduced the water-binding capacity, a parameter inversely proportional to the extent of crosslinking, of collagen scaffolds. Photochemical crosslinking also significantly increased the ultimate stress and tangent modulus at 90% of the rupture strain of the collagen scaffolds. Differential scanning calorimetry analysis showed a significantly higher shrinkage temperature and absence of the denaturation peak during the thermoscan comparing with the controls. This means greater thermostability in the photochemically crosslinked collagen scaffolds.
   This study demonstrates that the photochemical crosslinking technology is able to enhance the physicochemical. properties of collagen scaffolds by strengthening, stabilizing and controlling the swelling ratio of the collagen scaffolds so as to enable their use for tissue engineering.
C1 Univ Hong Kong, Med Engn Program, Hong Kong, Hong Kong, Peoples R China.
RP Chan, BP (reprint author), Univ Hong Kong, Med Engn Program, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
RI Chan, BP/C-1886-2009
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BALASUBRAMANIAN D, 1990, PHOTOCHEM PHOTOBIOL, V52, P761, DOI 10.1111/j.1751-1097.1990.tb08679.x
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   Chan BP, 2002, J SURG RES, V108, P77, DOI 10.1006/jsre.2002.6516
   CHAN BP, 2004, IN PRESS J SURG RES
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   HOTT JL, 1992, PHOTOCHEM PHOTOBIOL, V56, P257, DOI 10.1111/j.1751-1097.1992.tb02155.x
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   LI ST, 2000, BIOMEDICAL ENG HDB, pCH4
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   WEBSTER A, 1989, ANAL BIOCHEM, V179, P154, DOI 10.1016/0003-2697(89)90216-9
   Yannas I. V., 1996, BIOMATERIALS SCI INT, V1, P84
NR 16
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5669-1
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5695
BP 317
EP 327
DI 10.1117/12.597159
PG 11
WC Biophysics; Optics
SC Biophysics; Optics
GA BCH88
UT WOS:000229361500038
DA 2018-10-19
ER

PT S
AU Neogi, A
   Li, J
   Sarkar, A
   Neogi, PB
   Gorman, B
   Golding, T
   Morkoc, H
AF Neogi, A
   Li, J
   Sarkar, A
   Neogi, PB
   Gorman, B
   Golding, T
   Morkoc, H
BE Cartwright, A
   Cooper, TM
   Karna, SP
   Nakanishi, H
TI Self-assembled oligonucleoticle semiconductor conjugated to GaN
   nanostructures for biophotonic applications
SO Organic and Nanocomposite Optical Materials
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Organic and Nanocomposite Optical Materials held at the
   2004 MRS Fall Meeting
CY NOV 28-DEC 03, 2004
CL Boston, MA
SP MRS
ID DNA; MICROSCOPY; INTERFACE; GRAPHITE; SURFACES; ADENINE; WIRE; BASE
AB We investigate the optical properties of a new class of wide-bandgap semiconductor based biomaterial system. We have synthesized a guanosine derivative with a strong dipole moment, which self-assemble in similar to 50-100 nm confined pits to form a ribbon like semiconductor structure (SAGC). SAGC were successfully self-assembled on GaN/AIN QD matrix and the luminescence from GaN QDs can be resonantly transferred to the SAGC molecules resulting in a significant enhancement in emission from the guanine molecules. We also propose the design of ultraviolet-visible photonic bandgap structures based on hybrid SAGC-GaN photonic crystal.
C1 Univ N Texas, Dept Phys, Denton, TX 76203 USA.
RP Neogi, A (reprint author), Univ N Texas, Dept Phys, Denton, TX 76203 USA.
RI Gorman, Brian/F-4999-2011
OI Gorman, Brian/0000-0002-1837-564X
CR Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   Bumm LA, 1996, SCIENCE, V271, P1705, DOI 10.1126/science.271.5256.1705
   CASSAGNE D, 1995, PHYS REV B, V52, pR2217, DOI 10.1103/PhysRevB.52.R2217
   Forman SL, 2000, J AM CHEM SOC, V122, P4060, DOI 10.1021/ja9925148
   Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393
   Gerion D, 2002, J AM CHEM SOC, V124, P7070, DOI 10.1021/ja017822w
   Gottarelli G, 2000, CHEM-EUR J, V6, P3242, DOI 10.1002/1521-3765(20000901)6:17<3242::AID-CHEM3242>3.3.CO;2-B
   Gottarelli G, 1998, HELV CHIM ACTA, V81, P2078
   Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173
   LOMER WM, 1955, PROC R SOC LON SER-A, V227, P330, DOI 10.1098/rspa.1955.0014
   MARSH TC, 1995, NUCLEIC ACIDS RES, V23, P696, DOI 10.1093/nar/23.4.696
   Maruccio G, 2003, NANO LETT, V3, P479, DOI 10.1021/nl034046c
   Neogi A, 2003, IEEE T NANOTECHNOL, V2, P10, DOI 10.1109/TNANO.2003.808513
   NEOGI A, 2005, IN PRESS APPL PHYS L
   Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w
   Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029
   Samori P, 1999, CHEM-EUR J, V5, P2312, DOI 10.1002/(SICI)1521-3765(19990802)5:8<2312::AID-CHEM2312>3.0.CO;2-F
   Sessler JL, 2000, ANGEW CHEM INT EDIT, V39, P1300, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1300::AID-ANIE1300>3.0.CO;2-I
   Sowerby SJ, 1998, J PHYS CHEM B, V102, P5914, DOI 10.1021/jp980684l
   Uchihashi T, 1999, PHYS REV B, V60, P8309, DOI 10.1103/PhysRevB.60.8309
   Vollmer MS, 1999, CHEM-EUR J, V5, P96, DOI 10.1002/(SICI)1521-3765(19990104)5:1<96::AID-CHEM96>3.0.CO;2-9
   WILLIAMSON JR, 1993, CURR OPIN STRUC BIOL, V3, P357, DOI 10.1016/S0959-440X(05)80106-X
NR 22
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-794-6
J9 MATER RES SOC SYMP P
PY 2005
VL 846
BP 193
EP 199
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Composites;
   Optics; Physics, Condensed Matter
SC Materials Science; Optics; Physics
GA BCO27
UT WOS:000230391000027
DA 2018-10-19
ER

PT J
AU Belway, D
   Rubens, FD
   Wozny, D
   Henley, B
   Nathan, HJ
AF Belway, D
   Rubens, FD
   Wozny, D
   Henley, B
   Nathan, HJ
TI Are we doing everything we can to conserve blood during bypass? A
   national survey
SO PERFUSION-UK
LA English
DT Article
ID CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; ULTRAFILTRATION;
   AUTOTRANSFUSION; FIBRINOLYSIS; TRANSFUSION
AB Introduction: Despite major advances in biomaterial research and blood conservation, bleeding is still a common complication after cardiopulmonary bypass and cardiac surgery remains a major consumer of blood products. Although the underlying mechanisms for these effects are not fully established, two proposed major etiologies are the hemodilution associated with the use of the heart-lung machine and the impact of reinfusion of shed cardiotomy blood. Therapeutic strategies that primarily encompass the use of devices or technologies to overcome these effects may result in improved clinical outcomes. Objective: To determine the extent to which 1) lipid/leukocyte filtration and centrifugal processing of cardiotomy blood, and 2) modified ultrafiltration (MUF) are currently applied in adult cardiac surgery in Canada. Methods: A questionnaire was mailed to the chief perfusionist at all adult cardiac surgical centers in Canada, addressing details regarding the frequency of use of cardiotomy blood processing and MUF. Results: All questionnaires (36, 100%) were completed and returned. With regards to cardiotomy blood management, in 21 centers (58%), no specific processing steps were utilized exclusive of the integrated cardiotomy reservoir filter. Of the remaining centers, two (6%) reported using lipid/leukocyte filtration and 15 (42%) reported washing their cardiotomy blood. Three centers (8%) reported using MUF at the end of CPB. Conclusions: Despite growing concern about the potential detrimental effects of cardiotomy blood, few centers in Canada routinely manage this blood with additional filtration and/or centrifugal processing prior to reinfusion. Similarly, MUF, demonstrated to be effective in the pediatric population, has not seen popular application in adult cardiac surgical practice.
C1 Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   Univ Ottawa, Inst Heart, Div Perfus Serv, Ottawa, ON K1Y 4W7, Canada.
   Univ Ottawa, Inst Heart, Div Cardiac Anesthesia, Ottawa, ON K1Y 4W7, Canada.
RP Rubens, FD (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St,Room H3403, Ottawa, ON K1Y 4W7, Canada.
CR Bartels C, 2002, J THORAC CARDIOV SUR, V124, P20, DOI 10.1067/mtc.2002.121506
   Boyle EM, 1996, ANN THORAC SURG, V62, P1549, DOI 10.1016/0003-4975(96)00836-3
   Brooker RF, 1998, ANN THORAC SURG, V65, P1651, DOI 10.1016/S0003-4975(98)00289-6
   Brown WR, 2000, STROKE, V31, P707, DOI 10.1161/01.STR.31.3.707
   Dalrymple-Hay MJR, 1999, EUR J CARDIO-THORAC, V15, P830, DOI 10.1016/S1010-7940(99)00112-8
   DEHAAN J, 1995, ANN THORAC SURG, V59, P901, DOI 10.1016/0003-4975(95)00012-A
   Despotis GJ, 1999, ANESTHESIOLOGY, V91, P1122, DOI 10.1097/00000542-199910000-00031
   Despotis GJ, 2001, ANN THORAC SURG, V72, P1821
   ESCOLAR G, 1988, TRANSFUSION, V28, P406, DOI 10.1046/j.1537-2995.1988.28588337325.x
   LAUB GW, 1993, CHEST, V104, P686, DOI 10.1378/chest.104.3.686
   Leyh RG, 2001, EUR J CARDIO-THORAC, V19, P145, DOI 10.1016/S1010-7940(00)00633-3
   Luciani Giovanni Battista, 2001, Circulation, V104, pI, DOI 10.1161/hc37t1.094931
   Munoz JJ, 1999, CIRCULATION, V99, P81, DOI 10.1161/01.CIR.99.1.81
   NAIK SK, 1991, CIRCULATION, V84, P422
   Rubens FD, 2004, PERFUSION-UK, V19, pS5, DOI 10.1191/0267659104pf717oa
   Rubens FD, 2003, CAN J ANAESTH, V50, pS31
   TABUCHI N, 1993, J THORAC CARDIOV SUR, V106, P828
NR 17
TC 14
Z9 14
U1 0
U2 2
PU HODDER ARNOLD, HODDER HEADLINE PLC
PI LONDON
PA 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2005
VL 20
IS 5
BP 237
EP 241
DI 10.1191/0267659105pf821oa
PG 5
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 973AS
UT WOS:000232495900002
PM 16231618
DA 2018-10-19
ER

PT S
AU Martin, DS
   Isted, GE
   Cole, RJ
   Weightman, P
AF Martin, DS
   Isted, GE
   Cole, RJ
   Weightman, P
BE Stutzmann, M
TI Investigating the adsorption of the amino acid L-cysteine onto Ag(110)
SO Physica Status Solidi C - Conferences and Critical Reviews, Vol 2 , No
   12
SE PHYSICA STATUS SOLIDI C-CURRENT TOPICS IN SOLID STATE PHYSICS
LA English
DT Proceedings Paper
CT 6th International Conference on Optics of Surfaces and Interfaces
CY JUN 06-10, 2005
CL Aalborg, DENMARK
ID REFLECTION ANISOTROPY SPECTROSCOPY; CU(110) SURFACES; METAL-SURFACES;
   SILVER; ORIENTATION; MONOLAYERS; STM
AB The adsorption of the amino acid L-cysteine (L-Cys) onto the Ag(110) surface at room temperature is investigated using reflection anisotropy spectroscopy (RAS). The adsorption of L-Cys at metal surfaces offers a route to the immobilisation of proteins with potential applications in the nanoscale fabrication of biomaterial surfaces. L-Cys binds strongly to Ag(l 10) by the formation of a thiolate linkage. Heating the L-Cys saturated surface to 580 K results in the decomposition of the adsorbate, leaving a chernisorbed S adlayer with a c(8 x 2) structure. (c) 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
C1 Univ Liverpool, Dept Phys, Liverpool L69 3BX, Merseyside, England.
RP Martin, DS (reprint author), Univ Liverpool, Dept Phys, Liverpool L69 3BX, Merseyside, England.
CR ASPNES DE, 1988, J VAC SCI TECHNOL A, V6, P1327, DOI 10.1116/1.575694
   Bremer J, 2000, SURF SCI, V459, P39, DOI 10.1016/S0039-6028(00)00440-4
   Brolo AG, 2002, J PHYS CHEM B, V106, P5982, DOI 10.1021/jp025650z
   Carley AF, 2000, SURF SCI, V447, P39, DOI 10.1016/S0039-6028(99)01191-7
   Carley AF, 2003, TOP CATAL, V22, P161, DOI 10.1023/A:1023559516485
   Frederick BG, 1998, PHYS REV LETT, V80, P4490, DOI 10.1103/PhysRevLett.80.4490
   Frederick BG, 1998, PHYS REV B, V58, P10883, DOI 10.1103/PhysRevB.58.10883
   Hansen JK, 1998, SURF SCI, V418, pL58, DOI 10.1016/S0039-6028(98)00756-0
   Kuhnle A, 2002, NATURE, V415, P891, DOI 10.1038/415891a
   Laiho T, 2005, J ELECTRON SPECTROSC, V142, P105, DOI 10.1016/j.elspec.2004.10.001
   Li TH, 2004, NANOTECHNOLOGY, V15, pS660, DOI 10.1088/0957-4484/15/10/026
   Mandal S, 2001, LANGMUIR, V17, P6262, DOI 10.1021/la010536d
   Martin DS, 2004, J PHYS-CONDENS MAT, V16, pS4375, DOI 10.1088/0953-8984/16/39/012
   Martin DS, 2004, THIN SOLID FILMS, V455, P752, DOI 10.1016/j.tsf.2003.11.261
   Martin DS, 2003, SURF SCI, V532, P1, DOI 10.1016/S0039-6028(03)00131-6
   Martin DS, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155427
   Martin DS, 2003, SURF SCI, V539, P171, DOI 10.1016/S0039-6028(03)00788-X
   Martin DS, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.155403
   MARTIN DW, UNPUB
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Stahrenberg K, 2000, PHYS REV B, V61, P13287, DOI 10.1103/PhysRevB.61.13287
   STENSGAARD I, 1992, SURF SCI, V270, P81
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Weightman P, 2005, REP PROG PHYS, V68, P1251, DOI 10.1088/0034-4885/68/6/R01
NR 24
TC 5
Z9 5
U1 1
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1610-1634
J9 PHYS STATUS SOLIDI C
PY 2005
VL 2
IS 12
SI 2005
BP 4043
EP 4047
DI 10.1002/pssc.200562209
PG 5
WC Materials Science, Multidisciplinary; Optics; Physics, Condensed Matter
SC Materials Science; Optics; Physics
GA BDU71
UT WOS:000235501900019
DA 2018-10-19
ER

PT J
AU Foster, LJR
   Tighe, BJ
AF Foster, LJR
   Tighe, BJ
TI Centrifugally spun polyhydroxybutyrate fibres: accelerated hydrolytic
   degradation studies
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE centrifugal spinning; polyhydroxybutyrate fibre; biomaterial;
   degradation; photoacoustic spectroscopy
ID BIODEGRADABLE MEDICAL DEVICES; HYDROXYBUTYRATE-HYDROXYVALERATE
   COPOLYMERS; POLYMERS; BLENDS; ACID; POLYSACCHARIDES; MICROSPHERES;
   ADHESION; INVITRO; RELEASE
AB Centrifugal spinning is a novel process that readily permits the incorporation of particulate additive; while avoiding the thermal damage often associated with melt spinning. Centrifugal spinning of the biopolyester. poly(;3-hvdroxvbutvrate), produced a fibrous matrix described here as "wool". The in vitro degradation of this wool was investigated in an accelerated hvdrolytic model at 70degreesC and pH 10.6. Degradation rates were markedly enhanced by the high surface area of the wool and individual degradation profile could be manipulated by varying the purity of the polymer and process conditions. Physical heterogeneity of the wool exered a marked influence upon the degradation process which proceeded through a combination of fibre fragmentation and erosion. Degradation was accompanied by a series of physical changes up to the point of matrix collapse. The unique features of the centrifugal-spinning process, as illustrated by the structure of the fibres and the degradation profiles. suggest possible applications of centrifugally spun biopolymers as wound scaffolding devices. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Aston Univ, Biomat Res Unit, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England.
RP Tighe, BJ (reprint author), Aston Univ, Biomat Res Unit, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England.
EM b.j.tighe@aston.ac.uk
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   BISSERY M, 1984, MICROSPHERES DRUG TH
   BONFIELD W, 1986, BIOL BIOMECHANICAL P
   DAWES EA, 1986, MICROBIAL ENERGIES
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   Foster LJR, 2001, J BIOMAT SCI-POLYM E, V12, P317, DOI 10.1163/156856201750180843
   GOULD PL, 1987, INT J PHARM, V38, P231, DOI 10.1016/0378-5173(87)90119-0
   GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P127, DOI 10.1016/0141-3910(84)90032-6
   Gursel I, 1998, BIOMATERIALS, V19, P1137, DOI 10.1016/S0142-9612(98)00009-X
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   Khang G, 2001, BIO-MED MATER ENG, V11, P89
   Lootz D, 2001, BIOMATERIALS, V22, P2447, DOI 10.1016/S0142-9612(00)00245-3
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   Schmack G, 2000, J POLYM SCI POL PHYS, V38, P2841, DOI 10.1002/1099-0488(20001101)38:21<2841::AID-POLB130>3.0.CO;2-#
   STEEL ML, 1981, Patent No. 21606
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   WILLIAMS DF, 1987, ADV BIOMATER, V7, P471
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
   YASIN M, 1992, BIOMATERIALS, V13, P9, DOI 10.1016/0142-9612(92)90087-5
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 23
TC 15
Z9 15
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JAN
PY 2005
VL 87
IS 1
BP 1
EP 10
DI 10.1016/j.polymdegradstab.2003.11.012
PG 10
WC Polymer Science
SC Polymer Science
GA 879UC
UT WOS:000225743400001
DA 2018-10-19
ER

PT S
AU Zhou, YL
   Niinomi, M
   Akahori, T
   Fukui, H
AF Zhou, YL
   Niinomi, M
   Akahori, T
   Fukui, H
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Development of Ti-30 mass% Ta alloy for biomedical applications
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE Ti-Ta alloy; Young's modulus; tensile property; corrosion capacity;
   biocompatibility
ID TITANIUM-ALLOYS; MODULUS
AB In the present study, the effects of Ta content on the dynamic Young's modulus and tensile properties of Ti-Ta alloys were investigated in order to find a Ti-Ta alloy that gives low modulus and high strength for biomedical applications. For this purpose, the ingots of Ti-Ta alloys with Ta contents from 10 to 50 mass % were melted, and then rolled into the plate of 3 mm, thick. All the specimens were solution treated at 1223 K in the P field for 3.6 ks and then quenched in ice water. Subsequently, some of them were aged at 773 K for 259.2 ks followed by a rapid quenching in ice water. The corrosion capacity and biocompatibility of typical Ti-Ta alloy were also evaluated. The experimental results indicate that the Ti-30% Ta alloy has better mechanical biocompatibility, corrosion capacity and cyto-toxicity than Ti-6Al-4V alloy used as a standard biomaterial, and thus it will be of considerable development for biomedical applications.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
EM shuu@sp-mac4.tutpse.tut.ac.jp; niinomi@sp-mac4.tutpse.tut.ac.jp;
   akahori@so-mac4.tutpse.tut.ac.jp; fukui@dpc.aichi-gakuin.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Boyer R., 1994, MAT PROPERTIES HDB
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   HUNT M, 1991, MATER ENG, V108, P27
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   ZHOU M, 2003, BIOMATERIALS, V24, P2673
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 8
TC 5
Z9 5
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2309
EP 2312
DI 10.4028/www.scientific.net/MSF.475-479.2309
PN 1-5
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702154
DA 2018-10-19
ER

PT S
AU Chiba, A
   Kumagai, K
   Takeda, H
   Nomura, N
AF Chiba, A
   Kumagai, K
   Takeda, H
   Nomura, N
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Mechanical properties of forged low Ni and C-containing Co-Cr-Mo
   biomedical implant alloy
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE joint prostheses; biomaterial; Co-Cr-Mo alloy; hot-forging; mechanical
   properties; wear
AB In order to examine the influence of variation in grain size and microstructure on mechanical properties of a low Ni and C-containing Co-29Cr-6Mo alloy for biomedical implant materials, the tensile properties and the dry friction wear characteristics of the wrought Co-29Cr-6Mo alloy without addition of Ni and C were investigated. The microstructure of as-forged alloys, consisting of fcc phase mixed with athermal hcp martensite, is found to become finer as the reduction during forging increases. The hot-forging processes for fabricating the fine microstructure with different grain sizes of 43, 11 and 3 pm has been successfully established under the condition that forging temperature of higher than 1273 K is strictly kept during forging. The tensile properties, such as the yield stress, the tensile stress and the elongation, are improved with decreasing the gram size and thereby increasing the volume fraction of the fcc phase in the microstructure. The dry wear resistance against the alumina ball is enhanced by decreasing the grain size.
C1 Iwate Univ, Dept Welfare Engn, Morioka, Iwate 0200801, Japan.
   Iwate Univ, Morioka, Iwate 0200801, Japan.
RP Chiba, A (reprint author), Iwate Univ, Dept Welfare Engn, Morioka, Iwate 0200801, Japan.
EM a.chiba@iwate-u.ac.jp; t5103002@iwate-u.ac.jp; N.Nomura@iwate-u.ac.jp
RI Chiba, Akihiko/D-1326-2011; NOMURA, Naoyuki/L-7149-2017
CR BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x
   CLEMOW AJT, 1980, WEAR, V61, P219, DOI 10.1016/0043-1648(80)90287-2
   HOLLANDER R, 1975, J BIOMED MATER RES, V9, P367, DOI 10.1002/jbm.820090311
   Montero-Ocampo C, 1999, METALL MATER TRANS A, V30, P611, DOI 10.1007/s11661-999-0052-6
   Sage M., 1950, REV MET, V47, P139
NR 5
TC 48
Z9 48
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2317
EP 2321
DI 10.4028/www.scientific.net/MSF.475-479.2317
PN 1-5
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702156
DA 2018-10-19
ER

PT S
AU Czarnowska, E
   Sowinska, A
   Cukrowska, B
   Sobiecki, JR
   Wierzchon, T
AF Czarnowska, E
   Sowinska, A
   Cukrowska, B
   Sobiecki, JR
   Wierzchon, T
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Response of human osteoblast-like cells and fibroblasts to titanium
   alloy nitrided under glow discharge conditions
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE titanium nitride; topography; sterilization; biocompatibility; human
   fibroblasts; human osteoblast-like cells
ID WEAR
AB Cell adhesion to biomaterials and cell proliferation are affected, among others, by the chemical composition and surface microtopography of the biomaterial. These are, in turn, influenced by sterilisation processes. The aim of this study was to evaluate the sensitivity of osteoblasts and fibroblasts to TiN surfaces deprived of an oxide film or with an enhanced oxide film due to sterilisation in plasma or in an autoclave, respectively. Type TiN+T2N+alpha Ti(N) nitrided surface layers were produced under glow discharge conditions and sterilized in plasma Sterrad 100 and in a steam autoclave. The results provide evidence that nitrided surface layers improved wear-and corrosion, resistance of the titanium alloy and that these features were not influenced by sterilisation procedures that resulted in various oxide films. In vitro study of human fibroblast and osteoblast-like cells cultured on TiN surfaces modified by sterilisation processes showed that cells respond to the presence of an enhanced oxide film by aggregating, exhibiting lower viability and increased apoptosis, while to a surface deprived of oxides, by regular spreading and high viability. It can be concluded that differences in surface composition and topography of the nitrided surface layers due to various types of sterilisation elicit specific cell responses, and plasma sterilisation seems to be optimal for bone implants with this surface layer.
C1 Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland.
   Warsaw Univ Technol, Fac Mat Sci & Engn, PL-02507 Warsaw, Poland.
RP Czarnowska, E (reprint author), Childrens Mem Hlth Inst, Dept Pathol, Al Dzieci Polskich 20, PL-04730 Warsaw, Poland.
EM czar@czd.waw.pl; jrs@inmat.pw.edu.pl; twierz@inmat.pw.edu.pl
OI Sowinska, Agnieszka/0000-0002-6853-2340; Czarnowska,
   Elzbieta/0000-0002-1785-1405
CR Biel M, 2003, MATER CHEM PHYS, V81, P430, DOI 10.1016/S0254-0584(03)00040-3
   Cyster LA, 2004, BIOMATERIALS, V25, P97, DOI 10.1016/S0142-9612(03)00480-0
   CZAMOWSKA E, 2004, IN PRESS ANN TRANSPL
   Czarnowska E, 2000, J Mater Sci Mater Med, V11, P73, DOI 10.1023/A:1008980631780
   Fleszar A, 2000, SURF COAT TECH, V131, P62, DOI 10.1016/S0257-8972(00)00760-X
   HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cellbio.1.1.67
   PAPPAS MJ, 1995, CLIN ORTHOP RELAT R, P64
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
NR 9
TC 2
Z9 2
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2415
EP 2418
DI 10.4028/www.scientific.net/MSF.475-479.2415
PN 1-5
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702178
DA 2018-10-19
ER

PT S
AU Yung, CT
   Lian, SS
   Sung, YJ
AF Yung, CT
   Lian, SS
   Sung, YJ
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI The study of apoptosis and phagocytosis of rabbit synoviocytes induced
   by particulate joint replacement materials
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE apoptosis; phagocytosis; synoviocytes; particulate joint replacement
   materials
ID BINDING
AB Synoviocyte is one of the cells in direct contact with the wear particles and the role of synoviocytes in the prosthesis loosening remains to be further understood. The purpose of the present study is to investigate whether particulate biomaterials cause synoviocyte dead or simply activate these cells. The activation of synoviocyte in response to particulate biomaterial exposure will be indicated with its phagocytotic ability. As to the effects of particulate biomaterials to apoptosis will be tested on rabbit synoviocytes, HIG-82 cells. The results demonstrate that the addition of cobalt particles would lead the HIG-82 cells to apoptosis and apoptosis accompanying caspase3 cleavage, which means that apoptosis of the HIG-82 cells resulted from the addition of cobalt particles might went through caspase-dependent pathway. On the other hand, exposing to nonmetal particles such as TiO2 and SiO2, particles did not provoke apoptosis of the HIG-82 cells. TiO2 Particles activated the cells and were phagocytosed by the HIG-82 synoviocytes, no significant biological effects were found while the HIG-82 cells exposed to SiO2 particles.
C1 Natl Taiwan Univ, Dept Mat Sci & Engn, Taipei 10764, Taiwan.
   Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
   Natl Yang Ming Univ, Dept Anat & Cell Biol, Taipei 112, Taiwan.
RP Yung, CT (reprint author), Natl Taiwan Univ, Dept Mat Sci & Engn, Taipei 10764, Taiwan.
EM lian@ntu.edu.tw
CR ANDREE HAM, 1990, J BIOL CHEM, V265, P4923
   Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   JEPPESEN C, 1989, EUR J BIOCHEM, V182, P437, DOI 10.1111/j.1432-1033.1989.tb14850.x
   Mahdi F, 2002, BLOOD, V99, P3585, DOI 10.1182/blood.V99.10.3585
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
NR 7
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2419
EP 2422
DI 10.4028/www.scientific.net/MSF.475-479.2419
PN 1-5
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702179
DA 2018-10-19
ER

PT S
AU Huang, QJ
   Liu, GQ
   Li, Y
   Gao, J
   Gu, ZQ
   Ma, YZ
   Xue, HB
AF Huang, QJ
   Liu, GQ
   Li, Y
   Gao, J
   Gu, ZQ
   Ma, YZ
   Xue, HB
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Three-dimensional finite element modeling for biomaterial selection and
   shape design of the nucleus prosthesis
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE finite element model; nucleus prosthesis; PVA hydrogel; biomaterial;
   Chinese man
AB Nucleus prosthesis replacement is considered as an ideal solution to low back pain. The purpose of this paper is to predict the suitable material properties and shape for the nucleus prosthesis of Chinese people based on biomechanical analysis using three-dimensional (3D) finite element (FE) method combined with experiments. The results suggest that a pillow-shaped nucleus prosthesis made of the polymer biomaterial with a Young's modulus of 0.1-100 MPa is qualified to replace the degenerated nucleus. Then under the guidance of the FE predictions, a novel nucleus replacement material of polyvinyl alcohol hydrogel was prepared; the mechanical experiment shows that it has a compressive modulus of 1.0-6.8 MPa over a strain range of 10-60 %. The finite element predictions and experimental results have implications for the nucleus prosthesis designs.
C1 Univ Sci & Technol Beijing, Beijing 100083, Peoples R China.
   PLA Hosp 309, Dept Orthopaed Surg, Beijing 100091, Peoples R China.
RP Huang, QJ (reprint author), Univ Sci & Technol Beijing, Beijing 100083, Peoples R China.
EM qjhuang@126.com; G.liu@ustb.edu.cn
CR FERNSTORN U, 1966, ACTA CHIR SCAND, V357, P156
   GU ZQ, 1999, J BIOMED ENG, V16, P15
   HIGHAM PA, 1993, Patent No. 5192326
   MAO BY, 2004, J CHINESE MED, V39, P13
   MEAKIN JR, 2001, J MATER SCI, V12, P210
   RAY CD, 2002, EUROSPINE, V11, P138
   SINEAD K, 2002, EUROSPINE, P4
   WANG DL, 2003, J CLIN REHABILITATIO, V7, P942
   WILKE HJ, 2001, J CLIN BIOMECHANICS, V16, P114
   WU JP, 2004, J MED SCI, V31, P56
   ZHAO DL, 1984, J SHANGHAI MED SCI, V7, P249
NR 11
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 3303
EP 3306
DI 10.4028/www.scientific.net/MSF.475-479.3303
PN 1-5
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494703180
DA 2018-10-19
ER

PT B
AU Ikada, Y
AF Ikada, Y
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Approach to clinical tissue engineering
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
AB Polymers and fibers have been used in tissue engineering for the restoration of severely diseased or lost tissues along with cells. The major function of polymers in the tissue engineering is support of cells for their differentiation, proliferation, and extracellular matrix formation. To achieve this function, polymers are processed to the shape of scaffolds and carriers so as to incorporate cells and growth factors inside the biomaterials. To allow for seeding cells as many as possible and sufficient delivery of nutrients to the incorporated cells, scaffolds should be resorbable and porous with interconnected porosity. Fibers are very useful as a starting material to fabricate porous scaffolds. Bioabsorbable fibers made from polyglycolide(PGA) and poly(glycolide-co-lactide)(PGLA) have been extensively applied for scaffold fabrication as non-woven fabrics. Poly(lactide-co-epsilon-caprolactone)[P(LA/CL)] also has a high potential as a biomaterial for scaffolds. When the LA/CL ratio is around 50150, the copolymer exhibits elasticity with low Young's modulus. This presentation will display some clinical applications of these resorbable polymers and fibers in tissue engineering of soft tissues.
C1 Suzuka Univ Med Sci, Dept Med Engn, Suzuka Shi, Mie 5100293, Japan.
RP Ikada, Y (reprint author), Suzuka Univ Med Sci, Dept Med Engn, Suzuka Shi, Mie 5100293, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 879
EP 880
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600219
DA 2018-10-19
ER

PT B
AU Jiang, X
   Wang, WZ
AF Jiang, X
   Wang, WZ
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Study on the mechanical properties of absorbable seeding carrier with
   new structure for brachytherapy
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
DE absorbable seeding carrier; biomaterial; brachytherapy; mechanical
   properties
AB A kind of absorbable seeding carrier with new structure made of a copolymer of 90% PGA and 10% PLA, which is called PGLA (910) filament, for holding radioactive seeds in brachytherapy has been developed oil braiding and novel knitting machines. Tensile, compressive and biodegradable tests were carried out to determine the mechanical properties of the novel absorbable seeding carrier. And the difference of the absorbable seeding carrier between under and not under the influence of radioactive seeds was compared in this paper. The experimental results confirmed that the absorbable seeding carrier with new structure is mechanically feasible.
C1 Donghua Univ, Biomed Text Res Ctr, Shanghai 200051, Peoples R China.
RP Jiang, X (reprint author), Donghua Univ, Biomed Text Res Ctr, Shanghai 200051, Peoples R China.
CR HOROWITZ BS, 1988, Patent No. 4754745
   LI Y, 2003, J DONGHUA U, V20, P8
   SHI DL, 2002, BIOMATERIALS TISSUE, P201
   SUN J, 2002, J BIOMEDICAL ENG, V19, P139
   2005, Patent No. 20040473
NR 5
TC 0
Z9 0
U1 0
U2 0
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 893
EP 896
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600223
DA 2018-10-19
ER

PT B
AU Yang, SX
   Zeng, J
   Guo, C
   Sun, FC
AF Yang, SX
   Zeng, J
   Guo, C
   Sun, FC
BE Zhao, MS
   Shi, ZZ
TI A novel neuro-fuzzy model for supercritical fluid extraction
SO PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON NEURAL NETWORKS AND
   BRAIN, VOLS 1-3
LA English
DT Proceedings Paper
CT International Conference on Neural Networks and Brain (ICNN&B 2005)
CY OCT 13-15, 2005
CL Beijing, PEOPLES R CHINA
SP China Neural Networks Council, IEEE Computat Intelligence Soc, Beijing Chapter, Chinese Inst Elect, Chinese Assoc Artificial Intelligence
ID CARBON-DIOXIDE; OIL
AB Supercritical fluid extraction is an environmental friendly separation technique in food and chemical industry that exploits the solvent properties of fluid near the critical point. Modeling of the solubility of biomaterials is an essential issue in supercritical fluid extraction. In this paper, a novel neuro-fuzzy model is developed to model the relationship between pressure and yield of biomaterial. The results using the proposed neurofuzzy model are generally better than those using the conventional model by Peng-Robinson equation of state. The effectiveness of the proposed approaches was demonstrated by simulation and comparison studies.
C1 Dalian Maritime Univ, Coll Automat & Elect Engn, Dalian, Peoples R China.
RP Yang, SX (reprint author), Dalian Maritime Univ, Coll Automat & Elect Engn, Dalian, Peoples R China.
CR CLIFFORD T, 1998, FUNDAMENTALS SUPERCR
   Czogala E., 2000, FUZZY NEUROFUZZY INT
   GOTO M, 1993, J CHEM ENG JPN, V26, P401, DOI 10.1252/jcej.26.401
   JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541
   Karayiannis N. B., 1993, ARTIFICIAL NEURAL NE
   LI H, 2003, IN PRESS BIOSYSTEMS
   LI H, 2001, P IEEE INT C SYST MA, P1542
   Oliveira R, 2002, J AM OIL CHEM SOC, V79, P225, DOI 10.1007/s11746-002-0465-y
   SCHMITT WJ, 1986, J CHEM ENG DATA, V31, P204, DOI 10.1021/je00044a021
   SOVOVA H, 1994, CHEM ENG SCI, V49, P409, DOI 10.1016/0009-2509(94)87012-8
   Stuart G., 1997, Ciencia e Tecnologia de Alimentos, V17, P501, DOI 10.1590/S0101-20611997000400030
   ZENG J, 2003, IN PRESS 2003 IEEE I
NR 12
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-9422-4
PY 2005
BP 1774
EP 1779
PG 6
WC Computer Science, Artificial Intelligence
SC Computer Science
GA BEB63
UT WOS:000236575102100
DA 2018-10-19
ER

PT B
AU Zhou, DB
   Claffee, MR
   Lee, KM
   McMurray, GV
AF Zhou, DB
   Claffee, MR
   Lee, KM
   McMurray, GV
BE Gerhardt, LA
TI Modeling compression cutting of biomaterial for robot control
SO Proceedings of the Sixth IASTED International Conference on Robotics and
   Applications
LA English
DT Proceedings Paper
CT 6th IASTED International Conference on Robotics and Applications
CY OCT 31-NOV 02, 2005
CL Cambridge, MA
SP Int Assoc Sci & Technol Dev
DE robotics; modeling; cutting; sharpness
ID CHEESE
AB The application of robotics outside of the traditional tasks, such as those in the automotive industry is becoming more common. As robotics moves outside of these areas, the tasks required of the robot become more complicated. These tasks can arise in a number of different industries: the medical industry, which includes robotic surgery and sample microtoming, as well as the food processing industry, which includes meat, fruit, and vegetable processing. In this paper, based on the analysis of the applied cutting force and the internal stresses in compression cutting, the influence of the material properties (deformation and fracture toughness) on the cutting force is explained. Using this formulation, the authors provided a method to describe the sharpness of a blade and experimentally demonstrated its applicability. Based on the material properties and knife sharpness properties, the required force to realize compression cutting can be predicted.
C1 Georgia Tech Res Inst, Food Proc Technol Div, EOEM Lab, Atlanta, GA 30332 USA.
RP Zhou, DB (reprint author), Georgia Tech Res Inst, Food Proc Technol Div, EOEM Lab, Atlanta, GA 30332 USA.
CR *AB ROB PROD AB PU, 2000, PROD MAN IRB 140
   *ATI IND AUT INC P, 1998, INST OP MAN ISA FT 1
   Atkins A. G., 1985, ELASTIC PLASTIC FRAC
   Atkins AG, 2004, J MATER SCI, V39, P2761, DOI 10.1023/B:JMSC.0000021451.17182.86
   Dempsey PG, 2004, J OCCUP ENVIRON HYG, V1, P167, DOI 10.1080/15459620490424465
   Fischer-Cripps AC, 2000, INTRO CONTACT MECH
   Hellan K., 1984, INTRO FRACTURE MECH
   Kamyab I, 1998, J MATER SCI, V33, P2763, DOI 10.1023/A:1017517332112
   Mahvash M., 2001, HAPTICS E, V2, P1
   MCGORRY RW, 2005, APPL ERGON, V35, P71
   Michael W.H., 1998, STRESS ANAL FIBER RE
   Szabo RL, 2001, AIHAJ, V62, P428
   TIMOSHENKO SP, 1970, THEORY ELASTICITY
   Yoshitomi H., 2005, Japanese Journal of Systematic Entomology, P1
NR 14
TC 0
Z9 0
U1 0
U2 1
PU ACTA PRESS
PI CALGARY
PA B6, STE 101, 2509 DIEPPE AVE SW, CALGARY, ALBERTA T3E 7J9, CANADA
BN 0-88986-521-3
PY 2005
BP 114
EP 119
PG 6
WC Robotics
SC Robotics
GA BDP05
UT WOS:000234646100019
DA 2018-10-19
ER

PT S
AU Mistry, AS
   Mikos, AG
AF Mistry, AS
   Mikos, AG
BE Yannas, IV
TI Tissue engineering strategies for bone regeneration
SO REGENERATIVE MEDICINE II: CLINICAL AND PRECLINICAL APPLICATIONS
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE bone; mesenchymal stem cell; growth factor; biodegradable scaffold;
   bioreactor
ID MESENCHYMAL STEM-CELLS; POLY(PROPYLENE FUMARATE)-BASED NETWORKS;
   MINERALIZED MATRIX DEPOSITION; MARROW STROMAL OSTEOBLASTS; 3D PERFUSION
   CULTURE; IN-VITRO DEGRADATION; MORPHOGENETIC PROTEIN-2; GENE-THERAPY;
   ORTHOPEDIC-SURGERY; CANCELLOUS BONE
AB Bone loss due to trauma or disease is an increasingly serious health problem. Current clinical treatments for critical-sized defects are problematic and often yield poor healing due to the complicated anatomy and physiology of bone tissue, as well as the limitations of medical technology. Bone tissue engineering offers a promising alternative strategy of healing severe bone injuries by utilizing the body's natural biological response to tissue damage in conjunction with engineering principles. Osteogenic cells, growth factors, and biomaterial scaffolds form the foundation of the many bone tissue engineering strategies employed to achieve repair and restoration of damaged tissue. An ideal biomaterial scaffold will provide mechanical support to an injured site and also deliver growth factors and cells into a defect to encourage tissue growth. Additionally, this biomaterial should degrade in a controlled manner without causing a significant inflammatory response. The following chapter highlights multiple strategies and the most recent advances in various areas of research for bone tissue regeneration.
C1 Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
RP Mistry, AS (reprint author), Rice Univ, Dept Bioengn, 6100 Main,MS-142,POB 1892, Houston, TX 77005 USA.
EM amistry@rice.edu; mikos@rice.edu
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU NIAMS NIH HHS [R01 AR48756]
CR Alden TD, 1999, HUM GENE THER, V10, P2245, DOI 10.1089/10430349950017220
   *AM AC ORTH SURG, 2003, FACTS FRACT
   *AM CANC SOC, 2003, KEY STAT BONE CANC
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bancroft GN, 2001, INT CONGR SER, V1222, P151
   Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719
   Blum JS, 2003, CLIN PLAST SURG, V30, P611, DOI 10.1016/S0094-1298(03)00079-8
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   BOSTROM RD, 1997, SYNTHETIC BIODEGRADA, P215, DOI DOI 10.1007/978-1-4612-4154-6
   BOWENPOPE DF, 1984, BLOOD, V64, P458
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   BROWN KLB, 1982, J BONE JOINT SURG AM, V64, P270, DOI 10.2106/00004623-198264020-00020
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Bruder SP, 2000, PRINCIPLES TISSUE EN, P683
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   Cattermole HR, 1996, BRIT J SPORT MED, V30, P171, DOI 10.1136/bjsm.30.2.171
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   Currey J. D., 2002, BONES STRUCTURE MECH
   Drake CJ, 1998, ANN NY ACAD SCI, V857, P155, DOI 10.1111/j.1749-6632.1998.tb10115.x
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   ENNEKING WF, 1980, J BONE JOINT SURG AM, V62, P1039, DOI 10.2106/00004623-198062070-00001
   Erbe EM, 2001, EUR SPINE J, V10, pS141, DOI 10.1007/s005860100287
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gitelis S, 2002, J AM COLL SURGEONS, V194, P788, DOI 10.1016/S1072-7515(02)01198-5
   Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183, DOI 10.1111/j.1749-6632.2002.tb03079.x
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Hall MJ, 2002, NATL HOSP DISCHARGE, V329
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hedberg EL, 2002, J CONTROL RELEASE, V84, P137, DOI 10.1016/S0168-3659(02)00261-4
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   HOLY CE, 2000, BONE ENG, P496
   Horch RA, 2004, BIOMACROMOLECULES, V5, P1990, DOI 10.1021/bm049768s
   Huard J, 2003, J GENE MED, V5, P93, DOI 10.1002/jgm.344
   Ikenaga M, 1998, J BIOMED MATER RES, V40, P139, DOI 10.1002/(SICI)1097-4636(199804)40:1<139::AID-JBM16>3.0.CO;2-J
   Jilka RL, 2003, MED PEDIATR ONCOL, V41, P182, DOI 10.1002/mpo.10334
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118
   *NATL OST FDN, 2003, FAST FACTS OST
   Neufeld G, 1999, FASEB J, V13, P9
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   *OST IMP FDN, 2003, FAST FACTS OST IMP
   Parfitt AM, 1984, CALCIF TISSUE INT S, V36, P37
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   PETTY W, 1988, J BONE JOINT SURG AM, V70A, P536, DOI 10.2106/00004623-198870040-00009
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Richards M, 1999, J BIOMECH ENG-T ASME, V121, P116, DOI 10.1115/1.2798032
   Richards M, 1999, J ORTHOP RES, V17, P900, DOI 10.1002/jor.1100170615
   Rutherford RB, 2003, DRUG NEWS PERSPECT, V16, P5, DOI 10.1358/dnp.2003.16.1.829301
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Sodian R, 2001, J BIOMED MATER RES, V58, P401, DOI 10.1002/jbm.1034
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Taton TA, 2001, NATURE, V412, P491, DOI 10.1038/35087687
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2000, BONE ENG, P454
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Timmer MD, 2003, J BIOMED MATER RES A, V66A, P811, DOI 10.1002/jbm.a.10011
   Timmer MD, 2003, BIOMATERIALS, V24, P571, DOI 10.1016/S0142-9612(02)00368-X
   TIMMER MD, IN PRESS J BIOMATER
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Vogelson CT, 2000, CHEM MATER, V12, P795, DOI 10.1021/cm990648e
   WEINER S, 1992, FASEB J, V6, P879
   Werntz JR, 1996, J ORTHOP RES, V14, P85, DOI 10.1002/jor.1100140115
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 105
TC 215
Z9 231
U1 1
U2 53
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0724-6145
BN 3-540-22868-3
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2005
VL 94
BP 1
EP 22
DI 10.1007/b99997
PG 22
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BCC39
UT WOS:000228557400001
PM 15915866
DA 2018-10-19
ER

PT S
AU Kinner, B
   Capito, RM
   Spector, M
AF Kinner, B
   Capito, RM
   Spector, M
BE Yannas, IV
TI Regeneration of articular cartilage
SO REGENERATIVE MEDICINE II: CLINICAL AND PRECLINICAL APPLICATIONS
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE articular cartilage; collagen; chondrocyte; joints; microfracture
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE ACTIN; AUTOLOGOUS CHONDROCYTE
   TRANSPLANTATION; FULL-THICKNESS DEFECTS; GROWTH-FACTOR-I; OSTEOCHONDRAL
   DEFECTS; CANINE MODEL; MATRIX SYNTHESIS; CHONDRAL DEFECT; COLLAGEN GEL
AB Loss of articular cartilage from the ends of bones forming diarthrodial joints can be the source of profound pain and disability, and eventually lead to complete degeneration of the joint, necessitating total joint replacement. Until a few years ago, there seemed little hope of treating such defects. Novel surgical procedures and cell therapies have recently been found, however, to stimulate the formation of reparative tissue resulting in the relief of pain and restoration of function, at least for a limited time period. Moreover, studies of the healing of chondral defects in animal models have revealed that there is some potential for regeneration of this connective tissue. The introduction of certain biomaterial scaffolds along with selected surgical procedures and cell therapies has been demonstrated in animal studies to facilitate the cartilage reparative process and now offers the promise of extending the longevity of clinical treatments of cartilage defects. Collectively these findings provide the basis for the rational development of approaches for the more complete regeneration of articular cartilage, and demonstrate that meaningful clinical outcomes can be achieved even if complete regeneration is not achieved.
C1 Clin Univ Regensburg, Dept Trauma Surg, Regensburg, Germany.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Med, Brigham & Womens Hosp, Orthopaed Res Lab, Boston, MA 02115 USA.
   VA Boston Healthcare Syst, Boston, MA 02130 USA.
RP Kinner, B (reprint author), Clin Univ Regensburg, Dept Trauma Surg, Regensburg, Germany.
EM drkinner@aol.com; rmc_16@mit.edu; mspector@rics.bwh.harvard.edu
OI Spector, Myron/0000-0003-3328-4858
CR ALTMAN RD, 1992, ANN RHEUM DIS, V51, P1056, DOI 10.1136/ard.51.9.1056
   AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   Ben-Yishay A, 1995, Tissue Eng, V1, P119, DOI 10.1089/ten.1995.1.119
   Breinan HA, 2001, J ORTHOPAED RES, V19, P482, DOI 10.1016/S0736-0266(00)90015-9
   Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   Breinan HA, 1998, TISSUE ENG, V4, P101, DOI 10.1089/ten.1998.4.101
   BREINAN HA, 2001, CLIN ORTHOP S, V391, P219
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   BRUNS J, 1994, VIRCHOWS ARCH, V424, P169
   BUCKWALTER JA, 1990, BRIS MYER Z, P19
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   CALANDRUCCIO RA, 1962, J BONE JOINT SURG AM, V44, P431, DOI 10.2106/00004623-196244030-00001
   Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271
   Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0
   CHIROFF RT, 1977, J BIOMED MATER RES, V11, P165, DOI 10.1002/jbm.820110203
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Coutts RD, 2001, CLIN ORTHOP RELAT R, pS271, DOI 10.1097/00003086-200110001-00025
   Dounchis JS, 2000, CLIN ORTHOP RELAT R, P248
   EWING JW, 1990, BRIS MYER Z, P137
   Fawcett D. W., 1986, TXB HISTOLOGY
   Fortier LA, 1999, J ORTHOPAED RES, V17, P467, DOI 10.1002/jor.1100170403
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Freeman M. A. R., 1979, ADULT ARTICULAR CART
   Frenkel SR, 1996, ARTHRITIS RHEUM, V39, P1905, DOI 10.1002/art.1780391118
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   FRIEDMAN MJ, 1984, CLIN ORTHOP RELAT R, P200
   Fujimoto E, 1999, ARCH ORTHOP TRAUM SU, V119, P139, DOI 10.1007/s004020050377
   FULLER JA, 1972, CLIN ORTHOP RELAT R, P193
   GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594
   GHADIALLY FN, 1983, FINE STRUCTURE SYNOV
   Ghazavi MT, 1997, J BONE JOINT SURG BR, V79B, P1008, DOI 10.1302/0301-620X.79B6.7534
   GRANDE DA, 1987, ANAT REC, V218, P142, DOI 10.1002/ar.1092180208
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   GRANDE DA, 1989, SOC BIOM 15 ANN M LA, V15, P226
   GREEN WT, 1977, CLIN ORTHOP RELAT R, P237
   GROSS AE, 1975, CLIN ORTHOP RELAT R, P7
   Hacker SA, 1997, OSTEOARTHR CARTILAGE, V5, P343, DOI 10.1016/S1063-4584(97)80038-6
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003
   HOWES R, 1988, CALCIFIED TISSUE INT, V42, P34, DOI 10.1007/BF02555836
   Huard J, 2003, J GENE MED, V5, P93, DOI 10.1002/jgm.344
   Hunter W, 1743, PHILOS T R SOC LOND, V470, P514, DOI DOI 10.1098/RSTL.1742.0079)
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   HUNZIKER EB, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P183
   JEFFERY AK, 1991, J BONE JOINT SURG BR, V73, P795
   John Anitha, 2001, Pathology and Oncology Research, V7, P14
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Johnstone B., 1999, CLIN ORTHOP RELAT R, V367, P156
   KARAGIANES MT, 1975, ARCH PATHOL, V100, P398
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   Kim AC, 2000, J ORTHOP RES, V18, P749, DOI 10.1002/jor.1100180511
   KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004
   Kinner B, 2001, J ORTHOPAED RES, V19, P233, DOI 10.1016/S0736-0266(00)00081-4
   Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561
   KINNER B, IN PRESS ORTHOPAEDIC
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   LEE CR, 1998, CURR OPIN ORTHOP, V9, P88
   Lee GM, 1999, EXP CELL RES, V248, P294, DOI 10.1006/excr.1999.4418
   Louwerse RT, 2000, J BIOMED MATER RES, V49, P506, DOI 10.1002/(SICI)1097-4636(20000315)49:4<506::AID-JBM9>3.0.CO;2-A
   MAKOWER AM, 1989, CELL BIOL INT REP, V13, P259, DOI 10.1016/0309-1651(89)90148-3
   MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009
   MATSUSUE Y, 1993, ARTHROSCOPY, V9, P318, DOI 10.1016/S0749-8063(05)80428-1
   MCDERMOTT AGP, 1985, CLIN ORTHOP RELAT R, P96
   MCGRATH MH, 1982, PLAST RECONSTR SURG, V69, P975, DOI 10.1097/00006534-198206000-00012
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   NAMBA RS, 1998, J BONE JOINT SURG AM, V80, pA4
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404
   NIXON AJ, 1993, AM J VET RES, V54, P349
   O'Connor WJ, 2000, ORTHOP CLIN N AM, V31, P399, DOI 10.1016/S0030-5898(05)70159-0
   ODRISCOLL SW, 1986, CLIN ORTHOP RELAT R, P131
   ODRISCOLL SW, 1999, CLIN ORTHOP S, V367, pS186
   PAGET J, 1853, LECT SURG PATHOL LON, V1, P262
   PALETTA GA, 1992, AM J SPORT MED, V20, P725, DOI 10.1177/036354659202000614
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   PINEDA S, 1992, ACTA ANAT, V143, P335
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   QIU W, 2000, WOUND REPAIR REGEN, V18, P383
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Rodrigo J.J., 1994, AM J KNEE SURG, V7, P109
   ROTHWELL AG, 1990, ORTHOPEDICS, V13, P433
   SCHURCH W, 1997, HISTOLOGY PATHOLOGIS, P129
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   SHAHGALDI BF, 1991, J BONE JOINT SURG BR, V73, P57
   Smith P, 2000, ARTHRITIS RHEUM, V43, P1156, DOI 10.1002/1529-0131(200005)43:5<1156::AID-ANR26>3.0.CO;2-M
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Spangenberg KM, 2002, TISSUE ENG, V8, P839, DOI 10.1089/10763270260424196
   Spector M, 2001, WOUND REPAIR REGEN, V9, P11, DOI 10.1046/j.1524-475x.2001.00011.x
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   Suominen E, 1996, J BIOMED MATER RES, V32, P543, DOI 10.1002/(SICI)1097-4636(199612)32:4<543::AID-JBM7>3.0.CO;2-R
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wang Q, 2000, WOUND REPAIR REGEN, V8, P145, DOI 10.1046/j.1524-475x.2000.00145.x
   Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L
   Wirth CJ, 1996, ARTHROSCOPY, V12, P300, DOI 10.1016/S0749-8063(96)90062-6
   Worster AA, 2001, J ORTHOPAED RES, V19, P738, DOI 10.1016/S0736-0266(00)00054-1
   Yannas Ioannis V., 1998, Wound Repair and Regeneration, V6, P518, DOI 10.1046/j.1524-475X.1998.60604.x
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zaleskas JM, 2004, BIOMATERIALS, V25, P1299, DOI 10.1016/j.biomaterials.2003.08.005
NR 120
TC 29
Z9 30
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0724-6145
BN 3-540-22868-3
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2005
VL 94
BP 91
EP 123
DI 10.1007/b100001
PG 33
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BCC39
UT WOS:000228557400005
PM 15915870
DA 2018-10-19
ER

PT S
AU Rabkin-Aikawa, E
   Mayer, JE
   Schoen, FJ
AF Rabkin-Aikawa, E
   Mayer, JE
   Schoen, FJ
BE Yannas, IV
TI Heart valve regeneration
SO REGENERATIVE MEDICINE II: CLINICAL AND PRECLINICAL APPLICATIONS
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE heart valve; regeneration; valvular interstitial cells; valvular
   endothelial cells; tissue engineering
ID HUMAN PULMONARY VALVE; IN-VITRO ENDOTHELIALIZATION; TISSUE-ENGINEERED
   HEART; PORCINE MITRAL-VALVE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA;
   AORTIC-VALVE; INTERSTITIAL-CELLS; EXTRACELLULAR-MATRIX; ADHESION
   MOLECULES
AB The valves of the heart cannot regenerate spontaneously. Therefore, heart valve disease generally necessitates surgical repair or replacement of the diseased tissue by mechanical or bioprosthetic valve substitutes in order to avoid potentially fatal cardiac or systemic consequences. Although survival and quality of life is enhanced for many patients treated surgically, currently available valve substitutes remain imperfect. This is especially the case in pediatric applications, where physiologically corrective procedures can be successfully performed, but reoperations are frequently required to replace failed valve substitutes or accommodate growth of the patient. While much work is currently underway to incrementally improve existing valve substitutes, a major impact will require radically new technologies, including tissue engineering or regeneration. The use of engineered tissue offers the potential to create a non-obstructive, non-thrombogenic tissue valve substitute containing living cells capable of providing ongoing remodeling and repair of cumulative injury to the extracellular matrix. Ideally, this would allow growth in maturing recipients. The innovative fabrication of materials and the development of sophisticated methods to repair or regenerate damaged or diseased heart valves requires integration of a diverse array of basic scientific principles and enabling technologies. Thus, heart valve tissue engineering requires an understanding of relationships of structure to function in normal and pathological valves (including mechanisms of embryological development, tissue repair and functional biomechanics), and the ability to control cell and tissue responses to injury, physical stimuli and biomaterial surfaces, through chemical, pharmacological, mechanical and potentially genetic manipulations. These approaches created by advances in cell biology raise exciting possibilities for in situ regeneration and repair of heart valves.
C1 Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Childrens Hosp, Dept Cardiovasc Surg, Boston, MA USA.
RP Rabkin-Aikawa, E (reprint author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.
EM fschoen@partners.org
CR AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000
   Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Ballas CB, 2002, J CELL BIOCHEM, P20, DOI 10.1002/jcb.10127
   BENGTSSON LA, 1995, ANN THORAC SURG, V60, pS365, DOI 10.1016/0003-4975(95)00316-D
   BERESFORD WA, 1999, TISSUE ENG VASCULAR, P403
   Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0
   BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211
   Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080
   Butany J, 2001, J Long Term Eff Med Implants, V11, P115
   Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a
   Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742
   Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Chen RH, 2000, J THORAC CARDIOV SUR, V119, P1216, DOI 10.1067/mtc.2000.106526
   Chester AH, 2000, J HEART VALVE DIS, V9, P250
   Curtil A, 1997, J HEART VALVE DIS, V6, P296
   Davies PF, 2004, ARTERIOSCL THROM VAS, V24, P1331, DOI 10.1161/01.ATV.0000130659.89433.cl
   de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419
   de Wert G, 2002, Med Health Care Philos, V5, P79
   DECKER RS, 1982, SCIENCE, V215, P987, DOI 10.1126/science.6818687
   Della Rocca F, 2000, ANN THORAC SURG, V70, P1594, DOI 10.1016/S0003-4975(00)01979-2
   DeRuiter MC, 1997, CIRC RES, V80, P444, DOI 10.1161/01.RES.80.4.444
   Dreger SA, 2002, J HEART VALVE DIS, V11, P875
   Durbin AD, 2002, CARDIOVASC PATHOL, V11, P69, DOI 10.1016/S1054-8807(01)00109-0
   Dvorin EL, 2003, J HEART VALVE DIS, V12, P617
   Edelman ER, 1999, CIRC RES, V85, P1115
   EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1
   El Oakley RM, 2001, ANN THORAC SURG, V71, P1724, DOI 10.1016/S0003-4975(00)02596-0
   Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P87
   Elkins RC, 2001, ANN THORAC SURG, V71, P428
   Gencbay M, 1998, J HEART VALVE DIS, V7, P601
   Ghaisas NK, 2000, J AM COLL CARDIOL, V36, P2257, DOI 10.1016/S0735-1097(00)00998-0
   Gitler AD, 2003, CELL CYCLE, V2, P96, DOI 10.4161/cc.2.2.299
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   Hafizi S, 2000, J HEART VALVE DIS, V9, P454
   Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2
   HARKEN DE, 1962, AM J CARDIOL, V9, P292, DOI 10.1016/0002-9149(62)90047-4
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Jiang XB, 2000, DEVELOPMENT, V127, P1607
   Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200
   Jones GT, 2003, J VASC SURG, V38, P1363, DOI 10.1016/S0741-5214(03)01027-9
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Krane SM, 1996, J BIOL CHEM, V271, P28509, DOI 10.1074/jbc.271.45.28509
   Kunzelman K S, 1993, J Heart Valve Dis, V2, P236
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   LANGER R, 1993, SCIENCE, V56, P423
   Lee TC, 2000, CIRCULATION, V101, P2345, DOI 10.1161/01.CIR.101.20.2345
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   LESTER W, 1988, LAB INVEST, V59, P710
   LESTER WM, 1988, CIRC RES, V62, P833, DOI 10.1161/01.RES.62.4.833
   LESTER WM, 1993, IN VITRO CELL DEV-AN, V29A, P41
   LESTER WM, 1992, J MOL CELL CARDIOL, V24, P43, DOI 10.1016/0022-2828(92)91158-2
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051
   Mann BK, 2001, ANAT REC, V263, P367, DOI 10.1002/ar.1116
   MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108
   MARKWALD RR, 1975, DEV BIOL, V42, P160, DOI 10.1016/0012-1606(75)90321-8
   Massia S.P., 1999, TISSUE ENG PROSTHETI, P583
   Masuda H, 2000, Hum Cell, V13, P153
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Menasche Philippe, 2002, Semin Thorac Cardiovasc Surg, V14, P157, DOI 10.1053/stcs.2002.32319
   Meredith JE, 1997, TRENDS CELL BIOL, V7, P146, DOI 10.1016/S0962-8924(97)01002-7
   MIKOS AG, IN PRESS BIOMATERIAL
   Mitchell RN, 1998, J THORAC CARDIOV SUR, V115, P118, DOI 10.1016/S0022-5223(98)70450-7
   Mjaatvedt GH, 1999, HEART DEV, P159
   Muller AM, 2000, J PATHOL, V191, P54, DOI 10.1002/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   *NIH, 1999, WORK GROUP TISS GEN
   Norris RA, 2004, ANAT REC PART A, V281A, P1227, DOI 10.1002/ar.a.20135
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5
   Pins GD, 2000, FASEB J, V14, P593
   Platt JL, 1999, CLIN EXP PHARMACOL P, V26, P1026, DOI 10.1046/j.1440-1681.1999.03186.x
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Rabkin E, 2002, J HEART VALVE DIS, V11, P308
   Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489
   Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841
   Rabkin-Aikawa E, 2004, J THORAC CARDIOV SUR, V128, P552, DOI 10.1016/j.jtcvs.2004.04.016
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Rahimtoola SH, 2003, J AM COLL CARDIOL, V42, P1720, DOI 10.1016/j.jacc.2003.07.008
   Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426
   Reiss M J, 2000, J Appl Philos, V17, P253, DOI 10.1111/1468-5930.00160
   Robertson JA, 2001, NAT REV GENET, V2, P74, DOI 10.1038/35047594
   Roy A, 2000, J HEART VALVE DIS, V9, P459
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sameni Mansoureh, 2003, Mol Imaging, V2, P159, DOI 10.1162/153535003322556903
   Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944
   Schoen F., 1989, INTERVENTIONAL SURG
   Schoen F. J., 2001, CARDIOVASC PATHOL, P402
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   Schoen FJ, 1997, J HEART VALVE DIS, V6, P1
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   Schoen FJ, 1999, J HEART VALVE DIS, V8, P350
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   SCHOEN FJ, 2001, ROBBINS COTRAN PATHO, P555
   Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5
   Schurch W, 1998, AM J SURG PATHOL, V22, P141, DOI 10.1097/00000478-199802000-00001
   Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F
   SCOTT M, 1995, ANN THORAC SURG, V60, P5391
   SHIMIZU K, 2001, NAT MED, V7, P378
   Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957
   Sievers HH, 2003, Z KARDIOL, V92, P53, DOI 10.1007/s00392-003-0883-x
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P821, DOI 10.1002/jbm.820270615
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181
   Tamura K, 2000, J HEART VALVE DIS, V9, P53
   Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0
   Taylor PM, 2002, J HEART VALVE DIS, V11, P298
   Taylor PM, 2000, J HEART VALVE DIS, V9, P150
   Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006
   Tien J, 2002, IEEE ENG MED BIOL, V21, P95
   VALENTE M, 1985, AM J PATHOL, V119, P12
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa
   Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021
   Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Woodard AS, 1998, J CELL SCI, V111, P469
   Ye S, 2000, MATRIX BIOL, V19, P623, DOI 10.1016/S0945-053X(00)00102-5
NR 133
TC 75
Z9 79
U1 2
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0724-6145
BN 3-540-22868-3
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2005
VL 94
BP 141
EP 179
DI 10.1007/b100003
PG 39
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BCC39
UT WOS:000228557400007
PM 15915872
DA 2018-10-19
ER

PT J
AU Wilson, CJ
   Clegg, RE
   Leavesley, DI
   Pearcy, MJ
AF Wilson, CJ
   Clegg, RE
   Leavesley, DI
   Pearcy, MJ
TI Mediation of biomaterial-cell interactions by adsorbed proteins: A
   review
SO TISSUE ENGINEERING
LA English
DT Review
ID OSTEOBLAST-LIKE CELLS; SUBSTRATUM-BOUND FIBRONECTIN; UNALLOYED TITANIUM
   IMPLANTS; TISSUE-CULTURE POLYSTYRENE; SELF-ASSEMBLED MONOLAYERS;
   SOLID-LIQUID INTERFACES; MARROW STROMAL CELLS; HUMAN BONE-CELLS;
   IMMOBILIZED ADHESIVE PEPTIDES; PATTERNED SURFACE-CHEMISTRY
AB An appropriate cellular response to implanted surfaces is essential for tissue regeneration and integration. It is well described that implanted materials are immediately coated with proteins from blood and interstitial fluids, and it is through this adsorbed layer that cells sense foreign surfaces. Hence, it is the adsorbed proteins, rather than the surface itself, to which cells initially respond. Diverse studies using a range of materials have demonstrated the pivotal role of extracellular adhesion proteins - fibronectin and vitronectin in particular - in cell adhesion, morphology, and migration. These events underlie the subsequent responses required for tissue repair, with the nature of cell surface interactions contributing to survival, growth, and differentiation. The pattern in which adhesion proteins and other bioactive molecules adsorb thus elicits cellular reactions specific to the underlying physicochemical properties of the material. Accordingly, in vitro studies generally demonstrate favorable cell responses to charged, hydrophilic surfaces, corresponding to superior adsorption and bioactivity of adhesion proteins. This review illustrates the mediation of cell responses to biomaterials by adsorbed proteins, in the context of osteoblasts and selected materials used in orthopedic implants and bone tissue engineering. It is recognized, however, that the periimplant environment in vivo will differ substantially from the cell - biomaterial interface in vitro. Hence, one of the key issues yet to be resolved is that of the interface composition actually encountered by osteoblasts within the sequence of inflammation and bone regeneration.
C1 Queensland Univ Technol, Sch Mech Mfg & Med Engn, Inst Hlth & Biomed Innovat, Tissue Bioregenerat Domain, Brisbane, Qld 4001, Australia.
   Queensland Univ Technol, Sch Engn Syst, Brisbane, Qld 4001, Australia.
   Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia.
RP Wilson, CJ (reprint author), Queensland Univ Technol, Sch Mech Mfg & Med Engn, Inst Hlth & Biomed Innovat, Tissue Bioregenerat Domain, GPO Box 2434, Brisbane, Qld 4001, Australia.
EM c2.wilson@qut.edu.au
RI Wilson, Cameron/F-8713-2010; Pearcy, Mark/B-4289-2010; Leavesley,
   David/C-9532-2009
OI Wilson, Cameron/0000-0002-5954-6820; Pearcy, Mark/0000-0002-1108-6503;
   Leavesley, David/0000-0002-1033-5459; Clegg, Richard/0000-0002-9556-0507
CR Aarden EM, 1996, BONE, V18, P305, DOI 10.1016/8756-3282(96)00010-5
   ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   ARAI T, 1990, COLLOID SURFACE, V51, P17, DOI 10.1016/0166-6622(90)80128-Q
   ARAI T, 1990, COLLOID SURFACE, V51, P1, DOI 10.1016/0166-6622(90)80127-P
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   BAGAMBISA FB, 1994, J CRANIO MAXILL SURG, V22, P12, DOI 10.1016/S1010-5182(05)80290-2
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BALE MD, 1989, BLOOD, V74, P2698
   BALL V, 1998, BIOPOLYMERS INTERFAC, P453
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   BAUTISTA CM, 1991, BIOCHEM BIOPH RES CO, V176, P756, DOI 10.1016/S0006-291X(05)80249-9
   Bentaleb A, 1997, LANGMUIR, V13, P729, DOI 10.1021/la9605192
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BRASH JL, 1983, J COLLOID INTERF SCI, V95, P28, DOI 10.1016/0021-9797(83)90068-1
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   Callen BW, 1995, PROG SURF SCI, V50, P269, DOI 10.1016/0079-6816(95)00061-5
   CALLEN BW, 1995, J BIOMED MATER RES, V29, P279, DOI 10.1002/jbm.820290302
   Castoldi M, 1997, CELL BIOL INT, V21, P7, DOI 10.1006/cbir.1996.0110
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen SF, 2003, LANGMUIR, V19, P2859, DOI 10.1021/la026498v
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Clemmons DR, 2003, ENDOCRINOLOGY, V144, P1664, DOI 10.1210/en.2002-221102
   CLOVER J, 1992, J CELL SCI, V103, P267
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   CULP LA, 1976, J SUPRAMOL STR CELL, V5, P239, DOI 10.1002/jss.400050210
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   DALTON SL, 1992, J BIOL CHEM, V267, P8186
   Damsky CH, 1997, KIDNEY INT, V51, P1427, DOI 10.1038/ki.1997.195
   Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X
   Davies J., 1988, SURFACE CHARACTERIZA, P219
   Davies J.E., 2000, BONE ENG, P1
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   Davies John E, 2003, J Dent Educ, V67, P932
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   Edmiston PL, 1997, J AM CHEM SOC, V119, P560, DOI 10.1021/ja962366a
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   ELWING HB, 1995, PROTEINS INTERFACES, V2, P138
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FABRIZIUSHOMAN DJ, 1992, THROMB HAEMOSTASIS, V68, P194
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Giacomelli CE, 2001, J COLLOID INTERF SCI, V233, P234, DOI 10.1006/jcis.2000.7219
   Globus RK, 1998, J CELL SCI, V111, P1385
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Grzesik Wojciech J., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P271
   HALL H, 2004, 7 WORLD BIOM C SYDN
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   HANEIN D, 1993, J CELL SCI, V104, P275
   HANEIN D, 1993, LANGMUIR, V9, P1058, DOI 10.1021/la00028a030
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   HAYNES CA, 1994, J COLLOID INTERF SCI, V164, P394, DOI 10.1006/jcis.1994.1182
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Horbett T. A., 2003, BIOPOLYMERS INTERFAC, P393
   Horbett T. A., 1999, BMES BULL, V13, P5
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Horbett TA, 1995, ACS SYM SER, V602, P1
   Horbett Thomas A., 1996, P133
   HORMIA M, 1994, J PERIODONTAL RES, V29, P146, DOI 10.1111/j.1600-0765.1994.tb01103.x
   Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551
   Hyde C, 2004, J INVEST DERMATOL, V122, P1198, DOI 10.1111/j.0022-202X.2004.022527.x
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kikuchi A, 1996, J BIOMAT SCI-POLYM E, V8, P77, DOI 10.1163/156856296X00165
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Kilpadi DV, 1998, COLLOID SURFACE A, V135, P89, DOI 10.1016/S0927-7757(97)00237-9
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   KISS E, 2001, PROGR COLLOID POLYM, V117, P167
   KLEBE RJ, 1981, J CELL PHYSIOL, V109, P481, DOI 10.1002/jcp.1041090314
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Koistinen P, 1999, MATRIX BIOL, V18, P239, DOI 10.1016/S0945-053X(99)00022-0
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   KOUTSOUKOS PG, 1983, J COLLOID INTERF SCI, V95, P385, DOI 10.1016/0021-9797(83)90198-4
   Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101
   Lee YJ, 2003, BIOMATERIALS, V24, P1059, DOI 10.1016/S0142-9612(02)00439-8
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   LIU L, 2004, 7 WORLD BIOM C SYDN
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MALMSTEN M, 1995, PROTEINS INTERFACES, V2, P228
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Masuda T, 1997, INT J ORAL MAX IMPL, V12, P472
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   Morra M, 2003, INT J ORAL MAX IMPL, V18, P40
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Norde W, 1999, MACROMOL SYMP, V145, P125, DOI 10.1002/masy.19991450114
   Norde W., 1995, PROTEINS INTERFACES, P26
   NORDE W, 1998, BIOPOLYMERS INTERFAC, P27
   Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200
   Nygren H, 1996, COLLOID SURFACE B, V6, P329, DOI 10.1016/0927-7765(96)01270-2
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   PITT WG, 1989, J COLLOID INTERF SCI, V129, P231, DOI 10.1016/0021-9797(89)90435-9
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   RAPOZA RJ, 1990, J BIOMED MATER RES, V24, P1263, DOI 10.1002/jbm.820241002
   RAPOZA RJ, 1989, J BIOMAT SCI-POLYM E, V1, P69
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Roche P, 1999, BONE, V24, P329, DOI 10.1016/S8756-3282(98)00194-X
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   SAFINIA L, 2003, EUR CELLS MAT, V5, P84
   SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   SCHWARZ MA, 1984, EXP CELL RES, V153, P550, DOI 10.1016/0014-4827(84)90624-4
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Scotchford CA, 2003, BIOMATERIALS, V24, P1147, DOI 10.1016/S0142-9612(02)00488-X
   Seiffert D, 1996, J HISTOCHEM CYTOCHEM, V44, P275, DOI 10.1177/44.3.8648088
   Seiffert D, 1997, J BIOL CHEM, V272, P13705, DOI 10.1074/jbc.272.21.13705
   SERRO AP, 1999, J BIOMED MATER RES, V46, P376
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   SLACK SM, 1995, PROTEINS INTERFACES, V2, P112
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   Steele JG, 1997, BIOMATERIALS, V18, P1541, DOI 10.1016/S0142-9612(97)00088-4
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   STUART MAC, 1998, BIOPOLYMERS INTERFAC, P1
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Tengvall P, 2003, BIO-IMPLANT INTERFACE: IMPROVING BIOMATERIALS AND TISSUE REACTIONS, P285
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   Upton Z, 1999, ENDOCRINOLOGY, V140, P2928, DOI 10.1210/en.140.6.2928
   van Kooten TG, 1999, TISSUE ENG, V5, P223
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   VROMAN L, 1982, BIOMATERIALS INTERFA, P265
   VROMAN L, 1983, BIOCOMPATIBLE POLYM, P81
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang H, 2004, LANGMUIR, V20, P1877, DOI 10.1021/la035376f
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Wennerberg A, 1998, INT J MACH TOOL MANU, V38, P657, DOI 10.1016/S0890-6955(97)00114-4
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   WIKESJO UME, 1991, J PERIODONTOL, V62, P5, DOI 10.1902/jop.1991.62.1.5
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   WORCH H, 1998, METALS BIOMATERIALS, P177
   Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47
NR 226
TC 817
Z9 834
U1 27
U2 402
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JAN
PY 2005
VL 11
IS 1-2
BP 1
EP 18
DI 10.1089/ten.2005.11.1
PG 18
WC Cell & Tissue Engineering
SC Cell Biology
GA 904QU
UT WOS:000227513600001
PM 15738657
DA 2018-10-19
ER

PT B
AU Oku, M
   Nakajima, S
   Tadokoro, Y
   Shimoyamada, N
   Nagase, Y
   Iwasaki, Y
   Ishihara, K
AF Oku, Masataka
   Nakajima, Satoshi
   Tadokoro, Yoshinori
   Shimoyamada, Naoya
   Nagase, Yu
   Iwasaki, Yasuhiko
   Ishihara, Kazuhiko
BE Somiya, S
   Doyama, M
TI Preparation and biocompatibitity of aromatic polyamides containing
   phosphorylcholine moiety
SO Transactions of the Materials Research Society of Japan, Vol 30, No 4
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT Joint Symposia of the Materials-Research-Society-of-Japan
CY DEC 23-24, 2004
CL Nihon Univ, Tokyo, JAPAN
SP Mat Res Soc Japan
HO Nihon Univ
DE biomaterial; biocompatibility; MPC polymer; phosphorylcholine; aromatic
   polyamide
AB The phosphorylcholine (PC) group is an important component of cell membrane, and it is well known that 2-methacryloxyethyl phosphorylcholine (MPC) polymer has been reported as an ideal biocompatible material. In this study, in order to develop the durability of MPC polymer, the synthesis of a novel aromatic diamine compound containing PC group was carried out to prepare aromatic polyamides with PC moiety. The polycondensation of the diamine monomer containing PC group and 4,4'-diamino-3,3'dimethyldiphenylmethane with isophthaloyl chloride gave the desired copolyamides with different PC contents. The obtained copolyamides exhibited the excellent biocompatibility, even though the PC content was around 10 mol%. From the results of contact angle of water and XPS analysis on the surface of the copolyamide films, it was found that PC units were concentrated on the surface after the treatment with water. Therefore, the biocompatibility of the copolyamide containing PC group would be due to the surface property covered with PC units.
C1 Tokai Univ, Grad Sch Engn, Hiratsuka, Kanagawa 2591292, Japan.
RP Oku, M (reprint author), Tokai Univ, Grad Sch Engn, 1117 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR Ishihara K, 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P255
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
J9 T MRS JAP
PY 2005
VL 30
IS 4
BP 1037
EP 1040
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFA87
UT WOS:000240547000029
DA 2018-10-19
ER

PT B
AU Choi, YS
   Lee, KS
   Park, DH
AF Choi, YS
   Lee, KS
   Park, DH
GP IEEE
TI Biochip microarray using magnetic force interaction and self-assembly
SO Transducers '05, Digest of Technical Papers, Vols 1 and 2
LA English
DT Proceedings Paper
CT 13th International Conference on Solid-State Sensors, Actuators and
   Microsystems
CY JUN 05-09, 2005
CL Seoul, SOUTH KOREA
SP Korean Sensors Soc, IEEE Electron Devices Soc, IEEE Robot & Automat Soc, IEE Japan, Sensors & Micromach Soc, Int Federat Automat Control, Inst Control, Automat & Syst Engineers, Inst Elect Engineers Korea, Korean Inst Elect Engineers, Korean Soc Mech Engineers, Korean Soc Precis Engn, Korean Robot Soc
DE multifunctional biosensor; biomaterials; metal particle; magnetic force
   interaction
AB This paper describes a new constructing method of multifunctional biosensor using many kinds of biomaterials. A metal particle and an array were fabricated by photolithographic. The metal particles were in a multilayer structure. Biomaterials were immobilized on the metal particle. Sidewalls of patterned Ni dots on the array were covered by thick negative photoresist, and the array was magnetized. The array and the particles were mixed in a buffer solution, and were arranged by magnetic force interaction and random fluidic self-assembly. The particles were successfully arranged on the array. The biomaterial activities were detected by electrochemical methods.
CR Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610
   Choi YS, 2002, COLLOID SURFACE A, V201, P261, DOI 10.1016/S0927-7757(01)01029-9
   Huck WTS, 1998, J AM CHEM SOC, V120, P8267, DOI 10.1021/ja981390g
   Lavigne JJ, 1998, J AM CHEM SOC, V120, P6429, DOI 10.1021/ja9743405
   Lemmo AV, 1997, ANAL CHEM, V69, P543, DOI 10.1021/ac960808v
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8994-8
PY 2005
BP 1581
EP 1583
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BCZ93
UT WOS:000232189100390
DA 2018-10-19
ER

PT S
AU Chen, JF
   Kawano, H
   Nabekawa, Y
   Mizuno, H
   Miyawaki, A
   Tanabe, T
   Kannari, F
   Midorikawa, K
AF Chen, JF
   Kawano, H
   Nabekawa, Y
   Mizuno, H
   Miyawaki, A
   Tanabe, T
   Kannari, F
   Midorikawa, K
BE Kobayashi, T
   Okada, T
   Kobayashi, T
   Nelson, KA
   DeSilvestri, S
TI Engineering cost function for optimizing coherent control between
   processes with different nonlinearities
SO ULTRAFAST PHENOMENA XIV
SE Springer Series in Chemical Physics
LA English
DT Proceedings Paper
CT 14th International Conference on Ultrafast Phenomena
CY JUL 25-30, 2004
CL Niigata, JAPAN
SP Opt Soc Amer
ID FLUORESCENCE
AB It has been known that three-photon absorption of DNA or protein is one of the causes of phototoxicity. Here, we apply coherent control to enhance the contrast between the two-photon absorption of fluorescent label and the three-photon absorption of biomaterial with engineered cost function, leading to effectively reduced three-photon absorption with few loss of valuable two-photon fluorescence.
C1 RIKEN, Laser Technol Lab, Wako, Saitama 3510198, Japan.
RP Chen, JF (reprint author), RIKEN, Laser Technol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kmidori@riken.jp
CR DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Kawano H, 2003, BIOCHEM BIOPH RES CO, V311, P592, DOI 10.1016/j.bbrc.2003.09.236
NR 2
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0172-6218
BN 3-540-24110-8
J9 SPRINGER SER CHEM PH
PY 2005
VL 79
BP 640
EP 642
PG 3
WC Optics
SC Optics
GA BBW62
UT WOS:000228159300196
DA 2018-10-19
ER

PT B
AU Yeong, WY
   Chua, CK
   Leong, KF
   Chandrasekaran, M
   Lee, MW
AF Yeong, WY
   Chua, CK
   Leong, KF
   Chandrasekaran, M
   Lee, MW
BE Bartolo, PJ
   Mateus, AJ
   Batista, FC
   Almeida, HA
   Vasco, JC
   Correia, MA
   Alves, NF
   Andre, NC
   Novo, PP
   Lima, P
   Custodio, PC
   Martinho, PG
   Carvolho, RA
TI Development of scaffolds for tissue engineering using a 3D inkjet model
   maker
SO VIRTUAL MODELING AND RAPID MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL
   AND RAPID PROTOTYPING
LA English
DT Proceedings Paper
CT 2nd International Conference on Advanced Research and Rapid Prototyping
CY SEP 28-OCT 01, 2005
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Sch Technol & Management, Global Alliance Rapid Prototyping Assoc, Portuguese Rapid Prototyping Assoc
AB One of the major approaches in tissue engineering is the utilization of scaffold as a temporary template to support tissue ingrowth and to guide the organization of cells. As a result, scaffold technology is critical to ensure the success of this approach. Scaffold with intricate internal morphology can be achieved by the application of Rapid Prototyping (RP). In this project, a commercial RP system was employed to produce tissue-engineering scaffolds via an indirect method. This method offers great degree of design freedom compared to conventional as well as direct fabrication method. Material opportunity is significantly enhanced with this sacrificial mold method while enabling the utilization of natural biomaterial. Flow channels can be incorporated into the design to increase the nutrient diffusion rate through the scaffold.
C1 Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RP Yeong, WY (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RI Chua, Chee Kai/B-6171-2009; Leong, Kah-Fai/B-6183-2009; Yeong, Wai
   Yee/G-2655-2013
OI Yeong, Wai Yee/0000-0003-3640-0877
CR Chua C K, 2003, RAPID PROTOTYPING PR
   GAO F, 1992, P ROY SOC LOND A MAT, V444, P533
   Lalan S, 2001, WORLD J SURG, V25, P1458
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 7
TC 30
Z9 30
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
BN 0-415-39062-1
PY 2005
BP 115
EP 118
PG 4
WC Engineering, Manufacturing
SC Engineering
GA BDL91
UT WOS:000234204500015
DA 2018-10-19
ER

PT J
AU Mahmood, TA
   de Jong, R
   Riesle, J
   Langer, R
   van Blitterswijk, CA
AF Mahmood, TA
   de Jong, R
   Riesle, J
   Langer, R
   van Blitterswijk, CA
TI Adhesion-mediated signal transduction in human articular chondrocytes:
   the influence of biomaterial chemistry and tenascin-C
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
ID PROTEIN-KINASE-C; DIFFERENTIATED COLLAGEN PHENOTYPE; CELL-SHAPE; FOCAL
   ADHESIONS; RETINOIC ACID; IN-VITRO; MICROFILAMENT MODIFICATION; INDUCED
   REEXPRESSION; MESENCHYMAL CELLS; CARTILAGE REPAIR
AB Chondrocyte 'dedifferentiation' involves the switching of the cell phenotype to one that no longer secretes extracellular matrix found in normal cartilage and occurs frequently during chondrocyte expansion in culture. It is also characterized by the differential expression of receptors and intracellular proteins that are involved in signal transduction pathways, including those associated with cell shape and actin microfilament organization. The objective of this study was to examine the modulation of chondrocyte phenotype by cultivation on polymer substrates containing poly(ethylene glycol) (PEG). We observed differential arrangement of actin organization in articular chondrocytes, depending on PEG length. When cultivated on 300 g/mol PEG substrates at day 19, chondrocytes had lost intracellular markers characteristic of the differentiated phenotype, including type 11 collagen and protein kinase C (PKC). On these surfaces, chondrocytes also expressed focal adhesion and signaling proteins indicative of cell attachment, spreading, and FA turnover, including RhoA, focal adhesion kinase, and vinculin. The switch to a dedifferentiated chondrocyte phenotype correlated with integrin expression. Conversely, the expression of CD44 receptors coincided with chondrogenic characteristics, suggesting that binding,via these receptors could play a role in maintaining the differentiated phenotype on such substrates. These effects can be similar to those of compounds that interfere in intracellular signaling pathways and can be utilized to engineer cellular response. (C) 2004 Elsevier Inc. All rights reserved.
C1 IsoTis SA, NL-3723 MB Bilthoven, Netherlands.
   MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
RP Mahmood, TA (reprint author), Amgen Inc, Dept Pharmaceut, 1 Amgen Ctr Dr,MS 8-2-D, Thousand Oaks, CA 91320 USA.
EM tmahmood@amgen.com
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BENYA PD, 1988, J CELL BIOL, V106, P161, DOI 10.1083/jcb.106.1.161
   BENYA PD, 1993, EXP CELL RES, V204, P268, DOI 10.1006/excr.1993.1033
   BENYA PD, 1986, DEV BIOL, V118, P296, DOI 10.1016/0012-1606(86)90096-5
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BENYA PD, 1988, PATHOL IMMUNOPATH R, V7, P51, DOI 10.1159/000157093
   BEUMER GJ, 1993, BIOMATERIALS, V14, P598, DOI 10.1016/0142-9612(93)90178-5
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Boyan B D, 1993, J Oral Implantol, V19, P116
   BROWN PD, 1988, J CELL BIOL, V106, P171, DOI 10.1083/jcb.106.1.171
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164
   Chen F S, 1999, Am J Orthop (Belle Mead NJ), V28, P31
   Chicurel ME, 1998, NATURE, V392, P730
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Clancy R, 1999, OSTEOARTHR CARTILAGE, V7, P399, DOI 10.1053/joca.1998.0223
   Clancy RM, 1997, J CLIN INVEST, V100, P1789, DOI 10.1172/JCI119706
   Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x
   FRONDOZA C, 1996, BIOMATERIALS, V17, P888
   GEIGER B, 1995, ACTA ANAT, P154
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857
   Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243
   HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411
   Huang S, 2002, EXP CELL RES, V275, P255, DOI 10.1006/excr.2002.5504
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   HUANG S, 1999, NATURE CELL BIOL, V1, P131
   HULKOWER KI, 1989, AGENTS ACTIONS, V27, P442, DOI 10.1007/BF01972847
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   KNUDSON CB, 1993, FASEB J, V7, P1233
   Knudson CB, 1999, BIOCHEM SOC T, V27, P142, DOI 10.1042/bst0270142
   Knudson Cheryl B., 2003, Birth Defects Research, V69, P174, DOI 10.1002/bdrc.10013
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   KORNBERG L, 1992, J BIOL CHEM, V267, P23439
   Langelier E, 2000, J HISTOCHEM CYTOCHEM, V48, P1307, DOI 10.1177/002215540004801002
   Lee SJ, 2002, J BIOMAT SCI-POLYM E, V13, P197, DOI 10.1163/156856202317414375
   LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084
   Loeser RF, 2002, BIORHEOLOGY, V39, P119
   Loty C, 1997, J BIOMED MATER RES, V37, P137, DOI 10.1002/(SICI)1097-4636(199710)37:1<137::AID-JBM17>3.0.CO;2-D
   LOTY S, 1995, BIOL CELL, V83, P149, DOI 10.1016/0248-4900(96)81303-7
   Loty S, 2000, BIORHEOLOGY, V37, P117
   MAHMOOD TA, 2003, UNPUB DIFFERENTIAL P
   MALLEINGERIN F, 1991, EUR J CELL BIOL, V56, P364
   MAROUDAS NG, 1977, J CELL PHYSIOL, V90, P511, DOI 10.1002/jcp.1040900314
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292
   Nicoll SB, 2002, BIOCHEM BIOPH RES CO, V292, P819, DOI 10.1006/bbrc.2002.6697
   Orend G, 2000, EXP CELL RES, V261, P104, DOI 10.1006/excr.2000.5041
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489
   Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4
   STOKER M, 1968, INT J CANCER, V3, P638
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639
   van Dorp AGM, 1999, J BIOMED MATER RES, V47, P292, DOI 10.1002/(SICI)1097-4636(19991205)47:3<292::AID-JBM2>3.0.CO;2-B
   Van Dorp Annette G. M., 1998, Wound Repair and Regeneration, V6, P556, DOI 10.1046/j.1524-475X.1998.60608.x
   Wang L, 2001, OSTEOARTHR CARTILAGE, V9, P73, DOI 10.1053/joca.2000.0352
   Wenk MB, 2000, J CELL BIOL, V150, P913, DOI 10.1083/jcb.150.4.913
   Wyre R. M., 2002, Biomaterials, V23, P357, DOI 10.1016/S0142-9612(01)00113-2
   Yang MS, 1998, MOL CELLS, V8, P266
   Yoon YM, 2000, J BIOL CHEM, V275, P12353, DOI 10.1074/jbc.275.16.12353
   Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200
NR 72
TC 52
Z9 52
U1 0
U2 9
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495, UNITED STATES
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD DEC 10
PY 2004
VL 301
IS 2
BP 179
EP 188
DI 10.1016/j.yexcr.2004.07.027
PG 10
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 873DY
UT WOS:000225260800008
PM 15530854
DA 2018-10-19
ER

PT J
AU Wang, DA
   Williams, CG
   Yang, F
   Elisseeff, JH
AF Wang, DA
   Williams, CG
   Yang, F
   Elisseeff, JH
TI Enhancing the tissue-biomaterial interface: Tissue-initiated integration
   of biomaterials
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID CARTILAGE REPAIR; CYTOCHROME-C; HYDROGEN-PEROXIDE; CROSS-LINKING;
   IN-VITRO; RADICALS; COLLAGEN; MATRIX
AB Integration of biomaterials within the body is a longstanding problem in medicine. The lack of proper biomaterial integration within the body sacrifices artificial implant longevity and function. Materials such as hydrogels may be able to integrate with soft tissue; however, a challenge remains to improve tissue-biomaterial interaction for hard tissues such as cartilage and bone. Cartilage poses a particularly difficult challenge for biomaterial integration since it has a dense extracellular matrix that impedes cellular migration, additionally, it has a smooth, lubricating surface. Collagen fibers, are abundant in the cartilage matrix and throughout the body, provide structural integrity and were chosen as the target for polymerization initiation, anchoring, and integration of hydrogel biomaterials. Principles of protein biochemistry and polymer science were applied to formulate a novel strategy to initiate and directly polymerize biomaterials to collagen. Initially, proteoglycans were removed from the cartilage surface by enzymatic digestion, followed by treatment with a mild oxidative reagent to create tyrosyl radicals on collagen. Afterwards, polymers containing acrylate groups were added and tyrosyl radicals, confirmed by electron spin resonance (ESR) were used to initiate polymerization with light. Chemical (Fourier-transform infrared spectroscopy) and morphological (scanning electron microscopy (SEM)) analyses revealed the presence of polymer bound to the cartilage surface after tissue-initiated photopolymerization. Mechanical analysis by the application of torsional stress demonstrated enhanced functional tissue integration of the tissue-initiated polymerized material. Cells in the surrounding cartilage tissue and encapsulated in the hydrogel, remained viable during the bonding and polymerization processes.
C1 Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
RP Wang, DA (reprint author), Johns Hopkins Univ, Dept Biomed Engn, 3400 N Charles St Clark Hall 106, Baltimore, MD 21218 USA.
EM jhe@bme.jhu.edu
RI Wang, Dong-an/G-6195-2010
CR Ahsan T, 1999, J ORTHOPAED RES, V17, P850, DOI 10.1002/jor.1100170610
   Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498
   BRIERE R, 1971, MOL PHYS, V20, P211, DOI 10.1080/00268977100100211
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Chen YR, 1999, J BIOL CHEM, V274, P3308, DOI 10.1074/jbc.274.6.3308
   DiMicco MA, 2002, OSTEOARTHR CARTILAGE, V10, P218, DOI 10.1053/joca.2001.0502
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   FRANK EH, 1987, J BIOMECH, V20, P615, DOI 10.1016/0021-9290(87)90282-X
   Giurea A, 2002, J ORTHOPAED RES, V20, P1274, DOI 10.1016/S0736-0266(02)00084-0
   Givens RS, 2003, PHOTOCHEM PHOTOBIOL, V78, P23
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Mow VC, 1990, BIOMECHANICS DIARTHR, V1, P215
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Oh TJ, 2002, J PERIODONTOL, V73, P322, DOI 10.1902/jop.2002.73.3.322
   Qian SY, 2002, BIOCHEM J, V363, P281, DOI 10.1042/0264-6021:3630281
   Quinn TM, 2002, TISSUE ENG, V8, P799, DOI 10.1089/10763270260424150
   SJOBERG BM, 1978, J BIOL CHEM, V253, P6863
   Stubbe J, 2003, CHEM COMMUN, P2511, DOI 10.1039/b307617m
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
NR 22
TC 47
Z9 49
U1 1
U2 30
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD DEC
PY 2004
VL 14
IS 12
BP 1152
EP 1159
DI 10.1002/adfm.200305018
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 884RL
UT WOS:000226103500002
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Bone biomaterial for dental use
SO AMERICAN CERAMIC SOCIETY BULLETIN
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 600 N CLEVELAND AVE, WESTERVILLE, OH 43082 USA
SN 0002-7812
EI 1945-2705
J9 AM CERAM SOC BULL
JI Am. Ceram. Soc. Bull.
PD DEC
PY 2004
VL 83
IS 12
BP 6
EP 6
PG 1
WC Materials Science, Ceramics
SC Materials Science
GA 886TF
UT WOS:000226250800027
DA 2018-10-19
ER

PT J
AU Falkner, E
   Eder, C
   Kapeller, B
   Froschl, W
   Schmatz, C
   Macfelda, K
   Losert, UM
AF Falkner, E
   Eder, C
   Kapeller, B
   Froschl, W
   Schmatz, C
   Macfelda, K
   Losert, UM
TI The mandatory CAM testing of cells and scaffolds for tissue engineering:
   Benefits for the three Rs of cooperation with the vaccine industry
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE angiogenesis; biomaterial; cell/tissue implantation/transplantation;
   chorio-allantoic membrane; HET-CAM; tissue engineering
ID EMBRYO CHORIOALLANTOIC MEMBRANE; CHICK-EMBRYO; IN-VIVO; MODEL;
   ANGIOGENESIS; ASSAY
AB In cooperation with BAXTER Vaccine AG, which supplies incubated special pathogen-free chicken eggs (including a full veterinary record), a permanent hen's egg chorio-allantoic membrane test (HET-CAM) unit has been established, where angiogenesis testing, cell culture, and digital and histological analyses are performed. At the Core Unit for Biomedical Research, the location of the animal testing facility of the Medical University Vienna, cell-scaffold constructs must be evaluated in vitro and in ovo prior to eventual in vivo tissue engineering experiments. The animal testing advisory committee requires that new test proposals are first evaluated by using cell culture and HET-CAM models. Approvals for in vivo experiments are postponed and not issued prior to in vitro/in ovo evaluation. Examples are presented of protocols planned for in vivo studies on cell seeded scaffolds, which were refined after in vitro/in ovo evaluations.
C1 Univ Vienna, AKH Wien, Core Unit Biomed Res, A-1090 Vienna, Austria.
   BAXTER Vaccine AG, Orth, Austria.
RP Falkner, E (reprint author), Univ Vienna, AKH Wien, Core Unit Biomed Res, Leitstelle 1Q,Waehringer Guertel 18, A-1090 Vienna, Austria.
EM erwin.falkner@meduniwien.ac.at
CR *ASTM INT, 2003, F74898 ASTM
   AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Falkner E, 2000, ALTEX-ALTERN TIEREXP, V17, P135
   FALKNER E, 2003, REPLACEMENT SERA CEL
   HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404
   Hartung T, 2002, ATLA-ALTERN LAB ANIM, V30, P407
   HOLZMANN P, 2002, CHORIOALLANTOIC MEMB
   Jux Christian, 2003, J Interv Cardiol, V16, P149, DOI 10.1046/j.1540-8183.2003.08027.x
   KALWEIT S, 1987, Molecular Toxicology, V1, P597
   Kunzi-Rapp K, 2001, J UROLOGY, V166, P1502, DOI 10.1016/S0022-5347(05)65820-X
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   Pacini S, 2002, BIOCHEM BIOPH RES CO, V290, P820, DOI 10.1006/bbrc.2001.6254
   Ribatti D, 1999, J PATHOL, V189, P590
   Ribatti D, 1997, J VASC RES, V34, P455, DOI 10.1159/000159256
   SCHUTTLE E, 2004, TISSUE ENG MED PRODU
   Sicard RE, 1996, IN VIVO, V10, P477
   Spielmann H, 1995, Methods Mol Biol, V43, P199
   Vollrath F, 2002, IN VIVO, V16, P229
NR 19
TC 11
Z9 11
U1 0
U2 4
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD DEC
PY 2004
VL 32
IS 6
BP 573
EP 580
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 900PD
UT WOS:000227225900009
PM 15757495
DA 2018-10-19
ER

PT J
AU Li, XQ
   Liu, TQ
   Chen, YT
AF Li, XQ
   Liu, TQ
   Chen, YT
TI The effects of the nanotopography of biomaterial surfaces on pseudomonas
   fluorescens cell adhesion
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE nanotopography; Pseudomonas fluorescens; biomaterial surfaces
ID BIOTECHNOLOGY; TOPOGRAPHY; CHEMISTRY; TITANIUM; BEHAVIOR; GROWTH
AB The nano-Al2O3 and nanO-SiO2 particle-modified surfaces were built up by Layer-by-Layer self-assembled method. The properties of these nanoparticle-modified surfaces and the controls were investigated with atomic force microscope for topography analysis. Pseudomonas fluorescens (PF) cell adhesion was evaluated by microscopic determination of the numbers of cells that adhered to the controls and modified surfaces exposed to PF cell suspension under dynamic and static conditions. The results show that the adhesion numbers of PF cells on both surfaces readily increase with the exposition time, and the number on the modified surfaces is much more than that on the controls. Meanwhile, the PF cell morphologies on these nanoparticle-modified surfaces studied by inverted microscope show that the majority of PF cells adhering to the modified surfaces are in presence of clusters, which contributes overwhelming amount to the total adhesion numbers during the later time of cell adhesion; while on the controls, few PF cells are confluent. The results suggest that nanoparticle-modified surfaces may enhance the interactions between bacteria and materials. (C) 2004 Elsevier B.V. All rights reserved.
C1 Dalian Univ Technol, Dept Chem Engn, Dalian 116012, Peoples R China.
RP Li, XQ (reprint author), Dalian Univ Technol, Dept Chem Engn, Zhong Shan Rd,158, Dalian 116012, Peoples R China.
EM xiangqinli@163.com
CR ABRARAMS GA, NANOSCIENCE NANOTECH
   AN YH, 1997, J MICROBIOL MATH, V30, P143
   AN YH, 2000, HDB BACTERIAL ASHESI, V1, P29
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   DECHER G, 1991, EUR C ORG ORG THIN F, P321
   DeFlaun MF, 1999, APPL ENVIRON MICROB, V65, P759
   DURAN LW, 2000, MED DEVICE TECHNOL, V8, P14
   Fulda KU, 1998, THIN SOLID FILMS, V327, P752, DOI 10.1016/S0040-6090(98)00780-9
   Galli C, 2001, SURF SCI, V474, pL180, DOI 10.1016/S0039-6028(00)01054-2
   Geesey GG, 2001, CURR OPIN MICROBIOL, V4, P296, DOI 10.1016/S1369-5274(00)00206-X
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   KALMINDER K, 1990, THESIS U BIRMINGHAM
   Lee SC, 1998, TRENDS BIOTECHNOL, V16, P239, DOI 10.1016/S0167-7799(98)01187-1
   Liu TQ, 2002, CHEM ENG J, V88, P249, DOI 10.1016/S1385-8947(02)00021-9
   Marshall Kevin C., 1994, Current Opinion in Biotechnology, V5, P296, DOI 10.1016/0958-1669(94)90032-9
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   PAULAM M, 1999, APPL ENVIRON MICROB, V65, P5082
   PINHEIRO MM, 1988, CAN J CHEM ENG, V66, P63, DOI 10.1002/cjce.5450660109
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WHITESIDES G, NANOTECHNOLOGY RES D
NR 28
TC 9
Z9 9
U1 1
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD DEC
PY 2004
VL 22
IS 1
BP 11
EP 17
DI 10.1016/j.bej.2004.07.011
PG 7
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 897MC
UT WOS:000227007300002
DA 2018-10-19
ER

PT J
AU Cortizo, MC
   De Mele, MFL
AF Cortizo, MC
   De Mele, MFL
TI Cytotoxicity of copper ions released from metal - Variation with the
   exposure period and concentration gradients
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE biocompatibility; cytotoxicity; copper; biomaterial; released ions;
   exposure period
ID CELL-PROLIFERATION; CASTING ALLOYS; IN-VITRO; BIOCOMPATIBILITY; CULTURE;
   APOPTOSIS; CORROSION; NECROSIS; BEHAVIOR; INVITRO
AB The aim of this work is to contribute to the elucidation of the cytotoxic process caused by the copper ions released from the biomaterials. Clonal cell lines UMR106 were used in the experiments. Copper ions were obtained from two different sources: copper salts and metal dissolution. Experiments carried out with constant ion concentrations (copper salts) were compared with those with concentrations that vary with time and location (dissolution of the metal). Present results and others previously reported could be interpreted through mathematical models that describe: (1) the variation of concentration of copper ions with time and location within a biofilm and (2) the variation of the killing rate with the concentration of the toxic ion and time. The large number of dead cells found near the copper sample with an average ion concentration below the toxic limit could be interpreted bearing in mind that these cells should be exposed to a local concentration higher than this limit. A logarithmic dependence between the number of cells and exposure time was found for nearly constant ion concentrations. Apparent discrepancies, observed when these results and those of different researchers were contrasted, could be explained considering the dissimilar experimental conditions such as the source of the ions and their local concentration at real time.
C1 Natl Univ La Plata, INIFTA, RA-1900 La Plata, Argentina.
   Natl Univ La Plata, Catedra Mat Dent, Fac Odontol, RA-1900 La Plata, Argentina.
RP De Mele, MFL (reprint author), Natl Univ La Plata, INIFTA, Casilla Correo 16,Sucursal 4, RA-1900 La Plata, Argentina.
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551
CR BUMGERDNER JD, 1993, J DENT RES, V74, P1521
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V100, P151, DOI 10.1385/BTER:100:2:151
   Cortizo MC, 2002, METAL IONS BIOL MED, V7, P149
   CORTIZO MC, 2003, P BIOM 03
   de Mele MFL, 2002, J APPL ELECTROCHEM, V32, P157
   de Mele MFL, 2000, J APPL ELECTROCHEM, V30, P95
   Dodds MG, 2000, BIOTECHNOL BIOENG, V68, P456, DOI 10.1002/(SICI)1097-0290(20000520)68:4<456::AID-BIT11>3.0.CO;2-Z
   Granchi D, 1998, J MATER SCI-MATER M, V9, P31, DOI 10.1023/A:1008878527233
   Grill V, 1997, ARCH ORAL BIOL, V42, P641, DOI 10.1016/S0003-9969(97)00055-1
   Grill V, 2000, J BIOMED MATER RES, V52, P479, DOI 10.1002/1097-4636(20001205)52:3<479::AID-JBM5>3.0.CO;2-X
   *ISO, 1997, 109935 ISO 5
   KAGA M, 1991, DENT MATER, V7, P68, DOI 10.1016/0109-5641(91)90031-S
   Kapanen A, 2002, BIOMATERIALS, V23, P645, DOI 10.1016/S0142-9612(01)00143-0
   Locci P, 2000, J BIOMED MATER RES, V51, P561, DOI 10.1002/1097-4636(20000915)51:4<561::AID-JBM3>3.0.CO;2-H
   MERRITT K, 1984, J BIOMED MATER RES, V18, P1005, DOI 10.1002/jbm.820180905
   Nicotera P, 1999, BIOCHEM SOC SYMP, V66, P69, DOI 10.1042/bss0660069
   PARTRIDGE NC, 1983, CANCER RES, V43, P4308
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Schedle A, 1998, J BIOMED MATER RES, V39, P560, DOI 10.1002/(SICI)1097-4636(19980315)39:4<560::AID-JBM9>3.0.CO;2-H
   SHMALZ G, 1998, J DENT RES, V77, P1772
   Sjogren G, 2000, J PROSTHET DENT, V84, P229, DOI 10.1067/mpr.2000.107227
   Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9
   STEWART PS, 1984, BIOFILMS, V2, P373
   Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x
   Wataha J C, 1995, Int J Prosthodont, V8, P9
   Wataha JC, 2000, J PROSTHET DENT, V83, P223, DOI 10.1016/S0022-3913(00)80016-5
   Wataha JC, 2002, J ORAL REHABIL, V29, P133, DOI 10.1046/j.1365-2842.2002.00845.x
   WATAHA JC, 1991, J BIOMED MATER RES, V25, P1333
NR 28
TC 27
Z9 27
U1 3
U2 12
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD WIN
PY 2004
VL 102
IS 1-3
BP 129
EP 141
DI 10.1385/BTER:102:1-3:129
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 884LE
UT WOS:000226085500013
PM 15621934
DA 2018-10-19
ER

PT J
AU Keselowsky, BG
   Collard, DM
   Garcia, AJ
AF Keselowsky, BG
   Collard, DM
   Garcia, AJ
TI Surface chemistry modulates focal adhesion composition and signaling
   through changes in integrin binding
SO BIOMATERIALS
LA English
DT Article
DE surface chemistry; focal adhesion; integrin; cell adhesion; signaling
ID CALVARIAL OSTEOBLAST DIFFERENTIATION; SELF-ASSEMBLED MONOLAYERS;
   EMBRYONIC STEM-CELLS; FIBRONECTIN CONFORMATION; FIBROBLAST ADHESION;
   PROTEIN ADSORPTION; LIVING CELLS; IN-VITRO; KINASE; GOLD
AB Biomaterial surface properties influence protein adsorption and elicit diverse cellular responses in biomedical and biotechnological applications. However, the molecular mechanisms directing cellular activities remain poorly understood. Using a model system with well-defined chemistries (CH3, OIL COOH, NH2) and a fixed density of the single adhesive ligand fibronectin, we investigated the effects of surface chemistry on focal adhesion assembly and signaling. Surface chemistry strongly modulated integrin binding and specificity-alpha(5)beta(1) integrin binding affinity followed the pattern OH > NH2 = COOH > CH3, while integrin alpha(5)beta(1) displayed the relationship COOH > NH2 much greater than OH = CH3. Immunostaining and biochemical analyses revealed that surface chemistry modulates the structure and molecular composition of cell-matrix adhesions as well as focal adhesion kinase (FAK) signaling. The neutral hydrophilic OH functionality supported the highest levels of recruitment of talin, alpha-actinin, paxillin, and tyrosine-phosphorylated proteins to adhesive structures. The positively charged NH2 and negatively charged COOH surfaces exhibited intermediate levels of recruitment of focal adhesion components, while the hydrophobic CH3 substrate displayed the lowest levels. These patterns in focal adhesion assembly correlated well with integrin alpha(5)beta(1) binding. Phosphorylation of specific tyrosine residues in FAK also showed differential sensitivity to surface chemistry. Finally, surface chemistry-dependent differences in adhesive interactions modulated osteoblastic differentiation. These differences in focal adhesion assembly and signaling provide a potential mechanism for the diverse cellular responses elicited by different material properties. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRANDS R, 1988, EXP CELL RES, V176, P309, DOI 10.1016/0014-4827(88)90333-3
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BRASH JL, 1987, PROTEINS INTERFACES, P490
   BRODBECK WG, 2003, P NATL ACAD SCI USA, V99, P10287
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Cary LA, 1996, J CELL SCI, V109, P1787
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ilic Dusko, 1995, Nature (London), V377, P539
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KESELOWSKY BG, IN PRESS BIOMATERIAL
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   MERWIN JR, 1990, J CELL PHYSIOL, V142, P117, DOI 10.1002/jcp.1041420115
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121
   Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 59
TC 385
Z9 392
U1 9
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2004
VL 25
IS 28
BP 5947
EP 5954
DI 10.1016/j.biomaterials.2004.01.062
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 845AQ
UT WOS:000223208400005
PM 15183609
DA 2018-10-19
ER

PT J
AU Turner, NJ
   Kielty, CM
   Walker, MG
   Canfield, AE
AF Turner, NJ
   Kielty, CM
   Walker, MG
   Canfield, AE
TI A novel hyaluronan-based biomaterial (Hyaff-11((R))) as a scaffold for
   endothelial cells in tissue engineered vascular grafts
SO BIOMATERIALS
LA English
DT Article
DE hyaluronan; scaffold; vascular grafts; endothelialisation; ECM
   (extracellular matrix)
ID SMOOTH-MUSCLE CELLS; IN-VITRO; BLOOD-VESSELS; VIII COLLAGEN; PROSTHESES;
   REGENERATION; ARTERIES; INVITRO; MATRIX
AB Current prosthetic small diameter vascular grafts show poor long-term patency rates, leading to the pursuit of a biological alternative. Hyaff-1 I is a hyaluronan-based biodegradable polymer developed for tissue-engineering applications. This study aimed to determine whether human vascular endothelial cells attach to Hyaff-11 scaffolds and produce a subendothelial matrix. Two forms of fibrous, non-woven Hyaff-1 scaffolds: unpressed and pressed felts, were analysed. Attachment of human venous endothelial cells was investigated after 1, 5, 10 and 20 days in culture using SEM and confocal microscopy. The deposition of subendothelial matrix components was investigated by immunofluorescent staining.
   We demonstrate that endothelial cells adhere to the individual fibres of both unpressed and pressed scaffolds: with a seeding density of I X 10(6) cells/cm(2), 94% of the cells attached to Hyaff-11 fibres after 24 h. The pressed material provided the best environment for cell growth, allowing the formation of a complete endothelial monolayer after 20 days. Furthermore, endothelial cells on Hyaff-11 pressed felts deposited an organised subendothelial matrix containing laminin, fibronectin, type IV and type VIII collagen. This work indicates Hyaff-11 based biopolymers as suitable scaffolds to promote endothelialisation within the next generation of vascular grafts. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Manchester, UK Ctr Tissue Engn, Manchester M13 9PT, Lancs, England.
   Univ Manchester, Dept Vasc Surg, Manchester M13 9WL, Lancs, England.
   Univ Manchester, Dept Med, Manchester M13 9PT, Lancs, England.
RP Canfield, AE (reprint author), Univ Manchester, UK Ctr Tissue Engn, 2-205 Stopford Bldg,Oford Rd, Manchester M13 9PT, Lancs, England.
EM ann.canfield@man.ac.uk
OI Turner, Neill/0000-0001-5024-5610; Canfield, Ann/0000-0002-8983-5674
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ANDERSON JS, 1987, SURGERY, V101, P577
   BERGER K, 1972, ANN SURG, V175, P119
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Caravaggi C, 2003, DIABETES CARE, V26, P2853, DOI 10.2337/diacare.26.10.2853
   Conte MS, 1998, FASEB J, V12, P43
   Edelman ER, 1999, CIRC RES, V85, P1115
   FORD JW, 1981, IN VITRO CELL DEV B, V17, P44, DOI 10.1007/BF02618029
   Furukawa KS, 2002, CELL TRANSPLANT, V11, P475
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   IRUELAARISPE ML, 1991, ARTERIOSCLER THROMB, V11, P805, DOI 10.1161/01.ATV.11.4.805
   IRUELAARISPE ML, 1991, DEV BIOL, V144, P107, DOI 10.1016/0012-1606(91)90483-J
   Kumar TRS, 2002, TISSUE ENG, V8, P763
   Milella E, 2002, BIOMATERIALS, V23, P1053, DOI 10.1016/S0142-9612(01)00217-4
   Musey PI, 2002, ANN NY ACAD SCI, V961, P279, DOI 10.1111/j.1749-6632.2002.tb03102.x
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Ounpuu S, 2000, EUR HEART J, V21, P880, DOI 10.1053/euhj.1999.1880
   Perler BA, 1995, J VASC INTERV RADIOL, V6, pS111, DOI 10.1016/S1051-0443(95)71259-3
   RADOMSKI JS, 1987, J SURG RES, V42, P133, DOI 10.1016/0022-4804(87)90110-7
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   SAELMAN EUM, 1994, BLOOD, V83, P1244
   SAGE H, 1983, J BIOL CHEM, V258, P3391
   SAGE H, 1990, ANN NY ACAD SCI, V580, P17, DOI 10.1111/j.1749-6632.1990.tb17914.x
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   SCHNEIDER PA, 1988, J VASC SURG, V8, P229, DOI 10.1067/mva.1988.avs0080229
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   VOHRA R, 1991, BRIT J SURG, V78, P417, DOI 10.1002/bjs.1800780411
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   WILLIAMS SK, 1985, J SURG RES, V38, P618, DOI 10.1016/0022-4804(85)90084-8
NR 35
TC 73
Z9 75
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2004
VL 25
IS 28
BP 5955
EP 5964
DI 10.1016/j.biomaterials.2004.02.002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 845AQ
UT WOS:000223208400006
PM 15183610
DA 2018-10-19
ER

PT J
AU Matsuzaka, K
   Yoshinari, M
   Kokubu, E
   Shimono, M
   Inoue, T
AF Matsuzaka, Kenichi
   Yoshinari, Masao
   Kokubu, Eitoyo
   Shimono, Masaki
   Inoue, Takashi
TI Behavior of osteoblast-like cells on fibronectin or BMP-2 immobilized
   surface
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article
ID ALKALINE-PHOSPHATASE ACTIVITY; MESSENGER-RNA EXPRESSION; IN-VITRO;
   DIODE-LASER; PROTEINS; ADHESION; ACID; PROLIFERATION; OSTEOPONTIN;
   ATTACHMENT
AB Property modification of an implant surface is known to influence the behavior of cells surrounding implant material. This study examined the osteogenic cell behavior on protein immobilized surface in vitro. Following plasma surface modification, fibronectin or bone morphogenetic protein-2 (BMP-2) was immobilized. The number of cells adhering to fibronectin-immobilized surface increased after 1 and 2 h of incubation compared with non-immobilized surface. Alkaline phosphatase activity and osteocalcin mRNA expression of the osteogenic cells on the BMP-2 immobilized surface was greater than that on the non-immobilized surface. This study demonstrated that protein can be immobilized to a polystyrene surface after treatment with O-2 plasma and that the osteogenic cells surrounding a biomaterial can be controlled by the immobilization of protein to the biomaterial.
C1 Tokyo Dent Coll, Dept Clin Pathophysiol, Oral Hlth Sci Ctr, Mihama Ku, Chiba 2618502, Japan.
   Tokyo Dent Coll, Dept Dent Mat Sci, Mihama Ku, Chiba 2618502, Japan.
   Tokyo Dent Coll, Dept Pathol, Mihama Ku, Chiba 2618502, Japan.
RP Matsuzaka, K (reprint author), Tokyo Dent Coll, Dept Clin Pathophysiol, Oral Hlth Sci Ctr, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.
EM matsuzak@tdc.ac.jp
CR AKIYAMA SK, 1981, J SUPRAMOL STR CELL, V16, P345, DOI 10.1002/jsscb.1981.380160405
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Culp LA, 1998, J BIOMAT SCI-POLYM E, V9, P1161, DOI 10.1163/156856298X00703
   DEAN JW, 1995, J ORAL MAXILLOFAC IM, V10, P721
   Ganapathy R, 1998, J BIOMAT SCI-POLYM E, V9, P389, DOI 10.1080/09205063.1998.9753063
   Ikumoto H, 2003, BIOMED RES-TOKYO, V24, P239, DOI 10.2220/biomedres.24.239
   Jui-Che L., 1995, BIOMATERIALS, V16, P1017
   KELLER JC, 1989, J ADHESION, V28, P115, DOI 10.1080/00218468908030878
   Maniatopoulos C, 1988, CELL TISSUE RES, V254, P3179
   Matsuzaka K, 2004, BIOMED RES-TOKYO, V25, P105, DOI 10.2220/biomedres.25.105
   Matsuzaka K, 2004, BIOMED RES-TOKYO, V25, P165, DOI 10.2220/biomedres.25.165
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   RUOSLAHTI E, 1982, J INVEST DERMATOL, V79, P65
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Steffens GCM, 2002, BIOMATERIALS, V23, P3523, DOI 10.1016/S0142-9612(02)00091-1
   Suzuki T, 2002, ANALYST, V127, P1342, DOI 10.1039/b205085d
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
   Yoshinari M, 2004, J ORAL TISSUE ENG, V1, P69
NR 27
TC 4
Z9 5
U1 0
U2 4
PU BIOMEDICAL RESEARCH PRESS LTD
PI TOKYO
PA 5F KYOWA BLDG, 2-1-3 KYOBASHI, CHUO-KU, TOKYO, 104-0031, JAPAN
SN 0388-6107
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PD DEC
PY 2004
VL 25
IS 6
BP 263
EP 268
DI 10.2220/biomedres.25.263
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 056WE
UT WOS:000238555000003
OA Bronze
DA 2018-10-19
ER

PT J
AU Huse, RO
   Ruhe, PQ
   Wolke, JGC
   Jansen, JA
AF Huse, RO
   Ruhe, PQ
   Wolke, JGC
   Jansen, JA
TI The use of porous calcium phosphate scaffolds with transforming growth
   factor beta 1 as an onlay bone graft substitute - An experimental study
   in rats
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone engineering; calcium phosphate cement; onlay bone graft;
   osteoinduction; rat model; transforming growth factor beta-1
ID BMP-INDUCED OSTEOGENESIS; CORTICAL PERFORATIONS; BIOMATERIAL CARRIERS;
   ECTOPIC MODEL; HOST BED; CEMENT; HYDROXYAPATITE; CERAMICS;
   OSTEOINDUCTION; IMPLANTS
AB Objectives: Autogeneous bone grafting is regarded to be the golden standard for onlay grafts, but it requires a harvesting procedure and the remodeling pattern over time is unpredictable. New materials are constantly being sought to overcome these problems. An in vivo experiment was carried out to evaluate whether (1) porous calcium phosphate cement is a suitable biomaterial for onlay bone grafting, and (2) the addition of transforming growth factor beta 1 (TGF-beta1) accelerates de novo bone formation inside the cement porosity.
   Material and methods: A carrier of porous calcium phosphate cement (Calcibon(R)) was designed and 16 rats received one preshaped implant each. In 8 out of 16 implants 0.75 mug TGF-beta1 was applied. The animals were killed after 4 weeks and the characteristics of tissue ingrowth into the onlay graft were evaluated.
   Results: Histologic and quantitative histomorphometrical measurements demonstrated osteoid-like tissue formation in both experimental groups. The addition of TGF-beta1 did not induce significantly more osteoid-like tissue formation. On the other hand, in TGF-beta-loaded implants, a higher number of pores contained an inflammatory infiltrate.
   Conclusion: This study indicated that porous calcium phosphate cement is a promising material for clinical situations where bone formation has to be supported.
C1 Univ Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Med Ctr, Dept Biomat, POB 9101,117 Thk, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014; Wolke, J.G.C./L-4768-2015
CR Alberius P, 1996, EUR J ORAL SCI, V104, P554, DOI 10.1111/j.1600-0722.1996.tb00141.x
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aspenberg P, 1996, BONE, V19, P499, DOI 10.1016/S8756-3282(96)90257-4
   Blom EJ, 2002, J BIOMED MATER RES, V59, P265, DOI 10.1002/jbm.1241
   Blom EJ, 2001, CLIN ORAL IMPLAN RES, V12, P609, DOI 10.1034/j.1600-0501.2001.120609.x
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Comuzzi L, 2002, CLIN ORAL IMPLAN RES, V13, P304, DOI 10.1034/j.1600-0501.2002.130311.x
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   de Bruijn J.D., 1999, T 25 ANN M SOC BIOM, P235
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   FRAME JW, 1987, INT J ORAL MAX SURG, V16, P642, DOI 10.1016/S0901-5027(87)80048-6
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   Gordh M, 1997, OTOLARYNG HEAD NECK, V117, P664, DOI 10.1016/S0194-5998(97)70050-0
   Gosain AK, 1996, PLAST RECONSTR SURG, V97, P1001, DOI 10.1097/00006534-199604001-00018
   Hartman EHM, 2002, J INVEST SURG, V15, P185, DOI 10.1080/08941930290085967
   Hing KA, 1998, P I MECH ENG H, V212, P437, DOI 10.1243/0954411981534204
   HJORTING-HANSEN E, 1990, International Journal of Oral and Maxillofacial Implants, V5, P255
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LATRENTA GS, 1989, PLAST RECONSTR SURG, V84, P578, DOI 10.1097/00006534-198984040-00004
   Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137
   LIN KY, 1990, PLAST RECONSTR SURG, V86, P449, DOI 10.1097/00006534-199009000-00010
   ONG JL, 1999, CRIT REV BIOMED ENG, V28, P667
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   PHILLIPS JH, 1990, PLAST RECONSTR SURG, V85, P891, DOI 10.1097/00006534-199006000-00009
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yamasaki H., 1990, JPN J ORAL BIOL, V32, P190, DOI DOI 10.2330/JORALBIOSCI1965.32.190
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Yuan H., 1997, BIOMEDICAL MAT RES F, P228
   Yuan H, 1997, BIOMED ENG-APP BAS C, V9, P274
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 47
TC 12
Z9 12
U1 1
U2 5
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD DEC
PY 2004
VL 15
IS 6
BP 741
EP 749
DI 10.1111/j.1600-0501.2004.01068.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 869VK
UT WOS:000225012400013
PM 15533136
DA 2018-10-19
ER

PT J
AU Tjandra, JJ
   Lim, JF
   Hiscock, R
   Rajendra, P
AF Tjandra, JJ
   Lim, JF
   Hiscock, R
   Rajendra, P
TI Injectable silicone biomaterial for fecal incontinence caused by
   internal anal sphincter dysfunction is effective
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY MAY 08-13, 2004
CL Dallas, TX
SP Amer Soc Colon & Rectal Surg
DE sphincter; silicone; augmentation; fecal incontinence; quality of life
ID AUTOLOGOUS FAT; INJECTION; AUGMENTATION; MANAGEMENT; SYMPTOMS
AB PURPOSE: Fecal incontinence caused by a weak or disrupted internal anal sphincter is common but there has been no effective treatment. This prospective study evaluates the medium-term clinical effects of an injectable silicone biomaterial, PTP(TM) (Bioplastique), used to augment the internal anal sphincter. METHOD: Eighty-two patients (64 females; median age, 66 years) with severe fecal incontinence and a low anal resting pressure caused by internal anal sphincter dysfunction (defect, n = 11; intact, n = 71) were randomized to PTP(TM) injection into intersphincteric space and internal anal sphincter with (Group A, n = 42) or without (Group B, n = 40) guidance by endoanal ultrasound. Both groups were similar in terms of age, gender, past anorectal surgery, duration of follow-up (median, 6 months; range, 1-12 months), and baseline continence score. Sixty-two percent of Group A and 55 percent of Group B had prolonged pudendal nerve terminal motor latency. RESULTS: There was no significant complication. Two patients in Group A and four patients in Group B noted minor discomfort at injection sites. At one month postprocedure, endoanal ultrasound confirmed retention of silicone biomaterial without migration. In both groups, fecal continence was significantly improved by PTP(TM) implants I month after injection, but continued to improve significantly for up to 12 months in Group A and 6 months in Group B (P < 0.001). Improvement in fecal continence and maximum anal resting pressure was significantly greater in Group A, in whom injection was guided by endoanal ultrasound, than in Group B. At three months after injection, significantly more Group A patients than Group B patients achieved >50 percent improvement in Wexner's continence score (69 percent vs. 40 percent; P = 0.014). Ninety-three percent of Group A and 92 percent of Group B had >50 percent improvement in global quality of life scores (visual analog scale). At a median follow-up of 6 months, all domains of the fecal incontinence quality of life scale improved significantly in both groups; however, the physical function and mental health scores of Short Form-12 only improved in Group A. A prolonged pudendal nerve terminal motor latency had no effect on functional outcome in either group. CONCLUSION: Injection of silicone biomaterial provided a marked improvement in fecal continence and quality of life in patients with internal sphincter dysfunction, despite the presence of pudendal neuropathy.
C1 Univ Melbourne, Royal Melbourne Hosp, Private Med Ctr, Dept Colorectal Surg, Melbourne, Vic 3050, Australia.
   Univ Melbourne, Dept Colorectal Surg, Epworth Hosp, Melbourne, Vic, Australia.
RP Tjandra, JJ (reprint author), Univ Melbourne, Royal Melbourne Hosp, Private Med Ctr, Dept Colorectal Surg, Suites 15 & 16,Royal Parade, Melbourne, Vic 3050, Australia.
EM tjandra@connexus.net.au
CR Baeten CG, 2000, DIS COLON RECTUM, V43, P743
   BEISANG AA, 1992, AESTHET PLAST SURG, V16, P83, DOI 10.1007/BF00455154
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   BURNETT SJD, 1991, INT J COLORECTAL DIS, V6, P2, DOI 10.1007/BF00703951
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, GUT, V35, P857, DOI 10.1136/gut.35.6.857
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P693, DOI 10.1097/00006534-199104000-00014
   FRENCKNER B, 1975, GUT, V16, P482, DOI 10.1136/gut.16.6.482
   Kalantar J, 2001, MED J AUSTRALIA, V176, P54
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kumar D, 1998, BRIT J SURG, V85, P978
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   Lowry A C, 2001, Colorectal Dis, V3, P272, DOI 10.1046/j.1463-1318.2001.00269.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Michot F, 2003, ANN SURG, V237, P52, DOI 10.1097/00000658-200301000-00008
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   OOI BS, 2000, COLORECTAL DIS, V2, P220
   Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Tjandra JJ, 2002, ANZ J SURG, V72, P757, DOI 10.1046/j.1445-2197.2002.02561.x
   TJANDRA JJ, 1993, AM J SURG, V165, P322, DOI 10.1016/S0002-9610(05)80834-7
   TJANDRA JJ, 1993, DIS COLON RECTUM, V36, P689, DOI 10.1007/BF02238597
   TJANDRA JJ, 1994, AUST NZ J SURG, V64, P322, DOI 10.1111/j.1445-2197.1994.tb02219.x
   TJANDRA JJ, IN PRESS ANZ J SURG
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Ware JE, 1995, SF12 SCORE SF12 PHYS
NR 29
TC 111
Z9 114
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD DEC
PY 2004
VL 47
IS 12
BP 2138
EP 2146
DI 10.1007/s10350-004-0760-3
PG 9
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 878MD
UT WOS:000225650000023
PM 15657666
DA 2018-10-19
ER

PT J
AU Elisseeff, J
AF Elisseeff, J
TI Injectable cartilage tissue engineering
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE biomaterials; cartilage; hydrogels; injectable; stem cells; tissue
   engineering
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; HUMAN ARTICULAR CHONDROCYTES;
   MESENCHYMAL STEM-CELLS; IN-VITRO; FIBRIN GLUE; TRANSDERMAL
   PHOTOPOLYMERIZATION; OSTEOCHONDRAL TRANSPLANTATION;
   MECHANICAL-PROPERTIES; GENE-EXPRESSION; HYALURONIC-ACID
AB Cartilage is the tissue that lines the surface of bones in articulating joints, allowing painless joint movement. Cartilage loss is an increasingly significant problem, particularly with the ageing of active baby boomers, with few efficacious treatments available at present. Tissue engineering is a field that has evolved over recent years to combat tissue loss by providing a living tissue equivalent or substitute that can mimic the properties of the lost tissue. The general strategy of tissue engineering is to place cells on a biomaterial scaffold that is designed to promote cell function and form new tissue. This review describes the status of materials that are available as injectable scaffolds for tissue engineering and the numerous cell types that can be applied to cartilage repair, including cells derived from cartilage and stem cells. The current state of injectable cartilage tissue engineering and the hurdles that remain for widespread clinical application are discussed.
C1 Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
RP Elisseeff, J (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
CR Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Ashhurst DE, 2004, MATRIX BIOL, V23, P15, DOI 10.1016/j.mathbio.2004.02.001
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   Aydelotte MB, 1998, IN VITRO CELL DEV-AN, V34, P123
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BELL E, 1981, PLAST RECONSTR SURG, V67, P386, DOI 10.1097/00006534-198103000-00024
   Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208
   BRITTBERG M, 2001, CLIN ORTHOP S, V391, pS337
   Bryant S J, 1999, Biomed Sci Instrum, V35, P309
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cao BH, 2004, CELL CYCLE, V3, P104
   Cao Y, 1997, PLAST RECONSTR SURG, V100, P303
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Chia SH, 2004, LARYNGOSCOPE, V114, P38, DOI 10.1097/00005537-200401000-00006
   Chow JCY, 2004, ARTHROSCOPY, V20, P681, DOI 10.1016/j.arthro.2004.06.005
   Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1211, DOI 10.1177/002215540104901003
   Demarteau O, 2003, BIORHEOLOGY, V40, P331
   Devine SM, 2001, CANCER J, V7, pS76
   DiMicco MA, 2002, OSTEOARTHR CARTILAGE, V10, P218, DOI 10.1053/joca.2001.0502
   DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   FREED E, 1993, J BIOMED MATER RES, V27, P11
   Freed L., 1995, BIOMEDICAL ENG HDB, P1778
   FRIEDLAENDER GE, 1984, ANNU REV MED, V35, P311, DOI 10.1146/annurev.med.35.1.311
   Fussenegger M, 2003, ANN PLAS SURG, V51, P493, DOI 10.1097/01.sap.0000067726.32731.E1
   Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Gole MD, 2004, J ORTHOP RES, V22, P781, DOI 10.1016/j.orthres.2003.11.006
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846
   Isogai N, 2000, PLAST RECONSTR SURG, V105, P953, DOI 10.1097/00006534-200003000-00019
   Jakob RP, 2002, CLIN ORTHOP RELAT R, P170
   Jeong B, 2002, BIOMACROMOLECULES, V3, P865, DOI 10.1021/bm025536m
   Jobanputra P, 2001, Health Technol Assess, V5, P1
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   KIM MS, 2004, IN PRESS STEM CELLS
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Kim W.S., 1994, PLAST RECONSTR SURG, V94, P8
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Kramer J, 2003, METHOD ENZYMOL, V365, P251
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee David A, 2004, Methods Mol Biol, V238, P159
   Lemare F, 1998, J CELL PHYSIOL, V176, P303, DOI 10.1002/(SICI)1097-4652(199808)176:2<303::AID-JCP8>3.0.CO;2-S
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   Mercier NR, 2004, ANN BIOMED ENG, V32, P418, DOI 10.1023/B:ABME.0000017547.84146.fd
   MEYERS MH, 1978, SURG CLIN N AM, V58, P429
   Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peppas NA, 1987, HYDROGELS MED PHARM
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Quinn TM, 2002, TISSUE ENG, V8, P799, DOI 10.1089/10763270260424150
   Raimondi MT, 2002, BIOMECH MODEL MECHAN, V1, P69, DOI 10.1007/s10237-002-0007-y
   Ronga M, 2004, ARTHROSCOPY, V20, P79, DOI 10.1016/j.arthro.2003.11.012
   Saadeh PB, 1999, ANN PLAS SURG, V42, P509, DOI 10.1097/00000637-199905000-00008
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   SCHNAPER HW, 1993, PEDIATR NEPHROL, V7, P96, DOI 10.1007/BF00861587
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Shasha Nadav, 2002, Cell and Tissue Banking, V3, P175, DOI 10.1023/A:1023658832356
   Siebold R, 2003, KNEE SURG SPORT TR A, V11, P183, DOI 10.1007/s00167-003-0363-x
   Silverman RP, 2000, PLAST RECONSTR SURG, V105, P1393, DOI 10.1097/00006534-200004040-00019
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Sledge SL, 2001, CLIN SPORT MED, V20, P365, DOI 10.1016/S0278-5919(05)70311-2
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2003, BIOMACROMOLECULES, V4, P1605, DOI 10.1021/bm030056w
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thirion S, 2004, METH MOLEC MED, V100, P1
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Timmer MD, 2003, BIOMATERIALS, V24, P4707, DOI 10.1016/S0142-9612(03)00364-8
   Ting V, 1998, ANN PLAS SURG, V40, P413, DOI 10.1097/00000637-199804000-00016
   Ting V., 1998, ANN PLAST SURG, V40, P20
   TRIPPEL SB, 1995, NEW ENGL J MED, V332, P539
   Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Xu JW, 2004, PLAST RECONSTR SURG, V113, P1361, DOI 10.1097/01.PRS.000011594.52661.29
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 107
TC 88
Z9 89
U1 0
U2 27
PU ASHLEY PUBLICATIONS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1471-2598
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD DEC
PY 2004
VL 4
IS 12
BP 1849
EP 1859
DI 10.1517/14712598.4.12.1849
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 878XI
UT WOS:000225680300001
PM 15571448
DA 2018-10-19
ER

PT J
AU Siggelkow, W
   Gescher, DM
   Siggelkow, A
   Klee, D
   Malik, E
   Rath, W
   Faridi, A
AF Siggelkow, W
   Gescher, DM
   Siggelkow, A
   Klee, D
   Malik, E
   Rath, W
   Faridi, A
TI In vitro analysis of modified surfaces of silicone breast implants
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE silicone breast implants; surface modification; fibronectin; GRGDS; cell
   culture
ID CAPSULAR CONTRACTURE; PROTEIN ADSORPTION; CELL-ADHESION; SMOOTH; RUBBER
AB Background: Although silicone breast implants are well tolerated, local complications such as capsular contracture occur because of insufficient integration with surrounding tissues. In this study, cell behaviour on hydrophilized silicone breast implant foils was analysed qualitatively and quantitatively under in vitro conditions in order to provoke the desired responses in a defined environment.
   Methods: Silicone breast implant foils with different surface modifications were tested after 24 hours, 5 days and 7 days. The following modifications of silicone implant foils were tested: Unmodified silicone, silicone after-graft polymerisation for polyacrylic acid (pAAc), silicone-pAAc-fibronectin adsorptive, silicone-pAAC-fibronectin covalent, positive and negative controls. Experiments were conducted using cell culture with murine mouse fibroblasts L-929. Cytotoxicity assays were carried out in direct and indirect contact with cells grown on the material. For the viability test and qualitative analysis of cell proliferation on different foils, both fluoresceine-diacetate and ethidiumbromide were used and in addition the morphologic description of hemalaun-stained cells were used. Quantitative cell analysis was carried out using XTT after resuspension.
   Results: Toxic influence on cell cultures could be excluded for coated and uncoated surfaces in contact with dissolved biomaterials. Unmodified silicone surfaces showed poor cell growth in direct contact. We found a gradual improvement of cell morphology, with the spread and proliferation depending on the type of surface modification. Better results were achieved with covalently coupled fibronectin and GRGDS than with pAAc.
   Conclusion: Covalent immobilisation of hydrophobic silicone rubber can improve the initial cell-biomaterial interactions that are required to aid the successful development of tissue-like structures.
C1 Univ Aachen, Dept Obstet & Gynecol, D-5100 Aachen, Germany.
   Dept Breast Surg, Aachen, Germany.
   Dept Text Chem & Macromol Chem, Aachen, Germany.
RP Siggelkow, W (reprint author), Univ Mainz, Dept Obstet & Gynecol, Langenbeck Str 1, D-55101 Mainz, Germany.
EM awsiggelkow@web.de
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   Embrey M, 1999, AESTHET PLAST SURG, V23, P197, DOI 10.1007/s002669900268
   FARGELL D, 2001, PLAST RECONSTR SURG, V108, P2108
   Hakelius L, 1997, PLAST RECONSTR SURG, V100, P1566, DOI 10.1097/00006534-199711000-00030
   HANDEL N, 1995, PLAST RECONSTR SURG, V96, P1521, DOI 10.1097/00006534-199512000-00003
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   KANTLEHNER M, 2000, CHEM BIOCH, V18, P107
   LAHANN J, 1998, P 24 ANN M SOC BIOM, P136
   Langefeld S, 1999, INT J ARTIF ORGANS, V22, P235
   LATEEF SS, 2002, BIOMATERIALS, V2, P3159
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Peters W, 1997, ANN PLAS SURG, V39, P9, DOI 10.1097/00000637-199707000-00002
   PFAFF M, 1994, J BIOL CHEM, V269, P2233
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Price C, 2002, J BIOMED MATER RES, V63, P122, DOI 10.1002/jbm.10094
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Siggelkow W, 2003, BIOMATERIALS, V24, P1101, DOI 10.1016/S0142-9612(02)00429-5
   Tarpila E, 1997, PLAST RECONSTR SURG, V99, P1934, DOI 10.1097/00006534-199706000-00019
NR 21
TC 4
Z9 4
U1 0
U2 11
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD DEC
PY 2004
VL 27
IS 12
BP 1100
EP 1108
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 883TP
UT WOS:000226038900014
PM 15645622
DA 2018-10-19
ER

PT J
AU Nakai, K
   Kojima, T
   Hattori, K
   Miyachi, S
   Ishihara, M
   Kobayashi, N
   Okamoto, T
   Yoshida, J
AF Nakai, K
   Kojima, T
   Hattori, K
   Miyachi, S
   Ishihara, M
   Kobayashi, N
   Okamoto, T
   Yoshida, J
TI Feasibility of photocrosslinkable chitosan as an embolization material
   for aneurysms - Biological reaction after aneurysm embolization
SO INTERVENTIONAL NEURORADIOLOGY
LA English
DT Article; Proceedings Paper
CT 19th Annual Meeting of the
   Japanese-Society-of-Intravascular-Neurosurgery
CY NOV   17, 2003
CL Yokohama, JAPAN
SP Japanese Soc Intravasc Neurosurg
DE chitosan; embolization
ID GUGLIELMI DETACHABLE COILS; WOUND-HEALING ACCELERATOR; CAROTID-ARTERY
   MODEL; CYTOKINE PRODUCTION; DELAYED VASOSPASM; CHITIN; PRETREATMENT;
   STIMULATION; BIOMATERIAL; IRRADIATION
AB The purpose of this study was to evaluate the feasibility of photocrosslinkable chitosan as an embolization material for aneurysms. Three experimental aneurysms were created in three Japanese white rabbits. All of the aneurysms were packed with chitosan hydrogel.
   Histopathologic data were analyzed on two, seven, and 30 days after embolization. Unorganized clots and minimal inflammation around the applied chitosan hydrogel were observed two days after implantation. After seven days, the chitosan was reduced and inflammatory response appeared. At 30 days, most of the aneurysm lumen was replaced with inflammatory cells, and the remaining chitosan was not observed. Severe complications such as anaphylaxis did not occur after the embolization with the chitosan. These results suggest that photocrosslinkable chitosan might be a candidate for an embolization material for endovascular treatment of cerebral aneurysms.
C1 Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668550, Japan.
   Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 359, Japan.
RP Nakai, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, Tsurumai 65, Nagoya, Aichi 4668550, Japan.
CR Bavinzski G, 1999, J NEUROSURG, V91, P284, DOI 10.3171/jns.1999.91.2.0284
   Byrne JV, 1999, J NEUROSURG, V90, P656, DOI 10.3171/jns.1999.90.4.0656
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Fernandez Zubillaga Amelia, 1994, AJNR (American Journal of Neuroradiology), V15, P815
   Hayakawa M, 2000, J NEUROSURG, V93, P561, DOI 10.3171/jns.2000.93.4.0561
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   MAWAD ME, 1995, AM J NEURORADIOL, V16, P7
   MOLYNEUX AJ, 1995, J NEUROSURG, V83, P129, DOI 10.3171/jns.1995.83.1.0129
   Molyneux AJ, 2004, AM J NEURORADIOL, V25, P39
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Murayama Y, 2002, STROKE, V33, P1120, DOI 10.1161/01.STR.0000014423.20476.EE
   Nakai K, 2000, J NEUROSURG, V92, P671, DOI 10.3171/jns.2000.92.4.0671
   Nakai K, 2002, AM J NEURORADIOL, V23, P1725
   Nakai K, 2001, NEUROSURGERY, V48, P1318
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
NR 23
TC 1
Z9 1
U1 0
U2 0
PU EDIZIONI CENTAURO
PI BOLOGNA
PA VIA DEL PRATELLO, 8, 40122 BOLOGNA, ITALY
SN 1123-9344
J9 INTERV NEURORADIOL
JI Interv. Neuroradiol.
PD DEC
PY 2004
VL 10
SU 2
BP 95
EP 100
DI 10.1177/15910199040100S217
PG 6
WC Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 902CJ
UT WOS:000227328600016
PM 20587256
DA 2018-10-19
ER

PT J
AU Furno, F
   Morley, KS
   Wong, B
   Sharp, BL
   Arnold, PL
   Howdle, SM
   Bayston, R
   Brown, PD
   Winship, PD
   Reid, HJ
AF Furno, F
   Morley, KS
   Wong, B
   Sharp, BL
   Arnold, PL
   Howdle, SM
   Bayston, R
   Brown, PD
   Winship, PD
   Reid, HJ
TI Silver nanoparticles and polymeric medical devices: a new approach to
   prevention of infection?
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE antimicrobial biomaterials; implantable devices; medical polymers
ID CENTRAL VENOUS CATHETERS; HYDROCEPHALUS; EFFICACY; ROUTE; TRIAL
AB Objectives: Implantable devices are major risk factors for hospital-acquired infection. Biomaterials coated with silver oxide or silver alloy have all been used in attempts to reduce infection, in most cases with controversial or disappointing clinical results. We have developed a completely new approach using supercritical carbon dioxide to impregnate silicone with nanoparticulate silver metal. This study aimed to evaluate the impregnated polymer for antimicrobial activity.
   Methods: After impregnation the nature of the impregnation was determined by transmission electron microscopy. Two series of polymer discs were then tested, one washed in deionized water and the other unwashed. In each series, half of the discs were coated with a plasma protein conditioning film. The serial plate transfer test was used as a screen for persisting activity. Bacterial adherence to the polymers and the rate of kill, and effect on planktonic bacteria were measured by chemiluminescence and viable counts. Release rates of silver ions from the polymers in the presence and absence of plasma was measured using inductively coupled plasma mass spectrometry (ICP-MS).
   Results: Tests for antimicrobial activity under various conditions showed mixed results, explained by the modes and rates of release of silver ions. While washing removed much of the initial activity there was continued release of silver ions. Unexpectedly, this was not blocked by conditioning film.
   Conclusions: The methodology allows for the first time silver impregnation (as opposed to coating) of medical polymers and promises to lead to an antimicrobial biomaterial whose activity is not restricted by increasing antibiotic resistance.
C1 Univ Nottingham, Sch Med & Surg Sci, Biomat Related Infect Grp, Nottingham NG7 2UH, England.
   Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   Univ Loughborough, Dept Chem, Loughborough LE11 3TU, Leics, England.
   Univ Nottingham, Sch Mech Mat & Mfg Engn, Nottingham NG7 2RD, England.
RP Bayston, R (reprint author), Univ Nottingham, Sch Med & Surg Sci, Biomat Related Infect Grp, Nottingham NG7 2UH, England.
EM roger.bayston@nottingham.ac.uk
RI Howdle, Steven/A-2954-2010; Arnold, Polly/E-6229-2011
OI Howdle, Steven/0000-0001-5901-8342; Arnold, Polly/0000-0001-6410-5838;
   Brown, Paul/0000-0002-1911-5225
CR ALLISON DG, 1995, J IND MICROBIOL, V15, P311, DOI 10.1007/BF01569985
   ARNOW PM, 1993, CLIN INFECT DIS, V16, P778, DOI 10.1093/clind/16.6.778
   BAUMGARTNER JN, 1996, J AM SOC ARTIFICIAL, V42, pM476
   BAYSTON R, 1989, J NEUROL NEUROSUR PS, V52, P605, DOI 10.1136/jnnp.52.5.605
   Bayston R, 2004, J ANTIMICROB CHEMOTH, V53, P778, DOI 10.1093/jac/dkh183
   Bayston R, 1999, DENT PLAQUE REVISITE, P111
   Crabtree JH, 2003, PERITON DIALYSIS INT, V23, P368
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   ELLIOTT TSJ, 1995, J HOSP INFECT, V30, P181, DOI 10.1016/S0195-6701(95)90313-5
   Everaert EPJM, 1998, J MATER SCI-MATER M, V9, P147, DOI 10.1023/A:1008867619481
   Govender ST, 2003, J NEUROSURG, V99, P831, DOI 10.3171/jns.2003.99.5.0831
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Lai KK, 2002, AM J INFECT CONTROL, V30, P221, DOI 10.1067/mic.2002.12018
   Morley KS, 2004, J MATER CHEM, V14, P1212, DOI 10.1039/b311065f
   Morley KS, 2002, J MATER CHEM, V12, P1898, DOI 10.1039/b111111f
   Morris NS, 1998, J HOSP INFECT, V39, P227, DOI 10.1016/S0195-6701(98)90262-6
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   Proctor RA, 1998, DRUG RESIST UPDATE, V1, P227, DOI 10.1016/S1368-7646(98)80003-4
   RILEY DM, 1995, AM J MED, V98, P349, DOI 10.1016/S0002-9343(99)80313-1
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Walder B, 2002, INFECT CONT HOSP EP, V23, P748, DOI 10.1086/502005
   Webb PB, 2000, PURE APPL CHEM, V72, P1347, DOI 10.1351/pac200072071347
   WILCOX M, 1998, J HOSP INFECT, V40, P322
   Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537
NR 24
TC 449
Z9 470
U1 7
U2 144
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD DEC
PY 2004
VL 54
IS 6
BP 1019
EP 1024
DI 10.1093/jac/dkh478
PG 6
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 878VU
UT WOS:000225676200007
PM 15537697
OA Bronze
DA 2018-10-19
ER

PT J
AU Karageorgiou, V
   Meinel, L
   Hofmann, S
   Malhotra, A
   Volloch, V
   Kaplan, D
AF Karageorgiou, V
   Meinel, L
   Hofmann, S
   Malhotra, A
   Volloch, V
   Kaplan, D
TI Bone morphogenetic protein-2 decorated silk fibroin films induce
   osteogenic differentiation of human bone marrow stromal cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone morphogenetic protein-2; human bone marrow stromal cells;
   osteogenesis; silk fibroin films
ID MESENCHYMAL STEM-CELLS; POROUS CHITOSAN BEADS; IN-VITRO;
   POLYETHYLENE-GLYCOL; COLLAGEN; BMP-2; VIVO; PEPTIDES; BIOMATERIALS;
   MIGRATION
AB Bone morphogenetic protein (BMP)-2 has a critical role in bone formation and regeneration. Therefore, the ability to immobilize this molecule in certain matrices may be crucial in bone tissue engineering. Using carbodiimide chemistry, BMP-2 was directly immobilized on silk fibroin films. Whereas human bone marrow stromal cells cultured on unmodified silk fibroin films in the presence of osteogenic stimulants exhibited little if any osteogenesis, the same cells cultured on BMP-2 decorated films in the presence of osteogenic stimulants differentiated into an osteoblastic lineage as assessed by their significantly elevated alkaline phosphatase activity, calcium deposition, and higher transcript levels of collagen type I, bone sialoprotein, osteopontin, osteocalcin, BMP-2, and cbfa1. Using cell culture inserts, it was demonstrated that differentiation was induced by the immobilized protein and not by protein released into the culture medium. Comparison with a similar amount of medium-supplemented BMP-2, where no additional protein was added with medium changes, showed that delivery of BMP-2 immobilized on the biomaterial surface was more efficient than soluble delivery. The results illustrate that BMP-2 covalently coupled on silk biomaterial matrices retains biological function in vitro based on the induction of osteogenic markers in seeded bone marrow stromal cells. (C) 2004 Wiley Periodicals, Inc.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8057 Zurich, Switzerland.
RP Kaplan, D (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Meinel, Lorenz/D-9997-2015; Hofmann, Sandra/F-2832-2010
OI Meinel, Lorenz/0000-0002-7549-7627; Hofmann, Sandra/0000-0002-2568-8388;
   Karageorgiou, Vassilis/0000-0002-0892-510X
FU NIDCR NIH HHS [DE13405/04]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Andrades JA, 1999, EXP CELL RES, V250, P485, DOI 10.1006/excr.1999.4528
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Blum JS, 2001, J CELL BIOCHEM, V80, P532, DOI 10.1002/1097-4644(20010315)80:4<532::AID-JCB1007>3.0.CO;2-B
   Chen JS, 2002, J MATER SCI-MATER M, V13, P1029, DOI 10.1023/A:1020380203499
   Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gouda MK, 2002, MICROBIOL RES, V157, P275, DOI 10.1078/0944-5013-00165
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   ITOYAMA K, 1994, BIOTECHNOL PROGR, V10, P225, DOI 10.1021/bp00026a013
   Jennissen HP, 1999, MATERIALWISS WERKST, V30, P838, DOI 10.1002/(SICI)1521-4052(199912)30:12<838::AID-MAWE838>3.0.CO;2-W
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kim HD, 1998, TISSUE ENG, V4, P35, DOI 10.1089/ten.1998.4.35
   Kirkwood Keith, 2003, J Oral Implantol, V29, P57, DOI 10.1563/1548-1336(2003)029<0057:IVMSWS>2.3.CO;2
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Noshi T, 2001, ARTIF ORGANS, V25, P201, DOI 10.1046/j.1525-1594.2001.025003201.x
   Pereira EB, 2001, APPL BIOCHEM BIOTECH, V91-3, P739, DOI 10.1385/ABAB:91-93:1-9:739
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prabhakar U, 1998, CALCIFIED TISSUE INT, V63, P214, DOI 10.1007/s002239900517
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Santos EM, 1998, J BIOMED MATER RES, V41, P87, DOI 10.1002/(SICI)1097-4636(199807)41:1<87::AID-JBM11>3.0.CO;2-E
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   Wiemann M, 2002, J BIOMED MATER RES, V62, P119, DOI 10.1002/jbm.10251
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
NR 34
TC 224
Z9 239
U1 0
U2 66
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2004
VL 71A
IS 3
BP 528
EP 537
DI 10.1002/jbm.a.30186
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871OS
UT WOS:000225143600017
PM 15478212
DA 2018-10-19
ER

PT J
AU Fu, QN
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
AF Fu, QN
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
TI Preparation and characterization of a novel bioactive bone cement: Glass
   based nanoscale hydroxyapatite bone cement
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ANTIBIOTIC DELIVERY SYSTEM; GIANT-CELL TUMOR; RELEASE
AB A novel type of glass-based nanoscale hydorxypatite (HAP) bioactive bone cement (designed as GBNHAPC) was synthesized by adding nanoscale hydroxyapatite (HAP) crystalline (20-40 nm), into the self-setting glass-based bone cement (GBC). The inhibition rate of nanoscale HAP and micron HAP on osteosarcoma U2-OS cells was examined. The effects of nanoscale HAP on the crystal phase, microstructure and compressive strength of GBNHAPC were studied respectively. It was concluded that nanoscale HAP could inhibit the cell proliferation, while micron HAP could not, and that nanoscale HAP could be dispersed in the cement evenly and the morphology did not change significantly after a longer immersion time. XRD and FTIR results show nanoscale HAP did not affect the setting reaction of the cement. Furthermore, GBNHAPC had a higher compressive strength (92 MPa) than GBC. It was believed that GBNHAPC might be a desirable biomaterial that could not only fill bone defects but also inhibit cancer cell growth. (C) 2004 Kluwer Academic Publishers.
C1 Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
   Tongji Univ, Tongji Hosp, Shanghai 200065, Peoples R China.
RP Huang, WH (reprint author), Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
EM whhuang@mail.tongji.edu.cn
RI Fu, Qiang/B-1972-2013
CR Aoki H., 1993, REP I MED DENT ENG, V27, P39
   BINI SA, 1995, CLIN ORTHOP RELAT R, P245
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   CAMPANACCI M, 1987, J BONE JOINT SURG AM, V69A, P106, DOI 10.2106/00004623-198769010-00018
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   OTSUKA M, 1994, J PHARM SCI, V83, P259, DOI 10.1002/jps.2600830230
   Otsuka M, 1997, BIOMATERIALS, V18, P1559, DOI 10.1016/S0142-9612(97)00097-5
   Shinzato S, 2001, J BIOMED MATER RES, V56, P571, DOI 10.1002/1097-4636(20010915)56:4<571::AID-JBM1129>3.0.CO;2-H
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
   ZHANG SC, 1996, J WUHAN UNIV TECHNOL, V18, P5
NR 13
TC 13
Z9 13
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2004
VL 15
IS 12
BP 1333
EP 1338
DI 10.1007/s10856-004-5742-4
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 895CJ
UT WOS:000226838200010
PM 15747186
DA 2018-10-19
ER

PT J
AU Koo, KT
   Polimeni, G
   Albandar, JM
   Wikesjo, UME
AF Koo, KT
   Polimeni, G
   Albandar, JM
   Wikesjo, UME
TI Periodontal repair in dogs: Analysis of histometric assessments in the
   supraalveolar periodontal defect model
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE histometric analysis; models; animal; periodontal regeneration;
   premolars; tissue engineering; tooth root; wound healing
AB Background: Traditionally, the mean value from histometric assessments of several histologic sections from the same site has been, used for the histometric characterization of the site. The histometric analysis of the supraalveolar periodontal defect model uses observations from buccal and lingual sites in three step-serial sections representing the central aspect of the mesial and distal root-for the third and fourth mandibular premolar teeth. The objectives of this study were to investigate the correlations and determine whether there are significant differences in the measurement values of various histometric parameters between the three step-serial sections and to test the hypothesis that, in this animal model, histometric assessments using the most central section of each root are comparable to the mathematical means of corresponding assessments of the site using the three step-serial sections.
   Methods: Histometric analysis using light microscopy, an attached digital camera system, and a personal computer-based image analysis system including a custom program for the supraalveolar periodontal defect model was performed on histologic sections acquired from one jaw quadrant in each of 12 dogs. The animals had received a protocol including placement of a coral biomaterial and guided tissue regeneration (GTR) membranes, and were evaluated following a 4-week healing interval. Twelve parameters were assessed using three central step-serial sections from each root. For each parameter, pair-wise comparisons were performed using the mixed models analysis of variance, and the correlations between measurements were assessed by the intraclass correlation coefficient (ICC).
   Results: For all parameters assessed, there were no significant differences (P >0.05) among the three sections. The differences between the central section and the means of the three step-serial sections were small and not statistically significant. Parameters that could be assessed on most or all specimens, such as defect height and area, membrane height, and bone regeneration area, showed high correlations among the three step-serial sections (intraclass coefficient [ICC] similar to 0.91 to 0.98), and between each of the three sections and the mean for the three step-serial sections (ICC greater than or equal to0.95). The most central section had somewhat higher correlation with the mean than measurements made on the lateral sections.
   Conclusion: The results suggest that using the supraalveolar periodontal defect model representative histometric data can be obtained evaluating only the central section from each defect site.
C1 Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19140 USA.
   Temple Univ, Sch Dent, Dept Periodontol, Periodontal Diagnost Res Lab, Philadelphia, PA 19122 USA.
RP Wikesjo, UME (reprint author), Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, 3223 N Broad St, Philadelphia, PA 19140 USA.
EM uwikesjo@temple.edu
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583; Albandar, Jasim M./0000-0001-7801-3811
CR HANEY JM, 1995, J CLIN PERIODONTOL, V22, P208
   Koo KT, 2004, J CLIN PERIODONTOL, V31, P439, DOI 10.1111/j.1600-051X.2004.00508.x
   KOO KT, 2005, IN PRESS J CLIN PERI
   Littell R. C., 1996, SAS SYSTEM MIXED MOD, P633
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   WIKESJO UME, 1990, J PERIODONTOL, V61, P719, DOI 10.1902/jop.1990.61.12.719
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
NR 10
TC 11
Z9 11
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD DEC
PY 2004
VL 75
IS 12
BP 1688
EP 1693
DI 10.1902/jop.2004.75.12.1688
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 890UF
UT WOS:000226535700017
PM 15732872
DA 2018-10-19
ER

PT J
AU Flesch, C
   Delaite, C
   Dumas, P
   Bourgeat-Lami, E
   Duguet, E
AF Flesch, C
   Delaite, C
   Dumas, P
   Bourgeat-Lami, E
   Duguet, E
TI Grafting of poly(epsilon-caprolactone) onto maghemite nanoparticles
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE ring-opening polymerization; nanocomposite; biomaterial;
   poly(epsilon-caprolactone); maghemite
ID IRON-OXIDE NANOPARTICLES; MAGNETIC POLYMER LATEXES; SURFACE
   MODIFICATION; BIOMEDICAL APPLICATIONS; PARTICLES; SILICA; EMULSION;
   MICROSPHERES; STYRENE
AB We report the coating of maghemite (gamma-Fe2O3,) nanoparticles with poly(epsilon-caprolactone) (PCL) through a covalent grafting to technique. omega-Hydroxy-PCL was first synthesized by the ring-opening polymerization of E-caprolactone with aluminum isopropoxide and benzyl alcohol as a catalytic system. The hydroxy end groups of PCL were then derivatized with 3-isocyanatopropyltriethoxysilane in the presence of tetraoctyltin. The triethoxysilane-functionalized PCL macromolecules were finally allowed to react on the surface of maghemite nanoparticles. The composite nanoparticles were characterized by diffuse reflectance infrared Fourier transform (DRIFT) spectroscopy, thermal gravimetric analysis (TGA) and differential scanning calorimetry (DSC). Effects of the polymer molar mass and concentration on the amount of polymer grafted to the surface were investigated. Typical grafting densities up to 3 mumol of polymer chains per m(2) of maghemite surface were obtained with this grafting to technique. (C) 2004 Wiley Periodicals, Inc.
C1 Ecole Natl Super Chim, Lab Chim Macromol, CNRS, ICSI UPR 9069, F-68093 Mulhouse, France.
   Lab Chim & Proc Polymerisat, CNRS, CPE, LCPP UMR 140, F-69616 Villeurbanne, France.
   Univ Bordeaux 1, ICMCB, UPR 9048, Inst Chim Mat Condensee Bordeaux, F-33608 Pessac, France.
RP Delaite, C (reprint author), Ecole Natl Super Chim, Lab Chim Macromol, CNRS, ICSI UPR 9069, 3 Rue Werner, F-68093 Mulhouse, France.
EM c.delaite@uha.fr
RI Duguet, Etienne/B-7620-2011
OI Duguet, Etienne/0000-0002-0675-5987
CR ARSHADY R, 2002, MICROSPHERES MICROCA, V5, P283
   Audran RGL, 1981, US Patent, Patent No. [4,302,523, 4302523]
   BENOUADA H, 1988, J COLLOID INTERF SCI, V122, P441, DOI 10.1016/0021-9797(88)90378-5
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   Bourlinos AB, 2002, CHEM MATER, V14, P3226, DOI 10.1021/cm0204041
   BRIDGER K, 1980, EUR POLYM J, V16, P1017, DOI 10.1016/0014-3057(80)90185-8
   Britain J. W., 1960, J APPL POLYM SCI, V4, P207
   Butterworth MD, 2001, COLLOID SURFACE A, V179, P93, DOI 10.1016/S0927-7757(00)00633-6
   CHARLES SW, 1987, J MAGN MAGN MATER, V65, P350, DOI 10.1016/0304-8853(87)90069-2
   Chatterjee J, 2002, J MAGN MAGN MATER, V246, P382, DOI 10.1016/S0304-8853(02)00110-5
   CHIANG CH, 1980, J COLLOID INTERF SCI, V74, P396, DOI 10.1016/0021-9797(80)90209-X
   FARKAS A, 1962, ADV CATAL, V13, P393, DOI 10.1016/S0360-0564(08)60290-4
   Fauconnier N, 1999, J MOL LIQ, V83, P233, DOI 10.1016/S0167-7322(99)00088-4
   Gomez-Lopera SA, 2001, J COLLOID INTERF SCI, V240, P40, DOI 10.1006/jcis.2001.7579
   Hergt R, 2004, J MAGN MAGN MATER, V270, P345, DOI 10.1016/j.jmmm.2003.09.001
   HOFMANCARIS CHM, 1994, NEW J CHEM, V18, P1087
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   Kataby G, 1997, LANGMUIR, V13, P6151, DOI 10.1021/la960929q
   Liu XY, 2003, POLYM INT, V52, P235, DOI 10.1002/pi.1031
   Maitra P, 2003, LANGMUIR, V19, P8994, DOI 10.1021/la034048c
   Massart R., 1982, [No title captured], Patent No. [4.329 241, 4329241, 4 329 241]
   Matsuno R, 2004, MACROMOLECULES, V37, P2203, DOI 10.1021/ma035523g
   MCMICHAEL RD, 1992, J MAGN MAGN MATER, V111, P29, DOI 10.1016/0304-8853(92)91049-Y
   Miola-Delaite C, 1999, MACROMOL CHEM PHYSIC, V200, P1771, DOI 10.1002/(SICI)1521-3935(19990701)200:7<1771::AID-MACP1771>3.0.CO;2-V
   Montagne F, 2002, J MAGN MAGN MATER, V250, P302, DOI 10.1016/S0304-8853(02)00412-2
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Mornet Sp, 2002, EUR CELLS MATER, V3, P110
   RAMIREZ PL, 2004, MACROMOL CHEM PHYS, V204, P22
   Roger J, 1999, EUR PHYS J-APPL PHYS, V5, P321, DOI 10.1051/epjap:1999144
   SATO M, 1976, J CATAL, V7, P342
   Sauzedde F, 1999, COLLOID POLYM SCI, V277, P1041, DOI 10.1007/s003960050488
   Sauzedde F, 1999, COLLOID POLYM SCI, V277, P846, DOI 10.1007/s003960050461
   Shinkai M, 2002, J BIOSCI BIOENG, V94, P606, DOI 10.1016/S1389-1723(02)80202-X
   Spanova A, 2004, J CHROMATOGR B, V800, P27, DOI 10.1016/j.jchromb.2003.09.010
   Tian D, 1997, J POLYM SCI POL CHEM, V35, P2295, DOI 10.1002/(SICI)1099-0518(199708)35:11<2295::AID-POLA21>3.0.CO;2-8
   Wormuth K, 2001, J COLLOID INTERF SCI, V241, P366, DOI 10.1006/jcis.2001.7762
   YANASE N, 1993, J APPL POLYM SCI, V50, P765, DOI 10.1002/app.1993.070500504
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
NR 38
TC 54
Z9 55
U1 0
U2 23
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD DEC 1
PY 2004
VL 42
IS 23
BP 6011
EP 6020
DI 10.1002/pola.20449
PG 10
WC Polymer Science
SC Polymer Science
GA 872IQ
UT WOS:000225201300018
DA 2018-10-19
ER

PT J
AU Watrin-Pinzano, A
   Ruaud, JP
   Cheli, Y
   Gonord, P
   Grossin, L
   Bettembourg-Brault, I
   Gillet, P
   Payan, E
   Guillot, G
   Netter, P
   Loeuille, D
AF Watrin-Pinzano, A
   Ruaud, JP
   Cheli, Y
   Gonord, P
   Grossin, L
   Bettembourg-Brault, I
   Gillet, P
   Payan, E
   Guillot, G
   Netter, P
   Loeuille, D
TI Evaluation of cartilage repair tissue after biomaterial implantation in
   rat patella by using T2 mapping
SO MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
LA English
DT Article
DE magnetic resonance imaging; T2 mapping; chondrocyte; cartilage repair;
   chondral lesion
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; DEFECTS; KNEE;
   ALGINATE; OSTEOARTHRITIS; SYSTEM; RABBIT; MATRIX; CELLS
AB To evaluate the ability of MR T2 mapping (8.5 T) to characterize ex vivo longitudinally, morphologically and quantitatively, alginate-based tissue engineering in a rat model of patellar cartilage chondral focal defect. Calibrated rat patellar cartilage defects (1.3 mm) were created at day 0 (D0) and alginate sponge with (Sp/C+) or without (Sp/C-) autologous chondrocytes were implanted. Animals were sacrificed sequentially at D20, D40 and D60 after surgery and dissected patellae underwent MRI exploration (8.5 T). T2 values were calculated from eight SE images by using nonlinear least-squares curve fitting on a pixel-by-pixel basis (constant repetition time of 1.5 s, eight different echo times: 5.5, 7.5, 10.5, 12.5, 15.0, 20.0, 25.0 and 30.0 ms). On the T2 map, acquired in a transversal plane through the repair zone, global T2 values and zonal variation of T2 values of repair tissue were evaluated versus control group and compared with macroscopic score and histological studies (toluidine blue, sirius red and hematoxylin-eosin). "Partial", "total" and "hypertrophic" repair patterns were identified. At D40 and D60, Sp/C+ group was characterized by a higher proportion of "total" repair in comparison to Sp/C- group. At D60, the proportion of "hypertrophic" repair was two fold in Sp/C- group versus Sp/C+ group. As confirmed morphologically and histologically, the T2 map also permitted the distinction of three types of repair tissue: "total", "partial" and "hypertrophic". "Total" repair tissue was characterized by high T2 values versus normal cartilage (p < 0.05). Zonal variation, reflecting the collagen network organization, appeared only at D60 for Sp/C+ group (p < 0.05). "Hypertrophic" tissue, mainly observed at D60, presented high T2 global values without zonal variation with cartilage depth. These results confirm the potency of the MR T2 map (8.5 T) to characterize macroscopically and microscopically the patterns of the scaffold guided-tissue repair of a focal chondral lesion in the rat patella ("total", "partial" and "hypertrophic"). On T2 map, three parameters (i.e. MRI macroscopic pattern, T2 global values and zonal variation of T2 values) permit to characterize chondral repair tissue, as a virtual biopsy.
C1 Fac Med Vandoeuvre Nancy, UMR 7561 CNRS, Dept Pharmacol, F-54505 Vandoeuvre Les Nancy, France.
   Univ Paris 11, UMR 8081 CNRS, Unite Rech Resonance Magnet Med, F-91405 Orsay, France.
   Hop Brabois, Dept Rheumatol, F-54505 Vandoeuvre Les Nancy, France.
   Hop Brabois, Dept Pharmacol, F-54505 Vandoeuvre Les Nancy, France.
RP Gillet, P (reprint author), Fac Med Vandoeuvre Nancy, UMR 7561 CNRS, Dept Pharmacol, BP 184,Ave Foret Haye, F-54505 Vandoeuvre Les Nancy, France.
EM Pierre.Gillet@medecine.uhp-nancy.fr
RI Cheli, Yann/O-5783-2016
CR Alparslan L, 2001, SEMIN ULTRASOUND CT, V22, P341, DOI 10.1053/sult.2001.25201
   Azer NM, 2004, RADIOL CLIN N AM, V42, P43, DOI 10.1016/S0033-8389(03)00157-X
   Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859
   DOUGADOS M, 1994, ARTHROSCOPY, V10, P69, DOI 10.1016/S0749-8063(05)80295-6
   Espanha MM, 2001, CONNECT TISSUE RES, V42, P97, DOI 10.3109/03008200109014252
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   Goodwin D W, 2001, Semin Musculoskelet Radiol, V5, P305, DOI 10.1055/s-2001-19041
   Hangody Laszlo, 2004, J Bone Joint Surg Am, V86-A Suppl 1, P65
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ibusuki S, 2003, TISSUE ENG, V9, P1133, DOI 10.1089/10763270360728044
   Im GI, 2001, J BONE JOINT SURG BR, V83B, P289, DOI 10.1302/0301-620X.83B2.10495
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Kawasaki K, 2004, ARCH HISTOL CYTOL, V67, P13, DOI 10.1679/aohc.67.13
   Loeuille D, 2002, BIORHEOLOGY, V39, P269
   MCALINDON TE, 1992, ANN RHEUM DIS, V51, P844, DOI 10.1136/ard.51.7.844
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Mlynarik V, 2004, J MAGN RESON, V169, P300, DOI 10.1016/j.jmr.2004.05.003
   MOONEY V, 1966, J BONE JOINT SURG AM, VA 48, P1145, DOI 10.2106/00004623-196648060-00012
   Nieminen MT, 2001, MAGN RESON MED, V46, P487, DOI 10.1002/mrm.1218
   Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322
   Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613
   Sanders TG, 2001, SKELETAL RADIOL, V30, P570, DOI 10.1007/s002560100371
   Verstraete KL, 2004, CLIN RADIOL, V59, P674, DOI 10.1016/j.crad.2004.01.012
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Watrin A, 2001, RADIOLOGY, V219, P395, DOI 10.1148/radiology.219.2.r01ma32395
   Watrin-Pinzano A, 2004, OSTEOARTHR CARTILAGE, V12, P191, DOI 10.1016/j.joca.2003.10.010
   Yoshioka M, 1998, OSTEOARTHR CARTILAGE, V6, P66, DOI 10.1053/joca.1997.0093
NR 30
TC 49
Z9 52
U1 2
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0968-5243
J9 MAGN RESON MATER PHY
JI Magn. Reson. Mat. Phys. Biol. Med.
PD DEC
PY 2004
VL 17
IS 3-6
BP 219
EP 228
DI 10.1007/s10334-004-0071-7
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 906DM
UT WOS:000227620700017
PM 15580373
DA 2018-10-19
ER

PT J
AU Smith, MJ
   Paran, TS
   Quinn, F
   Corbally, MT
AF Smith, MJ
   Paran, TS
   Quinn, F
   Corbally, MT
TI The SIS extracellular matrix scaffold - preliminary results of use in
   congenital diaphragmatic hernia (CDH) repair
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE neonate; congenital diaphragmatic hernia tissue replacement; tissue
   engineering; SIS
ID SMALL-INTESTINAL SUBMUCOSA; IN-VIVO; MANAGEMENT
AB There is no ideal bio-tensile material for tissue replacement in paediatric surgical conditions. A variety of materials have been described to replace or reinforce tissue deficits in congenital diaphragmatic hernia (CDH). The problems with these materials range from extensive surgery to body wall deformity and hernia recurrence. The ideal graft would be safe, strong, have the potential to grow and not require replacement, not affect chest wall development or produce deformity, and have minimal risk of recurrence. Surgisis is a biomaterial composed of porcine intestinal submucosa that provides inherent tensile strength as a collagen lattice and is ultimately replaced by native collagen tissue. Our objective was to prospectively assess the utility of Surgisis as a replacement graft in a cohort of 10 children undergoing primary or recurrent CDH repair. The graft was well tolerated, and there was no recurrence of herniation. We conclude that Surgisis collagen mesh may be a useful alternative for tissue replacement or reinforcement in difficult cases of CDH and diaphragmatic agenesis. The biological framework of Surgisis may also prove useful in other situations of complex tissue loss in children.
C1 Our Ladys Hosp Sick Children, Dept Paediat Surg, Dublin 12, Ireland.
RP Smith, MJ (reprint author), Our Ladys Hosp Sick Children, Dept Paediat Surg, Dublin 12, Ireland.
EM mylessmith@iolfree.ie
RI Smith, Myles/B-7803-2009
OI Smith, Myles/0000-0002-3254-4817
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Calvano CJ, 2000, J ENDOUROL, V14, P213, DOI 10.1089/end.2000.14.213
   Clark RH, 1998, J PEDIATR SURG, V33, P1004, DOI 10.1016/S0022-3468(98)90522-X
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   Hajer GF, 1998, EUR J PEDIATR SURG, V8, P329, DOI 10.1055/s-2008-1071226
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Moss RL, 2001, J PEDIATR SURG, V36, P152
   Moyer V, 2002, COCHRANE DB SYST REV
   PURI P, 1987, PEDIATR SURG INT, V2, P327
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Specke V, 2002, TRANSPL IMMUNOL, V9, P281, DOI 10.1016/S0966-3274(02)00039-4
NR 12
TC 34
Z9 37
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0179-0358
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD DEC
PY 2004
VL 20
IS 11-12
BP 859
EP 862
DI 10.1007/s00383-004-1298-0
PG 4
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 887DJ
UT WOS:000226285200010
PM 15565305
DA 2018-10-19
ER

PT J
AU Wang, LC
   Chen, JW
   Liu, HI
   Chen, ZQ
   Zhang, Y
   Wang, CY
   Feng, ZG
AF Wang, LC
   Chen, JW
   Liu, HI
   Chen, ZQ
   Zhang, Y
   Wang, CY
   Feng, ZG
TI Synthesis and evaluation of biodegradable segmented multiblock
   poly(ether ester) copolymers for biomaterial applications
SO POLYMER INTERNATIONAL
LA English
DT Article
DE poly(ether ester); degradation; cytotoxicity; cell adhesion;
   biocompatibility
ID HUMAN ENDOTHELIAL-CELLS; IN-VITRO DEGRADATION; BLOCK-COPOLYMERS;
   CONTROLLED-RELEASE; TEREPHTHALATE); POLYESTERS; POLYMERS; BONE;
   PROTEINS; ADHESION
AB Based on 1,4-succinic acid, 1,4-butanediol, poly(ethylene glycol)s and dimethyl terephthalate, biodegradable segmented multiblock copolymers of poly[(butylene terephthalate)-co-poly(butylene succinate)-block-poly(ethylene glycol)] (PTSG) were synthesized with different poly(butylene succinate) (PBS) molar fractions and varying the poly(ethylene glycol) (PEG) segment length, and were evaluated as biomedical materials. The copolymer extracts showed no in vitro cytotoxicity. However, sterilization of the copolymers by gamma irradiation had some limited effect on the cytotoxicity and mechanical properties. A copolymer consisting of PEG-1000 and 20 mol% PBS, assigned as 1000PBS20 after SO2 gas plasma treatment, sustained the adhesion and growth of dog vascular smooth muscle cells. The in vivo biocompatibility of this sample was also measured subcutaneously in rats for 4 weeks. The assessments indicated that these poly(ether ester) copolymers are good candidates for anti-adhesion barrier and drug controlled-release applications. (C) 2004 Society of Chemical Industry.
C1 Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China.
   Acad Mil Med Sci, Lab Tissue Engn, Beijing 100850, Peoples R China.
RP Feng, ZG (reprint author), Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China.
EM sainfeng@bit.edu.cn
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   BOUNEKHEL M, 1995, POLYM DEGRAD STABIL, V49, P347, DOI 10.1016/0141-3910(95)00097-6
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   Deschamps AA, 2001, POLYMER, V42, P9335, DOI 10.1016/S0032-3861(01)00453-0
   Deschamps AA, 2003, BIOMATERIALS, V24, P2643, DOI 10.1016/S0142-9612(03)00054-1
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Du C, 2002, BIOMATERIALS, V23, P4649, DOI 10.1016/S0142-9612(02)00214-4
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Kellomaki M, 2002, BIOMATERIALS, V23, P283, DOI 10.1016/S0142-9612(01)00107-7
   KIM HC, 2001, POLYMER, V42, P1849
   Kint DPR, 2003, POLYMER, V44, P1321, DOI 10.1016/S0032-3861(02)00938-2
   Muller RJ, 2001, J BIOTECHNOL, V86, P87, DOI 10.1016/S0168-1656(00)00407-7
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   REED AM, 1981, POLYMER, V22, P499, DOI 10.1016/0032-3861(81)90169-5
   Signori F, 2003, MACROMOL SYMP, V197, P289, DOI 10.1002/masy.200350726
   van Dorp AGM, 1999, J BIOMED MATER RES, V47, P292, DOI 10.1002/(SICI)1097-4636(19991205)47:3<292::AID-JBM2>3.0.CO;2-B
   VANDIJKHUIZENRADER, 2002, BIOMATERIALS, V23, P4719
   Witt U, 2001, CHEMOSPHERE, V44, P289, DOI 10.1016/S0045-6535(00)00162-4
   Witt U, 1999, ANGEW CHEM INT EDIT, V38, P1438, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1438::AID-ANIE1438>3.0.CO;2-U
   Zhang Y, 2003, POLYM INT, V52, P1351, DOI 10.1002/pi.1222
   Zhang Y, 2002, ACTA CHIM SINICA, V60, P2225
NR 25
TC 20
Z9 20
U1 1
U2 15
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD DEC
PY 2004
VL 53
IS 12
BP 2145
EP 2154
DI 10.1002/pi.1645
PG 10
WC Polymer Science
SC Polymer Science
GA 874JW
UT WOS:000225347700034
DA 2018-10-19
ER

PT J
AU Archambault, JG
   Brash, JL
AF Archambault, JG
   Brash, JL
TI Protein resistant polyurethane surfaces by chemical grafting of PEO:
   amino-terminated PEO as grafting reagent
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE protein adsorption; protein resistance; poly(ethylene oxide); surface
   grafting; polyurethane; XPS; contact angle; SDS-PAGE
ID SELF-ASSEMBLED MONOLAYERS; POLY(ETHYLENE OXIDE); CELL-ADHESION;
   BIOMATERIAL SURFACES; PLATELET-ADHESION; ADSORPTION; PLASMA; FIBRINOGEN;
   BLOOD; SIZE
AB The objective of this work was to gain a better understanding of the mechanism of resistance to protein adsorption of surfaces grafted with poly(ethylene oxide) (PEO). A polyurethane-urea was used as a substrate to which PEO was grafted. Grafting was carried out by introducing isocyanate groups into the surface followed by reaction with amino-terminated PEO. Surfaces grafted with PEO of various chain lengths (PUU-NPEO) were prepared and characterized by water contact angle and X-ray photoelectron spectroscopy (XPS). XPS data indicated higher graft densities on the PUU-NPEO surfaces than on analogous surfaces prepared using hydroxy-PEO (PUU-OPEO) as reported previously [J.G. Archambault, J.L. Brash, Colloids Surf. B: Biointerf. 33 (2004) 111-120]. Protein adsorption experiments using radiolabeled myoglobin, concanavalin A, albumin, fibrinogen and ferritin as single proteins in buffer showed that adsorption was reduced on the PEO-grafted surfaces by up to 95% compared to the control. Adsorption decreased with increasing PEO chain length and reached a minimum at a PEO MW of 2000. Adsorption levels on surfaces with 5000 and 2000 MW grafts were similar. There was no clear effect of protein size on resistance to protein adsorption. Adsorption on the PUU-NPEO surfaces was significantly lower than on the corresponding PUU-OPEO surfaces, again suggesting higher graft densities on the former. Adsorption of fibrinogen from plasma was also greatly reduced on the grafted surfaces. From analysis (SDS-PAGE, immunoblotting) of the proteins eluted after plasma exposure, it was found that the grafted surfaces and the unmodified substrate adsorbed the same proteins in roughly the same proportions, suggesting that adsorption to the PEO surfaces occurs on patches of bare substrate. The PEO grafts did not apparently cause differential access to the substrate based on protein size. (C) 2004 Elsevier B.V. All rights reserved.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM brashjl@mcmaster.ca
CR Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HARKER LA, 1993, CARDIOVASCULAR PATHO, V2
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   HERDE K, 1977, PLASMA PROTEIN FRACT
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   Ishihara K, 2002, ARTIF ORGANS, V26, P1014, DOI 10.1046/j.1525-1594.2002.07039.x
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Kingshott P, 2002, BIOMATERIALS, V23, P4775, DOI 10.1016/S0142-9612(02)00228-4
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   McClung WG, 2003, J BIOMED MATER RES A, V66A, P795, DOI 10.1002/jdm.a.10017
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   McPherson TB, 1997, J BIOMED MATER RES, V38, P289
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Papadopoulos S, 2000, BIOPHYS J, V79, P2084, DOI 10.1016/S0006-3495(00)76456-3
   Parl HD, 2003, J BIOMED MATER RES A, V66A, P596, DOI 10.1002/jbm.a.10505
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RIGHETTI PG, 1976, J CHROMATOGR, V127, P1, DOI 10.1016/S0021-9673(00)98537-6
   Ruegsegger MA, 2001, J BIOMED MATER RES, V56, P159, DOI 10.1002/1097-4636(200108)56:2<159::AID-JBM1080>3.0.CO;2-R
   Tan J., 2003, T SOC BIOMATER, V26, P470
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
NR 35
TC 98
Z9 100
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 25
PY 2004
VL 39
IS 1-2
BP 9
EP 16
DI 10.1016/j.colsurfb.2004.08.009
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 874YB
UT WOS:000225385500002
PM 15542334
DA 2018-10-19
ER

PT J
AU Parent, ME
   Velegol, D
AF Parent, ME
   Velegol, D
TI E-coli adhesion to silica in the presence of humic acid
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE bacterial adhesion; humic acid; Escherichia coli; silica particles;
   bioremediation
ID ATOMIC-FORCE MICROSCOPY; POROUS-MEDIA; COLLOIDAL PARTICLES; BACTERIAL
   ADHESION; DIFFERENTIAL ELECTROPHORESIS; BIOMATERIAL SURFACES; CHARGE
   NONUNIFORMITY; MICROBIAL ADHESION; ORGANIC-MATTER; IONIC-STRENGTH
AB The influence of humic acid on the adhesion of Escherichia coli to silica particles or glass surfaces was investigated. After adsorbing various amounts of humic acid to the particles or surfaces, bacteria were added to the sample and allowed to adhere. For the silica particles the number of bacteria-particle couplets formed were counted from video microscopy images. For the glass surfaces, a differential electrophoresis force was applied, and the force required to detach the bacteria was quantified. These experiments showed a slight increase in the number of couplets formed in the presence of humic acid, and also showed a slight increase in the force required for detachment of the bacteria. Although ail increase in adhesion number and strength was measured, the magnitude of the increase was small, indicating that humic acid plays a small role in bacterial adhesion to silica or glass surfaces. (C) 2004 Elsevier B.V. All rights reserved.
C1 Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.
RP Velegol, D (reprint author), Penn State Univ, Dept Chem Engn, 111 Fenske Lab, University Pk, PA 16802 USA.
EM velegol@psu.edu
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   AVENA MJ, 1999, ENVIRON SCI TECHNOL, V33, P27
   Balnois E, 1999, ENVIRON SCI TECHNOL, V33, P3911, DOI 10.1021/es990365n
   BECKETT R, 1990, SURFACE COLLOID CHEM, pCH1
   Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453
   Bob MM, 2001, COLLOID SURFACE A, V177, P215, DOI 10.1016/S0927-7757(00)00679-8
   BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   Butterfield P. W., 2002, WATER RES, V36, P3893
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015
   CHIOU CT, 1987, ENVIRON SCI TECHNOL, V21, P1231, DOI 10.1021/es00165a012
   Davies G., 1998, HUMIC SUBSTANCES STR
   Davis CJ, 2002, COLLOID POLYM SCI, V280, P52, DOI 10.1007/s003960200007
   DAVIS JA, 1982, GEOCHIM COSMOCHIM AC, V46, P2381, DOI 10.1016/0016-7037(82)90209-5
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   Feick JD, 2004, LANGMUIR, V20, P3090, DOI 10.1021/la0355545
   Feick JD, 2002, LANGMUIR, V18, P3454, DOI 10.1021/la011515m
   Feick JD, 2000, LANGMUIR, V16, P10315, DOI 10.1021/la001031a
   Fein JB, 1999, CHEM GEOL, V162, P33, DOI 10.1016/S0009-2541(99)00075-3
   FLEER GJ, 1998, POLYM INTERFACES, pCH2
   FLEMMING H, 1994, BIOFOULING BIOCORROS, pCH5
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HAYES MHB, 1998, HUMIC SUBSTANCES STR, pCH1
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Holtzer GL, 2003, LANGMUIR, V19, P4090, DOI 10.1021/la026736m
   Hunter R. J., 1981, POTENTIAL COLLOID SC, V2
   Jin G, 1997, WATER ENVIRON RES, V69, P1100, DOI 10.2175/106143097X125821
   Johnson WP, 1996, WATER RES, V30, P923, DOI 10.1016/0043-1354(95)00225-1
   Jones JF, 2003, APPL ENVIRON MICROB, V69, P6515, DOI 10.1128/AEM.69.11.6515-6519.2003
   KEH HJ, 1985, J FLUID MECH, V153, P417, DOI 10.1017/S002211208500132X
   Klavins M, 2002, COLLOID SURFACE A, V203, P47, DOI 10.1016/S0927-7757(01)01066-4
   Koopal LK, 1998, COLLOID SURFACE A, V141, P385, DOI 10.1016/S0927-7757(97)00170-2
   Lahlou M, 2000, ENVIRON SCI TECHNOL, V34, P3649, DOI 10.1021/es000021t
   Langmark J, 2004, WATER RES, V38, P740, DOI 10.1016/j.watres.2003.10.021
   Li Q, 1999, WATER RES, V33, P1090, DOI 10.1016/S0043-1354(98)00291-7
   LITTLE BJ, 1988, MAT MARINE SYSTEM ST, V28, pCH3
   LOVELY DR, 1999, ENVIRON MICROBIOL, V1, P89
   Ludensky M, 2003, INT BIODETER BIODEGR, V51, P255, DOI 10.1016/S0964-8305(03)00038-6
   MARLOW HJ, 1991, J HAZARD MATER, V28, P65, DOI 10.1016/0304-3894(91)87006-N
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   MOSLEY LM, 2003, ENVIRON SCI TECHNOL, V37, P3033
   OCHS M, 1994, GEOCHIM COSMOCHIM AC, V58, P639, DOI 10.1016/0016-7037(94)90494-4
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   POORTINGA AT, 1999, SURF SCI REP, V47, P1
   ROSENBERG M, 1984, FEMS MICROBIOL LETT, V22, P289
   Schmidt LM, 1999, CHEMOSPHERE, V38, P2897, DOI 10.1016/S0045-6535(98)00480-9
   Stickler DJ, 1998, APPL ENVIRON MICROB, V64, P3486
   Van de Ven T. G., 1989, COLLOIDAL HYDRODYNAM
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   Velegol D, 1996, LANGMUIR, V12, P4103, DOI 10.1021/la960037q
   WERSHAW R L, 1986, Journal of Contaminant Hydrology, V1, P29, DOI 10.1016/0169-7722(86)90005-7
   Yuan W, 2000, ENVIRON SCI TECHNOL, V34, P5043, DOI 10.1021/es0012366
NR 52
TC 37
Z9 39
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 25
PY 2004
VL 39
IS 1-2
BP 45
EP 51
DI 10.1016/j.colsurfb.2004.08.020
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 874YB
UT WOS:000225385500007
PM 15542339
DA 2018-10-19
ER

PT J
AU Salerno, MB
   Logan, BE
   Velegol, D
AF Salerno, MB
   Logan, BE
   Velegol, D
TI Importance of molecular details in predicting bacterial adhesion to
   hydrophobic surfaces
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; PSEUDOMONAS-PUTIDA KT2442; POROUS-MEDIA;
   ESCHERICHIA-COLI; BIOMATERIAL SURFACES; CHARGE NONUNIFORMITY; POLYMER
   INTERACTIONS; COLLOIDAL PARTICLES; PROTEIN ADSORPTION; BED FILTRATION
AB Electrostatic and hydrophobic forces are generally recognized as important in bacterial adhesion. Current continuum models for these forces often wrongly predict measurements of bacterial adhesion forces. The hypothesis tested here is that even qualitative guides to bacterial adhesion often require more than continuum information about hydrophobic forces; they require knowledge about molecular details of the bacteria and substrate surface. In this study, four different strains of bacteria were adsorbed to silica surfaces hydrophobized with alkylsilanes. The thickness of the lipopolysaccharide layers varied on the different bacteria, and the lengths of the alkylsilane molecules were varied from experiment to experiment. Bacterial adhesion was assessed using column experiments and atomic force microscopy (AFM) experiments. Results show that hydrophobized surfaces have higher bacterial sticking coefficients and stronger adhesion forces than bare silica surfaces, as expected. However, adhesion decreased as the solution Debye length became longer than the alkylsilane, perhaps since the silane molecules could not "reach" the bacterial surface. Similarly, those bacteria with a long o-antigen layer had decreased adhesion, perhaps since the silane molecules could not reach surface-bound proteins on the bacteria. This study reveals that macroscopic measurements such as contact angle are not able to fully describe bacterial adhesion; rather, additional details such as the molecular length are required to predict adhesion.
C1 Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.
   Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA.
RP Velegol, D (reprint author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.
EM velegol@psu.edu
RI Logan, Bruce/E-7063-2012
OI Logan, Bruce/0000-0001-7478-8070
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Abu-Lail NI, 2003, BIOMACROMOLECULES, V4, P1000, DOI 10.1021/bm034055f
   Abu-Lail NI, 2002, LANGMUIR, V18, P4071, DOI 10.1021/la015695b
   Adamson W, 1997, PHYS CHEM SURFACES
   Almanza-Workman AM, 2003, THIN SOLID FILMS, V423, P77, DOI 10.1016/S0040-6090(02)00997-5
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   APPELBAUM B, 1979, INFECT IMMUN, V25, P717
   Appenzeller BMR, 2002, ENVIRON SCI TECHNOL, V36, P646, DOI 10.1021/es010155m
   Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a
   BUSSCHER HJ, 1986, APPL ENVIRON MICROB, V51, P910
   Camesano TA, 2000, LANGMUIR, V16, P4563, DOI 10.1021/la990805o
   Camesano TA, 1998, ENVIRON SCI TECHNOL, V32, P1699, DOI 10.1021/es970996m
   Camesano TA, 1999, COLLOID SURFACE A, V160, P291, DOI 10.1016/S0927-7757(99)00156-9
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   CASSIE ABD, 1948, DISCUSS FARADAY SOC, V3, P11, DOI 10.1039/df9480300011
   DeFlaun MF, 1999, APPL ENVIRON MICROB, V65, P759
   Docoslis A, 1999, COLLOID SURFACE B, V13, P83, DOI 10.1016/S0927-7765(98)00111-8
   Docoslis A, 2001, COLLOID SURFACE B, V22, P205, DOI 10.1016/S0927-7765(01)00195-3
   Feick JD, 2004, LANGMUIR, V20, P3090, DOI 10.1021/la0355545
   Feick JD, 2002, LANGMUIR, V18, P3454, DOI 10.1021/la011515m
   Feick JD, 2000, LANGMUIR, V16, P10315, DOI 10.1021/la001031a
   FINN DH, 1994, COLLOID SURF A, V87, P163
   Fletcher M., 1996, BACTERIAL ADHESION
   Gallardo-Moreno AM, 2003, J ADHES SCI TECHNOL, V17, P1877, DOI 10.1163/156856103770572034
   Gotzinger M, 2004, LANGMUIR, V20, P5298, DOI 10.1021/la049914f
   GROSS MJ, 1995, WATER RES, V29, P1151, DOI 10.1016/0043-1354(94)00235-Y
   HUNTER R, 1981, ZETA POTENTIAL
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   JEWETT DG, 1995, WATER RES, V29, P1673, DOI 10.1016/0043-1354(94)00338-8
   Jucker BA, 1998, COLLOID SURFACE B, V11, P33, DOI 10.1016/S0927-7765(98)00029-0
   Jucker BA, 1998, ENVIRON SCI TECHNOL, V32, P2909, DOI 10.1021/es980211s
   KOLENBRANDER PE, 1985, INFECT IMMUN, V48, P741
   Kotra LP, 1999, J AM CHEM SOC, V121, P8707, DOI 10.1021/ja991374z
   LASSEN B, 1994, COLLOID POLYM SCI, V272, P1143, DOI 10.1007/BF00652384
   Lee PS, 2003, BIOTECHNOL BIOENG, V84, P801, DOI 10.1002/bit.10848
   Li Q, 1999, WATER RES, V33, P1090, DOI 10.1016/S0043-1354(98)00291-7
   LINDSAY SM, 1993, J VAC SCI TECHNOL A, V11, P808, DOI 10.1116/1.578309
   LOGAN BE, 1993, WATER RES, V27, P955, DOI 10.1016/0043-1354(93)90059-Q
   LOGAN BE, 1995, J ENVIRON ENG-ASCE, V121, P869, DOI 10.1061/(ASCE)0733-9372(1995)121:12(869)
   MADIGAN MT, 1997, BROCK BIOL MICROORGA
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Poortinga AT, 2001, LANGMUIR, V17, P2851, DOI 10.1021/la001673y
   Qin Y, 2003, J CHEM PHYS, V119, P9745, DOI 10.1063/1.1615493
   RAJAGOPALAN R, 1976, AICHE J, V22, P523, DOI 10.1002/aic.690220316
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es0348871
   Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5
   Sharma PK, 2003, COLLOID SURFACE B, V29, P21, DOI 10.1016/S0927-7765(02)00180-7
   Shellenberger K, 2002, ENVIRON SCI TECHNOL, V36, P184, DOI 10.1021/es015515k
   Steffan RJ, 1999, ENVIRON SCI TECHNOL, V33, P2771, DOI 10.1021/es9812204
   STEMMER A, 1990, ULTRAMICROSCOPY, V34, P129, DOI 10.1016/0304-3991(90)90067-V
   Sun N, 2001, J COLLOID INTERF SCI, V234, P90, DOI 10.1006/jcis.2000.7248
   Tros ME, 1996, APPL ENVIRON MICROB, V62, P437
   van der Mei H C, 1997, Adv Dent Res, V11, P388
   van Oss CJ, 2001, COLLOID SURFACE B, V22, P285, DOI 10.1016/S0927-7765(01)00151-5
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Williams V, 1996, APPL ENVIRON MICROB, V62, P100
   WINGENDER J, 1999, MICROBIOL EXTRA CELL
NR 61
TC 46
Z9 48
U1 2
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 23
PY 2004
VL 20
IS 24
BP 10625
EP 10629
DI 10.1021/la048372z
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 872KZ
UT WOS:000225207400037
PM 15544394
DA 2018-10-19
ER

PT J
AU Mendez-Vilas, A
   Gallardo-Moreno, AM
   Gonzalez-Martin, ML
   Calzado-Montero, R
   Nuevo, MJ
   Bruque, JM
   Perez-Giraldo, C
AF Mendez-Vilas, A
   Gallardo-Moreno, AM
   Gonzalez-Martin, ML
   Calzado-Montero, R
   Nuevo, MJ
   Bruque, JM
   Perez-Giraldo, C
TI Surface characterisation of two strains of Staphylococcus epidermidis
   with different slime-production by AFM
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Meeting on Applied Physics (APHYS-2003)
CY OCT 15-18, 2003
CL Badajoz, SPAIN
SP Dept Phys Univ Extremadura, Junta Extremadura & Consejer Educ, Cienc Tecnol, INNOVA
DE Staphylococcus epidermidis; slime production; biofilm; AFM
ID ADHERENCE; BIOFILMS; LENSES
AB Slime-producer Staphylococcus epidermidis is one opportunistic bacteria directly related to biomaterial infections inside the human body. The characterisation of the bacterial surface is crucial when trying to control its adhesion process and prevent the biofilm formation. This work aims to analyse the microscopic and submicroscopic surface structure of two strains of S. epidermidis with different slime production, as well as mapping the surface interaction forces. Atomic force microscopy (AFM) shows that S. epidermidis ATCC35984 is covered by a granular-like film, highly compacted with the presence of repeated "holes". However, S. epidermidis ATCC35983 only shows a partial coverage by a less compacted granular-like film, mainly located in the inter-cellular zones. Both films are related to the slime of the two strains studied. As regards to the adhesion forces, results show a greater adhesion of the tip to the slime covering S. epidermidis ATCC35984, than that covering the surface of S. epidermidis ATCC35983. In addition, the adhesion to the free-slime zones of the last strain was higher than to the slime-covered parts. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Extremadura, Dept Phys, E-06071 Badajoz, Spain.
   Univ Extremadura, Dept Microbiol, E-06071 Badajoz, Spain.
RP Mendez-Vilas, A (reprint author), Univ Extremadura, Dept Phys, Avda Elvas S-N, E-06071 Badajoz, Spain.
EM amvilas@unex.es
RI Morales Bruque, Jose/N-2521-2014; Nuevo, Maria/H-6135-2015; Gonzalez
   Martin, Maria Luisa/L-3476-2014
OI Morales Bruque, Jose/0000-0002-9336-4350; Nuevo,
   Maria/0000-0002-5634-4318; Gonzalez Martin, Maria
   Luisa/0000-0002-9207-444X; Perez-Giraldo, Ciro/0000-0002-2358-1982
CR Carballo J, 1992, J Biomater Appl, V7, P130, DOI 10.1177/088532829200700203
   Dufrene YF, 1999, J BACTERIOL, V181, P5350
   Gallardo-Moreno AM, 2002, LANGMUIR, V18, P3639, DOI 10.1021/la011675y
   Garcia-Saenz MC, 2002, CORNEA, V21, P511, DOI 10.1097/01.ICO.00000186880.51067.E8
   HIROSHI Y, 2002, GLYCOSCI GLYCOTECHNO, V8, P409
   Lundberg F, 1998, BIOMATERIALS, V19, P1727, DOI 10.1016/S0142-9612(98)00081-7
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
NR 8
TC 10
Z9 10
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2004
VL 238
IS 1-4
BP 18
EP 23
DI 10.1016/j.apsusc.2004.05.183
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 864TG
UT WOS:000224655200005
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Uskokovic, D
AF Ignjatovic, N
   Uskokovic, D
TI Synthesis and application of hydroxyapatite/polylactide composite
   biomaterial
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Meeting on Applied Physics (APHYS-2003)
CY OCT 15-18, 2003
CL Badajoz, SPAIN
SP Dept Phys Univ Extremadura, Junta Extremadura & Consejer Educ, Cienc Tecnol, INNOVA
DE hydroxyapatite/poly-L-lactide; structure designing; hot pressing;
   mechanical properties; Ii vitro and in vivo research
ID DIFFERENT MOLECULAR-WEIGHTS; POLY-L-LACTIDE; HAP/PLLA COMPOSITE;
   INTERNAL-FIXATION; BONE-FRACTURES; SPECTROSCOPY; PLLA; RODS
AB Hydroxyapatite/bioresorbable-polymer composite biomaterials can be used for the bone tissue reconstruction. There are different methods to obtain hydroxyapatite/poly-L-lactide (HAp/PLLA) composite biomaterial, but up to now only hot pressing and forging have been successfully used to produce blocks with mechanical properties similar to the natural bone tissue. By dissolving PLLA polymer mixed with HAp, highly porous HAp/PLLA composite biomaterial was obtained. A wide spectrum of blocks with different properties was produced by hot pressing, varying the pressing parameters. HAp/PLLA blocks were implanted into mice (intraperitoneally) and after implantation, the phenomenon was studied histopathologically and by FT-IR spectroscopy. The obtained composite biomaterial blocks have a compressive strength of up to 140 MPa and elasticity module of up to 10 GPa. After implantation, good adhesion of the surrounding tissue on the surface of the implant as well as its integration indicate high degree of its biocompatibility. (C) 2004 Elsevier B.V. All rights reserved.
C1 Acad Sci & Arts, Inst Tech Sci, YU-11000 Belgrade, Serbia Monteneg, Yugoslavia.
RP Ignjatovic, N (reprint author), Acad Sci & Arts, Inst Tech Sci, K Mihailova 35-4, YU-11000 Belgrade, Serbia Monteneg, Yugoslavia.
EM its@itn.sanu.ac.yu
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
CR AKAMATSU N, 1993, ASIAN MED J, V36, P621
   [Anonymous], 1993, [No title captured], Patent No. [0289562 B1, 0289562]
   BLACH N, 2002, BIOMATERIALS, V23, P1579
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2000, ADV ENG MATER, V2, P511, DOI 10.1002/1527-2648(200008)2:8<511::AID-ADEM511>3.0.CO;2-B
   Ignjatovic N., 2002, Science of Sintering, V34, P79, DOI 10.2298/SOS0201079I
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2000, MATER SCI FORUM, V352, P143, DOI 10.4028/www.scientific.net/MSF.352.143
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic N, 2001, KEY ENG MATER, V192-195, P737
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Laurencin C., 1998, US Patent, Patent No. [5 766 618, 5766618]
   Najman S, 2004, BIO-MED MATER ENG, V14, P61
   PARK J, 1992, BIOMATERIALS INTRO, P7
   RUSSELL AD, 1992, PRINCIPLES PRACTICE, P46
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Sosnowski S, 2001, POLYMER, V42, P637, DOI 10.1016/S0032-3861(00)00362-1
   Suljovrujic E., 2003, RADIAT PHYS CHEM, V67, P375
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
NR 23
TC 60
Z9 66
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2004
VL 238
IS 1-4
BP 314
EP 319
DI 10.1016/j.apsusc.2004.05.227
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 864TG
UT WOS:000224655200061
DA 2018-10-19
ER

PT J
AU Marreco, PR
   da Luz Moreira, P
   Genari, SC
   Moraes, AM
AF Marreco, PR
   da Luz Moreira, P
   Genari, SC
   Moraes, AM
TI Effects of different sterilization methods on the morphology, mechanical
   properties, and cytotoxicity of chitosan membranes used as wound
   dressings
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE chitin; chitosan; wound dressing; biomaterial; sterilization;
   characterization
ID IN-VITRO; PHYSICAL-PROPERTIES; FILMS; GROWTH; CHITIN; FABRICATION;
   FIBROBLASTS; MANAGEMENT; RESPONSES; POLYMERS
AB The aim of this work was to compare the effects induced by two different sterilization methods (exposure to gamma radiation or ethylene oxide) and an antiseptic technique (immersion in 70% ethanol aqueous solution) on the morphology, tensile strength, percentage of strain at break, and in vitro cytotoxicity to Vero cells on chitosan membranes designed for wound healing. Four distinct membrane compositions were evaluated, with chitosan, glycerol, and chitin used as components. Gamma radiation, in spite of being one of the most commonly employed sterilizing agents, negatively affected the morphology of membranes composed solely by chitosan as well as the percentage of strain at break of the chitosan-membranes containing glycerol on their composition. Moreover, its use affected the color of the chitosan membranes. The use of 70% ethanol aqueous solution did not change the chitosan-membrane characteristics significantly, but its use has limitations concerning the process scale up. With ethylene oxide (EtO), chitosan-membrane morphology, percentage of strain at break, and in vitro cytotoxicity to Vero cells were not significantly affected. The tensile strength of the membranes containing chitin were reduced after the treatment with ethylene oxide; however, the obtained values were comprised in the range verified for normal human skin. Therefore, because the final characteristics of the membranes treated with ethylene oxide are appropriate when considering their use as wound healing devices, and because this sterilization process is easily adjusted to use on an industrial scale, EtO can be considered the most adequate sterilizing agent for chitosan membranes. However, it should be considered that this chemical is associated with toxicity, flammability, and environmental risks, as well as with possible material contamination with ethylene oxide residues. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Estadual Campinas, Sch Chem Engn, Dept Biotechnol Proc, BR-13081970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Inst Biol, Dept Cellular Biol, BR-13094970 Campinas, SP, Brazil.
   Centro Reg Univ Espirito Santo do Pinhal, Sao Paulo, Brazil.
RP Moraes, AM (reprint author), Univ Estadual Campinas, Sch Chem Engn, Dept Biotechnol Proc, POB 6066, BR-13081970 Campinas, SP, Brazil.
EM ammoraes@feq.unicamp.br
RI Moraes, Angela/K-5181-2012
OI Moraes, Angela/0000-0002-5813-332X
CR Andrady AL, 1996, J APPL POLYM SCI, V62, P1465
   [Anonymous], 109935 ISO
   *ANSI AAMI, 1988, ST271988 ANSIAAMI
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   ENDLER E, STERILIZATION POLYM
   Furuta M, 2002, RADIAT PHYS CHEM, V63, P323, DOI 10.1016/S0969-806X(01)00520-5
   GUERREIROBELTRA.JA, 1999, I FOOD TECHN ANN M C
   Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   KIRKPATRICK CJ, 1992, REGULATORY AFFAIRS, V4, P13
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   LI JC, 1999, TSINGHUA SCI TECHNOL, V4, P1515
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MU Y, 1999, TSINGHUA SCI TECHNOL, V4, P1578
   Murakami N, 1998, J CELL PHYSIOL, V176, P127, DOI 10.1002/(SICI)1097-4652(199807)176:1<127::AID-JCP15>3.0.CO;2-4
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   OHASHI E, 1995, J BIOTECHNOL, V40, P13, DOI 10.1016/0168-1656(95)00028-O
   PARISI AN, 1991, DISINFECTION STERILI, P581
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Silver F.H., 1994, BIOMATERIALS MED DEV, P46
   SKIENS WE, 1980, RADIAT PHYS CHEM, V15, P47, DOI 10.1016/0146-5724(80)90096-5
   Suzuki T, 1997, J FERMENT BIOENG, V84, P128, DOI 10.1016/S0922-338X(97)82541-X
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   WILES JJL, 2000, THESIS CLEMSON U CLE
   Yamaguchi I, 2003, BIOMATERIALS, V24, P2031, DOI 10.1016/S0142-9612(02)00633-6
   YOSOF NLB, 2001, J BIOMED MATER RES, V54, P59
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 41
TC 84
Z9 87
U1 1
U2 24
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV 15
PY 2004
VL 71B
IS 2
BP 268
EP 277
DI 10.1002/jbm.b.30081
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 867MM
UT WOS:000224846700007
PM 15455369
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Suijovrujic, E
   Budinski-Simendic, J
   Krakovsky, I
   Uskokovic, D
AF Ignjatovic, N
   Suijovrujic, E
   Budinski-Simendic, J
   Krakovsky, I
   Uskokovic, D
TI Evaluation of hot-pressed hydroxyapatite/poly-L-lactide composite
   biomaterial characteristics
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE composite biomaterials; hydroxyapatite; poly-L-lactide; hot pressing;
   crystallinity; mechanical properties
ID DIFFERENT MOLECULAR-WEIGHTS; POLY-L-LACTIDE; MECHANICAL-PROPERTIES;
   HAP/PLLA COMPOSITE; INTERNAL-FIXATION; IN-VIVO; POLY(L-LACTIDE);
   POLYLACTIDE; DEGRADATION; POLYCARBONATES
AB Hydroxyapatite/poly-L-lactide (HAp/PLLA) is a ceramic/polymer composite, whose application as a resorbable biomaterial for the substitution and repair of hard bone tissue is widely promising in orthopedic, oral, maxillofacial, and reconstructive surgery. Hot processing is a necessary step for obtaining HAp/PLLA composite blocks with mechanical properties similar to those of bones. In this article, the changes in structure and physicochemical properties of HAp/PLLA composite, hot pressed for different pressing times (5, 15, 30, 45, and 60 min), were studied. Because the morphology of HAp/PLLA composite biomaterial is very sensitive to this procedure, its surface microstructure was analyzed by scanning electron microscopy (SEM) coupled with an energy-dispersive X-ray (EDX) detector system. Structural changes occurring in the material, mostly changes in crystallinity of PLLA, were studied by wide-angle X-ray structural analyses (WAXS) and infrared (FTIR) spectroscopy. Using differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and gel permeation chromatography (GPC), the influence of hot pressing on the properties, crystallization kinetics, and decomposition of HAp/PLLA composite biomaterial was analyzed. (C) 2004 Wiley Periodicals, Inc.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia Monteneg, Serbia Monteneg.
   Vinca Inst Nucl Sci, Belgrade, Serbia Monteneg, Serbia Monteneg.
   Univ Novi Sad, Fac Technol, Novi Sad, Serbia Monteneg, Serbia Monteneg.
   Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Knez Mihailova 35-IV, Belgrade, Serbia Monteneg, Serbia Monteneg.
EM uskok@itn.sanu.ac.yu
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Budinski-Simendic,
   Jaroslava/0000-0002-5706-5193; Suljovrujic, Edin/0000-0001-8774-4341
CR BEVER M, 1986, ENCY MAT SCI ENG BIO, V1
   Bleach NC, 2002, BIOMATERIALS, V23, P1579, DOI 10.1016/S0142-9612(01)00283-6
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FABBRI M, 1995, BIOMATERIALS, V16, P225, DOI 10.1016/0142-9612(95)92121-L
   FLORY PJ, 1969, STATISTICAL MECHANIC, P249
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   Gogolewski S, 1996, J BIOMED MATER RES, V32, P227
   GRASSIE N, 1988, POLYM DEGRADATION ST, P17
   GUPTA MC, 1982, COLLOID POLYM SCI, V260, P514, DOI 10.1007/BF01452999
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hong K, 2000, POLYMER, V41, P4567, DOI 10.1016/S0032-3861(99)00677-1
   Ignatius AA, 2001, J BIOMED MATER RES, V57, P126, DOI 10.1002/1097-4636(200110)57:1<126::AID-JBM1151>3.0.CO;2-M
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2000, ADV ENG MATER, V2, P511, DOI 10.1002/1527-2648(200008)2:8<511::AID-ADEM511>3.0.CO;2-B
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2000, MATER SCI FORUM, V352, P143, DOI 10.4028/www.scientific.net/MSF.352.143
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   IGNJATOVIC N, 2000, 9 EUR C POLYM MED SU
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   MCNEILL IC, 1985, POLYM DEGRAD STABIL, V11, P309, DOI 10.1016/0141-3910(85)90035-7
   MCNEILL IC, 1985, POLYM DEGRAD STABIL, V11, P267, DOI 10.1016/0141-3910(85)90050-3
   Miyata T, 1997, POLYMER, V38, P4003, DOI 10.1016/S0032-3861(96)00987-1
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   Moroi H H, 1993, Int J Prosthodont, V6, P564
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   PARK J, 1992, BIOMATERIALS INTRO, P7
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Sosnowski S, 2001, POLYMER, V42, P637, DOI 10.1016/S0032-3861(00)00362-1
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tsuji H, 2000, POLYMER, V41, P3621, DOI 10.1016/S0032-3861(99)00545-5
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   Yoon JS, 1999, POLYMER, V40, P2303, DOI 10.1016/S0032-3861(98)00463-7
NR 35
TC 56
Z9 56
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV 15
PY 2004
VL 71B
IS 2
BP 284
EP 294
DI 10.1002/jbm.b.30093
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 867MM
UT WOS:000224846700009
PM 15386398
DA 2018-10-19
ER

PT J
AU Zhang, R
   An, Y
   Toth, CA
   Draughn, RA
   Dimaano, NM
   Hawkins, MV
AF Zhang, R
   An, Y
   Toth, CA
   Draughn, RA
   Dimaano, NM
   Hawkins, MV
TI Osteogenic protein-1 enhances osseointegration of titanium implants
   coated with peri-apatite in rabbit femoral defect
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE osteogenic protein-1; hydroxyapatite; titanium; implant fixation;
   rabbits
ID BONE MORPHOGENETIC PROTEIN-2; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS;
   CALCIUM-PHOSPHATE; HYDROXYAPATITE; PHARMACOKINETICS; DOGS
AB This study evaluated the effect of osteogenic protein-1 (OP-1) carried by Peri-Apatite (PA) on bone healing in the gap surrounding implants in a rabbit model. Cylindrical titanium implants (3 x 9 mm) were uniformly coated with PA precipitated from a calcium and phosphate solution. OP-1 solution containing 60 mug OP-1 was directly loaded on the implants immediately before implantation for the experimental group, whereas buffer solution was loaded on the implants for the control. The implant was placed in the distal femur and surrounded by a 1-mm gap. The implants were retrieved and examined 6 weeks after implantation. Mechanical testing (push-out) data showed that OP-1 enhanced implant fixation by 80%. Histomorphometric measurements indicated that bone ingrowth in the initial gap expressed as a percentage of the whole gap was significantly higher in the specimens treated with OP-1 than the control group (25.4% vs. 8.9%, p < 0.05). The percentage of the surface of implants, which was covered by bone, was significantly higher in the OP-1-treated group compared to the control group (65% vs. 25%, p < 0.05). This study suggests that OP-1 can be loaded on orthopedic implants through PA to enhance the osseointegration of orthopedic implant. (C) 2004 Wiley Periodicals, Inc.
C1 Stryker Orthopaed, Mahwah, NJ USA.
   Med Univ S Carolina, Dept Orthoped Surg, Charleston, SC 29425 USA.
   Stryker Biotech, Hopkinton, MA USA.
RP Zhang, R (reprint author), Stryker Orthopaed, Mahwah, NJ USA.
EM rzhang@howost.com
CR ABERMAN HM, 1993, T ORS 1993, P466
   Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004
   Anderson DE, 1997, ACTA ORTHOP SCAND, V68, P571, DOI 10.3109/17453679708999029
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   CURTIS MJ, 1992, J BONE JOINT SURG BR, V74, P372
   DALTON JE, 1995, J BONE JOINT SURG AM, V77A, P97, DOI 10.2106/00004623-199501000-00012
   Friedlaender GE, 2001, J BONE JOINT SURG S1, V83, P151
   GEESINK RGT, 1990, CLIN ORTHOP RELAT R, P39
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Jensen TB, 2002, ACTA ORTHOP SCAND, V73, P31, DOI 10.1080/000164702317281378
   Kadoya Y, 1998, ACTA ORTHOP SCAND, V69, P1
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P611, DOI 10.3109/17453679608997766
   Lind M, 2000, J ARTHROPLASTY, V15, P339, DOI 10.1016/S0883-5403(00)90693-4
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Ono I, 1996, BONE, V19, P581, DOI 10.1016/S8756-3282(96)00282-7
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   SUMMER DR, 1995, J BONE JOINT SURG AM, V77, P1135
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   WOLFE MW, 1994, MED PROG TECHNOL, V20, P155
   ZHANG R, 2003, T 49 ANN M ORS, P34
   Zitelli JP, 2000, MATER RES SOC SYMP P, V599, P117
NR 27
TC 25
Z9 27
U1 1
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV 15
PY 2004
VL 71B
IS 2
BP 408
EP 413
DI 10.1002/jbm.b.30110
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 867MM
UT WOS:000224846700025
PM 15389505
DA 2018-10-19
ER

PT J
AU Dupont, L
   Bouanda, J
   Ghanbaja, J
   Dumonceau, J
   Aplincourt, M
AF Dupont, L
   Bouanda, J
   Ghanbaja, J
   Dumonceau, J
   Aplincourt, M
TI Use of analytical microscopy to analyze the speciation of copper and
   chromium ions onto a low-cost biomaterial
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE low-cost biomaterial; copper; chromium; EELS; TEM-EDXS
ID ENERGY-LOSS SPECTROSCOPY; NICA-DONNAN APPROACH; HEAVY-METALS; WHEAT
   BRAN; BINDING; REDUCTION; REMOVAL
AB In this paper, we present our study of the speciation of copper and hexavalent chromium sorbed onto a lignocellulosic substrate, using analytical microscopy. The lignocellulosic substrate constitutes a low-cost biomaterial that can be used in wastewater treatment. Transmission electron microscopy (TEM) coupled with energy-dispersive X-ray spectroscopy (EDXS) was used to determine the speciation of the two metal ions on the constitutive moieties of the lignocellulosic substrate. The use of a staining agent sensitive to carbon unsaturation allowed us to differentiate between the microstructures rich in lignin entities and those rich in cellulose entities. The EDX analysis showed that metal ions are preferentially sorbed onto microstructures rich in lignin moieties. The energy electron loss spectroscopy (EELS) was used to determine the oxidation states of chromium in association with lignocellulosic moieties. We showed that the sorption process of hexavalent chromium requires the reduction of Cr(VI) into Cr(III) and the probable oxidation of lignin moieties. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Reims, GRECI, F-51687 Reims 2, France.
   UHP, Fac Sci, Serv Commun Microscopie Electron Transmiss, F-54506 Vandoeuvre Les Nancy, France.
RP Dupont, L (reprint author), Univ Reims, GRECI, BP 1039, F-51687 Reims 2, France.
EM laurent.dupont@univ-reims.fr
OI Dumonceau, Jean-Marc/0000-0002-4802-4779
CR Bouanda J, 2002, ANAL BIOANAL CHEM, V373, P174, DOI 10.1007/s00216-002-1305-z
   Daulton TL, 2002, J MICROBIOL METH, V50, P39, DOI 10.1016/S0167-7012(02)00013-1
   DAVILA JS, 1992, WATER SCI TECHNOL, V26, P2309
   Dupont L, 2003, J COLLOID INTERF SCI, V263, P35, DOI 10.1016/S0021-9797(03)00241-8
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   DUVERNEUIL P, 1997, THESIS PARIS
   Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6
   FROMM J, 2003, STRUCT BIOL, V143, P77
   Gaballah I, 1998, J GEOCHEM EXPLOR, V62, P241, DOI 10.1016/S0375-6742(97)00068-X
   Gauthier A, 2002, ANAL BIOANAL CHEM, V373, P830, DOI 10.1007/s00216-002-1371-2
   Guillon E, 2001, J COLLOID INTERF SCI, V239, P39, DOI 10.1006/jcis.2001.7535
   Koshino M, 2000, MICRON, V31, P373, DOI 10.1016/S0968-4328(99)00116-X
   Lee A, 1999, INT J COAL GEOL, V39, P329, DOI 10.1016/S0166-5162(98)00050-0
   Nassiri Y, 1996, BIOL CELL, V86, P151, DOI 10.1016/0248-4900(96)84779-4
   Nassiri Y, 1997, ARCH ENVIRON CON TOX, V33, P147, DOI 10.1007/s002449900236
   Neal AL, 2002, APPL SURF SCI, V202, P150, DOI 10.1016/S0169-4332(02)00550-0
   Nishikawa K, 2003, FEMS MICROBIOL ECOL, V44, P253, DOI 10.1016/S0168-6496(03)00049-7
   PEARSON DH, 1993, PHYS REV B, V47, P8471, DOI 10.1103/PhysRevB.47.8471
   PERRET D, 1995, MICROSC MICROANAL M, V6, P41, DOI 10.1051/mmm:1995106
   TELES LA, 1992, EUR WATER POLLUT CON, V2, P13
NR 20
TC 12
Z9 12
U1 3
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD NOV 15
PY 2004
VL 279
IS 2
BP 418
EP 424
DI 10.1016/j.jcis.2004.06.069
PG 7
WC Chemistry, Physical
SC Chemistry
GA 868RA
UT WOS:000224929500015
PM 15464806
DA 2018-10-19
ER

PT J
AU Yadav, AV
   Bhise, SB
AF Yadav, AV
   Bhise, SB
TI Chitosan: A potential biomaterial effective against typhoid
SO CURRENT SCIENCE
LA English
DT Article
ID CULTURED GLYCINE-MAX; ANTIMICROBIAL ACTIVITY; MEMBRANE-PERMEABILITY;
   MOLECULAR-WEIGHT; CELLS
C1 Govt Coll Pharm, Karad 415124, India.
RP Yadav, AV (reprint author), Govt Coll Pharm, Karad 415124, India.
EM avyadav03@rediffmail.com
CR ARAI K, 1968, B TOKAI REG FISH LAB, V43, P89
   Balassa L. L., 1978, P 1 INT C CHIT CHIT, P296
   BALASSA LL, 1975, Patent No. 3911116
   BALASSA LL, 1974, Patent No. 3804949
   *DEP HLTH SCOTT HO, 1993, BRIT PHARMACOPOEIA
   Ericsson H, 1971, ACTA PATHOL MICR B S, P217
   EVANS EE, 1962, J HISTOCHEM CYTOCHEM, V10, P24, DOI 10.1177/10.1.24
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Jackson D., 1987, United States Patent, Patent No. [4,659,700, 4659700]
   KIM KY, 1990, POLYM-KOREA, V14, P527
   Leuba S, 1986, CHITIN NATURE TECHNO, P215
   *MIN HLTH FAM WELF, 1985, PHARMACOPOEIA INDI A, V2, P90
   MOSBEY DT, 1990, Patent No. 356060
   *NAT COMM CLIN LAB, 1993, REF STAND ANT DISC S, V13, P24
   TAKAJI S, 1990, Patent No. 02268766
   Tsai GJ, 2004, J FOOD PROTECT, V67, P396, DOI 10.4315/0362-028X-67.2.396
   YOUNG DH, 1983, PLANT PHYSIOL, V73, P698, DOI 10.1104/pp.73.3.698
   YOUNG DH, 1982, PLANT PHYSIOL, V70, P1449, DOI 10.1104/pp.70.5.1449
   Zivanovic S, 2004, J FOOD PROTECT, V67, P952, DOI 10.4315/0362-028X-67.5.952
NR 19
TC 21
Z9 22
U1 0
U2 5
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD NOV 10
PY 2004
VL 87
IS 9
BP 1176
EP 1178
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 872BL
UT WOS:000225180800008
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Pramatarova, L
   Pecheva, E
   Dimova-Malinovska, D
   Pramatarova, R
   Bismayer, U
   Petrov, T
   Minkovski, N
AF Pramatarova, L
   Pecheva, E
   Dimova-Malinovska, D
   Pramatarova, R
   Bismayer, U
   Petrov, T
   Minkovski, N
TI Porous silicon as a substrate for hydroxyapatite growth
SO VACUUM
LA English
DT Article; Proceedings Paper
CT 13th International Summer School on Vacuum, Electron and Ion
   Technologies
CY SEP 15-19, 2003
CL Varna, BULGARIA
SP Bulgarian Acad Sci, Inst Elect, Inst Ion Beam Phys & Mat Res, Res Ctr Rossendorf, FZR, Fdn Evrika
DE porous silicon; hydroxyapatite; growth; laser-liquid-solid interaction
ID SURFACE; PHOSPHATE
AB Porous silicon has been shown to be an excellent candidate biomaterial, following studies establishing its biostability and non-toxicity. These favorable properties, coupled with the ease of its topographical manipulation, make it a promising material for the growth of hydroxyapatite, which is used as an artificial bone material. In this paper, the use of porous silicon as a substrate for hydroxyapatite growth induced by two methods is reported: a simple soaking process in a simulated body fluid and a laser-liquid-solid interaction process which allows interaction between a scanning laser beam and the substrate immersed in the simulated body fluid. The grown layers are investigated by light microscopy, electron microprobe analysis and X-ray diffraction. It is found that the layer topography obtained after applying the two processes is different. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Bulgarian Acad Sci, Inst Solid State Phys, BU-1784 Sofia, Bulgaria.
   Bulgarian Acad Sci, Cent Lab Solar Energy & New Energy Sources, BU-1784 Sofia, Bulgaria.
   Univ Hamburg, Inst Mineral & Petrog, D-20146 Hamburg, Germany.
RP Pramatarova, L (reprint author), Bulgarian Acad Sci, Inst Solid State Phys, 72 Tzarigradsko Chaussee, BU-1784 Sofia, Bulgaria.
EM lpramat@issp.bas.bg
OI Pecheva, Emilia/0000-0002-4802-519X
CR Boskey A. L., 1999, DYNAMICS BONE CARTIL, P153
   Dahmen C, 2003, THIN SOLID FILMS, V427, P201, DOI 10.1016/S0040-6090(02)01228-2
   De Groot Klaas, 1993, P49
   DimovaMalinovska D, 1997, THIN SOLID FILMS, V297, P285, DOI 10.1016/S0040-6090(96)09433-3
   DimovaMalinovska D, 1996, THIN SOLID FILMS, V276, P248, DOI 10.1016/0040-6090(95)08064-3
   Frayssinet P, 1997, SCANNING, V19, P253
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   MANN S, 1993, J CHEM SOC DALTON, P1, DOI 10.1039/dt9930000001
   Mayne AH, 2000, PHYS STATUS SOLIDI A, V182, P505, DOI 10.1002/1521-396X(200011)182:1<505::AID-PSSA505>3.0.CO;2-#
   PECHEVA E, 2003, P EUR VAC C 23 26 JU
   PRAMATAROVA L, 2003, P ILLA LTL 2003 INT
   Rangavittal N, 2000, J BIOMED MATER RES, V51, P660, DOI 10.1002/1097-4636(20000915)51:4<660::AID-JBM14>3.0.CO;2-B
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
NR 15
TC 19
Z9 20
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD NOV 5
PY 2004
VL 76
IS 2-3
BP 135
EP 138
DI 10.1016/j.vacuum.2004.07.004
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 868CL
UT WOS:000224890100005
DA 2018-10-19
ER

PT J
AU van der Borden, AJ
   van der Werf, H
   van der Mei, HC
   Busscher, HJ
AF van der Borden, AJ
   van der Werf, H
   van der Mei, HC
   Busscher, HJ
TI Electric current-induced detachment of Staphylococcus epidermidis
   biofilms from surgical stainless steel
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; EXTERNAL FIXATION; INITIAL ADHESION; SURFACE
   GROWTH; IN-VITRO; BACTERIA; EFFICACY
AB Biomaterial-centered infections of orthopedic percutaneous implants are serious complications which can ultimately lead to osteomyelitis, with devastating effects on bone and surrounding tissues, especially since the biofilm mode of growth offers protection against antibiotics and since removal frequently is the only ultimate solution. Recently, it was demonstrated that as a possible pathway to prevent infections of percutaneous stainless steel implants, electric currents of 60 to 100 muA were effective at stimulating the detachment of initially adhering staphylococci from surgical stainless steel. However, initially adhering bacteria are known to adhere more reversibly than bacteria growing in the later stages of biofilm formation. Hence, the aim of this study was to examine whether a growing Staphylococcus epidermidis biofilm can be stimulated to detach from surgical stainless steel by the use of electric currents. In separate experiments, four currents, i.e., 60 and 100 muA of direct current (DC) and 60 and 100 muA of block current (50% duty cycle, 1 Hz), were applied for 360 min to stimulate the detachment of an S. epidermidis biofilm that had grown for 200 min. A 100-muA DC yielded 78% detachment, whereas a 100-muA block current under the same experimental conditions yielded only 31% detachment. The same trend was found for 60 muA, with 37% detachment for a DC and 24% for a block current. Bacteria remaining on the surface after the current application were less viable than they were prior to the current application, as demonstrated by confocal laser scanning microscopy. In conclusion, these results suggest that DCs are preferred for curing infections.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.rug.nl
RI Hori, Katsutoshi/K-5289-2012
OI Hori, Katsutoshi/0000-0003-1994-3124
CR ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   Bernardo L M, 2001, Orthop Nurs, V20, P29, DOI 10.1097/00006416-200109000-00007
   BULSTRA SK, 1994, J BONE JOINT SURG BR, V76B, P468
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Gomez-Suarez C, 2002, MICROBIOL-SGM, V148, P1161, DOI 10.1099/00221287-148-4-1161
   Gordon JE, 2000, J PEDIATR ORTHOPED, V20, P163
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   Gracia E, 1998, J SURG RES, V79, P146, DOI 10.1006/jsre.1998.5416
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   KAYSINGER KK, 1995, J ORTHOP TRAUMA, V9, P303, DOI 10.1097/00005131-199509040-00006
   KHOURY A. E., 1992, AM SOC ARTIF INTERN, V38, P174
   Mostafavi HR, 1997, CLIN ORTHOP RELAT R, P187
   Poortinga AT, 2001, BIOTECHNOL BIOENG, V76, P395, DOI 10.1002/bit.10129
   Sims M., 2000, J ORTHOP NURSING, V4, P59
   SJOLLEMA J, 1989, J MICROBIOL METH, V9, P73, DOI 10.1016/0167-7012(89)90057-2
   van der Borden AJ, 2004, J BIOMED MATER RES B, V68B, P160, DOI 10.1002/jbm.b.20015
NR 20
TC 59
Z9 60
U1 0
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD NOV
PY 2004
VL 70
IS 11
BP 6871
EP 6874
DI 10.1128/AEM.70.11.6871-6874.2004
PG 4
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 870RR
UT WOS:000225076100064
PM 15528555
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Cavalieri, F
   Miano, F
   D'Antona, P
   Paradossi, G
AF Cavalieri, F
   Miano, F
   D'Antona, P
   Paradossi, G
TI Study of gelling behavior of poly(vinyl alcohol)-methacrylate for
   potential utilizations in tissue replacement and drug delivery
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTROLLED-RELEASE; DEXTRAN HYDROGELS; ALCOHOL); BIOMATERIAL; POLYMERS;
   PROTEINS; NETWORKS
AB The need of innovative, multifunctional biomaterials for the partial or complete tissue replacement is the driving-force for the search of improvements of the performances of the available materials and in the formulation of new ones. Addressing the focus to vitreous substitution, we have explored the possibility of using injectable aqueous solutions of poly(vinyl alcohol), PVA, derivatives able to form hydrogels in the ocular cavity upon UV-vis irradiation with visible light. In particular, we describe the features of hydrogels from methacrylate grafted PVA, PVA-MA, in terms of structural characteristics, degradation processes, release of low- and high- molecular weight molecules, and in vitro gelation kinetics. The mechanical properties, drug delivery tests, and theology tests suggest that PVA-MA derivatives have the potential to become a useful material for vitreous substitution.
C1 Univ Roma Tor Vergata, Dipartimento Sci & Tecnnol Chim, I-00133 Rome, Italy.
   Univ Roma Tor Vergata, INFM, Sez B, I-00133 Rome, Italy.
   SIFI, Catania, Italy.
   Eni Tecnol SpA, I-20097 San Donato Milanese, Milano, Italy.
RP Paradossi, G (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnnol Chim, Via Ric Sci, I-00133 Rome, Italy.
EM paradossi@stc.uniroma2.it
RI Paradossi, Gaio/B-8330-2014
OI Paradossi, Gaio/0000-0003-3051-3811; CAVALIERI,
   FRANCESCA/0000-0001-5391-5069
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   Baker RW, 1974, ADV EXPT MED BIOL, P15
   CHIRILA TV, 1995, CELL MATER, V5, P83
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Colthurst MJ, 2000, BIOMATERIALS, V21, P649, DOI 10.1016/S0142-9612(99)00220-3
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Hennink WE, 1996, J CONTROL RELEASE, V39, P47, DOI 10.1016/0168-3659(95)00132-8
   Hennink WE, 1997, J CONTROL RELEASE, V48, P107, DOI 10.1016/S0168-3659(97)00047-3
   Martens P, 2000, POLYMER, V41, P7715, DOI 10.1016/S0032-3861(00)00123-3
   Meyvis TKL, 1999, J RHEOL, V43, P933, DOI 10.1122/1.551012
   Muhlebach A, 1997, J POLYM SCI POL CHEM, V35, P3603
   Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Paradossi G, 2001, MACROMOLECULES, V34, P8179, DOI 10.1021/ma010418x
   PARK K, 1993, BIODEGRADABLE HYDROG, P196
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   PEPPAS NA, 1985, J BIOMED MATER RES, V19, P394
   Qiu B, 2003, BIOMATERIALS, V24, P11, DOI 10.1016/S0142-9612(02)00227-2
   TAMADA Y, 1986, POLYM MED, V2, P101
   VADIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P3411, DOI 10.1021/ma961764v
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P4639, DOI 10.1021/ma9704018
   WAN WK, 2002, J BIOMED MATER RES, V23, P854
   YAMAUCHI A, 1991, POLYMER GELS, P127
NR 24
TC 51
Z9 52
U1 2
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2004
VL 5
IS 6
BP 2439
EP 2446
DI 10.1021/bm049654g
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 870XI
UT WOS:000225091700043
PM 15530061
DA 2018-10-19
ER

PT J
AU Amsden, BG
   Misra, G
   Gu, F
   Younes, HM
AF Amsden, BG
   Misra, G
   Gu, F
   Younes, HM
TI Synthesis and characterization of a photo-cross-linked biodegradable
   elastomer
SO BIOMACROMOLECULES
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; EPSILON-CAPROLACTONE; TRIMETHYLENE CARBONATE;
   MOLECULAR-WEIGHT; POLY(ESTER-URETHANE) ELASTOMER; PHOTOCURING
   CHARACTERISTICS; ALIPHATIC POLYESTERS; NETWORK FORMATION; L-LACTIDE;
   COPOLYMERS
AB The synthesis and characterization of a photocurable biodegradable elastomer as a potential biomaterial for the delivery of thermosensitive drugs are described. The clastomer was prepared from UV initiated cross-linking of an acrylated star-poly(is an element of-caprolactone-co-D,L-lactide) prepolymer. The influence of the molecular weight of the acrylated prepolymer on the final elastomer mechanical and thermal properties was determined. The glass-transition temperature of the elastomers was independent of the prepolymer molecular weight and was from -6 to -8 degreesC. The Young's modulus and stress at break of the elastomers was proportional to the inverse of the prepolymer molecular weight, while the strain at break increased in a linear fashion with the prepolymer molecular weight. Over a degradation period of 12 weeks in phosphate buffered saline, the elastomers exhibited little mass loss, appreciable mechanical strength loss, and little dimensional or strain at break change.
C1 Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
RP Amsden, BG (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM amsden@chee.queensu.ca
RI Gu, Frank/C-5187-2008
OI Gu, Frank/0000-0001-8749-9075
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Alberti C, 2000, Minerva Urol Nefrol, V52, P219
   AMSDEN B, 1995, J CONTROL RELEASE, V33, P99, DOI 10.1016/0168-3659(94)00073-4
   AMSDEN B, 2004, IN PRESS BIOMACROMOL
   Andreopoulos FM, 1998, BIOMATERIALS, V19, P1343, DOI 10.1016/S0142-9612(97)00219-6
   AOYAGI T, 1994, J CONTROL RELEASE, V32, P87
   BEZWADA RS, 1998, Patent No. 5713920
   BEZWADA RS, 2000, Patent No. 6113624
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   CARELLI V, 1989, INT J PHARMACEUT, V50, P181, DOI 10.1016/0378-5173(89)90120-8
   DAHIYAT BI, 1995, REACT POLYM, V25, P101, DOI 10.1016/0923-1137(95)91297-P
   de Groot JH, 1998, POLYM BULL, V41, P299, DOI 10.1007/s002890050366
   DICOLO G, 1992, BIOMATERIALS, V13, P850
   Espartero JL, 1996, MACROMOLECULES, V29, P3535, DOI 10.1021/ma950529u
   GALE R, 1980, J MEMBRANE SCI, V7, P319, DOI 10.1016/S0376-7388(00)80476-7
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P675
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P213
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   Helminen A, 2001, POLYMER, V42, P3345, DOI 10.1016/S0032-3861(00)00708-4
   Helminen AO, 2002, MACROMOL CHEM PHYSIC, V203, P2630, DOI 10.1002/macp.200290039
   HINRICHS WLJ, 1992, BIOMATERIALS, V13, P585, DOI 10.1016/0142-9612(92)90026-K
   Hubbell JA, 1995, U.S.A Patent Application, Patent No. 5410016
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Kim SH, 1999, CARBOHYD POLYM, V40, P183, DOI 10.1016/S0144-8617(99)00053-3
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   Lang MD, 2002, J APPL POLYM SCI, V86, P2296, DOI 10.1002/app.11221
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Matsuda T, 2004, BIOMACROMOLECULES, V5, P295, DOI 10.1021/bm034231k
   Matsuda T, 2000, MACROMOLECULES, V33, P795, DOI 10.1021/ma991404i
   Matsuda T, 2002, BIOMACROMOLECULES, V3, P942, DOI 10.1021/bm0200229
   Mizutani M, 2002, BIOMACROMOLECULES, V3, P668, DOI 10.1021/bm0101670
   Muhlebach A, 1997, J POLYM SCI POL CHEM, V35, P3603
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Nagata M, 2004, POLYMER, V45, P87, DOI 10.1016/j.polymer.2003.11.003
   Palmgren R, 1997, J POLYM SCI POL CHEM, V35, P1635, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1635::AID-POLA5>3.0.CO;2-Q
   PERRIN DE, 1997, HDB BIODEGRADABLE PO, P3
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PITT CG, 1987, J POLYM SCI POL CHEM, V25, P955, DOI 10.1002/pola.1987.080250402
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   Pitt CG, 1984, J CONTROL RELEASE, V1, P3
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Sandner B, 1997, POLYMER, V38, P2515, DOI 10.1016/S0032-3861(96)00809-9
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   Sinclair R. G., 1977, US Patent, Patent No. [4057537, 4 057 537]
   SINCLAIR RG, 1977, Patent No. 4045418
   SIPOS L, 1995, MACROMOL RAPID COMM, V16, P935, DOI 10.1002/marc.1995.030161209
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   STOREY RF, 1993, POLYMER, V34, P4365, DOI 10.1016/0032-3861(93)90203-M
   Storey RF, 1997, POLYMER, V38, P6295, DOI 10.1016/S0032-3861(97)00208-5
   Treloar L. R. G, 1975, PHYS RUBBER ELASTICI
   Turunen MPK, 2002, POLYM INT, V51, P92, DOI 10.1002/pi.805
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
   WADA R, 1991, PHARMACEUT RES, V8, P1292, DOI 10.1023/A:1015860030772
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
NR 58
TC 93
Z9 97
U1 5
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2004
VL 5
IS 6
BP 2479
EP 2486
DI 10.1021/bm049578h
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 870XI
UT WOS:000225091700048
PM 15530066
DA 2018-10-19
ER

PT J
AU Giavaresi, G
   Ambrosio, L
   Battiston, GA
   Casellato, U
   Gerbasi, R
   Finia, M
   Aldini, NN
   Martini, L
   Rimondini, L
   Giardino, R
AF Giavaresi, G
   Ambrosio, L
   Battiston, GA
   Casellato, U
   Gerbasi, R
   Finia, M
   Aldini, NN
   Martini, L
   Rimondini, L
   Giardino, R
TI Histomorphometric, ultrastructural and microhardness evaluation of the
   osseointegration of a nanostructured titanium oxide coating by
   metal-organic chemical vapour deposition: an in vivo study
SO BIOMATERIALS
LA English
DT Article
DE titanium oxide; metal surface treatment; osseointegration;
   histomorphometry; scanning electron microscopy (SEM); mechanical
   properties
ID SURFACE SPECTROSCOPIC CHARACTERIZATION; THIN-FILMS; VITRO
   BIOCOMPATIBILITY; IMPLANT MATERIALS; BONE; OSTEOINTEGRATION;
   INTEGRATION; MORPHOLOGY; MOCVD
AB Over the past decade the increase of elderly population has determined a rise in the incidence of bone fractures, and the improvement of the implant-bone interface remains an open problem. Metal-organic chemical vapour deposition (MOCVD) has recently been proposed as a technique to coat orthopaedic and dental prostheses with metal nanostructured oxide films either through the decomposition of oxygenated compounds (single-source precursors) or the reaction of oxygen-free metal compounds with oxygenating agents. The present study was performed to assess the in vivo biocompatibility of commercially pure Ti (control material: TI/MA) implants (circle divide 2 mm x 5 mm length) coated with nanostructured TiO2 films by MOCVD (Ti/MOCVD) and then inserted into rabbit femoral cortical (middhiaphysis) and cancellous (distal epiphysis) bone. Histomorphometric, ultrastructural and microhardness investigations were carried out. Four and 12 weeks after surgery, significant (p<0.0005) increases in Al of Ti/MOCVD implants were observed as compared to Ti/MA implants (distal femoral epiphysis: 4 weeks = 8.2%, ns; 12 weeks = 52.3%, p<0.005: femoral diaphysis: 4 weeks=20.2%, p<0.0005; 12 weeks=10.7%, p<0.005). Bone microhardness results showed significant increases for the Ti/MOCVD versus Ti/MA implants at 200 mum in the femoral diaphysis (4 weeks=14.2, p<0.005) and distal femoral epiphysis (12 weeks = 14.5, p<0.01) at 4 and 12 weeks, respectively. In conclusion, the current findings demonstrate that the nanostructured TiO2 coating positively affects the osseointegration rate of commercially pure Ti implants and the bone mineralization at the bone-biomaterial interface in both cortical and cancellous bone. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Ist Ric Codivilla Putti, Ist Ortoped, Serv Chirurg Sperimentale, Dept Expt Surg, I-40132 Bologna, BO, Italy.
   CNR, Inst Composite & Biomed Mat, Naples, Italy.
   CNR, Inst Inorgan Chem & Surfaces, Padua, Italy.
   Univ Bologna, Fac Med, Bologna, Italy.
RP Giavaresi, G (reprint author), Ist Ric Codivilla Putti, Ist Ortoped, Serv Chirurg Sperimentale, Dept Expt Surg, Via Barbiano 1-10, I-40132 Bologna, BO, Italy.
EM gianluca.giaveresi@ior.it; roberto.giardino@ior.it
OI Giavaresi, Gianluca/0000-0001-7843-5969; gerbasi,
   rosalba/0000-0002-9583-9364; AMBROSIO, LUIGI/0000-0002-8367-2405
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Barreca D, 2000, J MATER CHEM, V10, P2127, DOI 10.1039/b002968h
   BATTISTON G, Patent No. 000051
   BATTISTON GA, 1994, THIN SOLID FILMS, V239, P186, DOI 10.1016/0040-6090(94)90849-4
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8
   Codato S, 1999, CHEM VAPOR DEPOS, V5, P159, DOI 10.1002/(SICI)1521-3862(199908)5:4<159::AID-CVDE159>3.0.CO;2-E
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Demri B, 1997, BIOMATERIALS, V18, P305, DOI 10.1016/S0142-9612(96)00130-5
   Duyck J, 1998, Clin Oral Investig, V2, P102, DOI 10.1007/s007840050054
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Fini M, 2003, INT J ARTIF ORGANS, V26, P520
   Fini M, 2002, J ORTHOP RES, V20, P756, DOI 10.1016/S0736-0266(01)00158-9
   Giavaresi G, 2003, INT J ARTIF ORGANS, V26, P774
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   Huja SS, 2000, MECH TESTING BONE BO, P247
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   LI J., 1998, HDB BIOMATERIAL PROP, P340
   Rimondini L, 2002, MATERIALWISS WERKST, V33, P716, DOI 10.1002/mawe.200290001
   STANFORD C M, 1991, Critical Reviews in Oral Biology and Medicine, V2, P83
   Tripi TR, 2003, J ENDODONT, V29, P132, DOI 10.1097/00004770-200302000-00011
NR 27
TC 48
Z9 51
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 25
BP 5583
EP 5591
DI 10.1016/j.biomaterials.2004.01.017
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829ID
UT WOS:000222040300003
PM 15159074
DA 2018-10-19
ER

PT J
AU Klapperich, CM
   Bertozzi, CR
AF Klapperich, CM
   Bertozzi, CR
TI Global gene expression of cells attached to a tissue engineering
   scaffold
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; differential gene expression; oligonucleotide
   microarrays
ID PROBE LEVEL DATA; EXTRACELLULAR-MATRIX; CXC CHEMOKINES; DESIGN
   PRINCIPLES; EPITHELIAL-CELLS; SKIN SUBSTITUTES; ARTIFICIAL SKIN;
   COLLAGEN GELS; ANGIOGENESIS; CONTRACTION
AB A goal of tissue engineering is to produce a scaffold material that will guide cells to differentiate and regenerate functional replacement tissue at the site Of injury. Little is known about how cells respond on a molecular level to tissue engineering scaffold materials. In this work we used oligonucleotide microarrays to interrogate gene expression profiles associated with cell-biomaterial interactions. We seeded collagen-glycosaminoglycan meshes, a widely used tissue engineering scaffold material. with human IMR-90 fibroblasts and compared transcript levels with control cells grown on tissue Culture polystyrene. Genes involved in cell signaling, extracellular matrix remodeling, inflammation, angiogenesis and hypoxia were all activated in cells on the collagen-GAG mesh. Understanding the impact of a scaffold on attached cells will facilitate the design of improved tissue engineering materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.
RP Klapperich, CM (reprint author), Boston Univ, Dept Mfg, Boston, MA 02215 USA.
EM catherin@bu.edu
RI Klapperich, Catherine/D-5533-2011
OI Klapperich, Catherine/0000-0001-6103-849X
CR Alberts B, 2002, MOL BIOL CELL
   Bard J, 2003, BIOESSAYS, V25, P501, DOI 10.1002/bies.10260
   Barzansky B, 2002, JAMA-J AM MED ASSOC, V288, P1067, DOI 10.1001/jama.288.9.1067
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   BELLOWS CG, 1981, J CELL SCI, V50, P299
   Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   Boyce ST, 2001, BURNS, V27, P523, DOI 10.1016/S0305-4179(01)00019-5
   Breen EC, 1999, AM J RESP CELL MOL, V21, P746, DOI 10.1165/ajrcmb.21.6.3312
   Cheresh DA, 2002, NAT MED, V8, P193, DOI 10.1038/nm0302-193
   Chiquet M, 1996, BIOCHEM CELL BIOL, V74, P737, DOI 10.1139/o96-080
   Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098
   Coulomb B, 2002, WOUND REPAIR REGEN, V10, P109, DOI 10.1046/j.1524-475X.2002.02104.x
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Edwards JCW, 2000, ARTHRITIS RES, V2, P344, DOI 10.1186/ar110
   Feng Z, 2003, ARTIF ORGANS, V27, P84, DOI 10.1046/j.1525-1594.2003.07187.x
   Freyman TM, 2001, BIOMATERIALS, V22, P2883, DOI 10.1016/S0142-9612(01)00034-5
   Gerritsen ME, 2003, MICROCIRCULATION, V10, P63, DOI 10.1038/sj.mn.7800170
   Gorter A, 1999, IMMUNOL TODAY, V20, P576, DOI 10.1016/S0167-5699(99)01537-6
   Griendling KK, 1999, CIRC RES, V85, P562, DOI 10.1161/01.RES.85.6.562
   Hogaboam CM, 1999, FASEB J, V13, P1565
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Janeway CA, 2001, IMMUNOBIOLOGY 5 IMMU
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Keane MP, 1999, CHEST, V116, p93S, DOI 10.1378/chest.116.suppl_1.93S
   Kimura K, 2002, BIOCHEM BIOPH RES CO, V294, P359, DOI 10.1016/S0006-291X(02)00493-X
   Kuberka M, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P485, DOI 10.1515/bmte.2002.47.s1a.485
   Lafrenie RM, 1998, J CELL PHYSIOL, V175, P163, DOI 10.1002/(SICI)1097-4652(199805)175:2<163::AID-JCP6>3.0.CO;2-M
   Lam K, 2001, J CELL PHYSIOL, V189, P79, DOI 10.1002/jcp.1142
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121
   Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667
   LU L, 2001, CLIN ORTHOP S, V391, pS251
   Maulik N, 2002, FREE RADICAL BIO MED, V33, P1047, DOI 10.1016/S0891-5849(02)01005-5
   Moyer KE, 2002, J CELL PHYSIOL, V193, P173, DOI 10.1002/jcp.10160
   Ochoa ER, 2002, ANN NY ACAD SCI, V979, P10, DOI 10.1111/j.1749-6632.2002.tb04863.x
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   SAITO H, 1995, EXP CELL RES, V217, P272, DOI 10.1006/excr.1995.1087
   Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200
   Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7
   Woessner JF, 2001, J CLIN INVEST, V108, P799, DOI 10.1172/JCI200113709
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200
NR 56
TC 44
Z9 46
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 25
BP 5631
EP 5641
DI 10.1016/j.biomaterials.2004.01.025
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829ID
UT WOS:000222040300008
PM 15159079
DA 2018-10-19
ER

PT J
AU Chen, PR
   Ming, MH
   Sun, JS
   Chen, MH
   Tsai, CC
   Lin, FH
AF Chen, PR
   Ming, MH
   Sun, JS
   Chen, MH
   Tsai, CC
   Lin, FH
TI Biocompatibility of NGF-grafted GTG membranes for peripheral nerve
   repair using cultured Schwann cells
SO BIOMATERIALS
LA English
DT Article
DE biodegradable nerve conduit; gelatin; Schwann cell; nerve growth factor
ID GROWTH-FACTOR; COLORIMETRIC ASSAY; COLLAGEN TUBES; SCIATIC-NERVE;
   REGENERATION; RAT; INVITRO; GUIDE; PROLIFERATION; OSTEOBLASTS
AB We previously developed a biodegradable composite with potentially good biocompatibility composed by tricalcium phosphate and glutaraldehyde cross-linking gelatin (GTG) with good mechanical property feasible for surgical manipulation. The purpose of this study was to evaluate the feasibility of immobilizing nerve growth factor (NGF) onto the composite (GTG) with carbodiimide (GEN composite). Cultured Schwann cells were seeded onto the GTG and GEN composites. For comparison, GTG membrane soaked in NGF solution without carbodiimide (GN composite) as cross-linking agent was also used to culture Schwann cells. Cell morphology was observed by a scanning electron microscope. Cell survival, cytotoxicity and cellular metabolism on the NGF-grafted GTG membrane were assessed quantitatively in terms of cell protein content, leakage of cytosolic lactate dehydrogenase (LDH) activity and by the well-established MTT assay, respectively. The result of LDH study did not show significant difference among GTG. NGF-modified GTG and control group. This indicated that GTG composite, whether cross-linking with NGF or not, has little cytotoxic effect. Comparing the protein content and MTT assay among GEN, GN composite and control group, the data confirmed more attachment of Schwann cells on GEN composite. Although GTG cross-linking with NGF did not promote Schwann cell proliferation. the techniques we used in this study provided a method to fabricate a novel biomaterial incorporation of Schwann cells and covalently immobilized NGF. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Taiwan Univ Hosp, Dept Biomed Engn, Taipei, Taiwan.
   Natl Taiwan Univ, Coll Med, Coll Engn, Inst Biomed Engn, Tiapei, Taiwan.
   Cathay Gen Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.
   Yunlin Hosp, Dept Orthopaed, Yunlin, Taiwan.
   Far Eastern Mem Hosp, Dept Med, Taipei, Taiwan.
   Far Eastern Mem Hosp, Dept Pathol, Taipei, Taiwan.
RP Lin, FH (reprint author), Natl Taiwan Univ Hosp, Dept Biomed Engn, Taipei, Taiwan.
EM double@ha.mc.ntu.edu.tw
RI Lin, Feng-Huei/E-3970-2010
OI SUN, JUI-SHENG/0000-0001-5142-8777
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   AMADOR E, 1963, CLIN CHEM, V9, P391
   ANUFORO DC, 1978, IN VITRO CELL DEV B, V14, P981
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   BOSCH EP, 1989, J NEUROSCI, V9, P3690
   BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9
   Brown RE, 1996, J RECONSTR MICROSURG, V12, P149, DOI 10.1055/s-2007-1006468
   COLIN W, 1984, J DENT RES, V63, P987, DOI 10.1177/00220345840630071601
   DENDUNNEN WFA, 1993, J MATER SCI-MATER M, V4, P521, DOI 10.1007/BF00120133
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Hanthamrongwit M, 1996, BIOMATERIALS, V17, P775, DOI 10.1016/0142-9612(96)81414-1
   HE CL, 1992, MICROSURG, V13, P151, DOI 10.1002/micr.1920130310
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   KEELEY R, 1993, RESTOR NEUROL NEUROS, V5, P353, DOI 10.3233/RNN-1993-55606
   Laemmel E, 1998, J BIOMED MATER RES, V39, P446, DOI 10.1002/(SICI)1097-4636(19980305)39:3<446::AID-JBM14>3.0.CO;2-8
   LEVI ADO, 1994, J NEUROSCI, V14, P1309
   Lin FH, 2003, BIOMATERIALS, V24, P2413, DOI 10.1016/S0142-9612(03)00031-0
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nicoli Aldini N., 1996, Biomaterials, V17, P959
   OHNISHI ST, 1978, ANAL BIOCHEM, V86, P193, DOI 10.1016/0003-2697(78)90334-2
   Peppas NA, 1996, BIOMATERIALS SCI, P63
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5
   RIDLEY AJ, 1989, J CELL BIOL, V109, P3419, DOI 10.1083/jcb.109.6.3419
   ROBINSON PH, 1991, MICROSURG, V12, P412, DOI 10.1002/micr.1920120608
   SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   SUGANUMA J, 1993, J APPL BIOMATER, V4, P13, DOI 10.1002/jab.770040103
   TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094
   TOUNTAS CP, 1993, J APPL BIOMATER, V4, P261, DOI 10.1002/jab.770040308
   Whitworth IH, 1996, J HAND SURG-BRIT EUR, V21B, P514, DOI 10.1016/S0266-7681(96)80058-1
NR 45
TC 33
Z9 36
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 25
BP 5667
EP 5673
DI 10.1016/j.biomaterials.2004.01.052
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829ID
UT WOS:000222040300012
PM 15159083
DA 2018-10-19
ER

PT J
AU Gorbet, MB
   Sefton, MV
AF Gorbet, MB
   Sefton, MV
TI Biomaterial-associated thrombosis: roles of coagulation factors,
   complement, platelets and leukocytes
SO BIOMATERIALS
LA English
DT Review
DE leukocytes; tissue factor; CD11b; platelets; biomaterials; complement
   activation; thrombosis; coagulation
ID SIMULATED EXTRACORPOREAL-CIRCULATION; COATED CARDIOPULMONARY BYPASS;
   TISSUE FACTOR EXPRESSION; GLYCOPROTEIN IIB/IIIA RECEPTOR; MONOCYTE
   PROCOAGULANT ACTIVITY; ADHESION MOLECULE EXPRESSION; OXYGEN SPECIES
   PRODUCTION; FACTOR PATHWAY INHIBITOR; MEMBRANE ATTACK COMPLEX; EX-VIVO
   HEMODIALYSIS
AB Our failure to produce truly non-thrombogenic materials may reflect a failure to fully understand the mechanisms of biomaterial-associated thrombosis. The community has focused on minimizing coagulation or minimizing platelet adhesion and activation. We have infrequently considered the interactions between the two although we are generally familiar with these interactions. However, we have rarely considered in the context of biomaterial-associated thrombosis the other major players in blood: complement and leukocytes. Biomaterials are known agonists of complement and leukocyte activation, but this is frequently studied only in the context of inflammation. For us, thrombosis is a special case of inflammation. Here we summarize current perspectives on all four of these components in thrombosis and with biomaterials and cardiovascular devices. We also briefly highlight a few features of biomaterial-associated thrombosis that are not often considered in the biokmaterials literature:
   The importance of tissue factor and the extrinsic coagulation system.
   Complement activation as a prelude to platelet activation and its role in thrombosis.
   The role of leukocytes in thrombin formation.
   The differing time scales of these contributions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, 4 Taddle Creek Rd,Room 407D, Toronto, ON M5S 3G9, Canada.
EM sefton@chem-eng.utoronto.ca
CR Agostoni A, 1989, J Biomater Appl, V4, P102, DOI 10.1177/088532828900400202
   ALLAN R, 1979, INT ARCH ALLER A IMM, V58, P140, DOI 10.1159/000232186
   ALTIERI DC, 1995, SEMIN CELL BIOL, V6, P269, DOI 10.1006/scel.1995.0036
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ANDREWS JM, 1978, J MED CHEM, V21, P1202, DOI 10.1021/jm00210a006
   [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Bahra P, 1998, J LAB CLIN MED, V132, P223, DOI 10.1016/S0022-2143(98)90171-8
   Bailly AL, 1996, J BIOMED MATER RES, V30, P101, DOI 10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R
   Barstad RM, 1998, THROMB HAEMOSTASIS, V79, P302
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   BAUER KA, 1995, WILLIAMS HEMATOLOGY, P1239
   Baufreton C, 1997, ANN THORAC SURG, V63, P50
   BAZZONI G, 1992, PHARMACOL RES, V26, P269, DOI 10.1016/1043-6618(92)90214-V
   BICK RL, 1992, DISORDERS THROMBOSIS, P195
   BING DH, 1970, J IMMUNOL, V105, P1289
   Bittl JA, 1996, J AM COLL CARDIOL, V28, P368, DOI 10.1016/0735-1097(96)00183-0
   BLAJCHMAN MA, 1986, PROG HEMATOL, V14, P149
   Blezer R, 1998, THROMB HAEMOSTASIS, V79, P296
   BLOCKMANS D, 1995, BLOOD REV, V9, P143, DOI 10.1016/0268-960X(95)90020-9
   Bluestein D, 2000, J BIOMECH ENG-T ASME, V122, P125, DOI 10.1115/1.429634
   BOISCLAIR MD, 1993, BLOOD, V82, P3350
   BOISCLAIR MD, 1993, BLOOD COAGUL FIBRIN, V4, P1007, DOI 10.1097/00001721-199304060-00017
   BRUIL A, 1995, POLYM BIOMATERIALS S, P357
   BURMAN JF, 1994, LANCET, V344, P1192, DOI 10.1016/S0140-6736(94)90509-6
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1
   Camerer E, 1996, THROMB RES, V81, P1, DOI 10.1016/0049-3848(95)00209-X
   Cameron D, 1996, J CARDIOVASC PHARM, V27, pS1
   CASKO G, 1988, THROMB HAEMOSTASIS, V59, P375
   CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2
   CASTIGLIONE A, 1991, NEPHROL DIAL TRANSPL, V6, P31
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHEUNG AK, 1991, KIDNEY INT, V40, P1123, DOI 10.1038/ki.1991.324
   CHINN JA, 1992, BIOMATERIALS, V13, P322, DOI 10.1016/0142-9612(92)90057-U
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   Chung JH, 1996, CIRCULATION, V93, P2014, DOI 10.1161/01.CIR.93.11.2014
   Clagett GP, 1994, HEMOSTASIS THROMBOSI, P1486
   Coller BS, 1996, HAEMOSTASIS, V26, P285
   COLMAN RW, 1993, CARDIOVASC PATHOL, V2, pS23
   COOKE ED, 1977, LANCET, V2, P797
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Cote AV, 2001, MAYO CLIN PROC, V76, P890
   Cox D, 1996, THROMB HAEMOSTASIS, V75, P503
   COX D, 1992, THROMB HAEMOSTASIS, V68, P731
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   CRISTOL JP, 1994, NEPHROL DIAL TRANSPL, V9, P389
   Defraigne JO, 2000, ANN THORAC SURG, V69, P1084, DOI 10.1016/S0003-4975(00)01093-6
   DELMASCHIO A, 1993, ANN HEMATOL, V67, P23, DOI 10.1007/BF01709662
   DELMASCHIO A, 1989, BRIT J HAEMATOL, V72, P329
   EBERHART RC, 1991, SEMIN HEMATOL, V28, P42
   Edens R, 1993, COMPLEMENT PROFILES, P96
   Edmunds LH, 1996, TEX HEART I J, V23, P24
   ELAM JH, 1992, BIOMATERIALS, V13, P3, DOI 10.1016/0142-9612(92)90086-4
   ELHABBAL MH, 1995, CARDIOVASC RES, V29, P102, DOI 10.1016/0008-6363(96)88553-1
   ELLIS SG, 1991, J AM COLL CARDIOL, V17, pB89
   ENDERS G, 1995, INFECT IMMUN, V63, P2473
   *EPIC INV, 1994, NEW ENGL J MED, V330, P956
   Eriksson C, 2001, J LAB CLIN MED, V137, P296, DOI 10.1067/mlc.2001.114066
   Ernofsson M, 1997, J THORAC CARDIOV SUR, V113, P576, DOI 10.1016/S0022-5223(97)70373-8
   ESMON CT, 1995, SEMIN CELL BIOL, V6, P257, DOI 10.1006/scel.1995.0034
   ESMON CT, 1997, HEMOSTASIS THROMBOSI, P1597
   Finn A, 1996, J THORAC CARDIOV SUR, V111, P451, DOI 10.1016/S0022-5223(96)70456-7
   Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499
   Fosse E, 1997, EUR J CARDIO-THORAC, V11, P320, DOI 10.1016/S1010-7940(96)01062-7
   FRERING B, 1994, J THORAC CARDIOV SUR, V108, P636
   FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3
   GAWAZ M, 1994, CLIN INVESTIGATOR, V72, P424
   Geiser T, 1998, STROKE, V29, P1770, DOI 10.1161/01.STR.29.9.1770
   GEMMELL CH, 1990, MICROVASC RES, V40, P327, DOI 10.1016/0026-2862(90)90031-L
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Gemmell CH, 2000, J BIOMAT SCI-POLYM E, V11, P1197, DOI 10.1163/156856200744273
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P176, DOI 10.1002/(SICI)1097-4636(199711)37:2<176::AID-JBM5>3.3.CO;2-Z
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   Gemmell CH, 1998, J LAB CLIN MED, V131, P84, DOI 10.1016/S0022-2143(98)90081-6
   Gemmell CH, 1998, J BIOMED MATER RES, V42, P611, DOI 10.1002/(SICI)1097-4636(19981215)42:4<611::AID-JBM18>3.0.CO;2-D
   GEMMELL CH, 1986, J BIOMED MATER RES, V32, P29
   GILLINOV AM, 1993, ANN THORAC SURG, V55, P619, DOI 10.1016/0003-4975(93)90264-I
   GILLINOV AM, 1993, ANN THORAC SURG, V56, P847, DOI 10.1016/0003-4975(93)90342-F
   GILLINOV AM, 1994, ANN THORAC SURG, V57, P345, DOI 10.1016/0003-4975(94)90995-4
   Gillis S, 1997, SEMIN HEMATOL, V34, P336
   GINIS I, 1990, BLOOD, V76, P1233
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   GORBET MB, 2001, THESIS U TORONTON
   GORBET MB, UNPUB LEUKOCYTE ACTI
   GORBET MB, UNPUB J BIOMED MAT R
   Gorman RC, 1996, J THORAC CARDIOV SUR, V111, P1, DOI 10.1016/S0022-5223(96)70395-1
   Grooteman MPC, 1997, NEPHROL DIAL TRANSPL, V12, P492, DOI 10.1093/ndt/12.3.492
   Grooteman MPC, 2000, NEPHRON, V85, P267, DOI 10.1159/000045671
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Gustafsson D, 2003, THROMB RES, V109, pS9, DOI 10.1016/S0049-3848(03)00249-4
   HAAGWEBER M, 1989, ARTIF ORGANS, V13, P92, DOI 10.1111/j.1525-1594.1989.tb02842.x
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HAKIM RM, 1985, AM J MED, V78, P575, DOI 10.1016/0002-9343(85)90398-5
   Hans D, 1993, Eur J Med, V2, P157
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   Hanson SR, 1998, AM HEART J, V135, pS132, DOI 10.1016/S0002-8703(98)70241-8
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1985, J CLIN INVEST, V75, P1591, DOI 10.1172/JCI111865
   HAUPTMANN J, 1977, BIOCHEM PHARMACOL, V26, P325, DOI 10.1016/0006-2952(77)90185-X
   Hernandez MR, 1997, HAEMATOLOGICA, V82, P566
   HERZLINGER GA, 1980, ASAIO T, V36, P165
   HIGUCHI DA, 1992, BLOOD, V79, P1712
   HIMMELFARB J, 1991, AM J KIDNEY DIS, V17, P271, DOI 10.1016/S0272-6386(12)80473-2
   HIMMELFARB J, 1994, AM J KIDNEY DIS, V24, P901, DOI 10.1016/S0272-6386(12)81058-4
   HIMMELFARB J, 1995, J LAB CLIN MED, V126, P392
   HIRSH J, 1991, NEW ENGL J MED, V324, P1865
   HIRSH J, 1995, CHEST, V108, pS258, DOI 10.1378/chest.108.4_Supplement.258S
   HIRSH J, 1996, ACUTE MYOCARDIAL INF
   HIRTHLER M, 1992, J PEDIATR SURG, V27, P1199, DOI 10.1016/0022-3468(92)90787-8
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   Holme PA, 1998, THROMB HAEMOSTASIS, V79, P389
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HORL WH, 1986, CLIN NEPHROL, V26, pS30
   INQUE T, 1996, J AM COLL CARDIOL, V28, P1127
   IP WF, 1991, J BIOMED MATER RES, V25, P1321, DOI 10.1002/jbm.820251012
   IRVINE L, 1991, T AM SOC ART INT ORG, V37, P569
   Janvier G, 1996, ANN THORAC SURG, V62, P1926, DOI 10.1016/S0003-4975(96)00942-3
   JETSY J, 1995, WILLIAMS HEMATOLOGY, P1227
   Jobes DR, 1998, J CARDIOTHOR VASC AN, V12, P17
   Johnson R. J., 1996, BIOMATERIALS SCI, P173
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Jones DA, 1996, BIOMATERIALS, V17, P337, DOI 10.1016/0142-9612(96)85572-4
   Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   KAPLAN SS, 2000, J BIOMED MATER RES, V28, P377
   KAPPELMAYER J, 1993, CIRC RES, V72, P1075, DOI 10.1161/01.RES.72.5.1075
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Khabar KSA, 1997, CLIN IMMUNOL IMMUNOP, V85, P97, DOI 10.1006/clin.1997.4413
   KHAZAZMI A, 1989, J THORAC CARDIOVASC, V98, P381
   Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   Kuijper PHM, 1997, BLOOD, V89, P166
   Kuijper PHM, 1996, BLOOD, V87, P3271
   Kuijper PHM, 1997, BLOOD, V89, P2131
   KUIJPERS TW, 1990, J IMMUNOL, V145, P2588
   KUWAHARA T, 1989, ARTIF ORGANS, V13, P427
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   LAUDESHARP M, 1990, KIDNEY INT, V38, P1089, DOI 10.1038/ki.1990.317
   LAWSON JH, 1994, J BIOL CHEM, V269, P23357
   LEMKE HD, 1994, NEPHROL DIAL TRANSPL, V9, P90
   Levy M, 1996, INT J CARDIOL, V53, pS81, DOI 10.1016/0167-5273(96)02611-3
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   LLANOS GR, 1993, J BIOMED MATER RES, V27, P1383, DOI 10.1002/jbm.820271105
   LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V
   MAKONI SN, 2002, HEART, V86, pC18
   Marcus A. J., 1996, ATHEROSCLEROSIS CORO, P607
   MARCUS AJ, 1994, SEMIN HEMATOL, V31, P261
   Matata BM, 1996, J BIOMED MATER RES, V31, P63, DOI 10.1002/(SICI)1097-4636(199605)31:1<63::AID-JBM8>3.0.CO;2-O
   May AE, 1999, THROMB HAEMOSTASIS, V82, P962
   May AE, 1997, EUR HEART J, V18, P1913
   MCGEE MP, 1994, J EXP MED, V179, P1847, DOI 10.1084/jem.179.6.1847
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Melder RJ, 1995, BIOPHYS J, V69, P2131, DOI 10.1016/S0006-3495(95)80087-1
   Mickelson JK, 1999, J AM COLL CARDIOL, V33, P97, DOI 10.1016/S0735-1097(98)00532-4
   Mickelson JK, 1996, J AM COLL CARDIOL, V28, P345, DOI 10.1016/0735-1097(96)00164-7
   Misoph M, 1998, THORAC CARDIOV SURG, V46, P222, DOI 10.1055/s-2007-1010229
   Moen O, 1997, ANN THORAC SURG, V63, P105
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   MORRISSEY JH, 1993, BLOOD, V81, P734
   Muehrcke DD, 1996, J THORAC CARDIOV SUR, V112, P472, DOI 10.1016/S0022-5223(96)70275-1
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   Murkin JM, 1997, J CARDIOTHOR VASC AN, V11, P19, DOI 10.1016/S1053-0770(97)80006-7
   NEMERSON Y, 1996, HYPERCOAGULABLE STAT, P21
   Neumann FJ, 1996, J AM COLL CARDIOL, V27, P819, DOI 10.1016/0735-1097(95)00563-3
   Nieuwland R, 1997, CIRCULATION, V96, P3534
   NILSSON L, 1990, J THORAC CARDIOV SUR, V100, P777
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   NOVOTNY WF, 1988, BLOOD, V72, P2020
   OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M
   ODA A, 1995, THROMB HAEMOSTASIS, V74, P736
   OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260
   PABST MJ, 1994, IMMUNOPHARMACOLOGY N, P195
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   Parratt R, 1998, BRIT J HAEMATOL, V101, P40, DOI 10.1046/j.1365-2141.1998.00674.x
   PEARSON FC, 1985, BACTERIAL ENDOTOXINS, P251
   Peek GJ, 1999, ASAIO J, V45, P250, DOI 10.1097/00002480-199907000-00003
   Peerschke EIB, 1998, IMMUNOBIOLOGY, V199, P239, DOI 10.1016/S0171-2985(98)80030-2
   PHILIPS MR, 1988, J CLIN INVEST, V82, P495, DOI 10.1172/JCI113623
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rand MD, 1996, BLOOD, V88, P3432
   Rao AK, 1999, THROMB HAEMOSTASIS, V82, P140
   RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   REBUCK N, 1994, FEMS IMMUNOL MED MIC, V8, P189, DOI 10.1111/j.1574-695X.1994.tb00442.x
   REDMOND JM, 1993, ANN THORAC SURG, V56, P474, DOI 10.1016/0003-4975(93)90882-I
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rinder C, 1996, J CARDIOVASC PHARM, V27, pS6
   RINDER CS, 1992, BLOOD, V79, P1201
   Rinder CS, 1999, CIRCULATION, V100, P553, DOI 10.1161/01.CIR.100.5.553
   Rinder CS, 1999, J THORAC CARDIOV SUR, V118, P460, DOI 10.1016/S0022-5223(99)70183-2
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   RINDER HM, 1991, BLOOD, V78, P1730
   RINDER HM, 1994, THROMB HAEMOSTASIS, V72, P750
   ROCKE DA, 1987, J THORAC CARDIOV SUR, V93, P832
   Rousseau Y, 1999, BIOMATERIALS, V20, P1959, DOI 10.1016/S0142-9612(99)00101-5
   RUBENS FD, 1993, THROMB HAEMOSTASIS, V69, P130
   Schmaier AH, 1997, THROMB HAEMOSTASIS, V78, P101
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   SENGELOV H, 1995, CRIT REV IMMUNOL, V15, P107, DOI 10.1615/CritRevImmunol.v15.i2.10
   Serrano CV, 1997, J AM COLL CARDIOL, V29, P1276, DOI 10.1016/S0735-1097(97)00070-3
   SERRUYS PW, 1991, J AM COLL CARDIOL, V17, pB143
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   Siljander P, 1996, BLOOD, V87, P4651
   SIMON P, 1987, NEPHRON, V45, P172, DOI 10.1159/000184109
   SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037
   SIMS PJ, 1989, PLATELET IMMUNOBIOLO, P354
   SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672
   SPINLER SA, 2002, ANN PHARM, V35, P589
   STAHL RF, 1991, J THORAC CARDIOV SUR, V101, P230
   STEGMAYR BG, 1992, INT J ARTIF ORGANS, V15, P10
   SUBBARAO K, 1979, BIOCHEM PHARMACOL, V28, P531, DOI 10.1016/0006-2952(79)90248-X
   Sundaram S, 1996, THROMB HAEMOSTASIS, V75, P76
   TAKADA Y, 1978, IMMUNOLOGY, V34, P509
   Takala AJ, 1996, SCAND J THORAC CARD, V30, P141, DOI 10.3109/14017439609107259
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANS G, 1991, BLOOD, V77, P2641
   Thylen P, 1996, INT J ARTIF ORGANS, V19, P156
   Tielemans C, 1996, KIDNEY INT, V49, P236, DOI 10.1038/ki.1996.33
   TOOMBS CF, 1995, J PHARMACOL EXP THER, V275, P941
   Topol EJ, 2002, AM J MED, V113, P1, DOI 10.1016/S0002-9343(02)01145-2
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   TULUNAY M, 1993, ANAESTH INTENS CARE, V21, P50
   Turitto VT, 1998, THROMB RES, V92, pS25, DOI 10.1016/S0049-3848(98)00157-1
   TURITTO VT, 1980, MICROVASC RES, V19, P352, DOI 10.1016/0026-2862(80)90054-0
   van der Wieken L R, 1999, Semin Interv Cardiol, V4, P77
   VANBEUSEKOM HMM, 1993, J AM COLL CARDIOL, V21, P45, DOI 10.1016/0735-1097(93)90715-D
   VANDERKAMP KWHJ, 1994, J BIOMED MATER RES, V28, P349, DOI 10.1002/jbm.820280309
   VANDERKAMP KWHJ, 1995, J BIOMED MATER RES, V29, P1303, DOI 10.1002/jbm.820291018
   VANGINKEL CJW, 1977, BRIT J HAEMATOL, V37, P35
   Vertrees R A, 1994, ASAIO J, V40, pM554, DOI 10.1097/00002480-199407000-00060
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P794, DOI 10.1016/S0022-5223(99)70301-6
   VIDEM V, 1992, ANN THORAC SURG, V54, P725, DOI 10.1016/0003-4975(92)91018-5
   von Appen K, 1994, ASAIO J, V40, pM609, DOI 10.1097/00002480-199407000-00071
   WACHTFOGEL YT, 1987, BLOOD, V69, P324
   WACHTFOGEL YT, 1994, THROMB HAEMOSTASIS, V72, P843
   WACHTFOGEL YT, 1993, J THORAC CARDIOV SUR, V106, P1
   Wachtfogel YT, 1998, THROMB HAEMOSTASIS, V80, P686
   Ware J. A., 1995, WILLIAMS HEMATOLOGY, P1161
   Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742
   WEILY HS, 1974, NEW ENGL J MED, V290, P534, DOI 10.1056/NEJM197403072901002
   WEINGARTEN R, 1993, J LEUKOCYTE BIOL, V53, P518
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Wilhelm CR, 1998, ANN THORAC SURG, V65, P1071, DOI 10.1016/S0003-4975(98)00111-8
   WRIGHT SD, 1991, J EXP MED, V173, P1281, DOI 10.1084/jem.173.5.1281
   YEO EL, 1994, BLOOD, V83, P2498
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 256
TC 692
Z9 709
U1 14
U2 204
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 26
BP 5681
EP 5703
DI 10.1016/j.biomaterials.2004.01.023
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829QL
UT WOS:000222064600001
PM 15147815
DA 2018-10-19
ER

PT J
AU Eisenbarth, E
   Velten, D
   Muller, M
   Thull, R
   Breme, J
AF Eisenbarth, E
   Velten, D
   Muller, M
   Thull, R
   Breme, J
TI Biocompatibility of beta-stabilizing elements of titanium alloys
SO BIOMATERIALS
LA English
DT Review
DE beta-titanium alloy; biocompatibility; cell morphology; osteoblast
ID CORROSION BEHAVIOR; PURE TITANIUM; IMPLANTS; NIOBIUM; BONE; FIBROBLASTS;
   CYTOTOXICITY; TI-6AL-7NB; PASSIVITY; TANTALUM
AB In comparison to the presently used alpha + beta titanium alloys for biomedical applications, beta-titanium alloys have many advantageous mechanical properties, such as an improved wear resistance, a high elasticity and an excellent cold and hot formability. This will promote their future increased application as materials for orthopaedic joint replacements. Not all elements with beta-stabilizing properties in titanium alloys are suitable for biomaterial applications-corrosion and wear processes cause a release of these alloying elements to the surrounding tissue. In this investigation, the biocompability of alloying elements for beta- and near beta-titanium alloys was tested in order to estimate their suitability for biomaterial components. Titanium (grade 2) and the implant steel X2CrNiMo18153 (AISI 316 L) were tested as reference materials. The investigation included the corrosion properties of the elements, proliferation, mitochondrial activity, cell morphology and the size of MC3T3-E1 cells and GM7373 cells after 7 days incubation in direct contact with polished slices of the metals. The statistical significance was considered by Weir-test and Lord-test (alpha = 0.05). The biocompatibility range of the investigated metals is (decreasing biocompatibility): niobium-tantalum, titanium, zirconium-aluminium-316 L-molybdenum. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
   Univ Wurzburg, Lehrstuhl Funkt Swerkstoffe Med & Zahnmed, D-97070 Wurzburg, Germany.
RP Eisenbarth, E (reprint author), Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
EM e.eisenbarth@mx.uni-saarland.de
CR BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   BRUNETTE DM, 2001, TITANIUM MED MAT SCI, P174
   COLLINGS EW, 1994, TITANIUM ALLOYS MAT, P3
   EISENBARTH E, 2001, BIOMATERIALIEN, V2
   Helsen J. A., 1998, METALS BIOMATERIALS, P30
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Jonsson AK, 2002, THIN SOLID FILMS, V402, P242, DOI 10.1016/S0040-6090(01)01715-1
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P625, DOI 10.1023/A:1008927407556
   Messer RLW, 1999, DENT MATER, V15, P1, DOI 10.1016/S0109-5641(99)90023-4
   Messer RLW, 1999, BIOMATERIALS, V20, P1647, DOI 10.1016/S0142-9612(99)00044-7
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.3.CO;2-3
   Okazaki Y, 1998, MATER T JIM, V39, P1063, DOI 10.2320/matertrans1989.39.1063
   OKAZAKI Y, 2000, ADV ENG MATER, V2, pS278
   Peuster M, 2003, BIOMATERIALS, V24, P4057, DOI 10.1016/S0142-9612(03)00274-6
   Pypen CMJM, 1998, J MATER SCI-MATER M, V9, P761, DOI 10.1023/A:1008919422520
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   ROSENBERG HW, 1970, P 1 INT C TIT, P851
   SACHS L, 1984, ANGEWANDTE STAT
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   TANGVALL P, 2001, J BIOMED MATER RES, V57, P285
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   UNGERSBOCK A, 1994, J MATER SCI-MATER M, V5, P788, DOI 10.1007/BF00213136
   VELTEN D, 2003, Z METALLKD, V94, P6
   Wack T, 1999, MATER SCI FORUM, V299-3, P348, DOI 10.4028/www.scientific.net/MSF.299-300.348
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   ZITTER H, 1988, WERKST KORROS, V39, P574, DOI 10.1002/maco.19880391204
   Zwicker R, 1980, P 4 INT C TIT KYOT J, P505
NR 37
TC 369
Z9 382
U1 7
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 26
BP 5705
EP 5713
DI 10.1016/j.biomaterials.2004.01.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829QL
UT WOS:000222064600002
PM 15147816
DA 2018-10-19
ER

PT J
AU Cho, JH
   Kim, SH
   Park, KD
   Jung, MC
   Yang, WI
   Han, SW
   Noh, JY
   Lee, JW
AF Cho, JH
   Kim, SH
   Park, KD
   Jung, MC
   Yang, WI
   Han, SW
   Noh, JY
   Lee, JW
TI Chondrogenic differentiation of human mesenchymal stem cells using a
   thermosensitive poly(N-isopropylacrylamide) and water-soluble chitosan
   copolymer
SO BIOMATERIALS
LA English
DT Article
DE thermally responsive material; chitosan; mesenchymal stem cell; sol-gel
   technique; poly(N-isopropylarcylamide)
ID DRUG-DELIVERY SYSTEMS; BIODEGRADABLE POLYMERS; VESICOURETERAL REFLUX;
   GEL; TEMPERATURE; TRANSITION; HYDROGELS; COLLAGEN; CULTURE
AB Poly(N-isopropylacrylamide) (PNIPAAm) is known to be thermally responsive material and has a lower critical Solution temperature (LCST, 32degreesC) at which a macromolecular transition from a hydrophilic to a hydrophobic structure occurs. Chitosan is a useful natural polymeric biomaterial due to its biocompatibility and biodegradable properties. It has good characteristics for cell attachment, proliferation and viability. The aim of this study was to assess the ability to differentiate from mesenchymal stem cells (MSCs) to chondrocytes and mass formation using a newly developed injectable material, a thermosensitive (water-soluble chitosan-g-PNIPAAm) gel, and evaluate cartilage formation in vivo after injecting a cell-thermosensitive gel complex.
   The MSCs were cultured in the chitosan-PNIPAAm in vitro. Fluorescence-activated cell sort analysis, viability test, collagen type I, II, X formation and the aggrecan levels were examined. These Cultured cells can be easily recovered from a copolymer gel by simply lowering the temperature. An animal study was performed to assess cartilage formation in the submucosal layer of the bladder of rabbits. The cartilage formation Could be detected. This can be used to treat vesicoureteral reflux or reflux esophagitis by the effective mass effect. This is a simple method (sol-gel technique in LCST), and good cartilage formation occurs in the bladder tissue. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Yonsei Univ, Coll Med, Dept Orthopaed Surg 29, Seoul 120752, South Korea.
   Ajou Univ, Coll Med, Dept Orthopaed Surg, Suwon 442749, South Korea.
   Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.
   Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea.
   Yonsei Univ, Coll Med, Dept Urol, Seoul 120752, South Korea.
   Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
RP Lee, JW (reprint author), Yonsei Univ, Coll Med, Dept Orthopaed Surg 29, CPO Box 8044, Seoul 120752, South Korea.
EM ljwos@yumc.yonsci.ac.kr
CR An YH, 2001, ANAT REC, V263, P336, DOI 10.1002/ar.1114
   Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CILENTO BG, 1995, DIALOGUES PEDIAT URO, V18, P11
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREY P, 1995, J UROLOGY, V154, P804, DOI 10.1016/S0022-5347(01)67169-6
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Huard J, 2002, GENE THER, V9, P1617, DOI 10.1038/sj.gt.3301816
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Loty S, 1998, J BIOMED MATER RES, V42, P213, DOI 10.1002/(SICI)1097-4636(199811)42:2<213::AID-JBM6>3.0.CO;2-S
   Maeda Y, 2000, LANGMUIR, V16, P7503, DOI 10.1021/la0001575
   MALSTOM M, 1992, MACROMOLECULES, V25, P5440
   RICHARD TK, 2000, WORLD J UROL, V18, P51
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Vernon B, 1999, J BIOMAT SCI-POLYM E, V10, P183, DOI 10.1163/156856299X00126
   Yokoyama T, 2001, J UROLOGY, V165, P271, DOI 10.1097/00005392-200101000-00077
   YOSHIDA R, 1994, J BIOMAT SCI-POLYM E, V6, P585, DOI 10.1163/156856294X00536
NR 23
TC 167
Z9 178
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 26
BP 5743
EP 5751
DI 10.1016/j.biomaterials.2004.01.051
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829QL
UT WOS:000222064600006
PM 15147820
DA 2018-10-19
ER

PT J
AU Fini, M
   Giavaresi, G
   Torricelli, P
   Borsari, V
   Giardino, R
   Nicolini, A
   Carpi, A
AF Fini, M
   Giavaresi, G
   Torricelli, P
   Borsari, V
   Giardino, R
   Nicolini, A
   Carpi, A
TI Osteoporosis and biomaterial osteointegration
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE osteoporosis; biomaterial; osteointegration; cell cultures; animal
   models
ID TERM OVARIECTOMIZED SHEEP; MESENCHYMAL STEM-CELLS; OSTEOBLAST CULTURES;
   IN-VITRO; PROSTHETIC DEVICES; TITANIUM SCREWS; OSTEOPENIC BONE; FRACTURE
   REPAIR; RAT MODEL; IMPLANTS
AB Biomaterial osteointegration depends not only on the properties of the implanted material but also on the characteristics and regenerative capability of the host bone. For this reason, researchers involved in biomaterial evaluation now place great importance on the various pathologies often present in orthopaedic patients which can negatively affect the success of surgical implants. Osteoporosis is undoubtedly one of the most frequently encountered of such diseases. Models reproducing the osteoporotic condition can be useful to understand the influence of the pathology on cell behaviour, bone regeneration and osteointegration processes, thus increasing our basic knowledge and allowing the development of surgical techniques and implant biomaterials more suitable for use in the surgical treatment of fractures in osteoporotic patients. The present paper is a literature review and, after a short description of how the presence of osteoporosis could influence bone regenerative processes, the results of the main studies on biomaterial biocompatibility and osteointegration both in vitro and in vivo in the presence of osteoporotic condition are reported. Both cell cultures and animal models are able to demonstrate the different response of bone to biomaterials by comparing healthy and pathological conditions. The use of pathological bone-derived cells and pathological animals is therefore recommended to test candidate orthopaedic materials. (C) 2004 Elsevier SAS. All rights reserved.
C1 Rizzoli Orthopaed Inst, Dept Expt Surg, Res Inst Codivilla Putti, I-40136 Bologna, Italy.
   Univ Bologna, Chair Surg Pathophysiol, Bologna, Italy.
   Univ Pisa, Dept Internal Med, Pisa, Italy.
   Univ Pisa, Dept Reprod & Aging, Pisa, Italy.
RP Fini, M (reprint author), Rizzoli Orthopaed Inst, Dept Expt Surg, Res Inst Codivilla Putti, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM milena.fini@ior.it
RI Borsari, Veronica/D-1869-2017; Fini, Milena/J-4808-2016; TORRICELLI,
   PAOLA/J-5298-2016
OI Borsari, Veronica/0000-0002-6327-4653; Fini, Milena/0000-0002-3732-3570;
   TORRICELLI, PAOLA/0000-0001-7494-9970; Giavaresi,
   Gianluca/0000-0001-7843-5969; Nicolini, Andrea/0000-0002-5178-9510
CR Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P23
   Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P319
   Aldini NN, 2002, J ORTHOPAED RES, V20, P1217
   An YH, 1999, ANIMAL MODELS ORTHOP, P39
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bellino FL, 2000, MENOPAUSE, V7, P14, DOI 10.1097/00042192-200007010-00004
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   DAVIES JE, 1999, HISTODYNAMICS ENDOSS, P1
   Ding M, 2000, Acta Orthop Scand Suppl, V292, P1
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2001, ARTIF CELL BLOOD SUB, V29, P213, DOI 10.1081/BIO-100103045
   Fini M, 2001, J BONE JOINT SURG BR, V83B, P139, DOI 10.1302/0301-620X.83B1.10162
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   FINI M, IN PRESS J BIOMED MA
   Fujimoto T, 1998, INT J ORAL MAX IMPL, V13, P183
   Giavaresi G, 2001, J APPL ANIM RES, V20, P221, DOI 10.1080/09712119.2001.9706756
   Giavaresi G, 2001, INT J ARTIF ORGANS, V24, P814
   Goseki MS, 1996, J NUTR SCI VITAMINOL, V42, P55
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Hayashi K, 1989, J Arthroplasty, V4, P257, DOI 10.1016/S0883-5403(89)80022-1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   *ISO, 109936 ISO
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Kotani Y, 1996, SPINE, V21, P278, DOI 10.1097/00007632-199602010-00005
   Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1
   Lill CA, 2000, J ORTHOP TRAUMA, V14, P559, DOI 10.1097/00005131-200011000-00007
   Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8
   LOMRI A, 1990, J BONE MINER RES, V5, P1149
   MARIE PJ, 1989, J CLIN ENDOCR METAB, V69, P272, DOI 10.1210/jcem-69-2-272
   MCKANE WR, 1994, J BONE MINER RES, V9, P1313
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   NeidlingerWilke C, 1995, J BIOMECH, V28, P1411, DOI 10.1016/0021-9290(95)00089-5
   NEWMAN E, 1995, BONE, V16, P277
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Pan JL, 2000, J ORAL MAXIL SURG, V58, P877, DOI 10.1053/joms.2000.8212
   RALTSON SH, 1992, ROLE CYTOKINES CLIN, P362
   Rocca M, 2002, BIOMATERIALS, V23, P1017, DOI 10.1016/S0142-9612(01)00213-7
   Rocca M, 2001, INT J ARTIF ORGANS, V24, P649
   Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.3.CO;2-3
   SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292
   SHIGENO Y, 1995, J BONE JOINT SURG BR, V77B, P139
   SIMMONS DJ, 1985, CLIN ORTHOP RELAT R, P100
   Thorndike E. A., 1998, FRONT BIOSCI, V3, P17
   Torricelli P, 2000, J BIOMED MATER RES, V52, P177, DOI 10.1002/1097-4636(200010)52:1<177::AID-JBM23>3.0.CO;2-F
   Torricelli P, 2003, BIOMED PHARMACOTHER, V57, P57, DOI 10.1016/S0753-3322(02)00329-3
   Torricelli P, 2002, ARTIF CELL BLOOD SUB, V30, P219, DOI 10.1081/BIO-120004341
   TORRICELLI P, 2001, BIOMATERIALS, V22, P1535
   Torricelli Paola, 2000, Artificial Cells Blood Substitutes and Immobilization Biotechnology, V28, P181, DOI 10.3109/10731190009118580
   Tresguerres IF, 2002, CLIN ORAL IMPLAN RES, V13, P631, DOI 10.1034/j.1600-0501.2002.130609.x
   TURNER AS, 1998, 44 ANN M ORTH RES SO, P4
   WONG MM, 1994, OSTEOPOROSIS INT, V4, P21, DOI 10.1007/BF02352257
NR 61
TC 80
Z9 83
U1 0
U2 33
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD NOV
PY 2004
VL 58
IS 9
BP 487
EP 493
DI 10.1016/j.biopha.2004.08.016
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 874LN
UT WOS:000225352000001
PM 15511604
DA 2018-10-19
ER

PT J
AU Yong, P
   Macaskie, LE
   Sammons, RL
   Marquis, PM
AF Yong, P
   Macaskie, LE
   Sammons, RL
   Marquis, PM
TI Synthesis of nanophase hydroxyapatite by a Serratia sp from waste-water
   containing inorganic phosphate
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE calcium phosphate; hydroxyapatite; nanophase; nanotechnology; Serratia;
   waste-water
ID ACCUMULATING CITROBACTER SP; MECHANICAL-PROPERTIES; PHOSPHORUS REMOVAL;
   CONTINUOUS-CULTURE; CALCIUM; RELEASE; CEMENTS; CELLS; PH
AB Synthesis of nanophase hydroxyapatite (HA) on a bacterial surface was achieved at the expense of CaCl2 and inorganic phosphate (Pi). After initial nucleation, calcium was precipitated on and around the cells as calcium phosphate at the expense of inorganic phosphate in the challenge solution, with no precipitation in cell-free controls. HA was also biomanufactured using inorganic phosphate ions scavenged from a phosphate-containing waste-water. With additional Ca2+, the concentration of phosphate was decreased from 0.27 (similar to25 ppm) to similar to0.02mM (similar to2 ppm) in the waste-water. Crystals of calcium phosphate manufactured by the cells were located by scanning electron microscopy (SEM) and identified as HA by X-ray powder diffraction, with an average crystal size calculated as similar to25 nm. Possible application of bioHA as a biomaterial and implications for one-step 'waste-into product' are discussed.
C1 Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   Univ Birmingham, Sch Dent, Birmingham B15 2TT, W Midlands, England.
RP Macaskie, LE (reprint author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM l.e.macaskie@bham.ac.uk
OI Sammons, Rachel/0000-0002-4787-048X
CR Badar U, 2000, BIOTECHNOL LETT, V22, P829, DOI 10.1023/A:1005649113190
   Beruto DT, 1999, J EUR CERAM SOC, V19, P1731, DOI 10.1016/S0955-2219(98)00276-3
   Bonthrone KM, 2000, ENVIRON TECHNOL, V21, P123, DOI 10.1080/09593330.2000.9618893
   Boswell CD, 2001, J IND MICROBIOL BIOT, V26, P333, DOI 10.1038/sj.jim.7000139
   Boudeville P, 1999, J MATER SCI-MATER M, V10, P99, DOI 10.1023/A:1008921104080
   COOK DI, 1987, HDB PHYSL GASTROINTE, V2, P1
   CRANIN AN, 1994, J ORAL IMPLANTOL, V20, P235
   DEAN JA, 1992, LANGS HDB CHEM
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P223, DOI 10.1023/A:1008958112257
   Finlay JA, 1999, BIOTECHNOL BIOENG, V63, P87, DOI 10.1002/(SICI)1097-0290(19990405)63:1<87::AID-BIT9>3.0.CO;2-0
   Gabriel CTM, 2002, BIOMATERIALS, V23, P1283
   Gachter R., 1985, CHEM PROCESSES LAKES, P365
   GAUTHIER O, 1999, BONE, V25, P71
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jeong BC, 1998, ARCH MICROBIOL, V169, P166, DOI 10.1007/s002030050556
   LANGFORD JI, 1992, NIST SPEC PUBL, V846, P110
   Low D, 2000, J MATER SCI-MATER M, V11, P399, DOI 10.1023/A:1008942223938
   MACASKIE LE, 1985, BIOTECHNOL LETT, V7, P627, DOI 10.1007/BF01040198
   Macaskie LE, 2000, MICROBIOL-SGM, V146, P1855, DOI 10.1099/00221287-146-8-1855
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   Matsuya S, 2000, J MATER SCI-MATER M, V11, P305, DOI 10.1023/A:1008961314500
   Morse GK, 1998, SCI TOTAL ENVIRON, V212, P69, DOI 10.1016/S0048-9697(97)00332-X
   PATTANAPIPITPAISAL, 2002, ENVIRON TECHNOL, V23, P731
   Sammons R., 2004, PHOSPHORUS ENV TECHN, P582
   Stante L, 1997, WATER RES, V31, P1317, DOI 10.1016/S0043-1354(96)00351-X
   Suzuki K, 2002, WATER RES, V36, P2991, DOI 10.1016/S0043-1354(01)00536-X
   VANGROENESTIJN JW, 1989, A VAN LEEUW J MICROB, V55, P67, DOI 10.1007/BF02309620
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Yeong KCB, 2001, BIOMATERIALS, V22, P2705, DOI 10.1016/S0142-9612(00)00257-X
   YONG P, 1995, B ENVIRON CONTAM TOX, V54, P892
   Zhao DY, 1998, WATER RES, V32, P1613, DOI 10.1016/S0043-1354(97)00371-0
   1992, 090432 JCPDS
NR 33
TC 20
Z9 20
U1 2
U2 10
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD NOV
PY 2004
VL 26
IS 22
BP 1723
EP 1730
DI 10.1007/s10529-004-3744-4
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 881XE
UT WOS:000225902000007
PM 15604826
DA 2018-10-19
ER

PT J
AU Chun, KW
   Yoo, HS
   Yoon, JJ
   Park, TG
AF Chun, KW
   Yoo, HS
   Yoon, JJ
   Park, TG
TI Biodegradable PLGA microcarriers for injectable delivery of
   chondrocytes: Effect of surface modification on cell attachment and
   function
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
ID POLYMER SCAFFOLDS; CARTILAGE DEFECTS; RGD-PEPTIDE; GROWTH; MATRIX;
   MICROPARTICLES; BIOMATERIAL; EXPRESSION; CULTURE; FILMS
AB Poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres were prepared by an oil/water emulsion solvent evaporation method to use as an injectable microcarrier for cell delivery. Three different kinds of PLGA microspheres having hydrophobic, negatively charged, and positively charged surfaces were prepared. Hydrophobic and negatively charged PLGA microspheres were prepared by using terminally capped and uncapped PLGA polymer, respectively. Positively charged PLGA microspheres were prepared by blending PLGA with PLGA-g-poly(L-lysine) graft copolymer as a surface modifying agent. Bovine chondrocytes were cultured on the three PLGA microspheres under serum conditions to comparatively evaluate cell attachment, cell proliferation, and cell function with respect to surface properties. Positively charged PLGA microspheres showed the highest cell attachment, growth, and function compared to hydrophobic and negatively charged microspheres. Surface-modified PLGA microspheres can potentially be used as an injectable delivery system for cells into a tissue defect site.
C1 Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.
RP Park, TG (reprint author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.
EM tgpark@kaist.ac.kr
OI yoo, hyuksang/0000-0002-4346-9154
CR Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380
   Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1
   Baek CH, 2002, LARYNGOSCOPE, V112, P1050, DOI 10.1097/00005537-200206000-00021
   Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cui CJ, 2001, MACROMOLECULES, V34, P8426, DOI 10.1021/ma0105744
   Ellingworth P, 2000, J THEOL STUD, V51, P164, DOI 10.1093/jts/51.1.164
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   JACOBSON BS, 1982, TISSUE CELL, V14, P69, DOI 10.1016/0040-8166(82)90008-8
   Jeong JH, 2002, J CONTROL RELEASE, V82, P159, DOI 10.1016/S0168-3659(02)00131-1
   JOENG JH, 2003, J BIOMAT SCI-POLYM E, V14, P1
   Kim HK, 2001, INT J PHARM, V229, P107, DOI 10.1016/S0378-5173(01)00852-3
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Malda J, 2003, TISSUE ENG, V9, P939, DOI 10.1089/107632703322495583
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Ohya Y, 2003, J BIOMED MATER RES A, V65A, P79, DOI 10.1002/jbm.a.10446
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   Singh M, 2000, P NATL ACAD SCI USA, V97, P811, DOI 10.1073/pnas.97.2.811
   Thornhill TS, 1997, ORTHOPEDICS, V20, P819
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
   Zheng J, 1999, BIOTECHNOL PROGR, V15, P763, DOI 10.1021/bp9900817
NR 29
TC 91
Z9 95
U1 4
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD NOV-DEC
PY 2004
VL 20
IS 6
BP 1797
EP 1801
DI 10.1021/bp0496981
PG 5
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 877HI
UT WOS:000225558200024
PM 15575714
DA 2018-10-19
ER

PT J
AU Fantner, GE
   Birkedal, H
   Kindt, JH
   Hassenkam, T
   Weaver, JC
   Cutroni, JA
   Bosma, BL
   Bawazer, L
   Finch, MM
   Cidade, GAG
   Morse, DE
   Stucky, GD
   Hansma, PK
AF Fantner, GE
   Birkedal, H
   Kindt, JH
   Hassenkam, T
   Weaver, JC
   Cutroni, JA
   Bosma, BL
   Bawazer, L
   Finch, MM
   Cidade, GAG
   Morse, DE
   Stucky, GD
   Hansma, PK
TI Influence of the degradation of the organic matrix on the microscopic
   fracture behavior of trabecular bone
SO BONE
LA English
DT Article
DE fracture mechanism; organic matrix; bone strength; mechanical
   properties; microcracks
ID HUMAN CORTICAL BONE; AGE-RELATED-CHANGES; MECHANICAL-PROPERTIES;
   BIOMECHANICAL PROPERTIES; LAMELLAR BONE; COLLAGEN; TOUGHNESS; STRENGTH;
   MICROSTRUCTURE; DAMAGE
AB In recent years, the important role of the organic matrix for the mechanical properties of bone has become increasingly apparent. It is therefore of great interest to understand the interactions between the organic and inorganic constituents of bone and learn the mechanisms by which the organic matrix contributes to the remarkable properties of this complex biomaterial. In this paper, we present a multifaceted view of the changes of bone's properties due to heat-induced degradation of the organic matrix. We compare the microscopic fracture behavior (scanning electron microscopy; SEM), the topography of the surfaces (atomic force microscopy; AFM), the condition of bone constituents [X-ray diffraction (XRD), thermogravimetric analysis (TGA), and gel electrophoresis], and the macromechanical properties of healthy bovine trabecular bone with trabecular bone that has a heat-degraded organic matrix. We show that heat treatment changes the microfracture behavior of trabecular bone. The primary failure mode of untreated trabecular bone is fibril-guided delamination, with mineralized collagen filaments bridging the gap of the microcrack. In contrast, bone that has been baked at 200degreesC fractures nondirectionally like a brittle material, with no fibers spanning the microcracks. Finally, bone that has been boiled for 2 h in PBS solution fractures by delarnination with many small filaments spanning the microcracks, so that the edges of the microcracks become difficult to distinguish. Of the methods we used, baking most effectively weakens the mechanical strength of bone, creating the most brittle material. Boiled bone is stronger than baked bone, but weaker than untreated bone. Boiled bone is more elastic than untreated bone, which is in turn more elastic than baked bone. These studies clearly emphasize the importance of the organic matrix in affecting the fracture mechanics of bone. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.
RP Fantner, GE (reprint author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.
EM fantner@physics.ucsb.edu
RI Fantner, Georg/F-7392-2011; Hassenkam, Tue/B-8391-2015
OI Birkedal, Henrik/0000-0002-4201-2179
FU NIGMS NIH HHS [GM65354]
CR AARON JE, 1987, CLIN ORTHOP RELAT R, P260
   Ammann P, 2003, OSTEOPOROS INT S3, V14, P13
   Catanese J, 1999, J BIOMED MATER RES, V45, P327, DOI 10.1002/(SICI)1097-4636(19990615)45:4<327::AID-JBM7>3.0.CO;2-L
   Courtney AC, 1996, J BIOMECH, V29, P1463, DOI 10.1016/0021-9290(96)84542-8
   Currey JD, 1997, J ORTHOP RES, V15, P111, DOI 10.1002/jor.1100150116
   Currey JD, 1996, J BIOMECH, V29, P257, DOI 10.1016/0021-9290(95)00048-8
   Currey JD, 2003, OSTEOPOROSIS INT, V14, P29
   DANIELSEN CC, 1990, BIOCHEM J, V272, P697, DOI 10.1042/bj2720697
   DYSON ED, 1970, NATURE, V225, P957, DOI 10.1038/225957a0
   ERTS D, 1994, J MATER SCI-MATER M, V5, P200, DOI 10.1007/BF00121089
   EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gutsmann T, 2003, BIOPHYS J, V84, P2593, DOI 10.1016/S0006-3495(03)75064-4
   Jepsen KJ, 1996, J ORTHOP RES, V14, P493, DOI 10.1002/jor.1100140320
   Jepsen KJ, 1997, J BIOMECH, V30, P1141, DOI 10.1016/S0021-9290(97)00088-2
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Liu D, 2000, J MATER SCI-MATER M, V11, P49, DOI 10.1023/A:1008989719560
   Majumdar S, 1998, BONE, V22, P445, DOI 10.1016/S8756-3282(98)00030-1
   Muller Ralph, 2002, Top Magn Reson Imaging, V13, P307, DOI 10.1097/00002142-200210000-00003
   Murugan R, 2003, B MATER SCI, V26, P523, DOI 10.1007/BF02707351
   Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832
   Oxlund H, 1996, BONE, V19, P479, DOI 10.1016/S8756-3282(96)00283-9
   Oxlund H., 1995, BONE S, V17, p365S
   RAIF EM, 1993, BIOMATERIALS, V14, P978, DOI 10.1016/0142-9612(93)90189-9
   RASPANTI M, 1994, BIOMATERIALS, V15, P433, DOI 10.1016/0142-9612(94)90222-4
   Reilly GC, 2000, J BIOMECH, V33, P337, DOI 10.1016/S0021-9290(99)00167-0
   Rem AI, 2001, EXP EYE RES, V72, P153, DOI 10.1006/exer.2000.0939
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414
   Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Silva MJ, 1997, BONE, V21, P191, DOI 10.1016/S8756-3282(97)00100-2
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   THURNER P, 2003, T EUR ORTHOP RES SOC, V13, P14
   Venturoni M, 2003, BIOCHEM BIOPH RES CO, V303, P508, DOI 10.1016/S0006-291X(03)00390-5
   WANG A, 2002, BONE, V31, P1
   Wang XD, 2000, CLIN ORTHOP RELAT R, P228
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   WOLFF J, 1870, VIRCHOWS ARCH PATHOL, V50, P389, DOI DOI 10.1007/BF01944490
   Yeni YN, 2000, BONE, V26, P499, DOI 10.1016/S8756-3282(00)00258-1
   Yeni YN, 2001, ASME BIOENG C, V50, P293
   Zioupos P, 1999, J BIOMED MATER RES, V45, P108, DOI 10.1002/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.0.CO;2-A
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
   Zioupos P, 2001, J MICROSC-OXFORD, V201, P270, DOI 10.1046/j.1365-2818.2001.00783.x
   ZIOUPOS P, 1995, PHILOS T ROY SOC B, V347, P383, DOI 10.1098/rstb.1995.0031
NR 48
TC 88
Z9 92
U1 1
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD NOV
PY 2004
VL 35
IS 5
BP 1013
EP 1022
DI 10.1016/j.bone.2004.05.027
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 874UY
UT WOS:000225376900002
PM 15542025
DA 2018-10-19
ER

PT J
AU MacLeod, TM
   Sarathchandra, P
   Williams, G
   Sanders, R
   Green, CJ
AF MacLeod, TM
   Sarathchandra, P
   Williams, G
   Sanders, R
   Green, CJ
TI The diamond CO2 laser as a method of improving the vascularisation of a
   permanent collagen implant
SO BURNS
LA English
DT Article
DE Permaco (TM); vascularity; porosity; diamond CO2 laser; VEGF
ID INGROWTH; BONE; FIXATION; SURFACE; GRAFTS; PORES
AB For a biomaterial to be considered as anything other than a simple filler material it must allow a certain degree of ingrowth from the surrounding host tissues. Permacol(TM) is a novel porcine derived biomaterial that is isocynate crosslinked to prevent its degradation in vivo, but while it appears to be biocompatible in terms of its histological tissue response, our early studies demonstrate only a limited degree of fibrovascular ingrowth. The aim of this study was to assess the effectiveness of both laser perforations and topically applied VEGF as methods of encouraging fibrovascular ingrowth. Treatment of Permacol(TM) with the diamond CO2 laser significantly increased the porosity of the material as assessed by seescan image analysis. Fibrovascular ingrowth as assessed in the Sprague-dawley rat model was found to be limited to the pores themselves and not the surrounding native matrix. Pre-soaking of laser treated Permacol(TM) in vascular endothelial growth factor (VEGF) did not further increase fibrovascular ingrowth. Increasing the porosity of Permacol(TM) may allow its use as a dermal replacement in the support of an overlying skin graft or keratinocyte sheet; however using the laser may not be the optimal method of achieving this aim. (C) 2004 Elsevier Ltd and ISBI. All rights reserved.
C1 Mt Vernon Hosp, Restorat Appearance & Funct Trust, Northwood HA6 2RN, Middx, England.
   Northwick Pk Hosp & Clin Res Ctr, Northwick Pk Inst Med Res, Harrow HA1 3UJ, Middx, England.
RP MacLeod, TM (reprint author), Mt Vernon Hosp, Restorat Appearance & Funct Trust, Northwood HA6 2RN, Middx, England.
EM tmhighlander@yahoo.co.uk; grwilliams@doctors.org.uk;
   s.jenks@imperial.ac.uk
CR BENBASSAT H, 1992, PLAST RECONSTR SURG, V89, P510, DOI 10.1097/00006534-199203000-00020
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P223
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Domankevitz Yacov, 1997, Journal of Burn Care and Rehabilitation, V18, P206, DOI 10.1097/00004630-199705000-00005
   GOODMAN S, 1993, J BIOMED MATER RES, V27, P247, DOI 10.1002/jbm.820270215
   Guyton AC, 1981, TXB MED PHYSL
   HOLMES RE, 1988, PLAST RECONSTR SURG, V81, P662, DOI 10.1097/00006534-198805000-00003
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   LABERGE M, 1990, J BIOMED MATER RES, V24, P959, DOI 10.1002/jbm.820240712
   MACLEOD TM, 2004, UNPUB BR J PLAST SUR
   MARTENS M, 1980, ARCH ORTHOP TRAUM SU, V97, P111, DOI 10.1007/BF00450933
   Masuda S, 1997, ASAIO J, V43, pM530
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MOONEY DJ, 1995, BIOMEDICAL ENG HDB, P627
   Onuki Y, 1997, ANN VASC SURG, V11, P604, DOI 10.1007/s100169900098
   SAUR BW, 1974, J BIOMED MAT RES S, V5, P145
   Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
NR 19
TC 6
Z9 9
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-4179
J9 BURNS
JI Burns
PD NOV
PY 2004
VL 30
IS 7
BP 704
EP 712
DI 10.1016/j,.burns.2004.03.008
PG 9
WC Critical Care Medicine; Dermatology; Surgery
SC General & Internal Medicine; Dermatology; Surgery
GA 865PT
UT WOS:000224715700015
PM 15475147
DA 2018-10-19
ER

PT J
AU Whittlesey, KJ
   Shea, LD
AF Whittlesey, KJ
   Shea, LD
TI Delivery systems for small molecule drugs, proteins, and DNA: the
   neuroscience/biomaterial interface
SO EXPERIMENTAL NEUROLOGY
LA English
DT Review
DE drug delivery; biodegradable polymer; neurotrophin; regeneration;
   neurodegenerative disease; gene therapy
ID NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; BIODEGRADABLE POLYMER
   MICROPARTICLES; DOUBLE-WALLED MICROSPHERES; LOADED PLGA MICROSPHERES;
   IN-VIVO EVALUATION; CONTROLLED-RELEASE; GENE DELIVERY;
   SUSTAINED-RELEASE; FUNCTIONAL RECOVERY
AB Manipulation of cellular processes in vivo by the delivery of drugs, proteins or DNA is of paramount importance to neuroscience research. Methods for the presentation of these molecules vary widely, including direct injection (either systemic or stereotactic), osmotic pump-mediated chronic delivery, or even implantation of cells engineered to indefinitely secrete a factor of interest. Biomaterial-based delivery systems represent an alternative to more traditional approaches, with the possibility of increased efficacy. Drug-releasing biomaterials, either as injectable microspheres or as three-dimensional implants, can deliver a molecule of interest (including small molecule drugs, biologically active proteins, or DNA) over a more prolonged period of time than by standard bolus injection, avoiding the need for repeated administration. Furthermore, sustained-release systems can maintain therapeutic concentrations at a target site, thus reducing the chance for toxicity. This review summarizes applications of polymer-based delivery of small molecule drugs, proteins, and DNA specifically relevant to neuroscience research. We detail the fabrication procedures for the polymeric systems and their utility in various experimental models. The biomaterial field offers unique experimental tools with downstream clinical application for the study and treatment of neurologic disease. (C) 2004 Elsevier Inc. All rights reserved.
C1 Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
RP Whittlesey, KJ (reprint author), Northwestern Univ, Dept Biol & Chem Engn, 2145 sheridan Rd Room E136, Evanston, IL 60208 USA.
EM k-whittlesey@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NINDS NIH HHS [NS 42364-01]
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   AEBISCHER P, 1989, J NEUROSCI RES, V23, P282, DOI 10.1002/jnr.490230306
   Anderson WF, 1998, NATURE, V392, P25
   Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Baekelandt V, 2000, CURR OPIN MOL THER, V2, P540
   Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166
   Barekzi NA, 2002, PHARMACEUT RES, V19, P1801, DOI 10.1023/A:1021481122011
   Barnett SC, 2004, J ANAT, V204, P57, DOI 10.1111/j.1469-7580.2004.00257.x
   Barras FM, 2002, J NEUROSCI RES, V70, P746, DOI 10.1002/jnr.10434
   BAZZETT TJ, 1993, EXP NEUROL, V120, P177, DOI 10.1006/exnr.1993.1053
   Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647
   Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   Birnbaum DT, 2000, J CONTROL RELEASE, V65, P375, DOI 10.1016/S0168-3659(99)00219-9
   Blitts B, 2003, NEUROSCIENCE, V118, P271, DOI 10.1016/S0306-4522(02)00970-3
   Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778
   BOISDRONCELLE M, 1995, J PHARM PHARMACOL, V47, P108, DOI 10.1111/j.2042-7158.1995.tb05760.x
   Boison D, 1999, EXP NEUROL, V160, P164, DOI 10.1006/exnr.1999.7209
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bonadio J, 2002, ANN NY ACAD SCI, V961, P58, DOI 10.1111/j.1749-6632.2002.tb03048.x
   Bonadio J, 1998, ADV DRUG DELIVER REV, V33, P53, DOI 10.1016/S0169-409X(98)00020-9
   Brem H, 1995, J NEURO-ONCOL, V26, P111, DOI 10.1007/BF01060217
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   Brosamle C, 2000, J NEUROSCI, V20, P8061
   BROWN L, 1986, DIABETES, V35, P684, DOI 10.2337/diabetes.35.6.684
   BROWN L, 1986, DIABETES, V35, P692, DOI 10.2337/diabetes.35.6.692
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   CAMARATA PJ, 1992, NEUROSURGERY, V30, P313, DOI 10.1227/00006123-199203000-00001
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Chandler LA, 2000, MOL THER, V2, P153, DOI 10.1006/mthe.2000.0102
   Chen W, 1999, J MICROENCAPSUL, V16, P551
   Chen W, 1997, DRUG DELIV, V4, P301, DOI 10.3109/10717549709052017
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253
   Davidson BL, 1997, ADV DRUG DELIVER REV, V27, P1, DOI 10.1016/S0169-409X(97)00017-3
   De Rosa G, 2003, BIOMACROMOLECULES, V4, P529, DOI 10.1021/bm025684c
   De Rosa G, 2003, INT J PHARM, V254, P89, DOI 10.1016/S0378-5173(02)00689-0
   DOLBEARE F, 1995, HISTOCHEM J, V27, P339
   Dolbeare F, 1996, HISTOCHEM J, V28, P531, DOI 10.1007/BF02331377
   DONDROW M, 1991, MICROCAPSULES NANOPA
   DRAGUNOW M, 1985, EPILEPSIA, V26, P480, DOI 10.1111/j.1528-1157.1985.tb05684.x
   DRAGUNOW M, 1988, TRENDS PHARMACOL SCI, V9, P193, DOI 10.1016/0165-6147(88)90079-X
   DURING MJ, 1989, ANN NEUROL, V25, P351, DOI 10.1002/ana.410250406
   Dutt M, 2001, INT J ANTIMICROB AG, V17, P115, DOI 10.1016/S0924-8579(00)00330-7
   Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X
   EIDE FF, 1993, EXP NEUROL, V121, P200, DOI 10.1006/exnr.1993.1087
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114
   Emerick AJ, 2003, J NEUROSCI, V23, P4826
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Feng S. S., 2000, Annals Academy of Medicine Singapore, V29, P633
   Fiedler M, 2002, PROTEIN ENG, V15, P931, DOI 10.1093/protein/15.11.931
   FREESE A, 1989, EXP NEUROL, V103, P234, DOI 10.1016/0014-4886(89)90047-2
   FREESE A, 1994, J NEURO-ONCOL, V20, P81, DOI 10.1007/BF01057964
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Fu K, 1999, J CONTROL RELEASE, V58, P357, DOI 10.1016/S0168-3659(98)00192-8
   Furlan R, 2003, CURR PHARM DESIGN, V9, P2002, DOI 10.2174/1381612033454315
   Gill JS, 2002, BIOMATERIALS, V23, P2773, DOI 10.1016/S0142-9612(02)00013-3
   GIORDANO GG, 1993, INVEST OPHTH VIS SCI, V34, P2743
   Glorioso JC, 2003, J NEUROVIROL, V9, P165, DOI 10.1080/13550280390193984
   Gombotz W. R., 1991, U.S. Patent, Patent No. [5019400, US5019400 A]
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969
   Grill R, 1997, J NEUROSCI, V17, P5560
   Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704
   GROSSMAN SA, 1992, J NEUROSURG, V76, P640, DOI 10.3171/jns.1992.76.4.0640
   Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416
   Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010
   Hadlock TA, 2003, J RECONSTR MICROSURG, V19, P179
   Haik KL, 2000, EXP NEUROL, V163, P430, DOI 10.1006/exnr.2000.7384
   HARBAUGH RE, 1988, NEUROSURGERY, V23, P693, DOI 10.1227/00006123-198812000-00001
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hedley ML, 1998, NAT MED, V4, P365, DOI 10.1038/nm0398-365
   HEINRICH N, 1991, J PHARM PHARMACOL, V43, P762, DOI 10.1111/j.2042-7158.1991.tb03478.x
   Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983
   HOFFMAN D, 1990, EXP NEUROL, V110, P39, DOI 10.1016/0014-4886(90)90049-X
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Horton C E, 1974, Am Surg, V40, P729
   Hsu YY, 1999, J DRUG TARGET, V7, P313, DOI 10.3109/10611869909085514
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Isobe M, 1996, J BIOMED MATER RES, V32, P433
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Johnson OL, 1996, NAT MED, V2, P795, DOI 10.1038/nm0796-795
   Jollivet C, 2004, BIOMATERIALS, V25, P933, DOI 10.1016/S0142-9612(03)00601-X
   Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144
   Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x
   Kalyanasundaram S, 1999, CANCER GENE THER, V6, P107, DOI 10.1038/sj.cgt.7700025
   Khan A, 2000, J DRUG TARGET, V8, P319, DOI 10.3109/10611860008997909
   Kim SC, 2001, J CONTROL RELEASE, V72, P191, DOI 10.1016/S0168-3659(01)00275-9
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Kneuer C, 2000, BIOCONJUGATE CHEM, V11, P926, DOI 10.1021/bc0000637
   Krewson CE, 1996, J BIOMAT SCI-POLYM E, V8, P103
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1
   Lakkaraju A, 2001, J BIOL CHEM, V276, P32000, DOI 10.1074/jbc.M100138200
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Langer R, 1998, NATURE, V392, P5
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee TH, 2002, J CONTROL RELEASE, V83, P437, DOI 10.1016/S0168-3659(02)00235-3
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537
   Lewin SL, 1997, LARYNGOSCOPE, V107, P992, DOI 10.1097/00005537-199707000-00029
   LOO TI, 1966, J PHARM SCI, V55, P492, DOI 10.1002/jps.2600550509
   Lowenstein PR, 2001, PHYSIOL BEHAV, V73, P833, DOI 10.1016/S0031-9384(01)00520-0
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Luo D, 1999, PHARMACEUT RES, V16, P1300, DOI 10.1023/A:1014870102295
   Ma D D, 2000, Biotechnol Annu Rev, V5, P155, DOI 10.1016/S1387-2656(00)05035-3
   Manuel WS, 2001, J DRUG TARGET, V9, P15, DOI 10.3109/10611860108995629
   MARRANNES R, 1988, PHARMACOL BIOCHEM BE, V31, P153, DOI 10.1016/0091-3057(88)90327-9
   Matthews CB, 1999, GENE THER, V6, P1558, DOI 10.1038/sj.gt.3300978
   MAURIN MB, 1992, J PHARM SCI, V81, P79, DOI 10.1002/jps.2600810116
   MAYSINGER D, 1993, NEUROREPORT, V4, P971, DOI 10.1097/00001756-199307000-00034
   Maysinger D, 1996, EXP NEUROL, V138, P177, DOI 10.1006/exnr.1996.0056
   MAYSINGER D, 1994, LIFE SCI, V54, P27, DOI 10.1016/0024-3205(94)00574-5
   MCRAE A, 1994, NEUROCHEM INT, V25, P27, DOI 10.1016/0197-0186(94)90049-3
   MCRAE A, 1994, MOL NEUROBIOL, V9, P191, DOI 10.1007/BF02816119
   MENEI P, 1994, NEUROSURGERY, V34, P1058, DOI 10.1097/00006123-199406000-00016
   MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q
   Menei P, 1996, NEUROSURGERY, V39, P117, DOI 10.1097/00006123-199607000-00023
   Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253
   MITTAL S, 1994, NEUROREPORT, V5, P2577, DOI 10.1097/00001756-199412000-00043
   MorrissKay GM, 1996, FASEB J, V10, P961
   Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Nutt JG, 2000, TRENDS NEUROSCI, V23, pS109, DOI 10.1016/S1471-1931(00)00029-X
   OBESO JA, 1994, EUR J NEUROSCI, V6, P889, DOI 10.1111/j.1460-9568.1994.tb00584.x
   Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   Pean JM, 1998, J CONTROL RELEASE, V56, P175, DOI 10.1016/S0168-3659(98)00086-8
   Pean JM, 1999, PHARMACEUT RES, V16, P1294, DOI 10.1023/A:1014818118224
   PEKAREK KJ, 1994, NATURE, V367, P258, DOI 10.1038/367258a0
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   POWELL EM, 1990, BRAIN RES, V515, P309, DOI 10.1016/0006-8993(90)90612-F
   PROCTOR RA, 1987, REV INFECT DIS, V9, pS317
   Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153
   Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4
   Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9
   Reza MS, 1998, J MICROENCAPSUL, V15, P789, DOI 10.3109/02652049809008261
   RHINE WD, 1980, J PHARM SCI, V69, P265, DOI 10.1002/jps.2600690305
   Richardson TP, 2001, CRIT REV EUKAR GENE, V11, P47
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   Romero MI, 2001, J NEUROSCI, V21, P8408
   Roullin VG, 2003, ANTICANCER RES, V23, P21
   SABEL BA, 1990, J PHARMACOL EXP THER, V255, P914
   Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   SANBERG PR, 1989, EXP NEUROL, V105, P45, DOI 10.1016/0014-4886(89)90170-2
   SANBERG PR, 1993, BRAIN RES, V628, P327, DOI 10.1016/0006-8993(93)90974-R
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0
   Schwendeman SP, 2002, CRIT REV THER DRUG, V19, P73, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.20
   Segovia Jose, 2002, Am J Pharmacogenomics, V2, P135, DOI 10.2165/00129785-200202020-00006
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Segura T, 2001, ANNU REV MATER RES, V31, P25, DOI 10.1146/annurev.matsci.31.1.25
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shear DA, 1998, EXP NEUROL, V150, P305, DOI 10.1006/exnr.1998.6767
   Shi M, 2003, J CONTROL RELEASE, V89, P167, DOI 10.1016/S0168-3659(02)00493-5
   Shoichet MS, 2000, ADV DRUG DELIVER REV, V42, P81, DOI 10.1016/S0169-409X(00)00055-7
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X
   SUN YE, 2003, CELL DEV BIOL, V14, P161
   Tenenbaum L., 2002, Current Gene Therapy, V2, P451, DOI 10.2174/1566523023347661
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   terBeek LC, 1996, BIOPHYS J, V70, P2396, DOI 10.1016/S0006-3495(96)79807-7
   Tornqvist N, 2000, EXP NEUROL, V164, P130, DOI 10.1006/exnr.2000.7411
   Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Verhaagen J, 1996, CLIN NEUROSCI, V3, P275
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   Washbourne P, 2002, CURR OPIN NEUROBIOL, V12, P566, DOI 10.1016/S0959-4388(02)00365-3
   WATTS PJ, 1990, CRIT REV THER DRUG, V7, P235
   WINN SR, 1989, EXP NEUROL, V105, P244, DOI 10.1016/0014-4886(89)90126-X
   Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1
   Xu XY, 2002, BIOMATERIALS, V23, P3765, DOI 10.1016/S0142-9612(02)00116-3
   Yamamoto A, 2001, NEUROBIOL DIS, V8, P923, DOI 10.1006/ndbi.2001.0452
   Yang K, 1997, J NEUROTRAUM, V14, P281, DOI 10.1089/neu.1997.14.281
   Yang YY, 2003, J CONTROL RELEASE, V88, P201, DOI 10.1016/S0168-3659(02)00491-1
   Yeh MK, 2001, J MICROENCAPSUL, V18, P507
   Zhang Y, 1998, J NEUROSCI RES, V54, P554
   Zheng J, 2000, BIOTECHNOL PROGR, V16, P254, DOI 10.1021/bp990150h
   Zhou LJ, 2003, J NEUROSCI RES, V74, P221, DOI 10.1002/jnr.10718
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 194
TC 61
Z9 65
U1 1
U2 24
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD NOV
PY 2004
VL 190
IS 1
BP 1
EP 16
DI 10.1016/j.expneurol.2004.06.020
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA 867DJ
UT WOS:000224822100001
PM 15473976
DA 2018-10-19
ER

PT J
AU Miller, DC
   Webster, TJ
   Haberstroh, KM
AF Miller, DC
   Webster, TJ
   Haberstroh, KM
TI Technological advances in nanoscale biomaterials: the future of
   synthetic vascular graft design
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE nanostructured; tissue engineering; vascular graft
ID SMOOTH-MUSCLE-CELL; COLLOIDAL LITHOGRAPHY; EXTRACELLULAR-MATRIX;
   SCAFFOLDS; ADHESION; TOPOGRAPHY; MORPHOLOGY; POLYCAPROLACTONE;
   PROLIFERATION; POLYURETHANE
AB Currently, autologous veins are the first choice for patients in need of bypass grafting materials. However, due to either pre-existing conditions or previous bypass surgery, some patients lack the necessary amount of host tissue for such procedures. Unfortunately, current synthetic vascular grafts of less than 6 mm in diameter have been plagued by a variety of problems. For this reason, there has been significant research aimed at finding more suitable small-diameter vascular graft materials. In order to improve vascular cell functions on such synthetic materials, several techniques are currently under development that attempt to mimic the natural nanometer architecture of the vascular basement membrane. This review presents several processes Including colloidal lithography, chemical etching, electrospinning and solid free-form fabrication that could play a role in the future of vascular nanostructured biomaterial development.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.
RP Haberstroh, KM (reprint author), Purdue Univ, Dept Biomed Engn, 500 Cent Dr, W Lafayette, IN 47907 USA.
EM kgaberst@ecn.purdue.edu
CR Berkland C, 2004, BIOMATERIALS, V25, P5649, DOI 10.1016/j.biomaterials.2004.01.018
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Buer A, 2001, TEXT RES J, V71, P323, DOI 10.1177/004051750107100408
   CANING J, 1997, J VAC SCI TECHNOL B, V15, P2109
   Chen JC, 2001, J OPT COMMUN, V22, P2
   Chen VJ, 2004, BIOMATERIALS, V25, P2065, DOI 10.1016/j.biomaterials.2003.08.058
   CHEN Y, 1994, J VAC SCI TECHNOL B, V12, P3959, DOI 10.1116/1.587410
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   FRIEDMAN SG, 1995, SURGERY, V117, P7, DOI 10.1016/S0039-6060(05)80223-5
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   GAO J, 1998, J BIOMED MATER RES, V3, P417
   Goodman SL, 1996, BIOMATERIALS, V17, P2087, DOI 10.1016/0142-9612(96)00016-6
   Green RM, 2000, J VASC SURG, V31, P417, DOI 10.1016/S0741-5214(00)90300-8
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Price RL, 2003, J BIOMED MATER RES A, V67A, P1284, DOI 10.1002/jbm.a.20011
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   SCHAKENRAAD JM, 1996, BIOMATERIALS SCI, P136
   *SEM IND ASS, 1999, NAT TECHN ROADM SEM
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Suthar A, 2001, CHEM ENG, V726, P26
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 43
TC 14
Z9 14
U1 1
U2 24
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2004
VL 1
IS 2
BP 259
EP 268
DI 10.1586/17434440.1.2.259
PG 10
WC Engineering, Biomedical
SC Engineering
GA 018XG
UT WOS:000235797500024
PM 16293046
DA 2018-10-19
ER

PT J
AU Xu, P
   Sefton, MV
AF Xu, P
   Sefton, MV
TI Expression of matrix metalloproteinase-2 and-9 in exudates associated
   with polydimethyl siloxane and gelatin tubes implanted in mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE matrix metalloproteinases; biomaterial; gelatin; polydimethyl siloxane;
   biocompatibility; remodeling
ID ENDOTHELIAL-CELLS; IN-VITRO; COLLAGEN; INHIBITORS; TISSUE;
   BIOCOMPATIBILITY; GLUTARALDEHYDE; ANGIOGENESIS; MECHANISMS; GROWTH
AB The expression of matrix metalloproteinases (MMPs), MMP-2 and -9, during the inflammatory response to two implanted biomaterials was determined. To illustrate this phenomenon, polydimethyl siloxane (PDMS), weakly crosslinked gelatin, and highly crosslinked gelatin tubes were implanted subcutaneously in mice for up to 3 weeks. Latent MMP-2 (pro-MMP-2) was seen in exudates throughout the experimental period and did not show any apparent changes in time or among the three biomaterials. The expression of MMP-9, however, showed a very different pattern. At days 4 and 8, the predominant form of MMP-9 is pro-MMP-9 (the latent form) and its level is much higher for the PDMS tube than either of the gelatin tubes. The active form of MMP-9, initially low, rose progressively over the 3-week period and reached its peak at week 2 for PDMS and highly crosslinked gelatin and at week 3 for the more degradable, weakly crosslinked gelatin. Data from the histological and cytological analysis also showed that the PDMS tube induced a much stronger cellular response than gelatin tubes, although endotoxin contamination precludes a conclusion related to biomaterial effects. We concluded that MMP-9 is a useful marker of the host inflammatory response to the implanted biomaterials and it may be useful in the assessment of biomaterial biocompatibility. Perhaps more importantly, the consequences of MMPs on matrix remodeling may become of concern in biomaterials used for tissue engineering. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
EM sefton@chem-eng.utoronto.ca
CR ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   Barrick B, 1999, WOUND REPAIR REGEN, V7, P410, DOI 10.1046/j.1524-475X.1999.00410.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CORNELIUS LA, 1995, J INVEST DERMATOL, V105, P170, DOI 10.1111/1523-1747.ep12317080
   Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614
   FISHER SJ, 1995, EXTRACELLULAR MATRIX, P260
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   HEY KB, 1990, BIOTECHNOL APPL BIOC, V12, P85
   HUHTALA P, 1990, J BIOL CHEM, V265, P11077
   Inkinen K, 2000, APMIS, V108, P318, DOI 10.1034/j.1600-0463.2000.d01-63.x
   KALEBIC T, 1983, SCIENCE, V221, P281, DOI 10.1126/science.6190230
   Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MURPHY G, 1989, J CELL SCI, V92, P487
   MURPHY G, 1995, METHOD ENZYMOL, V248, P470
   Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67
   OLIVER RF, 1982, BRIT J EXP PATHOL, V63, P13
   OVERALL CM, 1989, J BIOL CHEM, V264, P1860
   RAY JM, 1994, EUR RESPIR J, V7, P2062
   SALO T, 1994, LAB INVEST, V70, P176
   SENIOR RM, 1991, J BIOL CHEM, V266, P7870
   VANNOORT R, 1982, BIOMATERIALS, V3, P21, DOI 10.1016/0142-9612(82)90056-4
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Zhu WH, 2000, LAB INVEST, V80, P545, DOI 10.1038/labinvest.3780060
NR 27
TC 2
Z9 2
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV 1
PY 2004
VL 71A
IS 2
BP 226
EP 232
DI 10.1002/jbm.a.30139
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 861LW
UT WOS:000224419000005
PM 15386490
DA 2018-10-19
ER

PT J
AU Liu, WG
   Zhang, JR
   Cao, ZQ
   Xu, FY
   Yao, KD
AF Liu, WG
   Zhang, JR
   Cao, ZQ
   Xu, FY
   Yao, KD
TI A chitosan-arginine conjugate as a novel anticoagulation biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NONLINEAR-OPTICAL CRYSTAL; N-ALKYLATED CHITOSAN; BLOOD COMPATIBILITY;
   SURFACE MODIFICATION; ACTIVATION; MEMBRANE; DELIVERY
AB Chitosan (CS) was modified with arginine using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS) as coupling agents. FTIR and C-13 NMR spectra showed that arginine was chemically coupled to CS to form a chitosan-arginine conjugate (CS-ArgC). The substitution degree of arginine in CS estimated from elemental analysis was 20.1%. The circular dichroism spectra indicated that the incorporation of arginine significantly altered the conformation of thrombin; while no obvious variation in the conformation of thrombin was observed with the addition of CS. The anticoagulation activity of glucose alclehyde crosslinked CS-ArgC and CS membranes was evaluated by assaying prothrombin time (PT), thrombin time (TT) and activated partial thromboplastin time (APTT). The APTT of CS-ArgC membrane was prolonged two times as that of CS counterpart, suggesting that the CS-ArgC is a promising candidate as an anticoagulation biomaterial. (C) 2004 Kluwer Academic Publishers.
C1 Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
   Chinese Acad Med Sci, Inst Hematol, Tianjin 300020, Peoples R China.
   Chinese Acad Med Sci, Blood Dis Hosp, Tianjin 300020, Peoples R China.
   PUMC, Tianjin 300020, Peoples R China.
RP Liu, WG (reprint author), Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
EM wgliu@tju.edu.cn
RI Cao, Zhiqiang/C-5288-2011
CR Amiji MM, 1998, COLLOID SURFACE B, V10, P263, DOI 10.1016/S0927-7765(98)00005-8
   Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Amiji MM, 1996, J BIOMAT SCI-POLYM E, V8, P281, DOI 10.1163/156856296X00309
   Anfossi G, 1999, THROMB RES, V94, P307, DOI 10.1016/S0049-3848(99)00011-0
   Banerjee T, 2002, INT J PHARM, V243, P93, DOI 10.1016/S0378-5173(02)00267-3
   Bartkowiak A, 2000, CHEM MATER, V12, P206, DOI 10.1021/cm991128m
   Drouet C, 1999, FEBS LETT, V458, P415, DOI 10.1016/S0014-5793(99)01194-1
   Gamzazade A, 1997, CARBOHYD POLYM, V34, P113, DOI 10.1016/S0144-8617(97)00067-2
   Gils A, 1998, THROMB HAEMOSTASIS, V80, P531
   Hari PR, 1996, J APPL POLYM SCI, V59, P1795
   HIDEYUKI T, 1997, J PHARM SCI, V86, P1016
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   KIMINORI M, 2001, INT J BIOL MACROMOL, V28, P395
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Liu WG, 2003, BIOCONJUGATE CHEM, V14, P782, DOI 10.1021/bc020051g
   Pal T, 2002, J CRYST GROWTH, V234, P267, DOI 10.1016/S0022-0248(01)01662-1
   Stief TW, 2001, THROMB RES, V104, P265, DOI 10.1016/S0049-3848(01)00368-1
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vongchan P, 2002, CARBOHYD RES, V337, P1239, DOI 10.1016/S0008-6215(02)00098-8
   Xu D, 2003, J CRYST GROWTH, V253, P481, DOI 10.1016/S0022-0248(03)01084-4
NR 22
TC 38
Z9 47
U1 6
U2 45
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2004
VL 15
IS 11
BP 1199
EP 1203
DI 10.1007/s10856-004-5672-1
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 894SM
UT WOS:000226811900005
PM 15880928
DA 2018-10-19
ER

PT J
AU Yang, JM
   Lin, HT
AF Yang, JM
   Lin, HT
TI Properties of chitosan containing PP-g-AA-g-NIPAAm bigraft nonwoven
   fabric for wound dressing
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE polypropylene nonwoven fabric; acrylic acid; N-isopropylacrylamide;
   chitosan; wound dressing
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; WATER-VAPOR TRANSMISSION;
   BIOMATERIAL USAGE; RADIATION; POLYMERIZATION; ACCELERATOR; MORPHOLOGY;
   SURFACES; HEPARIN
AB In this study polypropylene nonwoven fabric (PP) was modified with acrylic acid (AA) by gamma-ray irradiation-induced method to get PP-AA nonwoven fabric. The carboxyl group of the grafted acrylic acid chains was oxidized to peracid group. The peracid group was used as initiator. then N-isopropylacrylamide (NIPAAm) was graft-copolymerized onto PP-g-AA nonwoven fabric with ultraviolet photografting to get PP-q-AA-g-NIPAAm bigraft nonwoven fabric. Chitosan was impregnated onto the PP-g-AA-g-NIPAAm bigraft nonwoven fabric with freeze-drying to form chitosan containing PP-g-AA-g-NIPAAm bigraft nonwoven fabric (PP-g-AA-g-NIPAAm-Chi). The relative wicking time and antibacterial assessment on the modified PP nonwoven fabric were evaluated. The transport of bacterial and water vapor transmission rates, permeance and permeability through the modified nonwoven fabric were also conducted. From the evaluation of these properties, the modified PP nonwoven fabric will be considered for wound dressing in the future. (C) 2004 Elsevier B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
CR Amiji MM, 1996, J BIOMAT SCI-POLYM E, V8, P281, DOI 10.1163/156856296X00309
   CARDONA LR, 1996, BIOMATERIALS, V17, P1639
   Chandy TSP, 1990, ARTIF CELLS ARTIF OR, V18, P1, DOI DOI 10.3109/10731199009117286
   CHEN CC, 2000, Patent No. 6022330
   GREENBERG AE, 1992, STANDARD METHODS EXA, P9
   HIRANO S, 1980, J BIOMED MATER RES, V14, P477, DOI 10.1002/jbm.820140414
   HIRANO S, 1978, AGR BIOL CHEM TOKYO, V42, P1938
   HSIUE GH, 1991, J APPL POLYM SCI, V42, P1899, DOI 10.1002/app.1991.070420712
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   KAIFU K, 1982, J BIOMED MATER RES, V16, P757, DOI 10.1002/jbm.820160602
   KIFUNE K, 1992, ADVANCES IN CHITIN AND CHITOSAN, P9
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Lee WF, 2000, J POLYM RES, V7, P29, DOI 10.1007/s10965-006-0101-4
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Minami S, 1996, CARBOHYD POLYM, V29, P295, DOI 10.1016/S0144-8617(96)00078-1
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   OKAMOTO Y, 1992, ADVANCES IN CHITIN AND CHITOSAN, P70
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Okamoto Y., 1982, BIOMATERIALS, V11, P430
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang JM, 1997, J APPL POLYM SCI, V65, P365, DOI 10.1002/(SICI)1097-4628(19970711)65:2<365::AID-APP17>3.0.CO;2-Z
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   YANO H, 1985, Mie Medical Journal, V35, P53
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 37
TC 65
Z9 70
U1 2
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD NOV 1
PY 2004
VL 243
IS 1-2
BP 1
EP 7
DI 10.1016/j.memsci.2004.03.019
PG 7
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 860TL
UT WOS:000224366100001
DA 2018-10-19
ER

PT J
AU Simon, CG
AF Simon, CG
TI Imaging cells on polymer spherulites
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE biomaterial; birefringence; fluorescence microscopy; osteoblast;
   polymer; poly(lactic acid); spherulite; thin film; tissue engineering
ID CRYSTALLINITY
AB Polymers are commonly used to construct tissue-engineered medical products and the conditions used to process these polymeric materials can affect their biological performance. For semi-crystalline polymers, thermal processing conditions can induce crystallization of the polymer chains into spherulites, which cause the polymer surface to become roughened. This change in surface topology can influence cell behaviours such as adhesion, morphology and proliferation. Herein, a simple microscope technique is presented, which combines fluorescence microscopy with transmitted white light microscopy using crossed polarizers. This technique allows simultaneous imaging of cells and polymer spherulites, which enables the biomaterials researcher to observe the effects of spherulites on cell alignment and morphology.
C1 Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
RP Simon, CG (reprint author), Natl Inst Stand & Technol, Div Polymers, 100 Bur Dr, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
CR Attawia MA, 1996, J ORTHOPAED RES, V14, P445, DOI 10.1002/jor.1100140315
   Park A, 1996, J BIOMED MATER RES, V31, P117
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tsuji H, 1996, POLYMER, V37, P595, DOI 10.1016/0032-3861(96)83146-6
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
NR 7
TC 6
Z9 6
U1 0
U2 6
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD NOV
PY 2004
VL 216
BP 153
EP 155
DI 10.1111/j.0022-2720.2004.01401.x
PN 2
PG 3
WC Microscopy
SC Microscopy
GA 866WL
UT WOS:000224804000006
PM 15516226
DA 2018-10-19
ER

PT J
AU Low, IM
AF Low, IM
TI Depth-profiling of crystal structure, texture, and microhardness in a
   functionally graded tooth enamel
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID SYNCHROTRON-RADIATION DIFFRACTION; MECHANICAL-PROPERTIES; DENTIN;
   DAMAGE; RESISTANCE; JUNCTION; DETAILS; TEETH
AB The graded nature of crystal structure, texture, and microhardness of human enamel has been characterized by grazing-incidence synchrotron radiation diffraction and Vickers indentation. Results show that the composition of tooth enamel consists mainly of calcium apatite or hydroxyapatite (RAP). The RAP crystals formed near the occlusal surface are aligned approximately orthogonal to each other between the axial and occlusal sections. In addition, the tooth enamel has been shown to be a hierarchical graded biomaterial with a distinct gradation in crystallinity, texture, crystallite size, and hardness, which is somewhat akin to that of the fibrous microstructures found in natural plants. A "graded-interface" approach is proposed as a biomimetic model for designing new dental or restorative materials as well as for joining of dissimilar materials.
C1 Curtin Univ Technol, Dept Appl Phys, Mat Res Grp, Perth, WA 6845, Australia.
RP Low, IM (reprint author), Curtin Univ Technol, Dept Appl Phys, Mat Res Grp, Perth, WA 6845, Australia.
RI Low, It Meng/A-1322-2008
OI Low, It Meng/0000-0002-4674-7826
CR AMADA S, 1995, MRS BULL, V20, P35
   BRES EF, 1993, J CRYST GROWTH, V129, P149, DOI 10.1016/0022-0248(93)90444-2
   Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7
   Finke M, 2001, SURF SCI, V491, P456, DOI 10.1016/S0039-6028(01)01311-5
   Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   Jung YG, 1999, J DENT RES, V78, P887, DOI 10.1177/00220345990780040901
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Lim G., 1987, Journal of Materials Research, V2, P471, DOI 10.1557/JMR.1987.0471
   LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901
   LOW IM, 2000, PROCESSING FABRICATI, V8, P365
   LUCAS PW, 1979, BASIC PRINCIPLES TOO, P154
   Luo YM, 2003, MAT SCI ENG A-STRUCT, V345, P99
   Meredith N, 1996, ARCH ORAL BIOL, V41, P539, DOI 10.1016/0003-9969(96)00020-9
   Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3
   Probster L, 1993, Int J Prosthodont, V6, P259
   Singh M, 2002, MATER LETT, V55, P344, DOI 10.1016/S0167-577X(02)00390-7
   Singh M, 2002, MATER RES BULL, V37, P1279, DOI 10.1016/S0025-5408(02)00764-X
   Singh M, 2002, J EUR CERAM SOC, V22, P2877, DOI 10.1016/S0955-2219(02)00056-0
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716
   TENCATE AR, 1989, ORAL HISTOLOGY DEV S
   VINEYARD GH, 1982, PHYS REV B, V26, P4146, DOI 10.1103/PhysRevB.26.4146
   Wang RZ, 1998, J BIOMECH, V31, P135
   WATERS NE, 1980, MECH PROPERTIES BIOL, P99
   Wolf WD, 1996, J AM CERAM SOC, V79, P1769, DOI 10.1111/j.1151-2916.1996.tb07994.x
   Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601
   YOUNG RA, 1974, J DENT RES, V53, P193, DOI 10.1177/00220345740530020601
NR 28
TC 27
Z9 29
U1 1
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
EI 1551-2916
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD NOV
PY 2004
VL 87
IS 11
BP 2125
EP 2131
DI 10.1111/j.1151-2916.2004.tb06369.x
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 880XR
UT WOS:000225824000018
DA 2018-10-19
ER

PT J
AU Silva, FC
   Menezes, GC
AF Silva, FC
   Menezes, GC
TI Osteoblasts attachment and adhesion: how bone cells fit
   fibronectin-coated surfaces
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 2nd Meeting of the Brazilian-Society-for-Materials-Research (Brazil-MRS)
CY OCT 26-29, 2003
CL Rio de Janeiro, BRAZIL
SP Brazilian Soc Mat Res
DE cell attachment; cell adhesion; bone cells; osteoblasts; osteoblasts
   biomaterial interaction relationships
ID EXTRACELLULAR-MATRIX; FORCES
AB Biocompatibility of a material relates, among other factors, to the absence of adverse cellular reactions and modulation of cell interaction and subsequent responses. The assessment of biomaterial compatibility relies on the macroscopic and physiologic cellular responses to material interaction which basically includes two phenomena: (a) cell attachment, which is mainly governed by physico-chemical properties of the interacting surfaces, and (b) cell adhesion, which is, in turn, dictated by molecular properties of both surfaces and also the interaction medium. The aim of this study is to present evidences that attachment and adhesion represent two different types of osteoblast cell responses to fibronectin-coated or uncoated glass surfaces. (C) 2004 Elsevier B.V. All rights reserved.
C1 Fed Univ Rio De Janeiro, Inst Biofis Carlos Chagas Filho, Progr Bioengn & Anim Biotechnol, BR-21949900 Rio De Janeiro, Brazil.
RP Silva, FC (reprint author), Fed Univ Rio De Janeiro, Inst Biofis Carlos Chagas Filho, Progr Bioengn & Anim Biotechnol, CCS Bloco G, BR-21949900 Rio De Janeiro, Brazil.
EM fcsf@biof.ufij.br
RI Menezes, Gustavo/F-6751-2012
CR AKASHI M, 1992, BIOCONJUGATE CHEM, V3, P363, DOI 10.1021/bc00017a002
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Bonilha V L, 1992, Cell Biophys, V20, P1, DOI 10.1007/BF02782651
   BROWN E, 2003, CURR OPIN CELL BIOL, V15, P1
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Freyman TM, 2001, EXP CELL RES, V269, P140, DOI 10.1006/excr.2001.5302
   Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498
   Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6
   HYNES RO, 1999, TRENDS CELL BIOL, V9, P33
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   SCHWARTZ MA, 2001, CURR OPIN CELL BIOL, V13, P525
   Van Oss CJ, 2001, CELL MOL BIOL, V47, P721
   VANOSS CJ, 1983, VOX SANG, V44, P183
   WEBB DJ, 2003, CURR OPIN CELL BIOL, V15, P1
   Webb Donna J, 2002, Nat Cell Biol, V4, pE97
   Zamir E, 2000, NAT CELL BIOL, V2, P191
NR 21
TC 10
Z9 11
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD NOV 1
PY 2004
VL 24
IS 5
BP 637
EP 641
DI 10.1016/j.msec.2004.08.036
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 879PY
UT WOS:000225730900010
DA 2018-10-19
ER

PT J
AU Silva, CCG
   Higa, OZ
   Bressiani, JC
AF Silva, CCG
   Higa, OZ
   Bressiani, JC
TI Cytotoxic evaluation of silicon nitride-based ceramics
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 2nd Meeting of the Brazilian-Society-for-Materials-Research (Brazil-MRS)
CY OCT 26-29, 2003
CL Rio de Janeiro, BRAZIL
SP Brazilian Soc Mat Res
DE silicon nitride; biomaterial; cytotoxicity
ID PROSTHESES
AB Silicon nitride-based ceramics are potential candidates as materials for orthopedic implants due to their chemical stability associated with suitable fracture toughness and propitious tribologic characteristics. Therefore, in this work, dense silicon nitride components are investigated considering their suitability as biomaterials. Initially, two different compositions of silicon nitride were considered, using ytterbium, yttrium and aluminum oxides as sintering aids. The materials were sintered in a carbon resistance furnace under nitrogen atmosphere and were analyzed by means of X-ray diffraction (XRD) and scanning electron microscopy (SEM) in order to characterize the microstructure. Indentation method was applied in order to obtain hardness and fracture toughness measurements, and in vitro test of cytotoxicity was performed for a preliminary biological evaluation. A microstructure composed of grains of beta-silicon nitride distributed in a secondary phase was observed. The samples achieved fracture toughness values of 5 MPa m(1/2) and Vickers hardness values of 13 GPa. Since a nontoxic behavior has been observed during the cytotoxicity tests with the samples, this finding suggests that silicon nitride-based ceramic can be used as a material for clinical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 CTMSP, Ctr Tecnol Marinha Sao Paulo, BR-05508000 Sao Paulo, Brazil.
   IPEN CNEN SP, BR-05508000 Sao Paulo, Brazil.
RP Silva, CCG (reprint author), CTMSP, Ctr Tecnol Marinha Sao Paulo, Av Prof Lineu Prestes 2468,Cidade Univ, BR-05508000 Sao Paulo, Brazil.
RI Bressiani, Jose/I-1426-2012; Guedes e Silva, Cecilia/A-9658-2014
CR Antis G. R., 1981, J AM CERAM SOC, V64, P533, DOI DOI 10.1111/J.1151-2916.1981.TB10320.X
   FREDEL MC, 1996, MAT SCI, V23, P4375
   *INT STAND ORG, 1992, 10993 ISO
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Morita Y, 2003, WEAR, V254, P147, DOI 10.1016/S0043-1648(02)00296-X
   NAKAMURA A, 1989, P JAP AT RES I JAERI, P79
   OLSSON PO, 1990, J MATER SCI, V25, P1824, DOI 10.1007/BF01045393
   Santos J. D., 2001, KEY ENG MATER, V192-195, P589
   Trindade MCD, 2001, BIOMATERIALS, V22, P253, DOI 10.1016/S0142-9612(00)00181-2
   Zhou YS, 1997, MAT SCI ENG C-BIOMIM, V5, P125, DOI 10.1016/S0928-4931(97)00032-5
NR 10
TC 25
Z9 26
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD NOV 1
PY 2004
VL 24
IS 5
BP 643
EP 646
DI 10.1016/j.msec.2004.08.007
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 879PY
UT WOS:000225730900011
DA 2018-10-19
ER

PT J
AU Teixeira, MI
   Andrade, LR
   Farina, M
   Rocha-Leao, MHM
AF Teixeira, MI
   Andrade, LR
   Farina, M
   Rocha-Leao, MHM
TI Characterization of short chain fatty acid microcapsules produced by
   spray drying
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 2nd Meeting of the Brazilian-Society-for-Materials-Research (Brazil-MRS)
CY OCT 26-29, 2003
CL Rio de Janeiro, BRAZIL
SP Brazilian Soc Mat Res
DE gum arabic; maltodextrin; scanning electron microscopy; SCFA
   microcapsules; spray drying
ID PROPIONIC-ACID; MICROENCAPSULATION; CARBOHYDRATE; FLAVORS; CELLS
AB Microcapsules containing short chain fatty acids (SCFA) were produced by spray drying technique using different proportions of gum arabic and maltodextrin as wall materials. Proportions of 5% and 10% of gum arabic and maltodextrin isolated, and a mixture of 5% of maltodextrin and 5% of gum arabic were added to samples of fermented permeate containing SCFA, and spray dried. The microstructure of microcapsules was studied by scanning electron microscopy (SEM) and the size distribution was obtained by laser diffraction. SEM observations showed that the microcapsules structures were affected by type and proportion of wall material tested. Most of the microcapsules containing gum arabic as wall material had surface dents or invaginations. Microcapsules containing maltodextrin were spherical with few surface dents and some of them had pores. The larger microcapsule sizes were observed in those containing maltodextrin. Our results show that microstructure and size of microcapsules are affected by type and proportion of biomaterial used. The samples containing 5% of maltodextrin and the mixture of 5% of gum arabic with 5% of maltodextrin presented smooth surfaces and homogenous size distributions. The corresponding microcapsules are considered optimal to food industrial uses due to the flowability property. Besides, these capsules were found to present a homogenous distribution of diameters, which may give a homogenous flavor distribution to the food products. (C) 2004 Elsevier B.V. All rights reserved.
C1 Fed Univ Rio De Janeiro, Inst Quim, Ctr Tecnol, Programa Posgrad Ciencia Alimentos, BR-21910900 Rio De Janeiro, Brazil.
   Fed Univ Rio De Janeiro, CCS, Inst Ciencias Biomed, Dept Histol & Embriol, BR-21941590 Rio De Janeiro, Brazil.
   Fed Univ Rio De Janeiro, Escola Quim, Dept Engn Bioquim, BR-21910900 Rio De Janeiro, Brazil.
RP Rocha-Leao, MHM (reprint author), Fed Univ Rio De Janeiro, Inst Quim, Ctr Tecnol, Programa Posgrad Ciencia Alimentos, Bloco A, BR-21910900 Rio De Janeiro, Brazil.
EM mhrl@eq.uftj.br
RI Andrade, Leonardo/C-9554-2011
OI Andrade, Leonardo/0000-0002-0004-5677
CR Aguilera J.M., 1990, MICROSTRUCTURAL PRIN, P309
   BHANDARI BR, 1992, J FOOD SCI, V57, P217, DOI 10.1111/j.1365-2621.1992.tb05459.x
   COLOMBAN A, 1993, BIOTECHNOL BIOENG, V42, P1091, DOI 10.1002/bit.260420911
   JACKSON LS, 1991, FOOD SCI TECHNOL-LEB, V24, P289
   Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj/cdd/4400935
   JANSSENS L, 1992, PROCESS BIOCHEM, V27, P195, DOI 10.1016/0032-9592(92)80020-4
   Krings U, 1998, APPL MICROBIOL BIOT, V49, P1, DOI 10.1007/s002530051129
   MARCOUX V, 1992, J FERMENTATION BIOEN, V74, P295
   PAIK HD, 1994, APPL MICROBIOL BIOT, V42, P22, DOI 10.1007/s002530050210
   Re MI, 1998, DRY TECHNOL, V16, P1195, DOI 10.1080/07373939808917460
   ROSENBERG M, 1985, J FOOD SCI, V50, P139, DOI 10.1111/j.1365-2621.1985.tb13295.x
   Sheu TY, 1998, J FOOD SCI, V63, P491, DOI 10.1111/j.1365-2621.1998.tb15770.x
   SHEU TY, 1995, J FOOD SCI, V60, P98, DOI 10.1111/j.1365-2621.1995.tb05615.x
   TEIXEIRA MI, SINAFERM 15 S NAC FE
   Yang ST, 1995, J DAIRY SCI, V78, P2541, DOI 10.3168/jds.S0022-0302(95)76884-9
NR 15
TC 70
Z9 76
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD NOV 1
PY 2004
VL 24
IS 5
BP 653
EP 658
DI 10.1016/j.msec.2004.08.008
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 879PY
UT WOS:000225730900013
DA 2018-10-19
ER

PT J
AU Yoshida, K
   Mishina, H
   Sasaki, S
   Morita, M
   Mabuchi, K
AF Yoshida, K
   Mishina, H
   Sasaki, S
   Morita, M
   Mabuchi, K
TI Development of 3Y-PSZ/AISI 316L composites for joint prostheses
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE joint prostheses; biomaterial; PSZ-AISI 316L composite; toughness; wear
   resistance
AB The authors developed 3Y-PSZ/AISI 316L composites for the bearings of joint prostheses, which were then evaluated in terms of their mechanical properties, such as density, hardness, bending strength, fracture toughness and wear resistance, as well as corrosion resistance. The composites (AIST 3 16L contents were 0, 10, 20 and 30 vol%) were fabricated by spark plasma sintering. The composites consist of tetragonal zirconia and austenite stainless steel. The Vickers hardness and bi-axial bending strength of the composite decrease from 14.3 GPa to 8.93 GPa and 1585 MPa to 617 MPa, respectively, when the AISI 316L content is increased from 0 vol% to 30 vol%. Fracture toughness of the composite increased from 4.99 MPa-m(1/2) to 6.03 MPa-m(1/2). The composites showed improved wear resistance (3Y-PSZ; 3.08 x 10(-10) mm(2)/N, 10vol% composite; 2.11 x 10(-10) mm(2)/N, 20 vol% composite; 0.28 x 10(-10) mm(2)/N, 30vol% composite; 0.00 x 10(-10) mm(2)/N). The wear resistance of the 30vol% composite was higher than conventional biometal and bioceramic (AISI 316L; 35.4 x 10(-10) mm(2)/N, Co-28Cr-6Mo; 11.0 x 10(-10) mm(2)/N, Al2O3; 0.30 x 10(-10) mm(2)/N). The composites showed more than 3 times greater corrosion resistance than the monolithic AIST 316L in PBS(-) at 37degreesC. In particular, nickel ion release was lower than for AISI 316L. The corrosion resistance of 30 vol% composite during the wear test was more than 37 times higher than for AISI 316L. The 30 vol% composite was successfully toughened and showed higher resistance to wear and corrosion when used as hearing material for joint prostheses.
C1 Chiba Univ, Grad Sch Sci & Technol, Dept Artificial Sci & Syst, Chiba 2630022, Japan.
   Chiba Univ, Fac Engn, Dept Elect & Mech Engn, Chiba 2630022, Japan.
   Natl Inst Adv Ind Sci & Technol, AIST, Tsukuba, Ibaraki 3058564, Japan.
   Saitama Univ, Fac Engn, Dept Mech Engn, Sakura Ku, Urawa, Saitama 3388570, Japan.
   Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2288555, Japan.
RP Yoshida, K (reprint author), Chiba Univ, Grad Sch Sci & Technol, Dept Artificial Sci & Syst, Chiba 2630022, Japan.
CR *ASTM, 1996, F39478 ASTM
   CHARNLEY J, 1961, LANCET, V27, P1129
   DAVIDSON JA, 1989, 8TH P SO BIOM ENG C, P33
   *JIS, 1998, R1634 JIS
   *JIS, 1996, R1625 JIS
   *JIS, 1991, R1610 JIS
   Jung YG, 1997, J MATER SCI, V32, P3841, DOI 10.1023/A:1018640126751
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   NIIHARA K, 1982, J AM CERAM SOC, V65, pC116
   SUZUKI K, 1993, METAL ALLERGY NO MOR, P79
   Weibull W., 1939, ING VETENSKAPS AKAD, V151, P1
   Wildan M, 2002, MATER CHEM PHYS, V75, P276, DOI 10.1016/S0254-0584(02)00076-7
   WILES P, 1958, BRIT J SURG, V45, P488, DOI 10.1002/bjs.18004519315
   YAMADA Y, 1994, J JPN I MET, V58, P162, DOI 10.2320/jinstmet1952.58.2_162
NR 14
TC 9
Z9 9
U1 0
U2 2
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD NOV
PY 2004
VL 45
IS 11
BP 3209
EP 3215
DI 10.2320/matertrans.45.3209
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 876LE
UT WOS:000225497500020
OA Bronze
DA 2018-10-19
ER

PT J
AU Bini, TB
   Gao, SJ
   Tan, TC
   Wang, S
   Lim, A
   Hai, LB
   Ramakrishna, S
AF Bini, TB
   Gao, SJ
   Tan, TC
   Wang, S
   Lim, A
   Hai, LB
   Ramakrishna, S
TI Electrospun poly(L-lactide-co-glycolide) biodegradable polymer nanofibre
   tubes for peripheral nerve regeneration
SO NANOTECHNOLOGY
LA English
DT Article
ID IN-VITRO; CONDUIT; GUIDE; BIOCOMPATIBILITY; REPAIR; TISSUE;
   POLY(PHOSPHOESTER); GRAFTS; FIBERS
AB Nanotechnology is an area receiving increasing attention as progress is made towards tailoring the morphology of polymeric biomaterial for a variety of applications. In the present study an attempt was made to electrospin poly(L-lactide-co-glycolide) biodegradable polymer nanofibres. In this process, polymer fibres with diameters down to the nanometre range are formed by subjecting a fluid jet to a high electric field. The nanofibres were collected on to a rotating Teflon mandrel and fabricated to tubes or conduits, to function as nerve guidance channels. The feasibility of in vivo nerve regeneration was investigated through several of these conduits. The biological performance of the conduits were examined in the rat sciatic nerve model with a 10 mm gap length. After implantation of the nanofibre nerve guidance conduit to the right sciatic nerve of the rat, there was no inflammatory response. One month after implantation five out of eleven rats showed successful nerve regeneration. None of the implanted tubes showed tube breakage. The nanofibre nerve guidance conduits were flexible, permeable and showed no swelling. Thus, these new poly(L-lactide-co-glycolide) nanofibre conduits can be effective aids for nerve regeneration and repair. Improvements could be done by impregnating nerve growth factors or Schwann cells and may lead to clinical applications.
C1 Natl Univ Singapore, Dept Mech Engn, Bioengn Div, Singapore 119260, Singapore.
   Natl Univ Singapore, Mol & Biomat Lab, Inst Mat Sci & Engn, Singapore 117602, Singapore.
   Natl Univ Singapore, Natl Univ Hosp, Dept Hand & Reconstruct Microsurg, Singapore 119074, Singapore.
RP Bini, TB (reprint author), Natl Univ Singapore, Dept Mech Engn, Bioengn Div, Singapore 119260, Singapore.
RI wang, shu/H-6744-2012
CR Aldini NN, 1996, BIOMATERIALS, V17, P959, DOI 10.1016/0142-9612(96)84669-2
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   DENDUNNEN WFA, 1995, J BIOMED MATER RES, V29, P757, DOI 10.1002/jbm.820290612
   FoidartDessalle M, 1997, EXP NEUROL, V148, P236, DOI 10.1006/exnr.1997.6542
   GIARDINO R, 1995, INT J ARTIF ORGANS, V18, P225
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   JENQ CB, 1987, EXP NEUROL, V97, P662, DOI 10.1016/0014-4886(87)90123-3
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kenawy ER, 2003, BIOMATERIALS, V24, P907, DOI 10.1016/S0142-9612(02)00422-2
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Meek MF, 1996, MICROSURG, V17, P555, DOI 10.1002/(SICI)1098-2752(1996)17:10<555::AID-MICR5>3.0.CO;2-P
   Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   ZONG X, 2002, POLYMER, V42, P4402
NR 21
TC 130
Z9 136
U1 3
U2 47
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD NOV
PY 2004
VL 15
IS 11
BP 1459
EP 1464
AR PII S0957-4484(04)76545-9
DI 10.1088/0957-4484/15/11/014
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 876PK
UT WOS:000225509200014
DA 2018-10-19
ER

PT J
AU Chew, BH
   Denstedt, JD
AF Chew, Ben H.
   Denstedt, John D.
TI Technology Insight: novel ureteral stent materials and designs
SO NATURE CLINICAL PRACTICE UROLOGY
LA English
DT Review
DE biomaterial; encrustation; obstruction; stent; ureter
AB Ureteral stents are an important tool for aiding upper urinary tract drainage, but can cause significant patient morbidity. Common problems include stent-induced pain, hematuria, dysuria, infection, and encrustation. From a urologist's perspective, stents must be easy to maneuver in the urinary tract, radiopaque, and affordable. Since the development of the modern day stent in 1978, stents have evolved to include softer biomaterials that are more resistant to encrustation and infection. An ideal biomaterial is one that is not affected by its environment and does not elicit reactive changes in surrounding tissues. To date, the ideal biomaterial or stent does not exist. This review discusses developments that address the issues of infection, biofilm formation, encrustation, and patient comfort. Stent materials including polyurethane, silicone, biodegradable substances and new combination polymers are reviewed, in addition to novel stent coatings such as heparin, hydrogel, and silver nitrate. Ureteral stent technologies currently lag behind vascular stents, particularly drug-eluting stents, but new developments will continue to improve these essential urological tools.
C1 Univ Western Ontario, Dept Surg, Div Urol, London, ON N6A 4V2, Canada.
RP Denstedt, JD (reprint author), Univ Western Ontario, Dept Surg, Div Urol, London, ON N6A 4V2, Canada.
EM John.Denstedt@sjhc.london.on.ca
CR Amiel GE, 2001, J UROLOGY, V165, P2091, DOI 10.1016/S0022-5347(05)66300-8
   Barbalias GA, 2002, J UROLOGY, V168, P2383, DOI 10.1097/01.ju.0000032172.60874.6d
   Barbalias GA, 2002, EUR UROL, V42, P276, DOI 10.1016/S0302-2838(02)00281-6
   BEIKO DT, IN PRESS J ENDOUROL
   Bloom DA, 1999, UROLOGY, V54, P767, DOI 10.1016/S0090-4295(99)00305-2
   CHEW BH, 2004, IN PRESS P 56 ANN M
   Chitale SV, 2002, CLIN RADIOL, V57, P1118, DOI 10.1053/crad.2002.1114
   Choong S, 2000, BJU INT, V86, P935, DOI 10.1046/j.1464-410x.2000.00949.x
   Damiano R, 2004, EUR UROL, V46, P381, DOI 10.1016/j.eururo.2004.04.004
   Damiano R, 2002, UROL INT, V69, P136, DOI 10.1159/000065563
   Daskalopoulos G, 2001, EUR J RADIOL, V39, P194, DOI 10.1016/S0720-048X(01)00331-X
   Denstedt JD, 2001, J UROLOGY, V165, P1419, DOI 10.1016/S0022-5347(05)66320-3
   Desgrandchamps F, 1997, BRIT J UROL, V79, P24, DOI 10.1046/j.1464-410X.1997.02775.x
   Dunn MD, 2000, J ENDOUROL, V14, P195, DOI 10.1089/end.2000.14.195
   FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Granada Juan F, 2003, Curr Atheroscler Rep, V5, P308, DOI 10.1007/s11883-003-0054-6
   Hosking DH, 1999, J UROLOGY, V161, P48, DOI 10.1016/S0022-5347(01)62058-5
   *HOUGHT MIFFL CO, 2000, AM HER DICT ENGL LAN
   Isotalo T, 2002, J ENDOUROL, V16, P759, DOI 10.1089/08927790260472926
   Jones DS, 2004, BIOMATERIALS, V25, P1421, DOI 10.1016/j.biomaterials.2003.08.01
   Joshi HB, 2003, J UROLOGY, V169, P1065, DOI 10.1097/01.ju.0000048980.33855.90
   Kulkarni R, 2001, J UROLOGY, V166, P1750, DOI 10.1016/S0022-5347(05)65667-4
   Laaksovirta S, 2002, J ENDOUROL, V16, P311, DOI 10.1089/089277902760102811
   Landman J, 2004, J UROLOGY, V171, P2450, DOI 10.1097/01.ju.0000127756.64619.27
   Liatsikos EN, 2002, UROLOGY, V59, P15, DOI 10.1016/S0090-4295(01)01475-3
   Lingeman JE, 2003, J ENDOUROL, V17, P169, DOI 10.1089/089277903321618734
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   MARX M, 1988, J UROLOGY, V139, P180, DOI 10.1016/S0022-5347(17)42349-4
   Mittelman MW, 2004, J UROLOGY, V171, P443
   Multanen M, 2000, UROL RES, V28, P327, DOI 10.1007/s002400000133
   Multanen M, 2002, UROL RES, V30, P227, DOI 10.1007/s00240-002-0252-7
   O'Connor RC, 2002, UROLOGY, V60, P906, DOI 10.1016/S0090-4295(02)01965-9
   Olweny EO, 2002, J UROLOGY, V167, P2198, DOI 10.1016/S0022-5347(05)65128-2
   Paick SH, 2003, UROLOGY, V62, P214, DOI 10.1016/S0090-4295(03)00325-X
   PAUER W, 1992, J UROLOGY, V148, P281, DOI 10.1016/S0022-5347(17)36573-4
   Reid G, 2001, INT J ANTIMICROB AG, V17, P317, DOI 10.1016/S0924-8579(00)00353-8
   Riedl CR, 1999, EUR UROL, V36, P53, DOI 10.1159/000019927
   Riedl CR, 2002, INT J ANTIMICROB AG, V19, P507, DOI 10.1016/S0924-8579(02)00097-3
   Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6
   Smith TG, 2002, UROLOGY, V60, P931, DOI 10.1016/S0090-4295(02)01890-3
   Stickler DJ, 2002, INT J ANTIMICROB AG, V19, P499, DOI 10.1016/S0924-8579(02)00091-2
   Stoller ML, 2000, BJU INT, V85, P628, DOI 10.1046/j.1464-410x.2000.00489.x
   Taylor WN, 2002, J UROLOGY, V168, P2020, DOI 10.1097/01.ju.0000033964.15384.e2
   Tieszer C, 1998, J UROLOGY, V160, P876, DOI 10.1016/S0022-5347(01)62825-8
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Watterson JD, 2003, J ENDOUROL, V17, P523, DOI 10.1089/089277903769013711
   Watterson JD, 2003, J ENDOUROL, V17, P269, DOI 10.1089/089277903322145431
   Zupkas P, 2000, J ENDOUROL, V14, P483, DOI 10.1089/end.2000.14.483
NR 51
TC 28
Z9 29
U1 1
U2 17
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1743-4270
J9 NAT CLIN PRACT UROL
JI Nat. Clin. Pract. Urol.
PD NOV
PY 2004
VL 1
IS 1
BP 44
EP 48
DI 10.1038/ncpuro0014
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA V43JH
UT WOS:000202930900014
PM 16474466
DA 2018-10-19
ER

PT J
AU Yuan, J
   Zhu, J
   Zhu, CH
   Shen, J
   Lin, SC
AF Yuan, J
   Zhu, J
   Zhu, CH
   Shen, J
   Lin, SC
TI Platelet adhesion on a polyurethane surface grafted with a zwitterionic
   monomer of sulfobetaine via a Jeffamine spacer
SO POLYMER INTERNATIONAL
LA English
DT Article
DE zwitterion; sulfobetaine; polyurethane; Jeffamine; platelet adhesion;
   non-thrombogenic biomaterials
ID IMPROVING BLOOD COMPATIBILITY; OXIDE) COUPLING-POLYMER;
   CHEMICAL-MODIFICATION; POLY(ETHER URETHANE); VINYL MONOMER; COPOLYMERS;
   HEMOCOMPATIBILITY; FILM; IMMOBILIZATION; CHITOSAN
AB A possible approach to improve the blood compatibility of poly(ether urethane)s (PU) involves the covalent attachment of key molecules on its surface. The purpose of the present study was to design and synthesise a novel non-thrombogenic biomaterial by modifying the surface of the PU with a zwitterionic monomer of sulfobetaine via a Jeffamine spacer. In this study, sulfobetaine was grafted onto a PU surface through the following reaction steps: (1) The PU surface was activated with hexamethylene diisocyanate (HDI) in toluene at 50degreesC in the presence of di-n-butyltin dilaurate (DBTDL) as a catalyst. The extent of the reaction was measured by ATR-FTIR spectra; a maximum number of free NCO groups was obtained after a reaction time of 90 min. (2) One cap of Jeffamine was reacted with isocyanate groups bound on the surface, so Jeffamine was introduced. (3) The PU surface terminated by Jeffamine was recoupled with isocyanate groups by HDI. (4) The hydroxyl groups of 4-dimethylamino-1-butanol (DMAB) or 2-dimethylaminoethanol (DMAE) were allowed to react with the isocyanate groups capped on Jeffamine. (5) Sulfobetaines were constructed on the surface through the ring-opening reaction between tertiary amine and 1,3-propanesultone (PS). It was confirmed by ATR-FTIR and XPS that the grafted surfaces were composed of sulfobetaine. The results of the contact-angle measurements and water absorption showed that they were strongly hydrophilic. The results of this platelet adhesion experiment as a preliminary test showed that PU grafted with sulfobetaine has good blood compatibility featured by the low platelet adhesion. (C) 2004 Society of Chemical Industry.
C1 Nanjing Univ, Coll Chem & Chem Engn, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Coll Chem & Chem Engn, Nanjing 210093, Peoples R China.
EM alchem@eyou.com
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   CHRISTINA FL, 1993, J APPL POLYM SCI, V50, P345
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Harris J. M., 1992, POLYM B
   HART R, 1958, J POLYM SCI, V28, P638, DOI 10.1002/pol.1958.1202811820
   Hwang JS, 1998, BIOMATERIALS, V19, P1189, DOI 10.1016/S0142-9612(98)00008-8
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Kurusu F, 2003, POLYM ADVAN TECHNOL, V14, P27, DOI 10.1002/pat.286
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LELAH MD, 1968, POLYURETHANE MED, P57
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Liaw DJ, 2000, POLYMER, V41, P6123, DOI 10.1016/S0032-3861(99)00824-1
   Lin JC, 2001, J MATER SCI-MATER M, V12, P827, DOI 10.1023/A:1017937304964
   Lowe AB, 2000, J BIOMED MATER RES, V52, P88, DOI 10.1002/1097-4636(200010)52:1<88::AID-JBM11>3.0.CO;2-#
   Lowe AB, 2002, CHEM REV, V102, P4177, DOI 10.1021/cr020371t
   MCCORMICK CL, 1992, POLYMER, V33, P4617, DOI 10.1016/0032-3861(92)90422-S
   Monroy V.M., 1984, POLYMER, V25, P121
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   SALAMONE JC, 1977, POLYMER, V18, P1058, DOI 10.1016/0032-3861(77)90013-1
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Wang DA, 2002, BIOCONJUGATE CHEM, V13, P792, DOI 10.1021/bc0255079
   Wang DA, 2001, J BIOMED MATER RES, V58, P372, DOI 10.1002/jbm.1031
   Yuan J, 2003, POLYM INT, V52, P1869, DOI 10.1002/pi.1277
   Yuan J, 2003, J BIOMATER APPL, V18, P123, DOI 10.1177/088532803038100
   Yuan J, 2003, CHINESE J POLYM SCI, V21, P419
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan J, 2003, COLLOID SURFACE B, V30, P147, DOI 10.1016/S0927-7765(03)00082-1
   [袁江 Yuan Jiang], 2003, [应用化学, Chinese Journal of Applied Chemistry], V20, P269
   Yuan YL, 2004, POLYM INT, V53, P121, DOI 10.1002/pi.1122
   Yuan YL, 2003, COLLOID SURFACE B, V29, P247, DOI 10.1016/S0927-7765(02)00210-2
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   Zhang J, 2003, COLLOID SURFACE B, V30, P249, DOI 10.1016/S0927-7765(03)00069-9
   Zhang J, 2003, BIOMATERIALS, V24, P4223, DOI 10.1016/S0142-9612(03)00365-X
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhang J, 2003, EUR POLYM J, V39, P847, DOI 10.1016/S0014-3057(02)00286-0
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
NR 44
TC 20
Z9 21
U1 1
U2 36
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD NOV
PY 2004
VL 53
IS 11
BP 1722
EP 1728
DI 10.1002/pi.1545
PG 7
WC Polymer Science
SC Polymer Science
GA 864BL
UT WOS:000224607700018
DA 2018-10-19
ER

PT J
AU Lucchinetti, E
   Stussi, E
AF Lucchinetti, E
   Stussi, E
TI Prediction of elasticity constants in small biomaterial samples such as
   bone. A comparison between classical optimization techniques and
   identification with artificial neural networks
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE inverse problems; elasticity; optimization; neural networks
ID ALGORITHM
AB Measuring the elasticity constants of biological materials often sets important constraints, such as the limited size or the irregular geometry of the samples. In this paper, the identification approach as applied to the specific problem of accurately retrieving the material properties of small bone samples from a measured displacement field is discussed. The identification procedure can be formulated as an optimization problem with the goal of minimizing the difference between computed and measured displacements by searching for an appropriate set of material parameters using dedicated algorithms. Alternatively, the backcalculation of the material properties from displacement maps can be implemented using artificial neural networks. In a practical situation, however, measurement errors strongly affect the identification results, calling for robust optimization approaches in order accurately to retrieve the material properties from error-polluted sample deformation maps. Using a simple model problem, the performances of both classical and neural network driven optimization are compared. When performed before the collection of experimental data, this evaluation can be very helpful in pinpointing potential problems with the envisaged experiments such as the need for a sufficient signal-to-noise ratio, particularly important when working with small tissue samples such as specimens cut from rodent bones or single bone trabeculae.
C1 Univ Zurich, Inst Pharmacol, Sect Cardiovasc Res, CH-8057 Zurich, Switzerland.
   Swiss Fed Inst Technol, Dept Mat, Biomech Lab, Schlieren, Switzerland.
RP Lucchinetti, E (reprint author), Univ Zurich, Inst Pharmacol, Sect Cardiovasc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM eliana.zaugg@pharma.unizh.ch
CR Beck JV, 1977, PARAMETER ESTIMATION
   Burnett D. S., 1987, FINITE ELEMENT ANAL
   Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274
   den Camp OMGCO, 1999, INT J NUMER METH ENG, V45, P1315, DOI 10.1002/(SICI)1097-0207(19990730)45:9<1315::AID-NME633>3.0.CO;2-A
   Fletcher R., 1987, PRACTICAL METHODS OP
   Goldberg DE, 2000, COMPUT METHOD APPL M, V186, P121, DOI 10.1016/S0045-7825(99)00380-1
   Haykin S., 1999, NEURAL NETWORKS COMP
   HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8
   Hughes T. J. R., 1987, FINITE ELEMENT METHO
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Lucchinetti E, 2002, INVERSE PROBL, V18, P837, DOI 10.1088/0266-5611/18/3/320
   MOULTON MJ, 1995, J BIOMECH, V28, P935, DOI 10.1016/0021-9290(94)00144-S
   NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308
   OOMENS CWJ, 1993, J BIOMECH, V26, P617, DOI 10.1016/0021-9290(93)90024-9
   Scales LE., 1985, INTRO NONLINEAR OPTI
   SCHALKO RJ, 1997, ARTIFICIAL NEURAL NE
   Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X
   WHITLEY D, 1994, STAT COMPUT, V4, P65
NR 18
TC 2
Z9 2
U1 0
U2 4
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD NOV
PY 2004
VL 218
IS H6
BP 389
EP 405
DI 10.1243/0954411042632090
PG 17
WC Engineering, Biomedical
SC Engineering
GA 923VD
UT WOS:000228936500003
PM 15648663
DA 2018-10-19
ER

PT J
AU Naumann, A
   Dennis, JE
   Aigner, J
   Coticchia, J
   Arnold, J
   Berghaus, A
   Kastenbauer, ER
   Caplan, AI
AF Naumann, A
   Dennis, JE
   Aigner, J
   Coticchia, J
   Arnold, J
   Berghaus, A
   Kastenbauer, ER
   Caplan, AI
TI Tissue engineering of autologous cartilage grafts in three-dimensional
   in vitro macroaggregate culture system
SO TISSUE ENGINEERING
LA English
DT Article
ID ARTICULAR-CARTILAGE; GROWTH-FACTOR; BIOMECHANICAL PROPERTIES; ALGINATE
   BEADS; HUMAN BONE; CHONDROCYTES; COLLAGEN; RECONSTRUCTION;
   PERICHONDRIUM; INSULIN
AB In the field of tissue engineering, techniques have been described to generate cartilage tissue with isolated chondrocytes and bioresorbable or nonbioresorbable biomaterials serving as three-dimensional cell carriers. In spite of successful cartilage engineering, problems of uneven degradation of biomaterial, and unforeseeable cell - biomaterial interactions remain. This study represents a novel technique to engineer cartilage by an in vitro macroaggregate culture system without the use of biomaterials. Human nasoseptal or auricular chondrocytes were enzymatically isolated and amplified in conventional monolayer culture before the cells were seeded into a cell culture insert with a track-etched membrane and cultured in vitro for 3 weeks. The new cartilage formed within the in vitro macroaggregates was analyzed by histology ( toluidine blue, von Kossa-safranin O staining), and immunohistochemistry ( collagen types I, II, V, VI, and X and elastin). The total glycosaminoglycan ( GAG) content of native and engineered auricular as well as nasal cartilage was assayed colorimetrically in a safranin O assay. The biomechanical properties of engineered cartilage were determined by biphasic indentation assay. After 3 weeks of in vitro culture, nasoseptal and auricular chondrocytes synthesized new cartilage with the typical appearance of hyaline nasal cartilage and elastic auricular cartilage. Immunohistochemical staining of cartilage samples showed a characteristic pattern of staining for collagen antibodies that varied in location and intensity. In all samples, intense staining for cartilage-specific collagen types I, II, and X was observed. By the use of von Kossa - safranin O staining a few positive patches - a possible sign of beginning mineralization within the engineered cartilages - were detected. The unique pattern for nasoseptal cartilage is intense staining for type V collagen, whereas auricular cartilage is only weakly positive for collagen types V and VI. Engineered nasal and auricular macroaggregates were negative for anti-elastin antibody (interterritorially). The measurement of total GAG content demonstrated higher GAG content for reformed nasoseptal cartilage compared with elastic auricular cartilage. However, the total GAG content of engineered macroaggregates was lower than that of native cartilage. In spite of the mechanical stability of the auricular macroaggregates, there was no equilibrium of indentation. The histomorphological and immunohistochemical results demonstrate successful cartilage engineering without the use of biomaterials, and identify characteristics unique to hyaline as well as elastic cartilage. The GAG content of engineered cartilage was lower than in native cartilage and the biomechanical properties were not determinable by indentation assay. This study illustrates a novel in vitro macroaggregate culture system as a promising technique for tissue engineering of cartilage grafts. Further long-term in vitro and in vivo studies must be done before this method can be applied to reconstructive surgery of the nose or auricle.
C1 Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, D-81377 Munich, Germany.
   Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA.
   Tech Univ Munich, Inst Med Engn, D-8000 Munich, Germany.
   Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.
RP Naumann, A (reprint author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.
EM andreas.naumann@med.uni-muenchen.de
OI Caplan, Arnold/0000-0002-8677-6621
FU NIDCR NIH HHS [DE 015322]
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Aigner J, 1997, IN VITRO CELL DEV-AN, V33, P407, DOI 10.1007/s11626-997-0054-x
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BREITBART AS, 1998, CURR OPIN OTOLARYNGO, V6, P226
   Brent B, 1999, PLAST RECONSTR SURG, V104, P319, DOI 10.1097/00006534-199908000-00001
   BURGESON RE, 1982, J BIOL CHEM, V257, P7852
   BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   CARRINO DA, 1991, BIOCHEM INT, V24, P485
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Cogswell LK, 2000, BRIT J PLAST SURG, V53, P117, DOI 10.1054/bjps.1999.3233
   COX RW, 1977, J ANAT, V123, P283
   DICKSON WA, 1988, BRIT J PLAST SURG, V41, P408, DOI 10.1016/0007-1226(88)90083-5
   Dounchis JS, 1997, J ORTHOPAED RES, V15, P803, DOI 10.1002/jor.1100150603
   FROESCH ER, 1985, DIABETOLOGIA, V28, P485, DOI 10.1007/BF00281982
   GIBSON GJ, 1984, J CELL BIOL, V99, P208, DOI 10.1083/jcb.99.1.208
   GUENTHER HL, 1982, EXPERIENTIA, V38, P979, DOI 10.1007/BF01953688
   Habiballah JA, 2000, SAUDI MED J, V21, P1173
   Hammer C, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P3
   Homicz Mark R, 2003, Arch Facial Plast Surg, V5, P53
   HUETTENBRINK KB, 1995, LARYN RHINOL OTOL, V69, P327
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Kamil SH, 2003, LARYNGOSCOPE, V113, P90, DOI 10.1097/00005537-200301000-00017
   Kaplan Brian A, 2003, Arch Facial Plast Surg, V5, P96
   KASTENBAUER ER, 1983, HNO, V31, P371
   KASUGA M, 1981, J BIOL CHEM, V256, P5305
   Klein-Nulend J, 1998, J BIOMED MATER RES, V40, P614, DOI 10.1002/(SICI)1097-4636(19980615)40:4<614::AID-JBM13>3.0.CO;2-F
   KUBLER N, 1993, J ORAL MAXIL SURG, V51, P1346
   Loty S, 1998, J BIOMED MATER RES, V42, P213, DOI 10.1002/(SICI)1097-4636(199811)42:2<213::AID-JBM6>3.0.CO;2-S
   MAROUDAS A, 1968, NATURE, V219, P1260, DOI 10.1038/2191260a0
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mierisch CM, 2002, CONNECT TISSUE RES, V43, P559, DOI 10.1080/03008200290001285
   MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9
   NAGATA S, 1994, PLAST RECONSTR SURG, V93, P243, DOI 10.1097/00006534-199402000-00003
   Naumann A, 2003, EUR ARCH OTO-RHINO-L, V260, P568, DOI 10.1007/s00405-003-0636-5
   Naumann A, 1998, AM J RHINOL, V12, P59, DOI 10.2500/105065898782102972
   Naumann A, 2002, J HISTOCHEM CYTOCHEM, V50, P1049, DOI 10.1177/002215540205000807
   NERLICH AG, 1992, HISTOCHEMISTRY, V98, P275, DOI 10.1007/BF00270010
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Palmer JL, 1995, J ORTHOP RES, V13, P854, DOI 10.1002/jor.1100130608
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   ROSS MH, 1995, HISTOLOGY TEXT ATLAS
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Rotter N, 2002, ARCH BIOCHEM BIOPHYS, V403, P132, DOI 10.1016/S0003-9861(02)00263-1
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   ten Koppel PGJ, 1998, PLAST RECONSTR SURG, V102, P2012, DOI 10.1097/00006534-199811000-00031
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   van Osch GJVM, 2000, TISSUE ENG, V6, P321, DOI 10.1089/107632700418047
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Xia W Y, 1999, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V13, P244
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
NR 58
TC 68
Z9 72
U1 1
U2 19
PU MARY ANN LIEBERT INC
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD NOV
PY 2004
VL 10
IS 11-12
BP 1695
EP 1706
DI 10.1089/ten.2004.10.1695
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 883XM
UT WOS:000226049100010
PM 15684678
DA 2018-10-19
ER

PT J
AU Li, SJ
   Yang, R
   Li, S
   Hao, YL
   Cui, YY
   Niinomi, M
   Guo, ZX
AF Li, SJ
   Yang, R
   Li, S
   Hao, YL
   Cui, YY
   Niinomi, M
   Guo, ZX
TI Wear characteristics of Ti-Nb-Ta-Zr and Ti-6Al-4V alloys for biomedical
   applications
SO WEAR
LA English
DT Article
DE titanium-niobium-tantalum-zirconium alloy; biomaterial; wear
ID MOLECULAR-WEIGHT POLYETHYLENE; TITANIUM-ALLOYS; STAINLESS-STEEL;
   CORROSIVE WEAR
AB The influences of heat treatment, variation in Nb content, surface modification and counterface materials on the wear characteristics of new beta type Ti-Nb-Ta-Zr alloys and conventional metallic implant alloy Ti-6Al-4V were investigated, using a reciprocal pin-on-disc wear device in a 0.9% NaCl solution. For the wear test of sliding on stainless steel disc, experimental results show that the wear resistance of Ti-29Nb-13Ta-4.6Zr and Ti-6Al-4V is insensitive to their mechanical properties, such as hardness and ultimate tensile strength. Increase in Nb content results in an improvement of the wear resistance of the beta type alloy to some degree. The wear resistance of Ti-29Nb-13Ta-4.6Zr improved significantly after oxidation treatment, due to the presence of Nb2O5 oxide particles on the diffusion hardened surface of the alloy. For wear test of sliding on ultra-high molecular weight polyethylene (UHMWPE) and bone of pig, the wear losses of both Ti-Nb-Ta-Zr and Ti-6Al-4V are much less compared with that sliding on stainless steel and there is almost no wear on the surface of oxided Ti-29Nb-13Ta-4.6Zr. (C) 2004 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Univ London Queen Mary & Westfield Coll, Dept Mat, London E1 4NS, England.
RP Yang, R (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM ryang@imr.ac.cn
RI Guo, Zheng Xiao/C-1706-2009; Niinomi, Mitsuo/B-5965-2011
OI Guo, Zheng Xiao/0000-0001-5404-3215; 
CR ALLEN C, 1981, WEAR, V74, P287, DOI 10.1016/0043-1648(81)90169-1
   Black J., 1992, BIOL PERFORMANCE MAT
   BLANCHET TA, 1989, TRIBOL T, V32, P371, DOI 10.1080/10402008908981902
   GROBLER PE, 1990, WEAR, V135, P339, DOI 10.1016/0043-1648(90)90035-9
   IJZERMANS AB, 1969, WEAR, V14, P397, DOI 10.1016/0043-1648(69)90002-7
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   Li HD, 1990, SURFACE INTERFACE MA, P106
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MARCUS K, 1991, WEAR, V151, P323, DOI 10.1016/0043-1648(91)90259-W
   MARCUS K, 1993, SOV J FRICT WEAR, V14, P27
   Mishra A. K., 1996, ASTM STP, V1272, P96
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1
   PETERSON MB, 1989, INT8617231 NSF CHIN
   PETERSON MB, 1989, P 16 LEEDS LYON S VI
   PETERSON MB, 1992, 124248 NTIS ADA US D
   Poggie RA, 1996, MATER MANUF PROCESS, V11, P185, DOI 10.1080/10426919608947472
   RODENBECK GM, 1992, WEAR, V154, P305
   SILVER FH, 1994, BIOMATERIALS MED DEV, P5
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   TUMMLER HP, 1985, TITANIUM 84 SCI TECH, V2, P1335
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR
   Wang KK, 1996, ASTM STP, V1272, P76
   ZWICKER J, 1985, TITANIUM 84 SCI TECH, V2, P1343
NR 26
TC 67
Z9 74
U1 2
U2 41
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD NOV
PY 2004
VL 257
IS 9-10
BP 869
EP 876
DI 10.1016/j.wear.2004.04.001
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 866BH
UT WOS:000224747400002
DA 2018-10-19
ER

PT J
AU Fini, M
   Giavaresi, G
   Giardino, R
   Lenger, H
   Bernauer, J
   Rimondini, L
   Torricelli, P
   Borsari, V
   Chiusoli, L
   Chiesa, R
   Cigada, A
AF Fini, M
   Giavaresi, G
   Giardino, R
   Lenger, H
   Bernauer, J
   Rimondini, L
   Torricelli, P
   Borsari, V
   Chiusoli, L
   Chiesa, R
   Cigada, A
TI A new austenitic stainless steel with a negligible amount of nickel: An
   in vitro study in view of its clinical application in osteoporotic bone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE in vitro cultures; osteoblasts; osteoporosis; stainless steel; nickel
ID PRIMARY OSTEOBLAST CULTURES; ORTHOPEDIC-SURGERY; OSTEOPENIC SHEEP;
   TISSUE-RESPONSE; RAT BONE; BIOMATERIALS; PROLIFERATION; TITANIUM; VIVO;
   AGE
AB A biomaterial named P558 is a new austenitic stainless steel (SS) with a negligible amount of Ni (<0.20%). In previous in vitro and in vivo studies it was compared with conventional SS and Ti6A14V and shown to be a promising material in orthopedics. Because osteoporosis is a type of pathology very often encountered in implanted patients and can be studied with in vitro models, the purpose of the present study was to evaluate P558 in vitro through comparison of normal (nOB) with osteopenic (oOB) bone-derived primary rat osteoblasts. Osteoblasts were cultured directly on P558 and polystyrene as controls for 72 h. Osteoblast proliferation, adhesion, and activity (ALP, OC, TGF-beta1, and IL-6) were evaluated at 24 and 72 h. Results demonstrated that the growth of nOB and oOB cultured on P558 was not affected negatively when compared to control. Cells on P558 did not show any alteration in terms of adhesion, proliferation, and metabolic marker production in nOB and oOB cultures, and a significant increase in ALP, OC, and TGF-beta1 production was observed. SEM images revealed no alteration in cell morphology. The current findings demonstrate that P558 promotes osteoblast proliferation, activation, and differentiation not only in normal bone, but also in osteopenic bone-derived osteoblasts. (C) 2004 Wiley Periodicals, Inc.
C1 Ist Ric Codivilla Putti, Ist Ortoped Rizzoli, Dept Expt Surg, I-40136 Bologna, Italy.
   Univ Bologna, Chair Surg Pathophysiol, Bologna, Italy.
   Bohler Edelstahl GmbH & Co Kg, Res Dept, Kapfenberg, Austria.
   SAMO SpA, Cadriano Granarolo Emilai, Bologna, Italy.
   Polytech Inst Milan, Dept Chem Mat & Chem Engn G Natta, Milan, Italy.
RP Giardino, R (reprint author), Ist Ric Codivilla Putti, Ist Ortoped Rizzoli, Serv Chirurg Sperimentale, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM roberto.giardino@ior.it
RI Fini, Milena/J-4808-2016; Chiesa, Roberto/N-2605-2013; TORRICELLI,
   PAOLA/J-5298-2016; Borsari, Veronica/D-1869-2017
OI Fini, Milena/0000-0002-3732-3570; TORRICELLI, PAOLA/0000-0001-7494-9970;
   Borsari, Veronica/0000-0002-6327-4653; Chiesa,
   Roberto/0000-0002-5317-6849; Cigada, Alberto/0000-0002-0925-5558;
   Giavaresi, Gianluca/0000-0001-7843-5969
CR Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   *CARP TECHN CORP, 1999, CARP TECHN CORP ALL
   Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929
   CHRISTAKOS S, 2002, PRINCIPLES BONE BIOL, P574
   Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218
   Disegi J., 2000, INJURY, V31, pD2
   Eliades T, 2002, ANGLE ORTHOD, V72, P222
   ESCHBACH L, 2002, LOW NICKEL STEEL SMA, P15
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Fini M, 2003, J BIOMED MATER RES A, V66A, P176, DOI 10.1002/jbm.a.10605
   Fini M, 2001, BIOMED PHARMACOTHER, V55, P213, DOI 10.1016/S0753-3322(01)00054-3
   Fini M, 2001, J BONE JOINT SURG BR, V83B, P139, DOI 10.1302/0301-620X.83B1.10162
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   Gawkrodger DJ, 1996, CONTACT DERMATITIS, V35, P267, DOI 10.1111/j.1600-0536.1996.tb02386.x
   Giavaresi G, 1999, ELECTRO MAGNETOBIOL, V18, P119, DOI 10.3109/15368379909012906
   Goseki MS, 1996, J NUTR SCI VITAMINOL, V42, P55
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   Kassem M, 2000, EUR J CLIN INVEST, V30, P429
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kim YK, 1997, J ORAL MAXIL SURG, V55, P322, DOI 10.1016/S0278-2391(97)90115-4
   Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1
   Lavos-Valereto ID, 2002, J PERIODONTOL, V73, P900, DOI 10.1902/jop.2002.73.8.900
   Lohmann CH, 2001, ARCH ORTHOP TRAUM SU, V121, P583, DOI 10.1007/s004020100291
   MCKANE WR, 1994, J BONE MINER RES, V9, P1313
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   PETILLO O, 2001, INTEGRATED BIOMATERI, P655
   RALTSON SH, 1992, CYTOKINE BONE METABO, P362
   ROWE DW, 1982, J BIOL CHEM, V257, P8009
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   SHIGENO Y, 1995, J BONE JOINT SURG BR, V77B, P139
   SKJODT H, 1985, J ENDOCRINOL, V105, P391, DOI 10.1677/joe.0.1050391
   Toricelli P, 2000, ARTIF CELL BLOOD SUB, V28, P181
   Torricelli P, 2000, J BIOMED MATER RES, V52, P177, DOI 10.1002/1097-4636(200010)52:1<177::AID-JBM23>3.0.CO;2-F
   Torricelli P, 2003, INT J ARTIF ORGANS, V26, P952
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
NR 39
TC 15
Z9 16
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT 15
PY 2004
VL 71B
IS 1
BP 30
EP 37
DI 10.1002/jbm.b.30068
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 858KK
UT WOS:000224190500005
PM 15368225
DA 2018-10-19
ER

PT J
AU Wong, JY
   Leach, JB
   Brown, XQ
AF Wong, JY
   Leach, JB
   Brown, XQ
TI Balance of chemistry, topography, and mechanics at the cell-biomaterial
   interface: Issues and challenges for assessing the role of substrate
   mechanics on cell response
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT INternational Conference on BIOSURF V - Functional Polymeric Surfaces in
   Biotechnology
CY SEP 25-26, 2003
CL Univ Zurich, Zurich, SWITZERLAND
HO Univ Zurich
DE surface tension; adhesion; surface structure, morphology, roughness; and
   topography; atomic force microscopy
ID SMOOTH-MUSCLE-CELLS; SILICONE-RUBBER; WOUND CONTRACTION; NEURITE
   EXTENSION; POLYMER SURFACES; ELASTIC-MODULUS; IN-VITRO; GELS; ADHESION;
   FIBROBLASTS
AB Cells respond to three main categories of physicochemical cues: chemical, topographical, and mechanical. While surface chemistry and topography have been studied extensively, substrate mechanics has only recently been appreciated. Recent technologies of creating surfaces with well-defined chemistry and topography combined with sensitive surface characterization techniques have unquestionably deepened our understanding of surface chemical and topographical effects on cell behavior. In contrast, much less is known about substrate mechanics effects on cell behavior. This review summarizes the types of substrata and characterization methods that have been used to investigate substrate mechanics effects on cell behavior. We also speculate on the relationships between changes in substrate elasticity that occur naturally in vivo (e.g. wound healing) and cellular response. We present recent developments in creating substrata with well-defined mechanical properties in our own laboratory and conclude by discussing the major challenges and issues of determining whether substrate mechanics effects on cells are a material-independent phenomenon. This relatively new field would benefit significantly from contributions by surface scientists, and we hope that this review will stimulate the development of methods to create novel substrata with tunable mechanical properties and sensitive microscale techniques to probe their mechanical properties. Such model systems in which chemistry, topography, and mechanics can be independently controlled will facilitate the quest for design principles and material selection rules to control cell response. (C) 2004 Elsevier B.V. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Wong, JY (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM jywong@bu.edu
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
CR Abe H., 1996, DATA BOOK MECH PROPE
   Ai H, 2003, CELL BIOCHEM BIOPHYS, V38, P103, DOI 10.1385/CBB:38:2:103
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   BENGUIGUI L, 1995, J PHYS II, V5, P437, DOI 10.1051/jp2:1995132
   Berry DP, 1998, PLAST RECONSTR SURG, V102, P124, DOI 10.1097/00006534-199807000-00019
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   BONASSAR LJ, 1995, ARTHRITIS RHEUM, V38, P173, DOI 10.1002/art.1780380205
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   BROWN XQ, 2004, UNPUB EVALUATION POL
   Burton K, 1997, NATURE, V385, P450, DOI 10.1038/385450a0
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0
   Cunningham JJ, 2002, BIOTECHNIQUES, V32, P876, DOI 10.2144/02324rr05
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Durmaz S, 2001, POLYM BULL, V46, P409, DOI 10.1007/s002890170050
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FRANK EH, 1987, J BIOMECH, V20, P629, DOI 10.1016/0021-9290(87)90283-1
   Gao YC, 2000, MECH RES COMMUN, V27, P203, DOI 10.1016/S0093-6413(00)00083-5
   GAUDET C, 2003, BIOPHYS J, V85, P2239
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   Hayashi K, 1997, J BIOMECH, V30, P573, DOI 10.1016/S0021-9290(96)00185-6
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   Jacot JG, 2004, J VASC SURG, V39, P547, DOI 10.1016/j.jvs.2003.09.045
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   LEE RT, 1991, CIRCULATION, V83, P1764, DOI 10.1161/01.CIR.83.5.1764
   Lehoux S, 2003, J BIOMECH, V36, P631, DOI 10.1016/S0021-9290(02)00441-4
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   LVOV Y, 2000, PROTEIN ARCHITECTURE
   Maeda N, 2002, SCIENCE, V297, P379, DOI 10.1126/science.1072378
   Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880
   Matsumoto T, 2002, PHYSIOL MEAS, V23, P635, DOI 10.1088/0967-3334/23/4/304
   Nerem RM, 2003, BIORHEOLOGY, V40, P281
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   RAJAGOPALAN P, 2004, IN PRESS BIOPHYS J, V87
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   SARKAR S, UNPUB ACTA BIOMATERI
   SCHNAAR RL, 1985, ANAL BIOCHEM, V151, P268, DOI 10.1016/0003-2697(85)90175-7
   SMIDSROD O, 1972, ACTA CHEM SCAND, V26, P2063, DOI 10.3891/acta.chem.scand.26-2063
   Sun YL, 2002, BIOCHEM BIOPH RES CO, V295, P382, DOI 10.1016/S0006-291X(02)00685-X
   Thomas TW, 2000, MED BIOL ENG COMPUT, V38, P360, DOI 10.1007/BF02347059
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   ZAARI N, UNPUB
NR 67
TC 203
Z9 208
U1 3
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 10
PY 2004
VL 570
IS 1-2
BP 119
EP 133
DI 10.1016/j.susc.2004.06.186
PG 15
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 863DH
UT WOS:000224540300011
DA 2018-10-19
ER

PT J
AU Cedola, A
   Lagomarsino, S
   Komlev, V
   Rustichelli, F
   Mastrogiacomo, M
   Cancedda, R
   Milita, S
   Burghammer, M
AF Cedola, A
   Lagomarsino, S
   Komlev, V
   Rustichelli, F
   Mastrogiacomo, M
   Cancedda, R
   Milita, S
   Burghammer, M
TI High spatial resolution X-ray microdiffraction applied to biomaterial
   studies and archeometry
SO SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY
LA English
DT Article; Proceedings Paper
CT 17th International Congress on X-Ray Optics and Microanalysis
CY SEP 22-26, 2003
CL Chamonix, FRANCE
SP Ecole Normale Superieure, European Synchrotron Radiat Facil
DE microdiffraction; X-ray waveguide; orthopaedic prosthesis; bone marrow
   stromal cells; cultural heritage
ID WAVE-GUIDE; BIOLOGICAL GLASS; BEAM; SURFACE; BONE
AB The high spatial resolution X-ray microdiffraction by using X-ray optics can provide unique information on regions with very high gradients in physical quantities, as in the case of interfaces. Among the several available X-ray optics for synchrotron radiation producing high intensity micron and sub-micron beams, the X-ray waveguide (WG) can provide the smallest X-ray beam in one direction. Moreover, its applicability has been widened by an improved set-up installed at ID13 beamline at ESRF, where a new undulator is combined with an horizontally focusing mirror. In this work, we show different applications of waveguide-based microdiffraction, the first two regard biological problems and in particular the structural analysis of newly formed bone in ceramic scaffolds. The second application regards archeometry and in particular the sulphatation process and the thin gypsum crust formation on the surface of carbonate rocks (travertine, marbles), due to the exposure of the monuments at aggressive atmospheres. In the three cases, the local structural information derived thanks to the high spatial resolution demonstrates the power of the microdiffraction technique based on WG, and the possibility to apply this new methododogy in different scientific fields. (C) 2004 Elsevier B.V. All rights reserved.
C1 CNR, Ist Foton & Nanotecnol, I-00156 Rome, Italy.
   Univ Ancona, Ist Sci Fis, I-60131 Ancona, Italy.
   INFM, Unita Ancona, I-60131 Ancona, Italy.
   Univ Ancona, Ist Sci Fis, I-60131 Ancona, Italy.
   Univ Genoa, Ist Nazl Ric Canc, I-16132 Genoa, Italy.
   Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy.
   European Synchrotron Radiat Facil, F-38043 Grenoble, France.
   CNR, IMM, Sez Bologna, I-40129 Bologna, Italy.
   European Synchrotron Radiat Facil, F-38043 Grenoble, France.
RP Cedola, A (reprint author), CNR, Ist Foton & Nanotecnol, V Cineto Romano 42, I-00156 Rome, Italy.
EM cedola@ifn.cnr.it
RI Milita, Silvia/A-6048-2015; lagomarsino, stefano/J-1626-2012; Cedola,
   Alessia/F-3865-2012; komlev, vladimir/F-8678-2010
OI Milita, Silvia/0000-0002-9612-2541; komlev,
   vladimir/0000-0003-2068-7746; Cedola, Alessia/0000-0002-9256-8853
CR Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   ANDERSON EH, 1990, XRAY MICROSCOPY, P75
   Aoki H., 1991, SCI MED APPL HYDROXY, P179
   AREGBADRIOLLET D, 2001, PREPRINT IAC CNR
   Cedola A, 2003, PHYS MED BIOL, V48, pN37, DOI 10.1088/0031-9155/48/3/401
   Di Fonzo S, 2000, NATURE, V403, P638, DOI 10.1038/35001035
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Feng Y. P., 1995, APPL PHYS LETT, V67, P24
   GARBASSI F, 1985, DURABILITY BUILDING, V3, P51
   GAURI KL, 1982, DURABILITY BUILD MAT, V1, P217
   GAURI KL, 1982, DURABILITY BUILDING, V1, P209
   Haynie F.H., 1982, DURABILITY BUILDING, V1, P241
   Jark W, 1996, J APPL PHYS, V80, P4831, DOI 10.1063/1.363524
   Jark W, 2001, APPL PHYS LETT, V78, P1192, DOI 10.1063/1.1350956
   KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766
   Krajewski A, 1998, J MATER SCI-MATER M, V9, P309, DOI 10.1023/A:1008846728859
   Lagomarsino S, 1996, J APPL PHYS, V79, P4471, DOI 10.1063/1.361761
   Mathew M, 2001, J RES NATL INST STAN, V106, P1035, DOI 10.6028/jres.106.054
   Muller M, 2000, J APPL CRYSTALLOGR, V33, P1231, DOI 10.1107/S0021889800009249
   Snigirev A, 1996, NATURE, V384, P49, DOI 10.1038/384049a0
   TAMBE S, 1991, ENVIRON SCI TECHNOL, V25, P2071, DOI 10.1021/es00024a013
   THIEL DJ, 1992, NUCL INSTRUM METH A, V317, P597, DOI 10.1016/0168-9002(92)91006-U
NR 23
TC 12
Z9 12
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0584-8547
J9 SPECTROCHIM ACTA B
JI Spectroc. Acta Pt. B-Atom. Spectr.
PD OCT 8
PY 2004
VL 59
IS 10-11
BP 1557
EP 1564
DI 10.1016/j.sab.2004.05.031
PG 8
WC Spectroscopy
SC Spectroscopy
GA 867MZ
UT WOS:000224848000010
DA 2018-10-19
ER

PT J
AU Xu, G
   Nie, DY
   Wang, WZ
   Zhang, PH
   Shen, J
   Ang, BT
   Liu, GH
   Luo, XG
   Chen, NL
   Xiao, ZC
AF Xu, G
   Nie, DY
   Wang, WZ
   Zhang, PH
   Shen, J
   Ang, BT
   Liu, GH
   Luo, XG
   Chen, NL
   Xiao, ZC
TI Optic nerve regeneration in polyglycolic acid-chitosan conduits coated
   with recombinant L1-Fc
SO NEUROREPORT
LA English
DT Article
DE chitosan; L1; optic nerve; PGA; regeneration
ID SPINAL-CORD-INJURY; CELL-DEATH; IN-VIVO; REPAIR; RATS; L1
AB Autografts have been extensively studied to facilitate optic nerve (ON) regeneration in animal experiments, but the clinical application of this approach to aid autoregeneration has not yet been attempted. This study aims to explore the guided regeneration by an artificial polyglycolic acid-chitosan conduit coated with recombinant LI-Fc. Consistent with previous studies; in vitro assay showed that both chitosan, a natural biomaterial, and the neural cell adhesion molecule LI-Fc enhanced neurite outgrowth. Rat optic nerve transection was used as an in vivo model. The implanted PGA-chitosan conduit was progressively degraded and absorbed, accompanied by significant axonal regeneration as revealed by immunohistochemistry, anterograde and retrograde tracing. The polyglycolic acid-chitosan conduit coated with LI-Fc showed more effective to promote axonal regeneration and remyelination. Taken together, our observations demonstrated that the LI-Fc coated PGA-chitosan conduits provided a compatible and supportive canal to guild the injured nerve regeneration and remyelination.
C1 Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore.
   Cent S Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Xiangya, Peoples R China.
   Natl Univ Singapore, Dept Anat, Singapore 117548, Singapore.
   Donghua Univ, Coll Text, Shanghai, Peoples R China.
   Inst Mol & Cell Biol, Singapore, Singapore.
RP Xiao, ZC (reprint author), Singapore Gen Hosp, Dept Clin Res, Block A,No 7 Hosp Dr, Singapore 169608, Singapore.
EM gcrxzc@sgh.com.sg
RI xiao, zhicheng/A-1529-2011; ASTAR, IMCB/E-2320-2012
CR Asher R A, 2001, Prog Brain Res, V132, P611
   BARTSCH U, 2003, FRONT BIOSCI, V8, P477
   Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6
   DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6
   Ellezam B, 2003, NEUROBIOL DIS, V12, P1, DOI 10.1016/S0969-9961(02)00013-X
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809
   Sauve Y, 2001, J NEUROSCI, V21, P951
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Vasconcelos BCE, 2000, J ORAL MAXIL SURG, V58, P1257, DOI 10.1053/joms.2000.16626
   Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959
   Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x
   Zhang SL, 1995, CHEM J CHINESE U, V16, P193
NR 23
TC 40
Z9 46
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0959-4965
J9 NEUROREPORT
JI Neuroreport
PD OCT 5
PY 2004
VL 15
IS 14
BP 2167
EP 2172
DI 10.1097/00001756-200410050-00004
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 871NW
UT WOS:000225141400004
PM 15371726
DA 2018-10-19
ER

PT J
AU Etienne, O
   Picart, C
   Taddei, C
   Haikel, Y
   Dimarcq, JL
   Schaaf, P
   Voegel, JC
   Ogier, JA
   Egles, C
AF Etienne, O
   Picart, C
   Taddei, C
   Haikel, Y
   Dimarcq, JL
   Schaaf, P
   Voegel, JC
   Ogier, JA
   Egles, C
TI Multilayer polyelectrolyte films functionalized by insertion of
   defensin: A new approach to protection of implants from bacterial
   colonization
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL) LAYERS; METAL-OXIDE SURFACES;
   STAPHYLOCOCCUS-EPIDERMIDIS; ANTIMICROBIAL ACTIVITIES; BIOMEDICAL
   POLYMERS; PROTEIN ADSORPTION; RESISTANCE; ADHESION; NISIN; BIOMATERIALS
AB Infection of implanted materials by bacteria constitutes one of the most serious complications following prosthetic surgery. In the present study, we developed a new strategy based on the insertion of an antimicrobial peptide (defensin from Anopheles gambiae mosquitoes) into polyelectrolyte multilayer films built by the alternate deposition of polyanions and polycations. Quartz crystal microbalance and streaming potential measurements were used to follow step by step the construction of the multilayer films and embedding of the defensin within the films. Antimicrobial assays were performed with two strains: Micrococcus luteus (a gram-positive bacterium) and Escherichia coli D22 (a gram-negative bacterium). The inhibition of E. coli D22 growth at the surface of defensin-functionalized films was found to be 98% when 10 antimicrobial peptide layers were inserted in the film architecture. Noticeably, the biofunctionalization could be achieved only when positively charged poly(L-lysine) was the outermost layer of the film. On the basis of the results of bacterial adhesion experiments observed by confocal or electron microscopy, these observations could result from the close interaction of the bacteria with the positively charged ends of the films, which allows defensin to interact with the bacterial membrane structure. These results open new possibilities for the use of such easily built and functionalized architectures onto any type of implantable biomaterial. The modified surfaces are active against microbial infection and represent a novel means of local host protection.
C1 Univ Strasbourg 1, INSERM U595, Fac Chirurg Dent, F-67085 Strasbourg, France.
   Inst Charles Sadron, UPR 22 CNRS, F-67083 Strasbourg, France.
   Entomed SA, Illkirch Graffenstaden, France.
RP Egles, C (reprint author), Univ Strasbourg 1, INSERM U595, Fac Chirurg Dent, 11 Rue Humann, F-67085 Strasbourg, France.
EM christophe.egles@odonto-ulp.u-strasbg.fr
RI SCHAAF, Pierre/J-2751-2016; ETIENNE, olivier/D-1601-2013; etienne,
   olivier/D-9542-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; ETIENNE,
   olivier/0000-0001-8870-4659; PICART, Catherine/0000-0003-0130-1000;
   PICART, Catherine/0000-0002-4854-6366
CR BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Bower CK, 2002, COLLOID SURFACE B, V25, P81, DOI 10.1016/S0927-7765(01)00318-6
   Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4
   Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   COCIANCICH S, 1993, J BIOL CHEM, V268, P19239
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Dielbandhoesing SK, 1998, APPL ENVIRON MICROB, V64, P4047
   Dimarcq JL, 2003, DRUG DISCOV TODAY, V8, P107, DOI 10.1016/S1359-6446(02)02582-5
   Ganzle MG, 1999, INT J FOOD MICROBIOL, V48, P37, DOI 10.1016/S0168-1605(99)00026-4
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Ladam G, 2002, BIOMOL ENG, V19, P273, DOI 10.1016/S1389-0344(02)00031-X
   Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x
   OFEK I, 1994, BACTERIAL ADHESION C
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Rodahl M, 1996, SENSOR ACTUAT B-CHEM, V37, P111, DOI 10.1016/S0925-4005(97)80077-9
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   STICKLER DJ, 1995, CELL MATER, V5, P167
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vautier D, 2003, CELL MOTIL CYTOSKEL, V56, P147, DOI 10.1002/cm.10140
   Vizioli J, 2001, INSECT BIOCHEM MOLEC, V31, P241, DOI 10.1016/S0965-1748(00)00143-0
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
NR 39
TC 142
Z9 143
U1 0
U2 40
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD OCT
PY 2004
VL 48
IS 10
BP 3662
EP 3669
DI 10.1128/AAC.48.10.3662-3669.2004
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 858UH
UT WOS:000224217000003
PM 15388417
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Emerson, RJ
   Camesano, TA
AF Emerson, RJ
   Camesano, TA
TI Nanoscale investigation of pathogenic microbial adhesion to a
   biomaterial
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SOFT-PARTICLE ANALYSIS; PSEUDOMONAS-AERUGINOSA;
   CANDIDA-PARAPSILOSIS; SACCHAROMYCES-CEREVISIAE; ELECTROPHORETIC
   MOBILITY; CELL-SURFACES; BIOFILMS; INFECTIONS; BACTERIA
AB Microbial infections of medical implants occur in more than 2 million surgical cases each year in the United States alone. These increase patient morbidity and mortality, as well as patient cost and recovery time. Many treatments are available, but none are guaranteed to remove the infection. In many cases, the device infections are caused by the adhesion of microbes to the implant, ensuing growth, pathogenesis, and dissemination. The purpose of this work is to examine the initial events in microbial adhesion by simulating the approach and contact between a planktonic cell, immobilized on an atomic force microscope (AFM) cantilever, and a biomaterial or biofilm substrate. The two model microbes used in this study, Candida parapsilosis (ATCC 90018) and Pseudomonas aeruginosa (ATCC 10145), were chosen for both their clinical relevance and their ease of acquisition and handling in the laboratory setting. Attractive interactions exist between C. parapsilosis and both unmodified silicone rubber and P. aeruginosa biofilms. Using C. parapsilosis cells immobilized on AFM cantilevers with a silicone substrate, we have measured attractive forces of 4.3 +/- 0.25 nN in the approach portion of the force cycle. On P. aeruginosa biofilms, the magnitude of the attractive force decreases to 2.0 +/- 0.40 nN and is preceded by a 2.0-nN repulsion at approximately 75 nm from the cell surface. These data suggest that C. parapsilosis may adhere to both silicone rubber and P. aeruginosa biofilms, possibly contributing to patient morbidity and mortality. Characterization of cell-biomaterial and cell-cell interactions allows for a quantitative link between the physicomechanical and physicochemical properties of implant materials and the nanoscale interactions leading to microbial colonization and infection.
C1 Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA.
RP Camesano, TA (reprint author), Worcester Polytech Inst, Dept Chem Engn, 100 Inst Rd, Worcester, MA 01609 USA.
EM terric@wpi.edu
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Abu-Lail NI, 2003, BIOMACROMOLECULES, V4, P1000, DOI 10.1021/bm034055f
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000
   Bos R, 1998, BIOPHYS CHEM, V74, P251, DOI 10.1016/S0301-4622(98)00189-6
   Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437
   BOYD A, 1995, J IND MICROBIOL, V15, P162, DOI 10.1007/BF01569821
   Burnham N. A., 1993, Nanotechnology, V4, P64, DOI 10.1088/0957-4484/4/2/002
   Burnham NA, 1999, HDB MICRONANOTRIBOLO, P247
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   CAPPELLARO C, 1994, EMBO J, V13, P4737, DOI 10.1002/j.1460-2075.1994.tb06799.x
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   DRUMMOND CJ, 1994, COLLOID SURFACE A, V87, P217, DOI 10.1016/0927-7757(94)80070-7
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   Dufrene YF, 2001, ULTRAMICROSCOPY, V86, P113, DOI 10.1016/S0304-3991(00)00079-6
   Dumont-Hornebeck B, 1999, CARBOHYD RES, V321, P214, DOI 10.1016/S0008-6215(99)00194-9
   EMERSON RJ, 2004, THESIS WORCESTER POL
   Gallardo-Moreno AM, 2003, COLLOID SURFACE B, V28, P119, DOI 10.1016/S0927-7765(02)00145-5
   Grasso D, 1996, ENVIRON SCI TECHNOL, V30, P3604, DOI 10.1021/es960332x
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hayashi H, 2001, COLLOID SURFACE B, V22, P149, DOI 10.1016/S0927-7765(01)00161-8
   KHARDORI N, 1995, J IND MICROBIOL, V15, P141, DOI 10.1007/BF01569817
   Knirel YA, 2001, EUR J BIOCHEM, V268, P4708, DOI 10.1046/j.1432-1327.2001.02396.x
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   Levin AS, 1998, DIAGN MICR INFEC DIS, V30, P243, DOI 10.1016/S0732-8893(98)00006-6
   Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4
   Martinko J M, 2000, BIOL MICROORGANISMS
   OHSHIMA H, 1989, J COLLOID INTERF SCI, V130, P281, DOI 10.1016/0021-9797(89)90101-X
   Palabiyikoglu I, 2001, J HOSP INFECT, V47, P239, DOI 10.1053/jhin.2000.0897
   Pembrey RS, 1999, APPL ENVIRON MICROB, V65, P2877
   Poortinga A. T., 2002, SURF SCI REP, P1, DOI [10.1016/S0167-5729(02)00032-8, DOI 10.1016/S0167-5729(02)00032-8]
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   SENDEN TJ, 1995, COLLOID SURFACE A, V94, P29, DOI 10.1016/0927-7757(94)02954-Q
   SHIBATA N, 1995, J BIOL CHEM, V270, P1113, DOI 10.1074/jbc.270.3.1113
   Singh RS, 1999, CRIT REV BIOTECHNOL, V19, P145, DOI 10.1080/0738-859991229224
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534
   Touhami A, 2003, LANGMUIR, V19, P1745, DOI 10.1021/la026145w
   Vadillo-Rodriguez V, 2003, LANGMUIR, V19, P2372, DOI 10.1021/la020658l
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g
   VELEGOL SB, 2003, LANGMUIR, V16, P851
NR 48
TC 91
Z9 96
U1 0
U2 27
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD OCT
PY 2004
VL 70
IS 10
BP 6012
EP 6022
DI 10.1128/AEM.70.10.6012-6022.2004
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 860PT
UT WOS:000224356200040
PM 15466545
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Younes, HM
   Bravo-Grimaldo, E
   Amsden, BG
AF Younes, HM
   Bravo-Grimaldo, E
   Amsden, BG
TI Synthesis, characterization and in vitro degradation of a biodegradable
   elastomer
SO BIOMATERIALS
LA English
DT Article
DE elastomer; biodegradable; bis-caprolactone; starcopolymer
ID DRUG-DELIVERY SYSTEMS; EPSILON-CAPROLACTONE; L-LACTIDE;
   POLY(ESTER-URETHANE) ELASTOMER; MOLECULAR-WEIGHT; COPOLYMERS;
   POLYESTERS; NETWORKS; POLY(EPSILON-CAPROLACTONE); GLYCOLIDE
AB An elastorner was prepared front biodegradable components as a potential biomaterial for drug delivery and tissue engineering applications. The elastomer was synthesized in two steps. First, a star copolymer (SCP) was manufactured via ring opening polymerization of epsilon-caprolactone (epsilon-CL) with D,L-lactide using glycerol as initiator and stannous 2-ethylhexanoate as catalyst. This living SCP was further reacted with different ratios of a crosslinking nionorner, 2,2-bis(epsilon-CL-4-yl)-propane in the presence of epsilon-Cl as a solvent and co-monomer. The elastomers had very low glass transitions (-32degreesC), sol contents ranging from 17% to 37%, and were soft and weak with physical properties similar to those of natural elastomers such as elastin. The physical properties decreased in a logarithmic fashion with time when degraded in phosphate buffered saline, indicative of first-order degradation kinetics. The elastomers degraded relatively slowly, with degradation being incomplete after 12 weeks. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
RP Amsden, BG (reprint author), Queens Univ, Dept Chem Engn, 19 Div St,Dupius Hall, Kingston, ON K7L 3N6, Canada.
EM amsden@chee.queensu.ca
CR BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Crank J, 1968, DIFFUSION POLYM
   DAHIYAT BI, 1995, REACT POLYM, V25, P101, DOI 10.1016/0923-1137(95)91297-P
   de Groot JH, 1998, POLYM BULL, V41, P299, DOI 10.1007/s002890050366
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P213
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GRAESSLEY WW, 1979, MACROMOLECULES, V12, P959, DOI 10.1021/ma60071a035
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   HINRICHS WLJ, 1992, BIOMATERIALS, V13, P585, DOI 10.1016/0142-9612(92)90026-K
   In't Veld PJA, 1997, J POLYM SCI POL CHEM, V35, P219, DOI 10.1002/(SICI)1099-0518(19970130)35:2<219::AID-POLA3>3.0.CO;2-N
   KIM SH, 1992, MAKROMOL CHEM, V193, P1623
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   Li YX, 1998, POLYMER, V39, P4421, DOI 10.1016/S0032-3861(97)10362-7
   Mark J. E., 1999, POLYM DATA HDB
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Palmgren R, 1997, J POLYM SCI POL CHEM, V35, P1635, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1635::AID-POLA5>3.0.CO;2-Q
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   Pitt CG, 1984, J CONTROL RELEASE, V1, P3
   PITT CG, 1990, BIODGRADABLE POLYM D
   Pitt CG, 1983, United States Patent, Patent No. [4,379,138, 4379138]
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   SINCLAIR RG, 1977, Patent No. 4045418
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   STARCHER PS, 1963, Patent No. 3072680
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   STOREY RF, 1993, POLYMER, V34, P4365, DOI 10.1016/0032-3861(93)90203-M
   Storey RF, 1997, POLYMER, V38, P6295, DOI 10.1016/S0032-3861(97)00208-5
   Treloar L. R. G, 1975, PHYS RUBBER ELASTICI
   WADA R, 1991, PHARMACEUT RES, V8, P1292, DOI 10.1023/A:1015860030772
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
NR 32
TC 80
Z9 83
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2004
VL 25
IS 22
BP 5261
EP 5269
DI 10.1016/j.biomaterials.2003.12.024
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DJ
UT WOS:000221366800005
PM 15110477
DA 2018-10-19
ER

PT J
AU von Knoch, M
   von Knoch, F
   Heckelei, A
   Wedemeyer, C
   Saxler, G
   Hilken, G
   Henschke, F
   Loer, F
AF von Knoch, M
   von Knoch, F
   Heckelei, A
   Wedemeyer, C
   Saxler, G
   Hilken, G
   Henschke, F
   Loer, F
TI Fe-OPG suppresses biomaterial-induced bone resorption
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Meeting Abstract
CT 5th International Congress on Progress in Bioengineering and the
   Vascular Endothelium/8th International Congress on Advances in
   Management of Malignancies
CY OCT 13-15, 2004
CL Pisa, ITALY
ID INDUCED OSTEOLYSIS; POLYETHYLENE; MODEL
C1 Univ Duisburg Essen, Dept Orthopaed, Essen, Germany.
   Kantonsspital Chur, Dept Orthopaed Surg, Chur, Switzerland.
   Univ Duisburg Essen, Cent Anim Lab, Duisburg, Germany.
   Inst Johannisstift, Paderborn, Germany.
EM mariusvonknoch@yahoo.com
CR Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Schwarz EM, 2000, J ORTHOPAED RES, V18, P472, DOI 10.1002/jor.1100180321
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P33
   Ulrich-Vinther M, 2002, J BONE JOINT SURG AM, V84A, P1405, DOI 10.2106/00004623-200208000-00017
   von Knoch M, 2004, J ORTHOPAED RES, V22, P237, DOI 10.1016/j.orthres.2003.08.013
   VONKNOCK M, 2004, IN PRESS BIOMATERIAL
   Yang SY, 2002, ARTHRITIS RHEUM, V46, P2514, DOI 10.1002/art.10527
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD OCT
PY 2004
VL 58
IS 8
BP 459
EP 461
PG 3
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 865OB
UT WOS:000224711300013
DA 2018-10-19
ER

PT J
AU Gristina, A
   Sherk, HH
AF Gristina, A
   Sherk, HH
TI Biomaterial-centered infection - Microbial adhesion versus tissue
   integration - (Reprinted from Science, vol. 237, pg. 1588-1595, 1987)
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Reprint
ID STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA;
   EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; GRAFT
   INFECTION; SURFACES; COLONIZATION; FIBRONECTIN
RP Sherk, HH (reprint author), 3300 Henry Ave,7th Floor, Philadelphia, PA 19129 USA.
EM Henry.H.Sherk@drexel.edu
CR ALBERTS B, 1983, MOL BIOL CELL
   ALBREKTSSON T, 1985, Critical Reviews in Biocompatibility, V1, P53
   ALBREKTSSON T, 1985, T 5 EUR C BIOM, P151
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   Andrade JD, 1985, SURFACE INTERFACIAL, VI, P15
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   BARTH E, 1985, ACTA ORTHOP SCAND, V56, P491, DOI 10.3109/17453678508993042
   BARTH E, IN PRESS ACTA ORTHOP
   BEACHEY EH, 1980, QUEUES RECEPTORS R B, V6
   BIRINYI LK, 1987, J VASC SURG, V5, P193, DOI 10.1067/mva.1987.avs0050193
   BROWN MRW, 1985, ANNU REV MICROBIOL, V39, P527, DOI 10.1146/annurev.mi.39.100185.002523
   BURWELL RG, 1985, CLIN ORTHOP RELAT R, P141
   CALLEJA GB, 1984, MICROBIAL ADHESION A, P304
   CHRISTENSEN GD, 1985, BACTERIAL ADHESION M, P279
   CIERNY G, 1986, AM AC ORTH SURG 54 A, P86
   COMIZZOLI RB, 1986, SCIENCE, V234, P340, DOI 10.1126/science.234.4774.340
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DHO M, 1984, AVIAN DIS, V28, P1016, DOI 10.2307/1590278
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P269
   ENGEL T, 1986, SCIENCE, V234, P327, DOI 10.1126/science.234.4774.327
   Fletcher M., 1985, BACTERIAL ADHESION M, P339
   GIBBONS RJ, 1980, QUEUES RECEPTORS R B, P63
   GOMER R, 1982, SCI AM, V247, P98, DOI 10.1038/scientificamerican0882-98
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1963, J BONE JOINT SURG AM, V45, P1104
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   GRISTINA AG, 1980, 1 WORLD BIOM C 8 12
   GRISTINA AG, IN PRESS J AM MED AS
   GRISTINA AG, IN PRESS INFECT ORTH
   GRISTINA AG, 1984, ORTHOP CLIN N AM, V15, P3
   Gristina AG, 1987, PATHOGENICITY CLIN S, P143
   HAMILL RJ, 1986, INFECT IMMUN, V54, P833
   HIRSCH P, 1984, P373
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   HSIEH YL, 1986, J APPL BACTERIOL, V60, P535, DOI 10.1111/j.1365-2672.1986.tb01093.x
   ICHIMAN Y, 1981, J APPL BACTERIOL, V51, P229, DOI 10.1111/j.1365-2672.1981.tb01237.x
   JONES GW, 1982, CRIT REV MICROBIOL, V10, P229
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   Kozinn S C, 1986, J Arthroplasty, V1, P249, DOI 10.1016/S0883-5403(86)80015-8
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   Lehninger AL, 1982, PRINCIPLES BIOCH
   LUDWICKA A, 1983, ZBL BAKT MIK HYG B, V177, P527
   LYKLEMA J, 1985, SURFACE INTERFACIAL, V1, P293
   Mandelbrot BB, 1982, FRACTAL GEOMETRY NAT
   MASUR H, 1980, J THORAC CARDIOV SUR, V80, P31
   MEAKIN P, 1986, J THEOR BIOL, V118, P101, DOI 10.1016/S0022-5193(86)80011-X
   Mears D. C, 1979, MAT ORTHOPAEDIC SURG
   MERRITT K, 1985, 11 ANN M SOC BIOM SA
   NOONAN JR, 1986, SCIENCE, V234, P310, DOI 10.1126/science.234.4774.310
   OGA M, UNPUB
   Paerl HW., 1985, BACTERIAL ADHESION M, P363
   PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RYAN US, 1986, ANNU REV PHYSIOL, V48, P263
   SANDER LM, 1987, SCI AM, V256, P94, DOI 10.1038/scientificamerican0187-94
   Savage D. C., 1985, BACTERIAL ADHESION M
   SLUSHER MM, 1987, ARCH OPHTHALMOL-CHIC, V105, P110
   SRIYOSACHATI S, 1986, INFECT IMMUN, V52, P885
   STENSTROM TA, 1985, ARCH MICROBIOL, V143, P6, DOI 10.1007/BF00414759
   STERN GA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1221, DOI 10.1001/archopht.1985.01050080133033
   Sugarman B, 1984, INFECT ASS PROSTHETI
   SUTHERLAND IW, 1978, SURFACE CARBOHYDRATE, P27
   SWITALSKI LM, 1983, INFECT IMMUN, V42, P628
   TROMP RM, 1986, SCIENCE, V234, P304, DOI 10.1126/science.234.4774.304
   VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13
   WEBB LX, 1986, J VASC SURG, V4, P16
   WRANGSTADH M, 1986, ARCH MICROBIOL, V145, P220, DOI 10.1007/BF00443649
NR 70
TC 25
Z9 26
U1 4
U2 43
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD OCT
PY 2004
IS 427
BP 4
EP 12
DI 10.1097/01.blo.0000145156.89115.12
PG 9
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 861NC
UT WOS:000224422500002
PM 15552128
DA 2018-10-19
ER

PT J
AU Schultz, P
   Vautier, D
   Egles, C
   Debry, C
AF Schultz, P
   Vautier, D
   Egles, C
   Debry, C
TI Experimental study of a porous rat tracheal prosthesis made of T40:
   long-term survival analysis
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Article
DE porous titanium; prosthesis; trachea; survival; histology
ID REPLACEMENT; GRAFTS
AB In order to repair large defects in the laryngotracheal area, we developed a biomaterial based on porous titanium (Ti40) formed of spherical particles that are welded together. These Ti40 beads were arranged in several layers to create the rat tracheal prosthesis. After a partial tracheal resection, the prosthesis was fixed to both extremities to replace the missing part. Tissue surrounding the prosthesis was collected from 33 surviving animals after an implantation period of 3 to 12 months. Histological analyses showed that the periphery of the prosthesis was covered with fibroblasts and a few lymphocytes that penetrated the titanium layers. A ciliary cylindrical epithelium of respiratory type was found on the endoluminal side. The inflammatory reaction observed was minimal. These data indicate that the prosthesis, implanted in a laryngotracheal environment, is well tolerated by animals. Our results represent the first step towards the construction of a total laryngeal prosthesis that should allow restoration of the essential functions of the larynx after a laryngectomy in cancer treatment.
C1 CHU Hautepierre, Dept Otorhinolaryngol, F-67098 Strasbourg, France.
   INSERM 595, Dept Res, Strasbourg, France.
RP Schultz, P (reprint author), CHU Hautepierre, Dept Otorhinolaryngol, Ave Moliere, F-67098 Strasbourg, France.
EM philippe.schultz@chru-strasbourg.fr
OI EGLES, Christophe/0000-0003-0982-7752; schultz,
   patrick/0000-0002-7310-6186
CR AMENTA PS, 1996, ANDERSONS PATHOLOGY, P416
   BORRIE J, 1973, J THORAC CARDIOV SUR, V65, P956
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dayal V S, 1982, Ann Otol Rhinol Laryngol Suppl, V95, P1
   Debry C, 2003, J LARYNGOL OTOL, V117, P113
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   KALLIYANA K, 1984, POLYM-PLAST TECHNOL, V23, P185
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LEAKE D, 1985, BIOMATERIALS, V6, P17, DOI 10.1016/0142-9612(85)90032-8
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P1090
   MERRIT K, 1991, J BIOMED APP, V5, P186
   MONTGOMERY WW, 1974, ANN OTO RHINOL LARYN, V83, P71, DOI 10.1177/000348947408300112
   RAO KR, 1991, BIOMATERIALS, V18, P259
   Schultz P, 2002, ANN THORAC SURG, V73, P1747, DOI 10.1016/S0003-4975(02)03569-5
   TILNEY NL, 1975, ARCH SURG-CHICAGO, V110, P1469
   VILLEGASCABELLO O, 1994, THORAC CARDIOV SURG, V42, P302, DOI 10.1055/s-2007-1016509
   WILLIAMS DF, 1973, IMPLANTS SURG, P137
NR 17
TC 10
Z9 10
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0937-4477
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD OCT
PY 2004
VL 261
IS 9
BP 484
EP 488
DI 10.1007/s00405-003-0717-5
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 868LN
UT WOS:000224915200005
PM 14655018
DA 2018-10-19
ER

PT J
AU Gache, Y
   Baldeschi, C
   Del Rio, M
   Gagnoux-Palacios, L
   Larcher, F
   Lacour, JP
   Meneguzzi, G
AF Gache, Y
   Baldeschi, C
   Del Rio, M
   Gagnoux-Palacios, L
   Larcher, F
   Lacour, JP
   Meneguzzi, G
TI Construction of skin equivalents for gene therapy of recessive
   dystrophic epidermolysis bullosa
SO HUMAN GENE THERAPY
LA English
DT Article
ID KERATINOCYTE STEM-CELLS; VII COLLAGEN; CULTURED EPITHELIUM; RETROVIRAL
   VECTORS; LENTIVIRAL VECTORS; ANCHORING FIBRILS; PROCOLLAGEN-VII;
   IN-VITRO; EXPRESSION; MUTATION
AB We have shown that retroviral vectors efficiently transfer the 9-kb collagen type VII cDNA into keratinocytes of dogs with recessive dystrophic epidermolysis bullosa (RDEB) and achieve correction of the RDEB phenotype in vitro. As a next step toward gene therapy applications, we have assessed the suitability of retroviral vectors to transduce human collagen type VII cDNA into primary human RDEB keratinocytes and generate transplantable autologous skin equivalents. The transduced RDEB keratinocytes permanently express high levels of recombinant collagen type VII that assembles into functional homotrimers readily secreted into the extracellular matrix. The recombinant collagen type VII reverts the migration and invasion potential of the transduced RDEB keratinocytes in vitro and is efficiently deposited at the dermal epidermal junction of artificial skin prepared with the reverted cells and artificial dermis made of biomaterial sponges embedded with dermal RDEB fibroblasts. Transplantable fibrin-based skin equivalents made with the transduced RDEB keratinocytes and grafted onto SCID mice either orthotopically or in accordance with the flap method generated cohesive and orderly stratified epithelia with all the characteristics of normal human epidermis, including rapid formation of anchoring fibrils. Because transplantable epithelia are routinely used to cure patients suffering from large skin or mucosal defects, the full phenotypic reversion of primary RDEB epidermal clonogenic cells mediated by recombinant retroviral vectors opens new perspectives in the long-term treatment of genodermatoses.
C1 Fac Med Nice, UFR Med, INSERM, U634, F-06107 Nice 2, France.
   Fdn Botin, CIEMAT, Madrid 28040, Spain.
   Archet II Hosp, Dept Dermatol, F-06202 Nice, France.
RP Meneguzzi, G (reprint author), Fac Med Nice, UFR Med, INSERM, U634, 27 Ave Valombrose, F-06107 Nice 2, France.
EM meneguzz@unice.fr
RI Gagnoux, Laurent/O-9954-2016; DEL RIO, MARCELA/H-2796-2015; Larcher,
   Fernando/J-1527-2016
OI Larcher, Fernando/0000-0002-6771-3561; Gache,
   Yannick/0000-0002-5638-4854; Lacour, Jean-Philippe/0000-0001-7663-2053
CR Arnold U, 1999, ANAL BIOCHEM, V271, P197, DOI 10.1006/abio.1999.4149
   Baldeschi C, 2003, HUM MOL GENET, V12, P1897, DOI 10.1093/hmg/ddg200
   BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302
   BARRANDON Y, 1988, J INVEST DERMATOL, V91, P315, DOI 10.1111/1523-1747.ep12475646
   Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998
   Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7
   Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9
   BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551
   Buchschacher GL, 2000, BLOOD, V95, P2499
   BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129
   Chen M, 2002, NAT GENET, V32, P670, DOI 10.1038/ng1041
   CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62
   Christiano AM, 1997, J INVEST DERMATOL, V109, P811, DOI 10.1111/1523-1747.ep12341013
   Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069
   Dellambra E, 1998, HUM GENE THER, V9, P1359, DOI 10.1089/hum.1998.9.9-1359
   Dellambra E, 2000, HUM GENE THER, V11, P2283, DOI 10.1089/104303400750035825
   DELUCA M, 1989, BURNS, V15, P303, DOI 10.1016/0305-4179(89)90007-7
   DELUCA M, 1990, TRANSPLANTATION, V50, P454, DOI 10.1097/00007890-199009000-00019
   Farson D, 2001, HUM GENE THER, V12, P981, DOI 10.1089/104303401750195935
   Fine JD, 2000, J AM ACAD DERMATOL, V42, P1051, DOI 10.1016/S0190-9622(00)90302-5
   Gache Y, 1996, J CLIN INVEST, V97, P2289, DOI 10.1172/JCI118671
   GagnouxPalacios L, 1997, LAB INVEST, V77, P459
   Hovnanian A, 1997, AM J HUM GENET, V61, P599, DOI 10.1086/515495
   Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405
   Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140
   Lowenstein PR, 2004, GENE THER, V11, P1, DOI 10.1038/sj.gt.3302186
   Mallipeddi R, 2002, CLIN EXP DERMATOL, V27, P616, DOI 10.1046/j.1365-2230.2002.01130.x
   Mathor MB, 1996, P NATL ACAD SCI USA, V93, P10371, DOI 10.1073/pnas.93.19.10371
   Mecklenbeck S, 2002, HUM GENE THER, V13, P1655, DOI 10.1089/10430340260201743
   Michiels F, 2000, METHOD ENZYMOL, V325, P295
   Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766
   Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI.200317193
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   ROMAGNOLI G, 1990, NEW ENGL J MED, V323, P527, DOI 10.1056/NEJM199008233230806
   Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009
   Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937
   Shang ML, 2001, J BIOL CHEM, V276, P33045, DOI 10.1074/jbc.M100798200
   Shin NH, 2000, J VIROL, V74, P2694, DOI 10.1128/JVI.74.6.2694-2702.2000
   TEEPE RGC, 1990, BRIT J DERMATOL, V122, P81, DOI 10.1111/j.1365-2133.1990.tb08243.x
   Trono D, 2000, J GENE MED, V2, P61
   Vailly J, 1998, GENE THER, V5, P1322, DOI 10.1038/sj.gt.3300730
   VERRANDO P, 1991, LAB INVEST, V64, P85
   Vogel J, 2003, J INVEST DERMATOL, V120, pXI, DOI 10.1046/j.1523-1747.2003.12118.x
   Yang A, 1999, NATURE, V398, P714
NR 48
TC 56
Z9 59
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1043-0342
J9 HUM GENE THER
JI Hum. Gene Ther.
PD OCT
PY 2004
VL 15
IS 10
BP 921
EP 933
DI 10.1089/hum.2004.15.921
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 863RE
UT WOS:000224578600001
PM 15585108
DA 2018-10-19
ER

PT J
AU Giordani, EJ
   Guimaraes, VA
   Pinto, TB
   Ferreira, I
AF Giordani, EJ
   Guimaraes, VA
   Pinto, TB
   Ferreira, I
TI Effect of precipitates on the corrosion-fatigue crack initiation of ISO
   5832-9 stainless steel biomaterial
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Article
DE biomaterial; stainless steel; corrosion-fatigue; crack initiation
ID AQUEOUS ENVIRONMENTS; ORTHOPEDIC IMPLANTS; NITROGEN; METALS; MECHANISMS;
   FAILURE; DEVICES; GROWTH
AB The correlation between the microstructure and fatigue crack initiation behavior (in air and 0.9% NaCl solution) of ISO 5832-9 austenitic stainless steel biomaterial was investigated. A combination of techniques such as extraction of precipitates, SEM, EDS and X-ray diffraction was found to be very useful to characterize Z-phase precipitates, which are abundant in this steel. An analysis of fatigue crack initiation, using SEM, revealed that fatigue and corrosion-fatigue cracking initiate preferentially in the elongated Z-phase precipitates, which are parallel to the tensile direction, and in coarse precipitates usually associated with M-rich nonmetallic inclusions. Crack initiation is caused by particle rupture rather than by separation of the particle/matrix interface. The findings indicate that coarse Z-phase precipitates and nonmetallic inclusions are detrimental to the fatigue properties of the steel. These microstructural constituents accelerate the initiation of fatigue and especially corrosion-fatigue cracks. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Estadual Campinas, Fac Engn Mecan, Dept Mat Engn, BR-13083970 Campinas, SP, Brazil.
   Univ Passo Fundo, Fac Engn & Arquitectura, BR-99001970 Passo Fundo, RS, Brazil.
RP Giordani, EJ (reprint author), Univ Estadual Campinas, Fac Engn Mecan, Dept Mat Engn, Caixa Postal 6122, BR-13083970 Campinas, SP, Brazil.
EM enricogiordani@uol.com.br
CR Azuma S, 1996, ISIJ INT, V36, P793, DOI 10.2355/isijinternational.36.793
   DICKSON JI, 1992, MATER CHARACT, V28, P327, DOI 10.1016/1044-5803(92)90020-I
   GIORDANI EJ, 2001, THESIS STATE U CAMPI
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Grabke HJ, 1996, ISIJ INT, V36, P777, DOI 10.2355/isijinternational.36.777
   HUGHES H, 1967, J IRON STEEL I, V205, P775
   HUSAIN Z, 1989, MAT SCI ENG A-STRUCT, V119, pL1, DOI 10.1016/0921-5093(89)90550-9
   JACK DH, 1972, J IRON STEEL I, V210, P790
   Jargelius-Pettersson RFA, 1999, CORROS SCI, V41, P1639, DOI 10.1016/S0010-938X(99)00013-X
   LEVEY PR, 1995, CORROSION, V51, P911, DOI 10.5006/1.3293567
   LOPEZ GD, 1993, MEDICINA-BUENOS AIRE, V53, P260
   MARTIN JW, 1981, NUCL TECHNOL, V55, P499, DOI 10.13182/NT55-504
   Mudali UK, 1996, ISIJ INT, V36, P799, DOI 10.2355/isijinternational.36.799
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   PARKINS RN, 1985, MATER SCI TECH SER, V1, P480, DOI 10.1179/mst.1985.1.6.480
   Pickering FB, 1989, P 1 INT C HIGH NITR, P10
   Qian YR, 1997, CORROSION, V53, P129, DOI 10.5006/1.3280442
   RIMNAC CM, 1991, MATER CHARACT, V26, P201, DOI 10.1016/1044-5803(91)90012-S
   Rondelli G, 1997, BRIT CORROS J, V32, P193
   SHIH T, 1973, T IRON STEEL I JPN, V13, P11
   SIVAKUMAR M, 1994, J MATER ENG PERFORM, V3, P744, DOI 10.1007/BF02818375
   SIVAKUMAR M, 1995, STEEL RES, V66, P35, DOI 10.1002/srin.199501768
   SRIVATSAN TS, 1988, J MATER SCI, V23, P1521
   SUDARSHAN TS, 1990, ENG FRACT MECH, V36, P827, DOI 10.1016/0013-7944(90)90262-F
   WHITWHAM D, 1950, J IRON STEEL I, V165, P72
NR 25
TC 35
Z9 36
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD OCT
PY 2004
VL 26
IS 10
BP 1129
EP 1136
DI 10.1016/j.ijfatigue.2004.03.002
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 845FS
UT WOS:000223223300010
DA 2018-10-19
ER

PT J
AU Yoshida, M
   Babensee, JE
AF Yoshida, M
   Babensee, JE
TI Poly(lactic-co-glycolic acid) enhances maturation of human
   monocyte-derived dendritic cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(lactic-co-glycolic acid); dendritic cells; adjuvant
ID IN-VITRO; VACCINE ADJUVANTS; IMMUNE-RESPONSE; HOST RESPONSE; HUMAN
   BLOOD; MICROSPHERES; PHAGOCYTOSIS; MACROPHAGES; PARTICLES; DELIVERY
AB Immature dendritic cells (iDCs) were derived from human peripheral blood monocytes, and treated with 75:25 poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) or film to assess the resultant dendritic cell (DC) maturation as compared to positive control of lipopolysaccharide (LPS) treatment for DC maturation or negative control of untreated iDCs. The effect of PLGA contact on DC maturation was examined as one possible explanation for the PLGA adjuvant effect we have observed in the enhancement of an immune response to codelivered model antigen, as adjuvants act through the maturation of DCs. Culturing iDCs with PLGA MPs or PLGA film resulted in morphology similar to that of LPS-matured DCs and the association, or possible internalization, of PLGA MPs. Furthermore, biomaterial-treated iDCs demonstrated an increase in MHC class II and costimulatory molecule expression compared to iDCs but to a lower level than that of LPS-matured DCs. Direct iDC contact with PLGA MPs was necessary for maturation. Immature DCs exposed to PLGA MPs were stimulatory of allogeneic T-cell proliferation, whereas cells exposed to PLGA film were not. Further, PLGA MPs supported a moderate delayed type hypersensitivity reaction in mice indicative of in vivo DC maturation. Taken together, these results suggest that PLGA is a DC maturation stimulus and that the form of the biomaterial may influence the extent of DC maturation. (C) 2004 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
CR Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2000, TISSUE ENG, V6, P165, DOI 10.1089/107632700320784
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   COLIGAN JE, 1994, CURRENT PROTOCOSL IM
   Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251
   Ding ZM, 1999, J IMMUNOL, V163, P5029
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Gao JX, 1999, IMMUNOLOGY, V98, P159
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142
   Jotwani R, 2003, EUR J IMMUNOL, V33, P2980, DOI 10.1002/eji.200324392
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Lutsiak MEC, 2002, PHARM RES-DORDR, V19, P1480, DOI 10.1023/A:1020452531828
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   Newman KD, 1998, J CONTROL RELEASE, V54, P49, DOI 10.1016/S0168-3659(97)00142-9
   Reece JC, 2001, IMMUNOL CELL BIOL, V79, P255, DOI 10.1046/j.1440-1711.2001.01011.x
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Sun HF, 2003, VACCINE, V21, P849, DOI 10.1016/S0264-410X(02)00531-5
   TACHIYAMA G, 1986, THROMB RES, V37, P309
   Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317
   Zhao Z, 1996, J PHARM SCI-US, V85, P1261, DOI 10.1021/js9602812
   Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588
NR 33
TC 84
Z9 85
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2004
VL 71A
IS 1
BP 45
EP 54
DI 10.1002/jbm.a.30131
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 854CE
UT WOS:000223877000006
PM 15368253
DA 2018-10-19
ER

PT J
AU Knabe, C
   Howlett, CR
   Klar, F
   Zreiqat, H
AF Knabe, C
   Howlett, CR
   Klar, F
   Zreiqat, H
TI The effect of different titanium and hydroxyapatite-coated dental
   implant surfaces on phenotypic expression of human bone-derived cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE dental implants; human bone-derived cells; cell-biomaterial
   interactions; in situ hybridization; immunocyto-chemistry
ID ACID-ETCHED SURFACE; IN-VITRO; MINIATURE PIGS; MARROW CELLS; PROSPECTIVE
   MULTICENTER; ENDOSSEOUS INTEGRATION; EXTRACELLULAR-MATRIX; OSTEOBLASTIC
   CELLS; REMOVAL TORQUE; CALCIUM
AB Roughened titanium (Ti) surfaces have been widely used for dental implants. In recent years, there has been the tendency to replace Ti plasma-sprayed surfaces by sandblasted and acid-etched surfaces in order to enhance osseous apposition. Another approach has been the utilization of hydroxyapatite (HA)-coated implants. This study examines the effect of two roughened Ti dental implant surfaces on the osteoblastic phenotype of human bone-derived cells (HBDC) and compares this behavior to that for cells on an HA-coated surface. Test materials were an acidetched and sandblasted Ti surface (Ti-DPS), a porous Ti plasma-sprayed coating (Ti-TPS), and a plasma-sprayed porous HA coating (HA). Smooth Ti machined surfaces served as control (Ti-ma). HBDC were grown on the substrata for 3, 7, 14, and 21 days, counted and probed for various bone-related mRNAs and proteins (type I collagen, osteocalcin, osteopontin, osteonectin, alkaline phosphatase, and bone sialoprotein). All dental implant surfaces significantly affected cellular growth and the temporal expression of an array of bone-related genes and proteins. HA-coated Ti had the most effect on osteoblastic differentiation inducing a greater expression of an array of osteogenic markers than recorded for cells grown on Ti-DPS and Ti-TPS, thus suggesting that the HA-coated surface may possess a higher potency to enhance osteogenesis. Furthermore, Ti-DPS surfaces induced greater osteoblast proliferation and differentiation than Ti-TPS. (C) 2004 Wiley Periodicals, Inc.
C1 Free Univ Berlin, Hosp Benjamin Franklin, Dept Expt Dent, D-14197 Berlin, Germany.
   Friadent Dentsply Inc, D-68229 Mannheim, Germany.
   Univ New S Wales, Fac Med, Sch Med Sci, Dept Pathol, Sydney, NSW 2052, Australia.
RP Knabe, C (reprint author), Free Univ Berlin, Hosp Benjamin Franklin, Dept Expt Dent, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
EM Christine.Knabe@medizin.fu-berlin.de
CR Anselme K, 1997, J BIOMED MATER RES, V34, P247, DOI 10.1002/(SICI)1097-4636(199702)34:2<247::AID-JBM14>3.0.CO;2-F
   Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Aubin JE, 2000, BONE ENG, P19
   Bahat O, 2000, Int J Oral Maxillofac Implants, V15, P646
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Bornstein MM, 2003, INT J ORAL MAX IMPL, V18, P659
   Boyan B. D., 2000, BONE ENG, P232
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buser D, 1998, INT J ORAL MAX IMPL, V13, P611
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Caulier H, 1997, J BIOMED MATER RES, V35, P19, DOI 10.1002/(SICI)1097-4636(199704)35:1<19::AID-JBM3>3.0.CO;2-P
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   COCHRAN DL, 2000, BONE ENG, P391
   Cordioli G, 2000, INT J ORAL MAX IMPL, V15, P668
   CUNE MS, 1994, J PROSTHET DENT, V72, P144, DOI 10.1016/0022-3913(94)90072-8
   Davarpanah M, 2002, INT J ORAL MAX IMPL, V17, P820
   Davies JE, 1996, ANAT REC, V245, P426
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   DUCHEYNE P, 1988, Journal of Oral Implantology, V14, P325
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   DUCHEYNE P, 1987, J APPL BIOMAT, V1, P219
   DVIES JE, 2000, J DENT EDUC, V67, P932
   FRAYSSINET P, 1994, J MAT SCI MAT MD, V5, P511
   Friberg B, 2000, Clin Implant Dent Relat Res, V2, P184
   Gehrke Peter, 2003, Dent Implantol Update, V14, P57
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   GUERS NC, 2002, INT J ORAL MAXILLOF, V17, P811
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   JANSEN JA, 2000, BONE ENG, P345
   Jeffcoat MK, 2003, INT J ORAL MAX IMPL, V18, P406
   KAHARI VM, 1987, MED SCI RES-BIOCHEM, V15, P417
   Keller J C, 1998, Implant Dent, V7, P331, DOI 10.1097/00008505-199807040-00012
   Keller John C, 2003, Implant Dent, V12, P175
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Klokkevold PR, 2001, CLIN ORAL IMPLAN RES, V12, P350, DOI 10.1034/j.1600-0501.2001.012004350.x
   Knabe C, 2002, BIOMATERIALS, V23, P3235, DOI 10.1016/S0142-9612(02)00078-9
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Lacefield W R, 1998, Implant Dent, V7, P315, DOI 10.1097/00008505-199807040-00010
   Lazzara R J, 1998, J Esthet Dent, V10, P280, DOI 10.1111/j.1708-8240.1998.tb00505.x
   LAZZARA RJ, 2000, BONE ENG, P381
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Naert I, 2002, CLIN ORAL IMPLAN RES, V13, P381, DOI 10.1034/j.1600-0501.2002.130406.x
   Ong JL, 2002, INT J ORAL MAX IMPL, V17, P581
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Schenk RK, 1998, PERIODONTOL 2000, V17, P22, DOI 10.1111/j.1600-0757.1998.tb00120.x
   Schroeder A, 1976, SSO Schweiz Monatsschr Zahnheilkd, V86, P713
   SODEK J, 1991, BONE-BIOMATERIAL INTERFACE, P97
   SODEK J, 2000, BONE ENG, P31
   Stach Renee M, 2003, Implant Dent, V12, P87
   Sullivan D Y, 2001, Compend Contin Educ Dent, V22, P326
   ter Brugge PJ, 2003, CLIN ORAL IMPLAN RES, V14, P472, DOI 10.1034/j.1600-0501.2003.00886.x
   ter Brugge PJ, 2002, TISSUE ENG, V8, P615, DOI 10.1089/107632702760240535
   ter Brugge PJ, 2002, BIOMATERIALS, V23, P3269, DOI 10.1016/S0142-9612(02)00085-6
   ter Brugge PJ, 2002, J BIOMED MATER RES, V60, P70, DOI 10.1002/jbm.10031
   Testori T, 2002, CLIN ORAL IMPLAN RES, V13, P154, DOI 10.1034/j.1600-0501.2002.130205.x
   Vercaigne S, 1998, CLIN ORAL IMPLAN RES, V9, P261, DOI 10.1034/j.1600-0501.1998.090407.x
   Vernino AR, 2002, INT J PERIODONT REST, V22, P399
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 79
TC 47
Z9 48
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2004
VL 71A
IS 1
BP 98
EP 107
DI 10.1002/jbm.a.30130
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 854CE
UT WOS:000223877000012
PM 15368259
DA 2018-10-19
ER

PT J
AU Diener, A
   Nebe, B
   Bulnheim, U
   Luthen, F
   Becker, P
   Neumann, H
   Rychly, J
AF Diener, A
   Nebe, B
   Bulnheim, U
   Luthen, F
   Becker, P
   Neumann, H
   Rychly, J
TI Dynamics of focal adhesions in osteoblastic cells on biomaterial
   surfaces
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT 26th Annual Meeting of the
   American-Society-for-Bone-and-Mineral-Research
CY OCT 01-05, 2004
CL Seattle, WA
SP Amer Soc Bone & Mineral Res
C1 Univ Rostock, Dept Internal Med, D-2500 Rostock, Germany.
   Diagnost Nord GmbH, Rostock, Germany.
   DOT GmbH, Rostock, Germany.
   Univ Rostock, Expt Res Ctr, D-2500 Rostock, Germany.
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD OCT
PY 2004
VL 19
SU 1
BP S274
EP S274
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 860FB
UT WOS:000224326801457
DA 2018-10-19
ER

PT J
AU Ganesh, SK
   Babu, K
   Biswas, J
AF Ganesh, SK
   Babu, K
   Biswas, J
TI Phacoemulsification with intraocular lens implantation in cases of pars
   planitis
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID CATARACT-EXTRACTION; UVEITIS; SURGERY; EYES
AB Purpose: To analyze the results of phacoemulsification cataract surgery with implantation of posterior chamber intraocular lenses (IOLs) of different biomaterials in eyes with pars planitis.
   Setting: Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.
   Methods: The records of 86 patients (100 eyes) with pars planitis who had phacoemulsification with IOL implantation between January 1997 and April 2003 were retrospectively analyzed. The eyes were divided into 3 groups depending on IOL biomaterial: poly(methyl methacrylate) (PMMA) (n = 32), heparin-surface-modified PMMA (n = 39), or acrylic (n = 29). The postoperative visual outcome and complications in each group were analyzed.
   Results: Forty-seven patients were men and 39, women. The mean age was 38 years (range 10 to 65 years) and the mean follow-up, 19.67 months (range 3.00 to 54.53 months). At the final follow-up, 91 eyes (91%) had better visual acuity than preoperatively; 79 had an improvement of 2 or more Snellen lines, 12 had an improvement of 1 Snellen line, 4 had no change, and 5 had a decrease as a result of reactivation of the pars planitis and progression of cystoid macular edema (CME). Significant posterior capsule opacification occurred in 10 eyes (10%), CME in 50 eyes (50%), reactivation of pars planitis in 51 eyes (51%), IOL deposits in 29 eyes (29%), IOL decentration in 1 eye (1%), and anterior capsule fibrosis in 14 eyes (14%). The most frequent cause of poor visual recovery was CME, submacular fibrosis, and epiretinal membrane. There was no statistically significant difference in these complications between the 3 groups.
   Conclusions: Phacoemulsification with IOL implantation in eyes with pars planitis was safe and led to good visual outcomes in most cases. The factors in surgical success were control of inflammation, meticulous surgery, in-the-bag IOL implantation, and vigilant postoperative care. (C) 2004 ASCRS and ESCRS.
C1 Med & Vis Res Fdn, Madras 600006, Tamil Nadu, India.
RP Ganesh, SK (reprint author), Med & Vis Res Fdn, Sankara Nethralaya 18 Coll Rd, Madras 600006, Tamil Nadu, India.
EM ganeshsugam@yahoo.com
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6
   Alio JL, 2002, J CATARACT REFR SURG, V28, P2096, DOI 10.1016/S0886-3350(02)01452-9
   Amon M, 1996, J CATARACT REFR SURG, V22, P825, DOI 10.1016/S0886-3350(96)80169-6
   Estafanous MFG, 2001, AM J OPHTHALMOL, V131, P620, DOI 10.1016/S0002-9394(00)00909-0
   Fogla R, 1999, OPHTHALMIC SURG LAS, V30, P191
   Foster Charles Stephen, 2003, Curr Opin Ophthalmol, V14, P1, DOI 10.1097/00055735-200302000-00001
   FOSTER CS, 1989, OPHTHALMOLOGY, V96, P281, DOI 10.1016/S0161-6420(89)32898-3
   HOOPER PL, 1990, SURV OPHTHALMOL, V35, P120, DOI 10.1016/0039-6257(90)90068-7
   KAUFMAN AH, 1993, OPHTHALMOLOGY, V100, P1210
   Lardenoye CWTA, 1996, DOC OPHTHALMOL, V92, P41, DOI 10.1007/BF02583275
   MALINOWSKI SM, 1993, OPHTHALMOLOGY, V100, P818
   Meier Fabio M, 2002, Ophthalmol Clin North Am, V15, P365, DOI 10.1016/S0896-1549(02)00033-0
   MICHELSON JB, 1990, OPHTHALMOLOGY, V97, P1023
   Okhravi N, 1999, OPHTHALMOLOGY, V106, P710, DOI 10.1016/S0161-6420(99)90155-0
   Raja SC, 1999, OPHTHALMOLOGY, V106, P594, DOI 10.1016/S0161-6420(99)90122-7
   Rauz S, 2000, OPHTHALMOLOGY, V107, P909, DOI 10.1016/S0161-6420(00)00056-7
   Rojas B, 1996, Curr Opin Ophthalmol, V7, P11, DOI 10.1097/00055735-199602000-00003
   Smith RE, 1989, UVEITIS CLIN APPROAC, P51
   Suresh PS, 2001, EYE, V15, P621
   TESSLER HH, 1993, OPHTHALMOLOGY, V100, P1206
NR 20
TC 35
Z9 36
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD OCT
PY 2004
VL 30
IS 10
BP 2072
EP 2076
DI 10.1016/j.jcrs.2004.02.090
PG 5
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 865RB
UT WOS:000224719200021
PM 15474816
DA 2018-10-19
ER

PT J
AU Godley, R
   Starosvetsky, D
   Gotman, I
AF Godley, R
   Starosvetsky, D
   Gotman, I
TI Bonelike apatite formation on niobium metal treated in aqueous NaOH
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CHEMICAL SURFACE-TREATMENT; TITANIUM SURFACES; CALCIUM-PHOSPHATE;
   MINERALIZATION; ALLOYS; TI
AB The essential condition for a biomaterial to bond to the living bone is the formation of a biologically active bonelike apatite on its surface. In the present work, it has been demonstrated that chemical treatment can be used to create a calcium phosphate (CaP) surface layer, which might provide the alkali treated Nb metal with bone-bonding capability. Soaking Nb samples in 0.5 M NaOH, at 25degreesC for 24 h produced a nano-porous similar to40 nm thick amorphous sodium niobate hydrogel layer on their surface. Immersion in a simulated body fluid (SBF) lead to the deposition of an amorphous calcium phosphate layer on the alkali treated Nb. The formation of calcium phosphate is assumed to be a result of the local pH increase caused by the cathodic reaction of oxygen reduction on the finely porous surface of the alkali-treated metal. The local rise in pH increased the ionic activity product of hydroxyapatite and lead to the precipitation of CaP from SBF that was already supersaturated with respect to the apatite. The formation of a similar CaP layer upon implantation of alkali treated Nb into the human body should promote the bonding of the implant to the surrounding bone. This bone bonding capability could make Nb metal an attractive material for hard tissue replacements. (C) 2004 Kluwer Academic Publishers.
C1 Technion Israel Inst Technol, Fac Mat Engn, IL-32000 Haifa, Israel.
RP Godley, R (reprint author), Technion Israel Inst Technol, Fac Mat Engn, IL-32000 Haifa, Israel.
EM reutrose@tx.technion.ac.il
CR BETTS F, 1981, J CRYST GROWTH, V53, P63, DOI 10.1016/0022-0248(81)90056-7
   Cuisinier FJG, 1996, CURR OPIN SOLID ST M, V1, P436, DOI 10.1016/S1359-0286(96)80037-4
   Himeno T, 2002, KEY ENG MAT, V218-2, P641
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim HM, 2000, J MATER SCI-MATER M, V11, P555, DOI 10.1023/A:1008924102096
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   LOWENSTAM HA, 1985, SCIENCE, V227, P51, DOI 10.1126/science.227.4682.51
   Miyazaki T, 2000, J BIOMED MATER RES, V50, P35, DOI 10.1002/(SICI)1097-4636(200004)50:1<35::AID-JBM6>3.0.CO;2-8
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Pipino F, 2000, J ORTHOP TRAUMATOL, V1, P3
   Rosenberg R, 2003, J MATER SCI LETT, V22, P29, DOI 10.1023/A:1021769906118
   Wen HB, 1998, J BIOMED MATER RES, V41, P227, DOI 10.1002/(SICI)1097-4636(199808)41:2<227::AID-JBM7>3.0.CO;2-K
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
NR 14
TC 46
Z9 47
U1 4
U2 19
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2004
VL 15
IS 10
BP 1073
EP 1077
DI 10.1023/B:JMSM.0000046388.07961.81
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 866VR
UT WOS:000224802000003
PM 15516867
DA 2018-10-19
ER

PT J
AU Bjerketorp, J
   Rosander, A
   Nilsson, M
   Jacobsson, K
   Frykberg, L
AF Bjerketorp, J
   Rosander, A
   Nilsson, M
   Jacobsson, K
   Frykberg, L
TI Sorting a Staphylococcus aureus phage display library against ex vivo
   biomaterial
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID VON-WILLEBRAND-FACTOR; FIBRINOGEN-BINDING PROTEIN; NUCLEOTIDE-SEQUENCE;
   CLUMPING FACTOR; ANTIPHOSPHOLIPID ANTIBODIES; BETA(2)-GLYCOPROTEIN I;
   APOLIPOPROTEIN-H; PLASMA-PROTEINS; GENE; FIBRONECTIN
AB A phage display library made from Staphylococcus aureus DNA was sorted against a central venous catheter (CVC) that had been removed from a patient 2 days after insertion. After the first panning, approximately 50% of the clones encoded proteins known to interact with mammalian proteins. After the second and third pannings, fibrinogen-binding and beta(2)-glycoprotein I (beta(2)-GPI)-binding phage particles were clearly dominating. Proteins adsorbed to different CVCs were investigated using specific antibodies. Among the proteins probed for, fibrinogen was most abundant, but, interestingly, beta(2)-GPI was also detected on all tested CVCs.
C1 Swedish Univ Agr Sci, Dept Microbiol, SE-75007 Uppsala, Sweden.
RP Frykberg, L (reprint author), Swedish Univ Agr Sci, Dept Microbiol, Box 7025, SE-75007 Uppsala, Sweden.
EM lars.frykberg@mikrob.slu.se
CR BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   Bjerketorp J, 2002, MICROBIOL-SGM, V148, P2037, DOI 10.1099/00221287-148-7-2037
   BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x
   BODEN MK, 1989, INFECT IMMUN, V57, P2358
   BORCHMAN D, 1995, CLIN EXP IMMUNOL, V102, P373
   Chamley LW, 1999, CLIN EXP IMMUNOL, V115, P571
   CHONN A, 1995, J BIOL CHEM, V270, P25845, DOI 10.1074/jbc.270.43.25845
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   Fabrizi F, 1999, J NEPHROL, V12, P89
   Fischer BE, 1997, CELL MOL LIFE SCI, V53, P943, DOI 10.1007/s000180050115
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   FUQUAY JI, 1986, INFECT IMMUN, V52, P714
   GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J
   Hartleib J, 2000, BLOOD, V96, P2149
   Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   Herrmann M, 1997, J INFECT DIS, V176, P984, DOI 10.1086/516502
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Jacobsson K, 1998, BIOTECHNIQUES, V24, P294, DOI 10.2144/98242rr01
   JACOBSSON K, 1995, BIOTECHNIQUES, V18, P878
   Jacobsson K, 1996, BIOTECHNIQUES, V20, P1070
   Jacobsson K, 2001, COMB CHEM HIGH T SCR, V4, P135
   Jacobsson Karin, 2003, Biological Procedures Online, V5, P123, DOI 10.1251/bpo54
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   KAIDA S, 1987, J BIOCHEM-TOKYO, V102, P1177, DOI 10.1093/oxfordjournals.jbchem.a122156
   KATO H, 1991, BIOCHEMISTRY-US, V30, P11687, DOI 10.1021/bi00114a012
   KAWABATA S, 1986, J BIOL CHEM, V261, P1427
   Kronvall G, 1999, J MOL RECOGNIT, V12, P38, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<38::AID-JMR378>3.0.CO;2-Q
   Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2
   Li Z, 2003, AUTOIMMUN REV, V2, P229, DOI 10.1016/S1568-9972(03)00015-6
   Malik P, 1996, J MOL BIOL, V260, P9, DOI 10.1006/jmbi.1996.0378
   MCDEVITT D, 1992, INFECT IMMUN, V60, P1514
   McIntyre JA, 2003, LUPUS, V12, P555, DOI 10.1191/0961203303lu401oa
   MCNEIL HP, 1991, ADV IMMUNOL, V49, P193
   MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120
   NIMPF J, 1986, BIOCHIM BIOPHYS ACTA, V884, P142, DOI 10.1016/0304-4165(86)90237-0
   Shi T, 2004, P NATL ACAD SCI USA, V101, P3939, DOI 10.1073/pnas.0400281101
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   Steiner R. F., 1991, TOPICS FLUORESCENCE, V2, P1, DOI DOI 10.1007/0-306-47058-6_
   UHLEN M, 1984, J BIOL CHEM, V259, P1695
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   VROMAN L, 1980, BLOOD, V55, P156
   Wang SX, 2000, BIOCHEM J, V348, P103, DOI 10.1042/0264-6021:3480103
   Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863
   Zhang LH, 1999, MICROBIOL-UK, V145, P177, DOI 10.1099/13500872-145-1-177
   Zhang LH, 1998, MICROBIOL-UK, V144, P985, DOI 10.1099/00221287-144-4-985
NR 49
TC 10
Z9 11
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD OCT
PY 2004
VL 53
IS 10
BP 945
EP 951
DI 10.1099/jmm.0.45638-0
PG 7
WC Microbiology
SC Microbiology
GA 865FB
UT WOS:000224686800001
PM 15358815
OA Bronze
DA 2018-10-19
ER

PT J
AU Gaengler, P
   Hoyer, I
   Montag, R
   Gaebler, P
AF Gaengler, P
   Hoyer, I
   Montag, R
   Gaebler, P
TI Micromorphological evaluation of posterior composite restorations - a
   10-year report
SO JOURNAL OF ORAL REHABILITATION
LA English
DT Article
DE clinical trial; composite restoration; micromorphologic assessment;
   longevity
ID CLINICAL-ASSESSMENT; MARGIN ANALYSIS; LAST; LONG
AB The summarized scanning electron microscopic-supported micromorphologic data of a 10-year longitudinal clinical study of GIC/Hybrid composite posterior restorations is reported. The aim of this study was to compare the results to USPHS-compatible clinical criteria of the CPM index and to analyse the deterioration pattern and the success rate. Out of a total of 194 Class I and Class II fillings 46 restorations were at baseline, after 1, 3, 5, 7 and 10 years. The restorations were micromorphologically examined using gold-sputtered replicas and coded according to the M-criteria of the CPM index. The features for surface roughness, surface texture, marginal integrity, excess of material, marginal fracture, loss of material, marginal leakage and other filling imperfections were assessed. Eighteen fillings showed perfect margins, rapidly deteriorating after the first year of service. Despite poor micromorphologic marginal conditions all restorations retained optimal functional characteristics. Parallel longitudinal micromorphologic and clinical assessment of posterior GIC/Composite restorations revealed fine structure and deterioration patterns of the tooth-biomaterial interface. The layer-technique using GIC as dentine replacement and resin-based composite as enamel replacement results, according to previous biocompatibility testing, and clinical data, in optimal pulp protection and correct anatomic form over a 10-year period. The myth of the need for perfect marginal integrity requires further discussion.
C1 Univ Witten Herdecke, Fac Med Dent, Dept Conservat Dent, D-58448 Witten, Germany.
   Univ Jena, Sch Dent Med, Dept Conservat Dent, D-6900 Jena, Germany.
RP Gaengler, P (reprint author), Univ Witten Herdecke, Fac Med Dent, Dept Conservat Dent, D-58448 Witten, Germany.
EM peter.gaengler@uni-wh.de
CR AINAMO A, 1984, INT DENT J, V34, P87
   Beer R, 1990, Dtsch Zahnarztl Z, V45, P202
   Black GV, 1908, WORK OPERATIVE DENT
   DAVIDSON CL, 1996, PHILLIP J, V3, P171
   Downer MC, 1999, BRIT DENT J, V187, P432, DOI 10.1038/sj.bdj.4800298a1
   Gaengler P, 2001, J Adhes Dent, V3, P185
   GAENGLER P, 1987, ZAHN MUND KIEFERHEIL, V73, P435
   GAENGLER P, 1995, ZAHNAERZTL WELT REFO, V104, P836
   HOYER I, 1988, Zahn- Mund- und Kieferheilkunde, V76, P721
   HOYER I, 1989, DEUT ZAHNAERZTL Z, V44, P100
   Hoyer I, 1989, Zahn Mund Kieferheilkd Zentralbl, V77, P775
   KAMANN WK, 1999, ZAHNARZTL WELT, V108, P270
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KOSA W, 1991, DTSCH STOMATOL, V41, P53
   Mair LH, 1998, QUINTESSENCE INT, V29, P483
   Meskin LH, 2000, J AM DENT ASSOC, V131, P35
   Nordbo H, 1998, QUINTESSENCE INT, V29, P5
   Raskin A, 1999, J DENT, V27, P13, DOI 10.1016/S0300-5712(98)00026-8
   Rezwani-Kaminski T, 2002, J ORAL REHABIL, V29, P1131, DOI 10.1046/j.1365-2842.2002.00975.x
   Roulet J F, 1978, SSO Schweiz Monatsschr Zahnheilkd, V88, P345
   ROULET JF, 1991, DENT MATER, V7, P44, DOI 10.1016/0109-5641(91)90026-U
   ROULET JF, 1989, SCANNING MICROSCOPY, V3, P147
   SCHWARZ U, 1998, DTSCH ZAHNARZTLICHE, V53, P374
   Shimizu T, 1995, Dent Mater J, V14, P120
   Stoll R, 1999, Clin Oral Investig, V3, P100
   van Dijken JWV, 2000, J DENT, V28, P299, DOI 10.1016/S0300-5712(00)00010-5
   Wilder A D Jr, 1999, J Esthet Dent, V11, P135, DOI 10.1111/j.1708-8240.1999.tb00390.x
   WITZEL A, 1899, FULLEN ZAHNE AMALGAM
NR 28
TC 36
Z9 37
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-182X
EI 1365-2842
J9 J ORAL REHABIL
JI J. Oral Rehabil.
PD OCT
PY 2004
VL 31
IS 10
BP 991
EP 1000
DI 10.1111/j.1365-2842.2004.01329.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 856UA
UT WOS:000224069300012
PM 15387840
DA 2018-10-19
ER

PT J
AU Staudenmaier, R
   Hoang, TN
   Kleinsasser, N
   Schurr, C
   Frolich, K
   Wenzel, MM
   Aigner, J
AF Staudenmaier, R
   Hoang, TN
   Kleinsasser, N
   Schurr, C
   Frolich, K
   Wenzel, MM
   Aigner, J
TI Flap prefabrication and prelamination with tissue-engineered cartilage
SO JOURNAL OF RECONSTRUCTIVE MICROSURGERY
LA English
DT Article
DE prefabrication; prelamination; tissue engineering
ID SKIN FLAPS; IN-VITRO; ARTERIOVENOUS PEDICLE; VENOUS FLAPS; BONE-MATRIX;
   RAT MODEL; RECONSTRUCTION; COLLAGEN; PERICHONDRIUM; CHONDROCYTES
AB In reconstructive surgery, the integration of tissue-engineered cartilage in a prefabricated free flap may make it possible to generate flaps combining a variety of tissue components, to meet the special requirements of particular defects. One aim of the present study was to investigate prefabrication of a microvascular free flap by implanting a vessel loop under a skin flap in a rabbit model. A second aim was to report on the authors' preliminary experiences in prelaminating prefabricated flaps with autologous tissue-engineered cartilage, in terms of matrix development, inflammatory reaction, and host-tissue interaction.
   The flap was prefabricated by implanting a vessel loop under a random-pattern abdominal skin flap. The tissue-engineered cartilage constructs were made by isolating chondrocytes from auricular biopsies. Following a period of amplification, the cells were seeded onto a non-woven scaffold made of a hyaluronic-acid derivative and cultivated for 2 weeks. One cell-biomaterial construct was placed beneath the prefabicated flap, and two additional constructs were placed subcutaneously and intramuscularly. In addition, a biomaterial sample without cells was placed subcutaneously to provide a control. All implanted specimens were left in position for 6 or 12 weeks. Neovascularization in the prefabricated flap and biomaterial construct was analyzed by angiography. After explantation, the specimens were examined by histologic and immunohistochemical methods.
   The prefabricated flaps showed a well-developed network of blood vessels between the implanted vessel loop and the original random-pattern blood supply. The tissue-engineered constructs remained stable in size and showed signs of tissue similar to hyaline cartilage, as evidenced by the expression of cartilage-specific collagen type II and proteoglycans. No inflammatory reactions were observed. The physiologic environment of the autologous rabbit model provided favorable conditions for matrix deposition and maturation of the cell-biomaterial constructs.
   These initial results demonstrated the potential of prefabricating an axial perfused flap, combined with tissue-engineered cartilage, thus creating functionally competent tissue components for reconstructive surgery with minimal donor-site morbidity.
C1 Univ Hosp Regensburg, ENT Dept, D-93053 Regensburg, Germany.
RP Staudenmaier, R (reprint author), Univ Hosp Regensburg, ENT Dept, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
FU NICHD NIH HHS [HD-6-2915]
CR Ahn KM, 2003, J RECONSTR MICROSURG, V19, P195
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Alam MI, 2001, PLAST RECONSTR SURG, V108, P952, DOI 10.1097/00006534-200109150-00020
   Arevalo-Silva CA, 2000, ARCH OTOLARYNGOL, V126, P1234, DOI 10.1001/archotol.126.10.1234
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Casabona F, 1998, PLAST RECONSTR SURG, V101, P577, DOI 10.1097/00006534-199803000-00003
   Cavadas PC, 1996, PLAST RECONSTR SURG, V98, P1052, DOI 10.1097/00006534-199611000-00020
   Chiarini L, 2002, MICROSURG, V22, P177, DOI 10.1002/micr.22511
   Cronin KJ, 2004, PLAST RECONSTR SURG, V113, P260, DOI 10.1097/01.PRS.0000095942.71618.9D
   Delaere PR, 2001, ANN OTO RHINOL LARYN, V110, P849, DOI 10.1177/000348940111000909
   EROL O, 1978, SURG FORUM, V29, P594
   Geishauser M, 1998, BRIT J PLAST SURG, V51, P603, DOI 10.1054/bjps.1998.0152
   Hickey MJ, 1998, PLAST RECONSTR SURG, V101, P1296, DOI 10.1097/00006534-199804050-00021
   HIRASE Y, 1987, Microsurgery, V8, P218, DOI 10.1002/micr.1920080410
   Hong JP, 2003, ANN PLAS SURG, V50, P484, DOI 10.1097/01.SAP.0000044146.45427.1B
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   ISOGAI N, 1999, J BONE JOINT SURG AM, V81, P309
   ITOH Y, 1992, ANN PLAS SURG, V28, P140, DOI 10.1097/00000637-199202000-00003
   Kamil SH, 2003, LARYNGOSCOPE, V113, P90, DOI 10.1097/00005537-200301000-00017
   Kandel R, 1999, TISSUE ENG, V5, P25, DOI 10.1089/ten.1999.5.25
   Karatas O, 2000, ANN PLAS SURG, V44, P44, DOI 10.1097/00000637-200044010-00008
   Kimura N, 2001, PLAST RECONSTR SURG, V108, P1972, DOI 10.1097/00006534-200112000-00020
   MacLeod TM, 2003, BRIT J PLAST SURG, V56, P775, DOI 10.1016/S0007-1226(03)00383-7
   Meinhart J, 1999, ANN PLAS SURG, V42, P673, DOI 10.1097/00000637-199906000-00016
   MORRISON WA, 1990, BRIT J PLAST SURG, V43, P645, DOI 10.1016/0007-1226(90)90184-2
   Morrison WA, 1997, PLAST RECONSTR SURG, V99, P378, DOI 10.1097/00006534-199702000-00011
   NGUYEN HS, 1997, THESIS WARSAW U, P1
   Ozerden OR, 2003, PLAST RECONSTR SURG, V111, P2166, DOI 10.1097/01.PRS.0000060109.58552.B2
   PIRSIG W, 1995, INT J PEDIATR OTORHI, V32, P171, DOI 10.1016/0165-5876(94)01121-D
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PRIBAZ JJ, 1994, MICROSURG, V15, P618, DOI 10.1002/micr.1920150903
   Pribaz JJ, 2001, CLIN PLAST SURG, V28, P261
   Pribaz JJ, 1999, PLAST RECONSTR SURG, V103, P808, DOI 10.1097/00006534-199903000-00006
   Rasp G, 2000, LARYNGO RHINO OTOL, V79, P155
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Rohner D, 2003, PLAST RECONSTR SURG, V112, P748, DOI 10.1097/01.PRS.0000069709.89719.79
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Saadeh PB, 1999, ANN PLAS SURG, V42, P509, DOI 10.1097/00000637-199905000-00008
   Safak T, 2000, PLAST RECONSTR SURG, V105, P1304
   Saray A, 2002, J RECONSTR MICROSURG, V18, P281, DOI 10.1055/s-2002-30184
   SCHECHTER GL, 1969, LARYNGOSCOPE, V79, P1647, DOI 10.1288/00005537-196909000-00008
   Seikaly H, 2003, LARYNGOSCOPE, V113, P897, DOI 10.1097/00005537-200305000-00023
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Shen TY, 1982, PLAST RECONSTR SURG, V69, P568
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   TAKATO T, 1993, BRIT J PLAST SURG, V46, P122, DOI 10.1016/0007-1226(93)90142-X
   TAMAKA Y, 2003, PLAST RECONSTR SURG, V112, P1626
   Tark KC, 1996, ANN PLAS SURG, V37, P298, DOI 10.1097/00000637-199609000-00011
   ten Koppel PGJ, 1998, PLAST RECONSTR SURG, V102, P2012, DOI 10.1097/00006534-199811000-00031
   van Osch GJVM, 2000, TISSUE ENG, V6, P321, DOI 10.1089/107632700418047
   Vogelin E, 2002, PLAST RECONSTR SURG, V109, P190
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
NR 55
TC 19
Z9 20
U1 0
U2 2
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0743-684X
J9 J RECONSTR MICROSURG
JI J. Reconstr. Microsurg.
PD OCT
PY 2004
VL 20
IS 7
BP 555
EP 564
DI 10.1055/s-2004-836127
PG 10
WC Surgery
SC Surgery
GA 868QW
UT WOS:000224929100007
PM 15534783
DA 2018-10-19
ER

PT J
AU Busuttil, SJ
   Ploplis, VA
   Castellino, FJ
   Tang, L
   Eaton, JW
   Plow, EF
AF Busuttil, SJ
   Ploplis, VA
   Castellino, FJ
   Tang, L
   Eaton, JW
   Plow, EF
TI A central role for plasminogen in the inflammatory response to
   biomaterials
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE cell trafficking; macrophages; neutrophils; transgenic/knockout
ID UROKINASE; MICE; DEGRADATION; DEFICIENCY; FIBRINOGEN; MONOCYTES;
   ACTIVATOR; RECEPTOR; RELEASE; BIOCOMPATIBILITY
AB The inflammatory response to implanted biomaterials severely limits their deployment in patients. Plasminogen has been shown to play a central role in cell migration, and therefore could regulate this inflammatory response. We sought to determine if plasminogen influences recruitment of inflammatory cells to a biomaterial implanted into plasminogen-deficient (Plg(-/-)) mice. Small disks of polyethylene terephthalate, a material used in vascular grafts, were surgically implanted into the peritoneum of wild-type and Plg(-/-) mice. Recruitment of neutrophils and monocytes/macrophages into the peritoneum and onto the disks was measured, primarily at 18 h. Monocyte/macrophage recruitment was markedly blunted in Plg(-/-) mice compared with wild-type mice. Unexpectedly, neutrophil recruitment was also markedly decreased in the Plg-/- mice. While recruitment of leukocytes into the peritoneum was plasminogen-dependent, the adhesion of the emigrating cells to the implants was not. In contrast, adhesion but not recruitment was reduced in fibrinogen-deficient mice. Reconstitution of Plg(-/-) mice with intravenous or intraperitoneal plasminogen differentially restored monocyte/macrophage and neutrophil recruitment. Tranexamic acid, an inhibitor of the lysine binding sites of plasminogen, suppressed leukocyte recruitment in wild-type mice, but aprotinin, a plasmin inhibitor, did not. Plasminogen exerts a marked influence on both neutrophil and monocyte/macrophage recruitment to implanted biomaterials. This role is distinct from that of fibrinogen, and the two inflammatory cell types use plasminogen in different ways. Plasminogen represents a therapeutic target for controlling the inflammatory response to implanted materials.
C1 Case Western Reserve Univ, Cleveland, OH 44106 USA.
   Cleveland VAMC, Cleveland, OH USA.
   Univ Notre Dame, Dept Chem & Biochem, WM Keck Ctr Transgene Res, Notre Dame, IN USA.
   Univ Texas, Joint Program Biomed Engn, Arlington, TX USA.
   Univ Texas, SW Med Ctr, Arlington, TX USA.
   Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.
   Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH USA.
   Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH USA.
RP Plow, EF (reprint author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol NB50, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM plowe@ccf.org
FU NIBIB NIH HHS [EB00287]; NHLBI NIH HHS [HL13423, HL63682, HL60787,
   HL17964]
CR ANDERSON DC, 1985, J INFECT DIS, V152, P668, DOI 10.1093/infdis/152.4.668
   ANDERSSON L, 1968, ANN NY ACAD SCI, V146, P642, DOI 10.1111/j.1749-6632.1968.tb20322.x
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bianchi E, 1996, J CLIN INVEST, V98, P1133, DOI 10.1172/JCI118896
   Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298
   Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439
   DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095
   Ding ZM, 1999, J IMMUNOL, V163, P5029
   ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783
   Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123
   HAMILTON KK, 1985, J CLIN INVEST, V76, P261, DOI 10.1172/JCI111956
   Herren T, 2001, BLOOD, V97, P1070, DOI 10.1182/blood.V97.4.1070
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   LAWLER JW, 1981, THROMB RES, V22, P267, DOI 10.1016/0049-3848(81)90119-5
   LIBBY P, 1992, CIRCULATION, V86, P47
   Lijnen HR, 2000, FIBRINOLYSIS PROTEOL, V14, P175, DOI 10.1054/fipr.2000.0065
   LIOTTA LA, 1981, CANCER RES, V41, P4629
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P799, DOI 10.1002/jbm.820200611
   MATSUSHIMA K, 1986, J IMMUNOL, V136, P2883
   MCKENZIE R, 1975, THROMB RES, V6, P1, DOI 10.1016/0049-3848(75)90145-0
   Moons L, 1998, J CLIN INVEST, V102, P1788, DOI 10.1172/JCI3316
   ODEKON LE, 1994, J CELL PHYSIOL, V158, P398, DOI 10.1002/jcp.1041580303
   Ploplis VA, 1998, BLOOD, V91, P2005
   PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585
   Ploplis VA, 2000, AM J PATHOL, V157, P703, DOI 10.1016/S0002-9440(10)64582-8
   PLOW EF, 1995, FASEB J, V9, P939
   PYKE C, 1993, CANCER RES, V53, P1911
   Rifkin D B, 1992, Matrix Suppl, V1, P20
   ROLLINS BJ, 2001, CYTOKINE REFERENCE, V1, P1145
   Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Syrovets T, 1997, BLOOD, V89, P4574
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
NR 37
TC 70
Z9 72
U1 0
U2 5
PU BLACKWELL PUBL LTD
PI OXFORD
PA 108 COWLEY RD, OXFORD OX4 1JF, OXON, ENGLAND
SN 1538-7933
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD OCT
PY 2004
VL 2
IS 10
BP 1798
EP 1805
DI 10.1111/j.1538-7836.2004.00916.x
PG 8
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 859TE
UT WOS:000224290000019
PM 15456492
OA Bronze
DA 2018-10-19
ER

PT J
AU Guo, LF
   Zhang, WG
   Wang, CT
AF Guo, LF
   Zhang, WG
   Wang, CT
TI Preparation and crystallization control of nanoparticle hydroxyapatite
SO JOURNAL OF UNIVERSITY OF SCIENCE AND TECHNOLOGY BEIJING
LA English
DT Article
DE precipitation; hydroxyapatite; crystallization; nanoparticle;
   biomaterial
ID POROUS HYDROXYAPATITE; BEHAVIOR; CERAMICS; APATITES; POWDERS
AB Nanoparticle hydroxyapatite was prepared by a wet chemical precipitation method. The effects of different synthesis conditions, i.e. contents of reagents (0.2, 0.5 and 0.8 mol/L), reaction temperatures (20, 37, 55 and 75degreesC) and reaction time (0-24 h), were studied based on crystallization process analysis and the effects of washing methods (with water or alcohol) were also studied. Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), transmission electron microscopy (TEM), electron diffraction (ED) and inductively coupled plasma spectroscopy (ICP) were used to characterize the powders. Chemical analysis shows that the purity of the precipitated hydroxyapatite largely depends on reaction time. X-ray diffraction and TEM micrographs results show that reaction temperature is a key factor affecting crystallinity, morphology and particle size. Degree of supersaturation and stirring also affects the crystallization. Particles are in a shape of short rod and have a size of 20-40 nm in length at 20degreesC and 37degreesC, but acicular morphology and a size of 150-170 nm in length at 75degreesC. Particles are monocrystalline at 20degreesC and 37degreesC, and are polycrystalline at 55degreesC and 75degreesC. The results show that stoichiometry hydroxyapatite with controlled particle size, morphology and crystallinity can be obtained by carefully controlling the reaction conditions.
C1 Shanghai Jiao Tong Univ, Sch Mech & Power Engn, Shanghai 200030, Peoples R China.
RP Guo, LF (reprint author), Shanghai Jiao Tong Univ, Sch Mech & Power Engn, Shanghai 200030, Peoples R China.
EM glfglf@sjtu.edu.cn
CR Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA, P555
   DEGROOT K, 1993, CERAM INT, V19, P363, DOI 10.1016/0272-8842(93)90050-2
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P937, DOI 10.1002/jbm.820260708
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   Knowles JC, 2000, BIOMATERIALS, V21, P1387, DOI 10.1016/S0142-9612(00)00032-6
   KWEH SWK, 1999, J MATER PROCESS TECH, V89, P373
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   Luo P, 1996, BIOMATERIALS, V17, P1959, DOI 10.1016/0142-9612(96)00019-1
   MULLIN JW, 1961, CRYSTALLIZATION, P1
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   Tampieri A, 2000, MATER CHEM PHYS, V64, P54, DOI 10.1016/S0254-0584(99)00252-7
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Yeong KCB, 1999, MATER LETT, V38, P208, DOI 10.1016/S0167-577X(98)00160-8
   Zhang HQ, 2001, CERAM INT, V27, P451, DOI 10.1016/S0272-8842(00)00100-0
NR 20
TC 2
Z9 2
U1 0
U2 5
PU JOURNAL OF UNIV OF SCIENCE AND TECHNOLOGY BEIJING
PI BEIJING
PA 30 XUEYUANLU, BEIJING 100083, PEOPLES R CHINA
SN 1005-8850
J9 J UNIV SCI TECHNOL B
JI J. Univ. Sci. Technol. Beijing
PD OCT
PY 2004
VL 11
IS 5
BP 449
EP 454
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mining &
   Mineral Processing
GA 864KT
UT WOS:000224633100014
DA 2018-10-19
ER

PT J
AU Gosain, AK
   Riordan, PA
   Song, LS
   Amarante, MT
   Kalantarian, B
   Nagy, PG
   Wilson, CR
   Toth, JM
   McIntyre, BL
AF Gosain, AK
   Riordan, PA
   Song, LS
   Amarante, MT
   Kalantarian, B
   Nagy, PG
   Wilson, CR
   Toth, JM
   McIntyre, BL
TI A 1-year study of osteoinduction in hydroxyapatite-derived Biomaterials
   in an adult sheep model: Part II. Bioengineering implants to optimize
   bone replacement in reconstruction of cranial defects
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID POROUS HYDROXYAPATITE; TISSUE; CRANIOPLASTY
AB The present study investigated hydroxyapatite biomaterials implanted in critical-size defects in the calvaria of adult sheep to determine the optimal bioengineering of hydroxyapatite composites to facilitate bone ingrowth into these materials. Five calvarial defects measuring 16.8 mm in diameter were made in each of 10 adult sheep. Three defects were filled with cement paste composites of hydroxyapatite and beta-tricalcium phosphate as follows: (1) 100 percent hydroxyapatite-cement paste, (2) 60 percent hydroxyapatite-cement paste, and (3) 20 percent hydroxyapatite- cement paste. One defect was filled with a ceramic composite containing 60 percent hydroxyapatite-ceramic, and the fifth defect remained unfilled. One year after implantation, the volume of all biomaterials was determined by Computed tomography, and porosity and bone replacement were determined using backscatter electron microscopy. Computed tomography-based volumetric assessment 1 year after implantation demonstrated that none of the unfilled cranial defects closed over the 1-year period, confirming that these were critical-size defects. There was a significant increase in volume in both the cement paste and ceramic implants containing 60 percent hydroxyapatite (p < 0.01). There was no significant change in volume of the remaining cement paste biomaterials. Analysis of specimens by backscatter electron microscopy demonstrated mean bone replacement of 4.8 +/- 1.4 percent (mean +/- SEM) in 100 percent hydroxyapatite- cement paste, 11.2 +/- 2.3 percent in 60 percent hydroxyapatite- cement paste, and 28.5 +/- 4.5 percent in 20 percent hydroxyapatite- cement paste. There was an inverse correlation between the concentration of hydroxyapatite and the amount of bone replacement in the cement paste for each composite tested (p < 0.01). Bone replacement in 60 percent hydroxyapatite-ceramic composite (13.6 +/- 2.0 percent) was not significantly different from that in 60 percent hydroxyapatite-cement paste. Of note is that the ceramic composite contained macropores (200 to 300 mum) that did not change in size over the 1-year period. All cement paste composites initially contained micropores (3 to 5 nm), which remained unchanged in 100 percent hydroxyapatite-cement paste. Cement paste implants containing increased tricalcium phosphate demonstrated a corresponding increase in macropores following resorption of the tricalcium phosphate component. Bone replacement occurred within the macropores of these implants. In conclusion, there was no significant bone ingrowth into pure hydroxyapatite-cement paste (Bone Source, Stryker-Leibinger Inc., Dallas, Texas) in the present study. The introduction of macropores in a biomaterial can optimize bone ingrowth for reconstruction of critical-size defects in calvaria. This was demonstrated in both the ceramic composite of hydroxyapatite tested and the cement paste composites of hydroxyapatite by increasing the composition of a rapidly resorbing component such as beta-tricalcium phosphate.
C1 Med Coll Wisconsin, Dept Plast Surg, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Dept Orthoped Surg, Milwaukee, WI 53226 USA.
   Univ Rochester, Inst Opt, Rochester, NY 14627 USA.
RP Gosain, AK (reprint author), Med Coll Wisconsin, Dept Plast Surg, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.
EM gosain@mcw.edu
CR BAKER SB, 2000, PLAST SURG FORUM, V23, P29
   BORETOS JW, 1987, ADV CERAM MATER, V2, P15
   CHIROFF RT, 1975, J BIOMED MATER RES S, V6, P29
   COHEN M, 2001, 9 INT C INT SOC CRAN
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   FARRIOR RT, 1966, LARYNGOSCOPE, V76, P934
   Gosain A. K, 2003, OPER TECH PLAST RECO, V9, P23
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Gosain AK, 1997, J CRANIOFAC SURG, V8, P506, DOI 10.1097/00001665-199711000-00017
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HOLMES RE, 1988, PLAST RECONSTR SURG, V81, P662, DOI 10.1097/00006534-198805000-00003
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   HOLMES RE, 1987, J BIOMED MATER RES, V21, P731, DOI 10.1002/jbm.820210605
   Hulbert S. F., 1982, Ceramics International, V8, P131, DOI 10.1016/0272-8842(82)90003-7
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KALANTARIAN B, 2001, 70 ANN M AM SOC PLAS
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   LEGEROS R, 1991, ORAL BIOL MED, P154
   MAAS CS, 1990, ARCH OTOLARYNGOL, V116, P551
   MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4
   MEACHIM G, 1981, FUNDAMENTAL ASPECTS, V1, P231
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V90, P382, DOI 10.1097/00006534-199209000-00004
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 26
TC 50
Z9 54
U1 2
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD OCT
PY 2004
VL 114
IS 5
BP 1155
EP 1163
DI 10.1097/01.prs.0000135852.45465.a9
PG 9
WC Surgery
SC Surgery
GA 861DQ
UT WOS:000224396700019
PM 15457027
DA 2018-10-19
ER

PT J
AU Iliescu, M
   Nelea, V
   Werckmann, J
   Mihailescu, IN
AF Iliescu, M
   Nelea, V
   Werckmann, J
   Mihailescu, IN
TI Transmission electron microscopy investigation of pulsed-laser deposited
   hydroxylapatite thin films prepared by tripod and focused ion beam
   techniques
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE biocompatible and bioactive thin films; hydroxylapatite thin films;
   pulsed laser deposition; electron microscopy; focused ion beam;
   mechanical polishing with tripod
ID SPRAYED HYDROXYAPATITE COATINGS; CALCIUM-PHOSPHATE CERAMICS;
   BIOMATERIAL; TI-6AL-4V; SPECIMENS; INTERFACE; SUBSTRATE; ALLOY
AB Hydroxylapatite-based ceramics are largely applied as coatings and thin films on metallic components of prostheses for inducing osteoblasts apposition and subsequent bone re-growth. We report for the first time the focused ion beam technique (FIB) as a milling method to prepare specimens for transmission electron microscopy investigations of HA thin films gown on metallic substrates. New FIB technique results were compared to those obtained by the thinning method of mechanical polishing with tripod. HA films were obtained by pulsed laser deposition on Si wafers and polished Ti-5Al-2.5Fe substrates coated with TiN buffer layers. A KrF* excimer laser (lambda = 248 nm, tau(FWHM) greater than or equal to20) was used for deposition. HA films were grown in vacuum (10(-4) Pa) on room temperature substrates, subsequently annealed at 550 degreesC in ambient air for 1 h. Processed structures were investigated by transmission electron microscopy (TEM), grazing incidence X-ray diffraction, selected area electron diffraction, and energy dispersive X-ray spectroscopy. We show that both tripod polishing and focused ion beam milling techniques well preserve the structural and chemical integrity of the thin layers, and their interfaces. Additionally, focused ion beam milling allows for preparation of long specimens (approx. 12 mum in our case). HA films were stoichiometric and had a nano-crystalline structure with an average grain size of 35 mum. Cross-section TEM patterns show a granular growth morphology of the films. Particulates trapped within the film were visualized. High resolution TEM analysis shows that the transition from cubic TiN to hexagonal HA is intermediated by a very thin amorphous calcium phosphate interlayer of similar to 3 -4 nm thickness. (C) 2004 Published by Elsevier B.V.
C1 Inst Phys & Chim Mat, Grp Surfaces Interfaces, F-67037 Strasbourg, France.
   Inst Natl Sci Appl, Lab Ingn Surfaces, F-67084 Strasbourg, France.
   Natl Inst Lasers Plasma & Radiat Phys, Lasers Dept, Bucharest 77125, Romania.
RP Iliescu, M (reprint author), Inst Phys & Chim Mat, Grp Surfaces Interfaces, 23 Rue Loess, F-67037 Strasbourg, France.
EM Monica.Iliescu@ipcms.u-strasbg.fr
RI Mihailescu, Ion/A-5403-2011
CR Anderson J. M., 1991, MRS BULL, P75
   AOKI H, 1991, SCI MED APPL HYDROXY
   Ayache J, 1995, ULTRAMICROSCOPY, V60, P195, DOI 10.1016/0304-3991(95)00073-8
   BENEDICT J, 1992, MATER RES SOC SYMP P, V254, P121
   BROWN SR, 1994, J MATER SCI-MATER M, V5, P756, DOI 10.1007/BF00120371
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Campbell PA, 1996, J VAC SCI TECHNOL B, V14, P1167, DOI 10.1116/1.588422
   CASEY JD, 1994, MICROELECTRON ENG, V24, P43, DOI 10.1016/0167-9317(94)90053-1
   Chrisey D., 1994, PULSED LASER DEPOSIT
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   COTELL CM, 1994, PULSED LASER DEPOSIT, P549
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Elliott JC, 1994, STRUCTURE CHEM APATI
   EVASON AF, 1985, ELECTRON LETT, V21, P629, DOI 10.1049/el:19850445
   Fernandez-Pradas JM, 1998, THIN SOLID FILMS, V317, P393, DOI 10.1016/S0040-6090(97)00629-9
   FRANGINI S, 1994, J MATER SCI, V29, P714, DOI 10.1007/BF00445984
   GHICA C, 2001, THESIS U STRASBOURG
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Gross KA, 1998, J BIOMED MATER RES, V39, P407, DOI 10.1002/(SICI)1097-4636(19980305)39:3<407::AID-JBM9>3.0.CO;2-N
   Hamdi M, 2000, THIN SOLID FILMS, V377, P484, DOI 10.1016/S0040-6090(00)01276-1
   HARRIOTT LR, 1986, J VAC SCI TECHNOL B, V4, P181, DOI 10.1116/1.583433
   Heaney PJ, 2001, AM MINERAL, V86, P1094
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1993, INTRO BIOCERAMICS
   HENCH LL, 1982, BIOMATERIALS INTERFA
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kao CT, 2002, J BIOMED MATER RES, V63, P786, DOI 10.1002/jbm.10484
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   Leitao E, 1997, J BIOMED MATER RES, V36, P85, DOI 10.1002/(SICI)1097-4636(199707)36:1<85::AID-JBM10>3.3.CO;2-G
   LEVISETTI R, 1983, NUCL INSTRUM METHODS, V205, P299, DOI 10.1016/0167-5087(83)90201-6
   Li XD, 1997, BIOMATERIALS, V18, P1487, DOI 10.1016/S0142-9612(97)00085-9
   Lipp S, 1996, J VAC SCI TECHNOL B, V14, P3996, DOI 10.1116/1.588630
   LIU DM, 1994, J MATER SCI-MATER M, V5, P147, DOI 10.1007/BF00053335
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Mavis B, 2000, J AM CERAM SOC, V83, P989
   Nelea V, 2002, J MATER SCI-MATER M, V13, P1167, DOI 10.1023/A:1021150207350
   Nelea V, 2000, APPL SURF SCI, V168, P127, DOI 10.1016/S0169-4332(00)00616-4
   OVERWIJK MHF, 1993, J VAC SCI TECHNOL B, V11, P2021, DOI 10.1116/1.586537
   PARK JB, 1987, BIOMATERIALS SCI ENG
   Peaker AJS, 1996, THIN SOLID FILMS, V287, P174, DOI 10.1016/S0040-6090(96)08755-X
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Saka H, 1998, J VAC SCI TECHNOL B, V16, P2522, DOI 10.1116/1.590202
   SHAVER DC, 1986, J VAC SCI TECHNOL B, V4, P185, DOI 10.1116/1.583434
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   STECKL AJ, 1988, NATO ASI SER, P179
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wen J, 2000, BIOMATERIALS, V21, P1339, DOI 10.1016/S0142-9612(99)00273-2
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
NR 53
TC 14
Z9 14
U1 1
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD OCT 1
PY 2004
VL 187
IS 1
BP 131
EP 140
DI 10.1016/j.surfcoat.2004.01.022
PG 10
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 856CF
UT WOS:000224020500018
DA 2018-10-19
ER

PT J
AU Li, X
   Logan, BE
AF Li, X
   Logan, BE
TI Analysis of bacterial adhesion using a gradient force analysis method
   and colloid probe atomic force microscopy
SO LANGMUIR
LA English
DT Article
ID STREPTOCOCCUS-MITIS STRAINS; PSEUDOMONAS-PUTIDA KT2442; BIOMATERIAL
   SURFACES; MINERAL SURFACES; ELASTICITY; TRANSPORT; POLYMERS; AFM
AB The atomic force microscope (AFM) has been used to examine the stickiness of bacteria on the basis of the analysis of approach and retraction force curves between the AFM tip and the bacterial surface. One difficulty in analyzing approach curve data is that the distance between the AFM tip and the surface of the bacterium is difficult to define. The exact distances are difficult to determine because the surface of the bacterium deforms during force imaging, producing a highly nonlinear region in the approach curve. In this study, AFM approach and retraction curves were obtained using a colloid probe AFM for three strains of Escherichia coli (D21, D21F2, and JM109). These strains differed in their relative adhesion to glass surfaces, on the basis of measurements of sticking coefficients in packed bed flow through column tests. A gradient force curve analysis method was developed to model the interactions between the colloid probe and a surface. Gradient analysis of the approach curve revealed four different regions of colloid-surface interactions during the approach and contact of the probe with the bacterial surface: a noninteraction region, a noncontact phase, a contact phase, and a constant compliance region. The noncontact phase, which ranged from 28 to 59 nm for the three bacterial strains, was hypothesized to arise primarily from steric repulsion of the colloid by extracellular polymers on the bacterial surface. The contact phase, spanning 59-113 nm, was believed to arise from the initial pressure of the colloid on the outer membrane of the cell. The constant compliance region likely reflected the response of the colloid probe to the stiff peptidoglycan layer that confers strength and rigidity to gram negative bacteria. It was shown that the sticking coefficients reported for the three E. coli strains were correlated with the length of the noncontact phase but not the properties of the other phases. Sticking coefficients were also not correlated with any parameters determined from retraction force curves such as pull-off distances or separation energies. These results show that gradient analysis is useful for studying the contribution of the length of the exopolymers on the cell surface to bacterial adhesion to glass surfaces.
C1 Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA.
RP Logan, BE (reprint author), Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA.
EM blogan@psu.edu
RI Li, Xu/K-1957-2014; Logan, Bruce/E-7063-2012
OI Logan, Bruce/0000-0001-7478-8070
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Abu-Lail NI, 2003, BIOMACROMOLECULES, V4, P1000, DOI 10.1021/bm034055f
   Abu-Lail NI, 2002, LANGMUIR, V18, P4071, DOI 10.1021/la015695b
   Brant JA, 2002, J MEMBRANE SCI, V203, P257, DOI 10.1016/S0376-7388(02)00014-5
   Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Ikai A, 2002, COLLOID SURFACE B, V23, P165, DOI 10.1016/S0927-7765(01)00230-2
   Israelachvili J., 1995, INTERMOLECULAR SURFA
   JOHNSON WP, 1995, WATER RESOUR RES, V31, P2649, DOI 10.1029/95WR02311
   KASTOWSKY M, 1992, J BACTERIOL, V174, P4798
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   Lower SK, 2000, GEOCHIM COSMOCHIM AC, V64, P3133, DOI 10.1016/S0016-7037(00)00430-0
   Madigan M. T., 2000, BROCK BIOL MICROORGA
   MADIGAN MT, 1997, BROCK BIOL MICROORGA
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Razatos AP, 1998, ABSTR PAP AM CHEM S, V216, pU271
   Stevens MM, 2002, LANGMUIR, V18, P6659, DOI 10.1021/la0202024
   Vadillo-Rodriguez V, 2003, LANGMUIR, V19, P2372, DOI 10.1021/la020658l
   Vadillo-Rodriguez V, 2004, MICROBIOL-SGM, V150, P1015, DOI 10.1099/mic.0.26828-0
   Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g
NR 21
TC 56
Z9 58
U1 2
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 28
PY 2004
VL 20
IS 20
BP 8817
EP 8822
DI 10.1021/la0488203
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 856IN
UT WOS:000224039000061
PM 15379512
DA 2018-10-19
ER

PT J
AU Agnihotri, A
   Siedlecki, CA
AF Agnihotri, A
   Siedlecki, CA
TI Time-dependent conformational changes in fibrinogen measured by atomic
   force microscopy
SO LANGMUIR
LA English
DT Article
ID PROTEIN ADSORPTION; HYDROPHOBIC SURFACES; BIOMATERIAL SURFACES;
   COMPETITIVE BEHAVIOR; RELAXATION KINETICS; AQUEOUS CONDITIONS;
   FIBRONECTIN; STABILITY; ANTIBODY; ALBUMIN
AB Tapping-mode atomic force microscopy was used to study the time-dependent changes in the structure of fibrinogen under aqueous conditions following adsorption on two model surfaces: hydrophobic graphite and hydrophilic mica. Fibrinogen was observed in the characteristic trinodular form, and the dimensions of the adsorbed molecules were consistent with previously reported values for these surfaces. On the basis of the differences in the relative heights of the D and the E domains, four orientation states were observed for fibrinogen adsorbed on both the surfaces. On graphite, the initial asymmetric orientation states disappeared with spreading over time. Some small lateral movements of the adsorbed proteins were observed on mica during repeated scanning, whereas no such movement was observed on graphite, indicating strong adhesion of fibrinogen to a hydrophobic surface. Spreading kinetics of fibrinogen on the two surfaces was determined by measuring the heights of the D and E domains over a time period of similar to2 h. On graphite, the heights of both the D and E domains decreased with time to a lower plateau value of 1.0 nm. On mica, the heights of both the D and E domains showed an increase, rising to an upper plateau value of similar to2.1 nm. The spreading of the D and E domains on graphite was analyzed using an 'exponential-decay-of-height' model. A spreading rate constant of similar to4.7 x 10(-4) s(-1) was observed for the whole fibrinogen molecule adsorbed on graphite, corresponding to a free energy of unfolding of similar to37 kT. Extrapolation of the exponential curve in the model to t = 0 yielded values of 2.3 and 2.2 nm for the heights of the D and the E domains at the time of contact with the hydropbobic graphite substrate, significantly less than their free solution diameters. A two-step spreading model is proposed to explain this observation.
C1 Penn State Univ, Coll Med, Inst Biomed Engn, Dept Bioengn, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Inst Biomed Engn, Dept Surg, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Coll Med, Inst Biomed Engn, Dept Bioengn, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Best RB, 2002, P NATL ACAD SCI USA, V99, P12143, DOI 10.1073/pnas.192351899
   BOS MA, 1995, BIOPHYS J, V68, P2566, DOI 10.1016/S0006-3495(95)80439-X
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   Clarke J, 1997, J MOL BIOL, V270, P771, DOI 10.1006/jmbi.1997.1147
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   Fong S, 1996, J MOL BIOL, V264, P624, DOI 10.1006/jmbi.1996.0665
   GOLDBERG ME, 1991, TRENDS BIOCHEM SCI, V16, P358, DOI 10.1016/0968-0004(91)90148-O
   Greenfield NJ, 1999, TRAC-TREND ANAL CHEM, V18, P236, DOI 10.1016/S0165-9936(98)00112-5
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Hantgan R. R., 2001, HEMOSTASIS THROMBOSI, P203
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kidoaki S, 2002, COLLOID SURFACE B, V23, P153, DOI 10.1016/S0927-7765(01)00232-6
   Lee I, 2003, ULTRAMICROSCOPY, V97, P341, DOI 10.1016/S0304-3991(03)00059-7
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   MARCHANT RE, 1992, J COLLOID INTERF SCI, V148, P261, DOI 10.1016/0021-9797(92)90135-9
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   Marchin KL, 2003, LANGMUIR, V19, P9883, DOI 10.1021/la035127r
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Oberdorfer Y, 2000, LANGMUIR, V16, P9955, DOI 10.1021/la0008176
   PEFFERKORN E, 1990, J COLLOID INTERF SCI, V138, P187, DOI 10.1016/0021-9797(90)90194-S
   SIEDLECKI CA, 1994, J BIOMED MATER RES, V28, P971, DOI 10.1002/jbm.820280902
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanford C, 1997, PROTEIN SCI, V6, P1358, DOI 10.1002/pro.5560060627
   vanEijk MCP, 1997, LANGMUIR, V13, P5447, DOI 10.1021/la960473c
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Wilson DL, 1996, J VAC SCI TECHNOL B, V14, P2407, DOI 10.1116/1.588870
NR 39
TC 111
Z9 111
U1 1
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 28
PY 2004
VL 20
IS 20
BP 8846
EP 8852
DI 10.1021/la049239
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 856IN
UT WOS:000224039000065
PM 15379516
DA 2018-10-19
ER

PT J
AU Olivier, V
   Faucheux, N
   Hardouin, P
AF Olivier, V
   Faucheux, N
   Hardouin, P
TI Biomaterial challenges and approaches to stem cell use in bone
   reconstructive surgery
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID MARROW STROMAL CELLS; RANDOMIZED CLINICAL-TRIAL; POROUS POLYMER
   SCAFFOLDS; IN-VITRO; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC
   DIFFERENTIATION; GROWTH-FACTORS; PEG HYDROGELS; GENE-THERAPY; TISSUE
AB As life expectancy increases, so does the need to treat large bone defects. New biomaterials combined with osteogenic cells are now being developed as an alternative to autogenous bone grafts. The goal is to make the stem cells adhere to the scaffold, and then grow to differentiate into functional osteogenic cells and organize into healthy bone as the scaffold degrades. Decisive improvements have been made in the fields of stem cell biology, 3-D scaffold fabrication and tissue engineering, but the ideal bone substitute that fulfils all functional and safety requirements has yet to be developed.
C1 Univ Littoral, Cote Opale, INSERM, ERI 002, F-62608 Berck Sur Mer, France.
   Univ Sherbrooke, Dept Genie Chim, Sherbrooke, PQ J1K 2R1, Canada.
RP Olivier, V (reprint author), Univ Littoral, Cote Opale, INSERM, ERI 002, LR2B,52 Rue Docteur Calot, F-62608 Berck Sur Mer, France.
EM Phardouin@hopale.com
CR Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Bruder SP, 2000, PRINCIPLES TISSUE EN, P683
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Calvert JW, 2003, CLIN PLAST SURG, V30, P641, DOI 10.1016/S0094-1298(03)00081-6
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6
   Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   Cinotti G, 2004, J BONE JOINT SURG BR, V86B, P135, DOI 10.1302/0301-620X.86B1.14308
   Connolly JF, 1998, CLIN ORTHOP RELAT R, pS257, DOI 10.1097/00003086-199810001-00026
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3
   Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003
   *EUR COMM, 2003, 21000 EUR EN
   Fisher J., 2003, TOPICS TISSUE ENG, V1, P1
   Flautre B, 1999, J MATER SCI-MATER M, V10, P811, DOI 10.1023/A:1008923625599
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Godbey WT, 2004, BIOMATERIALS, V25, P2799, DOI 10.1016/j.biomaterials.2003.09.056
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Horwitz EM, 2003, ARCH MED RES, V34, P600, DOI 10.1016/j.arcmed.2003.09.006
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Hunter AC, 2002, DRUG DISCOV TODAY, V7, P998, DOI 10.1016/S1359-6446(02)02444-3
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   JONES DB, 2003, EUR CELL MAT S2, V5, P47
   Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kohn DH, 2002, J BIOMED MATER RES, V60, P292, DOI 10.1002/jbm.10050
   Kruyt MC, 2004, J ORTHOPAED RES, V22, P544, DOI 10.1016/j.orthres.2003.10.010
   Lappa M, 2003, BIOTECHNOL BIOENG, V84, P518, DOI 10.1002/bit.10821
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lloyd-Evans M, 2004, MATER TODAY, V7, P48, DOI 10.1016/S1369-7021(04)00235-4
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nakamura S, 2002, J BIOMED MATER RES, V61, P593, DOI 10.1002/jbm.10224
   Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Oreffo ROC, 1999, J MATER SCI-MATER M, V10, P607, DOI 10.1023/A:1008931607002
   Pallu S, 2003, PEPTIDES, V24, P1349, DOI 10.1016/j.peptides.2003.09.003
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100
   Prockop DJ, 2002, NAT BIOTECHNOL, V20, P791, DOI 10.1038/nbt0802-791
   Riminucci M, 2003, BRAZ J MED BIOL RES, V36, P1027, DOI 10.1590/S0100-879X2003000800008
   Rohwedel J, 2001, TOXICOL IN VITRO, V15, P741, DOI 10.1016/S0887-2333(01)00074-1
   Rose FRAJ, 2004, J PHARM PHARMACOL, V56, P415, DOI 10.1211/0022357023312
   Sachlos E., 2003, European Cells & Materials, V5, P29
   SVENDSEN C, 2002, DRUG DISCOV TODAY, V15, P455
   VACANTI CA, 2000, PRINCIPLES TISSUE EN, P617
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Vogel G, 2002, SCIENCE, V297, P175
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wiemann M, 2002, J BIOMED MATER RES, V62, P119, DOI 10.1002/jbm.10251
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Zhang JY, 2003, J BIOMED MATER RES A, V67A, P389, DOI 10.1002/jbm.a.10015
NR 78
TC 66
Z9 70
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD SEP 15
PY 2004
VL 9
IS 18
BP 803
EP 811
AR PII S1359-6446(04)03222-2
DI 10.1016/S1359-6446(04)03222-2
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 854EO
UT WOS:000223884000009
PM 15364068
DA 2018-10-19
ER

PT J
AU Shen, MC
   Garcia, I
   Maier, RV
   Horbett, TA
AF Shen, MC
   Garcia, I
   Maier, RV
   Horbett, TA
TI Effects of adsorbed proteins and surface chemistry on foreign body giant
   cell formation, tumor necrosis factor alpha release and procoagulant
   activity of monocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE foreign body giant cell; monocyte adhesion; TNF alpha; procoagulant
   activity; IgG; fibrinogen; fibronectin; polystyrene; tissue culture
   polystyrene; Primaria
ID HUMAN MACROPHAGE ADHESION; FORMATION-IN-VITRO; MONOCYTE/MACROPHAGE
   ADHESION; BIOMEDICAL POLYMERS; TNF-ALPHA; FIBRINOGEN ADSORPTION;
   HEMODIALYSIS-PATIENTS; CYTOKINE PRODUCTION; VASCULAR ACCESS; RECEPTOR
AB The adhesion and activation of monocytes and macrophages are thought to affect the foreign body response to implanted medical devices. However, these cells interact with devices indirectly, because of the prior adsorption of proteins. Therefore, we preadsorbed several "model" biomaterial surfaces with proteins and then measured foreign body giant cell (FBGC) formation, tumor necrosis factor alpha (TNFalpha) release, and procoagulant activity. The model surfaces were tissue culture polystyrene (TCPS), untreated polystyrene (PS), and Primaria, whereas the proteins used were albumin, fibronectin, fibrinogen, and immunoglobulin. FBGC formation, TNFalpha release, and procoagulant activity of monocytes were the highest for surfaces preadsorbed with IgG. FBGC formation was lower on surfaces with adsorbed fibrinogen and fibronectin than on uncoated surfaces. TNFalpha release and procoagulant activity of monocytes were similar on surface adsorbed with fibrinogen, fibronectin, or albumin. Monocyte activation was also affected by the surface chemistry of the substrates, because FBGC formation was the highest on PS and the lowest on TCPS. Monocyte procoagulant activity was the highest on Primaria. Adsorbed proteins and surface chemistry were found to have strong effects on FBGC formation, monocyte TNFalpha release, and procoagulant activity in vitro, providing support for the idea that these same variables could affect macrophage-mediated foreign body response to biomaterials in vivo. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Surg, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Horbett, TA (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM horbett@cheme.washington.edu
FU NCRR NIH HHS [RR01926]
CR ALTIERI DC, 1991, J IMMUNOL, V147, P1891
   ANDERSON CL, 1986, J BIOL CHEM, V261, P2856
   ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Boissy P, 1998, J CELL SCI, V111, P2563
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BROWN DL, 1989, J CLIN INVEST, V84, P366, DOI 10.1172/JCI114166
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   CULP K, 1995, AM J KIDNEY DIS, V26, P341, DOI 10.1016/0272-6386(95)90655-X
   DEAN RT, 1979, EXP CELL BIOL, V47, P454
   DEBETS JMH, 1988, J IMMUNOL, V141, P1197
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   FERRERI NR, 1986, CELL IMMUNOL, V98, P57, DOI 10.1016/0008-8749(86)90267-4
   Field M, 1997, RHEUMATOL INT, V17, P113, DOI 10.1007/s002960050019
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Hirth RA, 1996, JAMA-J AM MED ASSOC, V276, P1303
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   KALMAN PG, 1993, J VASC SURG, V17, P531, DOI 10.1016/0741-5214(93)90154-E
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KEIDAN I, 1995, J LAB CLIN MED, V125, P72
   KINDT GC, 1993, AM J PHYSIOL, V265, pL178
   Liu ZX, 1996, SCAND J GASTROENTERO, V31, P706, DOI 10.3109/00365529609009154
   Lo CJ, 1996, ARCH SURG-CHICAGO, V131, P44
   Mattana J, 1997, KIDNEY INT, V52, P1478, DOI 10.1038/ki.1997.478
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Melendez A, 1998, CURR BIOL, V8, P210, DOI 10.1016/S0960-9822(98)70085-5
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MONTESANO R, 1985, J CELL PHYSIOL, V122, P424, DOI 10.1002/jcp.1041220313
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   Riches DWH, 1996, IMMUNOBIOLOGY, V195, P477, DOI 10.1016/S0171-2985(96)80017-9
   Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003
   Rubel C, 1999, IMMUNOLOGY, V97, P429
   SCHMIDT JA, 1982, J IMMUNOL, V128, P673
   SCHMIERER AS, 1998, THESIS U WASHINGTON
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   SURPRENANT YM, 1989, THROMB RES, V53, P339, DOI 10.1016/0049-3848(89)90108-4
   Tabata Nobutada, 1994, Journal of Immunology, V153, P3256
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680
   VANGINKEL CJ, 1977, BR J HAEMATOL, V37
   VILCEK J, 1991, J BIOL CHEM, V266, P7313
   WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 64
TC 49
Z9 49
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2004
VL 70A
IS 4
BP 533
EP 541
DI 10.1002/jbm.a.30069
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 849KR
UT WOS:000223538000002
PM 15307157
DA 2018-10-19
ER

PT J
AU Miyamoto, K
   Sasaki, M
   Minamisawa, Y
   Kurahashi, Y
   Kano, H
   Ishikawa, S
AF Miyamoto, K
   Sasaki, M
   Minamisawa, Y
   Kurahashi, Y
   Kano, H
   Ishikawa, S
TI Evaluation of in vivo biocompatibility and biodegradation of
   photocrosslinked hyaluronate hydrogels (HADgels)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE photocrosslinked hyaluronate hydrogel (HAD-gel); biocompatibility;
   biodegradation; injectable; adhesion barrier
ID ADHESION FORMATION; SODIUM HYALURONATE; POSTSURGICAL ADHESIONS;
   CHEMICAL-MODIFICATION; TENDON REPAIR; ACID; PREVENTION; SURGERY; HYLAN;
   REDUCTION
AB HADgels are newly developed photocrosslinked hyaluronate hydrogels. They are produced from an aqueous solution of a hyaluronan derivative (HAD) in which cinnamic acid is introduced into the carboxyl moiety of hyaluronan using 3-aminopropanol as a spacer. High-energy ultraviolet irradiation of the HAD solution induces photodimerization of cinnamic acid, resulting in the development of a macromolecular network of each hyaluronan to water-insoluble hydrogels. The biocompatibility and biodegradation of HADgels were evaluated by guinea pig intracutaneous injection testing for up to 28 days. By macroscopic and histological observations, HADgels showed good tissue compatibility and did not induce excess inflammation at the injection sites. Biodegradation of the HADgels clearly depended on the degree of crosslinking at the fixed weight concentrations of HAD (0.5% and 1.0%). In addition, serum analyses showed that the injected guinea pigs did not produce specific antibodies against HADgels. These results indicate that HADgels have preferable biocompatibility and can be used as a new class of injectable, absorbable biomaterial, especially for preventing postsurgical adhesion formations. (C) 2004 Wiley Periodicals, Inc.
C1 Seikagaku Corp, Cent Res Labs, Med Device Res Grp, Tokyo 2070021, Japan.
   Seikagaku Corp, Cent Res Labs, Toxicol Res Grp, Tokyo 2070021, Japan.
RP Sasaki, M (reprint author), Seikagaku Corp, Cent Res Labs, Med Device Res Grp, Tokyo 2070021, Japan.
EM sasaki2@seikagaku-co.jp
CR ABITBOL JJ, 1994, SPINE, V19, P1809, DOI 10.1097/00007632-199408150-00004
   AMIEL D, 1989, J HAND SURG-AM, V14A, P837, DOI 10.1016/S0363-5023(89)80085-1
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Belluco C, 2001, J SURG RES, V100, P217, DOI 10.1006/jsre.2001.6248
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Bucher W, 2002, ARTHRITIS RHEUM, V46, P2543, DOI 10.1002/art.10450
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Chen AL, 2002, J BONE JOINT SURG AM, V84A, P1142, DOI 10.2106/00004623-200207000-00008
   DeCherney AH, 1997, SURG CLIN N AM, V77, P671, DOI 10.1016/S0039-6109(05)70574-0
   Diamond MP, 1998, FERTIL STERIL, V69, P1067, DOI 10.1016/S0015-0282(98)00057-0
   EGERTON PL, 1981, J AM CHEM SOC, V103, P3859, DOI 10.1021/ja00403a039
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   HAGBERG L, 1992, J HAND SURG-AM, V17A, P935, DOI 10.1016/0363-5023(92)90474-4
   Isik S, 1999, BRIT J PLAST SURG, V52, P373, DOI 10.1054/bjps.1999.3128
   Jaibaji M, 2000, ANN PLAS SURG, V45, P83, DOI 10.1097/00000637-200045010-00017
   Johns DB, 1997, FERTIL STERIL, V68, P37, DOI 10.1016/S0015-0282(97)81472-0
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Matsuda T, 1992, ASAIO J, V38, pM154, DOI 10.1097/00002480-199207000-00008
   Miller JA, 1997, J BIOMED MATER RES, V38, P25, DOI 10.1002/(SICI)1097-4636(199721)38:1<25::AID-JBM4>3.0.CO;2-J
   MIYAMOTO K, 2003, Patent No. 6602859
   Panay N, 1999, CURR OPIN OBSTET GYN, V11, P379, DOI 10.1097/00001703-199908000-00004
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   PUTTICK MPE, 1995, J RHEUMATOL, V22, P1311
   RICH A, 1981, J CELL SCI, V50, P1
   RICHTER AW, 1979, INT ARCH ALLER A IMM, V59, P45, DOI 10.1159/000232238
   RICHTER W, 1974, INT ARCH ALLER A IMM, V47, P211, DOI 10.1159/000231214
   Rodgers KE, 1997, FERTIL STERIL, V67, P553, DOI 10.1016/S0015-0282(97)80085-4
   Sasaki M, 2003, TOXICOL PATHOL, V31, P321, DOI 10.1080/01926230390204360
   Thornton MH, 1998, HUM REPROD, V13, P1480, DOI 10.1093/humrep/13.6.1480
   URMAN B, 1991, FERTIL STERIL, V56, P568
   *US FDA, 2001, PREM NOT HADG 510K S
   WAKI M, 2000, Patent No. 6107410
   WATANABE N, 1977, J IMMUNOL METHODS, V14, P380
   West JL, 1996, J REPROD MED, V41, P149
NR 35
TC 22
Z9 22
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2004
VL 70A
IS 4
BP 550
EP 559
DI 10.1002/jbm.a.30112
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 849KR
UT WOS:000223538000004
PM 15307159
DA 2018-10-19
ER

PT J
AU Inoue, M
   LeGeros, RZ
   Inoue, M
   Tsujigiwa, H
   Nagatsuka, H
   Yamamoto, T
   Nagai, N
AF Inoue, M
   LeGeros, RZ
   Inoue, M
   Tsujigiwa, H
   Nagatsuka, H
   Yamamoto, T
   Nagai, N
TI In vitro response of osteoblast-like and odontoblast-like cells to
   unsubstituted and substituted apatites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fluoride substituted apatite; hydroxyapatite; osteoblast; odontoblast
ID FLUORIDE; HYDROXYAPATITE; PROLIFERATION; CULTURES; TITANIUM; SYSTEMS;
   LINE
AB Different types of calcium phosphate compounds [calcium-deficient apatite (CDA); beta-tricalcium phosphate (beta-TCP); biphasic calcium phosphate (BCP)] are commercially available for medical and dental applications as bone substitute materials. Most of the reported in vitro studies on cell-material interactions have used osteoblast-like cells. The purpose of this study was to investigate the in vitro response of osteoblast-like (MC3T3-E1) and odontoblast-like (MDPC23) cells on unsubstituted (HA) and substituted (F-substituted) apatites. MC3T3-E1 and MDPC23 were cultured in alpha-modified medium containing 10% fetal bovine serum, ascorbic acid (50 mug/mL) and beta-glycerophosphate (2 mM). The cells were seeded on pellets made from HA, and FAp (with low, medium, and high F concentrations). Cell morphology was observed after 7 and 14 days using scanning electron microscopy (SEM). Cell attachment and differentiation were determined from the DNA content, alkaline phosphatase (ALP) activity, and total collagen content. Pellet surface composition was characterized by using Fourier Transform infrared spectroscopy. MC3T3-E1 and MDPC23 cells on HA were normal in shape and in fusion but not on FAp. Results of this study showed that the pattern of cell proliferation of osteoblast-like cells was different from that of the odontoblast-like cells. This study suggests that cell morphology, fusion, and proliferation on biomaterial surfaces depend on cell type (osteoblast-like vs odontoblast-like cell) and biomaterial composition (unsubstituted vs substituted F-apatites). (C) 2004 Wiley Periodicals, Inc.
C1 NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
   Okayama Univ, Grad Sch Med & Dent, Dept Oral Morphol, Okayama 7008525, Japan.
   Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Struct & Funct Res, Tokushima 7708514, Japan.
   Okayama Univ, Grad Sch Med & Dent, Dept Oral Pathol & Med, Okayama 7008525, Japan.
RP Inoue, M (reprint author), NYU, Coll Dent, Dept Biomat & Biomimet, 345 E 24th St, New York, NY 10010 USA.
EM mi8@md.okayama-u.ac.jp
CR Akhouayri Omar, 1999, Journal of Cellular Biochemistry, V76, P217
   ARRO E, 1981, SCANNING ELECTRON MI, V2, P159
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BOIVIN G, 1989, BONE, V10, P89, DOI 10.1016/8756-3282(89)90004-5
   BOSKEY AL, 1992, CELLS MAT, V2, P774
   Costa CAD, 1999, DENT MATER, V15, P434
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Di Silvio L., 1998, BIOCERAMICS, V11, P293
   ELBEL J, 1998, BIOCERAMICS, V11, P305
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   FARLEY JR, 1983, SCIENCE, V222, P330
   FRONDOZA CG, 1998, BIOCERAMICS, V11, P289
   FUJIMORI Y, 1998, BIOCERAMICS, V11, P335
   Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442
   HJORTING-HANSEN E, 1990, International Journal of Oral and Maxillofacial Implants, V5, P255
   Inoue M, 2002, J DENT RES, V81, pA362
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KAZIMIROFF J, 1996, BIOCERAMICS, V9, P169
   LeGeros R Z, 1996, Adv Dent Res, V10, P225
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros R. Z., 1970, DEV APPL SPEC      B, V7B, P3
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LEGEROS RZ, 1983, CARIES RES, V17, P419, DOI 10.1159/000260696
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   Luyten F P, 1992, Acta Orthop Belg, V58 Suppl 1, P263
   MARIE PJ, 1990, J BONE MINER RES, V5, pS140
   MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   PAK CYC, 1989, J CLIN ENDOCR METAB, V68, P150, DOI 10.1210/jcem-68-1-150
   Peaker A.J.S., 1998, BIOCERAMICS, V11, P285
   SAKAE T, 2000, BIOCERAMICS, V13, P347
   WERGEDAL JE, 1988, CLIN ORTHOP RELAT R, P274
   WINTER J, 1989, Journal of Dental Research, V68, P353
NR 34
TC 24
Z9 24
U1 1
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2004
VL 70A
IS 4
BP 585
EP 593
DI 10.1002/jbm.a.30116
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 849KR
UT WOS:000223538000008
PM 15307163
DA 2018-10-19
ER

PT J
AU Braunecker, J
   Baba, M
   Milroy, GE
   Cameron, RE
AF Braunecker, J
   Baba, M
   Milroy, GE
   Cameron, RE
TI The effects of molecular weight and porosity on the degradation and drug
   release from polyglycolide
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE polyglycolide; PGA; porosity; molecular weight; controlled drug release;
   theophylline
ID DEGRADING POLYGLYCOLIDE; PART II; WATER; BIOMATERIAL; MORPHOLOGY
AB This paper explores the influence of initial molecular weight and porosity on the release of the drug, theophylline, from polyglycolide (PGA). PGA was made by a variety of processes to vary the molecular weight and was blended with NaCl with different crystal sizes and in different proportions to vary the pore size and volume. Overall, results showed that decreasing the molecular weight and increasing the pore size and volume increased the rate of drug release, The exact variation of these trends agreed well with the previously established four-stage degradation mechanism for PGA, but was more complex than a simple linear behaviour. Because both the molecular weight and the porosity of PGA have a substantial influence on the polymer degradation, and can be varied in a controlled manner, these parameters can play an important role in developing PGA as a controlled drug delivery material with tailored drug release. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Cezeaux Univ, Lab Photochem Mol & Macromol, F-63177 Clermont Ferrand, France.
   ETH, Swiss Fed Inst Technol Zurich, CH-8092 Zurich, Switzerland.
RP Cameron, RE (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St,New Museums Site, Cambridge CB2 3QZ, England.
EM rec11@cam.ac.uk
OI Cameron, Ruth/0000-0003-1573-4923
CR BISCHOFF CA, 1894, LIEBIGS ANN CHEM, V179, P45
   CHU CC, 1997, WOUND CLOUSRE BIOMAT
   DICKERS KJ, 2002, THESIS U CAMBRIDGE U
   Epple M, 1998, J BIOMED MATER RES, V43, P83
   Epple M, 1997, J MATER CHEM, V7, P1037, DOI 10.1039/a700275k
   Epple M, 1996, J CHEM SOC DALTON, P11, DOI 10.1039/dt9960000011
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Harris D. A., 1987, SPECTROPHOTOMETRY SP
   Hurrell S, 2003, J MATER SCI-MATER M, V14, P457, DOI 10.1023/A:1023271003571
   Hurrell S, 2003, POLYMER, V44, P1421, DOI 10.1016/S0032-3861(02)00883-2
   Hurrell S, 2003, POLYM INT, V52, P358, DOI 10.1002/pi.1164
   Hurrell S, 2002, BIOMATERIALS, V23, P2401, DOI 10.1016/S0142-9612(01)00376-3
   Hurrell S, 2001, J MATER SCI-MATER M, V12, P811, DOI 10.1023/A:1017925019985
   Hurrell S, 2001, J MATER SCI-MATER M, V12, P817, DOI 10.1023/A:1017910408871
   Milroy GE, 2003, J MATER SCI-MATER M, V14, P465, DOI 10.1023/A:1023223220409
   MILROY GE, 2001, THESIS U CAMBRIDGE
   MILROY GE, 2003, THESIS U CAMBRIDGE, V44, P1425
   MOLL F, 1991, ARCH PHARM, V324, P939, DOI 10.1002/ardp.2503241123
   Schwarz K, 1998, MACROMOL RAPID COMM, V19, P613, DOI 10.1002/(SICI)1521-3927(19981201)19:12<613::AID-MARC613>3.3.CO;2-D
NR 19
TC 32
Z9 33
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD SEP 10
PY 2004
VL 282
IS 1-2
BP 19
EP 34
DI 10.1016/j.ijpharm.2003.08.020
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 855UV
UT WOS:000224001300002
PM 15336379
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Garcifa-Honduvilla, N
   Carnicer, E
   Serrano, N
   Rodriguez, M
   Bujan, J
AF Bellon, JM
   Garcifa-Honduvilla, N
   Carnicer, E
   Serrano, N
   Rodriguez, M
   Bujan, J
TI Temporary closure of the abdomen using a new composite prosthesis
   (PL-PU99)
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
DE composite; temporary closure of abdomen; wound healing; abdominal wall
   repair; polypropylene; polyurethane
ID ABDOMINAL-WALL DEFECTS; COMPARTMENT SYNDROME; MESH; POLYPROPYLENE;
   COMPLICATIONS; MANAGEMENT; IMPLANT; WOUNDS; MARLEX; REPAIR
AB Background: Temporary abdominal wound closure is sometimes desirable when tension-free approximation of the wound edges is impractical or when reexploration is planned.
   Methods: The behavior of a composite prosthesis (PL-PU99) designed by our group was evaluated as a method of temporary abdominal closure in white New Zealand rabbits. After a 7 cm long midline laparotomy, a spindle-shaped 4 cm (maximum width) by 7 cm (length) fragment of PL-PU99 was sutured to the edges of the peritoneal, muscular, and fascial abdominal tissues, so that the biomaterial remained in contact with the exterior. The PL-PU99 composite is composed of a polypropylene mesh adhered to a sheet of polyurethane with an acrylic cement. At 7 and 14 days after implant, animals were sacrificed and specimens taken for morphological, ultrastructural, morphometry of the neoperitoneum, and immunohistochemical (macrophage reaction, RAM-11) analysis.
   Results: No death or signs of infection or rejection of the prostheses were recorded. No adhesions could be macroscopically ob. served between the composite and the intestinal loops. The biomaterial achieved a good seal, no leakage of fluids being detected. Fourteen days after implant, the neoperitoneum formed on the prosthesis was of An even structure and was made up of organized, vascularized connective tissue covered by an uninterrupted mesothelium.
   Conclusions: The PL-PU99 prosthesis shows optimal behavior at the prosthesis/visceral peritoneum interface, making it ideal for its use in the temporary closure of the abdomen. The implanted composite may also prove useful for the permanent repair of the abdominal wall. (C) 2004 Excerpta.Medica, Inc. All rights reserved.
C1 Univ Alcala de Henares, Fac Med, Dept Cirugia, E-28871 Alcala De Henares, Spain.
   Univ Alcala de Henares, Fac Med, Dept Especialidades Med, Madrid, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Cirugia, Campus Univ,Ctra Madrid Barcelona Km 33-600, E-28871 Alcala De Henares, Spain.
EM juanm.bellon@uah.es
RI Serrano Amarilla, Natalia/P-6803-2015
OI Serrano Amarilla, Natalia/0000-0002-8337-7211; BELLON, JUAN
   M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476; Garcia
   Honduvilla, Natalio/0000-0003-0904-6198
CR Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 1999, J AM COLL SURGEONS, V188, P466, DOI 10.1016/S1072-7515(99)00029-0
   Bellon JM, 2003, J MATER SCI-MATER M, V14, P359, DOI 10.1023/A:1022936016618
   Bellon JM, 2001, WORLD J SURG, V25, P147, DOI 10.1007/s002680020069
   Bellon JM, 2000, J MATER SCI-MATER M, V11, P25, DOI 10.1023/A:1008981517743
   BENDER JS, 1994, J TRAUMA, V36, P182, DOI 10.1097/00005373-199402000-00005
   BROCK WB, 1995, AM SURGEON, V61, P30
   Ciresi DL, 1999, AM SURGEON, V65, P720
   DIEBEL L, 1992, AM SURGEON, V58, P573
   FABIAN TC, 1994, ANN SURG, V219, P643, DOI 10.1097/00000658-199406000-00007
   Fernandez L, 1996, J TRAUMA, V40, P258, DOI 10.1097/00005373-199602000-00014
   Ghimenton F, 2000, BRIT J SURG, V87, P106, DOI 10.1046/j.1365-2168.2000.01337.x
   MIZRAHI S, 1993, AM J SURG, V166, P62, DOI 10.1016/S0002-9610(05)80585-9
   Nagy KK, 1996, AM SURGEON, V62, P331
   Ogilvie WH, 1940, LANCET, V2, P253
   Porter JM, 1995, J TRAUMA, V39, P1178, DOI 10.1097/00005373-199512000-00031
   Schein M, 1998, BRIT J SURG, V85, P1027
   Sherck J, 1998, AM SURGEON, V64, P854
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
NR 19
TC 6
Z9 7
U1 3
U2 3
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011 USA
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PD SEP
PY 2004
VL 188
IS 3
BP 314
EP 320
DI 10.1016/j.amjsurg.2004.06.014
PG 7
WC Surgery
SC Surgery
GA 854RQ
UT WOS:000223921400020
PM 15450840
DA 2018-10-19
ER

PT J
AU Pinzano, A
   Ruaud, JP
   Cheli, Y
   Gonord, P
   Grossin, L
   Bettembourg-Brault, I
   Gillet, P
   Payan, E
   Guilloc, G
   Netter, P
AF Pinzano, A
   Ruaud, JP
   Cheli, Y
   Gonord, P
   Grossin, L
   Bettembourg-Brault, I
   Gillet, P
   Payan, E
   Guilloc, G
   Netter, P
TI Evaluation of cartilage repair tissue after biomaterial implantation in
   rat patella by using T2 mapping.
SO ARTHRITIS AND RHEUMATISM
LA English
DT Meeting Abstract
CT 68th Annual Scientific Meeting of the
   American-College-of-Rheumatology/39th Annual Scientific Meeting of the
   Association-of-Rheumatology-Health-Professionals
CY OCT 16-21, 2004
CL San Antonio, TX
SP Amer Coll Rheumatol, Assoc Rheumatol Hlth Profess
C1 Univ Nancy 1, CNRS, UMR 7561, F-54506 Vandoeuvre Les Nancy, France.
   Univ Paris 11, CNRS, UMR 8081, U2R2M, Orsay, France.
RI Cheli, Yann/O-5783-2016
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0004-3591
J9 ARTHRITIS RHEUM
JI Arthritis Rheum.
PD SEP
PY 2004
VL 50
IS 9
SU S
BP S277
EP S277
PG 1
WC Rheumatology
SC Rheumatology
GA 853AS
UT WOS:000223799000696
DA 2018-10-19
ER

PT J
AU Griesser, HJ
   Kingshott, P
   McArthur, SL
   McLean, KM
   Kinsel, GR
   Timmons, RB
AF Griesser, HJ
   Kingshott, P
   McArthur, SL
   McLean, KM
   Kinsel, GR
   Timmons, RB
TI Surface-MALDI mass spectrometry in biomaterials research
SO BIOMATERIALS
LA English
DT Review
DE bio-interfaces; protein adsorption; MALDI mass spectrometry; surface
   analysis
ID LASER-DESORPTION-IONIZATION; COVALENT ATTACHMENT; PROTEIN ADSORPTION;
   COLLAGEN MIMETICS; PEPTIDE BINDING; CONTACT-LENSES; CLUSTER IONS;
   MATRIX; MOLECULES; ACID
AB Matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) has been used for over a decade for the determination of purity and accurate molecular masses of macromolecular analytes, such as proteins, in solution. In the last few years the technique has been adapted to become a new surface analysis method with unique capabilities that complement established biomaterial surface analysis methods such as XPS and ToF-SSIMS. These new MALDI variant methods, which we shall collectively summarize as Surface-MALDI-MS, are capable of desorbing adsorbed macromolecules from biomaterial surfaces and detecting their molecular ions with high mass resolution and at levels much below monolayer coverage. Thus, Surface-MALDI-MS offers unique means of addressing biomaterial surface analysis needs, such as identification of the proteins and lipids that adsorb from multicomponent biological solutions in vitro and in vivo, the study of interactions between biomaterial surfaces and biomolecules, and identification of surface-enriched additives and contaminants. Surface-MALDI-MS is rapid, experimentally convenient, overcomes limitations in mass resolution and sensitivity of established biochemical techniques such as SDS-PAGE, and can in some circumstances be used for the quantitative analysis of adsorbed protein amounts. At this early stage of development, however, limitations exist: in some cases proteins are not detectable, which appears to be related to tight surface binding. This review summarizes ways in which Surface-MALDI-MS methods have been applied to the study of a range of issues in biomaterials surfaces research. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   CSIRO, Mol Sci, Clayton, Vic 3169, Australia.
   Riso Natl Lab, Danish Polymer Ctr, DK-4000 Roskilde, Denmark.
   Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.
   Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA.
RP Griesser, HJ (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM hans.griesser@unisa.edu.au
RI Griesser, Hans/E-5628-2011; McArthur, Sally/B-6848-2008; McLean,
   Keith/H-1568-2011
OI Griesser, Hans/0000-0003-1072-7863; McArthur, Sally/0000-0002-4914-6989;
   Kingshott, Peter/0000-0001-5882-5804
CR Ademovic Z, 2002, BIOMOL ENG, V19, P177, DOI 10.1016/S1389-0344(02)00020-5
   ADEMOVIC Z, UNPUB STABILITY INSU
   BLACKLEDGE JA, 1995, ANAL CHEM, V67, P843, DOI 10.1021/ac00101a009
   Bornsen KO, 1997, RAPID COMMUN MASS SP, V11, P603, DOI 10.1002/(SICI)1097-0231(199704)11:6<603::AID-RCM879>3.0.CO;2-U
   Brockman AH, 1997, ANAL CHEM, V69, P4716, DOI 10.1021/ac970650u
   CAIN TC, 1994, RAPID COMMUN MASS SP, V8, P1026, DOI 10.1002/rcm.1290081224
   CHAN TWD, 1992, ORG MASS SPECTROM, V27, P53, DOI 10.1002/oms.1210270114
   CHATELIER RC, 1995, LANGMUIR, V11, P4122, DOI 10.1021/la00010a078
   Chatelier RC, 1995, J BIOMAT SCI-POLYM E, V7, P601, DOI 10.1163/156856295X00517
   Chatelier RC, 1997, LANGMUIR, V13, P3043, DOI 10.1021/la962013p
   Chen C, 1999, J MASS SPECTROM, V34, P1205, DOI 10.1002/(SICI)1096-9888(199911)34:11<1205::AID-JMS877>3.0.CO;2-1
   Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584
   Dai L., 1996, SURFACE MODIFICATION, P147
   Dai YQ, 1996, ANAL CHEM, V68, P2494, DOI 10.1021/ac960238z
   Ehring H, 1996, APPL SURF SCI, V96-8, P577, DOI 10.1016/0169-4332(95)00534-X
   EHRING H, 1992, ORG MASS SPECTROM, V27, P472, DOI 10.1002/oms.1210270419
   FENG L, 1994, BIOMATERIALS, V15, P323
   Franzen J, 2001, INT J MASS SPECTROM, V206, P275, DOI 10.1016/S1387-3806(01)00355-4
   Fung ET, 2001, CURR OPIN BIOTECH, V12, P65, DOI 10.1016/S0958-1669(00)00167-1
   GIMON ME, 1992, ORG MASS SPECTROM, V27, P827, DOI 10.1002/oms.1210270711
   Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W
   Griesser HJ, 1999, MATER RES SOC SYMP P, V544, P9
   GRIESSER HJ, 2003, BIOPOLYMERS INTERFAC
   HARVEY DJ, 1995, J MASS SPECTROM, V30, P1333, DOI 10.1002/jms.1190300918
   HOFFMAN A S, 1992, Clinical Materials, V11, P93, DOI 10.1016/0267-6605(92)90033-P
   HOLMESFARLEY SR, 1985, LANGMUIR, V1, P725, DOI 10.1021/la00066a016
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010
   Keller BO, 2001, J AM SOC MASS SPECTR, V12, P1055, DOI 10.1016/S1044-0305(01)00288-4
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   KINGSHOTT P, 1998, THESIS U NEW S WALES
   KINGSHOTT P, 1997, AM CHEM SOC POLYM PR, V38, P1008
   KINGSHOTT P, 1997, POLYM MAT SCI ENG, V76, P81
   Kinsel GR, 2002, J MASS SPECTROM, V37, P1131, DOI 10.1002/jms.374
   Krishnamurthy T, 1996, RAPID COMMUN MASS SP, V10, P883, DOI 10.1002/(SICI)1097-0231(19960610)10:8<883::AID-RCM594>3.3.CO;2-M
   Lahm HW, 2000, ELECTROPHORESIS, V21, P2105, DOI 10.1002/1522-2683(20000601)21:11<2105::AID-ELPS2105>3.0.CO;2-M
   Leize EM, 1999, ANAL BIOCHEM, V272, P19, DOI 10.1006/abio.1999.4142
   McArthur SL, 2001, BIOMATERIALS, V22, P3295, DOI 10.1016/S0142-9612(01)00166-1
   MCARTHUR SL, 1999, T AM SOC BIOMATER, V22, P243
   MCARTHUR SL, 2000, THESIS U NEW S WALES
   McLean KM, 2000, COLLOID SURFACE B, V17, P23, DOI 10.1016/S0927-7765(99)00055-7
   Muddiman DC, 1995, MASS SPECTROM REV, V14, P383, DOI 10.1002/mas.1280140603
   Narayanaswami G, 1997, J AM CHEM SOC, V119, P6888, DOI 10.1021/ja9609563
   ODonnell MJ, 1997, ANAL CHEM, V69, P2438, DOI 10.1021/ac961007v
   OVERBERG A, 1991, RAPID COMMUN MASS SP, V5, P128, DOI 10.1002/rcm.1290050308
   Perera IK, 1996, INT J MASS SPECTROM, V156, P151, DOI 10.1016/S0168-1176(96)04431-X
   PERERA IK, 1995, INT J MASS SPECTROM, V145, pL9, DOI 10.1016/0168-1176(95)04226-B
   Pfenninger A, 1999, J MASS SPECTROM, V34, P98, DOI 10.1002/(SICI)1096-9888(199902)34:2<98::AID-JMS767>3.0.CO;2-N
   Sadeghi M, 1998, APPL SURF SCI, V127, P226, DOI 10.1016/S0169-4332(97)00636-3
   Schiller J, 1999, ANAL BIOCHEM, V267, P46, DOI 10.1006/abio.1998.3001
   SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367
   STJOHN HAW, 1997, POLYM MAT SCI ENG, V76, P83
   STRUPAT K, 1991, INT J MASS SPECTROM, V111, P89, DOI 10.1016/0168-1176(91)85050-V
   VATHANATHAN T, 2000, THESIS U NEW S WALES
   Vestling MM, 1995, MASS SPECTROM REV, V14, P169, DOI 10.1002/mas.1280140302
   VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044
   Walker AK, 1999, ANAL BIOCHEM, V271, P123, DOI 10.1006/abio.1999.4141
   Walker AK, 2000, J AM SOC MASS SPECTR, V11, P62, DOI 10.1016/S1044-0305(99)00117-8
   Worrall TA, 1998, ANAL CHEM, V70, P750, DOI 10.1021/ac970969e
   Zhang J, 2003, LANGMUIR, V19, P3531, DOI 10.1021/la026705r
   Zhang J, 2002, LANGMUIR, V18, P4444, DOI 10.1021/la015594d
   ZHOU J, 1992, RAPID COMMUN MASS SP, V6, P671, DOI 10.1002/rcm.1290061109
   ZHU YF, 1995, RAPID COMMUN MASS SP, V9, P1315, DOI 10.1002/rcm.1290091318
NR 66
TC 58
Z9 60
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2004
VL 25
IS 20
BP 4861
EP 4875
DI 10.1016/j.biomaterials.2004.01.049
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DF
UT WOS:000221366300002
PM 15109847
DA 2018-10-19
ER

PT J
AU Mithieux, SM
   Rasko, JEJ
   Weiss, AS
AF Mithieux, SM
   Rasko, JEJ
   Weiss, AS
TI Synthetic elastin hydrogels derived from massive elastic assemblies of
   self-organized human protein monomers
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; biomimetic material; ECM; elasticity; elastin;
   mechanical properties
ID HUMAN TROPOELASTIN; LYSYL OXIDASE; DISEASE; BIOSYNTHESIS; FLUORESCENCE;
   EXPRESSION; PEPTIDES
AB A key objective of bioengineering is the development of new scaffolding biomaterials with appropriate mechanical and biological properties such as strength, elasticity and biocompatibility that mimic the native host connective tissue. Here we describe the production and properties of massive synthetic elastin assemblies formed by chemically cross-linking recombinant human tropoelastin with bis(sulfosuccinimidyl) suberate, permitting the construction of elastic sponges, sheets and tubes. The innate characteristics of synthetic elastin constructs are common with those of native elastin. The Young's Modulus ranged from 220 to 280 kPa with linearity of extension to at least 150%. Synthetic elastin was extensible by 200-370%. The constructs behaved as hydrogels and displayed stimuli-responsive characteristics towards temperature and salt concentrations. Intrinsic fluorescence spectroscopy demonstrated that the elastin fluorophore is a feature of the polypeptide. Scanning electron microscopy allowed us to construct a model of elastin assembly that was driven by the lateral association of small twisted rope-like fibrils. FT-Raman spectra at 100% strain gave amide I and III peaks that correlated with a stretch-dependent increase in alpha-helical content. Growth and proliferation of cells were supported in vitro while in vivo implants were well tolerated. We conclude that synthetic elastin has potential as a novel biomaterial that can be easily molded into a variety of shaped tissue substrates and has a range of properties that are required for elastic, cell-interacting and compliant applications. Furthermore, its in vitro construction provides a powerful tool to probe the early stages of elastin assembly and the molecular basis for its elasticity. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Sydney, Sydney, NSW 2006, Australia.
   Univ Sydney, Centenary Inst Canc Med & Cell Biol, Dept Expt Med, Sydney, NSW 2006, Australia.
   Sydney Canc Ctr, Newtown, NSW 2042, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Bldg G08, Sydney, NSW 2006, Australia.
EM a.weiss@mmb.usyd.edu.au
RI Rasko, John/F-5754-2013
OI WEISS, ANTHONY/0000-0002-8106-4836; Mithieux,
   Suzanne/0000-0001-6160-9352
CR Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   DAVIDSON JM, 1987, CONNECTIVE TISSUE DI, V12, P29
   Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   DEYL Z, 1980, BIOCHIM BIOPHYS ACTA, V625, P248, DOI 10.1016/0005-2795(80)90288-3
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Faury G, 1998, CIRC RES, V82, P328, DOI 10.1161/01.RES.82.3.328
   Fung YC, 1993, BIOMECHANICS MECH PR
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   KAGAN HM, 1982, METHOD ENZYMOL, V82, P637
   Kaiitani M, 2001, ASAIO J, V47, P342, DOI 10.1097/00002480-200107000-00009
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Martino M, 2002, BIOMACROMOLECULES, V3, P297, DOI 10.1021/bm010129g
   McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Ostuni A, 2002, INT J BIOCHEM CELL B, V34, P130, DOI 10.1016/S1357-2725(01)00115-7
   Petersen E, 2002, EUR J VASC ENDOVASC, V24, P440, DOI 10.1053/ejvs.2002.1750
   Robert L, 1995, CIBA F SYMP, V192, P286
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   SANDBERG LB, 1976, INT REV CONNECT TISS, V7, P160
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Stone PJ, 2001, AM J RESP CELL MOL, V24, P733, DOI 10.1165/ajrcmb.24.6.4304
   SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899
   THORNHILL DP, 1975, BIOCHEM J, V147, P215, DOI 10.1042/bj1470215
   TINKER DH, 1983, CONNECT TISSUE RES, V11, P299, DOI 10.3109/03008208309004862
   Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200
   URRY DW, 1978, PERSPECT BIOL MED, V21, P265
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
NR 34
TC 160
Z9 161
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2004
VL 25
IS 20
BP 4921
EP 4927
DI 10.1016/j.biomaterials.2004.01.055
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DF
UT WOS:000221366300007
PM 15109852
DA 2018-10-19
ER

PT J
AU Ben-Nissan, B
   Milev, A
   Vago, R
AF Ben-Nissan, B
   Milev, A
   Vago, R
TI Morphology of sol-gel derived nano-coated coralline hydroxyapatite
SO BIOMATERIALS
LA English
DT Article
DE bionnimetics; bone graft; calcium phosphate coatings; sol-gel
ID BIOMATERIAL; STABILITY; CERAMICS
AB Current bone graft materials are mainly produced from coralline hydroxyapatite (HAp). Due to the nature of the conversion process, commercial coralline HAp has retained coral or CaCO3. and the structure possesses nanopores within the inter-pore trabeculae, resulting in high dissolution rates. Under certain conditions these features reduce durability and strength and are not utilised where high structural strength is required. To overcome these limitations, a new coral double-conversion technique has been developed.
   The technique involves a two-stage application route where, in the first stage, complete conversion of coral to pure HAp is achieved. In the second, a new sol-gel-derived HAp nano-coating is directly applied to cover the micro- and nano-pores within the intra-pore material. whilst maintaining the large pores. Biaxial strength was improved two-fold due to this unique double treatment. This application is expected to result in enhanced durability and longevity due to the monophasic hydroxyapatite structure and strength in the physiological environment.
   It is anticipated that this new material can be applied to load-bearing bone graft applications where high strength requirements are pertinent. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Technol Sydney, Dept Chem Mat & Forens Sci, Sydney, NSW 2007, Australia.
   Univ Western Sydney, Coll Sci Technol & Environm, Penrith, NSW 1797, Australia.
   Ben Gurion Univ Negev, Inst Appl Bio Sci, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
RP Ben-Nissan, B (reprint author), Univ Technol Sydney, Dept Chem Mat & Forens Sci, POB 123, Sydney, NSW 2007, Australia.
EM b.ben-nissan@uts.edu.au
CR Ben-Nissan B, 2001, J SOL-GEL SCI TECHN, V21, P27, DOI 10.1023/A:1011281826850
   BENNISSAN B, 2001, BIOCERAMICS, V13, P959
   BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9
   CALVERT P, 1988, J MATER SCI, V23, P3801, DOI 10.1007/BF01106796
   CHAO LY, 1991, J AM CERAM SOC, V74, P333, DOI 10.1111/j.1151-2916.1991.tb06884.x
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   CURTIS A, 1997, BIOMATERIALS, V18, P8
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hu J, 2000, J MATER SCI TECHNOL, V16, P591
   Hu J, 2001, J MATER SCI LETT, V20, P85, DOI 10.1023/A:1006735319725
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Milev A, 2003, MATER LETT, V57, P1960, DOI 10.1016/S0167-577X(02)01112-6
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SARIKAYA M, 1995, NACRE PROPERTIES CRY, P34
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 21
TC 84
Z9 86
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2004
VL 25
IS 20
BP 4971
EP 4975
DI 10.1016/j.biomaterials.2004.02.006
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DF
UT WOS:000221366300013
PM 15109858
DA 2018-10-19
ER

PT J
AU Baveja, JK
   Li, G
   Nordon, RE
   Hume, EBH
   Kumar, N
   Willcox, MDP
   Poole-Warren, LA
AF Baveja, JK
   Li, G
   Nordon, RE
   Hume, EBH
   Kumar, N
   Willcox, MDP
   Poole-Warren, LA
TI Biological performance of a novel synthetic furanone-based antimicrobial
SO BIOMATERIALS
LA English
DT Article
DE furanone; antibacterial polymer; inflammation; flow cytometry; animal
   model
ID LEUKOCYTE ADHESION; ACTIVATION; EXPRESSION; MAC-1; BIOMATERIAL; CD44
AB Infection of medical devices causes significant. morbidity and mortality and considerable research effort has been directed at solving this problem. The aim of this study was to assess the biological performance of a novel furanone compound that has potential as an anti-infective coating for medical devices. This study examined in vitro leukocyte response following exposure to the antibacterial 3-(1'-broniohexyl)-5-dibromomethylene-2(5H)-furanone and assessed the tissue response following subcutaneous implantation of the furanone compound covalently bound to polystyrene (PS). Peripheral human blood was exposed to furanones in solution for 1 h and flow cytometry used to analyse viability and changes in expression of surface receptors CD11b/CD18 and CD44. Flow cytometry results from propidium iodide stained cell suspensions suggested that the leukocytes were viable after exposure to furanones in whole blood. No significant difference was found in the expression of CD11b/CD18 and CD44 between the furanone exposed samples and the negative control for neutrophils suggesting that the furanones themselves do not activate these leukocytes. The positive control lipopolysaccharide significantly up-regulated CD11b/CD18 and slightly down-regulated CD44 on both PMNs and monocytes. In vivo studies of the tissue response to furanone covalently bound to PS showed that there was no significant difference in cellularity of capsules surrounding the disk and no significant increase in myeloperoxidase expression. These results demonstrate negligible acute inflammatory response to synthetic brominated antibacterial furanones. Future studies will focus on chronic responses and examination of in vivo efficacy. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   Univ New S Wales, Cooperat Res Ctr Eye Res & Technol, Sydney, NSW 2052, Australia.
   Univ New S Wales, Ctr Marine Biofouling & Bioinnovat, Sydney, NSW 2052, Australia.
   Univ New S Wales, Sch Chem Sci, Sydney, NSW 2052, Australia.
RP Poole-Warren, LA (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM l.poolewarren@unsw.edu.au
OI Nordon, Robert/0000-0002-5923-4157; Poole-Warren,
   Laura/0000-0002-4414-022X
CR Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   BAVEJA JK, IN PRESS BIOMATERIAL
   Bonnema H, 2003, J BIOMED MATER RES A, V64A, P502, DOI 10.1002/jbm.a.10404
   BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462
   Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075
   Davey PC, 2000, BRIT J HAEMATOL, V111, P934
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Granchi D, 1998, J BIOMED MATER RES, V39, P549, DOI 10.1002/(SICI)1097-4636(19980315)39:4<549::AID-JBM7>3.0.CO;2-J
   Hidalgo E, 1998, TOXICOL LETT, V98, P169, DOI 10.1016/S0378-4274(98)00114-3
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Kawabata K, 2002, NEPHRON, V90, P273, DOI 10.1159/000049063
   KHAN MSY, 2002, PHARMAZIE, V7, P448
   KJELLEBERG S, 1999, Patent No. 3034
   Manny AJ, 1997, TETRAHEDRON, V53, P15813, DOI 10.1016/S0040-4020(97)10034-5
   Peltroche-Llacsahuanga H, 2001, J IMMUNOL METHODS, V258, P13, DOI 10.1016/S0022-1759(01)00468-9
   READ R, 2001, Patent No. 6812
   READ R, 1999, Patent No. 9900285
   Rousseau Y, 1999, BIOMATERIALS, V20, P1959, DOI 10.1016/S0142-9612(99)00101-5
   SCHACHT J, 1999, ACTA PHYSL PHARM THE, V49, P251
   Sundaram S, 1996, BIOMATERIALS, V17, P1041, DOI 10.1016/0142-9612(96)84681-3
NR 21
TC 25
Z9 29
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2004
VL 25
IS 20
BP 5013
EP 5021
DI 10.1016/j.biomaterials.2004.02.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DF
UT WOS:000221366300018
PM 15109863
DA 2018-10-19
ER

PT J
AU Unger, RE
   Peters, K
   Wolf, M
   Motta, A
   Migliaresi, C
   Kirkpatrick, CJ
AF Unger, RE
   Peters, K
   Wolf, M
   Motta, A
   Migliaresi, C
   Kirkpatrick, CJ
TI Endothelialization of a non-woven silk fibroin net for use in tissue
   engineering: growth and gene regulation of hunian endothelial cells
SO BIOMATERIALS
LA English
DT Article
DE endothelialization; silk; biocompatibility; angiogeniesis; gene
   expression; cell culture
ID INVITRO ENDOTHELIALIZATION; VASCULAR GRAFTS; BIOMATERIALS; SUBSTRATE;
   MEMBRANE; CULTURE; LINES; BONE
AB We have previously shown that a biomaterial consisting of a non-woven fibroin net produced from silk (Bombyx mori) cocoons is an excellent scaffolding material for a wide variety of human cells of different tissue types. Endothelialization must take place for a biomaterial to be successful after implantation. Therefore, primary human endothelial cells and the human endothelial cell lines, HPMEC-ST1.6R and ISO-HAS-1, were examined for adherence and growth patterns on the fibroin nets by confocal laser scanning microscopy after vital staining of the cells and by electron microscopy. Endothelial cells adhered and spread along individual fibers of the nets and did not fill the gaps between individual fibers. Higher attachment and growth coverage was obtained if nets were first coated with gelatin, fibronectin or collagen type 1. Proinflammatory markers of endothelial cells on the fibers exhibited a nonactivated state and LPS-stimulated cells exhibited activation of these markers. Furthermore, a typical PECAM-1 localization at cell-cell contacts was observed. Scanning electron microscopic examination of fibroin nets after removal of cells did not demonstrate any changes to the fibroin structure. HUVEC and HDMEC on fibroin nets embedded in collagen type 1 gels formed microvessel-like structures. Thus. silk fibroin nets are a highly endothelial cell-compatible scaffolding material that support the growth, normal and inducible cell functions and angiogenesis potential of human endothelial cells in vitro similar to that observed in vivo. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   Univ Trent, Dept Mat Engn, I-38050 Trent, Italy.
RP Unger, RE (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM unger@pathologie.klinik.uni-mainz.de
RI Peters, Kirsten/S-3484-2016
OI Motta, Antonella/0000-0003-4893-6863
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ANDERSON JS, 1987, SURGERY, V101, P577
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Doll B, 2001, CRIT REV EUKAR GENE, V11, P173
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Ripamonti U., 2000, Current Pharmaceutical Biotechnology, V1, P47, DOI 10.2174/1389201003379031
   Rossitch E Jr, 1987, N C Med J, V48, P669
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Unger RE, 2002, IN VITRO CELL DEV-AN, V38, P273
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   ZILLA P, 1989, SURGERY, V105, P515
NR 25
TC 161
Z9 173
U1 3
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2004
VL 25
IS 21
BP 5137
EP 5146
DI 10.1016/j.biomaterials.2003.12.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DG
UT WOS:000221366400004
PM 15109837
DA 2018-10-19
ER

PT J
AU Tieliewuhan, Y
   Hirata, I
   Sasaki, A
   Minagi, H
   Okazaki, M
AF Tieliewuhan, Y
   Hirata, I
   Sasaki, A
   Minagi, H
   Okazaki, M
TI Osteoblast proliferation behavior and bone formation on and in
   CO(3)apatite-collagen sponges with a porous hydroxyapatite frame
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE scaffold biomaterials; CO(3)Ap-collagen sponge; HAp frame
ID IN-VITRO; COMPOSITES; TITANIUM; STRENGTH; IMPLANTS; CEMENT; CELL
AB To develop a new biodegradable scaffold biomaterial reinforced with a frame, synthesized CO(3)apatite (CO(3)Ap) was mixed with a neutralized collagen gel. Then, 0 and 70%(w/w) CO(3)Ap-collagen mixtures (70% CO(3)Ap weight/mixture weight) were lyophilized into sponges in a HAp frame ring with 0.5-mm pores. SEM observation of CO(3)Ap-collagen sponges showed favorable pores for cells invasion. Mouse osteoblast MC3T3-E1 cells were cultured in alphaMEM with 10% FCS for 1, 10 and 20 days. Matrix substances on the pure collagen sponge samples increased with the culture period such that the sponge surface was almost covered. A sectional view of hematoxylin-eosin staining confirmed that osteoblast cells had well invaded the CO(3)Ap-collagen sponge. When these sponge-frame complexes were implanted beneath the periosteum cranii of rats, newly created bone was observed to grow toward the inner core of the complex from the surface of the periosteum cranii. Based on these results, reinforced CO(3)Ap-collagen sponges are expected to be used as hard tissue scaffold biomaterials for therapeutic purposes.
C1 Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Minami Ku, Hiroshima 7348553, Japan.
   Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Minami Ku, Hiroshima 7348553, Japan.
   Toyo Kohan Co Ltd, Inst Dev Res, Yamaguchi 7448611, Japan.
RP Okazaki, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
EM okazakix@hiroshima-u.ac.jp
CR Arita K, 2003, DENT MATER J, V22, P126, DOI 10.4012/dmj.22.126
   Ban S, 2002, DENT MATER J, V21, P306, DOI 10.4012/dmj.21.306
   Bokhari M, 2003, ADV EXP MED BIOL, V534, P247
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   CONWAY EJ, 1950, MICRODIFFUSION ANAL
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   EASTOE JE, 1965, METHOD DETERMINATION
   Fujikawa K, 2002, DENT MATER J, V21, P296, DOI 10.4012/dmj.21.296
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P564, DOI 10.1002/jbm.1055
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Tamura Y, 2002, DENT MATER J, V21, P355, DOI 10.4012/dmj.21.355
   Tanahashi M, 1996, BIOMATERIALS, V17, P47, DOI 10.1016/0142-9612(96)80754-X
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   Tsunoda M, 2003, DENT MATER J, V22, P371, DOI 10.4012/dmj.22.371
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 24
TC 27
Z9 28
U1 0
U2 7
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KAMAGOME TS BDG, KOMAGONE, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD SEP
PY 2004
VL 23
IS 3
BP 258
EP 264
DI 10.4012/dmj.23.258
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 873KI
UT WOS:000225278400002
PM 15510851
DA 2018-10-19
ER

PT J
AU Drotleff, S
   Lungwitz, U
   Breunig, M
   Dennis, A
   Blunk, T
   Tessmar, J
   Gopferich, A
AF Drotleff, S
   Lungwitz, U
   Breunig, M
   Dennis, A
   Blunk, T
   Tessmar, J
   Gopferich, A
TI Biomimetic polymers in pharmaceutical and biomedical sciences
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Review
DE biomaterial; biomimetic; tissue engineering; cell signaling; surface
   attachment; gene therapy; drug targeting
ID RECEPTOR-MEDIATED ENDOCYTOSIS; EPIDERMAL-GROWTH-FACTOR; POLYLYSINE DNA
   COMPLEXES; CELL-ADHESION PEPTIDES; MATRIX PROTEIN EXPRESSION;
   GENE-DELIVERY; EXTRACELLULAR-MATRIX; IN-VITRO; DRUG-DELIVERY;
   POLY(ETHYLENE GLYCOL)
AB This review describes recent developments in the emerging field of biomimetic polymeric biomaterials, which signal to cells via biologically active entities. The described biological effects are, in contrast to many other known interactions, receptor mediated and therefore very specific for certain cell types. As an introduction into this field, first some biological principles are illustrated such as cell attachment, cytokine signaling and endocytosis, which are some of the mechanisms used to control cells with biomimetic polymers. The next topics are then the basic design rules for the creation of biomimetic materials. Here, the major emphasis is on polymers that are assembled in separate building blocks, meaning that the biologically active entity is attached to the polymer in a separate chemical reaction. In that respect, first individual chemical standard reactions that may be used for this step are briefly reviewed. In the following chapter, the emphasis is on polymer types that have been used for the development of several biomimetic materials. There is, thereby, a delineation made between materials that are processed to devices exceeding cellular dimensions and materials predominantly used for the assembly of nanostructures. Finally, we give a few current examples for applications in which biomimetic polymers have been applied to achieve a better biomaterial performance. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93053 Regensburg, Germany.
   Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, Univ Str 31, D-93053 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Goepferich, Achim/G-1151-2016; Breunig, Miriam/K-2978-2016; Tessmar,
   Joerg/H-3606-2012
OI Goepferich, Achim/0000-0002-7646-0252; Breunig,
   Miriam/0000-0002-1320-6820; Tessmar, Joerg/0000-0001-7057-5369
CR ALBERTS B, 1994, MOL BIOL CELL, P502
   ALBERTS B, 1994, MOL BIOL CELL, P769
   ALBERTS B, 1994, MOL BIOL CELL, P618
   ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
   BARANY G, 1980, PEPTIDES, P1
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   BAZILE DV, 1992, BIOMATERIALS, V13, P1093, DOI 10.1016/0142-9612(92)90142-B
   Bettinger T, 1999, BIOCONJUGATE CHEM, V10, P558, DOI 10.1021/bc990006h
   Bhadriraju K, 2000, BIOMATERIALS, V21, P267, DOI 10.1016/S0142-9612(99)00175-1
   Bieber T, 2002, J CONTROL RELEASE, V82, P441, DOI 10.1016/S0168-3659(02)00129-3
   BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057
   Blunk T, 2003, BIOMATERIALS, V24, P4335, DOI 10.1016/S0142-9612(03)00336-3
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   BOBBITT JM, 1956, ADV CARBOHYD CHEM, V11, P1
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   BREWER CF, 1967, ANAL BIOCHEM, V18, P248, DOI 10.1016/0003-2697(67)90007-3
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   CHEN JB, 1994, FEBS LETT, V338, P167, DOI 10.1016/0014-5793(94)80357-9
   CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547
   Cho CW, 2000, BIOTECHNOL APPL BIOC, V32, P21, DOI 10.1042/BA20000022
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   COTTEN M, 1990, P NATL ACAD SCI USA, V87, P4033, DOI 10.1073/pnas.87.11.4033
   CRISTIANO RJ, 1993, P NATL ACAD SCI USA, V90, P11548, DOI 10.1073/pnas.90.24.11548
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850
   DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Erbacher P, 1999, J GENE MED, V1, P210
   ERBACHER P, 1995, BIOCONJUGATE CHEM, V6, P401, DOI 10.1021/bc00034a010
   Erbacher P, 1999, GENE THER, V6, P138, DOI 10.1038/sj.gt.3300783
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Fischbach C, 2001, SURF SCI, V491, P333, DOI 10.1016/S0039-6028(01)01297-3
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   GILLES MA, 1990, ANAL BIOCHEM, V184, P244, DOI 10.1016/0003-2697(90)90675-Y
   Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q
   Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177
   GREEN NM, 1971, BIOCHEM J, V125, P781, DOI 10.1042/bj1250781
   Gref R, 2003, BIOMATERIALS, V24, P4529, DOI 10.1016/S0142-9612(03)00348-X
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Harma H, 2000, LUMINESCENCE, V15, P351, DOI 10.1002/1522-7243(200011/12)15:6<351::AID-BIO624>3.0.CO;2-3
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   HEITZ JR, 1968, ARCH BIOCHEM BIOPHYS, V127, P627, DOI 10.1016/0003-9861(68)90271-3
   Hermanson T. H., 1996, BIOCONJUGATE TECHNIQ, P139
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P114
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P169
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P138
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P177
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P185
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P64
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HOECKER H, 1998, MACROMOL S, V130, P161
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   James K, 1996, MRS BULL, V21, P22, DOI 10.1557/S0883769400031808
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kircheis R, 2001, J CONTROL RELEASE, V72, P165, DOI 10.1016/S0168-3659(01)00272-3
   Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351
   Klee D, 1999, ADV POLYM SCI, V149, P1
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   Leamon CP, 1999, BIOCONJUGATE CHEM, V10, P947, DOI 10.1021/bc990066n
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Lee H, 2002, J CONTROL RELEASE, V83, P109, DOI 10.1016/S0168-3659(02)00166-9
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li YP, 2003, INT J PHARM, V259, P93, DOI 10.1016/S0378-5173(03)00211-4
   Lilli C, 2002, J BIOMED MATER RES, V63, P577, DOI 10.1002/jbm.10301
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matthew H. W. T., 2000, BIOMATERIALS, V21, P2589
   Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575
   MERWIN JR, 1995, J IMMUNOL METHODS, V186, P257, DOI 10.1016/0022-1759(95)00150-9
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109
   MISLICK KA, 1995, BIOCONJUGATE CHEM, V6, P512, DOI 10.1021/bc00035a002
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   Murphy WL, 2002, NAT BIOTECHNOL, V20, P30, DOI 10.1038/nbt0102-30
   Na K, 2003, EUR J PHARM SCI, V18, P165, DOI 10.1016/S0928-0987(02)00257-9
   Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Olivier JC, 2002, PHARMACEUT RES, V19, P1137, DOI 10.1023/A:1019842024814
   OMULLANE JE, 1990, INT J PHARM, V63, P177, DOI 10.1016/0378-5173(90)90169-5
   Pan D, 2003, CHEM COMMUN, P2400, DOI 10.1039/b307878g
   Park KH, 2002, BIOTECHNOL LETT, V24, P1401, DOI 10.1023/A:1019890229822
   PARTHASARATHI S, 1995, J VIROL, V69, P7991
   PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358
   PATCHORNIK A, 1957, J AM CHEM SOC, V79, P5227, DOI 10.1021/ja01576a043
   PENG L, 1987, APPL BIOCHEM BIOTECH, V14, P91, DOI 10.1007/BF02798427
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PLANK C, 1994, J BIOL CHEM, V269, P12918
   PLANK C, 1992, BIOCONJUGATE CHEM, V3, P533, DOI 10.1021/bc00018a012
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Purcell DFJ, 1996, J VIROL, V70, P887
   Putnam E A, 1992, Surg Oncol, V1, P49, DOI 10.1016/0960-7404(92)90056-Q
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Smith LC, 1998, ADV DRUG DELIVER REV, V30, P115, DOI 10.1016/S0169-409X(97)00111-7
   Stayton PS, 2000, J CONTROL RELEASE, V65, P203, DOI 10.1016/S0168-3659(99)00236-9
   Stella B, 2000, J PHARM SCI, V89, P1452, DOI 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
   Stewart J.M., 1984, SOLID PHASE PEPTIDE, P31
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   STOCKERT RJ, 1995, PHYSIOL REV, V75, P591
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   STUART CA, 1979, ENDOCRINOLOGY, V105, P1293, DOI 10.1210/endo-105-6-1293
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Tessmar J, 2003, BIOMATERIALS, V24, P4475, DOI 10.1016/S0142-9612(03)00345-4
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Trippel S B, 1995, J Rheumatol Suppl, V43, P129
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   von Harpe A, 2000, J CONTROL RELEASE, V69, P309, DOI 10.1016/S0168-3659(00)00317-5
   VONSTEENIS JH, 2003, J CONTROL RELEASE, V87, P167
   WAGNER E, 1994, ADV DRUG DELIVER REV, V14, P113, DOI 10.1016/0169-409X(94)90008-6
   WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255
   WAGNER E, 1991, BIOCONJUGATE CHEM, V2, P226, DOI 10.1021/bc00010a006
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P6099, DOI 10.1073/pnas.89.13.6099
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   WANG CY, 1984, BIOCHEMISTRY-US, V23, P4409, DOI 10.1021/bi00314a026
   Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Ward JH, 2001, J BIOMED MATER RES, V56, P351, DOI 10.1002/1097-4636(20010905)56:3<351::AID-JBM1103>3.0.CO;2-A
   Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6
   Xu B, 1998, GENE THER, V5, P1235, DOI 10.1038/sj.gt.3300719
   Yoon JJ, 2002, BIOTECHNOL BIOENG, V78, P1, DOI 10.1002/bit.10239
   Zanta MA, 1997, BIOCONJUGATE CHEM, V8, P839, DOI 10.1021/bc970098f
   Zhou SB, 2003, J CONTROL RELEASE, V86, P195, DOI 10.1016/S0168-3659(02)00423-6
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 171
TC 107
Z9 111
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0935-1221
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD SEP
PY 2004
VL 58
IS 2
BP 385
EP 407
DI 10.1016/j.ejpb.2004.03.018
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 849GQ
UT WOS:000223527100016
PM 15296963
DA 2018-10-19
ER

PT J
AU Sato, M
   Webster, TJ
AF Sato, M
   Webster, TJ
TI Nanobiotechnology: implications for the future of nanotechnology in
   orthopedic applications
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE ceramics; metals; nanocomposites; nanophase; nanotechnology; orthopedic;
   osteoblasts; polymers
ID ENHANCED OSTEOBLAST ADHESION; NANOPHASE CERAMICS; SURFACE-ROUGHNESS;
   PROTEIN ADSORPTION; CELL-ADHESION; METAL-IONS; IN-VITRO; PROLIFERATION;
   VITRONECTIN; ATTACHMENT
AB Nanotechnology Involves the use of materials with components, such as fibers, grains and particles, that have dimensions of less than 100 nm. While numerous advantages of nanomaterials; have been elucidated for catalytic, processing, mechanical, electrical, and optical applications, few have been described for orthopedic applications. Better orthopedic biomaterials are needed since the average lifetime of a bone biomaterial Is less than 15 years. This review discusses recent studies that have been conducted to determine the efficacy of nanophase materials as bone implants. In doing so, It is suggested that nanophase materials can be synthesized to possess similar nanometer dimensions to components of bone tissue to promote new bone formation, compared with conventional orthopedic Implant materials.
C1 Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Sato, M (reprint author), Purdue Univ, Sch Mat Engn, 501 Northwestern Ave, W Lafayette, IN 47907 USA.
EM satom@purdue.edu; twebster@purdue.edu
CR Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Boyan BD, 2001, J BIOMED MATER RES, V55, P350, DOI 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M
   CHUN AL, 2004, NANOTECHNOLOGY S, V15, pS1
   COWIN, 1987, HDB BIOENGINEERING
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Emery DFG, 1997, J BONE JOINT SURG BR, V79B, P240, DOI 10.1302/0301-620X.79B2.7165
   Fujibayashi S, 2004, KEY ENG MAT, V254-2, P953, DOI 10.4028/www.scientific.net/KEM.254-256.953
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   Gutwein LG, 2002, J NANOPART RES, V4, P231, DOI 10.1023/A:1019920105207
   Hogan J, 2003, NEW SCI, V177, P14
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Klabunde KJ, 1996, J PHYS CHEM-US, V100, P12142, DOI 10.1021/jp960224x
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   MEQUITA P, 2004, J BIOMED MATER RES, V254, P1091
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Que L, 2000, J BIOMED MATER RES, V50, P322, DOI 10.1002/(SICI)1097-4636(20000605)50:3<322::AID-JBM5>3.0.CO;2-U
   RATNER BD, 1996, BIOMATERIALS SCI, P132
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P24
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Savarino L, 1999, J BIOMED MATER RES, V47, P543, DOI 10.1002/(SICI)1097-4636(19991215)47:4<543::AID-JBM11>3.0.CO;2-G
   Schakenraad J, 1996, BIOMATERIAL SCI, P140
   Seal S, 2004, MRS BULL, V29, P16, DOI 10.1557/mrs2004.11
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   Tamura K, 2004, KEY ENG MAT, V254-2, P919, DOI 10.4028/www.scientific.net/KEM.254-256.919
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   WARHEIT DB, 2004, MAT TODAY        FEB, P32
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Webster TJ, 2001, SCRIPTA MATER, V44, P1639, DOI 10.1016/S1359-6462(01)00873-9
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Webster TJ, 2003, AM CERAMIC SOC B, V82, P1
   WEBSTER TJ, 2003, ADV CHEM ENG, V27, P125
   WEN SL, 1995, CERAM INT, V21, P109, DOI 10.1016/0272-8842(95)95880-Q
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
NR 49
TC 108
Z9 115
U1 0
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD SEP
PY 2004
VL 1
IS 1
BP 105
EP 114
DI 10.1586/17434440.1.1.105
PG 10
WC Engineering, Biomedical
SC Engineering
GA 018XC
UT WOS:000235797100020
PM 16293014
DA 2018-10-19
ER

PT J
AU Jang, JH
   Houchin, TL
   Shea, LD
AF Jang, JH
   Houchin, TL
   Shea, LD
TI Gene delivery from polymer scaffolds for tissue engineering
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; gene therapy; nonviral vector; regeneration; wound healing
ID BONE MORPHOGENETIC PROTEIN-2; ANTIBODY-TETHERED ADENOVIRUS;
   SPINAL-CORD-INJURY; GROWTH-FACTOR-B; IN-VIVO; DNA DELIVERY; PLASMID DNA;
   CONTROLLED-RELEASE; STEM-CELLS; RECOMBINANT ADENOVIRUS
AB The combination of gene therapy with tissue engineering offers the potential to direct progenitor cell proliferation and differentiation into functional tissue replacements. Many approaches to engineering tissue replacements feature a polymer scaffold to create and maintain a space, support cell adhesion, and organize tissue formation. Polymer scaffolds, either natural, synthetic, or a combination of the two, have also been adapted to serve as delivery vehicles for viral and nonviral vectors, which can induce the expression of tissue inductive factors. Gene delivery Is a versatile approach, capable of targeting any cellular process through localized expression of tissue inductive factors. The design and application of tissue engineering scaffolds for localized gene transfer are reviewed. Scaffolds are designed either to release the vector into the local tissue environment or maintain the vector at the polymer surface, which is regulated by the effective affinity of the vector for the polymer. Polymeric delivery can enhance gene transfer locally, promote and extend transgene expression, avoid vector distribution to distant tissues, and reduce the immune response to the vector. Scaffolds capable of controlled DNA delivery can provide a fundamental tool for directing progenitor cell function, which has applications with the engineering of numerous types of tissue. The utility of this approach will Increase with the development of design parameters that correlate release and transgene expression, and with continued research into the biology of tissue formation.
C1 Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Biol & Chem Engn, 2145 Sheridan Rd,E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009; Jang, Jae-Hyung/G-8030-2012
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   Alden TD, 1999, HUM GENE THER, V10, P2245, DOI 10.1089/10430349950017220
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117
   Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647
   Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bonadio J, 1998, ADV DRUG DELIVER REV, V33, P53, DOI 10.1016/S0169-409X(98)00020-9
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Cao L, 2004, BRAIN, V127, P535, DOI 10.1093/brain/awh072
   Chandler LA, 2000, WOUND REPAIR REGEN, V8, P473, DOI 10.1046/j.1524-475x.2000.00473.x
   CHANG WV, 2000, ACID BASE INTERACTIO, V2, P3
   Chen Y, 2001, GENE THER, V8, P1024, DOI 10.1038/sj.gt.3301482
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   De Rosa G, 2002, J PHARM SCI, V91, P790, DOI 10.1002/jps.10063
   Deasy BM, 2002, CURR OPIN MOL THER, V4, P382
   Devroe E, 2004, EXPERT OPIN BIOL TH, V4, P319, DOI 10.1517/eobt.4.3.319.27320
   Doukas J, 2002, MOL THER, V5, P517, DOI 10.1006/mthe.2002.0579
   Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720
   Eliaz RE, 2002, GENE THER, V9, P1230, DOI 10.1038/sj.gt.3301786
   Eliopoulos N, 2003, GENE THER, V10, P478, DOI 10.1038/sj.gt.3301919
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Gafni Y, 2004, GENE THER, V11, P417, DOI 10.1038/sj.gt.3302197
   Gronthos S, 2003, J BONE MINER RES, V18, P716, DOI 10.1359/jbmr.2003.18.4.716
   Gu DL, 2004, MOL THER, V9, P699, DOI 10.1016/j.ymthe.2004.02.018
   Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983
   Hijjawi J, 2004, ARCH SURG-CHICAGO, V139, P142, DOI 10.1001/archsurg.139.2.142
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Jozkowicz A, 2003, INT J ARTIF ORGANS, V26, P161
   Kai E, 2004, PHARM RES, V21, P838, DOI 10.1023/B:PHAM.0000026437.32238.6f
   Kim A, 2003, J CONTROL RELEASE, V90, P81, DOI 10.1016/S0168-3659(03)00175-5
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Kofron MD, 2003, IEEE ENG MED BIOL, V22, P57, DOI 10.1109/MEMB.2003.1256273
   Kofron MD, 2004, BIOMATERIALS, V25, P2637, DOI 10.1016/j.biomaterials.2003.09.042
   Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257
   Kushibiki T, 2003, J CONTROL RELEASE, V90, P207, DOI 10.1016/S0168-3659(03)00197-4
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Ledley FD, 1996, PHARMACEUT RES, V13, P1595, DOI 10.1023/A:1016420102549
   Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Li ZH, 2003, PHARMACEUT RES, V20, P884, DOI 10.1023/A:1023887203111
   Loser Peter, 2002, Curr Gene Ther, V2, P161, DOI 10.2174/1566523024605555
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Mason Deborah J, 2004, Eur Cell Mater, V7, P12
   Meilander NJ, 2003, J CONTROL RELEASE, V88, P321, DOI 10.1016/S0168-3659(03)00007-5
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Murray M, 2001, NEUROSCIENTIST, V7, P28, DOI 10.1177/107385840100700107
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   Ochiya T, 1999, NAT MED, V5, P707
   Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887
   Okubo Y, 2000, BIOCHEM BIOPH RES CO, V267, P382, DOI 10.1006/bbrc.1999.1975
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Ozbas-Turan S, 2003, J PHARM PHARM SCI, V6, P27
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pascher A, 2004, GENE THER, V11, P133, DOI 10.1038/sj.gt.3302155
   Perlstein I, 2003, GENE THER, V10, P1420, DOI 10.1038/sj.gt.3302043
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795
   Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Samuel RE, 2002, HUM GENE THER, V13, P791, DOI 10.1089/10430340252898975
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Segura T, 2001, ANNU REV MATER RES, V31, P25, DOI 10.1146/annurev.matsci.31.1.25
   SEGURA T, 2004, IN PRESS BIOMATERIAL
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Siemens DR, 2000, J NATL CANCER I, V92, P403, DOI 10.1093/jnci/92.5.403
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Tyrone JW, 2000, J SURG RES, V93, P230, DOI 10.1006/jsre.2000.5912
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200
   ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997
   Zaharoff DA, 2002, GENE THER, V9, P1286, DOI 10.1038/sj.gt.3301799
NR 94
TC 93
Z9 95
U1 0
U2 21
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD SEP
PY 2004
VL 1
IS 1
BP 127
EP 138
DI 10.1586/17434440.1.1.127
PG 12
WC Engineering, Biomedical
SC Engineering
GA 018XC
UT WOS:000235797100022
PM 16293016
DA 2018-10-19
ER

PT J
AU Tieche, C
   Alkema, PK
   Liu, SQ
AF Tieche, C
   Alkema, PK
   Liu, SQ
TI Vascular elastic laminae: Anti-inflammatory properties and potential
   applications to arterial reconstruction
SO FRONTIERS IN BIOSCIENCE
LA English
DT Review
DE monocytes; thrombosis; neointima formation; vessel; treatment; review
ID SMOOTH-MUSCLE-CELLS; SUPRAVALVULAR AORTIC-STENOSIS; HUMAN SKIN
   FIBROBLASTS; COACERVATED ALPHA-ELASTIN; DEPENDENT PROTEIN-KINASE;
   INTRACELLULAR CYCLIC-GMP; RAT PULMONARY-ARTERIES; BINDING-PROTEIN;
   GROWTH-FACTOR; EXTRACELLULAR-MATRIX
AB Biomaterials, including non-biodegradable and biodegradable polymers, and collagen and fibrin matrices, have been used in experimental and clinical arterial reconstruction. While these biomaterials exhibit various characteristics suitable for arterial reconstruction, the patency of biomaterial-based arterial substitutes remains problematic because of inflammation and thrombogenesis. Endothelial cell seeding of biomaterials has been proposed and used for reducing the thrombogenicity of biomaterials. However, difficulties in cell retention hamper the application of such an approach. Although autogenous vein grafts offer satisfactory results, not all patients possess veins available for arterial replacements. Thus, a critical issue in arterial reconstruction is developing arterial substitutes that are inflammation/thrombosis-resistant while possessing the characteristics of natural arteries. Here we show that allogenic vascular elastic laminae exhibit anti-inflammatory properties and may be considered a potential material for arterial reconstruction. In this article, we briefly review the composition, structure, and function of vascular elastic laminae, summarize recent discoveries on the role of elastic laminae in regulating leukocyte adhesion and vascular smooth muscle cell proliferation and migration, and discuss potential applications of allogenic elastic laminae to arterial reconstruction.
C1 Northwestern Univ, Inst Technol, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Tieche, C (reprint author), Northwestern Univ, Inst Technol, Dept Biomed Engn, E327,2145 Sheridan Rd, Evanston, IL 60208 USA.
EM c-tieche@northwestern.edu
RI Liu, Shu/B-7626-2009
CR BASHIR MM, 1989, J BIOL CHEM, V264, P8887
   Berk JL, 1999, AM J PHYSIOL-LUNG C, V277, pL566, DOI 10.1152/ajplung.1999.277.3.L566
   BISACCIA F, 1994, INT J PEPT PROT RES, V44, P332
   BOUDREAU N, 1991, LAB INVEST, V64, P187
   Boyle JR, 1998, EUR J VASC ENDOVASC, V16, P408, DOI 10.1016/S1078-5884(98)80008-7
   Braddon LG, 2002, TISSUE ENG, V8, P695, DOI 10.1089/107632702760240607
   Brassart B, 1998, CLIN EXP METASTAS, V16, P489, DOI 10.1023/A:1006550503612
   Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3
   BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Bujan J, 2003, WORLD J SURG, V27, P901, DOI 10.1007/s00268-003-6897-8
   Carmo M, 2002, EUR J VASC ENDOVASC, V23, P543, DOI 10.1054/ejvs.2002.1620
   DAVIS EC, 1995, J HISTOCHEM CYTOCHEM, V43, P1115, DOI 10.1177/43.11.7560894
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057
   FAURY G, 1995, J VASC RES, V32, P112, DOI 10.1159/000159084
   Faury G, 1998, CIRC RES, V82, P328, DOI 10.1161/01.RES.82.3.328
   Faury G, 1999, AM J PHYSIOL-HEART C, V277, pH1745, DOI 10.1152/ajpheart.1999.277.5.H1745
   FAZIO MJ, 1991, AM J HUM GENET, V48, P696
   FLEMING WW, 1980, BIOPOLYMERS, V19, P597, DOI 10.1002/bip.1980.360190311
   GRAHAM LM, 1982, SURGERY, V91, P550
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   GROULT V, 1991, CELL BIOCHEM FUNCT, V9, P171, DOI 10.1002/cbf.290090305
   Halloran B G, 1995, Semin Vasc Surg, V8, P85
   Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382
   Hauck M, 1995, BIOCHEM MOL BIOL INT, V37, P45
   HERRING M, 1979, ARCH SURG-CHICAGO, V114, P679
   Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9
   HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436
   HINEK A, 1992, EXP CELL RES, V203, P344, DOI 10.1016/0014-4827(92)90008-V
   HINEK A, 1993, J BIOL CHEM, V268, P1405
   HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538
   HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280
   Hinek A, 1996, BIOL CHEM, V377, P471
   Hinek Aleksander, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P15
   HOBAN LD, 1994, J SURG RES, V56, P179, DOI 10.1006/jsre.1994.1029
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   HORNEBECK W, 1986, P NATL ACAD SCI USA, V83, P5517, DOI 10.1073/pnas.83.15.5517
   HUNNINGHAKE GW, 1981, SCIENCE, V212, P925, DOI 10.1126/science.7233186
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Ito S, 1997, Cardiovasc Surg, V5, P176, DOI 10.1016/S0967-2109(97)00004-5
   Ito S, 1998, ASAIO J, V44, pM501, DOI 10.1097/00002480-199809000-00036
   Jensen N, 1996, ANN VASC SURG, V10, P530, DOI 10.1007/BF02000441
   JOHNSON DJ, 1995, CIRC RES, V77, P1107, DOI 10.1161/01.RES.77.6.1107
   KABEMBA JM, 1973, SURGERY, V73, P438
   Kallmes DF, 2001, J VASC INTERV RADIOL, V12, P1127, DOI 10.1016/S1051-0443(07)61669-8
   Kamisato S, 1997, J BIOCHEM-TOKYO, V121, P862
   Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kesler K A, 1986, Ann Vasc Surg, V1, P60, DOI 10.1007/BF02732457
   Kleinert LB, 1996, CELL TRANSPLANT, V5, P475, DOI 10.1016/0963-6897(96)00024-3
   Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200
   Kuang PP, 2003, AM J PHYSIOL-CELL PH, V285, pC1349, DOI 10.1152/ajpcell.00173.2003
   Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021
   Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Liu JH, 2003, AM J PHYSIOL-LUNG C, V285, pL1106, DOI 10.1152/ajplung.00180.2003
   Liu SQ, 2004, BIOMATERIALS, V25, P1869, DOI 10.1016/j.biomaterials.2003.08.044
   Liu SQ, 1997, J APPL PHYSIOL, V82, P1677
   Liu SQ, 2000, J BIOMECH ENG-T ASME, V122, P31, DOI 10.1115/1.429625
   Liu SQ, 1996, J APPL PHYSIOL, V81, P2147
   Lograno MD, 1998, INT J BIOCHEM CELL B, V30, P497, DOI 10.1016/S1357-2725(98)00008-9
   LONG MM, 1988, BIOCHIM BIOPHYS ACTA, V968, P300, DOI 10.1016/0167-4889(88)90021-3
   MECHAM RP, 1991, FASEB J, V5, P2538
   MECHAM RP, 1985, J BIOL CHEM, V260, P3255
   Merrilees MJ, 2002, CIRC RES, V90, P481, DOI 10.1161/hh0402.105791
   Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200
   Morelli MAC, 1997, J PEPT RES, V49, P492
   NAKASHIMA Y, 1990, LAB INVEST, V62, P751
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   OOYAMA T, 1987, ARTERIOSCLEROSIS, V7, P593, DOI 10.1161/01.ATV.7.6.593
   Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x
   RAINES EW, 1993, BRIT HEART J, V69, pS30
   REISER K, 1992, FASEB J, V6, P2439
   Rich CB, 1999, J BIOL CHEM, V274, P33433, DOI 10.1074/jbc.274.47.33433
   Robb BW, 1999, MOL BIOL CELL, V10, P3595, DOI 10.1091/mbc.10.11.3595
   ROBERT L, 1989, PATHOL BIOL, V37, P736
   ROBERT L, 1992, ANN NY ACAD SCI, V673, P331, DOI 10.1111/j.1749-6632.1992.tb27468.x
   Robert L, 1996, ATHEROSCLEROSIS, V123, P169, DOI 10.1016/0021-9150(96)05804-2
   Robert L, 1999, CONNECT TISSUE RES, V40, P75, DOI 10.3109/03008209909029103
   ROSENBLOOM J, 1991, ANN NY ACAD SCI, V624, P116, DOI 10.1111/j.1749-6632.1991.tb17012.x
   ROSENBLOOM J, 1993, FASEB J, V7, P1208
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2
   Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654
   SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926
   SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870
   Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sugitani H, 2001, BIOL PHARM BULL, V24, P461, DOI 10.1248/bpb.24.461
   Tajima S, 1997, ARCH DERMATOL RES, V289, P489, DOI 10.1007/s004030050227
   Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029
   TOKIMITSU I, 1994, BBA-PROTEIN STRUCT M, V1207, P68, DOI 10.1016/0167-4838(94)90052-3
   Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200
   Uemura Y, 1997, BIOCHEM MOL BIOL INT, V41, P57
   Urban Z, 2002, AM J HUM GENET, V71, P30, DOI 10.1086/341035
   Urban Z, 2000, PEDIATR DERMATOL, V17, P12, DOI 10.1046/j.1525-1470.2000.01703.x
   Urry DW, 2002, J MUSCLE RES CELL M, V23, P543, DOI 10.1023/A:1023422925910
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   WACHI H, 1995, FEBS LETT, V368, P215, DOI 10.1016/0014-5793(95)00641-L
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WOLFE BL, 1993, J BIOL CHEM, V268, P12418
   WRENN DS, 1988, J BIOL CHEM, V263, P2280
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   YAMAMOTO K, 1995, EXP CELL RES, V218, P339, DOI 10.1006/excr.1995.1164
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
   YOSHIDA Y, 1988, ARCH PATHOL LAB MED, V112, P987
NR 121
TC 7
Z9 9
U1 1
U2 6
PU FRONTIERS IN BIOSCIENCE INC
PI MANHASSET
PA C/O NORTH SHORE UNIV HOSPITAL, BIOMEDICAL RESEARCH CENTER, 350 COMMUNITY
   DR, MANHASSET, NY 11030 USA
SN 1093-9946
J9 FRONT BIOSCI
JI Front. Biosci.
PD SEP 1
PY 2004
VL 9
SU S
BP 2205
EP 2217
DI 10.2741/1391
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 852NS
UT WOS:000223763200018
PM 15353282
DA 2018-10-19
ER

PT J
AU Catani, M
   De Milito, R
   Pietroletti, R
   Chiaretti, M
   Spaziani, E
   Leardi, S
   Simi, M
AF Catani, M
   De Milito, R
   Pietroletti, R
   Chiaretti, M
   Spaziani, E
   Leardi, S
   Simi, M
TI Is there a place for intraperitoneal onlay mesh repair (IPOM) of
   inguinal hernia among laparoscopic techniques?
SO HEPATO-GASTROENTEROLOGY
LA English
DT Article
DE inguinal hernia; laparoscopy; IPOM
ID GROIN HERNIA; HERNIORRHAPHY; SURGERY; EXPERIENCE; TRIAL; CLASSIFICATION;
   HERNIOPLASTY; PREVENTION; MANAGEMENT; WALL
AB Background/Aims: The Authors report their experience on laparoscopic hernioplasty using the intraperitoneal onlay mesh repair in 56 patients.
   Methodology: Thirty patients had a monolateral hernia, 9 of which were recurrent and 26 had a bilateral hernia, 6 of which were recurrent. Overall, a total of 90 hernias were treated. The hernia repair was performed by using "GORETEX(R) Dual Mesh Plus biomaterial with holes" in the first 32 cases and the latest "Corduroy" type in the following 24 cases. The prostheses were fixed with titanium spiral tacks (Protack(R), Auto Suture, Tyco Healthcare).
   Results: No intraoperative complications occurred and no conversion was necessary. Five minor postoperative complications (5.5%), 2 seromas and 3 transient paresthesias, were observed. Four patients (7.1%) needed analgesics after the first 24 hours. Mean hospital stay was 36 hours with a minimum of 24 and a maximum of 48. Mean resumption of normal activity was 8 days with return to work within two weeks. At an average 18 months follow-up, 3 recurrences were recorded (3.3%).
   Conclusions: The results of this study as well as the meta-analysis of the series presented in the literature, indicate that the intraperitoneal onlay mesh repair may be a feasible, safe and effective procedure in the treatment of recurrent and bilateral hernias or when a hernia repair is performed during other laparoscopic procedures. The intraperitoneal onlay mesh repair has in fact been shown to be faster and easier than the other more commonly performed laparoscopic hernioplasties (trans-abdominal preperitoneal repair and total extra-peritoneal repair). These data may also suggest utilizing this technique in particular cases of primitive hernia such as very active young males or heavy-duty workers. However the limited series and the short follow-up ask for randomized prospective long-term studies to definitely ascertain the true incidence of recurrence and therefore the effectiveness of this attractive procedure.
C1 Paride Stefanini Univ Rome La Sapienza, Dept Surg, Rome, Italy.
   Univ Aquila, Dept Surg, I-67100 Laquila, Italy.
RP Simi, M (reprint author), FACS, Via Ronciglione 20, I-00191 Rome, Italy.
EM mario.simi@uniromal.it
RI Chiaretti, Massimo/L-7800-2015
OI Chiaretti, Massimo/0000-0002-9689-7566; pietroletti,
   renato/0000-0002-0790-1050; Catani, Marco/0000-0002-6249-104X
CR ALMEIDA JA, 2001, HERNIA, V5, pS54
   Arregui M E, 1992, Surg Laparosc Endosc, V2, P53
   Bartoloni A, 2000, Chir Ital, V52, P307
   Bellon JM, 2001, WORLD J SURG, V25, P147, DOI 10.1007/s002680020069
   Blanc P, 1999, Chirurgie, V124, P412, DOI 10.1016/S0001-4001(00)80014-8
   BOGOJAVALENSKY S, 1989, 18 ANN M AM ASS GYNE
   CANEIRO JMB, 1996, CIR ESP, V59, P296
   CONDON RE, 1989, HERNIA, P253
   Corbitt J D Jr, 1991, Surg Laparosc Endosc, V1, P23
   Crawford DL, 1998, SURG CLIN N AM, V78, P1047, DOI 10.1016/S0039-6109(05)70368-6
   CZUDEC S, 2001, HERNIA, V5, pS60
   DEANS GT, 1995, BRIT J SURG, V82, P539, DOI 10.1002/bjs.1800820433
   DeBord JR, 1998, SURG CLIN N AM, V78, P973, DOI 10.1016/S0039-6109(05)70365-0
   DEBORD JR, 1999, HERNIA, V3, P389
   DETURRIS SV, 2002, J AM COLL SURG S, V1, P65
   DION YM, 1992, CAN J SURG, V35, P209
   Edwards CC, 2000, SURG LAPARO ENDO PER, V10, P149, DOI 10.1097/00019509-200006000-00010
   FILIPI CJ, 1992, SURG CLIN N AM, V72, P1109
   FITZGIBBONS R, 1995, ANN SURG, V221, P313
   Fruchaud H., 1956, ANATOMIE CHIRURGICAL
   GER R, 1990, AM J SURG, V159, P370, DOI 10.1016/S0002-9610(05)81273-5
   GILBERT AI, 1989, AM J SURG, V157, P331, DOI 10.1016/0002-9610(89)90564-3
   Gillion J F, 1996, Ann Chir, V50, P821
   Greenberg D, 2001, Harefuah, V140, P580
   Haith L R Jr, 1998, JSLS, V2, P191
   HASSAON HM, 1971, AM J OBSTET GYNECOL, V110, P886, DOI 10.1016/0002-9378(71)90593-X
   Hasson HM, 2000, OBSTET GYNECOL, V96, P763, DOI 10.1016/S0029-7844(00)01026-7
   Hatzitheofilou C, 1997, SURG LAPAROSC ENDOSC, V7, P451, DOI 10.1097/00019509-199712000-00003
   Heikkinen TJ, 1998, SURG ENDOSC-ULTRAS, V12, P1199, DOI 10.1007/s004649900820
   Johansson B, 1999, ANN SURG, V230, P225, DOI 10.1097/00000658-199908000-00013
   Kapiris SA, 2001, SURG ENDOSC-ULTRAS, V15, P972, DOI 10.1007/s004640080090
   Kasirajan K, 1997, J LAPAROENDOSC ADV A, V7, P385, DOI 10.1089/lap.1997.7.385
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   Kingsley D, 1998, AM J SURG, V176, P548, DOI 10.1016/S0002-9610(98)00274-8
   Krahenbuhl L, 1998, DIGEST SURG, V15, P158, DOI 10.1159/000018611
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LICHTENSTEIN IL, 1993, SURG CLIN N AM, V73, P529
   Liem MSL, 1997, NEW ENGL J MED, V336, P1541, DOI 10.1056/NEJM199705293362201
   MCKERNAN JB, 1992, SURG ROUNDS, V15, P597
   Memon MA, 1999, SURG ENDOSC-ULTRAS, V13, P807, DOI 10.1007/s004649901105
   NEUGEBAUER E, 1995, SURG ENDOSC-ULTRAS, V9, P550
   NYHUS LM, 1964, SURG CLIN N AM, V44, P1305
   NYHUS LM, 1993, SURGERY, V114, P1
   O'Dwyer P, 1999, LANCET, V354, P185
   Paganini AM, 1998, SURG ENDOSC-ULTRAS, V12, P979, DOI 10.1007/s004649900760
   PHILLIPS EH, 1995, SURG ENDOSC-ULTRAS, V9, P140
   Ramshaw B, 2001, SURG ENDOSC-ULTRAS, V15, P50, DOI 10.1007/s004640001016
   Rutkow IM, 1998, SURG CLIN N AM, V78, P1117, DOI 10.1016/S0039-6109(05)70373-X
   SARLI L, 1997, SURG LAPARO ENDO PER, V6, P472
   Sayad P, 2000, SURG ENDOSC-ULTRAS, V14, P543, DOI 10.1007/s004640000101
   Schmidt J, 2001, SURG LAPARO ENDO PER, V11, P34, DOI 10.1097/00019509-200102000-00008
   Schultz C, 2001, SURG ENDOSC-ULTRAS, V15, P582, DOI 10.1007/s004640000376
   Schultz L, 1990, J Laparoendosc Surg, V1, P41, DOI 10.1089/lps.1990.1.41
   Spaw A T, 1991, J Laparoendosc Surg, V1, P269, DOI 10.1089/lps.1991.1.269
   STOPPA R, 1983, MEM ACAD CHIR, V99, P119
   Toy F K, 1991, Surg Laparosc Endosc, V1, P151
   Toy FK, 1996, J LAPAROENDOSC SURG, V6, P375, DOI 10.1089/lps.1996.6.375
   TSANG S, 1994, AM SURGEON, V6, P332
   Vanclooster P, 2001, ACTA CHIR BELG, V101, P135
   VOGT DM, 1995, AM J SURG, V169, P84, DOI 10.1016/S0002-9610(99)80114-7
   WRIGHT T, 2002, ANN SURG, V3, P333
NR 61
TC 6
Z9 7
U1 0
U2 3
PU H G E UPDATE MEDICAL PUBLISHING S A
PI ATHENS
PA PO BOX 17257, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD SEP-OCT
PY 2004
VL 51
IS 59
BP 1387
EP 1392
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 841BZ
UT WOS:000222905600036
PM 15362760
DA 2018-10-19
ER

PT J
AU Chakar, FS
   Ragauskas, AJ
AF Chakar, FS
   Ragauskas, AJ
TI Review of current and future softwood kraft lignin process chemistry
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article; Proceedings Paper
CT 6th Forum of the International-Lignin- Institute
CY JAN 22-23, 2003
CL Wageningen, NETHERLANDS
SP Int Lignin Inst, Wageningen UR, Dept Fibre & Paper Technol
DE lignin; kraft; phenol; biomaterial; biofuel
ID RESIDUAL LIGNIN; STRUCTURAL-CHANGES; HYDROXYL-GROUPS; PULPING PROCESSES;
   GENERAL CONCEPT; DELIGNIFICATION; CONDENSATION; COOKING; MODEL; FUELS
AB The structure of lignin has remained one of the most difficult biopolymers to characterize, however recent advances in analytical chemistry and spectroscopy have dramatically improved our knowledge of this natural resource. This paper highlights our current understanding of lignin structure and examines the process chemistry surrounding kraft pulping. The application of this knowledge, with respect to converting lignin into novel biomaterials, biocomposites, and biofuels is examined briefly. (C) 2004 Elsevier B.V. All rights reserved.
C1 Georgia Inst Technol, Sch Chem & Biochem, Inst Paper Sci & Technol, Atlanta, GA 30318 USA.
RP Ragauskas, AJ (reprint author), Georgia Inst Technol, Sch Chem & Biochem, Inst Paper Sci & Technol, 500 10th St, Atlanta, GA 30318 USA.
EM arthur.ragauskas@chemistry.gatech.edu
RI Ragauskas, Art/J-7486-2016
OI Ragauskas, Art/0000-0002-3536-554X
CR ADLER E, 1980, WOOD SCI TECHNOL, V14, P241
   ALEN R, 2000, PAPERMAKING SCI TECH, V3, P40
   ARGYROPOULOS DS, 1994, J WOOD CHEM TECHNOL, V14, P65, DOI 10.1080/02773819408003086
   ARGYROPOULOS DS, 2000, P TAPPI PULP PROC PR, P984
   AXEGARD P, 1983, SVEN PAPPERSTIDN, V86, pR178
   BERTHOLD F, 1993, P 7 INT S WOOD PULP, P160
   BUNGAY H, 1992, ENZYME MICROB TECH, V14, P501, DOI 10.1016/0141-0229(92)90145-E
   CHEN CL, 1991, INT FIBER SCI TECHNO, V11, P183
   Dence CW, 1996, PULP BLEACHING PRINC
   EDE RM, 1995, RES CHEM INTERMEDIAT, V21, P313, DOI 10.1007/BF03052261
   ENERI TM, 1994, KEMIA KEMI, V21, P174
   FAIX O, 1994, HOLZFORSCHUNG, V48, P387, DOI 10.1515/hfsg.1994.48.5.387
   Falkehag S. I., 1966, LIGNIN STRUCTURE REA, P75
   Freudenberg K., 1968, CONSTITUTION BIOSYNT
   Froass PM, 1998, HOLZFORSCHUNG, V52, P385, DOI 10.1515/hfsg.1998.52.4.385
   Froass PM, 1998, IND ENG CHEM RES, V37, P3388, DOI 10.1021/ie970812c
   Froass PM, 1996, J WOOD CHEM TECHNOL, V16, P347, DOI 10.1080/02773819608545820
   Froass PM, 1996, P TECH AS P, P163
   FULLERTON TJ, 1987, J WOOD CHEM TECHNOL, V7, P441, DOI 10.1080/02773818708085279
   GELLERSTEDT G, 1984, SVEN PAPPERSTIDN, V87, pR115
   GELLERSTEDT G, 1984, HOLZFORSCHUNG, V38, P151, DOI 10.1515/hfsg.1984.38.3.151
   GELLERSTEDT G, 1984, SVEN PAPPERSTIDN, V87, pR61
   GELLERSTEDT G, 2003, P 12 INT S WOOD PULP, V1, P1
   GELLERSTEDT G, 1982, P CAN WOOD S NIAGR F, P73
   Gellerstedt G., 1987, NORDIC PULP PAPER J, V2, P71
   GELLERSTEDT G, 1991, P INT PULP BLEACHING, V1, P73
   GIERER J, 1986, HOLZFORSCHUNG, V40, P347, DOI 10.1515/hfsg.1986.40.6.347
   GIERER J, 1985, WOOD SCI TECHNOL, V19, P289
   GIERER J, 1982, HOLZFORSCHUNG, V36, P43, DOI 10.1515/hfsg.1982.36.1.43
   GIERER J, 1979, ACTA CHEM SCAND B, V33, P580, DOI 10.3891/acta.chem.scand.33b-0580
   GIERER J, 1980, WOOD SCI TECHNOL, V14, P241, DOI 10.1007/BF00383453
   GIERER J, 1970, SVEN PAPPERSTIDN, V73, P571
   GIERER J, 1987, HOLZFORSCHUNG, V41, P79, DOI 10.1515/hfsg.1987.41.2.79
   GRANATA A, 1995, J AGR FOOD CHEM, V43, P1538, DOI 10.1021/jf00054a023
   GUSTAVSON C, 1998, P INT PULP BLEACH C, P13
   IVERSEN T, 1986, HOLZFORSCHUNG, V40, P19, DOI 10.1515/hfsg.1986.40.1.19
   Kadla JF, 2002, CARBON, V40, P2913, DOI 10.1016/S0008-6223(02)00248-8
   KARHUNEN P, 1995, TETRAHEDRON LETT, V36, P4501, DOI 10.1016/0040-4039(95)00769-9
   KARHUNEN P, 1995, TETRAHEDRON LETT, V36, P169, DOI 10.1016/0040-4039(94)02203-N
   KARHUNEN P, 1996, P 4 EUR WORKSH LIGN, P418
   KONDO Y, 1987, J ATMOS CHEM, V5, P37
   Koyama M, 1996, MOKUZAI GAKKAISHI, V42, P163
   LAI YZ, 1995, HOLZFORSCHUNG, V49, P319, DOI 10.1515/hfsg.1995.49.4.319
   Lee YY, 1998, J IND ENG CHEM, V4, P334
   Lewis NG, 1999, CURR OPIN PLANT BIOL, V2, P153, DOI 10.1016/S1369-5266(99)80030-2
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   MANSSON P, 1983, HOLZFORSCHUNG, V37, P143, DOI 10.1515/hfsg.1983.37.3.143
   Moe ST, 1999, HOLZFORSCHUNG, V53, P416, DOI 10.1515/HF.1999.069
   Nitz H, 2001, MACROMOL MATER ENG, V286, P737, DOI 10.1002/1439-2054(20011201)286:12<737::AID-MAME737>3.0.CO;2-2
   OASMAA A, 1993, ENERG FUEL, V7, P426, DOI 10.1021/ef00039a015
   Panshin AJ, 1980, TXB WOOD TECHNOLOGY
   PASCO MF, 1994, HOLZFORSCHUNG, V48, P504, DOI 10.1515/hfsg.1994.48.6.504
   Pasco MF, 1997, APPITA J, V50, P149
   PISKORZ J, 1989, ENERG FUEL, V3, P723, DOI 10.1021/ef00018a011
   *PULP PAP MAN, 1987, ALK PULP, V5
   Ragauskas AJ, 1999, TAPPI J, V82, P113
   Ragauskas AJ, 1997, P TECH AS P, P903
   Ralph J, 1998, TETRAHEDRON LETT, V39, P4963, DOI 10.1016/S0040-4039(98)00968-X
   Ralph J, 1999, P 6 BRAZ S CHEM LIGN, P97
   ROBERT DR, 1984, J WOOD CHEM TECHNOL, V4, P239, DOI 10.1080/02773818408070647
   Sarkanen K. V., 1971, LIGNINS OCCURRENCE F, P95
   Sjostrom E., 1981, WOOD CHEM FUNDAMENTA, P68
   SMIT R, 1999, APPITTA ANN GEN C P, V2, P773
   SMOOK GA, 1992, HDB PULP PAPER TECHN, V11, P163
   WYMAN CE, 1993, APPL BIOCHEM BIOTECH, V39, P41, DOI 10.1007/BF02918976
   YANG JM, 1981, CELL CHEM TECHNOL, V15, P337
   Zawadzki M, 2000, J PULP PAP SCI, V26, P102
   ZHANG L, 2001, CHEM COMMUN, V24, P2744
   1997, N AM PULP PAP FACT B, P332
NR 69
TC 451
Z9 463
U1 13
U2 226
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD SEP
PY 2004
VL 20
IS 2
BP 131
EP 141
DI 10.1016/j.indcrop.2004.04.016
PG 11
WC Agricultural Engineering; Agronomy
SC Agriculture
GA 864MD
UT WOS:000224636700003
DA 2018-10-19
ER

PT J
AU Oudadesse, H
   Derrien, AC
   Lucas-Girot, A
   Martin, S
   Cathelineau, G
   Sauvage, T
   Blondiaux, G
AF Oudadesse, H
   Derrien, AC
   Lucas-Girot, A
   Martin, S
   Cathelineau, G
   Sauvage, T
   Blondiaux, G
TI In vivo mineral composition evolution of a synthetic CaCO3 aragonite
   used as biomaterial for osseous substitution
SO INSTRUMENTATION SCIENCE & TECHNOLOGY
LA English
DT Article
DE aragonite; biomaterial; mineral composition; cartographies; kinetic;
   ossification
ID TRACE-ELEMENTS; PIXE
AB In orthopedic surgery, grafts are used as a substitute for defective bones. The development of synthetic biomaterials has been greatly successful. In this work, the in vivo behavior of synthetic aragonite calcium carbonate as a biomaterial was studied. This material porous at 44% was synthesized in our research group by double decomposition in an aqueous environment of salts of calcium and carbonate. Animal experimentation has been achieved on ovine spongy bony site. Biopsies have been carried out according to periods of 1, 3, 6, and 12 months after implantation. Samples were the subject of biologic assessments and in vivo mineral composition evolution. The analysis of trace and major elements (Ca, Sr, and P) of the biomaterial implanted has been achieved by the proton induced x-rays emission (PIXE) method. Cartographies of every element of the biomaterial, of the interface (biomaterial-bone), and finally, of the bony matrix were established. Results obtained highlight the centripetal migrations of phosphorus and the strontium, from the physiological environment toward the aragonite CaCO3 versus decreasing time of the calcium concentration in the biomaterial. The elements migration kinetics is inhomogeneous in the biomaterial -bone interface area. These results have been correlated with histological studies.
C1 Univ Rennes 1, Chim Solide & Inorgan Mol Lab, CNRS, Inst Chim Rennes,UMR 6511, F-35042 Rennes, France.
   Univ Rennes 1, UFR Odontol Biomat Site Osseux, Rennes, France.
   CERI, CNRS, Orleans, France.
RP Oudadesse, H (reprint author), Univ Rennes 1, Chim Solide & Inorgan Mol Lab, CNRS, Inst Chim Rennes,UMR 6511, CS 74205,Campus Beaulieu,Bat 10B, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Campbell JL, 2000, NUCL INSTRUM METH B, V170, P193, DOI 10.1016/S0168-583X(00)00156-7
   CHOI CG, 1996, THESIS U ORLEANS
   CHU TC, 1981, NUCL INSTRUM METH PH, V81, P190
   ELSOLH N, 1981, HDB STABLE STRONTIUM, P11
   FOLKMAN F, 1984, NUCL INSTRUM METH PH, V84, P11
   IYENER V, 1999, NAHRES39 IAEA
   IYENGAR GV, 1978, ELEMENTAL COMPOSITIO
   Johanson S. A. E., 1988, PIXE NOVEL TECHNIQUE
   Lucas A, 1999, J SOLID STATE CHEM, V146, P73, DOI 10.1006/jssc.1999.8310
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   LUCASGIROT A, 1996, THESIS U RENNES 1
   MARTIN S, 2002, THESIS U RENNES 1
   MAXWELL JA, 1995, NUCL INSTRUM METH B, V95, P407, DOI 10.1016/0168-583X(94)00540-0
   Oudadesse H, 2002, NUCL INSTRUM METH B, V190, P458, DOI 10.1016/S0168-583X(01)01252-6
   Oudadesse H, 2002, NUCL INSTRUM METH B, V190, P445, DOI 10.1016/S0168-583X(01)01251-4
NR 15
TC 7
Z9 7
U1 1
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1073-9149
J9 INSTRUM SCI TECHNOL
JI Instrum. Sci. Technol.
PD SEP
PY 2004
VL 32
IS 5
BP 545
EP 554
DI 10.1081/CI-200029803
PG 10
WC Chemistry, Analytical; Instruments & Instrumentation
SC Chemistry; Instruments & Instrumentation
GA 860GH
UT WOS:000224330000008
DA 2018-10-19
ER

PT J
AU Mack, D
   Becker, P
   Chatterjee, I
   Dobinsky, S
   Knobloch, JKM
   Peters, G
   Rohde, H
   Herrmann, M
AF Mack, D
   Becker, P
   Chatterjee, I
   Dobinsky, S
   Knobloch, JKM
   Peters, G
   Rohde, H
   Herrmann, M
TI Mechanisms of biofilm formation in Staphylococcus epidermidis and
   Staphylococcus aureus: functional molecules, regulatory circuits, and
   adaptive responses
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Review
DE foreign bode infection; quorum sensing; alternative sigma factor;
   biofilm formation; adhesion; stress response
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; FIBRONECTIN-BINDING PROTEIN;
   CATHETER-ASSOCIATED INFECTION; CYSTIC-FIBROSIS PATIENTS;
   VON-WILLEBRAND-FACTOR; BACILLUS-SUBTILIS; BACTERIAL BIOFILMS; SURFACE
   PROTEIN; GENE-EXPRESSION; FACTOR SIGMA(B)
AB Biomaterial-associated infections, most frequently caused by Staphylococcus epidermidis and Staphylococcus aureus, are of increasing importance in modern medicine. Regularly, antimicrobial therapy fails without removal of the implanted device. The most important factor in the pathogenesis of biomaterial-associated staphylococcal infections is the formation of adherent, multilayered bacterial biofilms. In this review, recent insights regarding factors functional in biofilm formation of S. epidermidis, their role in pathogenesis, and regulation of their expression are presented. Similarly, in S. aureus the biofilm mode of growth affects gene expression and the overall metabolic status. Experimental approaches for analysis of differential expression of genes involved in these adaptive responses and evolving patterns of gene expression are discussed. (C) 2004 Elsevier GmbH. All rights reserved.
C1 Univ Klinikum Hamburg, Zentrum Klin Theoret Med 1, Inst Infektionsmed, D-20246 Hamburg, Germany.
   Univ Klinikum Munchen, Inst Med Mikrobiol, D-48129 Munster, Germany.
   Univ Kliniken Saarlandes, Inst Infektionsmed, Inst Med Mikrobiol & Hyg, D-66421 Homburg, Germany.
RP Mack, D (reprint author), Univ Klinikum Hamburg, Zentrum Klin Theoret Med 1, Inst Infektionsmed, Martinistr 52, D-20246 Hamburg, Germany.
EM dmack@uke.uni-hamburg.de
RI Herrmann, Mathias/B-6475-2013; Knobloch, Johannes/D-6456-2011
OI Knobloch, Johannes/0000-0002-2591-6387
CR Becker P, 2001, APPL ENVIRON MICROB, V67, P2958, DOI 10.1128/AEM.67.7.2958-2965.2001
   BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   BROWN MRW, 1985, J ANTIMICROB CHEMOTH, V15, P7, DOI 10.1093/jac/15.suppl_A.7
   CHUARD C, 1991, J INFECT DIS, V163, P1369
   Chuard C, 1997, J ANTIMICROB CHEMOTH, V39, P603, DOI 10.1093/jac/39.5.603
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   DEIGHTON M, 1993, INFECT IMMUN, V61, P473
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   Fey PD, 1999, J INFECT DIS, V179, P1561, DOI 10.1086/314762
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gertz S, 2000, J BACTERIOL, V182, P6983, DOI 10.1128/JB.182.24.6983-6991.2000
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545
   Hartleib J, 2000, BLOOD, V96, P2149
   Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0
   Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   Herrmann M, 1997, J INFECT DIS, V176, P984, DOI 10.1086/516502
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HUSSAIN M, 1992, J HOSP INFECT, V20, P173, DOI 10.1016/0195-6701(92)90085-Z
   Hussain M, 2001, CLIN DIAGN LAB IMMUN, V8, P1271, DOI 10.1128/CDLI.8.6.1271-1276.2001
   Hussain M, 2001, MICROB PATHOGENESIS, V31, P261, DOI 10.1006/mpat.2001.0469
   Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001
   Hussain M, 1997, INFECT IMMUN, V65, P519
   JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457
   Joyce JG, 2003, CARBOHYD RES, V338, P903, DOI 10.1016/S0008-6215(03)00045-4
   Kahl BC, 2003, J CLIN MICROBIOL, V41, P4424, DOI 10.1128/JCM.41.9.4424-4427.2003
   KATAYAMA Y, 1988, J BIOL CHEM, V263, P15226
   Kies S, 2001, INFECT IMMUN, V69, P7933, DOI 10.1128/IAI.69.12.7933-7936.2001
   Kilstrup M, 1998, J BACTERIOL, V180, P3907
   Kim HJ, 2003, J BACTERIOL, V185, P1672, DOI 10.1128/JB.185.5.1672-1680.2003
   Kim HJ, 2002, MOL MICROBIOL, V45, P179, DOI 10.1046/j.1365-2958.2002.03003.x
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Kock H, 2004, MOL MICROBIOL, V51, P1087, DOI 10.1046/j.1365-2958.2003.03875.x
   Kreikemeyer B, 2002, INT J MED MICROBIOL, V292, P283, DOI 10.1078/1438-4221-00212
   Kruger E, 2001, EMBO J, V20, P852, DOI 10.1093/emboj/20.4.852
   Kruger E, 1997, MICROBIOL-SGM, V143, P1309, DOI 10.1099/00221287-143-4-1309
   KUUSELA P, 1978, NATURE, V276, P718, DOI 10.1038/276718a0
   LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Mack D, 2002, ANTIMICROB AGENTS CH, V46, P178, DOI 10.1128/AAC.46.1.178-183.2002
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   MACK D, 2000, HDB STUDYING BACTERI, P307
   Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   MILLER RD, 1995, NUCLEIC ACIDS RES, V23, P2339, DOI 10.1093/nar/23.12.2339
   MSADEK T, 1994, P NATL ACAD SCI USA, V91, P5788, DOI 10.1073/pnas.91.13.5788
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503
   Petersohn A, 1999, J BACTERIOL, V181, P5718
   PROCTOR RA, 1982, J BIOL CHEM, V257, P4788
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Rohde H, 2001, MED MICROBIOL IMMUN, V190, P105, DOI 10.1007/s00430-001-0099-5
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Saxild HH, 2001, J BACTERIOL, V183, P6175, DOI 10.1128/JB.183.21.6175-6183.2001
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003
   Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003
   Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TOJO M, 1988, J INFECT DIS, V158, P268
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239
   Weng ML, 2000, CURR MICROBIOL, V41, P56, DOI 10.1007/s002840010091
   WENG ML, 1995, P NATL ACAD SCI USA, V92, P7455, DOI 10.1073/pnas.92.16.7455
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI200213870
   Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035
NR 93
TC 115
Z9 126
U1 0
U2 40
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 1438-4221
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD SEP
PY 2004
VL 294
IS 2-3
BP 203
EP 212
DI 10.1016/j.ijmm.2004.06.015
PG 10
WC Microbiology; Virology
SC Microbiology; Virology
GA 859HA
UT WOS:000224252800017
PM 15493831
DA 2018-10-19
ER

EF